@@2096642699 There/EX was/VBD no/DT correlation/NN between/IN serum/NEWGENE LH/NEWGENE and/CC chronological/JJ or/CC bone/NN age/NN in/IN this/DT age/NN group/NN ,/, which/WDT suggests/VBZ that/IN the/DT correlation/NN found/VB is/VBZ not/RB due/NN to/IN age-related/JJ parallel/JJ phenomena/NNS ./.
@@79887316886 In/NN reviewing/VBG a/DT number/NN of/IN the/DT most/RB intensely/RB studied/VBN environmentally/RB inducible/NN promoters/NN it/PRP becomes/VBZ clear/JJ that/IN the/DT presence/NN of/IN two/JJ cis-acting/JJ elements/NNS are/VBP critical/JJ for/IN promoter/NN activity/NN ,/, one/PRP of/IN which/WDT is/VBZ the/DT G-box/NN (/( CCACGTGG/NEWGENE )/SYM ./.
@@2590097654 Nodular/JJ involvement/NN of/IN the/DT left/NN lung/NN and/CC infiltration/NN of/IN the/DT mucosa/NN of/IN the/DT left/NN lower/JJR lobe/NN bronchus/NN followed/VBN very/RB gradually/RB and/CC a/DT monoclonal/JJ gammopathy/NN (/( IgA--Type/NEWGENE Kappa/NEWGENE )/SYM was/VBD demonstrated/VBN ./.
@@25572178240 Beta-endorphin/NEWGENE ,/, ACTH/NEWGENE and/CC cortisol/NN secretion/NN were/VBD measured/VBN in/IN twelve/CD healthy/JJ adult/JJ males/NNS after/IN nasal/JJ spray/NN administration/NN 200/CD IU/NN salmon/NEWGENE calcitonin/NEWGENE ./.
@@86266679930 Transcription/NNS from/IN the/DT promoter/NN containing/JJ the/DT mutated/JJ direct/JJ repeats/NNS was/VBD increased/VBN greatly/RB ,/, consistent/JJ with/IN the/DT conclusion/NN that/IN these/DT motifs/NNS functions/NNS in/IN vivo/NN to/IN repress/VB GPT/NEWGENE gene/NEWGENE expression/NN ./.
@@32147093906 Fifty/CD min/NN after/IN release/NN from/IN stress/NN ,/, increases/VBZ in/IN plasma/NN corticosterone/NN levels/NNS induced/VBN by/IN stress/NN recovered/VBN in/IN the/DT biting/JJ group/NN but/CC remained/VBN high/JJ in/IN the/DT non-biting/JJ group/NN ./.
@@107042835407 Analysis/NNP of/IN 1/CD Mb/NN of/IN published/VBN sequence/NN from/IN the/DT region/NN of/IN conserved/VBN synteny/NN on/IN human/JJ chromosome/NN 5q31-q33/RB identified/VBD 45/CD gene/NN candidates/NNS ,/, including/JJ 35/CD expressed/VBN genes/NNS in/IN the/DT human/NEWGENE IL-4/NEWGENE cytokine/NEWGENE gene/NEWGENE cluster/NEWGENE ./.
@@79996047988 If/IN this/DT is/VBZ present/NN ,/, such/JJ patients/NNS should/MD be/VB closely/RB monitored/VBN ,/, and/CC any/DT atypical/JJ lesions/NNS biopsied/VBN ./.
@@74832765521 Analysis/NNP of/IN the/DT sequence/NN identified/VBN four/CD open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM which/WDT are/VBP designated/VBN UL1/NEWGENE ,/, UL2/NEWGENE ,/, UL3/NEWGENE ,/, and/CC UL3/NEWGENE ./NEWGENE 5/NEWGENE based/VBN on/IN their/PRP homology/NN with/IN proteins/NNS of/IN herpes/NN simplex/JJ virus-1/NN (/( HSV-1/NN )/SYM ,/, pseudorabies/NN virus/NN (/( PRV/NN )/SYM ,/, equine/NN herpesvirus-1/NN ,/, and/CC varicella-zoster/NN virus/NN ./.
@@113228201170 Diary/NNP ./.
@@94238562769 Protease/NEWGENE activities/NNS in/IN cultures/NNS of/IN the/DT streptococcal/JJ strains/NNS were/VBD associated/VBN with/IN species/NN of/IN different/JJ molecular/JJ masses/NNS ranging/VBG from/IN 130/CD to/IN 200/CD kDa/NN ,/, suggesting/VBG posttranslational/JJ processing/NN possibly/RB as/IN a/DT result/NN of/IN autoproteolysis/NN at/IN post-proline/JJ peptide/NN bonds/NNS in/IN the/DT N-terminal/NN parts/NNS of/IN the/DT molecules/NNS ./.
@@95222979478 Cell/NNP lines/NNS are/VBP checked/VBN to/IN find/NN out/RB whether/IN they/PRP develop/VBP tumors/NNS in/IN nude/JJ mice/NNS followed/VBN by/IN an/DT analysis/NN of/IN the/DT karyotype/NN ./.
@@113873511244 PATIENTS/IN AND/CC METHODS/IN :/: Between/IN June/NN 1991/CD and/CC December/NN 1996/CD ,/, we/PRP administered/VBD the/DT nucleoside/NN analog/NN 2-chlorodeoxyadenosine/JJ (/( 2-CDA/JJ )/SYM to/IN 73/CD children/NNS with/IN primary/JJ AML/NN and/CC 20/CD children/NNS with/IN secondary/JJ AML/NN or/CC myelodysplastic/JJ syndrome/NN (/( MDS/NN )/SYM ./.
@@17794335246 First/RB ,/, the/DT finding/NN of/IN a/DT monomeric/NEWGENE Alu/NEWGENE family/NEWGENE repeat/NEWGENE at/IN the/DT junction/NN between/IN nonhomology/JJ block/NN I/PRP and/CC homology/NN block/NN Y/NN of/IN the/DT alpha/NEWGENE 2/NEWGENE gene-containing/NEWGENE unit/NEWGENE in/NEWGENE rhesus/NEWGENE macaque/NEWGENE suggests/VBZ that/IN the/DT dimeric/NEWGENE Alu/NEWGENE family/NEWGENE repeat/NEWGENE ,/, Alu/NEWGENE 3/NEWGENE ,/, at/IN the/DT orthologous/JJ position/NN in/IN human/NN was/VBD generated/VBN by/IN insertion/NN of/IN a/DT monomeric/NEWGENE Alu/NEWGENE family/NEWGENE repeat/NEWGENE into/IN the/DT 3'/CD end/NN of/IN another/DT preexisting/JJ Alu/NEWGENE family/NEWGENE repeat/NEWGENE ./.
@@86273542069 Vertebrate/NEWGENE synapsins/NEWGENE constitute/VBP a/DT family/NN of/IN synaptic/JJ proteins/NNS that/WDT participate/VBP in/IN the/DT regulation/NN of/IN neurotransmitter/NN release/NN ./.
@@91360809326 The/DT results/NNS indicate/VBP that/DT DNA/NN methylation/NN ,/, chromatin/NN structure/NN ,/, and/CC transactivation/NN at/IN an/DT Sp1/NEWGENE site/NEWGENE contribute/VB to/IN the/DT highly/RB restricted/VBN expression/NN of/IN this/DT myelomonocytic/JJ lineage/NN specific/JJ gene/NN ./.
@@77028086820 Within-subject/NN BP/NN differences/NNS between/IN fish/NN oil/NN and/CC corn/NN oil/NN treatment/NN were/VBD similar/JJ for/IN Dinamap/NN (/( 3/CD ./CD 2/CD +/NN //NN -/NN 1/CD ./CD 8/CD //CD 2/CD ./CD 5/CD +/NN //NN -/NN 1/CD ./CD 0/CD mm/NN Hg/NN )/SYM and/CC for/IN 24-h/JJ ABP/NN (/( 2/CD ./CD 5/CD +/NN //NN -/NN 1/CD ./CD 0/CD //CD 2/CD ./CD 3/CD +/NN //NN -/NN 0/CD ./CD 8/CD mm/NN Hg/NN )/SYM ,/, but/CC were/VBD more/RB significant/JJ with/IN the/DT latter/NN ./.
@@1684312283 Steroid/NN glucuronides/NNS in/IN amniotic/JJ fluid/NN at/IN term/NN ./.
@@10866677936 Phd/NEWGENE antibody-immunoreactive/NN peptides/NN are/VBP seen/VBP in/IN light-adapted/JJ mouse/NN retinal/JJ cytosolic/JJ and/CC nuclear/JJ extracts/NNS ./.
@@23925113051 Serotonin/NEWGENE 5-HT2/NEWGENE receptor/NEWGENE binding/JJ on/IN blood/NN platelets/NNS as/IN a/DT state/JJ dependent/JJ marker/NN in/IN major/JJ affective/JJ disorder/NN ./.
@@15251535055 By/IN contrast/NN ,/, d/NN (/NN T2AG3T/NN )/NN and/CC d/NN (/NN T2G4T/NN )/NN form/NN only/RB the/DT G-quadruplex/NN monomer/NN structures/NNS independent/NN of/IN K/NN cation/NN concentration/NN as/IN reported/VBN previously/RB [/NN Sen/NN ,/, D/NN ./NN ,/, &/CC Gilbert/NNP ,/, W/NN ./NN
@@96351497506 Hematocrit/NNS and/CC PaO2/NN did/VBD not/RB change/VB ./.
@@62339242343 Fibrin/NEWGENE gels/NNS and/CC their/PRP possible/JJ implication/NN for/IN surface/NN hemorheology/NN in/IN health/NN and/CC disease/NN ./.
@@77178237671 Standard/NNP reference/NN sources/NNS indicate/VBP that/IN an/DT able-bodied/JJ 11-year-old/NN child/NN of/IN comparable/JJ height/NN requires/VBZ 1/CD ,/CD 493/CD kcal/NN //NN d/NN for/IN support/NN of/IN basal/JJ metabolic/JJ functions/NNS ./.
@@104670048046 The/DT intron/NN RNA/NN consists/VBZ of/IN 2492/CD nucleotides/NNS which/WDT can/MD be/VB folded/JJ into/IN a/DT secondary/JJ structure/NN with/IN all/PDT the/DT expected/VBN sequence/NN motifs/NNS of/IN subgroup-IIA1/NN introns/NNS (/( Michel/NNP et/FW al/NNS ./NNS
@@107867425796 In/NN the/DT control/NN group/NN ,/, platelet/NN markers/NN increased/VBN 1/CD h/NN after/IN surgery/NN ./.
@@3004364413 It/PRP was/VBD also/RB suggested/VBN that/IN the/DT biological/JJ activities/NNS of/IN 5-FU/JJ ,/, ADM/NNS and/CC MMC/NN in/IN FAMLIP/NNP were/VBD stable/JJ in/IN FULIP/NN ,/, ADRLIP/NN and/CC MMCLIP/NN ./.
@@86199108593 The/DT neural/JJ mechanism/NN of/IN parkinsonian/JJ motor/JJ symptoms/NNS ,/, i/FW ./FW e/FW ./FW ,/, rigidity/NN ,/, tremor/NN and/CC akinesia/NN ,/, which/WDT are/VBP the/DT result/NN of/IN nigrostriatal/JJ dopamine/NN deficiency/NN ,/, is/VBZ interpreted/VBN from/IN long-term/JJ observations/NNS on/IN the/DT effect/NN of/IN surgical/JJ and/CC pharmacological/JJ treatment/NN of/IN the/DT disease/NN in/IN relation/NN to/IN the/DT neuropathological/JJ findings/NNS within/IN the/DT substantia/NN nigra/NN zona/NN compacta/NN (/( SNc/NNS )/SYM ./.
@@25627878506 We/PRP have/VBP designated/VBN the/DT protein/NN "cellular/NEWGENE NBP"/NEWGENE (/( CNBP/NEWGENE )/SYM ./.
@@63970094264 After/IN description/NN of/IN his/PRP short/JJ life/NN and/CC an/DT explanation/NN of/IN the/DT light/NN conductor/NN Bozzini's/NN merit/NN is/VBZ emphasized/VBN ,/, by/IN his/PRP invention/NN as/IN first/JJ physician/NN to/IN have/NN made/VBP accessible/JJ to/IN medicine/NN endoscopic/JJ diagnostic/JJ possibilities/NNS ./.
@@20120972623 Paroxysmal/JJ fluctuations/NNS in/IN observed/VBN parasitemia/NN in/IN Plasmodium/NN falciparum/NN malaria/NN ./.
@@39117024564 We/PRP have/VBP earlier/RBR evolved/VBN an/DT experimental/JJ model/NN by/IN means/NN of/IN which/WDT changes/NNS identical/JJ to/IN the/DT microembolism/NN syndrome/NN can/MD be/VB induced/VBN from/IN a/DT reproducible/JJ musculo-skeletal/JJ trauma/NN in/IN pigs/NNS observed/VBN under/IN long-term/JJ anesthesia/NN under/IN standardized/JJ conditions/NNS ./.
@@23538752958 The/DT results/NNS suggest/VBP followings--1/NN )/NN both/DT eosinophils/NNS and/CC neutrophils/NNS participate/VB in/IN hypersecretion/NN of/IN type/NN Ib/NN in/IN atopic/JJ cases/NNS ,/, and/CC only/JJ eosinophils/NNS in/IN non-atopic/JJ cases/NNS ./.
@@115895683648 In/NN budding/JJ yeast/NN ,/, this/DT latter/JJ checkpoint/NN response/NN involves/VBZ the/DT proteins/NN Mad1/NEWGENE ,/NEWGENE 2/NEWGENE ,/NEWGENE 3/NEWGENE ,/, Bub1/NEWGENE and/CC Bub3/NEWGENE ,/, whose/WP vertebrate/JJ counterparts/NNS localize/VBP to/IN unattached/JJ kinetochores/NNS ./.
@@80982282954 A/DT transcript/NN of/IN about/RB 2/CD kb/NN is/VBZ expected/VBN for/IN each/DT PPO/NEWGENE ./.
@@115801738777 Plane/NNP wave/NN geometry/NN is/VBZ impractical/JJ for/IN clinical/JJ use/NN but/CC the/DT results/NNS of/IN this/DT work/NN encouraged/VBD us/PRP to/IN further/RB develop/VB the/DT P3/NN approximation/NN for/IN a/DT spherical/JJ geometry/NN ,/, described/VBN in/IN this/DT paper/NN ./.
@@105128576964 In/NN Wnt/NEWGENE signaling/JJ ,/, beta-catenin/NEWGENE and/CC plakoglobin/NEWGENE transduce/VB signals/NNS to/IN the/DT nucleus/NN through/JJ interactions/NNS with/IN TCF-type/NEWGENE transcription/NEWGENE factors/NEWGENE ./.
@@99647709962 Microstructure/NNS and/CC conductivity/NN of/IN hierarchical/JJ laminate/NN composites/NNS ./.
@@8543173879 There/EX is/VBZ no/DT TATA/NN box/NN around/IN the/DT transcriptional/JJ start/NN points/NNS (/( tsp/NN )/SYM ,/, as/IN determined/VBN by/IN primer/NN extension/NN analysis/NN ./.
@@112143547421 VE-DEF/NN animals/NNS had/VBP significantly/RB higher/JJ (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM levels/NNS of/IN myocardial/JJ lipid/NN peroxidation/NN and/CC lower/JJR (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM protein/NN thiols/NNS following/IN I-R/DT compared/VBN to/IN the/DT CON/NN animals/NNS ./.
@@98917079893 Five/CD different/JJ subtypes/NNS of/IN spondyloarthropathy/NN (/( SpA/NNP )/SYM are/VBP now/RB recognized/VBN ./.
@@5640325618 Changes/NNS in/IN ionic/JJ content/NN of/IN the/DT mucous/JJ suggest/VB that/IN cholinergic/JJ mechanisms/NNS affect/VBP pressure/NN in/IN the/DT excretory/JJ duct/NN of/IN the/DT gland/NN ./.
@@107645741587 Application/NNP of/IN the/DT method/NN to/IN a/DT representative/JJ set/NN of/IN 50/CD known/VBP genes/NNS from/IN Arabidopsis/NN thaliana/NN showed/VBD significant/JJ improvement/NN in/IN prediction/NN accuracy/NN compared/VBN to/IN previous/RB spliced/VBN alignment/NN methods/NNS ./.
@@118599431748 All/DT adults/NNS attending/VBG the/DT outpatient/NN clinics/NNS of/IN a/DT dermatological/JJ hospital/NN on/IN predetermined/JJ days/NNS were/VBD given/VBP the/DT 12-item/NNP General/NNP Health/NNP Questionnaire/NN ./.
@@23124702961 The/DT BAL-to-plasma/NNP specific/JJ activity/NN of/IN urea/NN was/VBD about/RB twice/RB that/IN of/IN Na+/NN ,/, indicating/VBG that/DT urea/NN diffused/VBN into/IN the/DT ELF/NN more/RB rapidly/RB than/IN Na+/NN during/IN the/DT 70/CD s/NN that/IN elapsed/VBN between/IN the/DT time/NN the/DT radioactive/JJ urea/NN and/CC Na+/NN were/VBD injected/VBN into/IN the/DT circulation/NN and/CC the/DT time/NN when/CC lavage/NN was/VBD complete/JJ ./.
@@109586739375 This/DT intracellular/JJ signaling/NN ,/, known/VBP as/IN the/DT unfolded/JJ protein/NN response/NN (/( UPR/NN )/SYM ,/, is/VBZ mediated/JJ by/IN the/DT cis-acting/JJ ER/NEWGENE stress/NEWGENE response/NEWGENE element/NEWGENE (/( ERSE/NEWGENE )/SYM in/IN mammals/NNS ./.
@@35670171135 Multiple/NNP dosing/VBG four/CD times/NNS daily/JJ for/IN 7/CD days/NNS of/IN indoprofen/NN 200/CD mg/NN ,/, a/DT non-steroidal/JJ anti-inflammatory/JJ drug/NN with/IN a/DT short/JJ half-life/NN (/( t1/NN //NN 2/NN )/SYM ,/, revealed/VBN drug/NN accumulation/NN in/IN eight/CD elderly/JJ subjects/NNS ./.
@@111327902346 The/DT standard/JJ method/NN for/IN calculating/JJ the/DT composite/JJ score/NN on/IN the/DT S-B/NN IV/NN excludes/VBZ subtests/NNS with/IN a/DT raw/JJ score/NN of/IN 0/CD ,/, which/WDT overestimates/VBZ cognitive/JJ functioning/NN in/IN young/JJ biologically/RB high/JJ risk/NN children/NNS ./.
@@33119543922 A/DT multicentre/JJ study/NN involving/VBG 9/CD Italian/JJ institutions/NNS was/VBD carried/VBN out/RB to/IN compare/NN the/DT efficacy/NN and/CC safety/NN of/IN ranitidine/NN 150/NN mg/NN b/CD ./CD i/CD ./CD d/CD ./. and/CC ranitidine/NN 300/NN mg/NN nocte/NN in/IN the/DT treatment/NN of/IN reflux/JJ oesophagitis/NN ./.
@@117083621549 The/DT astronaut/NN crew/NN operates/VBZ the/DT payload/NN and/CC documents/NNS its/PRP operation/NN ./.
@@85296307829 Stems/NNS contain/VBP distinctly/RB less/PRP P/NEWGENE protein/NEWGENE mRNA/NEWGENE and/CC the/DT relative/JJ level/NN in/IN roots/NNS is/VBZ very/RB low/JJ but/CC still/RB clearly/RB detectable/JJ ./.
@@110940913441 The/DT activity/NN of/IN the/DT transcription/NEWGENE factor/NEWGENE CREB/NEWGENE is/VBZ regulated/VBN by/IN extracellular/JJ stimuli/NNS that/WDT result/VBP in/IN its/PRP phosphorylation/NN at/IN a/DT critical/JJ serine/NN residue/NN ,/, Ser133/NN ./.
@@82934124838 A/DT randomized/JJ ,/, multicenter/JJ study/NN comparing/VBG the/DT efficacy/NN and/CC tolerability/NN of/IN tropisetron/NN ,/, a/DT new/JJ 5-HT3/NEWGENE receptor/NEWGENE antagonist/NN ,/, with/IN a/DT metoclopramide-containing/JJ antiemetic/JJ cocktail/NN in/IN the/DT prevention/NN of/IN cisplatin-induced/JJ emesis/NN ./.
@@77999502669 In/NN studies/NNS of/IN many/JJ different/JJ phenotypically/RB distinct/JJ cells/NNS ,/, the/DT CRE/NEWGENE of/IN the/DT somatostatin/NEWGENE gene/NEWGENE promoter/NEWGENE is/VBZ a/DT prototype/NN of/IN a/DT highly/RB cAMP-responsive/NEWGENE element/NEWGENE regulated/VBN by/IN CREB/NEWGENE ./.
@@3909324560 Capsular/JJ antigens/NNS of/IN Staphylococcus/NN aureus/NN ./.
@@114147545139 Copyright/NNP 2001/CD Academic/NNP Press/NNP ./.
@@7027736805 Althoug/DT RBF/NN tended/VBN to/IN increase/NN after/IN the/DT therapy/NN ,/, there/RB was/VBD no/DT statistically/RB significant/JJ change/NN in/IN RBF/NN ,/, GFR/NN and/CC cardiac/JJ output/NN ./.
@@91942508267 We/PRP suggest/VBP that/IN apart/RB from/IN the/DT World/NNP Summit/NNP for/IN Children's/NNP under-five/NN mortality/NN target/NN for/IN the/DT year/NN 2000/CD ,/, intraregional/NN targets/NN to/IN reduce/VB geographical/JJ inequalities/NNS in/IN under-five/NN mortality/NN should/MD be/VB specified/VBN ./.
@@29818406385 A/DT 114-base/JJ pair/NN sequence/NN of/IN predominantly/RB repeating/JJ purine-pyrimidine/NN nucleotides/NN separates/VBZ these/DT two/JJ d/NN (/NN AC/NN )/NN repeats/NNS ./.
@@89484403383 The/DT ERH/NEWGENE expression/NN profile/NN is/VBZ similar/JJ ,/, to/IN that/DT of/IN An3/NEWGENE ,/, which/WDT localizes/VBZ to/IN the/DT animal/NN hemisphere/NN of/IN oocytes/NNS and/CC is/VBZ abundantly/RB expressed/VBN in/IN the/DT embryo/NN ./.
@@19227397546 It/PRP was/VBD found/VBN that/IN the/DT ROSP/NN undergoes/VBZ a/DT number/NN of/IN fluctuations/NNS in/IN the/DT negative/JJ and/CC positive/JJ directions/NNS with/IN a/DT gradually/RB decreasing/JJ amplitude/NN in/IN the/DT course/NN of/IN 5-25/JJ days/NNS following/IN the/DT operation/NN ,/, after/IN which/WDT relatively/JJ stable/JJ negative/JJ values/NNS of/IN the/DT ROSP/NN are/VBP established/VBN on/IN the/DT average/NN in/IN electrodes/NNS implanted/VBN to/IN the/DT level/NN of/IN the/DT dura/NN mater/JJ ,/, and/CC positive/JJ values/NNS in/IN electrodes/NNS implanted/VBN to/IN the/DT level/NN of/IN the/DT pia/NN mater/NN ./.
@@113526638106 By/IN comparison/NN ,/, in/IN nontumorigenic/JJ Ad5/IN cells/NNS ,/, class/NEWGENE I/NEWGENE expression/NN is/VBZ high/JJ due/NN to/IN negligible/JJ binding/NN of/IN COUP-TF/NEWGENE and/CC strong/JJ binding/NN of/IN NF-kappaB/NEWGENE ./.
@@83876627857 After/IN surgery/NN ,/, patients/NNS self/NN administered/VBN one/PRP of/IN three/CD possible/JJ postsurgical/JJ medications/NNS ,/, which/WDT included/VBD placebo/NN ,/, codeine/NN 60/NN mg/NN ,/, and/CC ibuprofen/NN 400/CD mg/NN ,/, when/CC their/PRP pain/NN reached/VBD a/DT moderate/JJ or/CC severe/JJ intensity/NN ./.
@@85535801365 A/DT short/JJ open/JJ reading/JJ frame/NN (/( ORF2/NN )/SYM ,/, of/IN unknown/JJ function/NN ,/, is/VBZ present/VB in/IN all/DT FIV/NN isolates/NNS ./.
@@15465222156 Probable/JJ progressive/JJ multifocal/JJ leukoencephalopathy/NN (/( PML/NN )/SYM was/VBD diagnosed/VBN on/IN the/DT basis/NN of/IN clinical/JJ picture/NN and/CC magnetic/JJ resonance/NN imaging/JJ in/IN a/DT 63-year-old/JJ man/NN with/IN a/DT complete/JJ remission/NN of/IN a/DT non-Hodgkin's/JJ lymphoma/NN ./.
@@94369894593 Perhaps/RB in/IN addition/NN to/IN ,/, or/CC as/IN part/NN of/IN ,/, its/PRP essential/JJ function/NN in/IN late/JJ mitosis/NN ,/, MOB1/NEWGENE is/VBZ required/VBN for/IN a/DT cell/NN cycle/NN reset/NN function/NN necessary/JJ for/IN the/DT initiation/NN of/IN the/DT spindle/NN pole/NN body/NN duplication/NN ./.
@@37663706493 High/NNP radial/JJ r/JJ values/NNS with/IN small/JJ standard/JJ deviations/NNS were/VBD observed/VBN in/IN normal/JJ LV/NN (/( 0/CD ./CD 972/CD +/NN //NN -/NN 0/CD ./CD 016/CD )/SYM and/CC in/IN non-MI/JJ regions/NNS (/( 0/CD ./CD 964/CD +/NN //NN -/NN 0/CD ./CD 018/CD )/SYM ,/, indicating/VBG temporally/RB homogeneous/JJ radial/JJ shortening/NN ./.
@@114411631314 Foreigners/NNS return/NN ./.
@@87392608726 Catha/NN edulis/NN ,/, a/DT plant/NN that/WDT has/VBZ amphetamine/NN effects/NNS ./.
@@99958972616 Observation/NNS of/IN dipolar/JJ interactions/NNS between/IN Pb0/NNP defects/NNS at/IN the/DT (/( 111/CD )/SYM Si/NN //NN SiO2/NN interface/NN ./.
@@11595813291 Peripheral/JJ metabolism/NN of/IN androgens/NNS takes/VBP place/NN in/IN various/JJ areas/NNS within/IN the/DT pilosebaceous/JJ unit/NN ,/, as/IN indicated/VBN by/IN local/JJ differences/NNS in/IN the/DT activities/NNS of/IN aromatase/NEWGENE ,/, 5alpha-reductase/NEWGENE as/NNP well/VB as/IN of/IN the/DT presence/NN of/IN the/DT androgen/NEWGENE receptors/NEWGENE ./.
@@13957552007 Consequently/RB ,/, significant/JJ differences/NNS between/IN the/DT measured/VBN and/CC calculated/VBN methods/NNS were/VBD noted/VBN in/IN oxygen/NN uptake/NN (/( 213/CD +/NN //NN -/NN 41/CD ml/NNP //NNP min/NNP vs/NNP 193/CD +/NN //NN -/NN 25/CD ml/NN //NN min/NN ,/, p/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, oxygen/NN delivery/NN (/( 780/CD +/NN //NN -/NN 297/CD ml/NNP //NNP min/NNP vs/NNP 716/NN +/NN //NN -/NN 296/CD ml/NN //NN min/NN ,/, p/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, and/CC cardiac/JJ output/NN (/( 5/CD ./CD 8/CD +/NN //NN -/NN 2/CD ./CD 2/CD L/NNP //NNP min/NNP vs/NNP 5/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 8/CD L/NNS //NNS min/NNS ,/, p/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@99173911839 Transcription/NNS readthrough/NN into/IN the/DT inverted/JJ repeats/NNS has/VBZ little/JJ effect/NN on/IN this/DT event/NN ./.
@@34006944298 PATIENTS/IN and/CC METHODS/IN :/: Thallium-201/NN myocardial/JJ scintigraphy/NN was/VBD performed/VBN at/IN rest/NN and/CC after/IN 0/CD ./CD 56/CD mg/CD //CD kg/CD intravenous/JJ dipyridamole/NN during/IN four/CD minutes/NNS in/IN 16/CD patients/NNS with/IN sarcoidosis/NN ./.
@@8417330785 Previously/RB ,/, we/PRP identified/VBD a/DT 51-bp/JJ promoter/NN fragment/NN ,/, oligo31/NEWGENE //NEWGENE 32/NEWGENE ,/, which/WDT conferred/VBD heat/NN shock/NN inducibility/NN on/IN the/DT heterologous/JJ CYC1-lacZ/NEWGENE reporter/NEWGENE gene/NEWGENE in/IN S/NNP ./NNP cerevisiae/NN (/( N/NNP ./NNP
@@114860329611 Among/IN the/DT transcription/NN factors/NNS known/VBP to/IN interact/VB with/IN Groucho-related/NEWGENE protein/NEWGENE ,/, only/RB RUNX1/NEWGENE was/VBD appreciably/RB downregulated/VBN by/IN E2A-HLF/NEWGENE ./.
@@97554782009 Northern/NNP analysis/NN revealed/VBD no/DT detectable/JJ expression/NN of/IN the/DT transcript/NN in/IN diapause-/JJ or/CC nondiapause-programmed/JJ wandering/JJ larvae/NNS ,/, and/CC only/JJ trace/NN expression/NN in/IN nondiapausing/JJ pupae/NNS ./.
@@78606467952 Such/JJ an/DT intervention/NN may/MD be/VB of/IN considerable/JJ use/NN for/IN the/DT treatment/NN of/IN angiogenesis-dependent/JJ diseases/NNS involving/VBG FGF-2/NEWGENE ./.
@@10090146800 Differential/JJ expression/NN of/IN AP-2alpha/NEWGENE and/CC AP-2beta/NEWGENE in/IN the/DT developing/JJ chick/NN retina/NN :/: repression/NN of/IN R-FABP/NEWGENE promoter/NEWGENE activity/NN by/IN AP-2/NEWGENE ./.
@@929109864 A/DT specific/JJ distal/JJ promoter/NN controls/NNS gamma-glutamyl/NEWGENE transpeptidase/NEWGENE gene/NEWGENE expression/NN in/IN undifferentiated/JJ rat/NN transformed/VBD liver/NN cells/NNS ./.
@@84009281131 INTERVENTIONS--Patients/NNS allocated/VBN to/IN treatment/NN with/IN levodopa/NEWGENE //NEWGENE dopa/NEWGENE decarboxylase/NEWGENE inhibitor/NN alone/RB (/( arm/NN 1/CD )/SYM ,/, levodopa/NEWGENE //NEWGENE decarboxylase/NEWGENE inhibitor/NN //NN selegiline/NN in/IN combination/NN (/( arm/NN 2/CD )/SYM ,/, or/CC bromocriptine/NN (/( arm/NN 3/CD )/SYM ./SYM
@@13836951378 We/PRP analyzed/VBD an/DT EBV/NN B-cell/NN clone/NN ,/, E29/NN ./NN 1/NN ,/, derived/VBN from/IN an/DT 11/CD week-old/JJ embryo/NN ,/, and/CC secreting/JJ both/DT IgM/NEWGENE kappa/NEWGENE and/CC IgM/NEWGENE lambda/NEWGENE ./.
@@33724223554 The/DT maximum/JJ deflections/NNS of/IN phase/NN IV/NN for/IN Ar/NN and/CC N2/NN from/IN extrapolated/VBN phase/NN III/NNP slopes/NNS were/VBD smaller/JJR in/IN the/DT prone/JJ position/NN ,/, suggesting/VBG more/RB uniform/JJ tracer/NN gas/NN concentrations/NNS across/IN the/DT lungs/NNS ./.
@@65423726333 The/DT present/NN paper/NN elucidates/VBZ the/DT existing/JJ discrepancies/NNS ,/, and/CC offers/VBP a/DT consistent/JJ terminology/NN incorporating/JJ also/RB such/JJ terms/NNS as/IN "additivity"/NN ,/, "potentiation"/NN ,/, and/CC "simple/NN similarity"/NN ./.
@@88247988505 Human/NEWGENE ESP1/NEWGENE //NEWGENE CRP2/NEWGENE protein/NEWGENE has/VBZ two/JJ LIM/NEWGENE domains/NEWGENE ,/, and/CC each/DT shares/NN 35/CD ./CD 1%/CD and/CC 77/CD or/CC 79%/CD identical/JJ residues/NNS with/IN human/NEWGENE cysteine-rich/NEWGENE protein/NEWGENE (/( CRP/NEWGENE )/SYM and/CC rat/NEWGENE CRIP/NEWGENE ,/, respectively/RB ./.
@@2123300447 Human/NNP recombinant/JJ DNA-derived/JJ antihemophilic/NEWGENE factor/NEWGENE (/( factor/NEWGENE VIII/NEWGENE )/SYM in/IN the/DT treatment/NN of/IN hemophilia/NN A/NNP ./NNP recombinant/JJ Factor/NEWGENE VIII/NEWGENE Study/NNP Group/NNP ./.
@@115759771460 However/RB ,/, patients/NNS with/IN isolated/VBN office/NN hypertension/NN had/VBP fewer/DT previous/JJ cardiovascular/JJ complications/NNS ./.
@@24036344664 Sequence/NN analysis/NN indicates/VBZ that/IN in/IN addition/NN to/IN an/DT ATA/NN and/CC GC/NN box/NN ,/, this/DT region/NN contains/VBZ domains/NNS that/WDT have/VBP been/VBN implicated/VBN in/IN the/DT regulation/NN of/IN other/DT muscle-specific/NN genes/NN :/: a/DT CArG/NN box/NN at/IN -91/CD bp/NN ;/: myocyte-specific/NEWGENE enhancer-binding/NEWGENE nuclear/NEWGENE factor/NEWGENE 1/NEWGENE binding/NEWGENE site/NEWGENE homologies/NNS at/IN -58/CD ,/, -535/JJ ,/, and/CC -583/JJ bp/NN ;/: and/CC a/DT muscle-CAAT/NN consensus/NN sequence/NN at/IN -394/CD bp/NN relative/JJ to/IN the/DT cap/NN site/NN ./.
@@10472836313 Feed/VB intake/NN and/CC BW/NN gains/NNS were/VBD decreased/VBN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM by/IN dietary/JJ treatments/NNS containing/JJ M/NNP ./NNP
@@85950126414 In/NN nondiabetics/NNS the/DT response/NN of/IN tcPO2/NN but/CC not/RB of/IN LDF/NN was/VBD influenced/VBN by/IN the/DT values/NNS at/IN rest/NN ./.
@@87074243708 The/DT expression/NN of/IN ERV3/NEWGENE env/NEWGENE mRNA/NEWGENE was/VBD found/VBN to/IN be/VB differentiation-associated/JJ ,/, with/IN high/JJ expression/NN detected/VBN in/IN the/DT late/JJ stages/NNS of/IN monocytic/JJ development/NN ./.
@@87633112 Phenylephrine/WDT is/VBZ a/DT pure/JJ alpha-1/NEWGENE adrenoreceptor/NEWGENE agonist/NN known/VBP to/IN produce/NN marked/JJ systemic/JJ vasoconstriction/NN and/CC associated/VBN hypertension/NN with/IN occasional/JJ profound/JJ reflex/NN bradycardia/NN ./.
@@70901514663 Before/IN turnout/NN ,/, a/DT morantel/NN sustained/JJ release/NN bolus/NN (/( MSRB/NN )/SYM was/VBD administered/VBN to/IN each/DT animal/NN in/IN the/DT "treated"/NN category/NN ./.
@@72772227133 Similar/JJ waves/NNS were/VBD seen/VBP on/IN cross-correlating/PDT a/DT motor/JJ unit/NN with/IN an/DT electronic/JJ oscillator/NN ,/, confirming/VBG that/IN their/PRP occurrence/NN does/VBP not/RB necessarily/RB demonstrate/VB the/DT existence/NN of/IN active/JJ neural/JJ interactions/NNS ./.
@@63047719825 Another/DT sequence/NN ,/, GGGXGGAG/NEWGENE ,/, which/WDT is/VBZ repeated/VBN several/DT times/NNS in/IN many/JJ polyomaviruses/NNS and/CC adenoviruses/NNS ,/, and/CC which/WDT is/NNS thought/VBP to/IN play/NN a/DT role/NN in/IN DNA/NN replication/NN and/DT //DT or/DT transcription/NN ,/, is/VBZ not/RB found/VB in/IN the/PDT JCV/NEWGENE sequence/NEWGENE presented/VBN ./.
@@30195053731 Five/CD patients/NNS developed/VBD metastatic/JJ spread/NN ,/, and/CC all/DT of/IN them/PRP died/VBD of/IN tumor/NN ./.
@@35829826044 A/DT study/NN of/IN human/JJ genes/NNS coding/JJ for/IN U4/NEWGENE small/NEWGENE nuclear/NEWGENE RNA/NEWGENE is/VBZ presented/VBN ./.
@@82537771564 A/DT cAMP/NEWGENE response/NEWGENE element/NEWGENE (/( CRE/NEWGENE )/SYM consensus/NN signal/NN was/VBD identified/VBN in/IN the/DT 5'-noncoding/JJ region/NN ./. cAMP/NN regulates/VBZ the/DT expression/NN of/IN Kv1/NEWGENE ./NEWGENE 5/NEWGENE gene/NEWGENE in/IN a/DT cell-specific/JJ manner/NN ./.
@@62771596071 A/DT hypothesis/NN ./.
@@76246158895 Acute/JJ decrease/NN in/IN body/NN temperature/NN (/( TB/NN )/SYM lowered/VBN PaCO2/NN (/( 32/CD ./CD 5/CD to/IN 14/CD ./CD 5/CD mmHg/NN )/SYM and/CC [/NN HCO3-/NN ]/NN a/NN (/NN 24/NN ./NN 20/NN mEq/NN //NN L/NN to/IN 17/CD ./CD 56/CD mEq/NN //NN L/NN )/NN ,/, increased/VBN pHa/NN (/( 7/CD ./CD 481/CD to/IN 7/CD ./CD 608/CD )/SYM and/CC diminished/VBD the/DT [/NN OH-/NN ]/NN //NN [/NN H+/NN ]/NN ratio/NN ,/, but/CC had/VBP no/DT significant/JJ effect/NN on/IN [/NN SID/NN ]/NN or/CC [/NN Atot/NN ]/NN ,/, although/IN both/DT total/JJ phosphorus/NN [/NN PT/NN ]/NN and/CC inorganic/JJ phosphate/NN [/NN Pi/NN ]/NN increased/VBN ./.
@@89128077086 However/RB ,/, the/DT truncated/JJ deer/NEWGENE receptor/NEWGENE lacks/VBZ the/DT most/JJ C-terminal/NN tyrosine/NN residue/NN in/IN the/DT intracellular/JJ domain/NN which/WDT is/VBZ believed/VBN to/IN be/VB essential/JJ for/IN activation/NN of/IN the/DT beta-casein/NEWGENE promoter/NEWGENE ./.
@@114206128149 As/IN a/DT complement/NN to/IN genome-wide/JJ mapping/NN and/CC sequencing/VBG efforts/NNS ,/, it/PRP is/VBZ often/RB important/JJ to/IN generate/VB detailed/JJ maps/NNS and/CC sequence/NN data/NN for/IN specific/JJ regions/NNS of/IN interest/NN ./.
@@70620362799 Rats/NNP underwent/VBD either/DT a/DT 90-95%/CD JIB/NN or/CC a/DT sham/NN operation/NN ./.
@@29698197911 Ig/NEWGENE D-JH/NEWGENE recombinations/NNS may/MD precede/VB TcR/NEWGENE gene/NEWGENE recombination/NN in/IN these/DT early/JJ T/NN cell/NN lines/NNS ,/, and/CC some/DT but/CC not/RB all/DT express/JJ sterile/JJ Cmu/NEWGENE transcripts/NEWGENE ./.
@@98029024662 We/PRP have/VBP previously/RB shown/VBP that/IN ARNO/NEWGENE localizes/VBZ to/IN the/DT plasma/NN membrane/NN in/IN vivo/NN and/CC efficiently/RB catalyzes/VBZ ARF6/NEWGENE nucleotide/NN exchange/NN in/IN vitro/FW ./.
@@95360289996 In/NN contrast/NN ,/, the/DT contractile/JJ action/NN of/IN arachidonic/JJ acid/NN ,/, via/NN a/DT presumed/VBN cyclooxygenase/NEWGENE product/NN that/IN mediated/JJ the/DT contractions/NNS caused/VBN by/IN both/DT TF/NEWGENE and/CC EGF/NEWGENE ,/, was/VBD not/RB blocked/VBN by/IN any/DT of/IN the/DT signal/JJ pathway/NN probe/NN inhibitors/NNS ./.
@@14686257706 Among/IN these/DT ,/, ACT1/NEWGENE was/VBD isolated/VBN four/CD times/NNS ,/, and/CC NSR1/NEWGENE three/CD times/NNS ./.
@@29858124260 An/DT unusual/JJ feature/NN of/IN these/DT replicative/JJ genes/NNS is/VBZ that/IN the/DT smaller/JJR mRNA/NN begins/VBZ within/IN a/DT long/JJ open/JJ reading/JJ frame/NN of/IN the/DT larger/JJR mRNA/NN ./.
@@83967499159 LDL/NN cholesterol/NN decreased/VBN from/IN 4/CD ./CD 74/CD +/NN //NN -/NN 0/CD ./CD 87/CD to/IN 3/CD ./CD 78/CD +/NN //NN -/NN 0/CD ./CD 78/CD mmol/NN //NN l/NN after/IN 8/CD weeks/NNS on/IN simvastatin/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, and/CC apo/NEWGENE B/NEWGENE fell/NN from/IN 142/CD +/NN //NN -/NN 31/CD to/IN 112/CD +/NN //NN -/NN 22/CD mg/NN //NN dl/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@105025224138 Defective/JJ provirus/NN genomes/NNS of/IN human/JJ T-cell/NN leukemia/NN virus/NN type/NN I/NN are/VBP frequently/RB detected/VBN in/IN lymphocytes/NNS from/IN infected/VBN individuals/NNS and/CC in/IN infected/VBN cell/NN lines/NNS ./.
@@98723268434 Further/RB ,/, we/PRP show/VBP that/IN this/DT EIA-inducible/NEWGENE CBF/NEWGENE //NEWGENE cdc2/NEWGENE is/VBZ related/VBN to/IN the/DT CBF/NEWGENE which/WDT was/VBD shown/VBP to/IN activate/VB the/DT heat/NEWGENE shock/NEWGENE protein/NEWGENE 70/NEWGENE promoter/NEWGENE ./.
@@86276887122 This/DT result/NN suggested/VBN that/IN mutant/NEWGENE I299/NEWGENE has/VBZ diminished/VBN cap-binding/JJ activity/NN ./.
@@39122474567 The/DT volume/NN of/IN blood/NN to/IN the/DT flap/NN ranges/NNS from/IN 1/CD to/IN 2/CD ml/NN //NN min/NN ,/, collateral/JJ circulation/NN to/IN the/DT flap/NN exists/VBZ ,/, but/CC is/VBZ negligible/JJ ,/, and/CC there/RB is/VBZ little/JJ change/NN in/IN the/DT capillary/JJ blood/NN flow/NN as/IN the/DT flap/NN ages/NNS ./.
@@77607907664 Serum/NN induction/NN of/IN a/DT MEF2/NEWGENE reporter/NEWGENE gene/NEWGENE was/VBD not/RB observed/VBN in/IN a/DT line/NN of/IN NIH/NN 3T3/CD cells/NNS which/WDT contain/VBP low/JJ MEF2/NEWGENE site/NEWGENE binding/JJ activity/NN ./.
@@1007180671 The/DT rate/NN of/IN resectability/NN is/VBZ low/JJ and/CC 5-year/JJ survival/NN is/VBZ very/RB poor/JJ ./.
@@79343317902 A/DT simple/JJ registration/NN as/IN an/DT incentive/NN for/IN improvement/NN ./.
@@21238209151 Effects/NNPS of/IN a/DT selective/JJ monoamine/NEWGENE oxidase/NEWGENE (/NEWGENE MAO/NEWGENE )/NEWGENE --A/NEWGENE inhibitor/NN ,/, clorgyline/NN ,/, a/DT selective/JJ MAO-B/NEWGENE inhibitor/NN ,/, deprenyl/NN ,/, and/CC a/DT non-selective/JJ MAO/NEWGENE inhibitor/NN ,/, nialamide/NN ,/, were/VBD investigated/VBN on/IN footshock-induced/JJ aggression/NN (/( FIA/NN )/SYM in/IN paired/JJ rats/NNS ./.
@@15266582270 IFI/NEWGENE 16/NEWGENE mRNA/NEWGENE was/VBD found/VBN to/IN be/VB constitutively/RB expressed/VBN in/IN lymphoid/JJ cells/NNS and/CC in/IN cell/NN lines/NNS of/IN both/PDT the/DT T/NN and/CC B/NNP lineages/NNS ./.
@@27797524594 1-/NN (/NN 1-Naphthyl/NN )/NN piperazine/NN (/( 1-NP/JJ )/SYM has/VBZ been/VBN reported/VBN to/IN have/NN serotonin/NN antagonist/NN properties/NNS at/IN the/DT 5-HT2/NEWGENE subtype/NEWGENE of/IN receptor/NN ,/, and/CC it/PRP has/VBZ been/VBN suggested/VBN that/IN it/PRP may/MD have/VB agonist/NN actions/NNS at/IN the/DT 5-HT1/NEWGENE site/NEWGENE ./.
@@33315253634 "In/NN vitro"/NN study/NN of/IN dentin/NEWGENE adhesion/NN to/IN adhesives/NNS made/VBP from/IN urethane/NN molecules/NN with/IN free/JJ groups/NNS of/IN isocyanate/NN ./.
@@87063685489 RESULTS/NNS :/: The/DT LV/JJ maximum/JJ brightness/NN and/CC area/NN under/IN the/DT curve/NN showed/VBD significant/JJ negative/JJ correlations/NNS (/( p/NN =/SYM </SYM 0/CD ./CD 004/CD )/SYM with/IN the/DT FIO2/NN ,/, while/CC the/DT minimum/JJ brightness/NN showed/VBD a/DT significant/JJ positive/JJ correlation/NN (/( p/NN =/SYM </SYM 0/CD ./CD 002/CD )/SYM ./.
@@90201382242 Both/DT HEF1/NEWGENE and/CC Cas/NEWGENE were/VBD found/VBN to/IN complex/NN with/IN the/DT related/NEWGENE adhesion/NEWGENE focal/NEWGENE tyrosine/NEWGENE kinase/NEWGENE (/( RAFTK/NEWGENE )/SYM ,/, and/CC when/CC tyrosine/NN phosphorylated/VBN ,/, with/IN the/DT adapter/NN molecule/NN CrkL/NEWGENE ./.
@@33950096967 Statistical/NNP analysis/NN of/IN the/DT degrees/NNS of/IN secondary/JJ spinal/JJ cord/NN compression/NN was/VBD performed/VBN in/IN group-1/NNP dogs/NNS by/IN measuring/JJ and/CC comparing/VBG ratios/NNS of/IN the/DT vertical/NN to/IN the/DT horizontal/JJ diameters/NNS of/IN the/DT transverse/JJ spinal/JJ cord/NN sections/NNS from/IN locations/NNS within/IN (/( T12/NN to/IN L1/NN )/SYM and/CC out/RB of/IN (/( T11/NN ,/, T11-12/NN ,/, L1-2/NN ,/, and/CC L2/NN )/SYM the/DT region/NN of/IN surgical/JJ intervention/NN ./.
@@35954187834 The/DT nucleotide/NN sequences/NNS of/IN the/DT human/NEWGENE and/NEWGENE murine/NEWGENE ornithine/NEWGENE decarboxylase/NEWGENE mRNAs/NEWGENE share/VBP an/DT 85%/JJ homology/NN ,/, even/VB in/IN their/PRP 3'-noncoding/JJ regions/NNS ./.
@@13095933688 These/DT studies/NNS show/NN that/IN UCRBP/NEWGENE binds/VBZ to/IN various/JJ target/NN motifs/NNS that/WDT are/VBP distinct/JJ from/IN the/DT UCR/NEWGENE motif/NEWGENE :/: the/DT adeno-associated/NEWGENE virus/NEWGENE P5/NEWGENE promoter/NEWGENE and/CC elements/NNS in/IN the/DT immunoglobulin/NEWGENE light-/NEWGENE and/NEWGENE heavy-chain/NEWGENE genes/NEWGENE ,/, as/RB well/VB as/IN elements/NNS in/IN ribosomal/NEWGENE protein/NEWGENE genes/NEWGENE ./.
@@93262633673 Using/VBG 5'RACE/CD and/CC reverse/JJ transcription-PCR/NN (/( RT-PCR/NN )/SYM methodologies/NNS ,/, we/PRP cloned/VBN these/DT sequences/NNS from/IN brain/NN and/CC placenta/NN and/CC found/VB this/DT material/NN to/IN be/VB composed/VBN of/IN alternatively/RB spliced/VBN exons/NNS using/VBG a/DT previously/RB reported/VBN noncoding/NEWGENE exon/NEWGENE (/NEWGENE 1A/NEWGENE )/NEWGENE and/CC a/DT novel/JJ 97-bp/NEWGENE noncoding/NEWGENE exon/NEWGENE (/NEWGENE 1B/NEWGENE )/NEWGENE ./.
@@113509574467 PACAP/NEWGENE mRNA/NEWGENE was/VBD widely/RB expressed/VBN in/IN most/RB human/JJ tissues/NNS ;/: in/IN transfected/VBN cells/NNS ,/, PACAP/NEWGENE was/VBD diffusely/RB expressed/VBN in/IN the/DT cytoplasm/NN ./.
@@37530224421 Malignant/NN lymphoma/NN is/VBZ very/RB heterogeneous/JJ in/IN terms/NNS of/IN its/PRP biological/JJ behavior/NN ./.
@@80403919004 Number/NN and/CC size/NN of/IN silver-stained/JJ nucleoli/NNS (/( Ag-NOR/NN clusters/NN )/SYM in/IN canine/JJ seminomas/NNS :/: correlation/NN with/IN histological/JJ features/NNS and/CC tumour/NN behaviour/NN ./.
@@98823039064 These/DT data/NN further/RB define/VB a/DT role/NN for/IN TRADD/NEWGENE and/CC TRAF2/NEWGENE in/IN JNK/NEWGENE activation/NN and/CC confirm/VB that/IN LMP1/NEWGENE utilizes/VBZ signalling/JJ mechanisms/NNS used/VBN by/IN the/DT TNF/NEWGENE receptor/NEWGENE //NEWGENE CD40/NEWGENE family/NEWGENE to/IN elicit/VB its/PRP pleiotropic/JJ activities/NNS ./.
@@108347075788 Biologically/RB significant/JJ amounts/NNS of/IN platelet/NEWGENE activating/NEWGENE factor/NEWGENE were/VBD eluted/VBN from/IN the/DT sorbent/NN during/IN the/DT entire/JJ treatment/NN time/NN ./.
@@108177548334 H19/NEWGENE and/CC Igf2/NEWGENE monoallelic/JJ expression/NN is/VBZ regulated/VBN in/IN two/JJ distinct/JJ ways/NNS by/IN a/DT shared/JJ cis/JJ acting/JJ regulatory/JJ region/NN upstream/RB of/IN H19/NEWGENE ./.
@@10766493577 Recombination/NNS ,/, replication/NN ,/, repair/NN :/: from/IN complexity/NN to/IN harmony/NN ./.
@@113259443674 Elevated/NNP expression/NN of/IN full-length/NEWGENE UhpB/NEWGENE or/CC of/IN a/DT soluble/JJ hybrid/JJ protein/NN ,/, GST-Bc/NEWGENE ,/, which/WDT is/VBZ glutathione/NEWGENE S-transferase/NEWGENE (/( GST/NEWGENE )/SYM fused/VBN to/IN the/DT cytoplasmic/JJ C-terminal/NN portion/NN of/IN UhpB/NEWGENE ,/, results/VBZ in/IN complete/JJ blockage/NN of/IN uhpT/NEWGENE expression/NN in/IN a/DT uhp/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE strain/NN ./.
@@10597317658 Apoptosis/NNS of/IN small/JJ cells/NNS is/VBZ still/RB observed/VBN after/IN co-transfection/NN of/IN JBD/NEWGENE and/CC LMP1/NEWGENE but/CC in/IN addition/NN a/DT few/JJ apoptotic/JJ HD-MyZ/NNP cells/NNS with/IN large/RB fused/VBN nuclear/JJ masses/NNS are/VBP identified/VBN suggesting/VBG that/IN specific/JJ inhibition/NN of/IN JNK/NEWGENE leads/VBP also/RB to/IN apoptosis/NN of/IN LMP1/NEWGENE induced/VBN RS/NN cells/NNS ./.
@@16583561466 Recombination/NNS between/IN feline/JJ leukemia/NN virus/NN subgroup/NN B/NN or/CC C/NN and/CC endogenous/JJ env/NEWGENE elements/NN alters/VBZ the/DT in/NN vitro/FW biological/JJ activities/NNS of/IN the/DT viruses/NNS ./.
@@9266042621 Propranolol/NN (/( Inderal/NN )/SYM administered/VBN in/IN a/DT dose/NN which/WDT blocks/NNS the/DT beta-adrenergic/JJ apparatus/NN of/IN the/DT heart/NN prevents/VBZ the/DT development/NN of/IN the/DT positive/JJ inotropic/JJ effect/NN of/IN therapeutic/JJ doses/NNS of/IN strophanthin/NN K/NN on/IN a/DT hypodynamic/JJ left/NN ventricular/JJ myocardium/NN ./.
@@34998227564 Multivariate/JJ logistic/JJ regression/NN analysis/NN indicated/VBD that/DT seropositivity/NN was/VBD strongly/RB associated/VBN with/IN the/DT prevalence/NN of/IN hepatitis/NN B/NN in/IN an/DT employee's/NNS country/NN of/IN birth/NN and/CC with/IN age/NN ./.
@@87903878056 In/NN the/DT rat/NEWGENE rnu/NEWGENE allele/NEWGENE described/VBN here/RB ,/, a/DT nonsense/NN mutation/NN in/IN exon/NN 8/CD of/IN the/DT whn/NEWGENE gene/NEWGENE was/VBD identified/VBN ./.
@@8896804734 The/DT present/NN study/NN investigated/VBD dose/NN dependence/NN and/CC time/NN course/NN effects/NNS of/IN the/DT benzodiazepine/NN (/( BDZ/NN )/SYM partial/JJ inverse/JJ agonist/NN ,/, RO19-4603/NN (/( 0/CD ./CD 005-0/CD ./CD 30/CD mg/CD //CD kg/CD )/SYM alone/RB ,/, and/CC in/IN combination/NN with/IN the/DT BDZ/NEWGENE receptor/NEWGENE antagonists/NNS flumazenil/NN ,/, ZK/NN 93426/CD ,/, and/CC CGS/NNP 8216/CD (/( 20/CD mg/CD //CD kg/CD )/SYM in/IN selectively/RB bred/VBN alcohol-preferring/JJ (/( P/NN )/SYM rats/NNS provided/VBD a/DT two-bottle/JJ choice/JJ test/NN between/IN ethanol/NN (/( EtOH/NNS )/SYM (/( 10%/CD v/NN //NN v/NN )/SYM ,/, and/CC a/DT palatable/JJ saccharin/NN (/( 0/CD ./CD 0125%/CD g/NN //NN v/NN )/SYM solution/NN ./.
@@23104966996 Similar/JJ memory/NN impairments/NNS found/VBP in/IN medial/JJ septal-vertical/JJ diagonal/JJ band/NN of/IN Broca/NN and/CC nucleus/NN basalis/JJ lesioned/JJ rats/NNS :/: are/VBP memory/NN defects/NNS induced/VBN by/IN nucleus/NN basalis/NN lesions/NNS related/VBN to/IN the/DT degree/NN of/IN non-specific/JJ subcortical/JJ cell/NN loss/NN ?/. The/DT function/NN of/IN nucleus/NN basalis/NN (/( NB/JJ )/SYM and/CC medial/JJ septal-vertical/JJ diagonal/JJ band/NN of/IN Broca/NN (/( MS-VDBB/NN )/SYM in/IN a/DT place/NN navigation/NN task/NN requiring/JJ reference/NN memory/NN was/VBD investigated/VBN ./.
@@66580296409 The/DT carcinogen/NN bioassay/NN therefore/RB is/VBZ a/DT very/RB important/JJ component/NN of/IN the/DT battery/NN of/IN toxicological/JJ tests/NNS used/VBN in/IN hazard/NN evaluation/NN ./.
@@75679809047 Four/CD p53/NEWGENE DNA-binding/NEWGENE domain/NEWGENE peptides/NEWGENE bind/VBP natural/NN p53-response/NEWGENE elements/NEWGENE and/CC bend/VB the/DT DNA/NN ./.
@@93736519328 Bitter/JJ cassava/NN contains/VBZ cyanogenic/JJ glycosides/NNS ;/: processing/VBG breaks/NNS them/PRP down/NN to/IN acetone/NN cyanohydrin/NN and/CC hydrogen/NN cyanide/NN ./.
@@11094109928 RESULTS/NNS :/: Average/NNP age/NN at/IN symptom/NN onset/NN was/VBD 41/CD ./CD 2/CD years/NNS ./.
@@1744039481 The/DT fragments/NNS of/IN each/DT region/NN were/VBD amplified/VBN by/IN polymerase/NEWGENE chain/NN reaction/NN and/CC analyzed/VBN by/IN gel/NN electrophoresis/NN to/IN detect/VB single-strand/JJ conformation/NN polymorphism/NN ./.
@@7457759201 Two/CD out/RB of/IN five/CD patients/NNS undergoing/VBG selective/JJ spinal/JJ arteriography/NN developed/VBD transient/JJ neurological/JJ complications/NNS during/IN the/DT injection/NN of/IN Urografin/NN 310/NN M/NNP ./NNP
@@107447492705 To/TO investigate/VB the/DT molecular/JJ mechanisms/NNS of/IN this/DT Tax-mediated/JJ inhibition/NN ,/, we/PRP analyzed/VBD its/PRP effect/NN on/IN the/DT transcriptional/JJ activity/NN of/IN the/DT myogenic/JJ MyoD/NEWGENE protein/NEWGENE ,/, which/WDT was/VBD used/VBN as/IN a/DT paradigm/NN of/IN bHLH/NEWGENE factors/NEWGENE ./.
@@10517672653 When/WRB the/DT 73-bp/JJ fragment/NN was/VBD fused/VBN to/IN an/DT alpha1-globin/NEWGENE promoter-CAT/NEWGENE construct/NEWGENE and/CC cotransfected/VBN with/IN CCAAT/NEWGENE transcription/NEWGENE factor/NEWGENE 1/NEWGENE (/( CTF1/NEWGENE )/NN //NEWGENE NF1/NEWGENE into/IN Drosophila/NN Schneider/NN SL2/NNP insect/NN cells/NNS (/( which/WDT lack/VBP NF1-like/NEWGENE proteins/NEWGENE )/SYM trans-activation/NN of/IN CAT/NEWGENE activity/NN was/VBD observed/VBN ./.
@@115355327859 The/DT deubiquitinating/JJ enzyme/NN DUB-2/NEWGENE is/VBZ induced/VBN in/IN response/NN to/IN IL-2/NEWGENE but/CC as/IN yet/RB its/PRP function/NN has/VBZ not/RB been/VBN determined/VBN ./.
@@20149287111 Occupational/NNP asthma/NN and/CC rhinoconjunctivitis/NN from/IN inhalation/NN of/IN crystalline/NN bovine/NEWGENE serum/NEWGENE albumin/NEWGENE powder/NN ./.
@@80511519447 The/DT relative/JJ abundance/NN of/IN each/DT alternatively/RB spliced/VBN mRNA/NN was/VBD determined/VBN by/IN reverse/JJ transcription-polymerase/JJ chain/NN reaction/NN in/IN various/JJ human/JJ tissues/NNS and/CC cell/NN lines/NNS ./.
@@77537961645 Expression/NNS of/IN this/DT cDNA/NN in/IN vitro/FW yields/VBZ a/DT peptide/NN which/WDT comigrates/VBZ with/IN natural/NEWGENE eIF-2B/NEWGENE alpha/NEWGENE in/IN SDS/NNP //NNP polyacrylamide/NNP gels/NNS ./.
@@112232406442 Drosophila/NEWGENE Menin1/NEWGENE gene/NEWGENE transcripts/NEWGENE use/NN alternative/JJ polyadenylation/NN sites/NN resulting/JJ in/IN 4/CD ./CD 3/CD and/CC 5-kb/CD messages/NNS ./.
@@2349998254 Dopamine/IN SERS/NN spectra/NNS from/IN these/DT electrodes/NNS are/VBP similar/JJ to/IN those/DT obtained/VBN at/IN uncoated/JJ electrodes/NNS ./.
@@98695289859 Lead/JJ fixation/NN in/IN dogs/NNS achieved/VBN with/IN RF/NN energy/NN ./.
@@91113147789 The/DT importance/NN of/IN posttranslational/JJ regulation/NN of/IN p15INK4B/NEWGENE by/IN TGF-beta/NEWGENE is/VBZ underlined/VBN by/IN the/DT observation/NN that/IN in/IN TGF-beta-resistant/NNP 184A1L5R/CD ,/, although/IN the/DT p15/NEWGENE transcript/NEWGENE increased/VBN ,/, p15INK4B/NEWGENE protein/NEWGENE was/VBD not/RB stabilized/VBN and/CC did/VBD not/RB accumulate/VB ,/, and/CC cyclin/NEWGENE D1-cdk/NEWGENE association/NN and/CC kinase/NEWGENE activation/NN were/VBD not/RB inhibited/VBN ./.
@@113144289922 Further/RB ,/, the/DT osteo-retentive/JJ ability/NN of/IN the/DT hydroxyapatite/NN in/IN the/DT sockets/NNS was/VBD seen/VBP to/IN be/VB close/JJ to/IN significance/NN (/( after/IN six/CD months/NNS width/NN differences/NNS ,/, in/IN the/DT canine/NN region/NN :/: P/NN =/SYM 0/CD ./CD 059/CD ,/, LHS/NN ,/, and/CC P/NN =/SYM 0/CD ./CD 065/CD ,/, RHS/NN )/SYM ./.
@@75175447397 After/IN 7/CD days/NNS ,/, a/DT spontaneous/JJ regression/NN of/IN the/DT morphologic/JJ alterations/NNS caused/VBN by/IN caerulein-induced/JJ acute/JJ pancreatitis/NN occurs/VBZ ;/: however/RB ,/, recovery/NN of/IN the/DT secretory/JJ function/NN of/IN the/DT pancreas/NN was/VBD only/RB reached/VBN after/IN this/DT period/NN of/IN time/NN when/CC L-364/NN ,/NN 718/NN was/VBD administered/VBN therapeutically/RB (/( 0/CD ./CD 1/CD mg/NN //NN kg/NN //NN day/NN )/SYM ./.
@@107858803422 CONCLUSION/IN :/: The/DT probability/NN of/IN cardiopulmonary/JJ complications/NNS increases/NNS significantly/RB when/CC patients/NNS develop/VB class/NN 1/NN HELLP/NNP syndrome/NN ./.
@@14527032066 Laboratory/NNP studies/NNS showed/VBN that/IN the/DT direct/JJ fluorescent-antibody/JJ kits/NNS were/VBD the/DT least/RB sensitive/JJ in/IN this/DT case/NN and/CC did/VBD not/RB detect/VB fewer/DT than/IN 10/NN (/NN 4/NN )/NN elementary/JJ bodies/NNS per/IN ml/NN ,/, while/CC most/JJ ELISA/NN kits/NNS detected/VBN between/IN 130/CD and/CC 600/CD elementary/JJ bodies/NNS per/IN ml/NN ./NN
@@92362248751 Sustained/JJ activation/NN of/IN p21/NEWGENE expression/NN is/VBZ proposed/VBN to/IN be/VB a/DT distinguishing/JJ feature/NN of/IN the/DT activity/NN of/IN NGF/NEWGENE that/WDT contributes/VBZ to/IN PC12/NN growth/NN arrest/NN during/IN differentiation/NN
@@108437169814 The/DT tryptase/NEWGENE locus/NEWGENE also/RB contains/VBZ at/IN least/RB four/CD tryptase-like/NEWGENE pseudogenes/NEWGENE ,/, including/JJ mastin/NEWGENE ,/, a/DT gene/NN expressed/VBN in/IN dogs/NNS but/CC not/RB in/IN humans/NNS ./.
@@30156286707 Osteocalcin/NEWGENE (/( and/CC urinary/JJ hydroxyproline/NN )/SYM were/VBD not/RB elevated/VBN in/IN isolated/VBN hyperphosphatasaemia/NN ,/, indicating/VBG that/IN mechanisms/NNS other/DT than/IN increased/VBN bone/NN turnover/NN may/MD account/VB for/IN the/DT markedly/RB elevated/VBN serum/NEWGENE alkaline/NEWGENE phosphatase/NEWGENE activity/NN in/IN these/DT subjects/NNS ./.
@@37507004418 Possibilities/NNPS and/CC outlook/NN for/IN wrist/NN joint/JJ endoprosthesis/NN ./.
@@80495211363 Aberrant/JJ protein/NN phosphorylation/NN at/IN tyrosine/NN is/VBZ responsible/JJ for/IN the/DT growth-inhibitory/JJ action/NN of/IN pp60v-src/NEWGENE expressed/VBN in/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN ./.
@@97042961525 Acute/JJ idiopathic/JJ thrombocytopenic/JJ purpura/NN presenting/VBG a/DT high/JJ serum/JJ level/NN of/IN immunoglobulin/NEWGENE E/NEWGENE and/CC eosinophilia/NN in/IN an/DT elderly/JJ patient/NN ./.
@@90060518195 PrpB/NEWGENE showed/VBD homology/NN to/IN carboxyphosphonoenolpyruvate/NEWGENE phosphonomutase/NEWGENE of/NEWGENE Streptomyces/NEWGENE hygroscopicus/NEWGENE and/CC to/IN its/PRP homolog/NN in/IN the/DT carnation/NN Dianthus/NNP caryophyllus/NN ;/: PrpC/NEWGENE was/VBD homologous/JJ to/IN both/DT archaeal/NEWGENE and/NEWGENE bacterial/NEWGENE citrate/NEWGENE synthases/NEWGENE ;/: PrpD/NEWGENE showed/VBD homology/NN to/IN yeast/NN and/CC Bacillus/NN subtilis/JJ proteins/NNS of/IN unknown/JJ function/NN ;/: PrpE/NEWGENE showed/VBD homology/NN to/IN acetyl/NEWGENE coenzyme/NEWGENE A/NEWGENE synthetases/NEWGENE ./.
@@86681421228 The/DT introduction/NN of/IN hARF4/NEWGENE to/IN the/DT cells/NNS maintained/VBD the/DT balance/NN between/IN cytosolic/JJ and/CC membrane-associated/JJ Sec7p/NEWGENE pools/NNS ./.
@@1628904444 The/DT final/JJ screening/JJ yielded/VBN a/DT clone/NN containing/NN a/NN 2/NN kilobase/NN (/( kb/NN )/SYM insert/NN ./.
@@83555393072 METHODS/IN :/: Twenty-two/CD patients/NNS were/VBD grouped/VBN according/VBG to/IN their/PRP etiology/NN based/VBN on/IN the/DT study/NN of/IN antiadrenal/JJ antibodies/NNS at/IN diagnosis/NN of/IN the/DT disease/NN :/: 7/CD were/VBD positive/JJ (/( autoimmune/JJ etiology/NN or/CC EAA/NN )/SYM ,/, 11/CD were/VBD negative/JJ (/( tuberculous/JJ etiology/NN or/CC EAT/NN )/SYM and/CC in/IN four/CD serologic/JJ study/NN was/VBD not/RB available/JJ (/( undetermined/JJ etiology/NN or/CC EAI/NN )/SYM ./.
@@54126875528 Antidromic/NNP invasion/NN of/IN impulses/NNS and/CC recurrent/JJ collateral/JJ inhibition/NN in/IN pyramidal/JJ tract/NN neurones/NNS ./.
@@103949191200 Another/DT element/NN necessary/JJ for/IN augmenting/JJ the/DT amplitude/NN of/IN the/DT oscillation/NN lies/NNS between/IN -178/CD and/CC -264/CD ./.
@@9560390855 In/NN addition/NN to/IN restoring/JJ checkpoint/NN control/NN ,/, overexpression/NN of/IN sum1+/NEWGENE inhibits/VBZ the/DT normal/JJ cell/NN cycle/NN response/NN to/IN osmotic/JJ stress/NN ./.
@@92930065335 For/IN higher/JJ expression/NN of/IN lipA/NEWGENE in/IN S/NNP ./NNP lividans/NNS ,/, the/DT gene/NN was/VBD cloned/VBN next/JJ to/IN the/DT strong/JJ aphII/NEWGENE promoter/NEWGENE ./.
@@11543662144 Six/CD of/IN the/DT gstC'/NEWGENE mutants/NEWGENE ,/, primarily/RB in/IN the/DT C-terminal/NN half/NN of/IN C'/NEWGENE ,/, exhibited/VBD a/DT defect/NN in/IN the/DT ability/NN to/IN bind/NN L/NEWGENE protein/NEWGENE ./.
@@110002503946 LMP-1/NEWGENE is/VBZ targeted/VBN to/IN the/DT plasma/NN membrane/NN ,/, where/CC it/PRP binds/VBZ TRAF/NEWGENE ,/, TRADD/NEWGENE ,/, and/CC JAK/NEWGENE molecules/NEWGENE to/IN activate/VB NF-kappaB-/NNP ,/, AP-1-/NNP ,/, and/CC STAT-dependent/NNP pathways/NNS as/IN does/VBP CD40/NEWGENE ./.
@@22131282847 2/CD ./CD
@@21646375355 Disruption/NNS of/IN the/DT IRA2/NEWGENE gene/NEWGENE resulted/VBN in/IN (/( i/NN )/SYM increased/VBN sensitivity/NN to/IN heat/NN shock/NN and/CC nitrogen/NN starvation/NN ,/, (/( ii/NN )/SYM sporulation/NN defects/NNS ,/, and/CC (/( iii/NN )/SYM suppression/NN of/IN the/DT lethality/NN of/IN the/DT cdc25/NEWGENE mutant/NEWGENE ./.
@@36532264326 A/DT careful/JJ ,/, radiolabelled/JJ tissue-distribution/NN study/NN is/VBZ warranted/VBN to/IN elucidate/VB the/DT complicated/VBN metabolic/JJ fate/NN of/IN perhexiline/NN ./.
@@76355725323 CIITA/NEWGENE mRNA/NEWGENE is/VBZ normally/RB inducible/JJ by/IN IFN-gamma/NEWGENE in/IN class/NN II/NN non-inducible/JJ ,/, RB-defective/NNP lines/NNS ,/, and/CC in/IN one/PRP line/NN ,/, re-expression/NN of/IN RB/NEWGENE has/VBZ no/DT effect/NN on/IN CIITA/NEWGENE mRNA/NEWGENE induction/NN levels/NNS ./.
@@103504546172 MutY/NEWGENE is/VBZ an/DT adenine-DNA/NEWGENE glycosylase/NEWGENE with/IN specificity/NN for/IN mismatches/NNS involving/VBG 8-oxoguanine/CD (/( oG/CD ./CD A/CD )/SYM or/CC guanine/NN (/( G/NN ./NN A/NN )/SYM ./.
@@13246391956 Susceptibilities/NNS of/IN 540/CD anaerobic/JJ gram-negative/JJ bacilli/NNS to/IN amoxicillin/NN ,/, amoxicillin-BRL/JJ 42715/CD ,/, amoxicillin-clavulanate/NN ,/, temafloxacin/NN ,/, and/CC clindamycin/NN ./.
@@112743683141 This/DT effect/NN was/VBD observed/VBN in/IN the/DT absence/NN of/IN de/FW novo/FW protein/NN synthesis/NN and/CC was/VBD independent/NN of/IN histone/NEWGENE deacetylase/NEWGENE activity/NN ./.
@@104881482497 NF-kappaB/NEWGENE plays/VBP a/DT critical/JJ role/NN in/IN activation/NN of/IN HIV-1/NN gene/NN expression/NN by/IN cytokines/NNS and/CC other/DT stimuli/NNS ,/, but/CC the/DT signal/JJ transduction/NN pathways/NNS that/WDT regulate/VBP the/DT switch/NN from/IN latent/JJ to/IN productive/JJ infection/NN have/NN not/RB been/VBN defined/VBN ./.
@@23628038351 PCR-derived/NN fragments/NN were/VBD used/VBN as/IN probes/NNS for/IN the/DT isolation/NN of/IN the/DT U3/NEWGENE snRNA/NEWGENE genes/NEWGENE from/IN a/DT genomic/JJ library/NN of/IN Arabidopsis/NN ./.
@@111961915260 Thus/RB ,/, in/IN T47D/DT breast/NN carcinoma/NN cells/NNS ,/, IL-6/NEWGENE acts/NNS in/IN synergy/NN with/IN EGF/NEWGENE receptor/NEWGENE autocrine/JJ activity/NN to/IN signal/JJ through/RB the/DT MAPK/NEWGENE //NEWGENE PI3K/NEWGENE pathways/NNS ./.
@@7509472856 CONCLUSION/IN :/: This/DT study/NN documents/VBZ that/DT regression/NN of/IN choroidal/JJ neovascularization/NN that/WDT occurred/VBD with/IN alpha/NEWGENE interferon/NEWGENE treatment/NN was/VBD minimal/JJ ./.
@@69355146712 The/DT Authors/NNS have/NN proposed/VBN to/IN develop/VB this/DT research/NN employing/VBG a/DT preparation/NN containing/JJ exclusively/RB a/DT cortisonic/NN ,/, the/DT desametazone/NN ,/, in/IN order/NN to/IN evaluate/VB the/DT alterations/NNS of/IN the/DT dentinogenesis/NN to/IN be/VB attributed/VBN to/IN such/JJ component/NN ./.
@@90033115858 A/DT 5/CD ./CD 3-kb/CD DNA/NN fragment/NN ,/, which/WDT included/VBD the/DT entire/JJ structural/NN porin/NEWGENE gene/NEWGENE (/( named/VBN porCa/NEWGENE )/SYM and/CC its/PRP flanking/JJ regions/NNS ,/, was/VBD identified/VBN ./.
@@23209991782 The/DT procedure/NN has/VBZ been/VBN applied/VBN to/IN three/CD materials/NNS :/: particle/NN board/NN with/IN carpet/NN ;/: gypsum/NN board/NN with/IN wallpaper/NN ;/: and/CC plywood/NN with/IN polyurethane/NN lacquer/NN ,/, for/IN which/WDT the/DT steady-state/JJ emission/NN factors/NNS (/( mg/NN m-2/NN h-1/NN )/SYM of/IN several/DT compounds/NNS are/VBP given/VBP ./.
@@83862798535 The/DT transactivation/NN function/NN of/IN EBNA2/NEWGENE was/VBD also/RB observed/VBN in/IN the/DT HeLa/JJ epithelial/JJ cell/NN line/NN ,/, which/WDT suggests/VBZ that/DT EBV/NN and/CC HIV-1/NNP infection/NN of/IN non-B/NNP cells/NNS may/MD result/VB in/IN HIV-1/NN promoter/NN activation/NN ./.
@@86845227989 Immunofluorescence/NNS microscopy/NN revealed/VBD extensive/JJ deposition/NN of/IN such/JJ extracellular/JJ matrices/NNS as/IN type/NEWGENE IV/NEWGENE collagen/NEWGENE and/CC laminin/NEWGENE in/IN the/DT vascular/JJ wall/NN ./.
@@85063179359 Members/NNS of/IN the/DT C/NEWGENE //NEWGENE EBP/NEWGENE family/NEWGENE of/IN basic-leucine/NEWGENE zipper/NEWGENE (/( bZip/NEWGENE )/SYM transcription/NN factors/NNS form/NN heterodimers/NNS and/CC bind/VB to/IN the/DT CAAT/NN box/NN and/CC other/DT sequence-related/NN enhancer/NN motifs/NN ./.
@@117877462276 Vitrectomy/NN and/CC removal/NN of/IN retained/VBN lens/NN fragments/NNS restores/VBZ good/JJ visual/JJ acuity/NN and/CC reduces/VBZ secondary/JJ glaucoma/NN in/IN the/DT majority/NN of/IN patients/NNS ./.
@@36299748850 Comparison/NNS of/IN the/DT amino/JJ acid/NN sequence/NN of/IN the/DT M/NEWGENE RNA/NEWGENE product/NEWGENE of/NEWGENE Uukuniemi/NEWGENE virus/NEWGENE with/IN that/DT of/IN Punta/NNP Toro/NNP and/CC Rift/NN Valley/NNP fever/NN viruses/NNS showed/VBN in/IN both/DT cases/VBZ a/DT weak/JJ homology/NN that/WDT was/VBD more/RB pronounced/VBN for/IN the/DT proteins/NNS located/VBN at/IN the/DT COOH-terminal/NN end/NN of/IN the/DT precursor/NN ./.
@@72059677031 Adverse/JJ reaction/NN of/IN the/DT apparently/RB healthy/JJ partner/NN in/IN response/NN to/IN improvement/NN in/IN the/DT overtly/RB dysfunctional/JJ partner/NN ./.
@@75585832280 Our/PRP study/NN was/VBD addressed/VBN to/IN the/DT synthesis/NN of/IN some/DT derivatives/NNS of/IN this/DT sequence/NN in/IN order/NN to/IN obtain/VB both/DT peptide/NN substrates/NNS suitable/JJ for/IN the/DT detection/NN of/IN the/DT Src-like/NEWGENE tyrosine/NEWGENE kinase/NEWGENE activity/NN and/CC active/JJ site-directed/NN inhibitors/NN specific/JJ for/IN this/DT class/NN of/IN enzymes/NNS ./.
@@97352868569 The/DT defect/NN in/IN these/DT proteins/NNS was/VBD also/RB uniformly/RB suppressed/VBN by/IN either/DT Mn2+/NN ,/, or/CC the/DT Mu/NEWGENE B/NEWGENE protein/NEWGENE in/IN the/DT presence/NN of/IN ATP/NN and/CC target/NN DNA/NN ./.
@@10196597139 As/IN such/JJ the/DT findings/NNS support/NN existing/JJ studies/NNS that/WDT have/VBP identified/VBN given/VBP social/JJ characteristics/NNS of/IN drink/NN drivers/NNS ./.
@@7860208426 We/PRP have/VBP measured/VBN the/DT release/NN of/IN interleukin-1/NEWGENE beta/NEWGENE (/( IL-1/NEWGENE )/SYM and/CC tumour/NEWGENE necrosis/NEWGENE factor-alpha/NEWGENE (/( TNF/NEWGENE )/SYM by/IN unstimulated/JJ monocytes/NNS and/CC monocytes/NNS stimulated/VBN with/IN lipopolysaccharide/NN (/( LPS/NN )/SYM isolated/VBN from/IN the/DT peripheral/JJ blood/NN of/IN two/JJ patients/NNS with/IN acute/JJ poststreptococcal/JJ glomerulonephritis/NN (/( AGN/NNP )/SYM and/CC 16/CD healthy/JJ controls/NNS ./.
@@104007858606 SM/NEWGENE is/VBZ also/RB shown/VBP to/IN be/VB associated/VBN in/IN vivo/NN with/IN other/DT components/NNS of/IN the/DT CRM/NEWGENE 1/NEWGENE export/NN pathway/NN ,/, including/JJ the/DT small/NEWGENE GTPase/NEWGENE Ran/NEWGENE and/CC the/DT nucleoporin/NEWGENE CAN/NEWGENE //NEWGENE Nup214/NEWGENE ./.
@@110272896767 As/IN a/DT result/NN ,/, we/PRP have/VBP defined/VBN two/JJ arginine-rich/JJ motifs/NNS (/( ARM1/NN and/CC ARM2/NN )/SYM that/WDT mediate/VBP the/DT RNA/NN binding/JJ activity/NN of/IN SU/NEWGENE (/NEWGENE S/NEWGENE )/NEWGENE ./.
@@58900935821 Study/NNP on/IN micromelias/NNS in/IN the/DT mouse/NN fetus/NN caused/VBN by/IN x-radiation/NN ,/, hypoxia/NN ,/, trypan/JJ blue/JJ injection/NN of/IN hypervitaminosis-A/NN upon/IN mother/NN animals/NNS during/IN pregnancy/NN ./.
@@99838719980 Raman/JJ investigation/NN of/IN YBa2-xLaxCu3O7/NN ceramics/NN ./.
@@81692014113 Therefore/RB ,/, the/DT amino-terminal/NN sequence/NN of/IN the/DT purified/VBN carA/NEWGENE product/NEWGENE is/VBZ identical/JJ to/IN that/DT derived/VBD from/IN the/DT nucleotide/NN sequence/NN in/IN both/DT organisms/NNS ,/, P/NNP ./NNP stutzeri/NN having/VBG four/CD additional/JJ amino/JJ acids/NNS ./.
@@81919108166 San/NNP Martin's/NNP psychological/JJ traits/NNS coupled/VBN to/IN his/PRP work/NN with/IN masonic/JJ lodges/NNS that/WDT allowed/VBD him/PRP to/IN display/NN his/PRP abilities/NNS as/IN strategist/NN and/CC political/JJ ruler/NN ./.
@@104809377457 A/DT novel/JJ Drosophila/NEWGENE A/NEWGENE kinase/NEWGENE anchor/NEWGENE protein/NEWGENE ,/, Drosophila/NEWGENE A/NEWGENE kinase/NEWGENE anchor/NEWGENE protein/NEWGENE 200/NEWGENE (/( DAKAP200/NEWGENE )/SYM ,/, is/VBZ predicted/VBN to/IN be/VB involved/VBN in/IN routing/VBG ,/, mediating/JJ ,/, and/CC integrating/JJ signals/NNS carried/VBN by/IN cAMP/NN ,/, Ca/NN (/NN 2+/NN )/NN ,/, and/CC diacylglycerol/NN (/( Li/NN ,/, Z/NNP ./NNP ,/, Rossi/NNP ,/, E/NNP ./NNP
@@17262113290 These/DT risk/NN factors/NNS can/MD be/VB divided/VBN into/IN 2/CD groups/NNS :/: local/JJ vessel/NN wall-related/NN factors/NN ,/, and/CC local/JJ (/( focal/JJ action/NN )/SYM systemic/JJ factors/NNS ./.
@@33328484012 Hand-held/NNP ,/, continuous-wave/JJ Doppler/NN probes/NNS ,/, coupled/VBN with/IN sound/NN spectral/JJ analysis/NN ,/, can/MD successfully/RB predict/VB carotid/JJ artery/NN stenosis/NN ./.
@@113589582780 Expression/NNS of/IN human/NEWGENE RACK1/NEWGENE efficiently/RB relieves/VBZ E1A-mediated/JJ growth/NN inhibition/NN in/IN HF7c/NNP and/CC protects/VBZ human/JJ tumor/NN cells/NNS from/IN E1A-induced/JJ apoptosis/NN ./.
@@107131762432 D-cyclin-cdk/NEWGENE activity/NN is/VBZ required/VBN for/IN Rb/NEWGENE phosphorylation/NN in/IN v-Jun-transformed/JJ cells/NNS ,/, since/IN ectopic/JJ expression/NN of/IN the/DT cdk4-/NN and/CC cdk6-specific/NEWGENE inhibitor/NEWGENE p16/NEWGENE1 (/NEWGENE1 INK4A/NEWGENE1 )/NEWGENE1 inhibits/VBZ both/DT DNA/NN synthesis/NN and/CC cell/NN proliferation/NN ./.
@@8223425626 The/DT yeast/NEWGENE SSS1/NEWGENE gene/NEWGENE is/VBZ essential/JJ for/IN secretory/JJ protein/NN translocation/NN and/CC encodes/VBZ a/DT conserved/VBN protein/NN of/IN the/DT endoplasmic/JJ reticulum/NN ./.
@@61850145604 Intraoperatively/RB the/DT complement/NEWGENE factor/NEWGENE C3c/NEWGENE decreased/VBD by/IN 20%/CD ,/, while/CC alpha/NEWGENE 1-antitrypsin/NEWGENE showed/VBD postoperatively/RB an/DT increase/NN by/IN 30%/CD ./.
@@106062452895 Overexpression/NNS of/IN CDP/NEWGENE //NEWGENE cut/NEWGENE in/IN ROS/NN 17/CD //CD 2/CD ./CD 8/CD osteosarcoma/NN cells/NNS results/NNS in/IN repression/NN of/IN OC/NEWGENE promoter/NEWGENE activity/NN ;/: this/DT repression/NN is/VBZ abrogated/VBN by/IN mutating/JJ OC/NEWGENE box/NEWGENE I/NEWGENE ./.
@@72565437068 In/NN this/DT study/NN ,/, the/DT general/JJ clinical/JJ criteria/NNS for/IN inhalation/NN injury--presence/NN of/IN facial/JJ or/CC oropharyngeal/JJ burns/NNS ,/, carboxyhemoglobin/NN levels/NNS ,/, carbonaceous/JJ sputum/NN ,/, or/CC closed/JJ space/NN injury--did/JJ not/RB differentiate/VB patients/NNS with/IN airway/NN injury/NN only/RB from/IN those/DT with/IN parenchymal/JJ injury/NN ./.
@@17010885912 Co-existence/NNS of/IN these/DT regulatory/JJ elements/NNS with/IN other/DT elements/NNS ,/, such/JJ as/IN the/DT AP-2/NEWGENE element/NEWGENE or/CC CCAAT/NN box/NN ,/, was/VBD also/RB found/VB ./.
@@108043794409 Update/NNP on/IN maternal-fetal/JJ infections/NNS by/IN hepatitis/NN C/NN ,/, HIV/NN and/CC cytomegalovirus/NN ./.
@@32512109083 Many/JJ children/NNS with/IN BGC/NN are/VBP delayed/JJ in/IN their/PRP development/NN ,/, but/CC calcifications/NNS are/VBP not/RB directly/RB related/VBN to/IN specific/JJ forms/NNS of/IN neurologic/JJ dysfunction/NN ./.
@@10392266260 The/DT presence/NN of/IN cutaneous/JJ xanthomas/NNS with/IN normal/JJ serum/JJ lipid/NN levels/NNS is/VBZ due/NN to/IN the/DT antibetalipoproteic/JJ activity/NN of/IN the/DT monoclonal/NEWGENE immunoglobulin/NEWGENE ./.
@@103580319375 In/NN addition/NN ,/, these/DT cells/NNS contained/VBN one/PRP ,/, two/JJ ,/, or/CC multiple/JJ nuclei/NNS indicative/NN of/IN a/DT G2/NN //NN M/NN delay/NN in/IN nuclear/JJ division/NN and/CC also/RB a/DT defect/NN in/IN cytokinesis/NN and/DT //DT or/DT cell/NN separation/NN ./.
@@108879211482 CONCLUSIONS/IN :/: There/EX is/VBZ a/DT relation/NN in/IN the/DT topography/NN of/IN some/DT visual/JJ field/NN areas/NNS assessed/VBN by/IN SWAP/NN and/CC the/DT inferotemporal/JJ neuroretinal/JJ rim/NN area/NN ,/, which/WDT may/MD play/VB a/DT role/NN in/IN the/DT diagnosis/NN and/CC follow-up/NN of/IN suspected/VBN glaucoma/NN ./.
@@9369451630 Mutational/JJ analysis/NN shows/VBZ that/IN both/PDT an/DT AP-1/NEWGENE like/NEWGENE sequence/NEWGENE (/( -294/NEWGENE //NEWGENE -285/NEWGENE ,/NEWGENE TGAATCATCA/NEWGENE )/SYM and/CC an/DT A/NN //NN T-rich/NN myocyte/NEWGENE enhancer/NEWGENE factor/NEWGENE (/NEWGENE MEF/NEWGENE )/NEWGENE -2/NEWGENE like/NEWGENE sequence/NEWGENE (/( -310/NEWGENE //NEWGENE -298/NEWGENE ,/NEWGENE TTAAAAATAAAAA/NEWGENE )/SYM in/IN the/DT 33-bp/JJ region/NN are/VBP necessary/JJ for/IN the/DT OP-1/NEWGENE effect/NN ./.
@@7542698305 Sources/NNS of/IN noise/NN in/IN these/DT signals/NNS were/VBD evaluated/VBN in/IN preparations/NNS stained/VBN with/IN the/DT potentiometric/JJ probe/NN RH-414/NN ./.
@@36155504292 The/DT effects/NNS of/IN several/DT opioid/JJ agonists/NNS and/CC the/DT opioid/NN antagonist/NN naloxone/NN were/VBD examined/VBN in/IN rats/NNS responding/VBG under/IN a/DT fixed-consecutive-number/JJ (/( FCN/NNP )/SYM schedule/NN ./.
@@102352658356 In/NN one/PRP mechanism/NN ,/, a/DT specialized/JJ ubiquitin-dependent/JJ proteolytic/JJ system/NN (/( called/VBN the/DT APC-dependent/NNP proteolysis/NN machinery/NN )/SYM degrades/VBZ the/DT mitotic/JJ (/( Clb/NEWGENE )/SYM cyclin/NEWGENE subunit/NEWGENE ./.
@@89174351443 An/DT essential/JJ role/NN of/IN c-Jun/NEWGENE and/CC c-Fos/NEWGENE in/IN basal/JJ and/CC PMA-stimulated/JJ transcription/NN of/IN the/DT PAI-1/NEWGENE gene/NEWGENE is/VBZ demonstrated/VBN by/IN our/PRP finding/NN that/DT antisense/NN c-jun/NEWGENE and/CC c-fos/NEWGENE oligodeoxynucleotides/NN both/DT strongly/RB reduced/VBN basal/JJ and/CC PMA-stimulated/JJ PAI-1/NEWGENE synthesis/NN ./.
@@81448529620 The/DT responses/NNS of/IN the/DT "stress/NN hormones"/NN cortisol/NN ,/, 11-deoxycortisol/JJ ,/, ACTH/NEWGENE ,/, vasopressin/NEWGENE (/( AVP/NEWGENE )/SYM ,/, and/CC corticotropin/NEWGENE releasing/NEWGENE factor/NEWGENE (/( CRF/NEWGENE )/SYM were/VBD studied/VBN in/IN 6/CD normal/JJ males/NNS in/IN response/NN to/IN acute/JJ cortisol/NN deficiency/NN induced/VBN by/IN the/DT 11-beta-hydroxylase/NEWGENE inhibitor/NN ,/, metyrapone/NN ./.
@@79518747930 Cestode/NNS invasion/NN in/IN irradiated/JJ host/NN organism/NN increases/VBZ the/DT negative/JJ effect/NN of/IN ionizing/JJ radiation/NN on/IN the/DT hamster/NN immune/JJ system/NN ./.
@@87548277412 Hoeben/NNP ,/, F/NNP ./NNP J/NNP ./.
@@86014908850 These/DT animals/NNS were/VBD viable/JJ and/CC fertile/JJ ./.
@@117528213628 CONCLUSION/IN :/: MMF/NN (/( 2-3/CD g/NN //NN day/NN )/SYM is/VBZ unable/JJ to/IN control/NN the/DT signs/NNS of/IN mucocutaneous/JJ Adamantiades-Behcet's/JJ disease/NN ./.
@@6259220690 Five/CD experiments/NNS examined/VBD the/DT influence/NN of/IN opiate/JJ antagonists/NNS on/IN both/PDT the/DT short-term/JJ analgesic/JJ reaction/NN resulting/JJ 30/CD min/NN after/IN exposure/NN to/IN inescapable/JJ shock/NN and/CC the/DT long-term/JJ analgesic/JJ reaction/NN resulting/JJ after/IN reexposure/NN to/IN shock/NN 24/NN hr/NN after/IN inescapable/JJ shock/NN exposure/NN ./.
@@91728129122 It/PRP is/VBZ concluded/VBN that/DT fludarabine/NN is/VBZ a/DT highly/RB useful/JJ agent/NN in/IN CLL/NN ./.
@@7483285910 These/DT HPV16/NN E6/NEWGENE //NEWGENE E7/NEWGENE cDNAs/NN were/VBD cloned/VBN under/IN the/DT SV40/NEWGENE enhancer/NEWGENE //NEWGENE promoter/NEWGENE and/CC the/DT MMTV/NN LTR/NEWGENE to/IN examine/VB the/DT activities/NNS of/IN ras-collaborative/JJ transformation/NN and/CC induction/NN of/IN cellular/JJ DNA/NN synthesis/NN ,/, both/DT of/IN which/WDT depend/VBP on/IN the/DT E7/NEWGENE gene/NEWGENE product/NN ./.
@@92120595682 However/RB ,/, by/IN immobilized/JJ metal/NN affinity/NN chromatography/NN assay/NN ,/, self-association/NN of/IN PR-A/NEWGENE was/VBD 3/CD ./CD 5-fold/CD more/RB efficient/JJ than/IN that/DT of/IN either/DT the/DT DhLBD/NNP or/CC hLBD/NN constructs/NN ./.
@@81157448088 The/DT GafChromic/NN method/NN has/VBZ proven/VBP to/IN be/VB an/DT accurate/JJ and/CC rapid/JJ method/NN of/IN analysis/NN and/CC could/MD be/VB easily/RB incorporated/VBN into/IN a/DT quality/JJ assurance/NN program/NN ./.
@@100921325217 High-level/JJ gains/NNS (/( HLGs/NNP )/SYM indicative/NN of/IN gene/NN amplifications/NNS were/VBD identified/VBN at/IN 11q13/CD in/IN two/CD cases/NNS ,/, and/CC in/IN one/PRP case/NN each/DT at/IN 2q33-34/JJ ,/, 3q25-29/CD ,/, 5p15/NN ./NN 1-15/NN ./NN 2/NN ,/, 7q21-22/NN ,/, 11p11/NN ./NN 2/NN ,/, 12p11/NN ./NN 2-12/NN ,/, and/CC 13q34/NN ./.
@@55551498140 Sensitive/JJ fluorometric/JJ method/NN of/IN determining/NN SH-/NN and/CC S-S-groups/NNP when/CC jointly/RB present/VB ./.
@@8429019892 The/DT DNase/NEWGENE I/NEWGENE footprint/NN extended/VBN 5'/CD in/IN the/DT silencer/NN region/NN to/IN include/VB an/DT inverted/JJ repeat/NN of/IN a/DT six-nucleotide/NN motif/NN (/( epsilon/NN -267/CD to/IN -278/CD bp/NN )/SYM which/WDT shares/VBP 5/CD of/IN 6/CD bases/NNS with/IN the/DT GATA-1/NEWGENE consensus/NEWGENE sequence/NEWGENE ./.
@@39974678000 The/DT effect/NN of/IN the/DT opiate/NN antagonist/NN naloxone/NN was/VBD evaluated/VBN in/IN 11/CD unselected/JJ patients/NNS with/IN cerebral/JJ ischemia/NN ./.
@@80880228065 Thus/RB ,/, in/IN stress-induced/JJ arrhythmic/JJ disease/NN as/RB well/VB as/IN in/IN ischemic/JJ heart/NN disease/NN ,/, the/DT main/JJ pathogenetic/JJ links/NNS are/VBP outside/RB the/DT heart/NN ,/, but/CC they/PRP differ/VBP from/IN those/DT observed/VBN in/IN ischemia/NN ./.
@@107470991663 Extracellular-regulated/NEWGENE kinase/NEWGENE (/( ERK/NEWGENE )/SYM activation/NN and/CC molecular/JJ coupling/NN of/IN the/DT adaptor/NN proteins/NN p130/NEWGENE Crk-associated/NEWGENE substrate/NEWGENE (/( CAS/NEWGENE )/SYM and/CC c-CrkII/NEWGENE (/( Crk/NEWGENE )/SYM represent/VB two/JJ distinct/JJ pathways/NNS that/WDT induce/VBP cell/NN invasion/NN and/CC protect/VB cells/NNS from/IN apoptosis/NN in/IN a/DT three-dimensional/JJ collagen/NEWGENE matrix/NN ./.
@@106275329748 We/PRP demonstrate/VBP that/IN both/DT R/NN and/CC Z/NN activate/VB the/DT cellular/JJ stress/NN mitogen-activated/NEWGENE protein/NEWGENE (/NEWGENE MAP/NEWGENE )/NEWGENE kinases/NEWGENE ,/, p38/NEWGENE and/CC JNK/NEWGENE ,/, resulting/VBG in/IN phosphorylation/NN (/( and/CC activation/NN )/SYM of/IN the/DT cellular/NEWGENE transcription/NEWGENE factor/NEWGENE ATF2/NEWGENE ./.
@@108149891440 Hepatitis/NN C/NN virus/NN infection/NN and/CC lymphoproliferative/JJ diseases/NNS in/IN France/NN :/: a/DT national/JJ study/NN ./.
@@98195076439 In/NN this/DT study/NN ,/, rabbits/NNS were/VBD used/VBN to/IN evaluate/VB the/DT sutured/VBN wound/JJ reaction/NN with/IN Dexon/NN or/CC nylon/NN in/IN the/DT conjunctival/JJ flap/NN 1/NN ,/, 4/CD ,/, 7/CD ,/, 14/CD and/CC 28/CD days/NNS after/IN trabeculectomy/NN surgery/NN with/IN or/CC without/IN the/DT use/NN of/IN mitomycin-C/NN ./.
@@90083019780 Mutant/NNP enzyme/NN forms/NNS were/VBD prepared/VBN to/IN eliminate/VB the/DT initial/JJ autoprocessing/NN site/NN and/CC thus/RB form/VB an/DT active/JJ single-chain/NN protein/NN for/IN structure-function/NN studies/NNS ./.
@@112793851108 A/DT new/JJ echocardiographic/JJ technique/NN is/VBZ described/VBN with/IN a/DT conventional/JJ M/NN mode/NN ,/, digitalised/JJ 2D/JJ and/CC tissular/JJ Doppler/NN which/WDT has/VBZ a/DT comparable/JJ ability/NN to/IN identify/VB the/DT anomalous/JJ pathways/NNS of/IN electric/JJ conduction/NN using/VBG a/DT non-invasive/JJ method/NN ./.
@@75114445893 Hepatitis/NN C/NN virus/NN infection/NN is/VBZ a/DT risk/NN factor/NN for/IN liver/NN failure/NN from/IN veno-occlusive/JJ disease/NN after/IN bone/NN marrow/NN transplantation/NN ./.
@@115595646393 NB-506/NN completely/RB inhibits/VBZ the/DT capacity/NN of/IN topoisomerase/NEWGENE I/NEWGENE to/IN phosphorylate/VB ,/, in/IN vitro/FW ,/, the/DT human/NEWGENE splicing/NEWGENE factor/NEWGENE 2/NEWGENE //NEWGENE alternative/NEWGENE splicing/NEWGENE factor/NEWGENE (/( SF2/NEWGENE //NEWGENE ASF/NEWGENE )/SYM ./.
@@107816041450 An/DT analysis/NN of/IN synthetic/JJ peptides/NNS revealed/VBD a/DT minimal/JJ CTD/NN sequence/NN that/WDT is/VBZ sufficient/JJ to/IN bind/NN to/IN the/DT second/JJ Rsp5/NEWGENE WW/NEWGENE domain/NEWGENE (/( Rsp5/NEWGENE WW2/NEWGENE )/SYM in/IN vitro/FW and/CC in/IN yeast/NN two-hybrid/JJ assays/NNS ./.
@@31148293832 Clinical/NNP and/CC biological/JJ correlates/VBP of/IN panic/NN states/NNS ./.
@@13922774587 Comments/NNS are/VBP given/VBP on/IN the/DT present/NN status/NN of/IN regulations/NNS concerning/VBG water/NN in/IN swimming/JJ pools/NNS and/CC baths--1991--/NN (/NN in/NN connection/NN with/IN the/DT KOK/NN regulations--1972--and/NN the/DT Federal/JJ German/JJ standard/JJ [/NN DIN/NN ]/NN No/NN ./NN
@@81820568701 The/DT high/JJ degree/NN of/IN conservation/NN between/IN NQO2/NEWGENE and/CC NQO1/NEWGENE gene/NEWGENE organization/NN and/CC sequence/NN confirmed/VBN that/IN NQO2/NEWGENE gene/NEWGENE encodes/VBZ for/IN a/DT second/JJ member/NN of/IN the/PDT NQO/NEWGENE gene/NEWGENE family/NEWGENE in/IN human/NN ./.
@@77355903085 The/DT concentration/NN of/IN mite/NN allergen/NN was/VBD very/RB low/JJ (/( mean/JJ 0/CD ./CD 18/CD micrograms/NNS Der/NNP p/NN milligrams/NNS sieved/VBN house/JJ dust/NN )/SYM ,/, whereas/IN that/DT of/IN cat/NN allergen/NN was/VBD high/JJ in/IN homes/NNS with/IN a/DT cat/NN (/( 80/CD ./CD 8/CD micrograms/NNS Fel/NN d/NN milligrams/NNS )/SYM but/CC also/RB in/IN homes/NNS with/IN no/DT cat/NN (/( 3/CD ./CD 2/CD micrograms/NNS Fel/NN d/NN milligrams/NNS )/SYM ./.
@@75125523024 Joys/NNP and/CC F/NN ./NN
@@23842653036 These/DT results/NNS suggest/VBP an/DT increased/VBN risk/NN of/IN developing/JJ cancer/NN among/IN polyp/NN patients/NNS and/CC the/DT possibility/NN of/IN prophylactic/JJ effect/NN of/IN polypectomy/NN against/IN subsequent/JJ cancer/NN ./.
@@114649971339 Such/JJ knowledge/NN could/MD advance/VB diagnosis/NN and/CC treatment/NN of/IN the/DT patient/NN and/CC counseling/NN of/IN the/DT affected/VBN family/NN ./.
@@114074487459 Our/PRP results/NNS are/VBP reassuring/VBG and/CC we/PRP therefore/RB advise/VBP that/IN in/IN patients/NNS undergoing/VBG free/JJ jejunum/NN flap/NN reconstruction/NN of/IN the/DT hypopharyngo-esophageal/JJ tract/NN voice/NN restoration/NN should/MD be/VB attempted/VBN by/IN placing/VBG a/DT voice/NN prosthesis/NN through/RB a/DT secondary/JJ tracheo-esophageal/JJ puncture/NN and/CC providing/CC intensive/JJ speech/NN training/NN ./.
@@70042366790 The/DT results/NNS indicate/VBP that/IN folate/NN compounds/NNS decrease/NN formate/NN accumulation/NN after/IN methanol/NN by/IN stimulating/JJ formate/NN oxidation/NN or/CC utilization/NN and/CC suggest/VB a/DT possible/JJ use/NN for/IN folates/NNS in/IN the/DT treatment/NN of/IN certain/JJ cases/NNS of/IN human/JJ methanol/NN poisoning/VBG ./.
@@16953146417 Platelet/NN aggregation/NN and/CC metabolic/JJ control/NN are/VBP not/RB affected/VBN by/IN calcium/NN antagonist/NN treatment/NN in/IN type/NN II/NNP diabetes/NN mellitus/MD ./.
@@78657866740 Gene/NNP expression/NN occurs/VBZ in/IN a/DT circadian/JJ rhythm/NN and/CC induced/VBN by/IN light/NN in/IN leaves/NNS of/IN dark-adapted/JJ plants/NNS ./.
@@107641505020 In/NN this/DT study/NN ,/, the/DT abilities/NNS of/IN constitutive/JJ and/CC conditional/JJ forms/NNS of/IN the/DT three/CD Raf/NEWGENE kinases/NEWGENE to/IN abrogate/VB the/DT cytokine/NN dependency/NN of/IN FDC-P1/NNP cells/NNS were/VBD examined/VBN ./.
@@117301823678 There/EX was/VBD a/DT statistically/RB significant/JJ correlation/NN between/IN simultaneous/JJ weekly/JJ average/JJ pollen/NN levels/NNS in/IN Philadelphia/NN and/CC in/IN Cherry/NNP Hill/NN (/( Acer/NNP ,/, r/NN (/NN p/NN )/SYM =/SYM 0/CD ./CD 987/CD ,/, Quercus/ORG ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 645/CD ,/, Betula/ORG ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 896/CD ,/, Pinus/NN ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 732/CD ,/, Cupressaceae/JJ ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 695/CD ,/, Poaceae/JJ ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 950/CD ,/, Ambrosia/NN ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 903/CD ,/, and/CC Rumex/NN ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 572/CD ,/, P/NN </SYM 0/NN ./NN 001/NN )/NN ./.
@@85893158564 Despite/IN an/DT overall/JJ survival/NN rate/NN of/IN 43%/JJ ,/, survival/NN to/IN discharge/NN varied/VBN greatly/RB (/( 0/CD to/IN 100%/CD )/SYM among/IN the/DT 24/CD diagnostic/JJ groups/NNS :/: tumor/NN lysis/NN syndrome/NN and/CC systemic/JJ lupus/NN erythematosus/NN (/( 3/CD //CD 3/CD patients/NNS each/DT ,/, 100%/CD )/SYM ,/, hemolytic/JJ uremic/JJ syndrome/NN (/( 8/CD //CD 9/CD patients/NNS ,/, 89%/CD )/SYM ./.
@@88964021437 Natural/NN FL/NEWGENE protein/NEWGENE has/VBZ been/VBN purified/VBN from/IN a/DT stromal/JJ cell/NN line/NN and/CC shown/VBP to/IN be/VB a/DT 65/NN kD/NN nondisulfide-linked/NN homodimeric/NN glycoprotein/NN comprised/VBN of/IN 30/NN kD/NN subunits/NN ,/, each/DT containing/NN 12/NN kD/NN of/IN N-/DT and/CC O-linked/JJ sugars/NNS ./.
@@65218023361 Scientific/NNP cooperation/NN of/IN CMEA/NN member/NN countries/NNS has/VBZ been/VBN carried/VBN out/RB since/IN 1974/CD under/IN the/DT sponsorship/NN of/IN the/DT Cancer/NNP Research/NNP Institute/NNP ,/, Slovak/JJ Academy/NNP of/IN Sciences/NNPS (/( Czechoslovakia/NN )/SYM within/IN the/DT framework/NN of/IN CMEA/NN ./.
@@93937179802 These/DT observations/NNS provide/VBP strong/JJ support/NN for/IN the/DT idea/NN that/DT expression/NN of/IN mutant/JJ tRNA/NN can/MD confer/VB a/DT mutator/NN phenotype/NN ,/, including/JJ the/DT UVM-constitutive/NNP phenotype/NN observed/VBN in/IN mutA/NEWGENE and/CC mutC/NEWGENE cells/NNS ./.
@@9324720365 Prior/RB to/IN meals/NNS 2/CD to/IN 3/CD times/NNS daily/JJ ,/, 1-2/CD tablespoons/NNS of/IN Alzoon/NN are/VBP recommended/VBN ./.
@@80413623907 Molecular/NNP cloning/NN of/IN a/DT cysteine/NEWGENE synthase/NEWGENE cDNA/NEWGENE from/IN Citrullus/NNP vulgaris/JJ (/( watermelon/NN )/SYM by/IN genetic/JJ complementation/NN in/IN an/DT Escherichia/NN coli/JJ Cys-/NNP auxotroph/NN ./.
@@104360168388 Gel/NNP filtration/NN and/CC co-immunoprecipitation/NN analyses/NNS reveal/VBP that/IN Mad2p/NEWGENE tightly/RB associates/VBP with/IN another/DT spindle/NN checkpoint/NN component/NN ,/, Mad1p/NEWGENE ./.
@@29719573690 The/DT absorbable/JJ perisplenic/JJ mesh/NN is/VBZ an/DT important/JJ improvement/NN ,/, and/CC in/IN some/DT cases/NNS it/PRP may/MD replace/VB other/DT techniques/NNS for/IN arresting/JJ splenic/JJ bleeding/NN ./.
@@88236469251 Administration/NNP of/IN adrenaline/NN resulted/VBN in/IN a/DT large/JJ overestimation/NN of/IN the/DT SaO2/NN in/IN 6/CD of/IN the/DT 7/CD measurements/NNS ./.
@@7871754785 This/DT finding/NN represents/VBZ both/PDT a/DT potentially/RB important/JJ mechanism/NN by/IN which/WDT HPV/NN gene/NN expression/NN can/MD be/VB regulated/VBN and/CC an/DT interesting/JJ model/NN for/IN the/DT study/NN of/IN transcriptional/JJ cooperativity/NN ./.
@@78883062342 Expression/NNS of/IN h6/CD ./CD 1/CD in/IN COS-1/NNP cells/NNS led/VBN to/IN the/DT production/NN of/IN a/DT typical/JJ type/NEWGENE IV/NEWGENE PDE/NEWGENE activity/NN in/IN that/DT cAMP/NN ,/, but/CC not/RB cGMP/NN ,/, served/VBN as/IN substrate/NN and/CC its/PRP activity/NN was/VBD insensitive/JJ to/IN either/DT Ca2+/NNP //NNP CaM/NNP or/CC cGMP/NN but/CC was/VBD inhibited/VBN by/IN low/JJ concentrations/NNS of/IN rolipram/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@16206109638 In/NN conclusion/NN ,/, to/IN study/NN and/CC overcome/VB TI/NNP region-based/JJ expression/NN problems/NNS it/PRP is/VBZ worthwhile/JJ to/IN start/NN out/RB with/IN a/DT versatile/JJ vector/NN containing/JJ exhaustive/JJ mutations/NNS in/IN the/DT periShine-Dalgarno/NN sequences/NN ;/: as/IN a/DT rule/NN the/DT coding/JJ MTI/NN subregion/NN can/MD be/VB kept/VBP unchanged/JJ ./.
@@28004171079 In/NN the/DT group/NN of/IN asthmatics/NNS statistically/RB significant/JJ correlation/NN was/VBD found/VBN between/IN PC20/NN PGF2/NN alpha/NN and/CC histamine/NN values/NNS (/( r/JJ =/SYM 0/CD ./CD 538/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@114321121312 PURPOSE/NNS :/: The/DT objective/NN of/IN this/DT study/NN was/VBD to/IN assess/VB first/JJ embryo/NN cleavage/NN (/( FEC/NN )/SYM 25-27/JJ h/NN after/IN intracytoplasmic/JJ sperm/NN injection/NN (/( ICSI/NN )/SYM as/IN a/DT parameter/NN for/IN the/DT embryo/NN selection/NN process/NN ./.
@@40848964771 The/DT recommendation/NN is/NNS made/VBP that/IN specific/JJ sub-groups/NNS of/IN attempters/NNS need/NN to/IN be/VB identified/VBN and/CC may/MD warrant/VB specialized/JJ intervention/NN strategies/NNS ./.
@@84443451707 The/DT deduced/VBN bovine/JJ EFIA#1/NEWGENE amino/JJ acid/NN (/( aa/NNS )/SYM sequence/NN is/VBZ 98%/NN identical/JJ to/IN rat/NN EFIA/NEWGENE and/CC 100%/NN identical/JJ to/IN human/NEWGENE EFIA/NEWGENE //NEWGENE DbpB/NEWGENE //NEWGENE YB-1/NEWGENE family/NEWGENE member/NN DNA-binding/NEWGENE protein/NEWGENE B/NEWGENE (/( DbpB/NEWGENE )/SYM ./.
@@89145221715 The/DT STE20/NEWGENE gene/NEWGENE ,/, encoding/VBG a/DT protein/NEWGENE kinase/NEWGENE required/VBN for/IN pheromone/NN signal/JJ transduction/NN ,/, has/VBZ recently/RB been/VBN identified/VBN in/IN a/DT genetic/JJ screen/NN for/IN high-gene-dosage/NN suppressors/NNS of/IN a/DT partly/RB defective/NN G/NEWGENE beta/NEWGENE mutation/NN ./.
@@27663303466 The/DT author/NN gives/VBZ an/DT account/NN of/IN antipsychotic/JJ ,/, analgetic/JJ ,/, myorelaxing/VBG and/CC vasodilatating/JJ effects/NNS of/IN some/DT calcium/NN antagonists/NNS ,/, and/CC their/PRP clinical/JJ application/NN is/VBZ discussed/VBN ./.
@@34361194139 Quantitative/JJ computed/JJ tomography/NN for/IN measuring/JJ vertebral/JJ bone/NN mineral/JJ content/NN offers/VBP high/JJ sensitivity/NN and/CC reproducibility/NN ./.
@@113990649659 Autoregulation/NNS enables/VBZ different/JJ pathways/NNS to/IN control/NN CCAAT/NEWGENE //NEWGENE enhancer/NEWGENE binding/NEWGENE protein/NEWGENE beta/NEWGENE (/( C/NEWGENE //NEWGENE EBP/NEWGENE beta/NEWGENE )/SYM transcription/NN ./.
@@76780066725 Little/NN or/CC no/DT protection/NN was/VBD detected/VBN using/VBG adrenal/JJ cortex/NN ,/, adrenal/JJ medulla/NN ,/, liver/NN ,/, kidney/NN cortex/NN ,/, spleen/NN ,/, or/CC T-lymphocyte/NN total/JJ RNA/NN ./.
@@108914414719 Furthermore/RB ,/, a/DT pTyr317/NEWGENE Shc/NEWGENE phosphopeptide/NEWGENE selectively/RB recognized/VBD Grb2/NEWGENE ,/, Sos1/NEWGENE ,/, SHIP/NEWGENE ,/, and/CC the/DT p85/NEWGENE subunit/NEWGENE of/IN phosphatidylinositol/NEWGENE 3'/NEWGENE kinase/NEWGENE from/IN mast/NN cells/NNS ,/, as/IN characterized/VBN by/IN mass/JJ spectrometry/NN ./.
@@104825169663 A/DT 5'/CD RNA/NN stem-loop/NN participates/VBZ in/IN the/DT transcription/NN attenuation/NN mechanism/NN that/IN controls/NNS expression/NN of/IN the/DT Bacillus/NEWGENE subtilis/NEWGENE trpEDCFBA/NEWGENE operon/NEWGENE ./.
@@17218849666 A/DT second/JJ even/VB more/RB significant/JJ match/NN to/IN this/DT E/NNP ./NNP coli/JJ region/NN was/VBD found/VBN in/IN the/DT retroviral/NEWGENE ribonuclease/NEWGENE H/NEWGENE (/( RNase/NEWGENE H/NEWGENE )/SYM domain/NN ,/, and/CC corresponds/VBZ precisely/RB to/IN a/DT region/NN that/WDT has/VBZ been/VBN aligned/VBN by/IN previous/JJ investigators/NNS with/IN the/DT E/NEWGENE ./NEWGENE coli/NEWGENE RNase/NEWGENE H/NEWGENE ,/, suggesting/VBG that/IN Pol/NEWGENE I/NEWGENE helices/NNS O/NN and/CC P/NN are/VBP homologous/JJ to/IN helices/NNS A/DT and/CC D/NN of/IN the/DT RNase/NEWGENE H/NEWGENE crystal/NN structure/NN ,/, respectively/RB ./.
@@80011362301 Relationship/NNP of/IN CDK-activating/NEWGENE kinase/NEWGENE and/CC RNA/NEWGENE polymerase/NEWGENE II/NEWGENE CTD/NEWGENE1 kinase/NEWGENE1 TFIIH/NEWGENE //NEWGENE TFIIK/NEWGENE ./.
@@105927911499 In/NN conclusion/NN :/: (/( i/NN )/SYM TECRA/NN kit/NN is/VBZ suggested/VBN to/IN be/VB used/VBN for/IN screening/JJ SE/NN producing/JJ strains/NNS ;/: (/( ii/NN )/SYM SET-RPLA/NN and/CC RIDASCREEN/NN kits/NNS are/VBP suitable/JJ for/IN epidemiological/JJ investigation/NN of/IN SE/NN types/NNS ,/, but/CC the/DT lack/NN of/IN ability/NN for/IN detecting/JJ SEE/VBP ,/, long/JJ time/NN required/VBN for/IN testing/NN with/IN SET-RPLA/NN kit/NN and/CC high/JJ background/NN when/CC using/VBG RIDASCREEN/NN kit/NN must/MD be/VB overcome/VB ;/: and/CC (/( iii/NN )/SYM because/IN of/IN the/DT complicated/VBN test/NN procedures/NNS and/CC the/DT lack/NN of/IN ability/NN for/IN detecting/JJ SEE/VBP ,/, the/DT practicality/NN of/IN SET-EIA/NN kit/NN in/IN screening/JJ and/CC epidemiological/JJ research/NN purposes/NNS is/VBZ low/JJ ./.
@@10211919147 Significantly/RB greater/JJR improvement/NN (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM in/IN the/DT sertraline/NN group/NN first/NN became/VBD apparent/JJ by/IN the/DT end/NN of/IN week/NN 3/CD on/IN the/DT Y-BOCS/NNP and/CC the/DT CGI/NNP Improvement/NNP scale/NN ,/, and/CC by/IN the/DT end/NN of/IN weeks/NNS 6/CD and/CC 8/CD ,/, respectively/RB ,/, on/IN the/DT NIMH/NN and/CC CGI/DT Severity/NN scale/NN ./.
@@111086162743 Young/NN fish/NN (/( Oreochromis/NNP mossambicus/NN )/SYM were/VBD exposed/VBN to/IN microgravity/NN (/( mug/NN )/SYM for/IN 9/CD to/IN 10/CD days/NNS during/IN space/NN missions/NNS STS-55/NN and/CC STS-84/NN ,/, or/CC to/IN hypergravity/NN (/( hg/NN )/SYM for/IN 9/CD days/NNS ./.
@@108879129676 Both/PDT the/DT MVBF/NN and/CC the/DT maximum/JJ EMG/JJ activity/NN in/IN the/DT right/JJ masseter/NN and/CC the/DT left/JJ anterior/JJ temporalis/JJ muscles/NNS were/VBD significantly/RB decreased/VBN during/IN muscle/NN pain/NN when/CC the/DT subjects/NNS bit/NN on/IN the/DT painful/JJ side/NN ./.
@@103813776883 Molecular/NNP cloning/NN of/IN rat/NEWGENE SH2-containing/NEWGENE inositol/NEWGENE phosphatase/NEWGENE 2/NEWGENE (/( SHIP2/NEWGENE )/SYM and/CC its/PRP role/NN in/IN the/DT regulation/NN of/IN insulin/NEWGENE signaling/JJ ./.
@@96948605286 The/DT C-terminal/NN region/NN contains/VBZ the/DT PTP-like/NEWGENE domain/NEWGENE ,/, whereas/IN the/DT N-terminal/NN region/NN shows/VBZ no/DT homology/NN to/IN any/DT known/VBP mammalian/JJ protein/NN ./.
@@10578528405 It/PRP may/MD be/VB dependent/JJ on/IN location/NN of/IN a/DT focus/NN (/( according/VBG to/IN EEG/NN )/SYM as/RB well/VB as/IN on/IN the/DT character/NN and/CC manifestation/NN of/IN the/DT accompanying/JJ neuropsychologic/JJ symptomatology/NN ./.
@@19638582587 Selective/JJ activation/NN of/IN adrenaline/NN secretion/NN by/IN the/DT rat/NN adrenal/JJ in/IN neuroglycopenia/NN detected/VBD via/NN microdialysis/NN ./.
@@104537215792 A/DT limited/VBN sampling/JJ strategy/NN was/VBD used/VBN based/VBN on/IN a/DT bayesian/JJ parameter/NN estimation/NN algorithm/NN that/WDT is/VBZ part/NN of/IN the/DT ADAPT/NN II/NN software/NN package/NN ./.
@@112389474470 A/DT single/JJ base/NN change/NN (/( A8G/NNP )/SYM in/IN either/DT sequence/NN reduces/VBZ hnRNP/NEWGENE A2/NEWGENE binding/JJ and/CC ,/, in/IN the/DT case/NN of/IN A2RE-2/NEWGENE ,/, inhibits/VBZ RNA/NN transport/NN ./.
@@27742718862 Halothane/CHEM is/VBZ metabolized/VBN by/IN an/DT oxidative/JJ pathway/NN to/IN stable/JJ ,/, nonvolatile/JJ end/JJ products/NNS ,/, trifluoroacetic/JJ acid/NN (/( TFAA/NN )/SYM and/CC bromide/NN (/( Br-/IN )/SYM ,/, and/CC by/IN reductive/JJ pathways/NNS to/IN Br-and/NNP inorganic/JJ fluoride/NN (/( F-/DT )/SYM ./.
@@76263783149 Hepatitis/NN B/NN vaccine/NN :/: still/RB has/VBZ its/PRP problems/NNS ./.
@@94482682828 We/PRP have/VBP cloned/VBN a/DT kinase/NN ,/, Nlk/NEWGENE ,/, that/WDT is/VBZ a/DT murine/NEWGENE homolog/NEWGENE of/NEWGENE the/NEWGENE Drosophila/NEWGENE nemo/NEWGENE (/( nmo/NEWGENE )/SYM gene/NN ./.
@@83556964355 The/DT UV/NN induction/NN of/IN c-jun/NEWGENE is/VBZ mediated/JJ by/IN two/JJ UV/NEWGENE response/NEWGENE elements/NEWGENE consisting/VBG of/IN AP-1-like/NEWGENE sequences/NEWGENE within/IN its/PRP 5'/CD control/NN region/NN ./.
@@107066883521 We/PRP found/VBP that/IN TCR/NEWGENE signaling/NN induces/VBZ AP-1/NEWGENE binding/JJ to/IN this/DT site/NN and/CC regulates/VBZ the/DT fasl/NEWGENE promoter/NEWGENE function/NN in/IN a/DT fashion/NN dependent/JJ on/IN NF-kappaB/NEWGENE binding/JJ ./.
@@96931342308 Specifically/RB ,/, I/PRP use/NN molecular/JJ markers/NNS that/WDT identify/VBP particular/JJ neuroectodermal/JJ domains/NNS ,/, all/DT neuroblasts/NNS or/CC individual/JJ neuroblasts/NNS ,/, to/IN show/NN that/IN in/IN DER/NEWGENE mutant/NEWGENE embryos/NNS (/( 1/CD )/SYM intermediate/JJ column/NN neuroblasts/NNS do/VBP not/RB form/VB ,/, (/( 2/CD )/SYM medial/JJ column/NN neuroblasts/NNS often/RB acquire/VBP identities/NNS inappropriate/JJ for/IN their/PRP position/NN ,/, while/CC (/( 3/CD )/SYM lateral/JJ neuroblasts/NNS develop/VBP normally/RB ./.
@@80631088306 The/DT acfD/NEWGENE gene/NEWGENE encompasses/VBZ 254/CD nt/NN that/WDT are/VBP predicted/VBN to/IN encode/VB an/DT 88-amino-acid/JJ (/( aa/NNS )/SYM protein/NN ./.
@@63240894348 The/DT primary/JJ structure/NN of/IN the/DT GAL7/NEWGENE 5'/NEWGENE flanking/NEWGENE region/NEWGENE has/VBZ many/JJ features/NNS common/JJ to/IN those/DT of/IN multicellular/JJ eukaryotic/NN genes/NN ./.
@@38485276558 Hisako/NNP Minowa/NN who/WP has/VBZ worked/VBN as/IN a/DT psychiatric/JJ counsellor/NN in/IN industry/NN for/IN the/DT past/JJ 20/CD years/NNS ./.
@@89903973324 Finally/RB ,/, nonphotosynthetic/JJ mutants/NNS ,/, including/JJ the/DT tscA-lacking/NEWGENE photosystem/NEWGENE I/NEWGENE mutant/NEWGENE ,/, H13/NN ,/, did/VBD not/RB show/VB evidence/NN of/IN light-stimulated/JJ RNA/NN processing/VBG ./.
@@37993234485 Under/IN the/DT same/JJ hematocrit/NN and/CC flow/NN conditions/NNS ,/, the/DT rate/NN of/IN oxygen/NN saturation/NN decrease/NN was/VBD significantly/RB higher/JJ for/IN the/DT sickle/JJ cells/NNS than/IN for/IN normal/JJ cells/NNS ./.
@@9333026963 The/DT genomic/JJ structure/NN of/IN brk/NEWGENE consists/VBZ of/IN 8/CD exons/NNS ,/, whose/WP boundaries/NNS are/VBP distinct/JJ from/IN other/DT non-receptor/NN PTK/NEWGENE family/NEWGENE members/NN ,/, again/RB indicating/VBG a/DT structural/JJ and/CC functional/JJ divergence/NN ./.
@@72701637121 The/DT syncytial/JJ microvillous/JJ projections/NNS seemed/VBN to/IN be/VB more/RB numerous/JJ and/CC longer/JJR in/IN CNF/NNP ,/, otherwise/RB the/DT structure/NN of/IN the/DT trophoblastic/JJ layer/NN of/IN the/DT villi/NNS and/CC the/DT lining/NN of/IN the/DT subtrophoblastic/JJ vessels/NNS were/VBD identical/JJ in/IN CNF/NNP and/CC controls/NNS ./.
@@68330474714 This/DT study/NN was/VBD undertaken/VBP to/IN define/VB the/DT mechanism/NN for/IN the/DT respiratory/JJ inhibition/NN observed/VBN during/IN high-frequency/JJ oscillatory/JJ ventilation/NN (/( HFOV/NN )/SYM ./.
@@6683876998 These/DT cells/NNS averaged/VBN 17/CD microns/NNS in/IN diameter/NN and/CC reproduced/VBN by/IN fission/NN ,/, forming/NN clusters/NN of/IN two/JJ or/CC four/CD daughter/JJ cells/NNS ./.
@@92528792185 Then/RB we/PRP correlated/VBD HRCT/NN findings/NNS with/IN the/DT clinical/JJ features/NNS ,/, pulmonary/JJ functions/NNS and/CC methacholine/NN PC20/NN (/( PC20M/NN )/SYM and/CC studied/VBN their/PRP clinical/JJ significance/NN ./.
@@115350144588 From/IN the/DT above/RB results/VBZ ,/, we/PRP might/MD infer/VB that/IN the/DT seizure/NN type/NN of/IN TLE/NNS and/CC a/DT high/JJ frequency/NN of/IN seizure/NN are/VBP two/JJ major/JJ independent/JJ precipitate/NN factors/NNS for/IN abnormal/JJ latencies/NNS of/IN P300/NN in/IN the/DT epileptic/JJ patients/NNS ./.
@@82182308032 The/DT regulatory/JJ region/NN also/RB has/VBZ a/DT sequence/NN similar/JJ to/IN the/DT binding/JJ site/NN for/IN a/DT liver-specific/NN transcription/NN factor/NN ,/, hepatocyte/NEWGENE nuclear/NEWGENE factor/NEWGENE 1/NEWGENE (/( HNF-1/NEWGENE )/SYM ,/, at/IN positions/NNS -120/CD to/IN -132/CD ./.
@@15457929479 Deletion/NNS mutagenesis/NN demonstrated/VBN that/IN these/DT two/JJ elements/NNS are/VBP involved/VBN in/IN the/DT positive/JJ regulation/NN of/IN MLC-2/NEWGENE gene/NEWGENE transcription/NN ./.
@@22098112837 Horseradish/NEWGENE peroxidase/NEWGENE as/IN a/DT permeability/NN marker/NN in/IN injured/JJ rat/NN caudal/JJ and/CC iliac/JJ arteries/NNS ./.
@@16072238566 Recent/JJ investigations/NNS have/VBP detailed/VBD a/DT selective/JJ dye/NN release/NN technique/NN in/IN which/WDT a/DT pulse/NN of/IN laser/NN light/NN induces/VBZ the/DT release/NN of/IN a/DT fluorescent/JJ dye/NN from/IN temperature-sensitive/JJ liposomes/NNS circulating/JJ in/IN the/DT retinal/JJ vasculature/NN ./.
@@81882908207 Using/VBG the/DT sequence/NN data/NN obtained/VBN from/IN the/DT human/NEWGENE TCRAC/NEWGENE //NEWGENE TCRDC/NEWGENE region/NEWGENE ,/, we/PRP have/VBP extended/VBN a/DT polymerase/NEWGENE chain/NN reaction-based/JJ assay/NN to/IN test/NN for/IN the/DT expression/NN of/IN the/DT individual/JJ TCRAJ/NEWGENE gene/NEWGENE segments/NEWGENE ./.
@@21901342811 No/DT therapy/NN exists/VBZ for/IN halting/JJ the/DT progression/NN of/IN the/DT disease/NN with/IN the/DT possible/JJ exception/NN of/IN laser/NN photocoagulation/NN treatment/NN used/VBN to/IN ablate/VB subretinal/JJ neovascular/JJ membranes/NNS in/IN an/DT attempt/NN to/IN avoid/VB complications/NNS of/IN subretinal/JJ hemorrhages/NNS ./.
@@11084556923 Association/NNP of/IN stress/NN during/IN delivery/NN with/IN increased/VBN numbers/NNS of/IN nucleated/JJ cells/NNS and/CC hematopoietic/JJ progenitor/NN cells/NNS in/IN umbilical/JJ cord/NN blood/NN ./.
@@98159489795 The/DT pharmacokinetic/JJ parameters/NNS which/WDT helped/VBD predict/VB these/DT toxicities/NNS included/VBD area/NN under/IN the/DT curve/NN and/CC peak/NN plasma/NN level/NN ./.
@@82304526368 In/NN contrast/NN ,/, capsid/NN proteins/NNS derived/VBN from/IN the/DT P1/NEWGENE precursor/NEWGENE with/IN a/DT valine/NN substitution/NN at/IN the/DT amino/JJ terminus/NN of/IN VP1/NEWGENE (/( VP1-G001V/NEWGENE )/SYM assembled/VBN empty/JJ capsid/NN particles/NNS but/CC were/VBD deficient/JJ in/IN assembling/JJ RNA-containing/JJ virions/NNS ./.
@@108455229656 OBJECTIVE/IN :/: This/DT study/NN was/VBD conducted/VBN to/IN assess/VB the/DT relative/JJ roles/NNS of/IN 99mTc-sestamibi/NN scintimammography/NN and/CC sonography/NN in/IN the/DT evaluation/NN of/IN breast/NN lesions/NNS that/WDT are/VBP indeterminate/JJ or/CC suspicious/JJ on/IN mammography/NN or/CC clinical/JJ examination/NN ./.
@@22343452536 The/DT glial/NN cyst/NN wall/NN was/VBD lined/VBN in/IN part/NN by/IN flattened/JJ or/CC cuboidal/JJ epithelium/NN ./.
@@92721081546 Analysis/NNP of/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT gene/NN also/RB revealed/VBD the/DT presence/NN of/IN multiple/JJ TATA/NN and/CC CAAT/NN sequences/NN ./.
@@3259437451 In/NN the/DT infected/VBN neonates/NNS serum/JJ alpha-amylase/NEWGENE value/NN ,/, as/IN determined/VBN by/IN the/DT blue/JJ starch/NN method/NN ,/, was/VBD only/RB 40%/CD that/IN of/IN healthy/JJ controls/NNS ;/: the/DT mean/JJ value/NN of/IN 175/CD ./CD 1/CD +/NN //NN -/NN 64/CD ./CD 9/CD IU/NNS //NNS l/NNS for/IN healthy/JJ neonates/NNS was/VBD significantly/RB higher/JJ (/( p/NN less/PRP than/IN 0/CD ./CD 0010/CD )/SYM than/IN the/DT value/NN of/IN 82/CD ./CD 8/CD +/NN //NN -/NN 44/CD ./CD 4/CD IU/NNS //NNS l/NNS for/IN the/DT infected/VBN neonates/NNS ./.
@@88223998799 Motivational/JJ factors/NNS focusing/NN on/IN attitudes/NNS ,/, perceived/JJ susceptibility/NN to/IN pregnancy/NN ,/, and/CC normative/JJ factors/NNS were/VBD also/RB relevant/JJ ./.
@@630713705 Evaluation/NN of/IN the/DT Du/NN Pont/NN aca/NN ammonia/NN procedure/NN ./.
@@23102612958 The/DT abscess/NN was/VBD debrided/VBN and/CC the/DT septum/NN was/VBD patched/VBN with/IN a/DT single/JJ layer/NN of/IN autologous/JJ pericardium/NN ./.
@@76514247634 In/NN wild-type/JJ cells/NNS ,/, SSM1b/NEWGENE transcripts/NEWGENE accumulate/VBP to/IN twice/RB the/DT level/NN of/IN SSM1a/NEWGENE transcripts/NEWGENE ,/, suggesting/VBG that/IN SSM1b/NEWGENE is/VBZ responsible/JJ for/IN the/DT majority/NN of/IN the/DT Ssm1p/NEWGENE pool/NN ./.
@@84619462921 There/EX was/VBD either/DT no/DT change/NN or/CC an/DT improvement/NN in/IN renographic/JJ findings/NNS (/( t1/NN //NN 2/NN time/NN and/IN //IN or/IN split/JJ function/NN )/SYM in/IN 40/CD patients/NNS (/( 93%/CD )/SYM ./.
@@98356159218 Biochemical/NNP analysis/NN reveals/VBZ that/IN KS1/NEWGENE is/VBZ a/DT nuclear/JJ protein/NN containing/JJ two/JJ transcriptional/JJ repressor/NN domains/NNS ,/, R1/NEWGENE and/CC R2/NEWGENE ./.
@@10478951260 Is/VBZ criticism/NN of/IN patient/NN care/NN justified/VBN and/CC does/VBP it/PRP have/VBP educational/JJ value/NN ?/. Patients'/NN criticism/NN contributes/VBZ to/IN improved/VBN patient/NN care/NN ./.
@@96785794812 To/TO gain/VB insight/NN into/IN the/DT expression/NN of/IN the/DT AtCP1/NEWGENE gene/NEWGENE ,/, northern/JJ blot/NN analysis/NN was/VBD carried/VBN out/RB ./.
@@114355788511 These/DT TxRE/NEWGENE contain/VB cyclic/NEWGENE AMP-responsive/NEWGENE elements/NEWGENE (/( CRE/NEWGENE )/SYM ,/, but/CC ,/, remarkably/RB ,/, the/DT "TGACGTCA"/NEWGENE consensus/NEWGENE is/VBZ never/RB strictly/RB conserved/VBN in/IN any/DT viral/JJ strain/NN (/( e/NN ./NN g/NN ./NN ,/NN AGACGTCA/NN ,/, TGACGGCA/NEWGENE ,/, TGACCTCA/NEWGENE )/SYM ./.
@@94240129378 Three/CD large/JJ field/NN placement/NN errors/NNS (/( two/JJ patients/NNS with/IN 11/CD ./CD 5/CD and/CC 16/CD ./CD 0/CD mm/NN distances/NNS of/IN the/DT planned/VBN versus/IN simulated/JJ isocenter/NN ,/, respectively/RB and/CC one/PRP patient/NN with/IN a/DT 7/CD degree/NN rotational/JJ error/NN )/SYM were/VBD detected/VBN and/CC ,/, as/IN with/IN the/DT smaller/JJR errors/NNS ,/, were/VBD immediately/RB corrected/VBN ./.
@@104756109230 Natl/JJ ./.
@@86062674579 Variables/NNS evaluated/VBN were/VBD number/NN of/IN weekly/JJ anginal/JJ events/NNS ,/, data/NN from/IN ergometric/JJ exercise/NN testing/NN with/IN simultaneous/JJ electrocardiographic/JJ registration/NN ,/, semiquantitative/JJ evaluation/NN of/IN Tc-99m/NN 2-methoxy/JJ isobutyl/NN isonitrile/NN (/( MIBI/IN )/SYM scans/NNS and/CC rheologic/JJ variables/NNS ./.
@@89694951479 The/DT sequencing/VBG of/IN the/DT conditional/JJ lethal/JJ mutation/NN ts-A13/JJ ,/, localized/VBN in/IN the/DT nrdE/NEWGENE cistron/NEWGENE ,/, and/CC the/DT lethality/NN of/IN insertional/JJ mutations/NNS targeted/VBN in/IN the/DT internal/JJ region/NN of/IN nrdE/NEWGENE and/CC nrdF/NEWGENE ,/, demonstrated/VBD the/DT essential/JJ role/NN of/IN this/DT locus/NN ./.
@@97980688508 RESULTS/NNS :/: We/PRP identified/VBD a/DT full-length/JJ cDNA/NN with/IN an/DT open/JJ reading/JJ frame/NN of/IN 2883/CD bp/NN corresponding/JJ to/IN a/DT predicted/VBN protein/NN of/IN 961/CD amino/JJ acids/NNS that/WDT shares/VBP greater/JJR than/IN 95%/CD homology/NN with/IN the/DT rat/NEWGENE gamma-aminobutyric/NEWGENE acid/NEWGENE B/NEWGENE (/NEWGENE GABAB/NEWGENE )/NEWGENE receptor/NEWGENE ./.
@@75338805281 The/DT FinO/NEWGENE protein/NEWGENE of/IN IncF/ORG plasmids/NNS binds/VBZ FinP/NEWGENE antisense/NEWGENE RNA/NEWGENE and/CC its/PRP target/NN ,/, traJ/NEWGENE mRNA/NEWGENE ,/, and/CC promotes/VBZ duplex/JJ formation/NN ./.
@@93352675061 Because/IN of/IN the/DT operon/NN structure/NN of/IN this/DT organism/NN ,/, traditional/JJ methods/NNS such/JJ as/IN insertional/JJ mutagenesis/NN run/NN the/DT risk/NN of/IN introducing/JJ polar/JJ effects/NNS on/IN downstream/JJ genes/NNS or/CC creating/VBG secondary/JJ mutations/NNS elsewhere/RB in/IN the/DT genome/NN ./.
@@105900923888 However/RB ,/, mechanisms/NNS underlying/JJ HIV-1/NN gene/NN expression/NN in/IN the/DT CNS/NN are/VBP poorly/RB understood/VBP ./.
@@76107167562 The/DT analysis/NN of/IN the/DT prevalence/NN values/NNS shows/VBZ clearly/RB that/IN the/DT global/JJ MS-frequency/NN is/VBZ closer/RBR related/VBN to/IN the/DT geomagnetic/JJ than/IN to/IN the/DT geographic/JJ latitude/NN ./.
@@97675044365 A/DT single/JJ rectal/JJ dose/NN of/IN 25/CD mg/NN //NN kg/NN will/MD obtain/VB this/DT lower/JJR concentration/NN within/IN 1/CD h/NN of/IN administration/NN and/CC maintain/VB it/PRP for/IN up/JJ to/IN 6/CD h/CD ./CD
@@66154033762 During/IN a/DT single/JJ LAD/NN occlusion/NN lasting/JJ 35/CD minutes/NNS (/( series/NN I/PRP ,/, n/NN =/SYM 10/CD )/SYM 9/CD microns/NNS TMs/NNS were/VBD infused/VBN immediately/RB and/CC 30/CD minutes/NNS after/IN ligation/NN ,/, 15/CD microns/NNS TMs/NNS being/VBP infused/VBN after/IN 15-20/CD minutes/NNS ./.
@@86662387571 Selective/JJ translation/NN initiation/NN by/IN ribosome/NN jumping/JJ in/IN adenovirus-infected/JJ and/CC heat-shocked/JJ cells/NNS ./.
@@62146056023 The/DT number/NN of/IN elements/NNS and/CC their/PRP sizes/NNS relative/JJ to/IN the/DT configuration/NN were/VBD varied/VBN in/IN a/DT series/NN of/IN five/CD experiments/NNS ./.
@@10448285295 The/DT median/JJ durations/NNS for/IN response/NN and/CC survival/NN time/NN in/IN the/DT late/JJ phase/NN II/NNP trial/NN were/VBD 2/CD ./CD 3/CD months/NNS and/CC 5/CD ./CD 8/CD months/NNS ,/, respectively/RB ./.
@@86643477496 None/NN of/IN the/DT five/CD proprotein/NN processing/VBG proteases/NEWGENE tested/VBN were/VBD capable/JJ of/IN cleaving/JJ human/NEWGENE pro-LPH/NEWGENE ,/, strongly/RB suggesting/VBG that/IN they/PRP are/VBP not/RB involved/VBN in/IN the/DT maturation/NN of/IN this/DT enzyme/NN ./.
@@104825653806 Single-alanine-substitution/NNP mutations/NNS had/VBP minimal/JJ ,/, if/IN any/DT ,/, effects/VBZ on/IN S-induced/NN cell-to-cell/NN fusion/NN ./.
@@84708956090 Examination/NN of/IN the/DT immediate/JJ sequence/NN 5'/CD to/IN the/DT mRNA/NN start/NN site/NN reveals/VBZ no/DT TATA/NN box/NN and/CC multiple/JJ known/VBP enhancer/NN sequences/NNS ./.
@@15560688403 The/DT Klebsiella/NEWGENE aerogenes/NEWGENE gene/NEWGENE maoA/NEWGENE ,/, which/WDT is/VBZ involved/VBN in/IN the/DT synthesis/NN of/IN monoamine/NEWGENE oxidase/NEWGENE ,/, was/VBD induced/VBN by/IN tyramine/NN and/CC the/DT related/VBN compounds/NNS ,/, subjected/VBN to/IN catabolite/NN and/CC ammonium/NN ion/NN repression/NN ,/, and/CC cloned/VBN ./.
@@1516829274 We/PRP show/VBP that/IN LexA-GAL4/NEWGENE and/CC LexA-Bicoid/NEWGENE fusion/NEWGENE proteins/NEWGENE are/VBP both/DT dependent/NN on/IN SNF2/NEWGENE ,/, SNF5/NEWGENE ,/, and/CC SNF6/NEWGENE for/IN activation/NN of/IN target/NN genes/NNS containing/JJ one/PRP or/CC multiple/JJ lexA/NEWGENE operators/NEWGENE ./.
@@83717132991 Alternative/JJ transcript/NN of/IN the/DT nonselective-type/NN endothelin/NEWGENE receptor/NEWGENE from/IN rat/NN brain/NN ./.
@@34204664122 The/DT incidence/NN of/IN cryptosporidiosis/NN in/IN young/JJ children/NNS was/VBD determined/VBN by/IN staining/NN of/IN faecal/JJ specimens/NNS with/IN a/DT modified/JJ Kinyoun/NNP stain/NN ./.
@@108367863696 To/TO begin/VB to/IN characterize/VB the/DT role/NN of/IN the/DT RNA/NEWGENE subunits/NEWGENE in/IN enzyme/NN function/NN and/CC substrate/NN specificity/NN ,/, we/PRP swapped/VBD two/JJ hairpin/NN structures/NNS (/( MRP3/NEWGENE and/CC P3/NEWGENE )/SYM between/IN RNase/NEWGENE MRP/NEWGENE RNA/NEWGENE and/CC RNase/NEWGENE P/NEWGENE RNA/NEWGENE of/NEWGENE S/NEWGENE ./NEWGENE cerevisiae/NEWGENE ./.
@@117915851656 The/DT electrodes/NNS themselves/PRP do/VBP not/RB need/VB to/IN be/VB polished/VBN prior/NN to/IN their/PRP use/NN but/CC are/VBP observed/VBN to/IN be/VB slightly/RB recessed/JJ from/IN the/DT surrounding/JJ insulating/JJ surface/NN ./.
@@31687094795 The/DT central/NN visual/NN fields/NNS of/IN 2165/CD normal/JJ and/CC 106/CD glaucoma/NN eyes/NNS were/VBD measured/VBN using/VBG a/DT threshold/NN related/VBD suprathreshold/JJ strategy/NN ./.
@@98325059926 Thus/RB ,/, we/PRP have/VBP identified/VBN an/DT activation/NN target/NN of/IN a/DT human/JJ activator/NN ,/, Oct-1/NEWGENE ,/, within/IN its/PRP cognate/NN basal/NN transcription/NN complex/NN ./.
@@98694001795 Comparisons/NNS with/IN other/DT known/VBP germins/NEWGENE and/CC germin-like/NEWGENE proteins/NEWGENE indicate/VBP that/IN these/DT Arabidopsis/NN GLP/NEWGENE subfamilies/NNS are/VBP unique/JJ from/IN wheat/NN germin/NEWGENE ./.
@@18975152517 Bone/NN marrow/NN abnormalities/NNS in/IN Hodgkin's/NNP disease/NN are/VBP reviewed/VBN and/CC the/DT current/JJ understanding/NN of/IN the/DT pathological/JJ mechanisms/NNS leading/VBG to/IN aplastic/JJ anemia/NN is/VBZ discussed/VBN ./.
@@25412519872 That/DT of/IN the/DT T2/NEWGENE gene/NEWGENE contains/VBZ numerous/JJ potential/JJ sites/NNS for/IN binding/JJ the/DT mammalian/NEWGENE transcription/NEWGENE factor/NEWGENE SP1/NEWGENE ,/, but/CC no/DT TATA/NN or/CC CCAAT/NN sequences/NN are/VBP evident/JJ near/IN to/IN its/PRP 5'/CD end/NN ,/, although/IN these/DT latter/JJ features/NNS are/VBP associated/VBN with/IN the/DT human/NEWGENE T1/NEWGENE gene/NEWGENE ./.
@@112413326336 For/IN this/DT purpose/NN ,/, the/DT immediate/JJ and/CC the/DT final/JJ (/( after/IN swelling/NN )/SYM fixation/NN strengths/NNS of/IN two/JJ variations/NNS of/IN the/DT swellable/JJ bone/NN anchor/NN designs/NNS (/( a/DT smooth/NN anchor/NN and/CC a/DT screw/NN anchor/NN )/SYM were/VBD measured/VBN in/IN two/JJ different/JJ foams/NNS (/( used/VBN to/IN simulate/VB bone/NN )/SYM with/IN different/JJ densities/NNS ./.
@@68300338128 Similar/JJ observations/NNS were/VBD made/VBP with/IN unilateral/JJ pneumothorax/NN of/IN 15/CD cmH2O/NN for/IN 30/CD min/NN ./.
@@13169031903 The/DT unphosphorylated/JJ form/NN of/IN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE is/VBZ designated/VBN IIA/NEWGENE ,/, whereas/IN the/DT phosphorylated/VBN form/NN is/VBZ designated/VBN IIO/NEWGENE ./.
@@17155932298 When/WRB desipramine/NN was/VBD injected/VBN 16/CD hrs/NN after/IN fluoxetine/NN injection/NN ,/, brain/NN levels/NNS of/IN desipramine/NN were/VBD no/RB longer/RB elevated/VBN ./.
@@83601809278 When/WRB comparing/VBG the/DT barley/NEWGENE PSI-K/NEWGENE and/CC PSI-G/NEWGENE with/IN the/DT reported/VBN PSI-K/NEWGENE sequence/NEWGENE from/NEWGENE Synechococcus/NEWGENE vulcanus/NEWGENE ,/, the/DT degree/NN of/IN similarity/NN is/VBZ equal/VB ,/, suggesting/VBG that/IN an/DT ancestral/JJ gene/NN has/VBZ been/VBN duplicated/VBN in/IN a/DT chloroplast/NN progenitor/NN but/CC not/RB in/IN a/DT cyanobacterial/JJ ./.
@@93041239263 These/DT discoloration's/NNS can/MD be/VB treated/VBN in/IN several/DT ways/NNS but/CC up/JJ to/IN lately/RB tooth/NN structure/NN had/VBP to/IN be/VB removed/VBN in/IN an/DT irreversible/JJ manner/NN in/IN order/NN to/IN provide/VB sufficient/JJ bulk/NN for/IN the/DT new/JJ restorative/JJ material/NN ./.
@@86756088651 Outcome/NN of/IN severe/JJ congenital/JJ hypothyroidism/NN ./.
@@37121064385 The/DT effect/NN of/IN L-methionine/NN supplementation/NN on/IN the/DT utilization/NN of/IN a/DT soy/NN protein/NN isolate/NN (/( SPI/NNS )/SYM was/VBD evaluated/VBN by/IN short-term/JJ nitrogen/NN balance/NN studies/NNS in/IN young/JJ women/NNS ./.
@@99893342035 It/PRP was/VBD demonstrated/VBN that/IN the/DT processing/VBG signals/NNS in/IN the/DT transcript/NN ,/, i/NN ./NN e/NN ./. both/DT donor/NN splice/NN sites/NNS and/CC the/DT polyadenylation/NN site/NN located/VBN in/IN the/DT muscle-specific/JJ intron/NN ,/, have/VB to/IN be/VB weak/JJ ./.
@@96890473171 A/DT prerequisite/NN for/IN the/DT synthesis/NN of/IN sialylated/JJ glycoconjugates/NNS is/VBZ the/DT activated/VBN sugar-nucleotide/NN cytidine/NN 5'-monophosphate/NNP N-acetylneuraminic/NNP acid/NN (/( CMP-Neu5Ac/NNP )/SYM ,/, which/WDT provides/VBZ a/DT substrate/NN for/IN Golgi/NEWGENE sialyltransferases/NEWGENE ./.
@@29250133633 We/PRP conclude/VBP that/IN at/IN these/DT low/JJ levels/NNS studied/VBN ,/, aluminum/NN accumulates/VBZ in/IN intestinal/JJ tissue/NN ,/, and/CC that/IN this/DT accumulation/NN is/VBZ enhanced/VBN by/IN citrate/NN ligand/NN ./.
@@91113311840 The/DT Rlm1/NEWGENE protein/NEWGENE ,/, a/DT member/NN of/IN the/DT MADS/NEWGENE box/NEWGENE family/NEWGENE of/IN transcription/NN factors/NNS ,/, functions/NNS downstream/RB of/IN Mpk1/NEWGENE in/IN the/DT pathway/NN ./.
@@38601628651 Incorporation/NNS of/IN the/DT polyene/NN antibiotic/JJ amphotericin/NN B/NN (/( AMB/NN )/SYM in/IN liposomes/NNS results/NNS in/IN a/DT marked/JJ reduction/NN in/IN drug/NN toxicity/NN with/IN no/DT loss/NN of/IN antifungal/JJ potency/NN ./.
@@97366975632 Expression/NNS of/IN constitutively/RB active/JJ MEK1/NEWGENE ,/, the/DT kinase/NN that/WDT activates/VBZ ERKs/NEWGENE ,/, or/CC overexpression/NN of/IN ERK2/NEWGENE ,/, but/CC not/RB JNK1/NEWGENE ,/, inhibited/VBN Stat3/NEWGENE activation/NN ./.
@@106578993712 Pretreatment/NNS of/IN cells/NNS or/CC mouse/NN skin/NN with/IN antisense/NN oligonucleotides/NNS of/IN PKCzeta/NEWGENE impaired/VBN UV-induced/JJ activation/NN of/IN AP-1/NEWGENE in/IN JB6/NNP cells/NNS as/RB well/VBP as/IN in/IN AP-1-luciferase/NEWGENE transgenic/JJ mice/NNS ./.
@@8778575926 Serum/NEWGENE amylase/NEWGENE became/VBD markedly/RB elevated/VBN (/( 2/CD ,/CD 624/CD CU/NNP //NNP 100/NNP ml/NN )/SYM ,/, as/IN did/VBD the/DT serum/JJ FFA/NN (/( 29/CD ./CD 19/CD mEq/NN //NN liter/NN )/SYM ./.
@@106459215519 Multivariate/NN predictors/NN were/VBD concentric/JJ remodeling/NN (/( P/CD </CD 0/CD ./CD 0001/CD ;/: odds/NNS ratio/NN ,/, 13/CD ./CD 5/CD )/SYM ,/, left/NN ventricular/JJ ejection/NN fraction/NN >/SYM 2/CD SD/NN above/RB normal/JJ (/( P/CD </CD 0/CD ./CD 0001/CD )/SYM ,/, and/CC single-vessel/JJ left/NN circumflex/JJ disease/NN (/( P/NNP </NNP 0/NNP ./NNP 0007/NNP ;/: odds/NNS ratio/NN ,/, 7/CD ./CD 6/CD )/SYM ./.
@@62462546929 Restriction/NEWGENE enzyme/NEWGENE and/CC heteroduplex/JJ analyses/NNS confirmed/VBN that/IN sequences/NNS unique/JJ to/IN FeSV/NNP (/( src/NEWGENE sequences/NEWGENE )/SYM are/VBP located/VBN at/IN the/DT center/NN of/IN the/DT FeSV/NNP genome/NN and/CC are/VBP approximately/RB 1/CD ./CD 5/CD kilobase/NN pairs/NNS in/IN length/NN ./.
@@100749215188 Similar/JJ results/NNS were/VBD also/RB obtained/VBN with/IN a/DT HepG2/CELL hepatoblastoma/NN cell/NN line/NN carrying/JJ wt/NEWGENE p53/NEWGENE ./.
@@19164051285 Bronchial/JJ mucosa/NN tattooing/NN in/IN persons/NNS exposed/VBN to/IN different/JJ industrial/JJ aerosols/NNS did/VBD not/RB depend/VB on/IN the/DT forms/NNS of/IN PC/NN ,/, DB/NN and/CC the/DT diseases'/NN stages/NNS ./.
@@15807382171 Allagille's/NNP syndrome/NN associated/VBN with/IN antenatal/JJ ascites/NN ./.
@@51723205415 Studies/NNS on/IN the/DT hereditary/JJ nature/NN of/IN sole/JJ prints--with/JJ special/JJ reference/NN to/IN interdigital/JJ and/CC triradii/NN ./.
@@89223859316 We/PRP infer/VBP that/IN the/DT dominant/JJ negative/JJ inhibition/NN results/NNS from/IN both/DT direct/JJ proteolysis/NN of/IN the/DT beta-galactosidase/NEWGENE tetramer/NEWGENE by/IN the/DT fusion/NN subunit/NN and/CC detour/NN of/IN the/DT tetramer/NN to/IN the/DT lysosome/NN ./.
@@15119503108 Exposure/NN to/IN hepatitis/NN B/NN virus/NN in/IN the/DT general/JJ population/NN of/IN Hisayama/NNP ,/, Japan/NN :/: significance/NN of/IN isolated/VBN antibody/NN to/IN hepatitis/NEWGENE B/NEWGENE surface/NEWGENE antigen/NEWGENE in/IN general/JJ population/NN ./.
@@84089638372 Hops/NNP ,/, and/CC L/NNP ./NNP
@@1093847757 The/DT correcting/VBG action/NN of/IN tropatepine/NN hydrochloride/NN upon/IN the/DT extrapyramidal/JJ effects/NNS induced/VBN by/IN neuroleptics/NNS has/VBZ been/VBN studied/VBN in/IN 32/CD acute/JJ psychotic/JJ states/NNS ./.
@@13602944182 From/IN August/NN 1989/CD to/IN October/NN 1990/CD ,/, 83/CD pregnant/JJ Chinese/JJ women/NNS were/VBD the/DT subjects/NNS for/IN measuring/JJ the/DT levels/NNS of/IN plasma/NN functional/JJ antithrombin/NEWGENE III/NEWGENE (/( AT/NEWGENE III/NEWGENE )/SYM activity/NN ./.
@@58398446367 Histochemistry/NNP and/CC electron/NN microscopy/NN of/IN acute/JJ liver/NN lesions/NNS induced/VBN by/IN Aflatoxin/NEWGENE B1/NEWGENE in/IN ducklings/NNS ./.
@@29666714929 Schedule/NNP 2/CD ,/, in/IN which/WDT 2/CD ./CD 4/CD mg/CD //CD kg/CD c-DDP/NN was/VBD administered/VBN immediately/RB before/IN X-ray/NN on/IN 5/CD consecutive/JJ days/NNS produced/VBD the/DT highest/JJS degree/NN of/IN enhancement/NN of/IN radiation/NN effect/NN (/( expressed/VBN as/IN dose-effect/NN factor/NN )/SYM ;/: and/CC the/DT next/JJ greatest/JJS enhancement/NN was/VBD produced/VBN by/IN 12/CD mg/CD //CD kg/CD c-DDP/NN administered/VBN 24/CD h/NN before/IN the/DT start/NN of/IN fractionated/VBN daily/JJ radiotherapy/NN ./.
@@16476568487 The/DT relation/NN between/IN myocardial/NEWGENE beta-adrenergic/NEWGENE receptor/NEWGENE and/CC left/NN ventricular/JJ (/( LV/JJ )/SYM function/NN was/VBD studied/VBN in/IN 10/CD patients/NNS ,/, aged/VBN 41/CD to/IN 61/CD years/NNS (/( average/JJ 51/CD )/SYM ,/, with/IN LV/JJ volume/NN overload/NN mainly/RB due/NN to/IN chronic/JJ mitral/JJ regurgitation/NN ./.
@@92869815107 ArgR/NEWGENE was/VBD shown/VBP to/IN be/VB a/DT dimer/NN of/IN two/JJ equal/JJ subunits/NNS ,/, each/DT with/IN a/DT molecular/JJ mass/NN of/IN 37/CD ,/CD 000/CD Da/NNP ./NNP
@@111214909331 The/DT transcription/NEWGENE factor/NEWGENE CHOP/NEWGENE //NEWGENE GADD153/NEWGENE gene/NEWGENE is/VBZ induced/VBN by/IN cellular/JJ stress/NN and/CC is/VBZ involved/VBN in/IN mediating/JJ apoptosis/NN ./.
@@88087074942 Ha-RasV12/NEWGENE and/CC activated/VBN proteins/NNS in/IN both/PDT the/DT extra-cellular/NEWGENE regulated/NEWGENE kinase/NEWGENE (/( ERK/NEWGENE )/SYM and/CC the/DT stress-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( SAPK/NEWGENE )/SYM or/CC Jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE (/( JNK/NEWGENE )/SYM cascades/NNS independently/RB stimulated/VBN PEA3-mediated/JJ gene/NN expression/NN ./.
@@76858743226 Salivary/NNP sodium/NN ,/, calcium/NN ,/, and/CC magnesium/NN concentrations/NNS were/VBD significantly/RB higher/JJ in/IN the/DT SLE/NN patients/NNS with/IN systemic/JJ lupus/NN erythematosus/NN ,/, whereas/IN potassium/NN and/CC total/JJ protein/NN concentrations/NNS and/CC amylase/NEWGENE activity/NN did/VBD not/RB differ/VB significantly/RB from/IN the/DT controls/NNS ./.
@@75596506072 These/DT results/NNS indicate/VBP that/IN the/DT PCNA/NEWGENE gene/NEWGENE is/VBZ a/DT likely/JJ target/NN gene/NN of/IN E2F/NEWGENE ./.
@@7489502649 The/DT influenza/NN virus/NN NS1/NEWGENE protein/NN is/VBZ a/DT unique/JJ posttranscriptional/NN regulator/NN that/WDT has/VBZ two/JJ activities/NNS :/: inhibition/NN of/IN the/DT nuclear/JJ export/NN of/IN poly/NN A-containing/NN mRNAs/NN and/CC inhibition/NN of/IN pre-mRNA/NN splicing/JJ ./.
@@79617557933 Homology/NNS was/VBD also/RB detected/VBN between/IN the/DT putative/JJ transit/NN peptide/NN sequence/NN of/IN cysteine/NEWGENE synthase/NEWGENE C/NEWGENE and/CC other/DT mitochondrion-targeting/JJ leader/NN sequences/NNS ./.
@@112759869887 Of/IN its/PRP gene/NN products/NNS ,/, E6/NEWGENE binds/VBZ to/IN and/CC inactivates/VBZ p53/NEWGENE tumor/NEWGENE suppressor/NEWGENE protein/NEWGENE by/IN ubiquitin/JJ //JJ proteasome-dependent/JJ degradation/NN ./.
@@100909432600 As/IN normal/JJ B/NNP cells/NNS also/RB present/VBP this/DT variant/NN ,/, the/DT mechanism/NN of/IN CD79b/NEWGENE posttranscriptional/JJ regulation/NN might/MD reflect/VB the/DT activation/NN stage/NN of/IN the/DT normal/JJ B/NNP cell/NN from/IN which/WDT B-CLL/VBP derives/VBZ ./.
@@76425385345 In/NN contrast/NN ,/, both/DT C-Lys/NN and/CC C-Thr/NN retained/VBD high/JJ levels/NNS of/IN kinase/NN activity/NN and/CC were/VBD capable/JJ of/IN responding/VBG to/IN stimulation/NN ./.
@@117079778771 On/IN the/PDT other/DT hand/NN ,/, hepatic/JJ arterial/JJ infusion/NN therapy/NN prolongs/VBZ the/DT survival/NN of/IN H3/NN patients/NNS only/RB ./.
@@13784312126 C/NNP ./NNP ,/, Sun/NNP ,/, J/NNP ./NNP ,/, Hsu/NN ,/, M/NNP ./NNP -Y/NNP ./NNP ,/, Vallejo-Ramirez/NNP ,/, J/NNP ./NNP ,/, Inouye/NNP ,/, S/NNP ./NNP ,/, and/CC Inouye/NNP ,/, M/NNP ./NNP
@@78679441572 Upstream/NNS from/IN the/DT transcription/NN start/NN point/NN (/( tsp/NN )/SYM ,/, a/DT nucleotide/NN sequence/NN highly/RB homologous/JJ to/IN the/DT consensus/NN sequence/NN motif/NN for/IN the/DT sigma/NN 35-recognized/JJ promoters/NNS was/VBD found/VBN ./.
@@39337844423 The/DT possible/JJ origin/NN and/CC role/NN of/IN CSF/NEWGENE prolactin/NEWGENE are/VBP discussed/VBN ./.
@@97160959701 Pressure/NN ulcers/NNS ./.
@@30469318413 We/PRP also/RB found/VBP an/DT eIF-4A/NEWGENE intronless/JJ retroposon/NN which/WDT ,/, when/CC compared/VBD to/IN the/DT cDNA/NN ,/, contains/VBZ a/DT single/JJ nucleotide/NN difference/NN ./.
@@23241047575 High/NNP levels/NNS of/IN C/NN subunits/NN are/VBP observed/VBN in/IN several/DT subsequent/JJ larval/JJ and/CC adult/JJ stages/NNS of/IN development/NN ./.
@@80692987607 These/DT alternative/JJ splice/NN variants/NNS were/VBD detected/VBN in/IN RNA/NN isolated/VBN from/IN several/DT sources/NNS ,/, including/JJ primary/JJ leptomeningeal/JJ tissue/NN and/CC an/DT established/VBN line/NN of/IN leptomeningeal/JJ cells/NNS (/( LMC/NNS )/SYM ./.
@@26746798613 On/IN the/DT basis/NN of/IN S1/NEWGENE nuclease/NEWGENE protection/NN analysis/NN of/IN RNA/NN preparations/NNS from/IN several/DT mouse/NN tissues/NNS ,/, both/DT dhfr/NEWGENE and/CC divergent/JJ genes/NNS showed/VBD similar/JJ levels/NNS of/IN expression/NN but/CC did/VBD show/VB some/DT specificity/NN in/IN start/NN site/NN utilization/NN ./.
@@7151803345 Effect/NN of/IN time/NN and/CC dose/NN on/IN alterations/NNS following/IN inhalation/NN of/IN plutonium-239/NN dioxide/NN aerosol/NN in/IN rat/NN ./.
@@88941449694 Forty-eight/NNS 10-12-week-old/JJ male/JJ Sprague-Dawley/NN rats/NNS were/VBD randomized/JJ to/IN receive/VB ,/, daily/JJ for/IN 28/CD days/NNS :/: (/( 1/CD )/SYM CsA/NN vehicle/NN p/CD ./CD o/CD ./. plus/IN FB/NN vehicle/NN sc/NN ;/: (/( 2/CD )/SYM CsA/NN (/( 15/CD mg/CD //CD kg/CD )/SYM p/CD ./CD o/CD ./. plus/IN FB/NN vehicle/NN sc/NN ,/, (/( 3/CD )/SYM CsA/NN vehicle/NN p/CD ./CD o/CD ./. plus/IN FB/NN (/( 1/CD ./CD 5/CD mg/CD //CD kg/CD )/SYM sc/NN ;/: and/CC (/( 4/CD )/SYM CsA/NN (/( 15/CD mg/CD //CD kg/CD )/SYM p/CD ./CD o/CD ./. plus/IN FB/NN (/( 1/CD ./CD 5/CD mg/CD //CD kg/CD )/SYM sc/CD ./CD
@@75656887714 Immunofluorescence/NNS microscopy/NN and/CC cell/NN fractionation/NN analyses/NNS showed/VBN that/IN the/DT 110-kDa/NN protein/NN was/VBD exclusively/RB nuclear/JJ ,/, whereas/IN the/DT 150-kDa/NN protein/NN was/VBD present/VB in/IN both/PDT the/DT cytoplasm/NN and/CC nucleus/NN of/IN human/JJ cells/NNS ./.
@@76693518348 The/DT properties/NNS of/IN the/DT phi/NEWGENE 29/NEWGENE SSB-ssDNA/NEWGENE1 complex/NN are/VBP described/VBN ./.
@@107638275015 Thus/RB ,/, although/IN multiple/JJ senescence/NN pathways/NNS are/VBP activated/VBN in/IN response/NN to/IN a/DT ras/NEWGENE oncogene/NEWGENE ,/, inactivation/NN of/IN TGFbeta1/NEWGENE secretion/NN or/CC response/NN is/VBZ sufficient/JJ to/IN block/NN the/DT senescence/NN program/NN ./.
@@93489319302 An/DT end/NN to/IN the/DT lottery/NN ./.
@@324979265 Possible/JJ factors/NNS for/IN the/DT development/NN of/IN psychotic/JJ symptomatology/NN during/IN group/NN activities/NNS and/CC the/DT role/NN of/IN group/NN dynamics/NNS acting/JJ as/IN stress/NN factors/NN precipitating/JJ functional/JJ psychoses/NNS ,/, especially/RB bipolar/JJ manifestations/NNS ,/, are/VBP discussed/VBN ./.
@@79453301601 Upon/IN differentiation/NN with/IN retinoic/JJ acid/NN (/( RA/NN )/SYM ,/, transcription/NN of/IN the/DT Rex-1/NEWGENE gene/NEWGENE decreases/NNS rapidly/RB ./.
@@86265401164 They/PRP were/VBD found/VBN to/IN stimulate/VB at/IN nanomolar/JJ concentrations/NNS the/DT turnover/NN of/IN biosynthetically/RB labeled/JJ ceramide/NN ,/, glucosylceramide/NN ,/, and/CC lactosylceramide/NN ./.
@@83831298160 The/DT low/JJ molecular/JJ mass/JJ polypeptide/NN complex/NN is/VBZ assumed/VBN to/IN be/VB involved/VBN in/IN antigen/NN presentation/NN ,/, generating/JJ peptides/NNS from/IN cytosolic/JJ protein/NN antigens/NNS ,/, which/WDT are/VBP subsequently/RB presented/VBN to/IN cytotoxic/JJ T-lymphocytes/NNS on/IN the/DT cell/NN surface/NN ./.
@@93219306920 We/PRP found/VBP that/IN multiple/JJ tumor/NN suppressor/NN genes/NNS (/( e/FW ./FW g/FW ./FW ,/, p53/NEWGENE ,/, DCC/NEWGENE ,/, APC/NEWGENE ,/, MCC/NEWGENE ,/, BRCA1/NEWGENE ,/, and/CC WAF1/NEWGENE //NEWGENE CIP1/NEWGENE )/SYM were/VBD inactivated/VBN at/IN different/JJ frequencies/NNS via/NN various/JJ mechanisms/NNS [/NN e/NN ./NN g/NN ./NN ,/, loss/NN of/IN heterozygosity/NN (/( LOH/NN )/SYM ,/, loss/NN of/IN expression/NN (/( LOE/NNP )/SYM ,/, mutation/NN ,/, and/CC inactivation/NN by/IN cellular/JJ binding/JJ protein/NN ]/NN ./.
@@78543247729 The/DT expression/NN of/IN this/DT clone/NN in/IN a/DT wee1/NEWGENE //NEWGENE mik1-deficient/NEWGENE mutant/NEWGENE causes/VBZ an/DT elongated/NN cell/NN phenotype/NN under/IN non-permissive/JJ growth/NN conditions/NNS ./.
@@40508214728 This/DT suggests/VBZ that/IN mechanisms/NNS other/DT than/IN an/DT excessive/JJ increase/NN in/IN myocardial/JJ oxygen/NN demand/NN may/MD be/VB responsible/JJ for/IN the/DT many/JJ episodes/NNS occurring/VBG outside/RB the/DT hospital/NN ./.
@@79378415712 These/DT results/NNS provide/VBP evidence/NN of/IN a/DT bypass/NN of/IN p53-induced/JJ Waf1/JJ //JJ Cip1-mediated/JJ cell/NN cycle/NN regulatory/JJ pathways/NNS by/IN a/DT member/NN of/IN the/DT myb/NEWGENE oncogene/NEWGENE family/NEWGENE ./.
@@24568273116 The/DT 4-AP/CD (/( 4-20/JJ mM/NN )/SYM effect/NN resulted/VBN in/IN a/DT decrease/NN of/IN the/DT sensory/JJ activity/NN ,/, which/WDT was/VBD fully/RB restored/VBN by/IN TEA/NNP or/CC Ba2+/NN ./.
@@81906334542 The/DT transcription/NEWGENE factor/NEWGENE AP-2/NEWGENE is/VBZ encoded/VBN by/IN a/DT gene/NN located/VBN on/IN chromosome/NN 6/CD near/IN the/DT HLA/NEWGENE locus/NEWGENE ./.
@@107950982879 Cerebral/NNP vasculitis/NN secondary/JJ to/IN Crohn's/NN disease/NN seems/VBZ to/IN be/VB a/DT very/RB rare/JJ phenomenon/NN ./.
@@25304701037 The/DT overall/JJ prevalence/NN of/IN HBV/NN markers/NN was/VBD higher/JJ among/IN staff/NN members/NNS than/IN in/IN the/DT blood/NN donors/NNS of/IN our/PRP area/NN ./.
@@11686078813 The/DT routine/JJ administration/NN of/IN fat-soluble/JJ vitamins/NNS appears/VBZ unnecessary/JJ but/CC it/PRP is/VBZ prudent/JJ to/IN measure/NN prothrombin/NEWGENE time/NN and/CC serum/JJ vitamins/NN A/NN and/CC E/NN at/IN intervals/NNS ./.
@@95752178503 Many/JJ cytokine/NEWGENE receptors/NEWGENE employ/VBP Janus/NEWGENE protein/NEWGENE tyrosine/NEWGENE kinases/NEWGENE (/( Jaks/NEWGENE )/SYM and/CC signal/NEWGENE transducers/NEWGENE and/NEWGENE activators/NEWGENE of/NEWGENE transcription/NEWGENE (/( Stats/NEWGENE )/SYM for/IN nuclear/JJ signaling/NN ./.
@@33196219828 In/NN contrast/NN to/IN this/DT mRNA/NN ,/, 90%/NN of/IN alpha/NEWGENE and/NEWGENE beta/NEWGENE actin/NEWGENE mRNAs/NEWGENE were/VBD translated/VBN in/IN both/DT myoblasts/NNS and/CC myotubes/NNS ./.
@@74696927359 The/DT term/NN osteomesopycnosis/NN is/VBZ proposed/VBN for/IN a/DT sclerosing/JJ bone/NN disease/NN with/IN dominant/JJ inheritance/NN that/WDT has/VBZ been/VBN discovered/VBN in/IN five/CD members/NNS of/IN four/CD different/JJ families/NNS ./.
@@891888546 Kss1/NEWGENE binds/VBZ specifically/RB to/IN a/DT GST-Dig1/NEWGENE fusion/NN in/IN the/DT absence/NN of/IN any/DT other/DT yeast/NN protein/NN ./.
@@27173493409 Men/NNS were/VBD more/RB positive/JJ about/RB their/PRP physical/JJ fitness/NN than/IN women/NNS ./.
@@10473623725 In/NN early/JJ Xenopus/JJ embryos/NNS ,/, the/DT transforming/NEWGENE growth/NEWGENE factor-beta/NEWGENE member/NN activin/NEWGENE induces/VBZ the/DT gene/NEWGENE Mix/NEWGENE ./NEWGENE 2/NEWGENE by/IN stimulating/JJ the/DT formation/NN of/IN a/DT multiprotein/NN complex/NN ,/, activin-responsive/NEWGENE factor/NEWGENE (/( ARF/NEWGENE )/SYM ./.
@@1347664811 This/DT mutation/NN also/RB results/VBZ in/IN markedly/RB decreased/VBN levels/NNS of/IN CAD/NEWGENE mRNA/NEWGENE and/CC protein/NN in/IN the/DT mutant/NN ./.
@@35377117876 W/NN ./NN
@@117654481604 Described/NN X-ray/NN projection/NN were/VBD performed/VBN in/IN 70/CD patients/NNS ./.
@@85756098556 The/DT C/NN //NN D/NN ratio/NN was/VBD equal/VB to/IN or/CC over/RB 0/CD ./CD 6/CD in/IN 9/CD cases/NNS (/( 16/CD eyes/NNS )/SYM ,/, and/CC the/DT values/NNS were/VBD inconsistent/JJ between/IN both/DT eyes/NNS in/IN 55%/NN of/IN the/DT patients/NNS ./.
@@87836668354 In/NN addition/NN ,/, the/DT time/NN to/IN engraftment/NN was/VBD significantly/RB shorter/JJR in/IN the/DT amifostine/NN arm/NN in/IN both/DT cohorts/NNS ./.
@@47524555130 Disability/NN insurance/NN under/IN social/JJ security/NN ./.
@@78703056238 In/NN nucleus/NN ventralis/NN anterior/JJ thalami-nucleus/NN ventralis/JJ lateralis/JJ thalami/NNS neurons/NNS with/IN an/DT inhibitory/JJ input/NN from/IN nucleus/NN entopeduncularis/NN ,/, a/DT shortening/NN of/IN inhibition/NN from/IN 17/CD ./CD 5/CD +/NN //NN -/NN 3/CD ./CD 6/CD to/IN 9/CD ./CD 1/CD +/NN //NN -/NN 1/CD ./CD 8/CD ms/NN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM under/IN the/DT haloperidol/NN influence/NN was/VBD evident/JJ ./.
@@106945115967 The/DT expression/NN of/IN the/DT yam8/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE cDNA/NEWGENE in/IN the/DT mid1/NEWGENE mutant/NEWGENE cells/NNS partially/RB remediated/VBN the/DT mid/NN phenotype/NN and/CC resulted/VBN in/IN a/DT slight/JJ increase/NN in/IN Ca/NN (/NN 2+/NN )/NN uptake/NN activity/NN ./.
@@110358676809 OBJECTIVE/IN :/: To/TO evaluate/VB the/DT overall/JJ performance/NN of/IN a/DT new/JJ oscillometric/JJ wrist/NN blood/NN pressure/NN monitor/NN (/( Braun/NNP PrecisionSensor/NNP ,/, Braun/NNP GmbH/NN ,/, Kronberg/NNP ,/, Germany/NN )/SYM as/IN defined/VBN by/IN the/DT ANSI/NNP //NNP AAMI/NNP SP10-1992/NN guidelines/NNS ,/, and/CC to/IN analyze/VB the/DT data/NN for/IN the/DT optimized/VBN selection/NN of/IN the/DT algorithm/NN that/WDT derives/VBZ the/DT blood/NN pressure/NN values/NNS from/IN the/DT oscillometric/JJ blood/NN pressure/NN curves/NNS ./.
@@16495391302 Plasma/NN vitamin/NN E/NN ,/, total/JJ lipids/NNS and/CC myeloperoxidase/NEWGENE levels/NNS during/IN spinal/JJ surgery/NN ./.
@@78290575090 The/DT marker/NN orders/NNS from/IN the/DT genetic/JJ and/CC RH/NN maps/NNS were/VBD consistent/JJ ./.
@@105903685437 Is/VBZ radical/JJ trachelectomy/NN a/DT safe/JJ alternative/NN to/IN radical/JJ hysterectomy/NN for/IN patients/NNS with/IN stage/NN IA-B/NN carcinoma/NN of/IN the/DT cervix/NN ?/. BACKGROUND/IN :/: The/DT prognosis/NN associated/VBN with/IN lymph/NN node/NN negative/JJ ,/, early/JJ stage/NN carcinoma/NN of/IN the/DT cervix/NN is/VBZ excellent/JJ ,/, with/IN 5-year/JJ survival/NN rates/NNS greater/JJR than/IN 90%/CD ./.
@@27403479391 Cosmid/NN clones/NNS containing/JJ both/DT VNTR/NEWGENE sequences/NEWGENE were/VBD identified/VBN ,/, and/CC restriction/NN mapping/NN showed/VBD them/PRP to/IN be/VB less/PRP than/IN 15/CD kb/NN apart/RB ./.
@@94479633431 Sip1/NEWGENE was/VBD initially/RB identified/VBN by/IN virtue/NN of/IN its/PRP interaction/NN with/IN SC35/NEWGENE ,/, a/DT splicing/JJ factor/NN of/IN the/DT SR/NEWGENE family/NEWGENE ./.
@@108700436956 The/DT administration/NN of/IN the/DT GnRH/NEWGENE agonist/NN reduced/VBD the/DT bone/NN mineral/JJ density/NN in/IN the/DT whole/JJ femur/NN to/IN 91/CD ./CD 0%/CD of/IN that/DT in/NN the/DT control/NN group/NN ./.
@@91620848996 This/DT association/NN appears/VBZ to/IN be/VB mediated/JJ by/IN Src-SH2/NEWGENE domain/NEWGENE ,/, because/IN PECAM-1/NEWGENE can/MD be/VB precipitated/VBN by/IN a/DT GST-Src-SH2/NEWGENE affinity/NN matrix/NN ./.
@@79147001353 The/DT gene/NN for/IN the/DT RNA-dependent/NEWGENE eIF-2/NEWGENE alpha/NEWGENE protein/NEWGENE kinase/NEWGENE (/( PKR/NEWGENE )/SYM was/VBD isolated/VBN from/IN mouse/NN genomic/JJ DNA/NN and/CC characterized/VBN ./.
@@103757182701 Basic/NEWGENE fibroblast/NEWGENE growth/NEWGENE factor/NEWGENE (/( bFGF/NEWGENE )/SYM has/VBZ been/VBN shown/VBP to/IN induce/VB angiogenesis/NN in/IN various/JJ animal/JJ models/NNS ,/, but/CC the/DT methods/NNS of/IN administration/NN used/VBN experimentally/RB are/VBP not/RB clinically/RB feasible/JJ ./.
@@75427644553 1993/CD ./.
@@7687745932 The/DT immunosuppressant/NN FK506/NN inhibits/VBZ amino/JJ acid/NN import/NN in/IN Saccharomyces/NN cerevisiae/NN ./.
@@100928562713 The/DT cDNA/NN was/VBD expressed/VBN in/IN Saccharomyces/NN cerevisiae/NN under/IN the/DT control/NN of/IN the/DT yeast/NEWGENE triose/NEWGENE phosphate/NEWGENE isomerase/NEWGENE promoter/NEWGENE ./.
@@83967498360 LDL/NEWGENE cholesterol/NN decreased/VBN from/IN 4/CD ./CD 74/CD +/NN //NN -/NN 0/CD ./CD 87/CD to/IN 3/CD ./CD 78/CD +/NN //NN -/NN 0/CD ./CD 78/CD mmol/NN //NN l/NN after/IN 8/CD weeks/NNS on/IN simvastatin/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, and/CC apo/NEWGENE B/NEWGENE fell/NN from/IN 142/CD +/NN //NN -/NN 31/CD to/IN 112/CD +/NN //NN -/NN 22/CD mg/NN //NN dl/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@36126485239 It/PRP is/VBZ largely/RB predicted/VBN by/IN lupus/NN anticoagulant/JJ (/( estimated/VBN by/IN activated/JJ partial/JJ thromboplastin/NEWGENE time/NN )/SYM and/DT //DT or/DT antibody/NN to/IN cardiolipin/NN ./.
@@91048167370 The/DT effect/NN of/IN Vpu/NEWGENE on/IN class/NN I/NN biogenesis/NN was/VBD analyzed/VBN in/IN more/JJ detail/NN using/VBG a/DT Vpu-expressing/NN recombinant/JJ vaccinia/NN virus/NN (/( VV/JJ )/SYM ./.
@@10708243525 Following/VBG the/DT observation/NN that/IN non-organ-specific/JJ antibodies/NNS are/VBP related/VBN with/IN pregnancy/NN loss/NN and/CC preeclampsia/NN ,/, the/DT role/NN of/IN organ-specific/JJ antibodies/NNS is/VBZ currently/RB being/VBP extensively/RB investigated/VBN ./.
@@114119611278 Keratoconjunctivitis/NNP sicca/JJ appears/NNS to/IN be/VB a/DT common/JJ ocular/JJ complication/NN and/CC all/DT children/NNS with/IN JRA/NN should/MD be/VB screened/VBN for/IN it/PRP with/IN a/DT comprehensive/JJ battery/NN of/IN tests/NNS ./.
@@91577604139 Both/DT quantitative/JJ and/CC qualitative/JJ analysis/NN of/IN individual/JJ cytoarchitectonic/JJ peculiarities/NNS of/IN Meynart's/NN nucleus/NN as/RB well/VB as/IN of/IN external/NN part/NN of/IN dorsomedial/JJ nucleus/NN of/IN thalamus/NN was/VBD performed/VBN in/IN mentally/RB normal/JJ individuals/NNS ./.
@@117264131570 The/DT increased/VBN clearance/NN observed/VBN in/IN young/JJ infants/NNS is/VBZ in/IN contrast/NN to/IN other/DT opioids/NNS ./.
@@40932114787 We/PRP also/RB observed/VBD that/IN the/DT predictive/JJ ability/NN of/IN the/DT selected/VBN attitudes/NNS and/CC orientations/NNS increased/VBN considerably/RB from/IN 1975/CD to/IN 1982/CD ./.
@@88444486034 An/DT open-label/NN ,/, placebo-controlled/JJ ,/, randomized/JJ ,/, two-way/JJ crossover/JJ study/NN was/VBD performed/VBN in/IN 12/CD healthy/JJ volunteers/NNS (/( between/IN 20/CD and/CC 44/CD years/NNS of/IN age/NN )/SYM to/IN assess/VB the/DT effect/NN of/IN orlistat/NN ,/, a/DT gastrointestinal/NEWGENE lipase/NEWGENE inhibitor/NN that/WDT reduces/VBZ dietary/JJ fat/JJ absorption/NN and/CC is/NNS being/VBP developed/VBN for/IN weight/NN control/NN in/IN obesity/NN ,/, on/IN the/DT absorption/NN of/IN vitamins/NN A/NN and/CC E/NNP ./NNP
@@75630904869 Here/RB we/PRP demonstrate/VBP genetically/RB that/DT plus-strand/NN DNA/NN synthesis/NN of/IN the/DT yeast/NEWGENE Ty1/NEWGENE element/NEWGENE is/VBZ initiated/VBN at/IN two/JJ sites/NNS located/VBN at/IN the/DT 5'/CD boundary/NN of/IN the/DT 3'/CD long/JJ terminal/JJ repeat/NN (/( PPT1/NEWGENE )/SYM and/CC near/IN the/DT middle/NN of/IN the/DT pol/NEWGENE gene/NEWGENE in/IN the/DT integrase/NEWGENE coding/NEWGENE sequence/NEWGENE (/( PPT2/NEWGENE )/SYM ./.
@@49709181786 LA-3848-MS/NN ./.
@@63725636170 Renal/JJ response/NN to/IN captopril/NN in/IN severe/JJ heart/NN failure/NN :/: role/NN of/IN furosemide/NN in/IN natriuresis/NN and/CC reversal/NN of/IN hyponatremia/NN ./.
@@86200032893 Protein/NN splicing/JJ :/: evidence/NN for/IN an/DT N-O/NNP acyl/NN rearrangement/NN as/IN the/DT initial/JJ step/NN in/IN the/DT splicing/JJ process/NN ./.
@@93228729905 Because/IN the/DT deletion/NN included/VBD the/DT TK/NEWGENE gene/NEWGENE ,/, selection/NN with/IN gancyclovir/NN against/IN cells/NNS not/RB having/VBG undergone/VBP recombination/NN was/VBD possible/JJ ./.
@@83006112883 Concerted/JJ action/NN of/IN three/CD distinct/JJ domains/NNS in/IN the/DT DNA/NN cleaving-joining/JJ reaction/NN catalyzed/VBN by/IN relaxase/NEWGENE (/( TraI/NEWGENE )/SYM of/IN conjugative/JJ plasmid/NN RP4/NN ./.
@@22347313372 We/PRP conclude/VBP that/DT class/NN I/NN cytologic/JJ smears/NNS with/IN moderate/JJ to/IN severe/JJ inflammation/NN may/MD be/VB associated/VBN with/IN findings/NNS of/IN condylomata/NNS and/CC cervical/JJ dysplasia/NN ./.
@@83211996305 Epigenetic/JJ switching/NN of/IN transcriptional/JJ states/NNS :/: cis-/JJ and/CC trans-acting/JJ factors/NNS affecting/VBG establishment/NN of/IN silencing/VBG at/IN the/DT HMR/NEWGENE locus/NEWGENE in/IN Saccharomyces/NN cerevisiae/NN ./.
@@109433503 Flurazepam/NN thus/RB appears/VBZ to/IN be/VB an/DT effective/JJ hypnotic/JJ drug/NN with/IN the/DT optimum/JJ dose/NN for/IN use/NN in/IN general/JJ practice/NN being/VBP 15/CD mg/NN at/IN night/NN ./.
@@112501963252 The/DT (/( two-motif/JJ )/SYM domain/NN fold/NN contains/VBZ a/DT pair/NN of/IN calcium/NN binding/NN sites/NN very/RB similar/JJ to/IN those/DT found/VB in/IN a/DT two-domain/NEWGENE prokaryotic/NEWGENE betagamma-crystallin/NEWGENE fold/NEWGENE family/NEWGENE member/NEWGENE ,/, Protein/NEWGENE S/NNP ./NNP
@@103335267070 The/DT hTERT/NEWGENE gene/NEWGENE encompasses/VBZ more/RB than/IN 37kb/NN and/CC consists/VBZ of/IN 16/CD exons/NNS ./.
@@83491042825 Surprisingly/RB ,/, the/DT results/NNS of/IN several/DT experiments/NNS suggest/VBP that/IN the/DT TSF/NEWGENE genes/NEWGENE encode/VBP global/JJ regulatory/JJ factors/NNS ./. tsf1/NEWGENE to/IN tsf6/NEWGENE mutations/NN derepressed/VBN expression/NN from/IN yeast/NEWGENE CYC-GAL/NEWGENE hybrid/NEWGENE promoters/NEWGENE (/( fused/VBN to/IN lacZ/NEWGENE )/SYM that/WDT harbor/VBP a/DT variety/NN of/IN operator/NN sequences/NNS ,/, and/CC caused/VBD pleiotropic/JJ defects/NNS in/IN cell/NN growth/NN ,/, mating/JJ ,/, and/CC sporulation/NN ./.
@@1544918403 Characterization/NNS of/IN these/DT R/NN subunits/NN by/IN their/PRP 8-azido-cAMP/JJ photoaffinity/NN labeling/VBG and/CC immunoreactivity/NN ,/, as/RB well/VB as/IN by/IN a/DT phosphorylation-dependent/JJ mobility/NN shift/NN on/IN sodium/NN dodecyl/NN sulfate-polyacrylamide/NN gel/NN electrophoresis/NN (/( SDS-PAGE/NN )/SYM ,/, indicated/VBN subunit/NN sizes/NNS of/IN RII/NEWGENE beta/NEWGENE (/( 53/CD kDa/NN )/SYM greater/JJR than/IN RII/NEWGENE alpha/NEWGENE dephosphoform/NN (/( 51/CD kDa/NN )/SYM greater/JJR than/IN RI/NEWGENE alpha/NEWGENE (/( 49/CD kDa/NN )/SYM ./.
@@110555137817 In/NN general/JJ lookback/NN ,/, all/DT patients/NNS who/WP received/VBD blood/NN before/IN being/VBP tested/VBN for/IN hepatitis/NN C/NN are/VBP advised/VBN to/IN undergo/VB testing/NN ./.
@@84860358448 Closure/NNS of/IN the/DT patent/JJ ductus/NN arteriosus/NN with/IN a/DT Ligaclip/NN through/RB a/DT minithoracotomy/NN ./.
@@1050400335 Improvement/NNP of/IN nursing/JJ instruction/NN to/IN be/VB given/VBP at/IN the/DT time/NN of/IN discharge/NN from/IN the/DT ward/NN for/IN premature/JJ infants/NN ]/NN ./.
@@104177031038 Taken/VBN together/RB ,/, these/DT results/NNS demonstrate/VBP that/IN the/DT RP/NEWGENE ,/, like/NN the/DT 20S/NEWGENE proteasome/NEWGENE ,/, is/VBZ functionally/RB and/CC structurally/RB conserved/VBN among/IN eukaryotes/NNS and/CC indicate/VB that/IN the/DT plant/NEWGENE RPT/NEWGENE subunits/NEWGENE ,/, like/JJ their/PRP yeast/NN counterparts/NNS ,/, have/VB non-redundant/JJ functions/NNS ./.
@@76655672324 Sequence/NN analysis/NN of/IN the/DT 5'-flanking/JJ region/NN of/IN the/DT CD69/NEWGENE gene/NEWGENE revealed/VBD the/DT presence/NN of/IN a/DT potential/JJ TATA/NN element/NN 30/NN base/NN pairs/NNS upstream/RB of/IN the/DT major/JJ transcription/NN initiation/NN site/NN and/CC several/DT putative/JJ binding/JJ sequences/NNS for/IN inducible/NN transcription/NN factors/NN (/( NF-kappa/NEWGENE B/NEWGENE ,/, Egr-1/NEWGENE ,/, AP-1/NEWGENE )/SYM ,/, which/WDT might/MD mediate/VB the/DT inducible/JJ expression/NN of/IN this/DT gene/NN ./.
@@60957745920 Histogenetic/JJ aspects/NNS of/IN mesoblastic/JJ nephroma/NN ./.
@@30080947435 The/DT C-terminal/NN end/NN of/IN this/DT polypeptide/NN harbors/VBP three/CD types/NNS of/IN repeated/JJ sequences/NNS ./.
@@95701072545 Similarly/RB ,/, PCDFs/NNP //NNP PCDDs/NNP ratio/NN in/IN ESP/NN ash/NN was/VBD lower/JJR than/IN that/DT in/NN boiler/NN ash/NN ./.
@@87709818827 All/DT patients/NNS had/VBP abnormal/JJ von/NEWGENE Willebrand/NEWGENE factor/NEWGENE (/( vWF/NEWGENE )/SYM fragmentation/NN as/IN reflected/VBN by/IN decreased/VBN high/JJ molecular/JJ weight/NN and/CC increased/VBN low/JJ molecular/JJ weight/NN vWF/NEWGENE multimers/NEWGENE in/IN the/DT circulation/NN ./.
@@97217989705 Seventy-five/NNS percent/NN of/IN children/NNS who/WP received/VBD a/DT second/JJ transplant/NN for/IN HCV/NN hepatitis/NN had/VBP early/JJ histologic/JJ recurrence/NN that/WDT led/VBD to/IN liver/NN failure/NN and/CC death/NN ./.
@@10598101126 In/NN addition/NN to/IN the/DT bZIP/NEWGENE protein/NEWGENE Opaque2/NEWGENE (/( O2/NEWGENE )/SYM ,/, there/RB are/VBP other/DT maize/NN endosperm/NN nuclear/JJ proteins/NNS that/WDT recognize/VBP the/DT O2/NEWGENE box/NEWGENE in/IN 22/CD kDa/NN zein/NEWGENE gene/NN promoters/NNS ./.
@@4291514907 Year/NN one/PRP of/IN the/DT first/JJ general/JJ practitioner/NN medical/JJ unit/NN in/IN the/DT greater/JJR Glasgow/NN area/NN ./.
@@28330495799 Variations/NNS in/IN the/DT 5'/CD half/NN of/IN U3/NEWGENE were/VBD primarily/RB due/NN to/IN insertions/NNS and/CC deletions/NNS ./.
@@2323544772 Serum/NEWGENE ACTH/NEWGENE did/VBD not/RB respond/VB to/IN insulin/NEWGENE and/CC metyrapone/NN ./.
@@97635221938 Interestingly/RB ,/, an/DT antibody/NN against/IN N-SMase/NEWGENE can/MD abrogate/VB Ox-LDL-/NNP and/CC TNF-alpha-induced/JJ apoptosis/NN and/CC therefore/RB may/MD be/VB useful/JJ for/IN in/IN vivo/NN studies/NNS of/IN apoptosis/NN in/IN experimental/JJ animals/NNS ./.
@@80989148078 During/IN exercise/NN ,/, the/DT Pes-Ves/NNP relation/NN was/VBD shifted/VBN toward/IN the/DT left/NN and/CC the/DT slope/NN [/NN end-systolic/NN elastance/NN (/( Ees/NNS )/NN ]/NN increased/VBN from/IN 7/CD ./CD 7/CD +/NN //NN -/NN 2/CD ./CD 8/CD to/IN 12/CD ./CD 7/CD +/NN //NN -/NN 4/CD ./CD 2/CD (/( SD/NN )/SYM mmHg/NN //NN ml/NN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@85520925839 In/NN addition/NN to/IN protein/NN binding/JJ at/IN sequences/NNS known/VBP to/IN be/VB involved/VBN in/IN the/DT regulation/NN of/IN transcription/NN ,/, genomic/JJ footprinting/VBG of/IN the/DT entire/JJ promoter/NN region/NN also/RB showed/VBD that/IN a/DT protein/NN factor/NN is/VBZ constitutively/RB bound/JJ to/IN the/DT first/JJ intron/NN of/IN the/DT rep3/NEWGENE gene/NEWGENE ./.
@@112231533832 The/DT BFA/NN System/NNP reads/VBZ a/DT text/NN file/NN with/IN flows/NNS ,/, measured/VBN with/IN fluorescent/JJ microsphere/NN technique/NN ,/, and/CC constructs/VBZ the/DT lung/NN anatomy/NN with/IN volumetric/JJ pixels/NNS showing/VBG the/DT flows/NNS with/IN a/DT color/NN schema/NN ./.
@@7935997263 The/DT parameters/NNS of/IN nonspecific/JJ humoral/JJ immunity--serum/JJ immunoglobulins/NNS and/CC immune/JJ complexes--were/RB evaluated/VBN in/IN irradiated/JJ group/NN of/IN patients/NNS with/IN uterine/JJ cervix/NN carcinoma/NN (/( Stages/NNS IIB/NN and/CC IIIB/NN )/SYM ,/, during/IN one/PRP year/NN follow/VB up/RB ./RB
@@10730763550 Preliminary/JJ use/NN of/IN the/DT Nottingham/NN Eczema/NNS Severity/NN Score/NN would/MD support/VB further/JJ development/NN as/IN a/DT research/NN tool/NN for/IN a/DT simple/JJ assessment/NN of/IN disease/NN severity/NN that/WDT could/MD be/VB used/VBN in/IN epidemiological/JJ studies/NNS ./.
@@23534538458 The/DT order/NN of/IN the/DT helicase/NEWGENE motif/NEWGENE and/CC the/DT nsP3/NEWGENE homology/NEWGENE region/NEWGENE in/IN the/DT RUB/NN genome/NN is/VBZ reversed/VBN with/IN respect/NN to/IN the/DT alphavirus/NN genome/NN indicating/VBG that/IN a/DT genetic/JJ rearrangement/NN has/VBZ occurred/VBN during/IN the/DT evolution/NN of/IN these/DT viruses/NNS ./.
@@13394684983 The/DT ORF1/NN protein/NN was/VBD found/VBN to/IN be/VB highly/RB homologous/JJ to/IN the/DT putative/JJ potexvirus/NEWGENE RNA/NEWGENE replicases/NEWGENE ;/: ORF2/NN ,/, -3/NN ,/, -5/CD and/CC -6/CD proteins/NNS also/RB have/VBP analogues/NNS among/IN the/DT potex-/NN and/IN //IN or/IN carlavirus-encoded/JJ proteins/NNS ./.
@@77530305954 Hybridization/NNS signals/NNS were/VBD also/RB detected/VBN with/IN total/JJ DNAs/NNS of/IN Rhizobium/NN leguminosarum/NN bv/NN ./NN phaseoli/NN ,/, Rhodobacter/NN capsulatus/NN and/CC Escherichia/NN coli/JJ ,/, but/CC not/RB those/DT of/IN Xanthomonas/NNP campestris/NN pv/CD ./CD campestris/NN and/CC Pseudomonas/NNS putida/NN ./.
@@83875078052 The/DT regulation/NN of/IN Myf-5/NEWGENE and/CC MyoD/NEWGENE function/NN by/IN a/DT cAMP-dependent/JJ pathway/NN may/MD partly/RB explain/VB how/RB external/NN signals/NNS generated/VBN by/IN serum/JJ and/CC certain/JJ peptide/NEWGENE growth/NEWGENE factors/NEWGENE can/MD be/VB transduced/VBN to/IN the/DT nucleus/NN and/CC inhibit/VB dominant-acting/JJ factors/NNS that/WDT are/VBP responsible/JJ for/IN myoblast/NN differentiation/NN ./.
@@8530418694 Together/RB ,/, our/PRP data/NN suggest/VB that/IN the/DT TR2/NEWGENE orphan/NEWGENE receptor/NEWGENE may/MD be/VB a/DT master/JJ regulator/NN in/IN modulating/JJ the/DT activation/NN of/IN two/JJ key/JJ HREs/NN ,/, RARE/NEWGENE beta/NEWGENE and/CC CRBPIIp/NEWGENE ,/, involved/VBN in/IN the/DT retinoic/JJ acid/NN signal/JJ transduction/NN pathway/NN ./.
@@95451463805 CONCLUSIONS/IN :/: These/DT routinely/RB collected/VBN data/NN provided/VBD quantitative/JJ estimates/NNS of/IN changes/NNS in/IN CBZ/NN Cl/NN //NN F/NN due/NN to/IN comedication/NN and/CC an/DT age-related/JJ decrease/NN in/IN Cl/NNP //NNP F/NNP The/DT derived/VBN regression/NN equations/NNS reasonably/RB predicted/VBN concentrations/NNS in/IN a/DT separate/JJ validation/NN set/NN ./.
@@78917204033 We/PRP show/VBP here/RB that/IN the/DT binding/NN of/IN C1F/NEWGENE in/IN vitro/FW is/VBZ sensitive/JJ to/IN the/DT concentration/NN of/IN calcium/NN ions/NNS ./.
@@28707203553 Bisoprolol/NNP was/VBD found/VBN to/IN be/VB an/DT effective/JJ beta-adrenoceptor/NEWGENE antagonist/NN ,/, the/DT pA2/NN values/NNS determined/VBN against/IN isoprenaline/NN in/IN guinea/NN pig/NN atria/NNS and/CC tracheal/JJ muscle/NN being/VBP 7/CD ./CD 45/CD and/CC 6/CD ./CD 41/CD ,/, respectively/RB ./.
@@104445972170 Interestingly/RB ,/, following/IN induction/NN of/IN stress/NN by/IN heat/NN shock/NN ,/, high/JJ salt/NN ,/, or/CC ethanol/NN ,/, conditions/NNS under/IN which/WDT most/JJ mRNA/NN export/NN is/VBZ blocked/VBN ,/, Npl3p/NEWGENE is/VBZ still/RB exported/VBN from/IN the/DT nucleus/NN ./.
@@34517614717 After/IN a/DT baseline/NN study/NN ,/, WPW/NNP syndrome/NN was/VBD simulated/JJ by/IN stimulation/NN at/IN seven/JJ different/JJ sites/NNS around/IN the/DT base/NN of/IN the/DT ventricles/NNS ,/, and/CC RNV's/NN were/VBD obtained/VBN ./.
@@106697369006 There/EX was/VBD a/DT 2/CD ./CD 4-fold/CD difference/NN in/IN CAT/NEWGENE produced/VBN from/IN these/DT transcripts/NNS in/IN HeLa/DT cells/NNS ,/, which/WDT contain/VBP a/DT greater/RBR natural/JJ abundance/NN of/IN PTB/NEWGENE ./.
@@16976112294 We/PRP speculate/VBP that/IN these/DT tumors/NNS may/MD represent/VB congenital/JJ hamartomatous/JJ growths/NNS ./.
@@17482924262 We/PRP have/VBP isolated/VBN cDNAs/NNS for/IN a/DT gene/NN coding/JJ for/IN a/DT G/NEWGENE protein/NEWGENE alpha/NEWGENE subunit/NEWGENE from/NEWGENE tomato/NEWGENE (/( Lycopersicon/NN esculentum/NN ,/, cv/NN ./NN
@@63241218499 The/DT 12/NEWGENE ,/NEWGENE 000/NEWGENE MW/NEWGENE (/NEWGENE 12K/NEWGENE )/NEWGENE IE/NEWGENE polypeptide/NEWGENE encoded/VBN by/IN IEmRNA-5/NEWGENE is/VBZ translated/VBN from/IN an/DT 88/CD codon/NN open/JJ reading/JJ frame/NN ,/, leaving/VBG a/DT 1200/CD base/NN 3'/CD non-translated/JJ region/NN ./.
@@96570039575 Evolutionary/NNP relationships/NNS among/IN putative/JJ RNA-dependent/NEWGENE RNA/NEWGENE polymerases/NEWGENE encoded/VBN by/IN a/DT mitochondrial/NN virus-like/NN RNA/NN in/IN the/DT Dutch/JJ elm/NN disease/NN fungus/NN ,/, Ophiostoma/NNP novo-ulmi/JJ ,/, by/IN other/DT viruses/NNS and/CC virus-like/NN RNAs/NN and/CC by/IN the/DT Arabidopsis/NN mitochondrial/JJ genome/NN ./.
@@16596851512 Two/CD independent/JJ promoters/NNS as/RB well/VBP as/IN 5'/CD untranslated/JJ regions/NN regulate/NN Dd/NEWGENE ras/NEWGENE expression/NN in/IN Dictyostelium/DT ./.
@@10666509476 Ischemia-induced/JJ biphasic/JJ arrhythmias/NNS were/VBD suppressed/VBN in/IN both/DT zatebradine/NN and/CC propranolol/NN groups/NNS ./
@@18849984983 All/DT members/NNS are/VBP also/RB capable/JJ of/IN activating/JJ in/IN vivo/NN transcription/NN from/IN promoters/NNS that/WDT contain/VBP a/DT C/NEWGENE //NEWGENE EBP-binding/NEWGENE site/NEWGENE ./.
@@8334728314 Also/RB ,/, except/VB in/IN one/PRP patient/NN who/WP developed/VBD gallstones/NNS following/IN institution/NN of/IN colestipol/NN ,/, saturation/NN of/IN gallbladder/NN bile/NN with/IN cholesterol/NN was/VBD not/RB markedly/RB increased/VBN by/IN this/DT drug/NN alone/RB ./.
@@17519707405 Amino/NN acid/NN residues/NNS 147-167/NN of/IN the/DT previously/RB reported/VBN sequence/NN are/VBP replaced/VBN by/IN new/JJ residues/NNS 147/CD to/IN 150/CD ./.
@@66678688737 Morphofunctional/JJ status/NN of/IN the/DT formed/VBN elements/NNS of/IN the/DT blood/NN in/IN rats/NNS subjected/VBN to/IN different/JJ variants/NNS of/IN combined/JJ and/CC isolated/VBN exposure/NN to/IN BR-1/NN benzene/NN ./.
@@36520834323 Thus/RB in/IN this/DT region/NN of/IN the/DT vessel/NN pyridinoline/NN represents/VBZ the/DT major/JJ stabilising/JJ crosslink/NN of/IN collagen/NEWGENE ./.
@@77146086772 No/DT significant/JJ differences/NNS were/VBD identified/VBN between/IN groups/NNS for/IN pH/NN ,/, PaCO2/NN ,/, intracranial/JJ pressure/NN ,/, heart/NN rate/NN ,/, brain/NN temperature/NN ,/, or/CC glucose/NN levels/NNS ./.
@@105644744853 PhoP-PhoQ/NEWGENE homologues/NEWGENE in/NEWGENE Pseudomonas/NEWGENE aeruginosa/NEWGENE regulate/VB expression/NN of/IN the/DT outer-membrane/NEWGENE protein/NEWGENE OprH/NEWGENE and/CC polymyxin/NN B/NN resistance/NN ./.
@@107995953216 Thus/RB ,/, both/DT YY1/NEWGENE and/CC CDP/NEWGENE appear/VB to/IN be/VB negative/JJ regulators/NNS of/IN the/DT differentiation-induced/NN HPV-6/NEWGENE E1/NEWGENE promoter/NEWGENE and/CC thereby/RB the/DT HPV/NN life/NN cycle/NN ./.
@@90654634488 DNA/NN strand/NN exchange/NN catalyzed/VBN by/IN Rad51/NEWGENE protein/NEWGENE is/VBZ also/RB greatly/RB stimulated/VBN by/IN RPA/NEWGENE ./.
@@97907689992 Htra2-beta3/NEWGENE is/VBZ developmentally/RB regulated/VBN and/CC expressed/VBN predominantly/RB in/IN brain/NN ,/, liver/NN testis/NN ,/, and/CC weakly/RB in/IN kidney/NN ./.
@@62304996031 It/PRP has/VBZ been/VBN established/VBN that/IN preoperative/JJ irradiation/NN in/IN the/DT form/NN of/IN the/DT fractionation/NN of/IN a/DT single/JJ focal/JJ dose/NN of/IN 6/CD Gy/JJ every/DT other/DT day/NN ,/, the/DT summary/NN dose/NN of/IN 24/CD Gy/JJ within/IN 8-10/CD days/NNS followed/VBN by/IN surgery/NN 1-3/CD days/NNS after/IN irradiation/NN does/VBP not/RB either/DT complicate/VB its/PRP performance/NN or/CC the/DT course/NN of/IN the/DT postoperative/JJ period/NN ,/, and/CC by/IN the/DT short-/JJ and/CC long-term/JJ results/NNS it/PRP is/VBZ no/DT worse/JJ than/IN the/DT routine/JJ dose/NN fractionation/NN ./.
@@25440593469 Effects/NNPS of/IN nitrogen/NN (/( PN2/NN :/: 5/CD and/CC 14/CD MPa/NNS )/SYM and/CC helium/NN (/( PHe/NNP :/: 13/CD and/CC 14/CD MPa/NNS )/SYM were/VBD also/RB tested/VBN ./.
@@89278418887 Epidemiological/JJ data/NN are/VBP quite/RB controversial/JJ but/CC sudden/JJ death/NN occurring/VBG during/IN sporting/JJ activity/NN is/VBZ probably/RB not/RB a/DT rare/JJ occurrence/NN ./.
@@2211362844 A/DT similar/JJ phenomenon/NN has/VBZ been/VBN reported/VBN in/IN a/DT few/JJ humans/NNS ./.
@@95109255235 If/IN the/DT haemoglobin/NEWGENE concentration/NN (/( Hb/NEWGENE )/SYM was/VBD less/PRP than/IN 12/CD g/NN dL-1/NN they/PRP were/VBD given/VBP a/DT four/CD week/NN course/NN of/IN ferrous/JJ sulphate/NN ./.
@@104097413270 We/PRP have/VBP isolated/VBN three/CD mutant/NN alleles/NN of/IN CDC4/NEWGENE (/( cdc4-10/NEWGENE ,/, cdc4-11/NEWGENE ,/, and/CC cdc4-16/NEWGENE )/SYM which/WDT suppress/VBP the/DT nuclear/JJ division/NN defect/NN of/IN cdc20-1/NEWGENE cells/NNS ./.
@@8703010461 Therefore/RB ,/, we/PRP have/VBP identified/VBN a/DT cis-acting/JJ element/NN ,/, the/DT E1/NEWGENE E-box/NEWGENE ,/, located/VBN in/IN the/DT GAP-43/NEWGENE promoter/NN region/NN that/WDT modulates/VBZ either/DT positively/RB or/CC negatively/RB the/DT expression/NN of/IN the/DT GAP-43/NEWGENE gene/NEWGENE depending/VBG on/IN which/WDT E-box-binding/NEWGENE proteins/NEWGENE occupy/VBP this/DT site/NN ./.
@@107481642790 Scanning/NN mutations/NNS throughout/IN the/DT AC/NEWGENE element/NEWGENE interfered/VBN with/IN induction/NN but/CC allowed/VBN us/PRP to/IN define/VB five/CD overlapping/JJ sites/NNS for/IN regulatory/JJ factors/NNS in/IN AC/NEWGENE and/CC to/IN design/NN probes/NNS binding/JJ just/RB one/PRP or/CC two/JJ factors/NNS ./.
@@86105828586 Forty-five/CD patients/NNS with/IN pleural/JJ lesions/NNS identified/VBN on/IN CT/NN scans/NNS were/VBD subsequently/RB examined/VBN by/IN MR/NN imaging/JJ at/IN 0/CD ./CD 5/CD T/NNP ./NNP
@@108268615708 The/DT monoclonal/JJ immunoglobulin/NEWGENE products/NN of/IN plasma/NN cell/NN neoplasm/NN can/MD give/VB rise/VB to/IN a/DT variety/NN of/IN manifestations/NNS including/JJ hyperviscosity/NN ,/, amyloidosis/NN ,/, cryoglobulinemia/NN ,/, neuropathy/NN ,/, and/CC renal/JJ failure/NN ./.
@@117164411170 ISS/NN and/CC the/DT acute/JJ physiology/NN and/CC chronic/JJ health/NN evaluation/NN (/( APACHE/NN II/NN )/SYM calculated/VBN on/IN admission/NN ./.
@@29833161047 When/WRB the/DT coding/JJ segments/NNS ,/, including/JJ both/DT framework/NN and/CC complementarity-determining/NN regions/NN ,/, of/IN these/DT genes/NNS and/CC the/DT murine/JJ probe/NN sequences/NNS are/VBP compared/VBN by/IN metric/JJ analysis/NN ,/, it/PRP is/VBZ apparent/JJ that/IN the/DT caiman/NEWGENE genes/NEWGENE are/VBP only/RB slightly/RB more/RB related/VBN to/IN each/DT other/DT than/IN to/IN the/DT mammalian/JJ sequence/NN ,/, consistent/JJ with/IN significant/JJ preservation/NN of/IN nucleotide/NN sequence/NN over/RB an/DT extended/VBN period/NN of/IN phylogenetic/JJ time/NN ./.
@@55604285597 Behavioral/JJ and/CC electrographic/JJ expression/NN of/IN natural/JJ sleep/NN and/CC wakefulness/NN in/IN reptiles/NNS ./.
@@90400119197 In/NN summary/NN ,/, p56/NEWGENE (/NEWGENE lck/NEWGENE )/NEWGENE activity/NN stimulates/VBZ G1/NN //NN S/NN transition/NN in/IN immature/JJ thymoblasts/NNS and/CC maintains/VBZ cell/NN viability/NN via/NN transduction/NN of/IN constitutive/JJ activation/NN signals/NNS downstream/RB to/IN components/NNS of/IN the/DT Ras/NEWGENE //NEWGENE Raf/NEWGENE //NEWGENE MAPK/NEWGENE pathway/NEWGENE ./.
@@31371059039 A/DT prostaglandin/NN analogue/NN given/VBP in/IN early/JJ pregnancy/NN and/CC human/NEWGENE chorionic/NEWGENE gonadotropin/NEWGENE given/VBP near/IN the/DT end/NN of/IN the/DT ensuing/JJ follicular/JJ phase/NN were/VBD used/VBN for/IN controlling/VBG the/DT reproductive/JJ cycle/NN ,/, timing/JJ oocyte/NN collection/NN ,/, and/CC synchronizing/JJ the/DT cycles/NNS of/IN oocyte/NN donors/NNS and/CC embryo/NN recipients/NNS ./.
@@98192167054 (/( 1992/CD )/SYM Biochemistry/NNP 31/CD ,/, 3351-3358/NN ]/NN ./.
@@8876167355 However/RB ,/, an/DT intrinsic/NN DNA-binding/NN subunit/NN for/IN HiNF-D/NEWGENE was/VBD not/RB identified/VBN ./.
@@91384921993 Laboratory/NNP exam/NN :/: IDR/NNS of/IN the/DT tuberculin/NN was/VBD high/JJ positive/NN ,/, chest/NN radiography/NN shows/VBZ hilar/JJ bilateral/JJ calcifications/NNS ,/, ORL/NN exam/NN shows/VBZ a/DT tumor/NN at/IN the/DT foot/NN of/IN the/DT epiglottis/NN and/CC anatomopathological/JJ exam/NN shows/VBZ low/RB differentiated/VBN epidermoid/JJ carcinoma/NN ./.
@@1316476537 The/DT ORF/NEWGENE 4/NEWGENE gene/NEWGENE was/VBD minimally/RB active/JJ ,/, whereas/IN the/DT ORF/NEWGENE 62/NEWGENE gene/NEWGENE gave/VBD twofold/JJ induction/NN ;/: both/DT genes/NNS ,/, acting/JJ together/RB ,/, gave/VBD fivefold/JJ induction/NN ./.
@@92280421862 We/PRP have/VBP separated/VBN a/DT dermatan/NN sulfate/NN proteoglycan/NN ,/, epiphycan/NN ,/, from/IN decorin/NN and/CC biglycan/NN by/IN using/VBG dissociative/JJ extraction/NN of/IN bovine/JJ fetal/JJ epiphyseal/JJ cartilage/NN ,/, followed/VBN by/IN sequential/JJ ion-exchange/NN ,/, gel/NN permeation/NN ,/, hydrophobic/JJ ,/, and/CC Zn2+/NN chelate/JJ chromatographic/JJ steps/NNS ./.
@@12253391863 We/PRP suggest/VBP that/IN such/JJ occlusions/NNS occurred/VBN at/IN the/DT time/NN of/IN the/DT infarction/NN ./.
@@98587457923 In/NN vitro/FW transcription/NN assays/NNS demonstrate/VBP that/IN the/DT TCA-cycle/NNP intermediate/JJ ,/, fumarate/NN ,/, directly/RB and/CC specifically/RB inhibits/VBZ the/DT formation/NN of/IN the/DT clcA/NEWGENE transcript/NEWGENE ./.
@@103773456116 Green/NNP fluorescent/JJ protein-tagged/JJ UNC-49B/NEWGENE and/CC UNC-49C/NEWGENE subunits/NEWGENE are/VBP coexpressed/VBN in/IN muscle/NN cells/NNS and/CC are/VBP colocalized/VBN to/IN synaptic/JJ regions/NNS ./.
@@56838095645 Effect/NN of/IN thrombotic/JJ and/CC antithrombotic/JJ drugs/NNS on/IN the/DT surface/NN charge/NN characteristics/NNS of/IN canine/JJ blood/NN vessels/NNS :/: in/IN vivo/NN and/CC in/IN vitro/FW studies/NNS ./.
@@106841116421 It/PRP has/VBZ also/RB been/VBN shown/VBP that/IN a/DT variety/NN of/IN extracellular/JJ factors/NNS stimulate/VBP a/DT pair/NN of/IN MAPK/NEWGENE p44/NEWGENE1 and/CC MAPK/NEWGENE p42/NEWGENE1 of/IN MAPK/NEWGENE family/NEWGENE members/NEWGENE ./.
@@86494054842 Sp1/NEWGENE binds/VBZ two/JJ sites/NNS in/IN the/PDT CD11c/NEWGENE promoter/NEWGENE in/IN vivo/NN specifically/RB in/IN myeloid/JJ cells/NNS and/CC cooperates/VBZ with/IN AP1/NEWGENE to/IN activate/VB transcription/NN ./.
@@93745418197 Constitutive/JJ protection/NN of/IN E2F/NEWGENE recognition/NEWGENE sequences/NEWGENE in/IN the/DT human/NEWGENE thymidine/NEWGENE kinase/NEWGENE promoter/NEWGENE during/IN cell/NN cycle/NN progression/NN ./.
@@83701193610 These/DT contain/VB a/DT single/JJ 1977-bp/CD exon/NN that/IN encodes/VBZ 900/CD bp/NN of/IN the/DT 5'/CD and/CC 3'/CD untranslated/JJ sequences/NNS in/IN addition/NN to/IN a/DT 1077-bp/JJ open/JJ reading/JJ frame/NN identical/JJ to/IN that/DT found/VB in/IN vascular/NEWGENE smooth/NEWGENE muscle/NEWGENE cell/NEWGENE AT1a/NEWGENE receptor/NEWGENE cDNAs/NEWGENE ./.
@@22007368752 These/DT factors/NNS belong/VBP to/IN a/DT set/NN of/IN genetically/RB distinct/JJ molecules/NNS ,/, including/JJ AP-4/NEWGENE and/CC MLTF/NEWGENE ,/, that/WDT bind/VBP to/IN the/DT CACCTGTC/NEWGENE motif/NEWGENE or/CC related/VBN sequences/NNS ./.
@@7539119945 Both/DT mutations/NNS completely/RB abolished/VBN binding/NN of/IN the/DT Abl/NEWGENE SH3/NEWGENE domain/NEWGENE to/IN proline-rich/JJ target/NN proteins/NNS in/IN a/DT filter-binding/JJ assay/NN ./.
@@88584632255 We/PRP conclude/VBP that/IN ,/, in/IN AIDS/NN patients/NNS with/IN cryptococcosis/NN ,/, tolerance/NN to/IN ILd-AmB/NN was/VBD acceptable/JJ when/CC the/DT daily/JJ dosage/NN did/VBD not/RB exceed/VB 1/CD mg/CD //CD kg/CD ,/, but/CC the/DT higher/JJ 1/CD ./CD 5/CD mg/CD //CD kg/CD daily/JJ dosage/NN was/VBD associated/VBN with/IN an/DT unacceptable/JJ rate/NN of/IN nephrotoxicity/NN ./.
@@89060568866 These/DT patients/NNS appear/VBP to/IN have/NN slightly/RB better/RBR pulmonary/JJ function/NN and/CC nutritional/JJ status/NN ;/: yet/RB ,/, they/PRP seem/VBP to/IN have/NN a/DT higher/JJ degree/NN of/IN health/NN care/NN utilization/NN ./.
@@82078055041 The/DT p53/NEWGENE tumor/NEWGENE suppressor/NEWGENE gene/NEWGENE product/NEWGENE ,/, a/DT sequence-specific/NN DNA-binding/NN protein/NN ,/, has/VBZ been/VBN shown/VBP to/RB act/NN as/IN a/DT transcriptional/JJ activator/NN and/CC repressor/NN both/DT in/NN vitro/FW and/CC in/IN vivo/NN ./.
@@80458348036 The/DT PCr/NN resynthesis/NN rate/NN (/( P/NN </SYM 0/CD ./CD 01/CD )/SYM and/CC the/DT effective/JJ maximal/JJ rate/NN of/IN mitochondrial/JJ ATP/NN synthesis/NN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM also/RB improved/VBN ./.
@@87566365971 Semidominant/NNP mutations/NNS in/IN the/DT yeast/NEWGENE Rad51/NEWGENE protein/NEWGENE and/CC their/PRP relationships/NNS with/IN the/DT Srs2/NEWGENE helicase/NEWGENE ./.
@@30200014519 The/DT smallest/JJS of/IN the/DT mini-Mu/NEWGENE elements/NEWGENE is/VBZ only/RB 7/CD ./CD 9/CD kilobase/NN pairs/NNS long/JJ ,/, allowing/VBG the/DT cloning/NN of/IN DNA/NN fragments/NNS of/IN up/JJ to/IN 31/CD ./CD 1/CD kilobase/NN pairs/NNS ,/, and/CC the/DT largest/JJS of/IN them/PRP is/VBZ 21/CD ./CD 7/CD kilobase/NN pairs/NNS ,/, requiring/JJ that/IN clones/NNS carry/VBP insertions/NNS of/IN less/PRP than/IN 17/CD ./CD 3/CD kilobase/NN pairs/NNS ./.
@@87030053921 The/DT cis-acting/JJ elements/NNS that/WDT control/VBP promoter/NN activity/NN include/VB binding/JJ sites/NNS for/IN transcription/NN factors/NN Sp1/NEWGENE and/CC alphaCbf/NEWGENE ,/, a/DT 60-kDa/NEWGENE CCAAT/NEWGENE box-binding/NEWGENE protein/NEWGENE ./.
@@76746495879 A/DT single-case/JJ experimental/JJ ABAB/NN multiple/JJ baseline/NN design/NN was/VBD employed/VBN to/IN test/NN for/IN treatment/NN effectiveness/NN ./.
@@113068451135 Histological/JJ examination/NN showed/VBD lichenoid/JJ changes/NNS ,/, acantholytic/JJ blister/NN formation/NN and/CC apoptotic/JJ keratinocytes/NNS ./.
@@114699702518 Patients/NNS with/IN type/NN III/NN SOD/NN may/MD have/VB visceral/JJ hyperalgesia/NN ;/: a/DT trial/NN of/IN antidepressants/NNS or/CC a/DT therapeutic/JJ trial/NN with/IN botulinum/NEWGENE toxin/NEWGENE injection/NN into/IN the/DT ampulla/NN should/MD be/VB considered/VBN prior/NN to/IN more/RB invasive/JJ endoscopic/JJ therapy/NN ./.
@@2061282194 The/DT sequence/NN of/IN the/DT pMxL1/NN plasmid/NN containing/JJ the/DT invertible/JJ region/NN contains/VBZ a/DT perfect/JJ tandem/NN repeat/NN of/IN 19/CD bp/NN in/IN the/DT orientation/NN 1/CD nonexpressed/JJ pilin/NEWGENE gene/NEWGENE at/IN the/DT middle/NN of/IN the/DT recombination/NN junction/NN site/NN ./.
@@116863781533 Considering/VBG that/IN the/DT reactor/NN is/VBZ thoroughly/RB mixed/JJ during/IN each/DT discharge/NN and/CC that/DT LD50/NN =/SYM 0/CD ./CD 9/CD values/NNS are/VBP nearly/RB independent/NN of/IN E/NNP ./NNP coli/JJ concentrations/NNS in/IN the/DT range/NN of/IN 2/CD x/NN 10/NN (/NN 3/NN )/NN </SYM or/CC =/SYM E/NN coli/NN //NN cfu/NN mL/NN (/NN -1/NN )/NN </SYM or/CC =/SYM 3/CD x/NN 10/NN (/NN 6/NN )/NN ,/, we/PRP ascribe/VBP the/DT nonexponential/JJ Pn/NN decay/NN of/IN single-strain/NNP E/NNP ./NNP coli/JJ colonies/NNS to/IN a/DT shielding/NN phenomenon/NN where/CC inactive/JJ cells/NNS protect/VBP the/DT successively/RB smaller/JJR numbers/NNS of/IN viable/JJ cells/NNS in/IN the/DT EHD/NN ./.
@@13712722135 Perturbation/NNS of/IN dNTP/NN pools/NNS also/RB affected/VBN the/DT frameshift/JJ fidelity/NN of/IN the/DT replicative/JJ yeast/NEWGENE DNA/NEWGENE polymerase/NEWGENE alpha/NEWGENE ./.
@@2393001557 Although/IN %BF/NN was/VBD correlated/VBN with/IN all/PDT the/DT BMIs/NNS (/( r/JJ =/SYM 0/CD ./CD 60-0/CD ./CD 82/CD )/SYM ,/, applying/VBG objective/JJ definitions/NNS of/IN obesity/NN based/VBN on/IN BMIs/NNS or/CC %BF/NN by/IN densitometry/NN often/RB produced/VBD conflicting/JJ results/NNS ./.
@@80079756563 The/DT IPL1/NEWGENE gene/NEWGENE is/VBZ required/VBN for/IN high-fidelity/NN chromosome/NN segregation/NN in/IN the/DT budding/JJ yeast/NN Saccharomyces/NN cerevisiae/NN ./.
@@11064829899 Cardiovascular/NNP risk/NN factors/NNS and/CC antihypertensive/JJ treatment/NN ./.
@@114480511326 The/DT system/NN ,/, designed/VBN to/IN exploit/NN the/DT relatively/JJ constant/JJ small/JJ intestine/NN transit/NN time/NN ,/, consists/VBZ of/IN a/DT drug-containing/JJ core/NN coated/JJ with/IN a/DT polymeric/JJ matrix/NN formed/VBN by/IN a/DT channeling/VBG agent/NN (/( NaCl/NN ,/, mannitol/NN ,/, and/CC Emdex/NN )/SYM and/CC an/DT inert/JJ polymer/NN (/( Eudragit/NNP RS100/NNP )/SYM ./.
@@96502759622 Strengthening/VBG the/DT biological/JJ weapons/NNS convention/NN and/CC implications/NNS on/IN the/DT pharmaceutical/NN and/CC biotechnology/NN industry/NN ./.
@@1004451943 Drag/VB reduction/NN in/IN turbulent/JJ flows/NNS by/IN polymers/NNS ./.
@@112786717690 Neuron-specific/NEWGENE Bcl-2/NEWGENE homology/NEWGENE 3/NEWGENE domain-only/NEWGENE splice/NEWGENE variant/NEWGENE of/IN Bak/NEWGENE is/VBZ anti-apoptotic/JJ in/IN neurons/NNS ,/, but/CC pro-apoptotic/JJ in/IN non-neuronal/JJ cells/NNS ./.
@@14963482108 Caries/NNPS and/CC parodontitis/NN have/NN been/VBN one/PRP of/IN the/DT most/JJ spread/NN diseases/NNS of/IN mankind/NN ./.
@@9829916306 Expression/NNS of/IN lacZ/NEWGENE from/IN the/DT promoter/NN of/IN the/DT Escherichia/NEWGENE coli/NEWGENE spc/NEWGENE operon/NEWGENE cloned/VBN into/IN vectors/NNS carrying/VBG the/DT W205/NEWGENE trp-lac/NEWGENE fusion/NEWGENE ./.
@@80824408062 (/( LH/NEWGENE P/NN </SYM 0/CD ./CD 05/CD ,/, LH/NEWGENE //NEWGENE FSH/NEWGENE P/NN </SYM 0/CD ./CD 01/CD )/SYM ./.
@@100717618068 In/NN addition/NN ,/, mapping/NN of/IN the/DT promoter/NN region/NN and/CC the/DT identification/NN of/IN putative/JJ promoter/NN regulatory/JJ sequences/NNS should/MD give/VB insight/NN into/IN the/DT transcriptional/JJ regulation/NN of/IN UCP2/NEWGENE expression--in/JJ particular/NN by/IN anyone/NN of/IN the/DT above/RB mentioned/VBN factors--in/NN vitro/NN and/CC in/IN vivo/NN ./.
@@13330472402 Here/RB we/PRP show/VBP that/IN epidermal/NEWGENE growth/NEWGENE factor/NEWGENE or/CC platelet-derived/NEWGENE growth/NEWGENE factor/NEWGENE stimulation/NN of/IN intact/JJ human/JJ or/CC murine/JJ cells/NNS leads/VBP to/IN phosphorylation/NN of/IN Nck/NEWGENE protein/NEWGENE on/IN tyrosine/NN ,/, serine/NN ,/, and/CC threonine/NN residues/NNS ./.
@@79160032439 Similar/JJ to/IN the/DT mouse/NN gene/NN ,/, the/DT 5'/CD flanking/JJ region/NN of/IN human/NEWGENE CD79/NEWGENE alpha/NEWGENE lacks/VBZ a/DT TATA/NN box/NN ;/: however/RB ,/, unlike/IN mouse/NEWGENE CD79/NEWGENE alpha/NEWGENE ,/, a/DT classical/JJ octamer/NN motif/NN could/MD not/RB be/VB identified/VBN in/IN the/DT human/JJ gene/NN ./.
@@98381221957 Here/RB we/PRP report/VBP the/DT full-length/JJ coding/JJ cDNA/NN sequence/NN of/IN the/DT mouse/NEWGENE homologue/NEWGENE of/NEWGENE MPP3/NEWGENE ./.
@@3817836103 Bone/NN marrow/NN transplantation-1979/NN ./.
@@97927029419 Expression/NNS of/IN a/DT dominant-negative/JJ mutant/NN of/IN JNK1/NEWGENE also/RB suppressed/VBN glucose/NN deprivation-induced/NN JNK1/NEWGENE activation/NN as/RB well/VB as/IN HSP70/NEWGENE gene/NEWGENE expression/NN ./.
@@95648601057 In/NN contrast/NN ,/, receptor/NN //NN G/NN protein/NN coupling/NN appeared/VBD unaffected/JJ by/IN expression/NN of/IN loop/NN 3i/NN domains/NN derived/VBN from/IN two/JJ receptors/NNS coupled/VBN to/IN G/NEWGENE (/NEWGENE i/NEWGENE //NEWGENE o/NEWGENE )/NEWGENE proteins/NEWGENE (/( M2Ach-muscarinic/NEWGENE and/NEWGENE alpha2A-adrenergic/NEWGENE receptors/NEWGENE )/SYM ./.
@@113761191236 The/DT first/JJ exon/NN (/( exon/NN 1A/CD )/SYM that/WDT corresponded/VBD to/IN the/DT 5'-untranslated/JJ region/NN of/IN the/DT GHR/NEWGENE 1A/NEWGENE mRNA/NEWGENE was/VBD 15/CD ,/CD 250/CD bp/NN upstream/RB from/IN exon/NN 2/CD in/IN the/DT GHR/NEWGENE gene/NEWGENE ./.
@@97842453313 Cardiac/NEWGENE myosin-binding/NEWGENE protein/NEWGENE C/NEWGENE (/( MyBP-C/NEWGENE )/SYM :/: identification/NN of/IN protein/NEWGENE kinase/NEWGENE A/NEWGENE and/CC protein/NEWGENE kinase/NEWGENE C/NEWGENE phosphorylation/NN sites/NN ./.
@@88203241266 The/DT limits/NNS of/IN agreement/NN between/IN DBS/NNP and/CC TOF/NN responses/NNS were/VBD so/RB wide/JJ that/IN they/PRP cannot/MD be/VB used/VBN interchangeably/RB ./.
@@66599826417 The/DT analysis/NN of/IN the/DT structure/NN of/IN the/DT sleep/NN period/NN as/IN a/DT whole/NN reveals/VBZ that/IN with/IN increasing/NN of/IN the/DT age/NN the/DT delta-wave/NN stage/NN (/( DS/NN )/SYM of/IN the/DT QS/NN (/( determined/VBN by/IN defined/JJ polygraphic/JJ parameters/NNS )/SYM increases/NNS ,/, while/CC the/DT paradoxical/JJ phase/NN of/IN sleep/NN (/( PS/NN )/SYM decreases/NNS ,/, this/DT change/NN being/NN more/RB pronounced/VBD during/IN the/DT first/JJ six/CD months/NNS than/IN during/IN the/DT second/JJ ones/NNS of/IN the/DT first/JJ year/NN of/IN the/DT life/NN ./.
@@93495015655 We/PRP previously/RB showed/VBD that/IN the/DT N-terminal/NN portion/NN common/JJ to/IN various/JJ chimeric/NEWGENE MLL/NEWGENE products/NEWGENE ,/, as/RB well/VB as/IN to/IN MLL-LTG9/NEWGENE and/CC MLL-LTG19/NEWGENE ,/, localizes/VBZ in/IN the/DT nuclei/NNS ,/, and/CC therefore/RB suggested/VBN that/IN it/PRP might/MD play/VB an/DT important/JJ role/NN in/IN leukemogenesis/NN ./.
@@4792465165 Isolated/JJ calcaneal/JJ tuberculous/JJ osteomyelitis/NN ./.
@@85667733974 We/PRP propose/VBP that/IN CTS1/NEWGENE and/NEWGENE CTS2/NEWGENE of/NEWGENE Ci/NEWGENE are/VBP members/NNS of/IN two/JJ distinct/JJ classes/NNS of/IN fungal/NEWGENE chitinases/NEWGENE ,/, an/DT observation/NN not/RB previously/RB reported/VBN for/IN a/DT single/JJ fungus/NN ./.
@@95456387274 We/PRP recently/RB characterized/VBD a/DT single/NN yeast/NEWGENE hnRNP/NEWGENE methyltransferase/NEWGENE (/( HMT1/NEWGENE )/SYM ./.
@@99360018611 Electronic/NNP structure/NN of/IN delta/JJ -plutonium/CD and/CC of/IN single/NN Al/NN ,/, Ga/NN ,/, and/CC Sc/NN impurities/NNS in/IN delta/JJ -plutonium/CD ./.
@@56833637233 Investigation/NNP on/IN the/DT exchange/NN of/IN Ca45/NN in/IN intact/JJ and/CC burned/VBN rats/NNS by/IN the/DT kinetic/JJ analysis/NN method/NN ./.
@@114330246197 Telomerase/NEWGENE is/VBZ a/DT ribonucleoprotein/NN complex/NN that/WDT synthesizes/VBZ telomeric/NN DNA/NN onto/IN chromosomes/NNS using/VBG its/PRP RNA/NN component/NN as/IN template/NN ./.
@@10451209523 OBJECTIVE/IN :/: To/TO determine/VB whether/IN administration/NN of/IN misoprostol/NN prevents/VBZ gastric/JJ hemorrhage/NN in/IN healthy/JJ dogs/NNS treated/VBN with/IN high/JJ doses/NNS of/IN methylprednisolone/NN sodium/NN succinate/NN (/( MPSS/NN )/SYM ./.
@@96552485061 The/DT gp330/NEWGENE //NEWGENE Megalin/NEWGENE //NEWGENE LRP-2/NEWGENE protein/NEWGENE belongs/VBZ to/IN the/DT low-density/NEWGENE lipoprotein/NEWGENE receptor/NEWGENE gene/NEWGENE family/NEWGENE and/CC is/VBZ believed/VBN to/RB function/NN as/IN an/DT endocytic/JJ receptor/NN for/IN the/DT uptake/NN of/IN lipoproteins/NNS and/CC many/VB other/DT ligands/NNS ./.
@@108504539401 Moreover/RB ,/, expression/NN of/IN antisense/NEWGENE Ha-Ras/NEWGENE or/CC dominant/NEWGENE negative/NEWGENE Raf-1/NEWGENE abrogated/VBN the/DT mitogenic/JJ effect/NN of/IN TGF-beta1/NEWGENE in/IN TSU-Pr1/NNP ,/, and/CC the/DT TGF-beta1/NEWGENE inhibition/NN of/IN DU145/NN was/VBD switched/VBN to/IN stimulation/NN by/IN V12Ha-Ras/NEWGENE transfection/NN ./.
@@112227209188 We/PRP conclude/VBP that/IN RPMS/NEWGENE acts/NNS as/IN a/DT negative/JJ regulator/NN of/IN EBNA2/NEWGENE and/CC Notch/NEWGENE activity/NN through/RB its/PRP interactions/NNS with/IN the/DT CBF1-associated/NEWGENE corepressor/NEWGENE complex/NEWGENE ./.
@@8189533827 To/TO study/VB the/DT structure-function/NN of/IN the/DT gene/NEWGENE 5/NEWGENE product/NEWGENE ,/, wild-type/NN and/CC mutant/JJ forms/NNS of/IN NS53/NEWGENE were/VBD produced/VBN by/IN using/VBG a/DT recombinant/JJ baculovirus/NN expression/NN system/NN and/CC a/DT recombinant/JJ vaccinia/NN virus/NN //NN T7/NN (/( vTF7-3/NN )/SYM expression/NN system/NN ./.
@@48391765201 Effect/NN of/IN a/DT high-intensity/JJ SHF/NN field/NN on/IN the/DT blood/NN coagulation/NN system/NN ./.
@@112072616096 Functional/JJ analysis/NN of/IN various/JJ PTP-deficient/NNP DT40/NNP B/NNP cell/NN lines/NNS stably/RB expressing/NN wild-type/NEWGENE chimeric/NEWGENE Fc/NEWGENE gamma/NEWGENE RIIB1-PECAM-1/NEWGENE receptor/NEWGENE indicated/VBN that/IN cytoplasmic/NEWGENE Src/NEWGENE homology/NEWGENE 2-domain-containing/NEWGENE phosphatases/NEWGENE ,/, SHP-1/NEWGENE and/CC SHP-2/NEWGENE ,/, were/VBD both/DT necessary/JJ and/CC sufficient/JJ to/IN deliver/VB inhibitory/JJ negative/JJ regulation/NN upon/IN coligation/NN of/IN BCR/NEWGENE complex/NEWGENE with/IN inhibitory/JJ receptor/NN ./.
@@17266312304 Epidemiology/NNS and/CC prevention/NN of/IN hospital/NN infections/NNS in/IN the/DT Local/NNP Health/NNP Unit/NN of/IN Sassari/NNP :/: profile/NN of/IN bacterial/JJ resistance/NN and/CC antimicrobial/JJ agents/NNS of/IN large/JJ usage/NN ./.
@@95550468200 The/DT results/NNS confirm/VBP that/IN a/DT single/JJ base/NN change/NN in/IN the/DT branchpoint/NN consensus/NN sequence/NN of/IN an/DT intron/NN can/MD cause/NN human/JJ disease/NN although/IN this/DT sequence/NN is/VBZ poorly/RB conserved/VBN in/IN mammals/NNS ./.
@@93977239354 Responsibility/NNP matters--this/NN is/VBZ a/DT scientific/JJ council/NN ./.
@@24580803119 Prognosis/NNS of/IN asymptomatic/JJ multiple/JJ myeloma/NN ./.
@@92905719251 Among/IN 38/CD patients/NNS with/IN inducible/JJ reentrant/JJ VTs/NNS who/WP underwent/VBD electrophysiologic/JJ study/NN (/( EPS/NNS )/SYM ,/, 10/CD VTs/NNS of/IN six/CD patients/NNS were/VBD selected/VBN ./.
@@71918047015 The/DT hormonal/JJ response/NN to/IN a/DT standardized/JJ bicycle/NN exercise/NN test/NN was/VBD studied/VBN in/IN 11/CD male/JJ cadets/NNS exposed/VBN to/IN a/DT course/NN of/IN 107/CD h/NN of/IN continuous/JJ activity/NN with/IN less/PRP than/IN 2/CD h/NN sleep/NN ./.
@@118033251669 Only/RB one/PRP DC/JJ cardioversion/NN was/VBD required/VBN in/IN the/DT HBS/NNS group/NN ,/, whereas/IN 2/CD DC/JJ in/IN the/DT CBC/NN group/NN and/CC total/JJ 7/CD DC/JJ in/IN the/DT GIK/NN group/NN ./.
@@100508837787 Inhibition/NNS of/IN phosphatidylinositol-3/NEWGENE kinase/NEWGENE did/VBD not/RB have/VB a/DT significant/JJ effect/NN on/IN p53/NEWGENE conformation/NN but/CC did/VBD have/VBN a/DT weak/JJ but/CC significant/JJ effect/NN on/IN Tpo-enhanced/JJ viability/NN ./.
@@39207009394 This/DT suggests/VBZ that/DT alaproclate/NN acutely/RB increases/VBZ the/DT responsiveness/NN of/IN postsynaptic/JJ muscarinic/NEWGENE and/NEWGENE alpha/NEWGENE 1/NEWGENE adrenoceptors/NEWGENE ./.
@@11373277824 In/NN summary/NN ,/, we/PRP conclude/VBP that/IN the/DT adenoviral/NN oncoprotein/NN E1A/NEWGENE activates/VBZ transcription/NN from/IN the/DT endogenous/JJ AP-2alpha/NEWGENE gene/NEWGENE ,/, an/DT effect/NN that/WDT involves/VBZ transcriptional/JJ derepression/NN of/IN the/DT AP-2alpha/NEWGENE promoter/NEWGENE by/IN interaction/NN of/IN E1A/NEWGENE with/IN the/DT AP-2rep/NEWGENE corepressor/NN CtBP1/NEWGENE ./.
@@67772296544 The/DT subjects/NNS of/IN the/DT study/NN were/VBD 10/CD normal/JJ subjects/NNS and/CC 64/CD patients/NNS with/IN gastroduodenal/JJ disease/NN ./.
@@78717575045 Analysis/NNP of/IN the/DT sequence/NN upstream/RB of/IN this/DT initiation/NN codon/NN reveals/VBZ the/DT presence/NN of/IN a/DT promotor/NN sequence/NN ./.
@@94650352262 A/DT putative/JJ inhibitor/NN (/NN s/NN )/NN appears/VBZ to/IN co-elute/NN in/IN the/DT inactive/JJ fraction/NN that/WDT blocked/VBD the/DT L/NEWGENE (/NEWGENE alpha/NEWGENE )/NEWGENE activity/NN ./.
@@115923151484 PROCEDURE/NNP :/: Cannulas/NNP were/VBD surgically/RB positioned/VBN in/IN the/DT abomasal/JJ body/NN and/CC pyloric/JJ antrum/NN of/IN each/DT calf/NN ./.
@@97172469736 Generally/RB ILC/VBZ and/CC ILVF/NN values/NNS decreased/VBN with/IN increasing/JJ exposure/NN time/NN with/IN rate/NN constants/NNS ranging/VBG from/IN 0/CD ./CD 03/CD to/IN 0/CD ./CD 33/CD day-1/NN (/( wet/NN and/CC lipid/NN weight/NN )/SYM for/IN ILC/NNS and/CC 0/CD ./CD 03/CD to/IN 0/CD ./CD 31/CD day-1/NN for/IN ILVF/NN ./.
@@113109371575 RESULTS/NNS :/: Coronary/NNP mortality/NN during/IN the/DT median/JJ follow-up/JJ time/NN of/IN 17/CD months/NNS was/VBD 6-fold/CD higher/JJ in/IN the/DT highest/JJS tertile/NN for/IN CRP/NEWGENE and/CC IL-6/NEWGENE and/CC 3/CD ./CD 5-fold/CD higher/JJ in/IN the/DT highest/JJS tertile/NN for/IN fibrinogen/NEWGENE and/CC TNF-alpha/NEWGENE than/IN in/IN the/DT respective/JJ combined/JJ lower/JJR tertiles/NNS ./.
@@76891541505 Protein/NN phosphorylation/NN appears/VBZ to/IN play/NN a/DT critical/JJ role/NN in/IN uPA/NEWGENE gene/NEWGENE expression/NN in/IN these/DT cells/NNS ;/: protein/NEWGENE kinase/NEWGENE C-activating/JJ phorbol/NN esters/NNS cooperate/VBP with/IN pp60v-src/NEWGENE to/IN synergistically/RB increase/VBP uPA/NEWGENE mRNA/NEWGENE ,/, whereas/IN cyclic/JJ AMP/NN (/( cAMP/NN )/NN -dependent/NN protein/NN kinase-activating/JJ agents/NNS (/( e/FW ./FW g/FW ./FW ,/, 8-bromo/JJ cAMP/NN )/SYM repress/VB uPA/NEWGENE mRNA/NEWGENE levels/NNS ./.
@@95027208810 Cis-regulation/NNP downstream/RB of/IN cell/NN type/NN specification/NN :/: a/DT single/JJ compact/JJ element/NN controls/VBZ the/DT complex/NN expression/NN of/IN the/DT CyIIa/NEWGENE gene/NEWGENE in/IN sea/NN urchin/NN embryos/NNS ./.
@@93703079843 One/CD of/IN these/DT ,/, an/DT AACA/NN motif/NN ,/, has/VBZ been/VBN shown/VBP to/IN be/VB a/DT negative/JJ regulator/NN in/IN non-seed/JJ tissues/NNS and/CC has/VBZ a/DT similarity/NN to/IN the/DT barley/NEWGENE gibberellin/NEWGENE responsive/NEWGENE element/NEWGENE recognized/VBN by/IN MYB-like/NEWGENE DNA/NEWGENE binding/NEWGENE proteins/NEWGENE ./.
@@12848287397 Tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE ,/, its/PRP inhibitor/NN and/CC other/DT parameters/NNS of/IN fibrinolysis/NN in/IN blood/NN of/IN patients/NNS operated/VBN for/IN mild/JJ hypertrophy/NN of/IN the/DT prostate/NN ./.
@@87025175807 In/NN a/DT screen/NN for/IN genes/NNS with/IN oncogenic/JJ potential/RB expressed/VBN by/IN the/DT murine/JJ B6SUtA1/NN myeloid/JJ progenitor/NN cell/NN line/NN ,/, we/PRP isolated/VBD a/DT 2/CD ./CD
@@2062933281 When/WRB given/VBP the/DT choice/NN between/IN an/DT estrous/JJ female/JJ and/CC a/DT sexually/RB active/JJ male/NN in/IN the/DT AOF/NN ,/, flutamide/NN females/NNS ,/, as/RB well/VB as/IN controls/NNS ,/, preferred/VBD the/DT male/JJ partner/NN ./.
@@22838732935 Since/IN one/PRP group/NN of/IN adolescents/NNS more/RB difficult/JJ to/IN influence/NN are/VBP those/DT whose/WP parents/NNS smoke/NN ,/, parental/JJ involvement/NN in/IN smoking/NN prevention/NN may/MD be/VB a/DT powerful/JJ enhancer/NN ./.
@@13521131977 The/DT pulmonary/JJ toxic/JJ events/NNS induced/VBN by/IN acute/JJ nitrogen/NN dioxide/NN (/( NO/DT )/NN 2/NN exposure/NN were/VBD studied/VBN in/IN the/DT rat/NN to/IN develop/VB an/DT inhalation/NN model/NN to/IN investigate/VB therapeutic/JJ measures/NNS ./.
@@76147627525 The/DT cryptococcal/NEWGENE antigen/NEWGENE test/NN was/VBD positive/JJ at/IN 1/CD :/: 125/CD by/IN latex/NN agglutination/NN ./.
@@99274495167 Overexpression/NNS of/IN POG1/NEWGENE inhibits/VBZ alpha-factor-induced/NN G1/NN arrest/NN and/CC transcriptional/JJ repression/NN of/IN the/DT CLN1/NEWGENE and/CC CLN2/NEWGENE genes/NEWGENE ./.
@@75407732330 The/DT levels/NNS of/IN NSE/NEWGENE and/CC MBP/NEWGENE in/IN the/DT IJVB/NN were/VBD compared/VBN to/IN those/DT in/NN the/DT PVB/NN ./.
@@85736378549 The/DT method/NN has/VBZ been/VBN satisfactorily/RB applied/VBN to/IN the/DT determination/NN of/IN paracetamol/NN in/IN pharmaceutical/JJ formulations/NNS and/CC biological/JJ fluids/NNS ./.
@@24921113148 When/WRB considered/VBN with/IN the/DT known/VBP neurotoxic/JJ effects/NNS on/IN children/NNS of/IN "low/NN levels"/NN of/IN exposure/NN to/IN lead/NN ,/, these/DT results/NNS also/RB suggest/VBP that/IN either/DT an/DT excessively/RB narrow/JJ margin/NN of/IN safety/NN or/CC insufficient/JJ safety/NN is/VBZ provided/VBN by/IN present/NN U/NNP ./NNP S/NNP ./. guidelines/NNS ,/, which/WDT classify/VBP an/DT elevated/VBN blood/NN lead/NN concentration/NN as/IN 25/CD micrograms/NN //NN dl/NN or/CC greater/JJR ./.
@@118461871729 The/DT GT-foreign-pictures/NNP showed/VBD that/IN the/DT judgment/NN of/IN other/DT subjects/NNS changed/VBN toward/IN hedonic/JJ and/CC permeability/NN directions/NNS ./.
@@19236282545 Quantitative/JJ analysis/NN of/IN DNA/NN using/VBG flow/NN cytometry/NN and/CC immunocytochemical/JJ findings/NNS in/IN 16/CD cases/NNS of/IN cardiac/JJ myxomas/NNS ./.
@@86338557657 The/DT lacS/NEWGENE gene/NEWGENE was/VBD cloned/VBN in/IN an/DT E/NNP ./NNP coli-Streptococcus/NN shuttle/NN vector/NN and/CC was/VBD expressed/VBN both/DT in/NN a/DT lacS/NEWGENE deletion/NN derivative/NN of/IN S/NNP ./NNP thermophilus/JJ and/CC in/IN a/DT pNZ63-cured/NN strain/NN ,/, L/NNP ./NNP lactis/NN NZ6091/NN ./.
@@87238839740 The/DT concentrations/NNS of/IN vitamin/NN A/DT precursors/NNS and/CC vitamin/NN E/NN in/IN the/DT hay/NN were/VBD below/RB currently/RB recommended/VBN dietary/JJ levels/NNS for/IN llamas/NNS ,/, and/CC alfalfa/NN hay/NN appears/VBZ to/IN provide/VB an/DT unreliable/JJ source/NN of/IN vitamins/NN A/NN and/CC E/NN in/IN this/DT species/NN ./.
@@81445722103 ATP/NN by/IN itself/PRP also/RB reduced/VBD polypeptide/NN binding/JJ to/IN Ssb1/NEWGENE //NEWGENE 2p/NEWGENE to/IN a/DT level/NN that/WDT was/VBD intermediate/JJ between/IN that/DT observed/VBD for/IN the/DT Ssa/NEWGENE Hsp70/NEWGENE1 proteins/NEWGENE1 tested/VBN and/CC BiP/NEWGENE and/CC DnaK/NEWGENE ./.
@@7068496508 We/PRP compared/VBD the/DT volume/NN of/IN the/DT pulmonary/JJ extravascular/JJ ,/, extracellular/JJ water/NN space/NN using/VBG sodium/NN and/CC sucrose/NN indicators/NN in/IN 8/CD normal/JJ and/CC 11/CD edematous/JJ rabbit/NN lungs/NNS by/IN steady-state/JJ techniques/NNS ./.
@@17223196802 Analysis/NNP of/IN the/DT deduced/VBN amino/JJ acid/NN sequence/NN suggests/VBZ that/IN CHIP28/NEWGENE protein/NEWGENE contains/VBZ six/CD bilayer-spanning/JJ domains/NNS ,/, two/JJ exofacial/JJ potential/JJ N-glycosylation/NN sites/NN ,/, and/CC intracellular/JJ N/NN and/CC C/NN termini/NNS ./.
@@91999708390 Recombinant/NEWGENE soluble/NEWGENE pMCP/NEWGENE that/WDT lacked/VBD transmembrane/JJ and/CC cytoplasmic/JJ domains/NNS had/VBP factor/NEWGENE I/NEWGENE cofactor/NEWGENE activity/NN in/IN C3b/NEWGENE cleavage/NN ,/, indicating/VBG that/IN it/PRP is/VBZ functionally/RB ,/, as/RB well/VB as/IN structurally/RB homologous/JJ to/IN MCP/NEWGENE ./.
@@75577177443 However/RB ,/, division/NN of/IN the/DT chest/NN wall/NN muscles/NNS ,/, usually/RB with/IN diathermy/NN ,/, contributes/VBZ to/IN prolonged/JJ pain/NN and/CC morbidity/NN ./.
@@41405674811 Histamine/NNS metabolism/NN in/IN hemorrhagic-hypotensive/JJ shock/NN ./.
@@20697382671 A/DT method/NN for/IN establishing/VBG stimulus/NN control/NN of/IN ethanol/NN responding/VBG was/VBD developed/VBN ./.
@@98797664093 In/NN PAV-3/NN ,/, the/DT E1A/NEWGENE region/NEWGENE is/VBZ located/VBN between/IN 1/CD ./CD 5/CD and/CC 3/CD ./CD 8/CD map/NN units/NNS ./.
@@10983344817 The/DT article/NN deals/VBP with/IN the/DT diagnosing/NN and/CC correction/NN of/IN reversible/JJ ischemia/NN of/IN the/DT intestine/NN ./.
@@111262759138 Increased/VBN levels/NNS of/IN anticardiolipin/NEWGENE immunoglobulin/NEWGENE G/NEWGENE may/MD also/RB cause/VB bleeding/NN ./.
@@85730835264 This/DT region/NN contains/VBZ a/DT motif/NN with/IN partial/JJ identity/NN with/IN the/DT binding/JJ site/NN for/IN the/DT ubiquitous/JJ transcription/NN factor/NN upstream/NEWGENE stimulatory/NEWGENE factor/NEWGENE (/( USF/NEWGENE )/SYM ,/, which/WDT binds/VBZ to/IN the/DT human/NEWGENE insulin/NEWGENE promoter/NEWGENE ./.
@@16847914875 The/DT cis-acting/JJ element/NN mediating/JJ glucocorticoid/NN inducibility/NN of/IN the/DT chicken/NEWGENE glutamine/NEWGENE synthetase/NEWGENE gene/NEWGENE has/VBZ been/VBN identified/VBN ./.
@@20554845943 Some/DT of/IN the/DT PCR/NN products/NNS contained/VBD mutations/NNS in/IN ATG1/NEWGENE and/DT //DT or/DT ATG2/NEWGENE ./.
@@95449914459 The/DT dominant/JJ negative/JJ mutant/NN of/IN SHP-2/NEWGENE was/VBD found/VBN to/IN inhibit/VB the/DT induction/NN of/IN tyrosine/NN phosphorylation/NN and/CC DNA-binding/NN activity/NN of/IN m-Stat5a/NEWGENE ,/, m-Stat5b/NEWGENE ,/, and/CC the/DT carboxyl-terminal/NN deletion/NN variant/NN m-Stat5adelta749/NEWGENE ,/, as/RB well/VB as/IN the/DT transactivation/NN potential/NN of/IN m-Stat5a/NEWGENE and/CC m-Stat5b/NEWGENE ./.
@@4039439661 Male/JJ Japanese/JJ quail/NN were/VBD chronically/RB exposed/VBN to/IN 5000/CD ppm/NN manganese/NN (/( Mn/NN )/SYM as/IN particulate/JJ manganese/NN oxide/NN (/( Mn3O4/NN )/SYM in/IN their/PRP diet/NN from/IN hatching/NN to/IN 75/CD days/NNS of/IN age/NN ./.
@@11934588296 Routine/JJ isotope/NN cystography/NN using/VBG 99M/NN Tc/NN sulfur/JJ colloid/NN for/IN detection/NN and/CC follow-up/NN of/IN vesico-ureteral/JJ reflux/NN ./.
@@110084205805 The/DT detector/NN has/VBZ the/DT advantage/NN of/IN finding/VBG both/DT ST/NN segment/NN deviations/NNS and/CC entire/JJ ST-T/NN complex/NN changes/NNS thereby/RB providing/CC a/DT wider/JJR characterization/NN of/IN the/DT potential/JJ ischemic/JJ events/NNS ./.
@@93411829525 We/PRP have/VBP overexpressed/VBN ,/, purified/VBN ,/, characterized/VBN ,/, and/CC crystallized/VBD the/DT BTB/NEWGENE //NEWGENE POZ/NEWGENE domain/NEWGENE from/IN PLZF/NEWGENE (/( PLZF-BTB/NEWGENE //NEWGENE POZ/NEWGENE )/SYM ./.
@@88164592948 An/DT interaction/NN screen/NN with/IN the/DT repression/NN domain/NN of/IN the/DT orphan/NEWGENE receptor/NEWGENE RevErb/NEWGENE identified/VBD N-CoR/NEWGENE ,/, the/DT corepressor/NN for/IN thyroid/NEWGENE hormone/NEWGENE receptor/NEWGENE (/( TR/NEWGENE )/SYM and/CC retinoic/NEWGENE acid/NEWGENE receptor/NEWGENE (/( RAR/NEWGENE )/SYM ./.
@@78717188462 However/RB ,/, inclusion/NN of/IN the/DT neighboring/JJ CGGAAR/NEWGENE motifs/NEWGENE from/IN the/DT ICP4/NEWGENE promoter/NEWGENE ,/, which/WDT bind/VBP factors/NN GABP/NEWGENE alpha/NEWGENE and/NEWGENE beta/NEWGENE ,/, results/VBZ in/IN a/DT strong/JJ synergistic/JJ activation/NN ./.
@@98910659651 Furthermore/RB ,/, rhoA-mediated/JJ SRE/NEWGENE activation/NN was/VBD blocked/VBN by/IN dominant/JJ negative/JJ mutants/NNS of/IN PKC-alpha/NEWGENE or/CC PKC-epsilon/NEWGENE ./.
@@87811195483 The/DT 5'/CD flanking/JJ region/NN of/IN the/DT mouse/NEWGENE Met-ase-1/NEWGENE gene/NEWGENE also/RB shares/VBP considerable/JJ regions/NNS of/IN identity/NN with/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT rat/NEWGENE Met-ase-1/NEWGENE gene/NEWGENE ./.
@@96774055732 Pol32Delta/NEWGENE strains/NNS are/VBP weak/JJ antimutators/NNS and/CC are/VBP defective/JJ for/IN damage-induced/JJ mutagenesis/NN ./.
@@98551119250 Although/IN we/PRP predicted/VBD that/DT overexpression/NN of/IN the/DT COOH-terminal/NN domains/NN ,/, which/WDT were/VBD thought/VBP to/IN be/VB involved/VBN in/IN the/DT regulation/NN of/IN SREBP/NEWGENE processing/VBG ,/, would/MD result/VB in/IN disruption/NN of/IN the/DT SREBP-dependent/NNP transcriptional/JJ regulation/NN of/IN several/DT genes/NNS ,/, the/DT mRNA/NN levels/NNS for/IN 3-hydroxy-3-methylglutaryl/NEWGENE coenzyme/NEWGENE A/NEWGENE (/NEWGENE HMG/NEWGENE CoA/NEWGENE )/NEWGENE synthase/NEWGENE in/IN these/DT two/JJ cell/NN lines/NNS were/VBD regulated/VBN in/IN a/DT sterol-dependent/JJ manner/NN ./.
@@104986164387 Mammalian/NEWGENE M-Ras/NEWGENE and/CC a/DT Caenorhabditis/NNP elegans/NNS orthologue/NN exhibit/NN conserved/VBN structural/JJ features/NNS ,/, and/CC these/DT are/VBP likely/RB to/IN mediate/VB activation/NN of/IN distinctive/JJ signaling/JJ paths/NNS that/WDT function/VBP in/IN parallel/JJ to/IN those/DT downstream/RB of/IN p21/NEWGENE Ras/NEWGENE1 ./.
@@94421721178 Both/DT increasing/JJ basal/NN FSH/NEWGENE and/CC age/NN were/VBD associated/VBN significantly/RB with/IN increased/VBN total/JJ gonadotrophin/NEWGENE dose/NN ,/, and/CC reduced/VBD number/NN of/IN oocytes/NNS collected/VBN and/CC pregnancy/NN rate/NN ./.
@@91811302479 We/PRP have/VBP inactivated/VBN Krox-20/NEWGENE by/IN homologous/JJ recombination/NN in/IN ES/NNP cells/NNS and/CC demonstrated/VBN that/IN the/DT mutation/NN leads/VBP to/IN the/DT deletion/NN of/IN r3/NEWGENE and/CC r5/NEWGENE ./.
@@105414326094 Kinase-deficient/NNP erbB/NEWGENE proteins/NEWGENE reduced/VBD epidermal/NEWGENE growth/NEWGENE factor/NEWGENE (/( EGF/NEWGENE )/NN -induced/NN tyrosine/NN phosphorylation/NN of/IN endogenous/JJ Shc/NEWGENE proteins/NEWGENE and/CC also/RB reduced/VBN immediate/JJ and/CC sustained/JJ EGF-induced/NEWGENE ERK/NEWGENE MAPK/NEWGENE activities/NNS in/IN human/JJ glioblastoma/NN cells/NNS ,/, although/IN basal/NN ERK/NEWGENE MAPK/NEWGENE activities/NNS were/VBD unaffected/JJ ./.
@@81123412057 L/NNP ./NNP ,/, Greer/NNP ,/, J/NNP ./NNP &/CC Carter/NNP ,/, G/NNP ./NNP
@@8355697344 Protein/NEWGENE tyrosine/NEWGENE phosphatases/NEWGENE (/( PTPs/NEWGENE )/SYM ,/, together/RB with/IN protein/NEWGENE tyrosine/NEWGENE kinases/NEWGENE (/( PTKs/NEWGENE )/SYM ,/, are/VBP involved/VBN in/IN the/DT regulation/NN of/IN cell/NN activation/NN ,/, growth/NN ,/, and/CC differentiation/NN ./.
@@27082884512 The/DT dichloromethane/NN is/VBZ removed/VBN ,/, mobile/JJ phase/NN solvent/NN is/VBZ added/VBN ,/, and/CC aliquots/NNS are/VBP injected/VBN onto/IN a/DT PRP-1/NN liquid/JJ chromatographic/JJ column/NN ;/: fluazifop/NN acid/NN is/VBZ separated/VBN from/IN coextracted/VBN compounds/NNS and/CC detected/VBN at/IN an/DT applied/VBN potential/NN of/IN +/SYM 1/CD ./CD 25/CD V/NN ,/, using/VBG an/DT amperometric/JJ electrochemical/JJ detector/NN in/IN the/DT oxidation/NN mode/NN ./.
@@87756748763 OBJECTIVES/NNS :/: The/DT aim/NN of/IN the/DT study/NN was/VBD to/IN analyze/VB the/DT clinical/JJ characteristics/NNS ,/, treatment/NN and/CC outcome/NN of/IN 310/CD patients/NNS with/IN hydatidiform/JJ mole/NN ./.
@@39650127756 The/DT results/NNS from/IN the/DT first/JJ five/CD years/NNS of/IN follow/VB up/JJ in/IN 1972/CD showed/VBD a/DT 4/CD ./CD 7-fold/CD excess/NN mortality/NN for/IN ischaemic/JJ and/CC other/DT heart/NN diseases/NNS (/( ICD/NN A83-A84/NN )/SYM compared/VBN with/IN a/DT comparable/JJ reference/NN cohort/NN of/IN paper/NN mill/NN workers/NNS ./.
@@77688984639 Based/VBN on/IN the/DT estimated/VBN values/NNS of/IN divergence/NN of/IN apobec1/NEWGENE sequences/NEWGENE in/IN terms/NNS of/IN the/DT numbers/NNS of/IN synonymous/JJ and/CC non-synonymous/JJ suhstitutions/NNS per/IN site/NN ,/, we/PRP found/VBP that/IN apobec1/NEWGENE is/VBZ a/DT fairly/RB rapidly/RB evolving/JJ protein/NN ./.
@@108577515703 In/NN addition/NN ,/, the/DT mouse/NN ortholog/NN (/( Mharp/NEWGENE //NEWGENE Smarcal1/NEWGENE )/SYM was/VBD cloned/VBN ,/, and/CC the/DT Caenorhabditis/NNP elegans/NNS ortholog/NN (/( CEHARP/NEWGENE )/SYM was/VBD identified/VBN in/IN the/DT GenBank/NN database/NN ./.
@@108941495354 PNRC/NEWGENE :/: a/DT proline-rich/JJ nuclear/NN receptor/NN coregulatory/NN protein/NN that/WDT modulates/VBZ transcriptional/JJ activation/NN of/IN multiple/JJ nuclear/JJ receptors/NNS including/JJ orphan/NEWGENE receptors/NEWGENE SF1/NEWGENE1 (/( steroidogenic/NEWGENE factor/NEWGENE 1/NEWGENE )/SYM and/CC ERRalpha1/NEWGENE (/( estrogen/NEWGENE related/NEWGENE receptor/NEWGENE alpha-1/NEWGENE )/SYM ./.
@@86478222841 A/DT direct/JJ role/NN for/IN sterol/NEWGENE regulatory/NEWGENE element/NEWGENE binding/NEWGENE protein/NEWGENE in/IN activation/NN of/IN 3-hydroxy-3-methylglutaryl/NEWGENE coenzyme/NEWGENE A/NEWGENE reductase/NEWGENE gene/NEWGENE ./.
@@7588633702 We/PRP show/VBP that/IN c-Fos/NEWGENE (/( the/DT c-fos/NEWGENE protooncogene/NEWGENE product/NEWGENE )/SYM ,/, which/WDT is/VBZ an/DT intrinsically/RB unstable/JJ nuclear/JJ protein/NN ,/, is/VBZ metabolically/RB highly/RB stabilized/VBN ,/, and/CC greatly/RB enhances/VBZ the/DT transforming/JJ efficiency/NN of/IN NIH/NN 3T3/CD cells/NNS ,/, by/IN Mos/NEWGENE ./.
@@80004975250 METHODS--16/NN volunteered/VBN for/IN spirometry/NN with/IN methacholine/NN provocation/NN test/NN including/JJ a/DT test/NN for/IN small/JJ airways/NNS function/NN by/IN volume/NN of/IN trapped/VBN gas/NN (/( VTG/NN )/SYM ./.
@@85925902746 These/DT findings/NNS demonstrate/VBP that/IN haemodialysis/NN patients/NNS with/IN chronic/JJ hepatitis/NN C/NN respond/NN well/NN to/IN interferon/NEWGENE treatment/NN and/CC that/IN a/DT long-term/JJ response/NN is/VBZ achieved/VBN in/IN a/DT high/JJ proportion/NN of/IN patients/NNS ./.
@@97366979708 MEKs/NEWGENE and/CC ERKs/NEWGENE inhibited/VBN IL-6/NEWGENE activation/NN of/IN Stat3/NEWGENE harboring/VBG a/DT mutation/NN at/IN serine-727/JJ ,/, the/DT major/JJ site/NN for/IN serine/NN phosphorylation/NN ,/, similar/JJ to/IN inhibition/NN of/IN wild-type/NEWGENE Stat3/NEWGENE ,/, and/CC inhibited/VBD Janus/NEWGENE kinases/NEWGENE Jak1/NEWGENE1 and/CC Jak2/NEWGENE upstream/RB of/IN Stat3/NEWGENE in/IN the/DT Jak-STAT-signaling/JJ pathway/NN ./.
@@94420808102 A/DT reciprocal/JJ binding/JJ assay/NN using/VBG IM-9/CD cells/NNS as/IN a/DT source/NN of/IN SHP-1/NEWGENE and/CC SHP-2/NEWGENE revealed/VBN specific/JJ association/NN of/IN SHP-2/NEWGENE (/( but/CC not/RB SHP-1/NEWGENE )/SYM with/IN a/DT glutathione/NEWGENE S-transferase/NEWGENE fusion/NEWGENE incorporating/JJ GHR/NEWGENE cytoplasmic/NEWGENE domain/NEWGENE residues/NEWGENE 485-620/NEWGENE ,/, but/CC only/RB if/IN the/DT fusion/NN was/VBD first/RB rendered/VBN tyrosine-phosphorylated/JJ ./.
@@86762668653 The/DT mean/JJ values/NNS of/IN protease/NEWGENE activity/NN were/VBD significantly/RB higher/JJ in/IN the/DT test/NN groups/NNS than/IN in/IN the/DT control/NN group/NN at/IN baseline/NN ./.
@@86831063315 Although/IN IL-2/NEWGENE and/CC IFN-alpha/NEWGENE activated/VBN STAT1/NEWGENE alpha/NEWGENE and/CC STAT5/NEWGENE ,/, IL-2/NEWGENE predominantly/RB activated/VBN STAT5/NEWGENE ,/, while/CC IFN-alpha/NEWGENE predominantly/RB activated/VBN STAT1/NEWGENE alpha/NEWGENE ./.
@@11084334849 The/DT swa2-1/NEWGENE allele/NEWGENE recovered/VBN from/IN the/DT original/JJ screen/NN carries/VBZ a/DT point/NN mutation/NN in/IN its/PRP tetratricopeptide/NN repeat/NN (/( TPR/NN )/SYM domain/NN ,/, a/DT motif/NN not/RB found/VB in/IN auxilin/NEWGENE but/CC known/VBP in/IN other/DT proteins/NNS to/IN mediate/VB interaction/NN with/IN heat-shock/NEWGENE proteins/NEWGENE ./.
@@20239045566 The/DT CDC7/NEWGENE gene/NEWGENE has/VBZ two/JJ in-frame/NN AUG/NNS codons/NNS as/IN possible/JJ translation/NN start/NN sites/NNS ,/, which/WDT would/MD produce/VB 58-/DT and/CC 56-kDa/NN proteins/NN ,/, respectively/RB ./.
@@104853539073 Natural/NNP Haemophilus/NN influenzae/NNS type/NN b/NN capsular/JJ polysaccharide/NN antibodies/NNS in/IN 412/CD infants/NNS and/CC children/NNS from/IN West/NN Africa/NN (/( Burkina-Faso/NNP )/SYM and/CC France/NN :/: a/DT cross-sectional/JJ serosurvey/NN ./.
@@13290399267 Intermediate/NNP levels/NNS of/IN gene/NN activity/NN were/VBD observed/VBN for/IN TnI/NEWGENE enhancers/NEWGENE containing/JJ E-boxes/NNP derived/VBD from/IN the/DT MCK/NEWGENE left/NEWGENE E-box/NEWGENE site/NEWGENE or/CC from/IN the/DT Ig/NEWGENE kappa/NEWGENE E2/NEWGENE E-box/NEWGENE ./.
@@79294114149 A/DT comparison/NN of/IN the/DT predicted/VBN polypeptide/NN sequence/NN of/IN the/DT Drosophila/NN protein/NN with/IN the/DT equivalent/JJ subunits/NNS from/IN mouse/NN and/CC yeast/NN suggests/VBZ that/IN they/PRP are/VBP closely/RB related/VBN and/CC defines/VBZ three/CD conserved/VBN regions/NNS which/WDT are/VBP likely/RB to/IN be/VB important/JJ for/IN enzyme/NN activity/NN ./.
@@1188101770 Hemolytic/JJ disease/NN of/IN African/JJ newborn/NN ./.
@@104414833821 Oligonucleotide/NN probes/NNS corresponding/JJ to/IN wild-type/NEWGENE and/NEWGENE mutant/NEWGENE EpRE/NEWGENE sequences/NEWGENE were/VBD used/VBN in/IN gel-shift/JJ and/CC super-shift/JJ analyses/NNS to/IN identify/VB proteins/NNS binding/JJ ./.
@@114072899773 CONCLUSIONS/IN :/: Ketamine-induced/JJ dissociative/JJ anesthesia/NN produces/VBZ persistently/RB elevated/VBN BIS/NN index/NN which/WDT is/VBZ different/JJ from/IN thiamylal/NN and/CC those/DT reported/VBN with/IN other/DT conventional/JJ anesthetic/JJ agents/NNS ./.
@@9341192168 Osmotic/JJ shock/NN stimulates/VBZ GLUT4/NEWGENE translocation/NN in/IN 3T3L1/CD adipocytes/NNS by/IN a/DT novel/JJ tyrosine/NEWGENE kinase/NEWGENE pathway/NN ./.
@@84205711396 They/PRP were/VBD called/VBN PACE4/NEWGENE and/CC PC4/NEWGENE ./.
@@55748182016 Two/CD Lab/NN 8/NN computer/NN programmes/NNS for/IN use/NN in/IN the/DT study/NN of/IN the/DT isometric/JJ and/CC isotonic/JJ contractile/JJ characteristics/NNS of/IN skeletal/JJ muscle/NN ./.
@@9355269317 The/DT difficulties/NNS to/IN analyse/VB prostaglandins/NNS (/( PG/NN )/SYM by/IN gas-liquid/JJ chromatography/NN are/VBP mainly/RB due/NN to/IN the/DT lack/NN of/IN sensitivity/NN of/IN the/DT gas-chromatograph/JJ itself/PRP (/( higher/JJ than/IN 200/CD ng/NN )/SYM and/CC to/IN the/DT poor/JJ resolution/NN of/IN the/DT packed/JJ columns/NNS ./.
@@91307181511 Sequences/NNS needed/VBN for/IN iron-regulated/JJ expression/NN of/IN sid1/NEWGENE were/VBD localized/VBN to/IN a/DT 306/CD bp/NN region/NN mapping/NN 2/CD ./CD 3/CD and/CC 2/CD ./CD 6/CD kb/NN upstream/RB of/IN the/DT ATG/NN ./.
@@13498377203 cDNA/NN clones/NNS encoding/VBG Arabidopsis/NN thaliana/NN and/CC Zea/NEWGENE mays/NEWGENE mitochondrial/NEWGENE chaperonin/NEWGENE HSP60/NEWGENE1 and/CC gene/NN expression/NN during/IN seed/JJ germination/NN and/CC heat/NN shock/NN ./.
@@74951207383 Therefore/RB ,/, a/DT prospective/JJ Phase/NNP II/NNP trial/NN was/VBD conducted/VBN to/IN determine/VB the/DT safety/NN and/CC efficacy/NN of/IN cryosurgery/NN following/IN radiation/NN therapy/NN in/IN men/NNS with/IN local/JJ recurrence/NN ./.
@@98464829806 In/NN turn/NN ,/, assembly/NN of/IN this/DT complex/NN mediates/VBZ the/DT enzymatic/JJ activation/NN of/IN the/DT p21-activated/NEWGENE protein/NEWGENE kinase/NEWGENE 1/NEWGENE and/CC facilitates/VBZ actin/NEWGENE polymerization/NN ./.
@@9464525170 Expression/NNS and/CC characterization/NN of/IN recombinant/NEWGENE single-chain/NEWGENE Fv/NEWGENE and/CC Fv/NEWGENE fragments/NEWGENE derived/VBN from/IN a/DT set/NN of/IN catalytic/JJ antibodies/NNS ./.
@@85837838559 Although/IN ANP/NEWGENE induced/VBD systemic/JJ capillary/JJ filtration/NN ,/, in/IN the/DT calf/NN ,/, filtration/NN was/VBD reduced/VBN with/IN ANP/NEWGENE ./.
@@53440977186 Factors/NNS influencing/VBG in/IN vitro/FW skin/NN permeability/NN factor/NN production/NN by/IN Vibrio/NN cholerae/NNS ./.
@@68106945506 The/DT decrease/NN in/IN HDL-cholesterol/NN with/IN increasing/JJ VLDL-triglycerides/NNP was/VBD relatively/JJ much/RB larger/JJR than/IN the/DT concomitant/JJ decrease/NN in/IN apo/NEWGENE A-I/NEWGENE ./.
@@82470435652 Hepatitis/NN B/NN and/CC liver/NN transplantation/NN ./.
@@95998976039 The/DT clinical/JJ and/CC laboratory/NN features/NNS of/IN 72/CD children/NNS with/IN Henoch-Schonlein/NNP purpura/NN (/( HSP/NN )/SYM were/VBD examined/VBN to/IN determine/VB if/IN there/RB were/VBD associations/NNS between/IN the/DT laboratory/NN indices--including/JJ white/JJ blood/NN cell/NN (/( WBC/NN )/SYM counts/NNS ,/, serum/NEWGENE C-reactive/NEWGENE protein/NEWGENE (/( CRP/NEWGENE )/SYM levels/NNS ,/, platelet/NN (/( PLT/NN )/SYM counts--and/VBD the/DT clinical/JJ manifestations/NNS of/IN acute/NN HSP/NN ./.
@@7647377641 The/DT vigilance/NN task/NN and/CC the/DT measurement/NN of/IN attentional/JJ deficits/NNS ./. pp/NNS ./NNS
@@11037823874 CONCLUSIONS/IN :/: LSCC/NN malformation/NN ,/, like/VB other/DT inner/JJ ear/NN malformations/NNS such/JJ as/IN large/JJ vestibular/JJ aqueduct/NN and/CC X-linked/JJ mixed/JJ deafness/NN with/IN perilymph/NN gusher/NN ,/, can/MD be/VB associated/VBN with/IN CHL/DT ,/, SNHL/NNS ,/, or/CC normal/JJ hearing/NN ./.
@@67623213415 Nucleotide/NN sequence/NN of/IN DNA/NN controlling/JJ expression/NN of/IN genes/NNS for/IN maltosaccharide/NN utilization/NN in/IN Streptococcus/NN pneumoniae/NNS ./.
@@21196262722 Five/CD of/IN 10/CD scars/NNS studied/VBN decreased/VBN at/IN least/RB 50%/CD in/IN linear/JJ dimensions/NNS ./.
@@24766648787 Previously/RB ,/, we/PRP reported/VBD the/DT sequence/NN of/IN the/DT gene/NEWGENE encoding/NEWGENE human/NEWGENE K14/NEWGENE (/( D/NN ./NN
@@7607197205 Basal/JJ plasma/NN renin/NEWGENE activity/NN (/( PRA/NN )/SYM was/VBD slightly/RB raised/VBN prior/NN to/IN training/NN (/( P/NN </SYM 0/CD ./CD 07/CD )/SYM compared/VBN to/IN the/DT controls/NNS and/CC post-training/NN ./.
@@19381781461 Applications/NNS of/IN three-dimensional/JJ analysis/NN to/IN the/DT auditory/JJ P300/NN ./.
@@113418284308 Linear/NNP eight-/NEWGENE or/NEWGENE nine-residue/NEWGENE D-peptides/NEWGENE derived/VBD from/IN the/DT pocket-binding/JJ domain/NN of/IN the/DT cyclic/JJ molecules/NNS also/RB bind/VBP specifically/RB ./.
@@97990867536 Another/DT tentative/JJ hotspot/NN mutation/NN in/IN the/DT third/JJ patient/NN ,/, a/DT frame/NN shift/NN caused/VBN by/IN a/DT G/NN nucleotide/NN insertion/NN in/IN a/DT monotonous/JJ repeat/NN of/IN six/CD Gs/NNS in/IN HPRT/NEWGENE exon/NEWGENE 3/NEWGENE ,/, has/VBZ been/VBN reported/VBN previously/RB in/IN three/CD other/DT LN/NN patients/NNS ./.
@@82767624573 Effect/NN of/IN single/JJ base/NN substitutions/NNS at/IN glycine-870/JJ codon/NN of/IN gramicidin/NEWGENE S/NEWGENE synthetase/NEWGENE 2/NEWGENE gene/NEWGENE on/IN proline/NN activation/NN ./.
@@77610915962 Inactivation/NNS of/IN MAP/NEWGENE kinases/NEWGENE occurs/VBZ via/NN a/DT specific/NN phosphatase/NEWGENE ,/, MKP-1/NEWGENE ./.
@@92384679198 These/DT lesions/NNS may/MD be/VB treated/VBN by/IN propranolol/NN or/CC phentolamine/NN ./.
@@111913652482 Susceptibility/NNS to/IN ischemia-induced/JJ arrhythmias/NNS was/VBD lower/JJR in/IN 1-week/JJ diabetics/NNS :/: only/RB 42/CD %/NN of/IN diabetic/JJ hearts/NNS exhibited/VBD ventricular/JJ tachycardia/NN (/( VT/NN )/SYM and/CC 16/CD %/NN had/VBP short/JJ episodes/NNS of/IN ventricular/JJ fibrillation/NN (/( VF/NN )/SYM as/IN compared/VBN to/IN VT/NN 100/NN %/NN and/CC VF/NN 70/NN %/NN (/( including/JJ sustained/JJ VF/NN 36/NN %/NN )/SYM in/IN the/DT non-diabetics/NNS (/( P/CD </CD 0/CD ./CD 05/CD )/SYM ./.
@@61204295945 Can/MD thyroglobulin/NEWGENE assay/NN really/RB supplant/VB radioiodine/NN scans/NNS in/IN patients/NNS with/IN differentiated/VBN thyroid/JJ cancer/NN ?/.
@@28348438946 The/DT bactericidal/JJ activity/NN of/IN six/CD new/JJ rifamycin/NN derivatives--rifabutin/JJ (/( RBU/NNP )/SYM ,/, FCE/NNS 22250/CD (/( F22/NN )/SYM ,/, rifapentine/NN (/( RPE/NN )/SYM ,/, CGP/NN 29861/CD (/( C29/CD )/SYM ,/, CGP/NN 7040/CD (/( C70/NN )/SYM and/CC CGP/NN 27557/CD (/( C27/NNP )/SYM and/CC rifampicin/NN (/( RMP/NN )/NN --have/NN been/VBN measured/VBN against/IN log/NN phase/NN and/CC ,/, as/IN a/DT better/JJR test/NN of/IN sterilising/JJ activity/NN ,/, against/IN stationary/JJ phase/NN cultures/NNS of/IN Mycobacterium/NN tuberculosis/NN ,/, H37Rv/NN ./.
@@96422383318 The/DT intron/NN 8/NN enhancer/NN region/NN was/VBD not/RB activated/VBN by/IN GATA-1/NEWGENE together/RB with/IN Sp1/NEWGENE in/IN transactivation/NN experiments/NNS in/IN COS-1/NNP cells/NNS indicating/VBG the/DT involvement/NN of/IN a/DT related/NN Sp1/NEWGENE protein/NEWGENE or/CC of/IN another/DT unidentified/JJ erythroid/NN factor/NN ./.
@@107795087392 Estrogen/NEWGENE receptor-related/NEWGENE receptor/NEWGENE alpha/NEWGENE 1/NEWGENE interacts/VBZ with/IN coactivator/NN and/CC constitutively/RB activates/VBZ the/DT estrogen/NEWGENE response/NEWGENE elements/NEWGENE of/IN the/DT human/NEWGENE lactoferrin/NEWGENE gene/NEWGENE ./.
@@97652855986 However/RB ,/, changing/JJ the/DT half-site/NN to/IN the/DT consensus/NEWGENE sequence/NEWGENE AGGTCA/NEWGENE (/( IRper-1/NEWGENE )/SYM increased/VBN binding/NN of/IN AaEcR/NEWGENE ./NEWGENE AaUSP/NEWGENE 10-fold/JJ over/RB IRhsp-1/NEWGENE and/CC ,/, at/IN the/DT same/JJ time/NN ,/, reduced/VBD the/DT stringency/NN of/IN the/DT spacer/NN length/NN requirement/NN ,/, with/IN IRper-0/NEWGENE to/IN IRper-5/NEWGENE showing/VBG detectable/JJ binding/NN ./.
@@98337408465 Pyrrolidine/NNP dithiocarbamate/NN ,/, a/DT potent/JJ transcriptional/JJ inhibitor/NN of/IN the/DT viral/JJ LTR/NN ,/, abrogated/VBN the/DT cytokine/NN responses/NNS in/IN both/DT U1/NN and/CC ACH-2/NN cells/NNS ,/, suggesting/VBG a/DT common/JJ TNF-alpha-mediated/JJ transcriptional/JJ mechanism/NN in/IN these/DT cell/NN types/NNS despite/IN their/PRP different/JJ modes/NNS of/IN provirus/NN latency/NN ./.
@@111626666522 The/DT glucose/NN //NN insulin/NN stimulation/NN was/VBD inhibited/VBN by/IN the/DT addition/NN of/IN polyunsaturated/JJ fatty/JJ acids/NNS ./.
@@81341153489 MSSP-1/NEWGENE produced/VBN in/IN E/NNP ./NNP coli/JJ as/IN a/DT fusion/NN protein/NN with/IN GST/NEWGENE specifically/RB interacted/VBN with/IN single-stranded/JJ TCTTAT/NEWGENE (/NEWGENE plus/NEWGENE myc/NEWGENE (/NEWGENE H-P/NEWGENE )/NEWGENE 21/NEWGENE )/NEWGENE and/CC ACT-ATT/NEWGENE (/( in/IN minus/NEWGENE myc/NEWGENE (/NEWGENE H-P/NEWGENE )/NEWGENE 21/NEWGENE )/NN ,/, the/DT consensus/NN of/IN which/WDT can/MD be/VB referred/VBN to/RB as/IN A/NEWGENE //NEWGENE TCTA/NEWGENE //NEWGENE TA/NEWGENE //NEWGENE TT/NEWGENE ./.
@@99314351736 Although/IN both/DT transcripts/NNS share/NN the/DT first/JJ nine/JJ exons/NNS ,/, exon/NN 10/CD of/IN ZIS-2/NEWGENE is/VBZ lacking/VBG in/IN ZIS-1/NEWGENE ,/, and/CC instead/RB ,/, exon/NN 11/CD (/( 10th/CD exon/NN )/SYM of/IN ZIS-1/NEWGENE is/VBZ larger/JJR in/IN size/NN ,/, leading/JJ to/IN the/DT longer/JJR 3'-UTR/CD ./.
@@73452177194 Urological/JJ complications/NNS are/VBP frequent/VB during/IN and/CC after/IN the/DT treatment/NN of/IN gynecological/JJ malignancy/NN ./.
@@16478135268 Since/IN each/DT transcript/NN appears/VBZ to/IN encode/VB the/DT same/JJ protein/NN ,/, this/DT complexity/NN may/MD reflect/VB the/DT need/NN for/IN lineage-specific/JJ or/CC differentiation-dependent/JJ control/NN of/IN expression/NN ./.
@@86633263931 The/DT final/JJ sigma54-dependent/NEWGENE DmpR/NEWGENE activator/NEWGENE regulates/VBZ transcription/NN of/IN the/DT dmp/NEWGENE operon/NEWGENE that/IN encodes/VBZ the/DT enzymes/NNS for/IN catabolism/NN of/IN (/( methyl/NN )/NN phenols/NN ./.
@@93694828952 Electromobility/NNP shift/NN and/CC cotransfection/NN assays/NNS demonstrated/VBN that/IN HNF1alpha/NEWGENE ,/, but/CC not/RB HNF4/NEWGENE ,/, bound/JJ to/IN its/PRP cognate/NN site/NN and/CC transactivated/VBN G6Pase/NEWGENE gene/NEWGENE expression/NN ./.
@@17078002161 Although/IN the/DT N13-N20/NN interpeak/JJ interval/NN remained/VBD stable/JJ because/IN of/IN the/DT parallel/JJ shift/NN of/IN the/DT 2/CD peaks/NNS ,/, the/DT central/JJ conduction/NN time/NN measured/VBN from/IN onset/NN latencies/NNS of/IN N11/NN and/CC N20/NNS significantly/RB increased/VBN ./.
@@2957125749 In/NN nine/JJ patients/NNS with/IN renal/JJ failure/NN routine/JJ haemodialysis/NN was/VBD accompanied/VBN by/IN a/DT 30/CD per/IN cent/NN reduction/NN in/IN plasma/NN ANP/NEWGENE concentration/NN ./.
@@85290989785 Striking/VBG sequence/NN similarities/NNS (/( 57/CD and/CC 53%/CD )/SYM were/VBD observed/VBN with/IN yeast/NN mitochondrial/JJ proteins/NNS ,/, SMF1/NEWGENE and/CC SMF2/NEWGENE ,/, especially/RB within/IN putative/JJ functional/JJ domains/NNS :/: exon/NN 6/CD encoding/VBG the/DT second/JJ transmembrane/JJ spanning/VBG domain/NN ,/, site/NN of/IN the/DT murine/JJ susceptibility/NN mutation/NN ;/: and/CC exon/NN 11/CD encoding/VBG a/DT conserved/VBN transport/NN motif/NN ./.
@@110699997635 The/DT U17/NEWGENE //NEWGENE U16/NEWGENE and/CC the/DT U16+/NEWGENE gene/NEWGENE products/NEWGENE transactivated/VBN the/DT HIV/NEWGENE LTR/NEWGENE ./.
@@11128925246 BACKGROUND/IN :/: The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN determine/VB and/CC compare/VB interleukin-6/NEWGENE (/( IL-6/NEWGENE )/SYM levels/NNS in/IN gingival/JJ crevicular/JJ fluid/NN (/( GCF/NN )/SYM and/CC clinical/JJ periodontal/JJ findings/NNS in/IN patients/NNS with/IN rheumatoid/JJ arthritis/NN (/( RA/NN )/SYM and/CC adult/JJ periodontitis/NN (/( AP/NN )/SYM ./.
@@106849674694 NKX2/NEWGENE ./NEWGENE 1/NEWGENE is/VBZ a/DT member/NN of/IN the/DT NK2/NEWGENE family/NEWGENE of/IN homeodomain-containing/NN transcription/NN factors/NN whose/WP targeted/VBN disruption/NN in/IN mouse/NN results/NNS in/IN the/DT absence/NN of/IN thyroid/JJ tissue/NN and/CC a/DT severely/RB abnormal/JJ lung/NN phenotype/NN ./.
@@70688876840 Investigated/VBG the/DT reliability/NN ,/, validity/NN and/CC dimensionality/NN of/IN scores/NNS obtained/VBN by/IN acute/JJ psychiatric/JJ inpatients/NNS (/( N/JJ =/SYM 120/CD )/SYM on/IN the/DT Michigan/NN Alcoholism/DT Screening/NNP Test/NNP adapted/VBD to/IN assess/VB lifetime/NN and/CC current/JJ symptomatology/NN ./.
@@7330677189 To/TO minimize/VB reflux/JJ into/IN the/DT blind/JJ loop/NN ,/, a/DT number/NN of/IN technical/JJ steps/NNS are/VBP considered/VBN indispensable/JJ :/: 1/NN )/NN fluted/JJ section/NN of/IN the/DT jejunal/JJ stump/NN ;/: 2/NN )/NN isoperistaltic/JJ construction/NN of/IN the/DT anastomosis/NN and/CC ,/, particularly/RB ,/, 3/NN )/NN the/DT creation/NN of/IN a/DT single/JJ or/CC double/JJ valve/NN system/NN upstream/RB from/IN the/DT anastomosis/NN by/IN spiral/JJ introflexion/NN of/IN the/DT mucosa/NN using/VBG seroserous/JJ stitches/NNS parallel/JJ and/CC perpendicular/JJ to/IN the/DT ileal/JJ lumen/NN ./.
@@92090316839 The/DT C-terminal/NN mature/JJ region/NN is/VBZ highly/RB conserved/VBN in/IN other/DT serine/NEWGENE carboxypeptidases/NEWGENE ./.
@@22337158881 The/DT induction/NN by/IN pseudorabies/NN virus/NN of/IN an/DT IL-6/NEWGENE construct/NEWGENE containing/JJ the/DT IL-6/NEWGENE TATA/NEWGENE box/NEWGENE and/CC the/DT RNA/NN start/NN site/NN (/( "initiator"/NN or/CC Inr/NEWGENE element/NEWGENE )/SYM but/CC not/RB the/DT MRE/NEWGENE region/NEWGENE was/VBD also/RB repressed/VBN by/IN Dex/NN in/IN the/DT presence/NN of/IN wild-type/NEWGENE GR/NEWGENE ./.
@@24755061696 The/DT mRNA/NN was/VBD converted/VBN to/IN cDNA/NN and/CC amplified/VBN by/IN the/DT polymerase/NEWGENE chain/NN reaction/NN technique/NN ./.
@@78541308030 The/DT requirement/NN of/IN PilE/NEWGENE in/IN pilus/NN biogenesis/NN was/VBD confirmed/VBN by/IN demonstrating/VBG that/IN chromosomal/NEWGENE pilE/NEWGENE insertion/NEWGENE mutants/NEWGENE were/VBD pilus-/JJ and/CC twitching-motility/JJ deficient/JJ ./.
@@111629369053 The/DT continuing/JJ development/NN of/IN ligands/NNS that/WDT function/VBP as/IN selective/JJ estrogens/NNS or/CC antiestrogens/NNS for/IN ERalpha/NEWGENE or/CC ERbeta/NEWGENE should/MD allow/VB optimized/VBN tissue/NN selectivity/NN of/IN these/DT agents/NNS for/IN menopausal/JJ hormone/NN replacement/NN therapy/NN and/CC the/DT treatment/NN and/CC prevention/NN of/IN breast/NN cancer/NN ./.
@@113400806573 Three/CD of/IN the/DT proteins/NNS involved/VBN in/IN checkpoint/NN signaling/JJ ,/, Rad1/NEWGENE ,/, Hus1/NEWGENE ,/, and/CC Rad9/NEWGENE ,/, have/VB been/VBN shown/VBP to/IN interact/VB by/IN immunoprecipitation/NN and/CC yeast/NN two-hybrid/JJ studies/NNS ./.
@@96640331424 This/DT distribution/NN implies/VBZ that/IN the/DT polycistronic/JJ precursor/NN is/VBZ imported/VBN into/IN the/DT nucleolus/NN for/IN processing/VBG to/IN the/DT mature/JJ snoRNAs/NNS ,/, and/CC that/IN the/DT import/NN or/CC processing/VBG pathway/NN involves/VBZ coiled/VBN bodies/NNS ./.
@@75082507393 There/EX was/VBD also/RB a/DT highly/RB significant/JJ correlation/NN between/IN total/JJ selenium/NN intake/NN and/CC liver/NN selenium/NN concentration/NN (/( r/JJ =/SYM 0/CD ./CD 99/CD ,/, p/NN </SYM 0/CD ./CD 01/CD )/SYM after/IN 1/CD mo/NN of/IN treatment/NN ,/, but/CC this/DT time/NN liver/NN selenium/NN did/VBD not/RB change/VB with/IN time/NN ,/, and/CC the/DT correlation/NN remained/VBN highly/RB significant/JJ throughout/IN the/DT investigation/NN ./.
@@113025666811 Instead/RB ,/, affective/JJ flattening/NN was/VBD associated/VBN with/IN both/DT dopamine/NEWGENE receptor/NEWGENE sensitivity/NN and/CC psychomotor/JJ slowing/NN ./.
@@72253007051 These/DT results/NNS show/NN that/IN the/DT neonate/NN differs/VBZ from/IN the/DT adult/NN in/IN respect/NN of/IN both/PDT the/DT nature/NN of/IN effects/NNS of/IN the/DT drug/NN and/CC sensitivity/NN to/IN it/CD ./CD
@@17029721319 Whereas/IN cDNA/NN hybridization/NN to/IN genomic/JJ DNA/NN blots/NNS indicated/VBD a/DT small/NN subfamily/NN of/IN G0S19/NEWGENE genes/NEWGENE ,/, simple/JJ patterns/NNS of/IN bands/NNS indicated/VBN that/WDT most/RB cDNAs/VBZ ,/, including/JJ G0S30/NEWGENE cDNA/NEWGENE ,/, corresponded/VBN to/IN single-copy/JJ genes/NNS ./.
@@17311072411 Substitutions/NNS introduced/VBN at/IN bases/NNS surrounding/JJ the/DT ICR2/NEWGENE motif/NEWGENE yielded/VBD levels/NNS of/IN pRNA/NN replication/NN that/WDT differed/VBD ,/, depending/VBG on/IN the/DT maintenance/NN of/IN a/DT putative/JJ 5'/CD stem-loop/NN structure/NN in/IN the/DT positive/JJ strand/NN of/IN the/DT viral/JJ genome/NN ./.
@@83336434395 Pneumoscrotum/NN is/VBZ a/DT rare/JJ condition/NN that/WDT receives/VBZ little/JJ discussion/NN in/IN standard/JJ texts/NNS of/IN urology/NN ./.
@@13575284472 The/DT subunit/NN protein/NN of/IN curli/NEWGENE was/VBD highly/RB homologous/JJ at/IN its/PRP amino/JJ terminus/NN to/IN SEF-17/NEWGENE ,/, the/DT subunit/NN protein/NN of/IN thin/NEWGENE ,/, aggregative/JJ fimbriae/NNS of/IN Salmonella/NN enteritidis/NN 27655/CD strain/NN 3b/CD ,/, suggesting/VBG that/IN these/DT fibres/NNS form/NN a/DT novel/JJ class/NN of/IN surface/NN organelles/NNS on/IN enterobacteria/NNS ./.
@@79080123910 To/TO examine/VB the/DT possibility/NN that/IN LNNB/NN performance/NN of/IN the/DT schizophrenic/JJ groups/NNS may/MD have/VB been/VBN related/VBN to/IN neuroleptic/JJ medication/NN ,/, analyses/NNS were/VBD completed/VBN on/IN the/DT relationship/NN between/IN medication/NN levels/NNS and/CC LNNB/NN scores/NNS ./.
@@109509352225 To/TO facilitate/VB manipulation/NN of/IN large/JJ genomic/JJ sequences/NNS ,/, we/PRP developed/VBD a/DT method/NN of/IN converting/JJ Escherichia/NN coli/JJ P1/NN artificial/JJ chromosomes/NNS (/( PACs/NNS )/SYM into/IN yeast/NN artificial/JJ chromosomes/NNS (/( YACs/NNS )/SYM ./.
@@42390414683 The/DT effect/NN of/IN anticonvulsants/NNS on/IN sodium-potassium-activated/NEWGENE ATPase/NEWGENE ,/, sodium/NN ,/, and/CC potassim/NN in/IN cortex/NN ./.
@@21387078649 We/PRP have/VBP previously/RB identified/VBN ,/, by/IN screening/JJ a/DT lambda/NN gt11/NN expression/NN library/NN ,/, murine/NEWGENE protein/NEWGENE mXBP/NEWGENE ,/, which/WDT binds/VBZ to/IN a/DT sequence/NN which/WDT overlaps/VBP the/DT 3'/CD end/NN of/IN the/DT murine/NEWGENE class/NEWGENE II/NEWGENE major/NEWGENE histocompatibility/NEWGENE complex/NEWGENE A/NEWGENE alpha/NEWGENE gene/NEWGENE X/NEWGENE box/NEWGENE ,/, a/DT conserved/VBN transcription/NN element/NN found/VB upstream/RB of/IN all/DT class/NEWGENE II/NEWGENE genes/NEWGENE ./.
@@1447189272 Purification/NN and/CC cloning/NN of/IN a/DT novel/JJ serine/NEWGENE protease/NEWGENE ,/, RNK-Met-1/NEWGENE ,/, from/IN the/DT granules/NNS of/IN a/DT rat/NN natural/JJ killer/NN cell/NN leukemia/NN ./.
@@7947930897 The/DT fibrinogen/NEWGENE ,/, serum/JJ proteins/NNS ,/, sodium/NN heparin/NN and/CC membrane/NN contributed/VBN to/IN Cm/NN by/IN 20%/CD ,/, 14%/JJ ,/, 2%/JJ and/CC 64%/JJ ,/, respectively/RB ./.
@@114080999027 Positive/JJ and/CC significant/JJ correlations/NNS were/VBD found/VBN between/IN the/DT weeks/NNS of/IN pregnancy/NN and/CC Se/NN levels/NNS in/IN kidney/NN (/( r/NN =/NN 0/NN ./NN 433/NN ,/, P/CD =/CD 0/CD ./CD 023/CD )/SYM and/CC heart/NN (/( r/NN =/NN 0/NN ./NN 313/NN ,/, P/CD =/CD 0/CD ./CD 030/CD )/SYM ./.
@@10906999734 The/DT measurement/NN of/IN NO/DT in/NN biological/JJ systems/NNS using/VBG chemiluminescence/NN ./.
@@75194817679 In/NN female/JJ Sl/NEWGENE (/NEWGENE pan/NEWGENE )/NEWGENE //NEWGENE Sl/NEWGENE (/NEWGENE pan/NEWGENE )/NEWGENE mice/NNS ,/, ovarian/JJ follicle/NN development/NN is/VBZ arrested/VBN at/IN the/DT one/PRP layered/JJ cuboidal/JJ stage/NN as/IN a/DT result/NN of/IN reduced/VBN KL/NEWGENE expression/NN in/IN follicle/NN cells/NNS ,/, indicating/VBG a/DT role/NN for/IN c-kit/NEWGENE in/IN oocyte/NN growth/NN ./.
@@22360221534 The/DT protooncogene/NN c-myb/NEWGENE encodes/VBZ a/DT nuclear/JJ transcription/NN factor/NN that/WDT binds/VBZ to/IN DNA/NN in/IN a/DT sequence-specific/JJ manner/NN and/CC transactivates/VBZ transcription/NN of/IN several/DT viral/JJ and/CC cellular/JJ genes/NNS ./.
@@79806692052 Basal/JJ plasma/NN AVP/NEWGENE levels/NNS and/CC AVP/NEWGENE release/NN after/IN postural/JJ change/NN were/VBD assessed/VBN ,/, and/CC plasma/NN NPY/NEWGENE levels/NNS were/VBD measured/VBN in/IN the/DT same/JJ samples/NNS ./.
@@112578701091 The/DT present/NN study/NN was/VBD initiated/VBN to/IN explore/VB the/DT potential/NN of/IN a/DT hybrid/JJ biological/JJ reactor/NN ,/, combining/JJ trickling/NN filter/NN (/( TF/NN )/SYM and/CC activated/VBN sludge/NN process/NN (/( ASP/NN )/SYM ,/, to/IN treat/NN wastewater/NN containing/JJ trichloroethylene/NN (/( TCE/NN )/SYM at/IN ambient/JJ temperature/NN at/IN different/JJ hydraulic/JJ retention/NN time/NN (/( HRT/NN )/SYM ./.
@@74942449832 In/NN the/DT absence/NN of/IN E1A243/NEWGENE ,/, YY1/NEWGENE represses/VBZ CRE-dependent/NN transcription/NN of/IN c-fos/NEWGENE by/IN physically/RB interacting/VBG with/IN ATF/NEWGENE //NEWGENE CREB/NEWGENE proteins/NEWGENE bound/JJ to/IN the/DT -67/NEWGENE CRE/NEWGENE ./.
@@7651424933 Biochemical/NNP analysis/NN shows/VBZ that/IN Ssm1p/NEWGENE is/VBZ a/DT structural/JJ protein/NN that/IN forms/NNS part/NN of/IN the/DT largest/JJS 60S/NEWGENE ribosomal/NEWGENE subunit/NEWGENE ,/, which/WDT does/VBP not/RB exist/VB in/IN a/DT pool/NN of/IN free/JJ proteins/NNS ./.
@@33606674048 To/TO evaluate/VB the/DT effect/NN of/IN altitude/NN on/IN adolescent/JJ growth/NN and/CC development/NN ,/, three/CD groups/NNS of/IN healthy/JJ ,/, well-nourished/JJ youth/NN of/IN similar/JJ socioeconomic/JJ status/NN and/CC ethnic/JJ grouping/NN who/WP resided/VBD at/IN sea/NN level/NN (/( n/NN =/SYM 1262/CD subjects/NNS )/SYM ,/, mid-altitude/JJ (/( n/NN =/SYM 1743/CD subjects/NNS )/SYM ,/, and/CC high/JJ altitude/NN (/( n/NN =/SYM 1137/CD subjects/NNS )/SYM were/VBD studied/VBN ./.
@@71696306990 It/PRP was/VBD suggested/VBN that/IN the/DT absence/NN of/IN pronounced/VBN differences/NNS between/IN conditions/NNS may/MD have/VB been/VBN due/NN to/IN the/DT complexity/NN of/IN the/DT task/NN or/CC the/DT type/NN of/IN prompts/NNS employed/VBN ./.
@@9572965149 A/DT third/JJ ORF/NN ,/, ORF5/NNS ,/, shows/VBZ homology/NN with/IN gene/NEWGENE agrB/NEWGENE from/IN Staphylococcus/NN aureus/NN ,/, which/WDT is/VBZ involved/VBN in/IN the/DT mechanism/NN of/IN regulation/NN of/IN the/DT virulence/NN phenotype/NN in/IN this/DT species/NN ./.
@@37389194406 Calcifications/NNS in/IN the/DT thoracic/JJ aorta/NN at/IN the/DT level/NN of/IN the/DT 11th/CD and/CC the/DT 12th/CD thoracic/JJ vertebrae/NNS in/IN 592/NNP men/NNS and/CC 333/CD women/NNS were/VBD studied/VBN using/VBG computed/JJ tomography/NN ./.
@@111972881037 Most/JJS patients/NNS harboring/VBG metronidazole-/JJ and/CC clarithromycin-resistant/JJ strains/NNS were/VBD eradicated/VBN at/IN an/DT equal/NN rate/NN by/IN each/DT of/IN the/DT three/CD regimens/NNS ./.
@@90486174202 Here/RB we/PRP show/VBP that/IN the/DT type/NN of/IN tyrosine/NEWGENE kinase/NEWGENE receptor/NEWGENE stimulated/VBN also/RB participates/VBZ in/IN the/DT nature/NN of/IN the/DT cAMP/NN effect/NN ./.
@@83349893821 To/TO begin/VB to/IN examine/VB the/DT mechanism/NN controlling/JJ expression/NN of/IN this/DT gene/NN during/IN the/DT cell-cycle/NN ,/, a/DT mouse/NEWGENE B-myb/NEWGENE 5'/NEWGENE flanking/NEWGENE sequence/NEWGENE was/VBD isolated/VBN from/IN a/DT cosmid/NN library/NN and/CC shown/VBP to/IN promote/VB efficiently/RB the/DT transcription/NN of/IN a/DT luciferase/NEWGENE reporter/NEWGENE gene/NEWGENE when/CC transfected/VBN into/IN NIH3T3/CELL fibroblasts/NNS ./.
@@34365296948 The/DT structure/NN of/IN the/DT enhancer/NN was/VBD also/RB probed/VBN by/IN inserting/VBG a/DT pair/NN of/IN complementary/JJ synthetic/JJ oligodeoxynucleotides/NNS which/WDT represented/VBD the/DT region/NN between/IN nt/NN positions/NNS -235/CD and/CC -215/CD into/IN a/DT truncated/JJ template/NN which/WDT lacked/VBD the/DT enhancer/NN ./.
@@114085911969 We/PRP investigated/VBD the/DT production/NN of/IN hyaluronan/NN (/( HA/NN )/SYM and/CC its/PRP effect/NN on/IN cell/NN motility/NN in/IN cells/NNS expressing/JJ the/DT v-src/NEWGENE mutants/NEWGENE ./.
@@22286152867 For/IN 85Sr/CD ,/, larger-than-expected/JJ distribution/NN coefficients/NNS were/VBD obtained/VBN in/IN the/DT desorption/NN experiments/NNS ,/, an/DT indication/NN of/IN the/DT irreversible/JJ formation/NN of/IN metal-oxyhydroxides/NNS during/IN a/DT slow/JJ reaction/NN ./.
@@79990662529 The/DT role/NN of/IN HIV/NEWGENE tat/NEWGENE ,/, which/WDT is/VBZ the/DT main/JJ enhancing/JJ factor/NN for/IN viral/JJ LTR/NN ,/, in/IN the/DT regulation/NN of/IN IL-2/NEWGENE gene/NEWGENE transcription/NN has/VBZ been/VBN studied/VBN following/IN transient/JJ expression/NN of/IN the/DT tat/NEWGENE gene/NEWGENE in/IN phorbol/NN ester/NN and/CC calcium/NN ionophore-activated/JJ Jurkat/NN cells/NNS transfected/VBN with/IN IL-2/NEWGENE promoter-chloramphenicol/NEWGENE acetyltransferase/NEWGENE reporter/NEWGENE constructs/NEWGENE ./.
@@108052867985 In/NN the/DT study/NN on/IN PCI/NEWGENE mRNA/NEWGENE expression/NN in/IN the/DT reproductive/JJ organs/NNS ,/, we/PRP first/RB cloned/VBN rat/NEWGENE PCI/NEWGENE cDNA/NEWGENE and/CC then/RB evaluated/VBN the/DT effect/NN of/IN androgen/NN on/IN the/DT PCI/NEWGENE mRNA/NEWGENE expression/NN ./.
@@104097247644 Activation/NNS of/IN ERK1/NEWGENE //NEWGENE 2/NEWGENE is/VBZ correlated/VBN with/IN induction/NN of/IN the/DT immediate-early/JJ response/NN genes/NNS ./.
@@93674265599 We/PRP argue/VBP that/IN the/DT primary/JJ role/NN of/IN hh/NEWGENE in/IN controlling/JJ polarity/NN is/VBZ to/IN cause/NN anterior/JJ compartment/NN cells/NNS to/IN reverse/JJ their/PRP interpretation/NN of/IN an/DT underlying/JJ symmetric/JJ polarization/NN ./.
@@14599218236 Four/CD ruminally/RB and/CC duodenally/RB cannulated/VBN Hampshire/NNP wethers/NNS were/VBD used/VBN in/IN a/DT 4/CD x/NN 4/CD Latin/JJ square/NN experiment/NN to/IN determine/VB whether/IN linoleoyl/JJ methionine/NN and/CC calcium/NN linoleate/NN would/MD increase/VB duodenal/JJ flow/NN of/IN unsaturated/JJ fatty/JJ acids/NNS (/( C18/IN :/: 2/CD +/SYM cis/NN C18/NN :/: 1/CD )/SYM ./.
@@77688484163 Polypeptides/NNS of/IN the/DT same/JJ apparent/JJ sizes/NNS are/VBP detected/VBN in/IN spores/NNS of/IN a/DT cotE/NEWGENE null/JJ mutant/NN ,/, on/IN which/WDT basis/NN we/PRP infer/VBP that/IN the/DT products/NNS of/IN the/DT cotJ/NEWGENE operon/NEWGENE are/VBP required/VBN for/IN the/DT normal/JJ formation/NN of/IN the/DT inner/JJ layers/NNS of/IN the/DT coat/NN or/CC are/VBP themselves/PRP structural/JJ components/NNS of/IN the/DT coat/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@97675753783 This/DT domain/NN ,/, although/IN adjacent/JJ to/IN the/DT 5'/CD edge/NN of/IN the/DT SD/NN sequence/NN ,/, does/VBP not/RB inhibit/VB ribosome/NN binding/JJ as/RB long/RB as/IN the/DT single-stranded/JJ region/NN of/IN domain/NN 3/CD is/VBZ present/VB ./.
@@58934955796 Studies/NNS on/IN the/DT intracutaneous/JJ infection/NN of/IN rabbits/NNS by/IN Staphylococcus/NN aureus/NN ./.
@@85242725259 Differential/JJ regulation/NN of/IN the/DT alpha/NN //NN beta/NN interferon-stimulated/NN Jak/NEWGENE //NEWGENE Stat/NEWGENE pathway/NEWGENE by/IN the/DT SH2/NEWGENE domain-containing/NN tyrosine/NEWGENE phosphatase/NEWGENE SHPTP1/NEWGENE ./.
@@98345219819 The/DT retrovesical/JJ hydatid/NN cyst/NN is/VBZ a/DT very/RB rare/JJ site/NN ./.
@@98226026248 Thus/RB ,/, hypoxia-inducible/JJ nuclear/JJ import/NN and/CC transactivation/NN by/IN recruitment/NN of/IN CBP/NEWGENE can/MD be/VB functionally/RB separated/VBN from/IN one/PRP another/DT and/CC play/NN critical/JJ roles/NNS in/IN signal/JJ transduction/NN by/IN HIF-1alpha/NEWGENE ./.
@@14004015855 Western/JJ blot/NN analyses/NNS detect/VBP anti-E-specific/JJ immunoreactivity/NN in/IN affinity-purified/JJ extracts/NNS derived/VBN from/IN the/DT bacterial/JJ expression/NN of/IN a/DT truncated/NEWGENE AMPD3/NEWGENE cDNA/NEWGENE ./.
@@25250444197 The/DT recovery/NN index/NN (/( T25-T75/NN )/SYM after/IN the/DT infusion/NN stopped/VBN was/VBD similar/JJ in/IN patients/NNS who/WP received/VBD mivacurium/NN and/CC those/DT who/WP received/VBD suxamethonium/NN ./.
@@70735206843 During/IN conventional/JJ hemofiltration/NN using/VBG substitution/NN fluid/NN with/IN a/DT Na+/NN concentration/NN of/IN 140/CD mEq/NN //NN L/NN ,/, a/DT decrease/NN in/IN extracellular/JJ fluid/NN volume/NN was/VBD noted/VBN whereas/IN the/DT intracellular/JJ fluid/NN volume/NN was/VBD unaltered/JJ ./.
@@95287687315 Cells/NNS respond/VBP to/IN the/DT accumulation/NN of/IN unfolded/JJ proteins/NNS in/IN the/DT endoplasmic/JJ reticulum/NN (/( ER/NN )/SYM by/IN increasing/JJ the/DT transcription/NN of/IN the/DT genes/NNS encoding/VBG ER-resident/NN chaperone/NEWGENE proteins/NEWGENE ./.
@@61933516014 The/DT intracoronary/JJ administration/NN of/IN both/DT drugs/NNS markedly/RB reduced/VBN the/DT incidence/NN of/IN VF/NN induced/VBN by/IN the/DT release/NN of/IN a/DT 40-min/JJ coronary/JJ artery/NN occlusion/NN ./.
@@91489351478 FN-stimulated/JJ c-Src/NEWGENE PTK/NEWGENE1 activity/NN was/VBD enhanced/VBN by/IN wild/JJ type/NN FAK/NEWGENE expression/NN ,/, whereas/IN FN-stimulated/JJ activation/NN of/IN ERK2/NEWGENE was/VBD blocked/VBN by/IN expression/NN of/IN the/DT c-Src/NEWGENE binding/NEWGENE site/NEWGENE Phe-397/NEWGENE mutant/NEWGENE of/IN FAK/NEWGENE ./.
@@26928813367 In/NN comparison/NN with/IN normal/JJ pregnant/JJ women/NNS and/CC normal/JJ non-pregnant/JJ women/NNS ,/, women/NNS with/IN PIH/NN showed/VBD an/DT increase/NN in/IN heart/NN rate/NN ,/, suggesting/VBG an/DT increased/VBN peripheral/JJ sympathetic/JJ tone/NN ,/, and/CC an/DT initial/JJ derangement/NN in/IN renal/JJ function/NN as/IN shown/VBP by/IN the/DT increase/NN in/IN serum/JJ uric/JJ acid/NN and/CC reduction/NN in/IN sodium/NN excretion/NN and/CC total/JJ and/CC fractional/JJ calcium/NN excretion/NN at/IN any/DT given/NN level/NN of/IN sodium/NN excretion/NN ./.
@@17826696916 However/RB ,/, it/PRP was/VBD synthesized/VBN at/IN both/DT temperatures/NNS after/IN addition/NN of/IN A23187/NN ./.
@@96367086879 The/DT YccA/NEWGENE protein/NEWGENE was/VBD found/VBN to/IN be/VB degraded/VBN in/IN an/DT FtsH-dependent/NNP manner/NN in/IN vivo/NN and/CC in/IN vitro/FW ,/, whereas/IN the/DT YccA11/NEWGENE mutant/NEWGENE protein/NEWGENE ,/, lacking/JJ eight/CD amino/JJ acid/NN residues/NNS within/IN the/DT amino-terminal/JJ cytoplasmic/JJ domain/NN ,/, was/VBD refractory/JJ to/IN the/DT degradation/NN ./.
@@115568099424 Interestingly/RB ,/, the/DT CYP71D20-encoded/NEWGENE enzyme/NEWGENE activity/NN was/VBD capable/JJ of/IN converting/JJ both/DT 5-epi-aristolochene/JJ and/CC 1-deoxycapsidiol/JJ to/IN capsidiol/NN in/IN vitro/FW ,/, consistent/JJ with/IN the/DT notion/NN that/IN this/DT P450/NEWGENE enzyme/NEWGENE catalyzes/VBZ both/DT hydroxylations/NNS of/IN its/PRP hydrocarbon/NN substrate/NN ./.
@@107338801176 Copyright/NNP 2000/CD Academic/NNP Press/NNP ./.
@@109804166059 Parathyroid/NEWGENE hormone/NEWGENE regulation/NN of/IN bone/NEWGENE sialoprotein/NEWGENE (/( BSP/NEWGENE )/SYM gene/NN transcription/NN is/VBZ mediated/JJ through/RB a/DT pituitary-specific/NEWGENE transcription/NEWGENE factor-1/NEWGENE (/( Pit-1/NEWGENE )/SYM motif/NN in/IN the/DT rat/NEWGENE BSP/NEWGENE gene/NEWGENE promoter/NEWGENE ./.
@@36079614274 Hypoglycemic/NNP action/NN of/IN "he/NN xiang/NN zhuang/NN qi/NN gong"/NN and/CC its/PRP mechanism/NN on/IN diabetes/NN mellitus/MD ./.
@@72375608489 While/IN all/DT deletions/NNS within/IN the/DT sequence/NN coding/JJ for/IN the/DT mature/JJ tRNA/NN led/VBN to/IN inactivity/NN of/IN the/DT mutated/NN genes/NN ,/, substitution/NN of/IN the/DT central/JJ portion/NN by/IN concatenated/NEWGENE Hind/NEWGENE III/NEWGENE linkers/NEWGENE produced/VBD gene/NN units/NNS active/JJ in/IN transcription/NN ./.
@@24812305419 Similarly/RB ,/, a/DT human/JJ but/CC not/RB a/DT bovine/NEWGENE alpha/NEWGENE transgene/NEWGENE was/VBD expressed/VBN in/IN placenta/NN in/IN transgenic/JJ mice/NNS ./.
@@18560212452 The/DT method/NN has/VBZ been/VBN routinely/RB used/VBN in/IN our/PRP laboratory/NN for/IN 1/CD year/NN and/CC has/VBZ proven/VBP to/IN be/VB a/DT reliable/JJ procedure/NN for/IN the/DT biological/JJ control/NN of/IN occupational/JJ exposure/NN to/IN toluene/NN and/DT //DT or/DT xylene/NN ./.
@@80448026321 However/RB ,/, Southern/NNP blot/NN and/CC karyotype/NN analyses/NNS did/VBD not/RB reveal/VB any/DT significant/JJ changes/NNS in/IN copy/NN number/NN or/CC gross/JJ rearrangements/NNS of/IN the/DT p53/NEWGENE gene/NEWGENE in/IN any/DT of/IN the/DT p53-/NEWGENE cell/NN lines/NNS ./.
@@90774372774 Recognition/NNP mechanisms/NNS of/IN the/DT minus-strand/NN origin/NN of/IN phage/NN f1/NN by/IN Escherichia/NEWGENE coli/NEWGENE RNA/NEWGENE polymerase/NEWGENE ./.
@@107449747533 Phosphorylation/NNS and/CC spindle/NN pole/NN body/NN localization/NN of/IN the/DT Cdc15p/NEWGENE mitotic/NEWGENE regulatory/NEWGENE protein/NEWGENE kinase/NEWGENE in/NEWGENE budding/NEWGENE yeast/NEWGENE ./.
@@16116994713 Three/CD pyridoxine/NN derivatives/NNS have/VBP been/VBN isolated/VBN from/IN the/DT fresh/JJ stem/NN bark/NN of/IN Albizzia/NN julibrissin/NN DURAZZ/NNP ./NNP ./.
@@24004577700 In/NN Experiment/NN II/NNP ,/, as/IN performing/JJ moderate/JJ supine/JJ cycling/JJ (/( 55%/JJ VO2/NN max/NN )/SYM for/IN 50/CD minutes/NNS under/IN several/DT LBNP/NN conditions/NNS in/IN 5/CD sedentary/JJ women/NNS ,/, there/RB were/VBD correspondingly/RB similar/JJ changing/JJ manners/NNS of/IN the/DT cardiovascular/JJ adjustments/NNS to/IN each/DT of/IN the/DT phases/NNS given/NN in/IN Experiment/NN I/NNP ./NNP
@@91936714758 The/DT active/JJ state/NN is/VBZ terminated/VBN by/IN hydrolysis/NN of/IN bound/JJ GTP/NN ,/, producing/JJ inactive/JJ ARF-GDP/NEWGENE ./.
@@70406596816 All/DT patients/NNS in/IN the/DT control/NN group/NN showed/VBD a/DT significant/JJ improvement/NN in/IN their/PRP PEFR/NN while/CC only/RB 3/CD patients/NNS in/IN the/DT treated/VBN group/NN showed/VBD an/DT improvement/NN ./.
@@34293064132 A/DT Golgi/JJ study/NN of/IN the/DT sixth/JJ layer/NN of/IN the/DT cerebral/JJ cortex/NN ./.
@@80343189253 The/DT availability/NN of/IN sequence/NN from/IN multiple/JJ species/NN has/VBZ permitted/VBN us/PRP to/IN determine/VB that/IN the/DT UBE/NN site/NN has/VBZ close/JJ similarity/NN to/IN motifs/NNS that/WDT bind/VBP members/NNS of/IN the/DT NF-1/NEWGENE family/NEWGENE of/NEWGENE transcription/NEWGENE factors/NNS ./.
@@3078268640 Finally/RB ,/, the/DT pathophysiological/JJ aspects/NNS of/IN urinary/JJ acidification/NN are/VBP discussed/VBN ,/, focusing/NN on/IN renal/JJ tubular/JJ acidosis/NN models/NNS (/( induced/VBN by/IN maleate/NN and/CC amphotericin/NN B/NN treatment/NN )/SYM and/CC their/PRP cellular/JJ mechanisms/NNS ,/, as/RB well/VB as/IN the/DT role/NN of/IN adrenal/JJ steroids/NNS in/IN urinary/JJ acidification/NN ./.
@@21620499972 To/TO address/VB this/DT issue/NN ,/, the/DT gene/NN for/IN factor/NEWGENE Y/NEWGENE has/VBZ been/VBN cloned/VBN molecularly/RB and/CC its/PRP DNA/NN sequence/NN has/VBZ been/VBN determined/VBN ./.
@@60544115883 Retention/NNP behavior/NN of/IN steroids/NNS in/IN gas/NN chromatography/NN with/IN a/DT series/NN of/IN combination/NN columns/NNS ./.
@@20167696244 We/PRP found/VBP that/IN the/DT relative/JJ strengths/NNS of/IN the/DT promoters/NNS were/VBD similar/JJ in/IN different/JJ contexts/NNS ./.
@@39781324640 In/NN MCCP/NN functions/NNS of/IN the/DT source/NN emission/NN ,/, surface/NN reflection/NN ,/, photoacceptor/NN sensitivity/NN are/VBP approximated/VBN by/IN the/DT normal/JJ distribution/NN curves/NNS ./.
@@96608384899 Regulation/NN at/IN 37/CD degrees/NNS C/NN ,/, therefore/RB ,/, involves/VBZ the/DT action/NN of/IN three/CD protein/NEWGENE kinase/NEWGENE cascades/NNS that/WDT repress/VBP HSF1/NEWGENE through/JJ phosphorylation/NN of/IN serine/NN residues/NNS 303/CD ,/, 307/CD ,/, and/CC 363/CD and/CC may/MD promote/VB growth/VB by/IN suppressing/JJ the/DT heat/NN shock/NN response/NN ./.
@@13462622675 A/DT comparative/JJ study/NN of/IN the/DT total/JJ protein/NN profiles/NNS of/IN wild-type/NNP S/NNP ./NNP entomophila/NN UC9/CD and/CC mutant/NN UC21/NN revealed/VBN that/IN the/DT mutant/RB lacked/VBN an/DT approximately/RB 44-kDa/NN protein/NN and/CC overexpressed/VBN an/DT approximately/RB 20-kDa/NN protein/NN ./.
@@113838601234 The/DT images/NNS showed/VBD rapid/JJ ,/, predominantly/RB urinary/JJ excretion/NN of/IN 99mTc/NN ciprofloxacin/NN ,/, with/IN low/JJ to/IN absent/VB brain/NN ,/, lung/NN and/CC bone/NN marrow/NN uptake/NN and/CC low/JJ liver/NN uptake/NN and/CC excretion/NN ./.
@@20410889005 To/TO measure/VB the/DT enhancer/NN activity/NN of/IN DR60/NEWGENE ,/, a/DT reporter/NN plasmid/NN was/VBD constructed/VBN that/WDT contained/VBD DR60/NEWGENE cloned/VBN upstream/RB of/IN the/DT reporter/NN chloramphenicol/NEWGENE acetyltransferase/NEWGENE gene/NEWGENE under/IN the/DT control/NN of/IN the/DT delayed-early/NEWGENE 39K/NEWGENE promoter/NEWGENE ./.
@@81894988713 Identification/NNP of/IN an/DT immediate-early/NEWGENE gene/NEWGENE in/IN the/DT Marek's/NNP disease/NN virus/NN long/JJ internal/JJ repeat/NN region/NN which/WDT encodes/VBZ a/DT unique/JJ 14-kilodalton/JJ polypeptide/NN ./.
@@86764545979 Only/RB fully/RB processed/VBN Pra/NN (/( N0/IN and/CC Nb/NN )/SYM and/CC ICP35/NN (/( ICP35/NN e/NN ,/NN f/NN )/SYM are/VBP present/VB in/IN B/NNP capsids/NNS ,/, which/WDT are/VBP believed/VBN to/IN be/VB precursors/NNS of/IN mature/JJ virions/NNS ./.
@@27079097705 An/DT alternative/JJ method/NN of/IN UKM/NN is/VBZ proposed/VBN based/VBN on/IN collecting/JJ a/DT small/JJ fraction/NN of/IN spent/VBP dialysate/NN flow/NN for/IN 3/CD consecutive/JJ dialyses/NNS ./.
@@2217253389 The/DT decline/NN in/IN the/DT activity/NN of/IN cytochrome/NEWGENE oxidase/NEWGENE ,/, peroxidase/NEWGENE and/CC in/IN the/DT lipid/NN content/NN of/IN peripheral/JJ neutrophils/NNS was/VBD followed/VBN by/IN a/DT decrease/NN in/IN the/DT phagocytic/JJ activity/NN ./.
@@11108548943 MS/NN characteristics/NNS of/IN coumarins/NNS ,/, psoralens/NNS and/CC polymethoxylated/VBN flavones/NNS with/IN different/JJ substitution/NN patterns/NNS were/VBD determined/VBN on/IN the/DT basis/NN of/IN the/DT response/NN obtained/VBN with/IN the/DT APcI/NN interface/NN ./.
@@9445056914 We/PRP have/VBP used/VBN mutation-directed/JJ chemical/JJ cross-linking/VBG with/IN bis/NN (/NN sulfosuccinimidyl/NN )/NN suberate/NN (/( BS3/NN )/SYM to/IN investigate/VB the/DT architecture/NN of/IN the/DT gp41/NEWGENE oligomer/NEWGENE ./.
@@30480249233 Bacteriologic/NNP culture/NN of/IN pancreatic/JJ tissue/NN was/VBD positive/JJ in/IN 6/CD //CD 8/CD IB/NN and/CC 3/CD //CD 17/CD NIB/NN rats/NNS (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@808898994 The/DT clinico-pathological/JJ data/NN from/IN a/DT patient/NN with/IN irreversible/JJ post-partum/JJ renal/JJ failure/NN (/( IPRF/NN )/SYM are/VBP presented/VBN ./.
@@37513084420 Study/NNP of/IN the/DT energy/NN metabolism/NN of/IN the/DT sensomotor/JJ cortex/NN and/CC hippocampus/NN by/IN the/DT (/( 14C/CD )/NN 2-deoxyglucose/NN method/NN during/IN the/DT development/NN of/IN dissociated/VBN states/NNS ./.
@@24921113463 In/NN 76%/NN of/IN 59/CD lead-toxic/JJ children/NNS ,/, bone/NN lead/NN values/NNS measured/VBN by/IN LXRF/NN were/VBD equal/VB to/IN or/CC greater/JJR than/IN those/DT measured/VBN in/IN normal/JJ and/CC industrially/RB exposed/VBN adults/NNS ./.
@@37792054458 Only/RB seven/JJ patients/NNS ,/, five/CD of/IN whom/WP have/VBP metastatic/JJ disease/NN ,/, survive/VB more/RB than/IN 10/CD years/NNS after/IN first/JJ presentation/NN ;/: nine/JJ patients/NNS ,/, one/PRP of/IN whom/WP has/VBZ secondaries/NNS ,/, survive/VB for/IN 5/CD years/NNS or/CC less/PRP ./.
@@113748668768 Copyright/NNP 2001/CD Academic/NNP Press/NNP ./.
@@67841232013 The/DT 1/CD ./CD 9-kb/CD C/NEWGENE mu/NEWGENE RNA/NN contains/VBZ the/DT 3'/CD sequence/NN characteristic/NN of/IN secreted/VBN mu/NEWGENE chain/NEWGENE ,/, whereas/IN the/DT longer/JJR species/NN bear/NN that/IN of/IN membrane-bound/NN mu/NEWGENE chin/NN ./.
@@76385173384 From/IN May/NN 1985/CD to/IN May/NN 1989/CD ,/, 126/CD necropsies/NNS were/VBD performed/VBN at/IN the/DT Sao/NNP Paulo/NNP City/NNP Morgue/NNP on/IN cadavers/NNS of/IN individuals/NNS AIDS/NN victims/NN whose/WP unnatural/JJ deaths/NNS had/VBP prompted/VBN police/NNS investigations/NNS ./.
@@85756141401 Rad6/NEWGENE mutants/NEWGENE display/NN a/DT remarkably/RB pleiotropic/JJ phenotype/NN ,/, implicating/VBG the/DT protein/NN in/IN DNA/NN damage-induced/JJ mutagenesis/NN ,/, postreplication/JJ repair/NN ,/, repression/NN of/IN retrotransposition/JJ ,/, and/CC sporulation/NN ./.
@@88824927414 The/DT mammalian/NEWGENE homeodomain/NEWGENE proteins/NEWGENE encoded/VBN by/IN Hox/NEWGENE genes/NEWGENE play/VBP an/DT important/JJ role/NN in/IN embryonic/JJ development/NN by/IN providing/CC positional/JJ queues/NNS which/WDT define/VBP developmental/JJ identities/NNS along/IN the/DT anteroposterior/JJ axis/NN of/IN developing/JJ organisms/NNS ./.
@@27139943399 The/DT titer/NN of/IN anti/NEWGENE HSV/NEWGENE type/NEWGENE 1/NEWGENE and/CC anti/NEWGENE HSV/NEWGENE type/NEWGENE 2/NEWGENE antibodies/NEWGENE in/IN the/DT mothers'/NN and/CC cord/NN blood/NN was/VBD determined/VBN and/CC compared/VBN ./.
@@75719537470 Negative-staining/VBG ,/, refractile/JJ mycobacteria/NNS in/IN Romanowsky-stained/JJ smears/NNS ./.
@@40378091278 The/DT effective/JJ and/CC low/JJ toxic/JJ dose/NN schedules/NNS of/IN KW-2083/NN should/MD be/VB investigated/VBN further/RB ./.
@@94794985832 We/PRP have/VBP isolated/VBN a/DT new/JJ human/NEWGENE RING-finger/NEWGENE gene/NEWGENE (/( RNF4/NEWGENE )/SYM that/IN encodes/VBZ a/DT 190-amino-acid/NN protein/NN ./.
@@30404039443 The/DT PSS/NEWGENE gene/NEWGENE was/VBD subcloned/JJ into/IN a/DT 1/CD ./CD 1-kb/CD fragment/NN of/IN the/DT yeast/NN DNA/NN on/IN the/DT YEp13/NNP vector/NN ./.
@@2679804929 The/DT products/NNS of/IN genes/NN ura10/NEWGENE and/CC ura3/NEWGENE are/VBP proposed/VBN to/IN participate/VB in/IN the/DT channeling/VBG of/IN orotidine/NN monophosphate/NN ./.
@@97951309885 Interestingly/RB ,/, an/DT increase/NN of/IN distance/NN per/IN se/FW did/VBD not/RB have/VB a/DT deleterious/JJ effect/NN on/IN translation/NN efficiency/NN ./.
@@23618122749 Per/IN kg/NN FFM/NN SMR/NN was/VBD almost/RB restored/VBN to/IN baseline/NN values/NNS for/IN the/DT EX/NN group/NN ,/, whereas/IN the/DT non-exercising/JJ subjects/NNS still/RB showed/VBD depressed/VBN values/NNS (/( EX/NN 3/NN ./NN 7/NN per/IN cent/NN and/CC D/NN +/SYM DE/NNP 15/CD ./CD 8/CD per/IN cent/NN lower/JJR than/IN before/IN treatment/NN ;/: P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@16959059788 GLUT5/NEWGENE mRNA/NEWGENE is/VBZ expressed/VBN at/IN highest/JJS levels/NNS in/IN small/JJ intestine/NN and/CC at/IN much/RB lower/JJR levels/NNS in/IN kidney/NN ,/, skeletal/JJ muscle/NN ,/, and/CC adipose/JJ tissue/NN ./.
@@91723128543 Characterization/NNS of/IN CR1/NEWGENE repeat/NEWGENE random/JJ PCR/NN markers/NNS for/IN mapping/VBG the/DT chicken/NN genome/NN ./.
@@91219981563 Time-activity/NNP curves/NNS from/IN the/DT gastric/JJ region/NN of/IN interest/NN were/VBD used/VBN ,/, after/IN subjection/NN to/IN appropriate/JJ corrective/JJ procedures/NNS ,/, to/IN calculate/VB the/DT mean/JJ gastric/JJ transit/NN time/NN (/( MTT/NN 90/NN )/SYM and/CC the/DT fraction/NN of/IN the/DT test/NN meal/NN retained/VBN in/IN the/DT stomach/NN after/IN 90/CD min/NN (/( F90/CD )/SYM ./.
@@81083438369 Comparative/JJ analysis/NN with/IN an/DT antiandrogen/NN niftolid/NN and/CC synthetic/NEWGENE GnRH/NEWGENE was/VBD carried/VBN out/RB in/IN 22/CD normal/JJ subjects/NNS ,/, 14/CD patients/NNS with/IN primary/JJ and/CC 20/CD ones/NNS with/IN secondary/JJ hypogonadism/NN ,/, and/CC in/IN 5/CD patients/NNS with/IN clinical/JJ signs/NNS of/IN gonadal/JJ insufficiency/NN and/CC obscure/VB diagnosis/NN in/IN order/NN to/IN elucidate/VB the/DT pituitary/NEWGENE gonadotropin/NEWGENE reserves/NNS ./.
@@86172431788 We/PRP have/VBP isolated/VBN a/DT novel/JJ protein/NN from/IN Drosophila/NN nuclear/JJ extracts/NNS which/WDT binds/VBZ specifically/RB to/IN a/DT site/NN in/IN this/DT second/JJ region/NN ./.
@@112790869060 These/DT data/NN suggest/VB that/IN ADAM-TS12/NEWGENE may/MD play/VB roles/NNS in/IN pulmonary/JJ cells/NNS during/IN fetal/JJ development/NN or/CC in/IN tumor/NN processes/NNS through/RB its/PRP proteolytic/JJ activity/NN or/CC as/IN a/DT molecule/NN potentially/RB involved/VBD in/IN regulation/NN of/IN cell/NN adhesion/NN ./.
@@105214473214 Furthermore/RB ,/, overexpression/NN of/IN AML3/NEWGENE //NEWGENE CBFalpha1/NEWGENE could/MD rescue/VB the/DT AML1-ETO/NEWGENE repression/NN ./.
@@77448467648 Analysis/NNP of/IN Bcl-2/NEWGENE //NEWGENE Bcl-2/NEWGENE homodimerization/NN using/VBG both/DT in/NN vitro/FW binding/JJ assays/NNS as/RB well/VBP as/IN a/DT yeast/NN two-hybrid/JJ method/NN provided/VBD evidence/NN in/IN support/NN of/IN a/DT head-to-tail/JJ model/NN for/IN Bcl-2/NEWGENE //NEWGENE Bcl-2/NEWGENE homodimerization/NN and/CC revealed/VBN that/IN sequences/NNS within/IN the/DT NH2-terminal/NN A/NN domain/NN interact/VB with/IN a/DT structure/NN that/WDT requires/VBZ the/DT presence/NN of/IN both/PDT the/DT carboxyl/NN B/NN and/CC C/NN domains/NN in/IN combination/NN ./.
@@83170942672 The/DT 5'/CD ends/NNS of/IN F3R/NEWGENE late/JJ transcripts/NNS were/VBD located/VBN to/IN an/DT A/DT within/IN the/DT sequence/NEWGENE 5'-TAAAG/NEWGENE ,/, 41/CD nt/NN downstream/RB from/IN the/DT early/JJ promoter/NN and/CC 17/CD nt/NN upstream/RB from/IN the/DT initiation/NN codon/NN ./.
@@117265741571 These/DT results/NNS were/VBD robust/JJ to/IN changes/NNS in/IN the/DT baseline/NN assumptions/NNS of/IN the/DT model/NN ./.
@@114658441341 Lack/NN of/IN association/NN between/IN Kawasaki/NN syndrome/NN and/CC infection/NN with/IN Rickettsia/NN conorii/NN ,/, Rickettsia/NN typhi/NN ,/, Coxiella/NN burnetii/NN or/CC Ehrlichia/NNP phagocytophila/NN group/NN ./.
@@72496607081 Determination/NNS of/IN aortic/JJ distensibility/NN and/CC its/PRP variations/NNS in/IN arterial/JJ hypertension/NN ./.
@@9480831754 To/TO elucidate/VB the/DT regulatory/JJ mechanism/NN of/IN human/NEWGENE AM/NEWGENE gene/NEWGENE expression/NN ,/, functional/JJ elements/NNS of/IN 5'-flanking/JJ region/NN of/IN AM/NEWGENE gene/NEWGENE were/VBD studied/VBN in/IN human/JJ aortic/JJ endothelial/JJ cells/NNS (/( HAEC/NN )/SYM ./.
@@113568538986 Members/NNS of/IN the/DT AP-1/NEWGENE superfamily/NEWGENE of/NEWGENE basic-leucine/NEWGENE zipper/NEWGENE factors/NEWGENE bind/VBP to/IN the/DT StRE/NEWGENE ./.
@@22566782739 Finally/RB ,/, a/DT complementary/JJ footprinting/VBG analysis/NN of/IN the/DT upstream/JJ region/NN of/IN the/DT constitutively/RB expressed/VBN HSC82/NEWGENE gene/NEWGENE reveals/VBZ the/DT presence/NN of/IN three/CD discrete/JJ protein/NN complexes/NNS ./.
@@10766556580 The/DT somatoform/JJ conundrum/NN :/: a/DT question/NN of/IN nosological/JJ valves/NNS ./.
@@64299926231 Gonadotropin/NEWGENE levels/NNS in/IN mothers/NNS who/WP have/VBP had/VBP two/JJ sets/NNS of/IN DZ/JJ twins/NNS ./.
@@90289424518 Human/NEWGENE granulocyte-macrophage/NEWGENE colony-stimulating/NEWGENE factor/NEWGENE (/( hGM-CSF/NEWGENE )/SYM activates/VBZ a/DT set/NN of/IN genes/NNS such/JJ as/IN c-fos/NEWGENE ,/, jun/NEWGENE ,/, myc/NEWGENE ,/, and/CC early/NEWGENE growth/NEWGENE response/NEWGENE gene/NEWGENE 1/NEWGENE (/( egr-1/NEWGENE )/SYM ./.
@@10872851690 When/WRB the/DT LCx/NN was/VBD partially/RB occluded/VBN ,/, mild/JJ PM-induced/JJ tachycardia/NN resulted/VBN in/IN decreased/VBN AoP/NN (/( P/NN =/NN 0/NN ./NN 045/NN )/SYM as/RB well/VB as/IN in/IN decreased/VBN SV/NN (/( P/NNP =/NNP 0/NNP ./NNP 048/NNP )/SYM ;/: the/DT LVEDP/NN remained/VBD high/JJ (/( P/CD =/CD 0/CD ./CD 002/CD )/SYM ./.
@@112308892657 Two/CD cases/NNS with/IN marked/JJ chronic/JJ arm/NN lymphoedema/NN reported/VBD major/JJ and/CC persistent/JJ improvements/NNS in/IN arm/NN volume/NN for/IN at/IN least/RB 12/CD months/NNS after/IN treatment/NN with/IN HBO2/NN ./.
@@38632317191 The/DT M-3/NN subtype/NN was/VBD an/DT adverse/JJ prognostic/JJ factor/NN ./.
@@53649515505 Histopathology/NNS and/CC pathogenesis/NN of/IN exanthematous/JJ viroses/NNS ./.
@@90606236234 The/DT human/NN coreceptor/NN was/VBD as/RB active/JJ as/IN the/DT simian/NN for/IN SIV/NN entry/NN ./.
@@28394887288 Quantitative/JJ assays/NNS in/IN which/WDT the/DT activity/NN of/IN the/DT synthetic/NEWGENE alpha/NEWGENE s-1/NEWGENE was/VBD compared/VBN to/IN that/DT of/IN native/RB purified/VBN human/NEWGENE erythrocyte/NEWGENE type-1/NEWGENE Gs/NEWGENE ,/, indicated/VBN that/IN the/DT two/JJ products/NNS are/VBP equipotent/JJ within/IN a/DT 2-fold/JJ margin/NN of/IN error/NN ./.
@@78995814610 The/DT effect/NN of/IN the/DT Ca/NN entry/NN blocker/NN nitrendipine/NN ,/, the/DT antioxidant/JJ superoxide/NEWGENE dismutase/NEWGENE (/( SOD/NEWGENE )/SYM ,/, and/CC a/DT combination/NN of/IN nitrendipine/NN and/CC superoxide/NEWGENE dismutase/NEWGENE on/IN postischemic/JJ renal/JJ function/NN was/VBD studied/VBN in/IN four/CD groups/NNS (/( n/NN =/SYM 24/CD )/SYM of/IN rats/NNS ./.
@@81335028105 European/NNP Community/NNP Huntington's/NNP Disease/NNP Collaborative/NNP Study/NNP Group/NNP ./.
@@14690472246 Interestingly/RB ,/, a/DT portion/NN of/IN the/DT tail/NN domain/NN (/( aa/NNS ,/, 1/CD ,/CD 094-1/CD ,/CD 830/CD )/SYM shares/VBP 58%/JJ amino/JJ acid/NN sequence/NN identity/NN with/IN a/DT 723-aa/JJ protein/NN from/IN mouse/NN brain/NN reported/VBN to/IN be/VB a/DT glutamic/NEWGENE acid/NEWGENE decarboxylase/NEWGENE ./.
@@16407782243 This/DT accurate/JJ and/CC rapid/JJ method/NN makes/VBP the/DT MLPA/NN test/NN logistically/RB feasible/JJ for/IN large-scale/JJ screening/NN ./.
@@77116672573 A/DT multivariate/JJ analysis/NN of/IN risk/NN factors/NNS for/IN relapse/NN examined/VBD age/NN ,/, WBC/NN at/IN diagnosis/NN ,/, blast/NN count/NN at/IN diagnosis/NN ,/, percentage/NN of/IN marrow/NN blasts/NNS ,/, FAB/NEWGENE subtype/NN ,/, the/DT number/NN of/IN remission/NN induction/NN courses/NNS to/IN achieve/VB a/DT remission/NN ,/, maintenance/NN therapy/NN ,/, consolidation/NN therapy/NN ,/, marrow/NN cell/NN dose/NN ,/, donor-recipient/JJ sex/NN ,/, GVHD/NN prophylaxis/NN regimen/NN and/CC isolation/NN and/CC decontamination/NN in/IN laminar/JJ airflow/NN rooms/NNS ./.
@@82533864496 We/PRP have/VBP explored/VBN the/DT mechanism/NN of/IN action/NN of/IN the/DT fibronectin/NEWGENE splicing/NEWGENE enhancer/NEWGENE and/CC found/VB that/IN the/DT SE/NEWGENE element/NEWGENE is/VBZ required/VBN for/IN efficient/JJ assembly/NN of/IN early/JJ splicing/JJ complexes/NNS ,/, allowing/VBG a/DT more/RB efficient/JJ interaction/NN of/IN the/DT U2/NEWGENE snRNP/NEWGENE with/IN branch/NN site/NN sequences/NNS ./.
@@75763078086 Unexpectedly/RB ,/, all/DT ENK-specific/NEWGENE motifs/NEWGENE formed/VBD specific/JJ and/CC highly/RB abundant/JJ protein-DNA/JJ complexes/NNS when/CC nuclear/JJ extracts/NNS from/IN the/DT human/JJ tumor/NN cell/NN line/NN (/( HeLa/IN )/SYM ,/, which/WDT does/VBP not/RB express/VB ENK/NEWGENE ,/, were/VBD used/VBN ./.
@@109325278012 Subsequently/RB ,/, HD/NN inhibited/VBD healing/NN because/IN it/PRP significantly/RB delayed/JJ epithelialization/NN and/CC caused/VBN protracted/JJ inflammation/NN ./.
@@103929039525 The/DT bovine/NEWGENE papillomavirus/NEWGENE E2/NEWGENE protein/NEWGENE can/MD inhibit/VB the/DT proliferation/NN of/IN HT-3/NNP cells/NNS ,/, a/DT p53-negative/JJ cervical/JJ carcinoma/NN cell/NN line/NN containing/JJ integrated/JJ human/JJ papillomavirus/NN type/NN 30/NN DNA/NN ./.
@@89016588862 Vascular/JJ responses/NNS to/IN reactive/NN hyperemia/NN (/( with/IN flow/NN increase/NN leading/JJ to/IN endothelium-dependent/JJ dilation/NN )/SYM and/CC to/IN sublingual/JJ glyceryl/NN trinitrate/NN (/( GTN/NN ;/: endothelium-independent/JJ dilation/NN )/SYM were/VBD recorded/VBN ./.
@@77969354216 We/PRP compared/VBD the/DT inhibitory/JJ effect/NN of/IN naturally/RB occurring/VBG mutant/NEWGENE hTR/NEWGENE beta/NEWGENE 1/NEWGENE ,/, artificially/RB created/VBN hTR/NEWGENE alpha/NEWGENE 1/NEWGENE mutants/NEWGENE ,/, c-erbA/NEWGENE alpha/NEWGENE 2/NEWGENE and/CC the/DT human/NEWGENE peroxisome/NEWGENE proliferator-activated/NEWGENE receptor/NEWGENE (/( hPPAR/NEWGENE )/SYM on/IN three/CD prototypic/JJ T3-response/NEWGENE elements/NEWGENE (/( TREs/NEWGENE )/SYM ,/, TRE-PAL/NEWGENE ,/, DR/NEWGENE +/NEWGENE 4/NEWGENE and/CC TRE-LAP/NEWGENE ./.
@@2289639346 The/DT mean/JJ change/NN in/IN HbA1/NEWGENE ,/, adjusted/VBN for/IN the/DT initial/JJ value/NN ,/, was/VBD -0/CD ./CD 4%/CD in/IN the/DT experimental/JJ and/CC +0/CD ./CD 5%/CD in/IN the/DT control/NN group/NN (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@67554687294 Regions/NNS of/IN the/DT translated/VBN open/JJ reading/JJ frames/NNS of/IN cobA/NEWGENE and/CC the/DT third/JJ intron/NN of/IN the/DT cob/NEWGENE gene/NEWGENE in/NEWGENE yeast/NEWGENE show/NN high/JJ amino/JJ acid/NN homology/NN ./.
@@112909069069 Tumor-like/NNP accumulation/NN on/IN Tl-201/NN SPECT/NN in/IN subacute/JJ hemorrhagic/JJ cerebral/JJ infarction/NN ./.
@@13169036212 RNA/NEWGENE polymerase/NEWGENE IIA/NEWGENE was/VBD recovered/VBN in/IN transcriptionally/RB active/JJ complexes/NNS in/IN reactions/NNS in/IN which/WDT the/DT input/NN enzyme/NN was/VBD RNA/NEWGENE polymerase/NEWGENE IIA/NEWGENE ./.
@@89739177586 Isolation/NNS and/CC genomic/JJ structure/NN of/IN a/DT human/JJ homolog/NN of/IN the/DT yeast/NEWGENE periodic/NEWGENE tryptophan/NEWGENE protein/NEWGENE 2/NEWGENE (/( PWP2/NEWGENE )/SYM gene/NN mapping/NN to/IN 21q22/CD ./CD 3/CD ./.
@@67026437189 In/NN 14/CD of/IN 21/CD infant/NN hearts/NNS (/( 66%/JJ )/SYM with/IN aortic/JJ arch/NN interruption/NN between/IN the/DT left/JJ common/JJ carotid/NN and/CC left/NN subclavian/JJ arteries/NNS (/( type/NN B/NN of/IN Celoria/NNP and/CC Patton/NNP )/SYM ,/, the/DT right/JJ subclavian/JJ artery/NN (/( SA/NNP )/SYM arose/VBD anomalously/RB ./.
@@78445558066 They/PRP also/RB reported/VBD that/DT E/NEWGENE mu/NEWGENE pim-1/NEWGENE transgenic/JJ mice/NNS show/VBP greatly/RB accelerated/JJ lymphoma/NN development/NN when/CC infected/VBN with/IN wild-type/NN M-MuLV/IN at/IN birth/NN ./.
@@16790682276 Among/IN 953/CD infants/NNS in/IN 22/CD neonatal/JJ care/NN units/NNS studied/VBN ,/, 23%/JJ (/( median/JJ value/NN ,/, range/NN 0-78/JJ )/SYM were/VBD found/VBN to/IN be/VB faecally/RB colonized/VBN with/IN one/PRP of/IN 21/CD distinct/JJ nosocomial/JJ strains/NNS of/IN Escherichia/NN coli/JJ ,/, Klebsiella/NN or/CC Enterobacter/NN spp/NNS ./.
@@10993773829 This/DT slope/NN was/VBD further/RB significantly/RB decreased/VBN at/IN 5/CD min/NN ischemia/NN (/( -26/CD ./CD 5/CD +/NN //NN -/NN 8/CD ./CD 8/CD &mgr/NN ;/: m/NN //NN mmHg/NN )/SYM but/CC returned/VBN toward/IN control/NN values/NNS in/IN short-term/JJ hibernating/JJ myocardium/NN at/IN 90/CD min/NN ischemia/NN (/( -17/CD ./CD 2/CD +/NN //NN -/NN 6/CD ./CD 6/CD &mgr/NN ;/: m/NN //NN mmHg/NN )/SYM ./.
@@54242202082 Lipid/NN concentration/NN and/CC lipase/NEWGENE activity/NN in/IN the/DT epiphysis/NN of/IN adrenalectomized/JJ rats/NNS consuming/JJ food/NN with/IN different/JJ sodium/NN content/NN ./.
@@95826352740 Results/NNS showed/VBN that/IN the/DT mean/JJ bond/NN strength/NN of/IN H/NNP ./NNP T/NNP ./NNP V/NNP ./. specimens/NNS ranged/VBN from/IN 9/CD ./CD 6/CD to/IN 13/CD ./CD 12/CD kg/NN //NN cm2/NN ,/, while/CC the/DT mean/JJ bond/NN strength/NN of/IN R/NNP ./NNP T/NNP ./NNP V/NNP ./. specimens/NNS ranged/VBN from/IN 0/CD ./CD 36/CD to/IN 1/CD ./CD 75/CD kg/NN //NN cm2/NN ./.
@@37216661415 Nickel/NN is/VBZ the/DT most/RB common/JJ cause/NN of/IN allergic/JJ contact/NN dermatitis/NN in/IN Singapore/NN ,/, resulting/JJ in/IN positive/JJ reactions/NNS in/IN patch/NN tests/NNS between/IN 7/CD and/CC 14%/CD ./.
@@95496609500 One/CD hundred/JJ replicate/VB data/NN sets/NNS of/IN 100/CD subjects/VBZ each/DT were/VBD simulated/JJ for/IN each/DT missing/JJ data/NN scenario/NN ./.
@@97869496121 J/NNP ./NNP
@@22770052924 The/DT CT/NN characteristics/NNS are/VBP discussed/VBN and/CC the/DT recent/JJ literature/NN is/VBZ reviewed/VBN ./.
@@13479081967 The/DT rationale/NN for/IN continuous/JJ dopaminergic/JJ stimulation/NN in/IN patients/NNS with/IN Parkinson's/NNP disease/NN ./.
@@90884164129 Idiopathic/NNP bilateral/JJ recurrent/JJ branch/NN retinal/JJ arterial/JJ occlusion/NN (/( IBRBRAO/NN )/SYM is/VBZ a/DT rare/JJ syndrome/NN characterized/VBN by/IN migraine/JJ headaches/NNS ,/, tinnitus/NN ,/, vertigo/NN ,/, hearing/JJ loss/NN ,/, and/CC recurrent/JJ branch/NN retinal/JJ artery/NN occlusion/NN of/IN unknown/JJ etiology/NN ./.
@@111704762405 The/DT extraordinary/JJ stability/NN of/IN peptide--gp96/NEWGENE complexes/NEWGENE and/CC the/DT plasticity/NN of/IN the/DT peptide-binding/JJ pocket/NN support/NN the/DT proposed/VBN relay/NN of/IN diverse/JJ peptides/NNS to/IN MHC/NEWGENE and/IN //IN or/IN other/DT molecules/NNS via/NN molecular/JJ recognition/NN ./.
@@28134049707 Male-enhanced/NEWGENE antigen/NEWGENE gene/NEWGENE is/VBZ phylogenetically/RB conserved/VBN and/CC expressed/VBN at/IN late/JJ stages/NNS of/IN spermatogenesis/NN ./.
@@75381223482 In/NN this/DT report/NN we/PRP describe/VBP the/DT isolation/NN of/IN a/DT Fab/NEWGENE fragment/NEWGENE (/( Fab/NEWGENE A8/NEWGENE )/SYM showing/VBG a/DT high/JJ relative/JJ affinity/NN for/IN the/DT receptor/NN (/( 0/CD ./CD 5/CD nM/NN )/SYM ./.
@@77945569812 In/NN the/DT Center/NNP for/IN Human/NNP Genetics/NNP in/IN Leuven/NNP ,/, predictive/JJ DNA-testing/NN for/IN Huntington's/NN disease/NN is/VBZ available/JJ as/IN a/DT clinical/JJ service/NN since/IN November/NN 1987/CD ,/, initially/RB by/IN DNA-linkage/NNP and/CC since/IN mid/NN 1993/CD by/IN direct/JJ mutation/NN analysis/NN ./.
@@10024498429 Electrophoretic/JJ mobility-shift/JJ assays/NNS performed/VBN with/IN the/DT HNF-3/NEWGENE X/NEWGENE and/NEWGENE Y/NEWGENE sites/NEWGENE demonstrated/VBN that/IN both/DT sites/NNS are/VBP capable/JJ of/IN binding/JJ HNF-3alpha/NEWGENE and/CC HNF-3beta/NEWGENE ./.
@@86774434829 In/NN a/DT Hoosier/NNP Oncology/NNP Group/NNP randomized/JJ study/NN involving/VBG extensive-disease/NN SCLC/NN patients/NNS ,/, VIP/NN was/VBD superior/JJ to/IN etoposide/NN //NN cisplatin/NN with/IN regard/NN to/IN median/JJ time/NN to/IN progression/NN (/( 6/CD ./CD 6/CD v/NN 5/CD ./CD 8/CD months/NNS )/SYM ,/, median/JJ survival/NN times/NNS (/( 9/CD ./CD 1/CD v/NN 7/CD ./CD 3/CD months/NNS )/SYM ,/, and/CC 2-/CD and/CC 3-year/CD survival/NN rates/NNS (/( 13%/JJ v/NN 5%/JJ and/CC 5%/JJ v/NN 0%/CD ,/, respectively/RB )/SYM ./.
@@79371064038 The/DT v-ets/NEWGENE oncogene/NEWGENE of/IN the/DT avian/JJ retrovirus/NN E26/NN differs/VBZ from/IN its/PRP cellular/JJ progenitor/NN p68c-ets-1/NEWGENE by/IN two/JJ amino/JJ acid/NN substitutions/NNS (/( alanine/NN 285/CD and/CC isoleucine/NN 445/CD in/IN c-ets-1/NEWGENE both/DT substituted/JJ by/IN valine/NN in/IN v-ets/NEWGENE ,/, mutations/NN A/NN and/CC B/NNP respectively/RB )/SYM and/CC its/PRP carboxy-terminal/JJ end/NN (/( mutation/NN C/NN )/SYM ./SYM
@@19278451508 Since/IN the/DT morphology/NN of/IN the/DT lesions/NNS can/MD mimic/NN that/IN of/IN other/DT cutaneous/JJ disorders/NNS ,/, Bowen's/NN disease/NN is/VBZ often/RB not/RB recognized/VBN initially/RB ./.
@@84289539590 This/DT promoter/NN could/MD direct/VB the/DT constitutive/JJ expression/NN of/IN the/DT reporter/NN beta-galactosidase/NN at/IN high/JJ frequency/NN in/IN transfected/VBN colonies/NNS of/IN transformed/VBN cells/NNS that/WDT express/VBP L-plastin/NEWGENE constitutively/RB ;/: by/IN contrast/NN ,/, this/DT promoter/NN was/VBD virtually/RB inactive/JJ in/IN transfected/VBN colonies/NNS of/IN normal/JJ fibroblasts/NNS and/CC it/PRP exhibited/VBD a/DT low/JJ frequency/NN of/IN constitutive/JJ activation/NN in/IN transfected/VBN colonies/NNS of/IN in/IN vitro/FW SV40-transformed/JJ fibroblasts/NNS which/WDT did/VBD not/RB exhibit/VB L-plastin/NEWGENE expression/NN ./.
@@18844354340 This/DT study/NN examines/VBZ the/DT effects/NNS of/IN hypovolemia/NN on/IN the/DT extracellular/JJ ptO2/NN and/CC ptH/NN distributions/NNS at/IN multiple/JJ tissue/NN sites/NNS using/VBG a/DT recently/RB developed/VBN multipoint/JJ microelectrode/NN ,/, that/WDT provides/VBZ simultaneous/JJ measurements/NNS of/IN ptO2/NN and/CC ptH/NN ./.
@@2645276946 Construction/NN of/IN a/DT RIP1/NEWGENE deletion/NN strain/NN and/CC isolation/NN of/IN temperature-sensitive/JJ mutants/NNS ./.
@@86629287026 This/DT regulation/NN could/MD not/RB be/VB appreciably/RB modified/JJ by/IN enhanced/JJ expression/NN of/IN STAT/NEWGENE proteins/NEWGENE ./.
@@40529194735 These/DT data/NN showed/VBD :/: that/DT progesterone/NN secretion/NN is/VBZ pulsatile/JJ throughout/IN the/DT human/JJ luteal/JJ phase/NN ,/, with/IN maximum/JJ frequency/NN in/IN the/DT mid-luteal/JJ phase/NN ;/: that/IN during/IN the/DT mid-luteal/JJ phase/NN most/JJ subjects/NNS had/VBP progesterone/NN levels/VBZ both/DT above/RB and/CC below/RB currently/RB accepted/VBN ovulatory/JJ thresholds/NNS ;/: the/DT use/NN of/IN a/DT single/JJ measurement/NN of/IN progesterone/NN in/IN the/DT mid-luteal/JJ phase/NN is/VBZ not/RB always/RB a/DT reliable/JJ indicator/NN of/IN ovulation/NN ;/: a/DT threshold/NN greater/JJR than/IN 20/CD nmol/NN //NN l/NN may/MD yield/VB an/DT unacceptable/JJ number/NN of/IN false/JJ negative/JJ results/NNS ./.
@@36979715466 The/DT selenium/NN level/NN and/CC glutathione/NEWGENE peroxidase/NEWGENE activity/NN in/IN the/DT blood/NN ,/, liver/NN ,/, and/CC stomach/NN mucosa/NN were/VBD significantly/RB higher/JJ in/IN the/DT high-selenium/JJ diet/NN group/NN than/IN in/IN the/DT low-selenium/JJ diet/NN group/NN ./.
@@28997923606 Oestrogen/NN implant/NN overdose/NN ./.
@@95069591290 Identification/NNP and/CC characterization/NN of/IN specific/NN DNA-binding/NN complexes/NN containing/NN members/NN of/IN the/DT Myc/NEWGENE //NEWGENE Max/NEWGENE //NEWGENE Mad/NEWGENE network/NEWGENE of/IN transcriptional/NN regulators/NN ./.
@@49119255234 Electrocardiographic/NNP QRS/NN complexes/NNS and/CC vectorcardiographic/JJ QRS/NN loop/NN ./.
@@73562737204 Mucoepidermoid/JJ and/CC acinous/JJ cell/NN carcinomas/NNS of/IN salivary/JJ tissues/NNS ./.
@@117367923437 Fifty-six/NNS semen/NN samples/NNS were/VBD included/VBN in/IN this/DT study/NN ;/: 18/CD were/VBD subnormal/JJ (/( G1/NN )/SYM and/CC 38/CD were/VBD normal/JJ (/( G2/NN )/SYM based/VBN on/IN World/NNP Health/NNP Organization/NNP criteria/NNS ,/, except/VB for/IN morphology/NN ,/, which/WDT was/VBD evaluated/VBN according/VBG to/IN strict/JJ criteria/NNS ./.
@@19379891322 Both/DT groups/NNS then/RB underwent/VBD hypnotic/JJ induction/NN ,/, and/CC completed/VBD the/DT test/NN again/RB (/( R2/NN )/SYM ./.
@@89678709765 327/CD and/CC 736/CD protocols/NNS of/IN postmortem/JJ examinations/NNS from/IN Moscow/NN hospitals/NNS N/NN 31/NN and/CC 57/CD ,/, respectively/RB ,/, were/VBD evaluated/VBN statistically/RB ./.
@@10780018588 We/PRP examine/VBP current/JJ models/NNS of/IN the/DT effects/NNS of/IN aging/NN on/IN mean/JJ response/NN time/NN and/CC show/VB how/RB they/PRP might/MD be/VB reinterpreted/VBN ./.
@@98013337992 The/DT full-length/JJ N/NEWGENE gene/NEWGENE ,/, encoded/VBN by/IN open/JJ reading/JJ frame/NN 7/CD ,/, was/VBD cloned/VBN from/IN the/DT Canadian/JJ PRRS/NNS virus/NN ,/, PA-8/NNP ./.
@@74404302898 All/DT lambs/NNS with/IN B/NNP breeding/JJ had/VBP significantly/RB higher/JJ Hb/NEWGENE levels/NNS at/IN the/DT end/NN of/IN the/DT experiment/NN than/IN did/VBD NB/JJ lambs/NNS ./. b/NN and/CC S/NNP x/NN B/NNP lambs/NNS had/VBP higher/JJ (/( P/NN </SYM ./CD 05/CD )/SYM Hb/NEWGENE levels/NNS than/IN the/DT D/NN x/NN B/NNP lambs/NNS ,/, and/CC B/NNP lambs/NNS had/VBP the/DT highest/JJS (/( P/NN </SYM ./CD 05/CD )/SYM mean/JJ corpuscular/JJ hemoglobin/NEWGENE concentrations/NNS ./.
@@115096736230 In/NN the/DT stable/JJ transfectants/NNS (/( BM3/NNP cells/NNS )/SYM expressing/NN a/NN mutant/NEWGENE bacterial/NEWGENE P450/NEWGENE AA/NEWGENE epoxygenase/NEWGENE ,/, F87V/NN BM3/NN ,/, which/WDT was/VBD genetically/RB engineered/VBN to/IN metabolize/VB arachidonic/JJ acid/NN only/RB to/IN 14/CD ,/CD 15-EET/CD ,/, AA/NN did/VBD not/RB induce/VB apoptosis/NN and/CC protected/VBN against/IN agonist-induced/JJ apoptosis/NN ./.
@@102069596632 Pathol/NNP ./.
@@86259879051 In/NN sorted/VBD bone/NN marrow/NN cells/NNS expression/NN of/IN both/DT VpreB/NEWGENE genes/NEWGENE was/VBD detected/VBN in/IN pro-B/JJ //JJ pre-BI/JJ and/CC large/JJ pre-BII/JJ cells/NNS ,/, while/CC the/DT RNA/NN steady/JJ state/NN levels/NNS were/VBD at/IN least/RB 100-fold/RB lower/JJR in/IN small/JJ pre-BII/JJ and/CC immature/NNP //NNP mature/NNP B/NNP cells/NNS ./.
@@86642294018 Clinical/NNP evaluation/NN of/IN the/DT Allergan/NNP Humphrey/NN 500/CD autorefractor/NN and/CC the/DT Nidek/NNP AR-1000/NN autorefractor/NN ./.
@@74581717351 Fourteen/CD different/JJ species/NN (/( eight/CD Platyhelmintha/NNP ,/, one/PRP Nematoda/NNS and/CC five/CD Crustacea/NNS )/SYM have/VB been/VBN inventorized/VBN ./.
@@87667818759 In/NN the/DT same/JJ period/NN we/PRP pointed/VBD out/RB an/DT increase/NN of/IN hematocrit/NN (/( from/IN 29%/CD to/IN 35%/CD )/SYM and/CC of/IN the/DT Hb/NEWGENE (/( from/IN 9/CD ./CD 3/CD to/IN 11/CD ./CD 2/CD g/NN //NN dl/NN )/SYM ./.
@@35704556156 Rabbits/NNS developed/VBD profound/JJ hypocalcemia/NN ,/, with/IN levels/NNS falling/NN from/IN 15/CD ./CD 5/CD +/NN //NN -/NN 0/CD ./CD 2/CD to/IN 7/CD ./CD 6/CD +/NN //NN -/NN 0/CD ./CD 4/CD mg/NN //NN dl/NN under/IN the/DT influence/NN of/IN TSST-1/NN ./.
@@53799015516 Midge/NNP control/NN in/IN flood/NN channels/NNS ./.
@@99145006508 Nuclear/NEWGENE factor/NEWGENE kappa/NEWGENE B/NEWGENE (/( NF-kappaB/NEWGENE )/SYM is/VBZ an/DT important/JJ transcription/NN factor/NN for/IN the/DT genes/NNS of/IN many/JJ pro-inflammatory/JJ proteins/NNS and/CC is/VBZ strongly/RB activated/VBN by/IN the/DT cytokines/NNS interleukin-1/NEWGENE and/CC tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE (/NEWGENE TNF/NEWGENE )/NEWGENE alpha/NEWGENE under/IN various/JJ pathological/JJ conditions/NNS ./.
@@111762901017 Identification/NNP of/IN pulmonary/JJ vein/NN stenosis/NN after/IN radiofrequency/NN ablation/NN for/IN atrial/JJ fibrillation/NN using/VBG MRI/NN ./.
@@10369418709 EMSA/NN with/IN crude/JJ nuclear/JJ extracts/NNS demonstrated/VBD that/DT stimulation/NN with/IN CD40L/NEWGENE results/NNS in/IN the/DT induction/NN of/IN NF-kappaB/NEWGENE complexes/NEWGENE that/WDT bind/VBP to/IN each/DT of/IN the/DT three/CD NF-kappaB/NEWGENE sites/NEWGENE and/CC are/VBP composed/VBN mainly/RB of/IN p50/NEWGENE and/CC RelB/NEWGENE ,/, but/CC also/RB include/VB c-Rel/NEWGENE and/CC p65/NEWGENE ./.
@@103412197049 Furthermore/RB ,/, heparin/NEWGENE lyase/NEWGENE treatment/NN of/IN extracts/NNS of/IN cells/NNS expressing/JJ recombinant/NEWGENE YD-repeat/NEWGENE protein/NEWGENE releases/VBZ this/DT protein/NN from/IN high/JJ molecular/JJ mass/JJ aggregates/NNS ./.
@@67054566467 Absorption/NNS was/VBD rapid/JJ ,/, with/IN a/DT mean/JJ time/NN to/IN peak/NN of/IN 39/CD min/NN ./.
@@32430276426 Post-transcriptional/JJ regulation/NN of/IN ribosomal/NEWGENE protein/NEWGENE gene/NEWGENE expression/NN during/IN development/NN in/IN Dictyostelium/DT discoideum/JJ ./.
@@104024675038 Myosin/NEWGENE light/NEWGENE chain/NEWGENE kinase/NEWGENE functions/NNS downstream/RB of/IN Ras/NEWGENE //NEWGENE ERK/NEWGENE to/IN promote/VB migration/NN of/IN urokinase-type/NN plasminogen/NN activator-stimulated/JJ cells/NNS in/IN an/DT integrin-selective/JJ manner/NN ./.
@@81784901390 Thus/RB ,/, we/PRP have/VBP separated/VBN the/DT signal/JJ function/NN from/IN the/DT anchor/NN function/NN of/IN the/DT 6/CD ./CD 7K/CD SA/NN domain/NN ./.
@@110834321806 Studied/NN groups/NNS were/VBD (/( 1/CD )/SYM untreated/JJ control/NN ,/, n/NN =/SYM 12/CD ;/: (/( 2/CD )/SYM FK-1/NN ,/, n/NN =/SYM 8/CD ;/: (/( 3/CD )/SYM FK-3/NN ,/, n/NN =/SYM 8/CD ./CD
@@90013131028 Prevalence/NNS of/IN sleep-disordered/JJ breathing/JJ (/( SDB/NN )/SYM is/VBZ reported/VBN to/IN increase/NN in/IN menopausal/JJ women/NNS ./.
@@97129198318 In/NN the/DT studies/NNS described/VBN in/IN this/DT report/NN ,/, we/PRP have/VBP investigated/VBN the/DT signaling/JJ pathway/NN (/NN s/NN )/NN that/WDT are/VBP responsible/JJ for/IN CREB/NEWGENE activation/NN in/IN normal/JJ T/NN cells/NNS ./.
@@21571416432 With/IN only/RB purified/VBN T/NEWGENE antigen/NEWGENE in/IN the/DT presence/NN of/IN topoisomerase/NEWGENE I/NEWGENE to/IN unwind/VB purified/VBN DNA/NN ,/, ori-auxiliary/JJ sequences/NNS strongly/RB facilitated/VBN T-antigen-dependent/NN DNA/NN conformational/JJ changes/NNS consistent/JJ with/IN melting/JJ the/DT first/JJ 50/CD base/NN pairs/NNS ./.
@@100646048985 CPDs/NNS at/IN these/DT three/CD sites/NNS may/MD partially/RB displace/VB TFIIIA/NEWGENE ,/, thereby/RB enabling/JJ rapid/JJ repair/NN ./.
@@22498722686 This/DT interaction/NN occurs/VBZ over/RB a/DT wide/JJ range/NN of/IN both/DT parameters/NNS ;/: for/IN charge/NN density/NN from/IN at/IN least/RB 10/CD to/IN 800/CD microC/NN //NN cm2/NN and/CC ,/, for/IN charge/NN per/IN phase/NN ,/, from/IN at/IN least/RB 0/CD ./CD 05/CD to/IN 5/CD ./CD 0/CD microC/NN per/IN phase/NN ./.
@@25196793176 Inefficacy/NNS of/IN phosphine/NN fumigation/NN against/IN ticks/NNS ./.
@@33840334076 Of/IN the/DT 53/CD units/NNS tested/VBN during/IN sinusoidal/JJ motion/NN at/IN 0/CD ./CD 05/CD Hz/NN (/( 9/CD ./CD 1/CD cm/NNS //NNS s/NNS )/SYM ,/, 1/CD (/( 1/CD ./CD 9%/CD )/SYM was/VBD responsive/JJ to/IN the/DT otolith/NN input/NN only/RB ,/, 13/CD (/( 24/CD ./CD 5%/CD )/SYM were/VBD influenced/VBN by/IN the/DT visual/JJ input/NN only/RB and/CC 23/CD (/( 43/CD ./CD 4%/CD )/SYM responded/VBN to/IN both/DT modalities/NNS ./.
@@113454451193 In/NNP Cd-spiked/NNP OECD/NNP soil/NN ,/, internal/JJ Cd/NN levels/NNS were/VBD linearly/RB related/VBN to/IN external/NN Cd/NN concentrations/NNS ,/, whereas/IN the/DT springtails/NNS maintained/VBD fixed/JJ internal/JJ levels/NNS of/IN Cu/NN and/CC Zn/NN regardless/RB of/IN spiked/VBN concentrations/NNS ./.
@@13854622001 In/NN general/JJ ,/, two/JJ separate/JJ high-performance/JJ liquid/JJ chromatographic/JJ runs/VBP were/VBD performed/VBN ,/, one/PRP for/IN the/DT gamma-aminobutyric/JJ acid/NN determination/NN and/CC one/PRP for/IN the/DT determination/NN of/IN the/DT monoamines/NNS ./.
@@110739192305 In/NN addition/NN ,/, 26/CD amino/JJ acid/JJ residues/NNS ,/, K69/NN ,/, D88/NN ,/, E94/NN ,/, D134/NN ,/, R154/NN ,/, K169/NN ,/, H197/NN ,/, D233/NN ,/, G235/NN ,/, G236/NN ,/, G237/NN ,/, F238/NN ,/, E274/NN ,/, G276/NN ,/, R277/NN ,/, Y278/NN ,/, K294/NN ,/, Y323/NN ,/, Y331/NN ,/, D332/NN ,/, C360/NN ,/, D361/NN ,/, D364/NN ,/, G387/NN ,/, Y389/NN ,/, and/CC F397/NN (/( mouse/NN ODC/NEWGENE numbering/NN )/SYM ,/, all/DT of/IN which/WDT are/VBP implicated/VBN in/IN the/DT formation/NN of/IN the/DT pyridoxal/NN phosphate-binding/JJ domain/NN and/CC the/DT substrate-binding/JJ domain/NN and/CC in/IN dimer/NN stabilization/NN with/IN the/DT eukaryotic/JJ ODCs/NEWGENE ,/, were/VBD also/RB conserved/VBN in/IN S/NNP ./NNP ruminantium/NN LDC/NEWGENE ./.
@@37179362220 Amikacin/NN was/VBD the/DT most/JJ stable/NN and/CC tobramycin/NN was/VBD the/DT least/RB stable/JJ aminoglycoside/NN under/IN the/DT conditions/NNS tested/VBN ./.
@@112232462419 Sequence/NN analysis/NN indicates/VBZ that/IN RBP21/NEWGENE shares/VBP homology/NN with/IN other/DT retinoblastoma-binding/NEWGENE proteins/NEWGENE in/IN the/DT pRb-binding/NEWGENE motif/NEWGENE LxCxE/NEWGENE1 at/IN the/DT C-terminal/NN region/NN ./.
@@82529768170 Rinit/NN reflects/VBZ the/DT Newtonian/JJ resistances/NNS and/CC Rdiff/NN represents/VBZ the/DT viscoelastic/JJ //JJ inhomogeneous/JJ pressure/NN dissipations/NNS in/IN the/DT system/NN ./.
@@99211799918 The/DT role/NN of/IN intraoperative/JJ echocardiography/NN in/IN surgery/NN of/IN the/DT heart/NN and/CC large/JJ vessels/NNS ./.
@@9858619706 Recent/JJ studies/NNS have/VBP suggested/VBN that/IN Y319/NN also/RB positively/RB regulate/VB ZAP-70/NEWGENE function/NN ./.
@@86081266108 As/IN the/DT length/NN of/IN the/DT fatty/JJ acid/NN decreased/VBN ,/, the/DT binding/JJ affinity/NN was/VBD reduced/VBN ;/: myristic/JJ acid/NN (/( 14/CD :/: 0/CD )/SYM bound/JJ with/IN a/DT K/NN (/NN d/NN )/NN of/IN 1409/CD +/NN //NN -/NN 423/CD nM/NN ,/, but/CC medium-chain/JJ (/( decanoic/JJ acid/NN ,/, 10/CD :/: 0/CD )/SYM and/CC short-chain/JJ (/( octanoic/JJ acid/NN ,/, 8/CD :/: 0/CD )/SYM lipids/NNS were/VBD not/RB bound/JJ at/IN all/DT ./.
@@21633945409 The/DT sacT/NEWGENE gene/NEWGENE regulating/JJ the/DT sacPA/NEWGENE operon/NEWGENE in/NEWGENE Bacillus/NEWGENE subtilis/NEWGENE shares/NN strong/JJ homology/NN with/IN transcriptional/NN antiterminators/NN ./.
@@84972488543 The/DT gene/NN encoding/VBG the/DT receptor/NN for/IN macrophage/NEWGENE colony-stimulating/NEWGENE factor/NEWGENE 1/NEWGENE (/( CSF-1/NEWGENE )/SYM ,/, the/DT c-fms/NEWGENE protooncogene/NEWGENE ,/, is/VBZ selectively/RB expressed/VBN in/IN immature/JJ and/CC mature/JJ mononuclear/JJ phagocytes/NNS and/CC trophoblasts/NNS ./.
@@10586107272 They/PRP are/VBP subdivided/VBN into/IN two/JJ types/NNS that/WDT activate/VBP transduction/NN pathways/NNS via/NN different/JJ cell/NN surface/NN receptors/NNS ./.
@@72034101670 Family/NN visits/NN and/CC involvement/NN in/IN treatment/NN of/IN patients/NNS at/IN a/DT state/NN hospital/NN ./.
@@24630506683 The/DT corticosterone/NN synthesis/NN inhibitor/NN metyrapone/NN (/( 75/CD mg/CD //CD kg/CD i/CD ./CD p/CD ./CD )/SYM was/VBD given/VBP to/IN attenuate/VB the/DT rise/NN of/IN corticosterone/NN to/IN a/DT level/JJ typical/JJ of/IN stressed/VBN males/NNS ./.
@@31759423861 This/DT effect/NN and/CC the/DT fact/NN that/IN all/DT three/CD doses/NNS were/VBD toxic/JJ to/IN the/DT dams/NNS dictated/VBN that/IN a/DT second/JJ experiment/NN be/VB carried/VBN out/RB at/IN lower/JJR doses/NNS ./.
@@69696386756 Both/DT examinations/NNS are/VBP sensitive/NN indicators/NN of/IN CNS/NN abnormalities/NNS associated/VBN with/IN bacterial/JJ meningeal/JJ infections/NNS and/CC are/VBP important/JJ determinants/NNS of/IN the/DT therapy/NN and/CC ultimate/JJ prognosis/NN of/IN such/JJ complications/NNS ./.
@@104455066140 Some/DT of/IN them/PRP produce/VBP gigantic/JJ sperm/NN several/DT times/VBZ the/DT total/JJ male/JJ body/NN length/NN ./.
@@95655844165 A/DT cluster/NN of/IN basic/JJ amino/JJ acids/NNS ,/, KKKR/NEWGENE ,/, generated/VBN by/IN joining/NN of/IN the/DT sequences/NNS encoded/VBN by/IN the/DT constitutive/JJ exon/NN 13/CD and/CC the/DT alternative/JJ exon/NN 16/CD ,/, is/VBZ necessary/JJ for/IN the/DT nuclear/JJ targeting/NN of/IN 4/NEWGENE ./NEWGENE 1H/NEWGENE ,/, as/IN demonstrated/VBN by/IN site-directed/JJ mutagenesis/NN analysis/NN ./.
@@2273931875 Modulation/NNS of/IN 25-hydroxyvitamin/NEWGENE D3-24-hydroxylase/NEWGENE by/IN aminophylline/NN :/: a/DT cytochrome/NEWGENE P-450/NEWGENE monooxygenase/NEWGENE system/NN ./.
@@4318321312 Plasma/NN ion/NN changes/NNS in/IN venous/JJ blood/NN incubated/VBN with/IN beta/NEWGENE receptor/NEWGENE blockers/NNS and/CC subjected/VBN to/IN tonometry/NN in/IN vitro/FW ./.
@@27439817554 Transcripts/NNS characterized/VBN include/VB (/( i/NN )/SYM abundant/JJ monocistronic/JJ L11e/NEWGENE and/CC tricistronic/NNP L1e-L10e-L12e/NEWGENE transcripts/NEWGENE ;/: (/( ii/NN )/SYM less/PRP abundant/JJ bicistronic/JJ NAB-L11e/NEWGENE and/CC monocistronic/JJ NAB/NEWGENE transcripts/NEWGENE and/CC (/( iii/NN )/SYM a/DT very/RB rare/JJ ORF/NEWGENE monocistronic/NEWGENE transcript/NEWGENE ./.
@@8816460616 These/DT results/NNS indicate/VBP that/DT inhibition/NN of/IN Jun/NEWGENE kinase/NEWGENE activation/NN was/VBD sufficient/JJ to/IN inhibit/VB Ras/NEWGENE transformation/NN even/VB in/IN the/DT presence/NN of/IN activated/VBN Erk-2/NEWGENE ./.
@@87614803939 Interaction/NNS was/VBD apparently/RB determined/VBN by/IN the/DT N-terminal/NN splice/NN region/NN of/IN RPDE-6/NEWGENE ,/, as/IN the/DT PDE4A/NEWGENE splice/NN variant/NN RPDE-39/NEWGENE ,/, which/WDT differs/VBZ from/IN RPDE-6/NEWGENE at/IN the/DT extreme/JJ N-terminus/NN ,/, failed/VBN to/IN associate/NN with/IN v-Src-SH3/NEWGENE ;/: met26RD1/NEWGENE (/( where/CC RD1/NEWGENE is/VBZ rat/NEWGENE 'dunc-like'/NEWGENE PDE/NEWGENE )/SYM ,/, which/WDT has/VBZ the/DT N-terminal/NN splice/NN region/NN deleted/VBN ,/, failed/VBN to/IN associate/NN with/IN v-Src-SH3/NEWGENE ,/, and/CC the/DT association/NN of/IN RPDE-6/NEWGENE and/CC v-Src-SH3/NEWGENE was/VBD blocked/VBN by/IN a/DT fusion/NN protein/NN formed/VBN from/IN the/DT N-terminal/NN splice/NN region/NN ./.
@@97374536668 Plasma/NN was/VBD tested/VBN before/IN and/CC after/IN (/( 14/CD +/NN //NN -/NN 7/CD ./CD 5/CD [/NN SD/NN ]/NN days/NNS )/SYM surgery/NN for/IN IgG/NEWGENE antibodies/NEWGENE to/IN the/DT complex/NN of/IN heparin/NEWGENE //NEWGENE platelet/NEWGENE factor/NEWGENE 4/NEWGENE ,/, using/VBG a/DT standardized/JJ ,/, validated/VBN enzyme-linked/JJ immunosorbent/JJ assay/NN (/( ELISA/NN )/SYM ./.
@@13724561984 Necrosis/NNS appears/VBZ 6/CD h/NN after/IN TA/NN infusion/NN ,/, being/VBP 5/CD ./CD 77%/CD in/IN extent/NN after/IN 12/CD h/NN ,/, 14/NN ./NN 9%/NN after/IN 24/CD h/NN and/CC animals/NNS die/NN with/IN an/DT area/NN of/IN 29/CD ./CD 5%/CD necrosis/NN ./.
@@8812020909 In/NN a/DT third/JJ experiment/NN ,/, a/DT Chessmaster/NN gradually/RB increases/VBZ the/DT number/NN of/IN boards/NNS he/PRP can/MD reproduce/VB with/IN higher/JJ than/IN 70%/CD average/JJ accuracy/NN to/IN nine/JJ ,/, replacing/VBG as/RB many/JJ as/IN 160/CD pieces/NNS correctly/RB ./.
@@89718358406 In/NNP Group/NNP IV/NN dogs/NNS that/WDT received/VBD alpha-MSH/NEWGENE only/RB during/IN reperfusion/NN ,/, BAEPs/NNS were/VBD increased/VBN approximately/RB 10/CD to/IN 14%/CD more/RB than/IN in/IN Group/NNP II/NNP during/IN the/DT late/JJ reperfusion/NN period/NN ./.
@@97153848037 For/IN smaller/JJR vessels/NNS up/JJ to/IN a/DT diameter/NN of/IN 0/CD ./CD 5/CD mm/NN ,/, treatments/NNS at/IN 16/CD and/CC 18/CD J/NN //NN cm2/NN showed/VBD good/JJ results/NNS in/IN 60/CD and/CC 82%/CD respectively/RB ;/: for/IN vessels/NNS up/JJ to/IN 1/CD mm/NN in/IN 27/CD and/CC 33%/CD ./.
@@7635312507 Using/VBG mutagenesis/NN ,/, we/PRP have/VBP identified/VBN two/JJ mutations/NNS of/IN the/DT second/JJ actin-binding/NN domain/NN that/WDT can/MD also/RB suppress/VB the/DT act1/NEWGENE mutations/NN of/IN interest/NN ./.
@@105897118755 In/NN addition/NN ,/, narZ/NEWGENE expression/NN was/VBD induced/VBN approximately/RB 20-fold/JJ intracellularly/RB in/IN Madin-Darby/NNP canine/JJ kidney/NN epithelial/JJ cells/NNS and/CC 16-fold/JJ in/IN intracellular/JJ salts/NNS medium/NN ,/, which/WDT is/VBZ believed/VBN to/IN mimic/NN the/DT intracellular/JJ milieu/NN ./.
@@74992529642 As/IN hGM-CSF/NEWGENE receptor/NEWGENE (/( hGMR/NEWGENE )/SYM does/VBP not/RB contain/VB a/DT consensus/NN sequence/NN for/IN binding/NN of/IN PI/NEWGENE 3-kinase/NEWGENE ,/, hGMR/NEWGENE must/MD use/VB a/DT distinct/JJ mechanism/NN for/IN its/PRP association/NN with/IN and/CC activation/NN of/IN PI/NEWGENE 3-kinase/NEWGENE ./.
@@111023674109 This/DT study/NN allows/VBZ us/PRP to/IN draw/NN conclusions/NNS about/RB the/DT identity/NN of/IN proteins/NNS required/VBN for/IN the/DT development/NN of/IN the/DT nervous/JJ system/NN in/IN Drosophila/NN and/CC provides/VBZ an/DT example/NN of/IN a/DT molecular/JJ approach/NN to/IN characterize/VB en/NN masse/NN transposon-tagged/NN mutations/NN identified/VBN in/IN genetic/JJ screens/NNS ./.
@@15515681139 Marker/NNS rescue/NN analysis/NN has/VBZ localized/VBN ts8/NEWGENE to/IN a/DT 910-bp/CD internal/JJ segment/NN of/IN rpoB/NEWGENE that/IN encodes/VBZ the/DT Rif/NEWGENE domain/NEWGENE ./.
@@86259001019 Pituitary/NNP adenylate/NEWGENE cyclase-activating/NEWGENE polypeptide/NEWGENE regulates/VBZ prolactin/NEWGENE promoter/NEWGENE activity/NN via/NN a/DT protein/NEWGENE kinase/NEWGENE A-mediated/JJ pathway/NN that/WDT is/VBZ independent/NN of/IN the/DT transcriptional/JJ pathway/NN employed/VBN by/IN thyrotropin-releasing/NEWGENE hormone/NEWGENE ./.
@@79720121431 A/DT full-length/JJ cDNA/NN clone/NN isolated/VBN from/IN a/DT rat/NN lung/NN library/NN was/VBD predicted/VBN to/IN encode/VB a/DT 55-kDa/NN protein/NN containing/JJ at/IN its/PRP amino/JJ terminus/NN a/DT targeting/JJ domain/NN that/WDT binds/VBZ to/IN the/DT ANP-receptor/NEWGENE kinase-like/NEWGENE domain/NEWGENE and/CC containing/JJ at/IN its/PRP carboxyl/NN terminus/NN a/DT putative/JJ protein-serine/NEWGENE phosphatase/NEWGENE domain/NN ./.
@@64546258300 It/PRP has/VBZ been/VBN shown/VBP in/IN an/DT animal/NN experiment/NN that/IN alterations/NNS of/IN the/DT renal/JJ vasculature/NN and/CC parenchyma/NN after/IN hemostasis/NN performed/VBN by/IN Infrared-Contact-Coagulation/NN are/VBP best/JJS shown/VBP by/IN intravital/JJ magnification/NN angiography/NN (/( magnification/NN factor/NN 2/CD ./CD 22/CD )/SYM ./.
@@42823154904 Sensitization/NNS to/IN hyperlactatemia/NN induced/VBN by/IN phenformin/NN after/IN subtotal/JJ ablation/NN of/IN the/DT pancreas/NN ./.
@@82459338231 Partial/JJ engorgement/NN was/VBD higher/JJ in/IN the/DT treatments/NNS ./.
@@99113289912 Nonlocal/JJ approach/NN to/IN scattering/JJ in/IN a/DT one-dimensional/JJ problem/NN ./.
@@85420267792 DAF/NEWGENE is/VBZ a/DT 70/NN kD/NN glycoprotein/NN containing/NN complement/NN regulatory/JJ short/JJ consensus/NN repeats/NNS (/( SCRs/NNS )/SYM ;/: its/PRP gene/NN is/VBZ located/VBN in/IN the/DT regulation/NEWGENE of/NEWGENE complement/NEWGENE activation/NEWGENE (/( RCA/NEWGENE )/SYM gene/NN cluster/NN on/IN chromosome/NN 1/CD and/CC is/VBZ about/RB 40/CD kb/NN in/IN size/NN ./.
@@29679154575 In/NN addition/NN ,/, the/DT calbindin-D28K/NEWGENE promoter/NEWGENE is/VBZ composed/VBN of/IN a/DT variety/NN of/IN simple/JJ repeated/JJ sequences/NNS ,/, some/DT of/IN which/WDT are/VBP components/NNS of/IN putative/JJ regulatory/JJ signals/NNS ./.
@@83232945662 Chicken/NEWGENE sterol/NEWGENE carrier/NEWGENE protein/NEWGENE 2/NEWGENE //NEWGENE sterol/NEWGENE carrier/NEWGENE protein/NEWGENE x/NEWGENE :/: cDNA/NN cloning/NN reveals/VBZ evolutionary/JJ conservation/NN of/IN structure/NN and/CC regulated/VBN expression/NN ./.
@@14026471818 DR1/NEWGENE molecules/NEWGENE purified/VBN from/IN human/JJ lymphoblastoid/JJ cell/NN lines/NNS could/MD specifically/RB bind/VB to/IN these/DT peptide/NN sequences/NNS expressed/VBN on/IN the/DT phage/NN surface/NN ./.
@@110819621754 An/DT anchored/VBN AFLP-/NNP and/CC retrotransposon-based/NN map/NN of/IN diploid/JJ Avena/NN ./.
@@103335293375 Both/DT betaAPP/NEWGENE mRNA/NEWGENE and/CC Abeta/NEWGENE levels/NNS are/VBP increased/VBN in/IN trisomy/NN 21/CD ./CD
@@112978667238 In/NN contrast/NN ,/, neither/DT I/NNP ./NNP argentina/NN nor/CC I/NNP ./NNP theezans/NNS exerted/VBD any/DT effect/NN on/IN BF/NN or/CC intestinal/JJ propulsion/NN ./.
@@86566728449 An/DT apparent/JJ ufo/NEWGENE mRNA/NEWGENE overexpression/NN was/VBD not/RB found/VB in/IN any/DT of/IN the/DT positive/JJ leukemia/NN cell/NN lines/NNS ,/, but/CC was/VBD identified/VBN in/IN the/DT drug-resistant/NN subclones/NNS of/IN the/DT cervix/NN carcinoma/NN cell/NN line/NN HeLa/DT ./.
@@92347177766 Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN Cbl/NEWGENE ,/, the/DT 120-kDa/NN protein/NN product/NN of/IN the/DT c-cbl/NEWGENE proto-oncogene/NEWGENE ,/, serves/VBP as/IN a/DT substrate/NN of/IN a/DT number/NN of/IN receptor-coupled/NEWGENE tyrosine/NEWGENE kinases/NEWGENE and/CC forms/NNS complexes/NNS with/IN SH3/NEWGENE and/CC SH2/NEWGENE domain-containing/NN proteins/NN ,/, pointing/VBG to/IN its/PRP role/NN in/IN signal/JJ transduction/NN ./.
@@79673609762 The/DT present/NN data/NN also/RB indicate/VB that/IN patients/NNS with/IN TGBM/NN nephropathy/NN often/RB have/VB concomitant/JJ IgA/NEWGENE nephropathy/NN and/CC mesangial/JJ proliferative/JJ glomerulonephritis/NN ./.
@@111295157017 In/NN a/DT prospective/NN ,/, multicentre/JJ trial/NN the/DT efficacy/NN of/IN an/DT Vitex/NN agnus/NN castus/NN L/JJ extract/NN Ze/NN 440/NN was/VBD investigated/VBN in/IN 50/CD patients/NNS with/IN pre-menstrual/JJ syndrome/NN (/( PMS/NN )/SYM ./.
@@22017707443 Among/IN known/VBP flea/NN larvae/NNS ,/, the/DT genus/NN Anomiopsyllus/NNP (/( Anomiopsyllinae/NN ,/, Anomiopsyllini/NN )/SYM is/VBZ as/IN distinctive/JJ in/IN larval/JJ form/NN as/IN are/VBP the/DT adults/NNS ./.
@@105687447436 Among/IN the/DT remaining/JJ 22/CD sites/NNS ,/, six/CD are/VBP in/IN the/DT promoters/NNS of/IN known/VBP alpha-specific/NN genes/NN and/CC two/JJ other/DT sites/NNS have/NN an/DT alpha2-Mcm1-dependent/JJ role/NN in/IN determining/JJ the/DT direction/NN of/IN mating/JJ type/NN switching/NN ./.
@@12658871909 Acquired/VBN factor/NEWGENE VIII/NEWGENE inhibitor/NN in/IN non-hemophilic/JJ patients/NNS ./.
@@9851102789 Efferent/JJ projections/NNS of/IN the/DT ventral/JJ portion/NN of/IN the/DT putamen/NN to/IN the/DT frontal/JJ ,/, parietal/JJ and/CC temporal/NN regions/NN of/IN the/DT cat/NN cerebral/JJ cortex/NN ./.
@@84100975266 A/DT high/JJ mean/JJ intensity/NN of/IN CLTPA/NNP (/( standardized/JJ multivariate/JJ regression/NN coefficient/NN beta/NN -0/CD ./CD 059/CD ,/, p/NN =/SYM 0/CD ./CD 020/CD )/SYM and/CC a/DT high/JJ maximal/JJ oxygen/NN uptake/NN (/( beta/NN -0/CD ./CD 163/CD ,/, p/NN </SYM 0/CD ./CD 001/CD )/SYM were/VBD associated/VBN with/IN reduced/VBN plasma/NEWGENE fibrinogen/NEWGENE when/CC adjusting/VBG for/IN the/DT strongest/JJS covariates/NNS ./.
@@105866262296 Demyelinating/VBG diseases/NNS involving/VBG the/DT grey/JJ matter/NN were/VBD very/RB rare/JJ ,/, but/CC we/PRP must/MD consider/VB the/DT presence/NN of/IN symmetrical/JJ thalamic/JJ involvement/NN in/IN patients/NNS with/IN ADEM/NN ./.
@@85893587490 One/CD hundred/JJ units/NN //NN kg/NN of/IN recombinant/NEWGENE human/NEWGENE erythropoietin/NEWGENE (/( rhEPO/NEWGENE )/SYM was/VBD given/VBP subcutaneously/RB 3/CD times/VBZ a/DT week/NN for/IN 3/CD weeks/NNS ./.
@@39296104582 Mild/JJ orbital/JJ discomfort/NN occurred/VBN in/IN some/DT patients/NNS ./.
@@22290727042 This/DT growth/NN arrest/NN is/VBZ partly/RB suppressed/VBN on/IN minimal/JJ medium/NN or/CC under/IN conditions/NNS in/IN which/WDT the/DT cells/NNS are/VBP less/PRP dependent/JJ on/IN mitochondrial/JJ metabolism/NN ./.
@@103768773869 Removal/NNP of/IN each/DT of/IN three/CD contiguous/JJ segments/NNS from/IN the/DT N-terminal/NN half/NN specifically/RB inhibits/VBZ the/DT formation/NN of/IN 5/NEWGENE ./NEWGENE 8Ss/NEWGENE rRNA/NEWGENE ,/, whereas/IN deleting/VBG part/NN of/IN the/DT C-terminal/NN region/NN of/IN the/DT protein/NN only/RB blocks/NNS the/DT production/NN of/IN 18S/NEWGENE rRNA/NEWGENE ./.
@@32981348720 This/DT report/NN expands/VBZ on/IN previous/JJ work/NN with/IN interferon/NEWGENE alfa-2b/NEWGENE (/NEWGENE Intron/NEWGENE A/NEWGENE ;/NEWGENE Schering-Plough/NEWGENE )/NEWGENE in/IN the/DT treatment/NN of/IN hairy/JJ cell/NN leukemia/NN (/( HCL/NN )/SYM ./.
@@8093642694 In/NN addition/NN ,/, a/DT microsatellite/NN repeat/NN polymorphism/NN with/IN a/DT heterozygosity/NN of/IN 71%/JJ at/IN the/PDT RET/NEWGENE locus/NEWGENE and/CC a/DT restriction/NN fragment/NN length/NN polymorphism/NN with/IN a/DT heterozygosity/NN of/IN 42%/RB detected/VBN by/IN a/DT lambda/NN clone/NN from/IN the/DT D10S94/NEWGENE locus/NEWGENE have/NN been/VBN developed/VBN for/IN high-resolution/JJ genetic/JJ linkage/NN mapping/NN and/CC predictive/JJ diagnostic/JJ testing/NN ./.
@@86214488381 We/PRP isolated/VBD a/DT complementary/JJ DNA/NN (/( cDNA/NN )/SYM clone/NN from/IN an/DT RL95-2/NN expression/NN library/NN that/IN encodes/VBZ the/DT C1/NEWGENE site-binding/NEWGENE protein/NEWGENE ./.
@@8754777234 The/DT upTRE/NEWGENE binds/VBZ more/RB T3R/NEWGENE homodimers/NEWGENE and/CC less/PRP T3R-RXR/NEWGENE heterodimers/NEWGENE than/IN the/DT dnTRE/NEWGENE ,/, and/CC T3/NEWGENE more/RB readily/RB facilitates/VBZ heterodimer/NN binding/JJ to/IN the/DT dn-/NN than/IN to/IN the/DT upTRE/NEWGENE ./.
@@30159535808 Analysis/NNP of/IN glucocorticoid/NN unresponsive/JJ cell/NN variants/NNS using/VBG a/DT mouse/NEWGENE glucocorticoid/NEWGENE receptor/NEWGENE complementary/JJ DNA/NN clone/NN ./.
@@112541342881 Moreover/RB ,/, PTax/NEWGENE expressed/VBD higher/JJ background/NN activities/NNS than/IN PTF/NEWGENE ,/, indicating/VBG that/IN the/DT sequence/NN of/IN the/DT synthetic/JJ regulatory/JJ region/NN can/MD influence/VB background/NN levels/NNS ./.
@@99257772806 When/WRB the/DT high/NN affinity/NN hnRNP/NEWGENE A1/NEWGENE binding/NEWGENE site/NEWGENE was/VBD inserted/VBN into/IN the/DT beta-globin/NEWGENE reporter/NEWGENE ,/, Rev/NEWGENE was/VBD able/JJ to/IN increase/NN the/DT cytoplasmic/JJ levels/NNS of/IN unspliced/JJ mRNAs/NNS to/IN 14%/NN ./.
@@28808416711 Since/IN the/DT stability/NN of/IN TF1/NEWGENE resides/VBZ in/IN its/PRP primary/JJ structure/NN ,/, we/PRP cloned/VBN a/DT gene/NN coding/JJ for/IN TF1/NEWGENE ,/, and/CC the/DT primary/JJ structure/NN of/IN the/DT beta/NN subunit/NN was/VBD deduced/VBN from/IN the/DT nucleotide/NN sequence/NN of/IN the/DT gene/NN to/IN compare/NN the/DT sequence/NN with/IN those/DT of/IN beta's/NNS of/IN three/CD major/JJ categories/NNS of/IN F1's/NNS ;/: prokaryotic/JJ membranes/NNS ,/, chloroplasts/NNS ,/, and/CC mitochondria/NNS ./.
@@111525218576 Intact/JJ Flag-tagged/JJ protein/NN products/NNS from/IN all/DT six/CD were/VBD produced/VBN from/IN genomic/JJ expression/NN vectors/NNS ,/, although/IN the/DT ORF40/NEWGENE //NEWGENE 41/NEWGENE transcript/NEWGENE encoding/VBG a/DT primase-helicase/NEWGENE component/NEWGENE proved/VBN to/IN be/VB spliced/VBN with/IN a/DT 127-bp/JJ intron/NN ./.
@@26770022323 With/IN both/DT wild-type/NN and/CC the/DT mutant/JJ enzymes/NNS ,/, ATP/NN activates/VBZ both/DT [/NN 14C/NN ]/NN Asp/NN in/IN equilibrium/NN N-carbamyl-L-aspartate/JJ (/( C-Asp/NN )/SYM and/CC the/DT [/NN 32P/NN ]/NN carbamyl/NN phosphate/NN (/( C-P/NN )/SYM in/IN equilibrium/NN Pi/NN exchanges/NNS ./.
@@108968591579 The/DT effect/NN of/IN water/NN deprivation/NN for/IN 19/CD h/NN on/IN renal/NN Na/NN excretion/NN of/IN conscious/JJ adrenalectomized/JJ (/( ADX/NNS )/SYM sheep/NN maintained/VBN on/IN a/DT constant/JJ intravenous/JJ infusion/NN of/IN aldosterone/NN and/CC cortisol/NN (/( ADX-constant/NNP steroid/JJ sheep/NN )/SYM was/VBD investigated/VBN ./.
@@109922992316 As/IN in/IN the/PDT other/DT three/CD members/NNS whose/WP gene/NN expression/NN is/VBZ altered/VBN during/IN tumorigenesis/NN ,/, PI12/NEWGENE expression/NN was/VBD found/VBN to/IN be/VB down-regulated/IN in/IN tumor/NN brain/NN tissues/NNS and/CC in/IN two/JJ brain/NN cancer/NN cell/NN lines/NNS :/: U-87/NN MG/NN and/CC H4/NNP ./NNP
@@37468966756 It/PRP is/VBZ suggested/VBN that/IN these/DT results/NNS may/MD raise/NN the/DT interesting/JJ possibility/NN of/IN providing/CC a/DT means/NN of/IN identifying/JJ greater/JJR or/CC lesser/JJ susceptibility/NN to/IN the/DT coronary/JJ effects/NNS of/IN Type/NN A/NN behavior/NN ./.
@@35727068572 Similarly/RB ,/, actuarial/JJ interpretations/NNS for/IN the/DT second/JJ protocols/NNS were/VBD not/RB more/RB frequently/RB selected/VBN by/RB therapists/NNS as/IN more/RB valid/JJ ,/, regardless/RB of/IN treatment/NN condition/NN and/CC elevation/NN of/IN the/DT F/NN and/CC F-K/NN indices/NNS on/IN the/DT first/JJ MMPI/NN profile/NN ./.
@@61500697311 All/DT patients/NNS received/VBD VCR/NN 1/NN ./NN 0/NN mg/NN //NN m2/NN weekly/JJ for/IN 6/CD weeks/NNS with/IN dose/NN modification/NN for/IN neurotoxicity/NN ./.
@@119115521823 In/NN patients/NNS who/WP respond/VBP to/IN quetiapine/NN ,/, therapy/NN should/MD be/VB continued/VBN at/IN the/DT optimal/JJ dose/NN that/WDT maintains/VBZ remission/NN ,/, within/IN the/DT range/NN of/IN 150/CD to/IN 750/CD mg/NN //NN d/NN ./.
@@62084777840 The/DT construction/NN of/IN a/DT small/JJ library/NN of/IN mouse/NN repetitive/JJ DNA/NN has/VBZ been/VBN previously/RB reported/VBN (/( Pietras/NNP et/FW al/NNS ./NNS ,/, Nucleic/NNP Acids/NNS Res/NNS ./.
@@99733518213 This/DT suggests/VBZ that/IN the/DT DcuS-DcuR/NEWGENE system/NEWGENE responds/VBZ to/IN external/NN substrates/NNS ./.
@@40687744747 The/DT weak/JJ relationships/NNS between/IN F/NN and/CC Zn/NN to/IN Mg/NN clearly/RB have/VB no/DT significant/JJ effect/NN on/IN the/DT contents/NNS of/IN these/DT elements/NNS in/IN bone/NN ./.
@@27615401869 Deletion/NNS analysis/NN showed/VBN that/IN the/DT NF-4FA/NEWGENE ,/, NF-4FB/NEWGENE ,/, and/CC AP-1/NEWGENE sequences/NN are/VBP each/DT necessary/JJ for/IN full/JJ enhancer/NN activity/NN ./.
@@111786961020 Serial/JJ US/NN images/NNS were/VBD obtained/VBN before/IN and/CC 20/CD ,/, 30/CD ,/, 40/CD ,/, 50/CD ,/, 60/CD ,/, 90/CD ,/, 120/CD ,/, 150/CD ,/, 180/CD ,/, 240/CD ,/, and/CC 300/CD s/NN after/IN intravenous/JJ injection/NN of/IN 2/CD g/NN of/IN contrast/NN agent/NN using/VBG conventional/JJ and/CC harmonic/NN PD/NN US/NNP ./NNP
@@101961278259 The/DT catalytic/JJ site/NN has/VBZ an/DT S1/NEWGENE pocket/NEWGENE lined/VBN with/IN conserved/VBN hydrophobic/JJ residues/NNS to/IN accommodate/VB the/DT pyroglutamyl/NN residue/NN ./.
@@111161486202 Coexpression/NNS studies/NNS indicate/VBP that/DT insulin/NEWGENE and/CC PKB/NEWGENE suppress/VB transactivation/NN by/IN C/NEWGENE //NEWGENE EBPbeta/NEWGENE ,/, but/CC not/RB C/NEWGENE //NEWGENE EBPalpha/NEWGENE ,/, and/CC that/DT N-terminal/NN transactivation/NN domains/NNS in/IN C/NEWGENE //NEWGENE EBPbeta/NEWGENE are/VBP required/VBN ./.
@@115609921169 Thus/RB ,/, MKK7/NEWGENE is/VBZ an/DT essential/JJ and/CC specific/NN regulator/NN of/IN stress-induced/JJ SAPK/NEWGENE //NEWGENE JNK/NEWGENE activation/NN in/IN mast/NN cells/NNS and/CC MKK7/NEWGENE negatively/RB regulates/VBZ growth/NEWGENE factor/NEWGENE and/CC antigen/NN receptor-driven/JJ proliferation/NN in/IN hematopoietic/JJ cells/NNS ./.
@@46561855079 Glucose/NN disappearance/NN rate/NN and/CC changes/NNS in/IN plasma/NN nutrients/NNS after/IN intravenouly/RB injected/VBN glucose/NN in/IN normoglycaemic/JJ and/CC hypoglycaemic/JJ underweight/JJ newborns/NNS ./.
@@106045835142 Albumin/NEWGENE dialysis/NN :/: effective/JJ removal/NN of/IN copper/JJ in/IN a/DT patient/NN with/IN fulminant/JJ Wilson/NN disease/NN and/CC successful/JJ bridging/JJ to/IN liver/NN transplantation/NN :/: a/DT new/JJ possibility/NN for/IN the/DT elimination/NN of/IN protein-bound/JJ toxins/NNS ./.
@@95823273050 We/PRP have/VBP shown/VBP previously/RB that/IN GH3/NNP cells/NNS transfected/VBN with/IN the/DT rat/NEWGENE GnRH/NEWGENE receptor/NEWGENE cDNA/NEWGENE (/( GGH3-1'/NN cells/NNS )/SYM support/NN the/DT expression/NN of/IN a/DT cotransfected/VBN fusion/NN gene/NN composed/VBN of/IN 797/CD base/NN pairs/NNS of/IN rat/NEWGENE LHbeta/NEWGENE gene/NEWGENE 5'-flanking/NEWGENE sequence/NEWGENE and/CC the/DT first/JJ 5/CD base/NN pairs/NNS of/IN the/DT 5'-untranslated/JJ region/NN fused/VBN to/IN a/DT luciferase/NEWGENE reporter/NEWGENE (/NEWGENE -797/NEWGENE //NEWGENE +5LHbetaLUC/NEWGENE )/NEWGENE and/CC respond/VB to/IN a/DT GnRH/NEWGENE agonist/NN with/IN a/DT 10-fold/JJ stimulation/NN of/IN activity/NN ./.
@@82811532868 However/RB ,/, a/DT surprisingly/RB high/JJ degree/NN of/IN conservation/NN of/IN intron/NN sequences/NNS was/VBD observed/VBN between/IN both/DT species/NN ./.
@@101030571603 Here/RB we/PRP describe/VBP the/DT optimization/NN and/CC characterization/NN of/IN a/DT 140-residue/JJ fragment/NN ,/, containing/JJ the/DT Runt/NEWGENE domain/NEWGENE of/IN AML1/NEWGENE ,/, which/WDT is/VBZ suitable/JJ for/IN structural/JJ studies/NNS ./.
@@80907677555 We/PRP present/VBP evidence/NN that/DT DNA/NEWGENE polymerase/NEWGENE delta/NEWGENE of/NEWGENE Saccharomyces/NEWGENE cerevisiae/NEWGENE ,/, an/DT enzyme/NN that/WDT is/VBZ essential/JJ for/IN viability/NN and/CC chromosomal/JJ replication/NN ,/, is/VBZ also/RB required/VBN for/IN base/NN excision/NN repair/NN of/IN exogenous/JJ DNA/NN methylation/NN damage/NN ./.
@@32808079116 The/DT behavior/NN of/IN suf12-null/NEWGENE //NEWGENE SUF12+/NEWGENE heterozygotes/NEWGENE indicates/VBZ that/IN suf12/NEWGENE is/VBZ co-dominantly/RB expressed/VBN and/CC suggests/VBZ that/IN suf12/NEWGENE allele-specific/NN suppression/NN may/MD result/VB from/IN functionally/RB distinct/JJ mutant/JJ proteins/NNS rather/RB than/IN variation/NN in/IN residual/JJ wild-type/NEWGENE SUF12+/NEWGENE activity/NN ./.
@@36058954572 The/DT 4/CD patients/NNS with/IN carboxyhemoglobin/NN levels/NNS in/IN excess/NN of/IN 10%/NN may/MD represent/VB occult/JJ carbon/NN monoxide/NN poisoning/VBG in/IN this/DT population/NN ./.
@@83807367987 The/DT 7-kb/JJ mRNA/NN differs/VBZ by/IN alternative/JJ splicing/JJ such/JJ that/IN it/PRP encodes/VBZ a/DT protein/NN with/IN a/DT distinct/JJ amino/JJ terminus/NN ./.
@@77951047770 Risks/NNS of/IN chronicity/NN following/IN acute/NN hepatitis/NN B/NN virus/NN infection/NN :/: a/DT review/NN ./.
@@112231319274 Folate/NN metabolism/NN in/IN the/DT human/JJ malaria/NN parasite/NN Plasmodium/NN falciparum/NN is/VBZ an/DT essential/JJ activity/NN for/IN cell/NN growth/NN and/CC replication/NN ,/, and/CC the/DT target/NN of/IN an/DT important/JJ class/NN of/IN therapeutic/JJ agents/NNS in/IN widespread/JJ use/NN ./.
@@15895762182 The/DT decay/NN curves/NNS of/IN chlorophyll/NN fluorescence/NN showed/VBD a/DT superposition/NN of/IN three/CD exponentially/RB decaying/JJ components/NNS with/IN time/NN constants/NNS of/IN T1/NN =/SYM 100-200/JJ ps/NNS ,/, T2/NN =/SYM 300-500/JJ ps/NNS and/CC T3/NN =/SYM 2/CD ./CD 0-3/CD ./CD 5/CD ns/CD ./CD
@@117769223014 IV/IN ./IN combined/JJ sclerosis/NN and/CC resorption/NN of/IN the/DT skull/NN base/NN (/( 6/CD cases/NNS ,/, 2/NN group/NN I/NN lesions/NNS and/CC 4/NN group/NN II/NN lesions/NNS )/SYM ./.
@@75142954915 Tyrosine/NN phosphorylation/NN of/IN cellular/JJ proteins/NNS is/VBZ the/DT earliest/JJS identifiable/JJ event/NN following/IN T-cell/NEWGENE antigen/NEWGENE receptor/NEWGENE (/( TCR/NEWGENE )/SYM stimulation/NN and/CC is/VBZ essential/JJ for/IN activating/JJ downstream/RB signaling/JJ machinery/NN ./.
@@12288821865 Generally/RB ,/, a/DT correlation/NN was/VBD observed/VBN between/IN highest/JJS concentrations/NNS of/IN CSF/NN immunoglobulins/NNS and/CC degree/NN of/IN meningeal/JJ inflammatory/JJ response/NN ,/, even/VB if/IN this/DT was/VBD a/DT component/NN of/IN other/DT neurological/JJ diseases/NNS ./.
@@111711182692 High-affinity/NNP binding/NN of/IN NF-1/NEWGENE to/IN PSE-B/NEWGENE ,/, but/CC not/RB to/IN PSE-A/NEWGENE ,/, was/VBD confirmed/VBN by/IN competition/NN of/IN DNA-protein/NN interactions/NNS by/IN using/VBG NF-1/NEWGENE DNA/NN elements/NN and/CC antibodies/NNS ./.
@@10679649496 METHODS/IN :/: TBN/NN measurements/NNS were/VBD performed/VBN in/IN 31/CD female/JJ outpatients/NNS with/IN breast/NN carcinoma/NN who/WP were/VBD undergoing/VBG standard/JJ cyclophosphamide/NN ,/, methotrexate/NN ,/, and/CC 5-fluorouracil/NN (/( CMF/NN )/NN -based/NN chemotherapy/NN (/( median/JJ age/NN ,/, 48/CD years/NNS ;/: range/NN ,/, 26-/DT 77/CD years/NNS )/SYM ./.
@@77054767659 While/IN daily/JJ food/NN intake/NN was/VBD almost/RB constant/JJ regardless/RB of/IN the/DT dietary/JJ protein/NN level/NN ,/, water/NN intake/NN and/CC urine/NN volume/NN increased/VBN with/IN increasing/JJ the/DT dietary/JJ protein/NN ./.
@@84395974031 This/DT short/JJ communication/NN compares/VBZ a/DT novel/JJ fluorimetric/JJ microplate/NN enzyme/NN immunoassay/NN (/( FEIA/NNP )/SYM with/IN a/DT commercial/JJ time-resolved/JJ fluoroimmunoassay/NN for/IN the/DT determination/NN of/IN thyrotropin/NEWGENE in/IN dried/JJ blood/NN spots/NNS ./.
@@5752315704 None/NN of/IN the/DT cystometrograms/NNS showed/VBD uninhibited/JJ detrusor/NN contractions/NNS ./.
@@8550564920 CXC/NEWGENE chemokines/NEWGENE bind/VBP to/IN unique/JJ sets/NNS of/IN selectivity/NN determinants/NNS that/WDT can/MD function/VB independently/RB and/CC are/VBP broadly/RB distributed/VBN on/IN multiple/JJ domains/NNS of/IN human/NN interleukin-8/NEWGENE receptor/NEWGENE B/NEWGENE ./.
@@77840785323 An/DT explanation/NN explored/VBN for/IN this/DT lack/NN of/IN gene/NN expression/NN was/VBD that/WDT increased/VBD levels/NNS of/IN RAR/NEWGENE alpha/NEWGENE or/CC PML/NEWGENE might/MD suppress/VB APL/NN cell/NN growth/NN ./.
@@9643546241 Transcription/NNS initiation/NN occurred/VBN predominantly/RB at/IN the/DT putative/JJ sigmaA-dependent/NEWGENE promoter/NEWGENE in/IN exponentially/RB growing/JJ cells/NNS and/CC was/VBD induced/VBN under/IN stress/NN conditions/NNS ./.
@@91050422821 This/DT study/NN indicates/VBZ that/IN the/DT phenotype/NN of/IN myofibrillar/JJ disarray/NN seen/VBP in/IN HCM/NNS patients/NNS which/WDT harbor/VBP either/DT of/IN these/DT two/JJ mutations/NNS may/MD not/RB be/VB directly/RB due/NN to/IN the/DT failure/NN of/IN the/DT mutant/NEWGENE myosin/NEWGENE heavy/NEWGENE chain/NEWGENE protein/NEWGENE to/IN assemble/VB and/CC form/NN normal/JJ sarcomeres/NNS ,/, but/CC may/MD rather/RB be/VB a/DT secondary/JJ effect/NN possibly/RB resulting/JJ from/IN the/DT chronic/JJ stress/NN of/IN decreased/VBN beta/NEWGENE MHC/NEWGENE function/NN ./.
@@105560331968 The/DT RFX/NEWGENE protein/NEWGENE family/NEWGENE includes/VBZ members/NNS from/IN yeast/NN to/IN humans/NNS ,/, which/WDT function/VBP in/IN various/JJ biological/JJ systems/NNS ,/, and/CC share/VB a/DT DNA-binding/NN domain/NN and/CC a/DT conserved/VBN C-terminal/NN region/NN ./.
@@21353431397 In/NN this/DT article/NN we/PRP propose/VBP to/IN find/NN out/RB the/DT percentage/NN of/IN normal/JJ occlusion/NN and/CC the/DT distribution/NN of/IN maloclusions/NNS ,/, according/VBG to/IN the/DT anteroposterior/JJ relationship/NN between/IN the/DT dental/JJ archs/NNS (/( following/IN the/DT ANGLE3/NN classification/NN )/SYM ./.
@@13411192447 Some/DT research/NN studies/NNS have/VBP related/VBN this/DT kind/NN of/IN tumors/NNS with/IN prolonged/JJ ingestion/NN of/IN H2/NN inhibitors/NN and/CC others/NNS antacid/JJ ./.
@@86682012528 Detailed/VBN mutagenesis/NN of/IN the/DT element's/NN rare-codon/NN //NN AU-rich/NN sequence/NN boundary/NN revealed/VBN that/IN the/DT destabilizing/JJ activity/NN of/IN the/DT MATalpha1/NEWGENE IE/NEWGENE is/VBZ observed/VBN when/CC the/DT terminal/JJ codon/NN of/IN the/DT element's/NNS rare-codon/JJ interval/NN is/VBZ translated/VBN ./.
@@119154361830 The/DT observed/VBN incidence/NN rates/NNS were/VBD compared/VBN to/IN expected/VBN rates/NNS in/IN the/DT general/JJ population/NN ./.
@@1552662146 Electromagnetic/JJ blood/NN flow/NN (/( BF/NN )/SYM probe/NN was/VBD applied/VBN on/IN the/DT left/JJ anterior/JJ descending/JJ artery/NN (/( LAD/NN )/SYM ./.
@@98623433027 We/PRP now/RB show/VBP that/IN gp200-MR6/NEWGENE ligation/NN can/MD also/RB mimic/VB IL-4/NEWGENE and/CC have/VB an/DT anti-proliferative/JJ pro-maturational/JJ influence/NN within/IN the/DT immune/JJ system/NN ,/, causing/JJ up-regulation/NN of/IN co-stimulatory/JJ molecules/NNS on/IN B/NNP lymphocytes/NNS ./.
@@10829973635 Iodine/NNP deficiency/NN disorders/NNS in/IN Bangladesh/NN ./.
@@47532865134 Suppression/NN of/IN food/NN intake/NN in/IN the/DT rat/NN by/IN tung/NN oil/NN ./.
@@94021395899 Similarities/NNS between/IN the/DT hIGFBP-1/NEWGENE and/CC phosphoenolpyruvate/NEWGENE kinase/NEWGENE (/( PEPCK/NEWGENE )/SYM promoters/NNS ,/, including/JJ regions/NNS conferring/JJ insulin/NEWGENE ,/, glucocorticoid/NN ,/, and/CC cyclic/JJ adenosine-monophosphate/JJ responses/NNS ,/, are/VBP consistent/JJ with/IN our/PRP previous/JJ hypothesis/NN that/IN IGFBP-1/NEWGENE is/VBZ involved/VBN in/IN regulation/NN of/IN glucose/NN metabolism/NN ./.
@@14749906016 A/DT genomic/JJ clone/NN ,/, pTt21/NN ,/, containing/NN DNA/NN apparently/RB transcribed/VBN specifically/RB in/IN Trypanosoma/JJ cruzi/JJ trypomastigotes/NNS ,/, was/VBD obtained/VBN by/IN differentially/RB screening/JJ a/DT genomic/JJ library/NN with/IN trypomastigote/NN and/CC epimastigote/NN cDNA/NN ./.
@@112804951113 CONCLUSIONS/IN :/: Using/VBG icodextrin-based/JJ instead/RB of/IN glucose-based/JJ PD/NN fluids/NNS can/MD largely/RB reduce/VB the/DT formation/NN of/IN Amadori/NNP albumin/NEWGENE and/CC AGEs/DT ./.
@@21677844468 Five/CD healthy/JJ male/JJ subjects/NNS inspired/JJ air/NN for/IN 20/CD min/NN and/CC then/RB 5%/JJ CO2/CD //CD 95%/CD O2/NN for/IN 30/CD min/NN ,/, of/IN which/WDT the/DT first/JJ 10/CD min/NN was/VBD used/VBN to/IN achieve/VB a/DT steady-state/JJ end-tidal/JJ CO2/NN measurement/NN ./.
@@8088513114 Here/RB ,/, we/PRP present/VBP genetic/JJ evidence/NN in/IN Saccharomyces/NN cerevisiae/NN for/IN a/DT functional/JJ interaction/NN between/IN the/DT DEAH/NEWGENE protein/NEWGENE Prp16/NEWGENE ,/, and/CC the/DT U6/NEWGENE and/CC U2/NEWGENE spliceosomal/NEWGENE snRNAs/NEWGENE ./.
@@67097006471 Within/IN the/DT compartment/NN or/CC dimension/NN of/IN severity/NN of/IN depression/NN a/DT subscale/NN of/IN the/DT Hamilton/NNP Depression/NNP Scale/NNP (/( or/CC the/DT Melancholia/NNP Scale/NNP )/SYM was/VBD shown/VBP to/IN have/NN reached/VBD an/DT instrumental/JJ perfection/NN ,/, e/NN ./NN g/NN ./. as/IN an/DT outcome/NN measure/NN of/IN antidepressant/JJ treatment/NN ./.
@@75502167426 Although/IN within/IN normal/JJ limits/NNS ,/, latency/NN was/VBD high/JJ ./.
@@118351098016 Since/IN the/DT early/NN 1980s/NN there/RB has/VBZ been/VBN increasing/JJ awareness/NN of/IN the/DT importance/NN of/IN quantifying/JJ health-related/JJ quality/NN of/IN life/NN (/( HRQL/NNS )/SYM in/IN patients/NNS with/IN chronic/JJ respiratory/JJ disorders/NNS included/VBN in/IN clinical/JJ trials/NNS ./.
@@87567127471 Previous/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT 616/CD amino/JJ acid/NN ,/, 70-kDa/NEWGENE subunit/NEWGENE of/NEWGENE RPA/NEWGENE (/( RPA/NEWGENE 70/NEWGENE )/SYM is/VBZ composed/VBN of/IN multiple/JJ structural/NN //NN functional/NN domains/NN ./.
@@76238219580 One/CD of/IN these/DT factors/NNS ,/, HRF-1/NEWGENE ,/, recognizes/VBZ a/DT cis/NN element/NN consisting/VBG of/IN an/DT inverted/JJ palindromic/JJ motif/NN ./.
@@67409196509 Adult/NN Amblyomma/NN lepidum/NN ticks/NNS fed/VBN as/IN nymphs/NNS on/IN this/DT goat/NN transmitted/VBD heartwater/NN to/IN a/DT Friesian/JJ (/( Bos/NN taurus/NN )/SYM calf/NN ./.
@@10531342196 The/DT N-terminal/NN domain/NN of/IN approximately/RB 70/CD kDa/NN exhibits/VBP 11/CD imperfect/JJ amino/JJ acid/NN repeats/NNS that/WDT show/VBP some/DT homology/NN to/IN promastigote/NN surface/NN glycoproteins/NNS of/IN the/DT psa2/NEWGENE //NEWGENE gp46/NEWGENE complex/NEWGENE ./.
@@79733648141 In/NN the/DT present/NN article/NN ,/, the/DT causes/NNS of/IN death/NN or/CC ill-being/JJ as/IN found/VB in/IN 10/CD consecutive/JJ carcinogenicity/NN studies--5/JJ studies/NNS with/IN 2400/CD OFA/NN (/( Sprague-Dawley-derived/JJ )/SYM and/CC Wistar/NN rats/NNS and/CC 5/CD studies/NNS with/IN 2400/CD OF1/NN and/CC NMRI/NN mice--were/RB re-examined/VBD ./.
@@109937876117 Whereas/IN both/DT MAP/NN and/CC MSNA/NNS increase/NN during/IN SHG/NN ,/, the/DT transition/NN from/IN SHG/NN to/IN PHI/NN is/VBZ characterized/VBN by/IN a/DT transient/JJ reduction/NN in/IN MAP/NN but/CC sustained/JJ elevation/NN in/IN MSNA/NNS ,/, facilitating/JJ separation/NN of/IN these/DT factors/NNS in/IN vivo/NN ./.
@@28497592398 The/DT SV40/NN enhancer/NN augmented/VBD replication/NN 1/CD ./CD 5-10/CD fold/NN ./.
@@84586608423 Air/NNP lead/VB was/VBD not/RB a/DT significant/JJ explanatory/JJ variable/NN ./.
@@86478847538 E3/NEWGENE //NEWGENE 19K/NEWGENE resides/VBZ in/IN the/DT endoplasmic/JJ reticulum/NN where/CC it/PRP binds/VBZ to/IN MHC/NEWGENE class/NEWGENE I/NEWGENE molecules/NEWGENE ,/, thereby/RB preventing/JJ their/PRP transport/NN to/IN the/DT cell/NN surface/NN ./.
@@61912436009 Differential/JJ drawing/JJ size/NN associated/VBN with/IN unilateral/JJ brain/NN damage/NN ./.
@@71252389112 The/DT pia/NN mater/NN at/IN the/DT site/NN of/IN the/DT entry/NN of/IN blood/NN vessels/NNS into/IN the/DT central/JJ nervous/JJ system/NN ./.
@@109281799698 The/DT optimum/JJ technique/NN for/IN the/DT pathological/JJ examination/NN of/IN sentinel/NN lymph/NN nodes/NNS (/( SLNs/NN )/SYM is/VBZ still/RB under/IN debate/NN ./.
@@65852779717 In/NN a/DT man/NN with/IN myelomonocytic/JJ leukemia/NN ,/, the/DT association/NN of/IN increased/VBN prostatic/NEWGENE acid/NEWGENE phosphatase/NEWGENE activity/NN in/IN serum/JJ and/CC the/DT presence/NN of/IN typical/JJ bone/NN lesions/NNS on/IN roentgenography/NN suggested/VBD the/DT existence/NN of/IN disseminated/JJ prostatic/JJ carcinoma/NN ./.
@@110062847453 The/DT protein-tyrosine/NEWGENE kinase/NEWGENE fer/NEWGENE1 associates/VBP with/IN signaling/NN complexes/NN containing/NN insulin/NEWGENE receptor/NEWGENE substrate-1/NEWGENE and/CC phosphatidylinositol/NEWGENE 3-kinase/NEWGENE ./.
@@82550227646 The/DT degree/NN of/IN hypoperfusion/NN was/VBD slightly/RB related/VBN to/IN decrease/NN in/IN FEV1/NN ./NN 0%/NN ,/, V25/NN and/CC PaO2/NN and/CC increase/NN in/IN circulating/JJ blood/NN volume/NN and/CC peripheral/JJ red/JJ blood/NN cell/NN counts/NNS ./.
@@88477238820 IMPLICATIONS/NNP :/: Given/VBN the/DT small/JJ size/NN of/IN this/DT study/NN and/CC the/DT inconsistency/NN of/IN results/NNS among/IN the/DT few/JJ prospective/JJ studies/NNS of/IN ovarian/JJ cancer/NN conducted/VBN to/IN test/NN these/DT associations/NNS ,/, replications/VBZ of/IN these/DT findings/NNS are/VBP highly/RB desirable/JJ ./.
@@89618731763 Abnormal/JJ urinary/NEWGENE coproporphyrin/NEWGENE levels/NNS in/IN patients/NNS infected/VBN by/IN hepatitis/NN C/NN virus/NN with/IN or/CC without/IN human/JJ immunodeficiency/NN virus/NN ./.
@@76444666930 Here/RB we/PRP describe/VBP an/DT in/NN vitro/FW assay/NN where/CC the/DT NS3-4A/NEWGENE polyprotein/NEWGENE ,/, NS3/NEWGENE ,/, the/DT serine/NEWGENE proteinase/NEWGENE domain/NEWGENE (/NEWGENE the/NEWGENE N-terminal/NEWGENE 181/NEWGENE residues/NEWGENE of/NEWGENE NS3/NEWGENE )/NEWGENE ,/, and/CC the/PDT NS4A/NEWGENE cofactor/NEWGENE were/VBD produced/VBN by/IN cell-free/JJ translation/NN and/CC tested/VBN for/IN trans-processing/NN of/IN radiolabeled/JJ substrates/NNS ./.
@@88698256296 Previous/JJ studies/NNS demonstrated/VBN that/IN the/DT flavin-containing/NEWGENE monooxygenases/NEWGENE (/( FMO/NEWGENE )/SYM are/VBP expressed/VBN in/IN a/DT tissue-specific/JJ manner/NN ./.
@@112983267382 A/DT comparison/NN of/IN the/DT duplicated/VBN Vkappa/NEWGENE genes/NEWGENE suggests/VBZ positive/JJ selection/NN on/IN the/DT complementarity-determining/NN regions/NN of/IN the/DT duplicated/VBN genes/NNS by/IN point/NN mutations/NNS ./.
@@114160122458 Concerted/JJ transcriptional/JJ activation/NN of/IN the/DT low/NEWGENE density/NEWGENE lipoprotein/NEWGENE receptor/NEWGENE gene/NEWGENE by/IN insulin/NEWGENE and/CC luteinizing/NEWGENE hormone/NEWGENE in/IN cultured/JJ porcine/JJ granulosa-luteal/JJ cells/NNS :/: possible/JJ convergence/NN of/IN protein/NEWGENE kinase/NEWGENE a/NEWGENE ,/, phosphatidylinositol/NEWGENE 3-kinase/NEWGENE ,/, and/CC mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE signaling/JJ pathways/NNS ./.
@@62387046035 Synthesis/NNS of/IN (/( +/SYM )/NN -lysergic/NN acid/NN diethylamide/JJ tartrate/NN ./.
@@9749019735 Stimulation/NNS of/IN macrophage/NN function/NN by/IN killed/VBN Bordetella/NN pertussis/NN cells/NNS did/VBD not/RB show/VB any/DT beneficial/JJ effect/NN as/IN an/DT increased/VBN susceptibility/NN became/VBD apparent/JJ ./.
@@90609719284 RESULTS/NNS :/: Among/IN women/NNS ,/, the/DT age-related/JJ decline/NN in/IN BMD/NN at/IN all/DT non-spine/NN skeletal/NN sites/NN was/VBD significantly/RB different/JJ from/IN zero/NN ,/, with/IN the/DT largest/JJS decline/NN seen/VBP at/IN the/DT femoral/JJ neck/NN (/( -/CD ./CD 0038/CD g/NN //NN cm2/NN //NN y/NN ,/, p/NN </SYM ./CD 001/CD )/SYM and/CC the/DT smallest/JJS at/IN the/DT trochanter/NN of/IN the/DT hip/NN (/( -/CD ./CD 0023/CD g/NN //NN cm2/NN //NN y/NN ,/, p/NN =/SYM ./CD 03/CD )/SYM ./.
@@27279094327 A/DT raised/VBN amplitude/NN of/IN the/DT aggregation/NN of/IN plates/NNS and/CC a/DT decrease/NN in/IN the/DT threshold/NN of/IN their/PRP sensitivity/NN to/IN ADP/NN were/VBD established/VBN in/IN the/DT persons/NNS with/IN types/NNS IIa/NN and/CC IIb/NN HLP/NN and/CC in/IN CHD/NN without/IN HLP/NNS ./.
@@113917936182 To/TO determine/VB the/DT genomic/JJ complexity/NN of/IN the/DT deleted/VBN region/NN shared/VBN among/IN tumors/NNS ,/, we/PRP assembled/VBD a/DT physical/JJ map/NN of/IN the/DT I/NN Mbp/NN SRO/NNS consisting/VBG predominantly/RB of/IN bacteriophage/NN P1-derived/JJ artificial/JJ chromosome/NN (/( PAC/NN )/SYM clones/NNS ./.
@@10212332150 Chronotherapeutics/NNP in/IN cardiovascular/JJ disease/NN ./.
@@115409913868 In/NN order/NN to/IN quantify/VB these/DT effects/NNS ,/, tests/NNS were/VBD conducted/VBN in/IN the/DT NASA/NN MSFC/NN Neutral/NNP Buoyancy/NNP Simulator/NNP ,/, in/IN the/DT NASA/NN KC-135/NN in/IN parabolic/JJ flight/NN ,/, and/CC in/IN space/NN with/IN the/DT EASE/NNP program/NN during/IN the/DT Shuttle/NNP Atlantis/NNP mission/NN 61-B/NN ./.
@@85581878541 Cycles/NNS were/VBD repeated/VBN every/DT 3/CD weeks/NNS ./.
@@47874725162 Change/NNP in/IN the/DT makeup/NN of/IN the/DT blood/NN following/IN a/DT short-term/JJ local/JJ action/NN of/IN a/DT permanent/JJ magnetic/JJ field/NN on/IN the/DT human/JJ body/NN ./.
@@24270248501 Tolerance/NN to/IN fenfluramine/NN anorexia/NN :/: fact/NN or/CC fiction/NN ?/. Recent/JJ findings/NNS in/IN this/DT laboratory/NN with/IN regard/NN to/IN tolerance/NN to/IN fenfluramine/NN anorexia/NN are/VBP reviewed/VBN with/IN respect/NN to/IN generality/NN of/IN the/DT behavioural/JJ phenomenon/NN ./.
@@100267848768 Here/RB ,/, we/PRP evidence/VBP that/IN the/DT developmental/JJ functions/NNS of/IN the/DT family/NN of/IN transcription/NN factors/NNS characterized/VBN by/IN the/DT POU/NEWGENE DNA/NEWGENE binding/NEWGENE motif/NEWGENE exerts/VBZ roles/NNS in/IN mammalian/JJ development/NN ./.
@@8223576301 The/DT absence/NN of/IN H4PteGlun/VB bound/JJ to/IN the/DT T/NEWGENE protein/NEWGENE in/IN our/PRP experimental/JJ conditions/NNS demonstrates/VBZ that/WDT H4PteGlun/VBP is/VBZ not/RB covalently/RB linked/JJ to/IN the/DT T/NEWGENE protein/NEWGENE ./.
@@96587693223 He/NN was/VBD administered/VBN recombinant/NEWGENE IFN/NEWGENE alpha-2b/NEWGENE under/IN the/DT diagnosis/NN of/IN chronic/JJ hepatitis/NNP C/NNP ./NNP
@@62941112322 74/CD ,/, 193-197/NN )/NN ./.
@@61519425974 Serum/NN ascorbic/JJ acid/NN had/VBP an/DT inverse/JJ and/CC the/DT strongest/JJS association/NN with/IN systolic/JJ blood/NN pressure/NN among/IN the/DT risk/NN factors/NNS including/JJ blood/NN pressure/NN ,/, total/JJ cholesterol/NN ,/, triglyceride/NN ,/, gamma-GTP/NN and/CC obesity/NN ./.
@@16505572252 Discrepant/NNP results/NNS with/IN a/DT latex/NN agglutination/NN test/NN in/IN the/DT assessment/NN of/IN cytomegalovirus/NEWGENE antibody/NEWGENE status/NN of/IN cardiac/JJ transplant/NN donors/NNS ./.
@@26553813332 Many/JJ studies/NNS have/VBP pointed/VBN out/RB the/DT possibility/NN of/IN "masked"/JJ organic/JJ factors/NNS in/IN erectile/JJ impotence/NN ,/, detectable/JJ only/RB by/IN means/NN of/IN laboratory/NN investigations/NNS :/: mild/JJ hypogonadism/NN ,/, hyperprolactinemia/NN ,/, occlusions/NNS selectively/RB located/VBN at/IN the/DT site/NN of/IN the/DT sexual/JJ arteries/NNS ,/, venous/JJ incompetence/NN ,/, subclinical/JJ neuropathies/NNS ./.
@@88715678403 MSSP/NEWGENE proteins/NEWGENE have/VBP been/VBN identified/VBN by/IN their/PRP binding/JJ to/IN an/DT upstream/JJ element/NN of/IN c-myc/NEWGENE ./.
@@111410033737 Changes/NNS in/IN stimulation/NN levels/NNS over/JJ time/NN in/IN nucleus/NN 22/NN cochlear/JJ implant/NN users/NNS ./.
@@89216675938 A/DT given/JJ standard/JJ input/NN function/NN and/CC a/DT given/NN value/NN of/IN distribution/NN volume/NN (/( Vd/NN )/SYM used/VBN for/IN the/DT rCBF/NN measurement/NN of/IN this/DT method/NN were/VBD calculated/VBN from/IN the/DT dynamic/JJ study/NN by/IN six/CD normal/JJ volunteers/NNS ./.
@@104938763968 The/DT solution/NN structure/NN of/IN the/DT adduct/NN derived/VBN from/IN the/DT covalent/JJ bonding/NN of/IN the/DT fjord/NN region/NN (/( +/SYM )/NN -/NN (/NN 11S/NN ,/, 12R/CD ,/, 13R/CD ,/, 14S/NN )/NN stereoisomer/NN of/IN anti/JJ -11/NN ,/NN 12-dihydroxy-13/NN ,/NN 14-epoxy-11/NN ,/NN 12/NN ,/NN 13/NN ,/, 14-tetrahydrobenzo/NN [/NN g/NN ]/NN chrysene/NN ,/, (/( +/SYM )/JJ -/JJ anti/JJ -B/NN [/NN g/NN ]/NN CDE/NN ,/, to/IN the/DT exocyclic/JJ N/NN (/NN 6/NN )/NN amino/NN group/NN of/IN the/DT adenine/NN residue/NN dA6/CD ,/, (/( designated/VBN (/( +/SYM )/JJ -/JJ trans-anti/JJ -/NN (/NN B/NN [/NN g/NN ]/NN C/NN )/NN dA6/NN )/NN ,/, positioned/VBN opposite/NN a/DT thymine/NN residue/NN dT17/CD in/IN the/DT DNA/NN sequence/NN context/NN d/NN (/NN C1-T2-C3-T4-C5-/NN (/NN B/NN [/NN g/NN ]/NN C/NN )/NN A6-C7-T8-T9-C10-C11/NN )/NN ./. d/NN (/NN G12-G13-A14-A15-G16-T17-G18-A19-G20++/NN +-A21-G22/NN )/NN (/( designated/VBN (/( B/NN [/NN g/NN ]/NN C/NN )/NN dA/NN ./. dT/NN 11-mer/NN duplex/NN )/NN ,/, has/VBZ been/VBN studied/VBN using/VBG structural/JJ information/NN derived/VBN from/IN NMR/NN data/NN in/IN combination/NN with/IN molecular/JJ dynamics/NNS (/( MD/NN )/SYM calculations/NNS ./.
@@20346554411 Characterization/NNS of/IN the/DT alpha/NEWGENE 4/NEWGENE integrin/NEWGENE gene/NEWGENE promoter/NEWGENE ./.
@@21177995026 Uses/NNS of/IN orthoclone/NN OKT3/NEWGENE for/IN prophylaxis/NN of/IN rejection/NN and/CC induction/NN in/IN initial/JJ nonfunction/NN in/IN kidney/NN transplantation/NN ./.
@@48638955210 Relationship/NNP between/IN gross/JJ lesions/NNS and/CC Escherichia/NN coli/JJ serotypes/NNS in/IN chronic/JJ respiratory/JJ disease/NN (/( CRD/NN )/SYM of/IN poultry/NN ./.
@@98340707528 Furthermore/RB ,/, synergistic/JJ activation/NN of/IN ERK2/NEWGENE occurred/VBN in/IN the/DT absence/NN of/IN changes/NNS in/IN intracellular/JJ Ca2+/NN ,/, and/CC was/VBD not/RB blocked/VBN by/IN inhibition/NN of/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE activity/NN and/CC represents/VBZ a/DT separate/JJ pathway/NN by/IN which/WDT CD19/NEWGENE regulates/VBZ B/NNP cell/NN function/NN ./.
@@8305688967 Pancreatic/JJ and/CC biliary/JJ secretion/NN and/CC gastric/JJ emptying/NN rates/NNS of/IN a/DT liquid/JJ test/NN meal/NN (/( LTM/NN )/SYM were/VBD determined/VBN in/IN normal/JJ persons/NNS ,/, in/IN patients/NNS with/IN subtotal/JJ gastrectomy/NN with/IN gastroduodenostomy/NN (/( STG-BI/NNP )/SYM or/CC with/IN gastrojejunostomy/NN (/( STG-BII/NN )/SYM ,/, and/CC in/IN patients/NNS with/IN truncal/JJ vagotomy/NN and/CC pyloroplasty/NN (/( V&P/NNP )/SYM ./.
@@19014053494 Analysis/NNP of/IN mRNA/NN expression/NN shows/VBZ that/IN AT-BP1/NEWGENE and/CC AT-BP2/NEWGENE are/VBP expressed/VBN in/IN all/PDT the/DT tissues/NNS examined/VBN ./.
@@25354608843 RNA/NN transcripts/NNS that/WDT hybridize/VBP to/IN the/DT introduced/VBN foreign/JJ gene/NN have/NN been/VBN identified/VBN ./.
@@104643106379 Transient/JJ tyrosine/NN phosphorylation/NN of/IN Crk/NEWGENE in/IN fibroblast/NN growth/NN factor-2-stimulated/NN endothelial/JJ cells/NNS was/VBD dependent/JJ on/IN the/DT juxtamembrane/JJ tyrosine/NN residue/NN 463/CD in/IN FGFR-1/NEWGENE ,/, and/CC a/DT Crk/NEWGENE SH2/NEWGENE1 domain/NEWGENE1 precipitated/VBN FGFR-1/NEWGENE via/NN phosphorylated/VBN Tyr-463/NN ,/, indicating/VBG direct/JJ complex/NN formation/NN between/IN Crk/NEWGENE and/CC FGFR-1/NEWGENE ./.
@@77147587662 Blood/NNP pressure/NN also/RB was/VBD increased/VBN by/IN lidocaine/NN (/( 6/CD mg/NN kg-1/NN )/SYM ./.
@@84972808260 Multiple/NNP SW16-dependent/NNP cis-acting/JJ elements/NN control/NN SWI4/NEWGENE transcription/NN through/RB the/DT cell/NN cycle/NN ./.
@@19711911952 We/PRP conclude/VBP that/IN the/DT beta-adrenergic/NN agonist/NN ,/, isoproterenol/NN ,/, has/VBZ little/JJ influence/NN on/IN vascular/JJ capacitance/NN or/CC liver/NN volume/NN of/IN dogs/NNS ,/, unless/IN the/DT hepatic/JJ outflow/NN resistance/NN is/VBZ elevated/VBN by/IN agents/NNS such/JJ as/IN histamine/NN ./.
@@21151188198 This/DT Mr/NNP is/VBZ similar/JJ to/IN those/DT of/IN the/DT purified/NEWGENE smg/NEWGENE p25A/NEWGENE GDI/NEWGENE1 estimated/VBN by/IN sodium/NN dodecyl/NN sulfate-polyacrylamide/NN gel/NN electrophoresis/NN and/CC sucrose/NN density/NN gradient/NN ultracentrifugation/NN ,/, which/WDT are/VBP about/RB 54/CD ,/CD 000/CD and/CC 65/CD ,/CD 000/CD ,/, respectively/RB ./.
@@82132358756 Measurement/NNP of/IN SaO2/NN at/IN moderate/JJ altitude/NN can/MD be/VB helpful/JJ in/IN the/DT care/NN of/IN both/DT healthy/JJ and/CC ill/JJ newborns/NNS or/CC infants/NNS ./.
@@90493047180 In/NN co-transfection/JJ studies/NNS ,/, an/DT AP-2/NEWGENE but/CC not/RB an/DT Egr-1/NEWGENE expression/NN vector/NN activated/VBN VPF/NEWGENE //NEWGENE VEGF/NEWGENE transcription/NN ,/, thus/RB indicating/VBG that/IN AP-2/NEWGENE protein/NEWGENE is/VBZ functionally/RB important/JJ in/IN TGF/NEWGENE alpha-induced/NEWGENE VPF/NEWGENE //NEWGENE VEGF/NEWGENE gene/NEWGENE expression/NN ./.
@@112073083259 Similarly/RB ,/, curcumin/NN (/( diferuloylmethane/NN )/SYM ,/, an/DT anti-inflammatory/JJ agent/NN ,/, suppressed/VBN OSM-stimulated/JJ STAT1/NEWGENE phosphorylation/NN ,/, DNA-binding/NN activity/NN of/IN STAT1/NEWGENE ,/, and/CC c-Jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE activation/NN without/IN affecting/VBG JAK1/NEWGENE ,/, JAK2/NEWGENE ,/, JAK3/NEWGENE ,/, ERK1/NEWGENE //NEWGENE 2/NEWGENE ,/, and/CC p38/NEWGENE phosphorylation/NN ./.
@@112889301121 The/DT reproductive/JJ effects/NNS of/IN the/DT administration/NN of/IN 4-chloro-2-methylphenoxyacetic/JJ acid/NN (/( MCPA/NN )/SYM to/IN rats/NNS were/VBD evaluated/VBN through/RB two/JJ generations/NNS ,/, from/IN prior/NN to/IN mating/JJ ,/, throughout/IN mating/JJ ,/, to/IN gestation/NN and/CC lactation/NN ./.
@@97294817723 The/DT rat/NEWGENE branched-chain-2-oxo-acid/NEWGENE dehydrogenase/NEWGENE (/NEWGENE BCOD/NEWGENE )/NEWGENE kinase/NEWGENE mRNA/NEWGENE is/VBZ transcribed/VBN from/IN a/DT TATA-less/NNP promoter/NN that/WDT has/VBZ GC-rich/NN sequences/NNS and/CC two/JJ putative/JJ Sp1/NEWGENE binding/NEWGENE sites/NEWGENE near/IN the/DT transcription/NN start/NN site/NN ./.
@@104072693842 67/CD 393/CD bp/NN of/IN contiguous/JJ DNA/NN located/VBN between/IN markers/NN cdc18/NEWGENE and/CC cdc14/NEWGENE on/IN the/DT right/JJ arm/NN of/IN fission/NN yeast/NN chromosome/NN II/NN has/VBZ been/VBN sequenced/VBN as/IN part/NN of/IN the/DT European/NNP Union/NNP Schizosaccharomyces/NN pombe/NN genome/NN sequencing/VBG project/NN ./.
@@118951841804 The/DT ability/NN of/IN rats/NNS with/IN control/NN or/CC hippocampal/JJ lesions/NNS to/IN learn/VB an/DT object-place/NN ,/, odor-place/JJ ,/, or/CC object-odor/NN paired-associate/NN task/NN was/VBD assessed/VBN in/IN a/DT cheeseboard/NN maze/NN apparatus/NN ./.
@@81895331254 Gel/NNP electrophoresis/NN and/CC Western/JJ immunoblot/VB analyses/NNS of/IN intracellular/JJ fractions/NNS derived/VBN from/IN infected/VBN cells/NNS revealed/VBN that/IN large/JJ amounts/NNS of/IN NS53/NEWGENE were/VBD present/VB in/IN the/DT cytosol/NN and/CC in/IN association/NN with/IN the/DT cytoskeletal/JJ matrix/NN ./.
@@81126011503 Structural/NNP organization/NN of/IN the/DT gene/NN encoding/VBG the/DT human/NEWGENE lipocalin/NEWGENE tear/NEWGENE prealbumin/NEWGENE and/CC synthesis/NN of/IN the/DT recombinant/JJ protein/NN in/IN Escherichia/NN coli/JJ ./.
@@8767228761 Bacterial/JJ meningitis/NN secondary/JJ to/IN abscess/NN of/IN the/DT nasal/JJ septum/NN ./.
@@89717213423 On/IN the/DT basis/NN of/IN serological/JJ studies/NNS ,/, the/DT highly/RB conserved/VBN A/DT domain/NN of/IN HspA/NEWGENE was/VBD found/VBN to/IN be/VB the/DT immunodominant/JJ domain/NN ./.
@@105328059570 In/NN PC12/NNP cells/NNS ,/, nerve/NEWGENE growth/NEWGENE factor/NEWGENE induces/VBZ neuronal/JJ differentiation/NN and/CC repressed/VBN expression/NN of/IN nrg-1/NEWGENE ./.
@@97652771954 The/DT murine/NEWGENE facilitative/NEWGENE glucose/NEWGENE transporter/NEWGENE isoform/NEWGENE 3/NEWGENE (/( Glut/NEWGENE 3/NEWGENE )/SYM is/VBZ developmentally/RB regulated/VBN and/CC is/VBZ predominantly/RB expressed/VBN in/IN neurons/NNS and/CC trophoblasts/NNS ./.
@@118723596822 It/PRP has/VBZ been/VBN proposed/VBN that/DT insulin/NEWGENE resistance/NN (/( IR/JJ )/SYM underlies/VBZ a/DT cluster/NN of/IN cardiovascular/JJ disease/NN (/( CVD/NN )/SYM risk/NN factors/NNS constituting/VBG a/DT "metabolic/JJ syndrome/NN ./NN "/NN CVD/NN is/VBZ a/DT leading/JJ cause/NN of/IN premature/JJ mortality/NN among/IN indigenous/JJ Australians/NNS ./.
@@81018393773 To/TO investigate/VB the/DT regulation/NN of/IN expression/NN of/IN the/DT human/NEWGENE mdr1/NEWGENE gene/NEWGENE ,/, the/DT response/NN of/IN the/DT mdr1/NEWGENE promoter/NEWGENE to/IN signals/NNS involved/VBN in/IN cell/NN proliferation/NN was/VBD examined/VBN ./.
@@6599629616 Increased/VBN urinary/NN riboflavin/NN excretion/NN resulting/JJ from/IN boric/JJ acid/NN ingestion/NN ./.
@@25322105493 The/DT adenovirus/NEWGENE E1A/NEWGENE gene/NEWGENE encodes/VBZ a/DT protein/NN that/WDT transcriptionally/RB activates/VBZ viral/JJ early/JJ genes/NNS ./.
@@65219996311 This/DT compares/VBZ favorably/RB to/IN results/NNS of/IN similarly/RB sized/JJ melanomas/NNS treated/VBN by/IN enucleation/NN ./.
@@33177964000 In/NN the/DT control/NN group/NN the/DT histological/JJ picture/NN resembled/VBD osteoarthritis/NN ./.
@@79166892906 The/DT isolated/VBN POT1/NEWGENE clones/NNS hybridized/VBN to/IN a/DT 1/CD ./CD 4/CD kb/NN RNA/NN species/NN ,/, which/WDT was/VBD induced/VBN approximately/RB 30-fold/JJ when/CC oleate/NN was/VBD the/DT carbon/NN source/NN ./.
@@85187973043 X-linked/JJ liver/NN glycogenosis/NN :/: localization/NN and/CC isolation/NN of/IN a/DT candidate/NN gene/NN ./.
@@75335273649 Cell/NNP lines/NNS derived/VBN from/IN the/DT tumors/NNS were/VBD examined/VBN by/IN fluorescent/JJ in/IN situ/NN hybridization/NN for/IN the/DT status/NN of/IN the/DT transferred/VBN human/JJ chromosome/NN and/CC by/IN PCR/NN for/IN marker/NN loss/NN ./.
@@68100709262 Other/JJ properties/NNS of/IN Hg-/NN and/CC Cd-spores/NN were/VBD similar/JJ to/IN those/DT of/IN control/NN spores/NNS ./.
@@16824842279 During/IN coronary/JJ stenosis/NN ,/, on/IN the/DT contrary/NN ,/, intracoronary/JJ procaterol/NN at/IN the/DT same/JJ dose/NN significantly/RB deteriorated/VBD regional/JJ myocardial/JJ dysfunction/NN without/IN changing/JJ LCX/NNS flow/NN ,/, global/JJ hemodynamics/NN and/CC cardiac/JJ lactate/NN metabolism/NN ./.
@@104111396960 Accumulation/NNP of/IN the/DT U4/NEWGENE //NEWGENE U6/NEWGENE duplex/NEWGENE was/VBD relieved/VBN by/IN overexpression/NN of/IN wild-type/NEWGENE Prp44p/NEWGENE ./.
@@87987008286 Its/PRP transcription/NN has/VBZ been/VBN shown/VBP to/IN be/VB induced/VBN 40-50-fold/JJ in/IN response/NN to/IN oxygen/NN or/CC heme/NN deficiency/NN ,/, in/IN part/NN through/JJ relief/NN of/IN repression/NN exerted/VBN by/IN Rox1p/NEWGENE and/CC in/IN part/NN by/IN activation/NN mediated/JJ by/IN an/DT upstream/NEWGENE activation/NEWGENE sequence/NEWGENE (/( UAS/NEWGENE )/SYM ./.
@@23267163467 Methods/NNS used/VBN include/VB Cobb/NNP angle/NN and/CC a/DT segmental/JJ evaluation/NN (/( T7-T12/NN )/SYM of/IN each/DT of/IN convex/JJ and/CC concave/JJ rib-vertebra/JJ angles/NNS (/( RVAs/NNS )/SYM ,/, rib-vertebra/JJ angle/NN differences/NNS (/( RVADs/NN )/SYM ,/, vertebral/JJ rotation/NN ,/, tilt/NN and/CC displacement/NN ./.
@@91193918891 The/DT exonic/JJ sequence/NN encodes/VBZ a/DT protein/NN of/IN 495/CD amino/JJ acids/NNS that/WDT is/VBZ nearly/RB identical/JJ to/IN the/DT previously/RB reported/VBN protein/NN sequence/NN of/IN human/NEWGENE GPT-1/NEWGENE ./.
@@20702272673 Endothelial/JJ cell/NN seeding/NN ./.
@@86362113721 EMBO/NNP J/NNP ./NNP
@@94306682597 The/DT promoter/NN for/IN HMG-CoA/NEWGENE synthase/NEWGENE contains/VBZ two/JJ binding/JJ sites/NNS for/IN the/DT sterol/NEWGENE regulatory/NEWGENE element-binding/NEWGENE proteins/NEWGENE (/( SREBPs/NEWGENE )/SYM ./.
@@87219999409 U24/NEWGENE has/VBZ two/JJ separate/JJ 12/CD nt/JJ long/JJ complementarities/NNS to/IN a/DT highly/RB conserved/VBN tract/NN of/IN 28S/NEWGENE rRNA/NEWGENE ./.
@@11062047969 Thus/RB ,/, IHHNV/ORG is/VBZ closely/RB related/VBN to/IN densoviruses/NNS of/IN the/DT genus/NN Brevidensovirus/NNP in/IN the/DT family/NN Parvoviridae/NN ,/, and/CC we/PRP therefore/RB propose/VBP to/IN rename/VB this/DT virus/NN Penaeus/NNP stylirostris/NN densovirus/NN (/( PstDNV/NNP )/SYM ./.
@@109545646531 We/PRP have/VBP also/RB identified/VBN a/DT functional/JJ domain/NN in/IN the/DT ORF/NEWGENE 50/NEWGENE protein/NEWGENE ,/, an/DT immediate-early/NEWGENE gene/NEWGENE product/NEWGENE that/WDT is/VBZ mainly/RB encoded/VBN by/IN ORF/NEWGENE 50/NEWGENE ./.
@@107131759062 Collectively/RB ,/, the/DT results/NNS suggest/VBP that/DT ARF/NEWGENE binding/JJ to/IN Mdm2/NEWGENE induces/VBZ a/DT conformational/JJ change/NN that/WDT facilitates/VBZ nucleolar/JJ import/NN of/IN the/DT ARF-Mdm2/NEWGENE complex/NEWGENE and/CC p53-dependent/JJ cell/NN cycle/NN arrest/NN ./.
@@1074812553 Inhibitor-1/NEWGENE (/( I-1/NEWGENE )/SYM and/CC inhibitor-2/NEWGENE (/( I-2/NEWGENE )/SYM selectively/RB inhibit/VB type/NEWGENE 1/NEWGENE protein/NEWGENE serine/NEWGENE //NEWGENE threonine/NEWGENE phosphatases/NEWGENE (/( PP1/NEWGENE )/SYM ./.
@@18337162820 Deregulation/NN of/IN their/PRP expression/NN may/MD contribute/VB to/IN malignant/JJ transformation/NN associated/VBN with/IN HTLV-1/NN infection/NN ./.
@@81457708056 Thus/RB our/PRP observations/NNS establish/VBP a/DT functional/JJ link/NN between/IN the/DT PKC/NEWGENE and/CC retinoid/JJ pathways/NNS ,/, which/WDT are/VBP generally/RB considered/VBN to/IN have/NN antagonistic/JJ activities/NNS on/IN differentiation/NN processes/NNS ./.
@@35592324223 A/DT preliminary/JJ study/NN on/IN pyogenic/JJ arthritis/NN ./.
@@91537952226 In/NN several/DT studies/VBZ the/DT RDFS/NN has/VBZ shown/VBP evidence/NN of/IN reliability/NN and/CC validity/NN ./.
@@111577846429 We/PRP mapped/VBD the/DT DGCR6/NEWGENE gene/NEWGENE to/IN chromosome/NN 22q11/CD within/IN a/DT low/JJ copy/NN repeat/NN ,/, termed/JJ sc11/CD ./CD 1a/CD ,/, and/CC identified/VBD a/DT second/JJ copy/NN of/IN the/DT gene/NN ,/, DGCR6L/NEWGENE ,/, within/IN the/DT duplicate/JJ locus/NN ,/, termed/JJ sc11/CD ./CD 1b/CD ./.
@@37441684409 Pharmacological/JJ action/NN of/IN eptazocine/NN (/( l-1/JJ ,/JJ 4-dimethyl-10-hydroxy-2/JJ ,/JJ 3/JJ ,/JJ 4/JJ ,/JJ 5/JJ ,/JJ 6/JJ ,/JJ 7-hexahydro-1/JJ ,/JJ 6-methano-1H-4-benz/JJ azonine/NN )/SYM ./.
@@95101891294 We/PRP have/VBP elucidated/VBN the/DT exon-intron/JJ organization/NN of/IN the/DT entire/JJ human/NN CD58/NEWGENE gene/NEWGENE ,/, including/JJ approximately/RB 2/CD ./CD 5/CD kilobases/NNS (/( kb/NN )/SYM of/IN 5'-flanking/JJ DNA/NN ./.
@@84797426799 This/DT may/MD account/NN ,/, at/IN least/RB in/IN part/NN ,/, for/IN the/DT ability/NN of/IN excess/NN wt/NEWGENE p53/NEWGENE to/IN inhibit/VB cell/NN proliferation/NN and/CC to/IN interfere/VB with/IN neoplastic/JJ processes/NNS ./.
@@24741103129 In/NN addition/NN to/IN the/DT significant/JJ reduction/NN in/IN blood/NN pressure/NN ,/, the/DT angiotensin/NEWGENE converting/NEWGENE enzyme/NEWGENE (/( ACE/NEWGENE )/SYM inhibitor/NN ramipril/NN caused/VBD a/DT significant/JJ regression/NN of/IN pathologic/JJ left/NN ventricular/JJ hypertrophy/NN demonstrated/VBN by/IN magnetic/JJ resonance/NN imaging/JJ and/CC echocardiography/NN ./.
@@88913456426 We/PRP show/VBP that/IN the/DT 5'UTR/NN characteristic/NN of/IN testis-specific/NEWGENE c-mos/NEWGENE mRNA/NEWGENE strongly/RB represses/VBZ translation/NN relative/JJ to/IN the/DT translation/NN of/IN transcripts/NNS that/WDT contain/VBP a/DT 5'UTR/CD derived/VBN from/IN beta-globin/NEWGENE mRNA/NEWGENE ,/, and/CC this/DT is/VBZ mainly/RB due/NN to/IN the/DT four/CD uORFs/NNS ./.
@@113537709932 In/NN regards/VBZ to/IN the/DT latter/JJ activity/NN ,/, it/PRP has/VBZ been/VBN shown/VBP that/DT S3/NEWGENE contains/VBZ vigorous/NN N-glycosylase/NEWGENE activity/NN for/IN the/DT removal/NN of/IN 8-oxoguanine/CD residues/NNS in/IN DNA/NN that/WDT leaves/VBZ baseless/JJ sites/NNS in/IN their/PRP places/NNS ./.
@@63693552333 Analysis/NNP of/IN proteins/NNS synthesized/VBN by/IN plasmids/NNS containing/JJ deleted/VBN forms/NNS of/IN the/DT trfA/NEWGENE region/NEWGENE indicates/VBZ that/IN the/DT A2/NEWGENE protein/NEWGENE is/VBZ the/DT essential/JJ trfA-encoded/NEWGENE replication/NEWGENE protein/NEWGENE of/IN plasmid/NN RK2/NN ./.
@@25740168763 When/WRB the/DT first/JJ twitch/NN of/IN TOF/NN spontaneously/RB recovered/VBN to/IN 10%/CD of/IN control/NN value/NN ,/, neostigmine/NN was/VBD injected/VBN (/( 40/CD micrograms/NN //NN kg/NN in/IN adults/NNS ,/, 30/CD micrograms/NN //NN kg/NN in/IN infants/NNS and/CC children/NNS )/SYM ./.
@@8387508582 16/CD ,/, 99-104/NN )/NN ./.
@@115571277392 In/NN conclusion/NN ,/, NF-Y/NEWGENE and/CC Sp1/NEWGENE binding/NN sites/NN play/VBP a/DT decisive/JJ role/NN in/IN the/DT basal/JJ expression/NN of/IN the/DT rat/NEWGENE mrp2/NEWGENE gene/NEWGENE ,/, while/CC the/DT human/NEWGENE MRP2/NEWGENE gene/NEWGENE is/VBZ regulated/VBN differently/RB ./.
@@75286679016 Minor/NNP initiation/NN sites/NNS were/VBD found/VBN at/IN positions/NNS -128/CD ,/, -111/CD ,/, -91/CD ,/, and/CC -74/CD ./.
@@17087745758 The/DT DNA/NN sequence/NN conferring/JJ AP-1/NEWGENE activity/NN was/VBD located/VBN in/IN the/DT proximal/JJ promoter/NN region/NN ./.
@@85455023176 Thus/RB ,/, SPECT/NN was/VBD not/RB as/RB sensitive/JJ as/IN PET/NN in/IN this/DT activation/NN task/NN ./.
@@34435664146 In/NN both/DT experiments/NNS ,/, average/JJ daily/JJ gain/NN and/CC gain-to-feed/JJ ratio/NN were/VBD similar/JJ for/IN TR/NN and/CC CR/NNP ./NNP
@@113234193724 Molecular/NNP cloning/NN ,/, genomic/JJ mapping/NN ,/, and/CC expression/NN of/IN two/JJ secretor/NEWGENE blood/NEWGENE group/NEWGENE alpha/NEWGENE (/NEWGENE 1/NEWGENE ,/NEWGENE 2/NEWGENE )/NEWGENE fucosyltransferase/NEWGENE genes/NEWGENE differentially/RB regulated/VBN in/IN mouse/NN uterine/NN epithelium/NN and/CC gastrointestinal/JJ tract/NN ./.
@@23327981929 The/DT afferents'/NN phase/NN of/IN response/NN was/VBD unmodified/JJ by/IN electrical/JJ EVS/NN stimulation/NN ./.
@@113341247591 A/DT log-linear/JJ dose-response/NN was/VBD obtained/VBN for/IN the/DT average/JJ increase/NN in/IN FEV1/NN up/JJ to/IN 6/CD h/NN (/( AUC0-6/NN h/NN )/SYM and/CC peak/NN FEV1/NN across/IN the/DT dose/NN range/NN administered/VBN by/IN Respimat/NNP ./.
@@32084933901 The/DT glomerular/JJ filtration/NN rate/NN did/VBD not/RB change/VB but/CC lithium/NN clearance/NN fell/NN by/IN 30%/CD ./.
@@104469988614 Adipocyte/NN differentiation/NN of/IN nontransformed/JJ cells/NNS also/RB markedly/RB represses/VBZ the/DT ability/NN of/IN SRF/NEWGENE to/IN bind/NN to/IN the/DT junB/NEWGENE SRE/NEWGENE1 ,/, the/DT c-fos/NEWGENE SRE/NEWGENE1 ,/, and/CC other/DT SREs/NEWGENE ,/, as/IN determined/VBN by/IN mobility/NN shift/NN and/CC gel/NN supershift/NN assays/NNS ,/, without/IN affecting/VBG the/DT DNA/NN binding/JJ characteristics/NNS of/IN the/DT nuclear/NEWGENE protein/NEWGENE SP-1/NEWGENE ./.
@@76220586522 The/DT PEBP2/NEWGENE alpha/NEWGENE proteins/NEWGENE contain/VBP a/DT 128-amino-acid/JJ (/( aa/NNS )/SYM region/NN highly/RB homologous/JJ to/IN the/DT Drosophila/NEWGENE melanogaster/NEWGENE segmentation/NEWGENE gene/NEWGENE runt/NEWGENE ./.
@@108395472892 Consistent/JJ with/IN our/PRP model/NN ,/, CTCF/NEWGENE binding/NN is/VBZ abolished/VBN by/IN DNA/NN methylation/NN ./.
@@112788703935 Analysis/NNP of/IN regulatory/JJ regions/NNS in/IN the/DT promoter/NN of/IN the/DT ctr4/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE copper/NEWGENE transporter/NEWGENE gene/NEWGENE in/IN fission/NN yeast/NN Schizosaccharomyces/NN pombe/NN reveals/VBZ the/DT identity/NN of/IN a/DT conserved/VBN copper-signaling/NEWGENE element/NEWGENE (/( CuSE/NEWGENE )/SYM ,/, which/WDT is/VBZ recognized/VBN by/IN the/DT transcription/NEWGENE factor/NEWGENE Cuf1/NEWGENE ./.
@@3610594276 A/DT study/NN of/IN the/DT comparative/JJ efficacy/NN of/IN diflucortolone/NN valerate/NN 0/CD ./CD 3%/CD ointment/NN and/CC clobetasol/NN propionate/NN 0/CD ./CD 05%/CD ointment/NN ./.
@@78981787872 The/DT relative/JJ risk/NN of/IN graft/NN loss/NN after/IN conversion/NN to/IN azathioprine/NN compared/VBN with/IN graft/NN loss/NN after/IN conversion/NN to/IN azathioprine/NN compared/VBN with/IN cyclosporin/NN maintenance/NN was/VBD 0/CD ./CD 71/CD (/( 0/CD ./CD 37-1/CD ./CD 38/CD )/SYM and/CC the/DT relative/JJ risk/NN of/IN patient/NN death/NN was/VBD 0/CD ./CD 57/CD (/( 0/CD ./CD 23-1/CD ./CD 41/CD )/SYM ./.
@@100825702303 Therefore/RB ,/, we/PRP have/VBP named/VBN this/DT gene/NN UBP43/NEWGENE ./.
@@112641773460 Nucleotide/NN sequence/NN ,/, transcription/NN map/NN ,/, and/CC mutation/NN analysis/NN of/IN the/DT 13q14/NN chromosomal/NN region/NN deleted/VBN in/IN B-cell/NN chronic/JJ lymphocytic/JJ leukemia/NN ./.
@@38367775575 Practical/JJ use/NN and/CC interpretation/NN of/IN viral/NN hepatitis/NN B/NN markers/NN and/CC hepatic/JJ biopsy/NN in/IN HBs/NEWGENE Ag/NEWGENE carriers/NN and/CC at/IN the/DT chronic/JJ hepatitis/NN stage/NN ./.
@@104589076851 The/DT human/NEWGENE RAD30B/NEWGENE and/CC mouse/NEWGENE Rad30b/NEWGENE mRNA/NEWGENE transcripts/NEWGENE ,/, like/JJ many/JJ repair/NN proteins/NN ,/, are/VBP highly/RB expressed/VBN in/IN the/DT testis/NN ./.
@@86344206719 HuEpo-R/NEWGENE Ab/NEWGENE inhibited/VBD Epo-induced/JJ parental/JJ UT-7/NNP cell/NN growth/NN ,/, but/CC not/RB that/IN of/IN cells/NNS of/IN clone/NN 12/CD ,/, suggesting/VBG that/IN the/DT muEpo-R/NEWGENE is/VBZ able/JJ to/IN induce/VB human/JJ UT-7/NNP cell/NN proliferation/NN ./.
@@88066932938 In/NN order/NN to/IN determine/VB which/WDT sequences/NNS in/IN the/DT GATA-1/NEWGENE promoter/NEWGENE are/VBP crucial/JJ for/IN activation/NN by/IN the/DT ME26/NEWGENE viral/NEWGENE protein/NEWGENE ,/, we/PRP made/VBP deletions/NNS of/IN the/DT promoter/NN ,/, cloned/VBN them/PRP into/IN a/DT luciferase/NEWGENE expression/NN vector/NN and/CC tested/VBN their/PRP activity/NN in/IN mouse/NN fibroblasts/NNS ,/, which/WDT do/VBP not/RB express/VB GATA-1/NEWGENE ./.
@@112242266061 The/DT effects/NNS of/IN chlordiazepoxide/NN (/( 2/CD ./CD 5-15/CD ./CD 0mg/CD //CD kg/CD )/SYM ,/, a/DT full/JJ benzodiazepine/NEWGENE receptor/NEWGENE agonist/NN ,/, and/CC bretazenil/NN (/( 5/CD ./CD 0-30/CD ./CD 0mg/CD //CD kg/CD )/SYM ,/, a/DT partial/JJ benzodiazepine/NEWGENE receptor/NEWGENE agonist/NN ,/, were/VBD examined/VBN in/IN the/DT murine/RB elevated/VBN plus-maze/NN paradigm/NN ./.
@@78886235831 PMEK1/NEWGENE displays/VBP 96/CD and/CC 80%/CD identity/NN respectively/RB with/IN the/DT tobacco/NEWGENE NTF3/NEWGENE and/CC Arabidopsis/NEWGENE ATMPK1/NEWGENE kinases/NEWGENE ,/, and/CC only/RB 50%/CD to/IN the/DT more/RB distantly/RB related/VBN plant/NN MAP/NEWGENE kinase/NEWGENE MsERK1/NEWGENE from/IN alfalfa/NN ./.
@@88876618903 IRF-1/NEWGENE acts/NNS as/IN a/DT transcriptional/JJ activator/NN ,/, while/CC IRF-2/NEWGENE acts/NNS as/IN a/DT repressor/NN ./.
@@82291025822 We/PRP conclude/VBP that/IN the/DT QLMI/NN questionnaire/NN has/VBZ good/JJ potential/NN as/IN an/DT instrument/NN for/IN assessing/JJ QL/NN in/IN post-AMI/JJ patients/NNS and/CC that/IN it/PRP can/MD be/VB successfully/RB self-administered/VB ./.
@@9422351592 Ca2+/NEWGENE //NEWGENE calmodulin-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE II/NEWGENE (/( CaMK/NEWGENE II/NEWGENE )/SYM is/VBZ a/DT multifunctional/NN serine/NEWGENE //NEWGENE threonine/NEWGENE protein/NEWGENE kinase/NEWGENE that/WDT regulates/VBZ ion/NN channels/NNS ,/, metabolic/JJ enzymes/NNS ,/, cytoskeletal/JJ proteins/NNS ,/, and/CC possibly/RB transcription/NN factors/NNS ./.
@@74911115924 We/PRP studied/VBD the/DT GR/NEWGENE in/IN DMS-79/NNP cells/NNS derived/VBN from/IN a/DT human/JJ ACTH-secreting/JJ small/JJ cell/NN lung/NN cancer/NN ./.
@@93118085942 However/RB ,/, we/PRP were/VBD unable/JJ to/IN identify/VB a/DT p4/NEWGENE molecule/NN ./.
@@99659099963 Direct/JJ approach/NN to/IN the/DT study/NN of/IN soliton/NN perturbations/NNS ./.
@@105874601688 To/TO define/VB the/DT minimal/JJ VDRE/NEWGENE binding/JJ domain/NN for/IN human/NEWGENE VDR/NEWGENE (/( hVDR/NEWGENE )/SYM ,/, a/DT series/NN of/IN C-terminally/RB truncated/JJ hVDR/NEWGENE mutants/NEWGENE (/( Delta134/NEWGENE ,/, Delta113/NEWGENE ,/, Delta102/NEWGENE ,/, Delta90/NEWGENE ,/, Delta84/NEWGENE ,/, Delta80/NEWGENE ,/, and/CC Delta60/NEWGENE )/SYM was/VBD generated/VBN and/CC expressed/VBN in/IN bacteria/NNS ./.
@@2209243388 The/DT urinary/NN protein/NN ,/, serum/JJ albumin/NEWGENE ,/, BUN/NN and/CC SCr/NN all/DT had/VBP very/RB significant/JJ improvement/NN ./.
@@80944988069 Most/JJS ,/, however/RB ,/, would/MD tell/VB the/DT spouse/NN the/DT full/JJ truth/NN about/RB both/DT diagnosis/NN and/CC prognosis/NN ./.
@@27978774357 The/DT combination/NN PIP/NN 64/NN micrograms/NNS -/: PEF/NN 4/NN micrograms/NNS prevents/VBZ the/DT frequent/JJ secondary/JJ regrowth/NN seen/VBP after/IN 6/CD hours/NNS with/IN the/DT antibiotics/NNS used/VBN alone/RB ./.
@@10789821880 The/DT second/JJ and/CC third/RB responded/VBN similarly/RB to/IN either/DT a/DT combined/JJ cyclophosphamide/NN +/SYM antilymphocyte/NEWGENE globulin/NEWGENE (/( ALG/NEWGENE )/SYM treatment/NN or/CC to/IN ALG/NEWGENE administration/NN preceded/VBN by/IN a/DT small/JJ dosage/NN of/IN cyclophosphamide/NN ,/, which/WDT had/VBP proved/VBN ineffective/JJ when/CC administered/VBN alone/RB ./.
@@94215113075 These/DT and/CC other/DT comparisons/NNS suggest/VBP that/IN ,/, during/IN evolution/NN ,/, both/PDT the/DT RNA-polymerase/NEWGENE specificity/NN of/IN telomerase/NEWGENE RNA-gene/NEWGENE promoters/NEWGENE and/CC ,/, more/RB recently/RB ,/, the/DT position/NN of/IN the/DT template/NN sequence/NN in/IN the/DT telomerase/NEWGENE RNA/NEWGENE changed/VBN ./.
@@93729684144 Importantly/RB ,/, in/IN HeLa/DT and/CC 293/CD cells/NNS ,/, endogenous/JJ and/CC transfected/VBN I/NEWGENE kappaB/NEWGENE alpha/NEWGENE coimmunoprecipitated/VBN with/IN Myc-tagged/JJ or/CC endogenous/JJ Dlc-1/NEWGENE ./.
@@57509505699 Estrus/NNP and/CC copulative/JJ abilities/NNS of/IN androgen-sterilized/JJ rats/NNS ./.
@@49892515293 Analysis/NNP of/IN corticosteroids/NNS ./.
@@107125993287 Here/RB ,/, we/PRP show/VBP that/IN IRF-1/NEWGENE is/VBZ degraded/VBN via/NN the/DT ubiquitin-proteasome/NN pathway/NN ./.
@@74879086139 That/DT sequence/NN strongly/RB promoted/VBD the/DT transcription/NN of/IN the/DT promotorless/JJ chloramphenicol/NEWGENE acetyltranferase/NEWGENE (/( CAT/NEWGENE )/SYM gene/NN in/IN cells/NNS of/IN pancreatic/JJ origin/NN (/( AR-42J/NNP )/SYM but/CC not/RB in/IN cells/NNS of/IN non-pancreatic/JJ origin/NN (/( Rat/NNP 2/CD and/CC IEC/NN 6/NN )/SYM ./SYM
@@85761311807 We/PRP report/VBP the/DT molecular/JJ cloning/NN and/CC functional/JJ characterization/NN of/IN USF2/NEWGENE isoforms/NEWGENE ,/, corresponding/JJ to/IN a/DT 44-kDa/NN subunit/NN ,/, USF2a/NEWGENE ,/, and/CC a/DT new/JJ 38-kDa/NN subunit/NN ,/, USF2b/NEWGENE ,/, generated/VBN by/IN differential/JJ splicing/JJ ./.
@@81541718131 These/DT issues/NNS include/VBP the/DT use/NN of/IN LMWHs/DT in/NN patients/NNS with/IN arterial/JJ thrombosis/NN or/CC myocardial/JJ infarction/NN (/( e/NN ./NN g/NN ./. in/IN conjunction/NN with/IN thrombolytic/JJ treatment/NN )/SYM ,/, and/CC in/IN patients/NNS with/IN pulmonary/JJ embolism/NN ./.
@@85374039054 The/DT protein/NEWGENE kinase/NEWGENE domains/NEWGENE of/IN LIMK1/NEWGENE and/CC LIMK2/NEWGENE are/VBP unique/JJ in/IN that/DT they/PRP contain/VBP an/DT unusual/JJ sequence/NEWGENE motif/NEWGENE Asp-Leu-Asn-Ser-His-Asn/NEWGENE in/IN subdomain/NEWGENE VIB/NEWGENE and/CC a/DT highly/RB basic/JJ insert/NN between/IN subdomains/NEWGENE VII/NEWGENE and/NEWGENE VIII/NEWGENE ./.
@@86263258273 In/NN agreement/NN with/IN previous/JJ in/IN vitro/FW data/NN ,/, we/PRP have/VBP shown/VBP that/IN UmuD/NEWGENE and/CC UmuD'/NEWGENE are/VBP able/JJ to/IN form/NN both/DT homodimers/NNS (/( UmuD-UmuD/NEWGENE and/CC UmuD'-UmuD'/NEWGENE )/SYM and/CC a/DT heterodimer/NN (/( UmuD-UmuD'/NEWGENE )/SYM ./.
@@34276134129 In/NNP Salmo/NNP gairdneri/NN ,/, no/DT specialized/JJ system/NN of/IN portal/JJ vessels/NNS appears/VBZ to/IN exist/VB between/IN the/DT pineal/JJ organ/NN and/CC other/DT portions/NNS of/IN the/DT brain/NN ./.
@@2945027797 Diagnosis/NNP and/CC treatment/NN planning/NN in/IN Class/NN II/NN ,/, division/NN 2/CD ./CD
@@82790984658 Peripheral/NN vitreochorioretinal/NN dystrophies/NNS in/IN myopia/NN patients/NNS ./.
@@10518956351 ESS/NN type/NN 1/NN ,/, with/IN FT3/NN low/NN and/CC FT4/NN and/CC TSH/NEWGENE normal/JJ ,/, is/VBZ the/DT most/RB frequent/VB form/NN ./.
@@5538588580 Although/IN Grice's/NN operation/NN has/VBZ been/VBN used/VBN all/DT over/RB the/DT world/NN ,/, no/DT systematic/JJ account/NN of/IN it/PRP has/VBZ been/VBN found/VB in/IN the/DT literature/NN (/( including/JJ publications/NNS dealing/VBG with/IN technique/NN )/SYM ,/, which/WDT presents/VBP it/PRP in/IN terms/NNS related/VBN to/IN the/DT basic/JJ "classical"/JJ principles/NNS on/IN which/WDT the/DT operation/NN was/VBD conceived/VBN ./.
@@82289978206 Our/PRP results/NNS indicate/VBP that/DT periseizure/NN lipid/NN accumulation/NN is/VBZ related/VBN to/IN cortical/JJ oxygenation/NN ./.
@@68589672199 Serum/NN lactate/NEWGENE dehydrogenase/NEWGENE and/CC haptoglobin/NEWGENE levels/NNS were/VBD normal/JJ ,/, and/CC total/JJ bilirubin/NN was/VBD only/RB slightly/RB elevated/VBN ./.
@@107022535253 During/IN the/DT cloning/NN by/IN reverse/JJ transcriptase-polymerase/JJ chain/NN reaction/NN of/IN the/DT human/NEWGENE HIF-1alpha/NEWGENE subunit/NEWGENE ,/, we/PRP isolated/VBD two/JJ cDNA/NN clones/NNS which/WDT corresponded/VBD to/IN alternative/JJ splicing/JJ of/IN the/DT HIF-1alpha/NEWGENE gene/NEWGENE ./.
@@115281273783 With/IN a/DT GC/NN content/NN of/IN 45%/VBD the/DT one/PRP segment/NN would/MD correspond/VB to/IN "isochore/NEWGENE H1"/NEWGENE and/CC the/PDT other/DT segment/NN (/( 39%/CD GC/NN in/IN human/JJ ,/, 40%/CD GC/NN in/IN mouse/NN )/SYM to/IN "isochore/NEWGENE L1/NEWGENE //NEWGENE L2"/NEWGENE ./.
@@99871769985 Sixty/CD months/NNS after/IN the/DT initial/JJ vaccination/NN ,/, all/DT vaccinees/NNS who/WP received/VBD annual/JJ follow-up/JJ still/RB had/VBP protective/JJ levels/NNS of/IN anti-HAV/NEWGENE ./.
@@111936669305 This/DT could/MD lead/NN to/IN subsequent/JJ outbreaks/NNS if/IN Babesia/NN carrier/NN animals/NNS were/VBD to/IN be/VB introduced/VBN into/IN the/DT herd/NN ./.
@@39081964557 Shear/JJ bond/NN strength/NN of/IN a/DT composite/JJ resin/NN to/IN an/DT etched/JJ glass/NN ionomer/NN ./.
@@30210503732 There/EX were/VBD no/DT interfering/JJ peaks/NNS in/IN the/DT quantitation/NN of/IN sulbactam/NN ./.
@@4145754818 Ultrasonic/NN evaluation/NN of/IN renal/JJ calculi/NNS ./.
@@83832873195 Since/IN the/DT -172/JJ //JJ -148/JJ element/NN also/RB conferred/VBD estrogen/NN and/CC thyroid/JJ hormone/NN responsiveness/NN ,/, it/PRP can/MD be/VB considered/VBN a/DT composite/JJ hormone/NEWGENE response/NEWGENE element/NEWGENE ./.
@@77917637607 Molecular/NNP cloning/NN of/IN an/DT amphibian/NEWGENE insulin/NEWGENE receptor/NEWGENE substrate/NEWGENE 1-like/NEWGENE cDNA/NEWGENE and/CC involvement/NN of/IN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE in/IN insulin-induced/CD Xenopus/NN oocyte/NN maturation/NN ./.
@@63943477867 Hydrallazine/NNP also/RB caused/VBD a/DT slight/JJ increase/NN in/IN plasma/NEWGENE renin/NEWGENE activity/NN and/CC urinary/JJ excretion/NN of/IN noradrenaline/NN ./.
@@112875558872 The/DT Delta6CCI/NNP virus/NN was/VBD extremely/RB attenuated/VBN in/IN replication/NN capacity/NN yet/RB retained/VBD infectiousness/NN for/IN CEMx174/NN and/CC MT4/NN cells/NNS ./.
@@2475717363 Tissue/NN necrosis/NN was/VBD evaluated/VBN using/VBG triphenyltetrazolium/NN staining/NN and/CC was/VBD related/VBN to/IN two/JJ major/JJ baseline/NN predictors/NN of/IN infarct/NN size/NN :/: anatomic/JJ risk/NN zone/NN size/NN and/CC coronary/JJ collateral/JJ flow/NN ./.
@@25754906477 Northern/NNP blot/NN analysis/NN revealed/VBD multiple/JJ oIGF-I/NEWGENE transcripts/NEWGENE in/IN a/DT broad/JJ band/NN at/IN 800-1/JJ ,/JJ 100/JJ nucleotides/NNS and/CC other/DT transcripts/NNS of/IN higher/JJ molecular/JJ weight/NN in/IN liver/NN ./.
@@2253524008 Phenobarbital-induced/JJ alterations/NNS in/IN the/DT metabolism/NN of/IN [/NN 3H/NN ]/NN vitamin/NN D3/NN by/IN the/DT perfused/VBN rachitic/JJ rat/NN liver/NN in/IN vitro/FW ./.
@@16251319010 Therefore/RB ,/, with/IN a/DT biopsy/NN from/IN the/DT stoma/NN site/NN there/RB is/VBZ a/DT risk/NN of/IN missing/JJ early/JJ rejection/NN ./.
@@102176837000 Canalith/NN repositioning/VBG is/VBZ the/DT mainstay/NN of/IN treatment/NN ./.
@@67262572297 Further/RB ,/, the/DT reduction/NN in/IN 5-hydroxytryptophan/NN (/( 5-HTP/NN )/SYM accumulation/NN by/IN LSD/NN showed/VBD regional/JJ differences/NNS in/IN inhibition/NN by/IN methiothepin/NN (/( hypothalamus/NN greater/JJR than/IN cortex/NN greater/JJR than/IN striatum/NN )/SYM which/WDT paralleled/VBN the/DT autoreceptor/NN antagonist/NN activity/NN of/IN methiothepin/NN in/IN vitro/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@98585883855 The/DT slower-electrophoretic-mobility/JJ form/NN of/IN p68/NEWGENE was/VBD absent/VB in/IN human/JJ cells/NNS in/IN G1/NN //NN S/NN and/CC appeared/VBN as/IN the/DT cells/NNS entered/VBD G2/NN //NN M/NN ./.
@@21546869054 Fragments/NNS containing/JJ the/DT 21-base-pair/JJ repeat/NN region/NN ,/, the/DT enhancer/NN of/IN simian/JJ virus/NN 40/CD or/CC both/DT strongly/RB stimulated/VBN beta-galactosidase/NEWGENE synthesis/NN ,/, and/CC three/CD fragments/NNS from/IN the/DT polyomavirus/NN enhancer/NN region/NN stimulated/VBD moderate/JJ levels/NNS ./.
@@36913163377 It/PRP is/VBZ concluded/VBN that/DT contact/NN allergy/NN to/IN K-CG/NN is/VBZ common/JJ ./.
@@87717877413 Characterization/NNS of/IN LRP/NEWGENE ,/, a/DT leucine-rich/NEWGENE repeat/NEWGENE (/NEWGENE LRR/NEWGENE )/NEWGENE protein/NEWGENE from/NEWGENE tomato/NEWGENE plants/NEWGENE that/WDT is/VBZ processed/VBN during/IN pathogenesis/NN ./.
@@16532366301 We/PRP did/VBD not/RB detect/VB p50/NEWGENE in/IN association/NN with/IN native/NEWGENE glucocorticoid/NEWGENE receptor/NEWGENE in/IN L/JJ cells/NNS or/CC with/IN the/DT overexpressed/VBN glucocorticoid/NEWGENE receptor/NEWGENE in/IN Chinese/JJ hamster/NN ovary/NN cells/NNS ./.
@@20453667225 Hydrophobicity/NNS analysis/NN indicated/VBN that/IN the/DT KlaA/NEWGENE and/CC KlaB/NEWGENE polypeptides/NEWGENE are/VBP likely/RB to/IN be/VB soluble/JJ ,/, whereas/IN the/DT KlaC/NEWGENE polypeptide/NEWGENE was/VBD predicted/VBN to/IN have/NN four/CD potential/JJ membrane-spanning/NN domains/NN ./.
@@105418655534 Therefore/RB ,/, homozygous/JJ co-deletions/NNS of/IN CDKN2A/NEWGENE and/CC CDKN2B/NEWGENE rather/RB than/IN mutations/NNS targeting/JJ individual/JJ transcripts/NNS are/VBP frequently/RB selected/VBN for/IN in/IN these/DT tumors/NNS ./.
@@107971254121 To/TO test/VB the/DT hypothesis/NN that/IN progestin-mediated/JJ increases/NNS in/IN resting/JJ core/NN temperature/NN and/CC the/DT core/NN temperature/NN threshold/NN for/IN sweating/NN onset/NN are/VBP counteracted/VBN by/IN estrogen/NN ,/, we/PRP studied/VBD eight/CD women/NNS (/( 24/CD +/NN //NN -/NN 2/CD yr/NN )/SYM at/IN 27/CD degrees/NNS C/NN rest/NN ,/, during/IN 20/CD min/NN of/IN passive/JJ heating/NN (/( 35/CD degrees/NNS C/NN )/SYM ,/, and/CC during/IN 40/CD min/NN of/IN exercise/NN at/IN 35/CD degrees/NNS C/NNP ./NNP
@@107528079282 CONCLUSION/IN :/: Treatment/NNP of/IN sepsis/NN with/IN the/DT platelet-activating/NEWGENE factor/NEWGENE antagonist/NN BB-882/NN offers/VBP no/DT advantage/NN over/JJ placebo/NN on/IN survival/NN ,/, hemodynamic/JJ status/NN ,/, respiratory/JJ function/NN ,/, or/CC organ/NN failure/NN scores/NNS ./.
@@10835732642 No/DT differences/NNS in/IN total/JJ cholesterol/NN levels/NNS were/VBD observed/VBN between/IN mapuches/NNS and/CC aymaras/NNS ./.
@@4039667570 Scintigraphic/NNP visualisation/NN of/IN Walker/NN carcinoma-256/JJ in/IN Sprague-Dawley/NN rats/NNS by/IN means/NN of/IN 99mTc-labelled/NN monocytes/NNS ./.
@@107949368672 The/DT recovery/NN rates/NNS for/IN the/DT MB/NN //NN BacT/NN ,/, MGIT/NN 960/NN ,/, and/CC solid/JJ media/NN were/VBD 91/CD ./CD 6/CD ,/, 87/CD ./CD 4/CD ,/, and/CC 54/CD ./CD 7%/CD ,/, respectively/RB ,/, for/IN all/DT mycobacteria/NNS ;/: the/DT recovery/NN rates/NNS were/VBD 93/CD ./CD 6/CD ,/, 88/CD ./CD 9/CD ,/, and/CC 63/CD ./CD 4%/CD ,/, respectively/RB ,/, for/IN M/NNP ./NNP tuberculosis/NN complex/NN alone/RB ,/, and/CC 87/CD ./CD 5/CD ,/, 84/CD ./CD 4/CD ,/, and/CC 37/CD ./CD 5%/CD ,/, respectively/RB ,/, for/IN all/DT nontuberculous/JJ mycobacteria/NNS ./.
@@103769914545 Ras/NEWGENE is/VBZ not/RB associated/VBN with/IN the/DT tegument/NN ./.
@@77075235199 In/NN 293/CD cells/NNS ,/, expression/NN of/IN the/DT NF-kappa/NEWGENE B/NEWGENE inhibitor/NN ,/, I/NEWGENE kappa/NEWGENE B-alpha/NEWGENE ,/, reduced/VBD the/DT stimulatory/JJ activity/NN of/IN LMP/NEWGENE ./.
@@90322582326 Studies/NNS using/VBG HLA-DR-B7-1-LFA-3/NEWGENE triple/JJ transfectants/NNS showed/VBN that/IN the/DT LFA-3-induced/NN NF-AT/NEWGENE DNA/NN binding/JJ activity/NN was/VBD negatively/RB regulated/VBN by/IN B7-1/NEWGENE costimulation/NN ./.
@@77429177695 Icterus/FW and/CC beta-thalassemia/NN in/IN Congolese/JJ children/NNS in/IN Brazzaville/DT ./.
@@105437275981 It/PRP contains/VBZ binding/JJ sites/NNS for/IN several/DT transcription/NN factors/NNS ,/, for/IN example/NN :/: (/( i/NN )/SYM a/DT well-characterized/JJ binding/JJ site/NN for/IN rel/NEWGENE //NEWGENE NF-kappaB/NEWGENE transcription/NEWGENE factors/NEWGENE in/IN its/PRP 3'-end/CD (/( the/DT H2TF1/NEWGENE or/CC kappaB1/NEWGENE element/NEWGENE )/SYM ,/, (/( ii/NN )/SYM a/DT second/JJ kappaB/NEWGENE site/NEWGENE (/( the/DT kappaB2/NEWGENE element/NEWGENE )/SYM ,/, which/WDT is/VBZ located/VBN immediately/RB adjacent/JJ 5'/CD to/IN the/DT H2TF1/NEWGENE element/NEWGENE and/CC which/WDT is/VBZ recognized/VBN by/IN p65/NEWGENE //NEWGENE relA/NEWGENE in/IN the/DT human/NEWGENE HLA/NEWGENE system/NN ,/, and/CC (/( iii/NN )/SYM an/DT AP-1/NEWGENE //NEWGENE ATF/NEWGENE recognition/NEWGENE sequence/NEWGENE in/IN the/DT 5'/CD end/NN (/( EnA-TRE/NEWGENE )/SYM ./.
@@104165581372 PURPOSE/NNS :/: The/DT purposes/NNS of/IN the/DT present/NN study/NN were/VBD to/IN assess/VB the/DT effects/NNS of/IN a/DT 12-wk/JJ laboratory/NN based/VBD aerobic/JJ exercise/NN program/NN on/IN cardiopulmonary/JJ function/NN ,/, CD4/NN cell/NN count/NN ,/, and/CC physician-assessed/JJ health/NN status/NN among/IN symptomatic/JJ pre-AIDS/JJ HIV-infected/JJ individuals/NNS (/( N/JJ =/SYM 28/CD )/SYM and/CC to/IN assess/VB the/DT degree/NN to/IN which/WDT ill/JJ health/NN was/VBD associated/VBN with/IN exercise/NN relapse/NN ./.
@@72029197028 Ulcer/NNS appeared/VBN on/IN the/DT angulus/NN of/IN the/DT stomach/NN at/IN the/DT 28th/CD week/NN and/CC resulted/VBN in/IN ulcer/NN scar/NN at/IN the/DT 42nd/CD week/NN ./.
@@30495704988 These/DT similarities/NNS suggest/VBP that/IN these/DT E2/NEWGENE proteins/NEWGENE are/VBP structurally/RB and/CC evolutionarily/RB related/VBN ./.
@@12804131924 Treatment/NNP and/CC staining/NN of/IN smears/NNS and/CC sections/NNS for/IN detection/NN of/IN microorganisms/NNS ./.
@@45794365035 Taxonomically/RB significant/JJ colour/NN changes/NNS in/IN Brevibacterium/NNP linens/NNS probably/RB associated/VBN with/IN a/DT carotenoid-like/JJ pigment/NN ./.
@@41382242281 The/DT effect/NN of/IN a/DT tissue/NN emulsion/NN ,/, vitamin/NN A/DT and/CC nonspecific/NN gamma-globulin/NEWGENE on/IN the/DT blood/NN clearance/NN in/IN rabbits/NNS ./.
@@78246574452 The/DT enhanced/VBN cysteine/NN formation/NN in/IN a/DT pCSK4F/NN plant/NN responding/VBG to/IN sulfite/NN was/VBD also/RB observed/VBN in/IN leaf/NN discs/NNS ./.
@@19829975750 Examination/NN of/IN immediate-early/NN transcription/NN factor/NN expression/NN during/IN the/DT MDI/NN regimen/NN revealed/VBD that/DT RA/NN mediated/JJ an/DT elevated/VBN ,/, prolonged/JJ expression/NN of/IN c-Jun/NEWGENE mRNA/NEWGENE accompanied/VBN by/IN diminished/JJ expression/NN of/IN c-Fos/NEWGENE and/CC Jun-B/NEWGENE mRNAs/NEWGENE ./.
@@19072653282 Consistent/JJ with/IN the/DT in/NN vivo/NN result/NN ,/, the/DT pseudorevertant/NN endonucleases/NEWGENE in/IN the/DT crude/JJ cell/NN extract/NN display/NN site-specific/JJ partial/JJ DNA/NN cleavage/NN activity/NN ./.
@@77547136218 Six/CD of/IN them/PRP ,/, NUC1/NEWGENE ,/, PRP21/NEWGENE (/( also/RB called/VBN SPP91/NEWGENE )/SYM ,/, CDC6/NEWGENE ,/, CRY2/NEWGENE ,/, the/DT gene/NN encoding/VBG the/DT ribosomal/NEWGENE protein/NEWGENE S24/NEWGENE and/CC the/DT gene/NN coding/JJ for/IN a/DT hypothetical/JJ protein/NN of/IN 599/CD amino/JJ acids/NNS ,/, have/VB been/VBN sequenced/VBN previously/RB ./.
@@109586989400 The/DT spacing/NN of/IN the/DT essential/JJ N-terminal/NN domain/NN (/( END/NN )/SYM relative/JJ to/IN the/DT HFD/WDT can/MD be/VB changed/VBN significantly/RB without/IN an/DT apparent/JJ effect/NN on/IN Cse4p/NEWGENE function/NN ./.
@@97106153998 Vam7p/NEWGENE ,/, a/DT SNAP-25-like/NEWGENE molecule/NEWGENE ,/, and/CC Vam3p/NEWGENE ,/, a/DT syntaxin/NEWGENE homolog/NEWGENE ,/, function/NN together/RB in/IN yeast/NN vacuolar/JJ protein/NN trafficking/NN ./.
@@76513986477 A/DT potential/JJ binding/JJ site/NN for/IN the/DT dShc/NEWGENE PTB/NEWGENE1 domain/NEWGENE1 is/VBZ located/VBN at/IN Tyr-1228/NN of/IN DER/NEWGENE ./.
@@93716226425 Chimeras/NNS containing/NN IE1/NEWGENE peptides/NEWGENE dramatically/RB activated/VBN transcription/NN of/IN the/DT basal/JJ promoter/NN only/RB when/CC lac/NEWGENE operator/NEWGENE sequences/NEWGENE were/VBD present/VB ./.
@@104600154478 After/IN 10/CD months/NNS of/IN treatment/NN with/IN the/DT conjugated/NN estrogen/NN ,/, both/DT his/PRP height/NN and/CC weight/NN showed/VBD improvement/NN ,/, while/CC his/PRP bone/NN mineral/JJ density/NN and/CC bone/NN age/NN were/VBD increased/VBN ./.
@@26845854305 Agranulocytosis/NNP treatment/NN with/IN rhGM-CSF/NEWGENE ./.
@@97652716644 This/DT sequence/NN is/VBZ very/RB similar/JJ to/IN the/DT insulin/NEWGENE response/NEWGENE sequence/NEWGENE found/VB in/IN the/DT regulatory/JJ region/NN of/IN other/DT genes/NNS negatively/RB regulated/VBN by/IN insulin/NEWGENE such/JJ as/IN those/DT encoding/VBG phosphoenolpyruvate/NEWGENE carboxykinase/NEWGENE ,/, tyrosine/NEWGENE aminotransferase/NEWGENE ,/, and/CC insulin-like/NEWGENE growth/NEWGENE factor-binding/NEWGENE protein/NEWGENE 1/NEWGENE ./.
@@88976638857 Beyond/IN the/DT Tower/NNP of/IN Babel/NNP :/: a/DT nomenclature/NN for/IN suicidology/NN ./.
@@26200853295 Animal/NN experimental/JJ and/CC clinical/JJ applications/NNS of/IN plates/NNS ,/, screws/NNS and/CC spinal/JJ segmental/JJ replacement/NN implants/NNS made/VBP of/IN this/DT composite/JJ material/NN have/NN shown/VBP good/JJ results/NNS so/RB far/RB ./.
@@9267542367 Naltrexone/NN has/VBZ been/VBN recently/RB approved/VBN by/IN the/DT Food/NNP and/CC Drug/NNP Administration/NNP for/IN the/DT treatment/NN of/IN alcohol/NN dependence/NN ./.
@@31150873837 The/DT mean/JJ weight/NN and/CC height/NN velocities/NNS were/VBD 148%/CD and/CC 122%/CD of/IN the/DT standard/NN ,/, respectively/RB ./.
@@838463540 Albumin/NEWGENE and/CC cyclic/JJ AMP/NN levels/NNS in/IN peritoneal/JJ fluids/NNS in/IN the/DT child/NN ./.
@@74994216676 In/NN the/DT present/NN study/NN ,/, we/PRP transiently/RB expressed/VBD in/IN primary/JJ cultures/NNS of/IN rat/NN hepatocytes/NNS plasmids/NNS consisting/VBG of/IN CYP3A1/NEWGENE 5'-flanking/NEWGENE sequences/NEWGENE fused/VBN to/IN a/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE reporter/NEWGENE plasmid/NN ./.
@@24731565381 A/DT cDNA/NN encoding/VBG a/DT new/JJ human/JJ lymphocyte/NN cell/NN surface/NN molecule/NN has/VBZ been/VBN isolated/VBN and/CC shown/VBP to/IN identify/VB a/DT fourth/NN member/NN of/IN a/DT recently/RB discovered/VBN family/NN of/IN adhesion/NN proteins/NNS ./.
@@112876238717 Here/RB we/PRP demonstrate/VBP that/IN the/DT Ras-activated/JJ Raf-MEK-extracellular/NEWGENE signal-regulated/NEWGENE kinase/NEWGENE (/( ERK/NEWGENE )/SYM signaling/JJ pathway/NN can/MD specifically/RB control/VB the/DT expression/NN of/IN individual/JJ integrin/NEWGENE subunits/NEWGENE in/IN a/DT variety/NN of/IN human/NN and/CC mouse/NN cell/NN lines/NNS ./.
@@96196311972 RESULTS/NNS :/: We/PRP isolated/VBD a/DT C/NNP ./NNP elegans/NNS cDNA/NN that/IN encoded/VBN a/DT protein/NN which/WDT was/VBD similar/JJ to/IN ,/, but/CC not/RB exactly/RB homologous/JJ with/IN mammalian/JJ p120/NEWGENE Ras-GAP/NEWGENE ./.
@@21232937203 Petko/NNP ,/, and/CC S/NNP ./NNP
@@37954884478 Among/IN 82/CD superficial/JJ lesions/NNS 34/CD were/VBD classified/VBN as/IN showing/VBG CR/NN and/CC another/DT 23/CD as/IN showing/VBG PR/NNP ,/, with/IN a/DT response/NN rate/NN of/IN 69/CD ./CD 5%/CD ./.
@@91694206786 The/DT mammalian/NEWGENE phosphoinositide/NEWGENE 3-kinases/NEWGENE (/( PI3Ks/NEWGENE )/SYM p110alpha/NEWGENE ,/NEWGENE beta/NEWGENE ,/NEWGENE and/NEWGENE delta/NEWGENE form/NN heterodimers/NNS with/IN Src/NEWGENE homology/NEWGENE 2/NEWGENE (/NEWGENE SH2/NEWGENE )/NEWGENE domain-containing/NEWGENE adaptors/NEWGENE such/JJ as/IN p85alpha/NEWGENE or/CC p55/NEWGENE (/NEWGENE PIK/NEWGENE )/NEWGENE ./.
@@28954729384 Transformed/JJ bacterial/JJ colonies/NNS were/VBD screened/VBN for/IN recombinant/JJ plasmids/NNS containing/NN cDNA/NN coding/JJ for/IN BiP/NEWGENE by/IN hybrid-selected/JJ mRNA/NN translation/NN ./.
@@40710632048 Although/IN no/DT differences/NNS were/VBD noted/VBN in/IN the/DT decrease/NN in/IN platelet/NN counts/NNS between/IN the/DT two/JJ groups/NNS ,/, fibrinogen/NEWGENE levels/NNS and/CC alpha/NEWGENE 2-antiplasmin/NEWGENE levels/NNS declined/VBN less/PRP drastically/RB in/IN the/DT antithrombin-treated/JJ group/NN ./.
@@79353836907 Using/VBG an/DT RNase/NN H-mediated/JJ mapping/NN technique/NN ,/, we/PRP show/VBP that/IN the/DT 64-kDa/NN subunit/NN of/IN CstF/NEWGENE can/MD be/VB photo/NN cross-linked/VBN to/IN pre-mRNAs/NNS at/IN U-rich/NNP regions/NNS located/VBN downstream/RB of/IN the/DT cleavage/NN site/NN of/IN the/DT simian/JJ virus/NN 40/CD late/JJ and/CC adenovirus/NN L3/NN pre-mRNAs/NN ./.
@@71819856663 Either/CC 20/CD mg/NN mitomycin/NN //NN 20/NN ml/NN distilled/JJ water/NN or/CC 40/CD mg/CD //CD 40/CD ml/NN distilled/JJ water/NN was/VBD locally/RB instilled/VBN into/IN the/DT bladder/NN with/IN a/DT catheter/NN after/IN emptying/NN it/PRP and/CC was/VBD left/NN for/IN about/RB 25-l20/JJ min/NN ./.
@@76047947504 Total/JJ cholesterol/NN was/VBD also/RB reduced/VBN at/IN week/NN 12/CD by/IN 17/CD ./CD 0%/CD (/( 20/CD mg/NN //NN day/NN )/SYM and/CC 15/CD ./CD 7%/CD (/( 20-30/CD mg/NN //NN day/NN )/SYM ,/, and/CC at/IN week/NN 52/CD by/IN 20/CD ./CD 4%/CD (/( </SYM or/CC =/SYM 20/CD mg/NN //NN day/NN )/SYM and/CC 19/CD ./CD 2%/CD (/( >/SYM or/CC =/SYM 30/CD mg/NN //NN day/NN )/SYM ./.
@@1873999720 Saccharomyces/NN cerevisiae/NN has/VBZ been/VBN used/VBN widely/RB both/DT as/IN a/DT model/NN system/NN for/IN unraveling/VBG the/DT biochemical/NN ,/, genetic/JJ ,/, and/CC molecular/JJ details/NNS of/IN gene/NN expression/NN and/CC the/DT secretion/NN process/NN ,/, and/CC as/IN a/DT host/NN for/IN the/DT production/NN of/IN heterologous/JJ proteins/NNS of/IN biotechnological/JJ interest/NN ./.
@@22295412871 Giant/NNP pilomatrix/NN carcinoma/NN :/: report/VB and/CC review/NN of/IN the/DT literature/NN ./.
@@89774013498 The/DT RI/NEWGENE alpha/NEWGENE gene/NEWGENE is/VBZ composed/VBN of/IN nine/JJ coding/JJ exons/NNS of/IN varying/JJ lengths/NNS ,/, separated/VBN by/IN introns/NNS ,/, giving/JJ the/DT gene/NN a/DT total/JJ length/NN of/IN at/IN least/RB 21/CD kb/CD ./CD our/PRP recent/JJ cloning/NN of/IN a/DT processed/VBN RI/NEWGENE alpha/NEWGENE pseudogene/NEWGENE with/IN a/DT 5'-noncoding/JJ region/NN different/JJ from/IN the/DT previously/RB reported/VBN RI/NEWGENE alpha/NEWGENE complementary/NEWGENE RNA/NEWGENE indicated/VBN that/IN the/DT RI/NEWGENE alpha/NEWGENE gene/NEWGENE may/MD have/VB multiple/JJ leader/NN exons/NNS giving/JJ rise/NN to/IN alternately/RB spliced/VBN messenger/NN RNAs/NNS (/( mRNAs/NNS )/SYM ./.
@@97817615910 1/CD in/IN Ho/NN Chi/NN Minh/NNP City/NNP was/VBD studied/VBN by/IN culture/NN and/CC latex/NN agglutination/NN of/IN blood/NN ,/, cerebrospinal/JJ fluid/NN ,/, urine/NN and/CC pleural/JJ fluid/NN ./.
@@111253631225 Patients/NNS underwent/VBD pretreatment/JJ cystoscopy/NN and/CC detailed/JJ tumor/NN mapping/NN ,/, and/CC were/VBD treated/VBN with/IN 75/NN mg/NN ./NN //CD m/CD ./CD 2/CD cisplatin/NN on/IN day/NN 1/CD and/CC 1/CD gm/CD ./CD //CD m/CD ./CD 2/CD daily/JJ ,/, 5-fluorouracil/NN on/IN days/NNS 1/CD to/IN 4/CD and/CC definitive/JJ radiotherapy/NN ./.
@@84157126902 Genomic/NNP Southern/NNP blot/NN analysis/NN and/CC chromosome/NN mapping/NN showed/VBN that/IN GPRK6/NEWGENE hybridizes/VBZ to/IN two/JJ closely/RB related/VBN genes/NNS located/VBN on/IN chromosomes/NNS 5/CD and/CC 13/CD and/CC are/VBP ,/, therefore/RB ,/, distinct/JJ from/IN the/DT GPRK/NEWGENE located/VBN near/IN the/DT Huntington/NEWGENE disease/NEWGENE locus/NEWGENE on/IN chromosome/NN 4/CD ./CD
@@90946712938 Candidate/NNS tumor/NN suppressor/NN genes/NNS ,/, Mts1/NEWGENE (/( p16INK4a/NEWGENE )/SYM and/CC Mts2/NEWGENE (/( p15INK4b/NEWGENE )/SYM ,/, have/VB been/VBN mapped/VBN to/IN this/DT region/NN ,/, but/CC by/IN Southern/NNP blot/NN analysis/NN ,/, no/DT homozygous/JJ deletions/NNS were/VBD detected/VBN in/IN either/DT gene/NN ./.
@@118994891809 The/DT effects/NNS of/IN pharmacological/JJ treatment/NN and/CC professional/JJ care/NN and/CC support/NN may/MD improve/VB when/CC dementia/NN is/VBZ detected/VBN in/IN an/DT early/JJ stage/NN ./.
@@68106942357 Apo/NEWGENE A-I/NEWGENE level/NN was/VBD unrelated/JJ to/IN age/NN ,/, but/CC increased/VBD with/IN ethanol/NN consumption/NN and/CC decreased/VBN with/IN adiposity/NN ./.
@@92008115464 The/DT linear/JJ plasmid/NN pDHL1/NN from/IN Debaryomyces/JJ hansenii/NN encodes/VBZ a/DT protein/NN highly/RB homologous/JJ to/IN the/DT pGKL1-plasmid/NEWGENE DNA/NEWGENE polymerase/NEWGENE ./.
@@87709208753 Paradoxically/RB ,/, coexpression/NN of/IN the/DT transcriptionally/RB inactive/JJ ,/, amino-terminally/NN deleted/NN IDX-1/NEWGENE mutant/NEWGENE proteins/NEWGENE ,/, either/DT with/IN the/DT wild-type/NEWGENE IDX-1/NEWGENE or/CC with/IN themselves/PRP ,/, results/VBZ in/IN a/DT marked/JJ enhancement/NN of/IN transactivation/NN of/IN the/DT transcriptional/NN TAAT-1/NEWGENE element/NEWGENE reporter/NEWGENE ./.
@@1692135534 However/RB ,/, the/DT rtFc/NEWGENE gamma/NEWGENE R/NEWGENE alpha/NEWGENE cDNA/NEWGENE clone/NN is/VBZ complementary/JJ to/IN at/IN least/RB two/JJ different-sized/JJ mRNAs/NNS expressed/VBN by/IN CRNK-16/NNP cells/NNS ,/, contrasting/JJ the/DT single/NN Fc/NEWGENE gamma/NEWGENE R-related/NEWGENE mRNA/NEWGENE species/NN expressed/VBN by/IN human/NN and/CC mouse/NN natural/JJ killer/NN cells/NNS ./.
@@95292169484 Flap/NN survival/NN depends/VBZ on/IN the/DT development/NN of/IN a/DT small/JJ number/NN of/IN vascular/JJ connections/NNS between/IN vessels/NNS arising/VBG from/IN the/DT pedicle/NN and/CC preexisting/JJ dermal/JJ vessels/NNS ./.
@@27052964408 The/DT predicted/VBN molecular/JJ weight/NN of/IN the/DT polyprotein/NN encoded/VBN by/IN ORF1/NN is/VBZ 33/CD kilodaltons/NNS (/( kDa/NN )/SYM ./.
@@69193476697 After/IN a/DT year/NN of/IN planning/NN in/IN the/DT Laboratory/NNP Assistants'/NNP School/NNP in/IN Stockholm/NN :/: new/JJ education/NN for/IN laboratory/NN assistants/NNS is/VBZ now/RB arranged/VBN ./.
@@103640766656 These/DT regions/NNS contain/VBP inverted/JJ E-box/NNS palindromic/JJ or/CC direct/JJ repeat/NN motifs/NNS and/CC bind/VB SREBP-1/NEWGENE with/IN different/JJ affinities/NNS ./.
@@33718064301 Electronic/NNP data/NN processing/VBG (/( EDP/NN )/SYM latex/NN immunoassay/NN using/VBG anti-human/NEWGENE seminal/NEWGENE acid/NEWGENE phosphatase/NEWGENE (/( anti-HSAP/NEWGENE )/SYM immune/JJ serum/NN was/VBD applied/VBN for/IN the/DT species/NN and/CC organ/NN identification/NN of/IN human/JJ seminal/JJ stains/NNS ./.
@@27316113420 The/DT author/NN provides/VBZ a/DT rationale/NN for/IN an/DT interactional/JJ view/NN and/CC presents/VBP a/DT case/NN in/IN which/WDT post-surgical/JJ hiccups/NNS were/VBD successfully/RB treated/VBN ,/, using/VBG principles/NNS developed/VBN by/IN the/DT Mental/NNP Research/NNP Institute/NNP ./.
@@78570866588 Near/IN a/DT third/RB (/( 31/CD ./CD 6%/CD )/SYM of/IN Insulin/NEWGENE Dependent/NNP and/CC a/DT third/RB (/( 33/CD ./CD 41%/CD )/SYM for/IN Non/NN Insulin/NEWGENE Dependent/NNP were/VBD of/IN D/NN ,/, F/NN ,/, H/NNP White's/NNP Class/NNP ./.
@@82991818275 Subretinal/JJ fluid/NN was/VBD punctured/VBN on/IN the/DT poorer/JJR eye/NN in/IN 19/CD eyes/NNS (/( 52/CD ./CD 7%/CD )/SYM and/CC on/IN the/DT better/JJR eye/NN in/IN 7/CD eyes/NNS (/( 19/CD ./CD 4%/CD )/SYM ./.
@@39523877525 In/NN each/DT compartment/NN O2/NN is/VBZ removed/VBN by/IN the/DT tissues/NNS as/IN a/DT chemical/JJ reaction/NN takes/VBP place/NN between/IN O2/NN and/CC oxyhemoglobin/NEWGENE (/( HbO2/NEWGENE )/SYM ./.
@@75962835211 Additionally/RB ,/, the/DT enzyme/NN shows/VBZ activity/NN towards/IN triglycerides/NNS such/JJ as/IN olive/JJ oil/NN and/CC tributyrin/NN and/CC towards/IN egg-yolk/NN emulsions/NNS ./.
@@71379276945 In/NN the/DT past/NN ,/, immunology/NN in/IN Singapore/NN was/VBD mainly/RB confined/VBN to/IN serology/NN for/IN the/DT diagnosis/NN of/IN certain/JJ infectious/JJ diseases/NNS ./.
@@46531445078 General/NNP formulae/NNS for/IN estimating/VBG heritability/NN in/IN a/DT population/NN with/IN related/VBN parents/NNS ./.
@@74746172017 Patients/NNS with/IN psychotropic/JJ drugs/NNS showed/VBD significantly/RB higher/JJ PRL/NEWGENE levels/NNS ./.
@@10374632246 The/DT potency/NN of/IN the/DT effect/NN of/IN Nim/NNP (/( 0/CD ./CD 5/CD mg/CD ./CD kg-1/CD i/CD ./CD p/CD ./CD )/SYM was/VBD similar/JJ to/IN that/DT of/IN NBP/NN (/( 10/NN mg/NN ./NN kg-1/NN i/NN ./NN p/NN ./NN )/SYM ./.
@@112358178457 The/DT histamine/NEWGENE H1/NEWGENE receptor/NEWGENE antagonists/NNS (/( antihistamines/NNS )/SYM are/VBP an/DT important/JJ class/NN of/IN medications/NNS used/VBN for/IN the/DT relief/NN of/IN common/JJ symptoms/NNS associated/VBN with/IN hyperhistaminic/JJ conditions/NNS occurring/VBG in/IN children/NNS and/CC adults/NNS ./.
@@61588442498 Thalamotomy/NNP aiming/VBG at/IN the/DT CM-Pf/NN complex/NN and/CC using/VBG stereotactic/JJ gamma/JJ irradiation/NN has/VBZ been/VBN performed/VBN in/IN a/DT series/NN of/IN 52/CD patients/NNS with/IN severe/JJ pain/NN due/NN to/IN malignancy/NN ./.
@@98202055043 The/DT zona/NN pellucida/NN (/( ZP/NN )/SYM ,/, the/DT extracellular/JJ glycocalyx/NN that/WDT surrounds/VBZ the/DT oocyte/NN ,/, is/VBZ well/VB known/VBP to/IN mediate/VB homologous/JJ gamete/NN interaction/NN ./.
@@90969583046 We/PRP have/VBP characterized/VBN a/DT panel/NN of/IN 6/CD monoclonal/JJ antibodies/NNS raised/VBN against/IN human/NEWGENE platelet/NEWGENE talin/NEWGENE by/IN Western/JJ blotting/NN ,/, immune/JJ precipitation/NN ,/, and/CC immunofluorescence/NN ,/, and/CC shown/VBP that/IN antibodies/NEWGENE TA205/NEWGENE and/CC TD77/NEWGENE disrupt/VB actin/NEWGENE stress/NN fibers/NNS and/CC focal/JJ adhesions/NNS ,/, and/CC inhibit/VB cell/NN motility/NN when/CC microinjected/VBN into/IN human/JJ fibroblasts/NNS ./.
@@107470533826 The/DT cell/NN cycle/NN and/CC transcriptional/JJ defects/NNS caused/VBN by/IN taf17/NEWGENE (/NEWGENE slm7-1/NEWGENE )/NEWGENE are/VBP consistent/JJ with/IN the/DT role/NN of/RB TAF/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE s/NEWGENE as/IN modulators/NNS of/IN transcriptional/JJ activation/NN and/CC may/MD reflect/VB a/DT role/NN for/IN TAF17/NEWGENE in/IN regulating/JJ activation/NN by/IN SBF/NEWGENE and/CC MBF/NEWGENE ./.
@@104007574282 These/DT data/NN will/MD help/NN us/PRP to/IN better/JJR detail/NN the/DT CXCR4/NEWGENE structural/JJ requirements/NNS exhibited/VBN by/IN different/JJ HIV-1/NNP strains/NNS and/CC will/MD direct/VB further/JJ mutagenesis/NN efforts/NNS aimed/VBN at/IN better/JJR defining/VBG the/DT domains/NNS in/IN CXCR4/NEWGENE involved/VBN in/IN the/DT HIV-1/NN Env-mediated/NN fusion/NN process/NN ./.
@@82269563170 There/EX was/VBD no/DT apparent/JJ effect/NN of/IN growth/NN temperature/NN on/IN the/DT steady-state/JJ levels/NNS of/IN fad7/NEWGENE mRNA/NEWGENE in/IN wild/JJ type/NN plants/NNS ./.
@@114633592802 Here/RB ,/, we/PRP show/VBP that/IN the/DT phorbol/NN ester/NN PMA/NN decreases/VBZ both/DT basal/JJ and/CC dexamethasone/JJ //JJ cAMP-induced/JJ expression/NN of/IN a/DT luciferase/NEWGENE gene/NEWGENE under/IN the/DT control/NN of/IN the/DT G6Pase/NEWGENE promoter/NEWGENE in/IN transiently/RB transfected/VBN H4IIE/NNP hepatoma/NN cells/NNS ./.
@@107912513697 They/PRP are/VBP present/VB in/IN many/JJ kinds/NNS of/IN living/VBG things/NNS ,/, but/CC their/PRP functions/NNS ,/, especially/RB those/DT in/NN humans/NNS ,/, are/VBP unclear/JJ ./.
@@75924399631 A511/NN is/VBZ a/DT broad-host-range/NN ,/, virulent/JJ myovirus/NN for/IN Listeria/NN monocytogenes/NNS ./.
@@21512297078 Regional/NNP cerebral/JJ blood/NN flow/NN was/VBD measured/VBN using/VBG N-isopropyl-123I-iodoamphetamine/NNP with/IN single-photon/VB emission/NN computed/JJ tomography/NN (/( CT/NN )/SYM in/IN 16/CD aged/VBN patients/NNS with/IN noninsulin-dependent/JJ diabetes/NN mellitus/MD (/( NIDDM/NN ,/, average/JJ age/NN 72/CD ./CD 8/CD years/NNS ,/, average/JJ fasting/JJ plasma/NN glucose/NN 7/NN ./NN 7/NN mmol/NN //NN L/NN )/SYM ,/, and/CC 12/CD nondiabetic/JJ subjects/NNS (/( 71/CD ./CD 6/CD years/NNS ,/, 5/CD ./CD 3/CD mmol/NN //NN L/NN )/SYM ./.
@@105682755722 The/DT role/NN of/IN transport/NN by/IN sea/NN ice/NN from/IN the/DT Kara/NNP Sea/NNP into/IN the/DT Arctic/NNP Ocean/NNP was/VBD assessed/VBN by/IN a/DT small/NN subgroup/NN at/IN GEOMAR/NN ./.
@@113890851072 Inhibition/NNS of/IN constitutive/JJ NF-kappaB/NEWGENE activity/NN results/NNS in/IN cell/NN death/NN of/IN TT/NN cells/NNS and/CC blocks/NNS focus/NN formation/NN induced/VBN by/IN oncogenic/JJ forms/NNS of/IN RET/NEWGENE in/NN NIH/NN 3T3/CD cells/NNS ./.
@@93580692028 Codon/VBP optimization/NN for/IN high-level/JJ expression/NN of/IN human/NEWGENE erythropoietin/NEWGENE (/( EPO/NEWGENE )/SYM in/IN mammalian/JJ cells/NNS ./.
@@98191103665 CD4/NEWGENE lymphocyte/NN and/CC viral/JJ load/NN levels/NNS suggested/VBD an/DT optimal/JJ response/NN to/IN ARV/NN therapy/NN at/IN the/DT time/NN LD/JJ developed/VBN ./.
@@55726625605 Central/NNP venous/JJ catheter/NN used/VBN for/IN recording/JJ intracardiac/JJ electrocardiogram/NN ./.
@@86630002011 The/DT receptor/NEWGENE for/NEWGENE hyaluronan/NEWGENE mediated/NEWGENE motility/NEWGENE (/NEWGENE1 RHAMM/NEWGENE1 )/NEWGENE1 gene/NEWGENE1 expression/NN is/VBZ markedly/RB elevated/VBN in/IN fibrosarcomas/NNS exposed/VBN to/IN transforming/NEWGENE growth/NEWGENE factor-beta1/NEWGENE (/( TGF-beta1/NEWGENE )/SYM ./.
@@80898877205 SECONDARY/NN OUTCOME/NNP MEASURE--Double-blind/NN caffeine-withdrawal/JJ evaluation/NN ./.
@@80078353066 A/DT causal/JJ analysis/NN of/IN secondary/JJ variables/NNS showed/VBN that/IN the/DT formation/NN of/IN FB/NN memories/NNS was/VBD primarily/RB associated/VBN with/IN the/DT level/NN of/IN importance/NN attached/VBN to/IN the/DT event/NN and/CC level/NN of/IN affective/JJ response/NN to/IN the/DT news/NN ./.
@@48715895216 Plastic/JJ solution/NN of/IN elbow/NN joint/JJ ankylosis/NN with/IN a/DT decorticated/JJ cylindrical/JJ flap/NN ./.
@@85266204917 This/DT study/NN underlines/VBP the/DT importance/NN of/IN terminal/NN SC5b-9/NEWGENE complement/NEWGENE complex/NEWGENE as/IN a/DT suitable/JJ marker/NN in/IN the/DT evaluation/NN of/IN complement/NN activation/NN during/IN cardiopulmonary/JJ bypass/NN ./.
@@102155942883 Glucagon/IN also/RB induced/VBN LUC/NEWGENE activity/NN very/RB strongly/RB when/CC the/DT CRE1/NEWGENE and/CC CRE2/NEWGENE sites/NEWGENE were/VBD combined/JJ ;/: induction/NN of/IN the/DT (/NEWGENE CRE1/NEWGENE )/NEWGENE 3/NEWGENE (/NEWGENE CRE2/NEWGENE )/NEWGENE 2SV40-LUC/NEWGENE constructs/NEWGENE was/VBD positively/RB modulated/VBN by/IN the/DT pO2/NN ./.
@@53094715465 Problems/NNS in/IN the/DT determination/NN of/IN the/DT antigenic/JJ content/NN of/IN influenza/NN vaccines/NNS ./.
@@97944145447 The/DT role/NN of/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE signaling/JJ in/IN activated/VBN DRA/NEWGENE transcription/NN ./.
@@38660858048 It/PRP is/VBZ concluded/VBN that/IN the/DT unique/JJ suppository/NN formulation/NN of/IN CZX-S/NN is/VBZ useful/JJ in/IN the/DT treatment/NN of/IN infections/NNS in/IN children/NNS with/IN heavy/JJ psychophysiologic/JJ disorders/NNS and/CC in/IN children/NNS who/WP cannot/MD take/VB oral/JJ drugs/NNS because/IN of/IN severe/JJ vomiting/NN ./.
@@94639919420 Training/NNP for/IN audit/NN ./.
@@92524068459 Tyrosine/NN 1356/CD forms/VBZ a/DT multisubstrate/NN binding/NN site/NN for/IN the/DT Grb2/NEWGENE and/CC Shc/NEWGENE adaptor/NEWGENE proteins/NEWGENE ,/, the/DT p85/NEWGENE subunit/NEWGENE of/IN phosphatidylinositol/NEWGENE 3'-kinase/NEWGENE ,/, phospholipase/NEWGENE Cgamma/NEWGENE ,/, and/CC a/DT phosphatase/NEWGENE ,/, SHP2/NEWGENE ./.
@@10330146745 In/NN the/DT case/NN of/IN the/DT unspliceable/JJ intron/NN ,/, repression/NN of/IN luciferase/NEWGENE expression/NN likely/RB involved/VBD two/JJ AUF1-binding/NEWGENE sequences/NEWGENE ,/, since/IN luciferase/NEWGENE expression/NN was/VBD increased/VBN by/IN deletion/NN of/IN these/DT sites/NNS ./.
@@95922087843 Amongst/IN other/DT qualities/NNS ,/, the/DT book's/NNS importance/NN lies/NNS in/IN the/DT fact/NN that/IN it/PRP associates/VBP an/DT elaborate/JJ theoretical/JJ construction/NN with/IN the/DT empirical/JJ data/NN ,/, working/JJ within/IN the/DT possibilities/NNS provided/VBN by/IN late/JJ 19th-century/NN moral/JJ statistics/NN ./.
@@27171333407 A/DT method/NN for/IN determining/JJ optimal/JJ development/NN conditions/NNS by/IN summary/NN oxygen/NN consumption/NN ./.
@@95868321798 The/DT lines/NNS also/RB differed/VBN in/IN postsynaptic/JJ ,/, but/CC not/RB presynaptic/JJ ,/, 5-HT1A/NEWGENE receptors/NEWGENE ./.
@@76072139982 This/DT apparently/RB anomalous/JJ structure/NN //NN activity/NN relationship/NN raises/VBP important/JJ issues/NNS for/IN understanding/VBG the/DT evolution/NN of/IN regulatory/JJ peptides/NNS and/CC the/DT mechanisms/NNS that/WDT control/VBP their/PRP expression/NN ./.
@@34493584156 Ultrastructural/JJ study/NN of/IN polyarteritis/NN ./.
@@52532745435 Osteosarcoma/NNS caused/VBN by/IN 3/NN ,/NN 4-benzopyrene/NN ./.
@@14938641439 Dopamine/IN neurons/NNS in/IN subjects/NNS that/WDT received/VBD 6-OHDA/NN were/VBD protected/VBN by/IN pre-treatment/NN with/IN GBR-12909/CD ./.
@@103929034791 E2/NEWGENE point/NN mutants/NNS unable/JJ to/IN inhibit/VB cell/NN growth/NN did/VBD not/RB repress/VB cdc25A/NEWGENE and/CC cdc25B/NEWGENE expression/NN ,/, nor/CC did/VBD the/DT cell/NN cycle/NN inhibitors/NNS hydroxyurea/NN and/CC mimosine/NN ./.
@@110421977731 Lys/NN (/NN 193/NN )/NN and/CC Arg/NN (/NN 194/NN )/NN ,/, located/VBN at/IN the/DT COOH-terminal/NN end/NN of/IN HD/NEWGENE ,/, are/VBP essential/JJ for/IN dimerization/NN ./.
@@8299896203 Regression/NNS line/NN slopes/NNS of/IN IBDQ/NN scores/NNS were/VBD significantly/RB different/JJ in/IN patients/NNS who/WP deteriorated/VBD from/IN those/DT who/WP remained/VBD stable/JJ (/( [/NN b/NN ]/NN </SYM 0/CD ./CD 15/CD ;/: P/NN </SYM 0/CD ./CD 0001/CD )/SYM ./.
@@84744383779 A/DT variety/NN of/IN nuclear/JJ ribonucleoproteins/NNS are/VBP believed/VBN to/IN associate/NN directly/RB with/IN nascent/JJ RNA/NEWGENE polymerase/NEWGENE II/NEWGENE transcripts/NEWGENE and/CC remain/VB associated/VBN during/IN subsequent/JJ nuclear/JJ RNA/NN processing/VBG reactions/NNS ,/, including/JJ pre-mRNA/NN polyadenylation/NN and/CC splicing/JJ as/RB well/VB as/IN nucleocytoplasmic/JJ mRNA/NN transport/NN ./.
@@16889727752 Inducible/NN VT/NN was/VBD suppressed/VBN entirely/RB in/IN one/PRP patient/NN ./.
@@96681194402 Electrophoretic/JJ mobility/NN shift/NN assays/NNS demonstrated/VBD specific/JJ nuclear/JJ protein/NN binding/JJ to/IN -85/JJ //JJ -64/JJ ,/, and/CC single/JJ point/NN mutations/NNS suggested/VBD important/JJ binding/JJ nucleotides/NNS between/IN -79/CD //CD -68/CD with/IN five/CD critical/JJ bases/NNS between/IN -74/JJ //JJ -70/JJ (/( 5'-CTCCT-3'/NEWGENE )/SYM ./.
@@77999396142 The/DT 27-base/JJ element/NN interacts/VBZ with/IN a/DT PDGF-activated/NEWGENE serine/NEWGENE //NEWGENE threonine/NEWGENE phosphoprotein/NEWGENE that/WDT is/VBZ detected/VBN only/RB within/IN the/DT nucleus/NN of/IN PDGF-treated/JJ 3T3/CD cells/NNS ./.
@@79879248045 The/DT inflation/NN hub/NN of/IN the/DT probe/NN is/VBZ recreated/VBN by/IN modifying/JJ a/DT standard/JJ USCI/NNP Tuohy-Borst/NNP Y/NN adaptor/NN and/CC attaching/JJ this/DT to/IN the/DT transected/VBN probe/NN hypotube/NN ./.
@@31042457139 The/DT 8/CD patients/NNS receiving/JJ Ir192/NN implant/NN in/IN addition/NN to/IN external/NN radiation/NN showed/VBD improved/VBN (/( p/NN =/SYM 0/CD ./CD 06/CD )/SYM survival/NN compared/VBN to/IN the/DT 9/CD receiving/JJ external/NN only/RB :/: median/JJ 15/CD months/NNS (/( range/NN 1/CD ./CD 5-34/CD +/SYM months/NNS )/SYM versus/IN 7/CD months/NNS (/( range/NN 2/CD ./CD 5-21/CD months/NNS )/SYM ./.
@@108893993827 The/DT detection/NN success/NN rate/NN was/VBD determined/VBN for/IN different/JJ markers/NNS using/VBG this/DT MEK/NEWGENE ./.
@@110402195170 Binding/NN of/IN NusA/NEWGENE to/IN RNA/NN in/IN the/DT presence/NN of/IN alpha/NN or/CC N/NN involves/VBZ an/DT amino-terminal/NEWGENE S1/NEWGENE homology/NEWGENE region/NEWGENE that/WDT is/VBZ otherwise/RB inactive/JJ in/IN full-length/NEWGENE NusA/NEWGENE ./.
@@70649238833 Diagnosis/NNP of/IN phenylalanine/NEWGENE hydroxylase/NEWGENE deficiency/NN (/( phenylketonuria/NN )/SYM ./.
@@25477783045 The/DT unique/JJ nature/NN and/CC arrangement/NN of/IN the/DT ANT1/NEWGENE transcriptional/NEWGENE control/NEWGENE elements/NEWGENE may/MD account/VB for/IN this/DT differential/JJ expression/NN ./.
@@76542397115 Max/NEWGENE was/VBD constantly/RB transcribed/VBN at/IN a/DT relatively/JJ low/JJ level/NN during/IN cell/NN cycle/NN progression/NN ./.
@@106584457061 METHODS/IN :/: The/DT former/JJ group/NN included/VBD patients/NNS who/WP had/VBP been/VBN treated/VBN with/IN at/IN least/RB four/CD PGE1/NN alpha-ciclodestrina/NN ,/, short-term/JJ treatment/NN cycles/NNS per/IN year/NN while/CC the/DT latter/NN was/VBD a/DT historical/JJ reference/NN group/NN managed/VBN without/IN prostaglandins/NNS ./.
@@76518358121 However/RB ,/, the/DT relative/JJ binding/JJ affinity/NN for/IN the/DT motifs/NNS is/VBZ different/JJ ./.
@@89271698837 In/NN 1993/CD and/CC 1994/CD and/CC infection/NN with/IN body/NN lice/NN was/VBD registered/VBN 41/CD times/NNS in/IN 31/CD patients/NNS at/IN the/DT clinic/NN for/IN homeless/NN of/IN the/DT Community/NNP Health/NNP Service/NNP of/IN Utrecht/NNP ./.
@@98228257566 In/NN this/DT paper/NN ,/, we/PRP show/VBP that/IN ,/, like/JJ BAP2/NEWGENE ,/, the/DT expression/NN of/IN the/DT BAP3/NEWGENE gene/NEWGENE in/IN S/NNP ./NNP cerevisiae/NN is/VBZ induced/VBN by/IN the/DT addition/NN of/IN branched-chain/JJ amino/JJ acids/NNS to/IN the/DT medium/NN ./.
@@37492264417 When/WRB phencyclidine/NN was/VBD administered/VBN alone/RB ,/, overall/JJ response/NN rate/NN decreased/VBN and/CC percent/NN errors/NNS increased/VBN with/IN increasing/JJ doses/NNS ./.
@@74769751947 The/DT number/NN of/IN lactotropes/NNS ,/, somatotropes/NNS ,/, thyrotropes/NNS ,/, and/CC gonadotropes/NNS was/VBD not/RB altered/VBN compared/VBN with/IN controls/NNS ,/, indicating/VBG that/IN in/IN the/DT adult/JJ pituitary/NN ,/, POMC/NEWGENE products/NEWGENE are/VBP not/RB required/VBN to/IN maintain/VB the/DT distribution/NN of/IN cell/NN types/NNS ./.
@@82267778349 A/DT Dictyostelium/DT transformant/NN overexpressing/JJ DdPTPa/NEWGENE does/VBP not/RB develop/VB normally/RB ./.
@@35830014249 Using/VBG the/DT balloon-gas/NNS procedure/NN with/IN a/DT single/JJ gas/NN injection/NN ,/, a/DT bubble/NN was/VBD obtained/VBN that/WDT was/VBD large/JJ enough/RB to/IN tamponade/NN a/DT giant/NN tear/NN without/IN prior/NN drainage/NN of/IN subretinal/JJ fluid/NN or/CC vitrectomy/NN ./.
@@18495098856 Identification/NNP and/CC nucleotide/NN sequence/NN of/IN Rhizobium/NEWGENE meliloti/NEWGENE insertion/NEWGENE sequence/NEWGENE ISRm3/NEWGENE :/: similarity/NN between/IN the/DT putative/JJ transposase/NEWGENE encoded/VBN by/IN ISRm3/NEWGENE and/CC those/DT encoded/VBN by/IN Staphylococcus/NEWGENE aureus/NEWGENE IS256/NEWGENE and/CC Thiobacillus/NEWGENE ferrooxidans/NEWGENE IST2/NEWGENE ./.
@@19096212536 Lengthy/NNP and/CC repeated/JJ hemodialyses/NNS were/VBD required/VBN to/IN lower/JJR lithemia/NN to/IN nontoxic/JJ ranges/NNS ./.
@@18637688639 The/DT protein/NN encoded/VBN by/IN ORF113/NEWGENE contains/VBZ a/DT transmembrane/JJ domain/NN ./.
@@70622696075 When/WRB the/DT l-methadone-sensitive/NN ,/, opioid/NEWGENE receptor/NEWGENE is/VBZ blocked/VBN by/IN naloxone/NN or/CC tolerance/NN has/VBZ developed/VBN ,/, than/IN l-methadone/NN can/MD produce/VB behavioral/JJ effects/NNS by/IN a/DT nonopioid/JJ mechanism/NN ./.
@@92476454459 Two/CD new/JJ temperature-sensitive/JJ alleles/NNS of/IN SEC3/NEWGENE ,/, 1/CD of/IN 10/CD late-acting/NNP SEC/NEWGENE genes/NEWGENE required/VBN for/IN targeting/NN or/CC fusion/NN of/IN post-Golgi/JJ secretory/JJ vesicles/NNS to/IN the/DT plasma/NN membrane/NN in/IN Saccharomyces/NN cerevisiae/NN ,/, were/VBD isolated/VBN in/IN a/DT screen/NN for/IN temperature-sensitive/JJ secretory/JJ mutants/NNS that/WDT are/VBP synthetically/RB lethal/JJ with/IN sec4-8/NEWGENE ./.
@@69027226692 The/DT hyperacute/JJ phase/NN of/IN posterolateral/JJ myocardial/JJ infarction/NN ./.
@@75595108459 Although/IN Micrococcus/NEWGENE luteus/NEWGENE UV/NEWGENE endonuclease/NEWGENE has/VBZ been/VBN reported/VBN to/IN be/VB an/DT 18-kDa/NN enzyme/NN with/IN possible/JJ homology/NN to/IN the/DT 16-kDa/NEWGENE endonuclease/NEWGENE V/NEWGENE from/NEWGENE bacteriophage/NEWGENE T4/NEWGENE (/( Gordon/NNP ,/, L/NNP ./NNP
@@81563328134 Endoscopic/NNP transthoracic/JJ sympathectomy/NN as/IN adjuvant/JJ treatment/NN for/IN critical/JJ upper-limb/JJ ischaemia/NN ./.
@@112783105347 Furthermore/RB ,/, this/DT kinase-deficient/JJ mutant/RB inhibited/VBN 2-MeSADP-induced/NN caspase-3/NEWGENE stimulation/NN and/CC the/DT associated/VBN decrease/NN in/IN cell/NN number/NN ./.
@@87988937410 Furthermore/RB ,/, freezing/NN in/IN the/DT presence/NN of/IN bovine/NEWGENE lactalbumin/NEWGENE resulted/VBN in/IN a/DT good/JJ maintenance/NN of/IN the/DT cellular/JJ viability/NN and/CC of/IN the/DT CCCD/NNP heterogeneity/NN in/IN respect/NN to/IN fresh/JJ cells/NNS ./.
@@20449509292 Using/VBG the/DT polymerase/NEWGENE chain/NN reaction/NN ,/, we/PRP analyzed/VBD the/PDT U6/NEWGENE RNA/NEWGENE genes/NEWGENE of/IN 52/CD organisms/NNS ./.
@@17107682798 Our/PRP results/NNS also/RB indicate/VBP the/DT existence/NN of/IN sequences/NNS downstream/RB of/IN -0/CD ./CD 11/CD kb/NN which/WDT can/MD influence/VB the/DT pattern/NN of/IN tissue-specific/JJ expression/NN of/IN the/PDT HLA-B7/NEWGENE gene/NEWGENE and/CC the/DT ability/NN of/IN this/DT gene/NN to/IN respond/NN to/IN gamma/NEWGENE interferon/NEWGENE ./.
@@109405571303 Additionally/RB ,/, putative/JJ CF1/NEWGENE //NEWGENE USP/NEWGENE and/CC Broad/NEWGENE Complex/NEWGENE Z2/NEWGENE transcription/NN factor/NN elements/NN were/VBD found/VBN in/IN the/DT upstream/JJ regions/NNS of/IN MIH/NEWGENE and/CC MO-IH/NEWGENE genes/NNS respectively/RB ./.
@@107396716602 By/IN electrophoresis/NN mobility/NN shift/NN assays/NNS using/VBG probes/NNS corresponding/JJ to/IN different/JJ segments/NNS of/IN the/DT putative/JJ human/NEWGENE c-myb/NEWGENE intron/NEWGENE 1/NEWGENE transcription/NEWGENE pause/NEWGENE region/NEWGENE and/CC nuclear/JJ extracts/NNS from/IN myeloid/NN leukemia/NN HL/NN 60/NN and/CC fibroblast/NN WI/NN 38/CD cells/NNS ,/, we/PRP detected/VBD a/DT HL-60-specific/NEWGENE DNA-protein/NEWGENE complex/NEWGENE with/IN a/DT 123-bp/JJ fragment/NN containing/NN binding/NN sites/NN for/IN the/DT interferon/NEWGENE regulatory/NEWGENE factors/NEWGENE (/( IRFs/NEWGENE )/SYM nuclear/JJ proteins/NNS ./.
@@21247106240 This/DT model/NN is/VBZ further/RB supported/VBN by/IN binding/NN of/IN the/DT Fos-Jun/NEWGENE complex/NEWGENE at/IN an/DT AP-1/NEWGENE site/NEWGENE in/IN the/DT type/NEWGENE alpha/NEWGENE I/NEWGENE collagen/NEWGENE promoter/NEWGENE that/WDT is/VBZ contiguous/JJ with/IN ,/, but/CC not/RB overlapping/JJ ,/, the/DT VDRE/NEWGENE ./.
@@10833751488 Alpha-1/NEWGENE antitrypsin/NEWGENE and/CC Indian/JJ childhood/NN cirrhosis/NN ./.
@@82304529439 The/DT recombinant/NEWGENE vaccinia/NEWGENE virus-expressed/NEWGENE mutant/NEWGENE P1/NEWGENE polyproteins/NEWGENE were/VBD analyzed/VBN for/IN proteolytic/JJ processing/NN defects/NNS in/IN cells/NNS coinfected/VBN with/IN a/DT recombinant/JJ vaccinia/NN virus/NN (/( VVP3/NN )/SYM that/WDT expresses/VBP the/DT poliovirus/NEWGENE 3CD/NEWGENE protease/NEWGENE and/CC for/IN processing/VBG and/CC assembly/NN defects/NNS by/IN using/VBG a/DT trans/JJ complementation/NN system/NN in/IN which/WDT P1-expressing/JJ recombinant/JJ vaccinia/NN viruses/NNS provide/VBP capsid/NEWGENE precursor/NEWGENE to/IN a/DT defective/JJ poliovirus/NN genome/NN that/WDT does/VBP not/RB express/VB functional/JJ capsid/NEWGENE proteins/NEWGENE (/( D/NN ./NN
@@67132047563 The/DT AD/NN components/NN were/VBD markedly/RB more/RB dependent/JJ on/IN the/DT affective/JJ state/NN of/IN the/DT rat/NN then/RB was/VBD the/DT V1/NN component/NN ./.
@@59397489693 When/WRB the/DT cervical/JJ Pap/NN smear/NN is/VBZ positive/JJ ./.
@@28528943542 Causes/NNP of/IN death/NN found/VB in/IN an/DT epidemiological/JJ study/NN of/IN native/JJ chickens/NNS in/IN Thai/JJ villages/NNS ./.
@@76828421962 To/TO study/VB the/DT origin/NN of/IN different/JJ fMLF-R/NEWGENE transcripts/NEWGENE ,/, the/DT genetic/JJ linkage/NN of/IN chemotactic/NEWGENE receptor/NEWGENE genes/NNS ,/, and/CC the/DT regulation/NN of/IN fMLF-R/NEWGENE gene/NEWGENE expression/NN ,/, we/PRP determined/VBD the/DT copy/NN number/NN ,/, chromosomal/JJ location/NN ,/, structural/JJ organization/NN ,/, and/CC 5'-flanking/JJ sequence/NN of/IN the/DT human/NEWGENE fMLF-R/NEWGENE gene/NEWGENE ./.
@@92523973161 We/PRP had/VBP previously/RB analyzed/VBN repair/NN rates/NNS of/IN cyclobutane/NN pyrimidine/NN dimers/NN at/IN nucleotide/NN resolution/NN along/IN the/DT human/NEWGENE JUN/NEWGENE gene/NEWGENE in/IN normal/JJ fibroblasts/NNS and/CC found/VB very/RB efficient/JJ repair/NN of/IN sequences/NNS near/IN the/DT transcription/NN initiation/NN site/NN but/CC slow/JJ repair/NN along/IN the/DT promoter/NN ./.
@@94642485318 A/DT canonical/JJ TATA/NN box/NN was/VBD not/RB detected/VBN ./.
@@21389922735 This/DT multimodality/NN treatment/NN for/IN locally/RB advanced/JJ gynecologic/JJ tumors/NNS appears/VBZ feasible/JJ with/IN modification/NN ,/, and/CC continued/VBD work/NN exploring/VBG this/DT approach/NN is/VBZ encouraged/VBN ./.
@@107131612318 Inactivation/NNS of/IN Ulp2/NEWGENE also/RB suppresses/VBZ several/DT ulp1/NEWGENE (/NEWGENE ts/NEWGENE )/NEWGENE defects/NNS ,/, and/CC the/DT double/JJ mutant/NN accumulates/VBZ far/RB fewer/DT Smt3-protein/NEWGENE conjugates/NNS than/IN either/DT single/JJ mutant/NN ./.
@@11092809400 In/NN addition/NN ,/, our/PRP results/NNS show/VBP that/IN ERKs/NEWGENE and/CC PI3Ks/NEWGENE can/MD synergise/VB to/IN convert/NN ectoderm/NN into/IN mesoderm/NN ./.
@@90771089764 During/IN the/DT febrile/JJ period/NN ,/, pleocytosis/NN was/VBD associated/VBN with/IN high/JJ levels/NNS of/IN IgG/NEWGENE ,/, IL-6/NEWGENE ,/, TNF-alpha/NEWGENE ,/, and/CC PGE2/NEWGENE in/IN the/DT cerebrospinal/JJ fluid/NN ./.
@@95297219488 Potential/JJ indicators/NNS were/VBD assessed/VBN for/IN the/DT two/JJ classifications/NNS of/IN protein-energy/JJ malnutrition/NN in/IN the/DT guidelines/NNS for/IN integrated/JJ management/NN of/IN childhood/NN illness/NN :/: severe/JJ malnutrition/NN ,/, which/WDT requires/VBZ immediate/JJ referral/NN to/IN hospital/NN ,/, and/CC very/RB low/JJ weight/NN ,/, which/WDT calls/VBZ for/IN feeding/JJ assessment/NN ,/, nutritional/JJ counselling/NN and/CC follow-up/JJ ./.
@@76039567969 The/DT experimental/JJ design/NN represents/VBZ a/DT 2/CD x/NN 3/CD factorial/NN arrangement/NN of/IN treatments/NNS with/IN three/CD dietary/JJ levels/NNS of/IN incorporation/NN of/IN RSB/NN (/( 0/CD ,/, 50/CD ,/, and/CC 100%/CD )/SYM ,/, and/CC chickens/NNS either/DT infected/VBN or/CC uninfected/JJ ./.
@@112785632647 Deletion/NNS analyses/NNS implicate/VBP the/DT N-terminal/NN 110/NN amino/JJ acids/NNS of/IN Grb14/NEWGENE and/CC ankyrin/NEWGENE repeats/NNS 10-19/CD of/IN tankyrase/NEWGENE 2/NEWGENE in/IN mediating/JJ this/DT interaction/NN ./.
@@12817718658 Characterization/NNS of/IN the/DT human/NEWGENE gene/NEWGENE encoding/NEWGENE cytokeratin/NEWGENE 17/NEWGENE and/CC its/PRP expression/NN pattern/NN ./.
@@55677215047 Sensitivities/NNS of/IN thromboplastins/NEWGENE to/IN factor/NEWGENE VII/NEWGENE deficiency/NN ./.
@@87641365668 In/NN an/DT effort/NN to/IN isolate/NN genes/NN with/IN down-regulated/DT expression/NN at/IN the/DT mRNA/NN level/NN during/IN oncogenic/JJ transformation/NN of/IN human/JJ mammary/JJ epithelial/JJ cells/NNS (/( MECs/NNS )/SYM ,/, we/PRP performed/VBD subtractive/JJ hybridization/NN between/IN normal/JJ MEC/NN strain/NN 76N/CD and/CC its/PRP radiation-transformed/JJ tumorigenic/JJ derivative/NN 76R-30/JJ ./.
@@78792043427 OKT3/NEWGENE prophylaxis/NN improves/VBZ long-term/JJ renal/JJ graft/NN survival/NN in/IN high-risk/JJ patients/NNS as/IN compared/VBN to/IN cyclosporine/NN :/: combined/JJ results/NNS from/IN the/DT prospective/NN ,/, randomized/JJ Belgian/NN and/CC US/NN studies/NNS ./.
@@107670917864 Intra-operative/JJ ultrasound/JJ (/( IOUS/NN )/SYM has/VBZ been/VBN widely/RB used/VBN in/IN an/DT attempt/NN to/IN overcome/VB these/DT difficulties/NNS ,/, but/CC is/VBZ limited/VBN by/IN its/PRP two-dimensional/JJ nature/NN ,/, inter-user/JJ variability/NN ,/, and/CC image/NN obliteration/NN with/IN ablative/JJ or/CC resectional/JJ techniques/NNS ./.
@@93964028832 PATIENTS/IN AND/CC METHODS/IN :/: Semen/NNS analyses/NNS were/VBD performed/VBN on/IN 58/CD patients/NNS with/IN stages/NNS I-III/NN HD/NN before/RB ,/, during/IN ,/, and/CC after/IN chemotherapy/NN and/CC after/IN the/DT sperm/NN count/NN recovered/VBN from/IN the/DT effects/NNS of/IN abdominal/JJ radiotherapy/NN that/WDT was/VBD given/VBP after/IN chemotherapy/NN ./.
@@97337942378 We/PRP did/VBD not/RB observe/VB any/DT changes/NNS in/IN Bcl-2/NEWGENE or/CC Bcl-2-related/NEWGENE proteins/NEWGENE (/( Bcl-x/NEWGENE ,/, Bax/NEWGENE ,/, and/CC Bad/NEWGENE )/SYM in/IN control/NN or/CC KCREB-transfected/JJ cells/NNS before/IN or/CC after/IN treatment/NN with/IN Tg/NNP ./NNP
@@943842726 An/DT evolutionary/RB conserved/VBN element/NN is/VBZ essential/JJ for/IN somite/NN and/CC adjacent/JJ mesenchymal/JJ expression/NN of/IN the/DT Hoxa1/NEWGENE gene/NEWGENE ./.
@@18309288612 The/DT minus-end-directed/JJ microtubule/NN motors/NNS ,/, the/DT dyneins/NEWGENE ,/, may/MD also/RB constitute/VB a/DT superfamily/NN of/IN force-generating/JJ proteins/NNS with/IN distinct/JJ attachment/NN domains/NNS ./.
@@27135203393 Chronic/NN dose/NN effects/NNS of/IN methyl/NN parathion/NN on/IN nuthatches/NNS :/: cholinesterase/NEWGENE and/CC ptilochronology/NN ./.
@@94341606855 Several/JJ PTPases/NEWGENE were/VBD expressed/VBN abundantly/RB in/IN the/DT 5-FU-treated/JJ bone/NN marrow/NN stem/NN cells/NNS ./.
@@28634924354 No/DT significant/JJ differences/NNS between/IN the/DT two/JJ treatment/NN groups/NNS were/VBD found/VBN ,/, but/CC rapid/JJ responders/NNS had/VBP a/DT smaller/RBR mean/JJ initial/JJ platelet-associated/NEWGENE IgG/NEWGENE index/NN which/WDT returned/VBD more/RB rapidly/RB and/CC more/RB permanently/RB to/IN normal/JJ than/IN that/DT of/IN slow/JJ responders/NNS ./.
@@920381329 Decreased/JJ cardiac/NN glycogen/NN following/IN phenformin/NN injection/NN in/IN hyperglycemic/JJ ,/, hyperinsulinemic/JJ anaesthetized/JJ rats/NNS ./.
@@102190918047 Accordingly/RB ,/, we/PRP designated/VBD this/DT gene/NEWGENE CTL1/NEWGENE (/( capping/NEWGENE enzyme/NEWGENE RNAtriphosphatase-like/NEWGENE 1/NEWGENE )/SYM ./SYM
@@36327394309 Cyclosporine/DT treatment/NN for/IN intractable/JJ polymyositis/NN ./.
@@78976964734 Erythrocyte/NEWGENE delta-aminolevulinic/NEWGENE acid/NEWGENE dehydratase/NEWGENE (/( ALAD/NEWGENE )/SYM activity/NN ,/, erythrocyte/NN zinc/NN protoporphyrin/NN (/( ZPP/NN )/NN //NN heme/NN ratio/NN ,/, and/CC urinary/NN coproporphyrin/NN (/( UC/NN )/SYM concentration/NN have/NN been/VBN employed/VBN as/IN biological/JJ indicators/NNS of/IN moderate-to/JJ high-level/JJ lead/NN exposure/NN ,/, corresponding/JJ to/IN blood/NN levels/NNS in/IN excess/NN of/IN 50/CD micrograms/NN //NN dl/NN ,/, in/IN human/JJ subjects/NNS ./.
@@16304548182 A/DT 38-bp/JJ poly/NN (/NN dA-dT/NN )/NN region/NN was/VBD found/VBN to/IN be/VB a/DT positive/JJ regulator/NN of/IN Act1/NEWGENE promoter/NEWGENE activity/NN ./.
@@107918192269 This/DT tendency/NN is/VBZ likely/JJ due/NN to/IN the/DT biased/VBN nucleotide/NN composition/NN of/IN the/DT asparagus/NN genome/NN ,/, rather/RB than/IN to/IN the/DT translational/JJ selection/NN for/IN specific/JJ codons/NNS ./.
@@94635609415 PATIENTS/IN AND/CC METHOD/IN :/: Since/IN 1986/CD ,/, 62/CD patients/NNS were/VBD irradiated/JJ stereotactically/RB ./.
@@75122589588 Liver/NN transplantation/NN in/IN one/PRP patient/NN resolved/VBD metabolic/JJ complications/NNS but/CC did/VBD not/RB improve/VB PMN/NN count/NN or/CC the/DT infectious/JJ status/NN ,/, while/CC neutropenia/NN was/VBD corrected/VBN by/IN G-CSF/NEWGENE ./.
@@106536935802 The/DT RING/NN finger/NN ,/, B2/NN box/NN ,/, and/CC coiled-coil/NN region/NN are/VBP required/VBN for/IN oligomerization/NN of/IN KAP-1-RBCC/NEWGENE and/CC KRAB/NEWGENE binding/JJ ,/, as/IN mutations/NNS in/IN these/DT domains/NNS concomitantly/RB abolished/VBN these/DT functions/NNS ./.
@@106062724630 Injection/NNP of/IN double-stranded/JJ RNA/NN into/IN C/NNP ./NNP elegans/NNS results/NNS in/IN embryonic/JJ lethality/NN ;/: thus/RB ,/, the/DT SF1/NEWGENE gene/NEWGENE is/VBZ essential/JJ not/RB only/RB in/IN yeast/NN but/CC also/RB in/IN at/IN least/RB one/PRP metazoan/JJ ./.
@@99187154581 We/PRP suggest/VBP that/DT MotA/NEWGENE and/CC AsiA/NEWGENE may/MD function/VB like/JJ certain/JJ eukaryotic/NEWGENE TAFs/NEWGENE (/( TATA/NEWGENE binding/NEWGENE protein/NEWGENE (/NEWGENE TBP/NEWGENE )/NEWGENE associated/NEWGENE factors/NEWGENE )/NN whose/WP binding/JJ to/IN TBP/NEWGENE results/NNS in/IN transcription/NN from/IN new/JJ core/NN promoter/NN sequences/NNS ./.
@@8154182869 The/DT usefulness/NN of/IN the/DT lambda/NN PG15/NN and/CC the/DT lambda/NN AD5/NN cloning/NN vectors/NNS was/VBD demonstrated/VBN by/IN constructing/JJ large/JJ Neurospora/NN crassa/NN cDNA/NN libraries/NNS ./.
@@47608265137 Manifest/JJ anxiety/NN of/IN Vietnam/NN returnees/NNS and/CC undergraduates/NNS ./.
@@75754389949 This/DT action/NN is/VBZ dependent/JJ on/IN helix-loop-helix/JJ factors/NNS bound/JJ to/IN the/DT E1/NEWGENE element/NEWGENE ./.
@@110126807689 The/DT use/NN of/IN the/DT PLCgamma/NEWGENE inhibitory/NEWGENE peptide/NEWGENE ,/, neomycin/NN and/CC the/DT calcium/NN chelator/NN BAPTA-AM/IN on/IN oocytes/NN expressing/NN FGFR1/NEWGENE or/CC the/DT stimulation/NN by/IN PDGF-BB/NEWGENE of/IN oocytes/NNS expressing/JJ PDGFR-FGFR1/NEWGENE mutated/JJ on/IN the/DT PLCgamma/NEWGENE binding/NEWGENE site/NEWGENE ,/, prevented/VBN GVBD/NNS and/CC ERK2/NEWGENE phosphorylation/NN ./.
@@93214069137 The/DT pheromone/NN response/NN pathway/NN activates/VBZ transcription/NN of/IN Ty5/NEWGENE retrotransposons/NEWGENE located/VBN within/IN silent/JJ chromatin/NN of/IN Saccharomyces/NN cerevisiae/NN ./.
@@16945252832 Isopenicillin/NEWGENE N/NEWGENE isomerase/NEWGENE (/( epimerase/NEWGENE )/SYM has/VBZ been/VBN purified/VBN from/IN Streptomyces/NN clavuligerus/NN ,/, and/CC the/DT amino/JJ acid/NN sequence/NN of/IN the/DT N-terminus/NN has/VBZ been/VBN determined/VBN ./.
@@88164618956 Our/PRP analysis/NN suggests/VBZ that/IN Upf1p/NEWGENE is/VBZ a/DT multifunctional/NN protein/NN with/IN separable/JJ activities/NNS that/WDT can/MD affect/VB mRNA/NN turnover/NN and/CC nonsense/NN suppression/NN ./.
@@109133049204 A/DT 2/CD kb/NN transcript/NN was/VBD isolated/VBN from/IN brain/NN that/IN encodes/VBZ a/DT approximately/RB 57/NN kDa/NN protein/NN ;/: the/DT predicted/VBN protein/NN contains/VBZ the/DT known/VBP N-terminal/NEWGENE Ets/NEWGENE domain/NEWGENE of/IN PE1/NEWGENE and/CC a/DT novel/JJ C-terminal/NN domain/NN with/IN signficant/JJ homology/NN to/IN murine/NEWGENE ERF/NEWGENE ./.
@@95731874384 Transcriptional/JJ repression/NN mediated/JJ by/IN LysR-type/NEWGENE regulator/NEWGENE CatR/NEWGENE bound/JJ at/IN multiple/JJ binding/JJ sites/NNS ./.
@@109828256661 We/PRP show/VBP here/RB that/IN this/DT difference/NN is/VBZ due/NN to/IN the/DT presence/NN of/IN a/DT Mot3/NEWGENE binding/NEWGENE site/NEWGENE in/IN OpA/NEWGENE ./.
@@29144223617 Computer/NNP analysis/NN included/VBD digital/JJ averaging/NN ,/, followed/VBN by/IN digital/JJ filtering/NN in/IN different/JJ frequency/NN bands/NNS in/IN order/NN to/IN determine/VB the/DT frequency/NN range/NN corresponding/JJ to/IN notches/NNS and/CC slurs/NNS ./.
@@82576666791 In/NN the/DT present/NN study/NN ,/, lesions/NNS of/IN the/PDT OPT/NN complex/NN (/( the/DT thalamic/JJ source/NN of/IN afferents/NNS to/IN IHA/NN and/CC HD/NN )/SYM were/VBD found/VBN to/IN have/NN no/DT effect/NN on/IN color-reversal/JJ learning/JJ performance/NN ./.
@@77982075736 The/DT deduced/VBN amino/JJ acid/NN sequences/NNS of/IN each/DT of/IN the/DT W3A1/NEWGENE ETF/NEWGENE subunits/NEWGENE exhibit/VBP only/RB approximately/RB 30%/CD identity/NN with/IN the/DT corresponding/JJ subunits/NNS of/IN the/DT ETF/NEWGENE from/IN human/JJ ,/, rat/NN ,/, and/CC Paracoccus/ORG denitrificans/VBZ ,/, which/WDT as/IN a/DT group/NN are/VBP greater/JJR than/IN 50%/CD identical/JJ ./.
@@110581191117 These/DT results/NNS suggest/VBP that/IN XAB1/NEWGENE is/VBZ a/DT novel/JJ cytoplasmic/NEWGENE GTPase/NEWGENE involved/VBN in/IN nuclear/JJ localization/NN of/IN XPA/NEWGENE ./.
@@69488686723 The/DT scores/NNS are/VBP dependent/JJ in/IN part/NN on/IN the/DT reliability/NN of/IN faculty/NN evaluations/NNS ./.
@@92051139545 Thus/RB E14/NN ./NN 1TG3B1/NN is/VBZ a/DT useful/JJ ES/NNP cell/NN line/NN for/IN modifying/JJ the/DT mouse/NN genome/NN using/VBG the/DT HPRT/NEWGENE gene/NEWGENE as/IN a/DT selection/NN marker/NN and/CC for/IN transmission/NN at/IN a/DT high/JJ frequency/NN into/IN the/DT mouse/NN germ/NN line/NN ./.
@@79165887474 This/DT virus/NN is/VBZ not/RB merely/RB a/DT South/JJ African/JJ strain/NN of/IN passion/NN fruit/NN woodiness/NN virus/NN (/( PWV/NN )/SYM :/: the/DT deduced/VBN CP/NEWGENE sequence/NEWGENE is/VBZ only/RB distantly/RB related/VBN to/IN CPs/NEWGENE of/IN other/DT sequenced/VBN strains/NNS of/IN PWV/NN ,/, although/IN it/PRP is/VBZ part/NN of/IN a/DT distinct/JJ subgroup/NN of/IN potyviruses/NNS related/VBN to/IN PWV/NN ./.
@@103735237594 In/NN serum-free/JJ media/NN ,/, p50E4F/NEWGENE accelerated/JJ E1A-induced/JJ apoptosis/NN ./.
@@19680616200 Sci/NNS ./.
@@72349747065 Morphological/JJ features/NNS of/IN Jat/NN dentition/NN ./.
@@77316869545 The/DT TTG-2/NEWGENE gene/NEWGENE has/VBZ been/VBN identified/VBN at/IN the/DT site/NN of/IN chromosomal/JJ translocations/NNS in/IN acute/JJ T-cell/NN leukemia's/NNS (/( T-ALL/NN )/SYM ./.
@@114273293285 The/DT validity/NN of/IN the/DT FPS-R/NN was/VBD further/RB supported/VBN by/IN strong/JJ positive/JJ correlations/NNS with/IN the/DT VAS/NN (/( r/NN =/NN 0/NN ./NN 92/NN ,/, N/NN =/NN 45/NN )/SYM and/CC the/DT CAS/NN (/( r/NN =/NN 0/NN ./NN 84/NN ,/, N/NN =/NN 45/NN )/SYM in/IN this/DT clinical/JJ sample/NN ./.
@@18336377055 The/DT abundance/NN of/IN transcripts/NNS from/IN several/DT unrelated/NN genes/NN is/VBZ decreased/VBN in/IN cdc68-1/NEWGENE mutant/NEWGENE cells/NNS after/IN transfer/NN to/IN the/DT restrictive/JJ temperature/NN ,/, while/CC at/IN least/RB one/PRP transcript/NN ,/, from/IN the/DT HSP82/NEWGENE gene/NEWGENE ,/, persists/VBZ in/IN an/DT aberrant/JJ fashion/NN ./.
@@86831082464 Collectively/RB ,/, these/DT results/NNS suggest/VBP that/IN components/NNS of/IN the/DT protein/NEWGENE kinase/NEWGENE A/NEWGENE signaling/JJ pathway/NN are/VBP recruited/VBN by/IN mIg/NEWGENE to/IN induce/VB junB/NEWGENE transcription/NN ./.
@@91992923753 Strikingly/RB ,/, stoichiometric/JJ association/NN of/IN p107/NEWGENE or/CC p130/NEWGENE with/IN either/DT cyclin/NEWGENE E-cdk2/NEWGENE or/CC cyclin/NEWGENE A-cdk2/NEWGENE negated/VBN the/DT activities/NNS of/IN these/DT kinases/NEWGENE ./.
@@20230973716 The/DT human/NEWGENE immunodeficiency/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE (/NEWGENE HIV-1/NEWGENE )/NEWGENE Rev/NEWGENE protein/NEWGENE is/VBZ a/DT positive/JJ posttranscriptional/NN regulator/NN of/IN viral/JJ structural/JJ gene/NN expression/NN and/CC essential/JJ for/IN virus/NN replication/NN ./.
@@109157801894 Wnt-1/NEWGENE overexpression/NN in/IN mammary/JJ epithelial/JJ cells/NNS induced/VBD cyclin/NEWGENE D1/NEWGENE mRNA/NEWGENE and/CC targeted/VBN overexpression/NN of/IN Wnt-1/NEWGENE in/IN the/DT mammary/JJ gland/NN of/IN transgenic/JJ mice/NNS increased/VBD both/DT ILK/NEWGENE activity/NN and/CC cyclin/NEWGENE D1/NEWGENE levels/NNS ./.
@@108154105665 The/DT immune/JJ system/NN is/VBZ closely/RB integrated/JJ with/IN the/DT neuroendocrine/JJ system/NN ,/, and/CC infection-induced/JJ increases/NNS in/IN cytokines/NNS such/JJ as/IN IL-1/NEWGENE ,/, IL-6/NEWGENE and/CC TNF/NEWGENE have/NN numerous/JJ effects/NNS on/IN the/DT central/JJ nervous/JJ system/NN ./.
@@79227094102 Biological/JJ activities/NNS of/IN hematopoietic/NEWGENE growth/NEWGENE factors/NEWGENE that/WDT lead/VBP to/IN future/JJ clinical/JJ application/NN ./.
@@28771246819 Mature/NNP and/CC old/JJ B6AF1/NN and/CC B6D2F1/NN mice/NNS were/VBD given/VBP acidified/JJ tap/NN water/NN or/CC promethazine/NN HCl/NN (/( a/DT phenothiazine/NN with/IN H1/NEWGENE receptor/NEWGENE blocking/JJ activity/NN )/SYM ,/, chlorpheniramine/NN (/( an/DT H1/NEWGENE blocker/NN )/SYM or/CC trifluoperazine/NN (/( a/DT phenothiazine/NN with/IN no/DT H1/NEWGENE blocking/JJ activity/NN )/SYM in/IN their/PRP drinking/JJ water/NN ,/, and/CC the/DT effects/NNS of/IN these/DT agents/NNS on/IN bone/NN mineral/JJ content/NN were/VBD assessed/VBN by/IN intermittently/RB measuring/JJ the/DT 24-h/JJ whole/JJ body/NN retention/NN of/IN Tc/NN 99m/NN methylene/NN diphosphonate/NN (/( Tc/NN 99m/NN MDP/NN ,/, an/DT indicator/NN of/IN bone/NN metabolism/NN )/SYM and/CC at/IN the/DT end/NN of/IN the/DT studies/NNS by/IN determining/VBG ash/NN weights/NNS of/IN femur/NN ,/, ilium/NN and/CC sacrum/NN ./.
@@113848801116 The/DT mechanism/NN of/IN the/DT induction/NN of/IN 3beta-HSD/NEWGENE type/NEWGENE 1/NEWGENE gene/NEWGENE expression/NN was/VBD further/RB characterized/VBN in/IN ZR-75-1/NNP human/JJ breast/NN cancer/NN cells/NNS ./.
@@82646508858 Analysis/NNP of/IN strains/NNS harboring/VBG an/DT mds1/NEWGENE null/NEWGENE mutation/NEWGENE demonstrates/VBZ that/IN MDS1/NEWGENE is/VBZ not/RB essential/JJ during/IN normal/JJ vegetative/JJ growth/NN but/CC appears/VBZ to/IN be/VB required/VBN for/IN meiosis/NN ./.
@@25554182963 Insert2/NN contains/VBZ repetitive/JJ non-Ig-related/NN sequences/NN and/CC a/DT small/NN Ig-related/NN sequence/NN ./.
@@90092083497 The/DT primer/NN is/VBZ generated/VBN by/IN a/DT cleavage/NN that/WDT occurs/VBZ between/IN bases/NNS 11/CD and/CC 12/CD of/IN the/DT Tf1/NEWGENE mRNA/NEWGENE ./.
@@21251535461 A/DT bacteriological/JJ relapse/NN requiring/JJ treatment/NN occurred/VBN by/IN 5/CD years/NNS in/IN 16/CD ./CD 8%/CD of/IN 113/CD R3/NN ,/, 5/NN ./NN 2%/NN of/IN 97/CD R5/NN ,/, and/CC 20/CD ./CD 0%/CD of/IN 115/CD Z5/NN patients/NNS with/IN organisms/NNS sensitive/JJ to/IN streptomycin/NN and/CC isoniazid/NN initially/RB ./.
@@8230878212 Deflunia/NNP was/VBD well/VB tolerated/VBN by/IN 25/CD patients/NNS ,/, very/RB well/VB tolerated/VBN by/IN 2/CD ./CD
@@91441652703 In/NN a/DT model/NN of/IN the/DT ternary/JJ complex/NN ,/, the/DT segment/NN of/IN NFAT/NEWGENE nearest/JJS AP-1/NEWGENE is/VBZ the/DT Rel/NEWGENE insert/NEWGENE region/NEWGENE (/( RIR/NEWGENE )/SYM ,/, a/DT feature/NN that/WDT is/VBZ notable/JJ for/IN its/PRP hypervariability/NN in/IN size/NN and/CC in/IN sequence/NN amongst/IN members/NNS of/IN the/DT Rel/NEWGENE transcription/NEWGENE factor/NEWGENE family/NEWGENE ./.
@@75962878650 The/DT nucleotide/NN sequence/NN directly/RB upstream/RB of/IN fimA/NEWGENE contains/VBZ two/JJ open/JJ reading/JJ frames/NNS ,/, ORF5/NNS and/CC ORF1/NN ,/, whose/WP deduced/VBN protein/NN products/NNS are/VBP homologous/JJ to/IN members/NNS of/IN a/DT superfamily/NN of/IN ATP-binding/NEWGENE cassette/NEWGENE membrane/NEWGENE transport/NEWGENE proteins/NEWGENE ,/, including/JJ both/DT prokaryotic/JJ and/CC eukaryotic/JJ uptake/NN and/CC export/NN systems/NNS ./.
@@92944224847 The/DT two/JJ cysteine/NN residues/NNS located/VBN in/IN this/DT additional/JJ region/NN may/MD be/VB involved/VBN in/IN the/DT formation/NN of/IN a/DT disulfide/NN bridge/NN associated/VBN with/IN the/DT activation/NN process/NN of/IN the/DT catalytic/JJ activity/NN ./.
@@78658763188 The/DT tissue-specific/JJ expression/NN of/IN DP/NEWGENE family/NEWGENE members/NEWGENE suggests/VBZ that/IN the/DT combination/NN of/IN DP/NEWGENE //NEWGENE E2F/NEWGENE heterodimers/NEWGENE that/WDT constitute/VBP DRTF1/NEWGENE //NEWGENE E2F/NEWGENE is/VBZ influenced/VBN by/IN the/DT phenotype/NN of/IN the/DT cell/NN ./.
@@89433542008 Recent/JJ studies/NNS have/VBP suggested/VBN that/IN SHP-1/NEWGENE regulates/VBZ the/DT function/NN of/IN Jak/NEWGENE family/NN tyrosine/NEWGENE kinases/NEWGENE ,/, as/IN shown/VBP by/IN its/PRP constitutive/JJ association/NN with/IN the/DT Tyk2/NEWGENE kinase/NEWGENE and/CC the/DT hyperphosphorylation/NN of/IN Jak/NEWGENE kinases/NEWGENE in/IN the/DT motheaten/NN cells/NNS that/WDT lack/VBP functional/JJ SHP-1/NEWGENE ./.
@@43152334925 Clinico-physiological/JJ experiment/NN ./.
@@11222639108 These/DT results/NNS suggested/VBD a/DT critical/JJ role/NN for/IN tyrosine/NN residue/NN 1229/CD in/IN the/DT regulation/NN of/IN L1/NEWGENE endocytosis/NN ./.
@@87238831367 Blood/NNP GSH-Px/NEWGENE activity/NN was/VBD measured/VBN with/IN a/DT spectrophotometer/NN ,/, using/VBG a/DT modification/NN of/IN a/DT previously/RB described/VBN assay/NN ./.
@@51747535420 Cleidocranial/JJ dysostosis/NN ./.
@@80754218552 The/DT partial/JJ ORF/NN was/VBD found/VBN to/IN be/VB identical/JJ to/IN the/DT C/NN terminus/NN of/IN HrpJ2/NEWGENE ./.
@@91214328006 The/DT Ras/NEWGENE guanine/NEWGENE nucleotide-binding/NEWGENE protein/NEWGENE functions/NNS as/IN a/DT molecular/JJ switch/NN in/IN signalling/JJ downstream/RB of/IN protein-tyrosine/NEWGENE kinases/NEWGENE ./.
@@97139909273 Isolation/NNS of/IN a/DT novel/JJ TP53/NEWGENE target/NEWGENE gene/NEWGENE from/IN a/DT colon/NN cancer/NN cell/NN line/NN carrying/JJ a/DT highly/RB regulated/VBN wild-type/NEWGENE TP53/NEWGENE expression/NN system/NN ./.
@@88513378825 Tonsillectomy/NN is/VBZ an/DT effective/JJ means/NN of/IN prophylaxis/NN for/IN upper/JJ respiratory/JJ infection/NN in/IN habitual/JJ angina/NN patients/NNS ./.
@@67169776484 All/DT samples/NNS exhibited/VBD a/DT decline/NN in/IN ethanol/NN concentration/NN ,/, with/IN most/JJ losses/NNS falling/NN within/IN the/DT expected/VBN 20/CD to/IN 40/CD mg%/NN range/NN ./.
@@99187155082 MotA/NEWGENE also/RB binds/VBZ a/DT DNA/NN sequence/NN (/( a/DT MotA/NEWGENE box/NEWGENE )/SYM ,/, centered/VBN at/IN position/NN -30/CD ./.
@@99209307626 However/RB ,/, C3/NEWGENE toxin/NEWGENE alone/RB or/CC in/IN combination/NN with/IN growth/NEWGENE factors/NEWGENE did/VBD not/RB stimulate/VB AP-1/NEWGENE :/: Luc/NEWGENE activity/NN and/CC actually/RB antagonized/VBN the/DT synergistic/JJ activation/NN of/IN AP-1/NEWGENE :/: Luc/NEWGENE observed/VBD in/IN response/NN to/IN co-stimulation/NN with/IN growth/NEWGENE factors/NEWGENE and/CC Ro-31-8220/NN ./.
@@100637398173 Basal/JJ midexpiratory/RB lower/JJR esophageal/JJ sphincter/NN pressure/NN was/VBD similar/JJ in/IN the/DT study/NN group/NN (/( mean/JJ [/NN SD/NN ]/NN 20/CD ./CD 1/CD [/NN 9/NN ./NN 1/NN ]/NN mmHg/NN )/SYM and/CC controls/NNS (/( 17/CD ./CD 6/CD [/NN 6/NN ./NN 0/NN ]/NN mmHg/NN )/SYM ;/: the/DT pressure/NN did/VBD not/RB change/VB following/IN EVS/NN or/CC EVL/NN ./.
@@98068578553 An/DT open/JJ reading/JJ frame/NN encoding/VBG a/DT protein/NN which/WDT shows/VBZ significant/JJ similarity/NN to/IN invertases/NEWGENE and/CC resolvases/NEWGENE was/VBD located/VBN immediately/RB upstream/RB of/IN the/DT Pac25I/NEWGENE R-M/NEWGENE1 operon/NEWGENE1 ./.
@@82897838103 Using/VBG site-directed/JJ mutagenesis/NN ,/, we/PRP show/VBP that/IN the/DT RAREoct/NEWGENE contributes/VBZ to/IN the/DT transcriptional/JJ activation/NN of/IN Oct-3/NEWGENE //NEWGENE 4/NEWGENE promoter/NEWGENE in/IN P19/CD cells/NNS and/CC ,/, most/RB interestingly/RB ,/, mediates/VBZ the/DT RA-induced/JJ repression/NN in/IN RA-differentiated/JJ EC/NN cells/NNS ./.
@@80653656138 Binding/NN of/IN U2/NEWGENE small/NEWGENE nuclear/NEWGENE ribonucleoprotein/NEWGENE (/( snRNP/NEWGENE )/SYM to/IN the/DT pre-mRNA/NN is/VBZ an/DT early/JJ and/CC important/JJ step/NN in/IN spliceosome/NN assembly/NN ./.
@@25729283227 Monitoring/NN of/IN rheumatoid/JJ arthritis/NN ./.
@@40384546371 Furthermore/RB ,/, the/DT initial/JJ plasma/NN retinol/NN level/NN in/IN conjunction/NN with/IN RBP/NEWGENE was/VBD found/VBN to/IN be/VB even/VB lower/JJR in/IN 12/CD patients/NNS (/( 35/CD ./CD 1/CD micrograms/NNS dl-1/NN ,/, 3/CD ./CD 7/CD mg/NN dl-1/NN )/SYM who/WP subsequently/RB had/VBP cancer/NN recurrence/NN than/IN in/IN those/DT who/WP remained/VBD free/JJ of/IN apparent/JJ cancer/NN (/( 44/CD ./CD 5/CD micrograms/NNS dl-1/NN ,/, 4/CD ./CD 6/CD mg/NN dl-1/NN )/SYM ./.
@@112790388923 WRN/NEWGENE helicase/NEWGENE resolves/VBZ alternate/NN DNA/NN structures/NNS including/JJ tetraplex/NN and/CC triplex/JJ DNA/NN ,/, and/CC Holliday/NNP junctions/NNS ./.
@@5554955594 Study/NNP on/IN re-establishment/NN of/IN ovulation/NN after/IN termination/NN of/IN sex-steroidal/JJ treatment/NN --compared/JJ with/IN re-appearance/NN of/IN ovulation/NN after/IN abortion/NN and/CC premature/JJ delivery/NN ./.
@@95141593790 Most/JJS pituitary/NEWGENE hormone-coding/NEWGENE gene/NEWGENE promoters/NNS are/VBP activated/VBN by/IN Ptx1/NEWGENE ./.
@@78763005296 The/DT p97-depleted/NN nuclei/NNS remained/VBN largely/RB competent/JJ for/IN nuclear/JJ protein/NN import/NN ./.
@@106790655395 BCR/NEWGENE cross-linking/VBG also/RB led/VBN to/IN increased/VBN MAPK-activated/NEWGENE protein/NEWGENE kinase-2/NEWGENE activity/NN ,/, an/DT enzyme/NN that/IN lies/NNS immediately/RB downstream/RB from/IN p38/NEWGENE MAPK/NEWGENE ;/: MAPK-activated/NEWGENE protein/NEWGENE kinase-2/NEWGENE immune/JJ complexes/NNS phosphorylated/VBN a/DT peptide/NN substrate/NN containing/JJ the/DT CREB/NEWGENE serine/NEWGENE 133/NEWGENE phosphoacceptor/NEWGENE motif/NEWGENE ./.
@@95565669002 It/PRP bound/JJ to/IN vitamin/NEWGENE D/NEWGENE receptor/NEWGENE (/( VDR/NEWGENE )/SYM but/CC not/RB retinoic/NEWGENE acid/NEWGENE Xalpha/NEWGENE receptor/NEWGENE (/( RXRalpha/NEWGENE )/SYM in/IN the/DT human/JJ T/NN cell/NN line/NN MT2/NN cells/NNS ./.
@@50053115307 Immunogenicity/NNS of/IN various/JJ mycobacteria/NNS and/CC the/DT corresponding/JJ levels/NNS of/IN cross-protection/NN developed/VBN between/IN species/NN ./.
@@94351169389 Isomers/NNS were/VBD differentiated/VBN based/VBN on/IN the/DT MS-MS/NNP data/NN of/IN the/DT trofluoroacetyl-biphenylol/JJ derivatives/NNS ./.
@@83674878379 Most/JJS importantly/RB ,/, the/DT addition/NN of/IN purified/VBN 17S/NEWGENE U2/NEWGENE snRNPs/NEWGENE ,/, but/CC not/RB of/IN 12S/NEWGENE U2/NEWGENE snRNPs/NEWGENE ,/, to/IN HeLa/DT splicing/JJ extracts/NNS in/IN which/WDT the/DT endogeneous/NEWGENE U2/NEWGENE snRNPs/NEWGENE have/VBP been/VBN functionally/RB neutralized/VBN with/IN anti-PRP9/NEWGENE antibodies/NEWGENE fully/RB restores/VBZ the/DT mRNA-splicing/JJ activity/NN of/IN the/DT extracts/NNS ./.
@@6272026068 Diuretics/NNS :/: basic/JJ clinical/JJ pharmacology/NN and/CC therapeutic/JJ use/NN ./.
@@86470868871 The/DT Cdk2-cyclin-D1/NEWGENE complex/NEWGENE did/VBD not/RB phosphorylate/VB any/DT tested/VBN substrates/NNS ,/, such/JJ as/IN H1/NEWGENE histone/NEWGENE ,/, pRB/NEWGENE ,/, SV40/NEWGENE large/NEWGENE T/NEWGENE antigen/NEWGENE ,/, p53/NEWGENE ,/, E2F-1/NEWGENE or/CC a/DT preparation/NN of/IN nuclear/JJ proteins/NNS from/IN HeLa/DT cells/NNS ;/: in/IN contrast/NN ,/, Cdk2-cyclin-E/NEWGENE and/CC Cdk2-cyclin-A/NEWGENE phosphorylated/VBN these/DT proteins/NNS ./.
@@7671557600 The/DT December/NN armed/JJ revolt/NN in/IN Moscow/NN and/CC the/DT paramedical/JJ personnel/NN ./.
@@108694656640 In/NN situ/NN hybridization/NN with/IN the/DT antisense/NN RNA/NN probes/NNS further/RB supported/VBN the/DT expression/NN changes/NNS of/IN these/DT six/CD clones/NNS and/CC localized/VBN the/DT changes/NNS in/IN multiple/JJ germ/NN cell/NN stages/NNS as/RB well/VBP as/IN other/DT cell/NN types/NNS (/( Sertoli/NN ,/, interstitial/JJ and/CC peritubular/JJ cells/NNS )/SYM ./.
@@82019328175 On/IN physical/JJ examination/NN a/DT mild/JJ symmetrical/JJ polyarthritis/NN of/IN small/JJ and/CC large/JJ joints/NNS was/VBD seen/VBP ./.
@@113966854709 The/DT described/VBN results/NNS show/VBP that/DT DTD/NN is/VBZ fast/JJ ,/, simple/JJ ,/, and/CC easy/RB to/IN automate/VB ;/: requires/VBZ only/RB a/DT small/JJ amount/NN of/IN sample/NN (/( approximately/RB 50/CD mg/NN )/SYM ;/: and/CC affords/VBZ quantitative/JJ information/NN about/RB the/DT main/JJ groups/NNS of/IN compounds/NNS present/VBP in/IN cheeses/NNS ./.
@@81509708118 With/IN a/DT cutoff/NN level/NN for/IN TSST-1/NEWGENE of/IN less/PRP than/IN 100/CD pg/NN //NN ml/NN ,/, 28/CD samples/NNS obtained/VBN from/IN 12/CD patients/NNS were/VBD positive/JJ for/IN TSST-1/NEWGENE ./.
@@88164538021 The/DT elevation/NN of/IN cyclic/JJ AMP/NN (/( cAMP/NN )/SYM levels/NNS in/IN the/DT cell/NN downregulates/VBZ the/DT activity/NN of/IN the/DT Raf-1/NEWGENE kinase/NEWGENE ./.
@@17076594590 It/PRP is/VBZ ,/, however/RB ,/, extremely/RB homologous/JJ to/IN a/DT third/RB 'non-classical'/NN gene/NN ,/, HLA-5/NEWGENE ./NEWGENE 4/NEWGENE ,/, and/CC to/IN the/DT chimpanzee/NN gene/NN ,/, Ch28/NEWGENE ./.
@@40662744742 Twenty-five/CD patients/NNS (/( 80/CD ,/CD 6%/CD )/SYM with/IN mixed/JJ neoplasms/NNS were/VBD operated/VBN on/IN by/IN total/JJ conservative/JJ parotidectomy/NN (/( T/NNP ./NNP C/NNP ./NNP P/NNP ./NNP )/SYM ,/, 3/CD (/( 9/CD ,/CD 7%/CD )/SYM by/IN S/NN ./NN P/NN ./. and/CC 3/CD (/( 9/CD ,/CD 7%/CD )/SYM by/IN En/NN ./NN
@@118186751685 Karger/NNP AG/NN ,/, Basel/NNP
@@117751801617 Traditional/JJ surgical/JJ exploration/NN was/VBD followed/VBN by/IN survey/NN with/IN a/DT gamma-detecting/JJ probe/NN ./.
@@74744517362 Magnetic/JJ resonance/NN imaging/JJ (/( MRI/NN )/SYM has/VBZ enabled/VBN us/PRP to/IN see/VB the/DT spinal/JJ intramedullary/JJ pathology/NN as/IN differences/NNS in/IN signal/JJ intensity/NN ./.
@@74550422062 As/IN high-speed/JJ ,/, volumetric/JJ imaging/NN ,/, computed/JJ tomographic/JJ scan/NN machines/NNS such/JJ as/IN the/DT Dynamic/NNP Spatial/JJ Reconstructor/NN become/VB available/JJ with/IN higher/JJ density/NN resolution/NN ,/, perhaps/RB a/DT single/JJ injection/NN of/IN contrast/NN agent/NN into/IN the/DT right/JJ atrium/NN or/CC even/VB a/DT peripheral/NN vein/NN may/MD be/VB adequate/JJ to/IN obtain/VB all/PDT these/DT measurements/NNS ./.
@@111391485204 We/PRP demonstrate/VBP that/IN the/DT protein/NN is/VBZ a/DT murine/NEWGENE homologue/NEWGENE of/NEWGENE SAF-A/NEWGENE which/WDT has/VBZ been/VBN shown/VBP to/IN bind/NN selectively/RB to/IN MARs/NNS and/CC is/VBZ responsible/JJ for/IN the/DT satMa-binding/JJ activity/NN in/IN the/DT chromatographic/JJ fractions/NNS ./.
@@8759870717 The/DT extent/NN of/IN the/DT fbpA/NEWGENE operator/NEWGENE sequence/NEWGENE (/NEWGENE 42/NEWGENE bp/NEWGENE )/NEWGENE ,/, as/IN defined/VBN by/IN our/PRP footprinting/VBG analysis/NN ,/, would/MD suggest/VB the/DT binding/NN of/IN two/JJ Fur/NEWGENE repressor/NEWGENE dimers/NEWGENE ./.
@@25238008687 According/VBG to/IN the/DT published/VBN sequence/NN of/IN the/DT CHS1/NEWGENE gene/NEWGENE ,/, this/DT fragment/NN contains/VBZ four/CD repeats/NNS of/IN a/DT TGAAACA/NNP consensus/NN sequence/NN previously/RB identified/VBD in/IN the/DT alpha-factor-inducible/NN BAR1/NEWGENE promoter/NEWGENE [/NN Kronstad/NN ,/, J/NNP ./NNP
@@37034933501 The/DT number/NN of/IN crystalline/JJ deposits/NNS is/VBZ less/PRP in/IN the/DT advanced/JJ atrophic/JJ areas/NNS of/IN the/DT RPE-choriocapillaris/NN complex/NN ./.
@@54900347 Peroxydase/NEWGENE reaction/NN stains/NNS were/VBD negative/JJ ,/, chloroacetate/NEWGENE esterase/NEWGENE were/VBD strongly/RB positive/JJ ./.
@@43504104943 Genesis/NNP of/IN foam/NN cells/NNS :/: study/NN in/IN rats/NNS after/IN administration/NN of/IN Cloforex/NN ./.
@@76927543632 Risk/NN factors/NNS associated/VBN with/IN a/DT high/JJ seroprevalence/NN of/IN hepatitis/NN C/NN virus/NN infection/NN in/IN Egyptian/JJ blood/NN donors/NNS ./.
@@113011892647 In/NN contrast/NN ,/, the/DT ubiquitous/JJ expression/NN of/IN p19/NEWGENE (/NEWGENE INK4d/NEWGENE )/NEWGENE has/VBZ not/RB been/VBN previously/RB described/VBN in/IN human/JJ or/CC murine/JJ B-lineage/NNP cells/NNS ./.
@@10933154751 These/DT findings/NNS were/VBD reinforced/VBN by/IN an/DT analysis/NN that/WDT was/VBD restricted/VBN to/IN living/VBG donor/NN transplants/NNS without/IN acute/JJ rejection/NN ./.
@@87304702068 There/EX is/VBZ general/JJ agreement/NN that/IN the/DT hepatitis/NN C/NN virus/NN is/VBZ efficiently/RB transmitted/VBN parenterally/RB ,/, while/CC data/NN on/IN viral/JJ transmission/NN from/IN mothers/NNS to/IN babies/NNS or/CC by/IN sexual/JJ or/CC non-sexual/JJ household/NN contact/NN are/VBP conflicting/JJ ./.
@@90799152945 Molecular/NNP characterization/NN of/IN a/DT large/JJ Borrelia/NN burgdorferi/NN motility/NN operon/NN which/WDT is/VBZ initiated/VBN by/IN a/DT consensus/NN sigma70/NEWGENE promoter/NEWGENE ./.
@@808522873 Demographic/NN characteristics/NNS and/CC risk/NN factor/NN data/NN for/IN 76/NN ,/NN 672/NN clients/NNS were/VBD studied/VBN to/IN characterize/VB the/DT distribution/NN of/IN infection/NN with/IN human/JJ immunodeficiency/NN virus/NN (/( HIV/NN )/SYM and/CC the/DT use/NN of/IN counseling/NN and/CC testing/NN facilities/NNS in/IN Houston/NN ,/, Tex/NNP ./.
@@84169773423 These/DT CTD/NEWGENE kinases/NEWGENE ,/, designated/VBN CTDK1/NEWGENE and/CC CTDK2/NEWGENE ,/, are/VBP fractionated/VBN by/IN chromatography/NN on/IN Mono/NNP Q/NNP ./NNP
@@75196069301 Anti-NPROSP-C/NEWGENE also/RB exclusively/RB detected/VBN time-dependent/NN appearances/NNS of/IN 5-10-kDa/NEWGENE proSP-C/NEWGENE forms/NNS in/IN lamellar/JJ bodies/NNS and/CC homogenates/NNS ./.
@@90030017741 The/DT ubiquitously/RB expressed/VBN E12/NEWGENE bHLH/NEWGENE protein/NEWGENE dimerizes/VBZ with/IN numerous/JJ cell-specific/NN bHLH/NEWGENE factors/NEWGENE ./.
@@116692811514 Epithelial/JJ cytotoxicity/NN of/IN combined/JJ antibiotics/NNS was/VBD additive/JJ ,/, with/IN no/DT evidence/NN of/IN competition/NN or/CC synergism/NN ./.
@@33307114004 In/NN vitro/FW antimalarial/JJ activity/NN of/IN neem/NN (/( Azadirachta/NNP indica/NNP A/NNP ./NNP
@@14950697188 DIBA/NN was/VBD more/RB sensitive/JJ and/CC had/VBP a/DT better/RBR negative/JJ predictive/JJ value/NN and/CC a/DT lower/JJR false/JJ negative/JJ percentage/NN than/IN DFAT/NN ./.
@@21199462723 Managing/NNP dysphagia/NN in/IN a/DT chronic/JJ care/NN setting/NN :/: an/DT introduction/NN ./.
@@11251171489 In/NN none/NN of/IN the/DT 44/NN type/NN I/NN attacks/NNS and/CC 29/NN type/NN II/NN attacks/NNS which/WDT were/VBD recorded/VBN did/VBD circulatory/JJ changes/NNS ;/: the/DT latter/NN were/VBD different/JJ in/IN the/DT two/JJ groups/NNS ./.
@@84038048368 By/IN stepwise/JJ linear/JJ multiple/JJ regression/NN analysis/NN ,/, ionized/JJ magnesium/NN was/VBD significantly/RB related/VBN to/IN cyclosporin/NN trough/NN level/NN and/CC total/JJ cholesterol/NN but/CC not/RB to/IN serum/JJ creatinine/NN ,/, time/NN after/IN transplant/NN or/CC the/DT dose/NN of/IN cyclosporin/NN ./.
@@107227378567 These/DT findings/NNS indicate/VBP the/DT involvement/NN of/IN Sp1/NEWGENE and/CC an/DT Inr/NN in/IN non-cell-specific/JJ regulation/NN and/CC a/DT Kruppel-like/NEWGENE transcription/NEWGENE factor/NEWGENE and/CC Sp1/NEWGENE in/IN the/DT cell-specific/JJ regulation/NN of/IN the/DT LTC/NEWGENE (/NEWGENE 4/NEWGENE )/NEWGENE S/NEWGENE gene/NEWGENE ./.
@@22274385302 Primer/NNS extension/NN analysis/NN and/CC RNA/NN sequencing/VBG demonstrates/VBZ that/IN the/DT transcription/NN start/NN point/NN of/IN rat/NEWGENE ODC/NEWGENE mRNA/NEWGENE is/VBZ located/VBN 303/CD nt/NN upstream/RB from/IN the/PDT A/DT residue/NN in/IN the/DT start/NN codon/NN ./.
@@92378629196 In/NN all/DT experimental/JJ eyes/NNS ,/, there/RB was/VBD a/DT marked/JJ reduction/NN ,/, but/CC never/RB a/DT complete/JJ absence/NN of/IN adrenergic/JJ nerves/NNS in/IN the/DT iris/NN ./.
@@109509247832 RNA/NN in/IN situ/NN hybridization/NN on/IN brain/NN sections/NNS of/IN normal/JJ human/JJ embryos/NNS revealed/VBD a/DT strong/JJ labeling/NN in/IN restricted/VBN areas/NNS of/IN the/DT cerebral/JJ cortex/NN ./.
@@40269724693 Individual/JJ alcohol/NN reaction/NN profiles/NNS ./.
@@11058406896 Tobramycin-loaded/JJ SLN/NNS administered/VBN i/CD ./CD v/CD ./. showed/VBD a/DT prolonged/JJ circulation/NN time/NN compared/VBN to/IN the/DT i/CD ./CD v/CD ./. administered/VBN tobramycin/NN solution/NN ./.
@@13474769023 Mapping/NN of/IN the/DT mouse/NEWGENE ornithine/NEWGENE decarboxylase-related/NEWGENE sequence/NEWGENE family/NEWGENE ./.
@@27523033448 Lithium/WDT delays/VBZ the/DT circadian/JJ rhythm/NN of/IN wheel-running/NN in/IN Syrian/JJ hamsters/NNS at/IN plasma/NN concentrations/NNS (/( 0/CD ./CD 59-0/CD ./CD 74/CD mM/NN )/SYM that/IN also/RB cause/VBP toxic/JJ weight/NN loss/NN ./.
@@21754334235 The/DT recombinant/NN contains/VBZ the/DT normal/JJ beta/NEWGENE A-globin/NEWGENE gene/NEWGENE ,/, the/DT mutant/JJ gene/NN and/CC Ylp/NN vector/NN sequences/NNS between/IN the/DT two/JJ copies/NNS ./.
@@100865443647 The/DT following/JJ data/NN were/VBD recorded/VBN at/IN arrival/NN in/IN the/DT intensive/JJ care/NN unit/NN 6/NN ,/, 12/CD ,/, 24/CD ,/, and/CC 48/CD hours/NNS after/IN termination/NN of/IN CPB/NNP :/: heart/NN rate/NN ,/, blood/NN pressure/NN ,/, left/NN atrial/JJ pressure/NN ,/, central-peripheral/JJ temperature/NN difference/NN ,/, arterial-central/JJ venous/JJ oxygen/NN saturation/NN difference/NN ,/, urine/NN output/NN ,/, serum/JJ creatinine/NN ,/, lactate/NN and/CC neutrophil/NEWGENE elastase/NEWGENE levels/NNS ,/, the/DT Doppler/NN echocardiographic/JJ factors/NNS shortening/NN fraction/NN and/CC preejection/JJ period/JJ //JJ left-ventricular/JJ ejection/NN time/NN ,/, and/CC cumulative/JJ doses/NNS of/IN catecholamines/NNS (/( epinephrine/NN )/SYM ,/, enoximone/NN ,/, and/CC furosemide/NN ./.
@@8512868477 Deaths/NNP stopped/VBD 11/CD hours/NNS after/IN copper/JJ concentrations/NNS decreased/VBN below/RB 0/CD ./CD 2/CD ppm/NN and/CC signs/NNS of/IN distress/NN stopped/VBN in/IN surviving/JJ pinfish/NN by/IN approximately/RB 6/CD hours/NNS after/IN the/DT last/NN death/NN ./.
@@28488424397 A/DT family/NN of/IN RNA/NN molecules/NNS in/IN the/DT 2/CD ./CD 0-2/CD ./CD 2-kilobase/CD range/NN identified/VBN with/IN a/DT probe/NN from/IN this/DT gene/NN was/VBD overexpressed/VBN in/IN the/DT resistant/JJ cells/NNS ./.
@@115669611442 Body/NNP weight/NN reduction/NN increases/NNS insulin/NEWGENE sensitivity/NN and/CC improves/VBZ both/DT blood/NN glucose/NN and/CC blood/NN pressure/NN control/NN ./.
@@99717903215 Several/JJ mutations/NNS disrupted/VBD the/DT endonuclease/NEWGENE and/CC helicase/NEWGENE activities/NNS ;/: however/RB ,/, only/RB one/PRP amino-terminal-charge/NEWGENE cluster/NEWGENE mutant/NEWGENE protein/NEWGENE (/( D40A-D42A-D44A/NEWGENE )/SYM completely/RB lost/VBP AAV/NN hairpin/NN DNA/NN binding/JJ activity/NN ./.
@@107153229696 Gene/NNP silencing/VBG associated/VBN with/IN repeated/JJ DNA/NN sequences/NNS has/VBZ been/VBN reported/VBN for/IN many/JJ eukaryotes/NNS ,/, including/JJ plants/NNS ./.
@@85063847240 In/NN mammalian/JJ cells/NNS ,/, phosphorylation/NN of/IN eIF-2/NEWGENE alpha/NEWGENE inhibits/VBZ the/DT activity/NN of/IN eIF-2B/NEWGENE ,/, the/DT GDP-GTP/NEWGENE exchange/NEWGENE factor/NEWGENE for/IN eIF-2/NEWGENE ./.
@@17110415842 These/DT clones/NNS overlapped/VBN and/CC contained/VBD the/DT structural/JJ gene/NN encoding/VBG the/DT complete/JJ C5/NEWGENE alpha-chain/NEWGENE and/CC 90%/CD of/IN the/DT beta-chain/NN ./.
@@81252582121 Although/IN inactive/JJ in/IN cells/NNS under/IN normal/JJ conditions/NNS ,/, the/DT CHOP/NEWGENE gene/NEWGENE is/VBZ markedly/RB induced/VBN by/IN a/DT variety/NN of/IN cellular/JJ stresses/NNS ,/, including/JJ nutrient/JJ deprivation/NN and/CC metabolic/JJ perturbations/NNS ./.
@@92119345012 DNase/NEWGENE I/NEWGENE footprint/NN analysis/NN identified/VBD a/DT protected/VBN region/NN from/IN -37/CD to/IN -53/CD ./.
@@29936301973 Fine/NNP analysis/NN at/IN the/DT nucleotide/NN level/NN of/IN the/DT early/JJ events/NNS in/IN the/DT digestion/NN with/IN nuclease/NEWGENE S1/NEWGENE shows/VBZ that/IN the/DT enzyme/NN attacks/NNS preferentially/RB the/DT sequence/NN (/( G-A/NN )/NN 12/NN on/IN the/DT message/NN complementary/JJ strand/NN ./.
@@93588378557 Parodoxical/JJ rise/NN in/IN urinary/NEWGENE albumin/NEWGENE levels/NNS after/IN treatment/NN of/IN essential/JJ hypertension/NN ./.
@@22019053595 These/DT latter/JJ results/NNS showed/VBN that/IN the/DT ABFI/NEWGENE protein/NEWGENE ,/, like/VB the/DT RAP1/NEWGENE protein/NEWGENE ,/, bound/JJ sequences/NNS required/VBN for/RB positive/JJ as/RB well/VB as/IN negative/JJ regulation/NN of/IN gene/NN expression/NN ./.
@@68648376663 Efficacy/NNS of/IN cervical/JJ spine/NN immobilization/NN methods/NNS ./.
@@112519516689 BACKGROUND/IN :/: Dermoscopy/NN is/VBZ a/DT noninvasive/JJ technique/NN that/WDT increases/VBZ the/DT diagnostic/JJ accuracy/NN of/IN pigmented/JJ skin/NN lesions/NNS ,/, particularly/RB improving/JJ the/DT diagnosis/NN of/IN patients/NNS with/IN cutaneous/JJ melanoma/NN in/IN situ/NN (/( CMIS/NNP )/SYM and/CC early/JJ invasive/JJ melanoma/NN ./.
@@92301295864 3600-fold/JJ to/IN apparent/JJ homogeneity/NN with/IN a/DT 41%/JJ yield/NN by/IN affinity/NN chromatography/NN utilizing/VBG DNA-cellulose/NN ;/: the/DT purity/NN of/IN the/DT final/JJ preparation/NN was/VBD assessed/VBN by/IN SDS/NNS //NNS PAGE/NNS ,/, lack/NN of/IN contamination/NN by/IN other/DT nucleases/NEWGENE and/CC production/NN of/IN a/DT monospecific/JJ antibody/NN against/IN the/DT enzyme/NN ./.
@@75164695798 Several/JJ Src/NEWGENE SH3-binding/NEWGENE proteins/NEWGENE were/VBD phosphorylated/VBN in/IN Src-transformed/JJ cells/NNS ./.
@@107289454283 Patients/NNS enrolled/VBN in/IN the/DT Integrilin/NNP to/IN Minimize/DT Platelet/NN Aggregation/NNS and/CC Coronary/NNP Thrombosis-II/NN (/( IMPACT-II/NN )/SYM trial/NN were/VBD analyzed/VBN ./.
@@15825002173 The/DT circadian/JJ rhythmicity/NN of/IN sleep/NN was/VBD pronounced/VBN ./.
@@19090274856 Sequence/NN analysis/NN reveals/VBZ that/IN the/DT DNA/NN binding/JJ domain/NN of/IN ILF/NEWGENE has/VBZ strong/JJ homology/NN to/IN the/DT recently/RB described/VBN fork/NEWGENE head/NEWGENE DNA/NEWGENE binding/NEWGENE domain/NEWGENE found/VB in/IN the/DT Drosophila/NEWGENE homeotic/NEWGENE protein/NEWGENE fork/NEWGENE1 head/NEWGENE1 and/CC a/DT family/NN of/IN hepatocyte/NEWGENE nuclear/NEWGENE factors/NEWGENE ,/, HNF-3/NEWGENE ./.
@@67180644329 Plasma/NEWGENE lactoferrin/NEWGENE and/CC the/DT blood/NN count/NN of/IN polynuclear/JJ neutrophils/NNS ./.
@@13964322010 Although/IN a/DT wide/JJ range/NN of/IN cognitive/JJ functions/NNS had/VBP been/VBN tested/VBN ,/, all/DT but/CC one/PRP seizure/NN occurred/VBN during/IN assessment/NN of/IN memory/NN performance/NN ./.
@@117424322481 Because/IN results/NNS of/IN recent/JJ randomized/JJ trials/NNS indicate/VBP minimal/JJ efficacy/NN of/IN continuing/JJ MAC/NN prophylaxis/NN in/IN patients/NNS who/WP respond/VBP to/IN potent/JJ combination/NN antiretroviral/JJ therapy/NN ,/, the/DT observed/VBN high/JJ incidence/NN of/IN macrolide-resistant/JJ bacterial/JJ colonization/NN of/IN the/DT respiratory/JJ tract/NN in/IN this/DT trial/NN supports/VBP the/DT discontinuation/NN of/IN macrolide/NN prophylaxis/NN in/IN all/DT AIDS/NN patients/NNS whose/WP CD4/NN counts/NNS have/VBP risen/VBP above/RB 100/CD cells/NN //NN microL/NN ./.
@@37109734382 Mean/VB weighted/JJ skin/NN temperature/NN (/( Tsk/NN )/SYM was/VBD lower/JJR (/( P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM following/IN acclimation/NN than/IN before/RB ,/, and/CC acclimation/NN resulted/VBN in/IN a/DT larger/JJR (/( P/NN less/PRP than/IN 0/CD ./CD 02/CD )/SYM Tre-to-Tsk/NNP gradient/NN ./.
@@86214517586 Biol/NNP ./.
@@1331501484 Here/RB we/PRP show/VBP that/IN short/JJ synthetic/JJ peptides/NNS containing/JJ the/DT pRB-binding/NEWGENE sequences/NEWGENE of/IN E1A/NEWGENE are/VBP sufficient/JJ for/IN interaction/NN with/IN p107/NEWGENE ,/, cyclin/NEWGENE A/NEWGENE ,/, and/CC p130/NEWGENE ./.
@@57928685724 Evidence/NN forthe/NN electroosmosis/NN theory/NN of/IN transport/NN in/IN the/DT phloem/NN ./.
@@28335174561 Either/CC two/CD or/CC more/RB different/JJ sequences/NNS can/MD promote/VB cleavage/NN ,/, or/CC a/DT single/JJ element/NN exists/VBZ which/WDT is/VBZ long/JJ and/CC diffuse/JJ ./.
@@18741954160 Paradoxically/RB ,/, however/RB ,/, the/DT GH/NEWGENE receptor/NEWGENE cloned/VBN from/IN liver/NN exhibits/VBP no/DT sequence/NN similarity/NN to/IN receptors/NNS with/IN known/VBP signal/JJ transduction/NN mechanisms/NNS ,/, including/JJ those/DT exhibiting/VBG ligand-activated/NN tyrosine/NEWGENE kinase/NEWGENE activity/NN ./.
@@77012667650 RESULTS/NNS :/: Closure/NNS time/NN of/IN fistulas/NNS in/IN patients/NNS receiving/JJ TPN/NN +/SYM somatostatin/NEWGENE was/VBD significantly/RB shorter/JJR (/( 13/CD ./CD 86/CD +/NN //NN -/NN 1/CD ./CD 84/CD versus/IN 20/CD ./CD 4/CD +/NN //NN -/NN 2/CD ./CD 89/CD days/NNS )/SYM than/IN in/IN those/DT receiving/JJ TPN/NN alone/RB ./.
@@10868488682 In/NN the/DT premating/JJ period/NN male/JJ rate/NN of/IN aggression/NN was/VBD not/RB significantly/RB correlated/VBN with/IN testosterone/NN level/NN ./.
@@100022455646 Far-infrared/JJ hopping/JJ conductivity/NN in/IN the/DT CuO/NN chains/NN of/IN a/DT single-domain/NN YBa2Cu3O7-/NN delta/NN crystal/NN ./.
@@15231112145 Factors/NNS associated/VBN with/IN afterdrop/NN included/VBD age/NN ,/, end-of-surgery/NN temperature/NN (/( both/DT positively/RB )/SYM and/CC body/NN mass/JJ (/( negatively/RB )/SYM ./.
@@45479335027 Extracellular/JJ fibril/NN formation/NN by/IN neuroglial/JJ cells/NNS at/IN the/DT vitreoretinal/NN junction/NN of/IN the/DT human/JJ eye/NN ./.
@@26562575880 The/DT site-specific/NN DNA/NN inversion/NN system/NN Cin/NEWGENE encoded/VBN by/IN the/DT bacteriophage/NN P1/NN consists/VBZ of/IN a/DT recombinase/NEWGENE ,/, two/JJ inverted/JJ crossing-over/NN sites/NNS and/CC a/DT recombinational/JJ enhancer/NN ./.
@@110036698610 The/DT product/NN of/IN rat/NEWGENE gene/NEWGENE 33/NEWGENE was/VBD identified/VBN as/IN an/DT ErbB-2-interacting/NEWGENE protein/NEWGENE in/IN a/DT two-hybrid/JJ screen/NN employing/VBG the/DT ErbB-2/NEWGENE juxtamembrane/NEWGENE and/NEWGENE kinase/NEWGENE domains/NEWGENE as/IN bait/NN ./.
@@84212955642 Both/DT fusion/NN proteins/NNS form/NN stable/JJ specific/JJ complexes/NNS with/IN a/DT short/JJ DNA/NN duplex/JJ harboring/VBG the/DT CTGT/NEWGENE (/NEWGENE at/NEWGENE )/NEWGENE 4ACAG/NEWGENE consensus/NEWGENE sequence/NEWGENE of/IN the/PDT LexA/NEWGENE repressor/NEWGENE ./.
@@96112293615 The/DT ability/NN to/IN maintain/VB expression/NN of/IN FAS1/NEWGENE in/IN nmt1-451Dino2/NEWGENE Delta/NEWGENE cells/NNS suggests/VBZ the/DT existence/NN of/IN another/DT transcription/NN factor/NN ,/, or/CC factors/NNS ,/, whose/WP expression/NN //NN activity/NN is/VBZ inversely/RB related/VBN to/IN overall/JJ levels/NNS of/IN cellular/JJ protein/NN N-myristoy-lation/NN ./.
@@112547138619 Thus/RB ,/, the/DT interaction/NN of/IN Tat/NEWGENE with/IN the/DT components/NNS of/IN this/DT rel/NEWGENE //NEWGENE AP1/NEWGENE cooperative/NEWGENE complex/NEWGENE seems/VBZ to/IN induce/VB quantitative/JJ and/CC qualitative/JJ alterations/NNS of/IN this/DT complex/NN as/IN activation/NN progresses/VBZ ,/, resulting/VBG in/IN a/DT decrease/NN of/IN IL-2/NEWGENE gene/NEWGENE transcription/NN ./.
@@96501803663 The/DT general/JJ recombination/NN at/IN a/DT polarizing/JJ voltage/NN of/IN 300/CD V/NN is/VBZ less/PRP than/IN 2%/JJ for/IN dose-rates/NNS up/JJ to/IN about/RB 100/NN mGy/NN min-1/NN ./.
@@103295664425 The/DT 3'/CD terminus/NN of/IN the/DT genome/NN can/MD be/VB folded/JJ into/IN a/DT tRNA-like/NEWGENE secondary/JJ structure/NN that/WDT has/VBZ a/DT valine/NN anticodon/NN ;/: the/DT tRNA-like/NEWGENE structure/NN lacks/VBZ a/DT pseudoknot/NN in/IN the/DT aminoacyl/NN stem/NN ,/, a/DT feature/JJ common/JJ to/IN both/DT genera/NNS of/IN tetraviruses/NNS ./.
@@91865074846 Comprising/VBG a/DT 126-nucleotide/JJ 5'/CD untranscribed/JJ genomic/JJ sequence/NN and/CC a/DT 466-nucleotide/JJ 5'/CD noncoding/JJ cDNA/NN sequence/NN ,/, the/DT 592-nucleotide/NNP 5'/CD CpG/NN island/NN lacked/VBD TATA/NN and/CC CAAT/NN boxes/NNS but/CC displayed/VBD a/DT high/JJ G+C/NN content/NN ,/, was/VBD enriched/VBN for/IN CpG/NN dinucleotides/NN ,/, and/CC contained/VBD a/DT potential/JJ Sp1-binding/NEWGENE site/NEWGENE ,/, i/FW ./FW e/FW ./FW ,/, features/NNS compatible/JJ with/IN a/DT housekeeping/NN gene/NN ./.
@@85515724348 Oligodeoxynucleotides/NNP antisense/NN to/IN the/DT predicted/VBN translation/NN initiation/NN regions/NNS of/IN ICP4/NEWGENE and/CC pp38/NEWGENE mRNAs/NEWGENE inhibited/VBD proliferation/NN of/IN MSB1/NN cells/NNS but/CC not/RB MDCC-CU91/NN (/( CU91/NN )/SYM reticuloendotheliosis/NN virus-transformed/JJ cells/NNS ./.
@@114031731266 A/DT total/NN of/IN 25/CD patients/NNS with/IN malignant/JJ brain/NN tumours/NNS were/VBD investigated/VBN ./.
@@65050142066 Other/JJ uncertainties/NNS in/IN the/DT dosimetry/NN at/IN Y-12/NN and/CC Vinca/NN are/VBP unaltered/JJ ./.
@@90799281136 The/DT binding/JJ site/NN for/IN OxyR/NEWGENE overlapped/VBN P1oxyR/NEWGENE ,/, reminiscent/NN of/IN the/DT autoregulatory/JJ loops/NNS controlling/JJ expression/NN of/IN oxyR/NEWGENE in/IN enteric/JJ bacteria/NNS and/CC characteristic/NN of/IN the/DT LysR/NEWGENE superfamily/NEWGENE in/IN general/NN ./.
@@18282488872 Furthermore/RB ,/, the/PDT UvrA/NEWGENE protein/NEWGENE interacts/VBZ with/IN the/DT UvrB/NEWGENE protein/NEWGENE to/IN modulate/VB its/PRP activities/NNS ,/, both/DT in/NN solution/NN and/CC in/IN association/NN with/IN DNA/NN ,/, where/CC the/DT UvrAB/NEWGENE complex/NEWGENE possesses/VBZ a/DT helicase/NEWGENE activity/NN ./.
@@104896807656 Sputum/NEWGENE IL-8/NEWGENE and/CC MPO/NEWGENE were/VBD significantly/RB increased/VBN after/IN BPT/NN in/IN both/DT TDI-/NNP and/CC grain/NN dust-asthma/JJ (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@9585509537 Crisis/NNP of/IN the/DT therapeutic/JJ community/NN in/IN Great/NNP Britain/NN ./.
@@95732027536 Two/CD of/IN these/DT resulted/VBN in/IN increased/VBN levels/NNS of/IN the/DT alpha/NN subunit/NN ,/, and/CC one/PRP caused/VBN a/DT substitution/NN of/IN glycine/NN for/IN the/DT aspartic/JJ acid/NN residue/NN at/IN position/NN 171/CD ,/, in/IN the/DT N-terminal/NN domain/NN ./.
@@13144576408 Analysis/NNP of/IN nucleotide/NN sequence/NN of/IN the/DT rightmost/JJ 43/CD kbp/NN of/IN herpesvirus/NN saimiri/NN (/( HVS/NNS )/SYM L-DNA/NNS :/: general/JJ conservation/NN of/IN genetic/JJ organization/NN between/IN HVS/NNS and/CC Epstein-Barr/NNP virus/NN ./.
@@88955226541 Oncogenic/NNP activation/NN of/IN the/DT tyrosine/NEWGENE kinase/NEWGENE domain/NEWGENE of/IN the/DT human/NEWGENE trk/NEWGENE proto-oncogene/NEWGENE by/IN fusion/NN to/IN a/DT cell/NN adhesion/NN molecule/NN ./.
@@91651188980 In/NN unc-4/NEWGENE mutants/NEWGENE ,/, VA/NN motor/JJ neurons/NNS assume/VBP the/DT pattern/NN of/IN synaptic/JJ input/NN normally/RB reserved/VBD for/IN their/PRP lineal/JJ sister/JJ cells/NNS ,/, the/DT VB/JJ motor/JJ neurons/NNS ;/: the/DT loss/NN of/IN normal/JJ input/NN to/IN the/DT VAs/NNS produces/VBZ a/DT distinctive/JJ backward/JJ movement/NN defect/NN ./.
@@98671592349 With/IN regard/NN to/IN the/DT optimal/JJ threshold/NN values/NNS ,/, sensitivity/NN and/CC specificity/NN were/VBD 100%/CD //CD 97%/CD and/CC 95%/CD //CD 95%/CD with/IN FDG/NN PET/NN ,/, compared/VBN to/IN 86%/NN //NN 92%/NN and/CC 77%/NN //NN 82%/NN with/IN IS/VBZ ,/, respectively/RB ./.
@@17925802407 Among/IN blood/NN donors/NNS in/IN the/DT Republic/NNP of/IN Serbia/NN ,/, regardless/RB the/DT number/NN of/IN blood/NN donations/NNS ,/, the/DT percentage/NN of/IN female/JJ donors/NNS is/VBZ significantly/RB lower/RBR compared/VBN to/IN the/DT percentage/NN of/IN male/JJ blood/NN donors/NNS ./.
@@88248009548 The/DT fragments/NNS are/VBP separated/VBN and/CC directly/RB sized/JJ by/IN agarose/NN gel/NN electrophoresis/NN ./.
@@75920722641 In/NN Trial/NN 1/CD ,/, eight/CD sows/NNS were/VBD allowed/VBN to/IN farrow/NN naturally/RB (/( d/NN 114/NN ,/, NF/NN sows/NNS )/SYM and/CC eight/CD sows/NNS were/VBD induced/VBN to/IN farrow/NN (/( IF/IN sows/NNS )/SYM prematurely/RB by/IN injection/NN of/IN prostaglandin/NN F2/NN alpha/NN on/IN d/NN 112/NN of/IN gestation/NN ./.
@@115384372885 In/NN such/JJ conditions/NNS ,/, the/DT following/JJ kinetic/JJ reactions/NNS have/VBP been/VBN studied/VBN :/: N2/NN (/NN A/NN )/NN +/SYM N2/NN (/NN A/NN )/NN --/NNP >/NNP N2/NN (/NN C/NN ,/NN B/NN ,/NN V'/NN )/NN +/SYM N2/NN (/NN X/NN )/NN ,/, N2/NN (/NN A/NN )/NN +/SYM N2/NN (/NN X/NN ,/NN V/NN >/NN 5/NN )/NN --/NNP >/NNP N2/NN (/NN X/NN )/NN +/SYM N2/NN (/NN B/NN ,/NN V'/NN )/NN in/IN pure/JJ N2/NN post-discharges/NNS and/CC N2/NN (/NN A/NN )/NN +/SYM CH4/JJ --/JJ >/JJ products/NNS ,/, C/NN +/SYM N/JJ +/SYM M2/CD --/NNP >/NNP CN/NN (/NN B/NN ,/NN V'/NN )/NN +/SYM M2/CD ,/, N2/NN (/NN X/NN ,/NN V/NN >/NN 4/NN )/NN +/SYM CN/NN --/NNP >/NNP N2/NN (/NN X/NN )/NN +/SYM CN/NN (/NN B/NN ,/NN A/NN ,/NN V'/NN )/NN ,/, in/IN N2-1%/NNP CH4/NN post-discharges/NNS ./.
@@81390175661 Moreover/RB ,/, the/DT major/JJ site/NN of/IN transcriptional/JJ initiation/NN ,/, which/WDT was/VBD localized/VBN by/IN primer/NN extension/NN 250/CD bp/NN upstream/RB of/IN the/DT 5'/CD end/NN of/IN the/DT Ets-1/NEWGENE cDNA/NEWGENE clone/NEWGENE ,/, was/VBD shown/VBP to/IN be/VB identical/JJ in/IN normal/JJ cells/NNS and/CC tumors/NNS carrying/VBG a/DT provirus/NN in/IN the/DT Tpl-1/NEWGENE locus/NEWGENE ./.
@@106013442719 In/NN addition/NN ,/, using/VBG biochemical/JJ activity/NN assays/NNS for/IN Rho-like/NEWGENE GTPases/NEWGENE ,/, we/PRP show/VBP that/IN the/DT expression/NN of/IN beta1A/NEWGENE ,/, beta1D/NEWGENE ,/, or/CC IL2R-beta1A/NEWGENE in/IN GE11/NN or/CC GD25/NN cells/NNS triggers/VBP activation/NN of/IN both/DT RhoA/NEWGENE and/CC Rac1/NEWGENE ,/, but/CC not/RB of/IN Cdc42/NEWGENE ./.
@@31460175770 The/DT nucleotide/NN sequence/NN of/IN the/DT region/NN upstream/RB from/IN M/NEWGENE ./NEWGENE voltae/NEWGENE ORFtrpA/NEWGENE was/VBD determined/VBN and/CC revealed/VBD the/DT presence/NN of/IN an/DT ORF/NN of/IN 1227/CD nucleotides/NNS (/( ORFtrpB/NEWGENE )/SYM encoding/VBG a/DT 409/CD amino/JJ acid/NN polypeptide/NN of/IN mol/NN ./. wt/CD ./CD
@@77768827744 The/DT present/NN study/NN describes/VBZ the/DT cell/NN volume/NN dynamics/NNS in/IN intact/JJ rat/NN hearts/NNS ,/, during/IN ischemia/NN and/CC after/IN reperfusion/NN ./.
@@109951211820 Analysis/NNP of/IN Standard/NNP Reference/NNP Material/NNP 1846/CD ,/, Infant/JJ Formula/NN ,/, gave/VBD a/DT mean/JJ value/NN of/IN 0/CD ./CD 95/CD +/NN //NN -/NN 0/CD ./CD 088/CD mg/NN vitamin/NN K/NNP //NNP kg/NNP (/( K/NN or/CC K1/NN ?/. )/SYM (/( n/NN =/SYM 31/CD )/SYM with/IN a/DT coefficient/NN of/IN variation/NN of/IN 9/CD ./CD 26/CD ./.
@@90305812849 When/WRB expressed/VBN in/IN COS-7/NNP cells/NNS ,/, MKP-4/NEWGENE blocks/NNS activation/NN of/IN MAP/NEWGENE kinases/NEWGENE with/IN the/DT selectivity/NN ERK/NEWGENE >/SYM p38/NEWGENE =/SYM JNK/NEWGENE //NEWGENE SAPK/NEWGENE ./.
@@9770415428 Here/RB we/PRP demonstrate/VBP that/IN THOV/NEWGENE NP/NEWGENE contains/VBZ a/DT motif/NN (/( KRxxxxxxxxxKTKK/NEWGENE )/SYM at/IN amino/JJ acid/NN positions/NNS 179-193/CD that/WDT represents/VBZ a/DT classical/JJ bipartite/JJ nuclear/JJ localization/NN signal/JJ (/( NLS/NN )/SYM ./.
@@73049059150 Autotransfusion/NNS was/VBD performed/VBN as/IN follows/VBZ :/: Heparin-ACD-B-/NNP Heparin-DPD-/NNP Heparin-ACD-B/NN etc/NN ./.
@@57156135659 Sterols/NNS in/IN pollen/NN ./.
@@27748082886 The/DT values/NNS were/VBD consistently/RB lower/JJR (/( P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM during/IN summer/NN (/( 3/CD ./CD 79/CD +/NN //NN -/NN 0/CD ./CD 13/CD micrograms/NN //NN 100/NN ml/NN )/SYM ,/, as/IN compared/VBN to/IN winter/NN (/( 5/CD ./CD 06/CD +/NN //NN -/NN 0/CD ./CD 27/CD )/SYM ./.
@@98377158248 We/PRP report/VBP here/RB that/IN ,/, for/IN a/DT constant/JJ amount/NN of/IN transfected/VBN DNA/NN ,/, the/DT level/NN of/IN chloramphenicol/NEWGENE acetyltransferase/NEWGENE (/( CAT/NEWGENE )/SYM mRNA/NN is/VBZ increased/VBN in/IN Vpr-expressing/VBG cells/NNS using/VBG either/DT HIV-1/NNP or/CC a/DT murine/NEWGENE leukemia/NEWGENE virus/NEWGENE (/NEWGENE MLV/NEWGENE )/NEWGENE SL3-3/NEWGENE LTR-CAT/NEWGENE reporter/NEWGENE construct/NEWGENE ./.
@@87025431631 Gap1/NEWGENE (/NEWGENE IP4BP/NEWGENE )/NEWGENE ,/, one/PRP of/IN a/DT member/NN of/IN Ras/NEWGENE GTPase-activating/NEWGENE proteins/NEWGENE ,/, has/VBZ been/VBN identified/VBN as/IN a/DT specific/JJ inositol/NEWGENE 1/NEWGENE ,/NEWGENE 3/NEWGENE ,/NEWGENE 4/NEWGENE ,/NEWGENE 5-tetrakisphosphate/NEWGENE (/NEWGENE IP4/NEWGENE )/NEWGENE -binding/NEWGENE protein/NEWGENE (/( Cullen/NN ,/, P/NNP ./NNP
@@92187752397 Activity/NN of/IN palgD/NEWGENE in/IN the/DT cysB/NEWGENE mutant/NEWGENE ,/, in/IN CHA/NNS and/CC in/IN the/DT non-mucoid/JJ strain/NN PAO/NN was/VBD assessed/VBN by/IN the/DT use/NN of/IN a/DT transcriptional/NN algD-xylE/NEWGENE fusion/NEWGENE ./.
@@100851405426 These/DT results/NNS indicate/VBP that/IN ATF-2/NEWGENE plays/VBP a/DT central/JJ role/NN in/IN TGF-beta/NEWGENE signaling/JJ by/RB acting/JJ as/IN a/DT common/JJ nuclear/JJ target/NN of/IN both/DT Smad/NEWGENE and/CC TAK1/NEWGENE pathways/NEWGENE ./.
@@92463439208 Proteinuria/NNS in/IN a/DT young/JJ man/NN ./.
@@55569775596 Morphogenesis/NNS of/IN the/DT trochanter/NN produced/VBN by/IN femoral/JJ regeneration/NN in/IN the/DT phasmid/NNP Carausius/NNP morosus/NNP Br/NNP ./NNP
@@27031215117 Diagnosis/NNP of/IN primary/JJ sclerosing/JJ cholangitis/NN in/IN a/DT blood/NN donor/NN with/IN elevated/VBN serum/NEWGENE alanine/NEWGENE aminotransferase/NEWGENE ./.
@@7559488915 Control/NNP experiments/NNS showed/VBN that/IN each/DT fusion/NN protein/NN had/VBP a/DT high/NN affinity/NN binding/NN site/NN for/IN estradiol-17/NN beta/NN and/CC could/MD transactivate/VB an/DT ERE-LacZ/NEWGENE reporter/NEWGENE gene/NEWGENE in/IN yeast/NN similar/JJ to/IN the/DT wild/JJ type/NN ER/NNP ./NNP
@@106042463097 STUDY/NN DESIGN/IN AND/CC METHODS/IN :/: A/DT study/NN was/VBD initiated/VBN to/IN compare/NN the/DT collection/NN of/IN PBPCs/NN with/IN the/DT new/JJ device/NN ,/, the/DT AutoPBSC/NNP (/( version/NN [/NN V/NN ]/NN 6/NN ./NN 0/NN with/IN AutoPBSC/NNP tubing/NN set/NN )/SYM ,/, and/CC that/IN with/IN the/DT MNC/NN (/( mononuclear/JJ cell/NN )/SYM procedure/NN (/( V4/NNP ./NNP 7/NNP with/IN white/JJ cell/NN tubing/NN set/NN )/SYM ,/, for/IN patients/NNS and/CC healthy/JJ donors/NNS ./.
@@97634707751 Collectively/RB ,/, this/DT study/NN emphasizes/VBZ a/DT critical/JJ role/NN of/RB Phox2a/NEWGENE as/NNP well/VB as/IN its/PRP functional/JJ synergism/NN with/IN other/DT transcription/NN factors/NNS (/( e/FW ./FW g/FW ./FW ,/, CREB/NEWGENE ,/, AP2/NEWGENE ,/, and/CC Sp1/NEWGENE )/SYM in/IN transcriptional/JJ activation/NN of/IN the/DT DBH/NEWGENE gene/NEWGENE ./.
@@110005211463 Studying/VBG intracellular/JJ signaling/JJ pathways/NNS ,/, which/WDT may/MD be/VB involved/VBN in/IN malignant/JJ transformation/NN of/IN Ret-9bp/NEWGENE expressing/JJ NIH3T3/NNP cells/NNS ,/, we/PRP could/MD demonstrate/VB Ret-9bp/NEWGENE dependent/JJ phosphorylation/NN of/IN insulin/NEWGENE receptor/NEWGENE substrate-2/NEWGENE (/( IRS-2/NEWGENE )/SYM with/IN consecutive/JJ activation/NN of/IN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE (/( PI/NEWGENE 3-kinase/NEWGENE )/SYM and/CC protein/NEWGENE kinase/NEWGENE B/NEWGENE (/( PKB/NEWGENE //NEWGENE AKT/NEWGENE )/SYM ./.
@@10884978704 The/DT duration/NN of/IN reactive/NN hyperemia/NN decreased/VBN with/IN aging/NN ,/, but/CC the/DT difference/NN between/IN males/NNS and/CC females/NNS was/VBD not/RB significant/JJ at/IN any/DT age/NN ./.
@@104971176440 The/DT P/NEWGENE mRNA/NEWGENE also/RB contains/VBZ a/DT third/JJ ORF/NN for/IN the/DT V/NEWGENE protein/NEWGENE ,/, although/IN it/PRP is/VBZ unclear/JJ how/RB or/CC whether/IN this/DT ORF/NN is/VBZ accessed/VBN ./.
@@30352189034 Identification/NNP of/IN p40x-responsive/NN regulatory/NN sequences/NN within/IN the/DT human/JJ T-cell/NN leukemia/NN virus/NN type/NN I/NN long/JJ terminal/JJ repeat/NN ./.
@@10229668427 A/DT cdc33-1/NEWGENE strain/NN expressing/JJ either/DT stable/JJ Cln3p/NEWGENE (/( Cln3-1p/NEWGENE )/SYM or/CC a/DT hybrid/NN UBI4/NEWGENE 5'-CLN3/NEWGENE mRNA/NN ,/, whose/WP translation/NN displays/VBP decreased/VBN dependence/NN on/IN eIF4E/NEWGENE ,/, arrested/VBD randomly/RB in/IN the/DT cell/NN cycle/NN ./.
@@21495708278 Cutaneous/JJ necrosis/NN associated/VBN with/IN protein/NEWGENE S/NEWGENE deficiency/NN ./.
@@72622397099 Effects/NNPS of/IN early/JJ monocular/JJ deprivation/NN on/IN development/NN of/IN cortico-geniculate/JJ projections/NNS in/IN the/DT cat/NN ./.
@@80394224927 The/DT nerve/NEWGENE growth/NEWGENE factor/NEWGENE beta/NEWGENE gene/NEWGENE (/( NGFB/NEWGENE )/SYM belongs/VBZ to/IN a/DT conserved/VBN syntenic/JJ group/NN on/IN human/JJ chromosome/NN 1/CD and/CC mouse/NN Chromosome/NN 3/CD ./CD
@@525976313 Studies/NNS on/IN immunoglobulin/NEWGENE E/NEWGENE :/: the/DT impact/NN of/IN a/DT sojourn/NN with/IN Professor/NNP Dan/NNP H/NNP ./NNP
@@104713835769 272/CD ,/, 1904/NN ]/NN ./.
@@113599076229 Several/JJ dozen/NN HIF-1/NEWGENE targets/NEWGENE are/VBP known/VBP ,/, including/JJ the/DT gene/NN encoding/VBG vascular/NEWGENE endothelial/NEWGENE growth/NEWGENE factor/NEWGENE (/( VEGF/NEWGENE )/SYM ./.
@@3001645554 The/DT pet56/NEWGENE and/CC his3/NEWGENE genes/NEWGENE are/VBP transcribed/VBN divergently/RB from/IN initiation/NN sites/NNS that/WDT are/VBP separated/VBN by/IN only/RB 192/CD bp/CD ./CD
@@94698333674 To/TO further/RB investigate/VB the/DT nature/NN of/IN the/DT site/NN specificity/NN a/DT set/NN of/IN deletion/NN mutants/NNS of/IN the/DT 160/CD bp/NN sequence/NN were/VBD analysed/VBN ./.
@@74148177265 Cataract/NNS extraction/NN in/IN primary/JJ glaucoma/NN ./.
@@62865495413 WR-2721/NN (/( S-2-/NN (/NN 3/NN aminopropylamino/NN )/SYM ethylphosphorothioic/JJ acid/NN )/NN has/VBZ been/VBN investigated/VBN for/IN its/PRP ability/NN to/IN protect/VB gut/JJ ,/, lung/NN ,/, and/CC testis/NN ,/, as/RB well/VB as/IN fibrosarcoma/NN (/( FSa/NN )/SYM tumor/NN nodules/NNS ,/, in/IN the/DT lungs/NNS of/IN mice/NNS from/IN gamma-radiation/NN injury/NN ./.
@@89551896776 The/DT 0/NEWGENE ./NEWGENE 22-kb/NEWGENE NheI/NEWGENE //NEWGENE BglII/NEWGENE promoter/NEWGENE exhibited/VBD PMA/NN inducibility/NN in/IN myeloid/JJ cells/NNS and/CC contained/VBD a/DT PMA-responsive/NEWGENE element/NEWGENE recognized/VBN by/IN Sp1/NEWGENE and/CC EGR-1/NEWGENE transcription/NEWGENE factors/NEWGENE ./.
@@99312529800 Both/DT mutations/NNS confer/VBP amino/JJ acid/NN substitutions/NNS in/IN the/DT viral/NEWGENE coat/NEWGENE protein/NEWGENE but/CC differ/VB in/IN their/PRP relative/JJ abilities/NNS to/IN utilize/VB the/DT foreign/JJ scaffolding/NEWGENE protein/NEWGENE ./.
@@76982198979 Cell/NNP adhesion/NN and/CC migration/NN assays/NNS demonstrate/VBP that/DT alpha/NEWGENE 6/NEWGENE beta/NEWGENE 1/NEWGENE is/VBZ the/DT major/JJ laminin/NEWGENE receptor/NEWGENE in/IN undifferentiated/JJ F9/NN cells/NNS as/RB well/VBP as/IN F9-derived/CD PE/NN cells/NNS ./.
@@36261294305 Effects/NNPS of/IN a/DT low-energy/JJ laser/NN beam/NN on/IN the/DT cells/NNS of/IN the/DT newt/NN embryo/NN ./.
@@74790048888 In/NN electrophoretic/JJ mobility/NN shift/NN assays/NNS ,/, the/DT PERE/NEWGENE formed/VBD three/CD major/JJ complexes/NNS (/( P1/NEWGENE ,/, P2/NEWGENE and/CC P3/NEWGENE )/SYM with/IN proteins/NNS in/IN nuclear/JJ extracts/NNS from/IN HeLa/DT or/CC 293/CD cells/NNS ./.
@@101963185623 CCAAT/NEWGENE displacement/NEWGENE protein/NEWGENE binds/VBZ to/IN and/CC negatively/RB regulates/VBZ human/NEWGENE papillomavirus/NEWGENE type/NEWGENE 6/NEWGENE E6/NEWGENE ,/, E7/NEWGENE ,/, and/CC E1/NEWGENE promoters/NEWGENE ./.
@@86103288585 SUMMARY/NNP OF/IN REVIEW/NNP :/: We/PRP discuss/VBP the/DT criteria/NNS that/WDT make/VBP such/JJ studies/NNS comparable/JJ ,/, drawing/JJ on/IN the/DT experiences/NNS of/IN recent/JJ studies/NNS performed/VBN around/IN the/DT world/NN ./.
@@112203064077 Multiple/NNP copies/NNS of/IN rsmB+/NEWGENE DNA/NEWGENE ,/, on/IN the/PDT other/DT hand/NN ,/, stimulate/VB exoenzyme/NN production/NN by/IN relieving/JJ the/DT negative/JJ effects/NNS of/IN a/DT chromosomal/JJ copy/NN of/IN hexA+/NEWGENE ./.
@@85526437094 Clones/NNS that/WDT expressed/VBD DBD/NN exhibited/VBD a/DT dominant/JJ negative/JJ phenotype/NN and/CC did/VBD not/RB elicit/VB antiviral/JJ activity/NN against/IN vesicular/JJ stomatitis/NN virus/NN (/( VSV/NN )/SYM infection/NN upon/IN IFN/NEWGENE treatment/NN ./.
@@96394106338 These/DT genes/NNS may/MD represent/VB interesting/JJ targets/NNS for/IN new/JJ therapeutic/JJ strategies/NNS ./.
@@89174496026 Leukemia-inhibitory/NEWGENE factor/NEWGENE (/( LIF/NEWGENE )/SYM is/VBZ a/DT neuropoietin/NEWGENE able/JJ to/IN regulate/VB the/DT differentiation/NN and/CC the/DT survival/NN of/IN many/JJ cell/NN types/NNS ,/, which/WDT include/VBP some/DT neuronal/JJ populations/NNS ./.
@@36224238131 Groups/NNS of/IN male/JJ and/CC female/JJ Fischer/NN 344/CD rats/NNS ,/, B6C3F1/NN mice/NNS ,/, and/CC Hartley/NNP guinea/NN pigs/NNS were/VBD exposed/VBN once/CC for/IN 6/CD hr/NN to/IN mean/JJ concentrations/NNS of/IN 10/CD ./CD 5/CD ,/, 5/CD ./CD 4/CD ,/, 2/CD ./CD 4/CD ,/, 1/CD ./CD 0/CD ,/, or/CC 0/CD (/( control/NN )/SYM ppm/NN of/IN methyl/NN isocyanate/NN (/( MIC/NN )/SYM vapor/NN ./.
@@94318121303 Here/RB we/PRP demonstrate/VBP that/DT Hh/NEWGENE and/CC Patched/NEWGENE (/( Ptc/NEWGENE )/SYM act/VB through/RB those/DT Ci/NEWGENE binding/NN sites/NEWGENE to/IN modulate/VB the/DT level/NN of/IN Ci-dependent/NNP transcriptional/JJ activation/NN in/IN S2/NN cells/NNS ./.
@@91530104319 The/DT main/JJ advantages/NNS of/IN Multi-MUP/NNP analysis/NN are/VBP :/: (/( 1/CD )/SYM quick/JJ acquisition/NN of/IN many/JJ MUPs/NNS ;/: (/( 2/CD )/SYM simultaneous/JJ collection/NN of/IN several/DT MUPs/NNS at/IN one/PRP recording/JJ site/NN ;/: (/( 3/CD )/SYM possibility/NN to/IN analyze/VB not/RB only/RB low/JJ threshold/NN MUPs/NNS ;/: (/( 4/CD )/SYM less/PRP bias/NN in/IN the/DT selection/NN of/IN MUPs/NNS and/CC (/( 5/CD )/SYM the/DT reproducibility/NN of/IN the/DT results/NNS that/WDT allow/VBP the/DT same/JJ reference/NN values/NNS to/IN be/VB used/VBN in/IN different/JJ laboratories/NNS ./.
@@10560997576 CONCLUSION/NN (/NN S/NN )/NN :/: Measuring/VBG urinary/NN LH/NEWGENE levels/NNS is/VBZ an/DT excellent/JJ method/NN for/IN determining/JJ ovulation/NN ./.
@@8902548828 Intraperitoneal/JJ administration/NN of/IN L-5-hydroxytryptophan/NN (/( L-5-HTP/NN )/SYM at/IN doses/NNS of/IN 25/CD to/IN 100/CD mg/CD //CD kg/CD dramatically/RB increase/VBP defecation/NN in/IN mice/NNS ./.
@@97485139497 Copyright/NNP 1998/CD Elsevier/NNP Science/NNP B/NNP ./NNP V/NNP ./.
@@109185969941 It/PRP is/VBZ now/RB well/VB accepted/VBN that/IN the/DT p53/NEWGENE C-terminus/NEWGENE plays/VBP a/DT central/JJ role/NN in/IN controlling/JJ the/DT activity/NN of/IN the/DT wild-type/NN molecule/NN ./.
@@115211912852 We/PRP have/VBP previously/RB shown/VBP that/IN the/DT adenoviral/NEWGENE 12S/NEWGENE E1A/NEWGENE protein/NEWGENE modulates/VBZ the/DT phosphorylation/NN status/NN of/IN p130/NEWGENE and/CC p107/NEWGENE without/IN apparent/JJ changes/NNS in/IN the/DT cell/NN cycle/NN dependent/JJ phosphorylation/NN of/IN the/DT retinoblastoma/NEWGENE protein/NEWGENE ./.
@@108280226085 Endostatin/NNP treatment/NN for/IN 10/CD minutes/NNS or/CC 24/CD hours/NNS induced/VBD tyrosine/NN phosphorylation/NN of/IN Shb/NEWGENE and/CC formation/NN of/IN multiprotein/JJ complexes/NNS ./.
@@78907402675 The/DT PSD2/NEWGENE gene/NEWGENE was/VBD heterologously/RB expressed/VBN by/IN infection/NN of/IN Sf-9/CD insect/NN cells/NNS with/IN recombinant/JJ baculovirus/NN ,/, resulting/JJ in/IN a/DT 10-fold/JJ increase/NN in/IN PSD/NEWGENE activity/NN ./.
@@78621297300 In/NN acute-phase/JJ livers/NNS ,/, we/PRP observed/VBD a/DT dramatic/JJ reduction/NN in/IN HNF-3/NEWGENE alpha/NEWGENE expression/NN which/WDT correlates/VBP with/IN a/DT decrease/NN in/IN the/DT expression/NN of/IN its/PRP target/NN gene/NN ,/, the/DT TTR/NEWGENE gene/NEWGENE ./.
@@118623501750 A/DT comparative/JJ study/NN of/IN the/DT effects/NNS of/IN carbamazepine/NN and/CC the/DT NMDA/NEWGENE receptor/NEWGENE antagonist/NN remacemide/NN on/IN road/NN tracking/JJ and/CC car-following/JJ performance/NN in/IN actual/JJ traffic/NN ./.
@@16470708281 All/DT mutant/NEWGENE JCV/NEWGENE T/NEWGENE antigens/NEWGENE bound/JJ to/IN JCV/DT and/CC SV40/NN origins/NNS of/IN DNA/NN replication/NN ./.
@@80017925251 The/DT git1/NEWGENE ,/, git3/NEWGENE ,/, git5/NEWGENE ,/, git7/NEWGENE ,/, git8/NEWGENE and/CC git10/NEWGENE genes/NEWGENE act/VBP upstream/RB of/IN adenylate/NEWGENE cyclase/NEWGENE ,/, presumably/RB encoding/VBG an/DT adenylate/NEWGENE cyclase/NEWGENE activation/NN pathway/NN ./.
@@1068158898 EMSA/NN showed/VBN that/IN nuclear/JJ proteins/NNS from/IN PC12/CELL but/CC not/RB C6/VB or/CC Rat2/NNP cells/NNS bind/VBP the/DT CRE/NEWGENE as/IN a/DT complex/NN containing/NN activating/NEWGENE transcription/NEWGENE factor/NEWGENE (/NEWGENE ATF/NEWGENE )/NEWGENE -4/NEWGENE and/CC CCAAT/NEWGENE enhancer-binding/NEWGENE protein/NEWGENE beta/NEWGENE ,/, while/CC both/DT PC12/CELL and/CC C6/NN cell/NN nuclear/JJ extracts/NNS were/VBD recruited/VBN by/IN the/DT CCAAT-box/NNP as/IN a/DT complex/NN containing/NN nuclear/NEWGENE factor/NEWGENE Y/NNP ./NNP
@@27962163488 The/DT disease/NN ran/VBP an/DT atypical/JJ course/NN ;/: with/IN early/JJ jaundice/NN syndrome/NN ,/, severe/JJ enterorrhagia/NN and/CC late/JJ appearance/NN of/IN roseola/NN ./.
@@104475938807 The/DT core/NN enzyme/NN is/VBZ homologous/JJ to/IN those/DT of/IN bacteriophages/NNS T3/NN ,/, T7/NN and/CC SP6/NN whereas/IN the/DT specificity/NN factor/NN shows/VBZ similarities/NNS with/IN bacterial/NEWGENE sigma/NEWGENE factors/NEWGENE ./.
@@97128595299 The/DT binding/NN of/IN NF-ATp/NEWGENE ,/, although/IN not/RB NF-AT4/NEWGENE ,/, to/IN this/DT enhancer/NN also/RB occurs/VBZ along/IN with/IN HTLV-I-mediated/JJ infection/NN of/IN human/JJ peripheral/JJ blood/NN T-cells/NNS ./.
@@76766557606 The/DT serum/JJ concentration/NN of/IN iP/NN before/IN dialysis/NN (/( HD/NN )/SYM was/VBD on/IN average/JJ 3/CD ./CD 06/CD (/( +/NN //NN -/NN 0/CD ./CD 81/CD )/SYM mmol/NN //NN l/NN and/CC D/NN was/VBD on/IN average/JJ 55/CD ./CD 6/CD (/( +/NN //NN -/NN 10/CD ./CD 0/CD )/SYM mmol/NN ./.
@@10501448043 Since/IN 1968/CD ,/, a/DT steep/JJ decrease/NN in/IN the/DT number/NN of/IN strains/NNS resistant/JJ to/IN three/CD or/CC more/JJ antibiotics/NNS (/( multiple-resistant/JJ )/SYM and/CC in/IN strains/NNS of/IN the/DT 83A/NN complex/NN was/VBD noticed/VBN ./.
@@111340334556 An/DT int6/NEWGENE deletion/NEWGENE (/( int6Delta/NEWGENE )/SYM mutant/NN was/VBD viable/JJ but/CC grew/VBD slowly/RB in/IN minimal/JJ medium/NN ./.
@@34436094147 The/DT role/NN of/IN supercritical/JJ fluid/NN chromatography/NN (/( SFC/NN )/SYM as/IN a/DT viable/JJ technique/NN for/IN analyzing/VBG agricultural/JJ products/NNS has/VBZ been/VBN investigated/VBN using/VBG packed/JJ and/CC capillary/JJ column/NN methodology/NN ./.
@@39368284596 Chronic/NN thyroiditis/NN as/IN a/DT risk/NN factor/NN of/IN B-cell/NN lymphoma/NN in/IN the/DT thyroid/JJ gland/NN ./.
@@105367886489 After/IN 14/CD d/NN of/IN overfeeding/NN ,/, hepatic/JJ PL/NN profiles/NNS were/VBD identical/JJ in/IN the/DT two/JJ breeds/NNS and/CC similar/JJ to/IN that/DT in/NN control/NN livers/NNS ;/: choline-containing/NN PL/NN accounted/VBN for/IN 95%/CD of/IN total/JJ PL/NNP ./NNP
@@9328173305 Iodine-123/NN was/VBD satisfactorily/RB imaged/VBN only/RB with/IN the/DT MEC/NN and/CC pinhole/NN collimators/NNS ,/, which/WDT in/IN turn/NN yielded/VBN MTF/NN values/NNS comparable/JJ to/IN those/DT measured/VBN for/IN 99mTc/NN ./.
@@90069141846 JNK/NEWGENE and/CC p38/NEWGENE are/VBP constitutively/RB present/VB in/IN the/DT nucleus/NN ,/, and/CC DNA-bound/NN c-JUN/NEWGENE and/CC ATF-2/NEWGENE are/VBP stably/RB contacted/VBN by/IN JNK/NEWGENE and/CC p38/NEWGENE ,/, respectively/RB ./.
@@16182562202 The/DT mean/JJ minimum/JJ steady-state/JJ concentration/NN after/IN the/DT oral/JJ regimen/NN (/( 23/CD micrograms/CD ./CD l-1/CD )/SYM was/VBD 78%/NN of/IN that/DT after/IN the/DT intramuscular/JJ regime/NN (/( 29/CD micrograms/CD ./CD l-1/CD )/SYM ./.
@@111979263131 BACKGROUND/IN :/: Previous/JJ studies/NNS have/VBP indicated/VBN that/IN the/DT 60-/NN ,/, 30-/NN ,/, 28-/DT and/CC 12-item/JJ versions/NNS of/IN the/DT General/NNP Health/NNP Questionnaire/NN (/( GHQ/IN )/SYM are/VBP liable/JJ to/IN retest/VB effects/NNS ,/, especially/RB when/CC administered/VBN multiple/JJ times/NNS with/IN short/JJ intervals/NNS ./.
@@33987141568 Increasing/VBG the/DT RH/NN beyond/RB 32%/RB resulted/VBN in/IN solvation/NN of/IN the/DT peroxy/JJ radical/NN ,/, sterically/RB hindering/JJ the/DT radical/NN from/IN entering/VBG the/DT propagation/NN transition/NN state/NN ./.
@@113687871425 Promoter/NNS transcriptional/JJ activity/NN was/VBD determined/VBN for/IN a/DT wide/JJ 5'/CD portion/NN of/IN the/DT human/NN annexin/NEWGENE A5/NEWGENE gene/NEWGENE ,/, from/IN bp/NN -1275/CD to/IN +79/NN relative/JJ to/IN the/DT most/RB 5'/CD of/IN several/DT discrete/JJ transcription/NN start/NN points/NNS ./.
@@1003258128 Depth-controlled/JJ grazing-incidence/JJ diffraction/NN of/IN synchrotron/NN x/NN radiation/NN ./.
@@78657873100 Our/PRP results/NNS suggested/VBN that/IN the/DT hexamer/NN and/CC the/DT octamer/NN motifs/NNS may/MD play/VB important/JJ role/NN (/NN s/NN )/NN in/IN regulation/NN of/IN replication-dependent/JJ but/CC not/RB of/IN replication-independent/JJ expression/NN of/IN the/DT wheat/NEWGENE histone/NEWGENE H3/NEWGENE gene/NEWGENE ./.
@@112741845654 These/DT results/NNS indicate/VBP that/IN ATF4/NEWGENE regulates/VBZ basal/JJ and/CC CdCl/NN (/NN 2/NN )/NN -induced/NN expression/NN of/IN the/DT ho-1/NEWGENE gene/NEWGENE in/IN a/DT cell-specific/JJ manner/NN and/CC possibly/RB in/IN a/DT complex/NN with/IN Nrf2/NEWGENE ./.
@@1005287854 Therefore/RB ,/, high/JJ set-up/NN accuracy/NN and/CC reproducibility/NN are/VBP mandatory/JJ ./.
@@10192432130 A/DT list/NN of/IN 12/CD names/NNS for/IN the/DT disease/NN and/CC 37/CD diagnostic/JJ criteria/NNS were/VBD proposed/VBN to/IN a/DT Consensus/NNP Panel/NNP of/IN 12/CD Italian/JJ experts/NNS who/WP ranked/VBD them/PRP in/IN order/NN so/RB as/IN to/IN identify/VB a/DT core/NN set/NN of/IN criteria/NNS ./.
@@111480429481 As/IN well/NN ,/, mixtures/NNS of/IN (/( LA/NN )/NN (/NN 12/NN )/NN with/IN the/DT longer/JJR chain/NN PEs/NNS exhibit/VBP unusual/JJ biomodal/JJ enthalpy/NN variations/NNS ,/, suggesting/VBG peptide/NN immiscibility/NN in/IN thicker/JJR gel/NN state/NN bilayers/NNS ./.
@@18081366692 The/DT effects/NNS of/IN contrast/NN media/NN on/IN coagulation/NEWGENE factor/NEWGENE XII/NEWGENE ./.
@@113906848028 Evidence/NN from/IN a/DT Northern/NNP hybridization/NN indicated/VBD that/DT jadM/NEWGENE expression/NN is/VBZ correlated/VBN with/IN jadomycin/NEWGENE B/NEWGENE synthesis/NN ./.
@@74878116734 Two/CD experiments/NNS investigating/VBG the/DT effects/NNS of/IN short-term/JJ spaceflight/NN on/IN cancellous/JJ bone/NN turnover/NN were/VBD carried/VBN out/RB :/: Physiological/NNP Systems/NNPS Experiment-1/NN (/( PSE-1/NN )/SYM (/( a/DT 4-d/JJ orbital/JJ spaceflight/NN )/SYM and/CC PSE-2/NN (/( a/DT 10-d/JJ flight/NN )/SYM ./.
@@113915312916 Mutation/NN of/IN the/DT NF-kappaB/NEWGENE site/NEWGENE in/IN the/DT Mdr1b/NEWGENE promoter/NEWGENE prevents/VBZ its/PRP induction/NN by/IN TNF-alpha/NEWGENE ./.
@@97545713795 A/DT 5/CD ./CD 0-kb/CD transcript/NN detected/VBN by/IN the/DT differential/JJ display/NN amplicon/NN 3G1/NN was/VBD found/VBN to/IN correlate/NN strongly/RB with/IN RAG1/NEWGENE mRNA/NEWGENE expression/NN in/IN various/JJ human/JJ cell/NN lines/NNS ./.
@@9560325383 Post-translational/JJ modifications/NNS such/JJ as/IN glycosylation/NN and/CC phosphorylation/NN could/MD be/VB excluded/VBN as/IN potential/JJ explanations/NNS for/IN the/DT protein/NN heterogeneity/NN ./.
@@75484255403 In/NN 4/CD spinalized/VBN cats/NNS ,/, the/DT effects/NNS of/IN afferent/JJ inputs/NNS from/IN hindlimb/NN cutaneous/JJ nerves/NNS (/( sural/JJ cutaneous/JJ nerve/NN :/: Sur/FW )/SYM on/IN mono-and/JJ poly-synaptic/JJ reflex/NN recorded/VBN from/IN tail/NN muscle/NN motoneurons/NNS were/VBD studied/VBN before/IN and/CC after/IN spinal/JJ lesioning/VBG at/IN S2-3/NN level/NN ./.
@@87639534992 One/CD unit/NN encodes/VBZ traA/NEWGENE ,/, traF/NEWGENE ,/, and/CC traB/NEWGENE ,/, while/CC the/DT second/JJ encodes/NNS traC/NEWGENE ,/, traD/NEWGENE ,/, and/CC traG/NEWGENE ./.
@@73270975578 In/NN PB/NN mice/NNS ,/, there/RB was/VBD only/RB a/DT small/JJ deficit/NN in/IN the/DT number/NN of/IN the/DT hippocampal/JJ pyramidal/JJ neurons/NNS compared/VBN to/IN controls/NNS (/( 15%/JJ ,/, p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ,/, and/CC no/DT deficit/NN in/IN the/DT granule/NN cells/NNS ./.
@@65353846325 In/NN the/DT Arithmetic/NNP subtest/NN one/PRP of/IN the/DT items/NNS would/MD not/RB meet/VB the/DT difficulty/NN grading/JJ shown/VBP while/CC the/DT last/JJ two/JJ items/NNS offer/VBP very/RB little/JJ possibility/NN of/IN success/NN for/IN all/DT subjects/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@18787552488 In/NN the/DT ileum/NN ,/, enterotoxin/NEWGENE increased/VBD the/DT luminal/JJ disappearance/NN (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM and/CC peripheral/JJ blood/NN appearance/NN (/( P/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM of/IN chloroquine/NN ./.
@@111607426850 Both/DT Z/NEWGENE and/CC R/NEWGENE expression/NN resulted/VBN in/IN PML/NN dispersion/NN in/IN EBV-positive/NNP cells/NNS ./.
@@107925837584 Regulation/NN of/IN pituitary/JJ vasopressin/NEWGENE V1b/NEWGENE receptors/NEWGENE plays/VBP a/DT critical/JJ role/NN in/IN regulating/JJ pituitary/NEWGENE adrenocorticotropic/NEWGENE hormone/NEWGENE (/( ACTH/NEWGENE )/SYM secretion/NN during/IN adaptation/NN to/IN stress/NN ./.
@@99167869081 Measurements/NNS included/VBD bone/NN mineral/JJ density/NN of/IN the/DT lumbar/JJ spine/NN and/CC proximal/JJ femur/NN (/( by/IN dual-energy/JJ X-ray/NN absorptiometry/NN )/SYM and/CC biochemical/JJ markers/NNS of/IN bone/NN remodeling/NN (/( serum/JJ bone-specific/NN alkaline/NEWGENE phosphatase/NEWGENE by/IN immunoassay/NN and/CC urine/NN deoxypyridinoline/NN by/IN high-pressure/JJ liquid/JJ chromatography/NN )/SYM ./.
@@84229755617 The/DT obvious/JJ functional/JJ necessity/NN for/IN editing/VBG in/IN kinetoplastid/NN mitochondria/NNS is/VBZ the/DT formation/NN of/IN translatable/JJ mRNAs/NNS ./.
@@87026336186 The/DT mechanism/NN involves/VBZ Gbetagamma/NEWGENE subunit-mediated/JJ increases/NNS in/IN tyrosine/NN phosphorylation/NN of/IN the/PDT Shc/NEWGENE adapter/NEWGENE protein/NEWGENE ,/, Shc*Grb2/NEWGENE complex/NEWGENE formation/NN ,/, and/CC recruitment/NN of/IN Ras/NEWGENE guanine/NEWGENE nucleotide/NEWGENE exchange/NEWGENE factor/NEWGENE activity/NN ./.
@@28727869549 The/DT Hagen-Poiseuille/NN equation/NN is/VBZ used/VBN to/IN assess/VB the/DT effects/NNS of/IN attached/VBN parasites/NNS in/IN the/DT foregut/NN of/IN Leishmania-infected/JJ sandflies/NNS on/IN blood/NN flow/NN ./.
@@3023067834 Translation/NNP of/IN specific/JJ cellular/JJ genes/NNS from/IN the/DT chimeric/JJ viral-cellular/NN transcripts/NN seems/VBZ to/IN be/VB unlikely/JJ ./.
@@79887312491 Recently/RB ,/, a/DT protein/NN designated/VBN GF14/NEWGENE has/VBZ been/VBN isolated/VBN that/WDT is/VBZ associated/VBN with/IN the/DT GBF/NEWGENE protein/NEWGENE complex/NEWGENE ./.
@@76107357519 Diltiazem/NN caused/VBN significant/JJ decrease/NN in/IN the/DT ventricular/JJ response/NN without/IN conversion/NN to/IN sinus/NN rhythm/NN ./.
@@35139894194 Although/IN not/RB common/JJ ,/, the/DT disorder/NN is/VBZ the/DT most/RB frequently/RB diagnosed/VBN disturbance/NN of/IN porphyrin/NN metabolism/NN in/IN many/JJ countries/NNS ,/, and/CC further/JJ insight/NN into/IN its/PRP unusual/JJ pathogenesis/NN may/MD clarify/VB the/DT hepatotoxic/JJ effects/NNS of/IN the/DT 4/CD etiologic/JJ agents/NNS ./.
@@94601719310 Resistance/NNP to/IN thyroid/JJ hormone/NN :/: implications/NNS for/IN neurodevelopmental/JJ research/NN on/IN the/DT effects/NNS of/IN thyroid/NN hormone/NN disruptors/NN ./.
@@107793139672 We/PRP conclude/VBP that/IN ,/, both/DT in/NN atrial/JJ myocytes/NNS and/CC in/IN Xenopus/JJ oocytes/NNS ,/, beta-adrenergic/JJ stimulation/NN potentiates/VBZ the/DT ACh-evoked/JJ GIRK/NEWGENE channels/NEWGENE via/NN a/DT pathway/NN that/WDT involves/VBZ PKA-catalyzed/JJ phosphorylation/NN downstream/RB from/IN beta/NEWGENE (/NEWGENE 2/NEWGENE )/NEWGENE AR/NEWGENE ./.
@@95823437598 We/PRP established/VBD the/DT radiosensitive/JJ cell/NN line/NN SX9/CD from/IN mammary/JJ carcinoma/NN cell/NN line/NN FM3A/CELL ./.
@@81286296713 CRS/NEWGENE function/NN in/IN a/DT 5'/NEWGENE LTR-linked/NEWGENE gene/NEWGENE expression/NN assay/NN correlates/VBP with/IN the/DT ability/NN of/IN both/DT p60CRS/NEWGENE and/CC p40CRS/NEWGENE to/IN interact/VB with/IN 5'/NEWGENE LTR/NEWGENE RNA/NEWGENE in/IN vitro/FW ./.
@@93343302531 Null/NNP mutations/NNS in/IN daf-3/NEWGENE suppress/VB mutations/NNS in/IN genes/NNS encoding/VBG this/DT TGF-beta/NEWGENE signal/JJ ,/, its/PRP receptors/NNS ,/, and/CC associated/VBD Smad/NEWGENE signal/NEWGENE transduction/NEWGENE proteins/NEWGENE ./. daf-3/NEWGENE encodes/VBZ a/DT Smad/NEWGENE protein/NEWGENE that/WDT is/VBZ most/RB closely/RB related/VBN to/IN mammalian/NEWGENE DPC4/NEWGENE ,/, and/CC is/VBZ expressed/VBN throughout/IN development/NN in/IN many/NN of/IN the/DT tissues/NNS that/WDT are/VBP remodeled/VBN during/IN dauer/NN development/NN ./.
@@75596399136 In/NN addition/NN ,/, the/DT R206S/NEWGENE HSF/NEWGENE substitution/NN exhibits/VBP constitutive/JJ transcriptional/JJ activation/NN from/IN a/DT consensus/NN HSE/NEWGENE (/( HSE2/NEWGENE )/SYM ./.
@@11030066860 The/DT major/JJ neurological/JJ manifestations/NNS of/IN brain/NN injury/NN in/IN these/DT babies/NNS are/VBP spastic/JJ motor/JJ deficits/NNS ./.
@@386251319 The/DT IDF/NN standard/JJ method/NN for/IN the/DT detection/NN of/IN penicillin/NN in/IN milk/NN is/VBZ not/RB suitable/JJ for/IN the/DT detection/NN of/IN sulphonamide/NN residues/NNS in/IN milk/NN ./.
@@7802355823 Comparative/JJ study/NN of/IN the/DT differential/JJ white/JJ blood/NN cell/NN count/NN using/VBG three/CD automated/JJ analyzers/NNS :/: Coulter/NN STKS/NN ,/, Sysmex/NN NE/NN 8000/CD and/CC Technicon/VB H-1/NN ./.
@@84972691238 This/DT sequence/NN similarity/NN raises/VBP the/DT possibility/NN that/IN GCN1/NEWGENE interacts/VBZ with/IN ribosomes/NNS or/CC tRNA/NN molecules/NNS and/CC functions/NNS in/IN conjunction/NN with/IN GCN2/NEWGENE in/IN monitoring/VBG uncharged/JJ tRNA/NN levels/NNS during/IN the/DT process/NN of/IN translation/NN elongation/NN ./.
@@94633807517 Moreover/RB ,/, xTAK1KN/NEWGENE could/MD block/VB the/DT expression/NN of/IN ventral/JJ mesoderm/NN marker/NN genes/NNS induced/VBN by/IN Smad1/NEWGENE or/NEWGENE 5/NEWGENE ./.
@@2445751729 The/DT first/RB involved/VBN measurements/NNS of/IN the/DT steady/JJ state/NN levels/NNS of/IN mRNAs/NNS for/IN subunit/NN 5/CD of/IN cytochrome/NEWGENE oxidase/NEWGENE and/CC the/DT beta/NN subunit/NN of/IN F1/NEWGENE ATPase/NEWGENE in/IN wild/JJ type/NN and/CC in/IN a/DT hem2/NEWGENE mutant/NEWGENE ./.
@@733447190 In/NN 2/CD subjects/VBZ the/DT phytomitogen/NN reactivity/NN of/IN the/DT lymphocytes/NNS was/VBD improved/VBN after/IN treatment/NN ./.
@@68153686589 The/DT osmotic/JJ diuretic/JJ mannitol/NN was/VBD administered/VBN to/IN 21/CD patients/NNS ./.
@@75902683313 A/DT 2/NEWGENE ./NEWGENE 4-kb/NEWGENE MAPKAPK-2/NEWGENE message/NEWGENE is/VBZ expressed/VBN throughout/IN development/NN ,/, while/CC two/RB shorter/JJR transcripts/NNS of/IN 2/CD ./CD 3/CD and/CC 1/CD ./CD 8/CD kb/NN appear/VB to/IN be/VB specifically/RB expressed/VBN in/IN the/DT germline/NN ./.
@@91214241901 Here/RB we/PRP characterize/VBP an/DT S/NEWGENE ./NEWGENE cerevisiae/NEWGENE Swi3/NEWGENE homolog/NEWGENE (/( Swh3/NEWGENE )/SYM and/CC present/VB evidence/NN that/IN it/PRP associates/VBP in/IN a/DT complex/NN with/IN a/DT Snf2/NEWGENE homolog/NEWGENE ,/, Sthl/NEWGENE ./.
@@90181333768 Phylogenetic/JJ analysis/NN gave/VBD evidence/NN for/IN a/DT close/JJ evolutionary/JJ relationship/NN between/IN PhHV-1/NN and/CC members/NNS of/IN the/DT Varicellovirus/NNP genus/NN of/IN the/DT alpha-Herpesvirinae/NN and/CC canid/NN herpesvirus/NN in/IN particular/NN ./.
@@86043381124 Both/DT EWS-FLI-1/NEWGENE and/CC FLI-1/NEWGENE proteins/NEWGENE function/NN as/IN transcription/NN factors/NNS that/WDT bind/VBP specifically/RB to/IN ets/NEWGENE sequences/NEWGENE (/( the/DT ets/NEWGENE boxes/NEWGENE )/SYM present/VB in/IN promoter/NN elements/NNS ./.
@@73793349880 Changes/NNS in/IN immunologic/JJ reactivity/NN in/IN subjects/NNS receiving/JJ transfer/NEWGENE factor/NEWGENE could/MD not/RB be/VB distinguished/VBN from/IN those/DT in/NN subjects/NNS receiving/JJ placebo/NN ./.
@@64281166227 Transitory/JJ subclinical/JJ and/CC permanent/JJ hypothyroidism/NN in/IN the/DT course/NN of/IN subacute/JJ thyroiditis/NN (/( de/FW Quervain/NN )/SYM ./.
@@105972234460 Transient/JJ ,/, high-level/NNP Ras-expression/NN induces/VBZ transcriptional/JJ activation/NN of/IN p21/NEWGENE mediated/JJ by/IN a/DT GC-rich/NNP region/NN in/IN p21/NEWGENE promoter/NEWGENE -83-54/JJ bp/NN relative/JJ to/IN the/DT transcription/NN initiation/NN site/NN containing/NN binding/NN sites/NN for/IN Sp1-family/NEWGENE transcription/NEWGENE factors/NEWGENE ./.
@@13325891963 The/DT MICs/NNS of/IN this/DT compound/NN against/IN 90%/CD of/IN these/DT organisms/NNS ,/, except/VB for/IN methicillin-resistant/NNP S/NNP ./NNP aureus/NN ,/, ranged/VBN from/IN less/PRP than/IN or/CC equal/NN to/IN 0/CD ./CD 006/CD to/IN 3/CD ./CD 13/CD micrograms/NN //NN ml/NN ./.
@@68513273029 Five/CD patients/NNS with/IN type/NN III/NN musculoskeletal/JJ infection/NN from/IN nongonococcal/JJ Neisseria/NN species/NN were/VBD examined/VBN during/IN a/DT 13-month/CD period/NN ./.
@@37807044461 A/DT large/JJ increase/NN of/IN serum/JJ ketones/NNS occurred/VBN under/IN all/DT conditions/NNS ,/, and/CC the/DT exercise/NN respiratory/JJ quotient/NN suggested/VBD some/DT increase/NN of/IN fat/JJ utilization/NN ,/, WW/NN (/( 0/CD ./CD 85/CD )/SYM through/RB CW/JJ (/( 0/CD ./CD 84/CD )/SYM to/IN CC/NN (/( 0/CD ./CD 83/CD )/SYM ./.
@@92248112812 The/DT current/JJ study/NN demonstrates/VBZ that/IN T3-activated/JJ transcription/NN of/IN the/DT NADPH/NN :/: cytochrome/NEWGENE P450/NEWGENE oxidoreductase/NEWGENE (/( P450R/NEWGENE )/SYM gene/NN is/VBZ dependent/JJ on/IN the/DT thyroid/JJ hormonal/JJ status/NN of/IN the/DT animal/NN ,/, with/IN both/DT transcriptional/JJ and/CC post-transcriptional/JJ pathways/NNS being/VBP important/JJ in/IN regulating/JJ the/DT cellular/JJ P450R/NEWGENE mRNA/NEWGENE level/NN ./.
@@14686251883 From/IN this/DT library/NN ,/, LEU2/NEWGENE and/CC HIS3/NEWGENE cDNAs/NNS were/VBD recovered/VBN at/IN a/DT frequency/NN of/IN about/RB 1/CD in/IN 10/NN (/NN 4/NN )/NN and/CC in/IN 12/CD out/RB of/IN 13/CD cases/VBZ these/DT were/VBD expressed/VBN in/IN a/DT galactose-dependent/JJ manner/NN ./.
@@87260241533 However/RB ,/, as/IN determined/VBN by/IN PCR/NN with/IN primers/NNS specific/JJ for/IN the/DT 26-kDa/NN product/NN ,/, the/DT majority/NN of/IN cats/NNS at/IN 2/CD and/CC 4/CD weeks/NNS p/CD ./CD t/CD ./. had/VBP gastric/JJ fluid/NN samples/NNS which/WDT were/VBD positive/JJ for/IN H/NNP ./NNP pylori/NNS and/CC three/CD of/IN three/CD cats/NNS at/IN 2/CD weeks/NNS p/CD ./CD t/CD ./. had/VBP dental/JJ plaque/NN which/WDT was/VBD positive/JJ for/IN H/NNP ./NNP pylori/NNS ./.
@@24973407411 Functional/NEWGENE rearranged/NEWGENE antibody/NEWGENE genes/NEWGENE were/VBD detected/VBN with/IN JH/NEWGENE and/CC VH/NEWGENE heavy/NEWGENE chain/NEWGENE probes/NNS and/CC with/IN Jk/NEWGENE and/CC Vk/NEWGENE light/NEWGENE chain/NEWGENE probes/NNS ./.
@@19994597633 A/NNP ./NNP
@@63545946156 Sweet/JJ oranges/NNS ,/, mandarin/NN ,/, grapefruit/NN ,/, lemon/NN ,/, and/CC lime/NN are/VBP generally/RB used/VBN for/IN processing/VBG ./.
@@15869012176 Drug-drug/NNP interactions/NNS are/VBP most/RB likely/RB to/IN occur/VB in/IN patients/NNS receiving/JJ multiple/JJ medications/NNS and/CC with/IN drugs/NNS that/WDT have/VBP a/DT narrow/JJ therapeutic/JJ window/NN ./.
@@93637592353 Protein/NEWGENE phosphatases/NEWGENE play/VBP a/DT critical/JJ role/NN in/IN the/DT regulation/NN of/IN the/DT eukaryotic/JJ cell/NN cycle/NN and/CC signal/JJ transduction/NN ./.
@@92613972453 Gag/NEWGENE protein/NN sequence/NN motifs/NN of/IN the/DT NC/NEWGENE domain/NEWGENE of/IN primate/NN foamy/JJ viruses/NNS assumed/VBN to/IN be/VB involved/VBN in/IN genome/NN encapsidation/NN are/VBP not/RB conserved/VBN in/IN FeFV/NNP ./.
@@88876676597 The/DT requirement/NN of/IN Tyr-19/CD dephosphorylation/NN for/IN spindle/NN assembly/NN is/VBZ also/RB observed/VBN under/IN conditions/NNS in/IN which/WDT spindle/VBP formation/NN is/VBZ independent/NN of/IN mitosis/NN ,/, suggesting/VBG that/IN the/DT involvement/NN of/IN Cdc28/NEWGENE //NEWGENE Clb/NEWGENE kinase/NEWGENE in/IN SPB/NNP separation/NN is/VBZ direct/JJ ./.
@@90460135982 The/DT neuroprotective/JJ efficacy/NN of/IN the/DT selective/JJ N-type/NN voltage-sensitive/JJ calcium/NN channel/NN blocker/NN ,/, SNX-111/NN ,/, was/VBD evaluated/VBN in/IN spontaneously/RB hypertensive/JJ rats/NNS subjected/VBN to/IN 60/CD min/NN of/IN focal/JJ cerebral/JJ ischemia/NN by/IN permanent/JJ ligation/NN of/IN the/DT right/JJ common/JJ carotid/JJ artery/NN and/CC temporary/JJ occlusion/NN of/IN the/DT right/JJ middle/JJ cerebral/JJ artery/NN ./.
@@110461533018 Further/RB ,/, Tax-mediated/JJ apoptosis/NN was/VBD effectively/RB prevented/VBN by/IN ectopic/JJ expression/NN of/IN the/DT p300/NEWGENE coactivator/NEWGENE ./.
@@1008043680 Comparison/NNS of/IN frequencies/NNS of/IN atrial/JJ fibrillation/NN after/IN coronary/JJ artery/NN bypass/NN grafting/NN with/IN and/CC without/IN the/DT use/NN of/IN cardiopulmonary/JJ bypass/NN ./.
@@110530097155 Aspirin/NNP causes/VBZ peptic/JJ ulcers/NNS predominately/RB by/IN reducing/JJ gastric/NEWGENE mucosal/NEWGENE cyclooxygenase/NEWGENE (/( COX/NEWGENE )/SYM activity/NN and/CC prostaglandin/NN synthesis/NN ./.
@@105981017620 The/DT mEmBP-1/NEWGENE protein/NEWGENE can/MD activate/VB transcription/NN from/IN a/DT truncated/JJ promoter/NN containing/NN a/NN pentamer/NN of/IN the/DT O2/NEWGENE site/NEWGENE in/IN yeast/NN cells/NNS ;/: however/RB ,/, it/PRP inhibited/VBD regulated/VBN transcription/NN of/IN a/DT 22/NEWGENE kDa/NEWGENE zein/NEWGENE promoter/NEWGENE in/IN a/DT transient/JJ expression/NN assay/NN using/VBG cultured/JJ maize/NN endosperm/NN cells/NNS ./.
@@100754155144 Partial/JJ sequencing/VBG of/IN the/DT region/NN downstream/RB of/IN ORF-Pto/NNP revealed/VBD homology/NN to/IN the/DT ru/NEWGENE //NEWGENE AB/NEWGENE genes/NEWGENE ,/, involved/VBN in/IN UV/NN resistance/NN ,/, from/IN plasmid/NN pPSR1/NN ./.
@@10961585780 The/DT manifestations/NNS often/RB include/VBP a/DT moderate/JJ thrombocytopenia/NN and/CC ,/, less/PRP commonly/RB ,/, hemolysis/NN ./.
@@40021314663 During/IN a/DT disease/NN remission/NN there/RB was/VBD an/DT increase/NN in/IN GAG/NNP secretion/NN with/IN urine/NN ,/, linked/JJ with/IN hyperheparinuria/NN (/( 13/NN ./NN 1-fold/NN ,/, P/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@34175884117 Liquid/NNP chromatographic/JJ method/NN for/IN determination/NN of/IN citreoviridin/NN in/IN corn/NN and/CC rice/NN ./.
@@80958754146 Effects/NNPS of/IN moderate/JJ hypercapnia/NN on/IN hypothermia/NN induced/VBN by/IN cold/JJ He-O2/NN in/IN rats/NNS ./.
@@77046897655 Solitary/NNP thyroid/JJ nodule/NN ./.
@@108659404463 The/DT antioxidant/JJ agent/NN pyrrolidine/NN dithiocarbamate/NN (/( PDTC/NN )/SYM has/VBZ been/VBN shown/VBP to/IN protect/VB endothelial/JJ cells/NNS (/( EC/NN )/SYM from/IN pro-inflammatory-induced/JJ and/CC pro-oxidant-induced/NN NF-kappaB/NEWGENE activation/NN ./.
@@104480369436 The/DT interaction/NN of/IN zf4-6/NEWGENE with/IN full-length/NEWGENE 5/NEWGENE S/NEWGENE RNA/NEWGENE was/VBD far/RB more/RB sensitive/JJ to/IN non-specific/JJ competitor/NN concentration/NN than/IN was/VBD the/DT zf4-7/NEWGENE :/: 5/NEWGENE S/NEWGENE RNA/NEWGENE interaction/NN ,/, suggesting/VBG that/DT finger/NN seven/NN contributes/VBZ to/IN both/DT affinity/NN and/CC specificity/NN in/IN this/DT protein/NN :/: RNA/NN interaction/NN ./.
@@118041005504 It/PRP was/VBD found/VBN that/IN the/DT disappearance/NN of/IN BOD5/NN and/CC NH3-N/NN could/MD be/VB approximated/VBN using/VBG first-order/JJ kinetics/NN ,/, but/CC the/DT kinetics/NN of/IN TP/NN removal/NN were/VBD unclear/JJ ./.
@@28181223517 A/DT great/JJ deal/NN of/IN information/NN is/VBZ available/JJ on/IN the/DT morphology/NN of/IN the/DT claustrum/NN in/IN various/JJ animal/NN species/NN ,/, as/RB well/VB as/IN on/IN its/PRP neuronal/JJ distribution/NN and/CC relationships/NNS with/IN the/DT cerebral/JJ cortex/NN and/CC other/DT nuclei/NNS ./.
@@106923741051 These/DT results/NNS suggest/VBP that/IN the/DT M/NNP ./NNP jannaschii/NN as/RB well/VB as/IN related/VBN archaeal/JJ 20S/CD proteasomes/NNS require/VBP a/DT nucleotidase/NEWGENE complex/NEWGENE such/JJ as/IN PAN/NEWGENE to/IN mediate/VB the/DT energy-dependent/JJ hydrolysis/NN of/IN folded-substrate/NN proteins/NN and/CC that/IN the/DT N-terminal/NN 73/NN amino/JJ acid/NN residues/NNS of/IN PAN/NEWGENE are/VBP not/RB absolutely/RB required/VBN for/IN this/DT reaction/NN ./.
@@83871552280 This/DT stimulatory/JJ effect/NN could/MD also/RB be/VB elicited/VBN by/IN c-Jun/NEWGENE ,/, which/WDT interacts/VBZ with/IN topo/NEWGENE II/NEWGENE ,/, but/CC not/RB by/IN c-Fos/NEWGENE ,/, which/WDT does/VBP not/RB bind/VB topo/NEWGENE II/NEWGENE in/IN our/PRP in/IN vitro/FW assay/NN ./.
@@74943066607 Here/RB we/PRP examine/VBP the/DT potential/NN for/IN VP16/NEWGENE protein-protein/NN interactions/NNS specific/JJ to/IN virus-infected/JJ cells/NNS and/CC show/VB that/DT VP16/NEWGENE copurifies/VBZ in/IN a/DT highly/RB enriched/VBN fraction/NN with/IN a/DT single/JJ major/JJ polypeptide/NN which/WDT we/PRP identify/VBP as/IN the/DT virus-encoded/JJ structural/NN protein/NN VP22/NEWGENE ./.
@@415124819 Abstracts/NNP ./.
@@97776009763 A/DT simple/JJ analytical/JJ method/NN for/IN l-menthol/NN by/IN high-performance/JJ liquid/JJ chromatography/NN with/IN a/DT polarized/JJ photometric/JJ detector/NN was/VBD established/VBN ./.
@@111870161028 Multistage/NNP models/NNS and/CC the/DT A-bomb/NN survivor/NN data/NN :/: implications/NNS for/IN carcinogenic/JJ mechanisms/NNS ?/.
@@9050689790 The/DT best/JJS endometrial/JJ ablation/NN was/VBD seen/VBP when/CC SnET2/NN was/VBD given/VBP by/IN intrauterine/JJ administration/NN with/IN light/NN treatment/NN at/IN 150/CD J/NNP //NNP cm/NNP 24/CD hours/NNS later/JJR ./.
@@75606627452 After/IN recovery/NN ,/, a/DT hypertonic/JJ saline/JJ challenge/NN was/VBD performed/VBN ./.
@@21155726777 We/PRP also/RB discovered/VBD a/DT V/NEWGENE lambda/NEWGENE pseudogene/NEWGENE ,/, called/VBN psi/NEWGENE V/NEWGENE lambda/NEWGENE 1/NEWGENE ,/, 3/CD kb/NN upstream/RB of/IN the/DT U266/NEWGENE lambda/NEWGENE gene/NEWGENE ./.
@@10079179 These/DT results/NNS indicate/VBP that/IN cynomolgus/JJ monkeys/NNS are/VBP either/DT less/PRP sensitive/JJ or/CC respond/VB differently/RB than/IN rhesus/NN monkeys/NNS to/IN some/DT of/IN the/DT pharmacological/JJ effects/NNS of/IN norcocaine/NN ./.
@@12353471870 Experimental/JJ cardiotoxicity/NN of/IN adriamycin/NN ./.
@@23103502960 The/DT present/NN study/NN examined/VBD the/DT effect/NN of/IN intensity/NN ,/, rate/NN ,/, and/CC polarity/NN on/IN the/DT spectral/JJ content/NN of/IN ABRs/NNS of/IN 15/CD normal-hearing/JJ subjects/NNS ./.
@@88089242626 Its/PRP hydropathy/NN profile/NN predicts/VBZ seven/JJ transmembrane/JJ spans/NNS and/CC a/DT hydrophilic/JJ amino/JJ terminus/NN of/IN approximately/RB 100/CD residues/NNS ,/, and/CC it/PRP suggests/VBZ the/DT presence/NN of/IN an/DT amphiphilic/JJ alpha-helix/NN (/( L-61/NN to/IN F-97/CD )/SYM in/IN close/JJ proximity/NN to/IN the/DT first/JJ strongly/RB hydrophobic/JJ segment/NN of/IN ProW/NEWGENE ./.
@@106534004668 The/DT applicability/NN of/IN laparoscopic/JJ donor/NN nephrectomy/NN (/( LDN/NN )/SYM has/VBZ not/RB been/VBN assessed/VBN in/IN the/DT obese/JJ donor/NN ./.
@@104881481916 ERK/NEWGENE MAP/NEWGENE1 kinase/NEWGENE1 links/NNS cytokine/NN signals/NNS to/IN activation/NN of/IN latent/JJ HIV-1/NNP infection/NN by/IN stimulating/JJ a/DT cooperative/JJ interaction/NN of/IN AP-1/NEWGENE and/CC NF-kappaB/NEWGENE ./.
@@15848128418 Neural-specific/NN expression/NN ,/, genomic/JJ structure/NN ,/, and/CC chromosomal/JJ localization/NN of/IN the/DT gene/NN encoding/VBG the/DT zinc-finger/NEWGENE transcription/NEWGENE factor/NEWGENE NGFI-C/NEWGENE ./.
@@33668649283 The/DT skin/NN site/NN ,/, 6-cm-distal/NN and/CC -proximal/CD subcutaneous/JJ segments/NNS of/IN the/DT catheter/NN ,/, exudates/NNS ,/, and/CC blood/NN were/VBD cultured/JJ ./.
@@53056715463 A/DT brief/JJ discussion/NN of/IN color/NN deficiencies/NNS ./.
@@104883378017 A/DT human/JJ nuclear-localized/JJ chaperone/NN that/WDT regulates/VBZ dimerization/NN ,/, DNA/NN binding/JJ ,/, and/CC transcriptional/JJ activity/NN of/IN bZIP/NEWGENE proteins/NEWGENE ./.
@@93253228778 The/DT inhibition/NN by/IN cytosolic/JJ Ca2+/NN was/VBD caused/VBN by/IN a/DT decrease/NN in/IN cooperativity/NN and/CC by/IN a/DT shift/NN in/IN EC50/NN toward/IN higher/JJ InsP3/NN concentrations/NNS ./.
@@78362187938 Some/DT studies/NNS of/IN exercise/NN have/NN associated/VBD beta-endorphin/NEWGENE release/NN with/IN increased/VBN exertion/NN levels/NNS ,/, but/CC other/DT evidence/NN suggests/VBZ that/DT acidosis/NN may/MD stimulate/VB the/DT release/NN of/IN beta-endorphin/NEWGENE ./.
@@1170438054 The/DT event/NN rate/NN in/IN patients/NNS with/IN chronic/JJ Irr-rMFP/NN or/CC Un-nrMFP/NN was/VBD markedly/RB higher/JJ than/IN it/PRP was/VBD in/IN those/DT with/IN Rev-rMFP/NNP or/CC Sta-nrMFP/NNP ./.
@@21131749335 Krox-24/NEWGENE is/VBZ therefore/RB a/DT sequence-specific/NN transcriptional/NN activator/NN ./.
@@84289076479 In/NN wandering/JJ stage/NN larvae/NNS ,/, the/DT OBP/NEWGENE transcript/NEWGENE appeared/VBN to/IN be/VB at/IN least/RB 250-fold/JJ less/PRP abundant/JJ than/IN ribosomal/NEWGENE RNA/NEWGENE ./.
@@83942554766 A/DT sheep/NN testicular/JJ cDNA/NN library/NN constructed/VBN in/IN pcDNA1/NNP vector/NN was/VBD screened/VBN with/IN a/DT probe/NN generated/VBN by/IN polymerase/NN chain/NN reaction/NN (/( PCR/NN )/SYM and/CC corresponding/JJ to/IN a/DT 1/CD ./CD 6/CD kb/NN fragment/NN of/IN the/DT rat/NEWGENE luteinizing/NEWGENE hormone/NEWGENE receptor/NEWGENE cDNA/NEWGENE ./.
@@1071715543 Plethysmographic/NNP technique/NN and/CC indirect/JJ blood/NN pressure/NN recordings/NNS were/VBD used/VBN ./.
@@83716508333 Dissipation/NNS of/IN claudication/NN pain/NN after/IN walking/NN :/: implications/NNS for/IN endurance/NN training/NN ./.
@@114249921299 This/DT is/VBZ necessary/JJ if/IN psychiatric/JJ diagnoses/NNS are/VBP ultimately/RB going/JJ to/IN be/VB refined/VBN and/CC validated/VBN against/IN biological/JJ criteria/NNS ./.
@@97225086532 Furthermore/RB ,/, we/PRP demonstrated/VBD that/IN Galpha11/NEWGENE Q209L/NEWGENE stimulated/VBN Src/NEWGENE family/NEWGENE kinase/NEWGENE1 activity/NN and/CC induced/VBN tyrosine/NN phosphorylation/NN of/IN several/DT proteins/NNS in/IN HEK-293/CD cells/NNS ./.
@@10388670255 The/DT percentages/NNS of/IN recovery/NN decreased/VBN with/IN storage/NN time/NN ,/, although/IN the/DT addition/NN of/IN dispersant/NN (/( Tris-Tween/NNP 80/CD )/SYM before/IN storage/NN appeared/VBN to/IN partially/RB prevent/VB adhesion/NN ./.
@@119085291819 The/DT results/NNS are/VBP given/VBP as/IN :/: flux/NN ,/, number/NN of/IN stars/NNS per/IN CM3/NNP ,/, charge/NN of/IN the/DT ions/NNS ,/, comparison/NN with/IN other/DT detectors/NNS (/( plastics/NNS ,/, AgCl/NNP crystals/NNS ,/, LiF/NN )/SYM ,/, energy/NN loss/NN ,/, hit/JJ region/NN in/IN the/DT biological/JJ objects/NNS ./.
@@10146207115 Ultrasonography/NNS provides/VBZ excellent/JJ intraoperative/JJ evaluation/NN of/IN spinal/JJ cord/NN injury/NN ./.
@@76073424186 This/DT paper/NN summarises/VBZ the/DT experimental/JJ evidence/NN upon/IN which/WDT the/DT clinical/JJ trials/NNS of/IN aldose/NEWGENE reductase/NEWGENE inhibitors/NN in/IN diabetic/JJ patients/NNS have/VBP been/VBN initiated/VBN and/CC the/DT results/NNS of/IN published/VBN drug/NN trials/NNS in/IN these/DT patients/NNS ./.
@@80354993293 At/NN least/RB some/DT of/IN the/DT difference/NN in/IN stability/NN of/IN the/DT two/JJ kinds/NNS of/IN complexes/NNS was/VBD due/NN to/IN the/DT fact/NN that/IN the/DT dissociation/NN rate/NN of/IN the/PDT A/DT stem/NN substrate/NN from/IN the/DT protein-DNA/JJ complexes/NNS was/VBD approximately/RB fourfold/RB faster/RBR than/IN that/DT of/IN the/DT complete/JJ TR/NNP ./NNP
@@15457979793 Disruption/NNS mutations/NNS have/VBP been/VBN constructed/VBN in/IN the/DT SLK1/NEWGENE gene/NEWGENE ./. slk1/NEWGENE null/NEWGENE mutants/NEWGENE cannot/MD grow/VB at/IN 37/CD degrees/NNS C/NN ,/, but/CC many/JJ cells/NNS can/MD grow/VB at/IN 30/CD ,/, 24/CD ,/, and/CC 17/CD degrees/NNS C/NNP ./NNP
@@113526719649 As/IN an/DT application/NN of/IN reverse/JJ genetics/NN ,/, we/PRP introduced/VBD one/PRP nucleotide/NN change/NN (/( UCU/NNP to/IN ACU/NNP )/SYM to/IN immediate/JJ downstream/RB of/IN the/DT RNA-editing/NN site/NN of/IN the/DT V/NEWGENE gene/NEWGENE in/IN the/DT full-length/NEWGENE hPIV2/NEWGENE cDNA/NEWGENE and/CC were/VBD able/JJ to/IN obtain/VB infectious/JJ viruses/NNS [/NN rPIV2V/NN (/NN -/NN )/NN ]/NN from/IN the/DT cDNA/NN ./.
@@20938883150 ARPIA/NN has/VBZ been/VBN implemented/VBN by/IN using/VBG a/DT relational/JJ DBMS/NN ,/, very/RB cheap/JJ and/CC highly/RB diffused/VBN on/IN personal/JJ computers/NNS ./.
@@110622748594 Combined/VBN intravenous/JJ and/CC intra-arterial/JJ recombinant/JJ tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE in/IN acute/JJ ischemic/JJ stroke/NN ./.
@@60895755918 Stimulation/NNS with/IN MCh/NNS produced/VBD a/DT Ca-dependent/NNP transient/JJ elevation/NN of/IN cGMP/NN level/NN from/IN 10/CD to/IN 80/CD fmol/NN //NN gland/NN ,/, peaking/VBG at/IN 1-2/CD min/NN but/CC returning/VBG to/IN the/DT basal/JJ level/NN by/IN 5/CD min/NN ./.
@@60887225910 Courses/NNS were/VBD repeated/JJ monthly/NN upon/IN recovery/NN of/IN myelosuppression/NN ./.
@@88771031895 To/TO study/VB the/DT regulation/NN of/IN mdr2/NEWGENE expression/NN ,/, the/DT promoter/NN of/IN the/DT mdr2/NEWGENE gene/NEWGENE has/VBZ been/VBN isolated/VBN from/IN a/DT murine/JJ vinblastine-resistant/JJ cell/NN line/NN ,/, J7/CELL ./CELL V2-1/CELL ,/, and/CC characterized/VBD ./.
@@116041521496 The/DT MABP/NN and/CC MCBFV/NNP signals/NNS were/VBD bandpass/NN filtered/JJ in/IN the/DT very/RB low-frequency/JJ range/NN (/( VLF/NN ,/, 0/CD ./CD 015-0/CD ./CD 07/CD Hz/NN )/SYM ,/, low-frequency/JJ range/NN (/( LF/NN ,/, 0/CD ./CD 07-0/CD ./CD 15/CD Hz/NN )/SYM and/CC high-frequency/JJ range/NN (/( HF/NN ,/, 0/CD ./CD 15-0/CD ./CD 40/CD Hz/NN )/SYM before/IN applying/VBG CCF/NNP for/IN the/DT purpose/NN of/IN studying/VBG the/DT effect/NN of/IN different/JJ bandwidths/NNS on/IN the/DT resulting/JJ mean/JJ CCFs/NNP ./.
@@6443146243 Delayed/JJ hypersensitivity/NN in/IN man/NN :/: effects/NNS of/IN systemic/JJ anticoagulation/NN ./.
@@105675249730 The/DT elm1/NEWGENE kinase/NEWGENE functions/NNS in/IN a/DT mitotic/JJ signaling/JJ network/NN in/IN budding/JJ yeast/NN ./.
@@11015197835 We/PRP have/VBP mutated/JJ to/IN cysteine/NN ,/, one/PRP at/IN a/DT time/NN ,/, 21/CD consecutive/JJ residues/NNS in/IN the/DT fourth/NN TMS/NN (/( TM4/NNS )/SYM ./.
@@89950541045 D/NN ./NN melanogaster/NN HeT-A/NEWGENE coding/JJ sequences/NNS have/VBP a/DT polymorphic/JJ region/NN with/IN insertions/NNS //NNS deletions/NNS of/IN 1-31/CD codons/NNS and/CC many/JJ nucleotide/NN changes/NNS ./.
@@21265042727 Although/IN no/DT Rh-antibodies/NEWGENE were/VBD demonstrable/JJ ,/, a/DT similar/JJ mechanism/NN can/MD be/VB postulated/VBN for/IN the/DT Rh-system/NNP ./.
@@77537969891 The/DT predicted/VBN amino/JJ acid/NN sequence/NN contains/VBZ regions/NNS identical/JJ to/IN the/DT sequences/NNS of/IN peptides/NNS derived/VBN from/IN bovine/NEWGENE liver/NEWGENE eIF-2B/NEWGENE alpha/NEWGENE subunit/NEWGENE ./.
@@105875769021 These/DT REPs/NEWGENE ,/, or/CC clusters/NNS of/IN paralogous/JJ loci/NNS ,/, are/VBP 15-100/JJ kb/NN and/CC harbor/VB at/IN least/RB four/CD ESTs/NNS and/CC an/DT expressed/VBN SH3GL/NEWGENE pseudogene/NEWGENE ./.
@@104735897935 The/DT N/NEWGENE terminus/NEWGENE of/NEWGENE beta/NEWGENE (/NEWGENE 95/NEWGENE kDa/NEWGENE )/NEWGENE corresponds/VBZ to/IN alpha/NEWGENE with/IN the/DT integrase/NEWGENE domain/NEWGENE attached/VBN to/IN the/DT C/NN terminus/NN (/( 32/CD kDa/NN )/SYM ./.
@@109381029038 Eukaryotic/NEWGENE translation/NEWGENE initiation/NEWGENE factor/NEWGENE 4GI/NEWGENE is/VBZ a/DT cellular/JJ target/NN for/IN NS1/NEWGENE protein/NEWGENE ,/, a/DT translational/JJ activator/NN of/IN influenza/NN virus/NN ./.
@@92714006854 Various/JJ assays/NNS demonstrate/VBP promoter/NN activity/NN in/IN this/DT sequence/NN that/WDT reproduces/VBZ the/DT normal/JJ control/NN of/IN E2F2/NEWGENE expression/NN during/IN a/DT growth/NN stimulation/NN ./.
@@112830109456 This/DT activation/NN was/VBD then/RB blocked/VBN by/IN CGS/NN 12066A/NN ./.
@@112406004949 A/DT complete/JJ drug/NN history/NN was/VBD compiled/VBN ,/, specifying/VBG the/DT amount/NN and/CC duration/NN of/IN VGB/NN medication/NN ./.
@@93680571704 Thus/RB ,/, unlike/IN other/DT proteins/NNS reported/VBN to/IN inhibit/VB SRF/NEWGENE activity/NN ,/, the/DT repressor/NN activity/NN associated/VBN with/IN the/DT GC-rich/NNP element/NN does/VBP not/RB appear/VB to/IN function/NN through/RB direct/JJ inhibition/NN of/IN SRF/NEWGENE binding/JJ ./.
@@106425243752 The/DT concomitant/JJ interaction/NN of/IN mSTI1/NEWGENE with/IN hsp70/NEWGENE and/CC hsp90/NEWGENE at/IN its/PRP N-/DT and/CC C-termini/NNS respectively/RB is/VBZ mediated/JJ by/IN the/DT tetratricopeptide/NN repeat/NN (/( TPR/NN )/SYM motifs/NNS in/IN these/DT regions/NNS ./.
@@21028316679 The/DT 5'/CD regions/NNS of/IN these/DT two/JJ soybean/NEWGENE actin/NEWGENE genes/NEWGENE contain/VBP many/JJ unusual/JJ features/NNS including/JJ (/( CT/NN )/SYM repeats/NNS and/CC long/JJ stretches/NNS of/IN pyrimidine-rich/JJ DNA/NN ./.
@@107419473391 A/DT new/JJ technique/NN to/IN create/VB an/DT artificial/JJ stenosis/NN in/IN the/DT native/JJ LAD/NN using/VBG a/DT hemoclip/NN ./.
@@10908462736 The/DT effectiveness/NN of/IN NRT/NN appears/VBZ to/IN be/VB largely/RB independent/NN of/IN the/DT intensity/NN of/IN additional/JJ support/NN provided/VBN to/IN the/DT smoker/NN ./.
@@95358354257 ROCK-I/NEWGENE ,/, Kinectin/NEWGENE ,/, and/CC mDia2/NEWGENE can/MD bind/VB the/DT wild/JJ type/NN forms/NNS of/IN both/DT RhoA/NEWGENE and/CC Cdc42/NEWGENE in/IN a/DT GTP-dependent/NNP manner/NN in/IN vitro/FW ./.
@@104337299338 A/NNP ./NNP ,/, Bowers/NNP ,/, K/NNP ./NNP E/NNP ,/, and/CC Matthews/NNP ,/, C/NNP ./NNP
@@62375181584 The/DT customary/JJ coupling/NN reagent/NN sulfanilic/JJ acid/NN has/VBZ been/VBN replaced/VBN by/IN 1/JJ ,/JJ 3-dimethylbarbituric/JJ acid/NN ;/: CNCl/NN is/VBZ produced/VBN in/IN the/DT flow/NN through/JJ system/NN directly/RB from/IN KCN/DT and/CC chloramine/NN T/NNP ./NNP
@@21244331999 Of/IN 848/CD patients/NNS ,/, 819/CD cases/NNS with/IN complete/JJ description/NN of/IN patient's/VBZ background/NN were/VBD evaluable/JJ :/: Group/NNP A/DT (/( surgery/NN +/SYM MMC/NN +/SYM 5-FU/JJ :/: chemotherapy/NN )/SYM 253/CD cases/NNS ,/, group/NN B/NNP (/( surgery/NN +/SYM MMC/NN +/SYM 5-FU/JJ +/SYM OK-432/NN or/CC PSK/NN :/: immunochemotherapy/NN )/SYM 282/CD and/CC group/NN C/NN (/( surgery/NN alone/RB )/SYM 284/CD ./.
@@7532371032 A--A/NN natural/JJ hydrostatic/JJ phenomenon/NN ,/, at/IN the/DT level/NN of/IN the/DT ends/NNS of/IN the/DT plantar/JJ arcs/NNS ,/, diffuses/VBZ body/NN weight/NN ,/, as/IN PAIN/NN plays/VBP the/DT role/NN of/IN outsentry/NN (/( fig/CD ./CD --1/CD )/SYM (/( 5/CD )/SYM ;/: B--Plantar/JJ perforating/JJ ulceration/NN (/( PPU/NNS )/SYM is/VBZ caused/VBN by/IN a/DT combination/NN of/IN INSENSITIVITY/NNP and/CC TRAUMATIS/NNP (/( 1/CD )/SYM ;/: C--The/NNP patient/NN reposing/JJ ,/, as/IN body/NN weight/NN (/( traumatism/NN )/SYM effects/NNS disappear/VBP ,/, cicatrization/NN process/NN can/MD be/VB easily/RB observed/VBN ;/: D--PNEUMATIC/NNP INSOLE/NNP ,/, being/VBP elastic/JJ ,/, diffuses/VBZ localized/VBN compression/NN at/IN the/DT ends/NNS of/IN the/DT plantar/JJ arcs/NNS ,/, reduces/VBZ attrition/NN ,/, makes/VBP easier/JJR blood/NN circulation/NN ,/, as/RB well/VB as/IN cure/NN and/CC prophylaxis/NN of/IN PPU/NNS (/( fig/CD ./CD --6/CD )/SYM (/( 3/CD )/SYM ./.
@@19289237442 Equine/NN amnion/NN and/CC live/VB yeast/NN cell/NN derivative/NN were/VBD evaluated/VBN as/IN a/DT biological/JJ dressing/NN and/CC as/IN a/DT topical/JJ wound/JJ medicament/NN respectively/RB ,/, in/IN the/DT treatment/NN of/IN granulating/JJ wounds/NNS of/IN the/DT distal/JJ portion/NN of/IN the/DT limbs/NNS of/IN horses/NNS ./.
@@93680263914 Osteocalcin/NEWGENE (/( OC/NEWGENE )/SYM is/VBZ a/DT matrix/NN calcium-binding/NN protein/NN expressed/VBN in/IN osteoblasts/NNS and/CC odontoblasts/NNS undergoing/VBG mineralization/NN ./.
@@114162601285 A/DT computerized/JJ method/NN of/IN determining/JJ the/DT focal/JJ point/NN of/IN electrical/JJ activity/NN in/IN the/DT pallidum/NN of/IN parkinsonian/JJ patients/NNS was/VBD developed/VBN using/VBG on-line/JJ quantitative/JJ physiological/JJ data/NN analysis/NN ./.
@@115328564589 Third/NNP ,/, consistent/JJ with/IN these/DT data/NN ,/, N-acetylcysteine/NNP reduced/VBD the/DT stimulatory/JJ effect/NN of/IN HGF/NEWGENE on/IN stress/NEWGENE kinase/NEWGENE activities/NNS ,/, while/CC p42/NEWGENE //NEWGENE 44/NEWGENE mitogen/NEWGENE1 activated/NEWGENE1 kinase/NEWGENE1 (/( MAPK/NEWGENE )/SYM was/VBD unmodified/JJ ,/, suggesting/VBG an/DT involvement/NN of/IN c-Jun-N-terminal/NEWGENE kinase/NEWGENE (/( JNK/NEWGENE )/SYM and/CC p38/NEWGENE MAPK/NEWGENE in/IN HIF-1/NEWGENE activation/NN ./.
@@93118109769 (/( iv/NN )/SYM The/DT accumulation/NN of/IN cyclin/NEWGENE D3/NEWGENE protein/NEWGENE in/IN Vero/NNP cells/NNS infected/VBN with/IN an/DT alpha0/NEWGENE deletion/NEWGENE mutant/NEWGENE was/VBD reduced/VBN relative/JJ to/IN that/IN of/IN cells/NNS infected/VBN with/IN wild-type/NN virus/NN or/CC a/DT recombinant/JJ virus/NN in/IN which/WDT the/DT deleted/VBN alpha0/NEWGENE sequences/NEWGENE were/VBD restored/VBN ./.
@@10611228345 The/DT DAP5/NEWGENE //NEWGENE p86/NEWGENE apoptotic/JJ form/NN was/VBD more/RB potent/JJ than/IN DAP5/NEWGENE //NEWGENE p97/NEWGENE in/IN these/DT functional/JJ assays/NNS ./.
@@8902988452 Factor/NN V/NN Leiden/NN is/VBZ a/DT genetic/JJ disorder/NN associated/VBN with/IN an/DT increased/VBN risk/NN of/IN venous/JJ thrombosis/NN ./.
@@75143016007 The/DT interferon-induced/NN RNA-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE (/( PKR/NEWGENE )/SYM is/VBZ considered/VBN to/IN play/NN an/DT important/JJ role/NN in/IN the/DT cellular/JJ defense/NN against/IN viral/JJ infection/NN and/CC ,/, in/IN addition/NN ,/, has/VBZ been/VBN suggested/VBN to/IN be/VB a/DT tumor/NN suppressor/NN gene/NN because/IN of/IN its/PRP growth-suppressive/JJ properties/NNS ./.
@@85221757691 Egd1p/NEWGENE is/VBZ homologous/JJ to/IN human/NEWGENE BTF3b/NEWGENE ,/, recently/RB identified/VBN as/IN the/DT beta/NN subunit/NN of/IN the/DT heterodimeric/NEWGENE nascent-polypeptide-associated/NEWGENE complex/NEWGENE (/( NAC/NEWGENE )/SYM involved/VBN in/IN ensuring/VBG signal-sequence-specific/NN protein/NN sorting/NN and/CC translocation/NN [/NN Wiedmann/NN et/FW al/NNS ./NNS ,/, Nature/NNP 370/CD (/( 1994/CD )/SYM 434-440/NN ]/NN ./.
@@11150439988 Energy/NNP expenditure/NN was/VBD obtained/VBN using/VBG a/DT primed/JJ ,/, 3-hour/JJ infusion/NN of/IN NaH/NN (/NN 13/NN )/NN CO/NN (/NN 3'/NN )/NN ,/, breath/NN (/( 13/CD )/NN CO/NN (/NN 2/NN )/NN enrichment/NN determination/NN by/IN isotope/NN ratio/NN mass/JJ spectroscopy/NN ,/, and/CC the/DT application/NN of/IN a/DT standard/JJ regression/NN equation/NN ./.
@@76291964764 We/PRP have/VBP found/VBN that/IN the/DT expression/NN of/IN GTPase-deficient/NNP mutants/NNS of/IN alpha/NEWGENE 12/NEWGENE (/( alpha/NEWGENE 12Q229L/NEWGENE )/SYM or/CC alpha/NEWGENE 13/NEWGENE (/( alpha/NEWGENE 13Q226L/NEWGENE )/SYM leads/VBP to/IN robust/JJ activation/NN of/IN the/DT Jun/NEWGENE kinase/NEWGENE //NEWGENE stress-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/( JNK/NEWGENE //NEWGENE SAPK/NEWGENE )/SYM pathway/NN ./.
@@16263722216 Tissues/NNPS and/CC exudates/NNS contain/VB sufficient/JJ thymidine/NN for/IN growth/NN of/IN anaerobic/JJ bacteria/NNS in/IN the/DT presence/NN of/IN inhibitory/JJ levels/NNS of/IN trimethoprim-sulfamethoxazole/NN ./.
@@999006066 Two/CD of/IN these/DT motifs/NNS are/VBP part/NN of/IN a/DT highly/RB conserved/VBN and/CC inducible/JJ dyad/NN symmetry/NN element/NN shown/VBP previously/RB to/IN control/NN a/DT remote/JJ IL-2/NEWGENE enhancer/NEWGENE and/CC the/DT CD18/NEWGENE promoter/NEWGENE ./.
@@78593718914 Specific/JJ binding/NN was/VBD not/RB observed/VBN with/IN either/DT the/DT orthologous/JJ rat/NN or/CC mouse/NN fragments/NNS using/VBG human/NN or/CC rodent/NN extracts/NNS ./.
@@88965904720 Spliced/JJ exons/NNS of/IN adenovirus/NN late/JJ RNAs/NNS colocalize/VBP with/IN snRNP/NEWGENE in/IN a/DT specific/JJ nuclear/JJ domain/NN ./.
@@85242299926 Degradation/NNS of/IN the/DT soybean/NEWGENE ribulose-1/NEWGENE ,/NEWGENE 5-bisphosphate/NEWGENE carboxylase/NEWGENE small-subunit/NEWGENE mRNA/NEWGENE ,/, SRS4/NEWGENE ,/, initiates/VBP with/IN endonucleolytic/JJ cleavage/NN ./.
@@63942286195 Results/NNS of/IN a/DT controlled/VBN study/NN ./.
@@88474038819 How/WRB many/JJ embryos/NNS to/IN transfer/NN in/IN patients/NNS undergoing/VBG IVF/NN ?/.
@@35592874226 Legionella/NN ,/, microbial/JJ ecology/NN ,/, and/CC inconspicuous/JJ consumption/NN ./.
@@87695689379 The/DT structure/NN of/IN these/DT genes/NNS suggests/VBZ a/DT common/JJ ancestor/NN for/IN all/DT viperid/NEWGENE PLA2/NEWGENE genes/NEWGENE ./.
@@7112320613 CSF/NN adenosine/NEWGENE deaminase/NEWGENE activity/NN (/( ADA/NN )/SYM was/VBD measured/VBN at/IN the/DT same/JJ time/NN ./.
@@30072815424 The/DT Dox-A2/NEWGENE locus/NEWGENE is/VBZ within/IN 3/CD ./CD 4/CD to/IN 4/CD ./CD 4/CD kb/NN of/IN the/DT Df/NEWGENE (/NEWGENE 2L/NEWGENE )/NEWGENE OD15/NEWGENE breakpoint/NEWGENE ,/, placing/VBG four/CD of/IN the/DT vital/NN loci/NN within/IN a/DT maximum/NN of/IN 15/CD ./CD 5/CD kb/CD ./CD
@@9061698158 99Tcm-DMP-HSA/NN showed/VBD an/DT almost/RB identical/JJ behaviour/NN to/IN in/IN vitro/FW labelled/JJ red/JJ blood/NN cells/NNS (/( RBCs/NNS )/SYM ,/, which/WDT are/VBP generally/RB considered/VBN the/DT reference/NN standard/JJ for/IN blood/NN pool/NN agents/NNS ./.
@@5977155851 One-third/NN of/IN the/DT men/NNS with/IN azoospermia/NN and/CC with/IN sperm/NN density/NN of/IN less/PRP than/IN 10/CD million/NN had/VBP marked/JJ FSH/NEWGENE elevation/NN and/CC our/PRP experience/NN confirms/VBZ the/DT work/NN of/IN others/NNS that/WDT this/DT indicates/VBZ a/DT poor/JJ prognosis/NN ./.
@@30332837413 The/DT previously/RB described/VBN four/CD sets/NNS of/IN 13-/CD to/IN 18-base-pair/CD interspersed/JJ repeat/NN elements/NNS between/IN -55/NN and/CC -580/JJ provide/VB most/RB of/IN the/DT high/JJ basal/JJ transcriptional/JJ strength/NN ,/, whereas/IN the/DT arrangement/NN of/IN further/RB upstream/RB tandemly/RB repeated/JJ NF1-binding/NEWGENE sites/NEWGENE may/MD contribute/VB significantly/RB to/IN the/DT expanded/JJ biological/JJ host/NN range/NN for/IN expression/NN of/IN SCMV/NEWGENE IE94/NEWGENE compared/VBN with/IN HCMV/NEWGENE IE68/NEWGENE ./.
@@241151336 These/DT characteristics/NNS of/IN N22/NN //NN P22/NN indicate/VB that/IN it/PRP is/VBZ a/DT localized/VBN synaptically/RB dependent/JJ event/NN conforming/VBG to/IN a/DT transverse/JJ dipole/NN with/IN dorsal/JJ negativity/NN and/CC a/DT simultaneous/JJ anterior/JJ positivity/NN ./.
@@17110485599 Heterozygous/JJ mutation/NN in/IN the/DT G+5/NN position/NN of/IN intron/NN 33/CD of/IN the/DT pro-alpha/NEWGENE 2/NEWGENE (/NEWGENE I/NEWGENE )/NEWGENE gene/NEWGENE (/( COL1A2/NEWGENE )/SYM that/IN causes/NNS aberrant/JJ RNA/NN splicing/JJ and/CC lethal/JJ osteogenesis/NN imperfecta/NN ./.
@@37741114448 Evidence/NN that/IN opiate/JJ addiction/NN is/VBZ in/IN part/NN an/DT immune/JJ response/NN ./.
@@96327347466 These/DT widely/RB expressed/VBN proteins/NNS share/VBP a/DT C-terminal/NN region/NN that/WDT bears/VBP significant/JJ sequence/NN homology/NN to/IN a/DT group/NN of/IN GDP/NEWGENE //NEWGENE GTP/NEWGENE exchange/NEWGENE proteins/NEWGENE for/IN the/DT Rab3/NEWGENE family/NEWGENE of/IN small/NEWGENE GTP/NEWGENE binding/NEWGENE proteins/NEWGENE ./.
@@9385949520 On/IN cessation/NN of/IN steroid/JJ therapy/NN the/DT patient/NN was/VBD noted/VBN to/IN have/NN radiologic/JJ manifestations/NNS of/IN hypertrophic/JJ osteoarthropathy/NN (/( HOA/NN )/SYM as/RB well/VB as/IN clinical/JJ and/CC laboratory/NN features/NNS of/IN rheumatoid/JJ arthritis/NN (/( RA/NN )/SYM ./.
@@79329436723 Specifically/RB ,/, this/DT study/NN determined/VBD the/DT influence/NN of/IN :/: (/( 1/CD )/SYM an/DT awareness/NN strategy/NN ,/, (/( 2/CD )/SYM a/DT non-awareness/NN strategy/NN ,/, (/( 3/CD )/SYM a/DT Five-Step/NN Approach/NNP strategy/NN and/CC (/( 4/CD )/SYM a/DT control/NN condition/NN ./.
@@79081878429 ISIS/NN 5/NN possibilities/NNS ./.
@@93120255124 These/DT effects/NNS were/VBD abrogated/VBN by/IN co-expression/NN of/IN kinase-deficient/NEWGENE PKC/NEWGENE zeta/NEWGENE and/CC inhibition/NN of/IN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE p85alpha-p110/NEWGENE1 by/IN wortmannin/NN ,/, LY294002/NN and/CC a/DT dominant-negative/JJ mutant/NN of/IN p85alpha/NEWGENE ./.
@@38835414544 The/DT H2/NEWGENE receptor/NEWGENE antagonists/NNS and/CC sucralfate/NN cost/NN about/RB the/DT same/JJ and/CC have/NN few/JJ side/JJ effects/NNS ./.
@@94417462528 A/DT cDNA/NN clone/NN was/VBD identified/VBN encoding/VBG a/DT second/JJ GHS-R-related/NEWGENE gene/NEWGENE (/( GPR39/NEWGENE )/SYM ./.
@@101011595280 A/DT mutation/NN linked/JJ to/IN the/DT SOC1/NEWGENE gene/NEWGENE ,/, previously/RB defined/VBN by/IN recessive/JJ mutations/NNS that/WDT suppress/VBP cbp1/NEWGENE ts/NEWGENE alleles/NEWGENE and/CC stabilize/VB many/JJ mitochondrial/JJ mRNAs/NNS ,/, was/VBD also/RB isolated/VBN ./.
@@1618243342 Intravenous/JJ amine/NN pressor/NN tests/NNS in/IN healthy/JJ volunteers/NNS ./.
@@80713562426 During/IN transcript/NN elongation/NN ,/, the/DT sizes/NNS of/IN the/DT DNA/NN footprint/NN and/CC the/DT single-stranded/JJ transcription/NN bubble/NN vary/VB markedly/RB among/IN transcription/NN complexes/NNS halted/VBN at/IN different/JJ template/NN positions/NNS ./.
@@86377113801 Furthermore/RB ,/, we/PRP showed/VBD that/IN the/DT IL-6/NEWGENE //NEWGENE interferon/NEWGENE gamma/NEWGENE (/( IFN/NEWGENE gamma/NEWGENE )/SYM response/NN element/NN in/IN the/DT IRF-1/NEWGENE promoter/NEWGENE (/( IR/NEWGENE //NEWGENE IRF-1/NEWGENE )/SYM ,/, which/WDT contains/VBZ a/DT Stat-binding/NEWGENE site/NEWGENE and/CC an/DT adjacent/JJ CRE-like/NEWGENE site/NEWGENE ,/, also/RB makes/VBP IL-6-induced/JJ binding/JJ complexes/NNS similar/JJ to/IN JRE-IL6-BCs/NEWGENE ./.
@@63411391771 Blood/NNP glucose/NN and/CC plasma/NN insulin/NEWGENE were/VBD measured/VBN at/IN zero/NN time/NN and/CC then/RB at/IN 15/CD ,/, 30/CD ,/, 60/CD ,/, 90/CD and/CC 120/CD min/NN after/IN ingestion/NN of/IN 25/CD g/NN glucose/NN ,/, fructose/NN or/CC lactose/NN ,/, or/CC 30/CD g/NN honey/NN ,/, 50/CD g/NN white/NN bread/NN ,/, 125/CD g/NN white/NN rice/NN or/CC potatoes/NNS ,/, 150/CD g/NN apples/NNS or/CC 260/CD g/NN carrots/NNS ./.
@@110532639430 A/DT total/NN of/IN 1060/CD clones/NNS were/VBD randomly/RB selected/VBN for/IN sequencing/VBG of/IN one/PRP end/NN ./.
@@18543398283 The/DT 5'/NN region/NN shows/VBZ strong/JJ sequence/NN similarity/NN to/IN Escherichia/NN coli/JJ consensus/NN promoters/NNS and/CC ribosome-binding/NN sequences/NN and/CC allows/VBZ high/JJ levels/NNS of/IN expression/NN in/IN E/NNP ./NNP coli/JJ ./.
@@80448006228 This/DT DNA/NN containing/NN promoter/NN activity/NN has/VBZ been/VBN sequenced/VBN in/IN its/PRP entirety/NN and/CC found/VB to/IN contain/VB multiple/JJ putative/JJ regulatory/JJ sites/NNS ./.
@@102070872846 MEF/NEWGENE and/CC AML1B/NEWGENE synergistically/RB transactivated/VBN an/DT interleukin/NEWGENE 3/NEWGENE promoter/NEWGENE reporter/NEWGENE gene/NEWGENE construct/NEWGENE ,/, yet/RB the/DT activating/JJ activity/NN of/IN MEF/NEWGENE was/VBD abolished/VBN when/CC MEF/NEWGENE was/VBD coexpressed/VBN with/IN AML1/NEWGENE //NEWGENE ETO/NEWGENE ./.
@@93434269855 Alanine/NN substitution/NN mutations/NNS in/IN the/DT Zta/NEWGENE activation/NEWGENE domain/NEWGENE which/WDT eliminate/VBP the/DT ability/NN of/IN Zta/NEWGENE to/IN stimulate/VB the/DT D-A/NEWGENE complex/NEWGENE were/VBD examined/VBN ./.
@@94202349379 MpB/NEWGENE GroEL/NEWGENE has/VBZ extensive/JJ sequence/NN similarity/NN (/( 92%/CD )/SYM with/IN Escherichia/NEWGENE coli/NEWGENE GroEL/NEWGENE and/CC other/DT members/NNS of/IN the/DT chaperonin-60/NEWGENE family/NEWGENE ./.
@@85762458674 GRP78/NEWGENE ,/, a/DT molecular/JJ chaperone/NN expressed/VBN in/IN the/DT endoplasmic/JJ reticulum/NN ,/, is/VBZ a/DT "glucose-regulated/JJ protein"/NN induced/VBN by/IN stress/NN responses/NNS that/WDT deplete/VBP glucose/NN or/CC intracisternal/JJ calcium/NN or/CC otherwise/RB disrupt/VB glycoprotein/NN trafficking/NN ./.
@@2849100465 A/DT highly/RB hydrophobic/JJ sequence/NN located/VBN near/IN the/DT carboxyl-terminal/NN extremity/NN of/IN the/DT molecule/NN most/RB likely/RB constitutes/VBZ the/DT anchor/NN to/IN the/DT plasma/NN membrane/NN ./.
@@94367959393 Protein/NEWGENE C/NEWGENE deficiency/NN or/CC protein/NEWGENE S/NEWGENE deficiency/NN was/VBD the/DT only/RB identified/VBN risk/NN factor/NN for/IN 5/CD ./CD 4%/CD (/( 2/CD patients/NNS )/SYM and/CC 13/CD ./CD 5%/CD (/( 5/CD patients/NNS )/SYM ,/, respectively/RB ,/, of/IN these/DT 37/CD children/NNS ./.
@@20887817402 The/DT results/NNS showed/VBD that/DT fog/NN ,/, up/JJ to/IN a/DT level/NN of/IN base/NN plus/IN fog/NN of/IN 0/CD ./CD 6/CD optical/JJ density/NN units/NNS ,/, had/VBP no/DT influence/NN on/IN the/DT diagnostic/JJ accuracy/NN in/IN the/DT absence/NN of/IN any/DT compensation/NN ./.
@@61086105932 Theories/NNS proffered/VBN to/IN account/NN for/IN the/DT modality/NN shift/NN effect/NN are/VBP critically/RB evaluated/VBN ./.
@@90583782967 Conversely/RB ,/, activated/VBN glucocorticoid/NEWGENE receptors/NEWGENE suppressed/VBD the/DT transactivation/NN function/NN of/IN p53/NEWGENE ,/, while/CC transrepression/NN by/IN p53/NEWGENE was/VBD largely/RB unaffected/JJ ./.
@@85757543786 Molecular/NNP cloning/NN ,/, expression/NN pattern/NN ,/, and/CC chromosomal/JJ localization/NN of/IN human/NEWGENE CDKN2D/NEWGENE //NEWGENE INK4d/NEWGENE ,/, an/DT inhibitor/NN of/IN cyclin/NEWGENE D-dependent/NEWGENE kinases/NEWGENE ./.
@@1167591279 She/PRP drank/VBD alcohol/NN once/CC or/CC twice/RB a/DT week/NN and/CC regularly/RB took/VBD an/DT analgesic/JJ preparation/NN ,/, containing/NN aspirin/NN and/CC acetaminophen/NN ,/, for/IN alleviation/NN of/IN headaches/NNS ./.
@@8756597912 Mutants/NNS lacking/VBG the/DT 3'/CD stem-loop/NN exhibited/VBD a/DT 75%/JJ reduction/NN in/IN the/DT level/NN of/IN psaB/NEWGENE mRNA/NN ./.
@@74162049395 In/NN the/DT intact/JJ animal/NN ,/, postextrasystolic/JJ potentiation/NN depended/VBN on/IN the/DT basic/JJ pacing/NN interval/NN ,/, t0/NN ,/, and/CC the/DT timing/NN of/IN the/DT extrasystole/NN ,/, t1/NN :/: when/CC t0/CD was/VBD held/VBP constant/JJ and/CC t1/NN was/VBD increased/VBN ,/, potentiation/NN decreased/VBD ;/: when/CC t1/NN was/VBD held/VBP constant/JJ and/CC t0/CD was/VBD increased/VBN ,/, potentiation/NN increased/VBD ./.
@@13393916234 We/PRP have/VBP cloned/VBN and/CC characterized/VBD a/DT 55-kb/JJ region/NN of/IN DNA/NN surrounding/JJ HRAS1/NEWGENE ./.
@@16754246017 The/DT most/RB striking/JJ difference/NN in/IN the/DT birch/NEWGENE NAD/NEWGENE (/NEWGENE P/NEWGENE )/NEWGENE H-NR/NEWGENE sequence/NEWGENE in/IN comparison/NN to/IN NADH-NR/NEWGENE sequences/NEWGENE was/VBD found/VBN at/IN the/DT putative/JJ pyridine/NN nucleotide/NN binding/NN site/NN ./.
@@107499328402 Paxillin/NEWGENE acts/NNS as/IN an/DT adaptor/NN molecule/NN in/IN integrin/NEWGENE signaling/JJ ./.
@@95197572434 Two/CD rare/JJ novel/JJ mutations/NNS ,/, D811N/NNP in/IN exon/NN 20/CD and/CC R835C/NN in/IN exon/NN 21/CD ,/, were/VBD identified/VBN in/IN the/DT first/JJ nucleotide-binding/JJ fold/NN (/( NBF/NN )/SYM ,/, a/DT functionally/RB important/JJ region/NN of/IN SUR1/NEWGENE ,/, in/IN one/PRP patient/NN each/DT ,/, both/DT heterozygotes/NNS ./.
@@111037924398 Overexpression/NNS of/IN c-Myc/NEWGENE in/IN serum-starved/JJ human/NN or/CC mouse/NN embryonic/JJ cells/NNS leads/VBP to/IN apoptosis/NN which/WDT is/VBZ significantly/RB reduced/VBN in/IN the/DT presence/NN of/IN growth/NN factor-containing/NN serum/NN ./. c-Myc-induced/NN apoptosis/NN appears/VBZ to/IN be/VB deficient/JJ in/RB bax-null/JJ as/IN compared/VBN with/IN bax-wild-type/NEWGENE mouse/NN embryonic/JJ fibroblasts/NNS ./.
@@28400343531 Accurate/JJ evaluation/NN of/IN the/DT treatment/NN results/NNS in/IN unresectable/JJ lung/NN cancer/NN patients/NNS must/MD take/VB the/DT strong/JJ prognostic/JJ factors/NNS into/IN account/NN ./.
@@26003063254 Specifically/RB ,/, they/PRP were/VBD performed/VBN to/IN determine/VB whether/IN detection/NN of/IN envelope/NN phase/NN disparity/NN was/VBD consistent/JJ with/IN processing/VBG within/IN a/DT single/JJ channel/NN in/IN which/WDT the/DT AM/NN tones/NNS were/VBD simply/RB added/VBN ./.
@@110698973024 These/DT results/NNS suggested/VBN that/IN BACH1t/NEWGENE recruits/NNS BACH1/NEWGENE to/IN the/DT nucleus/NN through/RB BTB/NEWGENE domain-mediated/JJ interaction/NN ./.
@@99151187514 Unilateral/JJ naris/NN occlusion/NN and/CC the/DT rat/NN accessory/JJ olfactory/NN bulb/NN ./.
@@1005949659 Acoustic/NNP transmission/NN spectra/NNS in/IN the/DT Penrose/NNP lattice/NN ./.
@@7490278132 The/DT latter/JJ domain/NN appears/VBZ to/IN be/VB involved/VBN in/IN targeting/JJ Num1p/NEWGENE to/IN the/DT mother/NN cell/NN cortex/NN ./.
@@4995885295 Carbohydrate/NNS metabolism/NN and/CC the/DT semen/NN profile/NN :/: glucose/NN ,/, insulin/NEWGENE ,/, and/CC sperm/NN studies/NNS ./.
@@84961843335 The/DT active/JJ open/JJ reading/JJ frame/NN in/IN the/DT clone/NN maps/NNS at/IN 27/CD min/NN on/IN the/DT E/NNP ./NNP coli/JJ chromosome/NN and/CC is/VBZ identical/JJ in/IN sequence/NN to/IN a/DT wild/JJ type/NN counterpart/NN ./.
@@94490189402 Childhood/NNP misbehavior/NN and/CC the/DT risk/NN of/IN injecting/JJ drug/NN use/NN ./.
@@13630803858 Visual/JJ acuity/NN may/MD be/VB decreased/VBN by/IN transient/JJ changes/NNS in/IN refractive/JJ error/NN caused/VBN by/IN sulfonamides/NNS ,/, the/DT antifungal/JJ agent/NN metronidazole/NN ,/, thiazide/NN diuretics/NNS ,/, and/CC carbonic/NEWGENE anhydrase/NEWGENE inhibitors/NN ./.
@@83006056631 Transcriptional/JJ analysis/NN of/IN a/DT series/NN of/IN deletion/NN mutants/NNS of/IN the/DT gene/NN in/IN the/DT nuclear/JJ extracts/NNS prepared/VBN from/IN the/DT middle/JJ silk/NN gland/NN of/IN 2-day-old/NN fifth/JJ instar/NN larvae/NNS revealed/VBD the/DT presence/NN of/IN multiple/JJ cis-regulatory/NN elements/NN located/VBD both/DT upstream/RB and/CC downstream/RB of/IN the/DT initiation/NN site/NN ./.
@@79354473284 This/DT study/NN provides/VBZ direct/JJ evidence/NN that/IN USF/NEWGENE ,/, a/DT member/NN of/IN the/DT basic/NEWGENE helix-loop-helix/NEWGENE leucine/NEWGENE zipper/NEWGENE family/NEWGENE ,/, binds/VBZ to/IN MLE1/NEWGENE ,/, HF-1a/NEWGENE ,/, and/CC PRE/NEWGENE B/NEWGENE sites/NEWGENE and/CC suggests/VBZ that/IN it/PRP is/VBZ a/DT component/NN of/IN protein/NN complexes/NNS that/WDT may/MD coordinately/RB control/VB the/DT expression/NN of/IN MLC-2v/NEWGENE and/CC alpha-myosin/NEWGENE heavy-chain/NEWGENE genes/NEWGENE ./.
@@74258387278 We/PRP report/VBP a/DT case/NN of/IN pheochromocytoma/NN manifesting/VBG during/IN the/DT third/JJ trimester/NN of/IN pregnancy/NN ./.
@@18260438144 The/DT pp90rsk-protein/NEWGENE kinase/NEWGENE activity/NN (/( referred/VBN to/RB as/IN rsk-kinase/NEWGENE )/SYM is/VBZ also/RB not/RB related/VBN to/IN cofactor-dependent/JJ signal/JJ transducing/JJ protein/NEWGENE kinases/NEWGENE such/JJ as/IN the/DT cyclic/NEWGENE AMP-dependent/NEWGENE protein/NEWGENE kinases/NEWGENE ,/, members/NNS of/IN the/DT protein/NEWGENE kinase/NEWGENE C/NEWGENE family/NEWGENE ,/, or/CC other/DT Ca2/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE -dependent/NEWGENE protein/NEWGENE kinases/NEWGENE ./.
@@77218785320 The/DT beta/NN subunit/NN of/IN the/DT Fc/NEWGENE epsilon/NEWGENE R1/NEWGENE is/VBZ a/DT 33-kDa/NN tyrosine/NN phosphoprotein/NN ,/, but/CC the/DT p33/NEWGENE Grb2-binding/NEWGENE protein/NEWGENE described/VBN in/IN the/DT present/NN report/NN is/VBZ not/RB the/DT Fc/NEWGENE epsilon/NEWGENE R1/NEWGENE beta/NEWGENE chain/NEWGENE and/CC its/PRP identity/NN is/VBZ unknown/JJ ./.
@@104385403400 We/PRP also/RB identify/VBP several/DT regulatory/JJ domain/NN mutants/NNS in/IN which/WDT Cd/NN (/NN 2+/NN )/NN tolerance/NN of/IN the/DT mutant/JJ strain/NN and/CC transport/NN activity/NN of/IN the/DT protein/NN are/VBP dissociated/VBN ./.
@@79829647352 ATX/NEWGENE ,/, like/JJ PC-1/NEWGENE ,/, was/VBD found/VBN to/IN hydrolyze/VB the/DT type/NEWGENE I/NEWGENE phosphodiesterase/NEWGENE substrate/NN p-nitrophenyl/JJ thymidine-5'-monophosphate/NN ./.
@@80578331794 The/DT two/JJ ParA/NEWGENE proteins/NEWGENE that/WDT are/VBP produced/VBN as/IN a/DT result/NN of/IN independent/JJ translation/NN initiation/NN at/IN two/JJ different/JJ start/NN codons/NNS within/IN the/DT same/JJ open/JJ reading/JJ frame/NN were/VBD overexpressed/VBN in/IN Escherichia/NN coli/JJ and/CC partially/RB purified/VBN ./.
@@85093339075 A/DT 36-kDa/NN protein/NN that/WDT was/VBD localized/VBN to/IN the/DT membrane/NN fraction/NN was/VBD detected/VBN in/IN minicells/NNS containing/JJ plasmids/NNS with/IN the/DT ftsN/NEWGENE gene/NEWGENE ,/, confirming/VBG that/IN FtsN/NEWGENE was/VBD a/DT membrane/NN protein/NN ./.
@@16748176550 Mutations/NNS in/IN the/DT yeast/NEWGENE RNA14/NEWGENE and/CC RNA15/NEWGENE genes/NEWGENE result/NN in/IN an/DT abnormal/JJ mRNA/NN decay/NN rate/NN ;/: sequence/NN analysis/NN reveals/VBZ an/DT RNA-binding/NN domain/NN in/IN the/DT RNA15/NEWGENE protein/NEWGENE ./.
@@102711714004 Online/NNP LATCH/CELL demonstrates/VBZ a/DT shift/NN in/IN identification/NN of/IN the/DT library/NN as/IN an/DT isolated/VBN unit/NN to/IN an/DT interactive/JJ resource/NN center/NN ./.
@@13743985583 The/DT initial/JJ translation/NN protein/NN encoded/VBN by/IN the/DT cDNA/NN is/VBZ 53/NN ,/NN 932/NN kDa/NN and/CC possesses/VBZ a/DT hydrophilic/JJ amino/JJ acid/NN composition/NN with/IN glutamic/JJ acid/NN comprising/VBG 22%/NN of/IN the/DT total/JJ amino/JJ acid/NN residues/NNS ./.
@@18953702516 With/IN stepwise/JJ reductions/NNS in/IN flow/NN ,/, the/DT peak/NN (/( S/NNP )/SYM and/CC trough/NN (/( D/NN )/SYM points/NNS of/IN the/DT maximum/JJ shifted-frequency/JJ envelope/NN fell/NN in/IN parallel/JJ in/IN a/DT linear/JJ fashion/NN until/IN D/NN reached/VBD zero/NN ./.
@@81445046102 Kinetic/JJ coupling/NN and/CC requirement/NN for/IN ATP/NN hydrolysis/NN ./.
@@113937917809 Northern/NNP blot/NN analysis/NN of/IN RNAs/NNS from/IN a/DT number/NN of/IN mouse/NN tissues/NNS reveals/VBZ that/IN Atp6i/NEWGENE is/VBZ expressed/VBN predominantly/RB in/IN osteoclasts/NNS ,/, and/CC this/DT predominant/JJ expression/NN was/VBD confirmed/VBN by/IN reverse-transcription/NN polymerase/NN chain/NN reaction/NN (/( RT-PCR/NN )/SYM assay/NN and/CC immunohistochemical/JJ analysis/NN ./.
@@76782421716 We/PRP found/VBP a/DT direct/JJ correlation/NN between/IN the/DT levels/NNS of/IN transcription/NN of/IN the/DT acc/NEWGENE genes/NEWGENE and/CC the/DT rate/NN of/IN cellular/JJ growth/NN ./.
@@15188338623 A/DT lambda/NN gt10/NN cDNA/NN library/NN was/VBD constructed/VBN from/IN poly/NN (/NN A+/NN )/NN RNA/NN of/IN young/JJ green/JJ leaves/NNS of/IN spinach/NN ./.
@@37717499289 MICs/NNS of/IN four/CD antifungal/JJ agents/NNS (/( 5-fluorocytosine/NNP ,/, miconazole/NN ,/, ketoconazole/NN ,/, and/CC amphotericin/NN B/NN )/SYM for/IN 84/CD clinical/JJ isolates/NNS of/IN various/JJ Candida/NN species/NN were/VBD then/RB determined/VBN with/IN both/DT media/NN in/IN agar/NN dilution/NN and/CC microtiter/NN broth/NN dilution/NN systems/NNS ./.
@@54966195567 Foreign/NNP profiles/NNS in/IN air/NN pollution/NN control/NN activities/NNS ./.
@@83310645779 Release/NNP of/IN this/DT selective/JJ pressure/NN ,/, however/RB ,/, gave/VBD way/NN to/IN homologous/JJ resolution/NN of/IN the/DT cointegrate/NN structures/NNS ./.
@@78352147812 Therefore/RB the/DT prevalences/NNS of/IN total/JJ diabetes/NN and/CC GDM/NN were/VBD 1/CD ./CD 19%/CD and/CC 0/CD ./CD 56%/CD ,/, respectively/RB ./.
@@93120325826 These/DT introns/NNS contain/VBP only/RB single/NN snoRNA/NEWGENE genes/NEWGENE and/CC their/PRP processing/NN involves/VBZ exonucleolytic/JJ release/NN of/IN the/DT snoRNA/NEWGENE from/IN debranched/JJ intron/NN lariats/NNS ./.
@@11003807838 Symptoms/NNS ,/, however/RB ,/, appear/VB to/IN correlate/NN poorly/RB with/IN oesophagitis/NN ;/: hence/RB ,/, severe/JJ symptoms/NNS do/VBP not/RB indicate/VB there/RB is/VBZ greater/RBR oesophageal/JJ damage/NN ./.
@@80977326577 Activation/NNS of/IN the/DT aboral/JJ ectoderm-specific/NEWGENE Spec2a/NEWGENE gene/NEWGENE in/IN blastula-stage/NN sea/NN urchin/NN embryos/NNS requires/VBZ an/DT upstream/RB regulatory/JJ region/NN that/WDT is/VBZ part/NN of/IN a/DT repetitive/JJ sequence/NN element/NN (/( RSR/NEWGENE )/SYM associated/VBN with/IN all/DT Spec1/NEWGENE //NEWGENE Spec2/NEWGENE genes/NEWGENE ./.
@@13281978452 These/DT findings/NNS suggest/VBP that/IN the/DT MAP/NEWGENE kinase/NEWGENE activator/NEWGENE //NEWGENE MAP/NEWGENE kinase/NEWGENE system/NEWGENE may/MD be/VB the/DT downstream/JJ components/NNS of/IN ras/NEWGENE signal/NEWGENE transduction/NEWGENE pathways/NEWGENE ./.
@@105903682 The/DT present/NN research/NN evaluated/VBD the/DT possibility/NN that/DT polyethylene/NN glycol/NN 400/CD (/( PEG/NN 400/NN )/SYM might/MD be/VB efficacious/JJ ,/, toxic/JJ ,/, or/CC both/DT ./.
@@89199868877 Keeping/VBG in/IN mind/NN the/DT limited/VBN range/NN of/IN age/NN and/CC dosages/NNS ,/, advantages/NNS and/CC disadvantages/NNS of/IN the/DT drug/NN are/VBP discussed/VBN ,/, comparing/VBG the/DT experimental/JJ results/NNS with/IN those/DT derived/VBN from/IN the/DT literature/NN ./.
@@113276989384 Here/RB we/PRP show/VBP that/DT PKC/NEWGENE and/CC p44/NEWGENE //NEWGENE p42MAPK/NEWGENE signalings/NNS are/VBP required/VBN for/IN the/DT HBx-induced/NN Sp1-mediated/NN IGF-II/NEWGENE P4/NEWGENE transcriptional/JJ activity/NN since/IN (/( i/NN )/SYM PKC/NEWGENE activation/NN by/IN PMA/NN or/CC PKC/NEWGENE expression/NN vector/NN increases/NNS Sp1/NEWGENE phosphorylation/NN and/CC P4/NEWGENE activity/NN in/IN HBx-transfected/JJ HepG2/NNP cells/NNS ;/: (/( ii/NN )/SYM PKC/NEWGENE inhibition/NN by/IN PKC/NEWGENE inhibitor/NN Go6976/NN reduces/VBZ Sp1/NEWGENE phosphorylation/NN ,/, P4/NEWGENE activity/NN ,/, and/CC IGF-II/NEWGENE mRNA/NEWGENE in/IN HBx-transfected/JJ HepG2/NNP cells/NNS ;/: and/CC (/( iii/NN )/SYM the/DT inhibition/NN of/IN MEK/NEWGENE activation/NN by/IN U0126/NN reduces/VBZ Sp1/NEWGENE phosphorylation/NN ,/, P4/NEWGENE activity/NN and/CC IGF-II/NEWGENE mRNA/NEWGENE in/IN HBx-transfected/JJ HepG2/NNP cells/NNS ./.
@@24187017383 We/PRP evaluated/VBD the/DT likelihood/NN of/IN tissues/NNS to/IN be/VB positive/JJ for/IN carcinoembryonic/NEWGENE antigen/NEWGENE and/CC the/DT intensity/NN of/IN carcinoembryonic/NEWGENE antigen/NEWGENE staining/NN in/IN specimens/NNS of/IN villous/JJ adenomas/NNS ,/, mixed/JJ polypoid/NN villous/NN adenomas/NNS ,/, polypoid/JJ adenomas/NNS ,/, and/CC diverticulitis/NN using/VBG the/DT peroxidase-antiperoxidase/NN technique/NN ./.
@@87984437412 Serine/NN 528/CD is/VBZ phosphorylated/VBN in/IN vivo/NN in/IN several/DT cell/NN lines/NNS ,/, and/CC substitution/NN of/IN serine/NN 528/CD to/IN alanine/NN (/( S528A/NNP )/SYM resulted/VBN in/IN an/DT increased/VBN ability/NN of/IN Myb/NEWGENE to/IN transactivate/VB a/DT synthetic/JJ promoter/NN containing/JJ five/CD copies/NNS of/IN the/DT mim-1A/NEWGENE Myb-responsive/NEWGENE element/NEWGENE and/CC a/DT minimal/JJ herpes/NEWGENE tk/NEWGENE promoter/NEWGENE ./.
@@54661775551 Teratogenic/NNP effects/NNS of/IN actinomycin/NN D/NN in/IN rats/NNS ./.
@@79009157883 To/TO determine/VB whether/IN food/NN and/DT //DT or/DT water/NN in/IN the/DT gastrointestinal/JJ tract/NN affects/VBP restitution/NN of/IN blood/NN volume/NN and/CC plasma/NN protein/NN after/IN hemorrhage/NN ,/, fed/VBN and/CC 24-h-fasted/JJ awake/JJ rats/NNS received/VBD a/DT 20/CD ml/CD ./CD kg-1/CD x/NN 3/CD min-1/NN hemorrhage/NN ,/, and/CC restitution/NN of/IN blood/NN volume/NN was/VBD measured/VBN by/IN Evans/NN blue/JJ dye/NN and/CC dilution/NN of/IN hematocrit/NN ./.
@@111034723302 Children/NNS with/IN ADD/NNS showed/VBD an/DT attenuated/VBN frontal/JJ CNV-1/NN amplitude/NN and/CC a/DT trend/NN towards/IN increased/VBN CNV-1/NN and/CC CNV-2/NN occipital/JJ amplitudes/NNS ./.
@@17423412325 This/DT study/NN confirms/VBZ ,/, although/IN individual/JJ reaction/NN is/VBZ remarkably/RB different/JJ ,/, transportation/NN as/IN a/DT potent/JJ stressor/NN for/IN Beagle/NN dogs/NNS ./.
@@93729687958 Sequence/NN analysis/NN identified/VBD some/DT of/IN these/DT cDNA/NN clones/NNS as/IN Dlc-1/NEWGENE ,/, a/DT sequence/NN encoding/VBG a/DT small/NN ,/, 9-kDa/NEWGENE human/NEWGENE homolog/NEWGENE of/NEWGENE the/NEWGENE outer-arm/NEWGENE dynein/NEWGENE light-chain/NEWGENE protein/NN ./.
@@24743563131 The/DT ratio/NN of/IN radioactivity/NN in/IN tumour/NN compared/VBN with/IN normal/JJ tissue/NN (/( T/NN :/: N/JJ ratio/NN )/SYM was/VBD determined/VBN after/IN simultaneously/RB injecting/JJ microspheres/NNS into/IN the/DT portal/JJ and/CC arterial/JJ circulation/NN of/IN each/DT animal/NN ./.
@@92486397717 Five/CD cell/NN strains/NNS of/IN human/JJ dermal/JJ fibroblasts/NNS were/VBD each/DT treated/VBN with/IN three/CD samples/NNS of/IN burn/NN blister/NN fluid/NN and/CC the/DT effect/NN compared/VBN with/IN the/DT rate/NN of/IN contraction/NN of/IN free/JJ floating/JJ fibroblast/NN populated/VBD collagen/NEWGENE lattices/NNS (/( FPCL/NN )/SYM ./.
@@37009525476 Infants/NNS of/IN this/DT sample/NN had/VBP monocular/JJ PL/NN visual/NN acuities/NNS similar/JJ to/IN those/DT established/VBN by/IN McDonald/NNP et/FW al/NNS ./NNS in/IN a/DT laboratory/NN setting/NN ./.
@@19179628982 The/DT cDNA/NN segment/NN is/VBZ flanked/VBN by/IN the/DT immunoglobulin/NEWGENE gene/NEWGENE recombination/NEWGENE signal/NEWGENE sequences/NEWGENE so/RB that/IN the/DT cDNA/NN segment/NN can/MD invert/VB and/CC the/DT human/NEWGENE IL-2R/NEWGENE L/NEWGENE chain/NEWGENE is/VBZ subsequently/RB expressed/VBN under/IN the/DT control/NN of/IN the/DT SV40/NN promoter/NN ./.
@@1895555503 Evaluation/NN of/IN left/NN ventricular/JJ function/NN using/VBG gated/JJ planar/JJ myocardial/JJ imaging/NN with/IN Tc-99m-MIBI/NN ./.
@@81519808120 Panlobular/JJ emphysema/NN ./.
@@110036415236 Mutating/VBG the/DT Fcp1p-binding/NEWGENE motif/NEWGENE KEFGK/NEWGENE in/IN the/DT RAP74/NEWGENE (/( Tfg1p/NEWGENE )/SYM subunit/NN of/IN TFIIF/NEWGENE to/IN EEFGE/NNP led/VBD to/IN both/DT synthetic/JJ phenotypes/NNS in/IN certain/JJ fcp1/NEWGENE tfg1/NEWGENE1 double/JJ mutants/NNS and/CC a/DT reduced/VBN ability/NN of/IN Fcp1p/NEWGENE to/IN activate/VB transcription/NN when/CC it/PRP is/VBZ artificially/RB tethered/JJ to/IN a/DT promoter/NN ./.
@@91507747754 Anesthesia/NNS was/VBD maintained/VBN with/IN isoflurane/NN (/( ISO/NN )/NN //NN N2O/NN //NN O2/NN inhalation/NN ./.
@@112784883163 The/DT v-Src/NEWGENE SH3/NEWGENE1 domain/NEWGENE1 facilitates/VBZ a/DT cell/NN adhesion-independent/JJ association/NN with/IN focal/NEWGENE adhesion/NEWGENE kinase/NEWGENE ./.
@@12436288792 In/NN both/DT cases/NNS ,/, at/IN the/DT end/NN of/IN exposure/NN the/DT same/JJ level/NN of/IN blood/NEWGENE carboxyhemoglobin/NEWGENE (/( COHb/NEWGENE )/SYM (/( about/RB 50%/CD )/SYM was/VBD reached/VBN ./.
@@82032604591 We/PRP conclude/VBP that/IN the/DT SIMV/NN is/VBZ useful/JJ in/IN weaning/NN neonates/NNS from/IN the/DT ventilator/NN ./.
@@90069363714 Identification/NNP of/IN the/DT region/NN in/IN actin-binding/NEWGENE protein/NEWGENE that/WDT binds/VBZ to/IN the/DT cytoplasmic/JJ domain/NN of/IN glycoprotein/NEWGENE IBalpha/NEWGENE ./.
@@94765203041 Simple/JJ models/NNS of/IN bimolecular/JJ interaction/NN did/VBD not/RB fully/RB account/VB for/IN the/DT kinetic/JJ profiles/NNS obtained/VBN with/IN the/DT parental/JJ antibodies/NNS and/CC the/DT hybrids/NNS ,/, and/CC this/DT complexity/NN suggested/VBD the/DT existence/NN of/IN a/DT conformational/JJ heterogeneity/NN in/IN these/DT molecules/NNS ./.
@@3395249431 Histopathological/JJ examination/NN revealed/VBD dose-related/JJ proliferation/NN of/IN type/NN II/NN pneumocytes/NNS in/IN dams/NNS and/CC proliferation/NN of/IN interstitial/JJ cells/NNS and/CC delayed/JJ septal/JJ //JJ capillary/JJ development/NN in/IN neonates/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@91153575631 Little/NN is/NNS known/VBP about/RB the/DT mechanism/NN ,/, but/CC the/DT availability/NN of/IN rapid/JJ facile/JJ assays/NNS for/IN monitoring/VBG immunoglobulin/NEWGENE hypermutation/NN would/MD greatly/RB aid/VB the/DT development/NN of/IN culture/NN systems/NNS for/IN hypermutating/JJ B/NNP cells/NNS as/RB well/VBP as/IN the/DT screening/NN for/IN individuals/NNS deficient/JJ in/IN the/DT process/NN ./.
@@93652724063 Xenopus/NEWGENE Ran-binding/NEWGENE protein/NEWGENE 1/NEWGENE :/: molecular/JJ interactions/NNS and/CC effects/NNS on/IN nuclear/JJ assembly/NN in/IN Xenopus/NN egg/NN extracts/NNS ./.
@@10745563557 Thus/RB ,/, both/PDT the/DT hyperplasia/NN and/CC thrombotic/JJ complications/NNS which/WDT often/RB follow/VB stenting/NN might/MD be/VB minimized/VBN by/IN employing/VBG gold/JJ stents/NNS ,/, which/WDT have/VBP a/DT greater/JJR capacity/NN than/IN steel/NN in/IN supporting/JJ a/DT functional/JJ neo-endothelium/NN ./.
@@114282761302 The/DT Van/NNP der/NNP Hoeve's/NNP syndrome/NN lesions/NNS as/IN poorly/RB mineralized/JJ ,/, with/IN low/JJ calcium/NN salt/JJ and/CC apparent/JJ increase/NN of/IN phosphates/NNS ./.
@@1500662078 Native/NNP human/NEWGENE fibrinogen/NEWGENE was/VBD brought/VBP to/IN coagulation/NN by/IN adding/JJ thrombin/NEWGENE ./.
@@88876476597 Fission/NEWGENE yeast/NEWGENE mal2+/NEWGENE is/VBZ required/VBN for/IN chromosome/NN segregation/NN ./.
@@13981407995 Surprisingly/RB ,/, the/DT Xenopus/NEWGENE U7/NEWGENE gene/NEWGENE contains/VBZ two/JJ adjacent/JJ octamer-binding/NN motifs/NN located/VBN only/RB 12/CD and/CC 24/CD bp/NN upstream/RB from/IN the/DT PSE/NEWGENE ,/, instead/RB of/IN the/DT usual/JJ location/NN around/IN 150-200/JJ bp/NN upstream/RB ./.
@@91695937552 Insulin/NEWGENE regulation/NN of/IN mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE kinase/NEWGENE (/( MEK/NEWGENE )/SYM ,/, mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE and/CC casein/NEWGENE kinase/NEWGENE in/IN the/DT cell/NN nucleus/NN :/: a/DT possible/JJ role/NN in/IN the/DT regulation/NN of/IN gene/NN expression/NN ./.
@@10082554822 Functional/JJ domains/NNS of/IN c-myc/NEWGENE promoter/NEWGENE binding/NEWGENE protein/NEWGENE 1/NEWGENE involved/VBN in/IN transcriptional/JJ repression/NN and/CC cell/NN growth/NN regulation/NN ./.
@@75377363954 Our/PRP results/NNS indicate/VBP that/DT interaction/NN between/IN Jak2/NEWGENE and/CC PRLR/NEWGENE requires/VBZ a/DT proline-rich/JJ sequence/NN in/IN the/DT membrane/NN proximal/JJ region/NN of/IN the/DT receptor/NN ,/, which/WDT is/VBZ conserved/VBN among/IN the/DT different/JJ members/NNS of/IN the/DT cytokine/NEWGENE receptor/NEWGENE superfamily/NEWGENE ./.
@@93609939203 Mouse/NEWGENE mast/NEWGENE cell/NEWGENE protease/NEWGENE 9/NEWGENE ,/, a/DT novel/JJ member/NN of/IN the/DT chromosome/NN 14/NN family/NN of/IN serine/NEWGENE proteases/NEWGENE that/WDT is/VBZ selectively/RB expressed/VBN in/IN uterine/JJ mast/NN cells/NNS ./.
@@72142309122 Inhibition/NNS of/IN Fusarium/NN moniliforme/NN var/NN ./. subglutinans/NNS ,/, the/DT causal/JJ agent/NN of/IN pine/NN pitch/NN canker/NN ,/, by/IN the/DT soil/NN bacterium/NN Arthrobacter/NN sp/NN ./NN
@@86571356114 We/PRP conclude/VBP from/IN these/DT studies/NNS that/WDT CKII/NEWGENE may/MD act/NN as/IN a/DT positive/JJ regulator/NN of/IN myogenesis/NN by/IN preventing/JJ E/NEWGENE protein/NEWGENE homodimers/NEWGENE from/IN binding/JJ to/IN muscle/NN gene/NN regulatory/JJ elements/NNS ./.
@@86260651344 We/PRP have/VBP cloned/VBN and/CC sequenced/VBN a/DT 3574-bp/JJ Bacillus/NN subtilis/JJ (/( Bs/IN )/SYM DNA/NN fragment/NN located/VBN between/IN the/DT nrdA/NEWGENE and/CC citB/NEWGENE genes/NEWGENE at/IN about/RB 169/CD degrees/NNS on/IN the/DT chromosome/NN ./.
@@2536160942 At/NN the/DT basal/JJ unstimulated/JJ condition/NN ,/, Ren1d/NEWGENE 5'/NEWGENE flanking/NEWGENE sequence/NEWGENE in/IN the/DT sense/NN orientation/NN inhibited/VBD basal/JJ CAT/NEWGENE expression/NN from/IN the/DT TK/NEWGENE promoter/NEWGENE of/IN pUTKAT1/NN ,/, whereas/IN the/DT same/JJ sequence/NN in/IN the/DT antisense/NN orientation/NN did/VBD not/RB ./.
@@18458999078 The/DT adeno-associated/NEWGENE virus/NEWGENE (/NEWGENE AAV/NEWGENE )/NEWGENE rep/NEWGENE gene/NEWGENE encodes/VBZ four/CD proteins/NNS (/( Rep78/NEWGENE ,/, Rep68/NEWGENE ,/, Rep52/NEWGENE ,/, and/CC Rep40/NEWGENE )/SYM required/VBN for/IN AAV/NN DNA/NN replication/NN and/CC AAV/NN gene/NN regulation/NN ./.
@@10585311412 Patients/NNS with/IN types/NNS I/PRP and/CC III/NNP MPGN/NN did/VBD not/RB differ/VB in/IN age/NN at/IN apparent/JJ onset/NN ,/, age/NN at/IN diagnosis/NN ,/, or/CC interval/NN from/IN apparent/JJ onset/NN of/IN symptoms/NNS to/IN diagnosis/NN (/( biopsy/NN )/SYM ./.
@@63163471044 The/DT dnaQ-lacZ/NEWGENE and/CC the/DT rnh-lacZ/NEWGENE fused/NEWGENE genes/NEWGENE were/VBD constructed/VBN and/CC hybrid/JJ proteins/NNS with/IN beta-galactosidase/NEWGENE activity/NN were/VBD produced/VBN ./.
@@16304552942 We/PRP identified/VBD a/DT protein/NN ,/, termed/JJ NFIL-1/NEWGENE beta/NEWGENE A/NEWGENE (/( NF/NEWGENE beta/NEWGENE A/NEWGENE )/SYM ,/, that/WDT binds/VBZ to/IN a/DT highly/RB conserved/VBN 12-bp/JJ DNA/NN sequence/NN (/( -49/CD to/IN -38/CD )/SYM located/VBN upstream/RB of/IN the/DT TATA/NN box/NN motif/NN in/IN both/PDT the/DT human/NEWGENE and/NEWGENE murine/NEWGENE IL-1/NEWGENE beta/NEWGENE genes/NEWGENE ./.
@@85761313136 The/DT preferential/JJ heterodimerization/NN of/IN USF/NEWGENE subunits/NEWGENE was/VBD reproduced/VBN ex/NN vivo/NN ,/, while/CC the/DT in/NN vitro/FW association/NN of/IN cotranslated/VBN subunits/NNS ,/, or/CC recombinant/NEWGENE USF/NEWGENE proteins/NEWGENE ,/, appeared/VBN to/IN be/VB random/JJ ./.
@@10101744104 In/NN all/DT trials/NNS ,/, antigen/NN challenge/NN followed/VBN 1/CD h/NN after/IN the/DT last/NN treatment/NN ./.
@@25555194284 Since/IN considerable/JJ variations/NNS in/IN length/NN and/CC primary/JJ sequence/NN in/IN the/DT CDR3/NEWGENE (/( complementarity/NEWGENE determining/NEWGENE region/NEWGENE )/SYM peptides/NNS of/IN all/PDT the/DT H-chains/NEWGENE are/VBP evident/JJ ,/, conservation/NN of/IN the/DT D-region/NEWGENE structure/NN does/VBP not/RB appear/VB to/IN be/VB necessary/JJ for/IN effective/JJ hapten/NN binding/JJ ./.
@@19880417309 The/DT sequence/NN of/IN four/CD clones/NNS was/VBD sufficient/JJ to/IN construct/NN a/DT 3018-bp/NEWGENE BAL/NEWGENE cDNA/NEWGENE structure/NN ./.
@@95684459515 New-onset/NNP angina/NN preceding/JJ acute/JJ myocardial/JJ infarction/NN is/VBZ associated/VBN with/IN improved/VBN contractile/JJ recovery/NN after/IN thrombolysis/NN ./.
@@76933727627 This/DT agent/NN ,/, isolated/VBN from/IN the/DT fungus/NN Streptomyces/NN tsukubaensis/NN ,/, has/VBZ a/DT mechanism/NN of/IN action/NN similar/JJ to/IN that/DT of/IN cyclosporine/NN ./.
@@97040066244 Arnt3/NEWGENE mRNA/NEWGENE was/VBD expressed/VBN in/IN brain/NN ,/, skeletal/JJ muscle/NN ,/, 13/NN ./NN 5-day/NN embryos/NNS ,/, and/CC P19/CD cells/NNS treated/VBN with/IN retinoic/JJ acid/NN ./.
@@83255049519 Neither/CC RD19/NEWGENE nor/CC RD21/NEWGENE mRNA/NEWGENE synthesis/NN was/VBD responsive/JJ to/IN cold/JJ or/CC to/IN heat/NN stress/NN ./.
@@36015334265 Diagnostic/NNP importance/NN of/IN determining/JJ the/DT complement/NN constituents/NNS in/IN children/NNS with/IN autoimmune/JJ thyroiditis/NN ./.
@@78543249403 Because/IN of/IN the/DT functional/JJ conservation/NN of/IN cell/NN cycle/NN control/JJ elements/NNS ,/, the/DT expression/NN of/IN a/DT vertebrate/NEWGENE wee1/NEWGENE or/CC mik1/NEWGENE homolog/NEWGENE would/MD be/VB expected/VBN to/IN rescue/NN such/JJ lethal/JJ mutations/NNS in/IN yeast/NN ./.
@@78810779371 Supplementary/NNP Phase/NN Contraste/JJ RSE/NN (/( "Rapid/NN Sequential/NNP Excitation"/NN )/SYM sequences/NNS were/VBD carried/VBN out/RB in/IN 29/CD patients/NNS ./.
@@94737559432 PATIENTS/IN AND/CC METHODS/IN :/: Between/IN January/NN 1992/CD and/CC June/NN 1994/CD at/IN St/NN ./NN
@@30019523722 It/PRP is/VBZ concluded/VBN that/IN in/IN patients/NNS with/IN first-attack/JJ genital/JJ herpes/NN ,/, the/DT type/NN of/IN HSV/NN is/VBZ the/DT most/RB important/JJ determinant/NN of/IN subsequent/JJ recurrences/NNS and/CC that/IN intravenous/JJ acyclovir/NN has/VBZ little/JJ effect/NN on/IN subsequent/JJ recurrences/NNS ./.
@@77307955950 The/DT amino/JJ acid/NN sequences/NNS of/IN the/DT known/VBP largest/JJS subunits/NNS of/IN DdRPs/NEWGENE from/IN different/JJ species/NN contain/VB highly/RB conserved/VBN regions/NNS ./.
@@85348488127 All/DT three/CD NR/NEWGENE isoforms/NEWGENE are/VBP expressed/VBN in/IN cv/CD ./CD
@@87331238108 Facioscapulohumeral/JJ muscular/JJ dystrophy/NN (/( FSHD/NN )/SYM is/VBZ an/DT autosomal/JJ dominant/NN ,/, neuromuscular/JJ disorder/NN characterized/VBN by/IN progressive/JJ weakness/NN of/IN muscles/NNS in/IN the/DT face/NN ,/, shoulder/NN and/CC upper/JJ arm/NN ./.
@@35811605978 Significantly/RB lower/JJR heart/NN rate/NN reactivity/NN and/CC significantly/RB less/PRP pronounced/VBN left/NN temporal/JJ artery/NN pulse/NN amplitude/NN responses/NNS were/VBD found/VBN in/IN non-medicated/JJ TH/NN subjects/NNS than/IN in/IN controls/NNS ./.
@@86579186807 MATERIALS/NNP AND/CC METHODS/IN :/: Coronal/NNP 3D/NNP GRE/NNP imaging/VBG was/VBD used/VBN to/IN study/NN the/DT volar/JJ ,/, middle/JJ ,/, and/CC dorsal/JJ portions/NNS of/IN the/DT SLL/NN in/IN 14/CD patients/NNS with/IN an/DT arthroscopically/RB normal/JJ SLL/NN and/CC in/IN five/CD cadaveric/JJ wrists/NNS that/WDT had/VBP a/DT normal/NN SLL/NN proved/VBN with/IN dissection/NN ./.
@@95287588250 Rex-1/NEWGENE ,/, a/DT gene/NN encoding/VBG a/DT transcription/NN factor/NN expressed/VBN in/IN the/DT early/JJ embryo/NN ,/, is/VBZ regulated/VBN via/NN Oct-3/NEWGENE //NEWGENE 4/NEWGENE and/CC Oct-6/NEWGENE binding/JJ to/IN an/DT octamer/NN site/NN and/CC a/DT novel/JJ protein/NN ,/, Rox-1/NEWGENE ,/, binding/JJ to/IN an/DT adjacent/JJ site/NN ./.
@@67620252158 The/DT 13/NNS ,/NNS 14-dihydro-15-keto-metabolites/NNS of/IN PGE2/NEWGENE and/CC PGF2/NEWGENE alpha/NEWGENE had/VBP no/DT statistically/RB significant/JJ antiarrhythmic/JJ effect/NN ./.
@@40846075441 The/DT imino/JJ proton/NN of/IN T3/NN in/IN the/DT O6meG/NN ./NN T/NN 12-mer/NN and/CC G3/NN in/IN the/DT O6meG/NN ./NN N/NN 12-mer/NN helix/NN ,/, which/WDT are/VBP associated/VBN with/IN the/DT modification/NN site/NN ,/, resonate/VB at/IN unusually/RB high/JJ field/NN (/( 8/CD ./CD 5/CD to/IN 9/CD ./CD 0/CD ppm/NN )/SYM compared/VBN to/IN imino/JJ protons/NNS in/IN Watson-Crick/NNP base/NN pairs/NNS (/( 12/CD ./CD 5/CD to/IN 14/CD ./CD 5/CD ppm/NN )/SYM ./.
@@87973628162 Update/NNP :/: diphtheria/NN epidemic/JJ in/IN the/DT newly/RB independent/JJ states/NNS of/IN the/DT former/JJ USSR/NN ,/, January/NN 1995-March/NN 1996/CD ./.
@@33543414044 The/DT glomerular/JJ filtration/NN rate/NN and/CC effective/JJ renal/JJ plasma/NN flow/NN were/VBD determined/VBN by/IN a/DT standard/JJ clearance/NN method/NN ,/, employing/VBG continuous/JJ infusion/NN of/IN inulin/NN and/CC para-aminohippuric/JJ acid/NN ./.
@@76426337855 A/DT TATA-less/NNP promoter/NN containing/NN binding/NN sites/NN for/IN ubiquitous/JJ transcription/NN factors/NNS mediates/VBZ cell/NN type-specific/JJ regulation/NN of/IN the/DT gene/NN for/IN transcription/NEWGENE enhancer/NEWGENE factor-1/NEWGENE (/( TEF-1/NEWGENE )/SYM ./.
@@35076893804 Chimeric/NNP phage-plasmid/JJ expression/NN vectors/NNS were/VBD constructed/VBN from/IN pUC18/NN //NN 19/NN plasmids/NNS by/IN cloning/VBG a/DT single-stranded/JJ DNA/NN (/( ssDNA/NN )/SYM origin/NN of/IN replication/NN from/IN bacteriophage/NN f1/NN and/CC inserting/VBG a/DT bacteriophage/NN T7/NN promoter/NN within/IN the/DT beta-galactosidase/NEWGENE gene/NEWGENE ./.
@@104469104874 Analysis/NNP of/IN the/DT E2F1/NEWGENE gene/NEWGENE promoter/NEWGENE showed/VBN that/IN the/DT -146/NN to/IN -54/CD region/NN was/VBD required/VBN for/IN E2-responsiveness/NNP in/IN transient/JJ transfection/NN assays/NNS ,/, and/CC subsequent/JJ deletion/NN //NN mutation/NN analysis/NN showed/VBN that/IN a/DT single/JJ upstream/RB GC-rich/NNP and/CC two/JJ downstream/NN CCAAT-binding/NN sites/NN were/VBD required/VBN for/IN transactivation/NN by/IN E2/NEWGENE ./.
@@82293308210 Most/JJS smokers/NNS would/MD prefer/VB to/IN quit/NN smoking/NN on/IN their/PRP own/VB ./.
@@20930335868 Effect/NN of/IN separate/JJ and/CC combined/JJ effects/NNS of/IN plutonium-239/NN ,/, hexachlorobutadiene/NN and/CC tributyl/NN phosphate/NN on/IN the/DT thymus/NN gland/NN of/IN rats/NNS ./.
@@90833454563 However/RB ,/, the/DT range/NN of/IN values/NNS observed/VBN is/VBZ suggestive/JJ of/IN the/DT need/NN to/IN investigate/VB districts/NNS with/IN contrasting/JJ values/NNS of/IN SYPLR/NN with/IN respect/NN to/IN the/DT inter-relationships/NNS between/IN sociodemographic/JJ characteristics/NNS ,/, duration/NN of/IN symptoms/NNS ,/, clinical/JJ presentation/NN and/CC treatment/NN efficacy/NN ./.
@@100842945657 Because/IN there/RB is/VBZ great/JJ need/NN for/IN iron/NN in/IN the/DT EPO-stimulated/JJ erythroid/NN progenitors/NN ,/, it/PRP is/VBZ essential/JJ that/IN serum/NEWGENE ferritin/NEWGENE and/CC transferrin/NEWGENE saturation/NN levels/NNS should/MD be/VB maintained/VBN over/RB 300/CD microg/NN //NN liter/NN and/CC 30%/CD ,/, respectively/RB ./.
@@22694263524 IST/NEWGENE is/VBZ not/RB the/DT RNA/NN target/NN (/( TAR/JJ )/SYM for/IN Tat/NEWGENE trans-activation/NN ;/: however/RB ,/, because/IN it/PRP relies/VBZ entirely/RB on/IN cellular/JJ factors/NNS for/IN activity/NN ,/, IST/NEWGENE may/MD serve/VB to/IN provide/VB abundant/JJ RNA/NN targets/NNS for/IN Tat/NEWGENE trans-activation/NN without/IN a/DT requirement/NN for/IN full-length/JJ viral/JJ mRNA/NN expression/NN ./.
@@86320154779 Immunocytochemical/JJ analysis/NN demonstrated/VBD the/DT presence/NN of/IN DREF/NEWGENE polypeptide/NEWGENE in/IN nuclei/NNS after/IN the/DT eighth/JJ nuclear/JJ division/NN cycle/NN ,/, suggesting/VBG that/IN nuclear/JJ accumulation/NN of/IN DREF/NEWGENE is/VBZ important/JJ for/IN the/DT coordinate/JJ zygotic/JJ expression/NN of/IN DNA/NN replication-related/NN genes/NN carrying/VBG DRE/NEWGENE sequences/NEWGENE ./.
@@75981061435 Mean/VB growth/NN changes/NNS in/IN this/DT Class/NN II/NN sample/NN were/VBD comparable/JJ to/IN those/DT previously/RB reported/VBN for/IN male/JJ subjects/NNS with/IN Class/NN I/NN malocclusions/NNS over/RB the/DT same/JJ age/NN period/NN ,/, suggesting/VBG a/DT similarity/NN in/IN postpubertal/JJ development/NN between/IN these/DT two/JJ groups/NNS ./.
@@94051955355 Large/JJ genomic/JJ constructs/NNS integrate/VBP at/IN the/DT endogenous/JJ locus/NN by/IN homologous/JJ recombination/NN ,/, but/CC cDNA-derived/NN sequences/NN lacking/JJ long/JJ stretches/NNS of/IN contiguous/JJ genomic/JJ DNA/NN (/( due/NN to/IN intron/NN excision/NN )/SYM typically/RB integrate/VB into/IN chromosomal/JJ DNA/NN by/IN nonhomologous/JJ recombination/NN ./.
@@30537133462 DNA/NN sequencing/VBG of/IN the/DT DPM1/NEWGENE gene/NEWGENE revealed/VBD an/DT open/JJ reading/JJ frame/NN of/IN 801/CD bases/NNS ./.
@@93694531839 Unlike/IN most/RB other/DT members/NNS of/IN the/DT Bcl-2/NEWGENE family/NEWGENE ,/, BAD/NEWGENE (/( Bcl-xL/NEWGENE //NEWGENE Bcl-2/NEWGENE associated/NEWGENE death/NEWGENE promoter/NEWGENE )/SYM ,/, a/DT death/NEWGENE enhancer/NEWGENE ,/, has/VBZ no/DT C-terminal/NN transmembrane/JJ domain/NN for/IN targeting/JJ to/IN the/DT outer/JJ mitochondrial/JJ membrane/NN and/CC nuclear/JJ envelope/NN ./.
@@95372952232 Analysis/NNP of/IN promoter/NN and/CC androgen/NN regulatory/NN sequences/NN required/VBN for/IN optimal/JJ transcription/NN of/IN the/DT rat/NN androgen-binding/NEWGENE protein/NEWGENE gene/NN ./.
@@24360053099 These/DT results/NNS suggest/VBP that/IN the/DT negative/JJ inotropic/JJ action/NN of/IN nicorandil/NN is/VBZ caused/VBN by/IN inhibition/NN of/IN Ca/NN influx/NN and/CC intracellular/JJ mobilization/NN of/IN Ca/NNP ./NNP
@@13183103538 Plasma/NN membranes/NNS of/IN cultured/JJ cells/NNS contain/VBP high/JJ affinity/NN receptors/NNS for/IN high/JJ density/NN lipoprotein/NN (/( HDL/NN )/SYM that/WDT appear/VBP to/IN mediate/VB removal/NN of/IN excess/NN intracellular/JJ cholesterol/NN ./.
@@106536934623 We/PRP have/VBP addressed/VBN these/DT issues/NNS by/IN reconstituting/JJ and/CC characterizing/VBG the/DT KRAB/NEWGENE :/: KAP-1-RBCC/NEWGENE interaction/NN using/VBG purified/VBN components/NNS ./.
@@113808371221 Interventions/NNS aimed/VBN at/IN these/DT specific/JJ mediators/NNS and/CC processes/NNS may/MD be/VB successful/JJ in/IN reducing/JJ the/DT very/RB significant/JJ human/JJ and/CC economic/JJ costs/NNS of/IN vascular/JJ access/NN dysfunction/NN ./.
@@105928249874 Despite/IN the/DT high/JJ frequency/NN of/IN natural/JJ infection/NN ,/, the/DT seropositive/JJ rates/NNS of/IN JEV/NN antibody/NN still/RB correlated/VBD well/VB with/IN the/DT dose/NN of/IN vaccine/NN received/VBN ,/, i/FW ./FW e/FW ./FW ,/, 67%/JJ (/( 1122/CD //CD 1664/CD )/SYM ,/, 66%/JJ (/( 65/CD //CD 97/CD )/SYM ,/, 33%/JJ (/( 4/CD //CD 12/CD )/SYM and/CC 40%/CD (/( 19/CD //CD 47/CD )/SYM for/IN children/NNS receiving/JJ 3/CD ,/, 2/CD ,/, 1/CD ,/, and/CC 0/CD dose/NN of/IN JE/NN vaccines/NNS ,/, respectively/RB (/( P/NN </SYM 0/CD ./CD 0001/CD Chi-square/NN for/IN trend/NN test/NN )/SYM ./.
@@27492153442 Isolated/JJ proteinuria/NN (/( i/CD ./CD e/CD ./. without/IN hematuria/NN and/DT //DT or/DT pyuria/NN )/SYM is/VBZ a/DT frequent/JJ finding/NN ./.
@@91740496749 Concomitantly/RB ,/, p34CDC2/NEWGENE histone/NEWGENE1 H1/NEWGENE1 kinase/NEWGENE activity/NN increases/NNS in/IN the/DT former/NN ,/, but/CC not/RB in/IN the/DT latter/JJ cell/NN lines/NNS ,/, hence/RB suggesting/VBG a/DT role/NN for/IN this/DT protein/NN in/IN radiation-induced/JJ cell/NN death/NN ./.
@@104881484711 These/DT studies/NNS suggest/VBP that/IN MAPK/NEWGENE acts/NNS by/IN stimulating/NN AP-1/NEWGENE and/CC a/DT subsequent/JJ physical/JJ and/CC functional/JJ interaction/NN of/IN AP-1/NEWGENE with/IN NF-kappaB/NEWGENE ,/, resulting/VBG in/IN a/DT complex/NN that/WDT synergistically/RB transactivates/VBZ the/DT HIV-1/NEWGENE LTR/NEWGENE ./.
@@26291098732 Although/IN the/DT fertility/NN decline/NN in/IN the/DT black/JJ population/NN in/IN the/DT Mississippi/NN Delta/NN between/IN the/DT late/JJ 1870's/CD and/CC early/JJ 1930's/CD closely/RB paralleled/VBN that/IN of/IN the/DT national/JJ black/JJ population/NN ,/, it/PRP rose/VBD much/JJ more/RB dramatically/RB in/IN the/DT 1940's/CD and/CC 1950's/CD to/IN almost/RB 1880/CD levels/NNS ./.
@@32090199952 During/IN a/DT 28-week/CD promotion/NN bioassay/NN ,/, groups/NNS of/IN 30/CD male/JJ CD-1/NEWGENE mice/NNS were/VBD treated/VBN once/CC with/IN 50/CD microliter/NN of/IN either/DT DMBA/NN (/( 1/CD ./CD 0/CD mg/NN //NN ml/NN )/SYM or/CC acetone/NN ,/, rested/VBN for/IN 2/CD weeks/NNS ,/, and/CC then/RB treated/VBN twice/RB per/IN week/NN with/IN test/NN material/NN for/IN the/DT remaining/JJ 25/CD weeks/NNS ./.
@@76513409932 Retransformation/NNS of/IN uvsH77/NEWGENE mutants/NEWGENE with/IN the/DT rescued/VBN cosmids/NNS from/IN the/DT MMS-resistant/NNP transformants/NNS resulted/VBN in/IN restoration/NN of/IN both/DT UV/NN and/CC MMS/NNP resistance/NN to/IN wild-type/NN levels/NNS ./.
@@105493547937 Similar/JJ mechanisms/NNS leading/VBG to/IN deregulation/NN of/IN Tcf/NEWGENE target/NEWGENE gene/NEWGENE activity/NN are/VBP likely/RB to/IN be/VB involved/VBN in/IN melanoma/NN and/CC other/DT forms/NNS of/IN cancer/NN ./.
@@93087381240 In/NN the/DT United/NNP States/NNPS high-MW/JJ HES/NN 480/NN which/WDT is/VBZ difficult/JJ to/IN degrade/VB is/VBZ most/RB frequently/RB used/VBN and/CC results/NNS in/IN a/DT larger/JJR in/IN vivo/NN MW/NN and/CC subsequent/JJ decrease/NN in/IN factor/NEWGENE VIII/NEWGENE //NEWGENE von/NEWGENE Willebrand/NEWGENE factor/NEWGENE levels/NNS ./.
@@65247618275 However/RB ,/, there/RB was/VBD a/DT difference/NN in/IN the/DT quality/NN of/IN immunity/NN :/: fever/NN and/CC body/NN weight/NN loss/NN were/VBD seen/VBP in/IN hamsters/NNS vaccinated/VBN with/IN the/DT killed-toxoplasma/JJ vaccine/NN after/IN they/PRP were/VBD challenge/NN exposed/VBN with/IN T-1/NN strain/NN ,/, whereas/IN these/DT changes/NNS were/VBD rarely/RB seen/VBP in/IN hamsters/NNS given/VBP the/DT live-toxoplasma/JJ vaccine/NN and/CC then/JJ challenge/NN exposed/VBN with/IN RH/NN strain/NN ./.
@@89169608055 We/PRP analyzed/VBD serial/JJ biopsy/NN specimens/NNS from/IN eight/CD patients/NNS with/IN FL/NN for/IN secondary/JJ alterations/NNS of/IN the/DT rearranged/NEWGENE bcl-2/NEWGENE gene/NEWGENE in/IN the/DT breakpoint/NN and/CC open/JJ reading/JJ frame/NN (/( ORF/NN )/SYM regions/NNS ./.
@@15572172163 Eight/CD of/IN 14/CD infectious/JJ or/CC inflammatory/JJ lesions/NNS could/MD be/VB detected/VBN in/IN the/DT early/JJ scan/NN (/( 4-6/CD h/NN p/CD ./CD i/CD ./CD )/SYM ./.
@@92714176350 In/NN the/DT adult/JJ mouse/NN ,/, ERR/NEWGENE alpha/NEWGENE is/VBZ most/RB highly/RB expressed/VBN in/IN kidney/NN ,/, heart/NN ,/, and/CC brown/JJ adipocytes/NNS ,/, tissues/NNS which/WDT preferentially/RB metabolize/VB fatty/JJ acids/NNS ./.
@@67022571860 Antithrombin/NEWGENE III/NEWGENE in/IN hip/NN surgery/NN ./.
@@80125668303 The/DT pentafluorobenzyl/NN derivative/NN of/IN clonidine/NN yields/VBZ an/DT intense/JJ ion/NN fragment/NN at/IN m/NN //NN z/NN 354/NN ,/, and/CC the/DT lower/JJR limit/NN of/IN detection/NN is/VBZ 0/CD ./CD 025/CD ng/NN //NN ml/NN for/IN a/DT 1-ml/JJ plasma/NN sample/NN ./.
@@109305261398 We/PRP recently/RB reported/VBD the/DT molecular/JJ cloning/NN of/IN a/DT PL/NEWGENE scramblase/NEWGENE of/IN human/JJ (/( HuPLSCR1/NEWGENE )/SYM and/CC mouse/NN origin/NN ,/, respectively/RB ./.
@@76238445533 However/RB ,/, unlike/IN Bcl-2/NEWGENE and/CC the/DT E1B/NEWGENE 19K/NEWGENE proteins/NEWGENE ,/, which/WDT completely/RB block/VB apoptosis/NN but/CC not/RB p53-dependent/JJ growth/NN arrest/NN ,/, H-ras/NEWGENE expression/NN permitted/VBD DNA/NN synthesis/NN and/CC cell/NN proliferation/NN in/IN the/DT presence/NN of/IN high/JJ levels/NNS of/IN wild-type/NEWGENE p53/NEWGENE ./.
@@91153957250 Of/IN these/DT proteins/NNS ,/, five/CD have/VB previously/RB been/VBN shown/VBP to/IN be/VB phosphorylated/VBN during/IN mitosis/NN (/( epithelial-microtubule/NEWGENE associated/NEWGENE protein-115/NEWGENE ,/, Oct91/NEWGENE ,/, Elongation/NEWGENE factor/NEWGENE 1gamma/NEWGENE ,/, BRG1/NEWGENE and/CC Ribosomal/NEWGENE protein/NEWGENE L18A/NEWGENE )/SYM ,/, five/CD are/VBP related/VBN to/IN proteins/NNS postulated/VBN to/IN have/NN roles/NNS in/IN mitosis/NN (/( epithelial-microtubule/NEWGENE associated/NEWGENE protein-115/NEWGENE ,/, Schizosaccharomyces/NEWGENE pombe/NEWGENE Cdc5/NEWGENE ,/, innercentrosome/NEWGENE protein/NEWGENE ,/, BRG1/NEWGENE and/CC the/DT RNA/NEWGENE helicase/NEWGENE WM6/NEWGENE )/SYM ,/, and/CC nine/JJ are/VBP related/VBN to/IN transcription/NN factors/NNS (/( BRG1/NEWGENE ,/, negative/NEWGENE co-factor/NEWGENE 2alpha/NEWGENE ,/, Oct91/NEWGENE ,/, S/NNP ./NNP pombe/NN Cdc5/NEWGENE ,/, HoxD1/NEWGENE ,/, Sox3/NEWGENE ,/, Vent2/NEWGENE ,/, and/CC two/JJ isoforms/NNS of/IN Xbr1b/NEWGENE )/SYM ./.
@@29283763635 For/IN the/DT present/NN work/NN we/PRP used/VBD water/VBP saturated/JJ with/IN a/DT 50/CD //CD 50/CD mixture/NN of/IN H2/NN and/CC O2/NN gases/NNS ,/, for/IN which/WDT the/DT heat/NN defect/NN is/VBZ calculated/VBN to/IN be/VB -2/CD ./CD 1%/CD ./.
@@11902511814 Caution/NN should/MD be/VB exercised/VBN in/IN the/DT use/NN of/IN these/DT dyes/NNS for/IN lymphograms/NNS ./.
@@93546849966 In/NN addition/NN ,/, mutation/NN of/IN the/DT Sp1/NEWGENE site/NEWGENE also/RB significantly/RB reduced/VBN promoter/NN activity/NN ./.
@@85196218488 This/DT conclusion/NN is/VBZ based/VBN on/IN the/DT observations/NNS of/IN the/DT immunologic/JJ changes/NNS that/WDT characterize/VBP the/DT acute/JJ stages/NNS of/RB illness/NN as/RB well/VB as/IN on/IN the/DT demonstrated/VBN association/NN with/IN toxin-producing/JJ bacteria/NNS in/IN the/DT pharynx/NN and/CC gastrointestinal/JJ tract/NN ./.
@@115738916847 RESULTS/NNS :/: Sixty/CD per/IN cent/NN of/IN African/JJ Americans/NNS exposed/VBN in/IN 26/CD community/NN outbreaks/NNS were/VBD TST/NN positive/RB compared/VBD to/IN only/RB 40%/CD of/IN whites/NNS following/IN comparable/JJ exposures/NNS ./.
@@92823291649 To/TO address/VB mechanisms/NNS that/WDT define/VBP interactions/NNS of/IN Site/NEWGENE II/NEWGENE regulatory/NEWGENE factors/NEWGENE with/IN this/DT cell/NN cycle/NN control/NN element/NN ,/, we/PRP have/VBP investigated/VBN these/DT determinants/NNS of/IN transcriptional/JJ regulation/NN at/IN the/DT G1/NN //NN S/NN phase/NN transition/NN in/IN FDC-P1/NNP hematopoietic/JJ progenitor/NN cells/NNS ./.
@@83489197747 Botulinum/NEWGENE toxin/NEWGENE :/: preferred/VBN treatment/NN for/IN hemifacial/JJ spasm/NN ./.
@@106146761333 Objective/JJ :/: To/TO evaluate/VB endometrial/JJ thickness/NN and/CC the/DT incidence/NN of/IN uterine/JJ bleeding/NN in/IN postmenopausal/JJ women/NNS using/VBG either/DT tibolone/NN 2/NN ./NN 5/NN mg/NN or/CC continuous/JJ combined/JJ 2/CD mg/NN estradiol/NN and/CC 1/CD mg/NN norethisterone/NN acetate/NN (/( E+NETA/NNP )/SYM daily/JJ as/IN hormone/NN replacement/NN therapy/NN ./.
@@11305311134 Nerve/NN stimulation/NN (/( 1/CD ./CD 5-12/CD cycles/NNS //NNS s/NNS )/SYM produced/VBN frequency-dependent/JJ reductions/NNS in/IN CBF/NN ,/, a/DT decrease/NN of/IN 50/CD percent/NN occurring/VBG with/IN the/DT highest/JJS frequency/NN ./.
@@94677078960 Sibling/NN aggregation/NN of/IN low-/DT and/CC high-density/JJ lipoprotein/NN cholesterol/NN and/CC apolipoproteins/NEWGENE B/NEWGENE and/CC A-I/NEWGENE levels/NNS in/IN black/JJ and/CC white/JJ children/NNS :/: the/DT Bogalusa/NNP Heart/NNP Study/NNP ./.
@@75258437774 Dilutions/NNS of/IN H-2b/NEWGENE or/CC H-2d/NEWGENE NP/NEWGENE1 peptides/NEWGENE1 indicated/VBN that/IN 3-4/CD logs/NNS less/PRP H-2b/NEWGENE NP/NEWGENE1 peptide/NEWGENE1 was/VBD required/VBN to/IN sensitize/VB syngeneic/JJ target/NN cells/NNS for/IN CTL-specific/NNP lysis/NN ,/, suggesting/VBG that/IN the/DT differing/JJ affinities/NNS of/IN H-2b/NEWGENE and/CC H-2d/NEWGENE major/NEWGENE1 histocompatibility/NEWGENE1 complex/NEWGENE1 molecules/NEWGENE1 for/IN their/PRP peptides/NNS likely/JJ account/NN for/IN the/DT total/JJ removal/NN of/IN NP/NEWGENE CTL/NN in/IN the/DT H-2b/NEWGENE mice/NNS but/CC only/RB partial/JJ removal/NN in/IN H-2d/NEWGENE mice/NNS made/VBP to/IN express/NN thymic/NEWGENE NP/NNP ./NNP
@@106815887698 EMSA/NN showed/VBN that/IN nuclear/JJ proteins/NNS from/IN PC12/CELL but/CC not/RB C6/VB or/CC Rat2/NNP cells/NNS bind/VBP the/DT CRE/NEWGENE as/IN a/DT complex/NN containing/NN activating/NEWGENE transcription/NEWGENE factor/NEWGENE (/NEWGENE ATF/NEWGENE )/NEWGENE -4/NEWGENE and/CC CCAAT/NEWGENE enhancer-binding/NEWGENE protein/NEWGENE beta/NEWGENE ,/, while/CC both/DT PC12/CELL and/CC C6/NN cell/NN nuclear/JJ extracts/NNS were/VBD recruited/VBN by/IN the/DT CCAAT-box/NNP as/IN a/DT complex/NN containing/NN nuclear/NEWGENE factor/NEWGENE Y/NEWGENE ./.
@@22578992898 Auditory-visual/JJ interaction/NN in/IN the/DT generation/NN of/IN saccades/NNS in/IN man/NN ./.
@@110126712971 In/NN addition/NN ,/, a/DT noncanonical/NNP C/NEWGENE //NEWGENE EBP-binding/NEWGENE site/NEWGENE within/IN the/DT Gadd45gamma/NEWGENE promoter/NEWGENE where/CC C/NEWGENE //NEWGENE EBPbeta/NEWGENE and/CC C/NEWGENE //NEWGENE EBPdelta/NEWGENE could/MD bind/VB ,/, was/VBD identified/VBN by/IN electrophoretic/JJ mobility/NN shift/NN assay/NN (/( EMSA/NN )/SYM and/CC reporter/NN gene/NN analysis/NN ./.
@@83966678753 BCR-ABL/NEWGENE and/CC v-abl/NEWGENE oncogenes/NEWGENE induce/VBP distinct/JJ patterns/NNS of/IN thymic/JJ lymphoma/NN involving/VBG different/JJ lymphocyte/NN subsets/NNS ./.
@@80025647852 DNA/NN sequence/NN analysis/NN has/VBZ confirmed/VBN that/IN this/DT mutation/NN affects/VBP the/DT C-terminal/NN region/NN of/IN the/DT alpha/NN subunit/NN ,/, changing/JJ a/DT leucine/NN residue/NN at/IN position/NN 290/CD to/IN a/DT histidine/NN (/( rpoAL290H/NEWGENE )/SYM ./.
@@7011446791 Biometric/NN analysis/NN of/IN intraocular/JJ lens/NN power/NN required/VBN to/IN produce/NN emmetropia/NN :/: results/NNS of/IN 450/CD implants/NNS ./.
@@10563605384 There/EX was/VBD a/DT trend/NN toward/IN an/DT association/NN between/IN IENF/NN and/CC sural/JJ nerve/NN unmyelinated/JJ fiber/NN densities/NNS (/( r/JJ =/SYM 0/CD ./CD 32/CD ,/, p/NN =/SYM 0/CD ./CD 054/CD )/SYM ./.
@@90117451634 CDNA/NNP cloning/NN of/IN chick/NEWGENE brain/NEWGENE alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic/NEWGENE acid/NEWGENE receptors/NEWGENE reveals/VBZ conservation/NN of/IN structure/NN ,/, function/NN and/CC post-transcriptional/JJ processes/NNS with/IN mammalian/JJ receptors/NNS ./.
@@12808071233 The/DT apparent/JJ Kd/NN of/IN the/DT MetRS/NEWGENE //NEWGENE CAU/NEWGENE operator/NEWGENE complex/NEWGENE is/VBZ one/PRP order/NN magnitude/NN higher/JJ than/IN that/DT of/IN the/DT ThrRS/NEWGENE //NEWGENE CGU/NEWGENE operator/NEWGENE complex/NEWGENE ./.
@@84739676830 Bipolarity/NNS in/IN Jungian/NNP type/NN theory/NN and/CC the/DT Myers-Briggs/NNP Type/NN Indicator/NN ./.
@@112509425694 Deletional/JJ analyses/NNS of/IN VDR/NEWGENE indicated/VBN that/IN GRIP1/NEWGENE and/CC RAC3/NEWGENE required/VBN an/DT intact/JJ VDR/NEWGENE activation/NEWGENE1 function/NEWGENE1 (/NEWGENE1 AF-2/NEWGENE1 )/NEWGENE1 domain/NEWGENE1 for/IN efficient/JJ interaction/NN as/RB well/VB as/IN additional/JJ but/CC distinct/JJ regions/NNS of/IN the/DT VDR/NEWGENE ./.
@@97654111732 Sequence/NN comparisons/NNS strongly/RB suggest/VBP that/IN the/DT S27a/NEWGENE and/CC the/DT ubiquitin/NEWGENE coding/JJ sequences/NNS found/VBP in/IN the/DT genome/NN of/IN CP/NN Rit/NN were/VBD both/DT derived/VBN from/IN a/DT bovine/NN mRNA/NN encoding/VBG a/DT hybrid/JJ protein/NN with/IN the/DT structure/NN NH2-ubiquitin-S27a-COOH/NEWGENE ./.
@@83808965542 Kinetics/NNS of/IN the/DT inhibition/NN indicated/VBN that/IN this/DT polymerase/NEWGENE domain/NEWGENE can/MD inhibit/VB viral/JJ replication/NN only/RB during/IN the/DT preinitiation/JJ stage/NN ./.
@@90798174646 The/DT reduced/VBN NO/DT production/NN in/IN these/DT cells/NNS was/VBD associated/VBN with/IN low/JJ levels/NNS of/IN mRNA/NN of/IN inducible/NEWGENE NO/NEWGENE synthetase/NEWGENE ./.
@@8378115406 A/DT diagnosis/NN of/IN MS/NN was/VBD made/VBP based/VBN on/IN subtle/JJ neurologic/JJ signs/NNS ,/, spinal/JJ fluid/NN gamma/NEWGENE globulin/NEWGENE elevations/NNS ,/, and/CC abnormalities/NNS in/IN neuropsychological/JJ testing/NN ./.
@@97636076059 We/PRP found/VBP that/IN virulent/JJ Ngo/NNP strains/NNS induce/VBP phosphorylation/NN and/CC activation/NN of/IN JNK/NEWGENE but/CC not/RB of/IN p38/NEWGENE kinase/NEWGENE ./.
@@28201288232 In/NN terms/NNS of/IN sequence/NN repetitions/NNS ,/, seven/JJ tandemly/RB repeated/JJ copies/NNS of/IN the/DT hexanucleotide/NEWGENE ATTGTT/NEWGENE and/CC three/CD flanking/JJ regions/NNS of/IN dyad/NN symmetry/NN were/VBD detected/VBN ,/, all/DT in/NN ORF/NEWGENE T3C/NEWGENE ./.
@@87565569611 The/DT cDNA/NN encoded/VBN a/DT mature/JJ protein/NN of/IN 240/CD amino/JJ acids/NNS ,/, including/JJ a/DT 29-amino/CD acid/NN signal/JJ sequence/NN ./.
@@86470866252 Cdk2/NEWGENE formed/VBN a/DT complex/NN with/IN cyclin/NEWGENE D1/NEWGENE in/IN this/DT system/NN ./.
@@79837129323 However/RB ,/, when/CC domain/NN I/PRP and/CC domain/NN II/NNP were/VBD linked/JJ on/IN the/DT same/JJ plasmid/NN ,/, high/JJ levels/NNS of/IN replication/NN were/VBD observed/VBN ./.
@@7755827725 Biological/JJ properties/NNS of/IN sumithion/NN ./.
@@76483386029 These/DT results/NNS suggest/VBP that/IN different/JJ models/NNS of/IN intestinal/JJ ischemia/NN have/NN different/JJ cytokine/NN profiles/NNS and/CC that/IN the/DT early/NN TNF/NEWGENE response/NN associated/VBN with/IN SMA/NN occlusion/NN model/NN is/VBZ primarily/RB due/NN to/IN the/DT laparotomy/NN ./.
@@80653313550 An/DT in/NN vitro/NN binding/NN site/NN selection/NN procedure/NN was/VBD used/VBN to/IN determine/VB DNA/NN sequences/NNS preferentially/RB bound/JJ by/IN wild-type/NEWGENE HLF/NEWGENE and/CC chimeric/NEWGENE E2A-HLF/NEWGENE proteins/NEWGENE isolated/VBN from/IN various/JJ t/NN (/NN 17/NN ;/: 19/NN )/NN -bearing/NN leukemias/NNS ./.
@@10882462703 The/DT science/NN of/IN tissue/NN engineering/JJ ./.
@@87602867181 The/DT structural/JJ similarity/NN between/IN Vav/NEWGENE and/CC other/DT guanine/NEWGENE nucleotide/NEWGENE exchange/NEWGENE factors/NEWGENE for/IN small/NEWGENE GTP-binding/NEWGENE proteins/NEWGENE ,/, together/RB with/IN the/DT recent/JJ identification/NN of/IN biochemical/JJ routes/NNS specific/JJ for/IN members/NNS of/IN the/DT Ras/NEWGENE and/CC Rho/NEWGENE family/NEWGENE of/IN GTPases/NEWGENE ,/, prompted/VBD us/PRP to/IN explore/VB whether/IN MAPK/NEWGENE or/CC JNK/NEWGENE are/VBP downstream/JJ components/NNS of/IN the/DT Vav/NEWGENE signaling/JJ pathways/NNS ./.
@@81237878342 The/DT inferred/VBN amino/JJ acid/NN sequence/NN of/IN the/DT cyanobacterial/NEWGENE HemB/NEWGENE protein/NEWGENE indicates/VBZ a/DT significant/JJ difference/NN in/IN the/DT metal/NN cofactor/NN requirement/NN from/IN the/DT higher-plant/JJ enzymes/NNS ,/, which/WDT was/VBD confirmed/VBN by/IN overexpression/NN and/CC biochemical/JJ analysis/NN ./.
@@65791524399 Besides/IN ,/, it/PRP was/VBD considered/VBN that/IN the/DT NPF/NN was/VBD a/DT useful/JJ tool/NN for/IN activation/NN of/IN velopharyngeal/JJ activity/NN by/IN way/NN of/IN visual/JJ feed-back/NN control/NN ./.
@@15889633872 Using/VBG these/DT antibodies/NNS ,/, we/PRP were/VBD able/JJ to/IN define/VB the/DT conditions/NNS to/IN completely/RB solubilize/VB the/PDT Cdc25/NEWGENE protein/NEWGENE ./.
@@78761343849 Here/RB ,/, we/PRP report/VBP the/DT characterization/NN of/IN an/DT alternatively/RB processed/VBN form/NN of/IN AFAP-110/NEWGENE that/IN encodes/VBZ an/DT additional/JJ 258/CD base/NN pair/NN (/( bp/NN )/SYM of/IN open/JJ reading/JJ frame/NN ./.
@@98563979792 Dry/NNP matter/NN intake/NN ,/, apparent/JJ nutrient/JJ digestibilities/NNS ,/, serum/JJ chemistry/NN profiles/NNS ,/, sphingolipid/NN concentrations/NNS ,/, and/CC persistency/NN of/IN FB1/NN in/IN tissues/NNS were/VBD evaluated/VBN ./.
@@61618235982 2/CD Silastic/NN capsules/NNS ,/, each/DT containing/JJ 22-23/JJ mg/NN of/IN ethinyl/NN estradiol/NN ,/, were/VBD inserted/VBN subcutaneously/RB in/IN 5/CD men/NNS with/IN benign/JJ prostatic/JJ hypertrophy/NN ./.
@@115174453809 Sixty-one/NN cases/NNS of/IN cholera/NN ,/, all/DT caused/VBN by/IN V/NNP ./NNP cholerae/NNS O1/NN ,/, were/VBD reported/VBN ./.
@@97505409737 Multiple/NNP chemical/JJ sensitivity/NN (/( MCS/NNS )/SYM is/VBZ a/DT syndrome/NN in/IN which/WDT multiple/JJ symptoms/NNS reportedly/RB occur/VBP with/IN low-level/JJ chemical/JJ exposure/NN ./.
@@90774382980 The/DT minimum/JJ and/CC essential/JJ subunits/NNS for/IN RNA/NN synthesis/NN have/NN not/RB yet/RB been/VBN identified/VBN ./.
@@14044012690 Behind/IN the/DT ATPase/NEWGENE cluster/NEWGENE ,/, two/JJ open/JJ reading/JJ frames/NNS were/VBD detected/VBN that/WDT are/VBP not/RB homologous/JJ to/IN any/DT known/VBP chloroplast/NN gene/NN ./.
@@63642654427 Induced/NN gamma-ray/NN spectroscopy/NN ./.
@@118594001747 We/PRP compared/VBD the/DT efficacy/NN and/CC costs/NNS of/IN valacyclovir/NN in/IN preventing/JJ HSV/NN reactivation/NN among/IN HSV/NN seropositive/JJ autologous/JJ progenitor/NN cell/NN transplantation/NN (/( APCT/NNP )/SYM patients/NNS with/IN historical/JJ controls/NNS in/IN whom/WP intravenous/JJ acyclovir/NN or/CC no/DT HSV/NN prophylaxis/NN were/VBD used/VBN ./.
@@88937797627 Frozen/NN //NN thawed/NN extensor/NN digitorum/NN longus/NN muscle/NN tendon/NN units/NNS had/VBP significantly/RB lower/JJR values/NNS for/IN load/NN to/IN failure/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, energy/NN absorbed/VBD to/IN failure/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, and/CC strain/NN at/IN failure/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, and/CC they/PRP tended/VBD to/IN fail/NN at/IN a/DT different/JJ anatomic/JJ location/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM (/( broadly/RB at/IN the/DT fascia-muscle/JJ interface/NN as/IN compared/VBN with/IN horizontally/RB at/IN the/DT musculotendinous/JJ junction/NN )/SYM than/IN fresh/JJ units/NNS ./.
@@103506383387 Latexin/NEWGENE ,/, a/DT carboxypeptidase/NEWGENE A/NEWGENE inhibitor/NN ,/, is/VBZ expressed/VBN in/IN a/DT cell/NN type-specific/JJ manner/NN in/IN both/DT central/JJ and/CC peripheral/JJ nervous/JJ systems/NNS in/IN the/DT rat/NN ./.
@@66026004977 The/DT Sarns/NNP 51F/NN cavoatrial/JJ cannula/NN decompressed/VBN the/DT venous/JJ system/NN as/RB efficiently/RB as/IN the/DT double/JJ caval/JJ cannulas/NNS ./.
@@91550155586 We/PRP show/VBP here/RB that/IN the/DT protein/NEWGENE kinase/NEWGENE MEKK1/NEWGENE1 can/MD induce/VB reporter/NN gene/NN expression/NN from/IN the/DT atrial/NEWGENE natriuretic/NEWGENE factor/NEWGENE (/( ANF/NEWGENE )/SYM promoter/NN ,/, a/DT genetic/JJ marker/NN that/WDT is/VBZ activated/VBN during/IN in/IN vivo/NN hypertrophy/NN ./.
@@11301861132 The/DT other/DT hypoglycaemic/JJ patient/NN showed/VBD an/DT exaggerated/JJ insulin/NEWGENE release/NN in/IN response/NN to/IN tolbutamide/NN ./.
@@988930648 In/NN addition/NN ,/, the/DT regulation/NN of/IN Glvr-1/NEWGENE gene/NEWGENE expression/NN also/RB has/VBZ potential/JJ applications/NNS to/IN gene/NN therapy/NN ,/, since/IN retroviral/NN vectors/NN carrying/VBG gibbon/NEWGENE ape/NEWGENE leukemia/NEWGENE virus/NEWGENE envelope/NEWGENE proteins/NEWGENE are/VBP used/VBN for/IN gene/NN delivery/NN into/IN different/JJ cell/NN types/NNS ./.
@@7682207619 The/DT motor/JJ unit/NN viewed/VBN from/IN above/RB ./. pp/NNS ./NNS
@@105235201007 Thus/RB ,/, the/DT nematode/JJ genes/NNS could/MD be/VB the/DT homologs/NEWGENE of/NEWGENE Hh/NEWGENE molecules/NEWGENE in/IN other/DT phyla/NNS ./.
@@98408229830 The/DT method/NN also/RB eliminates/VBZ tagging/NN of/IN venous/JJ spins/NNS and/CC concern/NN about/RB asymmetric/JJ magnetization/NN transfer/NN effects/NNS ./.
@@100867255520 MDS1/NEWGENE //NEWGENE EVI1/NEWGENE ,/, located/VBN on/IN chromosome/NN 3/NN band/NN q26/NN ,/, encodes/VBZ a/DT zinc-finger/NN DNA-binding/NN transcription/NN activator/NN not/RB detected/VBD in/IN normal/JJ hematopoietic/JJ cells/NNS but/CC expressed/VBN in/IN several/DT normal/JJ tissues/NNS ./.
@@93609567212 We/PRP have/VBP now/RB shown/VBP that/IN in/IN vivo/NN phosphorylation/NN of/IN 14-3-3/NEWGENE zeta/NEWGENE at/IN the/DT CKIalpha/NEWGENE site/NEWGENE (/NEWGENE Thr-233/NEWGENE )/NEWGENE negatively/RB regulates/VBZ its/PRP binding/JJ to/IN c-Raf/NEWGENE ,/, and/CC may/MD be/VB important/JJ in/IN Raf-mediated/JJ signal/JJ transduction/NN ./.
@@19319669604 Fusion/NNS of/IN ubiquitin/NEWGENE to/IN pADPRP/NEWGENE increased/VBD the/DT yield/NN of/IN pADPRP/NEWGENE approximately/RB 10-fold/RB compared/VBN to/IN that/DT of/IN the/DT unfused/JJ enzyme/NN ./.
@@93766269428 Radiation/NN decreased/VBD the/DT levels/NNS of/IN T4/NN and/CC T3/NN 6/NN h/NN and/CC 72/CD h/NN in/IN group/NN C/NN ,/, in/IN group/NN A/DT at/IN 72/CD h/NN ,/, in/IN group/NN B/NNP at/IN 24/CD h/NN postexposure/RB ./.
@@113903953672 Reciprocally/RB ,/, HMGI-C/NEWGENE expression/NN also/RB coordinately/RB enhances/VBZ PIAS3-mediated/JJ repression/NN of/IN STAT3-dependent/NN transactivation/NN ./.
@@89626141234 The/DT determination/NN of/IN immunoglobulin/NEWGENE E/NEWGENE (/( IgE/NEWGENE )/SYM antibodies/NNS by/IN one/PRP of/IN several/DT laboratory/NN tests/NNS ,/, by/IN skin-prick/JJ tests/NNS or/CC by/IN appropriate/JJ challenge/NN procedures/NNS is/VBZ useful/JJ either/DT to/IN identify/VB atopic/JJ individuals/NNS or/CC as/IN outcome/NN predictors/NN in/IN wheezy/JJ children/NNS ./.
@@90926759169 A/DT P22/NEWGENE R17/NEWGENE derivative/NEWGENE with/IN an/DT OcRNA/NEWGENE site/NEWGENE (/( P22/NEWGENE R17/NEWGENE [/NEWGENE A/NEWGENE (/NEWGENE -10/NEWGENE )/NEWGENE U/NEWGENE ]/NEWGENE )/NEWGENE develops/VBZ lytically/RB following/IN infection/NN of/IN these/DT strains/NNS ./.
@@18994091132 Determinants/NNS of/IN recurrent/JJ ischaemia/NN and/CC revascularisation/NN procedures/NNS after/IN thrombolysis/NN with/IN recombinant/JJ tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE in/IN primary/JJ coronary/JJ occlusion/NN ./.
@@17404375522 The/DT major/JJ 49-kDa/CD core/NN protein/NN in/IN the/DT liver/NN HSPG/NN preparation/NN was/VBD found/VBN to/IN be/VB reactive/VBN to/IN an/DT antibody/NN that/WDT specifically/RB recognizes/VBZ the/DT cytoplasmic/JJ domain/NN of/IN fibroglycan/NEWGENE ./.
@@111775385961 Tumor/NNP cell/NN lines/NNS transduced/VBN at/IN an/DT MOI/NN of/IN 8/CD for/IN 3/CD days/NNS led/VBN to/IN >/SYM 90%/NN gene/NN transfer/NN efficiency/NN ./.
@@94734839308 It/PRP may/MD also/RB be/VB suggested/VBN that/IN particular/JJ care/NN should/MD be/VB taken/VBP when/CC such/JJ a/DT trans-dominant/NNP Rev/NEWGENE mutant/NEWGENE is/VBZ considered/VBN to/IN be/VB used/VBN as/IN a/DT genetic/JJ therapy/NN against/IN HIV-I/NNP infection/NN ,/, in/IN individuals/NNS infected/VBN with/IN both/DT HIV-I/NNP and/CC HTLV-1/NN ./.
@@110501686390 These/DT results/NNS provide/VBP direct/JJ evidence/NN for/IN differential/JJ susceptibility/NN to/IN endonuclease-mediated/JJ mRNA/NN decay/NN resulting/JJ from/IN the/DT differential/JJ affinity/NN of/IN a/DT RNA-binding/NN protein/NN for/IN cis-acting/JJ stability/NN determinants/NNS ./.
@@111395674958 LH/NEWGENE //NEWGENE CG/NEWGENE receptor/NEWGENE activation/NN of/IN ARNO/NEWGENE is/VBZ not/RB mediated/JJ by/IN activation/NN of/IN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE (/( PI/NEWGENE 3-kinase/NEWGENE )/SYM or/CC by/IN G/NEWGENE protein/NEWGENE beta/NEWGENE gamma/NEWGENE subunits/NEWGENE ./.
@@103580809165 Modulation/NNS of/IN human/NEWGENE heat/NEWGENE shock/NEWGENE factor/NEWGENE trimerization/NN by/IN the/DT linker/NN domain/NN ./.
@@82676588243 A/DT much/JJ less/PRP expensive/JJ solution/NN than/IN UW/NN ,/, containing/JJ only/RB K/NN (/NN +/NN )/NN -lactobionate/NN ,/, KH2PO4/NN ,/, MgSO4/IN and/CC raffinose/NN ,/, can/MD be/VB used/VBN successfully/RB for/IN preservation/NN of/IN rat/NN hepatocytes/NNS for/IN 24/CD hr/NN for/IN drug/NN transport/NN studies/NNS ./.
@@88983655832 Rss1p/NEWGENE encodes/VBZ a/DT novel/JJ essential/JJ protein/NN of/IN 538/CD amino/JJ acids/NNS ,/, which/WDT contains/VBZ an/DT extended/VBN predicted/VBN coiled-coil/NN domain/NN and/CC is/VBZ located/VBN both/DT at/IN nuclear/JJ pore/NN complexes/NNS (/( NPCs/NNS )/SYM and/CC in/IN the/DT cytoplasm/NN ./.
@@2989786113 In/NN the/DT absence/NN of/IN enhancer/NN sequences/NNS ,/, the/DT adenovirus/NEWGENE E1A/NEWGENE gene/NEWGENE can/MD not/RB stimulate/VB CATase/NEWGENE synthesis/NN ./.
@@9006022824 To/TO characterize/VB the/DT gene/NN products/NNS ,/, the/DT cvaA/NEWGENE gene/NEWGENE was/VBD subcloned/JJ and/CC expressed/VBN under/IN the/DT control/NN of/IN T7/NEWGENE RNA/NEWGENE polymerase/NEWGENE promoter/NEWGENE ./.
@@5651365624 Delayed/JJ mortality/NN of/IN mice/NNS following/IN inhalation/NN of/IN acute/JJ doses/NNS of/IN CH2O/NN ,/, SO2Cl2/NN ,/, and/CC Br2/NN ./.
@@108546994766 Three/CD FGF-AS/NEWGENE cDNAs/NEWGENE were/VBD isolated/VBN ;/: the/DT full-length/NEWGENE FGF-AS/NEWGENE mRNA/NEWGENE and/CC two/JJ alternative/JJ splice/NN variants/NNS lacking/JJ exon/NN 2/CD or/CC exons/NNS 2/CD and/CC 3/CD of/IN the/DT FGF-AS/NEWGENE sequence/NEWGENE ./.
@@112271821984 The/DT authors/NNS did/VBD not/RB detect/VB any/DT significant/JJ correlations/NNS between/IN parameters/NNS of/IN the/DT lipids/NNS of/IN bone/NN marrow/NN and/CC leptin/NEWGENE levels/NNS in/IN serum/NN and/CC bone/NN marrow/NN ./.
@@30345708965 We/PRP inserted/VBD genes/NNS or/CC gene/NN segments/NNS ,/, that/DT code/NN for/IN the/DT bacterial/NEWGENE chloramphenicol/NEWGENE acetyltransferase/NEWGENE ,/, the/DT bacterial/JJ gene/NN conferring/JJ resistance/NN against/IN hygromycin/NN ,/, and/CC the/DT ORF/NN E7/NEWGENE of/IN the/DT human/JJ papillomavirus/NN type/NN 18/CD into/IN these/DT vectors/NNS ./.
@@109354888186 Troglitazone/NNP also/RB induced/VBD an/DT endogenous/NEWGENE PPARgamma/NEWGENE target/NEWGENE gene/NEWGENE in/IN T24/DT cells/NNS ,/, adipocyte-type/NEWGENE fatty/NEWGENE acid/NEWGENE binding/NEWGENE protein/NEWGENE (/( A-FABP/NEWGENE )/SYM ,/, the/DT expression/NN of/IN which/WDT correlates/VBP with/IN bladder/NN cancer/NN differentiation/NN ./.
@@32439203934 The/DT temporal/JJ and/CC static/JJ plasma/NN concentration-effect/NN relationships/NNS were/VBD evaluated/VBN by/IN pharmacodynamic/JJ modeling/NN and/CC linear/JJ regression/NN ./.
@@2342062995 Bertioga/NNP (/( Guama/NNP group/NN )/SYM and/CC Anhembi/NNP (/( Bunyamwera/NNP group/NN )/SYM ,/, two/JJ new/JJ arboviruses/NNS isolated/VBN in/IN Sao/NNP Paulo/NNP ,/, Brazil/NN ./.
@@84156374229 The/DT ADP-ribosylation/NEWGENE factor/NEWGENE (/( ARF/NEWGENE )/SYM family/NN is/VBZ one/PRP of/IN four/CD subfamilies/NNS of/IN the/DT RAS/NEWGENE superfamily/NEWGENE of/IN low/NEWGENE molecular/NEWGENE weight/NEWGENE GTP-binding/NEWGENE proteins/NEWGENE (/( G/NEWGENE proteins/NEWGENE )/SYM ./.
@@14095811471 We/PRP found/VBP that/IN both/PDT the/DT E26/NN virus-encoded/JJ v-ets/NEWGENE and/CC the/DT myeloid/NEWGENE //NEWGENE B-cell-specific/NEWGENE factor/NEWGENE PU/NEWGENE ./NEWGENE 1/NEWGENE bind/VB efficiently/RB to/IN this/DT site/NN in/IN vitro/FW ./.
@@64375799759 Cimetidine/NN 800/NN mg/NN given/VBP at/IN night/NN is/VBZ as/RB effective/JJ as/IN 400/CD mg/NN twice/RB daily/JJ ;/: the/DT single/JJ dose/NN regimen/NN may/MD improve/VB patient/NN compliance/NN ,/, thus/RB facilitating/JJ treatment/NN ./.
@@86494255229 A/DT developmentally/RB modulated/VBN chromatin/NN structure/NN at/IN the/DT mouse/NEWGENE immunoglobulin/NEWGENE kappa/NEWGENE 3'/NEWGENE enhancer/NEWGENE ./.
@@10999301837 Quantitative/JJ evaluation/NN of/IN magneto-optical/JJ parameters/NNS is/VBZ necessary/JJ in/IN order/NN to/IN apply/VB scanning/JJ near-field/NN optical/JJ microscope/NN (/( SNOM/NNP )/SYM technology/NN to/IN the/DT study/NN of/IN magnetism/NN on/IN the/DT mesoscopic/JJ scale/NN ./.
@@92089307779 Identification/NNP of/IN five/CD new/JJ genes/NNS ,/, closely/RB related/VBN to/IN the/DT interleukin-1beta/NEWGENE converting/NEWGENE enzyme/NEWGENE gene/NEWGENE ,/, that/WDT do/VBP not/RB encode/VB functional/JJ proteases/NEWGENE ./.
@@233482984 Colorectal/JJ polyps/NNS should/MD be/VB removed/VBN endoscopically/RB whenever/CC possible/JJ ./.
@@73102067178 The/DT architecture/NN of/IN microvasculature/NN in/IN these/DT two/JJ regions/NNS was/VBD also/RB examined/VBN by/IN scanning/JJ electron/NN microscopy/NN ,/, using/VBG the/DT resin/NN casting/JJ method/NN ./.
@@32498408971 Baseline/NN measurements/NNS of/IN forced/JJ expiratory/JJ volume/NN in/IN 1/CD s/NN (/( FEV1/NN )/SYM ,/, specific/JJ airway/NN conductance/NN (/( SGaw/NNS )/SYM and/CC the/DT provocative/JJ dose/NN of/IN carbachol/NN causing/JJ a/DT 35%/JJ reduction/NN in/IN SGaw/NN (/( PD35/NN )/SYM ,/, and/CC a/DT 20%/CD reduction/NN in/IN FEV1/NN (/( PD20/NN )/SYM were/VBD established/VBN on/IN entry/NN while/CC each/DT subject/NN was/VBD still/JJ smoking/NN ./.
@@114239912677 Thus/RB ,/, the/DT screen/NN for/IN toxic/JJ p53/NEWGENE mutants/NEWGENE in/IN yeast/NN can/MD identify/VB novel/JJ p53/NEWGENE variants/NN that/WDT may/MD be/VB useful/JJ in/IN dissecting/JJ p53/NEWGENE regulated/VBN cellular/JJ responses/NNS and/CC in/IN developing/JJ p53-based/JJ cancer/NN therapies/NNS ./.
@@112447331074 Cases/NNS of/IN lung/NN cancer/NN with/IN intramedullary/JJ metastasis/NN are/VBP rare/JJ ,/, especially/RB those/DT diagnosed/VBN before/IN death/NN ./.
@@95725116962 The/DT new/JJ algorithm/NN ,/, called/VBN RBI-MAP/NN ,/, is/VBZ based/VBN on/IN the/DT rescaled/VBN block/NN iterative/JJ EM/NN (/( RBI-EM/NNP )/SYM algorithm/NN ./.
@@71063234564 These/DT results/NNS suggested/VBD the/DT possibility/NN that/IN the/DT fetus/NN played/VBD some/DT role/NN in/IN the/DT production/NN of/IN E3-16-G/NN in/IN early/JJ pregnancy/NN ./.
@@108960089454 PARTICIPANTS/NNP :/: Convenience/NNP sample/NN of/IN ambulatory/JJ outpatients/NNS with/IN hereditary/JJ motor/JJ and/CC sensory/JJ neuropathy/NN ,/, type/NN I/NN (/( n/NN =/SYM 9/CD )/SYM ,/, myotonic/JJ muscular/JJ dystrophy/NN (/( n/NN =/SYM 10/CD )/SYM ,/, and/CC able-bodied/JJ controls/NNS (/( n/NN =/SYM 11/CD )/SYM ./.
@@14437452061 Respiratory/NNP interaction/NN after/IN spinal/JJ anesthesia/NN and/CC sedation/NN with/IN midazolam/NN ./.
@@28059456660 The/DT percentages/NNS of/IN formed/VBN cysts/NNS and/CC growth/NN rates/NNS were/VBD monthly/RB estimated/VBN and/CC analyzed/VBN rhythmometrically/RB by/IN cosinor/NN for/IN 5/CD clonal/JJ cultures/NNS of/IN Scripsiella/NNP trochoidea/NN Stein/NN grown/VBP for/IN 2/CD years/NNS under/IN laboratory/NN conditions/NNS ,/, rended/VBD as/RB constant/JJ as/IN possible/JJ from/IN the/DT view/NN point/NN of/IN environmental/JJ temperature/NN (/( 24/CD +/NN //NN -/NN 1/CD degree/NN C/NN )/SYM ,/, lighting/JJ (/( 25/NN microEin/NN m-2/NN s-1/NN )/SYM ,/, and/CC artificial/JJ seawater/NN ./.
@@3504654190 Antenatal/JJ diagnosis/NN of/IN haematological/JJ disorders--'1978'/CD ./.
@@95922199549 The/DT results/NNS point/NN to/IN the/DT effectiveness/NN of/IN the/DT educational/JJ intervention/NN ./.
@@86215427670 The/DT novel/JJ protein/NEWGENE kinases/NEWGENE ,/, c-Jun/NEWGENE NH2-terminal/NEWGENE kinases/NEWGENE (/( JNKs/NEWGENE )/NN //NEWGENE stress-activated/NEWGENE protein/NEWGENE kinases/NEWGENE ,/, are/VBP also/RB activated/VBN by/IN TNF-alpha/NEWGENE ,/, IL-1/NEWGENE ,/, and/CC CD28/NEWGENE costimulation/NN ./.
@@113570633037 Descriptions/NNS of/IN this/DT locus/NN would/MD allow/VB comparison/NN with/IN functionally/RB relevant/JJ molecular/JJ genetic/JJ features/NNS of/IN other/DT species'/JJ homologous/JJ loci/NNS including/JJ the/DT single-copy/JJ equid/NEWGENE LH/NEWGENE //NEWGENE CGbeta/NEWGENE gene/NEWGENE and/CC the/DT primate/NEWGENE LHbeta-CGbeta/NEWGENE gene/NEWGENE cluster/NEWGENE locus/NEWGENE ./.
@@108671998922 In/NN contrast/NN to/IN the/DT morphological/JJ criteria/NNS ,/, the/DT few/JJ data/NN available/JJ from/IN recent/JJ studies/NNS at/IN the/DT genetic/JJ level/NN have/NN suggested/VBN that/IN EPVs/NNP infecting/JJ different/JJ insect/NN orders/NNS are/VBP phylogenetically/RB distant/JJ ./.
@@39803866906 To/TO assess/VB the/DT effects/NNS of/IN alveolar/JJ hypoxia/NN and/CC angiotensin/NEWGENE II/NEWGENE infusion/NN on/IN distribution/NN of/IN blood/NN flow/NN to/IN the/DT lung/NN we/PRP performed/VBD perfusion/NN lung/NN scans/NNS on/IN anesthetized/JJ mechanically/RB ventilated/VBN lambs/NNS ./.
@@27122463391 Its/PRP clinical/JJ and/CC histopathologic/JJ characteristics/NNS ./.
@@92184361329 Both/DT promoters/NNS lack/NN a/DT TATA/NN box/NN ,/, and/CC Pint/NEWGENE belongs/VBZ to/IN the/DT MED-1/NEWGENE class/NN of/IN promoters/NNS ,/, which/WDT initiate/VBP transcription/NN at/IN multiple/JJ sites/NNS ./.
@@88089273680 A/DT 1/NEWGENE ./NEWGENE 5-kb/NEWGENE HindIII/NEWGENE genomic/NEWGENE fragment/NEWGENE carrying/NEWGENE the/NEWGENE vspA/NEWGENE gene/NEWGENE from/IN M/NNP ./NNP bovis/NN PG45/NN was/VBD cloned/VBN and/CC sequenced/VBN ./.
@@41969861555 Cerebrospinal/JJ fluid/NN transferrin/NEWGENE II/NEWGENE studies/NNS in/IN ischemic/JJ disorders/NNS of/IN the/DT central/JJ nervous/JJ system/NN ./.
@@110036528199 These/DT results/NNS suggest/VBP that/IN Cdc42p/NEWGENE is/VBZ in/IN fact/NN required/VBN for/IN pheromone/NN response/NN and/CC that/DT interaction/NN with/IN the/DT PAK/NEWGENE Ste20p/NEWGENE1 is/VBZ critical/JJ for/IN that/DT role/NN ./.
@@1168466542 C/NNP ./NNP elegans/NNS embryogenesis/NN begins/VBZ with/IN a/DT stereotyped/JJ sequence/NN of/IN asymmetric/JJ cell/NN divisions/NNS that/WDT are/VBP largely/RB responsible/JJ for/IN establishing/VBG the/DT nematode/JJ body/NN plan/NN ./.
@@15426675110 The/DT gene/NN encoding/VBG IFN-gamma/NEWGENE was/VBD previously/RB found/VB to/IN contain/VB an/DT intronic/JJ enhancer/NN element/NN that/WDT was/VBD not/RB tissue-specific/JJ in/IN its/PRP activity/NN ,/, despite/IN the/DT restricted/VBN expression/NN of/IN the/DT intact/JJ IFN-gamma-encoding/NEWGENE gene/NEWGENE ./.
@@90493066449 The/DT HBP/NEWGENE gene/NEWGENE is/VBZ composed/VBN of/IN eight/CD exons/NNS covering/VBG 19/CD ./CD 5/CD kb/NN on/IN the/DT short/JJ arm/NN of/IN chromosome/NN 4/CD ./CD
@@72637457106 Bilateral/JJ Charnley/NN arthroplasty/NN as/IN a/DT single/JJ procedure/NN ./.
@@216283526 It/PRP is/VBZ likely/RB that/IN the/DT sequence/NN similarities/NNS reflect/VBP a/DT common/JJ molecular/JJ architecture/NN of/IN the/DT two/JJ heme/NN binding/JJ sites/NNS and/CC of/IN a/DT copper/JJ binding/JJ site/NN in/IN these/DT enzymes/NNS ./.
@@109267768040 Five/CD of/IN the/DT PDP1/NEWGENE isoforms/NEWGENE differ/VBP by/IN the/DT substitution/NN or/CC insertion/NN of/IN amino/JJ acids/NNS at/IN or/CC near/IN the/DT N-terminal/NN of/IN the/DT protein/NN ./.
@@105610955249 However/RB ,/, reoperation/NN for/IN bulky/JJ cervical/JJ disease/NN (/( group/NN 3/CD )/SYM rarely/RB results/VBZ in/IN normal/JJ calcitonin/NEWGENE levels/NNS and/CC is/VBZ associated/VBN with/IN a/DT high/JJ incidence/NN of/IN permanent/JJ hypoparathyroidism/NN ./.
@@116871803637 In/NN the/DT long/JJ term/NN ,/, questions/NNS still/RB remain/VBP about/RB whether/IN pre-dialysis/JJ rHu/NEWGENE EPO/NEWGENE either/DT speeds/NNS up/JJ or/CC delays/VBZ the/DT onset/NN of/IN dialysis/NN ./.
@@97744036488 T/NNP ./NNP ,/, Mahasneh/NNP ,/, A/NNP ./NNP ,/, and/CC Cote/NNP ,/, G/NNP ./NNP
@@15693445862 In/NN both/DT cities/NNS ,/, HTLV-I/NN //NN II/NN prevalence/NN increased/VBN significantly/RB with/IN age/NN ,/, and/CC the/DT New/NNP Orleans/NN age-/JJ and/CC sex-adjusted/JJ HTLV-I/NN //NN II/NN prevalence/NN was/VBD significantly/RB higher/JJ than/IN that/DT of/IN Baltimore/NN (/( P/NN less/PRP than/IN ./CD 001/CD )/SYM ./.
@@94685154128 As/IN well/NN ,/, further/JJ deletion/NN of/IN the/DT promoter/NN region/NN to/IN nucleotide/NN -110/NN ,/, which/WDT contains/VBZ only/RB one/PRP SF-1/NEWGENE binding/NEWGENE site/NEWGENE ,/, still/RB retained/VBN the/DT ability/NN to/IN respond/NN to/IN exogenous/JJ SF-1/NEWGENE ./.
@@107662464201 Integrin/NEWGENE adhesion/NEWGENE receptors/NEWGENE transduce/VBP signals/VBZ that/DT control/NN complex/NN cell/NN functions/NNS which/WDT require/VBP the/DT regulation/NN of/IN gene/NN expression/NN ,/, such/JJ as/IN proliferation/NN ,/, differentiation/NN and/CC survival/NN ./.
@@5165455413 Structural/NNP characteristics/NNS of/IN the/DT erythrocyte/NN membrane/NN ,/, peroxidation/NN processes/NNS and/CC antioxidant/JJ function/NN in/IN children/NNS with/IN diffuse/JJ glomerulonephritis/NN ./.
@@94699339300 In/NN the/DT tissues/NNS tested/VBN ,/, except/VB brain/NN ,/, the/DT message/NN for/IN CLIP-170/NEWGENE was/VBD more/RB abundant/JJ than/IN that/DT for/IN Restin/NEWGENE ./.
@@23947079703 Promoter/NNS elements/NNS include/VBP an/DT atypical/JJ TATA/NN box/NN (/( GTTA/NN )/SYM ,/, one/PRP CCAAT/NN box/NN much/JJ further/RB from/IN the/DT initiation/NN site/NN ,/, three/CD reverse/JJ compliments/NNS of/IN CCAAT/NNP (/( ATTGG/NNP )/SYM ,/, and/CC two/JJ pyrimidine-rich/JJ nucleotide/NN stretches/NNS ./.
@@76093727514 M/NNP ./NNP M/NNP ./NNP C/NNP ./. was/VBD used/VBN for/IN 2/CD ./CD 5/CD minutes/NNS in/IN 44/CD cases/NNS (/( 20/CD HR/JJ patients/NNS ,/, 24/CD LR/NN patients/NNS )/SYM ,/, and/CC for/IN 5/CD minutes/NNS in/IN 66/CD cases/NNS (/( 46/CD HR/JJ patients/NNS ,/, 20/CD LR/NN patients/NNS )/SYM ./.
@@75378514849 Transcription/NNS of/IN the/DT vascular/NEWGENE cell/NEWGENE adhesion/NEWGENE molecule/NEWGENE 1/NEWGENE (/( VCAM-1/NEWGENE )/SYM gene/NN in/IN endothelial/JJ cells/NNS is/VBZ induced/VBN by/IN lipopolysaccharide/NN and/CC the/DT inflammatory/JJ cytokines/NEWGENE interleukin-1/NEWGENE beta/NEWGENE and/CC tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE alpha/NEWGENE (/( TNF-alpha/NEWGENE )/SYM ./.
@@105593643895 In/NN HCMV/NN (/NN Towne/NN )/NN -infected/NN HF/NN cells/NNS at/IN 24/CD to/IN 48/CD h/NN ,/, IE2/NEWGENE also/RB accumulated/VBN in/IN newly/RB formed/VBN viral/JJ DNA/NN replication/NN compartments/NNS containing/JJ the/DT polymerase/NEWGENE processivity/NEWGENE factor/NEWGENE (/( UL44/NEWGENE )/SYM ,/, the/DT single-stranded/NEWGENE DNA/NEWGENE binding/NEWGENE protein/NEWGENE (/( SSB/NEWGENE ;/: UL57/NEWGENE )/SYM ,/, the/DT UL112-113/NEWGENE accessory/NEWGENE protein/NEWGENE ,/, and/CC newly/RB incorporated/VBN bromodeoxyuridine/NN (/( BrdU/NN )/SYM ./.
@@36370374315 A/DT preoperative/JJ teaching/JJ booklet/NN for/IN pediatric/JJ patients/NNS ./.
@@105560635934 These/DT kinases/NEWGENE belong/VBP to/IN a/DT new/JJ subfamily/NN related/VBN to/IN the/DT Trk/NEWGENE subfamily/NEWGENE ./.
@@11207288886 Substitutions/NNS in/IN the/DT YFV/NEWGENE Ag-binding/NEWGENE1 region/NEWGENE1 (/( ABR/NEWGENE )/SYM occur/VB at/IN four/CD of/IN the/DT eight/CD highly/RB conserved/VBN residues/NNS that/WDT are/VBP essential/JJ for/IN binding/NN of/IN peptide-Ag/JJ in/IN the/DT class/NEWGENE Ia/NEWGENE molecules/NEWGENE ./.
@@105484342833 Furthermore/RB ,/, the/DT striking/JJ ability/NN of/IN polyoma/NEWGENE middle/NEWGENE T/NEWGENE antigens/NEWGENE to/IN promote/VB retinoic/JJ acid-induced/JJ differentiation/NN appears/VBZ to/IN utilize/VB ERK/NEWGENE ,/, but/CC not/RB JNK/NEWGENE //NEWGENE SPK/NEWGENE or/CC p38/NEWGENE signaling/JJ ./.
@@118026011668 This/DT paper/NN reports/VBZ the/DT results/NNS of/IN a/DT laboratory/NN study/NN on/IN aldicarb/NN and/CC its/PRP main/JJ metabolites/NNS ,/, aldicarb/NN sulfone/NN and/CC aldicarb/NN sulfoxide/NN ./.
@@21431862329 In/NN comparison/NN with/IN the/DT 16/CD introns/NNS reported/VBN in/IN AHA3/NEWGENE ,/, AHA2/NEWGENE is/VBZ missing/JJ one/PRP intron/NN in/IN the/DT 5'-untranslated/JJ region/NN and/CC a/DT second/JJ intron/NN in/IN the/DT C-terminal/NN coding/JJ region/NN ./.
@@93881985315 The/DT data/NN provide/VB evidence/NN both/DT for/IN a/DT signal/JJ transduction/NN pathway/NN independent/NN of/IN JNK/NEWGENE ,/, ERK/NEWGENE ,/, and/CC p38/NEWGENE MAP/NEWGENE kinase/NEWGENE to/IN be/VB involved/VBN in/IN the/DT induction/NN of/IN rhoB/NEWGENE by/IN genotoxic/JJ stress/NN ,/, and/CC furthermore/RB ,/, indicate/VB autoregulation/NN of/IN rhoB/NEWGENE ./.
@@21207077580 Gel-mobility-shift/NNP assays/NNS confirmed/VBN that/IN the/DT Raji/NEWGENE nuclear/NEWGENE proteins/NEWGENE that/WDT bound/JJ to/IN W/NEWGENE and/NEWGENE V/NEWGENE elements/NEWGENE were/VBD competed/VBN with/IN by/IN an/DT HLA-DRA/NEWGENE X-box/NEWGENE oligonucleotide/NEWGENE ./.
@@32200773908 The/DT median/JJ survival/NN is/VBZ not/RB reached/VBN with/IN a/DT median/JJ follow-up/JJ time/NN of/IN 9/CD ./CD 6/CD years/NNS ./.
@@107793291982 Slap/NEWGENE negatively/RB regulates/VBZ Src/NEWGENE mitogenic/JJ function/NN but/CC does/VBP not/RB revert/VB Src-induced/JJ cell/NN morphology/NN changes/NNS ./.
@@10533066195 Twelve/CD patients/NNS without/IN abnormalities/NNS in/IN the/DT PTT/NN are/VBP assumed/VBN to/IN harbor/NN missense/JJ mutations/NNS ,/, probably/RB in/IN TSC2/NEWGENE ./.
@@109823915838 These/DT include/VB NPF/NEWGENE repeats/NEWGENE ,/, a/DT leucine/NN heptad/NN repeat/NN enriched/VBN in/IN charged/VBN residues/NNS ,/, and/CC a/DT proline-rich/NNP SH3-like/NEWGENE and/DT //DT or/DT WW/NEWGENE domain-binding/NEWGENE site/NEWGENE in/IN the/DT N-terminal/NN domain/NN ,/, which/WDT is/VBZ followed/VBN by/IN a/DT membrane/NN core/NN containing/JJ four/CD putative/JJ transmembrane/JJ spans/NNS and/CC three/CD amphiphilic/JJ segments/NNS that/WDT are/VBP the/DT most/RB highly/RB conserved/VBN structural/JJ elements/NNS ./.
@@24176697520 At/NN maximum/JJ photosensitivity/NN the/DT inhibitory/JJ amino/JJ acids/NNS gamma-aminobutyric/JJ acid/NN and/CC taurine/NN were/VBD lower/JJR ,/, and/CC those/DT of/IN asparagine/NN (/( metabolite/NN of/IN the/DT excitatory/JJ amino/JJ acid/NN aspartate/NN )/SYM were/VBD higher/JJ ,/, than/IN when/CC the/DT animals/NNS were/VBD not/RB photosensitive/JJ ./.
@@104288116401 Cat-1/NEWGENE is/VBZ identical/JJ to/IN the/DT recently/RB identified/VBN binding/JJ partner/NN for/IN the/DT beta-adrenergic/NEWGENE receptor/NEWGENE kinase/NEWGENE (/( betaARK/NEWGENE or/CC GRK-2/NEWGENE )/SYM ,/, which/WDT was/VBD shown/VBP to/IN have/NN Arf-GAP/NEWGENE activity/NN ./.
@@108649895793 RESULTS/NNS :/: The/DT introduction/NN of/IN the/DT PAIP/NN resulted/VBN in/IN a/DT significant/JJ (/( p/CD </CD 0/CD ./CD 001/CD )/SYM reduction/NN in/IN contaminating/JJ WBCs/NNS (/( median/JJ ,/, 30/CD ,/CD 000/CD )/SYM from/IN the/DT numbers/NNS seen/VBP with/IN FIP/NN (/( median/JJ ,/, 2/CD ,/CD 300/CD ,/CD 000/CD )/SYM while/CC maintaining/VBG the/DT separation/NN efficacy/NN (/( 47%/JJ )/SYM and/CC separation/NN time/NN ./.
@@96751549630 We/PRP then/RB studied/VBD four/CD unrelated/JJ Japanese/JJ families/NNS with/IN GSD-Ib/NNP ,/, and/CC found/VB three/CD novel/JJ mutations/NNS :/: a/DT four-base/JJ deletion/JJ //JJ two-base/JJ insertion/NN ,/, a/DT point/NN mutation/NN within/IN a/DT consensus/NN splicing/JJ donor/NN site/NN ,/, and/CC a/DT missense/JJ mutation/NN (/( W118R/NN )/SYM ./.
@@18701948976 Human/NEWGENE immunodeficiency/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE (/NEWGENE HIV-1/NEWGENE )/NEWGENE IN/NEWGENE ,/, expressed/VBN in/IN Escherichia/NN coli/JJ ,/, was/VBD purified/VBN to/IN near/IN homogeneity/NN ./.
@@114388385178 The/DT other/DT inhibitor/NN was/VBD a/DT single/JJ TAR/NEWGENE decoy/NN ,/, driven/VBP by/IN the/DT U6/NEWGENE small/NEWGENE nuclear/NEWGENE RNA/NEWGENE promoter/NEWGENE (/( U6-P/NEWGENE )/SYM ./.
@@87101512824 5/NN )/NN We've/NN noticed/VBN that/IN the/DT mean/JJ value/NN of/IN the/DT cost/NN for/IN episode/NN of/IN pnx/NN s/CD ./CD in/IN class/NN A/NN was/VBD more/RB than/IN 15%/RB compared/VBN to/IN class/NN B/NN and/CC the/DT cost/NN for/IN patient/NN in/IN class/NN A/NN was/VBD nearly/RB double/JJ than/IN in/IN class/NN B/NNP ./NNP
@@107673383052 Hailey-Hailey/NN disease/NN is/VBZ caused/VBN by/IN mutations/NNS in/IN ATP2C1/NEWGENE encoding/VBG a/DT novel/JJ Ca/NN (/NN 2+/NN )/NN pump/NN ./.
@@93964278969 Thus/RB ,/, the/DT absence/NN of/IN residual/JJ infarct-zone/NN viability/NN discriminates/NNS patients/NNS who/WP develop/VBP progressive/JJ left/NN ventricular/JJ dilation/NN after/IN reperfused/JJ AMI/NN from/IN those/DT who/WP maintain/VBP normal/JJ left/NN ventricular/JJ geometry/NN ./.
@@93432108268 Furthermore/RB ,/, deletion/NN and/CC mutation/NN analyses/NNS of/IN the/DT VCAM-1/NEWGENE promoter/NEWGENE performed/VBN with/IN chloramphenicol/NEWGENE acetyltransferase/NEWGENE constructs/NEWGENE revealed/VBN that/IN Tax/NEWGENE was/VBD trans/JJ activating/JJ the/DT VCAM-1/NEWGENE promoter/NEWGENE via/NN two/JJ NF-kappaB/NEWGENE sites/NEWGENE present/VBP at/IN bp/NN -72/CD and/CC -57/CD in/IN the/DT VCAM-1/NEWGENE gene/NEWGENE promoter/NEWGENE ,/, with/IN both/DT of/IN them/PRP being/VBP required/VBN for/IN the/DT Tax-induced/JJ expression/NN of/IN this/DT adhesion/NN molecule/NN ./.
@@86018069380 These/DT data/NN suggest/VB that/IN RPF-1/NEWGENE is/VBZ likely/RB to/IN be/VB involved/VBN in/IN early/JJ steps/NNS in/IN the/DT differentiation/NN of/IN amacrine/NN and/CC ganglion/NN cells/NNS ./.
@@39357975217 The/DT data/NN indicate/VB that/IN the/DT five/CD different/JJ (/( and/CC partially/RB overlapping/JJ )/SYM sry/NEWGENE messenger/NEWGENE RNAs/NEWGENE detectable/JJ in/IN early/JJ embryos/NNS are/VBP initiated/VBN at/IN three/CD separate/JJ sites/NNS ,/, each/DT directly/RB upstream/RB from/IN one/PRP of/IN the/DT three/CD protein-coding/NN regions/NN ,/, designated/VBN (/( in/IN 5'/CD to/IN 3'/CD order/NN )/SYM beta/NN ,/, alpha/NN and/CC delta/JJ ./.
@@10841601648 Paper/NNP alert/VB ./.
@@8570242468 Recurrence/NNS of/IN bladder/NN tumors/NNS among/IN the/DT original/JJ 9/CD cases/NNS has/VBZ occurred/VBN only/RB among/IN the/DT 5/CD whose/WP properdin/NEWGENE levels/NNS remained/VBN below/RB the/DT median/NN ./.
@@113913031607 CONCLUSIONS/IN :/: The/DT methodology/NN of/IN LHR/NNS measurement/NN significantly/RB influences/VBZ the/DT clinical/JJ contribution/NN of/IN Tl-201/NN lung/NN uptake/NN evaluation/NN ./.
@@78288118625 This/DT failure/NN to/IN execute/VB regulated/VBN G1/NN //NN S/NN arrest/NN is/VBZ correlated/VBN with/IN enhanced/VBN thermosensitivity/NN of/IN colony-forming/JJ ability/NN ./.
@@96327092918 One/CD cDNA/NN clone/NN designated/VBN NCoA-62/NN ,/, encoded/VBN a/DT 62/CD ,/, 000-Da/JJ protein/NN that/WDT is/VBZ highly/RB related/VBN to/IN BX42/NEWGENE ,/, a/DT Drosophila/NN melanogaster/NN nuclear/JJ protein/NN involved/VBN in/IN ecdysone-stimulated/JJ gene/NN expression/NN ./.
@@29706405915 Atomic/NNP absorption/NN spectrophotometry/NN applied/VBN to/IN bacterially/RB expressed/VBN E1A/NEWGENE proteins/NEWGENE revealed/VBN that/IN the/DT 289-amino/NN acid/NN protein/NN binds/VBZ one/PRP zinc/NN ion/NN ,/, whereas/IN the/DT 243-amino/JJ acid/NN protein/NN binds/VBZ no/DT zinc/NN ./.
@@115602929328 Using/VBG the/DT presented/VBN categorical/JJ structure/NN as/IN domain/NN model/NN a/DT prototype/NN DSS/NN for/IN dipslide/NN urine/NN cultures/NNS has/VBZ been/VBN developed/VBN ./.
@@98910856584 Nip7p-depleted/JJ cells/NNS exhibited/VBD the/DT same/JJ defects/NNS as/IN Nop8p-depleted/JJ cells/NNS ,/, except/VB that/IN they/PRP accumulated/VBD 27S/NEWGENE precursors/NEWGENE ./.
@@89361285817 Discordance/NNS on/IN the/DT cost/NN dimension/NN correlated/VBN negatively/RB with/IN G/NEWGENE Hb/NEWGENE ,/, suggesting/VBG better/RBR glycemic/JJ control/NN with/IN greater/JJR disagreement/NN ./.
@@112636221097 RESULTS/NNS :/: A/DT significant/JJ correlation/NN (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM was/VBD observed/VBN for/IN mean/JJ wall/NN thickness/NN and/CC vessel/NN wall/NN area/NN between/IN MRI/NN and/CC histopathology/NN (/( r/JJ =/SYM 0/CD ./CD 87/CD and/CC r/JJ =/SYM 0/CD ./CD 85/CD ,/, respectively/RB )/SYM ./.
@@111796878135 In/NN this/DT paper/NN the/DT tyrosine/NN dephosphorylating/JJ enzymes/NNS ,/, the/DT protein-tyrosine/NEWGENE phosphatases/NEWGENE (/( PTPs/NEWGENE )/SYM ,/, are/VBP studied/VBN which/WDT can/MD be/VB grouped/VBN into/IN two/JJ subfamilies/NNS ,/, the/DT soluble/NEWGENE PTPs/NEWGENE and/CC the/DT receptor/NEWGENE PTPs/NEWGENE (/( RPTPs/NEWGENE )/SYM ./.
@@80286714882 We/PRP report/VBP here/RB that/DT microinjection/NN of/IN an/DT anti-CBP/NEWGENE antiserum/NEWGENE into/IN fibroblasts/NNS can/MD inhibit/VB transcription/NN from/IN a/DT cAMP/NEWGENE responsive/NEWGENE promoter/NEWGENE ./.
@@17845891016 Relatively/RB little/NN is/NNS known/VBP regarding/IN the/DT role/NN of/IN 5-HT2/NEWGENE receptor/NEWGENE activity/NN in/IN male/JJ rat/NN sexual/JJ behavior/NN ./.
@@92861152930 S2F/NEWGENE ,/, a/DT leaf-specific/JJ trans-acting/JJ factor/NN ,/, binds/VBZ to/IN a/DT novel/JJ cis-acting/JJ element/NN and/CC differentially/RB activates/VBZ the/DT RPL21/NEWGENE gene/NEWGENE ./.
@@95358519498 Among/IN three/CD isoforms/NNS ,/, the/DT beta/NN isoform/NN has/VBZ the/DT greatest/JJS Vmax/NN value/NN for/IN the/DT PtdIns/NEWGENE (/NEWGENE 4/NEWGENE )/NEWGENE P/NEWGENE kinase/NEWGENE activity/NN and/CC the/DT gamma/NN isoform/NN is/VBZ most/RB markedly/RB stimulated/VBN by/IN phosphatidic/JJ acid/NN ./.
@@92120596752 The/DT overall/JJ results/NNS of/IN this/DT paper/NN are/VBP consistent/JJ with/IN the/DT conclusion/NN that/IN the/DT carboxyl-terminal/NN LBD/NN is/VBZ not/RB sufficient/JJ for/IN mediating/JJ PR/NEWGENE dimerization/NN and/CC that/IN multiple/JJ regions/NNS ,/, including/JJ the/DT hinge/NN and/CC amino-terminal/NN sequences/NN ,/, contribute/VB either/DT directly/RB or/CC indirectly/RB to/IN homodimerization/NN of/IN PR/NEWGENE ./.
@@7501016314 A/DT water-vapour/JJ giga-maser/NN in/IN the/DT active/JJ galaxy/NN TXFS2226-184/NN ./.
@@78765622008 A/DT potential/JJ outcome/NN of/IN these/DT biochemical/JJ effects/NNS may/MD include/VB the/DT limited/VBN responsiveness/NN of/IN infected/VBN T/NN cells/NNS to/IN antigenic/JJ stimulation/NN observed/VBN during/IN HIV-1/NNP infection/NN ./.
@@83885106437 Analysis/NNP by/IN cell/NN surface/NN immunofluorescence/NN showed/VBN that/IN the/DT UL28/NEWGENE gene/NEWGENE is/VBZ not/RB required/VBN for/IN expression/NN of/IN viral/JJ glycoproteins/NNS on/IN the/DT surface/NN of/IN infected/VBN cells/NNS ./.
@@107362239352 Based/VBN on/IN these/DT data/NN ,/, we/PRP conclude/VBP that/DT transcription/NN of/IN prgX/NEWGENE is/VBZ initiated/VBN from/IN the/DT Qa/NEWGENE promoter/NEWGENE in/IN prgQ/NEWGENE ,/, and/CC PrgX/NEWGENE autoregulates/VBZ its/PRP transcription/NN either/DT by/IN mediating/JJ transcriptional/JJ readthrough/NN or/CC increasing/JJ mRNA/NN stability/NN ./.
@@69389489929 Secretory/NEWGENE IgA/NEWGENE and/CC serum/NEWGENE immunoglobulins/NEWGENE as/IN indices/NNS of/IN the/DT local/JJ immunity/NN of/IN the/DT intestinal/JJ mucosa/NN in/IN acute/JJ leukemias/NNS ./.
@@78469422541 Digitalis/NN glycosides/NNS or/CC beta-receptor/NEWGENE antagonists/NNS are/VBP not/RB helpful/JJ in/IN the/DT therapy/NN of/IN this/DT form/NN of/IN atrial/JJ fibrillation/NN whereas/IN class/NN I/NN antiarrhythmic/JJ drugs/NNS have/VBP been/VBN shown/VBP to/IN be/VB more/RB effective/JJ ./.
@@111124179349 Our/PRP data/NN show/NN that/IN multiple/JJ MLSN1/NEWGENE transcripts/NEWGENE ,/, both/DT constitutively/RB expressed/VBN and/CC inducible/JJ ,/, are/VBP present/VB in/IN cultured/JJ pigmented/JJ melanoma/NN cells/NNS ,/, and/CC suggest/VB that/IN MLSN1/NEWGENE expression/NN can/MD be/VB regulated/VBN at/IN the/DT level/NN of/IN both/DT transcription/NN and/CC mRNA/NN processing/VBG ./.
@@74785252611 Both/DT classes/NNS of/IN MHBst/NEWGENE proteins/NEWGENE were/VBD found/VBN to/IN form/NN dimers/NNS ;/: an/DT which/WDT is/VBZ involved/VBN in/IN mediating/JJ the/DT dimerization/NN ./.
@@13187391952 After/IN the/DT first/JJ 28/CD patients/NNS vincristine/NN was/VBD replaced/VBN by/IN teniposide/NN (/( VM-26/IN )/SYM due/NN to/IN neurotoxicity/NN ./.
@@86320093323 The/DT specificity/NN of/IN action/NN of/IN C/NEWGENE //NEWGENE EBP/NEWGENE family/NEWGENE members/NEWGENE may/MD be/VB derived/VBN from/IN the/DT characteristics/NNS of/IN each/DT factor/NN ,/, including/JJ the/DT expression/NN profiles/NNS ,/, the/DT DNA/NN binding/JJ affinities/NNS ,/, the/DT cofactors/NNS ,/, and/CC so/RB on/IN ,/, in/IN addition/NN to/IN the/DT DNA/NN binding/JJ specificities/NNS ./.
@@88497785700 We/PRP have/VBP performed/VBN toeprinting/JJ analyses/NNS on/IN repA/NEWGENE mRNA/NEWGENE of/IN plasmid/NN R1/NN ,/, both/DT free/JJ and/CC in/IN duplex/JJ with/IN the/DT antisense/NN RNA/NN ,/, CopA/NEWGENE ./.
@@103596731918 The/DT yeast/NEWGENE LPD1/NEWGENE gene/NEWGENE encoding/VBG lipoamide/NEWGENE dehydrogenase/NEWGENE is/VBZ subject/NN to/IN the/DT general/JJ control/NN of/IN amino/JJ acid/NN biosynthesis/NN mediated/JJ by/IN the/PDT GCN4/NEWGENE transcription/NEWGENE factor/NEWGENE ./.
@@40322687006 Either/CC a/DT UV/NN detector/NN set/NN at/IN 268/CD nm/NN or/CC an/DT electrochemical/JJ (/( EC/NN )/SYM detector/NN set/NN at/IN a/DT potential/NN of/IN +0/CD ./CD 9/CD V/NN (/( versus/IN Ag/NN //NN AgCl/NN //NN 3/NN M/NN NaCl/NN )/SYM was/VBD used/VBN to/IN monitor/NN the/DT drug/NN ./.
@@85726162435 Apparent/JJ loss/NN of/IN differentiation/NN markers/NNS characterizes/VBZ advanced/JJ malignant/JJ neoplasms/NNS ./.
@@93311199295 The/DT most/RB common/JJ grade/NN 3/CD toxicity/NN was/VBD neutropenia/NN ,/, thrombocytopenia/NN ,/, and/CC parasthesias/NNS (/( observed/VBN in/IN </SYM 10%/CD of/IN cycles/NNS )/SYM ./.
@@79121237890 Mitogen-induced/JJ lymphocyte/NN proliferation/NN was/VBD diminished/VBN ./.
@@92035857572 A/DT striking/JJ feature/NN of/IN the/DT recombinant/NEWGENE H19/NEWGENE allele/NEWGENE is/VBZ the/DT occurrence/NN of/IN a/DT parental/JJ imprint/NN set/NN on/IN the/DT neo/NEWGENE replacement/NEWGENE cassette/NEWGENE ./.
@@105437306700 The/DT yeast/NEWGENE C-type/NEWGENE cyclin/NEWGENE Ume3p/NEWGENE //NEWGENE Srb11p/NEWGENE and/CC its/PRP cyclin-dependent/NEWGENE kinase/NEWGENE (/( Cdk/NEWGENE )/SYM Ume5p/NEWGENE are/VBP required/VBN for/IN the/DT full/JJ repression/NN of/IN genes/NNS involved/VBN in/IN the/DT stress/NN response/NN or/CC meiosis/NN ./.
@@109037333660 Coimmunoprecipitation/NNS experiments/NNS performed/VBN in/IN transfected/VBN cells/NNS showed/VBD that/DT BCMA/NEWGENE associates/VBP with/IN TNFR-associated/NEWGENE factor/NEWGENE (/NEWGENE TRAF/NEWGENE )/NEWGENE 1/NEWGENE ,/, TRAF2/NEWGENE ,/, and/CC TRAF3/NEWGENE adaptor/NEWGENE proteins/NEWGENE ./.
@@10496388329 Except/IN for/IN nonperfusion/NN of/IN neurosensory/JJ retinal/JJ vessels/NNS at/IN a/DT light/NN dose/NN of/IN 150/CD J/NN //NN cm2/NN ,/, no/DT other/DT adverse/JJ events/NNS were/VBD of/IN concern/NN ./.
@@22922722949 Interlimb/NNP coordination/NN during/IN fictive/JJ locomotion/NN in/IN the/DT thalamic/JJ cat/NN ./.
@@93676761048 Restriction/NNS enzyme/NN mapping/NN ,/, subcloning/NN ,/, and/CC DNA/NN sequencing/VBG analysis/NN of/IN recombinant/JJ phage/NN lambda/NN and/CC P1/NN clones/NNS revealed/VBN that/IN exons/NNS encoding/VBG the/DT 1/CD ./CD 9-kb/CD mouse/NEWGENE TS/NEWGENE mRNA/NEWGENE are/VBP dispersed/VBN over/RB >/SYM 150/CD kb/NN genomic/JJ DNA/NN ./.
@@16448212754 However/RB ,/, butyrate/NN was/VBD at/IN least/RB 2-fold/JJ more/RB effective/JJ in/IN stimulating/JJ CAT/NEWGENE activity/NN of/IN fusion/NN genes/NN containing/NN upstream/NN sequences/NN (/( -834/JJ to/IN -576/JJ )/SYM than/IN those/DT containing/JJ proximal/JJ sequences/NNS (/( -456/CD to/IN -172/CD )/SYM ,/, suggesting/VBG two/JJ regions/NNS in/IN the/DT PSG1-I/NEWGENE gene/NEWGENE that/WDT mediate/VBP the/DT butyrate/NN response/NN ./.
@@49678245272 Effects/NNPS of/IN temperature/NN and/CC moulting/JJ cycle/NN on/IN melanin/NN synthesis/NN in/IN the/DT newt/NN ,/, Triturus/NN cristatus/NN ./.
@@111340334114 The/DT murine/NEWGENE int-6/NEWGENE locus/NEWGENE ,/, identified/VBN as/IN a/DT frequent/JJ integration/NN site/NN of/IN mouse/NN mammary/JJ tumor/NN viruses/NNS ,/, encodes/VBZ the/DT 48-kDa/NEWGENE eIF3e/NEWGENE subunit/NEWGENE of/NEWGENE translation/NEWGENE initiation/NEWGENE factor/NEWGENE eIF3/NEWGENE ./.
@@24277973097 In/NN 30/CD dogs/VBZ the/DT left/NN limb/NN (/( tail/NN )/SYM of/IN the/DT pancreas/NN was/VBD removed/VBN but/CC left/NN in/IN the/DT abdominal/JJ cavity/NN after/IN cessation/NN of/IN blood/NN flow/NN to/IN produce/NN warm/JJ ischemia/NN for/IN 30/CD ,/, 60/CD ,/, and/CC 120/CD min/NN (/( 10/CD dogs/NNS at/IN each/DT time/NN point/NN )/SYM ,/, and/CC then/RB was/VBD flushed/VBN with/IN cold/JJ Ringers'/NNP lactate/NN and/CC transplanted/VBN to/IN the/DT iliac/JJ vessels/NNS ./.
@@10545248325 The/DT core/NN of/IN this/DT enhancer/NN contains/VBZ two/JJ evolutionarily/RB conserved/VBN binding/JJ sites/NNS for/IN the/DT homeodomain/NEWGENE protein/NEWGENE Tinman/NEWGENE1 (/( Tin/NEWGENE )/SYM ,/, expressed/VBN in/IN developing/JJ cardiac/NN ,/, somatic/JJ ,/, and/CC visceral/JJ muscle/NN lineages/NNS ./.
@@92944225224 The/DT por/NEWGENE gene/NEWGENE has/VBZ been/VBN expressed/VBN ,/, for/IN the/DT first/JJ time/NN ,/, in/IN anaerobically/RB grown/VBP Escherichia/NN coli/JJ behind/RB the/DT isopropyl-beta-D-thiogalactopyranoside-inducible/JJ tac/NEWGENE promoter/NEWGENE ,/, resulting/JJ in/IN the/DT production/NN of/IN POR/NEWGENE in/IN its/PRP active/JJ form/NN ./.
@@10784393603 Marrow/NN dysplasia/NN is/VBZ a/DT major/JJ characteristic/NN of/IN patients/NNS with/IN myelodysplastic/JJ syndrome/NN (/( MDS/NN )/SYM ,/, along/IN with/IN marrow/NN blastosis/NN ,/, cytopenia/NN and/CC cytogenetic/JJ anomalies/NNS ./.
@@88321467039 Proximal/JJ CBD/NN was/VBD inversely/RB correlated/VBN with/IN bone/NEWGENE alkaline/NEWGENE phosphatase/NEWGENE (/( r/JJ =/SYM -0/CD ./CD 71/CD ,/, p/NN </SYM 0/CD ./CD 01/CD )/SYM and/CC intact/JJ PTH/NN (/( r/JJ =/SYM -0/CD ./CD 59/CD ,/, p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@110277244619 Recombinant/NEWGENE BRI1-KD/NEWGENE autophosphorylated/VBN on/IN serine/NN (/( Ser/NN )/SYM and/CC threonine/NN (/( Thr/NN )/SYM residues/NNS with/IN p-Ser/JJ predominating/VBG ./.
@@10823961915 The/DT C/NN terminus/NN of/IN TRBP/NEWGENE binds/VBZ to/IN CBP/NEWGENE //NEWGENE p300/NEWGENE and/CC DRIP130/NEWGENE ,/, a/DT component/NN of/IN the/DT DRIP/NEWGENE //NEWGENE TRAP/NEWGENE //NEWGENE ARC/NEWGENE complex/NEWGENE ,/, which/WDT suggests/VBZ that/DT TRBP/NEWGENE may/MD activate/VB transcription/NN by/IN means/NN of/IN such/JJ interactions/NNS ./.
@@105645935531 FISH/ORG using/VBG a/DT whole/JJ chromosome/NN 4/CD paint/NN demonstrated/VBD multiple/JJ rearrangements/NNS involving/VBG chromosome/NN 4/CD in/IN MCF-7/NN AdVp3000/NN and/CC MCF-7/NN MX/NN ,/, while/CC S1-M1-80/NN contained/VBD only/RB a/DT simple/JJ reciprocal/JJ translocation/NN ./.
@@7876192791 In/NNP ICE/NEWGENE gamma/NEWGENE ,/, most/RB of/IN the/DT propeptide/NN (/( amino/JJ acids/NNS 20-112/CD )/SYM is/VBZ deleted/VBN ,/, which/WDT suggests/VBZ that/IN it/PRP may/MD function/VB as/IN a/DT catalyst/NN for/IN ICE/NEWGENE autoprocessing/NN in/IN vivo/NN ./.
@@118427288051 Schistosoma/ORG mansoni/NN schistosomiasis/NN Schistosomosis/NN are/VBP parasitic/JJ diseases/NNS caused/VBN by/IN blood/NN flukes/NNS of/IN the/DT Schistosoma/ORG genus/NN ./.
@@10181397122 They/PRP contrast/NN trends/NNS in/IN fertility/NN ,/, life/NN expectancy/NN ratios/NNS ,/, and/CC gender/NN differences/NNS in/IN these/DT countries/NNS with/IN the/DT Hispanic/NN population/NN of/IN the/DT United/NNP States/NNPS ./.
@@30623701616 These/DT results/NNS imply/VBP that/IN the/DT GCN3/NEWGENE product/NEWGENE can/MD promote/VB either/DT repression/NN or/CC activation/NN of/IN GCN4/NEWGENE expression/NN depending/VBG on/IN amino/JJ acid/NN availability/NN ./.
@@78878597718 Twenty-two/CD consecutive/JJ patients/NNS with/IN ischaemic/JJ ulcers/NNS had/VBP tcPO2/NN measured/VBN and/CC the/DT ankle/JJ //JJ brachial/JJ (/( ABI/NNS )/SYM and/CC toe/JJ //JJ brachial/JJ (/( TBI/NN )/SYM indices/NNS calculated/VBN ./.
@@10445945291 John/NN leonard/NN dawson/NN ./.
@@1007220572 In/NN order/NN to/IN better/JJR characterize/VB the/DT distribution/NN of/IN ML/NN and/CC MAP/NN estimates/NNS under/IN these/DT conditions/NNS ,/, we/PRP derive/VBP a/DT point/NN approximation/NN to/IN density/NN values/NNS of/IN the/DT conditional/JJ distribution/NN of/IN such/JJ estimates/NNS ./.
@@75436848079 We/PRP conclude/VBP that/DT cAMP/NN ,/, acting/JJ through/JJ PKA/NEWGENE ,/, is/VBZ an/DT essential/JJ regulator/NN of/IN basal/NN CFTR/NEWGENE gene/NEWGENE expression/NN and/CC may/MD mediate/VB an/DT induction/NN of/IN CFTR/NEWGENE in/IN responsive/JJ cell/NN types/NNS ./.
@@110079492153 We/PRP have/VBP demonstrated/VBN that/IN the/DT activity/NN of/IN ILK/NEWGENE is/VBZ constitutively/RB elevated/VBN in/IN PTEN/NEWGENE mutant/NEWGENE cells/NNS ./.
@@79717096552 A/DT normal/JJ systemic/JJ response/NN was/VBD obtained/VBN after/IN IF/IN ,/, indicating/VBG that/IN rhG-CSF/NEWGENE retains/VBZ activity/NN in/IN the/DT solid/JJ state/NN ./.
@@112388821587 In/NN Saccharomyces/NN cerevisiae/NN ,/, eIF6/NEWGENE is/VBZ encoded/VBN by/IN a/DT single-copy/JJ essential/JJ gene/NN ./.
@@111550968074 METHODS/IN :/: Thyroid/NN status/NN was/VBD measured/VBN at/IN baseline/NN (/( 1990-93/CD )/SYM ,/, through/JJ assessment/NN of/IN serum/JJ antibodies/NNS to/IN thyroid/NEWGENE peroxidase/NEWGENE (/( TPO-Abs/NEWGENE ,/, positive/JJ :/: >/SYM 10/CD IU/NNS //NNS ml/NNS )/SYM ,/, serum/NEWGENE TSH/NEWGENE levels/NNS ,/, and/CC when/CC TSH/NEWGENE was/VBD abnormal/JJ (/( </SYM 0/CD ./CD 4/CD or/CC >/SYM 4/CD ./CD 0/CD mU/NN //NN l/NN )/SYM ,/, serum/NEWGENE thyroxin/NEWGENE levels/NNS (/( T4/NN )/SYM ./.
@@60903698235 Two/CD hundred/JJ forty-three/CD patients/NNS have/VBP received/VBN WR-2721/NN in/IN Phase/NN I-II/NNS studies/NNS ./.
@@85348482198 All/DT three/CD NR/NEWGENE isoforms/NN are/VBP expressed/VBN in/IN cv/CD ./CD
@@80637917033 These/DT results/NNS demonstrate/VBP that/IN a/DT diverse/JJ set/NN of/IN carboxyl-terminal/NN sequence/NN motifs/NN and/CC posttranslational/JJ modifications/NNS lead/VBP to/IN functional/JJ Ras/NEWGENE proteins/NEWGENE in/IN yeast/NN ./.
@@90887373899 Epithelial/JJ and/CC corneal/JJ thickness/NN measurements/NNS by/IN in/IN vivo/NN confocal/JJ microscopy/NN through/JJ focusing/NN (/( CMTF/NN )/SYM ./.
@@88037107736 Five-year/JJ survivals/NNS amounted/VBN to/IN 100%/CD ,/, 86/CD ./CD 2%/CD ,/, 59/CD ./CD 4%/CD ,/, 29/CD ./CD 8%/CD ,/, and/CC 20%/CD for/IN stages/NNS I/PRP ,/, II/NNP ,/, III/NNP ,/, IVA/NNS and/CC IVB/NN respectively/RB ./.
@@715753215 In/NN biopsies/NNS CK-MB/NEWGENE fraction/NN of/IN total/JJ myocardial/JJ CPK/NEWGENE was/VBD 37%/JJ ,/, the/DT total-CPK/NEWGENE activity/NN of/IN human/JJ skeletal/JJ muscles/NNS still/RB shows/VBZ a/DT 5%/JJ fraction/NN of/IN CK-MB/NEWGENE ./.
@@113497962309 Measurements/NNS were/VBD obtained/VBN :/: (/( i/NN )/SYM just/RB after/IN the/DT traumatic/JJ exposure/NN (/( D0/NN )/SYM ;/: (/( ii/NN )/SYM 3/CD days/NNS after/IN this/DT first/JJ measurement/NN (/( D3/NN )/SYM ;/: and/CC (/( iii/NN )/SYM 30/CD days/NNS after/IN (/( D30/NN )/SYM ./.
@@118118251679 The/DT results/NNS of/IN our/PRP ten-fold/JJ cross-validation/NN experiments/NNS show/VBP that/IN ,/, on/IN the/DT average/NN ,/, the/DT system/NN increases/VBZ the/DT specificity/NN from/IN 0/CD ./CD 19/CD (/( 0/CD ./CD 35/CD )/SYM to/IN 0/CD ./CD 69/CD (/( 0/CD ./CD 74/CD )/SYM at/IN a/DT sensitivity/NN level/NN of/IN 1/CD ./CD 0/CD (/( 0/CD ./CD 95/CD )/SYM ./.
@@82013528723 In/NN the/DT case/NN of/IN congenital/JJ protein/NEWGENE C/NEWGENE deficiency/NN ,/, vitamin/NN K/NN antagonists/NNS must/MD be/VB started/VBN cautiously/RB due/NN to/IN the/DT risk/NN of/IN skin/NN necrosis/NN ./.
@@83567929675 HTLV-1/NN gene/NN expression/NN by/IN defective/JJ proviruses/NNS in/IN an/DT infected/VBN T-cell/NN line/NN ./.
@@82886228216 The/DT structural/JJ analysis/NN also/RB demonstrated/VBD that/IN the/DT heterogeneity/NN of/IN the/DT HDC/NEWGENE mRNA/NEWGENE is/VBZ caused/VBN by/IN an/DT insertion/NN of/IN the/DT seventh/JJ intron/NN sequence/NN and/CC alternative/JJ use/NN of/IN the/DT splicing/JJ acceptor/NN site/NN at/IN the/DT 12th/NN exon/NN ./.
@@93469351416 Thus/RB ,/, ZNF74/NEWGENE sublocalization/NN in/IN nuclear/JJ domains/NNS enriched/VBN in/IN pre-mRNA/JJ maturating/JJ factors/NNS ,/, its/PRP RNA/NN binding/JJ activity/NN ,/, and/CC its/PRP direct/JJ phosphodependent/NN interaction/NN with/IN the/DT pol/NEWGENE IIo/NEWGENE ,/, a/DT form/NN of/IN the/DT RNA/NEWGENE polymerase/NEWGENE functionally/RB associated/VBD with/IN pre-/NN mRNA/NN processing/VBG ,/, suggest/VB a/DT role/NN for/IN this/DT member/NN of/IN the/DT KRAB/NEWGENE multifinger/NEWGENE protein/NEWGENE family/NEWGENE in/IN RNA/NN processing/VBG ./.
@@112484631083 The/DT blood/NN levels/NNS of/IN lactate/NN ,/, pyruvate/NN and/CC amino/JJ acids/NNS were/VBD not/RB elevated/VBN ./.
@@86664046081 Isolation/NNS of/IN a/DT near/IN full-length/JJ cDNA/NN from/IN a/DT human/JJ fetal/JJ brain/NN cDNA/NN library/NN revealed/VBD a/DT protein/NEWGENE serine-threonine/NEWGENE phosphatase/NEWGENE with/IN a/DT tetratricopeptide/NEWGENE motif/NEWGENE ,/, almost/RB identical/JJ to/IN human/NEWGENE PPP5C/NEWGENE (/( PP5/NEWGENE )/SYM and/CC highly/RB homologous/JJ to/IN rat/NEWGENE PPT/NEWGENE ./.
@@18518763260 This/DT element/NN was/VBD used/VBN to/IN screen/NN an/DT EMBL3/NN mouse/NN genomic/JJ library/NN ./.
@@23864857230 The/DT nucleotide/NN sequence/NN consists/VBZ of/IN 48/CD bp/NN of/IN 5'-end/CD non-coding/JJ region/NN ,/, 1695/CD bp/NN of/IN coding/JJ region/NN and/CC 212/CD bp/NN of/IN 3'-end/CD non-coding/JJ region/NN including/JJ a/DT 20/CD bp/NN poly/NN (/NN A/NN )/NN tail/NN ./.
@@28799513782 Effects/NNPS of/IN a/DT new/JJ antihypertensive/JJ agent/NN ,/, SGB-1534/NN ,/, on/IN rat/NN platelet/NN aggregation/NN ./.
@@90883713854 Plasma/NN levels/NNS of/IN protein/NEWGENE C/NEWGENE ,/, protein/NEWGENE S/NEWGENE ,/, and/CC antithrombin/NEWGENE III/NEWGENE in/IN patients/NNS with/IN subarachnoid/JJ haemorrhage/NN ./.
@@82226188193 Two/CD BASIC/DT computer/NN programs/NNS using/VBG logit/NN transformation/NN for/IN the/DT analysis/NN of/IN S-shaped/JJ curves/NNS are/VBP presented/VBN ./.
@@7863992212 Among/IN 9/NN group/NN I/NN patients/NNS with/IN a/DT positive/JJ result/NN on/IN head-up/JJ tilt-table/JJ testing/NN and/CC no/DT evidence/NN of/IN structural/JJ heart/NN disease/NN (/( mean/JJ follow-up/JJ 4/CD ./CD 3/CD years/NNS )/SYM ,/, 7/CD are/VBP without/IN further/JJ episodes/NNS of/IN syncope/NN ;/: 3/CD have/VB discontinued/VBN medication/NN and/CC 5/CD have/VB resumed/VBN at/IN least/RB limited/VBN exercise/NN ./.
@@77769793602 In/NN contrast/NN ,/, COUP-TF/NEWGENE alone/RB had/VBP no/DT effect/NN on/IN repCRS2-dependent/JJ reporter/NN gene/NN activity/NN ./.
@@22064302824 Pups/NNS placed/VBN into/IN the/DT novel/JJ environment/NN with/IN their/PRP mothers/NNS exhibited/VBD an/DT intermediate/JJ level/NN of/IN DA/NN turnover/NN ./.
@@77807197752 With/IN this/DT bisected/VBN diastolic/JJ driving/NN ,/, the/DT abnormal/JJ echo/NN disappeared/VBN completely/RB ./.
@@75685763151 This/DT report/NN focused/VBN on/IN the/DT relationship/NN between/IN Type/NN A/NN behavior/NN and/CC eight/CD basic/JJ emotion/NN dimensions/NNS ./.
@@14066308973 Using/VBG either/DT a/DT p50-/NEWGENE or/CC p65-selected/NEWGENE kappa/NEWGENE B/NEWGENE motif/NEWGENE ,/, which/WDT displayed/VBD differential/JJ binding/NN with/IN respect/NN to/IN the/PDT other/DT protein/NN ,/, little/JJ to/IN no/DT binding/NN was/VBD observed/VBN with/IN the/DT heterodimeric/NEWGENE NF-kappa/NEWGENE B/NEWGENE complex/NEWGENE ./.
@@98409434894 We/PRP have/VBP isolated/VBN a/DT novel/JJ human/NEWGENE cyclin/NEWGENE ,/, cyclin/NEWGENE E2/NEWGENE ,/, that/WDT contains/VBZ significant/JJ homology/NN to/IN cyclin/NEWGENE E/NEWGENE ./.
@@89527968908 He/NN is/VBZ well/VB ,/, five/CD years/NNS after/IN relapse/NN ./.
@@89778446 The/DT concentration/NN of/IN alpha/NEWGENE 2-macroglobulin/NEWGENE ,/, alpha/NEWGENE 1-antitrypsin/NEWGENE ,/, plasminogen/NEWGENE ,/, C3-complement/NEWGENE ,/, fibrinogen/NEWGENE degradation/NN products/NNS (/( FDP/NN )/SYM and/CC fibrinolytic/JJ activity/NN ,/, were/VBD studied/VBN in/IN the/DT aqueous/JJ humour/NN and/CC serum/JJ from/IN nine/JJ patients/NNS with/IN Fuchs'/NN endothelial/JJ dystrophy/NN ,/, 17/CD patients/NNS with/IN uncomplicated/JJ senile/JJ cataract/NN and/CC in/IN the/DT secondary/JJ aqueous/JJ from/IN six/CD cataract/NN patients/NNS ./.
@@64799762681 Significant/JJ clinical/JJ differences/NNS between/IN the/DT patients/NNS treated/VBN with/IN and/CC without/IN AMB/NN were/VBD longer/JJR survival/NN time/NN following/IN diagnosis/NN of/IN illness/NN (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM and/CC more/RB frequent/VB cranial/JJ nerve/NN signs/NNS in/IN the/DT treated/VBN patients/NNS (/( P/NN =/SYM 0/CD ./CD 089/CD )/SYM ./.
@@95738844448 However/RB ,/, mandibular/JJ position/NN (/( S-N-B/NN and/CC S-N-Pog/NN )/SYM was/VBD found/VBN to/IN be/VB significantly/RB more/RB retrusive/JJ in/IN Class/NN II/NN when/CC compared/VBN with/IN Class/NN I/NN subjects/NNS ./.
@@35262794204 State-approved/NN schools/NNS of/IN nursing/JJ R/NNP ./NNP N/NNP ./.
@@96709439567 B/NEWGENE cell/NEWGENE antigen/NEWGENE receptor/NEWGENE (/( BCR/NEWGENE )/NN -mediated/NN formation/NN of/IN a/DT SHP-2-pp120/NEWGENE complex/NEWGENE and/CC its/PRP inhibition/NN by/IN Fc/NEWGENE gamma/NEWGENE RIIB1-BCR/NEWGENE coligation/NN ./.
@@84500158408 The/DT method/NN involves/VBZ preliminary/JJ isolation/NN of/IN oxiracetam/NN and/CC internal/JJ standard/NN from/IN plasma/NN by/IN solid-phase/JJ extraction/NN prior/NN to/IN the/DT formation/NN of/IN their/PRP n-propyl/JJ carbamate/NN derivatives/NNS ./.
@@92444309851 The/DT alternative/JJ splice/NN sites/NNS for/IN the/DT smallest/JJS adducin/NEWGENE isoform/NN ,/, beta-3/NEWGENE ,/, are/VBP alternative/JJ donor/NN and/CC acceptor/NN sites/NNS within/IN exons/NNS 7/CD and/CC 12/CD ./CD
@@18571432454 The/DT patient/NN was/VBD a/DT 78-year-old/JJ male/NN in/IN whom/WP skin/VBP lesions/NNS preceded/VBD the/DT diagnosis/NN of/IN myelofibrosis/NN ./.
@@25046036325 Isolation/NNS of/IN Weeksella/NNP virosa/NN (/( formerly/RB CDC/NN group/NN IIf/NN )/SYM from/IN a/DT vaginal/JJ sample/NN ./.
@@20221887069 Biochemical/NNP analysis/NN demonstrates/VBZ that/IN the/DT BJ1/NEWGENE protein/NEWGENE is/VBZ associated/VBN with/IN nucleosomes/NNS and/CC is/VBZ released/VBN from/IN chromatin/NN by/IN agents/NNS which/WDT intercalate/VBP into/IN DNA/NN ,/, as/IN previously/RB shown/VBP for/IN the/DT high/NEWGENE mobility/NEWGENE group/NEWGENE proteins/NEWGENE (/( HMGs/NEWGENE )/SYM ./.
@@110307444874 Overexpression/NNS of/IN Trdpm1/NEWGENE in/IN a/DT dpm1/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE :/: :/: his7/NEWGENE //NEWGENE dpm1/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE S/NNP ./NNP pombe/NNP diploid/RB resulted/VBD in/IN a/DT 4-fold/JJ increase/NN in/IN specific/NN DPM/NEWGENE synthase/NEWGENE activity/NN ./.
@@36687362848 The/DT average/JJ deviations/NNS in/IN the/DT X-ray/NN counts/NNS of/IN the/DT constant/NN elements/NN from/IN the/DT series/NN means/NN were/VBD used/VBN to/IN correct/VB the/DT recorded/VBN count/NN of/IN the/DT variable/JJ element/NN in/IN each/DT block/NN ./.
@@93740828758 The/DT proposed/VBN mechanism/NN of/IN effect/NN states/NNS that/WDT mono/NN (/NN 2-ethylhexyl/NN )/NN phthalate/NN (/( MEHP/NN )/SYM ,/, the/DT primary/JJ hydrolysis/NN product/NN of/IN DEHP/NN ,/, mimics/VBP the/DT inducing/JJ prostaglandins/NNS (/( PG/NN )/SYM PGD/NN (/NN 2/NN )/NN ,/, 9alpha/NN ,/NN 11betaPGF2/NN ,/, and/CC PGF2alpha/NN ,/, and/CC thromboxanes/NNS in/IN the/DT lungs/NNS ,/, thereby/RB increasing/JJ the/DT risk/NN of/IN inducing/JJ inflammation/NN in/IN the/DT airways/NNS ,/, which/WDT is/VBZ a/DT characteristic/NN of/IN asthma/NN ./.
@@32347903924 Effect/NN of/IN the/DT methods/NNS of/IN cutaneous/JJ administration/NN of/IN methyl/NN isobutyl/NN ketone/NN on/IN its/PRP toxicity/NN ./.
@@10698937386 TIP30/NEWGENE has/VBZ an/DT intrinsic/NN kinase/NEWGENE activity/NN required/VBN for/IN up-regulation/NN of/IN a/DT subset/NN of/IN apoptotic/JJ genes/NNS ./.
@@75545417438 The/DT optimal/JJ care/NN of/IN CHF/NN patient/NN includes/VBZ the/DT recognition/NN and/CC management/NN of/IN these/DT electrolyte/NN disturbances/NNS ./.
@@94868909452 However/RB ,/, laparoscopy/NN failed/VBD to/IN establish/VB inoperability/NN in/IN any/DT cases/NNS of/IN carcinoma/NN spread/NN to/IN areas/NNS not/RB accessible/JJ to/IN laparoscopic/JJ visualization/NN ./.
@@95045144660 Randomised/JJ comparison/NN of/IN addition/NN of/IN autologous/JJ bone-marrow/NN transplantation/NN to/IN intensive/JJ chemotherapy/NN for/IN acute/JJ myeloid/JJ leukaemia/NN in/IN first/JJ remission/NN :/: results/NNS of/IN MRC/NN AML/NN 10/NN trial/NN ./.
@@94341858102 The/DT organization/NN of/IN SPP1/NEWGENE genes/NEWGENE involved/VBN in/IN the/DT replication/NN ,/, DNA/NN packaging/NN and/CC phage/NN assembly/NN proteins/NNS resembles/VBZ the/DT organization/NN of/IN genes/NNS of/IN equivalent/JJ regions/NNS of/IN different/JJ E/NNP ./NNP coli/JJ double-stranded/JJ DNA/NN phages/NNS ./.
@@80542812668 The/DT retention/NN index/NN of/IN 201Tl/NN SPECT/NN is/VBZ a/DT useful/JJ indicator/NN of/IN metastatic/JJ potential/NN ,/, thereby/RB facilitating/JJ the/DT prediction/NN of/IN prognosis/NN ,/, and/CC provides/VBZ insight/NN into/IN the/DT relationship/NN between/IN 201Tl/CD uptake/NN and/CC malignancy/NN ./.
@@81137361743 The/DT gene/NN organization/NN of/IN CRSV/NEWGENE RNA-1/NEWGENE is/VBZ similar/JJ to/IN those/DT of/IN red/JJ clover/NN necrotic/JJ mosaic/NN (/( RCNMV/NNP )/SYM and/CC sweet/JJ clover/NN necrotic/JJ mosaic/NN (/( SCNMV/NNP )/SYM dianthoviruses/NNS with/IN the/DT exception/NN that/IN CRSV/NEWGENE RNA-1/NEWGENE contains/VBZ the/DT additional/JJ 3'-terminal/JJ ORF/NN ./.
@@16572493183 All/DT anti-I/NEWGENE and/NEWGENE anti-i/NEWGENE CA/NEWGENE were/VBD shown/VBP to/IN express/NN VH4/NEWGENE heavy/NEWGENE chains/NEWGENE ,/, and/CC 14/CD of/IN 17/CD CA/NN expressed/VBD a/DT previously/RB described/VBN VH4/NEWGENE second/JJ hypervariable/JJ region/NN determinant/NN ,/, termed/JJ VH4-HV2a/NEWGENE ./.
@@7477226444 The/DT data/NN indicate/VB a/DT three-phase/JJ reaction/NN after/IN B1/NN injection/NN :/: Phase/NN 1--shortly/JJ after/IN injection/NN there/RB is/VBZ a/DT drop/NN of/IN all/DT parameters/NNS lasting/JJ for/IN 30/CD sec/NN ./.
@@7798217311 A/DT secondary/JJ phosphorylation/NN of/IN CREB341/NEWGENE at/IN Ser129/NN is/VBZ required/VBN for/IN the/DT cAMP-mediated/JJ control/NN of/IN gene/NN expression/NN ./.
@@10967531799 After/IN declamping/NN of/IN the/DT aorta/NN ,/, there/RB were/VBD also/RB severe/JJ edema/NN ,/, local/JJ fibre/NN necrosis/NN ,/, and/CC adhesion/NN of/IN leucocytes/NNS ,/, whereas/IN muscle/NN fibre/NN areas/NNS became/VBD 3/CD ,/CD 935/CD ./CD 18/CD &mgr/NN ;/: 531/CD &mgr/NN ;/: m/NN (/NN 2/NN )/NN for/IN type/NN I/NN and/CC 5/CD ,/CD 804/CD +/NN //NN -/NN 1/CD ,/CD 075/CD &mgr/NN ;/: m/NN (/NN 2/NN )/NN for/IN type/NN II/NNS ./NNS
@@105236747097 RNase/NEWGENE MRP/NEWGENE is/VBZ a/DT ribonucleoprotein/NN endoribonuclease/NN that/WDT has/VBZ been/VBN shown/VBP to/IN have/NN roles/NNS in/IN both/DT mitochondrial/JJ DNA/NN replication/NN and/CC nuclear/NEWGENE 5/NEWGENE ./NEWGENE 8S/NEWGENE rRNA/NEWGENE processing/VBG ./.
@@112904154786 In/NN the/DT present/NN study/NN ,/, we/PRP have/VBP determined/VBN the/DT ICBP90/NEWGENE gene/NEWGENE structure/NN by/IN screening/NN of/IN a/DT human/JJ placenta/NN genomic/JJ library/NN and/CC PCR/NN analysis/NN ./.
@@30690463782 The/DT method/NN is/VBZ accurate/JJ ,/, with/IN good/JJ precision/NN and/CC adequate/JJ sensitivity/NN ./.
@@2555703217 Tyrosine/NEWGENE kinase/NEWGENE oncogenes/NN abrogate/VBP interleukin-3/NEWGENE dependence/NN of/IN murine/JJ myeloid/JJ cells/NNS through/RB signaling/JJ pathways/NNS involving/VBG c-myc/NEWGENE :/: conditional/JJ regulation/NN of/IN c-myc/NEWGENE transcription/NN by/IN temperature-sensitive/JJ v-abl/NEWGENE ./.
@@83365437293 In/JJ mice/NNS ,/, three/CD major/JJ families/NNS of/IN L1/NEWGENE elements/NEWGENE ,/, termed/JJ "A/NEWGENE ,/NEWGENE "/NEWGENE "F/NEWGENE1 ,/NEWGENE1 "/NEWGENE1 and/CC "V/NEWGENE ,/NEWGENE "/NEWGENE have/NN been/VBN defined/VBN on/IN the/DT basis/NN of/IN the/DT sequence/NN found/VB at/IN the/DT 5'/CD terminus/NN ./.
@@83558571362 ST/NN elevation/NN occurs/VBZ in/IN 5/CD patients/NNS (/( 55/CD ./CD 5%/CD )/SYM of/IN subgroup/NN A/NN and/CC in/IN no/DT patient/NN of/IN the/DT subgroup/NN B/NNP ./NNP
@@82973767445 Co-transfection/NNS of/IN expression/NN vectors/NNS for/IN CCAAT/NEWGENE //NEWGENE enhancer/NEWGENE binding/NEWGENE protein/NEWGENE (/NEWGENE C/NEWGENE //NEWGENE EBP/NEWGENE )/NEWGENE alpha/NEWGENE and/CC C/NEWGENE //NEWGENE EBP/NEWGENE beta/NEWGENE trans-activated/VBD the/DT rat/NEWGENE uncoupling/NEWGENE protein/NEWGENE gene/NEWGENE promoter/NEWGENE due/NN to/IN sequences/NNS in/IN the/DT 5'/CD proximal/JJ region/NN ./.
@@31467846398 Of/IN 49/CD receptors/NNS which/WDT fired/VBD in/IN phase/NN with/IN ventilation/NN ,/, 13/CD behaved/VBN like/JJ mammalian/JJ rapidly/RB adapting/JJ pulmonary/JJ stretch/JJ receptors/NNS ,/, 19/CD like/JJ mammalian/JJ slowly/RB adapting/JJ pulmonary/JJ stretch/NN receptors/NNS (/( PSR/NN )/SYM ,/, and/CC 17/CD like/JJ avian/JJ intrapulmonary/JJ CO2-sensitive/NN chemoreceptors/NN (/( IPC/NN )/SYM ./.
@@104111397448 Our/PRP results/NNS ,/, when/CC combined/JJ with/IN previously/RB published/VBN in/IN vitro/FW results/NNS ,/, support/NN a/DT direct/JJ role/NN for/IN Prp44p/NEWGENE in/IN unwinding/NN of/IN the/DT U4/NEWGENE //NEWGENE U6/NEWGENE helix/NN ./.
@@80494444238 Tryptic/JJ cleavage/NN and/CC peptide/NN sequence/NN analysis/NN demonstrated/VBN that/IN the/DT 98-kD/NN protein/NN is/VBZ identical/JJ to/IN a/DT recently/RB cloned/VBN protein/NN ,/, special/NEWGENE A-T-rich/NEWGENE binding/NEWGENE protein/NEWGENE 1/NEWGENE (/( SATB1/NEWGENE )/SYM ,/, that/WDT binds/VBZ selectively/RB to/IN nuclear/NN matrix/NN //NN scaffold-associated/NN regions/NN of/IN DNA/NN (/( MARs/NNP //NNP SARs/NNP )/SYM ./.
@@105749925486 Conversely/RB ,/, E1A/NEWGENE binding/JJ to/IN only/RB p300/NEWGENE //NEWGENE CBP/NEWGENE results/NNS in/IN an/DT increase/NN in/IN PARP/NEWGENE enzyme/NEWGENE activity/NN and/CC consequently/RB in/IN cell/NN death/NN susceptibility/NN to/IN irradiation/NN ,/, which/WDT is/VBZ effectively/RB counteracted/VBN by/IN the/DT PARP/NEWGENE chemical/JJ inhibitor/NN 3-aminobenzamide/JJ ./.
@@95531341868 The/DT N-syndecan-dependent/NNP neurite/NN outgrowth/NN is/VBZ inhibited/VBN by/IN the/DT tyrosine/NEWGENE kinase/NEWGENE inhibitors/NNS herbimycin/NN A/DT and/CC PP1/NEWGENE ./.
@@19927422608 We/PRP reviewed/VBD the/DT records/NNS of/IN 151/CD patients/NNS with/IN optic/JJ neuritis/NN examined/VBN over/RB an/DT eight-year/JJ period/NN ./.
@@18705002476 Contributions/NNS from/IN pairs/NNS of/IN source/NN and/CC target/NN volume/NN elements/NNS are/VBP summed/VBN for/IN the/DT S/NNP values/NNS between/IN the/DT tumor/NN and/CC itself/PRP ,/, between/IN the/DT remaining/JJ healthy/JJ host/NN organ/NN and/CC itself/PRP ,/, and/CC between/IN the/DT tumor/NN and/CC the/DT remaining/JJ healthy/JJ host/NN organ/NN ,/, with/IN the/DT reciprocity/NN theorem/NN assumed/VBN for/IN the/DT last/NN ./.
@@94789764821 Transfection/NNS studies/NNS also/RB showed/VBD that/IN 3'-deletion/NN of/IN sequences/NNS downstream/RB of/IN the/DT transcriptional/JJ start/NN site/NN (/( +1/CD //CD +47/CD )/SYM markedly/RB reduced/VBN OSM/NN -fold/CD induction/NN ./.
@@113954692036 Indeed/RB ,/, mutation/NN of/IN two/NN of/IN these/DT motifs/NNS ,/, known/VBP to/IN be/VB important/JJ to/IN regulation/NN of/IN sid1/NEWGENE ,/, altered/VBD the/DT differential/JJ regulation/NN of/IN sid2/NEWGENE by/IN iron/NN ./.
@@104685851094 Like/IN DNA/NN binding/JJ ,/, transcriptional/JJ enhancement/NN required/VBN amino-terminally/RB located/VBN basic/JJ amino/JJ acid/NN residues/NNS but/CC not/RB the/DT carboxyl-terminal/NN portion/NN of/IN Hap46/NEWGENE known/VBP to/IN participate/VB in/IN hsp70/NEWGENE interaction/NN ./.
@@94683866050 Pet-1/NEWGENE can/MD bind/VB specifically/RB to/IN a/DT PEA3/NEWGENE ETS/NEWGENE DNA-binding/NEWGENE motif/NEWGENE and/CC can/MD modulate/VB transcription/NN of/IN synthetic/JJ promoter/NN constructs/NNS in/IN a/DT sequence-specific/JJ manner/NN ./.
@@10601410426 In/NN conclusion/NN ,/, our/PRP data/NN do/NN not/RB support/VB a/DT role/NN for/IN IVIg/NNS in/IN the/DT remyelination/NN of/IN stable/JJ multiple/JJ sclerosis/NN lesions/NNS as/IN measured/VBN by/IN central/JJ conduction/NN time/NN ./.
@@48285875196 Isolation/NNS of/IN tha/NN avian/JJ reticuloendothelial/JJ virus/NN (/( strain/NN T/NN )/SYM ./SYM
@@76425381123 To/TO explore/VB the/DT mechanism/NN of/IN RSK/NEWGENE activation/NN ,/, a/DT cloned/VBN human/NN RSK/NEWGENE cDNA/NN (/( RSK3/NEWGENE )/SYM was/VBD used/VBN to/IN generate/VB and/CC characterize/VB several/DT site-directed/NN RSK/NEWGENE mutants/NEWGENE ;/: K91A/NN (/( N-Lys/NN ,/, NH2-terminal/NN ATP-binding/NN mutant/NN )/SYM ,/, K444A/NNP (/( C-Lys/NN ,/, COOH-terminal/NN ATP-binding/NN mutant/NN )/SYM ,/, N/NNP //NNP C-Lys/NNP (/( double/JJ ATP-binding/NN mutant/NN )/SYM T570A/NNP (/( C-Thr/NNP ,/, mutant/NN of/IN the/DT putative/JJ MAPK/NEWGENE phosphorylation/NN site/NN in/IN subdomain/NN VIII/NN of/IN the/DT C-domain/NN )/SYM ,/, S218A/NNP (/( N-Ser/NNP ,/, mutant/NN of/IN the/DT corresponding/JJ NH2-terminal/NN residue/NN )/SYM ./.
@@111131993379 Since/IN MEK/NEWGENE acts/NNS as/IN a/DT cytoplasmic/NN anchor/NN for/IN the/DT ERKs/NEWGENE ,/, the/DT lack/NN of/IN a/DT MEK/NEWGENE interaction/NN resulted/VBN in/IN the/DT aberrant/JJ nuclear/JJ localization/NN of/IN ERK2-Delta19-25/NEWGENE mutants/NEWGENE in/IN serum-starved/JJ cells/NNS ./.
@@5417525538 When/WRB two/JJ determinations/NNS were/VBD performed/VBN on/IN 12/CD samples/NNS of/IN plasma/NN taken/VBP from/IN normal/JJ adults/NNS in/IN October/NN ,/, the/DT values/NNS were/VBD 22/CD ./CD 6/CD +/NN //NN -/NN 4/CD ./CD 8/CD and/CC 21/CD ./CD 0/CD +/NN //NN -/NN 3/CD ./CD 6/CD (/( mean/JJ +/NN //NN -/NN SD/NN )/SYM ng/NN //NN ml/NN ,/, respectively/RB ./.
@@70386843751 Based/VBN on/IN peptide/NN map/NN similarities/NNS ,/, partial/JJ amino-terminal/NN sequence/NN data/NN ,/, and/CC common/JJ genetic/JJ origin/NN ,/, it/PRP is/VBZ suggested/VBN that/IN p60/NEWGENE and/CC p62/NEWGENE have/VB identical/JJ amino/JJ acid/NN sequences/NNS carboxy-terminal/JJ to/IN the/DT p60/NEWGENE initiator/NN methionine/NN (/( residue/NN 21/CD of/IN p62/NEWGENE )/SYM ./.
@@106468634721 Overexpression/NNS of/IN ICBP90/NEWGENE in/IN COS-1-transfected/CD cells/NNS induced/VBD an/DT enhanced/VBN expression/NN of/IN endogenous/NEWGENE topoisomerase/NEWGENE IIalpha/NEWGENE ./.
@@10400032266 The/DT latter/JJ method/NN adds/VBZ clamping/NN of/IN the/DT inferior/JJ vena/NN cava/NN ,/, which/WDT results/VBZ in/IN hypotension/NN ,/, requiring/JJ invasive/JJ anesthetic/JJ management/NN ./.
@@76571622247 We/PRP conclude/VBP that/DT transcription/NN activation/NN by/IN LEF-1/NEWGENE in/IN vitro/FW is/VBZ a/DT chromatin-dependent/JJ process/NN that/WDT requires/VBZ a/DT functional/JJ trans-activation/NN domain/NN in/IN addition/NN to/IN the/DT HMG/NEWGENE domain/NEWGENE ./.
@@79073283996 313/CD ,/, 98-102/NN )/NN ./.
@@85744145842 These/DT primers/NNS yielded/VBD a/DT PCR/NN product/NN of/IN a/DT characteristic/JJ length/NN within/IN most/RB Xanthomonas/NNP species/NN and/CC pathovars/NNS tested/VBN ./.
@@90646592968 We/PRP have/VBP thus/RB identified/VBN the/DT first/JJ mammalian/NEWGENE homolog/NEWGENE of/NEWGENE yeast/NEWGENE UPF1/NEWGENE ,/, a/DT protein/NN that/WDT regulates/VBZ levels/NNS of/IN nonsense/NN mRNA/NN ,/, and/CC we/PRP tentatively/RB name/VBP this/DT protein/NN human/NEWGENE HUPF1/NEWGENE (/( for/IN human/NEWGENE homolog/NEWGENE of/NEWGENE UPF1/NEWGENE )/SYM ./.
@@75014588027 Of/IN the/DT three/CD known/VBP C/NEWGENE //NEWGENE EBP/NEWGENE family/NEWGENE inhibitors/NNS ,/, Ig/NEWGENE //NEWGENE EBP/NEWGENE ,/, LIP/NEWGENE and/CC CHOP-10/NEWGENE ,/, only/RB Ig/NEWGENE //NEWGENE EBP/NEWGENE is/VBZ ubiquitously/RB expressed/VBN ./.
@@10391277574 BACKGROUND/IN :/: The/DT MAZE-III/NN is/VBZ the/DT surgical/JJ treatment/NN of/IN choice/JJ for/IN medically/RB refractory/JJ atrial/JJ fibrillation/NN ./.
@@37465084415 Failures/NNS of/IN colorimetric/JJ additivity/NN under/IN these/DT experimental/JJ conditions/NNS are/VBP discussed/VBN ./.
@@112204861222 0%/NN )/NN and/CC IL-12/NEWGENE (/( 42/CD ./CD 6%/CD vs/IN ./IN
@@116852846215 [/NN Diabetologia/NN (/( 2001/CD )/SYM 44/CD [/NN Suppl/NN 3/NN ]/NN :/: B/NNP 37-B/NN 44/NN ]/NN
@@40507714726 The/DT Cox/NN proportional/JJ hazards/NNS model/NN was/VBD applied/VBN to/IN the/DT data/NN in/IN order/NN to/IN determine/VB the/DT prognostic/JJ factors/NNS for/IN long-term/JJ survival/NN ./.
@@77210747675 Atopic/NN dermatitis/NN is/VBZ an/DT "itch/NN which/WDT rashes/NNS and/CC not/RB a/DT rash/NN which/WDT itches"/VBP and/CC therefore/RB ,/, any/DT patient/NN treatment/NN program/NN should/MD address/VB the/DT multiplicity/NN of/IN potential/JJ trigger/NN factors/NNS that/WDT provoke/VBP this/DT itching/NN ./.
@@91449588375 This/DT protein/NN can/MD bind/NN to/IN a/DT region/NN of/IN the/DT promoter/NN of/IN an/DT Arabidopsis/NEWGENE light-harvesting/NEWGENE chlorophyll/NEWGENE a/NEWGENE //NEWGENE b/NEWGENE protein/NEWGENE gene/NEWGENE ,/, Lhcb1*3/NEWGENE ,/, which/WDT is/VBZ necessary/JJ for/IN its/PRP regulation/NN by/IN phytochrome/NN ./.
@@111606888518 The/DT metabolic/JJ events/NNS occurring/VBG at/IN or/CC near/IN that/DT structure/NN and/CC involving/VBG cyclin/NEWGENE D3/NEWGENE cause/VBG the/DT translocation/NN of/IN ICP0/NEWGENE to/IN the/DT cytoplasm/NN ./.
@@76780519509 The/DT PDGFR/NEWGENE mutants/NEWGENE that/WDT failed/VBD to/IN associate/NN with/IN PLC/NEWGENE gamma/NEWGENE were/VBD not/RB able/JJ to/IN mediate/VB the/DT PDGF-dependent/NNP production/NN of/IN inositol/NN phosphates/NNS ./.
@@26672593338 There/EX were/VBD 3/CD //CD 32/CD (/( 9/CD ./CD 4/CD per/IN cent/NN )/SYM adverse/JJ reactions/NNS (/( ADRs/NNS )/SYM ,/, and/CC one/PRP case/NN each/DT of/IN nausea/NN ,/, dizziness/NN and/CC increased/VBN menstrual/JJ flow/NN ./.
@@102088654695 Moreover/RB ,/, when/CC added/VBD to/IN the/DT osteoclast/NN cultures/NNS ,/, mrIhh-N/NEWGENE markedly/RB stimulated/VBN the/DT formation/NN of/IN resorption/NN pits/NNS on/IN dentine/NN slices/NNS ./.
@@99440669939 II/NNS ./NNS
@@78442017817 Sex/NN selection/NN via/NN albumin/NEWGENE columns/NNS :/: 20/CD years/NNS of/IN results/NNS ./.
@@85156192204 Tl-201/NN uptake/NN ratio/NN of/IN the/DT right/JJ ventricle/NN ,/, which/WDT represents/VBZ the/DT ratio/NN of/IN total/JJ counts/NNS of/IN the/DT right/JJ ventricle/NN to/IN counts/NNS of/IN the/DT administered/VBN dose/NN of/IN Tl-201/NN ,/, was/VBD higher/JJ in/IN COPD/NN ,/, especially/RB in/IN pulmonary/JJ emphysema/NN and/CC B/NNP type/NN COPD/NN by/IN Burrows/NNS classification/NN than/IN in/IN controls/NNS ./.
@@31381903854 Substantial/JJ amounts/NNS of/IN liposomal/JJ ampicillin/NN were/VBD recovered/VBN from/IN isolated/VBN Kupffer/NN cells/NNS ,/, the/DT target/NN cells/NNS of/IN L/NNP ./NNP monocytogenes/NNS after/IN intravenous/JJ inoculation/NN ./.
@@82656021212 Val--/NNP >/NNP Ala/NNP mutations/NNS selectively/RB alter/VBP helix-helix/JJ packing/NN in/IN the/DT transmembrane/JJ segment/NN of/IN phage/NEWGENE M13/NEWGENE coat/NEWGENE protein/NEWGENE ./.
@@4537808049 The/DT preferential/JJ serum/NEWGENE IgA/NEWGENE response/NN observed/VBN in/IN the/DT patient/NN population/NN suggests/VBZ that/IN bronchial/RB associated/VBN lymphoid/JJ tissue/NN in/IN the/DT diseased/JJ lung/NN is/VBZ an/DT important/JJ source/NN of/IN circulating/JJ IgA/NEWGENE ./.
@@77502172775 Indium-111/NN OncoScint/NNP CR/NN //NN OV/NN and/CC F-18/NN FDG/NN in/IN colorectal/JJ and/CC ovarian/JJ carcinoma/NN recurrences/NNS ./.
@@35434854213 Possible/JJ pathogenetic/JJ mechanisms/NNS of/IN hemopoietic/JJ changes/NNS in/IN response/NN to/IN space/NN flight/NN effects/NNS are/VBP described/VBN ./.
@@84289405522 One/CD such/JJ mutant/JJ also/RB affects/VBP the/DT overlapping/JJ -10/CD hexamer/NN of/IN PR/NNP and/CC results/NNS in/IN reduced/VBN occupancy/NN by/IN both/DT MerR/NEWGENE and/CC RNA/NEWGENE polymerase/NEWGENE ,/, likely/RB as/IN a/DT result/NN of/IN inefficient/JJ transcriptional/JJ initiation/NN of/IN merR/NEWGENE mRNA/NEWGENE ./.
@@1159741488 All/DT groups/NNS were/VBD tested/VBN in/IN a/DT Hebb-Williams/NNP maze/NN at/IN 100/CD approximately/RB 10/CD days/NNS of/IN age/NN ./.
@@69861682658 Complete/JJ sequences/NNS were/VBD obtained/VBN for/IN the/DT three/CD large/JJ thrombic/JJ peptides/NNS ,/, and/CC these/DT were/VBD aligned/VBN by/IN using/VBG peptides/NNS from/IN the/DT V8/NEWGENE protease/NEWGENE digest/NN ./.
@@83863191468 Mutation/NN of/IN the/DT presumptive/RB phosphorylated/VBN tyrosine/NN and/CC threonine/NN residues/NNS of/IN Mpk1p/NEWGENE individually/RB to/IN phenylalanine/NN and/CC alanine/NN ,/, respectively/RB ,/, severely/RB impaired/VBN Mpk1p/NEWGENE function/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@95733742880 Using/VBG Southern/NNP blot/NN analysis/NN and/CC restriction/NN mapping/NN of/IN genomic/JJ YAC/NN (/( yeast/NN artificial/JJ chromosome/NN )/SYM and/CC cosmid/NN clones/NNS ,/, we/PRP located/VBD the/DT human/NEWGENE RIL/NEWGENE gene/NEWGENE 240-260/JJ kb/NN telomeric/JJ to/IN the/DT IRF1/NEWGENE gene/NEWGENE and/CC characterized/VBN its/PRP genomic/JJ structure/NN ./.
@@62913698174 In/NN 49/CD patients/NNS in/IN whom/WP gated/JJ equilibrium/NN ventriculography/NN and/CC cardiac/JJ catheterization/NN were/VBD performed/VBN within/IN a/DT 6/CD day/NN interval/NN ,/, total/JJ and/CC fractional/JJ portions/NNS of/IN global/JJ and/CC regional/JJ right/JJ ventricular/JJ ejection/NN fraction/NN (/( RVEF/NN )/SYM were/VBD correlated/VBN with/IN pulmonary/JJ arterial/JJ systolic/JJ pressure/NN ./.
@@70613501018 (/( 1980/CD )/SYM :/: Science/NNP 210/CD ,/, 77-72/NN )/NN that/IN stimulating/JJ the/DT crossed/JJ olivocochlear/JJ bundle/NN (/( COCB/NN )/SYM can/MD change/VB the/DT magnitude/NN of/IN the/DT distortion/NN product/NN (/( f2-f1/NN )/SYM in/IN the/DT ear-canal/JJ sound/NN pressure/NN ./.
@@117603981595 METHODS/IN :/: 302/CD consecutive/JJ patients/NNS with/IN BS/NN and/CC 438/CD patients/NNS with/IN other/DT rheumatological/JJ conditions/NNS were/VBD surveyed/VBN for/IN the/DT presence/NN or/CC absence/NN of/IN the/DT features/NNS of/IN BS/NN by/IN means/NN of/IN a/DT standard/JJ form/NN which/WDT had/VBP been/VBN prepared/VBN according/VBG to/IN ISG/NNS criteria/NNS ./.
@@12994899571 In/NN general/JJ ,/, however/RB ,/, this/DT study/NN provided/VBD little/JJ evidence/NN of/IN any/DT effect/NN of/IN supplementation/NN to/IN athletic/JJ performance/NN for/IN athletes/NNS consuming/JJ the/DT dietary/JJ RDIs/NN ./.
@@105638362835 In/NN contrast/NN ,/, AP-2/NEWGENE binding/JJ activity/NN was/VBD significantly/RB greater/JJR in/IN T47D/DT cells/NNS ,/, and/CC Western/JJ blots/NNS confirmed/VBN increased/VBN AP-2/NEWGENE protein/NEWGENE levels/NNS in/IN these/DT cells/NNS ./.
@@95291561920 Deletion/NNS of/IN the/DT last/JJ two/JJ Ser/NN residues/NNS ,/, including/JJ one/PRP PKC/NEWGENE consensus/NN site/NN in/IN the/DT receptor/NN tail/NN ,/, prevented/VBN only/JJ phorbol/NN 12-myristate/JJ 13-acetate-induced/JJ desensitization/NN by/IN 30%/CD ./.
@@94753789169 Competitive/JJ reverse/JJ transcription-polymerase/JJ chain/NN reaction/NN and/CC HPLC/NN analysis/NN showed/VBN that/IN RUSH-1alpha/NEWGENE is/VBZ the/DT progesterone-dependent/JJ splice/NN variant/NN ./.
@@84603468432 This/DT was/VBD performed/VBN in/IN a/DT double/JJ blinded/JJ ,/, randomized/JJ ,/, placebo-controlled/JJ study/NN ./.
@@97049277554 E2F-6/NEWGENE shares/VBP significant/JJ homology/NN with/IN E2Fs/NEWGENE 1-5/NEWGENE ,/, especially/RB within/IN the/DT DNA/NN binding/JJ ,/, heterodimerization/NN and/CC marked/JJ box/NN domains/NN ./.
@@109079718463 Pharmacoeconomic/NN assessment/NN of/IN HMG-CoA/NEWGENE reductase/NEWGENE inhibitor/NN therapy/NN :/: an/DT analysis/NN based/VBN on/IN the/DT CURVES/NNS study/NN ./.
@@78806501594 A/DT quantitative/JJ analysis/NN of/IN the/DT diffraction/NN intensity/NN as/IN function/NN of/IN the/DT accumulated/VBN electron/NN dose/NN suggests/VBZ the/DT possibility/NN of/IN recording/JJ up/NN to/IN 250/CD diffraction/NN patterns/NNS with/IN 3/CD ./CD 5/CD A/DT resolution/NN from/IN a/DT single/NN crotoxin/NN complex/NN crystal/NN 128/CD A/DT thick/NN ./.
@@79371084482 Consequently/RB functional/JJ mRNAs/NNS can/MD be/VB produced/VBN by/IN endogenous/NEWGENE RNA/NEWGENE polymerase/NEWGENE I/NNP ./NNP
@@80750708519 Essential/JJ features/NNS of/IN this/DT model/NN are/VBP bending/NN of/IN the/DT DNA/NN double/JJ helix/NN and/CC contact/NN of/IN operator/NN sites/NNS with/IN repressor/NN domains/NNS bearing/JJ sequence/NN homologies/NNS with/IN the/DT helix-turn-helix/NN (/( HTH/NNS )/SYM motifs/NNS of/IN other/DT DNA-binding/NN proteins/NN ./.
@@36669574330 Organisms/NNS were/VBD recovered/VBN from/IN the/DT conjunctiva/NN for/IN several/DT weeks/NNS ,/, and/CC persistent/JJ genital/JJ and/CC gastrointestinal/JJ infection/NN also/RB resulted/VBD from/IN the/DT ocular/JJ infection/NN in/IN some/DT cats/NNS ./.
@@34343476208 Mean/VB rCBF/NN increased/VBN in/IN some/DT patients/NNS 4-8/JJ weeks/NNS after/IN surgery/NN on/IN the/DT ipsilateral/JJ side/NN ./.
@@76828422716 The/DT first/JJ exon/NN encodes/VBZ 66/CD bp/NN of/IN the/DT 5'-untranslated/JJ sequence/NN ,/, while/CC exon/NN 2/CD encodes/VBZ the/DT coding/JJ and/CC 3'-untranslated/JJ sequences/NNS ./.
@@34635371744 Clinical/NNP method/NN for/IN the/DT treatment/NN of/IN Class/NN II/NN occlusal/JJ anomalies/NNS with/IN open/JJ bite/NN ./.
@@105916338421 A/DT key/NN event/NN in/IN this/DT process/NN is/VBZ the/DT selective/JJ recognition/NN of/IN the/DT target/NN membrane/NN by/IN the/DT vesicle/NN and/CC the/DT current/JJ view/NN is/VBZ that/DT SNARE/NEWGENE protein/NEWGENE interactions/NNS likely/RB play/VBP a/DT central/JJ role/NN in/IN vesicle-target/JJ recognition/NN and/CC or/CC membrane/NN fusion/NN ./.
@@87579438042 This/DT site/NN acts/NNS as/IN a/DT negative/JJ element/NN when/CC transferred/VBN to/IN the/DT thymidine/NEWGENE kinase/NEWGENE promoter/NEWGENE ,/, but/CC does/VBP not/RB confer/VB inducibility/NN ./.
@@10950415415 CONCLUSION/IN :/: Vitrectomy/NN for/IN vitreous/JJ hemorrhage/NN in/IN Terson/NN syndrome/NN is/VBZ a/DT safe/JJ and/CC effective/JJ procedure/NN ,/, offering/VBG a/DT rapid/JJ and/CC prolonged/JJ improvement/NN in/IN vision/NN ./.
@@106878553864 Mouse/NEWGENE growth/NEWGENE hormone/NEWGENE transcription/NEWGENE factor/NEWGENE Zn-16/NEWGENE :/: unique/JJ bipartite/JJ structure/NN containing/JJ tandemly/RB repeated/JJ zinc/NN finger/NN domains/NNS not/RB reported/VBN in/IN rat/NEWGENE Zn-15/NEWGENE ./.
@@74634657354 Early/JJ infection/NN was/VBD detected/VBN in/IN one/PRP of/IN 50/CD control/NN women/NNS who/WP gave/VBD birth/NN to/IN a/DT healthy/JJ infant/NN ./.
@@14067032709 By/IN screening/JJ a/DT Y1/NN cell/NN cDNA/NN library/NN with/IN the/DT DNA-binding/NN region/NN of/IN the/DT H-2RIIBP/NEWGENE nuclear/NEWGENE hormone/NEWGENE receptor/NEWGENE cDNA/NEWGENE ,/, we/PRP isolated/VBD a/DT cDNA/NN that/WDT is/VBZ selectively/RB expressed/VBN in/IN steroidogenic/JJ cells/NNS ./.
@@74668317437 Pentachlorophenol/CHEM accelerates/VBZ the/DT onset/NN of/IN HCB/NN porphyria/NN ,/, in/IN other/DT words/NNS it/PRP increases/VBZ the/DT total/JJ urinary/NEWGENE porphyrin/NEWGENE excretion/NN and/CC causes/VBZ an/DT earlier/JJR disturbance/NN of/IN the/DT porphyrin/NEWGENE pattern/NN ./.
@@112080179840 A/DT cDNA/NN clone/NN encoding/VBG C2H2-type/NEWGENE zinc/NEWGENE finger/NEWGENE protein/NEWGENE ,/, SCOF-1/NEWGENE ,/, was/VBD isolated/VBN from/IN soybean/NN ./.
@@63762276176 EGV/NN had/VBP no/DT detectable/JJ effect/NN on/IN PP/NEWGENE secretion/NN under/IN basal/JJ or/CC stimulated/VBN conditions/NNS ./.
@@15524579684 Intrapocket/NNP chemotherapy/NN in/IN adult/JJ periodontitis/NN using/VBG a/DT new/JJ controlled-release/NN insert/NN containing/NN ofloxacin/NN (/( PT-01/NN )/SYM ./.
@@106946051738 Linearized/JJ overall/JJ infection/NN rates/NNS (/( events/NN //NN 100/NN patient-days/NNS )/SYM were/VBD 2/CD ./CD 05/CD +/NN //NN -/NN 0/CD ./CD 33/CD (/( heart-lung/NN )/SYM and/CC 2/CD ./CD 34/CD +/NN //NN -/NN 0/CD ./CD 34/CD (/( double-lung/JJ ;/: P/NN =/SYM NS/NNP )/SYM at/IN 3/CD months/NNS ./.
@@116055988805 Hepatitis/NN B/NN and/CC C/NN seroprevalence/NN rates/NNS among/IN high-risk/JJ adolescents/NNS are/VBP lower/JJR in/IN El/NNP Paso/NNP than/IN in/IN other/DT similar/JJ US/NN populations/NNS ,/, presenting/VBG an/DT ideal/JJ climate/NN for/IN prevention/NN programs/NNS ./.
@@105422814784 The/DT results/NNS suggest/VBP that/IN the/DT presence/NN or/CC absence/NN per/IN se/FW of/IN keratan/NN sulfate/NN on/IN native/JJ G1-G2/NN does/VBP not/RB affect/VB the/DT activity/NN of/IN atrolysin/NN C/NN toward/IN the/DT two/JJ sites/NNS ./.
@@73868647226 Charcoal-facilitated/JJ dialysis/NN ./.
@@14525849269 Pseudomonas/NEWGENE aeruginosa/NEWGENE exotoxin/NEWGENE A/NEWGENE :/: its/PRP role/NN in/IN retardation/NN of/IN wound/JJ healing/NN :/: the/DT 1992/CD Lindberg/NNP Award/NNP ./.
@@35313174205 This/DT means/NN that/IN the/DT loss/NN of/IN recessives/NNS must/MD be/VB calculated/VBN by/IN using/VBG a/DT hypergeometric/JJ and/CC not/RB a/DT binomial/JJ model/NN as/IN Fisher/NN did/VBD ./.
@@105615462412 We/PRP have/VBP cloned/VBN a/DT novel/JJ 100-kDa/JJ mammalian/JJ protein/NN ,/, which/WDT was/VBD recognized/VBN by/IN an/DT anti-peptide/NN antibody/NN against/IN an/DT epitope-containing/JJ nuclear/JJ localization/NN signal/NN of/IN NF-kappaB/NEWGENE p65/NEWGENE1 subunit/NEWGENE1 ./.
@@7813466445 The/DT U14/NEWGENE genes/NEWGENE of/RB mouse/NN as/RB well/VB as/IN rat/NN ,/, hamster/NN ,/, human/JJ ,/, Xenopus/NN and/CC trout/NN are/VBP encoded/VBN within/IN introns/NNS of/IN the/DT constitutively/RB expressed/VBN 70-kDa-cognate-heat-shock/NEWGENE protein/NEWGENE gene/NEWGENE (/( hsc70/NEWGENE )/SYM ./.
@@22422222884 Presidential/JJ address/NN 1990--coming/NN in/IN from/IN the/DT cold/NN ./.
@@92094063304 However/RB ,/, we/PRP could/MD not/RB find/VB the/DT homologous/JJ regions/NNS with/IN guanine/NEWGENE nucleotide/NEWGENE exchange/NEWGENE factors/NEWGENE or/CC GTPase-activating/NEWGENE proteins/NEWGENE in/IN the/DT c-cbl/NEWGENE gene/NEWGENE ./.
@@10224758164 The/DT control/NN group/NN included/VBN 8/CD afterbirth/NN samples/NNS from/IN physiological/JJ full-term/JJ pregnancies/NNS ./.
@@77937832408 Scalp/NN flaps/NN can/MD be/VB expanded/JJ just/RB to/IN the/DT point/NN of/IN becoming/VBG noticeable/JJ over/RB 4/CD to/IN 6/CD weeks/NNS followed/VBN by/IN scalp/NN flap/NN transposition/NN and/CC easy/JJ closure/NN of/IN the/DT donor/NN site/NN ./.
@@25470793196 The/DT negative/JJ calcium/NN balance/NN with/IN hyperparathyroidemia/NN occurred/VBN after/IN continuous/JJ oral/JJ administration/NN of/IN Cd/NN and/CC developed/VBN via/NN increased/VBD urinary/JJ excretion/NN of/IN calcium/NN ./.
@@80772368042 Wild/NEWGENE type/NEWGENE and/NEWGENE mutant/NEWGENE Epo/NEWGENE cDNAs/NEWGENE were/VBD transiently/RB expressed/VBN at/IN high/JJ levels/NNS in/IN COS1/NN and/CC COS7/NN cells/NNS ./.
@@100261465467 The/DT inhibition/NN by/IN the/DT RIalpha/NEWGENE subunit/NEWGENE is/VBZ reversed/VBN by/IN addition/NN of/IN nanomolar/JJ concentrations/NNS of/IN cAMP/NN (/( Ka/NN =/SYM 40/CD nM/NN )/SYM ,/, thus/RB demonstrating/VBG that/IN PrKX/NEWGENE is/VBZ a/DT novel/NN ,/, type/NEWGENE I/NEWGENE cAMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE that/WDT is/VBZ activated/VBN at/IN lower/JJR cAMP/NN concentrations/NNS than/IN the/DT holoenzyme/NN with/IN the/DT Calpha/NEWGENE subunit/NEWGENE of/IN cAMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE ./.
@@88905376384 This/DT technique/NN was/VBD employed/VBN in/IN 12/CD patients/NNS with/IN a/DT unicameral/JJ bone/NN cyst/NN ./.
@@106395851086 Studies/NNS of/IN MPO/NEWGENE gene/NEWGENE regulation/NN can/MD help/VB to/IN elucidate/VB the/DT mechanism/NN of/IN normal/JJ and/CC abnormal/JJ myeloid/JJ differentiation/NN ./.
@@67946662248 The/DT sympathetic/JJ neuroeffector/NN influence/NN on/IN the/DT myocardium/NN with/IN ATCI/NN depends/VBZ to/IN a/DT large/JJ measure/NN on/IN the/DT intensity/NN of/IN the/DT neurotransmitter/NN biosynthesis/NN and/CC function/NN of/IN cardiomyocyte/NN adrenoreceptors/NEWGENE ./.
@@76103247515 Oncological/JJ ,/, clinical/JJ and/CC psychological/JJ aspects/NNS are/VBP evaluated/VBN according/VBG to/IN experience/NN accumulated/VBN in/IN recent/JJ years/NNS ,/, with/IN immediate/JJ and/CC delayed/JJ reconstruction/NN ,/, carried/VBD out/RB in/IN the/DT most/RB diverse/JJ specialized/JJ centers/NNS ./.
@@110297009022 Moreover/RB ,/, an/DT in/NN vitro/FW pull-down/JJ assay/NN showed/VBN that/IN Os/NEWGENE ;/NEWGENE CycH/NEWGENE ;/NEWGENE 1/NEWGENE specifically/RB bound/JJ to/IN R2/NEWGENE but/CC not/RB to/IN other/DT rice/NEWGENE CDKs/NEWGENE ./.
@@103312769709 All/DT of/IN the/DT elements/NNS exhibited/VBD a/DT uniform/JJ structure/NN ./.
@@26474038738 Vivid/NN visual/NN hallucinations/NNS without/IN other/DT psychopathology/NN have/NN been/VBN reported/VBN for/IN several/DT hundred/JJ years/NNS ./.
@@91974085839 Sequencing/NN of/IN the/DT facB/NEWGENE gene/NEWGENE revealed/VBN that/IN it/PRP encodes/VBZ a/DT protein/NN that/WDT contains/VBZ an/DT N-terminal/NEWGENE GAL4-like/NEWGENE Zn/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE 2Cys6/NEWGENE (/NEWGENE or/NEWGENE C6/NEWGENE zinc/NEWGENE )/NEWGENE binuclear/NEWGENE cluster/NEWGENE for/IN DNA/NN binding/JJ ,/, leucine/NN zipper-like/NN heptad/NN repeat/NN motifs/NNS and/CC central/NN and/CC C-terminal/NN acidic/NN alpha-helical/NN regions/NN ,/, consistent/JJ with/IN a/DT function/NN as/IN a/DT DNA-binding/NN transcriptional/NN activator/NN ./.
@@81259491126 The/DT previously/RB described/VBN enhanced/VBN translation/NN of/IN spinach/NN L12/NEWGENE mRNA/NEWGENE from/IN its/PRP two/JJ tandem/NN AUG/NNS codons/NNS and/CC the/DT two/JJ functional/JJ rpl12/NEWGENE genes/NEWGENE in/IN Arabidopsis/NN probably/RB provide/VB two/JJ mechanisms/NNS for/IN generating/JJ the/DT four/CD copies/NNS of/IN L12/NEWGENE //NEWGENE chloroplast/NEWGENE ribosome/NEWGENE ,/, qualitatively/RB different/JJ from/IN those/DT attempted/VBN in/IN eubacteria/NNS ./.
@@113567166322 An/DT 18-kb/JJ genomic/JJ clone/NN including/JJ sequences/NNS encoding/VBG for/IN the/DT two/JJ GHS-R/NEWGENE variants/NEWGENE was/VBD isolated/VBN ./.
@@16344646115 We/PRP report/VBP a/DT patient/JJ developing/JJ factor/NEWGENE VII/NEWGENE inhibitor/NEWGENE possibly/RB as/IN a/DT reaction/NN to/IN penicillin/NN administration/NN ;/: it/PRP gave/VBD rise/NN to/IN fatal/JJ haemorrhage/NN ./.
@@93717312084 Both/DT inserts/NNS are/VBP larger/JJR than/IN their/PRP homologues/NNS in/IN eIF-2alpha/NEWGENE kinases/NEWGENE ./.
@@16953224239 Wnt-1/NEWGENE (/( int-1/NEWGENE )/SYM is/VBZ a/DT cellular/JJ oncogene/NN often/RB activated/VBN by/IN insertion/NN of/IN proviral/JJ DNA/NN of/IN the/DT mouse/NN mammary/JJ tumor/NN virus/NN ./.
@@65715876337 Effects/NNPS of/IN ketamine/NN on/IN the/DT circulatory/JJ functions/NNS and/CC body/NN tissue/NN oxygenation/NN in/IN dogs/NNS under/IN normal/JJ and/CC hypovolemic/JJ conditions/NNS ./.
@@99271932732 To/TO date/VB ,/, two/JJ such/JJ proteins/NNS ,/, PLZF/NEWGENE and/CC LAZ-3/NEWGENE //NEWGENE BCL-6/NEWGENE ,/, have/VB been/VBN implicated/VBN in/IN oncogenesis/NN ./.
@@86216643515 Polymerization/NN of/IN neurofilament/NEWGENE L/NEWGENE protein/NEWGENE in/IN vitro/FW was/VBD inhibited/VBN by/IN phosphorylation/NN of/IN neurofilament/NEWGENE L/NEWGENE protein/NEWGENE by/IN PKN/NEWGENE ./.
@@77670117518 Repair/NNS of/IN this/DT insertion/NN by/IN homologous/JJ recombination/NN restores/VBZ the/DT activity/NN of/IN the/DT hprt/NEWGENE locus/NEWGENE ,/, thus/RB confirming/VBG the/DT site/NN of/IN mutation/NN ./.
@@84216877661 Ten/CD selenocysteine/NN residues/NNS (/( deduced/VBN )/SYM are/VBP present/VB ./.
@@95364407255 Recent/JJ studies/NNS have/VBP revealed/VBN unconventional/JJ myosin/NEWGENE V/NEWGENE to/IN be/VB an/DT important/JJ actin-based/JJ molecular/JJ motor/RB involved/VBN in/IN vesicular/JJ movement/NN ./.
@@75255968648 When/WRB expressed/VBN in/IN and/CC purified/VBN from/IN Escherichia/NN coli/JJ ,/, both/DT full-length/NEWGENE Fpr3/NEWGENE and/CC its/PRP isolated/VBN COOH-terminal/NN domain/NN exhibit/NN readily/RB detectable/JJ PPIase/NEWGENE activity/NN ./.
@@6234369123 Hepatitis-B/NN vaccination/NN in/IN the/DT elderly/NN ./.
@@11946731847 No/DT evidence/NN of/IN either/DT positive/JJ or/CC negative/JJ chemography/NN was/VBD found/VBN ./.
@@74579317346 A/DT third/JJ series/NN of/IN mice/NNS were/VBD given/VBP a/DT single/JJ injection/NN of/IN 5-OH-DA/JJ ,/, sacrificed/VBN ,/, and/CC prepared/VBD for/IN ultrastructural/JJ study/NN ./.
@@20680854404 We/PRP also/RB present/VBP evidence/NN for/IN a/DT negative/JJ regulatory/JJ element/NN in/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT Mlu/NEWGENE I/NEWGENE upstream/NEWGENE activation/NEWGENE sequence/NEWGENE ./.
@@89033397737 This/DT is/VBZ the/DT first/JJ determination/NN of/IN the/DT complete/JJ secondary/JJ structure/NN of/IN an/DT RNA/NN spliced/VBN in/IN a/DT spliceosome/NN ./.
@@22955212952 No/DT causal/JJ relations/NNS may/MD be/VB inferred/VBN from/IN the/DT correlation/NN between/IN the/DT level/NN of/IN trapezius/NN activity/NN and/CC complaints/NNS ,/, though/CC it/PRP indicates/VBZ that/IN individual/JJ ,/, inexpedient/JJ muscle/NN activity/NN patterns/NNS may/MD constitute/VB an/DT important/JJ risk/NN factor/NN for/IN development/NN of/IN musculo-skeletal/JJ complaints/NNS ./.
@@89805338760 Finally/RB ,/, the/DT C-terminal/NN region/NN of/IN ENBP1/NEWGENE shows/VBZ strong/JJ homology/NN to/IN a/DT protein/NN from/IN rat/NN that/WDT is/VBZ specifically/RB expressed/VBN in/IN testis/NN tissue/NN ./.
@@117371584400 Modality-specific/NNP areas/NNS (/( e/FW ./FW g/FW ./FW ,/, right/JJ Wernicke/NN ,/, left/NN fusiform/JJ gyrus/NN ,/, Broca/NN BA44/NN ,/, supramarginal/JJ gyrus/NN )/SYM ,/, appear/VB to/IN cope/NN with/IN the/DT computations/NNS relevant/JJ to/IN making/VBG contact/NN with/IN these/DT more/RB abstract/JJ dimensions/NNS ./.
@@7491791421 The/DT promoter/NN mutation/NN is/VBZ complemented/VBN in/IN trans/JJ by/IN E1A/NEWGENE products/NN of/IN the/DT heterologous/JJ helper/NN adenovirus/NN type/NN 5/CD (/( Ad5/DT )/SYM ./.
@@105644798161 Deletion/NNS of/IN fdsR/NEWGENE revealed/VBD a/DT dual/JJ regulatory/JJ effect/NN of/IN FdsR/NEWGENE on/IN the/DT fds/NEWGENE operon/NEWGENE by/RB acting/JJ as/IN transcriptional/JJ activator/NN in/IN the/DT presence/NN of/IN formate/NN or/CC as/IN repressor/NN in/IN the/DT absence/NN of/IN formate/NN ./.
@@86977288677 The/DT predictive/JJ value/NN of/IN a/DT positive/JJ flag/NN was/VBD 77/CD ./CD 7%/CD ./.
@@22831482933 Significance/NN of/IN cytokine/NN production/NN and/CC adhesion/NN molecules/NNS in/IN malarial/JJ immunopathology/NN ./.
@@92774729235 Myocardial/JJ interstitial/JJ edema/NN is/VBZ more/RB likely/RB a/DT potential/JJ mechanism/NN of/IN diastolic/JJ dysfunction/NN after/IN DC/JJ shocks/NNS ./.
@@105487221683 All/DT loci/NNS have/NN a/DT similar/JJ organization/NN ,/, except/VB for/IN H1/NEWGENE ./NEWGENE 8/NEWGENE that/WDT harbors/VBP two/JJ TcP2beta/NEWGENE genes/NEWGENE arranged/VBN in/IN tandem/NN and/CC separated/VBN by/IN a/DT short/JJ repetitive/JJ sequence/NN ,/, named/VBN SIRE/NEWGENE (/( short/NEWGENE interspersed/NEWGENE repetitive/NEWGENE element/NEWGENE )/SYM ,/, which/WDT is/VBZ also/RB found/VB upstream/RB of/IN the/DT first/JJ gene/NN of/IN the/DT tandem/NN and/CC downstream/RB of/IN the/DT second/NN ./.
@@25902783234 5/CD ./CD
@@106138166687 Statins/NEWGENE :/: lower/JJR lipids/NNS and/CC better/JJR bones/NNS ?/. Although/IN statins/NNS are/VBP widely/RB used/VBN as/IN cholesterol-lowering/JJ drugs/NNS ,/, a/DT recent/JJ study/NN suggests/VBZ that/IN these/DT compounds/NNS have/NN anabolic/JJ effects/NNS on/IN bone/NN and/CC could/MD be/VB developed/VBN into/IN new/JJ treatments/NNS for/IN common/JJ metabolic/JJ bone/NN diseases/NNS such/JJ as/IN osteoporosis/NN
@@103645237547 Campomelic/NNP dysplasia/NN translocation/NN breakpoints/NNS are/VBP scattered/JJ over/RB 1/CD Mb/NN proximal/JJ to/IN SOX9/NEWGENE :/: evidence/NN for/IN an/DT extended/VBN control/NN region/NN ./.
@@113245164228 It/PRP was/VBD found/VBN that/IN intrathecal/JJ administration/NN (/( i/CD ./CD t/CD ./CD )/SYM of/IN D2/NEWGENE receptor/NEWGENE agonist/NN LY171555/NN or/CC D1/NEWGENE //NEWGENE D2/NEWGENE receptor/NEWGENE agonist/NN apomorphine/NN increased/VBD pain/NN threshold/NN and/CC had/VBP a/DT potentiating/JJ effect/NN on/IN AA/NNS ./NNS
@@76185487530 The/DT Babcock/NNP Surgical/NNP Clinic/NNP ./.
@@74013181426 However/RB ,/, at/IN lower/JJR temperature/NN the/DT positive/JJ staircase/NN was/VBD not/RB clear/JJ and/CC rather/RB negative/JJ staircase/NN appeared/VBN (/( 1--3/NN Hz/NN )/SYM ./.
@@79272677900 Internal/NNP biliary/JJ drainage/NN ,/, unlike/IN external/NN drainage/NN ,/, does/VBP not/RB suppress/VB the/DT regeneration/NN of/IN cholestatic/JJ rat/NN liver/NN after/IN partial/JJ hepatectomy/NN ./.
@@106372309541 Induced/JJ expression/NN of/IN c-myc/NEWGENE is/VBZ likely/RB to/IN contribute/VB to/IN the/DT proliferation/NN of/IN Stat1-null/NNP cells/NNS in/IN response/NN to/IN IFNs/NEWGENE ./.
@@98920174541 Further/JJ experiments/NNS will/MD be/VB required/VBN to/IN highlight/NN the/DT in/NN vivo/NN role/NN of/IN ELE1/NEWGENE in/IN nuclear/JJ receptor/NN functioning/NN ./.
@@32191076268 The/DT incidence/NN of/IN early/JJ neonatal/JJ convulsions/NNS for/IN inborn/JJ babies/NNS was/VBD 3/NN ./NN 0/NN //NN 1000/NN live/VB births/NNS ./.
@@77318989654 In/NN vitro/FW studies/NNS with/IN blood/NN cells/NNS incubated/VBN with/IN acetate/NN or/CC bicarbonate/NN ions/NNS in/IN concentrations/NNS ,/, which/WDT are/VBP observed/VBN in/IN vivo/NN during/IN hemodialysis/NN ,/, suggest/VB that/IN probably/RB these/DT ions/NNS do/NN not/RB directly/RB affect/VB superoxide/NN anions/NNS generation/NN ,/, erythrocyte/NN SOD-1/NEWGENE and/CC catalase/NEWGENE activities/NNS and/CC erythrocyte/NN membrane/NN lipid/NN peroxidation/NN ./.
@@113096779719 A/DT comprehensive/JJ neuropsychological/JJ battery/NN was/VBD administered/VBN to/IN 48/CD veterans/NNS with/IN Gulf/NNP War/NNP Illness/NNS (/( GWI/NNP )/SYM characterized/VBN by/IN severe/JJ fatigue/NN (/( GV-F/NN )/SYM and/CC 39/CD healthy/JJ veterans/NNS (/( GV-H/NNP )/SYM ./.
@@24000703062 Comparison/NNS of/IN propofol/NN and/CC thiopentone/NN as/IN anaesthetic/JJ agents/NNS for/IN electroconvulsive/JJ therapy/NN ./.
@@31502963857 It/PRP is/VBZ suggested/VBN that/IN the/DT use/NN of/IN endogenous/JJ creatinine/NN clearance/NN to/IN estimate/NN the/DT glomerular/JJ filtration/NN rate/NN (/( GFR/NN )/SYM requires/VBZ caution/NN and/CC the/DT recognition/NN of/IN the/DT limitations/NNS of/IN the/DT method/NN ,/, and/CC that/IN simpler/JJR techniques/NNS (/( serum/JJ creatinine/NN or/CC estimated/VBN endogenous/JJ creatinine/NN clearance/NN )/SYM are/VBP preferable/JJ in/IN routine/JJ practice/NN ./.
@@9243587736 PURPOSE/NNS //NNS OBJECTIVES/NNS :/: To/TO examine/VB the/DT question/NN of/IN whether/IN an/DT early/JJ first/JJ full-term/JJ pregnancy/NN (/( FFTP/NN )/SYM protects/VBZ against/IN breast/NN cancer/NN and/CC whether/IN interruption/NN of/IN the/DT pregnancy/NN with/IN an/DT induced/VBN abortion/NN increases/NNS breast/NN cancer/NN risk/NN ./.
@@115115445341 The/DT loop/NN domain/NN of/IN heat/NEWGENE shock/NEWGENE transcription/NEWGENE factor/NEWGENE 1/NEWGENE dictates/VBP DNA-binding/VBG specificity/NN and/CC responses/NNS to/IN heat/NN stress/NN ./.
@@75593565382 The/DT hypBFCDE/NEWGENE operon/NEWGENE from/IN Rhizobium/NN leguminosarum/NN biovar/NN viciae/NNS is/VBZ expressed/VBN from/IN an/DT Fnr-type/NEWGENE promoter/NEWGENE that/IN escapes/NNS mutagenesis/NN of/IN the/DT fnrN/NEWGENE gene/NEWGENE ./.
@@110272941247 This/DT interaction/NN inhibits/VBZ the/DT histone/NEWGENE acetyltransferase/NEWGENE activity/NN of/IN p300/NEWGENE ,/, resulting/VBG in/IN drastic/JJ reduction/NN of/IN nucleosomal/JJ histone/NEWGENE acetylation/NN and/CC alteration/NN of/IN chromatin/NN structure/NN ./.
@@91110595850 Unlike/IN the/DT MAR-binding/JJ domain/NN ,/, the/DT homeodomain/JJ when/CC isolated/VBN binds/VBZ poorly/RB and/CC with/IN low/JJ specificity/NN to/IN DNA/NN ./.
@@113845761235 In/NN addition/NN ,/, severe/JJ vision/NN loss/NN can/MD be/VB seen/VBP with/IN interferon/NEWGENE alfa-2b-associated/JJ retinopathy/NN ./.
@@92638569450 Here/RB ,/, we/PRP report/VBP theoretical/JJ models/NNS for/IN the/DT Gla/NEWGENE and/CC EGF-1/NEWGENE modules/NEWGENE of/IN human/NEWGENE PS/NEWGENE constructed/VBN using/VBG prothrombin/NEWGENE and/CC factor/NEWGENE X/NEWGENE experimental/JJ structures/NNS ./.
@@19250922548 Previous/JJ investigators/NNS have/VBP suggested/VBN that/IN subretinal/JJ blood/NN damages/VBZ the/DT retina/NN in/IN part/NN because/IN of/IN its/PRP solid/JJ fibrin/NEWGENE meshwork/NN ./.
@@110500846375 High/NNP expression/NN of/IN the/DT peroxisome/NEWGENE proliferator-activated/NEWGENE receptor/NEWGENE alpha/NEWGENE (/( PPARalpha/NEWGENE )/SYM differentiates/VBZ brown/JJ fat/NN from/IN white/JJ ,/, and/CC is/VBZ related/VBN to/IN its/PRP high/JJ capacity/NN of/IN lipid/NN oxidation/NN ./.
@@98521093914 In/NN vitro/FW translation/NN and/CC in/IN vivo/NN polysome/NN profile/NN analysis/NN indicated/VBN that/IN transcripts/NEWGENE C/NEWGENE and/NEWGENE E/NEWGENE were/VBD translated/VBN with/IN similar/JJ translational/JJ efficiencies/NNS that/WDT are/VBP substantially/RB greater/JJR than/IN that/DT of/IN transcript/NEWGENE D/NEWGENE ,/, suggesting/VBG that/IN 5'-untranslated/JJ regions/NNS play/VBP a/DT role/NN in/IN translational/JJ control/NN ./.
@@76780066826 RNase/NEWGENE protection/NN analyses/NNS indicate/VBP that/IN either/DT 61-kDa/NEWGENE CaM/NEWGENE PDE/NEWGENE mRNA/NEWGENE or/CC structurally/RB related/VBN transcripts/NNS encoding/VBG different/JJ CaM/NEWGENE PDE/NEWGENE isoforms/NEWGENE are/VBP expressed/VBN in/IN a/DT tissue-specific/JJ manner/NN ./.
@@23484083001 Attitudes/NNS were/VBD found/VBN to/IN be/VB multidimensional/JJ ,/, with/IN similar/JJ dimensions/NNS being/VBP identified/VBN in/IN both/DT samples/NNS ./.
@@31599035099 The/DT 5'/CD end/NN of/IN the/DT coding/JJ region/NN was/VBD located/VBN precisely/RB by/IN comparing/VBG the/DT deduced/VBN amino/JJ acid/NN sequence/NN to/IN the/DT actual/JJ N-terminal/NN amino/JJ acid/NN sequence/NN of/IN IHF/NEWGENE ./.
@@99336413945 The/DT missing/JJ 5'/CD sequences/NNS were/VBD obtained/VBN by/IN 5'-rapid/JJ amplification/NN of/IN cDNA/NN ends/NNS and/CC by/IN analysis/NN of/IN an/DT NHE5/NEWGENE genomic/NEWGENE clone/NEWGENE ,/, and/CC the/DT missing/JJ 3'/CD sequences/NNS were/VBD obtained/VBN by/IN 3'-rapid/JJ amplification/NN of/IN cDNA/NN ends/NNS ./.
@@98641415424 We/PRP showed/VBD that/IN Stat3/NEWGENE and/CC Stat3beta/NEWGENE were/VBD affinity/NN purified/VBN using/VBG phosphopeptides/NN containing/NN Y704/NN and/CC Y744/NN but/CC not/RB by/IN nonphosphorylated/JJ peptide/NN analogues/NNS or/CC by/IN phosphopeptides/NN containing/NN Y729/NN and/CC Y764/NN ./.
@@27610083458 Brain/NEWGENE cholinesterase/NEWGENE activity/NN of/IN nestling/JJ great/JJ egrets/NNS ,/, snowy/JJ egrets/NNS and/CC black-crowned/JJ night-herons/NNS ./. inhibition/NN of/IN brain/NEWGENE cholinesterase/NEWGENE (/( ChE/NEWGENE )/SYM activity/NN in/IN birds/NNS is/VBZ often/RB used/VBN to/IN diagnose/VB exposure/NN or/CC death/NN from/IN organophosphorus/NN or/CC carbamate/NN pesticides/NNS ./.
@@29877773709 Three/CD cases/NNS of/IN primary/JJ signet-ring/NN cell/NN carcinoma/NN of/IN the/DT rectum/NN are/VBP described/VBN ./.
@@84290197405 Furthermore/RB ,/, competitor/NN containing/JJ the/DT YY1/NEWGENE consensus/NEWGENE sequence/NEWGENE competed/VBN for/IN protein/NEWGENE B/NEWGENE binding/JJ ,/, whereas/IN competitor/NN containing/JJ a/DT perfect/JJ yeast/NEWGENE ABF-1/NEWGENE consensus/NEWGENE sequence/NEWGENE did/VBD not/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@109185722469 VaI/NEWGENE and/CC VaII/NEWGENE co-immunoprecipitated/JJ with/IN ErbB2/NEWGENE ,/, but/CC not/RB with/IN ErbB1/NEWGENE ,/, ErbB3/NEWGENE ,/, or/CC ErbB4/NEWGENE ./.
@@20089822619 ELISA/NN was/VBD found/VBN to/IN make/NN a/DT contribution/NN to/IN the/DT diagnosis/NN of/IN tuberculosis/NN similar/JJ to/IN that/DT of/IN sputum/NN smear/NN ./.
@@24235338644 The/DT levels/NNS of/IN both/DT MAP1-specific/NEWGENE and/NEWGENE MAP2-specific/NEWGENE mRNAs/NEWGENE decline/NN in/IN the/DT postnatal/JJ developing/JJ brain/NN ;/: the/DT level/NN of/IN MAP1-specific/NEWGENE mRNA/NEWGENE also/RB increases/VBZ slightly/RB in/IN rat/NN PC12/NNP cells/NNS upon/IN exposure/NN to/IN nerve/NEWGENE growth/NEWGENE factor/NEWGENE ./.
@@38302554509 This/DT is/VBZ based/VBN on/IN partitioning/VBG an/DT underlying/JJ multivariate/JJ normal/JJ distribution/NN ./.
@@17482872138 Human/NN SRF-related/NEWGENE proteins/NEWGENE :/: DNA-binding/NN properties/NNS and/CC potential/JJ regulatory/JJ targets/NNS ./.
@@23241021179 Comparison/NNS of/IN transmembrane/JJ and/CC cytoplasmic/JJ domains/NNS to/IN a/DT third/JJ cell-surface/NN proteoglycan/NN ,/, 48K5/NEWGENE from/IN human/JJ lung/NN fibroblasts/NNS (/( Marynen/NNP ,/, P/NNP ./NNP ,/, Zhang/NNP ,/, J/NNP ./NNP ,/, Cassiman/NNP ,/, J/NNP ./NNP ,/, Vanden/NNP Berghe/NNP ,/, H/NNP ./NNP ,/, and/CC David/NN ,/, C/NNP ./NNP
@@18500962761 Heterodimers/NNS of/IN myogenin/NEWGENE and/CC E12/NEWGENE (/( or/CC MyoD/NEWGENE and/CC E12/NEWGENE )/SYM specifically/RB bound/VBD a/DT restriction/NN fragment/NN extending/VBG from/IN -200/CD to/IN -103/NN relative/JJ to/IN the/DT start/NN of/IN cardiac/NEWGENE alpha-actin/NEWGENE transcription/NN ./.
@@21748611906 Regulation/NN of/IN irgA/NEWGENE by/IN iron/NN in/IN V/NNP ./NNP cholerae/NNS occurs/VBZ at/IN the/DT transcriptional/JJ level/NN ,/, and/CC there/RB is/VBZ an/DT interrupted/VBN dyad/NN symmetric/JJ sequence/NN in/IN the/DT vicinity/NN of/IN the/DT promoter/NN that/WDT is/VBZ homologous/JJ to/IN Fur/NEWGENE binding/NEWGENE sites/NEWGENE of/IN E/NNP ./NNP coli/JJ ./.
@@24760303132 To/TO study/VB the/DT retinal/JJ surface/NN in/IN the/DT human/JJ eye/NN in/IN normal/JJ and/CC diseased/JJ states/NNS we/PRP used/VBD laser/VBP scanning/JJ tomography/NN ./.
@@113256851174 Intravenous/JJ L-carnitine/NNS treatment/NN increased/VBD plasma/NN carnitine/NN concentrations/NNS ,/, improved/VBN patient-assessed/JJ fatigue/NN ,/, and/CC may/MD prevent/VB the/DT decline/NN in/IN peak/NN exercise/NN capacity/NN in/IN hemodialysis/NN patients/NNS ./.
@@98050529773 Dose/NNS of/IN 20/CD ig/NN were/VBD administered/VBN within/IN a/DT scheme/NN from/IN 0/CD ./CD 1/CD to/IN 6/CD months/NNS in/IN order/NN to/IN study/NN its/PRP immunogenicity/NN ,/, which/WDT was/VBD evaluated/VBN at/IN 2/CD ,/, 7/CD ,/, and/CC 12/CD months/NNS after/IN the/DT first/JJ dose/NN ./.
@@7666538269 Initiation/NN of/IN translation/NN of/IN the/DT human/NN hepatitis/NN C/NN virus/NN (/( HCV/NN )/SYM RNA/NN genome/NN occurs/VBZ by/IN internal/JJ ribosome/NN entry/NN into/IN the/DT 5'/CD noncoding/JJ region/NN (/( 5'NCR/CD )/SYM in/IN a/DT cap-independent/JJ manner/NN ./.
@@17590522352 Appl/NNP ./.
@@1376711987 These/DT observations/NNS have/NN led/VBD us/PRP to/IN conclude/VB that/IN an/DT elevated/VBN VIII-ratio/NN is/VBZ a/DT very/RB sensitive/NN indicator/NN of/IN intravascular/JJ coagulation/NN ./.
@@9576230277 The/DT effect/NN of/IN nitric/NEWGENE oxide/NEWGENE synthase/NEWGENE inhibitor/NN on/IN reperfusion/NN injury/NN of/IN the/DT brain/NN under/IN hypothermic/JJ circulatory/JJ arrest/NN ./.
@@81341085112 The/DT c-myc/NEWGENE and/CC skeletal/NEWGENE alpha-actin/NEWGENE gene/NEWGENE promoters/NEWGENE contain/VBP YY1/NEWGENE binding/NEWGENE sites/NEWGENE thought/VBP to/IN act/NN either/DT as/IN positive/JJ or/CC negative/JJ cis-acting/JJ elements/NNS ./.
@@1930882550 Sixteen/CD other/DT normal/JJ subjects/NNS with/IN 2/CD g/NN of/IN Metyrapone/NN are/VBP best/JJS responses/NNS ./.
@@90275066100 cDNA/NN cloning/NN ,/, expression/NN analysis/NN ,/, and/CC chromosomal/JJ localization/NN of/IN a/DT gene/NN with/IN high/JJ homology/NN to/IN wheat/NEWGENE eIF-/NEWGENE (/NEWGENE iso/NEWGENE )/NEWGENE 4F/NEWGENE and/CC mammalian/NEWGENE eIF-4G/NEWGENE ./.
@@84100428373 Creutzfeldt-Jakob/NNP disease/NN and/CC lyophilised/JJ dura/NN mater/JJ grafts/NNS :/: report/VB of/IN two/JJ cases/NNS ./.
@@35531492510 We/PRP used/VBD oligonucleotide-directed/JJ mutagenesis/NN to/IN alter/VB a/DT site/NN in/IN MucA/NEWGENE homologous/JJ to/IN the/DT Ala-Gly/JJ cleavage/NN site/NN of/IN LexA/NEWGENE ./.
@@76403099514 The/DT C-terminal/NN peptide/NN sequences/NN of/IN the/DT human/NEWGENE lymphocyte-specific/NEWGENE high/NEWGENE mobility/NEWGENE group/NEWGENE (/NEWGENE HMG/NEWGENE )/NEWGENE -box/NEWGENE transcription/NEWGENE factor/NEWGENE TCF-1/NEWGENE are/VBP determined/VBN by/IN alternative/JJ splice/NN mechanisms/NNS affecting/VBG the/DT exons/NNS VIII/NNP to/IN X/NNP ./NNP
@@81785721624 Five/CD concensus/NN poly/NN A/DT addition/NN sites/NNS are/VBP located/VBN in/IN the/DT 350/CD base/NN pairs/NNS immediately/RB following/IN the/DT protein/NEWGENE IX/NEWGENE coding/JJ region/NN ./.
@@24237733091 Colorimetric/NNP method/NN of/IN determining/NN glycerin/NN in/IN the/DT blood/NN ./.
@@76731544511 The/DT tyrosine-phosphorylated/JJ state/NN of/IN CAK/NEWGENE beta/NEWGENE was/VBD not/RB reduced/VBN on/IN trypsinization/NN ,/, nor/CC enhanced/VBD in/IN response/NN to/IN plating/NN 3Y1/CD cells/NNS onto/IN fibronectin/NEWGENE ./.
@@91856451001 Comparison/NNS of/IN Tc-99m/NN sestamibi/NN perfusion/NN imaging/JJ and/CC echocardiography/NN using/VBG an/DT arbutamine/NN infusion/NN for/IN the/DT detection/NN of/IN coronary/JJ artery/NN disease/NN ./.
@@14594473666 These/DT sequences/NNS were/VBD then/RB used/VBN to/IN clone/NN the/DT full-length/JJ genes/NNS from/IN a/DT yeast/NN genomic/JJ library/NN ./.
@@30975096884 This/DT gave/VBD rise/NN to/IN RNA/NN molecules/NNS with/IN 3'-untranslated/JJ regions/NNS of/IN roughly/RB 375/CD ,/, 655/CD ,/, and/CC 945/CD base/NN pairs/NNS ./.
@@29794263693 Organ/NN transplantation/NN in/IN Denmark/NN ./.
@@113186085138 Transfection/NNS of/IN EGFP-tagged/NEWGENE DENTT/NEWGENE NLS/NEWGENE deletion/NEWGENE constructs/NEWGENE lacking/JJ the/DT bipartite/JJ NLS-1/NEWGENE were/VBD excluded/VBN from/IN the/DT nucleolus/NN ./.
@@25906153236 We/PRP conclude/VBP that/IN at/IN steady/JJ state/NN the/DT timing/NN of/IN a/DT light/NN meal/NN is/VBZ unlikely/JJ to/IN alter/VB in/IN any/DT clinically/RB important/JJ manner/NN the/DT pharmacokinetics/NN of/IN nifedipine/NN released/VBN from/IN 'biphasic'/NN tablets/NNS ./.
@@74679757357 Family/NNP planning/NN continues/VBZ to/IN play/NN a/DT minor/JJ role/NN ,/, and/CC only/RB 25/CD ./CD 3/CD per/IN cent/NN of/IN all/DT patients/NNS reviewed/VBN took/VBD to/IN oral/JJ contraceptives/NNS for/IN shorter/JJR or/CC longer/JJR periods/NNS of/IN time/NN ./. -/: The/DT percentages/NNS of/IN primiparae/NNS and/CC secundiparae/NNS in/IN all/DT births/NNS as/RB well/VBP as/IN the/DT high/JJ percentage/NN of/IN multigravidity/NN are/VBP parameters/NNS by/IN which/WDT the/DT approach/NN to/IN reproduction/NN differs/VBZ substantively/RB from/IN behaviour/NN patterns/NNS in/IN Europe/NN ./.
@@76284561351 The/DT double-stranded/JJ RNA/NN binding/JJ domain/NN (/( dsRBD/NN )/SYM is/VBZ an/DT approximately/RB 65/CD amino/JJ acid/NN motif/NN that/WDT is/VBZ found/VBN in/IN a/DT variety/NN of/IN proteins/NNS that/WDT interact/VBP with/IN double-stranded/JJ (/( ds/NNS )/SYM RNA/NN ,/, such/JJ as/IN Escherichia/NN coli/JJ RNase/NEWGENE III/NEWGENE and/CC the/DT dsRNA-dependent/NEWGENE kinase/NEWGENE ,/, PKR/NEWGENE ./.
@@119007701813 Sexually/RB conditioned/JJ incentives/NNS :/: Attenuation/NNS of/IN motivational/JJ impact/NN during/IN dopamine/NEWGENE receptor/NEWGENE antagonism/NN ./.
@@4397164959 Ophthalmosonographic/NNP evaluation/NN of/IN blood/NN flow/NN velocity/NN in/IN arteriocavernous/JJ fistula/NN ./.
@@14205791452 Of/IN the/DT serum/NEWGENE neutralizing/NEWGENE (/NEWGENE SN/NEWGENE )/NEWGENE antibody/NEWGENE negative/JJ calves/NNS 89/CD ./CD 7%/CD (/( 26/CD //CD 29/CD )/SYM and/CC 92/CD ./CD 8%/CD (/( 90/CD //CD 97/CD )/SYM developed/VBN SN/NEWGENE antibody/NEWGENE 1/NN month/NN after/IN intranasal/JJ and/CC intramuscular/JJ vaccination/NN ,/, respectively/RB ./.
@@80574218769 Direct/JJ binding/NN and/CC competition/NN assays/NNS using/VBG 30-mer/NN oligonucleotide/NN probes/NNS representing/VBG the/DT individual/JJ CBF1/NEWGENE binding/NEWGENE sites/NEWGENE indicated/VBN that/IN CBF1/NEWGENE bound/JJ less/PRP efficiently/RB to/IN the/DT CD23/NEWGENE promoter/NEWGENE and/CC the/DT EBV/NEWGENE LMP-1/NEWGENE promoter/NEWGENE sites/NEWGENE than/IN to/IN the/DT Cp/NEWGENE site/NEWGENE ./.
@@27438428360 The/DT present/NN study/NN investigates/VBZ whether/IN prostaglandins/NNS "cytoprotect"/VBG the/DT gastric/JJ mucosa/NN against/IN hemorrhage-induced/JJ stress/NN ulceration/NN by/IN assessing/JJ the/DT influence/NN of/IN 16/NN ,/NN 16-dimethyl/NN prostaglandin/NN E2/NN (/( 16/NN ,/NN 16-dm/NN PGE2/NN )/SYM on/IN gross/JJ and/CC microscopic/JJ lesion/NN formation/NN ,/, intramucosal/JJ tissue/NN pH/NN ,/, H+/NN back-diffusion/NN ,/, and/CC mucosal/JJ blood/NN flow/NN in/IN rat/NN gastric/JJ mucosa/NN exposed/VBN to/IN luminal/JJ acid/NN (/( 100/CD mM/NN HCl/NN )/SYM during/IN hemorrhagic/JJ shock/NN (/( 13/CD ml/NN //NN kg/NN for/IN 20/CD min/NN )/SYM ./.
@@19243159006 In/NN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN ,/, copper/JJ levels/NNS exert/VBP some/DT control/NN over/RB the/DT level/NN of/IN SOD1/NEWGENE expression/NN ./.
@@33984334094 The/DT state/NN of/IN the/DT liver/NN in/IN generalized/JJ forms/NNS of/IN meningococcal/JJ infection/NN ./.
@@111961998110 Human/NEWGENE homologue/NEWGENE of/NEWGENE yeast/NEWGENE Rad23/NEWGENE protein/NEWGENE A/NEWGENE interacts/VBZ with/IN p300/NEWGENE //NEWGENE cyclic/NEWGENE AMP-responsive/NEWGENE element/NEWGENE binding/NEWGENE (/NEWGENE CREB/NEWGENE )/NEWGENE -binding/NEWGENE protein/NEWGENE to/IN down-regulate/DT transcriptional/JJ activity/NN of/IN p53/NEWGENE ./.
@@71109996914 They/PRP consisted/VBP of/IN behavioural/JJ disorders/NNS ,/, tetraparesis/NN ,/, incontinence/NN and/CC oculomotor/JJ paralysis/NN ./.
@@95921687428 Structural/NNP features/NNS of/IN the/DT minimal/JJ DNA/NN binding/JJ domain/NN (/( M98-F219/NEWGENE )/SYM of/IN human/NEWGENE nucleotide/NEWGENE excision/NEWGENE repair/NEWGENE protein/NEWGENE XPA/NEWGENE ./.
@@58192495752 Mining/NNP the/DT diagnostic/JJ iron/NN ore/NN ./.
@@17974671216 RU486/IN and/CC ONO/NN 802/NN in/IN combination/NN have/NN been/VBN shown/VBP to/IN be/VB effective/JJ in/IN early/JJ termination/NN of/IN pregnancy/NN ./.
@@1386210639 We/PRP report/VBP the/DT successful/JJ use/NN of/IN electroconvulsive/JJ therapy/NN for/IN treatment/NN of/IN severe/JJ depression/NN in/IN a/DT young/JJ man/NN with/IN adult/JJ GM2/NN gangliosidosis/NN ./.
@@108910931156 The/DT transmembrane/JJ topology/NN of/IN Na/NN (/NN +/NN )/NN //NN H/NN (/NN +/NN )/NN exchanger/NN NHE3/NEWGENE has/VBZ been/VBN studied/VBN using/VBG in/IN vitro/FW transcription/NN //NN translation/NN of/IN two/JJ types/NNS of/IN fusion/NN vectors/NNS designed/VBN to/IN test/NN membrane/NN insertion/NN properties/NNS of/IN cDNA/NN sequences/NNS encoding/VBG putative/JJ NHE3/NEWGENE membrane/NN spanning/VBG domains/NNS (/( msds/NNS )/SYM ./.
@@11062067641 Stress-activated/NEWGENE protein/NEWGENE kinase/NEWGENE 1/NEWGENE (/( SAPK1/NEWGENE )/SYM ,/, also/RB called/VBN c-Jun/NEWGENE N-terminal/NEWGENE kinase/NEWGENE (/( JNK/NEWGENE )/SYM ,/, becomes/VBZ activated/VBN in/IN vivo/NN in/IN response/NN to/IN pro-inflammatory/JJ cytokines/NNS or/CC cellular/JJ stresses/NNS ./.
@@96238305014 The/DT therapeutic/JJ use/NN of/IN botulinum/NEWGENE toxin/NEWGENE (/( Botox/NEWGENE )/SYM is/VBZ increasing/JJ in/IN popularity/NN ./.
@@111593636435 Methylation/NNS at/IN both/DT cytosine/NN residues/NNS in/IN the/DT E2F/NEWGENE element/NEWGENE (/NEWGENE (/NEWGENE m/NEWGENE )/NEWGENE CG/NEWGENE (/NEWGENE m/NEWGENE )/NEWGENE CG/NEWGENE )/NEWGENE generated/VBD a/DT new/JJ methylcytosine-specific/NN DNA-protein/NN complex/NN ./.
@@10575642396 Skin/VBP pH/NN changes/NNS associated/VBN with/IN iontophoresis/NN ./.
@@115807572665 METHODS/IN :/: We/PRP retrospectively/RB selected/VBD 13/CD TFCD/NN patients/NNS who/WP underwent/VBD surgery/NN for/IN intractable/JJ epilepsy/NN with/IN the/DT aim/NN of/IN removing/JJ the/DT magnetic/JJ resonance/NN (/( MR/NN )/NN -detectable/NN lesion/NN and/IN //IN or/IN the/DT epileptogenic/JJ zone/NN defined/VBN by/IN stereoelectroencephalographic/JJ recordings/NNS ./.
@@20020513989 Isoform/NEWGENE C/NEWGENE beta/NEWGENE 2/NEWGENE ,/, an/DT unusual/JJ form/NN of/IN the/DT bovine/JJ catalytic/JJ subunit/NN of/IN cAMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE ./.
@@91519255653 The/DT C-LIP/NN also/RB was/VBD compared/VBN with/IN transcather/NN arterial/JJ embolization/NN (/( TAE/NN ;/: C-LIP/NN followed/VBN by/IN gelatin/NN sponge/NN )/SYM and/CC percutaneous/JJ ethanol/NN injection/NN therapy/NN (/( PEIT/NNP )/SYM ./.
@@12522232934 The/DT authors/NNS found/VBP that/WDT except/VBP for/IN fear/NN and/CC pugnacity/NN all/DT husband-wife/JJ trait/NN correlations/NNS were/VBD positive/JJ ,/, in/IN contrast/NN to/IN Winch's/NNP principle/NN of/IN type/NN I/NN complementarity/NN ./.
@@40026674666 In/NN metastasis-free/JJ patients/NNS ,/, the/DT best/JJS results/NNS were/VBD obtained/VBN with/IN tumor/NN diameters/NNS under/IN 2/CD cm/NN regardless/RB of/IN their/PRP localization/NN in/IN lung/NN tissue/NN and/CC with/IN 2--4/CD ./CD 9/CD cm/NN tumors/NNS embedded/VBN in/IN lung/NN parenchyma/NN ./.
@@32685553964 In/NN vitro/FW assessment/NN of/IN the/DT biocompatibility/NN of/IN dental/JJ materials--the/JJ millipore/NN filter/NN method/NN ./.
@@33125147822 The/DT N3/NN wave/NN of/IN the/DT SSEP's/NNP ,/, which/WDT has/VBZ been/VBN found/VB to/IN correlate/NN best/JJS with/IN neurological/JJ recovery/NN ,/, returned/VBN to/IN 65%/JJ +/NN //NN -/NN 48%/NN of/IN the/DT preischemia/NN amplitude/NN in/IN the/DT insulin-treated/JJ animals/NNS ,/, compared/VBN to/IN 40%/CD +/NN //NN -/NN 34%/JJ in/IN the/DT fasted/VBN group/NN and/CC 26%/JJ +/NN //NN -/NN 24%/JJ in/IN the/DT control/NN animals/NNS ./.
@@18903622512 Out/IN of/IN 40/CD patients/NNS ,/, who/WP initially/RB did/VBD not/RB show/VB eye/NN complications/NNS due/NN to/IN leprosy/NN ,/, 37/CD patients/NNS were/VBD essentially/RB the/DT same/JJ 10/CD years/NNS later/JJR ./.
@@51541325403 The/DT value/NN of/IN different/JJ sources/NNS of/IN nitrogen/NN in/IN diets/NNS for/IN the/DT early-weaned/JJ calf/NN ./.
@@113934636126 Data/NNP were/VBD obtained/VBN from/IN 2/CD undergraduate/NN student/NN samples/NNS ,/, a/DT self-report/NN group/NN (/( n/NN =/SYM 132/CD )/SYM who/WP provided/VBD NEO-PI-R/NN self-ratings/NNS on/IN 2/CD occasions/NNS separated/VBN by/IN a/DT 7-/CD to/IN 14-day/NN interval/NN and/CC an/DT informant/NN group/NN (/( n/NN =/SYM 109/CD )/SYM who/WP provided/VBD ratings/NNS of/IN well-known/JJ friends/NNS or/CC relatives/NNS on/IN 2/CD occasions/NNS separated/VBN by/IN a/DT 6/CD month/NN interval/NN ./.
@@74900796547 These/DT are/VBP two/JJ regions/NNS of/IN known/VBP conserved/VBN synteny/NN ,/, providing/CC further/JJ evidence/NN that/IN the/DT human/NEWGENE STEP/NEWGENE is/VBZ a/DT true/JJ homolog/NN of/IN the/DT murine/NEWGENE STEP/NEWGENE gene/NEWGENE ./.
@@109545256321 However/RB ,/, the/DT presence/NN of/IN Tax/NEWGENE I/NEWGENE increased/VBD the/DT extent/NN and/CC altered/VBD the/DT profile/NN of/IN proteins/NN binding/NN TRE-2/NEWGENE in/IN vivo/NN ./.
@@103674609015 The/DT FCMS/NNP conditions/NNS were/VBD as/IN follows/VBZ :/: 2/NN kW/NN maximum/JJ electrical/JJ power/NN consumption/NN ,/, 800/NN V/NN maximum/JJ capacitor/NN voltage/NN ,/, 720/CD microseconds/NNS pulsewidth/NN (/( 180/CD microseconds/NNS rise/NN time/NN )/SYM ,/, and/CC 5-30/CD Hz/NN frequency/NN ./.
@@90796389339 The/DT 3ASubE/CD cells/NNS expressing/NN CXCR2/NEWGENE with/IN mutation/NN of/IN Ser-346/NN ,/, -347/NN ,/, and/CC -348/CD to/IN alanine/NN ,/, or/CC with/IN mutation/NN of/IN only/RB one/PRP serine/NN in/IN this/DT domain/NN ,/, continue/VB to/IN be/VB phosphorylated/VBN in/IN response/NN to/IN ligand/NN and/CC are/VBP 60-70%/RB desensitized/VBN following/IN the/DT initial/JJ ligand/NN challenge/NN ./.
@@94269582582 The/DT study/NN goals/NNS were/VBD to/IN isolate/NN a/DT full-length/JJ clone/NN encoding/VBG CO-Ag/NEWGENE from/IN a/DT bovine/JJ corneal/JJ cDNA/NN library/NN and/CC to/IN express/NN this/DT clone/NN in/IN Escherichia/NN coli/JJ (/( E/NNP ./NNP coli/JJ )/SYM ./.
@@2182618461 The/DT promoter/NN activity/NN was/VBD measured/VBN by/IN a/DT transient/JJ expression/NN of/IN a/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE (/( CAT/NEWGENE )/SYM gene/NN connected/VBN with/IN various/JJ 5'-deletion/CD mutants/NNS of/IN the/DT 5'-flanking/JJ region/NN ./.
@@78295547808 To/TO further/RB our/PRP knowledge/NN about/RB the/DT systemic/JJ humoral/JJ immune/JJ system/NN response/NN to/IN weak/JJ hapten-syngeneic/JJ or/CC allogeneic/JJ protein/NN conjugates/NNS (/( corrosion/NN and/CC wear/NN products/NNS of/IN metallic/JJ orthopedic/JJ devices/NNS )/SYM ,/, a/DT sensitive/JJ enzyme-linked/JJ immunosorbent/JJ assay/NN (/( ELISA/NN )/SYM method/NN for/IN testing/NN for/IN antibody/NN (/( humoral/JJ immunity/NN )/SYM to/IN metals/NNS was/VBD developed/VBN ./.
@@83550621063 Single-photon/NNP emission/NN computed/JJ tomography/NN (/( SPECT/NN )/SYM with/IN 99mTc-hexamethylpropyleneamine/NNP oxime/NN (/( HMPAO/NN )/SYM was/VBD used/VBN to/IN investigate/VB changes/NNS in/IN cerebral/JJ blood/NN flow/NN in/IN seven/JJ patients/NNS with/IN cortical/JJ visual/JJ impairment/NN ./.
@@73494167197 100/CD more/RB than/IN in/IN the/DT summer/NN coat/NN )/NN ./.
@@10321158185 Post/NNP and/CC core/NN fabrication/NN for/IN divergent/JJ canals/NNS with/IN a/DT cast/JJ post/NN and/CC core/NN and/CC a/DT prefabricated/JJ dowel/NN ./.
@@94857909449 Alison/NN Bell/NNP Memorial/NNP Award/NNP ./.
@@20722382681 Menetrier/NNP disease/NN in/IN a/DT child/NN ./.
@@66250582085 The/DT population/NN of/IN between/IN 75/NN ,/NN 000/NN and/CC 100/CD ,/CD 000/CD was/VBD largely/RB unstable/JJ ,/, and/CC cost/NN per/IN capita/NNS was/VBD $0/CD ./CD 95/CD to/IN $1/CD ./CD 21/CD ./.
@@63183226781 This/DT is/VBZ consistent/JJ with/IN a/DT model/NN proposing/VBG that/DT SSV/NN was/VBD generated/VBN by/IN recombination/NN between/IN proviral/JJ DNA/NN of/IN a/DT simian/JJ sarcoma/NN associated/VBD virus/NN and/CC proto-sis/NEWGENE and/CC that/IN introns/NNS were/VBD spliced/VBN out/RB subsequently/RB from/IN a/DT fused/VBN viral-sis/NEWGENE messenger/NEWGENE RNA/NEWGENE ./.
@@32808071743 Mutations/NNS at/IN the/DT suf12/NEWGENE locus/NEWGENE were/VBD isolated/VBN in/IN Saccharomyces/NN cerevisiae/NN as/IN extragenic/JJ suppressors/NNS of/IN +1/NN frameshift/JJ mutations/NNS in/IN glycine/NN (/( GGX/NNP )/SYM and/CC proline/NN (/( CCX/NNP )/SYM codons/NNS ,/, as/RB well/VB as/IN UGA/DT and/CC UAG/NN nonsense/NN mutations/NNS ./.
@@43712795006 Absence/NNS of/IN action/NN potentials/NNS in/IN frog/NN slow/JJ muscle/NN fibres/NNS paralysed/VBN by/IN botulinum/NEWGENE toxin/NEWGENE ./.
@@83201206904 Pronounced/JJ microangiopathy/NN characterized/VBN by/IN avascular/JJ fields/NNS ,/, enlarged/JJ and/CC tortuous/JJ capillaries/NNS and/CC increased/VBN transcapillary/JJ diffusion/NN of/IN sodium/NN fluorescein/NN ,/, was/VBD clearly/RB demonstrable/JJ in/IN the/DT area/NN of/IN the/DT nodules/NNS ./.
@@10918164738 Logistic/JJ regression/NN analysis/NN revealed/VBN that/IN physicians/NNS were/VBD 3/CD ./CD 6/CD times/NNS more/RB likely/RB to/IN detect/VB thin/JJ lesions/NNS (/( </SYM //CD =/CD 0/CD ./CD 75/CD mm/NN )/SYM compared/VBN with/IN nonphysician/NN detectors/NNS (/( 95%/CD confidence/NN interval/NN [/NN 95%/NN CI/NN ]/NN ,/, 2/CD ./CD 1/CD ,/, 6/CD ./CD 5/CD ;/: P/NN =/SYM 0/CD ./CD 0001/CD )/SYM ./.
@@1000956514 GW/NN Gamma/NN approximation/NN for/IN electron/NN self-energies/NNS in/IN semiconductors/NNS and/CC insulators/NNS ./.
@@68763176671 Relationships/NNS with/IN the/DT acquired/VBN immune/JJ deficiency/NN syndrome/NN ./.
@@104268787551 The/DT results/NNS of/IN the/DT ISIS-2/NN trial/NN and/CC the/DT data/NN from/IN the/DT Antiplatelet/NNP Trialists'/NNP Collaboration/NNS indicated/VBD that/DT aspirin/NN is/VBZ mandatory/JJ in/IN patients/NNS with/IN acute/JJ myocardial/JJ infarction/NN and/CC for/IN secondary/JJ prevention/NN ./.
@@107250175327 This/DT paper/NN reviews/VBP the/DT middleware-based/JJ approach/NN adopted/VBN by/IN CEN/NN ENV/NN 12967-1/CD and/CC the/DT specialisation/NN necessary/JJ for/IN the/DT healthcare/NN record/NN based/VBN on/IN CEN/NN ENV/NN 12265/CD 'Electronic/NNP Healthcare/NNP Record/NNP Architecture'/NNP ./.
@@109053498139 Double/NNP mutant/JJ analysis/NN suggests/VBZ that/IN Rad54p/NEWGENE and/CC Mus81p/NEWGENE act/VB in/IN one/PRP pathway/NN for/IN the/DT repair/NN of/IN ,/, or/CC tolerance/NN to/IN ,/, UV-induced/NN DNA/NN damage/NN ./.
@@33098924680 Contrary/JJ to/IN the/DT observation/NN made/VBP with/IN other/DT S/NNP ./NNP pombe/NN genes/NNS transcribed/VBN in/IN the/DT budding/JJ yeast/NN ,/, the/DT heterologous/JJ actin/NEWGENE gene/NEWGENE transcript/NEWGENE is/VBZ initiated/VBN 39/CD nucleotides/NNS upstream/RB of/IN the/DT initiation/NN start/NN site/NN used/VBN in/IN the/DT homologous/JJ yeast/NN ./.
@@97246545581 Furthermore/RB ,/, early-/JJ and/CC late-firing/JJ origins/NNS differ/VBP not/RB in/IN the/DT timing/NN of/IN their/PRP recruitment/NN of/IN an/DT Mcm/NEWGENE protein/NEWGENE ,/, but/CC in/IN the/DT timing/NN of/IN RPA's/NEWGENE recruitment/NN ./.
@@986800191 All/DT Cu/NN values/NNS obtained/VBN from/IN the/DT organs/NNS investigated/VBN had/VBP reached/VBN a/DT saturation/NN level/NN at/IN 8/CD mug/NN Cu/NNS //NNS g/NNS diet/NN with/IN the/DT exception/NN of/IN the/DT values/NNS for/IN body/NN Cu/NN found/VB in/IN the/DT dams/NNS that/WDT were/VBD killed/VBN on/IN the/DT day/NN of/IN delivery/NN ./.
@@14829127012 The/DT CEM/NN receives/VBZ registration/NN updates/NNS via/NN an/DT HL7/NN message/NN and/CC evaluates/VBZ data/NN dependencies/NNS in/IN rules/NNS via/NN an/DT interface/NN to/IN the/DT relational/JJ database/NN ./.
@@72515647083 Since/IN only/JJ 58%/NN of/IN our/PRP sample/NN could/MD be/VB adequately/RB classified/VBN with/IN one/PRP diagnosis/NN ,/, we/PRP expect/VBP that/IN the/DT ASDC/NNP nosology/NN will/MD need/VB to/IN evolve/VB further/RB ./.
@@83885433388 Furthermore/RB ,/, a/DT mutant/JJ receptor/NN (/( Y977F/NEWGENE //NEWGENE Y989F/NEWGENE [/NEWGENE PLC/NEWGENE gamma-binding/NEWGENE sites/NEWGENE ]/NEWGENE )/SYM could/MD fully/RB activate/VB Ras/NEWGENE ,/, and/CC the/DT direct/JJ activation/NN of/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE and/CC calcium/NN mobilization/NN had/VBP almost/RB no/DT effect/NN on/IN the/DT GDP/NNP //NNP GTP/NNP state/NN of/IN Ras/NEWGENE in/IN this/DT cell/NN line/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@28152293513 The/DT treatments/NNS were/VBD 60/CD mg/NN t/CD ./CD i/CD ./CD d/CD ./. and/CC 120/CD mg/NN t/CD ./CD i/CD ./CD d/CD ./. during/IN 14/CD days'/NN treatment/NN ,/, with/IN the/DT last/NN dose/NN pulsed/JJ with/IN 1/CD ./CD 85/CD MBq/NN [/NN 14C/NN ]/NN diltiazem/NN ./.
@@98585939152 We/PRP have/VBP identified/VBN amino/JJ acid/NN sequences/NNS in/IN mammalian/NEWGENE and/NEWGENE Xenopus/NEWGENE NeuroD1/NEWGENE //NEWGENE BETA2/NEWGENE that/WDT are/VBP necessary/JJ for/IN insulin/NEWGENE gene/NEWGENE expression/NN and/CC ectopic/JJ neurogenesis/NN ./.
@@118448121727 For/IN the/DT 2/CD ./CD 5/CD to/IN 4/CD ng/NN //NN mL/NN model/NN ,/, the/DT AUC/NN of/IN the/DT ANN/NNP ROC/NN curve/NN was/VBD significantly/RB higher/JJ than/IN the/DT AUCs/NNS for/IN percentage/NN of/IN free/JJ PSA/NEWGENE (/( P/NN =/CD ./CD 0239/CD )/SYM ,/, PSA-TZ/NNP (/( P/NN =/CD ./CD 0204/CD )/SYM ,/, and/CC PSA/NEWGENE density/NN and/CC total/JJ prostate/NN volume/NN (/( P/NN </SYM ./CD 01/CD for/IN both/DT )/SYM ./.
@@100015413 Mechanisms/NNPS of/IN visible-light/JJ emission/NN from/IN electro-oxidized/JJ porous/JJ silicon/NN ./.
@@5905945816 Ovarian/JJ allotransplantation/NN in/IN human/NN ./.
@@28509711736 A/DT 17-mer/CD oligodeoxynucleotide/NN ,/, corresponding/JJ to/IN a/DT region/NN of/IN the/DT VtHb/NEWGENE amino/NEWGENE acid/NEWGENE sequence/NEWGENE was/VBD used/VBN as/IN a/DT hybridization/NN probe/NN to/IN screen/NN a/DT Vitreoscilla/JJ genomic/JJ library/NN constructed/VBN in/IN broad-host-range/JJ cosmid/NN vector/NN pVK102/NN ./.
@@89379895700 The/DT results/NNS suggest/VBP that/IN ,/, although/IN both/PDT the/PDT N-/DT and/CC C-terminal/NN regions/NN of/IN talin/NEWGENE bind/NN actin/NEWGENE ,/, the/DT properties/NNS of/IN these/DT two/JJ regions/NNS of/IN the/DT protein/NN are/VBP distinct/JJ ./.
@@110272809271 Cam/NEWGENE kinase/NEWGENE II/NEWGENE induces/VBZ in/IN vivo/NN phosphorylation/NN of/IN Smad2/NEWGENE and/CC Smad4/NEWGENE and/CC ,/, to/IN a/DT lesser/JJ extent/NN ,/, Smad3/NEWGENE ./.
@@82944593836 The/DT predicted/VBN amino/JJ acid/NN sequence/NN of/IN the/DT SAP-1/NEWGENE cDNA/NEWGENE showed/VBN that/IN mature/NEWGENE SAP-1/NEWGENE consisted/VB of/IN 1093/CD amino/JJ acids/NNS and/CC a/DT transmembrane-type/NEWGENE PTP/NEWGENE ,/, which/WDT possessed/VBD a/DT single/JJ PTP-conserved/NEWGENE domain/NEWGENE in/IN the/DT cytoplasmic/JJ region/NN ./.
@@111975493399 RESULTS/NNS :/: During/IN the/DT stabilization/NN period/NN ,/, PaCO2/NN (/( mean/JJ +/NN //NN -/NN SD/NN )/SYM was/VBD 33/CD +/NN //NN -/NN 5/CD mm/NN Hg/NNP ,/NNP and/NNP arrhythmias/NNS were/VBD not/RB detected/VBN ./.
@@112545043022 However/RB ,/, the/DT promoter/NN region/NN contains/VBZ several/DT potential/JJ cis-regulatory/NN elements/NN such/JJ as/IN Sp1/NEWGENE ,/, early/NEWGENE growth/NEWGENE response-1/NEWGENE ,/, activator/NEWGENE protein-2/NEWGENE ,/, MyoD/NEWGENE ,/, p300/NEWGENE ,/, nuclear/NEWGENE factor-kappaB/NEWGENE ,/, myeloid/NEWGENE zinc/NEWGENE finger/NEWGENE protein-1/NEWGENE ,/, caudal-related/NEWGENE homeobox/NEWGENE (/NEWGENE Cdx/NEWGENE )/NEWGENE gene/NEWGENE A/NEWGENE ,/, and/CC Cdx/NEWGENE protein-2/NEWGENE binding/NEWGENE sites/NEWGENE ./.
@@110735392755 Functional/JJ analysis/NN of/IN the/DT mutant/NEWGENE desmin/NEWGENE in/IN SW13/NNP (/( vim-/JJ )/SYM cells/NNS showed/VBD aggregation/NN of/IN abnormal/JJ coarse/JJ clumps/NNS of/IN desmin/NEWGENE positive/JJ material/NN dispersed/VBN throughout/IN the/DT cytoplasm/NN ./.
@@13981063818 Cleavage/NNS by/IN the/DT intron-encoded/JJ enzyme/NN (/( I-CreI/NEWGENE )/SYM occurs/VBZ 5/CD bp/NN and/CC 1/CD bp/NN 3'/CD to/IN the/DT intron/NN insertion/NN site/NN (/( in/IN the/DT 3'-exon/NN )/SYM in/IN the/DT top/JJ (/( //NN )/SYM and/CC bottom/NN (/( ,/, )/SYM strands/NNS ,/, respectively/RB ,/, resulting/JJ in/IN 4-nt/JJ single-stranded/JJ overhangs/NNS with/IN 3'-OH/JJ termini/NNS ./.
@@90997028696 Based/VBN on/IN the/DT sequence/NN of/IN the/DT conRTRE/NEWGENE ,/, we/PRP located/VBD a/DT putative/JJ RTRE/NEWGENE ,/, referred/VBN to/RB as/IN P2-RE/NEWGENE ,/, in/IN the/DT 5'/CD promoter-flanking/NN region/NN of/IN the/DT mouse/NEWGENE protamine/NEWGENE 2/NEWGENE gene/NEWGENE ,/, which/WDT is/VBZ induced/VBN during/IN the/DT same/JJ stage/NN of/RB spermatogenesis/NN as/IN RTR/NEWGENE ./.
@@96422275337 Osteoadherin/NEWGENE is/VBZ a/DT recently/RB described/VBN bone/NN proteoglycan/NN containing/JJ keratan/NN sulfate/NN ./.
@@13098153275 Possibly/RB ,/, the/DT scr1-1/NEWGENE mutation/NEWGENE does/VBP not/RB affect/VB signal/JJ recognition/NN or/CC translational/JJ arrest/NN but/CC instead/RB results/VBZ in/IN maintenance/NN of/IN translational/JJ arrest/NN of/IN AEP/NEWGENE synthesis/NN ./.
@@30165065963 A/DT recombinant/JJ vector/NN ,/, p410+/NN ,/, was/VBD constructed/VBN which/WDT carried/VBD the/DT BamHI-K/NEWGENE fragment/NEWGENE (/( nucleotides/NNS 107565/CD to/IN 112625/CD of/IN the/DT B95-8/CD strain/NN ,/, encoding/VBG the/DT EBV-associated/NEWGENE nuclear/NEWGENE antigen/NEWGENE EBNA-1/NEWGENE )/SYM ,/, the/DT cis-acting/JJ sequence/NN from/IN the/DT BamHI-C/NEWGENE fragment/NEWGENE ,/, and/CC a/DT dominant/JJ selectable/JJ marker/NN gene/NN encoding/VBG G-418/NN resistance/NN in/IN animal/NN cells/NNS ./.
@@113115636214 When/WRB this/DT CCAAT/NN box/NN was/VBD inserted/VBN into/IN a/DT heterologous/JJ promoter/NN construct/NN ,/, OA/NN induction/NN was/VBD dependent/JJ on/IN an/DT intact/JJ CCAAT/NN box/NN ./.
@@1398272016 Radioimmunoassays/NNS of/IN pregnenolone/NN ,/, progesterone/NN ,/, dehydroepiandrosterone/NN (/( DHA/NN )/SYM 16/CD alpha-hydroxy-DHA/JJ ,/, estriol/NN ,/, and/CC cortisol/NN were/VBD performed/VBN on/IN a/DT total/NN of/IN 0/CD ;/: 1/CD ml/NN ;/: of/IN fetal/JJ plasma/NN ,/, collected/VBN during/IN the/DT course/NN of/IN normal/JJ vaginal/JJ delivery/NN ./.
@@77775186183 DNA/NN sequencing/VBG and/CC Southern/NNP blot/NN analyses/NNS established/VBN that/IN the/DT cDNA/NN clones/NNS are/VBP derived/VBN from/IN two/JJ different/JJ genes/NNS ./.
@@2745444395 The/DT transcription/NN initiation/NN site/NN was/VBD determined/VBN by/IN S1/NEWGENE nuclease/NEWGENE mapping/NN ./.
@@18967772913 Ivermectin/NN uptake/NN and/CC distribution/NN in/IN the/DT plasma/NN and/CC tissue/NN of/IN Sudanese/JJ and/CC Mexican/JJ patients/NNS infected/VBN with/IN Onchocerca/NN volvulus/NN ./.
@@64152996215 Total/JJ cumulative/JJ doses/NNS of/IN doxorubicin/NN ranged/VBN from/IN 145/CD to/IN 625/CD mg/CD ./CD //CD m/CD ./CD 2/CD ./.
@@91757088420 Using/VBG PRL-R/NEWGENE tagged/VBD both/DT in/NN the/DT N-terminal/NN or/CC C-terminal/NN regions/NN of/IN the/DT mature/JJ receptor/NN excludes/VBZ the/DT possibility/NN of/IN a/DT cleaved/VBN fragment/NN which/WDT could/MD have/VB been/VBN subsequently/RB imported/VBN into/IN the/DT nucleus/NN ./.
@@110513703001 Response/NNP was/VBD extremely/RB poor/JJ in/IN African/JJ Americans/NNS and/CC those/DT with/JJ HCV/NN genotype/NN 1/CD ./CD
@@107217047320 Analysis/NNP of/IN the/DT 5'/CD end/NN of/IN the/DT mouse/NEWGENE Elavl1/NEWGENE (/( mHuA/NEWGENE )/SYM gene/NN reveals/VBZ a/DT transcriptional/JJ regulatory/JJ element/NN and/CC evidence/NN for/IN conserved/VBN genomic/JJ organization/NN ./. mHuA/NEWGENE (/( Elavl1/NEWGENE )/SYM belongs/VBZ to/IN a/DT highly/RB conserved/VBN family/NN of/IN genes/NNS encoding/VBG RNA-binding/NN proteins/NN and/CC has/VBZ been/VBN linked/JJ to/IN cell/NN growth/NN and/CC proliferation/NN through/RB its/PRP regulation/NN of/IN mRNA/NN stability/NN ./.
@@115530912459 The/DT results/NNS indicate/VBP that/IN a/DT more/RB differentiated/VBN diagnosis/NN of/IN the/DT molar/JJ relationship/NN will/MD allow/VB for/IN a/DT more/RB causally/RB directed/VBN correction/NN of/IN Class/NN II/NN molar/JJ relationship/NN ./.
@@10678144494 After/IN i/CD ./CD v/CD ./.
@@93356081385 Splice-junction/NNP elements/NNS and/CC intronic/JJ sequences/NNS regulate/VBP alternative/JJ splicing/JJ of/IN the/DT Drosophila/NN myosin/NEWGENE heavy/NEWGENE chain/NEWGENE gene/NEWGENE transcript/NN ./.
@@99275852595 Competitionsupershift/NNP EMSA/NN assays/NNS revealed/VBN that/IN multiple/JJ proteins/NNS were/VBD involved/VBN in/IN bandshift/NN complex/NN formation/NN with/IN KCS/NEWGENE ,/, one/PRP of/IN which/WDT was/VBD identified/VBN as/IN factor/NEWGENE Sp1/NEWGENE ./.
@@79138918233 Some/DT of/IN these/DT targets/NNS were/VBD reported/VBN to/IN code/NN for/IN molecules/NNS involved/VBN in/IN cell-cell/JJ interactions/NNS ,/, whereas/IN no/DT relationship/NN has/VBZ yet/RB been/VBN demonstrated/VBN between/IN Hox/NEWGENE genes/NEWGENE and/CC other/DT transcription/NN factors/NNS involved/VBN in/IN determining/VBG and/IN //IN or/IN maintaining/VBG tissue/NN specificity/NN ./.
@@60968632875 Upstream/NN activation/NN sites/NN of/IN the/DT CYC1/NEWGENE gene/NEWGENE of/IN Saccharomyces/NN cerevisiae/NN are/VBP active/JJ when/CC inverted/JJ but/CC not/RB when/CC placed/VBN downstream/RB of/IN the/DT "TATA/NN box"/NN ./.
@@80830113132 The/DT relative/JJ R-/DT and/CC L-brain/NNP weights/NNS were/VBD found/VBN to/IN be/VB inversely/RB related/VBN to/IN the/DT relative/JJ R-L/NNP brain/NN weight/NN only/RB in/IN the/DT RH/NN female/JJ cats/NNS with/IN R-L/NNP brain/NN weight/NN smaller/JJR than/IN zero/NN (/( testosterone/NN in/IN males/NNS ,/, estrogen/NN in/IN females/NNS )/SYM ./.
@@73965457247 Chemotherapy/NNS was/VBD administered/VBN without/IN altering/VBG the/DT course/NN of/IN the/DT disorder/NN ./.
@@88058248786 Furthermore/RB ,/, the/DT use/NN of/IN zero-loss/NN filtering/JJ in/IN combination/NN with/IN exit/NN wavefront/NN reconstruction/NN is/VBZ considerably/RB more/RB effective/JJ at/IN removing/JJ the/DT effects/NNS of/IN multiple/JJ elastic/JJ and/CC inelastic/JJ scattering/NN and/CC microscope/NN objective/JJ lens/NN aberrations/NNS than/IN either/DT technique/NN by/IN itself/PRP ./.
@@87092459626 Our/PRP studies/NNS also/RB excluded/VBN the/DT possibility/NN that/IN the/DT phosphorylation/NN of/IN Ser-2/NEWGENE ,/, Ser-123/NEWGENE ,/, or/CC Ser-210/NEWGENE ,/, had/VBP roles/NNS in/IN the/DT trans-suppression/JJ activity/NN of/IN the/DT large/NEWGENE HDAg/NEWGENE ,/, in/IN the/DT assembly/NN of/IN empty/JJ virus-like/NEWGENE HDAg/NEWGENE particle/NEWGENE ,/, and/CC in/IN the/DT nuclear/JJ transport/NN of/IN HDAgs/NEWGENE ./.
@@87050568681 Workplace/NN violence--nurses/NNS at/IN risk/NN ./.
@@44288004226 Effect/NN of/IN noise/NN on/IN CO-induced/JJ increases/NNS of/IN LAP/NEWGENE and/CC GPT/NEWGENE activity/NN in/IN the/DT plasma/NN of/IN rats/NNS ./.
@@75929466801 It/PRP contains/VBZ three/CD putative/JJ TATA/NN boxes/NNS far/RB upstream/RB of/IN the/DT main/JJ start/NN sites/NNS region/NN ,/, one/PRP AP-1/NEWGENE box/NEWGENE ,/, one/PRP AP-2/NEWGENE box/NEWGENE ,/, one/PRP Malt/NEWGENE box/NEWGENE ,/, one/PRP GAGA/NN box/NN ,/, one/PRP half/NN serum-responsive/NEWGENE element/NEWGENE ,/, and/CC putative/JJ binding/JJ sites/NNS for/IN Sp1/NEWGENE (/( five/CD )/SYM ,/, GC-rich/NEWGENE binding/NEWGENE factor/NEWGENE (/( five/CD )/SYM ,/, CTF-NF1/NEWGENE (/( one/PRP )/SYM ,/, Myb/NEWGENE (/( one/PRP )/SYM ,/, p53/NEWGENE (/( two/JJ )/SYM ,/, Ets-1/NEWGENE (/( one/PRP )/SYM ,/, NF-IL6/NEWGENE (/( two/JJ )/SYM ,/, MyoD/NEWGENE (/( two/JJ )/SYM ,/, Zeste/NEWGENE (/( one/PRP )/SYM ,/, and/CC hepatocyte/NEWGENE nuclear/NEWGENE factor-5/NEWGENE (/( one/PRP )/SYM ./.
@@6286443323 Postoperative/JJ serum/JJ ACTH/NEWGENE levels/NNS were/VBD normal/JJ ./.
@@106561612175 MBI/NNP and/CC MMBI/NN showed/VBD similar/JJ Cmax/JJ values/NNS ,/, but/CC the/DT former/RB disappeared/VBN slower/JJR in/IN the/DT serum/NN than/IN the/DT latter/JJ and/CC resulted/VBN in/IN its/PRP larger/JJR AUC/NN values/NNS ./.
@@82428617276 Both/DT 4/JJ ,/JJ 8-DiMeIQx/JJ and/CC A/DT alpha/NN C/NN were/VBD found/VBN at/IN </SYM 1/CD p/CD ./CD p/CD ./CD b/CD ./.
@@86059311762 Epitope/NNS mapping/NN revealed/VBN that/IN these/DT three/CD clones/NNS appear/VBP to/IN recognize/VB an/DT identical/JJ epitope/NN domain/NN present/NN on/IN the/DT C-terminal/NN RNP/NEWGENE motif/NEWGENE of/IN the/DT U1A/NEWGENE protein/NEWGENE ./.
@@118475801733 Emphysematous/JJ cholecystitis/NN :/: sonographic/JJ findings/NNS ./.
@@91397212422 Cyclin/NEWGENE G2/NEWGENE is/VBZ highly/RB expressed/VBN in/IN the/DT immune/JJ system/NN where/CC immunologic/JJ tolerance/NN subjects/VBZ self-reactive/JJ lymphocytes/NNS to/IN negative/JJ selection/NN and/CC clonal/JJ deletion/NN via/NN apoptosis/NN ./.
@@103595754335 Nevertheless/RB ,/, they/PRP are/VBP functionally/RB distinct/JJ in/IN that/DT FcalphaRI/NEWGENE binds/VBZ human/NEWGENE IgA/NEWGENE (/( hIgA/NEWGENE )/SYM but/CC not/RB bovine/NEWGENE IgG2/NEWGENE (/( bIgG2/NEWGENE )/SYM ,/, whereas/IN bFcgamma2R/NEWGENE binds/VBZ bIgG2/NEWGENE but/CC not/RB hIgA/NEWGENE ./.
@@90456366559 CD3/NEWGENE cross-linking/VBG induced/VBN tyrosine/NN phosphorylation/NN of/IN Sam68/NEWGENE in/IN uninfected/JJ T/NN cells/NNS ./.
@@106568029386 Another/DT long/JJ insertion/NN in/IN the/DT cathepsin/NEWGENE X/NEWGENE amino/NEWGENE acid/NEWGENE sequence/NN forms/VBZ a/DT beta-hairpin/NN pointing/VBG away/RB from/IN the/DT active/JJ site/NN ./.
@@83702758330 One/CD chimpanzee/NN reliably/RB selected/VBD the/DT larger/JJR numeral/NN 4/CD during/IN testing/NN with/IN a/DT nonadjacent/JJ pair/NN (/( 2-4/CD )/SYM ,/, and/CC 2/CD chimps/NNS showed/VBD no/DT preference/NN ./.
@@106373374192 We/PRP determined/VBD how/RB DNA/NN repair/NN is/VBZ affected/VBN by/IN TFA1/NEWGENE conditional/JJ mutations/NNS ./.
@@104409236850 Analysis/NNP of/IN cell/NN cycle/NN proteins/NNS showed/VBN that/IN 24/CD h/NN of/IN lovastatin/NN treatment/NN in/IN the/DT control/NN cells/NNS caused/VBD an/DT elevation/NN in/IN the/DT levels/NNS of/IN the/DT cyclin-dependent/NEWGENE kinase/NEWGENE inhibitor/NEWGENE p27/NEWGENE (/NEWGENE kip1/NEWGENE )/NEWGENE ,/, inhibition/NN of/IN both/DT cyclin/NEWGENE E-/NEWGENE and/CC cyclin/NEWGENE A-dependent/NEWGENE kinase/NEWGENE activity/NN ,/, and/CC decreased/VBD levels/NNS of/IN hyperphosphorylated/JJ retinoblastoma/NEWGENE protein/NEWGENE (/( pRb/NEWGENE )/SYM ./.
@@63958042006 Urease/NEWGENE activity/NN of/IN 97%/CD of/IN these/DT organisms/NNS became/VBD evident/JJ within/IN 30/CD min/NN ./.
@@30656218338 Structure/NNS and/CC regulation/NN of/IN a/DT nuclear/JJ gene/NN in/IN Saccharomyces/NN cerevisiae/NN that/WDT specifies/VBZ MRP13/NEWGENE ,/, a/DT protein/NN of/IN the/DT small/JJ subunit/NN of/IN the/DT mitochondrial/JJ ribosome/NN ./.
@@15425657332 Nuclear-encoded/NEWGENE chloroplast/NEWGENE ribosomal/NEWGENE protein/NEWGENE L12/NEWGENE of/IN Nicotiana/ORG tabacum/NN :/: characterization/NN of/IN mature/JJ protein/NN and/CC isolation/NN and/CC sequence/NN analysis/NN of/IN cDNA/NN clones/NNS encoding/VBG its/PRP cytoplasmic/JJ precursor/NN ./.
@@77970773163 The/DT amino-terminal/JJ DNA-binding/NN domain/NN of/IN Pip/NEWGENE exhibits/VBP a/DT high/JJ degree/NN of/IN homology/NN to/IN the/DT DNA-binding/NN domains/NN of/IN members/NNS of/IN the/DT interferon/NEWGENE regulatory/NEWGENE factor/NEWGENE (/( IRF/NEWGENE )/SYM family/NN ,/, which/WDT includes/VBZ IRF-1/NEWGENE ,/, IRF-2/NEWGENE ,/, ICSBP/NEWGENE ,/, and/CC ISGF3/NEWGENE gamma/NEWGENE ./.
@@63705534358 Resting/VBG plasma/NN norepinephrine/NN (/( NE/NN )/SYM and/CC epinephrine/NN (/( E/NN )/SYM levels/NNS were/VBD lower/JJR during/IN active/JJ therapy/NN than/IN 2/CD wk/NN after/IN withdrawal/NN (/( guanfacine/NN and/CC control/NN :/: plasma/NN NE/NN ,/, 0/NN ./NN 27/NN +/NN //NN -/NN 0/CD ./CD 03/CD //CD 0/CD ./CD 64/CD +/NN //NN -/NN 0/CD ./CD 13/CD ng/NN //NN ml/NN ;/: plasma/NN E/NN ,/, 0/NN ./NN 09/NN +/NN //NN -/NN 0/CD ./CD 02/CD //CD 0/CD ./CD 17/CD +/NN //NN -/NN 0/CD ./CD 05/CD ng/NN //NN ml/NN )/SYM ./.
@@10422291960 A/DT diagnosis/NN of/IN IgA/NEWGENE lambda/NEWGENE multiple/JJ myeloma/NN with/IN peritoneal/JJ involvement/NN was/VBD made/VBP ./.
@@1064124454 After/IN 90/NN d/NN a/DT subsurface/NN ,/, radiolucent/JJ caries-like/JJ lesion/NN was/VBD observed/VBN in/IN two/JJ specimens/NNS only/RB ./.
@@106254386168 In/NN all/DT tissues/NNS examined/VBD only/JJ transcripts/NNS positive/JJ for/IN insert/NN 3/CD ,/, an/DT 18/CD bp/NN insertion/NN in/IN repeat/NN 21/CD ,/, were/VBD amplified/VBN ,/, even/VB under/IN conditions/NNS in/IN which/WDT a/DT 30%/CD level/NN of/IN insert/NN 3/CD negative/JJ transcript/NN could/MD be/VB easily/RB detected/VBN in/IN artificially/RB prepared/VBN control/NN samples/NNS ./.
@@8432328391 The/DT background/NN processes/NNS depending/VBG on/IN the/DT etiological/JJ factor/NN and/CC the/DT character/NN of/IN lesion/NN of/IN the/DT epithelium/NN are/VBP divided/VBN into/IN dyshormonal/JJ ,/, inflammatory/JJ ,/, and/CC posttraumatic/JJ ./.
@@107815521501 Purple/NNP photosynthetic/JJ bacteria/NNS are/VBP capable/JJ of/IN generating/JJ cellular/JJ energy/NN from/IN several/DT sources/NNS ,/, including/JJ photosynthesis/NN ,/, respiration/NN ,/, and/CC H/NN (/NN 2/NN )/NN oxidation/NN ./.
@@90689899020 Effect/NN of/IN Azadirachta/NNP indica/NN hydroalcoholic/JJ leaf/NN extract/NN on/IN the/DT cardiovascular/JJ system/NN ./.
@@60925886084 Hepatitis/NN B/NN virus/NN and/CC hepatoma/NN ./.
@@79381377905 All/DT groups/NNS were/VBD challenged/VBN subsequently/RB with/IN naloxone/NN (/( 0/CD ./CD 4/CD mg/CD //CD kg/CD )/SYM in/IN the/DT distinctive/JJ environment/NN and/CC then/RB observed/VBN for/IN signs/NNS of/IN opiate/JJ withdrawal/NN ./.
@@100510305388 No/DT difference/NN in/IN percentage/NN of/IN males/NNS in/IN semen/NN production/NN was/VBD noted/VBN between/IN strains/NNS ,/, CP/NN levels/NNS ,/, or/CC feeding/JJ regimens/NNS ./.
@@86494406495 The/DT heterogeneity/NN of/IN bovine/NEWGENE IgG2--VIII/NEWGENE ./.
@@1177481614 Erythromycin/IN and/CC clindamycin/NN resistance/NN in/IN Corynebacterium/NN diphtheriae/NNS from/IN skin/NN lesions/NNS ./.
@@3875231473 MRI/NN disclosed/VBN one/PRP or/CC more/RB of/IN the/DT following/NN abnormalities/NNS in/IN 24/CD (/( 63%/JJ )/SYM of/IN 38/CD treated/VBN kidneys/NNS :/: (/( 1/CD )/SYM loss/NN of/IN corticomedullary/JJ differentiation/NN ,/, (/( 2/CD )/SYM perirenal/JJ fluid/NN ,/, (/( 3/CD )/SYM subcapsular/JJ hematoma/NN ,/, (/( 4/CD )/SYM hemorrhage/NN into/IN a/DT renal/NN cyst/NN ,/, and/CC (/( 5/CD )/SYM unexplained/JJ abnormalities/NNS ./.
@@13213373212 As/IN was/VBD observed/VBN previously/RB for/IN MATa/NEWGENE cna1/NEWGENE1 cna2/NEWGENE double/JJ mutants/NNS ,/, MATa/NEWGENE cnb1/NEWGENE1 mutants/NEWGENE1 were/VBD defective/JJ in/IN their/PRP ability/NN to/IN recover/VB from/IN alpha-factor-induced/JJ growth/NN arrest/NN ./.
@@83906659254 Lithium/DT phthalocyanine/NN (/( LiPc/NN )/SYM is/VBZ a/DT prototype/NN of/IN another/DT generation/NN of/IN synthetic/JJ ,/, metallic-organic/JJ ,/, paramagnetic/JJ crystallites/NNS that/WDT appear/VBP very/RB useful/JJ for/IN in/IN vitro/FW and/CC in/IN vivo/NN electron/NN paramagnetic/JJ resonance/NN oximetry/NN ./.
@@107326699087 In/NN transient/JJ assays/NNS ,/, using/VBG rice/NN suspension-cultured/JJ cells/NNS transformed/VBN by/IN particle/NN bombardment/NN ,/, we/PRP showed/VBD previously/RB that/IN Oshox1/NEWGENE can/MD transcriptionally/RB repress/VB the/DT activity/NN of/IN reporter/NN gene/NN constructs/NNS with/IN upstream/RB HD-Zip/NEWGENE binding/NEWGENE sites/NEWGENE ./.
@@98193774470 A/DT mutation/NN in/IN the/DT 5'/NEWGENE C2U4/NEWGENE repeat/NEWGENE causes/NNS underaccumulation/NN of/IN snR13F/NEWGENE ,/, whereas/IN mutations/NNS in/IN the/DT 3'/NEWGENE C2U4/NEWGENE repeat/NEWGENE cause/VBG the/DT accumulation/NN of/IN two/JJ novel/JJ RNAs/NNS that/WDT migrate/VBP in/IN the/DT 500-nt/JJ range/NN ./.
@@109079712661 Atorvastatin/NN was/VBD the/DT most/RB cost-effective/JJ HMG-CoA/NEWGENE reductase/NEWGENE inhibitor/NN ./.
@@103815705763 Slp1/NEWGENE represses/VBZ transcription/NN via/NN this/DT binding/JJ site/NN in/IN yeast/NN cells/NNS ,/, consistent/JJ with/IN its/PRP role/NN as/IN a/DT direct/JJ repressor/NN of/IN ftz/NEWGENE stripes/NNS in/IN interstripe/NN regions/NNS during/IN late/JJ stages/NNS of/IN embryogenesis/NN ./.
@@75630728414 Comparisons/NNS of/IN rrnB/NEWGENE P1-lacZ/NEWGENE expression/NN at/IN different/JJ ppGpp/NN levels/NNS is/VBZ interpreted/VBN for/IN the/DT rpoD/NEWGENE (/NEWGENE P504L/NEWGENE )/NEWGENE mutant/NEWGENE as/IN resulting/VBG from/IN a/DT hypersensitivity/NN to/IN ppGpp/NN ./.
@@17149028430 In/NN addition/NN to/IN targeting/JJ partially/RB assembled/VBN Ti/NEWGENE alpha-beta/NEWGENE CD3/NEWGENE1 gamma/NEWGENE1 delta/NEWGENE1 epsilon/NEWGENE1 TCR/NEWGENE complexes/NEWGENE to/IN the/DT cell/NN surface/NN ,/, CD3/NEWGENE zeta/NEWGENE appears/VBZ to/IN be/VB essential/JJ for/IN interleukin-2/NEWGENE production/NN after/IN TCR/NEWGENE stimulation/NN with/IN antigen/NEWGENE //NEWGENE major/NEWGENE histocompatibility/NEWGENE complex/NEWGENE ./.
@@25312036685 Quantitative/JJ predictions/NNS are/VBP confirmed/VBN for/IN the/DT positive/JJ responses/NNS ,/, but/CC not/RB for/IN the/DT negatives/NNS ,/, suggesting/VBG that/IN the/DT SSTS/NN model/NN is/VBZ incorrect/JJ ./.
@@54724855559 Bimodal/JJ cochlear/JJ response/NN curves/NNS in/IN rodents/NNS ./.
@@96366702405 Structure/NNS of/IN the/DT gene/NN encoding/VBG the/DT human/NEWGENE cyclin-dependent/NEWGENE kinase/NEWGENE inhibitor/NEWGENE p18/NEWGENE and/CC mutational/JJ analysis/NN in/IN breast/NN cancer/NN ./.
@@86610079885 Human/NEWGENE MN/NEWGENE //NEWGENE CA9/NEWGENE gene/NEWGENE ,/, a/DT novel/JJ member/NN of/IN the/DT carbonic/NEWGENE anhydrase/NEWGENE family/NEWGENE :/: structure/NN and/CC exon/NN to/IN protein/NN domain/NN relationships/NNS ./.
@@107064753444 However/RB ,/, when/CC ,/, where/CC and/CC how/RB the/DT DSPP/NEWGENE is/VBZ cleaved/VBN into/IN DSP/NEWGENE and/CC DPP/NEWGENE is/VBZ not/RB clear/JJ ./.
@@68630879215 Low-dose/NNP D/NN (/( 0/CD ./CD 4-0/CD ./CD 8/CD mg/NN )/SYM and/CC DB/NN (/( 1/CD ./CD 0-5/CD ./CD 0/CD mg/NN )/SYM did/VBD not/RB significantly/RB alter/VB any/DT parameter/NN from/IN control/NN ./.
@@8312243645 We/PRP have/VBP investigated/VBN the/DT influence/NN of/IN NaFe3+EDTA/NN ,/, and/CC of/IN increasing/JJ dietary/JJ levels/NNS of/IN Na2EDTA/NNP ,/, on/IN Zn/NN ,/, Cu/NN and/CC Ca/NN metabolism/NN in/IN rats/NNS fed/VBN on/IN Zn-sufficient/NNP and/CC Zn-deficient/NNP soya-bean-isolate-based/JJ diets/NNS ./.
@@84640568868 Further/JJ evidence/NN for/IN a/DT clustered/VBN organization/NN of/IN FAX-ZFP/NEWGENE transcription/NEWGENE units/NEWGENE is/VBZ provided/VBN by/IN Southern/NNP blot/NN analysis/NN of/IN large/JJ genomic/JJ restriction/NN fragments/NNS separated/VBN by/IN transverse/JJ field/NN gel/NN electrophoresis/NN ,/, and/CC by/IN in/IN situ/NN hybridization/NN on/IN intact/JJ chromosomes/NNS ./.
@@105422374216 Here/RB ,/, we/PRP show/VBP that/IN aortic/JJ explants/NNS isolated/VBN from/IN PPARalpha-null/NNP mice/NNS display/NN an/DT exacerbated/VBN response/NN to/IN inflammatory/JJ stimuli/NNS ,/, such/JJ as/IN lipopolysaccharide/NN (/( LPS/NN )/SYM ,/, as/IN demonstrated/VBN by/IN increased/JJ IL-6/NEWGENE secretion/NN ./.
@@43359654938 Metastasis/NNS of/IN colon/NN carcinoma/NN to/IN the/DT lip/NN ./.
@@79537857934 During/IN heat/NN exposure/NN ,/, chicks/NNS that/WDT had/VBP been/VBN subjected/VBN to/IN early/JJ 60%/CD restriction/NN with/IN non-metyrapone-treated/JJ food/NN had/VBP lower/JJR H/NNS //NNS L/NNS ratios/NNS and/CC improved/VBN resistance/NN to/IN marble/NN spleen/NN disease/NN infection/NN ./.
@@21605028797 No/DT recombination/NN signal/JJ sequences/NNS have/VBP been/VBN found/VB contiguous/JJ to/IN the/DT recombination/NN point/NN ./.
@@22092378138 Abnormal/JJ intrapulmonary/JJ shunting/NN (/( IPS/NNS )/SYM ,/, which/WDT was/VBD proved/VBN in/IN 4/CD cases/NNS by/IN whole-body/NN radionuclide/NN scanning/JJ with/IN 99mTc-MAA/NN ,/, is/VBZ suggested/VBN as/IN the/DT major/JJ cause/NN of/IN cyanosis/NN in/IN liver/NN cirrhosis/NN ./.
@@75194476861 Organization/NNP of/IN the/DT bovine/NN gene/NN encoding/VBG the/DT endothelial/NEWGENE nitric/NEWGENE oxide/NEWGENE synthase/NEWGENE ./.
@@30269152099 The/DT 5'-nontranslated/JJ sequences/NNS and/CC parts/NNS of/IN the/DT coding/JJ sequences/NNS of/IN various/JJ yeast/NN genes/NNS have/VBP been/VBN cloned/VBN into/IN representative/JJ lacZ/NEWGENE fusion/NN vectors/NN ./.
@@98409322259 In/NN this/DT study/NN we/PRP provide/VBP evidence/VBP that/IN B-Myb/NEWGENE is/VBZ a/DT direct/JJ physiological/JJ target/NN for/IN cyclin/NEWGENE A/NEWGENE //NEWGENE Cdk2/NEWGENE ./.
@@107217049162 Thus/RB ,/, while/CC the/DT genomic/JJ organization/NN of/IN mHuA/NEWGENE is/VBZ similar/JJ to/IN the/DT neural-restricted/NN members/NN of/IN the/DT Elav/NEWGENE family/NEWGENE ,/, the/DT promoter/NN element/NN differs/VBZ substantially/RB both/DT by/IN sequence/NN analysis/NN and/CC transcriptional/JJ activity/NN in/IN non-neural/JJ cell/NN types/NNS ./.
@@3963860417 A/DT total/NN of/IN 90/CD patients/NNS were/VBD randomly/RB allocated/VBN either/DT to/IN an/DT MY-1/NN treated/VBN or/CC an/DT untreated/JJ group/NN ./.
@@17748222377 Using/VBG an/DT image-processing/NN computer/NN ,/, regional/NN LV/NN time-density/JJ curves/NNS were/VBD constructed/VBN for/IN one/PRP cardiac/JJ cycle/NN ./.
@@75342867115 A/DT chicken/NEWGENE paxillin/NEWGENE cDNA/NEWGENE was/VBD also/RB cloned/VBN and/CC is/VBZ predicted/VBN to/IN encode/VB a/DT protein/NN approximately/RB 90%/NN identical/JJ to/IN human/NEWGENE paxil-lin/NEWGENE ./.
@@36022611174 In/NN the/DT normal/NN ,/, basal/JJ (/( unstimulated/JJ )/SYM condition/NN there/RB were/VBD no/DT significant/JJ correlations/NNS (/( p/NN greater/JJR than/IN 0/CD ./CD 05/CD )/SYM between/IN the/DT systolic/JJ blood/NN pressure/NN and/CC dopamine/NN (/( r/JJ =/SYM 0/CD ./CD 09/CD )/SYM ,/, norepinephrine/NN (/( r/JJ =/SYM 0/CD ./CD 26/CD )/SYM ,/, or/CC epinephrine/NN (/( r/JJ =/SYM 0/CD ./CD 27/CD )/SYM ,/, nor/CC were/VBD there/RB significant/JJ correlations/NNS between/IN melatonin/NN and/CC dopamine/NN (/( r/JJ =/SYM -0/CD ./CD 01/CD )/SYM ,/, norepinephrine/NN (/( r/JJ =/SYM -0/CD ./CD 26/CD )/SYM ,/, or/CC growth/NEWGENE hormone/NEWGENE (/( r/JJ =/SYM 0/CD ./CD 17/CD )/SYM ./.
@@112187396561 Transition/NN between/IN P-/NN and/CC H-BPPV/NN was/VBD found/VBN in/IN 6/CD cases/NNS ./.
@@10647633117 The/DT study/NN suggests/VBZ the/DT presence/NN of/IN an/DT anatomical/JJ sphincter/NN at/IN the/DT RSJ/NN which/WDT seems/VBZ to/IN regulate/VB the/DT passage/NN of/IN stools/NNS from/IN the/DT sigmoid/JJ colon/NN to/IN the/DT rectum/NN ./.
@@90058368970 No/DT correlation/NN between/IN the/DT age/NN of/IN the/DT horses/NNS and/CC the/DT antibody/NN level/NN could/MD be/VB found/VB ./.
@@79784067971 In/NN the/DT ISO/NN group/NN ,/, at/IN pre-DEX/JJ ,/, CBF/NN increased/VBD from/IN 86/CD +/NN //NN -/NN 8/CD to/IN 166/CD +/NN //NN -/NN 19/NN mL/NN ./NN min-1/NN ./NN 100/NN g-1/NN in/IN response/NN to/IN hypercapnia/NN (/( PCO2/NN approximately/RB 90/CD mmHg/NN )/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@106186456771 Maximum/NNP induction/NN of/IN AP-1/NEWGENE was/VBD reached/VBN at/IN a/DT concentration/NN of/IN 250/CD nmol/NN //NN L/NN of/IN CalC/NNP ./.
@@78988409179 Pregnancy/NNS screening/JJ by/IN uterine/JJ artery/NN Doppler/NN velocimetry--which/JJ criterion/NN performs/VBZ best/JJS ?/. OBJECTIVE/IN :/: To/TO test/VB whether/IN repeating/JJ Doppler/NN studies/NNS of/IN the/DT uteroplacental/JJ circulation/NN late/RB in/IN gestation/NN will/MD improve/VB the/DT test's/NNS power/NN for/IN predicting/JJ pregnancy-induced/JJ hypertension/NN and/CC fetal/JJ growth/NN restriction/NN (/( FGR/NN )/SYM ,/, and/CC whether/IN analysis/NN based/VBN on/IN a/DT combination/NN of/IN quantitative/JJ and/CC qualitative/JJ assessments/NNS of/IN the/DT uterine/JJ arterial/JJ waveforms/NNS will/MD yield/VB better/JJR results/NNS than/IN analysis/NN based/VBN on/IN either/DT alone/RB ./.
@@10852460660 The/DT relationships/NNS among/IN blood/NN concentrations/NNS of/IN thyroid/JJ hormones/NNS and/CC selenium/NN ,/, zinc/NN ,/, retinol/NN ,/, and/CC alpha-tocopherol/NN were/VBD studied/VBN in/IN 44/CD healthy/JJ Northern/NNP Italian/JJ oldest-old/JJ subjects/NNS (/( age/NN range/NN ,/, 90-107/CD yr/NN )/SYM ,/, selected/VBN by/IN the/DT criteria/NNS of/IN the/DT SENIEUR/NN protocol/NN ./.
@@40750214892 [/NN 14C/NN ]/NN -beta-phenethylamine/NN ,/, its/PRP distribution/NN after/IN administration/NN by/IN various/JJ routes/NNS to/IN cats/NNS ,/, and/CC the/DT effects/NNS of/IN monoamine/NEWGENE oxidase/NEWGENE inhibitors/NN ./.
@@33063404966 The/DT intrapancreatic/JJ spread/NN of/IN the/DT carcinoma/NN correlated/VBN with/IN portal/JJ invasion/NN of/IN carcinoma/NN ,/, hardness/NN of/IN the/DT body/NN and/CC tail/NN ,/, obstruction/NN of/IN main/JJ pancreatic/JJ duct/NN and/CC irregular/JJ pancreaticogram/NN ./.
@@52741285443 The/DT content/NN of/IN glucosamine/NN and/CC galactosamine/NN in/IN tartar/NN ./.
@@75596403706 The/DT two/JJ bases/NNS immediately/RB flanking/JJ the/DT 5'/CD end/NN of/IN the/DT element/NN proved/VBN to/IN be/VB very/RB important/JJ to/IN its/PRP function/NN as/IN a/DT UAS/NEWGENE element/NEWGENE as/IN did/VBD the/DT two/JJ bases/NNS immediately/RB 3'/CD of/IN the/DT bHLH/NN core/NN motif/NN ./.
@@80812938059 2/CD ./CD
@@21762093714 Moreover/RB ,/, radiolabeled/JJ EFI/NEWGENE ,/, NF-Y/NEWGENE ,/, or/CC CBF/NEWGENE DNAs/NEWGENE give/VBP rise/NN to/IN identical/JJ gel/NN retardation/NN patterns/NNS in/IN extracts/NNS from/IN a/DT variety/NN of/IN different/JJ cell/NN types/NNS ./.
@@17592822357 Issues/NNS of/IN distribution/NN of/IN kinetic/JJ energy/NN of/IN traumatizing/JJ object/NN in/IN direct/JJ contact/NN interaction/NN with/IN head/JJ during/IN impact/NN are/VBP discussed/VBN from/IN position/NN of/IN biomechanics/NN ./.
@@7014626792 Urine/NNS antibodies/NNS could/MD not/RB be/VB demonstrated/VBN in/IN any/DT other/DT cases/NNS ./.
@@81882583738 Glutamyl-tRNA/NEWGENE synthetase/NEWGENE and/CC prolyl-tRNA/NEWGENE synthetase/NEWGENE belong/VB to/IN different/JJ classes/NNS of/IN aminoacyl-tRNA/NEWGENE synthetases/NEWGENE that/WDT are/VBP thought/VBP to/IN have/NN evolved/VBN along/IN independent/JJ evolutionary/JJ pathways/NNS ./.
@@13344936507 This/DT soluble/JJ form/NN of/IN the/DT HGFr/NEWGENE (/( sHGFr/NEWGENE )/SYM bound/JJ HGF/NEWGENE with/IN an/DT affinity/NN similar/JJ to/IN that/DT of/IN the/DT authentic/NN ,/, membrane-associated/NN receptor/NN ./.
@@38712981836 Single/NNP photon/NN emission/NN computerized/JJ tomography/NN (/( SPECT/NN )/SYM ,/, by/IN providing/CC three-dimensional/JJ representation/NN of/IN myocardial/JJ Tl-201/NN ,/, offers/VBP promise/VB for/IN improved/VBN localization/NN of/IN CAD/NN ./.
@@9339900470 Functional/JJ analysis/NN of/IN promoter/NN activity/NN of/IN the/DT 5'-flanking/JJ region/NN of/IN cyclin/NEWGENE D2/NEWGENE suggested/VBN that/IN the/DT region/NN -/: 1/CD ,/CD 100/CD to/IN -/: 805/CD including/JJ C/NEWGENE //NEWGENE EBP/NEWGENE ,/, PEA3/NEWGENE ,/, AP2/NEWGENE ,/, NF-Y/NEWGENE ,/, c-Myc/NEWGENE ,/, and/CC Sp1/NEWGENE may/MD have/VB a/DT major/JJ positive/JJ regulatory/JJ activity/NN for/IN expression/NN of/IN cyclin/NEWGENE D2/NEWGENE ./.
@@2196748343 Technetium-99m/NN stannous/JJ pyrophosphate/NN myocardial/JJ scintigrams/NNS were/VBD obtained/VBN in/IN 138/CD clinically/RB stable/JJ patients/NNS 32/CD ./CD 7/CD +/NN //NN -/NN 47/CD ./CD 3/CD weeks/NNS (/( range/NN 6/CD to/IN 260/CD )/SYM after/IN acute/JJ myocardial/JJ infarction/NN ./.
@@111854751027 By/IN Caveman/NNP ./.
@@86316674545 Identification/NNP of/IN this/DT region/NN as/IN the/DT E/NEWGENE ./NEWGENE coli/NEWGENE tmk/NEWGENE gene/NEWGENE was/VBD confirmed/VBN by/IN functional/JJ complementation/NN of/IN a/DT yeast/NEWGENE dTMP/NEWGENE kinase/NEWGENE temperature-sensitive/JJ mutant/JJ and/CC by/IN in/IN vitro/NN enzyme/NN assay/NN of/IN the/DT thymidylate/NEWGENE kinase/NEWGENE activity/NN in/IN cell/NN extracts/NNS of/IN E/NNP ./NNP coli/JJ by/IN use/NN of/IN tmk-overproducing/JJ plasmids/NNS ./.
@@9037728995 Wherever/WRB the/DT site/NN of/IN the/DT conditioning/JJ stimulation/NN ,/, these/DT modifications/NNS disappeared/VBN after/IN ischaemia/NN of/IN the/DT leg/NN ./.
@@26769453350 62/CD :/: 2491-2499/CD ,/, 1987/NN )/NN ./.
@@10933728763 These/DT results/NNS further/JJ support/NN an/DT important/JJ role/NN for/IN CBF2/NEWGENE in/IN mediating/JJ EBNA2/NEWGENE transactivation/NN ;/: they/PRP identify/VBP the/DT hnRNP/NEWGENE protein/NEWGENE AUF1/NEWGENE as/IN a/DT major/JJ component/NN of/IN CBF2/NEWGENE and/CC are/VBP also/RB the/DT first/JJ evidence/NN of/IN a/DT cis-acting/JJ sequence/NN other/DT than/IN a/DT CBF1/NEWGENE binding/NEWGENE element/NEWGENE that/WDT is/VBZ able/JJ to/IN confer/VB responsiveness/NN to/IN EBNA2/NEWGENE ./.
@@48840605221 The/DT Twentieth/NNP Anniversary/NNP of/IN the/DT Pomeranian/NNP Medical/NNP Academy/NNP ./.
@@9778191609 We/PRP have/VBP developed/VBN a/DT new/JJ method/NN for/IN estimation/NN of/IN regional/NN CBF/NN (/( rCBF/NN )/SYM and/CC cerebrovascular/JJ reserve/NN capacity/NN on/IN a/DT pixel-by-pixel/JJ basis/NN by/IN means/NN of/IN dynamic/JJ magnetic/JJ resonance/NN imaging/JJ (/( MRI/NN )/SYM ./.
@@106410373799 AF154055/NEWGENE ./.
@@33462107416 The/DT epidermal/NEWGENE growth/NEWGENE factor/NEWGENE (/NEWGENE EGF/NEWGENE )/NEWGENE receptor/NEWGENE ,/, which/WDT exhibits/VBP intrinsic/NN protein/NEWGENE tyrosine/NEWGENE kinase/NEWGENE activity/NN ,/, undergoes/VBZ a/DT rapid/NN ,/, intramolecular/JJ self-phosphorylation/NN reaction/NN following/IN EGF/NEWGENE activation/NN ./.
@@36794079181 These/DT results/NNS suggest/VBP that/IN N-nitroso/NN compounds/NNS can/MD be/VB formed/VBN in/IN vivo/NN in/IN the/DT infected/VBN bladder/NN ,/, which/WDT could/MD explain/VB the/DT association/NN between/IN urinary-tract/NN infections/NNS and/CC increased/VBN risk/NN for/IN bladder/NN cancer/NN ./.
@@97503259736 The/DT effects/NNS of/IN high/JJ intensity/NN light/JJ emissions/NNS ,/, produced/VBN by/IN a/DT novel/JJ pulsed/JJ power/NN energization/NN technique/NN (/( PPET/NNP )/SYM ,/, on/IN the/DT survival/NN of/IN bacterial/JJ populations/NNS of/IN verocytotoxigenic/JJ Escherichia/NN coli/JJ (/( serotype/NN 0157/CD :/: H7/IN )/SYM and/CC Listeria/NN monocytogenes/NNS (/( serotype/NN 4b/CD )/SYM were/VBD investigated/VBN ./.
@@94094163074 Bilateral/JJ basal/JJ arteries/NNS were/VBD measured/VBN by/IN the/DT transtemporal/JJ approach/NN with/IN a/DT 2/CD MHz/NN pulsed/JJ Doppler/NN instrument/NN (/( TC-2/NN 64B/NN EME/NN )/SYM ./.
@@7874060460 TDEYA/NNP at/IN doses/NNS of/IN 200/CD to/IN 500/CD mg/CD //CD kg/CD significantly/RB suppressed/VBN xanthine/NEWGENE oxidase/NEWGENE (/( XO/NEWGENE )/SYM activity/NN in/IN the/DT stomach/NN tissue/NN following/IN its/PRP oral/JJ administration/NN ./.
@@111614551652 Southern/NNP blot/NN analysis/NN of/IN genomic/JJ DNA/NN from/IN somatic/JJ cell/NN hybrids/NNS showed/VBN that/IN endothelial-TACC-related/NEWGENE cDNA/NEWGENE maps/NNS to/IN chromosome/NN 10/CD ./CD
@@91591117130 We/PRP have/VBP tested/VBN this/DT proposal/NN by/IN carrying/JJ out/RB circular/JJ dichroism/NN (/( CD/NN )/SYM and/CC NMR/NN experiments/NNS on/IN the/DT Skn/NEWGENE domain/NEWGENE and/CC five/CD truncated/JJ proteins/NNS ./.
@@86282544624 We/PRP show/VBP here/RB that/IN these/DT Jun/NEWGENE //NEWGENE eb1/NEWGENE chimeras/NEWGENE are/VBP potent/JJ transactivators/NNS of/IN AP1/NEWGENE sites/NEWGENE and/CC that/IN they/PRP can/MD cooperate/VB with/IN c-Ha-Ras/NEWGENE to/IN induce/VB foci/NNS ./.
@@72180084620 Visual/JJ response/NN properties/NNS of/IN neurons/NNS in/IN four/CD extrastriate/NN visual/NN areas/NNS of/IN the/DT owl/NN monkey/NN (/( Aotus/NN trivirgatus/NN )/SYM :/: a/DT quantitative/JJ comparison/NN of/IN medial/JJ ,/, dorsomedial/JJ ,/, dorsolateral/JJ ,/, and/CC middle/JJ temporal/JJ areas/NNS ./.
@@78362286031 An/DT interatrial/JJ communication/NN mitigates/VBZ the/DT impairment/NN of/IN LV/NN function/NN after/IN an/DT acute/JJ and/CC sustained/JJ drop/NN of/IN intrathoracic/JJ pressure/NN ./.
@@33711394057 The/DT former/JJ group/NN did/VBD excrete/VB less/PRP dry/JJ fecal/JJ material/NN compared/VBN to/IN both/PDT other/DT groups/NNS ./.
@@91214356610 Domains/NN I/NN and/CC II/NNP of/IN B"/NEWGENE are/VBP buried/VBN upon/IN assembly/NN of/IN the/DT TFIIIB-DNA/NEWGENE complex/NEWGENE ,/, as/IN determined/VBN by/IN protein/NN footprinting/VBG ./.
@@80577621891 We/PRP have/VBP found/VBN a/DT satisfactory/JJ reproducibility/NN in/IN vitro/FW (/( T1/NN :/: 1/CD ./CD 9%/CD ;/: T2/NN :/: 6/CD ./CD 2%/CD )/SYM ,/, while/CC the/DT reproducibility/NN was/VBD less/PRP satisfactory/JJ in/IN vivo/NN (/( T1/NN :/: 16/CD ./CD 4%/CD ;/: T2/NN :/: 13/CD ./CD 4%/CD )/SYM ./.
@@71958807023 This/DT test/NN should/MD provide/VB another/DT practical/JJ means/NN to/IN study/NN leprosy/NN ./.
@@77528869261 The/DT smallest/JJS active/NEWGENE FecR/NEWGENE derivative/NEWGENE contained/VBN 59/CD amino/JJ acid/NN residues/NNS as/IN compared/VBN to/IN the/DT 317/CD residues/NNS of/IN wild-type/NEWGENE FecR/NEWGENE ./.
@@52843105452 The/DT non-role/NN of/IN fluoride/NN in/IN the/DT control/NN of/IN plasma/NN calcium/NN in/IN the/DT parathyroidectomized/VBN rat/NN ./.
@@76664151128 The/DT nucleotide/NN sequence/NN of/IN the/DT chloroplast/NN (/( cp/NN )/SYM DNA/NN from/IN maize/NN (/( Zea/NN mays/VBZ )/SYM has/VBZ been/VBN completed/VBN ./.
@@87945478777 Although/IN basal/JJ vessels/NNS may/MD constrict/VB distal/JJ parenchymal/JJ vessels/NNS tend/VBP to/IN dilate/VB after/IN SAH/NN ./.
@@75927061486 Exchange/NNP of/IN the/DT LPL/NEWGENE and/CC HL/NEWGENE lids/NNS resulted/VBN in/IN a/DT reversal/NN of/IN the/DT phospholipase/NN //NN neutral/NN lipase/NEWGENE ratio/NN ,/, establishing/VBG the/DT important/JJ role/NN of/IN this/DT region/NN in/IN mediating/JJ substrate/NN specificity/NN ./.
@@63360456126 Frog/NN type/NN I/NN (/( Ft/NN I/NN )/SYM and/CC frog/NN type/NN II/NN (/( Ft/NN II/NN )/SYM slowly/RB adapting/JJ (/( SA/NNP )/SYM units/NNS produced/VBD spikes/NNS only/RB at/IN the/DT indentation/NN phase/NN ,/, and/CC the/DT threshold/NN response/NN phase/NN (/( TRP/NN )/SYM ,/, i/FW ./FW e/FW ./FW ./. the/DT phase/NN of/IN the/DT first/JJ spike/NN was/VBD for/IN ca/NN ./NN
@@54744662436 A/DT new/JJ hemagglutination/NN test/NN for/IN the/DT on-slide/JJ assay/NN of/IN rheumatoid/NEWGENE factor/NEWGENE ./.
@@92236677453 Through/IN transient/JJ transfection/NN of/IN NIH3T3/NNP fibroblast/NN cells/NNS and/CC gel/NN mobility/NN shift/NN assays/NNS ,/, the/DT functional/JJ binding/JJ site/NN was/VBD localized/VBN to/IN a/DT short/JJ region/NN (/( -318/CD to/IN -303/CD bp/NN from/IN the/DT transcription/NN start/NN site/NN )/SYM which/WDT has/VBZ a/DT CTCCC/NEWGENE sequence/NEWGENE ./.
@@96504039625 The/DT DHEAS/NN levels/NNS in/IN all/DT stages/NNS of/IN decreased/VBN BMD/NN were/VBD significantly/RB lower/JJR than/IN those/DT in/NN the/DT group/NN with/IN normal/JJ BMD/NN ./.
@@15960076120 Most/JJS apneic/JJ events/NNS occurred/VBN during/IN Stages/NNS I/PRP and/CC II/NNP ,/, and/CC REM/NN ,/, but/CC this/DT proportion/NN was/VBD less/PRP during/IN the/DT gamma/NN OH/NN study/NN (/( 77/CD ./CD 9/CD +/NN //NN -/NN 8/CD ./CD 9%/CD )/SYM than/IN during/IN the/DT control/NN studies/NNS (/( 92/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 9/CD and/CC 95/CD ./CD 9/CD +/NN //NN -/NN 2/CD ./CD 2%/CD )/SYM ,/, apneas/NNS occurring/VBG even/VB during/IN SWS/NN with/IN gamma/JJ OH/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@114043121268 10/CD ./CD 0/CD +/NN //NN -/NN 2/CD ./CD 0/CD pmol/NN //NN 24/NN h/NN ,/, P/NN </SYM 0/NN ./NN 01/NN )/NN and/CC remained/VBN elevated/VBN ./.
@@91404749082 Is/VBZ leishmaniasis/NN endemic/JJ on/IN the/DT island/NN of/IN Minorca/NNP (/( Spain/NN )/SYM ?/. A/DT human/NN visceral/NN case/NN after/IN living/JJ 13/CD years/NNS in/IN Minorca/NNP ./.
@@93330186113 Interferon/NEWGENE Regulatory/NEWGENE Factor/NEWGENE (/NEWGENE IRF/NEWGENE )/NEWGENE -1/NEWGENE has/VBZ been/VBN characterized/VBN as/IN an/DT important/JJ growth/NN regulatory/JJ and/CC immunomodulatory/JJ transcription/NN factor/NN ./.
@@82048244370 A/DT genomic/JJ clone/NN for/IN the/DT cyc07/NEWGENE gene/NEWGENE ,/, which/WDT is/VBZ expressed/VBN specifically/RB at/IN the/DT S/NNP phase/NN during/IN the/DT cell/NN cycle/NN in/IN synchronous/JJ cultures/NNS of/IN periwinkle/NN (/( Catharanthus/NNP roseus/NN )/SYM cells/NNS ,/, was/VBD isolated/VBN ./.
@@82943868274 BACKGROUND/IN :/: To/TO determine/VB the/DT predictors/NNS of/IN desipramine-refractory/JJ depression/NN ,/, the/DT authors/NNS examined/VBD the/DT outcome/NN in/IN patients/NNS with/IN major/JJ depression/NN who/WP were/VBD admitted/VBN to/IN a/DT general/JJ hospital/NN and/CC treated/VBN with/IN desipramine/NN adjusted/VBN to/IN an/DT adequate/JJ blood/NN level/NN ./.
@@92388609635 It/PRP is/VBZ present/VB in/IN the/DT nucleus/NN of/IN the/DT cells/NNS in/IN which/WDT it/PRP is/VBZ expressed/VBN and/CC can/MD phosphorylate/VB and/CC activate/VB the/DT cyclic/NEWGENE AMP/NEWGENE response/NEWGENE element/NEWGENE binding/NEWGENE proteins/NEWGENE CREB/NEWGENE1 and/CC CREM/NEWGENE tau/NEWGENE in/IN a/DT manner/NN analogous/JJ to/IN protein/NEWGENE kinase/NEWGENE A/NEWGENE ./.
@@118305444091 Herceptin/NNP ,/, which/WDT recognizes/VBZ the/DT HER-2/NEWGENE //NEWGENE neu/NEWGENE antigen/NEWGENE and/CC has/VBZ similar/JJ size/NN (/( 10/CD nm/NN )/SYM to/IN G6-/NN (/NN 1B4M-Gd/NN )/NN (/NN 256/NN )/NN ,/, accumulated/VBN and/CC internalized/VBN in/IN the/DT WIBC-9/CD tumors/NNS more/RB quickly/RB than/IN in/IN the/DT control/NN MC-5/NN tumors/NNS that/WDT progress/VBP with/IN normal/JJ angiogenesis/NN ./.
@@82606353387 This/DT intron/NN occupies/VBZ a/DT conserved/VBN position/NN corresponding/JJ to/IN that/DT of/IN intron/NN 1/CD in/IN the/DT transit/NN peptide/NN region/NN of/IN chloroplast/NEWGENE GAPDH/NEWGENE genes/NEWGENE (/( GapA/NEWGENE and/CC GapB/NEWGENE )/SYM of/IN higher/JJ plants/NNS ./.
@@17715931627 We/PRP conclude/VBP that/DT TA/NN caused/VBD a/DT specific/JJ decrease/NN in/IN AGD/NNS on/IN GD/NN 20/NN that/WDT was/VBD largely/RB reversed/VBN by/IN PCD/NN 23/CD ./CD
@@95051359468 Peripheral/NN visual/NN stimuli/NNS and/CC monoaural/JJ auditory/JJ stimuli/NNS were/VBD used/VBN as/IN targets/NNS ./.
@@107829897791 The/DT interaction/NN does/VBP not/RB depend/VB on/IN the/DT presence/NN of/IN the/DT correct/JJ amino-terminal/NN DNA/NN binding/JJ domain/NN or/CC the/DT amino/JJ acid/NN sequences/NNS between/IN the/DT DNA/NN binding/JJ domain/NN and/CC the/DT last/NN ten/CD amino/JJ acids/NNS ./.
@@39980719517 Electrochemical/NNP detection/NN of/IN depressed/VBN circulating/JJ levels/NNS of/IN vitamin/NN K1/NN in/IN osteoporosis/NN ./.
@@94278444985 Conversely/RB ,/, the/DT inactive/JJ dAK/NEWGENE subunit/NEWGENE is/VBZ progressively/RB activated/VBN by/IN 1/NN )/NN association/NN with/IN a/DT dGK/NEWGENE or/CC dCK/NEWGENE subunit/NEWGENE and/CC 2/NN )/NN the/DT conformationally/RB driven/VBP heterotropic/JJ affect/NN of/IN dGuo/NEWGENE or/CC dCyd/NEWGENE bound/JJ to/IN the/DT opposing/JJ subunit/NN ./.
@@1048808732 Mutation/NN of/IN TTF-1-binding/NEWGENE sites/NEWGENE (/NEWGENE TBE/NEWGENE )/NEWGENE 1/NEWGENE ,/NEWGENE 3/NEWGENE ,/NEWGENE and/NEWGENE 4/NEWGENE in/IN combination/NN markedly/RB decreased/VBD transcriptional/JJ activity/NN of/IN SP-A/NEWGENE promoter-chloramphenicol/NEWGENE acetyltransferase/NEWGENE constructs/NN containing/NN SP-A/NEWGENE gene/NEWGENE sequences/NN from/IN -256/CD to/IN +45/CD ./.
@@8749428736 Unrecognized/JJ amnionitis/NN and/CC prematurity/NN :/: a/DT preliminary/JJ report/NN ./.
@@84112766741 A/DT patient/NN matches/VBZ a/DT PIC/NNP patient/NN if/IN both/DT have/NN the/DT same/JJ mechanism/NN of/IN injury/NN ,/, the/DT same/JJ coding/NN of/IN Revised/NNP Trauma/NN Score/NN variables/NNS (/( Glascow/NNP Coma/NNP Scale/NNP score/NN ,/, systolic/JJ blood/NN pressure/NN ,/, respiratory/JJ rate/NN )/SYM ,/, the/DT same/RB coded/VBN age/NN per/IN A/DT Severity/NN Characterization/NNS of/IN Trauma/NN )/NN (/( ASCOT/NNP )/SYM ,/, and/CC if/IN they/PRP differ/VBP by/IN no/DT more/RB than/IN 0/CD ./CD 5/CD for/IN A/DT ,/, B/NNP ,/, and/CC C/NN (/( the/DT ASCOT/NN components/NN for/IN serious/JJ injuries/NNS )/SYM ./.
@@88082756474 Although/IN the/DT RAD23/NEWGENE equivalents/NNS are/VBP well/VB conserved/VBN during/IN evolution/NN ,/, the/DT mammalian/JJ genes/NNS did/VBD not/RB express/VB the/DT UV-inducible/NNP phenotype/NN of/IN their/PRP yeast/NN counterpart/NN ./.
@@57740625714 Measurement/NNP of/IN gastric/JJ acid/NN secretion/NN by/IN conductivity/NN ./.
@@26865887919 Routine/JJ clinical/JJ analysis/NN revealed/VBN lower/JJR hematocrit/NN and/CC hemoglobin/NEWGENE ,/, and/CC elevated/VBD BUN/NN and/CC alkaline/NEWGENE phosphatase/NEWGENE in/IN the/DT treated/VBN group/NN ./.
@@83170922462 The/DT C-terminal/NN region/NN of/IN the/DT 150-kDa/NN protein/NN contains/VBZ an/DT NTP-binding/NN helicase/NEWGENE motif/NEWGENE and/CC the/DT readthrough/NN region/NN ,/, an/DT RNA/NEWGENE polymerase/NEWGENE motif/NEWGENE ,/, indicating/VBG that/IN these/DT two/JJ overlapping/JJ proteins/NNS may/MD form/VB an/DT RNA/NN replication/NN complex/NN similar/JJ to/IN those/DT of/IN tobamo-/JJ and/CC tobraviruses/NNS ./.
@@14646067172 Comparable/JJ amounts/NNS of/IN alpha/NEWGENE 5/NEWGENE beta/NEWGENE 1/NEWGENE integrin/NEWGENE were/VBD isolated/VBN from/IN these/DT cells/NNS by/IN chromatography/NN of/IN detergent/JJ extracts/NNS on/IN a/DT fibronectin/NEWGENE cell-binding/NN fragment/NN affinity/NN column/NN and/CC elution/NN with/IN EDTA/NN ./.
@@67958328585 In/NN the/DT course/NN of/IN Hepatitis/NEWGENE A/NEWGENE HBs-/NEWGENE and/NEWGENE HBe-antigen/NEWGENE as/NNP well/VB as/IN HBc/NEWGENE (/NEWGENE IgM/NEWGENE and/NEWGENE IgG/NEWGENE )/NEWGENE -/NEWGENE ,/, HBs-/NEWGENE and/NEWGENE HBe-antibodies/NEWGENE can/MD be/VB detected/VBN ./.
@@97653728293 The/DT high/JJ density/NN of/IN tegumental/JJ spines/NNS on/IN posterior/JJ half/NN of/IN the/DT body/NN and/CC the/DT distribution/NN of/IN type/NN II/NN papillae/NNS on/IN dorsal/JJ surface/NN are/VBP considered/VBN to/IN be/VB characteristic/NN of/IN C/NNP ./NNP armatus/NN ./.
@@83212275104 It/PRP could/MD be/VB detected/VBN exclusively/RB in/IN the/DT culture/NN medium/NN of/IN cDNA-transfected/JJ COS/NN cells/NNS ./.
@@87558987855 Two/CD classes/NNS of/IN Xanthomonas/NNP pathogens/NNS evading/JJ Bs2/NN host/NN resistance/NN and/CC displaying/VBG reduced/VBN fitness/NN were/VBD found/VBN to/IN be/VB specifically/RB mutated/JJ in/IN avrBs2/NEWGENE ./.
@@31333606625 Our/PRP findings/NNS suggest/VBP that/IN the/DT mtr/NEWGENE product/NEWGENE causes/VBZ both/DT transcription/NN attenuation/NN and/CC inhibition/NN of/IN translation/NN of/IN trpE/NEWGENE mRNA/NEWGENE ./.
@@665336941 At/NN the/DT same/JJ time/NN we/PRP obtained/VBD easily/RB understandable/JJ EEG-information/NN which/WDT has/VBZ never/RB previously/RB been/VBN available/JJ to/IN us/CD ./CD
@@11937701845 Air/NNP ion/NN action/NN on/IN bacteria/NNS ./.
@@103471974674 Induction/NNS of/IN the/DT urokinase/NEWGENE promoter/NEWGENE by/IN HGF/NEWGENE //NEWGENE SF/NEWGENE via/NN the/DT Met/NEWGENE receptor/NEWGENE was/VBD blocked/VBN by/IN co-expression/NN of/IN a/DT dominant-negative/JJ Grb2/NEWGENE and/CC Sos1/NEWGENE expression/NN construct/NN ./.
@@8296434419 The/DT Harleco/NN apparatus/NN is/VBZ a/DT simple/NN ,/, useful/JJ ,/, cost-effective/JJ adjunct/NN to/IN the/DT diagnosis/NN and/CC treatment/NN of/IN this/DT life-threatening/JJ condition/NN ./.
@@71794127252 The/DT average/JJ annual/JJ cost/NN per/IN head/NN of/IN population/NN was/VBD US+0/NN X/NN 46/CD ./CD
@@13108791570 A/DT patient/JJ suffering/JJ from/IN heparin-associated/JJ thrombocytopenia/NN (/( HAT/NN )/SYM ,/, recurrent/JJ arteriothromboses/NNS ,/, and/CC acute/JJ renal/JJ failure/NN after/IN treatment/NN with/IN standard/JJ heparin/NN is/VBZ described/VBN ./.
@@36886764354 However/RB ,/, conversions/NNS of/IN 12/CD mm/NN or/CC more/RB from/IN a/DT documented/VBN negative/JJ result/NN indicated/VBN spread/VB of/IN infection/NN ./.
@@92356182203 In/NN a/DT series/NN of/IN patients/NNS with/IN neuroinfection/NN ,/, Lyme/NNP disease/NN ,/, Guillain/NNP Barre/NN syndrome/NN ,/, demyelinization/NN ,/, partial/JJ or/CC generalized/JJ ,/, epilepsy/NN ,/, we/PRP have/VBP investigated/VBN antiphospholipid/NN antibodies/NNS of/IN IgG/NEWGENE and/CC IgM/NEWGENE subtypes/NNS ,/, together/RB with/IN anticoagulant/JJ factors/NNS ,/, member/NN of/IN thrombocytes/NNS ,/, sedimentation/NN rate/NN of/IN erythrocytes/NNS ./.
@@78143237274 Inclusion/NNS in/IN this/DT family/NN of/IN proteins/NNS suggests/VBZ that/IN FliQ/NEWGENE and/CC FliR/NEWGENE may/MD participate/VB in/IN an/DT export/NN pathway/NN required/VBN for/IN flagellum/NN assembly/NN ./.
@@14437484199 For/IN pressure/NN greater/JJR than/IN 121/CD atm/NN abs/NNS ,/, an/DT increased/VBN excitability/NN of/IN the/DT tadpoles/NNS made/VBP it/PRP difficult/JJ to/IN distinguish/VB the/DT righting/JJ reflex/NN from/IN involuntary/JJ movements/NNS ./.
@@70971826881 The/DT duration/NN and/CC the/DT amplitude/NN of/IN the/DT negative/JJ potential/NN were/VBD greatest/JJS for/IN completely/RB regenerating/JJ ears/NNS with/IN overgrowth/NN ,/, smaller/JJR for/IN partially/RB regenerating/JJ ears/NNS ,/, and/CC smallest/JJS for/IN the/DT nonregenerating/JJ ears/NNS ./.
@@103991369847 Ozagrel/NNP ,/, ifenprodil/NN ,/, cinnarizine/NN and/CC dilazep/NN were/VBD more/RB effective/JJ than/IN pentoxifylline/NN in/IN increasing/JJ rCBF/NN at/IN the/DT HPC/NN ./.
@@105919331273 Scapulae/NNP with/IN a/DT Type/NN I/NN configuration/NN were/VBD found/VBN to/IN have/NN low/JJ values/NNS for/IN the/DT coraco-glenoid/JJ angle/NN and/CC coracoid/JJ overlap/NN ,/, which/WDT are/VBP known/VBP to/IN be/VB associated/VBN with/IN a/DT short/JJ coraco-humeral/JJ distance/NN ./.
@@34237327735 Addition/NN of/IN sucralfate/NN or/CC De-Nol/CHEM resulted/VBD in/IN increments/NNS of/IN gastric/JJ HCO3/NN secretion/NN ,/, reaching/VBG about/RB 45%/JJ and/CC 59%/CD ,/, respectively/RB ,/, of/IN the/DT maximal/JJ HCO3/NN response/NN to/IN 16/NN ,/NN 16-dimethyl/NN PGE2/NN (/( dmPGE2/NN )/SYM ./.
@@26935932825 The/DT encoded/VBN protein/NN has/VBZ a/DT leader/NN sequence/NN of/IN 27/CD amino/JJ acids/NNS ./.
@@31855402823 Factors/NNS involved/VBN in/IN specific/JJ transcription/NN by/IN mammalian/JJ RNA/NEWGENE polymerase/NEWGENE II/NEWGENE :/: purification/NN ,/, genetic/JJ specificity/NN ,/, and/CC TATA/NN box-promoter/NN interactions/NNS of/IN TFIID/NEWGENE ./.
@@28331013528 Aplastic/JJ crisis/NN in/IN sickle/JJ cell/NN disorders/NNS :/: bone/NN marrow/NN necrosis/NN and/CC human/JJ parvovirus/NN infection/NN ./.
@@25112075641 K/NNP ./NNP
@@111187123269 This/DT sensitivity/NN analysis/NN showed/VBN that/IN the/DT practical/JJ limits/NNS of/IN the/DT accuracy/NN of/IN the/DT used/VBN screening/JJ test/NN jeopardize/VB the/DT estimation/NN of/IN the/DT true/JJ herd/NN prevalence/NN within/IN reasonable/JJ confidence/NN limits/NNS ,/, because/IN the/DT within-herd/JJ PTB/NN true/JJ prevalence/NN was/VBD low/CD ./CD For/CD this/DT reason/NN we/PRP augmented/VBD the/DT herd/NN specificity/NN for/IN herds/NNS with/IN larger/RBR adult/JJ herd/NN size/NN (/( >/SYM 5/CD )/SYM ./.
@@41721664684 Poliomyelitis/NN from/IN a/DT vaccine/NN ./.
@@13244049422 HNF-3/NEWGENE beta/NEWGENE amino-terminal/NEWGENE sequences/NEWGENE defined/VBN by/IN conserved/NEWGENE region/NEWGENE IV/NEWGENE also/RB contributed/VBD to/IN transactivation/NN ,/, but/CC region/NEWGENE IV/NEWGENE activity/NN required/VBD the/DT participation/NN of/IN the/DT region/NEWGENE II-III/NEWGENE domain/NEWGENE ./.
@@105612513863 PURPOSE/NNS :/: To/TO evaluate/VB the/DT disease-free/NN survival/NN (/( DFS/NN )/SYM and/CC overall/JJ survival/NN (/( OS/NNS )/SYM ,/, prognostic/JJ factors/NNS ,/, and/CC treatment-related/JJ mortality/NN of/IN women/NNS with/IN stage/NN IIIB/NN inflammatory/JJ breast/NN cancer/NN (/( IBC/NN )/SYM treated/VBN with/IN combined/JJ modality/NN therapy/NN (/( CMT/NN )/SYM and/CC high-dose/JJ chemotherapy/NN (/( HDCT/IN )/SYM with/IN autologous/JJ stem-cell/NN transplantation/NN ./.
@@80028577996 CONCLUSIONS/IN :/: These/DT findings/NNS indicate/VBP a/DT physical/JJ barrier/NN of/IN oesophageal/JJ surfactant/JJ which/WDT could/MD offer/VB some/DT degree/NN of/IN protection/NN against/IN gastro-oesophageal/JJ reflux/JJ but/CC one/PRP which/WDT is/VBZ particularly/RB prone/RB to/IN attack/NN by/IN bile/NN ./.
@@95685499517 In/NN this/DT study/NN ,/, the/DT effect/NN of/IN acute/JJ administration/NN of/IN various/JJ doses/NNS of/IN malathion/NN via/NN oral/JJ and/CC dermal/JJ routes/NNS to/IN mice/NNS and/CC rats/NNS on/IN serum/JJ levels/NNS of/IN histamine/NN was/VBD evaluated/VBN ./.
@@9234713299 In/NN this/DT study/NN ,/, we/PRP tested/VBD this/DT notion/NN by/IN using/VBG ligation-mediated/JJ PCR/NN to/IN assess/VB the/DT formation/NN of/IN recombination-activating/NEWGENE gene/NEWGENE (/( RAG/NEWGENE )/NN -dependent/NN double-strand/NN breaks/NNS (/( DSBs/NNS )/SYM at/IN RSSs/NN 3'/CD of/IN Ddelta3/NEWGENE and/CC 5'/NN of/IN Jdelta1/NEWGENE ./.
@@79117367888 At/NN the/DT MTD/NN (/( 8/CD mg/CD //CD m2/CD //CD day/CD )/SYM ,/, the/DT dose-limiting/JJ toxicity/NN of/IN this/DT agent/NN is/VBZ myelosuppression/NN ./.
@@74367023447 All/DT control/NN persons/NNS had/VBP a/DT normal/JJ reaction/NN to/IN DNFB/NN ./.
@@43119514921 Therapeutic/JJ action/NN of/IN a/DT new/JJ antibiotic-corticoid/JJ association/NN used/VBN for/IN instillations/NNS in/IN otology/NN ./.
@@97634465530 Small/NEWGENE GTPases/NEWGENE of/IN the/DT Ypt/NEWGENE //NEWGENE Rab/NEWGENE family/NEWGENE are/VBP involved/VBN in/IN the/DT regulation/NN of/IN vesicular/JJ transport/NN ./.
@@103735076502 SRFDelta5/NEWGENE acts/NNS as/IN a/DT naturally/RB occurring/VBG dominant/JJ negative/JJ regulatory/JJ mutant/NN that/IN blocks/NNS SRF-dependent/NEWGENE skeletal/NEWGENE alpha-actin/NEWGENE ,/, cardiac/NEWGENE alpha-actin/NEWGENE ,/, smooth/NEWGENE alpha-actin/NEWGENE ,/, SM22alpha/NEWGENE ,/, and/CC SRF/NEWGENE promoter-luciferase/NEWGENE reporter/NEWGENE activities/NNS ./.
@@53628665503 Renin/NEWGENE secretion/NN in/IN essential/JJ and/CC accelerated/JJ hypertension/NN ./.
@@37916454477 These/DT findings/NNS suggest/VBP that/IN there/RB may/MD be/VB a/DT relationship/NN between/IN the/DT pathogenesis/NN of/IN MAL/NN ,/, narcolepsy/NN ,/, and/CC OSA/NN ./.
@@89949689873 An/DT N-terminal/NN arm/NN from/IN each/DT subunit/NN wraps/NNS around/IN the/DT dinucleotide-binding/JJ domain/NN of/IN an/DT adjacent/JJ subunit/NN ,/, covering/VBG the/DT adenine/NN ring/NN of/IN NADP/NN ./.
@@15097981540 At/NN rest/NN AFF/NN was/VBD significantly/RB higher/JJ in/IN UT/NN (/( 29%/CD )/SYM as/IN compared/VBN to/IN AT/IN (/( 25%/JJ )/SYM and/CC UEA/NNP (/( 25%/JJ )/SYM ./.
@@90896535230 Recombinant/JJ plasmids/NNS containing/JJ the/DT entire/JJ 322/CD nt/NN 5'/CD UTR/NNS of/IN exon/NN 1/CD and/CC a/DT 1630/CD nt/NN segment/NN of/IN 5'/CD flanking/JJ sequence/NN stimulated/VBD luciferase/NEWGENE activity/NN nearly/RB 70/CD times/NNS higher/JJ than/IN a/DT promoterless/JJ control/NN plasmid/NN ./.
@@71097889731 In/NN concept/NN II/NN 62/NN patients/NNS were/VBD treated/VBN with/IN selective/JJ vagotomy/NN and/CC pyloroplasty/NN ./.
@@44469234974 Abnormal/JJ characteristics/NNS and/CC verticillation/NN in/IN Platynothrus/NNP peltifer/NN ./.
@@3017225872 Next/JJ ,/, with/IN carcinoma/NN presenting/VBG a/DT leather/NN bottle/NN (/( linitis/NN plastica/NN type/NN )/SYM of/IN the/DT stomach/NN itself/PRP ,/, the/DT II/NN c/NN portion/NN of/IN the/DT stomach/NN consisted/VB of/IN fundic/JJ glands/NNS (/( undifferentiated/JJ carcinoma/NN )/SYM shall/MD become/VB the/DT primary/JJ focus/NN supporting/JJ Nakamura's/NNP theory/NN ./.
@@62252792818 The/DT abluminal/JJ surface/NN is/VBZ often/RB almost/RB entirely/RB encircled/VBN by/IN a/DT thick/JJ layer/NN of/IN fibrillary/JJ connective/JJ tissue/NN ./.
@@91533488992 Thus/RB ,/, an/DT increase/NN in/IN plasma/NEWGENE TBG/NEWGENE and/CC a/DT shift/NN from/IN adrenal/JJ androgen/NN and/CC mineralocorticoid/JJ steroid/JJ secretion/NN towards/IN cortisol/NN secretion/NN may/MD be/VB endocrine/NN markers/NN for/IN progression/NN of/IN the/DT disease/NN in/IN patients/NNS with/IN HIV-infection/NN ./.
@@75640046362 By/IN 150/CD minutes/NNS after/IN Cr2O3/NN inhalation/NN ,/, FEV1/NN ./NN 0/NN had/VBP decreased/VBN by/IN 32%/NN ./.
@@101011986784 A/DT deletion/NN mutation/NN analysis/NN of/IN the/DT recombinant/JJ protein/NN has/VBZ shown/VBP that/IN the/DT N-terminal/NN region/NN and/CC the/DT two/JJ leucine/NN zippers/NN are/VBP necessary/JJ for/IN the/DT binding/NN ./.
@@10827265400 The/DT influence/NN of/IN a/DT mobile/JJ pupil/NN on/IN the/DT response/NN in/IN the/DT DC-ERG/NN is/VBZ demonstrated/VBN ./.
@@7999887989 On/IN the/DT basis/NN of/IN a/DT global/JJ assessment/NN patients/NNS showed/VBD a/DT highly/RB significant/JJ preference/NN for/IN imipramine/NN compared/VBD with/JJ placebo/NN as/IN adjunctive/JJ therapy/NN ./.
@@37791829411 The/DT growing/JJ drug/NN problem/NN is/VBZ also/RB reflected/VBN in/IN the/DT increasing/JJ number/NN of/IN cases/NNS of/IN hepatitis/NN B/NN and/CC of/IN drug-related/JJ deaths/NNS ./.
@@8869358709 Many/JJ human/JJ viruses/NNS are/VBP able/JJ to/IN develop/VB suitable/JJ strategies/NNS for/IN modifying/JJ apoptosis/NN in/IN virus-infected/JJ cells/NNS and/CC in/IN virus-primed/JJ T/NN cells/NNS ./.
@@7964459516 This/DT motif/NN is/VBZ similar/JJ to/IN but/CC distinct/JJ from/IN the/DT LIM/NEWGENE domain/NEWGENE and/CC the/DT RING/NEWGENE finger/NEWGENE family/NEWGENE ,/, and/CC is/VBZ reminiscent/NN of/IN known/VBP metal-binding/NN regions/NN ./.
@@80172909407 The/DT femoroarterial/JJ coronary/JJ sinus/NN difference/NN in/IN lactate/NN turned/VBD negative/JJ ,/, and/CC pH/NN ,/, PCO2/NN and/CC potassium/NN differences/NNS increased/VBN in/IN group/NN 2/CD during/IN pacing/NN ./.
@@13800623049 T/NEWGENE antigen/NEWGENE contains/VBZ four/CD H-2Db-restricted/NEWGENE cytotoxic/NEWGENE T/NEWGENE lymphocyte/NEWGENE (/NEWGENE CTL/NEWGENE )/NEWGENE recognition/NEWGENE epitopes/NEWGENE that/WDT are/VBP targets/NNS for/IN CTL/NN clones/NNS Y-1/NN ,/, Y-2/NN ,/, Y-3/NN ,/, and/CC Y-5/NN ./.
@@19853012598 Combined/VBN therapy/NN with/IN MK-801/NN and/CC nimodipine/NN for/IN protection/NN of/IN ischemic/JJ brain/NN damage/NN ./.
@@76229327543 Histopathological/JJ features/NNS of/IN relapsed/VBN leprosy/NN ./.
@@25999953250 Intracellular/JJ activity/NN studies/NNS indicated/VBN that/IN ,/, at/IN ten/CD times/NNS MBC/NN ,/, only/JJ penicillin/NN had/VBP any/DT significant/JJ activity/NN against/IN intracellular/JJ staphylococci/NNS ,/, reducing/JJ survival/NN by/IN 28%/NN ./.
@@105215097175 Regulators/NNS of/IN G/NEWGENE protein/NEWGENE signaling/NEWGENE (/NEWGENE RGS/NEWGENE )/NEWGENE proteins/NEWGENE that/WDT contain/VBP DEP/NEWGENE (/( disheveled/NEWGENE ,/, EGL-10/NEWGENE ,/, pleckstrin/NEWGENE )/SYM and/CC GGL/NEWGENE (/( G/NEWGENE protein/NEWGENE gamma/NEWGENE subunit-like/NEWGENE )/SYM domains/NNS form/NN a/DT subfamily/NN that/WDT includes/VBZ the/DT mammalian/NEWGENE RGS/NEWGENE proteins/NEWGENE RGS6/NEWGENE1 ,/, RGS7/NEWGENE ,/, RGS9/NEWGENE ,/, and/CC RGS11/NEWGENE ./.
@@90060077332 The/DT results/NNS demonstrate/VBP (/( i/NN )/SYM that/IN the/DT selenocysteine-specific/VBD UGA/DT codon/NN is/VBZ readily/RB suppressed/VBN under/IN conditions/NNS where/CC the/DT homologous/NEWGENE SelB/NEWGENE protein/NEWGENE is/VBZ absent/VB and/CC (/( ii/NN )/SYM that/IN apart/RB from/IN the/DT specificity/NN of/IN the/DT SelB-mRNA/NEWGENE interaction/NN ,/, a/DT structural/JJ compatibility/NN of/IN the/DT quaternary/JJ complex/NN with/IN the/DT ribosome/NN is/VBZ required/VBN ./.
@@96495376570 Genomic/NN and/CC cDNA/NN clones/NNS homologous/JJ to/IN the/DT yeast/NEWGENE GCN2/NEWGENE eIF-2alpha/NEWGENE kinase/NEWGENE (/( yGCN2/NEWGENE )/SYM were/VBD isolated/VBN from/IN Drosophila/NN melanogaster/NN ./.
@@78223337341 Chem/NNP ./.
@@89547254782 Later/RB in/IN development/NN ,/, Tbx6/NEWGENE expression/NN is/VBZ restricted/VBN to/IN presomitic/JJ ,/, paraxial/JJ mesoderm/NN and/CC to/IN the/DT tail/NN bud/NN ,/, which/WDT replaces/VBZ the/DT streak/NN as/IN the/DT source/NN of/IN mesoderm/NN ./.
@@86435787149 RAS2val19/NEWGENE ,/, a/DT dominant/RB activated/VBN form/NN of/IN Saccharomyces/NEWGENE cerevisiae/NEWGENE Ras2/NEWGENE ,/, stimulates/VBZ both/DT filamentous/JJ growth/NN and/CC expression/NN of/IN a/DT transcriptional/NEWGENE reporter/NEWGENE FG/NEWGENE (/NEWGENE TyA/NEWGENE )/NEWGENE :/: :/: lacZ/NEWGENE but/CC does/VBP not/RB induce/VB the/DT mating/NEWGENE pathway/NEWGENE reporter/NEWGENE FUS1/NEWGENE :/: :/: lacZ/NEWGENE ./.
@@23836934026 The/DT eluent/NN from/IN the/DT column/NN was/VBD mixed/JJ with/IN the/DT chemiluminescent/JJ solution/NN containing/NN lucigenin/NN and/CC Triton/NN X-100/NNS and/CC a/DT 0/CD ./CD 28/CD M/NN KOH/NN solution/NN by/IN pumps/NNS and/CC monitored/VBN by/IN a/DT chemiluminescence/NN detector/NN ./.
@@84846897433 Prevalence/NNS of/IN rheumatoid/JJ arthritis/NN and/CC rheumatoid/NEWGENE factor/NEWGENE in/IN women/NNS :/: evidence/NN for/IN a/DT secular/JJ decline/NN ./.
@@77303376799 The/DT Ng/NEWGENE //NEWGENE RC3/NEWGENE and/CC PKC-gamma/NEWGENE genes/NEWGENE have/VBP a/DT similar/JJ expression/NN pattern/NN in/IN the/DT brain/NN during/IN development/NN ./.
@@114795011850 RESULTS/NNS :/: In/NN vivo/NN ,/, there/RB was/VBD a/DT wide/JJ distribution/NN with/IN the/DT coefficient/NN of/IN variation/NN (/( SD/NN //NN mean/NN x/NN 100%/CD )/SYM for/IN different/JJ valve/NN sizes/NNS ranging/VBG from/IN 21%/JJ to/IN 39%/CD in/IN the/DT St/NNP Jude/NNP Medical/NNP valve/NN and/CC from/IN 25%/JJ to/IN 33%/JJ in/IN the/DT Omnicarbon/NNP valve/NN ./.
@@119103441822 CONCLUSIONS/IN :/: This/DT retrospective/JJ uncontrolled/JJ study/NN shows/VBZ that/IN in/IN patients/NNS with/IN type/NN 1/NN HRS/NN ,/, terlipressin-induced/RB improved/VBN renal/JJ function/NN is/VBZ associated/VBN with/IN an/DT increase/NN in/IN survival/NN ./.
@@75825926287 HRES/NNS has/VBZ been/VBN found/VB to/IN be/VB clinically/RB useful/JJ in/IN assessing/JJ histologic/JJ damage/NN following/IN pneumatic/JJ dilatation/NN and/CC in/IN localizing/JJ the/DT LES/NN during/IN the/DT administration/NN of/IN intrasphincter/NN botulinum/NEWGENE toxin/NEWGENE injection/NN in/IN the/DT treatment/NN of/IN achalasia/NN ./.
@@48133945185 Evaluation/NN of/RB 1/NN ,/NN 10-phenanthroline/NN as/IN a/DT reagent/NN for/IN sialic/JJ acid/NN determinations/NNS ./.
@@44878354982 On/IN parents/NNS ./.
@@57829435720 Relationship/NNP of/IN mast/NN cells/NNS to/IN sarcoidosis/NN granuloma/NN of/IN the/DT skin/NN ./.
@@23905385290 In/NN 6/CD of/IN 24/CD infants/NNS studied/VBN (/( 27th-40th/JJ weeks/NNS of/IN gestation/NN )/SYM ,/, acquired/VBN and/CC congenital/JJ structural/JJ anomalies/NNS of/IN the/DT airways/NNS were/VBD detected/VBN with/IN an/DT ultrathin/JJ flexible/JJ fiberscope/NN (/( Olympus/NN PF18/NN S/NN ,/, 1/CD ./CD 8/CD mm/NN )/SYM ./.
@@93469538428 The/DT cellular/JJ rate/NN of/IN anticoagulant/JJ heparan/NN sulfate/NN proteoglycan/NN (/( HSPGact/NNP )/SYM generation/NN is/VBZ determined/VBN by/IN the/DT level/NN of/IN a/DT kinetically/RB limiting/JJ microsomal/JJ activity/NN ,/, HSact/NNP conversion/NN activity/NN ,/, which/WDT is/VBZ predominantly/RB composed/VBN of/IN the/DT long/JJ sought/VBP heparan/NEWGENE sulfate/NEWGENE D-glucosaminyl/NEWGENE 3-O-sulfotransferase/NEWGENE (/( 3-OST/NEWGENE )/SYM (/( Shworak/NNP ,/, N/NNP ./NNP
@@108540045881 Basal/NN FVR/NN was/VBD reduced/VBN by/IN approximately/RB 18%/JJ by/IN ERT/NN and/CC HRT/NN ,/, but/CC FVR/NNS responses/NNS to/IN noradrenaline/NN ,/, angiotensin/NEWGENE II/NEWGENE ,/, acetylcholine/NN and/CC nitroprusside/NN were/VBD unaffected/JJ ./.
@@106715207807 Molecular/NNP cloning/NN of/IN a/DT novel/JJ human/NEWGENE I-mfa/NEWGENE domain-containing/NEWGENE protein/NEWGENE that/WDT differently/RB regulates/VBZ human/JJ T-cell/NN leukemia/NN virus/NN type/NN I/NN and/CC HIV-1/NNP expression/NN ./.
@@41762684839 Aluminium/NNP resin/NN for/IN the/DT treatment/NN of/IN the/DT hyperkalamia/NN of/IN renal/JJ failure/NN ./.
@@82659558242 Strategic/NNP change/NN in/IN the/DT NHS/NN ./.
@@96494262632 Interestingly/RB ,/, PKA/NEWGENE activity/NN is/VBZ dispensable/JJ in/IN a/DT strain/NN lacking/JJ Msn2p/NEWGENE and/CC Msn4p/NEWGENE activity/NN ./.
@@112375985774 The/DT homologous/JJ active-site/NN framework/NN of/IN these/DT enzymes/NNS with/IN distinct/JJ structures/NNS suggests/VBZ convergent/JJ evolution/NN of/IN a/DT common/JJ catalytic/JJ mechanism/NN ./.
@@104195215660 In/NN addition/NN to/IN its/PRP elongation/NN activity/NN ,/, ELL/NEWGENE contains/VBZ a/DT novel/JJ type/NN of/IN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE interaction/NEWGENE domain/NEWGENE that/WDT is/VBZ capable/JJ of/IN repressing/JJ polymerase/NEWGENE activity/NN in/IN promoter-specific/JJ transcription/NN ./.
@@32920823978 In/NN contrast/NN ,/, we/PRP observed/VBD high/JJ concentrations/NNS in/IN 29/CD of/IN 75/CD patients/NNS with/IN tumors/NNS of/IN the/DT central/JJ nervous/JJ system/NN ,/, especially/RB in/IN meningioma/NN (/( 6/CD //CD 9/CD )/SYM ,/, glioblastoma/NN (/( 9/CD //CD 23/CD )/SYM ,/, and/CC neurinoma/NN (/( 5/CD //CD 5/CD )/SYM ./.
@@8276234326 We/PRP present/VBP evidence/NN that/IN YY1/NEWGENE ,/, a/DT ubiquitously/RB expressed/VBN DNA-binding/NN protein/NN ,/, regulates/VBZ the/DT activity/NN of/IN the/DT c-fos/NEWGENE promoter/NEWGENE primarily/RB through/RB an/DT effect/NN on/IN DNA/NN structure/NN ./.
@@110940725808 DNase/NEWGENE I/NEWGENE genomic/JJ footprinting/VBG revealed/VBN that/IN the/DT c-Myb/NEWGENE site/NEWGENE is/VBZ occupied/VBN in/IN a/DT tissue-specific/JJ fashion/NN in/IN vivo/NN ./.
@@79712823715 Regulators/NNS responsible/JJ for/IN the/DT pervasive/JJ ,/, nonsex-specific/JJ alternative/JJ pre-mRNA/NN splicing/JJ characteristic/NN of/IN metazoans/NNS are/VBP almost/RB entirely/RB unknown/JJ or/CC uncertain/JJ ./.
@@96513214981 Cystatin/NEWGENE A/NEWGENE ,/, a/DT cysteine/NEWGENE proteinase/NEWGENE inhibitor/NN ,/, is/VBZ one/PRP of/IN the/DT precursor/NN proteins/NNS of/IN cornified/JJ cell/NN envelope/NN of/IN keratinocytes/NNS and/CC is/VBZ expressed/VBN during/IN the/DT late/JJ stage/NN of/IN keratinocyte/NN differentiation/NN ./.
@@34840754175 Emergency/NNP treatment/NN of/IN facial/JJ and/CC maxillary/JJ //JJ mandibular/JJ injuries/NNS ./.
@@29733043691 A/DT rare/JJ chronic/JJ course/NN of/IN Budd-Chiari/NNP syndrome/NN associated/VBN with/IN thrombosis/NN of/IN the/DT portal/JJ vein/NN was/VBD observed/VBN in/IN a/DT 30-year-old/CD male/JJ patient/NN suffering/JJ from/IN postmyocarditic/JJ cardiosclerosis/NN ./.
@@21880963623 The/DT contribution/NN that/IN alternative/JJ splicing/JJ events/NNS in/IN c-myb/NEWGENE expression/NN may/MD make/VB on/IN c-myb/NEWGENE function/NN remains/VBP to/IN be/VB elucidated/VBN ./.
@@106606045783 In/NN vivo/NN ,/, CARbeta/NEWGENE //NEWGENE RXRalpha/NEWGENE activated/VBN transcription/NN from/IN an/DT HD-PPRE/NEWGENE luciferase/NEWGENE1 reporter/NEWGENE1 construct/NEWGENE1 ./.
@@114689585771 We/PRP report/VBP the/DT results/NNS of/IN a/DT detailed/JJ policy/NN analysis/NN comparing/VBG 2/CD CJD-related/JJ decisions/NNS :/: a/DT 1995/CD recall/NN of/IN blood/NN from/IN a/DT donor/NN with/IN classic/JJ CJD/NN and/CC the/DT 1999/CD decision/NN to/IN defer/VB donations/NNS from/IN individuals/NNS with/IN a/DT 6-month/CD travel/NN history/NN to/IN the/DT UK/NN between/IN 1980/CD and/CC 1996/CD due/NN to/IN concerns/NNS related/VBN to/IN variant/NN CJD/NN ./.
@@89956149275 Identification/NNP of/IN a/DT cis-acting/JJ element/NN in/IN the/DT class/NEWGENE I/NEWGENE major/NEWGENE histocompatibility/NEWGENE complex/NEWGENE gene/NEWGENE promoter/NEWGENE responsive/JJ to/IN activation/NN by/IN retroviral/NN sequences/NN ./.
@@104164294835 DESIGN/IN :/: Comparison/NNS of/IN number/NN of/IN women/NNS with/IN PKU/NN aged/VBD 15-44/JJ years/NNS on/IN the/PDT NSW/NN PKU/NN database/NN (/( observed/VBN number/NN )/SYM with/IN expected/VBN number/NN derived/VBN from/IN population/NN data/NN ./.
@@22544181678 Most/JJS strains/NNS (/( 95%/CD )/SYM of/IN S/NNP ./NNP lugdunensis/NN produced/VBD a/DT delta/NEWGENE hemolysin/NEWGENE like/JJ that/WDT seen/VBP with/IN nine/JJ other/DT species/NN of/IN CNS/NN ./.
@@73724337213 Longitudinal/JJ force-length/JJ relationships/NNS of/IN guinea/NN pig/NN ureter/NN were/VBD studied/VBN in/IN vitro/FW in/IN animals/NNS 3/CD weeks/NNS ,/, 3/CD months/NNS ,/, and/CC 3/CD years/NNS of/IN age/NN ./.
@@105184963828 Aggregation/NNS of/IN vHnf1-deficient/JJ embryonic/JJ stem/NN cells/NNS with/IN wild-type/JJ tetraploid/JJ embryos/NNS ,/, which/WDT contribute/VBP exclusively/RB to/IN extraembryonic/JJ tissues/NNS ,/, rescues/VBP periimplantation/VBG lethality/NN and/CC allows/VBZ development/NN to/IN progress/NN to/IN early/JJ organogenesis/NN ./.
@@2459309845 Endogenous/JJ release/NN of/IN neuronal/NN serotonin/NN and/CC 5-hydroxyindoleacetic/JJ acid/NN in/IN the/DT caudate-putamen/NNS of/IN the/DT rat/NN as/IN revealed/VBN by/IN intracerebral/JJ dialysis/NN coupled/VBN to/IN high-performance/JJ liquid/JJ chromatography/NN with/IN fluorimetric/JJ detection/NN ./.
@@88288579226 The/DT use/NN of/IN primary/JJ GE/JJ cells/NNS thus/RB provides/VBZ a/DT convenient/JJ in/IN vitro/FW system/NN for/IN further/JJ study/NN of/IN the/DT endocrine/NN ,/, paracrine/JJ ,/, and/CC autocrine/NN factors/NN regulating/JJ endometrial/JJ gene/NN expression/NN during/IN pregnancy/NN ./.
@@93745411011 We/PRP found/VBP 14/NN protein/NN binding/NN sites/NN that/WDT were/VBD occupied/VBN in/IN vivo/NN ./.
@@13807161999 The/DT pulpal/JJ tissues/NNS of/IN the/DT permanent/JJ mandibular/JJ molars/NNS were/VBD amputated/VBN and/CC then/RB dressed/VBN with/IN calcium/NN hydrate/NN ./.
@@82391648223 CPAP/NN reduced/VBD isotime/NN (/( defined/VBN as/IN the/DT last/JJ common/JJ minute/NN of/IN exercise/NN )/SYM VO2/NN and/CC dyspnea/NN in/IN those/DT patients/NNS with/IN more/RB severe/JJ lung/NN disease/NN ,/, but/CC these/DT values/NNS tended/VBN to/IN increase/NN slightly/RB in/IN the/DT patients/NNS with/IN only/RB mild/JJ lung/NN disease/NN ./.
@@79151447893 High-frequency/NNP electrical/JJ stimulation/NN in/IN the/DT hippocampus/NN leads/VBP to/IN an/DT increase/NN in/IN synaptic/JJ efficacy/NN that/IN lasts/NNS for/IN many/JJ hours/NNS ./.
@@36807914347 The/DT histologic/JJ grade/NN for/IN the/DT same/JJ anatomic/JJ site/NN varied/VBN among/IN hearts/NNS and/CC among/IN different/JJ anatomic/JJ sites/NNS in/IN the/DT same/JJ heart/NN ./.
@@10330396253 The/DT RanQ69L/NEWGENE preincubation/NN leads/VBP to/IN accumulation/NN of/IN CRM1/NEWGENE at/IN the/DT cytoplasmic/JJ periphery/NN of/IN the/DT nuclear/NEWGENE pore/NEWGENE complex/NEWGENE (/( NPC/NEWGENE )/SYM in/IN association/NN with/IN the/DT p62/NEWGENE complex/NEWGENE and/CC Can/NEWGENE //NEWGENE Nup214/NEWGENE ./.
@@19399062570 This/DT generalization/NN of/IN MFP/NN involves/VBZ defining/VBG an/DT appropriate/JJ high-resolution/JJ cost/NN function/NN ,/, parametrizing/JJ the/DT search/NN space/NN of/IN the/DT environment/NN and/CC source/NN ,/, constructing/JJ solutions/NNS of/IN the/DT wave/NN equation/NN ,/, and/CC utilizing/VBG a/DT nonlinear/JJ optimization/NN method/NN to/IN search/NN the/DT parameter/NN landscape/NN for/IN the/DT global/JJ minimum/NN of/IN the/DT cost/NN function/NN ./.
@@113711607236 This/DT domain/NN without/IN the/DT canonical/JJ anticodon/NN loop/NN or/CC the/DT tyrosine/NN anticodon/NN acts/NNS as/IN an/DT anchor/NN for/IN TyrRS/NEWGENE interaction/NN leading/JJ to/IN a/DT better/JJR efficiency/NN of/IN tyrosylation/NN ./.
@@33058758826 Static/NN orthoses/NNS for/IN the/DT management/NN of/IN microstomia/NN ./.
@@64732196276 Value/NNP of/IN urine/NN glucose/NN tests/NNS in/IN the/DT management/NN of/IN type/NN II/NNP diabetes/NN mellitus/MD ./.
@@10627834327 Two/CD US/NN commercial/JJ cultivars/NNS (/( Tehama/NNP and/CC Vina/NNP )/SYM ,/, three/CD European/JJ commercial/JJ cultivars/NNS (/( Esterhazy/NNP ,/, 139/CD ,/, G120/NN )/SYM and/CC five/CD New/NNP Zealand/NNP selections/NNS (/( Rex/NNP ,/, Dublin's/NNP Glory/NN ,/, Meyric/NNP ,/, McKinster/NNP ,/, Stanley/NNP )/SYM were/VBD evaluated/VBN ./.
@@94366579392 This/DT review/NN seeks/VBZ to/IN summarize/VB the/DT disease/NN ,/, to/IN propose/VB pathways/NNS of/IN carcinogenesis/NN and/CC to/IN suggest/VB ways/NNS in/IN which/WDT the/DT "traditional"/NN risk/NN factors/NNS may/MD be/VB interpreted/VBN on/IN the/DT basis/NN of/IN evolving/JJ knowledge/NN ./.
@@15676492168 Twenty-eight/CD (/( 7/CD ./CD 0%/CD )/SYM infants/NNS without/IN periventricular/JJ hemorrhage/NN were/VBD revealed/VBN as/IN having/VBG spastic/JJ cerebral/JJ palsy/NN by/IN neurodevelopmental/JJ evaluation/NN in/IN later/JJR infancy/NN ./.
@@64149902683 The/DT statistical/JJ analysis/NN of/IN data/NN of/IN TRH/NEWGENE test/NN on/IN a/DT sample/NN of/IN 57/CD healthy/JJ volunteers/NNS has/VBZ permitted/VBN an/DT evaluation/NN of/IN the/DT upper/JJ limits/NNS of/IN the/DT normal/JJ thyrotropin/NEWGENE response/NN ;/: the/DT secretory/JJ area/NN (/( As/IN )/SYM was/VBD shown/VBP to/IN be/VB more/RB discriminating/JJ ./.
@@83851315841 The/DT alpha/NEWGENE 2A-adrenergic/NEWGENE receptor/NEWGENE (/( alpha/NEWGENE 2AAR/NEWGENE )/SYM is/VBZ coupled/VBN to/IN a/DT variety/NN of/IN effectors/NNS via/NN pertussis/NN toxin-sensitive/JJ GTP-binding/NEWGENE proteins/NEWGENE ./.
@@90356128994 Cardiac/NEWGENE endothelin/NEWGENE release/NN and/CC infarct/NN size/NN ,/, myocardial/JJ blood/NN flow/NN ,/, and/CC ventricular/JJ function/NN in/IN canine/JJ infarction/NN and/CC reperfusion/NN ./.
@@98065169777 This/DT association/NN was/VBD independently/RB significant/JJ for/IN patients/NNS treated/VBN primarily/RB (/( not/RB for/IN recurrence/NN )/SYM ./.
@@24640971931 The/DT effects/NNS of/IN L655/NNP ,/NNP 240/NNP ,/, a/DT selective/JJ thromboxane/NN and/CC prostaglandin/NN endoperoxide/NN antagonist/NN ,/, on/IN ischemia-/JJ and/CC reperfusion-induced/JJ cardiac/JJ arrhythmias/NNS ./.
@@87042407314 However/RB ,/, in/IN TF-1/NNP cells/NNS grown/VBP on/IN GM-CSF/NEWGENE before/IN starvation/NN ,/, CREB/NEWGENE phosphorylation/NN was/VBD observed/VBN 10/CD minutes/NNS after/IN PIXY321/NEWGENE stimulation/NN ./.
@@104475976224 The/DT Cr/NEWGENE ./NEWGENE psbA-4/NEWGENE ORF/NEWGENE contains/VBZ an/DT H-N-H/NEWGENE motif/NEWGENE ,/, and/CC possibly/RB a/DT GIY-YIG/NEWGENE motif/NEWGENE ./.
@@82516224757 The/DT promoter/NN and/CC upstream/JJ region/NN of/IN the/DT Brassica/NEWGENE napus/NEWGENE 2S/NEWGENE storage/NEWGENE protein/NEWGENE napA/NEWGENE gene/NEWGENE were/VBD studied/VBN to/IN identify/VB cis-acting/JJ sequences/NNS involved/VBN in/IN developmental/JJ seed-specific/JJ expression/NN ./.
@@9452421991 Antibodies/NNS raised/VBN against/IN GST/NEWGENE mSH2-B/NEWGENE identified/VBN a/DT cellular/JJ protein/NN of/IN 92/CD kDa/NN that/WDT was/VBD not/RB found/VB to/IN be/VB phosphorylated/VBN on/IN Tyr/NN ./.
@@35776709527 The/DT diagnosis/NN of/IN metachromatic/JJ leukodystrophy/NN (/( MLD/NNP )/SYM was/VBD confirmed/VBN by/IN the/DT finding/NN of/IN low/JJ arylsulfatase/NEWGENE A/NEWGENE (/( ASA/NEWGENE )/SYM levels/NNS in/IN cultured/JJ fibroblasts/NNS in/IN both/DT sisters/NNS ./.
@@54141865536 Once/RB more/RB Hong/NNP Kong/NNP influenza/NN in/IN the/DT Netherlands/NN ./.
@@81952336469 In/NN addition/NN ,/, this/DT kinase/NN is/VBZ well/NN conserved/VBN evolutionarily/RB ,/, ubiquitously/RB expressed/VBN ,/, and/CC its/PRP genes/NNS map/NN to/IN a/DT position/NN on/IN human/JJ chromosome/NN 1/CD frequently/RB deleted/VBN in/IN the/DT late/JJ stages/NNS of/IN tumorigenesis/NN ./.
@@93533044547 Deletions/NNS in/IN each/DT of/IN these/DT regions/NNS abolish/VBP membrane/NN localization/NN of/IN Tiam1/NEWGENE and/CC membrane/NN ruffling/JJ ,/, suggesting/VBG that/IN they/PRP function/NN cooperatively/RB ./.
@@104551839448 In/NN contrast/NN ,/, the/DT xtRNA/NEWGENE (/NEWGENE Sec/NEWGENE )/NEWGENE gene/NEWGENE needs/NN the/DT binding/NN of/IN the/DT seven/JJ Staf/NEWGENE zinc/NEWGENE fingers/NEWGENE ,/, but/CC not/RB Oct-1/NEWGENE ,/, for/IN optimal/JJ transcriptional/JJ capacity/NN ./.
@@77388398865 During/IN IC/NN breaths/NNS and/CC following/IN EC/NN and/CC VC/NN breaths/NNS at/IN rest/NN ,/, end-tidal/JJ CO2/NN pressure/NN (/( PET/NN ,/NN CO2/NN )/SYM fell/NN by/IN 7/CD ./CD 5/CD ,/, 8/CD ./CD 5/CD and/CC 9/CD ./CD 5/CD mmHg/NN ,/, respectively/RB ./.
@@71809012304 It/PRP is/VBZ postulated/VBN that/WDT altered/VBD blood/NN flow/NN ,/, mediated/JJ through/RB the/DT well-known/JJ prostaglandin/NEWGENE synthetase/NEWGENE inhibitory/JJ effects/NNS of/IN ibuprofen/NN ,/, resulted/VBN in/IN tubular/JJ necrosis/NN ./.
@@81635284520 Mitochondrial/NEWGENE Mas70p/NEWGENE signal/NEWGENE anchor/NEWGENE sequence/NEWGENE ./.
@@81395439049 Genetic/NNP and/CC phenotypic/JJ analysis/NN indicates/VBZ that/IN NHP6A/NEWGENE and/CC NHP6B/NEWGENE function/NN downstream/RB of/IN SLT2/NEWGENE ./.
@@28077803503 The/DT use/NN of/IN an/DT appropriate/JJ solution/NN of/IN methylene/NN blue/JJ (/( 0/CD ./CD 2%/CD in/IN 0/CD ./CD 9/CD M/NN NaCl/NN for/IN 15/CD min/NN )/SYM permits/VBP the/DT staining/NN of/IN premalignant/JJ areas/NNS and/CC CIS/NN ,/, and/CC their/PRP early/JJ diagnosis/NN ./.
@@98082169781 BACKGROUND/IN :/: Studies/NNS in/IN lean/JJ men/NNS show/VBP poor/JJ regulation/NN of/IN energy/NN (/( EB/NN )/SYM and/CC fat/JJ balance/NN (/( FB/NN )/SYM during/IN manipulation/NN of/IN dietary/JJ ratios/NNS of/IN fat/JJ to/IN carbohydrate/NN ./.
@@103841297368 TCR/NEWGENE alpha/NEWGENE (/( TCRA/NEWGENE )/SYM expression/NN was/VBD examined/VBN in/IN RNA/NN samples/NNS from/IN PBMC/NN and/CC isolated/VBN populations/NNS of/IN CD4+/NEWGENE ,/, CD8+/NEWGENE ,/, and/CC DN/NEWGENE T/NN cells/NNS from/IN 15/CD healthy/JJ individuals/NNS ./.
@@19959517937 The/DT long/JJ terminal/JJ repeat/NN (/( LTR/NN )/SYM of/IN the/DT human/JJ immunodeficiency/NN virus/NN (/( HIV/NN )/SYM contains/VBZ three/CD binding/JJ sites/NNS for/IN the/DT transcriptional/NN factor/NN Sp1/NEWGENE ./.
@@92584398378 The/DT used/VBN expression/NN system/NN could/MD allow/VB to/IN produce/NN mutated/JJ forms/NNS of/IN SsEF-2/NEWGENE obtained/VBN by/IN mutagenesis/NN of/IN the/DT corresponding/JJ gene/NN ./.
@@114355178629 Ileal/JJ digestibilities/NNS of/IN DM/NN ,/, OM/NN ,/, CP/NN ,/, total/JJ dietary/JJ fiber/NN (/( TDF/NN )/SYM ,/, fat/JJ and/CC gross/JJ energy/NN (/( GE/JJ )/SYM were/VBD lower/JJR (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM for/IN dogs/NNS fed/VBD diets/NNS containing/JJ supplemental/JJ fiber/NN compared/VBN with/IN dogs/NNS fed/VBD the/DT control/NN diet/NN ./.
@@98435724195 This/DT model/NN is/VBZ supported/VBN by/IN experiments/NNS showing/VBG that/IN Cdr2/NEWGENE associates/VBP with/IN the/DT N-terminal/NEWGENE regulatory/NEWGENE domain/NEWGENE of/NEWGENE Wee1/NEWGENE in/IN cell/NN lysates/NNS and/CC phosphorylates/VBZ Wee1/NEWGENE in/IN vitro/FW ./.
@@39332324591 Greek/JJ classicism/NN in/IN living/JJ structure/NN ?/. Some/DT deductive/JJ pathways/NNS in/IN animal/NN morphology/NN ./.
@@75342978635 We/PRP linked/VBD a/DT 4/CD ./CD 1-kilobase/CD pair/NN HindIII/NEWGENE DNA/NEWGENE fragment/NEWGENE from/IN the/DT region/NN upstream/RB of/IN the/DT human/NEWGENE AP/NEWGENE endonuclease/NEWGENE gene/NEWGENE (/( APE/NEWGENE )/SYM to/IN the/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE (/( CAT/NEWGENE )/SYM gene/NN ./.
@@918965131 It/PRP was/VBD concluded/VBN that/IN patients/NNS with/IN acute/JJ respiratory/JJ failure/NN requiring/JJ artificial/JJ ventilation/NN have/NN two/JJ componenents/NNS of/IN the/DT pulmonary/JJ shunt/NN ,/, one/PRP parallel/JJ with/IN and/CC the/PDT other/DT inversely/RB related/VBN with/IN the/DT PAO2/NN ./.
@@90858426525 Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN the/DT U1/NEWGENE snRNP/NEWGENE is/VBZ recruited/VBN to/IN the/DT 5'/CD splice/NN site/NN by/IN protein/NN //NN protein/NN interactions/NNS involving/VBG the/DT SR/NEWGENE domains/NN of/IN the/DT U1-70K/NEWGENE protein/NEWGENE and/CC SF2/NEWGENE //NEWGENE ASF/NEWGENE ./.
@@92255066935 The/DT control/NN group/NN revealed/VBN significantly/RB higher/JJ levels/NNS of/IN coagulation/NEWGENE factors/NEWGENE II/NEWGENE ,/, V/NEWGENE and/CC VIII/NEWGENE ,/, compared/VBN to/IN the/DT index/NN group/NN ./.
@@9741391464 Whereas/IN ,/, in/IN the/DT single-chambered/JJ body/NN box/NN ,/, PenH/NN units/NNS (/( Enhanced/NNP Pause/NN )/SYM reflect/VB "effort/NN of/IN breathing/NN ./NN "/NN This/DT is/VBZ measured/VBN as/IN the/DT pause/NN between/IN inspiration/NN and/CC expiration/NN ./.
@@105189567951 These/DT thyroid/JJ hormone/NN changes/NNS may/MD be/VB mediated/JJ in/IN part/NN by/IN cytokines/NNS or/CC other/DT inflammatory/JJ mediators/NNS ,/, acting/JJ at/IN the/DT level/NN of/IN the/DT hypothalamus/NN and/CC pituitary/JJ gland/NN ,/, the/DT thyroid/JJ gland/NN ,/, and/CC the/DT hepatic/NEWGENE deiodinase/NEWGENE system/NEWGENE ./.
@@112739952168 Compared/VBN with/IN normal/JJ control/JJ subjects/NNS ,/, all/DT 74/CD TOF/NN patients/NNS had/VBP decreased/VBN systolic/JJ and/CC diastolic/JJ myocardial/JJ velocities/NNS and/CC a/DT longer/RBR isovolumic/JJ relaxation/NN time/NN ./.
@@86928854445 The/DT ability/NN of/IN A20/NEWGENE to/IN block/NN NF-kappaB/NEWGENE activation/NN was/VBD mapped/VBN to/IN its/PRP C-terminal/NN zinc/NN finger/NN domain/NN ./.
@@113555767761 The/DT cyclins/NEWGENE bind/VBP to/IN and/CC activate/VB the/DT CDK/NEWGENE ,/, which/WDT leads/VBP to/IN phosphorylation/NN (/( and/CC then/JJ inhibition/NN )/SYM of/IN the/DT tumor/NN suppressor/NN protein/NN ,/, pRb/NEWGENE ./. pRb/NEWGENE controls/NNS commitment/NN to/IN progress/NN from/IN the/DT G1/NN to/IN S/NNP phase/NN ,/, at/IN least/RB in/IN part/NN by/IN repressing/JJ the/DT activity/NN of/IN the/DT E2F/NEWGENE transcription/NEWGENE factors/NEWGENE known/VBP to/IN promote/VB cell/NN proliferation/NN ./.
@@106066641286 Snail/NEWGENE family/NEWGENE proteins/NEWGENE are/VBP zinc/NN finger/NN transcriptional/NN regulators/NN first/RB identified/VBN in/IN Drosophila/NN which/WDT play/VBP critical/JJ roles/NNS in/IN cell/NN fate/NN determination/NN ./.
@@102051769067 When/WRB tethered/JJ to/IN a/DT heterologous/JJ DNA-binding/NN domain/NN ,/, PSU1/NEWGENE can/MD activate/VB transcription/NN on/IN its/PRP own/VB ./.
@@85504762261 The/DT promoter/NN of/IN the/DT first/JJ gene/NN ,/, epiF/NEWGENE ,/, responded/VBN to/IN the/DT activator/NEWGENE protein/NEWGENE EpiQ/NEWGENE and/CC contained/VBD a/DT palindromic/JJ sequence/NN similar/JJ to/IN the/DT EpiQ/NEWGENE binding/NEWGENE site/NEWGENE of/IN the/DT epiA/NEWGENE promoter/NEWGENE ,/, which/WDT is/VBZ also/RB activated/VBN by/IN EpiQ/NEWGENE ./.
@@91633327022 We/PRP have/VBP used/VBN a/DT site-directed/JJ mutagenesis/NN approach/NN to/IN examine/VB how/RB the/DT Xaa/NNP and/CC hydroxy/JJ (/( Ser/NNP //NNP Thr/NNP )/SYM amino/JJ acid/NN residues/NNS in/IN sequons/NNS influence/NN core-glycosylation/JJ efficiency/NN ./.
@@13312922828 Lastly/RB ,/, there/RB are/VBP multiple/JJ instances/NNS in/IN which/WDT short/JJ oligonucleotide/NN direct/JJ repeats/NNS flank/NN a/DT region/NN absent/VB from/IN either/DT variola/NN or/CC vaccinia/NN virus/NN ./.
@@11863441752 The/DT attainment/NN of/IN sexual/JJ maturity/NN in/IN terms/NNS of/IN secondary/JJ sexual/JJ characteristics/NNS ,/, the/DT production/NN of/IN spermatozoa/NNS in/IN the/DT male/NN ,/, and/CC the/DT cyclical/JJ female/JJ pattern/NN with/IN release/NN of/IN ova/NNS are/VBP end-points/NNS of/IN the/DT developmental/JJ process/NN ./.
@@84218238054 CONCLUSIONS/IN :/: Free/NNP protein/NEWGENE S/NEWGENE deficiency/NN is/VBZ common/JJ among/IN hospitalized/VBN patients/NNS ,/, even/VB in/IN the/DT absence/NN of/IN a/DT recognized/VBN predisposing/JJ condition/NN ./.
@@74820696572 She/PRP had/VBP been/VBN receiving/JJ MTX/NN 7/NN ./NN 5/NN mg/NN //NN week/NN for/IN 2/CD ./CD 5/CD months/NNS because/IN of/IN her/PRP vasculitis/NN symptoms/NNS ./.
@@114698538765 We/PRP interpret/VBP these/DT data/NN as/IN further/JJ evidence/NN that/DT interaction/NN with/IN a/DT small/NEWGENE GTPase/NEWGENE is/VBZ the/DT main/JJ regulatory/JJ function/NN of/IN the/DT C1/NEWGENE domain/NEWGENE in/IN yeast/NN ./.
@@90757398478 Type/NN IV/NN splice/NN pattern/NN ,/, containing/JJ exon/NEWGENE U3/NEWGENE and/NEWGENE S/NEWGENE was/VBD found/VBN both/DT in/NN kidney/NN and/CC ovary/NN ./.
@@86789598660 Sestamibi/NNP scintigraphy/NN ,/, performed/VBN in/IN 70/CD patients/NNS ,/, was/VBD less/PRP sensitive/JJ than/IN ultrasonography/NN (/( 80%/CD )/SYM ./.
@@84810048438 Neither/CC clone/NN encoded/VBN the/DT cognate/NN endonuclease/NEWGENE ./.
@@22024962819 Clinical/NNP nutrition/NN of/IN adult/JJ horses/NNS ./.
@@107226611527 To/TO determine/VB if/IN CYC2/NEWGENE is/VBZ found/VBN in/IN a/DT complex/NN with/IN previously/RB identified/VBN trypanosome/NEWGENE cdc2-related/NEWGENE kinases/NEWGENE (/( CRKs/NEWGENE )/SYM ,/, the/DT CYC2/NEWGENE gene/NEWGENE was/VBD fused/VBN to/IN the/DT TY/NEWGENE epitope/NEWGENE tag/NN ,/, integrated/JJ into/IN the/DT trypanosome/NN genome/NN ,/, and/CC expressed/VBD under/IN inducible/JJ control/NN ./.
@@107421147521 Dll3/NEWGENE is/VBZ mutated/JJ in/IN the/DT X-ray-induced/NN mouse/NEWGENE mutant/NEWGENE pudgy/NEWGENE (/( pu/NEWGENE )/SYM ,/, causing/JJ a/DT variety/NN of/IN vertebrocostal/JJ defects/NNS similar/JJ to/IN SD/NN phenotypes/NNS ./.
@@63086077478 The/DT junctions/NNS between/IN viral/JJ and/CC cellular/JJ sequences/NNS were/VBD determined/VBN by/IN DNA/NN sequence/NN analysis/NN to/IN be/VB 517/CD nucleotides/NNS into/IN the/DT p30/NEWGENE sequence/NEWGENE and/CC 1/CD ,/CD 920/CD nucleotides/NNS into/IN the/DT polymerase/NEWGENE sequence/NEWGENE ./.
@@104064592725 In/NN this/DT study/NN we/PRP describe/VBP that/IN platelet-derived/NEWGENE growth/NEWGENE factor/NEWGENE (/( PDGF/NEWGENE )/SYM ,/, 12-O-tetradecanoyl-phorbol-acetate/JJ (/( TPA/NN )/SYM ,/, and/CC forskolin/NN induced/NN CREB/NEWGENE (/( cAMP-responsive/NEWGENE element-binding/NEWGENE protein/NEWGENE )/SYM Ser-133/NN phosphorylation/NN with/IN comparable/JJ magnitude/NN and/CC kinetics/NN in/IN NIH/NN 3T3/CD cells/NNS ./.
@@883912291 On/IN the/PDT other/DT hand/NN factor/NEWGENE IX/NEWGENE activity/NN is/VBZ decreased/VBN in/IN coumarin/NN treatment/NN with/IN factor/NEWGENE IX/NEWGENE antigen/NN remaining/JJ normal/NN ./.
@@83907479190 In/NN this/DT report/NN ,/, we/PRP focus/VBP on/IN the/DT genetics/NN of/IN the/DT region/NN of/IN the/DT 17/NEWGENE hep/NEWGENE syn/NEWGENE gB/NEWGENE gene/NEWGENE that/WDT conferred/VBD both/PDT the/DT syncytial/JJ and/CC pathogenic/JJ phenotypes/NNS to/IN 17/CD syn+/NN ./.
@@19682247403 The/DT coding/JJ sequence/NN for/IN a/DT 260-amino-acid/JJ residue/NN polypeptide/NN was/VBD interrupted/VBN by/IN a/DT single/JJ short/JJ intron/NN of/IN 60/CD base/NN pairs/NNS (/( bp/NN )/SYM ,/, and/CC about/RB 70%/CD of/IN the/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN the/DT Drosophila/NEWGENE PCNA/NEWGENE was/VBD identical/JJ to/IN the/DT rat/NN and/CC human/NEWGENE PCNA/NEWGENE polypeptides/NEWGENE ,/, with/IN conserved/VBN unique/JJ repeats/NNS of/IN leucine/NN in/IN the/DT C-terminal/NN region/NN ./.
@@82371126152 No/DT homology/NN was/VBD found/VBN between/IN the/DT 36K/NN protein/NN and/CC known/VBP structures/NNS of/IN proteins/NNS ./.
@@39049524555 Nursing/NNP education--the/JJ computer/NN obligation/NN ./.
@@68512801318 Plasma/NN fibrinogen/NEWGENE was/VBD measured/VBN by/IN the/DT turbidimetric/JJ method/NN in/IN timol/JJ turbidimetric/JJ units/NNS ./.
@@89981158947 SUMMARY/NNP BACKGROUND/IN DATA/NNP :/: Melanoma/NNS care/NN has/VBZ not/RB changed/VBN significantly/RB in/IN the/DT last/NN 20/CD years/NNS ,/, and/CC the/DT controversy/NN of/IN elective/JJ lymph/NN node/NN dissections/NNS in/IN this/DT disease/NN continues/VBZ to/IN be/VB discussed/VBN ./.
@@40387024705 The/DT results/NNS indicate/VBP that/IN :/: 1/NN )/NN the/DT initial/JJ response/NN to/IN tethering/VBG varies/VBZ according/VBG to/IN previous/JJ penning/NN and/CC handling/VBG experience/NN ,/, 2/NN )/NN although/IN the/DT circadian/JJ rhythm/NN of/IN cortisol/NN was/VBD either/DT altered/VBN or/CC disrupted/VBN during/IN estrus/NN ,/, such/JJ disruptions/NNS were/VBD not/RB influenced/VBN by/IN type/NN of/IN penning/NN and/CC 3/NN )/NN tether/NN stalls/NNS may/MD chronically/RB increase/VB cortisol/NN concentrations/NNS in/IN gilts/NNS ./.
@@116394851506 This/DT unique/JJ work/NN needs/NN to/IN be/VB edited/VBN critically/RB and/CC afterwards/RB translated/VBN into/IN Urdu/NN and/CC other/DT languages/NNS for/IN the/DT benefit/NN of/IN the/DT present/NN day/NN students/NNS and/CC scholars/NNS ./.
@@105600144067 Macroscopic/NN researches/VBZ on/IN heart/NN vascularization/NN have/NN indicated/VBN that/IN the/DT angioarchitecture/NN of/IN the/DT conducting/JJ system/NN differs/VBZ from/IN that/DT of/IN the/DT normal/JJ myocardium/NN ./.
@@76547407577 Key/NNP areas/NNS of/IN the/DT selection/NN process/NN including/JJ medical/JJ and/CC surgical/JJ alternatives/NNS to/IN transplantation/NN ,/, the/DT composition/NN of/IN the/DT transplant/NN work-up/NN ,/, specific/JJ inclusion/NN criteria/NNS as/RB well/VBP as/IN specific/JJ psychosocial/JJ factors/NNS and/CC specific/JJ disease/NN etiologies/NNS and/CC co-morbidities/NNS that/WDT might/MD represent/VB contraindications/NNS were/VB extensively/RB reviewed/VBN ./.
@@115803015421 The/DT diagnosis/NN of/IN HCV/NN arthritis/NN in/IN patients/NNS with/IN positive/JJ rheumatoid/NEWGENE factor/NEWGENE and/CC chronic/JJ inflammatory/JJ polyarthritis/NN may/MD be/VB difficult/JJ ./.
@@14581708150 Adapromine/NN was/VBD established/VBN to/IN evoke/VB a/DT decrease/NN of/IN the/DT amplitude/NN of/IN the/DT dominant/JJ peak/NN and/CC dominant/JJ theta-activity/NN in/IN power/NN spectra/NNS of/IN the/DT EEG/NN in/IN the/DT cortex/NN and/CC hippocamp/NN ,/, with/IN an/DT increase/NN of/IN rapid/JJ wave/NN activity/NN in/IN the/DT beta/NN 2/NN range/NN in/IN the/DT right/JJ cortex/NN and/CC hippocamp/NN ./.
@@39119658408 Although/IN no/DT statistical/JJ significance/NN was/VBD achieved/VBN ,/, it/PRP is/VBZ remarkable/JJ that/IN there/RB was/VBD a/DT clear/JJ trend/NN for/IN the/DT superiority/NN of/IN Galphimia/NN D6/NN while/CC the/DT Galphimia/NNP dilution/NN 10/NN (/NN -6/NN )/NN was/VBD about/RB equally/RB effective/JJ compared/VBN with/IN placebo/NN ./.
@@27650013465 Definite/JJ JPsA/NN (/( 24/CD patients/NNS )/SYM was/VBD defined/VBN as/IN arthritis/NN associated/VBN ,/, but/CC not/RB necessarily/RB coincident/JJ ,/, with/IN a/DT typical/JJ psoriatic/JJ rash/NN ,/, or/CC arthritis/NN plus/IN at/IN least/RB 3/CD of/IN 4/CD minor/JJ criteria/NNS :/: dactylitis/NN ,/, nail/NN pitting/NN ,/, psoriasis-like/JJ rash/NN ,/, or/CC family/NN history/NN of/IN psoriasis/NN ./.
@@93284763796 Hprp3p/NEWGENE is/VBZ a/DT 77/NN kDa/NN protein/NN ,/, which/WDT is/VBZ homologous/JJ to/IN the/DT Saccharomyces/NEWGENE cerevisiae/NEWGENE splicing/NEWGENE factor/NEWGENE Prp3p/NEWGENE ./.
@@85343674888 PTP-S3/NEWGENE differs/VBZ from/IN PTP-S4/NEWGENE in/IN having/VBG a/DT deletion/NN of/IN 19/CD amino/JJ acids/NNS corresponding/JJ to/IN exon/NN E1/NNP ./NNP
@@72347557061 For/IN monocytes/NNS ,/, as/IN measured/VBN on/IN the/DT Hematrak/NNP ,/, it/PRP was/VBD 13/CD ./CD 4%/CD ./.
@@8062958045 Absorption/NNS varied/VBN between/IN 65/CD and/CC 95/CD per/IN cent/NN ,/, with/IN a/DT mean/JJ absorption/NN of/IN 80/CD per/IN cent/NN ,/, in/IN both/DT pregnant/JJ and/CC non-pregnant/JJ subjects/NNS ./.
@@89709794325 In/NN contrast/NN ,/, extracts/VBZ of/IN the/DT mutant/JJ virions/NNS catalyze/VBP the/DT wild-type/NN level/NN of/IN transcription/NN from/IN an/DT exogenous/JJ template/NN containing/JJ an/DT early/JJ promoter/NN ./.
@@50682715351 Influence/NNS of/IN diet/NN on/IN urinary/JJ VMA/NN excretion/NN ./.
@@7516597951 We/PRP also/RB examined/VBD the/DT effect/NN of/IN proteolytic/JJ processing/NN in/IN the/DT MVE/JJ nonstructural/JJ polyprotein/NN segment/NN mediated/JJ by/IN the/DT viral/NEWGENE proteinase/NEWGENE NS3/NEWGENE on/IN antigen/NN processing/VBG and/CC presentation/NN of/IN the/DT MVE/JJ H-2Kk-restricted/JJ T/NN cell/NN determinant/NN ./.
@@10820904622 BACKGROUND/IN :/: Hepatic/JJ encephalopathy/NN is/VBZ a/DT neuropsychiatric/JJ syndrome/NN associated/VBN with/IN acute/JJ liver/NN failure/NN ,/, chronic/JJ parenchymal/JJ liver/NN disease/NN or/CC portal/JJ systemic/JJ anastomosis/NN ./.
@@101939504223 METHODS/IN :/: Between/IN August/NN 1991/CD and/CC June/NN 1994/CD ,/, 198/CD men/NNS with/IN clinical/JJ T2/NN or/CC T3/NN classified/VBN (/( TNM/NN )/SYM prostate/NN carcinoma/NN (/( bone/NN scan/NN negative/JJ )/SYM who/WP were/VBD at/IN high/JJ risk/NN of/IN lymph/NN node/NN involvement/NN underwent/VBD a/DT 111In-capromab/JJ pendetide/NN scan/NN prior/NN to/IN staging/JJ lymphadenectomy/NN ./.
@@71744376996 Organisms/NNS were/VBD not/RB observed/VBN in/IN the/DT 5/CD bobcats/NNS trapped/VBN in/IN 2/CD other/DT counties/NNS ./.
@@75266092963 However/RB ,/, expression/NN of/IN sigma/NEWGENE 3/NEWGENE from/IN S4/NEWGENE (/( 3'UTR/NEWGENE //NEWGENE S1/NEWGENE )/SYM ,/, which/WDT included/VBD the/PDT PKR/NEWGENE activator/NEWGENE sequence/NEWGENE from/IN S1/NEWGENE within/IN the/DT 3'-UTR/NEWGENE of/NEWGENE S4/NEWGENE ,/, was/VBD comparable/JJ to/IN that/DT from/IN wild-type/NEWGENE S4/NEWGENE ./.
@@78247266647 Each/DT type/NN was/VBD divided/VBN into/IN two/JJ subgroups/NNS on/IN the/DT basis/NN of/IN whether/IN the/DT body/NN and/CC tail/NN of/IN the/DT pancreas/NN showed/VBD intense/JJ fatty/JJ replacement/NN (/( type/NN a/DT =/SYM negative/JJ for/IN intense/JJ fatty/JJ replacement/NN ,/, type/NN b/NN =/SYM positive/JJ for/IN intense/JJ fatty/JJ replacement/NN )/SYM ./.
@@15477751593 These/DT data/NN support/NN a/DT possible/JJ biological/JJ significance/NN of/IN the/DT frameshift/NN to/IN occur/VB at/IN this/DT position/NN of/IN the/DT large/JJ overlap/NN by/IN including/JJ the/DT putative/JJ RNA/NN template-binding/NN site/NN of/IN the/DT PLRV/NEWGENE replicase/NEWGENE in/IN the/DT ORF2a/NEWGENE //NEWGENE ORF2b/NEWGENE transframe/NEWGENE protein/NEWGENE ./.
@@65938626295 Hepatitis/NN B/NN vaccine/NN ./.
@@24582343123 A/DT new/JJ method/NN for/IN the/DT quantitative/JJ analysis/NN of/IN sleep/NN spindles/NNS during/IN continuous/JJ overnight/JJ EEG/NN recordings/NNS ./.
@@89805222814 The/DT cDNA/NN of/IN cpm7/NEWGENE encodes/VBZ a/DT closely/RB related/VBN protein/NN of/IN 36/CD ./CD 8/CD kDa/NN ./.
@@11337859634 The/DT COD/NN and/CC color/NN removals/NNS were/VBD both/DT more/RB than/IN 90%/NN when/CC FeCl3/NN was/VBD used/VBN as/IN the/DT coagulation/NN (/( dosages/NNS of/IN two-step/JJ coagulation/NN were/VBD 0/CD ./CD 031/CD and/CC 0/CD ./CD 012/CD mol/NN //NN L/NN respectively/RB )/SYM after/IN a/DT ferrous/JJ hydrogen/NN peroxide/NN oxidation/NN pretreatment/JJ at/IN a/DT H2O2/NN dosage/NN of/IN 0/CD ./CD 06/CD mol/NN //NN L/NN ./.
@@86282608080 Utilizing/JJ transient/JJ transfection/NN studies/NNS in/IN HepG2/NNP cells/NNS ,/, we/PRP have/VBP shown/VBP that/DT deletion/NN of/IN the/DT factor/NEWGENE VIII/NEWGENE promoter/NEWGENE sequences/NEWGENE distal/JJ to/IN nucleotide/NN -44/CD results/NNS in/IN a/DT significant/JJ but/CC small/JJ increase/NN in/IN promoter/NN activity/NN ./.
@@30980183819 Clinical/NNP findings/NNS were/VBD :/: height/NN 183/CD cm/NN ,/, weight/NN 62/CD kg/NN ,/, increased/VBN length/NN of/IN lower/JJR limbs/NNS ,/, P2-A2/NN pilosity/NN and/CC micropenis/NN ./.
@@105593244280 Moreover/RB ,/, a/DT recombinant/JJ Ad/NN expressing/NN Ad5/NEWGENE E4orf6/NEWGENE //NEWGENE 7/NEWGENE induced/VBD apoptosis/NN in/IN rat/NN cells/NNS when/CC coinfected/VBN with/IN wild-type/NN p53-expressing/JJ Ad/JJ ./JJ
@@28976513603 Hyperthyroidism/NNS is/VBZ one/PRP of/IN the/DT numerous/JJ causes/NNS of/IN infertility/NN and/CC recurrent/JJ abortion/NN ./.
@@84250504625 An/DT extensive/JJ inverted/JJ repeat/NN is/VBZ present/VB 3'/CD of/IN rpeA/NEWGENE ;/: inverted/JJ repeats/NNS are/VBP found/VB downstream/RB of/IN all/DT PE/NEWGENE operons/NEWGENE sequenced/VBN to/IN date/NN ,/, although/IN the/DT sequence/NN is/VBZ not/RB conserved/VBN ./.
@@93120877698 Recent/JJ studies/NNS have/VBP shown/VBP that/IN the/DT Src/NEWGENE homology-2/NEWGENE (/( SH2/NEWGENE )/SYM domain-containing/NN protein-tyrosine/NEWGENE phosphatase/NEWGENE ,/, SHP-2/NEWGENE ,/, associates/VBP with/IN the/DT cytoplasmic/JJ domain/NN of/RB PECAM-1/NEWGENE as/IN it/PRP becomes/VBZ tyrosine-phosphorylated/JJ during/IN platelet/NN aggregation/NN :/: a/DT process/NN that/WDT can/MD be/VB mimicked/VBN in/IN part/NN by/IN small/JJ synthetic/JJ phosphopeptides/NN corresponding/JJ to/IN the/DT cytoplasmic/JJ domain/NN of/IN PECAM-1/NEWGENE encompassing/VBG tyrosine/NN residues/NNS Tyr-663/NN or/CC Tyr-686/NN ./.
@@21031402704 All/DT 8/CD (/( 100%/CD )/SYM patients/NNS with/IN fulminant/JJ hepatic/JJ failure/NN who/WP received/VBD grafts/NNS survived/VBN ,/, including/JJ 3/CD who/WP received/VBD ABO-incompatible/NNP grafts/NNS ,/, though/CC 2/CD of/IN these/DT subsequently/RB required/VBN retransplantation/NN ./.
@@42139174859 High/NNP dosages/NNS of/IN D-penicillamine/NN in/IN pulmonary/JJ fibroses/NNS ./.
@@111225883577 MAIN/NNP OUTCOME/NNP MEASURES/NNS :/: Percentage/NN change/NN in/IN the/DT apnea-hypopnea/JJ index/NN (/( AHI/NNS ;/: apnea/NN events/NNS +/SYM hypopnea/NN events/NNS per/IN hour/NN of/IN sleep/NN )/SYM and/CC odds/NNS of/IN developing/JJ moderate-to-severe/JJ SDB/NN (/( defined/VBN by/IN an/DT AHI/NNS >/SYM or/CC =/CD 15/CD events/NNS per/IN hour/NN of/IN sleep/NN )/SYM ,/, with/IN respect/NN to/IN change/NN in/IN weight/NN ./.
@@103327337282 The/DT paramyxovirus/NEWGENE fusion/NEWGENE (/NEWGENE F/NEWGENE )/NEWGENE protein/NEWGENE mediates/VBZ membrane/NN fusion/NN ./.
@@106878553183 Expression/NNS in/IN early/JJ postnatal/JJ pituitary/JJ and/CC in/IN pre-somatotrophic/JJ cells/NNS suggests/VBZ that/IN Zn-16/NEWGENE could/MD play/VB a/DT role/NN in/IN pituitary/JJ development/NN prior/NN to/IN somatotroph/NN differentiation/NN ./.
@@109061765798 The/DT repetitive/JJ ETn/NEWGENE (/( early/NEWGENE transposon/NEWGENE )/SYM family/NN of/IN sequences/NNS represents/VBZ an/DT active/JJ "mobile/JJ mutagen"/NN in/IN the/DT mouse/NN genome/NN ./.
@@90656905287 Ume6p/NEWGENE ,/, which/WDT also/RB controls/VBZ the/DT expression/NN of/IN early/JJ meiotic/JJ genes/NNS ,/, represses/VBZ CAR1/NEWGENE expression/NN through/RB a/DT sequence/NN called/VBN URS/NEWGENE ,/, as/IN a/DT function/NN of/IN nitrogen/NN availability/NN ./.
@@51145156478 Slowed/JJ lysosomal/NEWGENE enzyme/NEWGENE release/NN and/CC its/PRP normalization/NN by/IN drugs/NNS in/IN adjuvant-induced/JJ polyarthritis/NN ./.
@@35553184221 The/DT pharmacology/NN of/IN carnitine/NN ./.
@@58268185760 I/NNP ./NNP
@@50156785311 Nitrogen-hydrogen/NNP tautomerism/NN in/IN porphyrins/NNS and/CC chlorins/NNS ./.
@@99887679339 Interspecific/NNP mouse/NN back-cross/NN analysis/NN identified/VBD the/DT loci/NNS for/IN mouse/NEWGENE 3Ost/NEWGENE genes/NEWGENE and/CC syntenic/JJ assignments/NNS of/IN corresponding/JJ human/JJ isologs/NNS were/VBD confirmed/VBN by/IN the/DT identification/NN of/IN mapped/VBN sequence-tagged/NN site/NN markers/NN ./.
@@93939661532 Two/CD closely/RB related/VBN IgH/NEWGENE constant/NEWGENE1 region/NEWGENE1 genes/NEWGENE1 ,/, CHA/NEWGENE and/CC CHB/NEWGENE ,/, have/VB been/VBN sequenced/VBN completely/RB ./.
@@22807774217 The/DT uteroglobin/NEWGENE promoter/NEWGENE contains/VBZ a/DT noncanonical/JJ estrogen/NEWGENE responsive/NEWGENE element/NEWGENE ./.
@@78358268050 Fraction/NNP 2/CD contains/VBZ 1/NN ,/NN 25/NN (/NN OH/NN )/NN 2-vitamin/NN D3/NN ,/, vitamin/NN D3/NN ,/, 25/NN (/NN OH/NN )/NN -vitamin/NN D3/NN and/CC 1/NN ,/NN 24/NN ,/NN 25/NN (/NN OH/NN )/NN 3-vitamin/NN D3/NN ./NN
@@10496553330 The/DT healing/NN rate/NN in/IN HIV-positive/NN patients/NNS was/VBD 66/CD percent/NN after/IN 14/CD weeks/NNS and/CC 100/CD percent/NN after/IN 32/CD weeks/NNS ;/: the/DT corresponding/JJ figures/NNS for/IN patients/NNS with/IN acquired/VBN immunodeficiency/NN syndrome/NN were/VBD 0/CD and/CC 50/CD percent/NN ./.
@@64391351224 Regional/NN CBF/NN was/VBD determined/VBN by/IN clearance/NN of/IN xenon/NN 133/CD in/IN 67/CD patients/NNS undergoing/VBG coronary/JJ bypass/NN grafting/NN procedures/NNS ./.
@@28383197072 RVEF/NN and/CC LVEF/NN both/DT increased/VBN by/IN about/RB 14%/JJ (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD and/CC p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@19821902593 Early/JJ cirrhosis/NN ,/, an/DT early/JJ modality/NN of/IN the/DT evolution/NN of/IN acute/JJ hepatitis/NN ./.
@@15316325251 Among/IN the/DT few/JJ proteins/NNS of/IN the/DT eukaryotic/JJ nucleolus/NN that/WDT have/VBP been/VBN characterized/VBN ,/, four/CD proteins/NNS ,/, nucleolin/NEWGENE ,/, fibrillarin/NEWGENE ,/, SSB1/NEWGENE and/CC NSR1/NEWGENE ,/, possess/VB a/DT common/JJ structural/JJ motif/NN ,/, the/DT GAR/NEWGENE domain/NEWGENE ,/, which/WDT is/VBZ rich/JJ in/IN glycine/NN and/CC arginine/NN residues/NNS ./.
@@72378174218 Cross/NN reactivity/NN in/IN theophylline/NN RIA/NN kit/NN decreased/VBN ./.
@@79589159049 In/NN particular/JJ ,/, changes/VBZ in/IN intracellular/JJ Ca2+/NN have/NN the/DT potential/NN to/IN either/DT inhibit/VB or/CC augment/VB the/DT ability/NN of/IN cAMP/NN to/IN stimulate/VB transcription/NN ,/, depending/VBG on/IN the/DT presence/NN of/IN specific/JJ forms/NNS of/IN Ca2+/NEWGENE //NEWGENE calmodulin-dependent/NEWGENE protein/NEWGENE kinases/NEWGENE ./.
@@75164663627 In/NN contrast/NN ,/, injection/NN of/IN a/DT plasmid/NN encoding/VBG simian/NEWGENE virus/NEWGENE 40/NEWGENE small/NEWGENE t/NEWGENE antigen/NEWGENE ,/, which/WDT interacts/VBZ with/IN PP2A/NEWGENE to/IN inhibit/VB its/PRP activity/NN towards/IN several/DT phosphoprotein/NN substrates/NN ,/, had/VBP no/DT effect/NN on/IN the/DT phosphorylation/NN state/NN of/IN CREB/NEWGENE in/IN stimulated/VBN or/CC unstimulated/JJ NIH/NN 3T3/CD cells/NNS ./.
@@1396247452 Eight/CD hours/NNS after/IN the/DT administration/NN of/IN colchicine/NN ,/, the/DT serum/NEWGENE ceruloplasmin/NEWGENE level/NN began/VBD to/IN rise/NN again/RB in/IN female/JJ rats/NNS ,/, but/CC not/RB in/IN male/JJ rats/NNS ./.
@@9753149741 Primary/JJ amenorrhoea/NN in/IN a/DT phenotypically/RB female/JJ individual/NN with/IN a/DT karyotype/NN 46/NN ,/, xy/NN and/CC bilateral/JJ gonadoblastoma/NN ./.
@@33718946349 Vimentin/NEWGENE positivity/NN was/VBD noted/VBN in/IN the/DT undifferentiated/JJ and/CC fibroblastic/NN components/NN ./.
@@62080248292 This/DT fraction/NN is/VBZ resistant/JJ to/IN digestions/NNS by/IN DNase/NEWGENE I/NEWGENE and/CC RNase/NEWGENE T1/NEWGENE and/CC disappears/VBZ completely/RB upon/IN alkali/NN hydrolysis/NN ./.
@@939885546 SCID/NN V/NEWGENE (/NEWGENE D/NEWGENE )/NEWGENE J/NEWGENE recombination/NN can/MD be/VB partly/RB rescued/VBN in/IN T-lymphocytes/NNS by/IN either/DT DNA-damaging/JJ agents/NNS (/( gamma-irradiation/NN and/CC bieomycin/NN )/SYM or/CC a/DT null/JJ mutation/NN of/IN the/DT p53/NEWGENE gene/NEWGENE ,/, possibly/RB because/IN of/IN transiently/RB elevated/VBN DNA/NN repair/NN activity/NN in/IN response/NN to/IN DNA/NN damage/NN or/CC to/IN delayed/JJ apoptosis/NN in/IN the/DT absence/NN of/IN p53/NEWGENE ./.
@@93937064621 Thus/RB ,/, Fis/NEWGENE acts/NNS as/IN an/DT accessory/JJ transcriptional/JJ activator/NN at/IN the/DT mar/NEWGENE promoter/NEWGENE ./.
@@27476533916 A/DT larval/NEWGENE albumin-like/NEWGENE protein/NEWGENE was/VBD not/RB detectable/JJ by/IN silver/NN staining/NN in/IN serum/NN of/IN tadpoles/NNS before/IN the/DT beginning/NN of/IN metamorphosis/NN at/IN stage/NN 48/CD ./CD
@@36071094269 All/PDT these/DT processes/NNS were/VBD fully/RB developed/VBN during/IN the/DT last/NN month/NN of/IN pregnancy/NN ,/, offering/VBG the/DT same/JJ picture/NN as/IN the/DT controls/NNS ./.
@@93434339323 It/PRP has/VBZ been/VBN previously/RB shown/VBP that/IN genes/NNS transcribed/VBN by/IN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE (/( RNAP/NEWGENE II/NEWGENE )/SYM are/VBP subject/NN to/IN position/NN effect/NN variegation/NN when/CC located/VBN near/IN yeast/NN telomeres/NNS ./.
@@115951709386 Alignment/NNS of/IN different/JJ cDNAs/NNS of/IN the/DT NR5A2/NEWGENE (/( hB1F/NEWGENE )/SYM gene/NN with/IN the/DT genomic/JJ sequence/NN facilitated/VBN the/DT delineation/NN of/IN its/PRP structural/JJ organization/NN ,/, which/WDT spans/VBZ over/RB 150/CD kb/NN and/CC consists/VBZ of/IN eight/CD exons/NNS interrupted/VBN by/IN seven/JJ introns/NNS ./.
@@98816928362 Conventionally/RB ,/, four/CD nominal/JJ allotypic/JJ variants/NNS ,/, b4/NEWGENE ,/, b5/NEWGENE ,/, b6/NEWGENE and/CC b9/NEWGENE have/VB been/VBN shown/VBP to/IN be/VB co-dominantly/RB expressed/VBN at/IN the/DT Ckappa1/NEWGENE gene/NEWGENE locus/NEWGENE ./.
@@83950143849 Genetic/NNP interactions/NNS between/IN BCK2/NEWGENE and/CC other/DT pathway/NN components/NN suggested/VBN that/IN BCK2/NEWGENE functions/NNS on/IN a/DT common/JJ pathway/NN branch/NN with/IN PPZ1/NEWGENE and/CC PPZ2/NEWGENE ./.
@@6657559718 Trial/NN 3/CD broiler/NN chickens/NNS were/VBD maintained/VBN on/IN control/NN feed/JJ until/IN they/PRP reached/VBD 3/CD weeks/NNS of/IN age/NN at/IN which/WDT time/VBP they/PRP were/VBD taken/VBP off/RB of/IN feed/JJ for/IN 2/CD ./CD 5/CD hr/NN and/CC then/RB placed/VBN on/IN either/DT control/JJ feed/JJ or/CC feed/JJ containing/JJ 4/CD ./CD 0/CD ppm/NN ochratoxin/NN A/NN ,/, and/CC heart/NN rate/NN and/CC blood/NN pressure/NN were/VBD measured/VBN every/DT half/NN hour/NN through/RB 7/CD hr/NN ./NN
@@25436799416 We/PRP also/RB provide/VBP evidence/NN that/IN neither/DT the/DT lambda/NEWGENE O/NEWGENE and/CC P/NEWGENE initiators/NEWGENE nor/CC the/DT E/NEWGENE ./NEWGENE coli/NEWGENE DnaJ/NEWGENE and/CC DnaK/NEWGENE heat/NEWGENE1 shock/NEWGENE1 proteins/NEWGENE1 play/VBP a/DT direct/JJ role/NN in/IN the/DT propagation/NN of/IN lambda/NN replication/NN forks/NNS in/IN vitro/FW ./.
@@86919628675 Limited/NNP role/NN for/IN PCR-based/JJ diagnosis/NN of/IN Whipple's/NNP disease/NN from/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS ./.
@@19274212549 Neuro-otological/JJ examinations/NNS revealed/VBD spontaneous/JJ downbeat/JJ nystagmus/NN ,/, bilateral/JJ gaze/NN nystagmus/NN and/CC rebound/JJ nystagmus/NN ./.
@@12088117303 Study/NNP of/IN the/DT physico-chemical/JJ state/NN of/IN plutonium-239/NN in/IN a/DT citrate/NN solution-blood/JJ system/NN ./.
@@81517874271 Insertion/NNS of/IN short/JJ oligonucleotides/NNS encoding/VBG the/DT basic/JJ amino/JJ acid/NN motifs/NNS 726-GRKRKSP-732/NEWGENE from/IN IE175/NEWGENE and/CC 500-VRPRKRR-506/NEWGENE from/IN IE110/NEWGENE into/IN deleted/VBN cytoplasmic/JJ forms/NNS of/IN the/DT two/JJ proteins/NNS restored/VBD the/DT karyophilic/JJ phenotype/NN and/CC confirmed/VBN that/IN these/DT motifs/NNS are/VBP both/DT necessary/JJ and/CC sufficient/JJ for/IN proper/JJ nuclear/JJ localization/NN ./.
@@83969135510 This/DT negative/JJ element/NN may/MD ,/, at/IN least/RB in/IN part/NN ,/, be/VB responsible/JJ for/IN the/DT cell/NN type-specific/JJ expression/NN of/IN the/DT DGK/NEWGENE gene/NEWGENE ./.
@@69736646763 A/DT case/NN of/IN anterior/JJ cleavage/NN syndrome/NN in/IN a/DT 27-year-old/CD female/JJ patient/NN is/VBZ described/VBN ./.
@@111794006596 Responses/NNS of/IN single-unit/NN carotid/JJ body/NN chemoreceptors/NN in/IN adult/JJ rats/NNS ./.
@@7828824241 Mutations/NNS that/WDT alter/VBP photoreceptor/NN cell/NN structure/NN and/CC development/NN were/VBD isolated/VBN that/DT fail/NN to/IN complement/NN these/DT deletions/NNS ./.
@@21355364321 In/NN that/DT case/NN ,/, the/DT ratio/NN of/IN brush/NN abrasion/NN was/VBD 0/CD ./CD 268/CD ,/, compressive/JJ and/CC transverse/JJ strength/NN ,/, 124/CD ./CD 3/CD and/CC 86/CD ./CD 3/CD MPa/NNS respectively/RB ,/, hardness/NN ,/, 43/CD ./CD 2/CD Hk/NNP ,/, water/NN absorption/NN 14/CD ./CD 2/CD micrograms/NN //NN mm3/NN and/CC thermal/JJ expansion/NN coefficient/NN ,/, 47/CD ./CD 4/CD x/NN 10/NN (/NN -6/NN )/NN //NN degrees/NN C/NNP ./NNP
@@105493545247 A/DT proportion/NN of/IN APC/NEWGENE wild-type/NN colon/NN carcinomas/NNS and/CC melanomas/NNS also/RB contains/VBZ constitutive/JJ nuclear/NEWGENE Tcf-4/NEWGENE //NEWGENE beta-catenin/NEWGENE complexes/NEWGENE as/IN a/DT result/NN of/IN dominant/JJ mutations/NNS in/IN the/DT N/JJ terminus/NN of/IN beta-catenin/NEWGENE that/WDT render/VBP it/PRP insensitive/JJ to/IN downregulation/NN by/IN APC/NEWGENE ,/, GSK3/NEWGENE beta/NEWGENE ,/, and/CC Axin/NEWGENE //NEWGENE Conductin/NEWGENE ./.
@@117102331554 Hydrogels/NNS for/IN tissue/NN engineering/JJ ./.
@@10490604787 Here/RB ,/, we/PRP demonstrate/VBP that/IN kinase-dead/JJ but/CC not/RB wild-type/VB forms/NNS of/IN Fyn/NEWGENE ,/, Lck/NEWGENE ,/, and/CC ZAP-70/NEWGENE block/NN 70Z/NN Cbl-mediated/NN NFAT/NEWGENE activation/NN ./.
@@16825422281 In/NN a/DT country/NN where/CC general/JJ HIV/NN prevalence/NN is/VBZ low/JJ ,/, the/DT strategy/NN is/VBZ cost-effective/JJ for/IN location/NN and/CC counselling/NN of/IN unknowingly/RB seropositive/JJ individuals/NNS ./.
@@10612773180 CONCLUSIONS/IN :/: Serum/NN levels/NNS of/IN S-100beta/NEWGENE are/VBP reliable/JJ markers/NNS for/IN adverse/JJ neurologic/JJ outcomes/NNS after/IN cardiac/JJ surgery/NN ./.
@@8381528341 If/IN ,/, however/RB ,/, the/DT mean/JJ temperature/NN rise/NN was/VBD higher/JJ (/( 0/CD ./CD 57/CD degrees/NNS C/NN or/CC 0/CD ./CD 69/CD degrees/NNS C/NN )/SYM ,/, such/JJ a/DT selection/NN practically/RB resulted/VBD in/IN the/DT disappearance/NN of/IN 'passable'/NN qualifications/NNS in/IN the/DT triplet/NN groups/NNS and/CC a/DT great/JJ predominance/NN of/IN 'to/MD be/VB rejected'/VBN qualifications/NNS in/IN the/DT large/JJ groups/NNS ./.
@@85545402552 These/DT regions/NNS overlap/NN with/IN the/DT HIT/NEWGENE protein/NEWGENE similarity/NEWGENE regions/NEWGENE ./.
@@80843395013 This/DT alternatively/RB spliced/VBN transcript/NN contained/VBD an/DT open/JJ reading/JJ frame/NN extending/VBG from/IN the/DT upstream/NN J/NEWGENE alpha/NEWGENE 11-2/NEWGENE region/NEWGENE to/IN 82/CD nucleotides/NNS downstream/RB of/IN the/DT beginning/NN of/IN the/DT TCR/NEWGENE C/NEWGENE alpha/NEWGENE region/NEWGENE ,/, and/CC potentially/RB encoded/VBN a/DT 36/CD amino/JJ acid/NN polypeptide/NN ./.
@@32231237376 Critical/NNP evaluation/NN of/IN various/JJ methods/NNS of/IN determining/NN markers/NN of/IN fetal/JJ maturity/NN in/IN amniotic/JJ fluid/NN ./.
@@10429740284 This/DT review/NN summarizes/VBZ the/DT clinical/JJ evidence/NN to/IN support/NN current/JJ therapies/NNS in/IN irritable/JJ bowel/NN syndrome/NN (/( IBS/NNS )/SYM ./.
@@84911248453 The/DT technical/JJ construction/NN of/IN the/DT mouth/NN protectors/NNS is/VBZ illustrated/VBN ,/, as/IN is/VBZ the/DT need/NN for/IN instrumentation/NN and/CC its/PRP costs/NNS and/CC the/DT materials/NNS required/VBN to/IN manufacture/NN these/DT mouth/NN protectors/NNS ./.
@@89169286090 The/DT same/JJ ligands/NNS also/RB exhibit/VBP a/DT similar/JJ inhibitory/JJ effect/NN on/IN PDGF-BB-dependent/NNP [/NN 3H/NN ]/NN thymidine/NN incorporation/NN in/IN PAE/NN cells/NNS expressing/JJ the/DT PDGF/NEWGENE beta-receptors/NEWGENE ./.
@@102260293304 In/NN epithelial/JJ cells/NNS ,/, the/DT PH/NEWGENE domain/NEWGENE of/IN Akt/NEWGENE //NEWGENE PKB/NEWGENE localised/VBN to/IN sites/NNS of/IN cell-cell/JJ and/CC cell-matrix/JJ contact/NN ,/, distinct/JJ from/IN focal/JJ contacts/NNS ,/, even/VB in/IN the/DT absence/NN of/IN serum/NN ./.
@@76584713524 The/DT plant/NN hormone/NN auxin/NN transcriptionally/RB activates/VBZ early/JJ genes/NNS ./.
@@33001183991 Oxygen/NN delivery/NN and/CC base/NN excess/NN decreased/VBN significantly/RB and/CC four/CD pigs/NNS died/VBN ./.
@@111455623518 The/DT P69/CD cell/NN line/NN was/VBD derived/VBN by/IN immortalization/NN of/IN human/JJ primary/JJ prostate/NN epithelial/JJ cells/NNS with/IN simian/NEWGENE virus-40/NEWGENE T/NEWGENE antigen/NEWGENE and/CC is/VBZ rarely/RB tumorigenic/JJ ./.
@@71126546917 It/PRP was/VBD also/RB found/VB that/WDT there/RB is/VBZ no/DT significant/JJ difference/NN between/IN the/DT prevalence/NN of/IN nasal/JJ carriage/NN of/IN S/NNP ./NNP aureus/NN amongst/IN the/DT hospital/NN staff/NN and/CC the/DT patients/NNS ./.
@@88164384062 Quantitative/JJ analysis/NN of/IN plasmid/NN loss/NN rates/NNS in/IN cdc28-1N/JJ strains/NNS carrying/VBG plasmids/NNS with/IN multiple/JJ replication/NN origins/NNS suggests/VBZ that/IN a/DT defect/NN in/IN initiating/JJ DNA/NN replication/NN probably/RB causes/VBZ this/DT plasmid/NN loss/NN phenotype/NN ./.
@@2547706967 The/DT application/NN of/IN ISH/NN and/CC IHC/NNS did/VBD not/RB change/VB significantly/RB the/DT routine/JJ histologic/JJ classification/NN of/IN pneumonias/NNS into/IN CMV-IP/NN and/CC IIP/NN ./.
@@71349246942 The/DT most/RB common/JJ types/NNS of/IN malformations/NNS were/VBD eye/NN defects/NNS and/CC open/JJ coeloms/NNS ./.
@@114161442860 Our/PRP findings/NNS further/RB our/PRP understanding/NN of/IN how/RB ZBP-89/NEWGENE modulates/VBZ cell/NN proliferation/NN and/CC reveals/VBZ a/DT novel/JJ mechanism/NN by/IN which/WDT the/DT p53/NEWGENE protein/NEWGENE is/VBZ stabilized/VBN ./.
@@116977602603 This/DT study/NN investigated/VBN whether/IN boron/NN would/MD enhance/VB the/DT ability/NN of/IN 17beta-estradiol/JJ (/( E2/NN )/SYM or/CC parathyroid/NEWGENE hormone/NEWGENE (/( PTH/NEWGENE )/SYM to/IN improve/VB bone/NN quality/NN in/IN ovariectomized/JJ OVX/JJ rats/NNS ./.
@@11543317361 The/DT absorbed/VBN dose/NN was/VBD measured/VBN by/IN combination/NN of/IN two/JJ integrating/JJ detectors/NNS :/: thermo-/JJ luminescent/JJ dosemeter/NN of/IN Mg2SiO4/NN :/: Tb/NN (/( TDMS/NNP )/SYM and/CC plastic/JJ nuclear/JJ track/NN detector/NN (/( PNTD/NNP )/SYM ./.
@@10453371302 Weight/NN and/CC height/NN z-scores/NNS were/VBD significantly/RB associated/VBN with/IN BMD/NN z-scores/NNS ./.
@@10393197977 DDP1/NEWGENE also/RB localizes/VBZ to/IN heterochromatin/NN in/IN interphase/NN nuclei/NNS of/IN larval/JJ neuroblasts/NNS ./.
@@84060044824 Moreover/RB ,/, in/IN transient/JJ transfection/NN assays/NNS ,/, PU/NEWGENE ./NEWGENE 1/NEWGENE alone/RB activated/VBN reporter/NN constructs/NNS containing/JJ the/DT JB/NEWGENE cis-element/NEWGENE ,/, and/CC the/DT activation/NN was/VBD shown/VBP to/IN be/VB dependent/JJ on/IN a/DT glutamine-rich/JJ sequence/NN in/IN the/DT amino-terminal/JJ portion/NN of/IN PU/NEWGENE ./NEWGENE 1/NEWGENE ./.
@@85103208474 It/PRP is/VBZ reported/VBN that/IN ,/, at/IN present/NN ,/, most/RB of/IN the/DT MRSAs/NNS spreading/JJ in/IN Japan/NN are/VBP acceleratedly/RB acquiring/JJ resistance/NN to/IN many/JJ drugs/NNS ,/, and/CC especially/RB ,/, they/PRP are/VBP developing/JJ high/JJ resistance/NN against/IN beta-lactams/NNS ./.
@@110144654430 The/DT mean/JJ day/NN of/IN diagnosis/NN of/IN periventricular/JJ echodensities/NNS was/VBD 3/CD +/NN //NN -/NN 2/CD days/NNS (/( range/NN 1-11/CD days/NNS )/SYM ,/, and/CC of/IN cystic/JJ PVL/NN 21/NN +/NN //NN -/NN 8/CD days/NNS (/( range/NN 2-47/JJ days/NNS )/SYM ./.
@@75907448630 The/DT integrity/NN of/IN the/DT cDNA/NN sequence/NN was/VBD confirmed/VBN by/IN analysis/NN of/IN several/DT overlapping/JJ genomic/JJ clones/NNS that/WDT span/VBP the/DT GAR1/NEWGENE gene/NEWGENE ./.
@@6027025873 In/NN one/PRP patient/NN with/IN severe/JJ diarrhea/NN the/DT estriol/NN concentration/NN in/IN serum/NN was/VBD low/JJ until/IN the/DT intestinal/JJ function/NN normalised/VBN and/CC the/DT estriol/NN concentration/NN went/VBD up/JJ exactly/RB when/CC the/DT diarrhea/NN stopped/VBN ./.
@@110940723715 We/PRP conclude/VBP that/IN c-Myb/NEWGENE regulates/VBZ the/DT RAG-2/NEWGENE promoter/NEWGENE in/IN T/NN cells/NNS by/IN binding/JJ to/IN this/DT consensus/NEWGENE c-Myb/NEWGENE binding/NEWGENE site/NEWGENE ./.
@@98131105622 The/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN CBP90/NEWGENE had/VBP no/DT significant/JJ similarity/NN to/IN any/DT other/DT protein/NN ,/, but/CC it/PRP had/VBP a/DT proline-rich/JJ domain/NN at/IN the/DT C-terminal/NN region/NN ./.
@@38886217302 The/DT structural/JJ gene/NN for/IN hydrogenase/NEWGENE encodes/VBZ a/DT protein/NN product/NN of/IN molecular/JJ mass/JJ 45820/CD Da/NNP ./NNP
@@89862288933 Children/NNS born/JJ from/IN chronic/JJ alcoholic/JJ mothers/NNS have/VBP shown/VBP behavioral/JJ teratogenic/JJ effects/NNS more/RB frequently/RB than/IN morphological/JJ malformations/NNS ./.
@@104963033940 CONCLUSIONS/IN :/: These/DT results/NNS show/NN that/IN once/CC daily/JJ oral/JJ valganciclovir/NN can/MD produce/VB exposures/NNS of/IN ganciclovir/NN (/( AUC24/NN )/SYM exceeding/VBG those/DT attained/VBN using/VBG intravenous/JJ ganciclovir/NN 10/CD mg/CD //CD kg/CD ./.
@@10650104466 Copyright/NNP 2000/CD The/DT Royal/NNP College/NNP of/IN Radiologists/NNS ./.
@@4656815080 A/DT rise/NN of/IN hemoglobin/NEWGENE concentration/NN accompanied/VBN by/IN an/DT increase/NN of/IN the/DT total/JJ iron/NN in/IN the/DT blood/NN serum/NN of/IN white/NN mice/NNS was/VBD found/VBN under/IN oxygen/NN pressure/NN of/IN 4/CD atm/NN for/IN an/DT hour/NN (/( preconvulsive/JJ state/NN )/SYM and/CC 6/CD atm/NN (/( convulsive/JJ state/NN )/SYM ./.
@@102097593837 Antithrombin/NEWGENE III/NEWGENE prevents/VBZ 60/CD min/NN warm/JJ intestinal/JJ ischemia/NN reperfusion/NN injury/NN in/IN rats/NNS ./.
@@92338116490 This/DT regulation/NN requires/VBZ two/JJ HMG-box/NEWGENE proteins/NEWGENE :/: the/DT ubiquitous/JJ Ste11/NEWGENE transcription/NEWGENE factor/NEWGENE and/CC the/DT M/NN cell-controlling/JJ protein/NN Mat1-Mc/NEWGENE ./.
@@92438405105 Two/CD related/VBN studies/NNS conducted/VBN over/RB a/DT five/CD week/NN period/NN measured/VBN and/CC typed/VBN HLA-DQA1/NEWGENE from/IN accumulated/VBN DNA/NN on/IN autopsy/NN room/NN and/CC Forensic/NNP DNA/NNP Laboratory/NNP structures/NNS ./.
@@90006329084 In/NN the/DT p51/NEWGENE subunit/NEWGENE ,/, the/DT Cys181/NN side-chain/NN is/VBZ oriented/VBN in/IN a/DT similar/JJ direction/NN to/IN the/DT Tyr181/NN side-chain/NN in/IN the/DT wild-type/NN complex/NN ./.
@@82068489677 The/DT pyrR/NEWGENE and/CC pyrP/NEWGENE genes/NEWGENE encoded/VBN polypeptides/NNS with/IN calculated/VBN molecular/JJ masses/NNS of/IN 19/CD ./CD 9/CD and/CC 45/CD ./CD 2/CD kDa/NN ,/, respectively/RB ./.
@@12761051922 In/NN contrast/NN ,/, the/DT insulin/NEWGENE response/NN had/VBP returned/VBN to/IN the/DT non-pregnant/JJ value/NN by/IN the/DT second/JJ day/NN of/IN the/DT puerperium/NN ./.
@@88237098806 Therapy/NNP with/IN dietary/JJ modification/NN and/CC triglyceride/NN lowering/JJ drugs/NNS resulted/VBN in/IN resolution/NN of/IN symptoms/NNS and/CC parotid/JJ swelling/NN in/IN one/PRP patient/NN ./.
@@30084052662 Further/JJ outbreaks/NNS of/IN ocular/JJ disease/NN in/IN farmed/JJ red/JJ deer/NN calves/NNS caused/VBN by/IN HVC-1/NN were/VBD investigated/VBN ./.
@@98130638687 Expression/NNS of/IN a/DT novel/JJ murine/NEWGENE phospholipase/NEWGENE D/NEWGENE homolog/NEWGENE coincides/VBZ with/IN late/JJ neuronal/JJ development/NN in/IN the/DT forebrain/NN ./.
@@106443577994 These/DT results/NNS suggest/VBP that/IN VP1/NEWGENE was/VBD efficiently/RB transported/VBN to/IN the/DT nucleus/NN and/CC localized/VBN in/IN the/DT discrete/JJ subnuclear/JJ regions/NNS ,/, possibly/RB with/IN VP2/NEWGENE and/CC VP3/NEWGENE ./.
@@88187189188 Moreover/RB ,/, following/IN a/DT single/JJ intravenous/JJ injection/NN of/IN the/DT bicistronic/JJ vector/NN complexed/VBN to/IN cationic/JJ liposomes/NNS into/IN recipient/JJ mice/NNS ,/, delivery/NN of/IN MDR1/NEWGENE and/CC GC/NEWGENE cDNAs/NEWGENE was/VBD achieved/VBN in/IN all/PDT the/DT organs/NNS we/PRP tested/VBD ./.
@@112688871101 To/TO avoid/VB misinterpretations/NNS ,/, special/JJ reference/NN values/NNS should/MD be/VB applied/VBN for/IN preadolescents/NNS ,/, at/IN least/RB with/IN regard/NN to/IN FVC/NN and/CC FEV1/NN ./.
@@22418925494 Utilization/NN of/IN alternative/JJ polyadenylation/NN signals/NNS was/VBD previously/RB shown/VBP to/IN generate/VB two/JJ sialophorin/NEWGENE mRNAs/NEWGENE of/NEWGENE 1/NEWGENE ./NEWGENE 9/NEWGENE and/NEWGENE 4/NEWGENE ./NEWGENE 3/NEWGENE kb/NEWGENE ,/, which/WDT differ/VBP in/IN the/DT length/NN of/IN their/PRP 3'/CD untranslated/JJ regions/NNS ./.
@@81199951799 Moreover/RB ,/, we/PRP observed/VBD that/IN the/DT function/NN of/IN T3R-RXR/NEWGENE heterodimers/NEWGENE on/IN response/NN elements/NN composed/VBN of/IN two/JJ half-sites/NNS in/IN a/DT directly/RB repeated/JJ orientation/NN spaced/VBN by/IN 4/CD nucleotides/NNS is/VBZ determined/VBN in/IN major/JJ parts/NNS by/IN the/DT 5'-flanking/JJ sequence/NN of/IN the/DT upstream/JJ half-site/NN ./.
@@178800281 Magnetotherapy/NNS of/IN hepatitis/NN A/NN and/CC B/NNP in/IN children/NNS ./.
@@91221983474 Point/NNP mutations/NNS of/IN the/DT five/CD tyrosine/NN residues/NNS in/IN the/DT cytoplasmic/JJ domain/NN of/IN the/DT receptor/NN were/VBD subsequently/RB used/VBN to/IN confirm/VB our/PRP conclusions/NNS ./.
@@67723702094 Volume/NN of/IN distribution/NN of/IN total/JJ DMDZ/NNP (/( range/NN ,/, 1/CD ./CD 33/CD to/IN 6/CD ./CD 30/CD l/NN //NN kg/NN )/SYM and/CC of/IN unbound/JJ DMDZ/NNP after/IN correction/NN for/IN protein/NN binding/JJ (/( range/NN ,/, 43/CD to/IN 243/CD l/NN //NN kg/NN )/SYM was/VBD larger/JJR in/IN women/NNS than/IN in/IN men/NNS of/IN all/DT ages/NNS ,/, and/CC in/IN the/DT elderly/NN as/IN opposed/VBN to/IN the/DT young/NN ./.
@@11685047124 Finally/RB ,/, a/DT chromogenic/JJ method/NN was/VBD used/VBN ,/, based/VBN on/IN thrombin/NEWGENE inhibition/NN and/CC the/DT substrate/NN S-2238/NN ./.
@@98298362344 It/PRP is/VBZ now/RB well/VB established/VBN that/DT progression/NN through/RB the/DT eukaryotic/JJ cell/NN cycle/NN is/VBZ controlled/VBN by/IN oscillations/NNS in/IN the/DT activity/NN of/IN cyclin-/NEWGENE dependent/NEWGENE kinases/NEWGENE (/( CDKs/NEWGENE )/SYM ./.
@@80110173653 No/DT drop/NN in/IN oxygen/NN saturation/NN (/( SaO2/NN )/SYM or/CC visual/JJ evidence/NN of/IN transient/JJ electroencephalographic/JJ (/( EEG/NN )/SYM arousals/NNS can/MD be/VB found/VB at/IN repeat/NN polysomnography/NN ./.
@@80346806653 The/DT mechanism/NN whereby/RB zeta/NEWGENE PKC/NEWGENE regulates/VBZ NF-kappa/NEWGENE B/NEWGENE most/RB probably/RB involves/VBZ the/DT activation/NN of/IN a/DT putative/JJ I/NEWGENE kappa/NEWGENE B/NEWGENE kinase/NEWGENE of/IN molecular/JJ mass/JJ approximately/RB 50/CD kDa/NN ,/, which/WDT phosphorylates/VBZ and/CC inactivates/VBZ I/NEWGENE kappa/NEWGENE B/NNP ./NNP
@@27900097267 Sequencing/NN analysis/NN revealed/VBN that/IN the/DT 0/NN ./NN 54-/NN and/CC 0/NN ./NN 4-kb/NN fragments/NNS are/VBP identical/JJ except/VB for/IN 150/CD nucleotides/NNS missing/JJ at/IN the/DT 5'/CD region/NN of/IN the/DT 0/CD ./CD 4-kb/CD fragment/NN ./.
@@91701591492 Instead/RB ,/, they/PRP contained/VBD dendritic/JJ cells/NNS that/WDT express/VBP melanogenic/JJ marker/NN proteins/NNS such/JJ as/IN tyrosinase/NEWGENE and/CC tyrosinase-related/NEWGENE protein/NEWGENE 1/CD ./CD
@@62586997133 A/DT double-blind/JJ trial/NN of/IN half-strength/NNP Polybactrin/NN Soluble/NN GU/NN bladder/NN irrigation/NN in/IN cystoscopy/NN ./.
@@114656557845 In/NN the/DT next/JJ week/NN ,/, the/DT beta-adrenergic/NN antagonist/NN atenolol/NN was/VBD added/VBN at/IN an/DT initial/JJ dose/NN of/IN 25/CD mg/NN //NN day/NN and/CC titrated/VBN to/IN 50/CD mg/NN //NN day/NN within/IN 1/CD week/NN ./.
@@111806882169 To/TO assess/VB the/DT maximum/JJ oxygen/NN uptake/NN (/( V'O2/NN max/NN )/SYM of/IN Hong/NNP Kong/NNP Chinese/JJ children/NNS and/CC to/IN explore/VB its/PRP association/NN with/IN respiratory/JJ illnesses/NNS ,/, we/PRP conducted/VBD the/DT Multistage/NNP Fitness/NNP Test/NNP (/( MFT/NN )/SYM ,/, a/DT 20-m/NN shuttle/NN run/NN test/NN ,/, in/IN 1/CD ,/CD 427/CD schoolchildren/NNS aged/VBN between/IN 8-12/CD years/NNS ./.
@@85157762444 A/DT second/JJ hydrophobic/JJ domain/NN ,/, bordered/VBN by/IN two/JJ hydrophilic/JJ regions/NNS strongly/RB suggests/VBZ a/DT transmembrane/JJ region/NN ./.
@@7592658505 The/DT insulin-induced/NEWGENE DNA-binding/NEWGENE complex/NEWGENE was/VBD identified/VBN as/IN the/DT p50/NEWGENE //NEWGENE p65/NEWGENE heterodimer/NEWGENE ./.
@@18822402499 It/PRP is/VBZ concluded/VBN that/DT attention/NN to/IN these/DT issues/NNS can/MD substantially/RB improve/VB the/DT quality/NN of/IN research/NN on/IN AIDS/NN related/VBD behaviors/NNS on/IN Black/NNP communities/NNS ./.
@@79920277979 2/CD patients/NNS (/( 11%/JJ )/SYM had/VBP significant/JJ morbidity/NN 502/CD and/CC 529/CD days/NNS respectively/RB after/IN transplantation/NN ./.
@@62419006040 This/DT study/NN was/VBD undertaken/VBP to/IN assess/VB the/DT effects/NNS of/IN hypothermia/NN and/CC chemical/JJ cardioplegia/NN on/IN the/DT functional/JJ recovery/NN of/IN hypertrophied/JJ non-failing/JJ rat/NN hearts/NNS subjected/VBN to/IN an/DT extended/VBN period/NN of/IN global/JJ ischaemia/NN ./.
@@84423845811 The/DT SCH9/NEWGENE protein/NEWGENE kinase/NEWGENE mRNA/NEWGENE contains/VBZ a/DT long/JJ 5'/CD leader/NN with/IN a/DT small/JJ open/JJ reading/JJ frame/NN ./.
@@94202753033 In/NN addition/NN ,/, the/DT affinities/NNS of/IN CBF2/NEWGENE for/IN binding/JJ to/IN the/DT LMP-1/NEWGENE ,/, LMP-2/NEWGENE ,/, and/CC CD23/NEWGENE promoters/NEWGENE were/VBD also/RB measured/VBN ./.
@@100075645 Multilayer-relaxation/NNP geometry/NN and/CC electronic/JJ structure/NN of/IN a/DT W/NN (/NN 111/NN )/NN surface/NN ./.
@@43698848257 Conditions/NNS influencing/VBG inhibitors/NNS of/IN the/DT colony-stimulating/NEWGENE factor/NEWGENE (/( CSF/NEWGENE )/SYM ./.
@@92004989155 Spatial/JJ zones/NNS for/IN muscle/NN coactivation/NN and/CC the/DT control/NN of/IN postural/JJ stability/NN ./.
@@76754494796 In/NN one/PRP glioblastoma/NN cell/NN line/NN ,/, a/DT Shc-associated/NN p190/NEWGENE was/VBD identified/VBN as/IN the/DT activated/VBN PDGFR/NEWGENE ./.
@@76351409457 The/DT expression/NN of/IN the/DT gene/NN encoding/VBG the/DT enzyme/NN (/( CYP19/NEWGENE )/SYM is/VBZ regulated/VBN ,/, in/IN part/NN ,/, by/IN tissue-specific/NN promoters/NN through/RB the/DT use/NN of/IN alternative-splicing/JJ mechanisms/NNS ./.
@@86571503828 The/DT role/NN of/IN negative/JJ regulators/NNS such/JJ as/IN NCE3/NEWGENE ,/, as/RB well/VB as/IN the/DT previously/RB described/VBN SIN5/NEWGENE gene/NEWGENE ,/, in/IN determining/VBG the/DT promoter/NN specificity/NN of/IN homologous/JJ activators/NNS is/VBZ discussed/VBN ./.
@@104064644299 By/IN contrast/NN ,/, mTRAP100/NEWGENE coprecipitates/NNS in/IN vivo/NN with/IN another/DT component/NN of/IN the/DT TRAP/NEWGENE complex/NEWGENE (/( TRAP220/NEWGENE )/SYM ,/, which/WDT directly/RB contacts/VBZ TR/NEWGENE and/CC the/DT vitamin/NEWGENE D/NEWGENE receptor/NEWGENE in/IN a/DT ligand-dependent/JJ manner/NN ./.
@@75887778864 These/DT observations/NNS lead/NN to/IN the/DT proposal/NN that/IN the/DT RNAP/NEWGENE II/NEWGENE CTD/NEWGENE might/MD be/VB an/DT in/NN vivo/NN target/NN for/IN the/DT activated/VBN p42mapk/NEWGENE and/CC p44mapk/NEWGENE MAP/NEWGENE kinases/NEWGENE ./.
@@69500046724 Study/NNP on/IN distribution/NN of/IN metal/NN in/IN the/DT teeth/NNS treated/VBN by/IN iontophoresis/NN with/IN transparent/JJ specimens/NNS ./.
@@76238218186 Regulation/NN of/IN Gax/NEWGENE homeobox/NEWGENE1 gene/NEWGENE1 transcription/NN by/IN a/DT combination/NN of/IN positive/JJ factors/NNS including/JJ myocyte-specific/NEWGENE enhancer/NEWGENE factor/NEWGENE 2/NEWGENE ./.
@@115951761776 The/DT genomic/JJ structure/NN of/IN the/DT human/NEWGENE SPEC1/NEWGENE gene/NEWGENE reveals/VBZ complex/NN splicing/JJ and/CC close/JJ promoter/NN proximity/NN to/IN the/DT AF1q/NEWGENE translocation/NEWGENE gene/NEWGENE ./.
@@111607328811 Quantitative/JJ PCR/NN studies/NNS indicated/VBD that/DT synthesis/NN and/CC transport/NN of/IN vector/NN DNA/NN into/IN the/DT nucleus/NN were/VBD similar/JJ for/IN macrophages/NNS infected/VBN with/IN the/DT clone/NN 239/CD and/CC 316/CD pseudotypes/NNS ,/, suggesting/VBG that/IN the/DT restriction/NN for/IN SIVmac239/NN infection/NN is/VBZ after/IN reverse/JJ transcription/NN and/CC nuclear/JJ import/NN of/IN viral/JJ DNA/NN ./.
@@39878577404 The/DT various/JJ muscles/NNS of/IN the/DT pelvic/JJ floor/NN region/NN could/MD be/VB reflexly/NN activated/VBN either/DT individually/RB or/CC as/IN a/DT mass/JJ unit/NN depending/VBG on/IN the/DT intensity/NN of/IN stimulation/NN ./.
@@10466306305 ECG-gated/JJ myocardial/JJ Technetium-99m/NN sestamibi/NN SPECT/NN is/VBZ a/DT useful/JJ technique/NN to/IN measure/NN myocardial/JJ perfusion/NN and/CC function/NN simultaneously/RB ./.
@@10952828772 This/DT suggests/VBZ that/IN cardiovascular/JJ magnetic/JJ resonance/NN is/VBZ the/DT preferred/VBN technique/NN for/IN volume/NN and/CC ejection/NN fraction/NN estimation/NN in/IN heart/NN failure/NN patients/NNS ,/, because/IN of/IN its/PRP 3D/JJ approach/NN for/IN non-symmetric/JJ ventricles/NNS and/CC superior/JJ image/NN quality/NN ./.
@@74612267353 No/DT symptoms/NNS other/DT than/IN hot/JJ flush/NN showed/VBD such/JJ significant/JJ correlation/NN with/IN plasma/NN epinephrine/NN or/CC norepinephrine/NN levels/NNS ./.
@@10555079373 Ti/NN exhibited/VBD a/DT feather-like/JJ morphology/NN ./.
@@98910612711 To/TO search/VB for/IN transcriptional/NN regulators/NN ,/, we/PRP used/VBD a/DT fragment/NN of/IN the/DT SpHE/NEWGENE promoter/NEWGENE containing/JJ several/DT individual/JJ elements/NNS instead/RB of/IN the/DT conventional/JJ bait/NN that/WDT contains/VBZ a/DT multimerized/JJ cis/NN element/NN ./.
@@81839153573 The/DT gene/NN encoding/VBG the/DT 105-kDa/NEWGENE protein/NEWGENE (/NEWGENE p105/NEWGENE )/NEWGENE precursor/NEWGENE of/IN the/DT p50/NEWGENE subunit/NEWGENE of/IN transcription/NN factor/NN NF-kappa/NEWGENE B/NEWGENE also/RB encodes/VBZ a/DT p70/NEWGENE I/NEWGENE kappa/NEWGENE B/NEWGENE protein/NEWGENE ,/, I/NEWGENE kappa/NEWGENE B/NEWGENE gamma/NEWGENE ,/, which/WDT is/VBZ identical/JJ to/IN the/DT C-terminal/NN 607/NN amino/JJ acids/NNS of/IN p105/NEWGENE ./.
@@12867321928 Though/IN hepatomegaly/NN and/CC mild/JJ elevation/NN of/IN enzymes/NNS can/MD be/VB observed/VBN in/IN a/DT significant/JJ proportion/NN of/IN patients/NNS ,/, involvement/NN of/IN liver/NN leading/JJ to/IN acute/JJ hepatitis/NN or/CC liver/NN cell/NN necrosis/NN is/VBZ a/DT relatively/JJ uncommon/JJ complication/NN in/IN P/NNP ./NNP falciparum/NN malaria/NN ./.
@@90157998981 Serotonin/NEWGENE receptors/NEWGENE in/IN suicide/NN victims/NNS with/IN major/JJ depression/NN ./.
@@17573419170 The/DT volume/NN fraction/NN (/( Vv/NN )/SYM and/CC number/NN //NN mm2/NN (/( Na/NN )/SYM of/IN all/DT capillaries/NNS (/( perfused/VBN and/CC nonperfused/JJ )/SYM in/IN a/DT given/NN area/NN of/IN brain/NN were/VBD determined/VBN after/IN staining/NN for/IN alkaline/NEWGENE phosphatase/NEWGENE ./.
@@82288054389 A/DT second/JJ important/JJ molecule/NN in/IN TCR/NEWGENE signal/JJ transduction/NN is/VBZ the/DT guanine/NEWGENE nucleotide/NEWGENE binding/NEWGENE protein/NEWGENE ,/, p21ras/NEWGENE ,/, which/WDT is/VBZ coupled/VBN to/IN the/DT TCR/NEWGENE by/IN a/DT protein/NEWGENE tyrosine/NEWGENE kinase/NEWGENE dependent/JJ mechanism/NN ./.
@@115248157707 Local/JJ control/NN rates/NNS were/VBD 91%/CD for/IN metastatic/JJ lung/NN cancer/NN ,/, 89%/NN for/IN primary/JJ lung/NN cancer/NN and/CC 85%/JJ for/IN T1/NN ,/, 2N0M0/NN cases/NNS ./.
@@3042403755 Here/RB the/DT conventional/JJ tests/NNS clearly/RB pointed/VBN to/IN the/DT presence/NN of/IN retrocochlear/JJ disease/NN ./.
@@97270451934 A/NEWGENE further/JJ mechanism/NN increasing/JJ specific/JJ activation/NN was/VBD cooperation/NN of/IN receptors/NNS at/IN multiple/JJ and/CC weak/JJ HREs/NEWGENE ,/, which/WDT was/VBD accentuated/VBN in/IN the/DT presence/NN of/IN both/PDT the/DT AR/NEWGENE N/NN terminus/NN and/CC ligand/NN binding/JJ domain/NN ./.
@@47465595535 Estimation/NNS of/IN renin/NEWGENE secretion/NN rate/NN and/CC renal/JJ plasma/NN flow/NN from/IN peripheral/JJ and/CC renal/NEWGENE vein/NEWGENE renin/NEWGENE levels/NNS ./.
@@82816348263 Other/JJ parameters/NNS of/IN iron/NN metabolism/NN ,/, including/JJ ferritin/NEWGENE ,/, were/VBD not/RB found/VB to/IN contribute/VB to/IN the/DT risk/NN ./.
@@1825027975 PAS1/NEWGENE ,/, a/DT yeast/NN gene/NN required/VBN for/IN peroxisome/NN biogenesis/NN ,/, encodes/VBZ a/DT member/NN of/IN a/DT novel/JJ family/NN of/IN putative/JJ ATPases/NEWGENE ./.
@@97537758940 However/RB ,/, ICK1/NEWGENE was/VBD induced/VBN by/IN ABA/NN ,/, and/CC along/IN with/IN ICK1/NEWGENE induction/NN there/RB was/VBD a/DT decrease/NN in/IN Cdc2-like/NEWGENE histone/NEWGENE1 H1/NEWGENE1 kinase/NEWGENE1 activity/NN ./.
@@10797586611 The/DT models/NNS were/VBD tested/VBN by/IN studying/VBG their/PRP response/NN to/IN disturbances/NNS of/IN the/DT afferent/JJ signal/NN from/IN the/DT bladder/NN ./.
@@77494613474 Functional/JJ analysis/NN of/IN the/DT sGTH/NEWGENE alpha/NEWGENE subunit/NEWGENE promoter/NEWGENE by/IN the/DT transient/JJ transfection/NN of/IN several/DT sGTH/NEWGENE alpha/NEWGENE //NEWGENE CAT/NEWGENE chimeric/JJ plasmids/NNS into/IN rainbow/NN trout/NN pituitary/JJ cells/NNS suggests/VBZ that/IN its/PRP pituitary-specific/JJ expression/NN is/VBZ GSE-dependent/NN ./.
@@91214523557 Domain/NNS switch/NN experiments/NNS reveal/VBP that/DT C/NEWGENE //NEWGENE EBP/NEWGENE beta/NEWGENE proteins/NEWGENE containing/JJ either/DT the/DT leucine/NN zipper/NN or/CC the/DT activation/NN domain/NN of/IN C/NEWGENE //NEWGENE EBP/NEWGENE alpha/NEWGENE are/VBP unable/JJ to/IN stimulate/VB the/DT 2D5/NEWGENE promoter/NEWGENE yet/RB are/VBP fully/RB capable/JJ of/IN transactivating/JJ an/DT artificial/JJ promoter/NN bearing/JJ a/DT high-affinity/JJ C/NEWGENE //NEWGENE EBP/NEWGENE site/NEWGENE ./.
@@103238637243 In/NN addition/NN ,/, we/PRP demonstrate/VBP that/IN the/DT production/NN of/IN active/NEWGENE recombinant/NEWGENE telomerase/NEWGENE requires/VBZ a/DT factor/NN in/IN rabbit/NN reticulocyte/NN lysate/NN that/WDT promotes/VBZ ribonucleoprotein/NN assembly/NN ./.
@@70726356841 A/DT simple/JJ method/NN for/IN measuring/JJ urinary/JJ iron/NN following/IN the/DT administration/NN of/IN desferrioxamine/NN (/( DF/NN )/SYM is/VBZ described/VBN ./.
@@112123278535 Recent/JJ studies/NNS using/VBG isolated/VBN rat/NN adipocytes/NNS and/CC chemically/RB synthesized/VBN PIG/NN compounds/NNS point/NN to/IN IRS1/NEWGENE //NEWGENE 3/NEWGENE tyrosine/NN phosphorylation/NN by/IN p59Lyn/NEWGENE kinase/NEWGENE as/IN the/DT site/NN of/IN cross-talk/NN ,/, the/DT negative/JJ regulation/NN of/IN which/WDT by/IN interaction/NN with/IN caveolin/NEWGENE is/VBZ apparently/RB abrogated/VBN by/IN PIG/NN ./.
@@9139892331 Thus/RB ,/, the/DT P/NNP ./NNP aeruginosa/NN orfX/NEWGENE and/CC vfr/NEWGENE promoters/NEWGENE are/VBP arranged/VBN in/IN a/DT back-to-back/JJ orientation/NN rather/RB than/IN the/DT face-to-face/JJ orientation/NN of/IN the/DT dorf/NEWGENE and/CC crp/NEWGENE promoters/NEWGENE ./.
@@114507769484 A/DT rare/JJ case/NN of/IN primary/NN group/NN A/NN streptococcal/JJ peritonitis/NN ./.
@@32612233957 Fourteen/CD patients/NNS were/VBD in/IN the/DT multifocal/JJ disease/NN group/NN ;/: 13/CD were/VBD detected/VBN by/IN SPECT/NN and/CC 10/CD by/IN TCT/NN ./.
@@75009538899 High/NNP ADR1/NEWGENE gene/NEWGENE dosage/NN increased/VBD the/DT transcription/NN of/IN genes/NNS encoding/VBG peroxisomal/JJ proteins/NNS as/IN compared/VBN to/IN one/PRP copy/NN of/IN the/DT ADR1/NEWGENE gene/NEWGENE ./.
@@25666133260 The/DT 65-bp/JJ sequence/NN contains/VBZ the/DT octameric/JJ cAMP-responsive/NEWGENE enhancer/NEWGENE (/( CRE/NEWGENE )/SYM TGACGTCA/NEWGENE (/( nucleotides/NNS -48/CD to/IN -41/CD )/SYM ./.
@@82341668217 The/DT bioavailability/NN of/IN etodolac/NN from/IN capsules/NNS exposed/VBN to/IN stressed/VBN conditions/NNS was/VBD compared/VBN in/IN both/DT dogs/NNS and/CC humans/NNS to/IN capsules/NNS stored/VBN at/IN RT/JJ conditions/NNS ./.
@@106533592443 Scmh1/NEWGENE maps/NNS to/IN 4D1-D2/CD ./CD 1/CD in/IN mice/NNS ./.
@@78697217851 In/NN this/DT paper/NN ,/, an/DT analysis/NN of/IN the/DT dynamics/NNS in/IN the/DT closing/JJ phase/NN of/IN the/DT occluder/NN of/IN a/DT mechanical/JJ monoleaflet/NN heart/NN valve/NN prosthesis/NN is/VBZ presented/VBN ./.
@@108269466654 Investigation/NNP of/IN the/DT structural/JJ basis/NN of/IN the/DT interaction/NN between/IN human/NEWGENE Igs/NEWGENE and/CC gp120/NEWGENE shows/VBZ that/IN the/DT viral/NEWGENE gp120/NEWGENE SAg/NEWGENE can/MD interact/VB only/RB with/IN a/DT subset/NN of/IN human/NEWGENE V/NEWGENE (/NEWGENE H/NEWGENE )/NEWGENE 3+/NEWGENE Igs/NEWGENE ./.
@@106540326682 JPEG/NN 53/NN ,/, resulting/VBG in/IN a/DT compression/NN ratio/NN of/IN 1/CD :/: 21/CD ,/, does/VBP not/RB compromise/VB the/DT diagnostic/JJ performance/NN in/IN general/NN ./.
@@16907286188 The/DT presence/NN of/IN the/DT corresponding/JJ mature/JJ mRNA/NN transcripts/NNS (/( 3/CD ./CD 2-3/CD ./CD 5/CD kilobase/NN pairs/NNS (/( kb/NN ]/NN in/IN human/JJ fibroblasts/NNS was/VBD shown/VBP by/IN Northern/NNP blot/NN hybridization/NN ,/, S1/NEWGENE nuclease/NEWGENE protection/NN assay/NN ,/, and/CC the/DT polymerase/NEWGENE chain/NN reaction/NN ./.
@@4837165197 In/NN case/NN of/IN a/DT pathologically/RB convoluted/JJ internal/JJ carotid/JJ the/DT common/JJ carotid/JJ artery/NN was/VBD resected/VBN with/IN an/DT end-to-end/JJ anastomosis/NN ./.
@@92263459180 However/RB ,/, mean/JJ food/NN intake/NN in/IN the/DT 40%/CD group/NN was/VBD half/NN that/IN of/IN the/DT ACT/NNP group/NN (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM and/CC significantly/RB less/PRP (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM than/IN the/DT SEP/NN group/NN ,/, which/WDT consumed/VBD amounts/NNS equivalent/JJ to/IN 65%/NN of/IN daily/JJ requirement/NN ./.
@@10394116262 Wrist/NN measurement/NN of/IN blood/NN pressure/NN :/: some/DT critical/JJ remarks/NNS to/IN oscillometry/NN ./.
@@112122497333 The/DT effects/NNS of/IN the/DT transfected/VBN receptors/NNS were/VBD associated/VBN with/IN antagonism/NN of/IN activator/NEWGENE protein/NEWGENE 1/NEWGENE (/( AP-1/NEWGENE )/SYM activity/NN ./.
@@111062161235 In/NN the/DT COPD/NN patients/NNS ,/, the/DT variability/NN of/IN Delta-inst/NN Rrs/NN (/( 30%/CD )/SYM was/VBD greater/JJR than/IN that/DT of/IN FOT/NN Rrs/NN (/( 21%/JJ )/SYM ./.
@@70374796809 The/DT "cracked-tooth"/JJ syndrome/NN ./.
@@103530739413 Regression/NNS analyses/NNS identified/VBN 7/CD risk/NN and/CC 7/NN protective/NN factors/NN with/IN minimal/JJ overlap/NN ./.
@@75338589469 However/RB ,/, multiple/JJ alanine/NN substitutions/NNS or/CC proline/NN (/( helix-destabilizing/JJ )/SYM substitutions/NNS disrupted/VBD both/DT oligomerization/NN and/CC transport/NN of/IN GP64/NEWGENE EFP/NEWGENE ./.
@@79584464475 The/DT hepatocyte/NEWGENE nuclear/NEWGENE factor-3/NEWGENE (/( HNF-3/NEWGENE )/NN //NEWGENE orkhead/NEWGENE (/( fkh/NEWGENE )/SYM proteins/NNS consist/VBP of/IN an/DT extensive/JJ family/NN of/IN tissue-specific/JJ and/CC developmental/JJ gene/NN regulators/NN which/WDT share/VBP homology/NN within/IN the/DT winged/NEWGENE helix/NEWGENE DNA/NEWGENE binding/NEWGENE motif/NEWGENE ./.
@@77700335562 Nucleotide/NN sequences/NNS of/IN the/DT clones/NNS revealed/VBN that/IN one/PRP clone/NN ,/, cap3/NEWGENE ,/, contained/VBD an/DT open/JJ reading/JJ frame/NN (/( ORF/NN )/SYM that/WDT would/MD code/VB for/IN a/DT 26-amino/JJ acid/NN ,/, cysteine-rich/JJ peptide/NN with/IN significant/JJ homology/NN to/IN Neurospora/NEWGENE crassa/NEWGENE copper/NEWGENE metallothionein/NEWGENE ./.
@@34783546510 In/NN treated/VBD herds/NNS ,/, cows/NNS more/RB than/IN 40/NN d/NN postpartum/JJ with/IN a/DT corpus/NN luteum/NN received/VBD prostaglandin/NN F2/NN alpha/NN ./.
@@2174105392 Immunohistochemical/JJ analysis/NN of/IN several/DT rat/NN organs/NNS also/RB showed/VBD staining/NN in/IN epithelial/JJ cells/NNS ./.
@@87607764598 CONCLUSION/IN :/: Twice/RB daily/JJ treatment/NN with/IN inhaled/JJ fluticasone/NN propionate/NN 50/NN micrograms/NNS or/CC 100/CD micrograms/NNS was/VBD significantly/RB more/RB effective/JJ than/IN theophylline/NN in/IN the/DT treatment/NN of/IN mild-to-moderate/JJ asthma/NN ./.
@@839378939 The/DT elevated/VBN Viso/NN V/NN in/IN the/DT RDS/NNS group/NN suggests/VBZ an/DT increase/NN in/IN small/JJ airway/NN resistance/NN secondary/JJ to/IN the/DT disease/NN or/CC to/IN its/PRP therapy/NN ./.
@@97634468507 The/DT GEF/NEWGENE and/CC GAP/NEWGENE activities/NNS for/IN Ypt1p/NEWGENE localize/VB to/IN particulate/JJ cellular/JJ fractions/NNS ./.
@@88167927046 DNA-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE (/( DNA-PK/NEWGENE )/SYM consists/VBZ of/IN a/DT heterodimeric/NN protein/NN (/( Ku/NEWGENE )/SYM and/CC a/DT large/JJ catalytic/JJ subunit/NN (/( DNA-PKcs/NEWGENE )/SYM ./.
@@90583232794 Our/PRP results/NNS demonstrate/VBP that/IN cis/NN elements/NN positioned/VBN between/IN the/DT alpha/NEWGENE 3/NEWGENE and/CC beta/NEWGENE 4/NEWGENE coding/JJ regions/NNS are/VBP important/JJ for/IN establishing/VBG part/NN of/IN the/DT restricted/VBN CNS/NN patterns/NNS of/IN beta/NEWGENE 4/NEWGENE ,/, alpha/NEWGENE 3/NEWGENE ,/, and/CC alpha/NEWGENE 5/NEWGENE gene/NEWGENE transcription/NN ./.
@@106128056784 However/RB ,/, no/DT genetic/JJ alteration/NN was/VBD detected/VBN in/IN any/DT of/IN the/DT cancers/NNS examined/VBN ./.
@@94357899803 Although/IN RAD17/NEWGENE ,/, RAD24/NEWGENE and/CC MEC3/NEWGENE are/VBP not/RB required/VBN for/IN cell/NN cycle/NN arrest/NN when/CC S/NNP phase/NN is/VBZ inhibited/VBN by/IN hydroxyurea/NN (/( HU/NN )/SYM ,/, they/PRP do/VBP contribute/VB to/IN the/DT viability/NN of/IN yeast/NN cells/NNS grown/VBP in/IN the/DT presence/NN of/IN HU/NN ,/, possibly/RB because/IN they/PRP are/VBP required/VBN for/IN the/DT repair/NN of/IN HU-induced/NN DNA/NN damage/NN ./.
@@108079037235 D5/NEWGENE //NEWGENE D1/NEWGENE (/NEWGENE CT/NEWGENE )/NEWGENE or/CC D5/NEWGENE //NEWGENE D1D/NEWGENE (/NEWGENE CT/NEWGENE )/NEWGENE tail/NN substitution/NN mutants/NNS displayed/VBD a/DT rank/JJ order/NN of/IN potency/NN and/CC agonist/NN affinities/NNS virtually/RB mimicking/VBG wild-type/NEWGENE (/NEWGENE wt/NEWGENE )/NEWGENE D1/NEWGENE receptors/NEWGENE ,/, as/IN indexed/VBN by/IN both/DT ligand/NN binding/JJ and/CC dopamine-stimulated/JJ cAMP/NN accumulation/NN assays/NNS ,/, and/CC ,/, similar/JJ to/IN wt/NN D1/NEWGENE receptors/NEWGENE ,/, did/VBD not/RB exhibit/VB receptor/NN constitutive/JJ activity/NN or/CC responsiveness/NN to/IN inverse/JJ agonists/NNS ./.
@@17715932372 When/WRB examined/VBN as/IN adults/NNS (/( 8/CD weeks/NNS old/JJ )/SYM ,/, the/DT external/NN genitalia/NNS of/IN TA-exposed/JJ offspring/NN were/VBD normal/JJ ./.
@@26578833336 Doppler/NN echo/NN in/IN evaluating/VBG arteriovenous/JJ fistulae/NNS for/IN dialysis/NN ./.
@@965137598 GTPase/NEWGENE activating/JJ specificity/NN of/IN RGS12/NEWGENE and/CC binding/JJ specificity/NN of/IN an/DT alternatively/RB spliced/VBN PDZ/NEWGENE (/( PSD-95/NEWGENE //NEWGENE Dlg/NEWGENE //NEWGENE ZO-1/NEWGENE )/SYM domain/NN ./.
@@110899119093 The/DT non-homologous/JJ sequences/NNS in/IN the/DT 5'/CD untranslated/JJ regions/NNS might/MD be/VB acquired/VBN at/IN or/CC after/IN transcription/NN during/IN retrotransposition/NN of/IN the/DT ATLN/NEWGENE elements/NEWGENE ./.
@@99208821741 Chem/NNP ./.
@@105969559145 Twelve/CD out/RB of/IN 43/CD renal/JJ failure/NN patients/NNS had/VBP troponin/NEWGENE I/NEWGENE 0/CD ./CD 13-0/CD ./CD 9/CD microg/NN //NN l/NN using/VBG Axsym/NNP method/NN and/CC 4/CD had/VBP levels/NNS of/IN 0/CD ./CD 07-0/CD ./CD 13/CD microg/NN //NN l/NN using/VBG Immuno/NNP 1/CD ./CD
@@53594645496 Pitfalls/NNS in/IN the/DT use/NN of/IN chromosome/NN aberration/NN analysis/NN for/IN biological/JJ radiation/NN dosimetry/NN ./.
@@15245492147 Both/DT GH/NEWGENE deficiency/NN and/CC impaired/VBN spinal/JJ growth/NN may/MD result/VB in/IN short/JJ stature/NN ,/, whereas/IN the/DT occurrence/NN of/IN early/JJ puberty/NN in/IN association/NN with/IN GH/NEWGENE deficiency/NN reduces/VBZ the/DT time/NN available/JJ for/IN GH/NEWGENE therapy/NN ./.
@@85956587283 The/DT DNA/NN sequences/NNS upstream/RB of/IN these/DT termini/NNS exhibit/NN homology/NN to/IN plant/NN mitochondrial-processing/JJ sites/NNS ,/, therefore/RB the/DT proximal/JJ 5'/CD ends/NNS are/VBP most/RB probably/RB generated/VBN by/IN RNA/NN processing/VBG ./.
@@61380155958 Brief/NNP report/VB ./.
@@86807064858 After/IN 6/CD h/NN of/IN reperfusion/NN ,/, PO2/NN //NN FlO2/NN ratio/NN was/VBD significantly/RB better/RBR after/IN Combined/VBN Therapy/NNP (/( 372/CD +/NN //NN -/NN 52/CD mm/NN Hg/NN )/SYM than/IN in/IN the/DT Recipient/NNS Instilled/JJ (/( 117/CD +/NN //NN -/NN 47/CD mm/NN Hg/NN )/SYM and/CC Control/NNP groups/NNS (/( 87/CD +/NN //NN -/NN 26/CD mm/NN Hg/NN )/SYM ,/, with/IN intermediate/JJ values/NNS in/IN Donor/NN Aerosol/NN dogs/NNS (/( 232/CD +/NN //NN -/NN 64/CD mm/NN Hg/NN )/SYM ./.
@@89439343148 But/CC ,/, as/IN Theriault/NN explains/VBZ ,/, improvements/NNS in/IN assessing/JJ exposure/NN have/NN not/RB yet/RB translated/VBN into/IN clear/JJ and/CC consistent/JJ findings/NNS ./.
@@102071151197 Concomitantly/RB ,/, the/DT total/JJ cellular/JJ level/NN of/IN p21/NEWGENE increased/VBN severalfold/JJ via/NN a/DT posttranscriptional/JJ mechanism/NN ./.
@@89172705849 BACKGROUND/IN :/: The/DT Bazett-corrected/JJ QT/NN (/( QTc/NN )/SYM interval/NN during/IN exercise/NN has/VBZ been/VBN used/VBN as/IN a/DT marker/NN for/IN ischemic/JJ disease/NN ,/, arrhythmogenic/JJ substrate/NN and/CC the/DT long/NN QT/NN syndrome/NN ./.
@@81784465285 The/DT data/NN suggest/VB that/IN ICP10/NEWGENE constitutively/RB increases/VBZ ras/NEWGENE activity/NN ,/, and/CC its/PRP TM/NN segment/NN plays/VBP a/DT critical/JJ role/NN in/IN transformation-related/JJ signaling/JJ pathways/NNS ./.
@@111639321008 Behavioural/JJ tests/NNS with/IN 192/CD specimen/NN of/IN the/DT roman/NN garden/NN snail/NN Helix/NNP pomatia/NNP L/NNP ./NNP were/VBD performed/VBN in/IN order/NN to/IN clarify/VB whether/IN the/DT thermopreferendum/NN of/IN this/DT pulmonate/NN is/VBZ influenced/VBN not/RB only/RB by/IN the/DT temperature/NN of/IN the/DT substratum/NN but/CC also/RB by/IN air/NN temperature/NN ./.
@@82763368257 In/NN a/DT retrospective/JJ analysis/NN of/IN first-time/JJ total/JJ colonoscopies/NNS in/IN 685/CD patients/NNS ,/, we/PRP investigated/VBD the/DT relationship/NN between/IN hyperplastic/JJ and/CC adenomatous/JJ polyps/NNS ./.
@@14203637429 The/DT TIMP/NEWGENE (/NEWGENE -59/NEWGENE //NEWGENE -53/NEWGENE )/NEWGENE AP1/NEWGENE site/NEWGENE is/VBZ a/DT promiscuous/JJ motif/NN that/WDT binds/VBZ c-Fos/NEWGENE //NEWGENE c-Jun/NEWGENE AP1/NEWGENE1 translated/VBN in/IN vitro/FW and/CC is/VBZ an/DT effective/JJ competitor/NN for/IN binding/NN of/IN nuclear/NEWGENE AP1/NEWGENE factors/NEWGENE to/IN the/DT consensus/NEWGENE TRE/NEWGENE ,/, but/CC in/IN addition/NN it/PRP binds/VBZ factors/NNS that/WDT do/VBP not/RB associate/VB with/IN the/DT consensus/NEWGENE TRE/NEWGENE ./.
@@111524511196 These/DT data/NN indicate/VB that/IN the/DT SmSmad2/NEWGENE responds/VBZ to/IN the/DT TGF-beta/NEWGENE signals/NNS by/IN interaction/NN with/IN receptor/NEWGENE I/NEWGENE ,/, which/WDT phosphorylates/VBZ it/PRP ,/, whereupon/CC it/PRP translocates/VBZ into/IN the/DT nucleus/NN presumably/RB to/IN regulate/VB target/NN gene/NN transcription/NN and/CC consequently/RB elicit/VB a/DT specific/NN TGF-beta/NEWGENE effect/NN ./.
@@92784753706 Hence/RB ,/, scs32/NEWGENE only/RB partially/RB suppressed/VBN the/DT ts/NN phenotype/NN and/CC was/VBD unable/JJ to/IN suppress/VB the/DT Ino-phenotype/NNP of/IN rpo26-31/NEWGENE ./.
@@17080989136 Using/VBG avidin-biotin/NN complex/NN DNA/NN binding/JJ assays/NNS ,/, a/DT series/NN of/IN overlapping/JJ alpha/NEWGENE promoter/NEWGENE DNA/NEWGENE sequences/NEWGENE between/IN -170/CD to/IN 29/CD basepairs/NNS were/VBD tested/VBN ,/, but/CC each/DT failed/VBN to/IN bind/NN GR/NEWGENE ,/, whereas/IN a/DT control/NN GRE/NEWGENE avidly/RB bound/JJ receptor/NN ./.
@@87029364540 An/DT expression/NN library/NN was/VBD constructed/VBN by/IN inserting/VBG 5'/CD portion-enriched/JJ cDNAs/NNS from/IN phytohemagglutinin-stimulated/JJ peripheral/JJ blood/NN mononuclear/JJ cells/NNS into/IN upstream/RB of/IN signal/NEWGENE sequence-deleted/NEWGENE CD4/NEWGENE cDNA/NEWGENE in/IN an/DT Epstein-Barr/NNP virus/NN shuttle/NN vector/NN ./.
@@75902832326 The/DT finding/NN that/IN the/DT chimeric/NEWGENE TdT/NEWGENE :/: :/: Pol/NEWGENE beta/NEWGENE protein/NEWGENE possessed/VBD significant/JJ template-dependent/NN polymerase/NEWGENE activity/NN suggests/VBZ that/IN aa/NNS 1-60/NN of/IN Pol/NEWGENE beta/NEWGENE are/VBP involved/VBN in/IN template/NN utilization/NN during/IN the/DT polymerization/NN reaction/NN ,/, as/IN suggested/VBN by/IN the/DT previous/JJ finding/NN that/IN the/DT 8-kDa/JJ N-terminal/NN domain/NN of/IN Pol/NEWGENE beta/NEWGENE possesses/VBZ ssDNA-binding/JJ activity/NN [/NN Kumar/NN et/FW al/NNS ./NNS ,/, J/NNP ./NNP
@@136835597 When/WRB extracorporeal/JJ CO2/NN removal/NN approximated/VBN CO2/NN production/NN (/( VCO2/NN )/SYM ,/, alveolar/JJ ventilation/NN almost/RB ceased/VBD ./.
@@86324635967 This/DT result/NN supports/VBP the/DT argument/NN that/IN the/DT beta'/NEWGENE subunit/NEWGENE plays/VBP an/DT essential/JJ role/NN in/IN determining/JJ the/DT progress/NN of/IN transcription/NN elongation/NN ./.
@@7135256943 Because/IN decreases/NNS in/IN the/DT disfluency/NN rates/NNS of/IN stutterers/NNS were/VBD observed/VBN during/IN the/DT presentation/NN of/IN all/DT three/CD stimulus/NN words/NNS ,/, the/DT data/NN failed/VBN to/IN support/NN the/DT operant/JJ model/NN ./.
@@65941052927 The/DT calculated/VBN values/NNS of/IN lambda/NN tb/NN at/IN 37/CD degrees/NNS C/NN and/CC 50/CD per/IN cent/NN haematocrit/NN were/VBD 0/CD ./CD 650/CD for/IN the/DT pulp/NN ,/, 0/CD ./CD 674/CD for/IN the/DT tongue/NN ,/, 0/CD ./CD 828/CD for/IN the/DT submandibular/JJ gland/NN and/CC 0/CD ./CD 881/CD for/IN the/DT gingiva/NN of/IN the/DT dog/NN ./. lambda/NN cp/NN increased/VBN and/CC lambda/NN tp/MD decreased/VBN as/IN the/DT temperature/NN was/VBD reduced/VBN from/IN 37/CD to/IN 4/CD degrees/NNS C/NNP ./NNP
@@81126118801 The/DT sequence/NN has/VBZ a/DT 1092-bp/CD open/JJ reading/JJ frame/NN encoding/VBG a/DT protein/NN of/IN 364/CD amino/JJ acids/NNS ./.
@@104264506451 Bacterial/JJ recovery/NN of/IN SA/NNP from/IN the/DT liver/NN //NN spleen/NN and/CC the/DT cecal/JJ tonsil/NN in/IN contact/NN poults/NNS and/CC SG/NN from/IN contact/NN chicks/NNS treated/VBN with/IN ILK/NEWGENE was/VBD dramatically/RB reduced/VBN when/CC compared/VBN to/IN non-treated/NN contact/NN poults/NNS and/CC chicks/NNS ./.
@@58069365746 Absorption/NNS of/IN electrolytes/NNS from/IN the/DT colon/NN in/IN cases/NNS of/IN ulcerative/JJ colitis/NN and/CC in/IN control/NN subjects/NNS ./.
@@77838227756 OBJECTIVE/IN :/: To/TO investigate/VB the/DT incidence/NN and/CC presentation/NN of/IN acute/JJ pernicious/JJ or/CC fulminating/JJ beriberi/NN in/IN a/DT general/JJ district/NN hospital/NN ./.
@@115308292815 This/DT article/NN reports/VBZ the/DT design/NN and/CC development/NN of/IN an/DT ECG/NN simulator/NN intended/VBN for/IN use/NN in/IN the/DT testing/NN ,/, calibration/NN and/CC maintenance/NN of/IN electrocardiographic/JJ equipment/NN ./.
@@34593854161 Allergy/NNS and/CC Tourette's/NNP syndrome/NN ./.
@@85840355733 Gel/NNP mobility/NN shift/NN assays/NNS indicated/VBN that/IN at/IN least/RB four/CD nuclear/JJ proteins/NNS with/IN distinct/JJ biochemical/JJ and/CC binding/JJ properties/NNS possess/VBP the/DT ability/NN to/IN bind/NN the/DT 3/NEWGENE beta/NEWGENE I-A/NEWGENE element/NEWGENE to/IN produce/NN four/CD DNA-protein/NN complexes/NNS (/( R1/NN to/IN R4/DT )/SYM ./.
@@2228272864 Workers/NNS with/IN "sensitivity"/NN to/IN toluene/NN diisocyanate/NN (/( TDI/NN )/SYM studied/VBN in/IN depth/NN in/IN an/DT attempt/NN to/IN determine/VB mechanisms/NNS of/IN bronchial/JJ hyperreactivity/NN ./.
@@13465343636 Characterization/NNS of/IN the/DT regulon/NN controlled/VBN by/IN the/DT leucine-responsive/JJ regulatory/JJ protein/NN in/IN Escherichia/NN coli/JJ ./.
@@10215803158 Calcinosis/NNS cutis/NN following/IN intravenous/JJ infusion/NN of/IN calcium/NN gluconate/NN ./.
@@11525640200 Inhibition/NNS of/IN JNK1/NEWGENE and/CC ERK/NEWGENE kinase/NN activities/NNS either/DT by/IN expression/NN of/IN the/DT dominant/JJ negative/JJ mutant/NN JNK1/NEWGENE or/CC by/IN treatment/NN with/IN a/DT selective/JJ chemical/JJ inhibitor/NN of/IN ERK/NEWGENE (/( PD098059/CD )/SYM substantially/RB abrogates/VBZ the/DT UV/NN induction/NN of/IN the/DT GADD45/NEWGENE promoter/NEWGENE ./.
@@110294596737 Transforming/NEWGENE growth/NEWGENE factor-beta1/NEWGENE (/( TGF-beta1/NEWGENE )/SYM can/MD act/VB as/IN a/DT tumor/NN suppressor/NN or/CC a/DT tumor/NN promoter/NN depending/VBG on/IN the/DT characteristics/NNS of/IN the/DT malignant/JJ cell/NN ./.
@@10822117623 Nor/CC is/VBZ such/JJ adjustment/NN possible/JJ unless/IN one/PRP posits/VBZ a/DT model/NN that/WDT relates/VBZ the/DT missing/JJ observations/NNS to/IN other/DT observed/VBN information/NN for/IN each/DT subject-models/NNS that/WDT are/VBP inherently/RB untestable/JJ ./.
@@110130797284 Multiple/NNP transcription/NN start/NN sites/NNS were/VBD revealed/VBN by/IN primer/NN extension/NN analysis/NN of/IN the/DT mouse/NN gene/NN ,/, and/CC transfection/NN constructs/NNS containing/JJ the/DT prospective/JJ promoter/NN generated/VBD transcriptional/JJ activity/NN comparable/JJ to/IN that/DT of/IN the/DT SV40/NEWGENE promoter/NEWGENE ./.
@@118607234642 A/DT mail/NN survey/NN of/IN Georgia/NN members/NN of/IN the/DT American/NNP College/NNP of/IN Obstetricians/NNPS and/CC Gynecologists/NN was/VBD conducted/VBN ./.
@@115325568242 Subacute/JJ diencephalic/JJ angioencephalopathy/NN (/( SDAE/NN )/SYM is/VBZ a/DT rare/JJ and/CC fatal/JJ disease/NN of/IN unknown/JJ etiology/NN that/WDT involves/VBZ the/DT thalami/NNS bilaterally/RB ./.
@@81646806469 We/PRP estimate/VBP that/IN the/DT protease/NEWGENE activity/NN is/VBZ at/IN least/RB 35-fold/RB greater/JJR in/IN mature/NNP B/NNP cells/NNS than/IN in/IN pre-B/NNP cells/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@11112700590 Plectin/NEWGENE and/CC desmoplakin/NEWGENE have/NN GSR-containing/NN domains/NN at/IN their/PRP C-termini/NNS and/CC we/PRP further/RB demonstrate/VBP that/IN the/DT GSR-containing/JJ domain/NN of/IN plectin/NEWGENE ,/, but/CC not/RB desmoplakin/NEWGENE ,/, can/MD bind/VB to/IN MTs/NNS in/IN vivo/NN ./.
@@8668190808 Vacuolar/JJ membrane/NN vesicles/NNS from/IN hum1/NEWGENE mutants/NEWGENE lack/NN all/DT Ca2+/NNP //NNP H+/NNP antiport/NN activity/NN ,/, demonstrating/VBG that/IN Hum1p/NEWGENE catalyzes/VBZ the/DT exchange/NN of/IN Ca2+/NN for/IN H+/NN across/IN the/DT yeast/NN vacuolar/JJ membrane/NN ./.
@@20242522635 During/IN the/DT years/NNS 1980-87/CD a/DT total/NN of/IN 287/CD persons/NNS received/VBD disability/NN pensions/NNS in/IN the/DT municipality/NN of/IN Nordreisa/NNP in/IN northern/JJ Norway/NN ./.
@@39353759482 This/DT article/NN will/MD briefly/NN review/NN the/DT published/VBN data/NN on/IN the/DT morphology/NN ,/, function/NN ,/, and/CC biochemistry/NN of/IN the/DT normal/JJ renal/JJ medulla/NN and/CC the/DT pathology/NN associated/VBN with/IN RPN/NN ,/, together/RB with/IN the/DT secondary/JJ changes/NNS which/WDT give/VBP rise/NN to/IN cortical/JJ degeneration/NN or/CC epithelial/JJ carcinoma/NN ./.
@@38404803010 Novel/JJ multigene/JJ families/NNS encoding/VBG highly/RB repetitive/JJ peptide/NN sequences/NNS ./.
@@89854152560 The/DT STAT-1/NEWGENE signaling/JJ pathway/NN provides/VBZ at/IN least/RB one/PRP mechanism/NN for/IN activation/NN of/IN the/DT CAEV/NEWGENE LTR/NEWGENE by/IN IFN-gamma/NEWGENE in/IN monocytes/NNS ./.
@@8285710589 A/DT single/JJ 1/CD ./CD 8-kb/CD transcript/NN mRNA/NN was/VBD detected/VBN by/IN Northern/NNP (/( RNA/NN )/SYM blot/NN analysis/NN ,/, and/CC its/PRP 5'/CD end/NN maps/NNS to/IN a/DT position/NN 51/CD bp/NN upstream/RB from/IN the/DT site/NN of/IN initiation/NN of/IN protein/NN synthesis/NN ./.
@@85056058470 Patient/NN characteristics/NNS associated/VBN with/IN deep/JJ wounds/NNS as/RB well/VBP as/IN patient/NN and/CC wound/JJ characteristics/NNS predictive/JJ of/IN the/DT extent/NN of/IN healing/NN and/CC time/NN required/VBN for/IN healing/NN were/VBD identified/VBN ./.
@@85054956022 The/DT retention/NN of/IN 75SeHCAT/NN was/VBD low/JJ ./.
@@86484086585 When/WRB the/DT PHT/NN and/CC CSA/NN groups/NNS were/VBD compared/VBN ,/, Hyp/NN levels/NNS were/VBD significantly/RB higher/JJ in/IN the/DT PHT-GO+/NNP group/NN than/IN in/IN the/DT CSA-GO+/NNP group/NN ./.
@@103932512183 Sequence/NN of/IN 10q24/NEWGENE locus/NEWGENE surrounding/JJ the/DT HOX11/NEWGENE oncogene/NEWGENE reveals/VBZ a/DT new/JJ gene/NN HUG1/NEWGENE expressed/VBN in/IN a/DT T-ALL/NN cell/NN line/NN ./.
@@79691151128 Using/VBG in/IN organello/NN footprint/NN analysis/NN ,/, we/PRP demonstrate/VBP that/IN within/IN human/JJ placental/JJ mitochondria/NNS there/RB is/VBZ a/DT high/JJ level/NN of/IN protein-DNA/JJ binding/NN at/IN regularly/RB phased/JJ intervals/NNS throughout/IN a/DT 500-bp/JJ region/NN encompassing/VBG the/DT D-loop/NN DNA/NN origins/NNS and/CC two/JJ promoter/NN regions/NNS ./.
@@62872311292 In/NN addition/NN ,/, TRP1/NN RI/NNP Circle/NNP DNA/NN is/VBZ organized/VBN into/IN nucleosomes/NNS whose/WP size/NN and/CC spacing/JJ are/VBP indistinguishable/JJ from/IN that/DT of/IN bulk/NN yeast/NN chromatin/NN ./.
@@95070328135 Surprisingly/RB ,/, the/DT CSF1R/NEWGENE //NEWGENE IRDelta960/NEWGENE was/VBD as/RB effective/JJ as/IN the/DT CSF1R/NEWGENE //NEWGENE IR/NEWGENE in/IN mediating/JJ CSF-1/NEWGENE protection/NN of/IN cells/NNS from/IN staurosporine-induced/JJ apoptosis/NN ./.
@@111796685143 Therefore/RB ,/, we/PRP suggested/VBD that/IN both/DT proteins/NNS might/MD belong/VB to/IN the/DT PLTP/NEWGENE family/NEWGENE ./.
@@17333588041 These/DT tumors/NNS were/VBD classified/VBN into/IN three/CD broad/JJ groups/NNS :/: I/PRP ,/, cystadenoma/NN ;/: II/NNP ,/, cystadenocarcinoma/NN ;/: and/CC III/NNP ,/, adenocarcinoma/NN with/IN mucin/NN production/NN or/CC an/DT associated/VBN cyst/NN ./.
@@16539182255 They/PRP were/VBD almost/RB regularly/RB excited/VBN by/IN pressure/NN to/IN the/DT ipsilateral/JJ cornea/NN or/CC to/IN both/DT corneas/NNS at/IN a/DT strength/NN well/NN above/RB the/DT human/JJ corneal/JJ pain/NN threshold/NN ./.
@@31812767767 26/CD micrograms/NNS PAF/NEWGENE or/CC placebo/NN was/VBD sprayed/VBN into/IN each/DT nasal/JJ cavity/NN 8/CD h/NN and/CC 1/CD h/NN before/IN a/DT nasal/JJ allergen/NN challenge/NN ./.
@@9121430948 In/NN contrast/NN ,/, Y239/NEWGENE //NEWGENE 240F/NEWGENE Shc/NEWGENE ,/, but/CC not/RB Y317F/NEWGENE Shc/NEWGENE ,/, reduced/VBD the/DT EGF-induced/NN c-myc/NEWGENE message/NN ./.
@@110756784857 The/DT wavenumbers/NNS corresponding/JJ to/IN the/DT normal/JJ modes/NNS of/IN vibration/NN were/VBD calculated/VBN using/VBG the/DT DFT/NN (/( B3LYP/NN //NN 6-31G**/NN )/SYM approximation/NN and/CC their/PRP agreement/NN with/IN the/DT measured/VBN values/NNS improved/VBN after/IN scaling/NN of/IN the/DT associated/VBN force/NN field/NN ./.
@@67123146478 A/DT total/JJ number/NN of/IN 1628/CD cases/NNS were/VBD collected/VBN from/IN 135/CD medical/JJ institutions/NNS ./.
@@24666653627 The/DT small/NEWGENE IGF-binding/NEWGENE protein/NEWGENE is/VBZ abundant/JJ in/IN human/JJ amniotic/JJ fluid/NN ./.
@@29348915344 By/IN adapting/JJ a/DT method/NN for/IN DNA-footprinting/JJ using/VBG impure/JJ extracts/NNS of/IN ner/NEWGENE overproducing/JJ cells/NNS ,/, we/PRP were/VBD able/JJ to/IN determine/VB that/IN the/DT ner-binding/NEWGENE sites/NEWGENE are/VBP located/VBN between/IN nucleotides/NNS 1026/CD and/CC 1058/CD from/IN the/DT Mu/NN left/NN end/NN ./.
@@36012754264 After/IN dopamine/NN infusion/NN in/IN women/NNS with/IN polycystic/JJ ovary/NN syndrome/NN and/CC in/IN matched/JJ controls/NNS ,/, steady/JJ state/NN levels/NNS of/IN plasma/NN dopamine/NN ,/, norepinephrine/NN ,/, and/CC the/DT ratio/NN of/IN dopamine/NN //NN norepinephrine/NN were/VBD similar/JJ in/IN the/DT two/JJ groups/NNS ./.
@@48207915190 Delta-aminolevulinic/NNP acid/NN in/IN physiological/JJ conditions/NNS and/CC some/DT diseases/NNS in/IN children/NNS ./.
@@85242352890 Cloning/VBG and/CC sequencing/VBG revealed/VBN that/DT dMax/NEWGENE contains/VBZ a/DT deletion/NN spanning/VBG the/DT basic/JJ region/NN and/CC helix/NN 1/CD and/CC the/DT loop/NN of/IN the/DT helix-loop-helix/JJ region/NN ,/, presumably/RB as/IN a/DT result/NN of/IN alternative/JJ splicing/JJ of/IN max/NEWGENE RNA/NEWGENE ./.
@@86518531134 Mesial/JJ temporal/JJ sclerosis/NN was/VBD characterized/VBN by/IN severe/JJ neuronal/JJ loss/NN accompanied/VBN by/IN gliosis/NN occurring/VBG in/IN the/DT CA1/NNP //NNP prosubiculum/NNP (/( 27/CD patients/NNS ,/, 100%/CD )/SYM ,/, focally/RB in/IN the/DT dentate/NN gyrus/NN (/( 12/CD patients/NNS ,/, 44%/JJ )/SYM ,/, and/CC in/IN the/DT CA4/NN region/NN (/( 11/CD patients/NNS ,/, 41%/JJ )/SYM ./.
@@10647859464 To/TO quantify/VB any/DT mechanical/JJ inhibitory/JJ effect/NN of/IN nasal/JJ intermittent/JJ positive/JJ pressure/NN ventilation/NN (/( IPPV/NN )/SYM on/IN inspiratory/JJ activity/NN of/IN the/DT diaphragm/NN we/PRP ventilated/VBD five/CD conscious/RB relaxed/VBN subjects/NNS on/IN two/JJ occasions/NNS at/IN respiratory/JJ rates/NNS similar/JJ to/IN quiet/JJ breathing/JJ (/( QB/NNP )/SYM and/CC at/IN three/CD levels/NNS of/IN applied/VBN pressure/NN (/( Pappl/NNP )/NN --6/NN ,/, 9/CD and/CC 12/CD cmH2O/NN ,/, each/DT during/IN hypocapnia/NN (/( P/NN (/NN CO2/NN )/SYM allowed/VBN to/IN decrease/NN )/NN and/CC eucapnia/NN (/( CO2/NN added/VBN to/IN inspired/JJ gas/NN )/SYM ./.
@@84287229048 In/NN the/DT multivariate/JJ analysis/NN ,/, six/CD variables/NNS were/VBD independently/RB correlated/VBN with/IN survival/NN :/: blood/NN urea/NN nitrogen/NN level/NN ,/, serum/NEWGENE aspartate/NEWGENE aminotransferase/NEWGENE level/NN ,/, community-acquired/JJ vs/IN ./IN hospital-acquired/JJ peritonitis/NN ,/, age/NN ,/, Child-Pugh/NNP score/NN and/CC ileus/NN ./.
@@34504381674 X2/NN test/NN ,/, with/IN Yates/NNP correction/NN if/IN need/NN ,/, was/VBD used/VBN as/IN statistical/JJ ./. method/NN ./.
@@86039211892 Carboxy-terminal/JJ Spc110p/NEWGENE truncations/NNS lacking/VBG the/DT calmodulin/NEWGENE binding/NN site/NN can/MD support/VB growth/VB and/CC are/VBP also/RB phosphorylated/VBN in/IN a/DT cell/NN cycle-specific/JJ manner/NN ./.
@@35776704240 The/DT study/NN disclosed/VBD generalized/JJ atrophy/NN and/CC diffuse/JJ symmetric/JJ white/JJ matter/NN hypodensities/NNS ./.
@@92784416727 Biol/NNP ./.
@@11764062732 The/DT Penn/NNP State/NNP Worry/NN Questionnaire/NN for/IN Children/NNS (/( PSWQ-C/NN )/SYM is/VBZ a/DT 14-item/JJ self-report/NN questionnaire/NN that/WDT intends/VBZ to/IN measure/NN the/DT tendency/NN of/IN children/NNS to/IN engage/VB in/IN excessive/JJ ,/, generalized/JJ ,/, and/CC uncontrollable/JJ worry/NN (/( Chorpita/NNP et/FW al/NNS ./NNS ,/, Behav/NNP ./.
@@105313421908 In/NN contrast/NN to/IN previously/RB characterized/VBN proteophosphoglycans/NNS ,/, the/DT ppg1/NEWGENE gene/NN product/NN is/VBZ predominantly/RB membrane-associated/JJ and/CC it/PRP is/VBZ expressed/VBN on/IN the/DT promastigote/NN cell/NN surface/NN ./.
@@63254159957 The/DT greatest/JJS difference/NN between/IN the/DT Ad7/NEWGENE and/NEWGENE Ad5/NEWGENE DBPs/NEWGENE is/VBZ the/DT absence/NN ,/, in/IN the/DT Ad7/NN protein/NN ,/, of/IN 12/CD amino/JJ acids/NNS located/VBN between/IN the/DT two/JJ functional/JJ domains/NNS in/IN the/PDT Ad5/NN protein/NN (/( amino/JJ acids/NNS 151-162/CD )/SYM ./.
@@117822188117 Compared/VBN to/IN white-on-white/JJ (/( W-W/NNP )/SYM perimetry/NN ,/, SWAP/NN is/VBZ limited/VBN clinically/RB by/IN :/: greater/JJR variability/NN associated/VBN with/IN the/DT estimation/NN of/IN threshold/NN ,/, ocular/JJ media/NN absorption/NN ,/, increased/VBN examination/NN duration/NN and/CC an/DT additional/JJ learning/JJ effect/NN ./.
@@12068961854 Characteristics/NNS of/IN anesthesia/NN and/CC resuscitation/NN in/IN emergency/NN lung/NN surgery/NN ./.
@@91101765336 Northern/NNP and/CC RT-PCR/NN analysis/NN of/IN Ube3a/NEWGENE expression/NN in/IN mouse/NN tissues/NNS from/IN animals/NNS with/IN segmental/JJ ,/, paternal/JJ uniparental/JJ disomy/NN failed/VBN to/IN detect/VB substantially/RB reduced/VBN or/CC absent/VB expression/NN compared/VBN to/IN control/JJ animals/NNS ,/, failing/VBG to/IN provide/VB any/DT evidence/NN for/IN maternal-specific/JJ expression/NN from/IN this/DT locus/NN ./.
@@42818564900 Age/NNP and/CC sex/NN structure/NN of/IN the/DT natural/JJ population/NN of/IN Ornithodoros/NN tatarovski/NNP Ol/NNP ./NNP
@@72950337152 Over/IN a/DT period/NN of/IN 15/CD days/NNS 16%/NN of/IN the/DT dose/NN administered/VBN was/VBD excreted/VBN with/IN faeces/NNS and/CC 0/CD ./CD 9%/CD in/IN the/DT urine/NN ./.
@@107477826745 Proteolysis/NNS of/IN Mbp1/NEWGENE and/CC Swi4/NEWGENE DNA-protein/NEWGENE complexes/NEWGENE has/VBZ revealed/VBN the/DT extent/NN of/IN these/DT sequences/NNS ,/, and/CC C-terminally/RB extended/VBN molecules/NNS with/IN substantially/RB enhanced/VBN DNA/NN binding/JJ activity/NN compared/VBN to/IN the/DT core/NN domains/NNS alone/RB have/VBP been/VBN produced/VBN ./.
@@825775482 The/DT fourth/NN dose/NN produced/VBD favorable/JJ results/NNS (/( 66/CD ./CD 7%/CD )/SYM in/IN individuals/NNS with/IN HB/NEWGENE antibodies/NEWGENE between/IN 10/CD and/CC 100/CD IU/NNS //NNS ml/NNS and/CC unfavorable/JJ ones/NNS (/( 3/CD ./CD 8%/CD )/SYM where/CC the/DT HB/NEWGENE antibodies/NEWGENE were/VBD below/RB 10/CD IU/NNS //NNS ml/NNS ./.
@@8286035600 Employing/VBG this/DT sequence/NN information/NN from/IN c11/NN //NN 1/NN ,/, the/DT c11/NN //NN 1-specific/NN cDNA/NN was/VBD generated/VBN from/IN poly/NN (/NN A/NN )/NN +RNA/NN of/IN bovine/JJ PMNLs/NNS by/IN reverse/JJ transcription/NN and/CC a/DT combination/NN of/IN polymerase/NEWGENE chain/NN reaction/NN (/( PCR/NN )/SYM methods/NNS ./.
@@98194214114 Cyclophilins/NEWGENE are/VBP cis-trans-peptidyl-prolyl/NEWGENE isomerases/NEWGENE that/WDT bind/VBP to/IN and/CC are/VBP inhibited/VBN by/IN the/DT immunosuppressant/NN cyclosporin/NN A/NN (/( CsA/NN )/SYM ./.
@@86235547003 The/DT 17-kDa/NN protein/NN is/VBZ required/VBN for/IN the/DT systemic/JJ infection/NN of/IN plants/NNS ./.
@@79665651421 The/DT defined/VBN length/NN of/IN the/DT mRNA/NN ,/, 1/NN ,/NN 838/NN nucleotides/NNS ,/, was/VBD in/IN agreement/NN with/IN that/DT of/IN a/DT 1/CD ./CD 9-kb/CD RNA/NN expressed/VBN throughout/IN the/DT replication/NN cycle/NN ,/, starting/JJ at/IN the/DT early/JJ stages/NNS of/IN infection/NN ./.
@@117862488212 Consumption/NN of/IN 4%/JJ sucrose/NN was/VBD not/RB affected/VBN by/IN excitotoxic/JJ lesions/NNS of/IN the/DT PPTg/NN ,/, but/CC PPTg/NN lesioned/JJ rats/NNS consumed/VBN significantly/RB more/RB 12%/JJ and/CC 20%/CD sucrose/NN than/IN sham/NN controls/NNS ./.
@@36180394300 The/DT presence/NN in/IN such/JJ patients/NNS of/IN antibodies/NNS to/IN adrenaline/NN and/CC noradrenaline/NN is/VBZ indicative/NN of/IN considerable/JJ disruption/NN of/IN catecholamine/NN biotransformation/NN ./.
@@28344789024 Low/NNP molecular/JJ weight/NN heparins/NNS have/VBP stimulated/VBN much/JJ interest/NN because/IN of/IN their/PRP supposedly/RB more/RB selective/JJ action/NN on/IN Xa/NEWGENE factor/NEWGENE ./.
@@114066427708 In/NN all/DT of/IN these/DT cases/NNS ,/, expression/NN of/IN the/DT implicated/VBN genes/NNS was/VBD absent/VB ./.
@@11729171575 Letter/NNP :/: Lactose/NNP tolerance/NN tests/NNS as/IN a/DT predictor/NN of/IN milk/NN tolerance/NN ./.
@@974178385 Anastrozole/CHEM is/VBZ the/DT first/JJ aromatase/NEWGENE inhibitor/NN to/IN show/NN a/DT significant/JJ survival/NN advantage/NN over/JJ megestrol/NN acetate/NN in/IN post-menopausal/JJ women/NNS with/IN advanced/JJ breast/NN cancer/NN ./.
@@21539777407 These/DT genes/NNS are/VBP expressed/VBN within/IN a/DT few/JJ hours/NNS of/IN the/DT initiation/NN of/IN development/NN ;/: their/PRP mRNAs/NNS accumulate/VBP to/IN a/DT peak/NN at/IN 12/CD hr/NN and/CC persist/VB until/IN culmination/NN ./.
@@9152656686 Fourteen/CD patients/NNS with/IN New/NNP York/NNP Heart/NNP Association/NNP class/NN II/NN congestive/JJ heart/NN failure/NN were/VBD enrolled/VBN in/IN a/DT double-blind/JJ ,/, cross-over/JJ study/NN ./.
@@117035583062 Doxorubicin/NN (/( DOX/NN )/SYM is/VBZ commonly/RB used/VBN for/IN the/DT treatment/NN of/IN hematological/JJ and/CC solid/JJ tumors/NNS ./.
@@76731286857 The/DT third/JJ domain/NN had/VBP the/DT motif/NN of/IN a/DT cAMP/NEWGENE response/NEWGENE element/NEWGENE (/( CRE/NEWGENE )/SYM ./.
@@37091916945 It/PRP was/VBD found/VBN that/IN the/DT primary/NN visual/NN cortex/NN of/IN the/DT rat/NN is/VBZ asymmetrical/JJ in/IN volume/NN ,/, and/CC that/IN the/DT asymmetry/NN reflects/VBZ side/JJ differences/NNS in/IN the/DT number/NN of/IN neurons/NNS ./.
@@88967958853 Using/VBG Spurr's/NNP resin/NN as/IN a/DT mounting/JJ medium/NN ,/, we/PRP could/MD observe/VB thick/JJ specimens/NNS with/IN oil/NN immersion/NN objective/JJ lens/NN without/IN the/DT use/NN of/IN coverslips/NNS ,/, then/RB avoid/VB air/NN bubbles/NNS near/IN the/DT specimen/NN ./.
@@86264936163 Mutations/NNS within/IN conserved/NEWGENE region/NEWGENE 2/NEWGENE (/( CR2/NEWGENE )/SYM of/IN E1A/NEWGENE that/WDT inhibit/VBP the/DT binding/NN of/IN E1A/NEWGENE to/IN the/DT retinoblastoma/NEWGENE gene/NEWGENE product/NEWGENE (/( pRb/NEWGENE )/SYM further/RB enhanced/VBN the/DT stimulation/NN of/IN transcription/NN from/IN the/DT PEPCK/NEWGENE promoter/NEWGENE by/IN 2/CD 3-fold/CD compared/VBN with/IN wild/NEWGENE type/NEWGENE E1A/NEWGENE ./.
@@67970634676 Factor/NEWGENE VIII/NEWGENE procoagulant/JJ activity/NN ,/, antigen/NN concentration/NN and/CC von/NNP Willebrand/NN activity/NN as/IN ristocetin/NEWGENE cofactor/NEWGENE were/VBD determined/VBN several/DT times/NNS in/IN 10/CD patients/NNS with/IN DIC/NN ./.
@@78621624352 In/NN the/DT presence/NN of/IN inositol/NN and/CC choline/NN (/( repressing/JJ )/SYM ,/, the/DT product/NN of/IN the/DT OPI1/NEWGENE gene/NEWGENE represses/VBZ transcription/NN dictated/VBN by/IN the/DT UASINO/NEWGENE element/NEWGENE ./.
@@110345474217 In/NN vitro/FW ,/, Arix/NEWGENE and/CC NBPhox/NEWGENE form/NN DNA-independent/NN multimers/NN and/CC exhibit/VB cooperative/JJ binding/NN to/IN the/DT DB1/NEWGENE regulatory/NEWGENE element/NEWGENE ,/, which/WDT contains/VBZ two/JJ homeodomain/NEWGENE recognition/NN sites/NN ./.
@@89401327593 These/DT findings/NNS suggest/VBP that/DT fodrin/NEWGENE proteolysis/NN in/IN vivo/NN may/MD reflect/VB the/DT activity/NN of/IN multiple/JJ ICE/NEWGENE //NEWGENE Ced-3/NEWGENE proteases/NEWGENE whose/WP partial/JJ sensitivity/NN to/IN DEVD-CHO/NN reflects/VBZ a/DT limited/VBN contribution/NN from/IN CPP32/NEWGENE ,/, or/CC an/DT ICE/NEWGENE //NEWGENE Ced-3/NEWGENE protease/NEWGENE less/PRP sensitive/JJ than/IN CPP32/NEWGENE to/IN DEVD-CHO/NN inhibition/NN ./.
@@74900793515 Molecular/NNP cloning/NN of/IN the/DT human/JJ homolog/NN of/IN a/DT striatum-enriched/NEWGENE phosphatase/NEWGENE (/NEWGENE1 STEP/NEWGENE1 )/NEWGENE1 gene/NEWGENE1 and/CC chromosomal/JJ mapping/NN of/IN the/DT human/JJ and/CC murine/NN loci/NN ./.
@@85432758528 According/VBG to/IN the/DT investigation/NN ,/, the/DT recent/JJ burst/NN of/IN pseudoterranovosis/NN in/IN this/DT area/NN can/MD be/VB attributed/VBN to/IN the/DT increased/VBN presence/NN of/IN sea/NN lions/NNS ,/, which/WDT proliferate/VBP in/IN the/DT Arctic/NN region/NN ,/, then/RB migrate/VB to/IN the/DT northern/JJ Japan/NNP Sea/NNP and/CC eat/VB the/DT intermediate/JJ host/NN fish/NN ./.
@@110278338749 Flow/NNP cytomery/NN was/VBD used/VBN for/IN cell/NN cycle/NN analysis/NN ./.
@@67506084652 Mutations/NNS in/IN seven/JJ other/DT lts/NEWGENE genes/NEWGENE do/VBP not/RB result/VB in/IN the/DT mak-/NEWGENE phenotype/NEWGENE ./.
@@14573803073 The/DT tramtrack/NEWGENE (/( ttk/NEWGENE )/SYM gene/NN of/IN Drosophila/NN encodes/VBZ 69-kDa/CD and/CC 88-kDa/NN proteins/NN through/RB alternative/JJ splicing/JJ of/IN the/DT primary/NN ttk/NEWGENE transcript/NEWGENE ./.
@@26146683285 The/DT lowest/JJS detectable/JJ concentration/NN was/VBD 1/CD ./CD 0/CD ng/NN //NN ml/NN in/IN the/DT serum/NN ./.
@@23349721585 The/DT examination/NN was/VBD focused/VBN on/IN assessment/NN of/IN different/JJ types/NNS of/IN drusen/NNS ,/, on/IN evaluation/NN of/IN the/DT development/NN and/CC incidence/NN of/IN risk/NN factors/NNS leading/JJ to/IN complications/NNS and/CC loss/NN of/IN central/NN vision/NN ./.
@@89016354686 In/NN spite/NN of/IN much/JJ effort/NN ,/, no/DT one/PRP has/VBZ succeeded/VBN in/IN isolating/JJ and/CC characterizing/VBG the/DT enzyme/NN (/NN s/NN )/NN responsible/JJ for/IN synthesis/NN of/IN cellulose/NEWGENE ,/, the/DT major/JJ cell/NN wall/NN polymer/NN of/IN plants/NNS ./.
@@94358069390 Clinical/NNP value/NN of/IN the/DT estimation/NN of/IN growth/NN kinetics/NN of/IN primary/JJ ovarian/JJ cancer/NN recurrences/NNS by/IN CA125/NEWGENE doubling/JJ time/NN ./.
@@91460719086 Dystonic/NNP movement/NN of/IN the/DT left/JJ upper/JJ limb/NN in/IN a/DT case/NN of/IN the/DT right/JJ pontine/JJ hemorrhage/NN ./.
@@109463035066 TNF-alpha/NEWGENE induced/VBD a/DT dose-/NN and/CC time-dependent/NN increase/NN in/IN cyclooxygenase-2/NEWGENE (/( COX-2/NEWGENE )/SYM expression/NN and/CC PGE2/NN formation/NN in/IN human/JJ NCI-H292/NNP epithelial/JJ cells/NNS ./.
@@30661313777 After/IN a/DT survey/NN of/IN the/DT anatomical/JJ and/CC physiological/JJ basis/NN of/IN operative/JJ treatment/NN of/IN behaviour/NN disorders/NNS by/IN stereotactic/JJ lesions/NNS in/IN the/DT amygdala/NN and/CC the/DT posterior/JJ medial/JJ hypothalamus/NN the/DT author/NN describes/VBZ his/PRP own/VB experiences/NNS with/IN 603/CD operations/NNS for/IN control/NN of/IN conservatively/RB untreatable/JJ aggressiveness/NN ./.
@@105624957509 Although/IN most/JJ SFV/NEWGENE genes/NEWGENE have/VBP homologs/NNS encoded/VBN by/IN other/DT Chordopoxvirinae/NN ,/, the/DT SFV/NN genome/NN lacks/VBZ a/DT key/NN gene/NN required/VBN for/IN the/DT production/NN of/IN extracellular/JJ enveloped/JJ virus/NN ./.
@@82815369180 Interleukin-6/NEWGENE may/MD possibly/RB potentiate/VB metastasis/NN of/IN cardiac/JJ myxoma/NN ./.
@@25386564886 We/PRP have/VBP determined/VBN that/IN several/DT E1/NEWGENE mutants/NEWGENE mapping/NN in/IN both/PDT the/DT M/NN and/CC R/NN regions/NN and/CC a/DT single/JJ mutant/NN of/IN the/DT upstream/RB regulatory/JJ region/NN have/NN a/DT higher/JJ transforming/JJ activity/NN on/IN mouse/NN C127/NNP cells/NNS than/IN the/DT wild-type/NN genome/NN does/VBP ./.
@@59852755859 Antimicrobial/JJ substance/NN isolated/VBN from/IN an/DT acorn/NN extract/NN ./.
@@84063528370 Army/NNP veterans/NNS given/VBP yellow/JJ fever/NN vaccine/NN contaminated/VBN with/IN hepatitis/NN B/NN virus/NN in/IN 1942/CD and/CC controls/NNS and/CC (/( b/NN )/SYM a/DT case-control/NN study/NN comparing/VBG veterans/NNS with/IN hepatocellular/JJ carcinoma/NN in/IN Veterans/NNP Affairs/NNP hospitals/NNS with/IN matched/JJ controls/NNS with/IN respect/NN to/IN receipt/NN of/IN contaminated/VBN vaccine/NN in/IN 1942/CD ./.
@@15732703039 The/DT IA4/NEWGENE mAb/NEWGENE was/VBD identified/VBN among/IN a/DT series/NN of/IN antibodies/NNS raised/VBN in/IN BALB/NN //NN c/NN mice/NNS after/IN immunization/NN against/IN a/DT HLA/NEWGENE class/NN I-deficient/NN ,/, lymphokine-activated/JJ killer/NN (/( LAK/NN )/NN -susceptible/NN EBV-B/NN lymphocyte/NN line/NN ./.
@@86422825906 This/DT is/VBZ the/DT first/JJ description/NN ,/, to/IN our/PRP knowledge/NN ,/, of/IN regulatory/JJ elements/NNS that/WDT control/VBP expression/NN of/IN a/DT gene/NN encoding/VBG a/DT B7/NEWGENE costimulatory/NEWGENE molecule/NEWGENE ./.
@@106120446969 Particularly/RB striking/JJ was/VBD the/DT conservation/NN of/IN an/DT AP-4/NEWGENE binding/NEWGENE site/NEWGENE within/IN 100/CD nucleotides/NNS upstream/RB of/IN the/DT transcription/NN initiation/NN site/NN in/IN both/DT Aal-rpL34/NEWGENE and/CC Aal-rpL8/NEWGENE genes/NEWGENE ./.
@@80637663566 We/PRP find/VBP that/DT beta/NEWGENE II/NEWGENE PKC/NEWGENE phosphorylates/VBZ nuclear/NEWGENE envelope/NEWGENE lamin/NEWGENE B/NEWGENE at/IN 10-20/CD times/VBZ the/DT rate/NN of/IN alpha/NEWGENE PKC/NEWGENE ,/, whereas/IN both/DT kinases/NEWGENE phosphorylate/NN soluble/NEWGENE lamin/NEWGENE B/NEWGENE at/IN similar/JJ rates/NNS ./.
@@63098556092 Gel/NNP route/NN preparation/NN of/IN low/JJ fusing/JJ dental/JJ porcelain/NN frit/NN ./.
@@103699656781 The/DT Aa-Pri2/NEWGENE gene/NEWGENE ,/, specifically/RB expressed/VBN during/IN basidiocarp/NN differentiation/NN of/IN the/DT mushroom/NN Agrocybe/NNP aegerita/NN ,/, was/VBD cloned/VBN ./.
@@9199413697 Even/RB when/CC the/DT inoculum/NN size/NN was/VBD reduced/VBN sixfold/RB (/( i/FW ./FW e/FW ./FW ,/, 6/CD x/NN 10/NN (/NN 6/NN )/SYM CFU/NN //NN mouse/NN )/NN ,/, 50%/CD of/IN the/DT RB6-8C5-treated/NN animals/NNS died/VBN within/IN 6/CD days/NNS ./.
@@77749253765 YAC/NN and/CC cosmid/NN contigs/NNS spanning/VBG the/DT BRCA1/NEWGENE region/NEWGENE were/VBD used/VBN to/IN select/VB cDNA/NN clones/NNS from/IN pools/NNS of/IN cDNAs/NNS derived/VBN from/IN human/JJ placenta/NN ,/, HeLa/IN cells/NNS ,/, activated/VBN T/NN cells/NNS ,/, and/CC fetal/JJ head/NN ./.
@@86226688680 These/DT results/NNS illuminate/VBP a/DT hitherto/RB unanticipated/JJ function/NN of/IN U6/NEWGENE RNA/NEWGENE :/: the/DT modulation/NN of/IN a/DT phosphorylation-dephosphorylation/NN cycle/NN of/IN C1/NEWGENE hnRNP/NEWGENE protein/NEWGENE that/WDT influences/VBZ the/DT binding/JJ affinity/NN of/IN this/DT protein/NN for/IN pre-mRNA/NN ./.
@@94188714336 The/DT interaction/NN between/IN DDB/NEWGENE and/CC E2F1/NEWGENE can/MD also/RB be/VB detected/VBN by/IN coimmunoprecipitation/NN experiments/NNS ./.
@@85520931284 Differentiation/NNS was/VBD not/RB observed/VBN after/IN cellular/JJ expression/NN of/IN GTPase-deficient/NNP forms/NNS of/IN alpha/NEWGENE i2/NEWGENE or/CC alpha/NEWGENE 0/NEWGENE ,/, indicating/VBG selectivity/NN for/IN the/PDT Gq/NEWGENE family/NEWGENE of/IN G/NEWGENE proteins/NEWGENE ./.
@@6173860454 In/NN most/JJ cases/NNS of/IN acute/JJ transmural/JJ infarction/NN ,/, the/DT reciprocal/JJ ST/NN segment/NN depressions/NNS observed/VBN in/IN contralateral/JJ leads/VBP are/VBP less/PRP marked/JJ than/IN the/DT primary/NN ST/NN segment/NN elevations/NNS ./.
@@4841774699 This/DT expression/NN assumes/VBZ :/: (/( 1/CD )/SYM a/DT laminar/JJ flow/NN regimen/NN during/IN expiration/NN ,/, and/CC (/( 2/CD )/SYM a/DT constant/NN CT/NN value/NN over/RB the/DT range/NN of/IN VT/NNP ./NNP
@@95453329623 Mutation/NN of/IN the/DT central/JJ Tyr497/CD to/IN Phe/NN blocks/NNS the/DT tyrosine/NN phosphorylation/NN of/IN the/DT insulin/NEWGENE receptor/NEWGENE substrate/NEWGENE 1/NEWGENE (/( IRS1/NEWGENE )/SYM and/CC diminishes/VBZ proliferation/NN in/IN response/NN to/IN IL-4/NEWGENE ./.
@@105570725161 ULKs/NEWGENE and/CC UNC-51/NEWGENE share/VB a/DT typical/JJ domain/NN structure/NN of/IN an/DT amino-terminal/NEWGENE kinase/NEWGENE domain/NEWGENE ,/, a/DT central/JJ proline/NN //NN serine/NN rich/JJ (/( PS/NN )/SYM domain/NN ,/, and/CC a/DT carboxy-terminal/JJ (/( C/NN )/SYM domain/NN ./.
@@17320332307 The/DT pathophysiology/NN and/CC clinical/JJ management/NN of/IN acute/JJ brain/NN injury/NN in/IN infancy/NN and/CC childhood/NN are/VBP presented/VBN using/VBG acute/JJ traumatic/JJ brain/NN injury/NN as/IN a/DT model/NN ./.
@@116426878087 Comparison/NNS of/IN German/JJ language/NN versions/NNS of/IN the/DT QWB-SA/NN and/CC SF-36/NN evaluating/VBG outcomes/NNS for/IN patients/NNS with/IN prostate/NN disease/NN ./.
@@97952138332 RBP56/NEWGENE protein/NEWGENE turned/VBN out/RB to/IN be/VB hTAFII68/NEWGENE which/WDT was/VBD isolated/VBN as/IN a/DT TATA-binding/NEWGENE protein/NEWGENE associated/NEWGENE factor/NEWGENE (/( TAF/NEWGENE )/SYM from/IN a/DT sub-population/NN of/IN TFIID/NEWGENE complexes/NEWGENE (/( Bertolotti/NNP A/NNP ./NNP ,/, Lutz/NNP ,/, Y/NNP ./NNP ,/, Heard/NNP ,/, D/NNP ./NNP J/NNP ./NNP ,/, Chambon/NNP ,/, P/NNP ./NNP ,/, Tora/NNP ,/, L/NNP ./NNP ,/, 1996/CD ./. hTAFII68/NEWGENE ,/, a/DT novel/JJ RNA/NEWGENE //NEWGENE ssDNA-binding/NEWGENE protein/NEWGENE with/IN homology/NN to/IN the/DT proto-oncoproteins/NEWGENE TLS/NEWGENE //NEWGENE FUS/NEWGENE and/CC EWS/NEWGENE is/VBZ associated/VBN with/IN both/DT TFIID/NEWGENE and/CC RNA/NEWGENE polymerase/NEWGENE II/NEWGENE ./.
@@60962465921 Effect/NN of/IN acute/JJ and/CC chronic/JJ psychogenic/JJ stress/NN on/IN corticoadrenal/JJ and/CC pituitary-thyroid/JJ hormones/NNS in/IN male/JJ rats/NNS ./.
@@16566755076 Capnography/NN curves/NNS of/IN 40/CD HVS/NNS patients/NNS ,/, 40/CD non-HVS/JJ patients/NNS with/IN psycho-somatic/JJ complaints/NNS and/CC 26/CD healthy/JJ controls/NNS were/VBD analyzed/VBN ./.
@@1463272076 The/DT majority/NN of/IN tumors/NNS occurred/VBN in/IN the/DT nasal/JJ cavities/NNS ,/, although/IN significant/JJ incidences/NNS were/VBD also/RB found/VB in/IN the/DT larynx/NN ,/, trachea/NN and/CC stem/NN bronchi/NNS ./.
@@105518168342 Human/NEWGENE LTBP-1/NEWGENE is/NNS known/VBP to/IN exist/VB in/IN different/JJ forms/NNS ./.
@@1396601711 In/NN contrast/NN ,/, the/DT lumenal/JJ domains/NNS of/IN Sec12p/NEWGENE ,/, Stl1p/NEWGENE and/CC Stl2p/NEWGENE are/VBP very/RB different/JJ in/IN size/NN and/CC do/VB not/RB show/VB any/DT appreciable/JJ homology/NN ./.
@@112301459197 Our/PRP results/NNS suggest/VBP that/IN the/DT central/JJ role/NN of/IN the/DT Notch-CBF1/NEWGENE //NEWGENE RBP-Jkappa/NEWGENE signaling/NEWGENE pathway/NEWGENE in/IN cell/NN fate/NN decisions/NNS renders/VBZ it/PRP susceptible/JJ to/IN pathways/NNS of/IN viral/JJ replication/NN and/CC oncogenic/JJ conversion/NN ./.
@@57996861427 The/DT possibility/NN of/IN selective/JJ chemotherapy/NN of/IN progressive/JJ recurring/JJ ovarian/JJ carcinoma/NN with/IN the/DT aid/NN of/IN cytodiagnosis/NN and/CC incorporation/NN of/IN tagged/JJ idoxuridine/NN ./.
@@891370677 Well-visualised/JJ arteriograms/NNS of/IN the/DT limbs/NNS can/MD be/VB obtained/VBN by/IN xeroradiography/NN after/IN rapid/JJ manual/JJ injection/NN of/IN contrast-medium/JJ into/IN an/DT arm/NN vein/NN ,/, as/IN demonstrated/VBN in/IN 28/CD patients/NNS ./.
@@15600214854 To/TO determine/VB the/DT genetic/JJ basis/NN for/IN the/DT differences/NNS between/IN the/DT cardiac/NN and/CC brain/NEWGENE AE3/NEWGENE variants/NEWGENE ,/, we/PRP isolated/VBD and/CC characterized/VBD the/DT rat/NN gene/NN ./.
@@24065707411 All/DT ABFI-binding/NEWGENE sites/NEWGENE ,/, regardless/RB of/IN origin/NN ,/, provided/VBN weak/JJ UAS/NN function/NN in/IN vivo/NN when/CC examined/VBN in/IN test/NN plasmids/NNS ./.
@@18650102461 Patterns/NNS of/IN connections/NNS underlying/JJ cross-modality/JJ integration/NN were/VBD studied/VBN by/IN injecting/JJ distinguishable/JJ ,/, retrograde/JJ tracers/NNS (/( Fluoro-Gold/NNP and/CC diamidino/NN yellow/JJ )/SYM in/IN pairwise/JJ manner/NN into/IN different/JJ sensory/JJ representations/NNS (/( visual/JJ ,/, somatosensory/JJ ,/, and/CC auditory/JJ )/SYM in/IN the/DT cerebral/JJ cortex/NN of/IN the/DT rat/NN ./.
@@75573878227 In/NN this/DT study/NN we/PRP have/VBP investigated/VBN the/DT role/NN of/IN C/NEWGENE //NEWGENE EBP/NEWGENE beta/NEWGENE in/IN initiating/JJ the/DT adipogenic/JJ program/NN by/IN overexpressing/JJ C/NEWGENE //NEWGENE EBP/NEWGENE beta/NEWGENE in/IN multipotential/JJ NIH-3T3/NN fibroblasts/NNS ./.
@@13309751960 Peripheral/JJ polyneuropathy/NN associated/VBN with/IN multiple/JJ myeloma/NN ./.
@@11120441958 As/IN hypothesized/VBN ,/, believers/NNS showed/VBD relatively/JJ higher/JJ right/JJ hemispheric/JJ activation/NN and/CC reduced/VBN hemispheric/JJ asymmetry/NN of/IN functional/JJ complexity/NN ./.
@@26479187455 In/NN the/DT whole/JJ group/NN ,/, basal/NN GH/NEWGENE and/CC somatomedin-C/NEWGENE levels/NNS decreased/VBN from/IN a/DT mean/JJ (/( +/NN //NN -/NN standard/JJ error/NN of/IN the/DT mean/JJ )/SYM of/IN 52/CD ./CD 3/CD +/NN //NN -/NN 12/CD ./CD 7/CD to/IN 11/CD ./CD 1/CD +/NN //NN -/NN 6/CD ./CD 3/CD ng/NN //NN ml/NN and/CC from/IN 7/CD ./CD 6/CD +/NN //NN -/NN 0/CD ./CD 7/CD to/IN 2/CD ./CD 5/CD +/NN //NN -/NN 0/CD ./CD 5/CD U/NNS //NNS ml/NNS ,/, respectively/RB ./.
@@80857828064 We/PRP describe/VBP 49/CD cases/NNS with/IN papillary/JJ tumor/NN </SYM 1/CD cm/NN ./NN
@@77303375252 Structure/NNS and/CC regulation/NN of/IN the/DT gene/NN encoding/VBG the/DT neuron-specific/NN protein/NEWGENE kinase/NEWGENE C/NEWGENE substrate/NN neurogranin/NEWGENE (/( RC3/NEWGENE protein/NEWGENE )/SYM ./.
@@367605478 In/NN group/NN I/PRP ,/, Paw/NN ,/, delta/NN V/NN ,/, PaO2/NN ,/, Vinj/NN and/CC VT/NN significantly/RB decreased/VBD whereas/IN operating/JJ pressure/NN and/CC E/NN significantly/RB increased/VBD when/CC the/DT internal/JJ diameter/NN of/IN the/DT injector/NN cannula/NN was/VBD reduced/VBN ./.
@@92910779252 Transient/JJ hyperammonaemia/NN in/IN an/DT adult/JJ German/JJ shepherd/NN dog/NN ./.
@@101711738831 Because/IN of/IN concerns/NNS regarding/IN blood/NN transfusion-related/JJ communicable/JJ disease/NN (/( eg/NN ,/, acquired/VBN immune/JJ deficiency/NN syndrome/NN and/CC non-A/NN ,/, non-B/NN hepatitis/NN )/SYM ,/, there/RB has/VBZ been/VBN increasing/JJ research/NN effort/NN into/IN postoperative/JJ hemorrhage/NN related/VBN to/IN cardiopulmonary/JJ bypass/NN with/IN extracorporeal/JJ circulation/NN ./.
@@91548222478 Inhibition/NNS of/IN the/DT Raf-1/NEWGENE kinase/NEWGENE by/IN cyclic/JJ AMP/NN agonists/NNS causes/NNS apoptosis/NN of/IN v-abl-transformed/JJ cells/NNS ./.
@@18378424657 CREB/NEWGENE was/VBD identified/VBN as/IN one/PRP of/IN the/DT protein/NN components/NNS in/IN several/DT of/IN the/DT gel/NN shift/NN complexes/NNS formed/VBN with/IN the/DT variant/NN CRE/NEWGENE ./.
@@82411395417 About/IN 20%/CD of/IN single-stranded/JJ DNA/NN binding/NN was/VBD observed/VBN in/IN the/DT presence/NN of/IN MgdTDP/NNP ,/, but/CC none/NN was/VBD detectable/JJ in/IN the/DT absence/NN of/IN nucleotides/NNS ./.
@@89447553351 Biol/NNP ./.
@@98226907629 Mammalian/JJ sperm/NN motility/NN is/VBZ regulated/VBN by/IN a/DT cascade/NN of/IN cAMP-dependent/NN protein/NN phosphorylation/NN events/NNS mediated/JJ by/IN protein/NEWGENE kinase/NEWGENE A/NNP ./NNP
@@78985897878 The/DT "tobacco/NN issue"/NN ./.
@@17255479370 Diltiazem/NN resulted/VBN in/IN a/DT significant/JJ increase/NN in/IN epicardial/JJ diameter/NN (/( +10%/CD ;/: p/NN =/SYM 0/CD ./CD 001/CD )/SYM and/CC in/IN coronary/JJ blood/NN flow/NN (/( CBF/NN )/SYM (/( +30%/CD ;/: p/NN =/SYM 0/CD ./CD 0001/CD )/SYM ./.
@@88014038783 Myelomatous/JJ pleural/JJ effusion/NN as/IN presentation/NN form/NN of/IN multiple/JJ myeloma/NN ./.
@@97032766514 These/DT results/NNS establish/VBP that/IN hydroquinones/NNS lead/VBP to/IN mutagenicity/NN and/CC carcinogenicity/NN ./.
@@61515185973 Glutamic/NN acid/NN in/IN a/DT dose/NN of/IN 1/CD //CD 100/CD of/IN the/DT LD50/NN was/VBD injected/VBN in/IN the/DT form/NN of/IN sodium/NN salt/JJ into/IN male/JJ and/CC female/JJ Wistar/NN rats/NNS for/IN 7/CD days/NNS after/IN 8-/CD and/CC 12-day/NN injections/NNS of/IN dexazone/NN ./.
@@106603045238 Members/NNS of/IN the/DT JAK/NEWGENE //NEWGENE Tyk/NEWGENE family/NEWGENE of/IN tyrosine/NEWGENE kinases/NEWGENE mediate/VBP phosphorylation/NN of/IN STAT3/NEWGENE at/IN Tyr705/NN during/IN CNTF/NEWGENE signaling/JJ ;/: however/RB ,/, the/DT kinase/NEWGENE responsible/JJ for/IN phosphorylation/NN at/IN STAT3/NEWGENE Tyr727/NN appears/VBZ to/IN depend/VB on/IN both/PDT the/DT extracellular/JJ stimulus/NN and/CC the/DT cellular/JJ context/NN ./.
@@82086181468 Also/RB ,/, HR21ap/NEWGENE as/RB well/VB as/IN HR21Xap/NEWGENE are/VBP specific/JJ in/IN their/PRP inhibition/NN of/IN Sp1/NEWGENE binding/JJ ./.
@@90604447073 This/DT promoter/NN segment/NN could/MD drive/VB expression/NN of/IN a/DT luciferase/NEWGENE reporter/NEWGENE gene/NEWGENE ,/, could/MD confer/VB correct/JJ transcriptional/JJ initiation/NN to/IN the/DT reporter/NN and/CC could/MD confer/VB the/DT EGF-responsiveness/NNP previously/RB observed/VBD in/IN the/DT native/JJ gene/NN ./.
@@88072885156 Isolation/NNS and/CC identification/NN of/IN genes/NN activating/NN UAS2-dependent/NEWGENE ADH2/NEWGENE expression/NN in/IN Saccharomyces/NN cerevisiae/NN ./.
@@72603898339 Methisergide/NNP (/( 0/CD ./CD 5/CD mg/CD //CD kg/CD ,/, i/CD ./CD p/CD ./CD )/SYM ,/, a/DT blocker/NN of/IN serotonin/NEWGENE receptors/NEWGENE ,/, prevented/VBD the/DT development/NN of/IN the/DT antinociceptive/JJ effect/NN of/IN serotonin/NN ./.
@@87943393436 Although/IN the/DT binding/NN of/IN IE2/NEWGENE 86/NEWGENE to/IN nonphosphorylated/JJ full-length/NEWGENE CREB/NEWGENE or/CC deltaCREB/NEWGENE is/VBZ minimal/JJ ,/, IE2/NEWGENE 86/NEWGENE does/VBP form/NN complexes/NNS with/IN p300/NEWGENE and/CC the/DT CREB-binding/NEWGENE protein/NEWGENE (/( CBP/NEWGENE )/SYM ,/, which/WDT in/IN turn/NN bind/NN to/IN CREB/NEWGENE and/CC can/MD serve/VB as/IN adaptor/NN proteins/NN for/IN CREB/NEWGENE function/NN ./.
@@14007752021 These/DT results/NNS demonstrate/VBP that/IN endogenous/JJ N-methylation/NNS of/IN salsolinol/NN into/IN N-methylsalsolinol/CHEM occurs/VBZ in/IN the/DT brain/NN in/IN vivo/NN ./.
@@83451913749 The/DT peptide/NN sequence/NN contains/VBZ a/DT region/NN of/IN 80/CD amino/JJ acids/NNS that/WDT shows/VBZ similarity/NN to/IN bcl-2/NEWGENE and/CC to/IN the/DT recently/RB described/VBN bcl-2-related/NEWGENE gene/NEWGENE ,/, MCL1/NEWGENE ./.
@@72593257098 Survival/NNP was/VBD calculated/VBN both/DT from/IN the/DT date/NN of/IN onset/NN and/CC from/IN the/DT date/NN of/IN diagnosis/NN ./.
@@113096782967 Reverse/VB transcription-PCR/NN analysis/NN of/IN mRNA/NN from/IN patients/NNS shows/VBZ that/IN each/DT of/IN these/DT five/CD mutations/NNS results/NNS in/IN aberrant/JJ splicing/JJ ./.
@@35568348129 Acute/JJ inhalation/NN toxicity/NN of/IN T-2/NN mycotoxin/NN in/IN mice/NNS ./.
@@99458389940 Envelope-function/NNP matching/JJ conditions/NNS for/IN GaAs/NEWGENE //NEWGENE (/NEWGENE Al/NEWGENE ,/NEWGENE Ga/NEWGENE )/NEWGENE As/NEWGENE heterojunctions/NEWGENE ./.
@@3426233592 Disrupted/JJ vaccines/NNS and/CC whole-virus/NN vaccines/NNS containing/NN type/NEWGENE B/NEWGENE antigen/NEWGENE only/RB did/VBD not/RB cause/VB significant/JJ reactivity/NN ./.
@@92104787010 The/DT ubiquitously/RB expressed/VBN hypoxia-inducible/NEWGENE factor-1/NEWGENE (/( HIF-1/NEWGENE )/SYM is/VBZ involved/VBN in/IN expression/NN of/IN a/DT large/JJ number/NN of/IN oxygen-regulated/NN genes/NN ./.
@@7730336674 Because/IN ATF-1/NEWGENE and/CC CREM/NEWGENE are/VBP known/VBP to/IN bind/NN to/IN cAMP/NEWGENE response/NEWGENE elements/NEWGENE (/( CRE/NEWGENE )/SYM ,/, this/DT functional/JJ sequence/NN was/VBD named/VBN the/DT kappa/NEWGENE E3'-CRE/NEWGENE ./.
@@19066922535 INTERVENTIONS/NNP :/: Patients/NNS received/VBD rt-PA/NEWGENE ,/, heparin/NN ,/, and/CC aspirin/NN ./.
@@42891564905 The/DT incidence/NN of/IN tumours/NNS in/IN young/JJ chickens/NNS ./.
@@83099537902 These/DT results/NNS demonstrate/VBP that/DT dopamine/NEWGENE receptor/NEWGENE stimulation/NN by/IN different/JJ dopamine/NN agonists/NNS produces/VBZ a/DT different/JJ pattern/NN of/IN effects/NNS on/IN the/DT characteristics/NNS of/IN the/DT reaction/NN time/NN response/NN ./.
@@605291849 In/NN the/DT matched/JJ control/NN group/NN the/DT acquisition-rate/NN of/IN both/DT symptomatic/JJ and/CC asymptomatic/JJ 0acteriuria/NN was/VBD over/RB 12%/JJ ,/, a/DT figure/NN similar/JJ to/IN the/DT percentage/NN of/IN women/NNS present/VBP in/IN the/DT practice/NN population/NN during/IN one/PRP year/NN with/IN transient/JJ ,/, symptomatic/JJ ,/, and/CC persistent/JJ A/NN ./NN B/NN ./.
@@98378244790 We/PRP identified/VBD telSMN/NEWGENE mutations/NN in/IN 11/CD of/IN these/DT unrelated/NN SMA-like/NN individuals/NNS who/WP carry/VBP a/DT single/JJ copy/NN of/IN telSMN/NEWGENE :/: these/DT include/VB two/JJ frameshift/JJ mutations/NNS (/( 800ins11/NN and/CC 542delGT/NN )/SYM and/CC three/CD missense/JJ mutations/NNS (/( A2G/NN ,/, S262I/NNP ,/, and/CC T274I/NNP )/SYM ./.
@@93673921189 The/DT presence/NN of/IN an/DT additional/JJ sequence/NN of/IN nucleotides/NNS 145-165/JJ from/IN the/DT 3'/CD end/NN of/IN RNA3/NEWGENE enhanced/VBN template/NN recognition/NN by/IN RdRp/NEWGENE in/IN vitro/FW and/CC accumulation/NN of/IN RNA3/NEWGENE in/IN vivo/NN to/IN wild-type/NN levels/NNS ./.
@@114697374697 At/NN visit/NN 5/NN ,/, the/DT isokinetic/JJ test/NN showed/VBD impaired/VBN muscle/NN function/NN recovery/NN from/IN 23%/JJ to/IN 32%/JJ ,/, while/CC the/DT manual/JJ test/NN showed/VBD almost/RB full/JJ recovery/NN ./.
@@92347366674 In/NN situ/NN hybridization/NN analysis/NN in/IN adult/JJ rat/NN tissue/NN reveals/VBZ good/JJ correlation/NN with/IN this/DT pattern/NN and/CC indicates/VBZ that/DT drm/NEWGENE mRNA/NEWGENE is/VBZ most/RB highly/RB expressed/VBN in/IN nondividing/JJ and/CC terminally/RB differentiated/VBN cells/NNS ,/, such/JJ as/IN neurons/NNS ,/, type/NN 1/CD lung/NN cells/NNS ,/, and/CC goblet/NN cells/NNS ./.
@@98826389876 Folded/NNP tissue/NN and/CC crimped/JJ collagen/NEWGENE fibers/NNS in/IN the/DT tunica/NN albuginea/NN permit/NN its/PRP expansion/NN during/IN erection/NN ./.
@@17650958334 12-O-Tetradecanoylphorbol/JJ 13-acetate/NN was/VBD found/VBN to/IN inhibit/VB rapidly/RB and/CC potently/RB the/DT expression/NN of/IN mRNAs/NNS coding/JJ for/IN the/DT myogenic/JJ regulators/NN CMD1/NEWGENE and/CC myogenin/NEWGENE ./.
@@85420279126 The/DT XS2/NEWGENE gene/NEWGENE down-regulates/VBZ but/CC does/VBP not/RB abolish/VB expression/NN of/IN LU/NEWGENE genes/NEWGENE and/CC does/VBP not/RB affect/VB expression/NN of/IN CD44/NEWGENE ./.
@@98932628107 Additionally/RB ,/, a/DT variety/NN of/IN regulatory/JJ schemes/NNS contribute/VBP temporal/JJ and/IN //IN or/IN spatial/JJ restriction/NN to/IN TGF-beta/NEWGENE responses/NNS ./.
@@9038202904 These/DT data/NN support/NN the/DT idea/NN that/IN the/DT repression/NN activity/NN of/IN NRSF/NEWGENE //NEWGENE REST/NEWGENE depends/VBZ upon/IN the/DT species/NN of/IN promoter/NN to/IN which/WDT it/PRP is/VBZ linked/JJ and/CC upon/IN the/DT proteins/NNS that/WDT bind/VBP to/IN those/DT promoters/NNS ./.
@@94420315681 This/DT information/NN ,/, together/RB with/IN estimation/NN of/IN the/DT size/NN of/IN the/DT deglycosylated/JJ A/DT subunit/NN relative/JJ to/IN a/DT series/NN of/IN C-terminal/NEWGENE truncated/NEWGENE TSHR/NEWGENE ectodomain/NEWGENE variants/NEWGENE ,/, places/NNS cleavage/NN Site/NNP 1/CD in/IN the/DT vicinity/NN of/IN ,/, or/CC closely/RB upstream/RB to/IN ,/, residue/NN 317/CD ./.
@@118210987137 MAIN/NNP OUTCOME/NNP MEASURE/NN (/NN S/NN )/NN :/: Serum/NN levels/NNS of/IN FSH/NEWGENE ,/, LH/NEWGENE ,/, and/CC inhibin/NEWGENE A/NEWGENE and/NEWGENE B/NEWGENE ./.
@@76786023834 We/PRP generated/VBD transformed/VBN B/NNP lymphoblast/NN cell/NN lines/NNS from/IN controls/NNS ,/, from/IN four/CD patients/NNS with/IN p47-phox-deficient/JJ chronic/JJ granulomatous/JJ disease/NN ,/, and/CC from/IN three/CD parents/NNS ./.
@@39294865436 In/NN a/DT blind/RB controlled/VBN trial/NN ,/, 15/CD patients/NNS with/IN COCM/NN (/( NYHA/NN II-III/NN )/SYM with/IN sinus/NN rhythm/NN and/CC a/DT left/JJ ventricular/JJ ejection/NN fraction/NN (/( LV-EF/NN )/SYM of/IN 34/CD ./CD 5/CD +/NN //NN -/NN 2/CD ./CD 6%/CD received/VBN consecutively/RB D/NN (/( 0/CD ./CD 25-0/CD ./CD 5/CD mg/NN //NN d/NN )/SYM ,/, placebo/NN (/( PLAC/NN )/SYM ,/, P/NN (/( slow/JJ releases/NNS =/SYM SR/NN )/SYM (/( 80/CD mg/NN //NN d/NN SR/NN )/SYM and/CC both/DT drugs/NNS combined/JJ in/IN respective/JJ doses/NNS ./.
@@96493155245 Examination/NN of/IN nuclear/JJ magnetic/JJ resonance/NN (/( NMR/NN )/SYM spectra/NNS of/IN a/DT series/NN of/IN N-terminally/NEWGENE truncated/NEWGENE MIP-1/NEWGENE beta/NEWGENE variants/NEWGENE reveals/VBZ that/IN these/DT proteins/NNS possess/VBP a/DT range/NN of/IN ability/NN to/IN dimerize/VB ./.
@@6149158581 Vitrectomy/NN in/IN ocular/JJ traumatology/NN ./.
@@95449872363 We/PRP further/RB demonstrate/VBP that/IN RU486-PR-B/NN interacts/VBZ physically/RB with/IN NCoR/NEWGENE in/IN vitro/FW ./.
@@16519188975 We/PRP have/VBP isolated/VBN and/CC sequenced/VBN two/JJ overlapping/JJ cDNA/NN fragments/NNS which/WDT could/MD encode/VB the/DT complete/JJ amino/JJ acid/NN sequence/NN of/IN rat/NEWGENE testis/NEWGENE fructose-6-phosphate/NEWGENE ,/NEWGENE 2-kinase/NEWGENE :/NEWGENE fructose-2/NEWGENE ,/NEWGENE 6-bisphosphatase/NEWGENE ./.
@@12793526925 One/CD site/NN ,/, PAL/NEWGENE ,/, occurs/VBZ within/IN the/DT 10/NEWGENE bp/NEWGENE sequence/NEWGENE GGGGAGGAGG/NEWGENE ./.
@@98527529841 We/PRP emphasize/VBP that/IN ANCA-associated/JJ vasculitis/NN is/VBZ another/DT important/JJ complication/NN of/IN RA/NN ./NN
@@84457292274 Replacement/NN of/IN the/DT spacer/NN sequence/NN between/IN the/DT two/JJ ARMs/NNS with/IN a/DT shorter/JJR stretch/NN of/IN sequence/NN also/RB reduced/VBD RNA/NN binding/JJ in/IN vitro/FW ./.
@@83771992367 It/PRP is/VBZ possible/JJ that/IN the/DT patch/NN determines/VBZ the/DT proper/JJ conformation/NN of/IN the/DT site/NN and/CC thereby/RB contributes/VBZ to/IN recognition/NN indirectly/RB ./.
@@112962886717 In/NN addition/NN ,/, another/DT derivative/NN of/IN pCMVJS21/NN (/( pCMVJS21DeltaGP/NN )/SYM in/IN which/WDT the/DT gag/NEWGENE ,/, pol/NEWGENE (/( and/CC orf-x/NEWGENE )/SYM coding/JJ sequences/NNS were/VBD deleted/VBN also/RB gave/VBD transformed/VBN foci/NNS ./.
@@95085115545 In/NN ferrets/NNS naturally/RB infected/VBN with/IN H/NNP ./NNP mustelae/NNS ,/, a/DT single/JJ dose/NN (/( 50/CD mg/CD //CD kg/CD ,/, per/IN os/NN )/SYM of/IN fluorofamide/NN completely/RB inhibited/VBD bacterial/NEWGENE urease/NEWGENE ./.
@@9332514592 Petrous/JJ meningioma/NN en/NN plaque/NN presenting/VBG as/IN a/DT right/JJ middle/JJ ear/NN tumor/NN ./.
@@95965429553 We/PRP show/VBP that/IN the/DT surfaces/NNS of/IN tracheal/JJ cartilage/NN matrix/NN are/VBP collagen-rich/JJ and/CC surround/VB a/DT proteoglycan-rich/JJ core/NN ./.
@@9622779591 Haemodilution/NNP in/IN cardiopulmonary/JJ bypass/NN using/VBG a/DT gelatine/NN derivative/NN for/IN priming/NN ./.
@@22463626453 The/DT Jenkins/NNP Activity/NNP Survey/NNP and/CC the/DT CPI-revised/JJ :/: further/JJ evidence/NN of/IN adaptive/JJ and/CC maladaptive/JJ type/NN A/NN traits/NNS ./.
@@28313986298 Irmiere/NNP ,/, and/CC W/NN ./NN
@@79651527602 Segments/NNS with/IN more/RB reduced/VBN BMIPP/NN uptake/NN than/IN MIBI/DT uptake/NN (/( mismatching/VBG )/SYM showed/VBD either/DT normal/JJ wall/NN motion/NN or/CC demonstrated/VBN inotropic/JJ reserve/NN during/IN dobutamine/NN stimulation/NN ./.
@@30102817683 Two/CD copies/NNS of/IN the/DT 72-bp/JJ repeat/NN provided/VBD efficient/JJ activation/NN of/IN gene/NN expression/NN ./.
@@102338859755 Consistent/JJ with/IN this/DT prediction/NN ,/, transfections/NNS into/IN the/DT hematopoietic/JJ cell/NN line/NN Jurkat/NN showed/VBD a/DT 9/CD ./CD 0-/CD and/CC 2/CD ./CD 5-fold/CD activation/NN of/IN the/DT mim-1/NEWGENE promoter/NEWGENE by/IN the/DT p32/NEWGENE and/CC p30/NEWGENE isoforms/NEWGENE ,/, respectively/RB ./.
@@93117966051 In/NN our/PRP previous/JJ studies/NNS ,/, transcriptional/JJ activation/NN was/VBD shown/VBP to/IN correlate/NN with/IN IEP86/NEWGENE binding/JJ to/IN both/PDT the/DT TATA-box/NEWGENE binding/NEWGENE protein/NEWGENE (/( TBP/NEWGENE )/SYM and/CC the/DT transcription/NN factor/NN bound/JJ upstream/RB ./.
@@40041683581 Two/CD siblings/NNS with/IN hemolytic/JJ anemia/NN caused/VBN by/IN triosephosphate/NEWGENE isomerase/NEWGENE deficiency/NN developed/VBD a/DT progressive/JJ neurological/JJ syndrome/NN featuring/VBG dystonic/JJ movements/NNS ,/, tremor/NN ,/, pyramidal/JJ tract/NN signs/NNS ,/, and/CC evidence/NN of/IN spinal/JJ motor/JJ neuron/NN involvement/NN ./.
@@13092443918 The/DT target/NN contained/VBN between/IN positions/NNS -403/CD and/CC -125/CD acts/NNS independently/RB of/IN orientation/NN ,/, in/IN different/JJ cell/NN types/NNS and/CC species/NN ,/, and/CC in/IN the/DT context/NN of/IN a/DT heterologous/JJ promoter/NN ./.
@@63190717092 Female/JJ subjects/NNS ,/, including/JJ both/DT normal/JJ subjects/NNS and/CC idiopathic/JJ calcium/NN stone-formers/NN ,/, have/VB higher/JJ urinary/JJ cyclic/JJ AMP/NN levels/NNS than/IN their/PRP male/JJ counterparts/NNS ,/, and/CC this/DT difference/NN is/VBZ significant/JJ when/CC urinary/JJ cyclic/JJ AMP/NN is/VBZ expressed/VBN in/IN the/DT units/NNS mumol/NN //NN g/NN of/IN creatinine/NN ./.
@@37282308433 He/NN visited/VBD our/PRP hospital/NN and/CC left/NN solitary/JJ renal/NN cyst/NN was/VBD suspected/VBN ./.
@@89550228910 The/DT effect/NN of/IN maternal/JJ ingestion/NN of/IN the/DT reduced/VBN energy/NN sweetener/NN erythritol/NN was/VBD investigated/VBN in/IN KBL/NNP :/: JW/NN strain/NN pregnant/JJ rabbits/NNS ./.
@@78676044597 Our/PRP results/NNS concluded/VBN that/IN 1/NN )/NN the/DT two/JJ inhibin/NEWGENE //NEWGENE activin/NEWGENE beta/NEWGENE B-subunit/NEWGENE1 mRNAs/NEWGENE1 were/VBD transcribed/VBN from/IN different/JJ initiation/NN sites/NNS ;/: 2/NN )/NN both/DT promoters/NNS may/MD be/VB controlled/VBN by/IN up-stream/NN negative/JJ regulatory/JJ elements/NNS ;/: and/CC 3/NN )/NN neither/DT of/IN these/DT promoters/NNS is/VBZ responsive/JJ to/IN cAMP/NN and/DT //DT or/DT phorbol/NN esters/NNS under/IN the/DT conditions/NNS employed/VBN ./.
@@114597943382 TE-671/NNP cells/NNS that/WDT were/VBD transfected/VBN with/IN cAMP/NEWGENE response/NEWGENE element/NEWGENE mutant/NN constructs/NN demonstrated/VBD a/DT diminished/VBN basal/JJ activity/NN of/IN the/DT GnRH-II/NEWGENE promoter/NEWGENE ./.
@@78350885787 The/DT HSD3B1/NEWGENE and/CC HSD3B2/NEWGENE genes/NEWGENE encoding/VBG the/DT types/NEWGENE I/NEWGENE and/NEWGENE II/NEWGENE 3/NEWGENE beta-HSD/NEWGENE isoenzymes/NEWGENE ,/, respectively/RB ,/, have/VB been/VBN previously/RB assigned/VBN by/IN in/IN situ/NN hybridization/NN to/IN the/DT chromosome/NN 1p13/NN ./NN 1/NN region/NN ./.
@@98230149801 Effect/NN of/IN enteral/JJ nutritional/JJ products/NNS differing/JJ in/IN carbohydrate/NN and/CC fat/JJ on/IN indices/NNS of/IN carbohydrate/NN and/CC lipid/NN metabolism/NN in/IN patients/NNS with/IN NIDDM/NN ./.
@@86357719441 A/DT study/NN was/VBD performed/VBN to/IN compare/NN the/DT ONLINE/NNP and/CC EMIT/NN II/NN immunoassays/NNS with/IN gas/NN chromatographic/NN //NN mass/NN spectrometric/JJ (/( GC/NN //NN MS/NN )/SYM analysis/NN of/IN methaqualone/NN metabolites/NNS on/IN urine/NN using/VBG samples/NNS obtained/VBN from/IN a/DT clinical/JJ study/NN ./.
@@74882473494 Functional/JJ analysis/NN of/IN aryl/NEWGENE hydrocarbon/NEWGENE receptor/NEWGENE nuclear/NEWGENE translocator/NEWGENE interactions/NNS with/IN aryl/NEWGENE hydrocarbon/NEWGENE receptor/NEWGENE in/IN the/DT yeast/NN two-hybrid/JJ system/NN ./.
@@76511415745 The/DT 5'-terminus/NN of/IN the/DT p-gvpF-M/NEWGENE mRNA/NEWGENE was/VBD located/VBN 169/CD nucleotides/NNS upstream/RB of/IN p-gvpF/NEWGENE within/IN p-gvpE/NEWGENE ./.
@@78621413945 Alternatively/RB ,/, loss-of-function/NN alleles/NNS of/IN genes/NNS that/WDT inhibit/VBP cAPK/NEWGENE lead/VB to/IN the/DT inability/NN to/IN undergo/VB sexual/JJ differentiation/NN ./.
@@86417056098 These/DT different/JJ observations/NNS exclude/VBP a/DT heterozygosity/NN of/IN the/PDT A/DT --/JJ >/JJ G/NN mutation/NN at/IN codon/NN beta/NN 77/NN ,/, as/RB well/VB as/IN a/DT deletion/NN comparable/JJ to/IN that/IN of/IN Hbs/NEWGENE Lepore/NEWGENE or/NEWGENE Kenya/NEWGENE ,/, or/CC a/DT beta-globin/NEWGENE gene/NEWGENE duplication/NN ,/, and/CC point/NN to/IN a/DT nontraditional/JJ inheritance/NN of/IN Hb/NEWGENE Costa/NEWGENE Rica/NEWGENE ./.
@@111131796482 Remarkably/RB ,/, a/DT construct/NN corresponding/JJ to/IN residues/NNS 631/CD to/IN 970/CD ,/, which/WDT contains/VBZ only/RB the/DT LXXLL/NEWGENE motifs/NEWGENE and/CC the/DT AD1/NEWGENE region/NEWGENE of/IN SRC1/NEWGENE ,/, retained/VBN strong/JJ coactivator/NN activity/NN in/IN our/PRP assays/NNS ./.
@@90427554793 The/DT alternative/JJ sigma/NEWGENE factor/NEWGENE sigmaB/NEWGENE in/NEWGENE Staphylococcus/NEWGENE aureus/NEWGENE :/: regulation/NN of/IN the/DT sigB/NEWGENE operon/NEWGENE in/IN response/NN to/IN growth/NN phase/NN and/CC heat/NN shock/NN ./.
@@16120851316 The/DT serum/JJ erythropoietin/NEWGENE (/( EPO/NEWGENE )/SYM concentrations/NNS of/IN 15/CD male/JJ triathletes/NNS (/( 26/CD ./CD 3/CD U/CD ./CD ml-1/CD )/SYM were/VBD significantly/RB lower/JJR than/IN those/DT of/IN 45/CD male/JJ distance/NN runners/NNS (/( 31/CD ./CD 6/CD U/CD ./CD ml-1/CD ;/: P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@61100267953 Endorphins/NEWGENE at/IN the/DT approach/NN of/IN death/NN ./.
@@19018598787 UDP-Gal/NEWGENE :/NEWGENE Gal/NEWGENE beta/NEWGENE 1----4GlcNAc/NEWGENE alpha/NEWGENE 1----3-galactosyltransferase/NEWGENE is/VBZ a/DT terminal/NEWGENE glycosyltransferase/NEWGENE that/WDT is/VBZ widely/RB expressed/VBN in/IN a/DT variety/NN of/IN mammalian/JJ species/NN ,/, with/IN the/DT notable/JJ exception/NN of/IN man/NN ,/, apes/NNS ,/, and/CC Old/NNP World/NNP monkeys/NNS ./.
@@2480419583 The/DT underlying/JJ cirrhosis/NN was/VBD alcoholic/JJ in/IN 11/CD (/( 53/CD ./CD 3%/CD )/SYM ,/, cryptogenic/JJ in/IN 5/CD (/( 23/CD ./CD 8%/CD )/SYM ,/, and/CC hepatitis/NN B/NN chronic/JJ infection/NN related/VBN in/IN 5/CD (/( 23/CD ./CD 8%/CD )/SYM ./.
@@86607488634 The/DT model/NN captures/VBP the/DT essence/NN of/IN predator-prey/JJ dynamics/NNS to/IN provide/VB reasonable/JJ predictions/NNS of/IN population/NN patterns/NNS ./.
@@103808907526 Forty-eight/NNS sequences/NNS ,/, 30/CD not/RB previously/RB identified/VBN as/IN IR-responsive/NNP ,/, were/VBD significantly/RB regulated/VBN by/IN IR/NNP ./NNP
@@10959676779 The/DT bases/NNS of/IN this/DT comparison/NN are/VBP reviewed/VBN and/CC discussed/VBN ./.
@@115761581461 In/NN the/DT TVD-patients/NNS decreases/NNS in/IN skin/NN blood/NN flow/NN were/VBD similar/RB compared/VBN with/IN the/DT healthy/JJ controls/NNS ./.
@@29674969078 The/DT cpc-1-encoded/JJ transcript/NN contains/VBZ three/CD open/JJ reading/JJ frames/NNS ,/, two/NN of/IN which/WDT are/VBP located/VBN in/IN the/DT 720-nucleotide/JJ leader/NN segment/NN preceding/JJ the/DT cpc-1/NEWGENE coding/NEWGENE region/NEWGENE ./.
@@95709527634 The/DT complete/JJ exon-intron/JJ organization/NN of/IN the/DT murine/NN gene/NN encoding/VBG M-protein/NEWGENE ,/, a/DT structural/JJ protein/NN of/IN sarcomeric/JJ myofibrils/NNS ,/, was/VBD determined/VBN ./.
@@108608466954 Functional/JJ studies/NNS which/WDT introduced/VBD a/DT mutation/NN in/IN the/DT AP2/NEWGENE core/NEWGENE binding/NEWGENE region/NEWGENE as/RB well/VB as/IN cotransfection/NN experiments/NNS using/VBG an/DT AP2/NEWGENE expression/NN vector/NN revealed/VBN that/IN AP2/NEWGENE exerts/VBZ a/DT repressive/JJ role/NN on/IN the/DT HGF/NEWGENE gene/NEWGENE promoter/NEWGENE activity/NN ./.
@@59332285822 Pigmentary/NNP rhythms/NNS as/IN indicators/NNS of/IN neurosecretion/NN ./.
@@94215167507 Deadenylation/NNS and/CC decay/NN of/IN beta-globin/NEWGENE mRNA/NEWGENE in/IN K562/NNP cells/NNS is/VBZ extraordinarily/RB slow/RB compared/VBN with/IN NIH/NN 3T3/CD cells/NNS ,/, suggesting/VBG that/IN the/DT increased/VBN stability/NN gained/VBN by/IN beta-globin/NEWGENE mRNA/NEWGENE in/IN K562/NNP cells/NNS is/VBZ mainly/RB controlled/VBN at/IN the/DT deadenylation/NN step/NN ./.
@@108460697674 Role/NN of/IN NH/NN (/NN 2/NN )/NN -/NN and/CC COOH-terminal/NN domains/NN of/IN the/DT P/NEWGENE protein/NEWGENE of/IN human/JJ parainfluenza/NN virus/NN type/NN 3/CD in/IN transcription/NN and/CC replication/NN ./.
@@77917719718 Otte/NNP ,/, Mol/JJ ./.
@@76090792178 Transactivation/NNS of/IN the/DT HIV-1/NEWGENE LTR/NEWGENE by/IN T3R/NEWGENE alpha/NEWGENE and/CC several/DT receptor/NN mutants/NNS revealed/VBN that/IN the/DT 50-amino-acid/JJ N-terminal/NN A/NEWGENE //NEWGENE B/NEWGENE region/NEWGENE of/IN T3R/NEWGENE alpha/NEWGENE ,/, known/VBP to/IN interact/VB with/IN the/DT basal/NEWGENE transcription/NEWGENE factor/NEWGENE TFIIB/NEWGENE ,/, is/VBZ critical/JJ for/IN activation/NN of/IN both/DT Tat-dependent/NNP and/CC Tat-independent/NEWGENE responsive/NEWGENE sequences/NEWGENE of/IN the/DT LTR/NEWGENE ./.
@@107125129134 Ste18p/NEWGENE was/VBD targeted/VBN to/IN the/DT plasma/NN membrane/NN even/VB in/IN the/DT absence/NN of/IN prenylation/NN or/CC thioacylation/NN ./.
@@29862793703 81/CD milk/NN samples/NNS collected/VBN from/IN 35/CD donors/NNS 3/CD days/NNS to/IN 7/CD months/NNS after/IN delivery/NN were/VBD examined/VBN for/IN the/DT occurrence/NN of/IN cytomegalovirus/NN (/( CMV/NN )/SYM ./.
@@86554979501 A/DT novel/JJ gene/NN designated/VBD cmr/NEWGENE ,/, which/WDT mapped/VBD to/IN 18/CD ./CD 8/CD min/NN of/IN the/DT Escherichia/NN coli/JJ K-12/NN genome/NN ,/, was/VBD shown/VBP to/IN mediate/VB resistance/NN to/IN chloramphenicol/NN when/CC it/PRP was/VBD expressed/VBN from/IN a/DT multicopy/JJ vector/NN ./.
@@95982054101 Neither/CC the/DT reaction/NN of/IN monosaccharides/NNS nor/CC the/DT disaccharides/NNS with/IN beta-alanine/NN resulted/VBN in/IN the/DT formation/NN of/IN maltol/NN ./.
@@8689033003 Amikacin/NN was/VBD used/VBN in/IN the/DT treatment/NN of/IN 56/CD serious/JJ gram-negative/JJ infections/NNS in/IN 54/CD patients/NNS of/IN whom/WP 47/CD survived/VBN ./.
@@63881896190 Transplantation/NNP of/IN kidneys/NNS of/IN juvenile/JJ donors/NNS in/IN adult/JJ recipients/NNS ./.
@@36285324307 The/DT role/NN of/IN saliva/NN in/IN sour/JJ taste/NN perception/NN was/VBD investigated/VBN in/IN a/DT series/NN of/IN 4/CD experiments/NNS ./.
@@26033743261 Ventral/JJ rhinotomy/NN is/VBZ no/DT more/RB difficult/JJ than/IN dorsal/JJ rhinotomy/NN ,/, has/VBZ less/PRP patient/NN morbidity/NN and/CC fewer/DT postoperative/JJ complications/NNS ,/, and/CC is/VBZ more/RB cosmetically/RB acceptable/JJ ./.
@@39666874612 The/DT financial/JJ impact/NN of/IN childhood/NN asthma/NN has/VBZ not/RB been/VBN assessed/VBN since/IN Vance/NNP and/CC Taylor/NN reported/VBD their/PRP data/NN in/IN Annals/NNS of/IN Allergy/NNS 13/CD years/NNS ago/RB ./.
@@93793019332 447/CD microns/NNS for/IN A/NNP ./NNP microcephalum/NN and/CC 350/CD microns/NNS for/IN A/NNP ./NNP wedli/NN )/NN ,/, and/CC fewer/DT testes/NNS per/IN proglottis/NN (/( 44-73/JJ vs/IN ./IN
@@34076764104 Primary/JJ infection/NN is/VBZ usually/RB managed/VBN conservatively/RB ./.
@@95701334453 In/NN addition/NN to/IN DNA-protein/JJ interactions/NNS ,/, protein-protein/JJ interactions/NNS with/IN partner/NN proteins/NNS often/RB play/VBP major/JJ roles/NNS in/IN targeting/NN ETS-domain/NEWGENE proteins/NEWGENE to/IN specific/JJ promoters/NNS ./.
@@14066301479 Alignment/NNS of/IN the/DT selected/VBN sequences/NNS allowed/VBN us/PRP to/IN predict/VB a/DT consensus/NN sequence/NN for/IN binding/NN of/IN the/DT individual/JJ homodimeric/NN Rel-related/NEWGENE proteins/NEWGENE ,/, and/CC DNA-protein/NN binding/JJ analysis/NN of/IN the/DT selected/VBN DNA/NN sequences/NNS revealed/VBD sequence/NN specificity/NN of/IN the/DT proteins/NNS ./.
@@8683018663 In/NN diethyl/JJ ether/NN solution/NN the/DT main/JJ peak/NN is/VBZ that/IN of/IN 2-benzylidenamio-1-phenylpropane/JJ ,/, which/WDT has/VBZ a/DT retention/NN time/NN of/IN 23/CD ,/CD 2/CD minutes/NNS under/IN the/DT condition/NN delineated/VBN ./.
@@78244647798 On-line/NNP angioscopic/JJ images/NNS of/IN tissue/NN flaps/NN floating/JJ in/IN the/DT lumen/NN ,/, recent/JJ or/CC structured/JJ thrombi/NNS ,/, artery/NN wall/NN dissections/NNS ,/, plaque/NN ruptures/NNS ,/, deep/JJ fissurations/NNS and/CC sub-intimal/JJ haemorrhages/NNS demonstrate/VBP ,/, in/IN live/VB colour/NN ,/, the/DT pathophysiological/JJ mechanisms/NNS of/IN coronary/JJ artery/NN stenosis/NN ./.
@@92798896447 Area/NNP under/IN the/DT drug/NN concentration-time/NN curves/NNS (/( AUC0-24/NNS hr/NN )/SYM for/IN MTX/NN were/VBD 2379/CD and/CC 3534/CD ng*hr/NN //NN ml/NN from/IN PG-2/NN ./NN 5%/NN Azone/NNP and/CC PG-7/NNP ./NNP 5%/NNP Azone/NNP systems/NNS respectively/RB ./.
@@21337317871 From/IN S3/NN (/( CBF/NN :/: 79-60%/NN )/SYM to/IN S5/NNS (/( CBF/NN :/: 39-0%/CD )/SYM ,/, %WTh/NN ,/, 1/NN //NN TPC/NN and/CC 1/CD //CD T/CD were/VBD significantly/RB decreased/VBN from/IN those/DT of/IN the/DT control/NN levels/NNS (/( all/DT p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@7822329885 One/CD complex/NN appears/VBZ to/IN be/VB ubiquitous/JJ but/CC enriched/VBN in/IN lymphoid/JJ cells/NNS and/CC represents/VBZ the/DT binding/NN of/IN a/DT potentially/RB novel/JJ factor/NN with/IN an/DT apparent/JJ molecular/JJ mass/NN of/IN approximately/RB 50/CD kDa/NN ./.
@@91993483650 With/IN a/DT view/NN to/IN identifying/JJ other/DT important/JJ U14/NEWGENE interactions/NNS ,/, a/DT stem-loop/NN domain/NN required/VBN for/IN activity/NN of/IN Saccharomyces/NEWGENE cerevisiae/NEWGENE U14/NEWGENE RNAs/NEWGENE (/( the/DT Y/NEWGENE domain/NEWGENE )/SYM was/VBD first/RB subjected/VBN to/IN detailed/JJ mutational/JJ analysis/NN ./.
@@78520378877 The/DT newly/RB devised/VBN DCT/NNS method/NN yields/NNS reliable/JJ data/NN in/IN measuring/JJ TBF/NN ./.
@@43643694479 Pre-beta-1/NEWGENE lipoprotein/NEWGENE and/CC early/JJ detection/NN of/IN risk/NN factors/NNS for/IN coronary/JJ heart/NN disease/NN ./.
@@40334025707 We/PRP conclude/VBP that/IN androgenic/JJ hormones/NNS reduce/VBP HDL-cholesterol/VBG concentrations/NNS and/CC the/DT HDL2-cholesterol/NNP subfraction/NN ,/, possibly/RB by/IN enhancing/JJ hepatic/NEWGENE triglyceride/NEWGENE lipase/NEWGENE activity/NN ./.
@@30675053781 Thus/RB ,/, prostacyclin/NN enhanced/VBD the/DT autoregulative/JJ property/NN of/IN the/DT inner/JJ ear/NN vessels/NNS ./.
@@74785235801 In/NN addition/NN to/IN the/DT nine/JJ and/CC 51/CD terminal/JJ amino/JJ acid/NN forms/NNS already/RB known/VBP ,/, we/PRP identified/VBD a/DT third/RB with/IN 43/CD terminal/JJ amino/JJ acids/NNS predicted/VBN to/IN encode/VB a/DT novel/JJ RET/NEWGENE protein/NEWGENE isoform/NEWGENE ./.
@@88102789417 Here/RB we/PRP demonstrate/VBP that/IN another/DT cellular/JJ protein/NN linked/JJ to/IN BCR/NEWGENE //NEWGENE ABL/NEWGENE through/RB the/DT CRKL-SH2/NEWGENE domain/NEWGENE is/VBZ p130/NEWGENE (/NEWGENE CAS/NEWGENE )/NEWGENE ./. p130/NEWGENE (/NEWGENE CAS/NEWGENE )/NEWGENE was/VBD found/VBN to/IN be/VB tyrosine/NN phosphorylated/VBN and/CC associated/VBN with/IN CRKL/NEWGENE in/IN BCR/NEWGENE //NEWGENE ABL/NEWGENE expressing/JJ cell/NN lines/NNS and/CC in/IN samples/NNS obtained/VBN from/IN CML/NN and/CC ALL/NN patients/NNS ,/, but/CC not/RB in/IN samples/NNS from/IN controls/NNS ./.
@@85206468490 Embryo/NN coculture/VB system/NN may/MD contribute/VB to/IN understand/VB the/DT mechanisms/NNS underlying/JJ the/DT decrease/NN of/IN fertility/NN with/IN aging/NN ./.
@@91682185645 METHODS/IN :/: The/DT responses/NNS of/IN a/DT 31-year-old/JJ woman/NN with/IN complex/NN regional/NN pain/NN syndrome/NN type/NN I/NN (/( reflex/NN sympathetic/JJ dystrophy/NN )/SYM to/IN a/DT thermal/JJ grill/NN were/VBD evaluated/VBN before/IN and/CC after/IN stellate/JJ ganglion/NN block/NN ./.
@@399921921 Ultrastructure/NNS of/IN the/DT tumor/NN in/IN 1/CD patient/NN in/IN whom/WP transurethral/JJ resection/NN was/VBD performed/VBN 2/CD weeks/NNS after/IN alum/NN irrigation/NN revealed/VBN well/VB preserved/VBN nuclear/NN chromatin/NN ,/, thus/RB ,/, suggesting/VBG that/IN whatever/WDT changes/NNS occur/VBP after/IN alum/NN irrigation/NN are/VBP short-lived/JJ ./.
@@80241398023 In/NN addition/NN ,/, we/PRP sought/VBP to/IN test/NN the/DT hypothesis/NN that/IN ,/, when/CC equal/VB volumes/NNS are/VBP administered/VBN intrathecally/RB ,/, significant/JJ differences/NNS exist/VBP in/IN the/DT potential/NN to/IN three/CD commonly/RB used/VBN anesthetic/JJ solutions/NNS to/IN induce/VB sensory/JJ impairment/NN ./.
@@87493948964 In/NN vitro/FW interaction/NN studies/NNS ,/, using/VBG proteins/NNS fused/VBN to/IN glutathione-S-transferase/NEWGENE ,/, showed/VBD that/IN RBP-J/NEWGENE kappa/NEWGENE and/CC Su/NEWGENE (/NEWGENE H/NEWGENE )/NEWGENE bind/VB directly/RB to/IN the/DT RAM23/NEWGENE regions/NEWGENE of/IN mouse/NEWGENE Notch1/NEWGENE and/CC Drosophila/NEWGENE Notch/NEWGENE ,/, respectively/RB ./.
@@79169833802 It/PRP is/VBZ concluded/VBN that/DT CT/NN should/MD be/VB routinely/RB employed/VBN in/IN patients/NNS with/IN N1-N3/NN neck/NN disease/NN to/IN determine/VB the/DT proper/JJ electron-energy/JJ prescription/NN ./.
@@64435506245 The/DT management/NN of/IN the/DT "chronic"/NN patient/NN ./.
@@16278285304 In/NN agreement/NN with/IN this/DT southern/JJ blotting/NN of/IN mouse/NN DNA/NN with/IN SmN/NEWGENE probes/NNS reveals/VBZ bands/NNS ,/, additional/JJ to/IN those/DT derived/VBN from/IN the/DT pseudogene/NN ,/, which/WDT are/VBP characteristic/NN of/IN an/DT intron-containing/NN SmN/NEWGENE gene/NEWGENE ./.
@@22470816748 Interestingly/RB ,/, disruption/NN of/IN the/DT VPS34/NEWGENE locus/NEWGENE resulted/VBN in/IN a/DT temperature-sensitive/JJ growth/NN defect/NN ,/, indicating/VBG that/IN the/DT VPS34/NEWGENE gene/NEWGENE is/VBZ essential/JJ for/IN vegetative/JJ growth/NN only/RB at/IN elevated/VBN growth/NN temperatures/NNS ./.
@@111564135422 Derivation/NNS and/CC initial/JJ characterization/NN of/IN a/DT mouse/NN mammary/JJ tumor/NN cell/NN line/NN carrying/JJ the/DT polyomavirus/NEWGENE middle/NEWGENE T/NEWGENE antigen/NEWGENE :/: utility/NN in/IN the/DT development/NN of/IN novel/JJ cancer/NN therapeutics/NN ./.
@@17178333294 Regulation/NN of/IN the/DT alpha/NEWGENE inhibin/NEWGENE gene/NEWGENE by/IN cyclic/JJ adenosine/NN 3'/CD ,/CD 5'-monophosphate/CD after/IN transfection/NN into/IN rat/NN granulosa/NN cells/NNS ./.
@@10962881786 Multiparity/NN had/VBP a/DT protective/JJ effect/NN with/IN 0/CD ./CD 66/CD less/PRP risk/NN (/( 95%/CD CI/NN 0/CD ./CD 44-0/CD ./CD 99/CD )/SYM ./.
@@98030819772 Renal/JJ pathology/NN and/CC long-term/JJ outcome/NN in/IN childhood/NN SLE/NN ./.
@@20160533736 Amino/NN acid/NN sequence/NN comparisons/NNS of/IN the/DT E74A/NEWGENE protein/NEWGENE reveal/VB a/DT highly/RB conserved/VBN C-terminal/NN region/NN that/WDT is/VBZ rich/JJ in/IN basic/JJ amino/JJ acid/NN residues/NNS and/CC which/WDT has/VBZ been/VBN proposed/VBN to/IN possess/VB sequence-specific/NN DNA/NN binding/JJ activity/NN ./.
@@50959885368 Conservative/NNP treatment/NN of/IN central/JJ nervous/JJ system/NN injuries/NNS ./.
@@2631566176 Alkoxymetgyl-3/NN ,/NN 4-dimethylpyridinium/NN chlorides/NNS were/VBD synthetized/VBN by/IN reacting/VBG 3/JJ ,/JJ 4-dimethylpyridine/JJ with/IN chloromethyl/JJ alkyl/NN ethers/NNS ,/, while/CC 1-ethyloxymethyl-3-alkylthiomethylimidazolium/JJ chlorides/NNS were/VBD obtained/VBN in/IN reactions/NNS of/IN 1-ethyloxymethylimidazol/JJ with/IN chloromethyl/JJ alkyl/NN sulfides/NNS ./.
@@90805179027 Thirty-five/CD patients/NNS were/VBD included/VBN ./.
@@176742439 Polyglactin/NN 910/NN suture/NN absorption/NN and/CC the/DT role/NN of/IN cellular/JJ enzymes/NNS ./.
@@86478027444 A/DT human/NN cytoplasmic/NN signaling/NN protein/NN has/VBZ been/VBN cloned/VBN that/WDT possesses/VBZ the/DT same/JJ structural/JJ arrangement/NN of/IN SH3-SH2-SH3/NEWGENE domains/NEWGENE as/IN Grb2/NEWGENE ./.
@@112218457507 The/DT Genescan/NNP program/NN predicted/VBD an/DT open/JJ reading/JJ frame/NN of/IN a/DT novel/NN ,/, intron-less/JJ gene/NN adjacent/JJ to/IN the/DT B236/NN spot/NN that/IN encodes/VBZ a/DT putative/JJ 493-amino/CD acid/NN protein/NN containing/JJ the/DT SNAG/NEWGENE repressor/NEWGENE motif/NEWGENE in/IN the/DT NH2-terminal/NN region/NN and/CC five/CD C2H2-type/NEWGENE zinc/NEWGENE finger/NEWGENE motifs/NEWGENE in/IN the/DT COOH-terminal/NN half/NN ./.
@@16572467850 The/DT transcription/NN initiation/NN site/NN was/VBD determined/VBN to/IN occur/VB 66/CD bp/NN upstream/RB of/IN the/DT initiating/JJ Met/NNP ./.
@@96210625086 The/DT importance/NN of/IN these/DT sites/NNS for/IN transcriptional/JJ activation/NN was/VBD studied/VBN by/IN site-directed/JJ mutagenesis/NN followed/VBN by/IN promoter/NN function/NN analysis/NN of/IN the/DT mutants/NNS with/IN a/DT chloramphenicol/NEWGENE acetyltransferase/NEWGENE reporter/NEWGENE system/NN ./.
@@78352734403 After/IN selection/NN and/CC conversion/NN to/IN adipocytes/NNS ,/, the/DT level/NN of/IN EGFR/NEWGENE expression/NN was/VBD retained/VBN in/IN infectant/JJ adipocytes/NNS (/( 150/CD ,/CD 000/CD and/CC 250/CD ,/CD 000/CD //CD cell/CD ,/, respectively/RB )/SYM ,/, but/CC not/RB in/IN the/DT parental/JJ 3T3-L1/CD adipocytes/NNS (/( </SYM 5000/NN //NN cell/NN )/SYM ./.
@@81941399435 CONCLUSIONS/IN :/: Serum/NEWGENE prolactin/NEWGENE concentrations/NNS show/VBP age/NN related/VBD variations/NNS in/IN presumably/RB fertile/JJ men/NNS ./.
@@83097268285 To/TO gain/VB further/JJ insight/NN into/IN the/DT pathogenesis/NN of/IN the/DT adult/JJ respiratory/JJ distress/NN syndrome/NN (/( ARDS/NNS )/SYM ,/, the/DT authors/NNS studied/VBD possible/JJ relationships/NNS among/IN the/DT activation/NN status/NN of/IN circulating/JJ polymorphonuclear/JJ neutrophils/NNS (/( PMN/NN )/SYM ,/, cytokine/NEWGENE levels/NNS ,/, and/CC the/DT severity/NN of/IN lung/NN injury/NN in/IN 31/CD patients/NNS :/: 15/CD with/IN ARDS/NNS ,/, 9/CD with/IN severe/JJ pneumonia/NN uncomplicated/JJ by/IN ARDS/NNS ,/, and/CC 7/CD mechanically/RB ventilated/VBN patients/NNS with/IN neither/DT ARDS/NNS nor/CC pneumonia/NN ./.
@@77907194978 There/EX is/VBZ a/DT national/JJ effort/NN to/IN begin/VB to/IN ask/VB all/DT female/JJ patients/NNS about/JJ family/NN violence/NN ./.
@@75996538279 In/NN addition/NN ,/, we/PRP found/VBP differences/NNS in/IN the/DT binding/NN of/IN nuclear/JJ factors/NNS from/IN shoots/NNS versus/IN from/IN roots/NNS ,/, in/IN agreement/NN with/IN the/DT different/JJ activities/NNS of/IN the/DT promoter/NN in/IN these/DT two/JJ organs/NNS ./.
@@58927125793 (/( 3/CD )/SYM ./.
@@13840407550 Interestingly/RB ,/, this/DT activation/NN occurred/VBN only/RB when/CC the/DT regions/NNS were/VBD cloned/VBN in/IN the/DT same/JJ relative/JJ orientation/NN in/IN which/WDT they/PRP exist/VBP on/IN wild-type/NN pCF10/NN ./.
@@17481942339 When/WRB both/DT lesions/NNS were/VBD complete/JJ lateral/JJ hemisections/NNS in/IN weanling/NN operates/VBZ ,/, little/JJ behavioral/JJ recovery/NN was/VBD observed/VBN ,/, similar/JJ to/IN complete/JJ spinal/JJ cord/NN transection/NN (/( N/JJ =/SYM 3/CD )/SYM ./SYM
@@15270206654 Exon-intron/NNP junctions/NNS in/IN the/DT human/NN and/CC rat/NEWGENE AdoMet/NEWGENE decarboxylase/NEWGENE genes/NEWGENE were/VBD in/IN identical/JJ positions/NNS except/VBP that/IN exons/NNS 6/CD and/CC 7/CD of/IN the/DT human/JJ gene/NN formed/VBD a/DT single/JJ exon/NN in/IN the/DT rat/NN gene/NN ./.
@@67559866519 Multiresistant/NNP strains/NNS isolated/VBN from/IN humans/NNS in/IN enteral/JJ toxico-infections/NNS kill/NN orally/RB infected/VBD mice/NNS more/RB frequently/RB than/IN strains/NNS isolated/VBN in/IN hospital/NN infections/NNS ./.
@@60128275871 Pharmacodynamic/NN studies/NNS on/IN the/DT cardiovascular/JJ system/NN of/IN spontaneously/RB hypertensive/JJ rats/NNS ./.
@@117144291557 Is/VBZ clopidogrel/NN superior/JJ to/IN aspirin/NN in/IN secondary/JJ prevention/NN of/IN vascular/JJ disease/NN ?/. The/DT cornerstone/NN in/IN clinical/JJ evidence/NN of/IN the/DT relative/JJ efficacy/NN of/IN thienopyridines/NNS (/( clopidogrel/NN ,/, ticlopidine/NN )/SYM versus/IN aspirin/NN in/IN the/DT secondary/JJ prevention/NN of/IN vascular/JJ disease/NN is/VBZ the/DT Clopidogrel/NNP versus/IN Aspirin/NNP in/IN Patients/NNS at/IN Risk/NN of/IN Ischaemic/NNP Events/NNS trial/NN ./.
@@94250369206 In/NN addition/NN ,/, a/DT catalytically/RB inactive/JJ version/NN of/IN the/PDT Src/NEWGENE family/NEWGENE member/NN ,/, Lck/NEWGENE (/( lymphoid/NEWGENE cell/NEWGENE kinase/NEWGENE )/SYM ,/, was/VBD expressed/VBN ,/, purified/VBN ,/, and/CC evaluated/VBD as/IN a/DT Csk/NEWGENE substrate/NN ./.
@@3004982984 The/DT N-terminal/NN sequence/NN of/IN one/PRP hydrophilic/JJ peptide/NN of/IN the/DT FeS/NEWGENE protein/NEWGENE has/VBZ been/VBN also/RB obtained/VBN confirming/VBG the/DT fbcF/NEWGENE reading/JJ frame/NN ./.
@@96984576525 The/DT mutant/JJ protein/NN is/VBZ present/VB at/IN levels/NNS slightly/RB greater/JJR than/IN wild-type/NN ,/, but/CC exhibits/VBP the/DT same/JJ tissue/NN distribution/NN as/IN wild-type/NN protein/NN ,/, and/CC has/VBZ approximately/RB normal/JJ affinity/NN for/IN known/VBP target/NN sequences/NNS (/( though/CC no/DT DNA/NN targets/NNS identified/VBN to/IN date/NN require/VB the/DT first/JJ cut/JJ repeat/NN for/IN binding/JJ )/SYM ./.
@@30168833999 13/CD men/NNS with/IN a/DT history/NN of/IN recurrent/JJ genital/JJ herpes/NN simplex/JJ virus/NN type/NN 2/CD (/( HSV-2/NN )/SYM infection/NN were/VBD followed/VBN daily/JJ for/IN 4/CD weeks/NNS with/IN samples/NNS taken/VBP from/IN the/DT urethra/NN for/IN virus/NN isolation/NN ./.
@@93807075841 Furthermore/RB ,/, DNA-bound/NNP LAZ3/NEWGENE //NEWGENE BCL6/NEWGENE recruits/NNS SMRT/NEWGENE in/IN vivo/NN ,/, and/CC both/DT overexpressed/VBN proteins/NNS completely/RB colocalize/VBP in/IN nuclear/JJ dots/NNS ./.
@@104912139240 Serum/NN concentrations/NNS of/IN bone/NEWGENE specific/NEWGENE alkaline/NEWGENE phosphatase/NEWGENE (/( BALP/NEWGENE )/SYM and/CC osteocalcin/NEWGENE (/( bone/NEWGENE Gla/NEWGENE protein/NEWGENE ,/, BGP/NEWGENE )/SYM ,/, urinary/JJ levels/NNS of/IN pyridinoline/NN (/( Pyr/NN )/SYM and/CC deoxypyridinoline/NN (/( Dpyr/NNP )/SYM and/CC computed/JJ tomography/NN (/( CT/NN )/SYM measurements/NNS of/IN the/DT cross-sectional/JJ areas/NNS of/IN the/DT vertebrae/NNS and/CC the/DT femurs/NNS ,/, the/DT apparent/JJ density/NN of/IN cancellous/JJ bone/NN in/IN the/DT vertebrae/NNS ,/, and/CC the/DT volume/NN and/CC the/DT material/NN density/NN of/IN cortical/JJ bone/NN in/IN the/DT femurs/NNS were/VBD determined/VBN in/IN 126/CD boys/NNS and/CC 143/CD girls/NNS ,/, ages/VBZ 7-18/JJ years/NNS ./.
@@6014013620 Such/JJ an/DT hemoglobin/NEWGENE solution/NN was/VBD shown/VBP to/IN exhibit/NN a/DT high/JJ affinity/NN for/IN oxygen/NN and/CC a/DT low/JJ Bohr/JJ effect/NN (/( assessed/VBN from/IN the/DT delta/JJ log/NN Po2/NN //NN delta/NN pH/NN ratio/NN )/SYM ./.
@@30210884118 The/DT latent/JJ periods/NNS from/IN the/DT antral/JJ exclusion/NN to/IN the/DT occurrence/NN of/IN anastomotic/JJ ulcers/NNS after/IN a/DT subtotal/JJ gastrectomy/NN with/IN Billroth's/NNP type/NN II/NN reconstruction/NN varied/VBN from/IN a/DT few/JJ days/NNS to/IN 19/CD years/NNS ,/, with/IN an/DT average/NN of/IN 2/CD ./CD 8/CD years/NNS ./.
@@86831085985 Consistent/JJ with/IN this/DT interpretation/NN ,/, recombinant/NEWGENE CREB/NEWGENE and/CC activating/NN transcription/NN factor/NN proteins/NN bound/VBD the/DT junB/NEWGENE CRE-like/NEWGENE1 site/NEWGENE1 ,/, but/CC did/VBD not/RB interact/VB with/IN a/DT mutant/NEWGENE CRE-like/NEWGENE site/NEWGENE ./.
@@77205723166 However/RB ,/, a/DT clear/JJ difference/NN exists/VBZ between/IN myoblasts/NNS and/CC 10T1/CD //CD 2/CD cells/NNS (/( and/CC other/DT non-muscle/JJ cell/NN types/NNS )/SYM in/IN the/DT chromatin/NN structure/NN of/IN the/DT chromosomal/NN myoD/NEWGENE core/NEWGENE enhancer/NEWGENE ,/, suggesting/VBG that/IN the/DT myoD/NEWGENE enhancer/NEWGENE is/VBZ repressed/VBN by/IN epigenetic/JJ mechanisms/NNS in/IN 10T1/CD //CD 2/CD cells/NNS ./.
@@60278416145 Nuclear/NNP spin/NN of/IN 249Bk/CD from/IN the/DT hyperfine/JJ structure/NN in/IN its/PRP emission/NN spectrum/NN ./.
@@100228807047 Mammalian/NEWGENE Ras/NEWGENE GTPase-activating/NEWGENE protein/NEWGENE (/( GAP/NEWGENE )/SYM ,/, p120/NEWGENE Ras-GAP/NEWGENE ,/, has/VBZ been/VBN implicated/VBN as/IN both/PDT a/DT downregulator/NN and/CC effector/NN of/IN Ras/NEWGENE proteins/NEWGENE ,/, but/CC its/PRP precise/JJ role/NN in/IN Ras-mediated/JJ signal/JJ transduction/NN pathways/NNS is/VBZ unclear/JJ ./.
@@118881831784 A/DT further/JJ analysis/NN has/VBZ been/VBN performed/VBN using/VBG the/DT series/NN of/IN maximum/JJ intensity/NN for/IN fixed/JJ duration/NN (/( 1/CD ,/, 3/CD ,/, 6/CD ,/, 12/CD ,/, 24/CD hrs/NN )/SYM and/CC annual/JJ daily/JJ maxima/NNS ./.
@@108912662979 ACE-2/NEWGENE has/VBZ a/DT hydrophobic/NN C/NN terminus/NN of/IN H/NN type/NN ./.
@@103642021995 The/DT coexpression/NN of/IN full-length/JJ expression/NN constructs/NNS for/IN both/DT DBP/NEWGENE and/CC hepatic/NEWGENE leukemia/NEWGENE factor/NEWGENE resulted/VBN in/IN a/DT dramatic/JJ increase/NN in/IN activation/NN mediated/JJ by/IN the/DT GAL4-DBP/NEWGENE fusion/NEWGENE proteins/NEWGENE ,/, suggesting/VBG the/DT involvement/NN of/IN a/DT regulated/NN coactivator/NN in/IN this/DT process/NN ./.
@@107216985500 These/DT data/NN indicate/VB that/DT expansion/NN of/IN the/DT dodecamer/NN repeat/NN located/VBN in/IN the/DT proximal/JJ promoter/NN of/IN CSTB/NEWGENE severely/RB disrupts/VBZ the/DT function/NN of/IN the/DT promoter/NN and/CC thereby/RB reduces/VBZ transcription/NN of/IN CSTB/NEWGENE ./.
@@8183805747 Rheumatoid/NEWGENE factor/NEWGENE and/CC antinuclear/JJ antibody/NN tests/NNS were/VBD frequently/RB positive/JJ ,/, and/CC reactions/NNS to/IN gold/NN therapy/NN were/VBD more/RB frequent/VB than/IN in/IN other/DT rheumatoid/JJ populations/NNS ./.
@@94070319838 Moreover/RB ,/, moderate/JJ overexpression/NN of/IN Chk1/NEWGENE suppresses/VBZ the/DT phenotypes/NNS of/IN cut5/NEWGENE and/CC crb2/NEWGENE mutants/NEWGENE ./.
@@95625581187 Solution/NNP structure/NN of/IN the/DT IRF-2/NEWGENE DNA-binding/NEWGENE domain/NN :/: a/DT novel/JJ subgroup/NN of/IN the/DT winged/NEWGENE helix-turn-helix/NEWGENE family/NEWGENE ./.
@@108012448179 Vancomycin/NN data/NN were/VBD analyzed/VBN according/VBG to/IN a/DT one-compartment/JJ open/JJ model/NN with/IN use/NN of/IN NONMEM/DT population/NN pharmacokinetic/JJ software/NN ./.
@@8245125224 Addition/NN of/IN phalloidin-stabilized/JJ F-actin/NEWGENE nuclei/NNS and/CC phalloidin/NN restored/VBN L266D/NNP actin's/NNS ability/NN to/IN polymerize/VB at/IN 4/CD degrees/NNS C/NNP ./NNP
@@111223812167 Addition/NN of/IN synthetic/JJ tyrosine-phosphorylated/JJ peptides/NNS derived/VBN from/IN betac/JJ cytoplasmic/JJ tyrosines/NNS prior/NN to/IN GM-CSF/NEWGENE stimulation/NN inhibited/VBD the/DT in/NN vitro/FW activation/NN of/IN STAT5/NEWGENE ./.
@@115455947610 Thus/RB ,/, while/CC the/DT folds/NNS of/IN all/DT Myb/NEWGENE domains/NEWGENE resemble/VBP each/DT other/DT closely/RB ,/, the/DT function/NN of/IN each/DT Myb/NEWGENE domain/NEWGENE depends/VBZ on/IN the/DT amino/JJ acid/NN residues/NNS that/WDT are/VBP located/VBN on/IN the/DT surface/NN of/IN each/DT protein/NN ./.
@@22374314584 The/DT Ets-1/NEWGENE binding/NEWGENE site/NEWGENE was/VBD localized/VBN to/IN a/DT 17-base/JJ pair/NN (/( bp/NN )/SYM region/NN from/IN the/DT 3'/CD end/NN of/IN T/NEWGENE alpha/NEWGENE 2/NEWGENE ./.
@@97904999732 Northern/NNP blot/NN analyses/NNS show/VBP that/IN the/DT hBub1/NEWGENE mRNA/NEWGENE level/NN is/VBZ abundantly/RB expressed/VBN in/IN tissues/NNS or/CC cells/NNS with/IN a/DT high/JJ mitotic/JJ index/NN ./.
@@105942398883 A/DT novel/JJ pleckstrin/NEWGENE homology-related/NEWGENE gene/NEWGENE family/NEWGENE defined/VBN by/IN Ipl/NEWGENE //NEWGENE Tssc3/NEWGENE ,/, TDAG51/NEWGENE ,/, and/CC Tih1/NEWGENE :/: tissue-specific/JJ expression/NN ,/, chromosomal/JJ location/NN ,/, and/CC parental/JJ imprinting/NN ./.
@@10607900386 Sak/NEWGENE kinase/NEWGENE gene/NN structure/NN and/CC transcriptional/JJ regulation/NN ./.
@@30291115021 Two/CD mutants/NNS ,/, each/DT representative/NN of/IN a/DT separate/JJ pet/NN complementation/NN group/NN ,/, have/VB been/VBN analyzed/VBN ./.
@@23947188670 The/DT cloned/VBN genes/NNS were/VBD identified/VBN in/IN genetic/JJ libraries/NNS by/IN hybridization/NN screening/JJ using/VBG four/CD deoxyoligonucleotide/NN probes/NNS which/WDT corresponded/VBD to/IN the/DT partial/JJ amino/JJ acid/NN sequence/NN of/IN the/DT purified/VBN enzyme/NN ./.
@@11097040930 The/DT objectives/NNS of/IN the/DT present/NN study/NN were/VBD to/IN evaluate/VB the/DT effects/NNS of/IN adding/JJ Equex/NN to/IN a/DT TRIS-extender/NNP ,/, diluting/JJ the/DT semen/NN in/IN 1/CD or/CC 2/CD steps/NNS ,/, freezing/NN according/VBG to/IN 2/CD methods/NNS ,/, thawing/NN at/IN 2/CD rates/NNS ,/, and/CC the/DT interactions/NNS between/IN these/DT treatments/NNS ,/, on/IN the/DT post-thaw/NN survival/NN of/IN dog/NN spermatozoa/NNS at/IN 38/CD degrees/NNS C/NNP ./NNP
@@86692741088 Stylohyoid/NN chain/NN ossification/NN :/: choice/NN of/IN the/DT surgical/JJ approach/NN ./.
@@84545919116 The/DT region/NN that/WDT imparts/VBZ inducibility/NN by/IN IL-1/NEWGENE or/CC TNF/NEWGENE (/( positions/NNS -165/CD to/IN -58/NN )/SYM contains/VBZ potential/JJ binding/JJ sites/NNS for/IN IRF-1/NEWGENE and/NEWGENE -2/NEWGENE ,/, AP-1/NEWGENE ,/, and/CC NF-IL-6/NEWGENE ./.
@@90582505037 To/TO avoid/VB complications/NNS ,/, accurate/JJ quantitative/JJ analysis/NN of/IN NO/DT and/CC NO2/NN is/VBZ necessary/JJ during/IN this/DT therapy/NN ./.
@@96455769614 RNA/NN of/IN GBV-C/NN was/VBD detected/VBN in/IN 14/CD (/( 18%/JJ )/SYM patients/NNS before/IN BMT/NN ./.
@@102233385865 In/NN addition/NN ,/, we/PRP also/RB constructed/VBD and/CC expressed/VBN chimeric/JJ fusion/NN protein/NN that/WDT contains/VBZ HIV-2/NEWGENE gag/NEWGENE with/IN V3/NEWGENE domains/NEWGENE of/IN HIV-1IIIB/NN ,/, HIV-1MN/NN ,/, HIV-1SF2/NN and/CC HIV-1RF/NN ./.
@@87507029801 Study/NNP groups/NNS were/VBD control/NN ,/, and/CC those/DT treated/VBN with/IN the/DT alpha1-adrenoceptor-subtype/NEWGENE blockers/NNS WB4101/NN (/( 0/CD ./CD 5/CD mg/CD //CD kg/CD i/CD ./CD v/CD ./CD )/SYM or/CC chloroethylclonidine/NN (/( 1/CD ./CD 9/CD mg/CD //CD kg/CD i/CD ./CD v/CD ./CD )/SYM ./.
@@75047126895 These/DT observations/NNS link/NN actin/NEWGENE plaque/NN assembly/NN to/IN increased/VBN cell/NN substrate/NN adhesion/NN ./.
@@79571067696 These/DT mutations/NNS are/VBP localized/VBN in/IN the/DT same/JJ region/NN where/CC the/DT HSV/NEWGENE transactivator/NEWGENE VP16/NEWGENE binds/VBZ ,/, but/CC did/VBD not/RB coincide/VB with/IN the/DT VP16/NEWGENE contacts/NNS ./.
@@64528273249 Statokinesimetric/NN recording/JJ in/IN Huntington/NN choreas/NNS ./.
@@61651329881 An/DT experiment/NN was/VBD carried/VBN on/IN 133/CD grown/VBP up/JJ fowls/NNS and/CC broilers/NNS from/IN 4/CD industrial/JJ farms/NNS ,/, vaccinated/VBN with/IN spray/NN lento/NN and/CC mesogenic/JJ vaccines/NNS for/IN straining/JJ the/DT immunity/NN against/IN pseodopest/JJS through/RB RIHA/NN and/CC provoking/JJ pseudoplague/NN with/IN a/DT pathogenic/JJ virus/NN ./.
@@110500844314 This/DT -2485/JJ //JJ -2458/JJ element/NN bound/JJ PPARalpha/NEWGENE and/CC PPARgamma/NEWGENE from/IN brown/JJ fat/JJ nuclei/NNS ./.
@@67406976506 The/DT results/NNS showed/VBN that/IN the/DT sensitivity/NN of/IN the/DT 3/CD given/NN guinea/NN pig/NN strains/NNS was/VBD comparable/JJ ./.
@@84032458365 Plasma/NEWGENE thromboxane/NEWGENE B2/NEWGENE levels/NNS in/IN the/DT older/JJR group/NN were/VBD about/RB double/VB those/DT in/NN younger/JJR piglets/NNS ./.
@@86764958964 However/RB ,/, one/PRP 3'/CD splice/NN site/NN ,/, located/VBN at/IN nucleotide/NN (/( nt/NN )/SYM 3225/CD ,/, is/VBZ used/VBN for/IN the/DT processing/NN of/IN most/RB BPV-1/NN pre-mRNAs/NN in/IN BPV-1-transformed/NNP C127/NNP cells/NNS and/CC at/IN early/RB to/IN intermediate/JJ times/NNS in/IN productively/RB infected/VBN warts/NNS ./.
@@43871034954 Particles/NNS resembling/VBG microbodies/NNS in/IN normal/JJ and/CC neoplastic/JJ perianal/JJ glands/NNS of/IN dogs/NNS ./.
@@10564495337 In/NN addition/NN ,/, all/DT three/CD Opa/NEWGENE proteins/NEWGENE of/IN C751/NN bind/NN equally/RB well/VB to/IN HeLa/DT cells/NNS transfected/VBN with/IN cDNA/NN encoding/VBG the/DT carcinoembryonic/NEWGENE antigen/NEWGENE [/NEWGENE CEA/NEWGENE (/NEWGENE CD66e/NEWGENE )/NEWGENE ]/NEWGENE subgroup/NN of/IN the/DT CD66/NEWGENE family/NEWGENE ,/, but/CC show/VB distinct/JJ tropism/NN for/IN CGM1-/NNP (/( CD66d/NEWGENE )/SYM and/CC NCA/NEWGENE (/( CD66c/NEWGENE )/NN -expressing/NN cells/NNS ./.
@@26344901694 The/DT differential/JJ diagnosis/NN of/IN both/DT affections/NNS is/VBZ based/VBN on/IN the/DT clinical/JJ course/NN ,/, sialography/NN and/CC CT/NN examination/NN which/WDT along/IN with/IN modern/JJ ATB/NN treatment/NN significantly/RB modify/VB hitherto/RB used/VBN surgical/JJ therapy/NN ./.
@@78184167797 The/DT pre-/JJ and/CC postoperative/JJ haemoglobin/NEWGENE concentrations/NNS in/IN the/DT autologous/JJ group/NN were/VBD lower/JJR by/IN 15/CD and/CC 10/CD g/NN //NN L/NN ,/, respectively/RB ,/, after/IN primary/NN THR/NN and/CC by/IN 10/CD g/NN //NN L/NN in/IN both/DT instances/NNS after/IN revision/NN THR/NNP ./.
@@95841804497 The/DT same/JJ IL-4-inducible/NNP reporter/NN gene/NN is/VBZ also/RB synergistically/RB activated/VBN by/IN the/DT endogenous/NEWGENE Stat6/NEWGENE and/CC NF-kappaB/NEWGENE proteins/NEWGENE in/IN IL-4-stimulated/JJ I/CD ./CD 29mu/CD B/NNP lymphoma/NN cells/NNS ./.
@@9952378966 The/DT odds/NNS ratio/NN for/IN CHD/NN was/VBD 1/CD ./CD 21/CD (/( 95%/CD confidence/NN interval/NN ,/, 0/CD ./CD 84-1/CD ./CD 75/CD )/SYM given/VBP a/DT positive/JJ serostatus/NN of/IN specific/NN IgG/NEWGENE antibodies/NNS after/IN adjustment/NN for/IN covariates/NNS ./.
@@108556908881 Taken/VBN together/RB ,/, these/DT results/NNS indicate/VBP that/DT MAP/NEWGENE kinase/NEWGENE stimulates/VBZ the/DT hPL-B/NEWGENE enhancer/NEWGENE by/IN an/DT NF-IL-6-dependent/NNP pathway/NN ./.
@@104280913299 This/DT report/NN presents/VBP state-specific/NN MMRs/NN for/IN 1987-1996/CD ,/, focusing/NN on/IN persistent/JJ disparities/NNS in/IN maternal/JJ mortality/NN between/IN black/JJ and/CC white/JJ women/NNS ./.
@@75886039682 The/DT results/NNS indicate/VBP considerable/JJ flexibility/NN in/IN the/DT spacing/NN between/IN DH/NN regulatory/NN sites/NN ./.
@@118706461761 The/DT utility/NN of/IN such/JJ analyses/NNS in/IN the/DT design/NN of/IN ceramic/JJ //JJ substrate/JJ bilayer/JJ systems/NNS for/IN optimal/JJ resistance/NN to/IN lifetime-threatening/JJ damage/NN is/VBZ discussed/VBN ./.
@@2231479247 Each/DT parent/NN interacted/VBN with/IN their/PRP 4-/CD or/CC 5-year-old/CD son/NN or/CC daughter/JJ in/IN each/DT of/IN two/JJ conversations--unstructured/JJ (/( social/JJ conversation/NN )/SYM and/CC structured/JJ (/( task/NN activity/NN )/SYM ./.
@@76665237147 Investigation/NNP of/IN the/DT control/NN of/IN coronavirus/NN subgenomic/JJ mRNA/NN transcription/NN by/IN using/VBG T7-generated/JJ negative-sense/JJ RNA/NN transcripts/NNS ./.
@@21851403255 The/DT Saccharomyces/NEWGENE cerevisiae/NEWGENE 14DM/NEWGENE gene/NEWGENE ,/, encoding/VBG cytochrome/NEWGENE P450/NEWGENE lanosterol/NEWGENE 14/NEWGENE alpha-demethylase/NEWGENE (/( 14DM/NEWGENE )/SYM ,/, was/VBD overexpressed/VBN in/IN various/JJ S/NNP ./NNP cerevisiae/NN strains/NNS under/IN the/DT control/NN of/IN three/CD strong/JJ heterologous/JJ yeast/NN transcription/NN promoters/NNS (/( pADC1/NEWGENE ,/, pGPD/NEWGENE ,/, pPHO5/NEWGENE )/SYM and/CC under/IN the/DT control/NN of/IN its/PRP own/VB promoter/NN ./.
@@106287506658 Previously/RB ,/, we/PRP showed/VBD that/IN the/DT APRE/NEWGENE is/VBZ a/DT cytokine/NN [/NN tumor/NEWGENE necrosis/NEWGENE factor-alpha/NEWGENE (/( TNFalpha/NEWGENE )/JJ ]/JJ -/JJ inducible/NN enhancer/NN by/IN binding/JJ the/DT heterodimeric/NEWGENE nuclear/NEWGENE factor-kappaB/NEWGENE (/( NF-kappaB/NEWGENE )/SYM complex/NN Rel/NEWGENE1 A/NEWGENE1 x/NN NF-kappaB1/NEWGENE ./.
@@17678996047 Marked/JJ thrombocytopenia/NN ,/, depletion/NN of/IN serum/NEWGENE fibrinogen/NEWGENE and/CC prolonged/JJ prothrombin/NEWGENE and/CC activated/VBN partial/JJ thromboplastin/NEWGENE time/NN ,/, were/VBD recorded/VBN at/IN 5/CD to/IN 10/CD and/CC 30/CD to/IN 40/CD minutes/NNS after/IN intravenous/JJ envenomation/NN ./.
@@82238233763 Stroop/NN interference/NN :/: aging/NN effects/NNS assessed/VBN with/IN the/DT Stroop/NN Color-Word/NNP Test/NNP ./.
@@111503154463 A/DT novel/JJ approach/NN was/VBD developed/VBN for/IN identifying/JJ transcription/NN factor/NN activities/NNS associated/VBN with/IN NGF-activated/JJ ,/, but/CC not/RB EGF-activated/JJ ,/, signaling/JJ ,/, using/VBG random/JJ oligonucleotide/NN clones/NNS from/IN a/DT DNA/NN recognition/NN library/NN to/IN isolate/NN specific/NN DNA/NN binding/NN proteins/NN from/IN PC12/NN nuclear/JJ extracts/NNS ./.
@@88040127530 The/DT partial/JJ categories/NNS of/IN the/DT SIP/NN that/WDT were/VBD more/RB affected/VBN were/VBD work/NN ,/, recreation/NN and/CC pastimes/NNS ,/, home/JJ management/NN ,/, and/CC sleep/NN and/CC rest/NN ./.
@@349354182 Patients/NNS with/IN Parkinson's/NNP disease/NN showed/VBD a/DT relatively/JJ high/JJ incidence/NN to/IN psychoses/NNS during/IN drug/NN treatment/NN (/( 51/CD ./CD 47%/CD )/SYM ./.
@@107067362097 Thus/RB ,/, patients/NNS with/IN metastatic/JJ melanoma/NN are/VBP not/RB tolerant/JJ to/IN gp100/NEWGENE Ag/NEWGENE based/VBN on/IN the/DT detection/NN of/IN CD8+/NEWGENE T/NN cells/NNS specific/JJ for/IN multiple/JJ HLA-A*0201-restricted/NN ,/, gp100-derived/JJ epitopes/NNS ./.
@@20119242622 Despite/IN the/DT small/JJ number/NN of/IN patients/NNS ,/, on/IN the/DT basis/NN of/IN this/DT report/NN ,/, we/PRP can/MD confirm/VB that/IN 1/CD ./CD 5/CD MU/NNS //NNS day/NNS of/IN alpha-IFN/NEWGENE is/VBZ an/DT adequate/JJ treatment/NN for/IN patients/NNS with/IN hairy/JJ cell/NN leukemia/NN ./.
@@37131874390 Overall/RB ,/, lesions/NNS infiltrating/JJ the/DT deep/JJ lamina/NN propria/NN do/NN not/RB exhibit/VB a/DT reduced/VBN frequency/NN of/IN occurrence/NN compared/VBN to/IN lesions/NNS infiltrating/JJ the/DT skeletal/JJ muscle/NN ;/: however/RB ,/, carcinomas/NNS affecting/VBG other/DT oral/JJ sites/NNS showed/VBD a/DT reduced/VBN frequency/NN of/IN deeply/RB infiltrating/JJ lesions/NNS in/IN comparison/NN to/IN more/RB superficial/JJ lesions/NNS ./.
@@76245818290 All/DT subjects/NNS were/VBD submitted/VBN to/IN ECG/NN and/CC arterial/JJ blood/NN pressure/NN determination/NN and/CC were/VBD assayed/VBN for/IN TSH/NEWGENE ,/, thyroid/JJ hormone/NN ,/, PRL/NEWGENE ,/, glucose/NN ,/, creatinine/NN ,/, nitrogen/NN ,/, glutamine/NEWGENE transaminase/NEWGENE ,/, cholesterol/NN and/CC triglycerides/NNS plasma/NN levels/NNS before/IN therapy/NN (/( T0/NN )/SYM ,/, after/IN 30/CD treatment/NN days/NNS (/( T30/NN )/SYM and/CC after/IN a/DT 15/CD days/NNS washout/NN (/( T45/NN )/SYM ./.
@@37206154394 This/DT may/MD explain/VB in/IN part/NN a/DT secular/JJ trend/NN towards/IN reduced/VBN birthweight/NN for/IN gestation/NN in/IN preterm/JJ infants/NNS ./.
@@111570355756 The/DT utilities/NNS measured/VBN in/IN our/PRP study/NN can/MD be/VB applied/VBN directly/RB to/IN quality-of-life/NN determinations/NNS in/IN clinical/JJ trials/NNS of/IN adjuvant/JJ IFN/NEWGENE alpha-2b/NEWGENE to/IN measure/NN the/DT net/JJ benefit/NN of/IN therapy/NN ./.
@@57799535719 Effect/NN of/IN castration/NN on/IN pituitary/NEWGENE and/NEWGENE serum/NEWGENE LH/NEWGENE and/CC FSH/NEWGENE in/IN testosterone-sterilized/JJ rats/NNS ./.
@@29412374153 In/NN the/DT former/JJ instance/NN ,/, in/IN addition/NN to/IN serum/JJ calcium/NN and/CC phosphorous/JJ ion/NN concentrations/NNS ,/, tissue/NN pH/NN ,/, blood/NN supply/NN ,/, hormones/NNS ,/, i/FW ./FW e/FW ./FW ,/, vitamin/NN D/NN ,/, vitamin/NN A/DT ,/, and/CC various/JJ enzymes/NNS (/( e/FW ./FW g/FW ./FW ,/, alkaline/NEWGENE phosphatase/NEWGENE and/CC pyrophosphatase/NEWGENE )/SYM may/MD all/DT play/NN significant/JJ ,/, ancillary/JJ ,/, time-dependent/NN ,/, but/CC as/IN yet/RB undetermined/JJ roles/NNS ./.
@@97873231689 PURPOSE/NNS :/: The/DT role/NN interleukin-6/NEWGENE (/( IL-6/NEWGENE )/SYM in/IN the/DT treatment/NN of/IN congenital/JJ thrombocytopenias/NNS is/VBZ unknown/JJ ./.
@@14600545256 Truncated/NEWGENE ICSBP/NEWGENE lacking/JJ the/DT first/JJ 33/CD amino-terminal/JJ amino/JJ acids/NNS fails/VBZ to/IN bind/NN to/IN the/DT ICS/NNP ,/, indicating/VBG that/IN at/IN least/JJ part/NN of/IN the/DT DNA/NN binding/JJ domain/NN is/VBZ located/VBN within/IN the/DT well/NN conserved/VBN amino/JJ terminus/NN ./.
@@79291654737 DNA/NN sequence/NN and/CC functions/NNS of/IN the/DT actVI/NEWGENE region/NEWGENE of/IN the/DT actinorhodin/NEWGENE biosynthetic/NEWGENE gene/NEWGENE cluster/NEWGENE of/NEWGENE Streptomyces/NEWGENE coelicolor/NEWGENE A3/NEWGENE (/NEWGENE 2/NEWGENE )/NEWGENE ./.
@@68649556235 Leads/VBZ from/IN the/DT MMWR/NN ./.
@@114840281367 At/NN cross/NN purposes/NNS ./.
@@111272008421 Using/VBG a/DT natural/JJ dominant/JJ negative/NN for/IN AP-1/NEWGENE transcriptional/JJ activity/NN in/IN ROS/NN 17/CD //CD 2/CD ./CD 8/CD cells/NNS ,/, we/PRP then/RB showed/VBD that/IN AP-1/NEWGENE transcription/NEWGENE factors/NEWGENE mediated/JJ TGF-beta1-/NNP and/CC BMP-2-regulated/JJ expression/NN of/IN the/DT (/NEWGENE alpha1/NEWGENE )/NEWGENE collagen/NEWGENE I/NEWGENE gene/NEWGENE as/RB well/VB as/IN TGF-beta1-regulated/JJ expression/NN of/IN the/DT parathyroid/NEWGENE hormone/NEWGENE (/NEWGENE PTH/NEWGENE )/NEWGENE //NEWGENE PTH-related/NEWGENE peptide/NEWGENE (/NEWGENE PTHrP/NEWGENE )/NEWGENE receptor/NEWGENE ./.
@@107717099007 The/DT physicians/NNS in/IN charge/NN of/IN all/DT patients/NNS with/IN evidence/NN of/IN acute/NN Q/NN fever/NN (/( seroconversion/NN and/DT //DT or/DT presence/NN of/IN IgM/NEWGENE )/SYM or/CC chronic/JJ Q/JJ fever/NN (/( prolonged/JJ disease/NN and/DT //DT or/DT IgG/NEWGENE antibody/NEWGENE titer/NN to/IN phase/NN I/PRP of/IN Coxiella/NN burnetii/NN >/SYM or/CC =/SYM 800/CD )/SYM were/VBD asked/VBN to/IN complete/VB a/DT questionnaire/NN ,/, which/WDT was/VBD computerized/JJ ./.
@@106299387891 Furthermore/RB ,/, the/DT wide/JJ distribution/NN of/IN the/DT GFP-POLO/NEWGENE protein/NEWGENE to/IN all/DT compartments/NNS of/IN the/DT mitotic/JJ apparatus/NN provides/VBZ a/DT valuable/NN tool/NN for/IN future/JJ studies/NNS on/IN cell/NN cycle/NN during/IN development/NN ./.
@@27082883378 Liquid/NNP chromatography/NN with/IN amperometric/JJ detection/NN (/( LC/NN //NN AD/NN )/SYM is/VBZ used/VBN to/IN determine/VB fluazifop/NN acid/NN produced/VBN from/IN the/DT metabolism/NN or/CC base/NN hydrolysis/NN of/IN fluazifop-butyl/JJ in/IN soybeans/NNS and/CC soybean/NN oil/NN ./.
@@10820829621 Flavonoids/NNS from/IN Brosimum/NNP acutifolium/NN ./.
@@10940562136 Sequence/NN analysis/NN reveals/VBZ that/IN the/DT newly/RB discovered/VBN oasA2/NEWGENE gene/NEWGENE represents/VBZ a/DT pseudogene/NN that/WDT is/VBZ still/RB transcribed/VBN ,/, but/CC is/VBZ not/RB functionally/RB translated/VBN ./.
@@93665179374 Our/PRP findings/NNS provide/VBP the/DT first/JJ evidence/NN that/IN the/DT function/NN of/IN WT1/NEWGENE can/MD be/VB modulated/VBN by/IN its/PRP phosphorylation/NN in/IN vivo/NN ./.
@@82249074999 Genomic/NNP Southern/NNP blot/NN analysis/NN of/IN rat/NEWGENE EFIA/NEWGENE (/( gene/NN encoding/VBG enhancer/NEWGENE factor/NEWGENE I/NEWGENE subunit/NEWGENE A/NEWGENE )/SYM reveals/VBZ a/DT complex/NN band/NN pattern/NN when/CC cDNA/NN subfragment/NN probes/NNS are/VBP used/VBN ./.
@@6165759868 To/TO study/VB the/DT sensitivity/NN of/IN some/DT central/JJ brain/NN structures/NNS to/IN the/DT action/NN of/IN an/DT electromagnetic/JJ field/NN of/IN decimeter/NN waves/NNS (/( EMF/NN of/IN DW/JJ )/SYM a/DT dynamic/JJ investigation/NN of/IN single/JJ unit/NN activity/NN was/VBD undertaken/VBP ./.
@@15636358228 Overproduction/NNS ,/, purification/NN and/CC characterization/NN of/IN M/NEWGENE ./NEWGENE HinfI/NEWGENE methyltransferase/NEWGENE and/CC its/PRP deletion/NN mutant/JJ ./.
@@10705783523 In/NN all/PDT other/DT cases/NNS ,/, vestibular/JJ neurectomy/NN or/CC chemical/JJ vestibular/JJ labyrinthectomy/NN ,/, by/IN means/NN of/IN intratympanic/JJ low/JJ concentration/NN gentamicin/NN (/( 20/CD mg/NN //NN mL/NN )/SYM ,/, are/VBP indicated/VBN ./.
@@78593019206 This/DT region/NN constitutes/VBZ the/DT DNA-binding/NN domain/NN with/IN basic-helix-loop-helix/JJ and/CC leucine-zipper/NN motifs/NN ,/, features/NNS common/JJ to/IN the/DT myc-related/NEWGENE transcription/NEWGENE factor/NEWGENE family/NEWGENE ./.
@@92713975214 Consistent/JJ with/IN this/DT model/NN ,/, a/DT synthetic/JJ construct/NN containing/JJ three/CD tandem/NN copies/NNS of/IN the/DT native/JJ LDL/NEWGENE receptor/NEWGENE SREBP/NEWGENE1 site/NN linked/JJ to/IN a/DT single/NN Sp1/NEWGENE site/NEWGENE was/VBD also/RB significantly/RB activated/VBN in/IN a/DT buttonhead-independent/JJ fashion/NN ./.
@@3584426927 Heat-labile-like/NN enterotoxin/NEWGENE (/( LT/NEWGENE )/SYM was/VBD produced/VBN by/IN 26/CD of/IN 42/CD stool/NN isolates/NNS (/( 62%/JJ )/SYM ,/, while/CC only/RB 1/CD of/IN the/DT 42/CD isolates/NNS (/( 2%/JJ )/SYM produced/VBN enterotoxinlike/NN activity/NN in/IN suckling/JJ mice/NNS ;/: 65%/NN of/IN the/DT cytotoxin-producing/JJ strains/NNS also/RB produced/VBN an/DT LT-like/NNP material/NN ./.
@@115545661429 The/DT hatcher/NN incubators/NNS of/IN both/DT companies/NNS were/VBD also/RB persistently/RB contaminated/VBN with/IN Salmonella/NN livingstone/NN and/CC Salmonella/NN thomasville/NN in/IN company/NN A/DT and/CC with/IN Salmonella/NN senftenberg/NN in/IN company/NN B/NNP ./NNP
@@8663120735 Oncogenic/NEWGENE Raf-1/NEWGENE activates/VBZ p70/NEWGENE S6/NEWGENE kinase/NEWGENE via/NN a/DT mitogen-activated/NN protein/NN kinase-independent/JJ pathway/NN ./.
@@80643518048 Long-latency/NNP :/: locked/VBN units/NNS responded/VBN to/IN shocks/NNS with/IN little/JJ jitter/NN and/CC long/JJ latency/NN (/( 4-11/CD ms/NN )/SYM ./.
@@76291039148 CCAAT/NEWGENE //NEWGENE enhancer-binding/NEWGENE protein/NEWGENE isoforms/NEWGENE beta/NEWGENE and/NEWGENE delta/NEWGENE are/VBP expressed/VBN in/IN mammary/JJ epithelial/JJ cells/NNS and/CC bind/VB to/IN multiple/JJ sites/NNS in/IN the/DT beta-casein/NEWGENE gene/NEWGENE promoter/NEWGENE ./.
@@94275444751 The/DT pel/NEWGENE gene/NEWGENE from/IN an/DT Amycolata/NNP sp/NN ./NN encoding/VBG a/DT pectate/NEWGENE lyase/NEWGENE (/( EC/NEWGENE 4/NEWGENE ./NEWGENE 2/NEWGENE ./NEWGENE 2/NEWGENE ./NEWGENE 2/NEWGENE )/SYM was/VBD isolated/VBN by/IN activity/NN screening/JJ a/DT genomic/JJ DNA/NN library/NN in/IN Streptomyces/NN lividans/VBZ TK24/DT ./.
@@100656844057 On/IN the/PDT other/DT hand/NN ,/, subjects/VBZ with/IN air/NN trapping/JJ (/( residual/JJ volume/NN (/( RV/NN )/NN //NN total/NN lung/NN capacity/NN (/( TLC/NN )/SYM >/SYM 37%/NN )/NN disclosed/VBN not/RB only/RB a/DT higher/JJ n/NN (/NN mit/NN )/NN (/( 0/CD ./CD 63+/CD //CD -0/CD ./CD 17/CD versus/IN 0/CD ./CD 43+/CD //CD -0/CD ./CD 07/CD mt/NN x/NN microm/NN (/NN -2/NN )/SYM ,/, p/NN </NN 0/NN ./NN 05/NN )/NN but/CC shorter/JJR sarcomeres/NNS (/( L/NN (/NN sar/NN )/NN )/NN than/IN subjects/NNS without/IN this/DT functional/JJ abnormality/NN (/( 2/NN ./NN 08+/NN //NN -0/NN ./NN 16/NN to/IN 2/CD ./CD 27+/CD //CD -0/CD ./CD 15/CD microm/NN ,/, p/NN </NN 0/NN ./NN 05/NN )/SYM ./.
@@88124905401 The/DT high/JJ sequence/NN homology/NN ,/, similar/JJ genomic/JJ structure/NN ,/, and/CC identical/JJ chromosomal/JJ loci/NNS of/IN hKID/NEWGENE ,/, MIP/NEWGENE ,/, and/CC AQP-2/NEWGENE suggest/VB a/DT MIP/NEWGENE family/NEWGENE gene/NEWGENE cluster/NEWGENE at/IN chromosome/NN locus/NN 12q13/CD ./.
@@103756405917 As/IN is/VBZ deduced/VBN from/IN the/DT nucleotide/NN sequence/NN of/IN the/DT cDNA/NN ,/, CBS-1/NEWGENE contains/VBZ an/DT open/JJ reading/JJ frame/NN consisting/VBG of/IN 182/CD amino/JJ acids/NNS ,/, with/IN a/DT molecular/JJ weight/NN of/IN 19/CD ./CD 5kDa/CD ./.
@@94875909454 The/DT mean/JJ duration/NN of/IN pain/NN relief/NN was/VBD 4-6/CD weeks/NNS ./.
@@10810083251 The/DT serine-threonine/NEWGENE kinase/NEWGENE gene/NEWGENE is/VBZ likely/RB functional/JJ ,/, whereas/IN the/DT zinc/NN finger/NN motif/NN is/VBZ likely/RB nonfunctional/JJ ./.
@@108092336893 Modeling/NNP also/RB revealed/VBD a/DT very/RB hydrophobic/JJ surface/NN due/NN to/IN the/DT absence/NN of/IN H12/NEWGENE ,/, exposing/VBG residues/NNS from/IN H3/NEWGENE ,/, loop/NEWGENE 3-4/NEWGENE ,/, H4/NEWGENE ,/, and/CC H11/NEWGENE ./.
@@84088419097 Genetic/NNP abnormalities/NNS that/WDT could/MD lead/VB to/IN mutagenesis/NN include/VB chromosomal/JJ abnormalities/NNS and/CC single-gene/NN mutations/NN ./.
@@84717967089 Based/VBN on/IN these/DT results/NNS ,/, a/DT new/JJ model/NN for/IN the/DT regulation/NN of/IN nif/NEWGENE //NEWGENE fix/NEWGENE gene/NEWGENE expression/NN in/IN A/NNP ./NNP caulinodans/NNS is/VBZ proposed/VBN ./.
@@86266988255 However/RB ,/, a/DT >/SYM 10-fold/JJ increase/NN in/IN ERK3/NEWGENE activity/NN in/IN each/DT PKC/NEWGENE beta/NEWGENE transfectant/NN was/VBD shown/VBP by/IN immunoprecipitation/NN with/IN anti-ERK3/NEWGENE monoclonal/NEWGENE antibody/NEWGENE followed/VBN by/IN either/DT immune/NN complex/NN kinase/NN assay/NN or/CC by/IN in/IN gel/NN kinase/NEWGENE assay/NN ./.
@@70075919330 The/DT residue/NN functions/NNS ,/, R/NN (/NN t/NN )/NN ,/, for/IN C-11/NN CPZ/NN and/CC In-113m/NN transferrin/NN were/VBD plotted/VBN against/IN time/NN for/IN selected/VBN areas/NNS of/IN interest/NN ,/, and/CC the/DT CPZ/NN area-weighted/JJ extraction/NN ,/, E/NN (/NN t/NN )/NN ,/, was/VBD computed/JJ for/IN the/DT same/JJ areas/NNS every/DT 250/CD msec/NN using/VBG the/DT formula/NN :/: E/NN (/NN t/NN )/NN =/SYM [/NN RT/NN (/NN t/NN )/NN -/: RR/NN (/NN t/NN )/NN ]/NN //NN [/NN 1/NN -/: RR/NN (/NN t/NN )/NN ]/NN ,/, where/CC RT/JJ and/CC RR/NN are/VBP the/DT normalized/VBN residue/NN functions/NNS for/IN CPZ/NN and/CC transferrin/NEWGENE ,/, respectively/RB ./.
@@10699684510 Furthermore/RB ,/, Zelen's/NN method/NN is/VBZ used/VBN to/IN balance/NN the/DT number/NN of/IN patients/NNS allocated/VBN to/IN the/DT two/JJ groups/NNS within/IN each/DT institution/NN (/( M/NNP ./NNP
@@100879932036 In/NN contrast/NN ,/, deletion/NN of/IN the/DT upstream/JJ portion/NN of/IN the/DT delta/NEWGENE promoter/NEWGENE led/VBN to/IN a/DT 10/CD fold/NN decrease/NN in/IN expression/NN ./.
@@10770065373 The/DT clinical/JJ stage/NN was/VBD I/PRP (/( T1N0M0/NNP )/SYM ,/, and/CC S2/NN sleeve/NN segmentectomy/NN with/IN lymph/NN node/NN dissection/NN (/( R/NN 2/NN b/NN )/SYM was/VBD performed/VBN ./.
@@80784734861 Expression/NNS of/IN ME31B/NEWGENE cDNA/NEWGENE in/IN S/NNP ./NNP pombe/NN suppresses/VBZ the/DT ste13/NEWGENE mutation/NN ./.
@@107919011978 Transduction/NNS of/IN the/DT human/JJ leukemic/JJ cell/NN line/NN K562/CELL showed/VBD that/IN viral/NN MRP1-PG13/NN supernatants/NN routinely/RB transfer/VBP the/DT MRP1/NEWGENE gene/NEWGENE to/IN approximately/JJ 35%/NN of/IN target/NN K562/NNP cells/NNS ,/, of/IN which/WDT at/IN least/RB one/PRP third/RB are/VBP capable/JJ of/IN proliferating/JJ in/IN the/DT presence/NN of/IN otherwise/RB toxic/JJ concentrations/NNS of/IN etoposide/NN ./.
@@88248841659 The/DT cytogenetic/JJ expression/NN of/IN the/DT folate/NN sensitive/JJ fragile/JJ site/NN ,/, FRAXE/NEWGENE ,/, is/VBZ due/NN to/IN the/DT expansion/NN of/IN a/DT GCC/NN repeat/NN in/IN proximal/JJ Xq28/NN of/IN the/DT human/JJ X/NN chromosome/NN and/CC is/VBZ associated/VBN with/IN a/DT mild/JJ form/NN of/IN mental/JJ handicap/NN ./.
@@72744827126 33/CD out/RB of/IN 90/CD neurons/NNS of/IN the/DT cat/NN medial/JJ geniculate/JJ body/NN revealed/VBD the/DT selectivity/NN of/IN their/PRP afterdischarges/NNS to/IN movement/NN of/IN sound/NN when/CC velocity/NN of/IN the/DT movement/NN changed/VBN from/IN 30/CD to/IN 180/CD deg/NNS //NNS s/NNS ./.
@@26315056917 Ampicillin/NN (/( AMP/NN )/SYM alone/RB or/CC with/IN an/DT aminoglycoside/NN (/( AMI/NN )/SYM was/VBD the/DT treatment/NN in/IN 9/CD and/CC 16/CD cases/NNS ,/, respectively/RB ./.
@@40397441960 These/DT results/NNS were/VBD compared/VBN with/IN those/DT obtained/VBN in/IN -D/CD mothers/NNS and/CC pups/NNS ,/, after/IN giving/JJ the/DT mothers/NNS an/DT oral/JJ supplement/NN (/( 10/CD i/CD ./CD u/CD ./. vitamin/NN D3/NN //NN day/NN )/SYM during/IN the/DT period/NN of/IN lactation/NN (/( 20/CD days/NNS )/SYM ./.
@@89872253157 The/DT most/RB common/JJ risk/NN factor/NN reported/VBN for/IN both/DT recent/JJ and/CC all/PDT other/DT hepatitis/NN C/NN cases/NNS was/VBD a/DT history/NN of/IN injecting/JJ drug/NN use/NN ,/, although/IN the/DT proportion/NN of/IN cases/NNS with/IN that/DT history/NN was/VBD different/JJ in/IN NT/NN from/IN ACT/NNP and/CC Queensland/NN ./.
@@25562649025 This/DT TC-II/NEWGENE enhanson/NEWGENE ,/, which/WDT is/VBZ identical/JJ to/IN the/DT kappa/NEWGENE B/NEWGENE motif/NEWGENE from/IN the/DT kappa/NEWGENE chain/NEWGENE enhancer/NEWGENE ,/, was/VBD active/JJ in/IN both/DT lymphoid/JJ and/CC non-lymphoid/JJ cells/NNS ,/, which/WDT contrasts/VBZ with/IN the/DT previously/RB reported/VBN lymphoid/JJ cell/NN specificity/NN of/IN the/DT kappa/NEWGENE B/NEWGENE motif/NEWGENE ./.
@@10487921776 ATF1/NEWGENE transcription/NN is/VBZ negatively/RB regulated/VBN by/IN unsaturated/JJ fatty/JJ acids/NNS and/CC oxygen/NN ./.
@@77485027707 Rats/NNP treated/VBD with/IN 8-OH-DPAT/NN were/VBD not/RB impaired/VBN in/IN their/PRP ability/NN to/IN learn/VB a/DT visual/JJ discrimination/NN in/IN a/DT water/NN maze/NN ./.
@@63316846120 An/DT immunologic/JJ test/NN using/VBG stomach/NEWGENE and/NEWGENE tumor/NEWGENE antigens/NEWGENE for/IN screening/NN of/IN those/DT at/IN high/JJ risk/NN for/IN stomach/NN cancer/NN is/VBZ suggested/VBN ./.
@@104570759729 Independent/NN protrudor/NN muscle/NN stimulation/NN increased/VBN VI/NNP ,/NNP max/NNP (/( peak/NN increase/NN 61/CD %/NN ,/, P/NN </SYM 0/CD ./CD 05/CD )/SYM ,/, did/VBD not/RB change/VB Pcrit/NNP ,/, and/CC decreased/VBD Rn/NN (/( peak/NN decrease/NN of/IN 41/CD %/NN ,/, P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@83496327343 Sequence/NN comparison/NN indicates/VBZ that/IN exons/NNS 5'/NN //NN L/NN and/CC L/NN //NN N/NN in/IN PSG12/NEWGENE and/CC PSG12/NEWGENE psi/NEWGENE are/VBP 99%/NN identical/JJ ,/, except/VB that/IN the/DT L/NNP //NNP N/NNP exon/NN in/IN the/DT PSG12/NEWGENE psi/NEWGENE gene/NEWGENE contains/VBZ a/DT stop/NN codon/NN ./.
@@79371129084 The/DT individual/JJ subunits/NNS of/IN Ku/NEWGENE have/NN been/VBN difficult/JJ to/IN isolate/NN from/IN human/JJ cells/NNS without/IN denaturation/NN and/CC attempts/NNS to/IN produce/NN functional/NEWGENE recombinant/NEWGENE Ku/NEWGENE have/VB been/VBN largely/RB unsuccessful/JJ ./.
@@9294189255 Role/NN of/IN the/DT infectious-disease/JJ specialist/NN of/IN a/DT polyclinic/NN in/IN reducing/JJ the/DT incidence/NN of/IN communicable/JJ diseases/NNS ./.
@@92410929201 CONCLUSIONS/IN :/: Valproate/NN appears/VBZ to/IN inhibit/VB the/DT glucuronidation/NN of/IN carbamazepine-10/JJ ,/JJ 11-trans-diol/JJ ,/, and/CC probably/RB also/RB inhibits/VBZ the/DT conversion/NN of/IN carbamazepine-10/NN ,/NN 11-epoxide/NN to/IN this/DT trans-diol/NN derivative/NN ,/, rather/RB than/IN simply/RB inhibiting/JJ the/DT latter/JJ reaction/NN only/RB ./.
@@76659483479 IgE/NEWGENE levels/NNS showed/VBD higher/JJ values/NNS compared/VBN to/IN normal/JJ individuals/NNS and/CC IgE/NEWGENE levels/NNS were/VBD higher/JJ in/IN children/NNS groups/NNS than/IN in/IN adults/NNS regardless/RB of/IN the/DT intensity/NN of/IN infection/NN ./.
@@68498426641 Penicillin-G/NN degradation/NN products/NNS inhibit/VBP in/IN vitro/FW granulopoiesis/NN ./.
@@78535245391 Removal/NNP of/IN the/DT GST/NEWGENE domain/NEWGENE from/IN GST-Tax/NEWGENE by/IN thrombin/NEWGENE restores/VBZ Tax's/NEWGENE ability/NN to/IN assemble/VB a/DT ternary/JJ Tax-CREB-21-bp-repeat/NEWGENE complex/NEWGENE ./NEWGENE (/NEWGENE ABSTRACT/NEWGENE TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@106113207581 Saccharomyces/NN cerevisiae/NN contains/VBZ a/DT genetically/RB and/CC biochemically/RB proven/VBP CAK/NEWGENE gene/NEWGENE ,/, CAK1/NEWGENE ,/, that/IN encodes/VBZ a/DT monomeric/JJ 44-kDa/NEWGENE Cak1p/NEWGENE protein/NEWGENE unrelated/JJ to/IN Cdk7/NEWGENE ./.
@@21930335342 R/NNP ./NNP
@@89058192134 The/DT majority/NN of/IN the/DT cases/NNS with/IN 0-I/JJ or/CC 0-III/NN components/NN were/VBD sm/CD ./CD cancer/NN ./.
@@78804426640 The/DT major/JJ PKC/NEWGENE beta/NEWGENE transcription/NN initiation/NN site/NN was/VBD identified/VBN by/IN primer/NN extension/NN and/CC S1/NEWGENE nuclease/NEWGENE protection/NN ./.
@@91474206555 TAR/NEWGENE and/CC Sp1-independent/NNP transactivation/NN of/IN HIV/NEWGENE long/NEWGENE terminal/NEWGENE repeat/NEWGENE by/IN the/DT Tat/NEWGENE protein/NEWGENE in/IN the/DT presence/NN of/IN human/NEWGENE cytomegalovirus/NEWGENE IE1/NEWGENE //NEWGENE IE2/NEWGENE ./.
@@100739403044 Ectopic/NN expression/NN of/IN d-axin/NEWGENE inhibited/VBN Wingless/NEWGENE signaling/NN ./.
@@102182008078 In/NN 11/CD eyes/NNS that/WDT had/VBP been/VBN selected/VBN at/IN random/JJ 10/CD micrograms/NNS of/IN recombinant/NEWGENE tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE were/VBD injected/VBN midvitreally/RB 24/CD hrs/NN later/JJR ./.
@@7910716636 Our/PRP study/NN cohorts/NNS consisted/VBP of/IN 15/CD patients/NNS who/WP received/VBD SC/NN rIL-2/NEWGENE at/IN doses/NNS of/IN 4/CD ./CD 8-14/CD ./CD 4/CD million/NN IU/NNS //NNS m2/NNS //NNS day/NNS on/IN 5/CD days/NNS per/IN week/NN for/IN a/DT total/NN of/IN 8/CD weeks/NNS ,/, 20/CD patients/NNS who/WP received/VBD rIFN-alpha/NEWGENE 2b/NEWGENE at/IN 3/CD ./CD 0-6/CD ./CD 0/CD million/NN U/NNS //NNS m2/NNS //NNS day/NNS thrice/RB weekly/JJ for/IN a/DT total/NN of/IN 6/CD weeks/NNS ,/, and/CC 72/CD patients/NNS who/WP were/VBD given/VBP SC/NN rIFN-alpha/NEWGENE 2b/NEWGENE at/IN 6/CD ./CD 0/CD million/NN U/NNS //NNS m2/NNS //NNS day/NNS thrice/RB weekly/JJ plus/IN SC/NN rIL-2/NEWGENE at/IN 14/CD ./CD 4-18/CD ./CD 0/CD million/NN IU/NNS //NNS m2/NNS //NNS day/NNS on/IN days/NNS 1/CD and/CC 2/CD ,/, followed/VBN by/IN 4/CD ./CD 8/CD million/JJ IU/NNS //NNS m2/NNS //NNS day/NNS ,/, 5/CD days/NNS per/IN week/NN for/IN 6/CD consecutive/JJ weeks/NNS ./.
@@75094509168 This/DT specific/JJ methylation/NN pattern/NN caused/VBD inactivation/NN of/IN the/DT HSV/NEWGENE tk/NEWGENE gene/NEWGENE ,/, while/CC methylation/NN of/IN the/DT cytosine/NN residues/NNS within/IN the/DT nucleotide/NN sequence/NN from/IN +811/NN to/IN +1309/CD had/VBP no/DT effect/NN on/IN HSV/NEWGENE tk/NEWGENE gene/NEWGENE activity/NN ./.
@@8118528091 Personal/JJ satisfaction/NN in/IN nursing/JJ :/: an/DT encounter/NN with/IN extremely/RB hostile/JJ patients/NNS ./.
@@23175542962 Determination/NNS of/IN three-dimensional/JJ imaging/NN properties/NNS of/IN a/DT light/NN microscope/NN system/NN ./.
@@78762103694 Mutation/NN of/IN the/DT P450BM-3/NEWGENE Barbie/NEWGENE box/NEWGENE significantly/RB increased/VBD the/DT expression/NN of/IN both/DT P450BM-3/NEWGENE and/CC Bm3P1/NEWGENE (/( another/DT small/JJ gene/NN located/VBN upstream/RB of/IN the/DT P450BM-3/NEWGENE gene/NEWGENE that/IN encodes/VBZ a/DT second/JJ putative/JJ regulatory/JJ protein/NN )/SYM in/IN response/NN to/IN pentobarbital/NN induction/NN but/CC left/NN the/DT basal/JJ levels/NNS unaffected/JJ ./.
@@111582951835 This/DT function/NN requires/VBZ not/RB only/RB the/DT kinase/NN domain/NN of/IN Csk/NEWGENE ,/, but/CC also/RB its/PRP Src/NEWGENE homology/NEWGENE 3/NEWGENE (/( SH3/NEWGENE )/SYM and/CC SH2/NEWGENE regions/NN ./.
@@75797049547 To/TO accomplish/VB this/DT ,/, actin/NEWGENE cables/NN and/CC patches/NNS are/VBP redistributed/VBN during/IN the/DT cell/NN cycle/NN to/IN direct/JJ secretory/JJ components/NNS to/IN appropriate/JJ sites/NNS for/IN cell/NN growth/NN ./.
@@75926478739 Association/NNP of/IN human/NEWGENE Pur/NEWGENE alpha/NEWGENE with/IN the/DT retinoblastoma/NEWGENE protein/NEWGENE ,/, Rb/NEWGENE ,/, regulates/VBZ binding/JJ to/IN the/DT single-stranded/JJ DNA/NN Pur/NEWGENE alpha/NEWGENE recognition/NEWGENE element/NEWGENE ./.
@@104717433804 A/DT cDNA/NN encoding/VBG a/DT putative/JJ RNA/NEWGENE and/NEWGENE //NEWGENE or/NEWGENE DNA/NEWGENE helicase/NEWGENE has/VBZ been/VBN isolated/VBN from/IN Arabidopsis/NN thaliana/NN cDNA/NN libraries/NNS ./.
@@111815162826 By/IN analyzing/VBG 5'-deletion/CD insulin/NEWGENE promoter-reporter/NEWGENE constructs/NEWGENE in/IN transient/JJ transfections/NNS of/IN clonal/JJ INS-1/NEWGENE beta-cells/NNS ,/, we/PRP located/VBD activating/JJ Hh-responsive/NEWGENE regions/NEWGENE within/IN the/DT rat/NEWGENE insulin/NEWGENE I/NEWGENE promoter/NEWGENE that/WDT include/VBP the/DT glucose-response/NEWGENE elements/NEWGENE Far/NEWGENE1 (/( E2/NEWGENE )/SYM and/CC Flat/NEWGENE (/( A2/NEWGENE //NEWGENE A3/NEWGENE )/SYM ./.
@@37852124296 Human/NNP and/CC Chinese/NEWGENE hamster/NEWGENE S14/NEWGENE protein/NEWGENE sequences/NEWGENE deduced/VBN from/IN the/DT cDNAs/NNS are/VBP identical/JJ ./.
@@91688791483 In/NN AcMNPV-infected/JJ Sf9/CD cells/NNS ,/, late/JJ transcription/NN initiation/NN is/VBZ detected/VBN from/IN only/RB two/JJ upstream/NN TAAG/NEWGENE sites/NEWGENE and/CC not/RB from/IN three/CD downstream/NN TAAG/NEWGENE sites/NEWGENE ./.
@@92976981167 These/DT transcripts/NNS contain/VBP the/DT 5'/CD ends/NNS of/IN mature/NNP UbCRBP/NEWGENE mRNAs/NEWGENE ;/: extend/VB through/RB UbCRBP/NEWGENE ,/, across/IN the/DT intergenic/JJ region/NN ,/, and/CC a/DT significant/JJ distance/NN 3'/CD into/IN the/DT enolase/NEWGENE gene/NEWGENE ./.
@@79606087949 Courses/NNS were/VBD repeated/VBN every/DT four/CD weeks/NNS ./.
@@103040905800 Medicare/NN SNF/NN benefits/NNS revised--again/JJ ./.
@@89597782115 There/EX were/VBD no/DT significant/JJ differences/NNS in/IN graft/NN survival/NN between/IN groups/NNS with/IN early/JJ graft/NN function/NN (/( EGF/NN )/SYM and/CC DGF/NN ,/, either/DT in/NN first/JJ transplantations/NNS or/CC retransplantations/NNS ./.
@@107728564261 Copyright/NNP 2000/CD Academic/NNP Press/NNP ./.
@@113454359229 One/CD of/IN the/DT conserved/VBN RNA/NN subdomains/NN ,/, designated/VBN P3/NEWGENE ,/, has/VBZ previously/RB been/VBN shown/VBP to/IN be/VB required/VBN for/IN nucleolar/JJ localization/NN ./.
@@92873529486 Consistent/JJ with/IN effects/NNS on/IN STAT/NEWGENE activation/NN ,/, altered/VBN SHP-1/NEWGENE expression/NN also/RB affected/VBD EGF-induced/JJ activation/NN of/IN the/DT mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE pathway/NEWGENE ;/: expression/NN of/IN SHP-1-/NEWGENE (/NEWGENE Cys/NEWGENE --/NEWGENE >/NEWGENE Ser/NEWGENE )/NEWGENE inhibited/VBD activity/NN of/IN MEK/NEWGENE by/IN approximately/RB 25%/JJ ,/, whereas/IN expression/NN of/IN SHP-1/NEWGENE resulted/VBN in/IN a/DT approximately/RB 25%/JJ increase/NN ./.
@@114137609685 Myasthenia/NN gravis/MD is/VBZ an/DT autoimmune/JJ disease/NN resulting/JJ from/IN the/DT production/NN of/IN antibodies/NNS against/IN the/DT ACh/NEWGENE receptors/NEWGENE of/IN the/DT neuromuscular/JJ synapse/NN ./.
@@98449214145 Raf/NEWGENE is/VBZ a/DT key/JJ serine-threonine/NEWGENE protein/NEWGENE kinase/NEWGENE which/WDT participates/VBZ in/IN the/DT transmission/NN of/IN growth/NN ,/, anti-apoptotic/NN and/CC differentiation/NN messages/NNS ./.
@@75790237482 During/IN the/DT dose-finding/NN ,/, two/JJ patients/NNS were/VBD temporarily/RB withdrawn/VBP from/IN medication/NN and/CC one/PRP patient/NN was/VBD excluded/VBN because/IN of/IN elevated/VBN levels/NNS of/IN liver/NN enzymes/NNS ./.
@@110597778005 Terminal/NNP deoxynucleotidyl/NN transferase-mediated/JJ nick/NN end/NN labeling/VBG assays/NNS revealed/VBN that/IN hormonal/JJ activation/NN of/IN the/DT PAX3/NEWGENE repressors/NEWGENE induced/VBD extensive/JJ apoptosis/NN that/WDT correlated/VBD with/IN down-regulation/NN of/IN BCL-X/NEWGENE (/NEWGENE L/NEWGENE )/NEWGENE expression/NN ./.
@@118041001670 It/PRP was/VBD found/VBN that/IN the/DT disappearance/NN of/IN BOD5/NN and/CC NH3-N/NN could/MD be/VB approximated/VBN using/VBG first-order/JJ kinetics/NN ,/, but/CC the/DT kinetics/NN of/IN TP/NN removal/NN were/VBD unclear/JJ ./.
@@75601379906 Differential/JJ sensitivity/NN of/IN the/DT MMPI-2/NN depression/NN scales/NNS and/CC subscales/NNS ./.
@@259754933 The/DT two/JJ most/RB recent/JJ patients/NNS (/( 35/CD and/CC 132/CD days/NNS )/SYM received/VBN only/RB oral/JJ dipyridamole/NN (/( 75/CD mg/NN X/NN 3/CD //CD day/CD )/SYM and/CC aspirin/NN (/( 80/CD mg/NN //NN day/NN )/SYM after/IN the/DT early/JJ recovery/NN period/NN (/( four-six/JJ days/NNS )/SYM ,/, resulting/VBG in/IN normal/JJ prothrombin/NEWGENE and/CC partial/JJ thromboplastin/NEWGENE times/NNS ./.
@@85694439920 The/DT purpose/NN of/IN the/DT study/NN reported/VBN here/RB was/VBD to/IN investigate/VB whether/IN differences/NNS in/IN T1/NN and/CC T2/NN between/IN tumors/NNS are/VBP mainly/RB a/DT consequence/NN of/IN differences/NNS in/IN the/DT fractional/JJ volume/NN of/IN the/DT extracellular/JJ compartment/NN ./.
@@32338623923 Neuromyelitis/NNP optica/NN (/( Devic's/NNP syndrome/NN )/SYM :/: not/RB always/RB multiple/JJ sclerosis/NN ./.
@@91930729815 Cytological/JJ data/NN suggest/VB that/IN the/DT transgenes/NNS associate/NN with/IN a/DT nucleolus/NN ./.
@@8626290676 Aeromonas/NNS salmonicida/NN possesses/VBZ two/JJ genes/NNS encoding/VBG homologs/NNS of/IN the/DT major/NEWGENE outer/NEWGENE membrane/NEWGENE protein/NEWGENE ,/, OmpA/NEWGENE ./.
@@18863682505 PO2/NN measurements/NNS using/VBG a/DT double/JJ barrelled/JJ recess/NN type/NN microelectrodes/NNS were/VBD measured/VBN in/IN the/DT optic/JJ nerve/NN head/NN of/IN miniature/NN pigs/NNS in/IN normoxia/NN and/CC hyperoxia/NN ./.
@@90943156911 In/NN this/DT study/NN ,/, we/PRP have/VBP examined/VBN the/DT regulation/NN of/IN B-Myb/NEWGENE activity/NN by/IN cyclin-Cdks/NEWGENE ./.
@@77614347884 Since/IN AP-1/NEWGENE is/VBZ an/DT important/JJ mediator/NN of/IN tumor/NN promoter/NN action/NN ,/, these/DT findings/NNS may/MD explain/VB the/DT anti-tumor-promoting/JJ activity/NN of/IN phenolic/JJ antioxidants/NNS ./.
@@77456859583 Interestingly/RB ,/, virions/NNS also/RB contained/VBN smaller/JJR proteins/NNS that/WDT reacted/VBD with/IN antibodies/NNS specific/JJ for/IN the/DT accessory/JJ proteins/NNS as/RB well/VBP as/IN SN/NEWGENE and/CC CAT/NEWGENE fusion/NEWGENE partners/NNS ./.
@@55526425590 Propagation/NNS and/CC hormone/NN production/NN by/IN human/JJ normal/JJ and/CC malignant/JJ trophoblast/NN in/IN rats/NNS ./.
@@74942937802 These/DT results/NNS demonstrate/VBP that/IN tip/NEWGENE acts/NNS at/IN an/DT early/JJ stage/NN of/IN the/DT T-cell/NN signal/JJ transduction/NN cascade/NN by/IN associating/JJ with/IN Lck/NEWGENE and/CC downregulating/JJ Lck-mediated/JJ activation/NN ./.
@@21791882789 The/DT electrically/RB induced/VBN motile/JJ responses/NNS were/VBD not/RB suppressed/VBN in/IN the/DT presence/NN of/IN dinitrophenol/NN or/CC cytochalasin/NN B/NNP ./NNP
@@40172954684 For/IN comparison/NN conventional/JJ heparin/NN was/VBD used/VBN during/IN 18/CD dialyses/NNS in/IN the/DT same/JJ patients/NNS ./.
@@93462381846 F-box/NEWGENE proteins/NEWGENE are/VBP receptors/NNS that/WDT recruit/VBP phosphorylated/VBN substrates/NNS to/IN the/DT SCF/NEWGENE ubiquitin-ligase/NEWGENE complex/NEWGENE ./.
@@79548917286 ERV1/NEWGENE is/VBZ involved/VBN in/IN the/DT cell-division/JJ cycle/NN and/CC the/DT maintenance/NN of/IN mitochondrial/JJ genomes/NNS in/IN Saccharomyces/NN cerevisiae/NN ./.
@@92337724009 This/DT protein/NN ,/, designated/VBN p532/NEWGENE based/VBN on/IN its/PRP predicted/VBN molecular/JJ weight/NN (/( EMBO/NNP J/NN 15/CD :/: 5738/CD ,/, 1996/CD )/SYM ,/, contains/VBZ multiple/JJ structural/JJ domains/NNS including/JJ two/JJ regions/NNS of/IN seven/JJ internal/JJ repeats/NNS highly/RB related/VBN to/IN the/DT cell/NN cycle/NN regulator/NN RCC1/NEWGENE ,/, a/DT guanine/NEWGENE nucleotide/NEWGENE exchange/NEWGENE factor/NEWGENE for/IN the/DT small/NEWGENE GTP-binding/NEWGENE protein/NEWGENE Ran/NEWGENE1 ,/, seven/JJ beta-repeat/NN domains/NN characteristic/NN of/IN the/DT beta/NN subunit/NN of/IN heterotrimeric/NEWGENE G/NEWGENE proteins/NEWGENE ,/, three/CD putative/JJ SH3/NEWGENE binding/NEWGENE sites/NEWGENE ,/, a/DT putative/JJ leucine-zipper/JJ and/CC a/DT carboxy-terminal/NEWGENE HECT/NEWGENE domain/NEWGENE characteristic/NN of/IN E3/NEWGENE ubiquitin-protein/NEWGENE ligases/NEWGENE ./.
@@38387976363 Northern/NNP blotting/NN with/IN a/DT unique/JJ 17-mer/CD oligonucleotide/NN demonstrated/VBD the/DT absence/NN of/IN the/DT mutant/JJ sequence/NN in/IN the/DT mRNA/NN from/IN which/WDT the/DT cDNA/NN library/NN giving/JJ rise/NN to/IN the/DT mutant/JJ cDNA/NN was/VBD constructed/VBN ./.
@@106772145906 For/IN wild/JJ type/NN MutT/NEWGENE and/CC its/PRP E53D/NEWGENE and/CC E44D/NEWGENE mutants/NEWGENE ,/, plots/VBZ of/IN log/NN (/NN k/NN (/NN cat/NN )/NN )/NN versus/IN pH/NN exhibited/VBD a/DT limiting/JJ slope/NN of/IN 1/CD on/IN the/DT ascending/JJ limb/NN and/CC then/RB a/DT hump/NN ,/, i/FW ./FW e/FW ./FW ,/, a/DT sharply/RB defined/VBN maximum/JJ near/IN pH/NN 8/CD followed/VBN by/IN a/DT plateau/NN ,/, yielding/JJ apparent/JJ pK/NN (/NN a/NN )/NN values/NNS of/IN 7/CD ./CD 6/CD +/NN //NN -/NN 0/CD ./CD 3/CD and/CC 8/CD ./CD 4/CD +/NN //NN -/NN 0/CD ./CD 4/CD for/IN an/DT essential/JJ base/NN and/CC a/DT nonessential/JJ acid/NN catalyst/NN ,/, respectively/RB ,/, in/IN the/DT active/JJ quaternary/JJ MutT-Mg/NEWGENE (/NEWGENE 2+/NEWGENE )/NEWGENE -dGTP-Mg/NEWGENE (/NEWGENE 2+/NEWGENE )/NEWGENE complex/NEWGENE ./.
@@74400855148 Arm/NN function/NN tests/NNS ./.
@@10125354111 Groups/NNS dicker/VBP for/IN price/NN breaks/NNS as/IN anesthetic/JJ gas/NN goes/VBP multi-source/JJ ./.
@@31091473822 Research/NNP on/IN ethylene/NN glycol/NN and/CC diethylene/NN glycol/NN for/IN carcinogenic/JJ effects/NNS ./.
@@9091149042 Diallylnitrosamine/NNP (/( DAN/IN )/SYM ,/, one/PRP of/IN the/DT few/JJ nitrosamines/NNS tested/VBN thus/RB far/RB that/WDT has/VBZ not/RB induced/VBN neoplasms/NNS in/IN rats/NNS ,/, caused/VBD a/DT high/JJ incidence/NN of/IN respiratory/JJ tract/NN tumors/NNS in/IN Syrian/JJ golden/JJ hamsters/NNS treated/VBD sc/NN with/IN single/JJ or/CC weekly/JJ doses/NNS of/IN the/DT compound/NN ./.
@@76815397617 Cytogenetic/JJ studies/NNS were/VBD performed/VBN in/IN lymphocytes/NNS from/IN hospital/NN workers/NNS exposed/VBN to/IN low/JJ doses/NNS of/IN radiation/NN (/( 1/CD ./CD 6-42/CD ./CD 71/CD mSv/NN )/SYM ./.
@@117912921650 According/VBG to/IN the/DT laboratory/NN results/NNS ,/, the/DT application/NN of/IN neural/JJ network/NN can/MD solve/VB the/DT problem/NN successfully/RB ./.
@@91149724028 Upon/IN induction/NN of/IN SOS/NN ,/, viability/NN increased/VBD 2-6-fold/JJ ./.
@@19846658911 Processing/NNP ,/, secretion/NN ,/, and/CC immunoreactivity/NN of/IN carboxy/NEWGENE terminally/NEWGENE truncated/NEWGENE dengue-2/NEWGENE virus/NEWGENE envelope/NEWGENE proteins/NEWGENE expressed/VBN in/IN insect/NN cells/NNS by/IN recombinant/JJ baculoviruses/NNS ./.
@@105432707218 Despite/IN i/CD ./CD v/CD ./. steroid/JJ therapy/NN ,/, [/NN NOexh/NN ]/NN remained/VBD elevated/VBN throughout/IN recovery/NN (/( 37/CD ./CD 9+/CD //CD -4/CD ./CD 8/CD ppb/NN ,/, p/NN </NN 0/NN ./NN 001/NN )/SYM until/IN discharge/NN (/( 40/CD ./CD 9+/CD //CD -4/CD ./CD 3/CD ppb/NN ,/, p/NN </NN 0/NN ./NN 001/NN )/SYM ./.
@@25462343194 Similarly/RB ,/, supraventricular/JJ tachycaydia/NN following/IN resuscitative/JJ efforts/NNS appeared/VBN to/IN be/VB associated/VBN with/IN a/DT negative/JJ outcome/NN ./.
@@11025367854 Abnormalities/NNS of/IN plasma/NEWGENE cholecystokinin/NEWGENE were/VBD observed/VBN only/RB in/IN patients/NNS with/IN delayed/JJ gastric/JJ emptying/NN ./.
@@65169776309 Reaction/NN of/IN human/JJ organism/NN to/IN exercise/NN ./.
@@18086022414 In/NN sixteen/CD patients/NNS with/IN moderate/JJ essential/JJ hypertension/NN the/DT effects/NNS of/IN 10-day/NN nifedipine/NN treatment/NN on/IN serum/JJ uric/JJ acid/NN and/CC renal/JJ excretion/NN of/IN uric/JJ acid/NN were/VBD evaluated/VBN ./.
@@93955259800 We/PRP now/RB demonstrate/VBP that/IN CCAAT/NEWGENE //NEWGENE enhancer-binding/NEWGENE protein/NEWGENE (/NEWGENE C/NEWGENE //NEWGENE EBP/NEWGENE )/NEWGENE delta/NEWGENE is/VBZ a/DT major/JJ component/NN of/IN a/DT PGE2-stimulated/NEWGENE DNA-protein/NEWGENE complex/NEWGENE involving/VBG HS3D/NEWGENE and/CC find/VB that/IN C/NEWGENE //NEWGENE EBPdelta/NEWGENE transactivates/VBZ IGF-I/NEWGENE promoter/NEWGENE 1/NEWGENE through/RB this/DT site/NN ./.
@@21633821715 To/TO characterize/VB the/DT O7-LPS/NEWGENE region/NEWGENE ,/, the/DT recombinant/JJ cosmids/NNS pJHCV31/NN and/CC pJHCV32/NN were/VBD mutagenized/VBN by/IN transposon/NN mutagenesis/NN with/IN Tn3HoHo1/NEWGENE ,/, which/WDT carries/VBZ a/DT promoterless/NN lac/NEWGENE operon/NEWGENE and/CC can/MD therefore/RB generate/VB lacZ/NEWGENE transcriptional/NN fusions/NN with/IN target/NN DNA/NN sequences/NNS ./.
@@97338541317 The/DT only/RB abundant/JJ viral/JJ transcript/NN expressed/VBN during/IN latency/NN is/VBZ the/DT latency-related/NEWGENE (/NEWGENE LR/NEWGENE )/NEWGENE RNA/NEWGENE ./.
@@10210918374 The/DT influence/NN of/IN adrenergic/JJ nerves/NNS of/IN the/DT response/NN of/IN blood/NN vessels/NNS in/IN the/DT rabbit/NN ear/NN to/IN 2--phenylalanine-8-lysine/NEWGENE vasopressin/NEWGENE (/( Octapressin/NEWGENE )/SYM ./.
@@10635209452 Following/VBG conditioning/JJ ,/, a/DT single/JJ coat/NN of/IN adhesive/NN was/VBD applied/VBN and/CC light-cured/JJ ./.
@@110297044770 In/NN transient/JJ analysis/NN using/VBG particle/NN bombardment/NN of/IN tobacco/NN leaf/NN sections/NNS ,/, a/DT tetramer/NN of/IN the/DT distB/NEWGENE ABRE/NEWGENE (/( abscisic/NEWGENE acid-responsive/NEWGENE element/NEWGENE )/SYM mediated/JJ transactivation/NN by/IN ABI3/NEWGENE and/CC ABI3-dependent/NN response/NN to/IN ABA/NN ,/, whereas/IN a/DT tetramer/NN of/IN the/DT composite/JJ RY/NN //NN G/NN complex/NN ,/, containing/NN RY/NN repeats/NNS and/CC a/DT G-box/NN ,/, mediated/JJ only/RB ABA-independent/NNP transactivation/NN by/IN ABI3/NEWGENE ./.
@@7753027540 The/DT gene/NN pairs/NNS psbB-psbT/NEWGENE and/CC psbH-psbN/NEWGENE are/VBP cotranscribed/VBN from/IN opposite/NN strands/NNS ./.
@@103934221160 About/IN 20/CD kb/NN upstream/RB of/IN LAMB2/NEWGENE we/PRP found/VBP a/DT gene/NN encoding/VBG a/DT transcribed/VBN ,/, non-processed/NNP LAMB2-like/NEWGENE pseudogene/NEWGENE (/( LAMB2L/NEWGENE )/SYM ./.
@@8710371542 Site/NEWGENE S-II/NEWGENE also/RB spans/VBZ a/DT 23/CD bp/NN sequence/NN containing/JJ two/JJ tandem/NN consensus/NN binding/JJ sites/NNS with/IN three/CD base/NN pair/NN mismatches/NNS in/IN each/DT and/CC a/DT one/PRP base/NN pair/NN deletion/NN ./.
@@105440374986 FZD4/NEWGENE is/VBZ homologous/JJ to/IN FZD9/NEWGENE and/CC FZD10/NEWGENE ,/, and/CC overall/JJ amino/JJ acid/NN identity/NN is/VBZ as/IN follows/VBZ :/: FZD4/NEWGENE vs/NNP FZD9/NEWGENE ,/, 51/CD ./CD 6%/CD ;/: FZD4/NEWGENE vs/NNP FZD10/NEWGENE ,/, 51/NN ./NN 2%/NN ;/: FZD9/NEWGENE vs/NNP FZD10/NEWGENE ,/, 65/CD ./CD 7%/CD ./.
@@115593663676 E2F1-mediated/JJ transcriptional/JJ inhibition/NN of/IN the/DT plasminogen/NEWGENE activator/NEWGENE inhibitor/NEWGENE type/NEWGENE 1/NEWGENE gene/NEWGENE ./.
@@25453578318 The/DT mustard/NEWGENE chloroplast/NEWGENE gene/NEWGENE rps16/NEWGENE is/VBZ split/JJ by/IN an/DT 887/CD bp/NN group/NN II/NNP (/( or/CC III/NNP )/SYM intron/NN ./.
@@20055472616 Armed/NNP with/IN a/DT clear/JJ understanding/NN of/IN the/DT pathophysiologic/JJ pathways/NNS that/WDT may/MD cause/VB and/WDT //WDT or/WDT contribute/VBP to/IN the/DT development/NN of/IN unconjugated/JJ hyperbilirubinemia/NN and/CC the/DT associated/VBN jaundice/NN ,/, the/DT practitioner/NN will/MD be/VB successful/JJ in/IN helping/JJ the/DT family/NN understand/VB their/PRP child's/NNS illness/NN ./.
@@112439809870 Twenty-five/CD patients/NNS also/RB received/VBN PET/NN examinations/NNS during/IN the/DT staging/JJ procedures/NNS ./.
@@35711354233 Reward/VB value/NN of/IN prosodic/JJ features/NNS of/IN language/NN for/IN autistic/JJ ,/, mentally/RB retarded/VBN ,/, and/CC normal/JJ children/NNS ./.
@@24613687889 In/NN this/DT report/NN we/PRP describe/VBP for/IN the/DT first/JJ time/NN the/DT complete/JJ primary/JJ structure/NN of/IN type/NEWGENE X/NEWGENE collagen/NEWGENE ,/, based/VBN on/IN cloning/NN and/CC sequencing/VBG of/IN cDNA/NN and/CC genomic/JJ DNA/NN ./.
@@85329678502 An/DT infectious/JJ origin/NN should/MD always/RB be/VB excluded/VBN since/IN specific/JJ etiologic/JJ therapy/NN may/MD be/VB implemented/VBN ./.
@@106989748417 We/PRP have/VBP mapped/VBN the/DT human/NEWGENE STAG3/NEWGENE gene/NEWGENE to/IN the/DT 7q22/NN region/NN of/IN chromosome/NN 7/CD ;/: six/CD human/NEWGENE STAG3-related/NEWGENE genes/NEWGENE have/VBP also/RB been/VBN mapped/VBN :/: two/JJ at/IN 7q22/NN near/IN the/DT functional/JJ gene/NN ,/, one/PRP at/IN 7q11/CD ./CD 22/CD ,/, and/CC three/CD at/IN 7q11/CD ./CD 23/CD ,/, two/NN of/IN them/PRP flanking/JJ the/DT breakpoints/NNS commonly/RB associated/VBN with/IN the/DT Williams-Beuren/NEWGENE syndrome/NEWGENE (/NEWGENE WBS/NEWGENE )/NEWGENE deletion/NEWGENE ./.
@@106662223937 Surprisingly/RB ,/, 3/CD full-length/NEWGENE murine/NEWGENE survivin/NEWGENE cDNA/NEWGENE clones/NNS were/VBD isolated/VBN ,/, predicting/JJ the/DT existence/NN of/IN 3/CD distinct/JJ survivin/NEWGENE proteins/NEWGENE ./.
@@9325278218 A/DT data/NN base/NN homology/NN search/NN revealed/VBN that/IN the/DT predicted/VBN ER1/NEWGENE amino/JJ acid/NN sequence/NN contains/VBZ three/CD regions/NNS of/IN similarity/NN to/IN the/DT rat/NN and/CC human/JJ proteins/NNS encoded/VBN by/IN the/DT metastasis-associated/NEWGENE gene/NEWGENE ,/, mta1/NEWGENE ,/, and/CC two/JJ regions/NNS of/IN similarity/NN to/IN the/DT Caenorhabditis/NNP elegans/NNS sequence/NN that/WDT is/VBZ similar/JJ to/IN mta1/NEWGENE ./.
@@16416282244 The/DT modalities/NNS for/IN using/VBG reference/NN values/NNS for/IN individual/JJ subjects/NNS as/RB well/VBP as/IN for/IN groups/NNS are/VBP then/RB discussed/VBN and/CC the/DT main/JJ points/NNS of/IN research/NN which/WDT must/MD be/VB faced/VBN in/IN the/DT near/IN future/JJ regarding/IN reference/NN values/NNS are/VBP highlighted/VBN ./.
@@104775839562 Cross-linking/VBG the/DT B/NEWGENE cell/NEWGENE Ag/NEWGENE receptor/NEWGENE (/( BCR/NEWGENE )/SYM to/IN surface/NEWGENE Fc/NEWGENE receptors/NEWGENE for/IN IgG/NEWGENE (/( Fc/NEWGENE gamma/NEWGENE R/NEWGENE )/SYM inhibits/VBZ G1-to-S/NN progression/NN ;/: the/DT mechanism/NN by/IN which/WDT this/DT occurs/VBZ is/VBZ not/RB completely/RB known/VBP ./.
@@94992543220 The/DT DSF/NN regimen/NN appears/VBZ to/IN have/NN significant/JJ activity/NN in/IN patients/NNS who/WP have/VBP metastatic/JJ pancreatic/JJ islet-cell/NN carcinoma/NN ,/, and/CC patient/NN tolerance/NN of/IN the/DT regimen/NN is/VBZ excellent/JJ ,/, thus/RB warranting/JJ further/JJ investigation/NN ./.
@@78589861141 A/DT comparative/JJ study/NN by/IN holographic/JJ interferometry/NN of/IN ten/CD porcine/JJ bioprosthetic/JJ valves/NNS (/( seven/JJ Carpentier-Edwards/JJ SAV/NN ,/, two/JJ BioImplant/NNP and/CC one/PRP Valcor/NNP )/SYM with/IN five/CD human/JJ aortic/JJ valves/NNS before/IN and/CC after/IN glutaraldehyde/NN treatment/NN is/VBZ presented/VBN ./.
@@112076091876 In/NN contrast/NN ,/, the/DT failure/NN of/IN the/DT QKTT/NEWGENE motif/NEWGENE and/CC TGN46/NEWGENE cytoplasmic/JJ tail/NN to/IN induce/VB steady-state/JJ ER/NN localization/NN of/IN vesicular/NEWGENE stomatitis/NEWGENE virus/NEWGENE glycoprotein/NEWGENE (/( VSVG/NEWGENE )/SYM chimeras/NNS in/IN HeLa/DT and/CC NRK/NN cells/NNS indicates/VBZ that/IN significant/JJ differences/NNS in/IN early/JJ secretory/JJ trafficking/NN also/RB exist/VB ./.
@@26915578902 The/DT incidence/NN of/IN fetal/JJ breathing/JJ movements/NNS (/( 06/CD ./CD 00-10/CD ./CD 00/CD h/NN )/SYM decreased/VBN with/IN increasing/JJ gestational/JJ age/NN while/CC fetal/JJ arterial/JJ concentrations/NNS of/IN plasma/NN PGE/NN increased/VBN significantly/RB over/RB the/DT same/JJ period/NN of/IN gestation/NN ./.
@@106497384407 Two/CD episodes/NNS of/IN peritonitis/NN occurred/VBN while/CC the/DT patient/NN received/VBD CAPD/NN (/( 1/CD episode/NN //NN 3/NN ./NN 5/NN patient-months/NNS )/SYM ./.
@@1832152233 Potential/JJ translational/JJ start/NN signals/NNS are/VBP upstream/RB of/IN ORF1/NN and/CC ORF2/NN ./.
@@90578401387 The/DT recombinant/JJ protein/NN was/VBD purified/VBN to/IN homogeneity/NN by/IN (/( NH4/DT )/NN 2SO4-precipitation/NN and/CC affinity/NN chromatography/NN on/IN 5'/CD AMP-Sepharose/NNP ./.
@@107131558944 Here/RB we/PRP show/VBP that/IN IIIa/NN pre-mRNA/NN splicing/JJ is/VBZ activated/VBN more/RB than/IN 200-fold/JJ in/IN nuclear/JJ extracts/NNS prepared/VBN from/IN late/JJ adenovirus-infected/JJ cells/NNS (/( Ad-NE/JJ )/SYM compared/VBN to/IN uninfected/JJ HeLa/DT cell/NN nuclear/JJ extracts/NNS (/( HeLa-NE/NNP )/SYM ./.
@@20942212694 Diuresis/NNS was/VBD induced/VBN by/IN scheduled/JJ drinking/NN of/IN tea/NN (/( 150/CD ml/NN //NN h/NN )/SYM ./.
@@96623395715 In/NN these/DT cells/NNS ,/, ras-induced/JJ transition/NN is/VBZ accompanied/VBN by/IN a/DT strong/JJ induction/NN of/IN AP-1-binding/JJ activity/NN along/IN with/IN increased/VBN expression/NN of/IN CD44/NEWGENE mRNA/NEWGENE and/CC protein/NN ./.
@@96661145916 Structural/NNP analysis/NN of/IN the/DT 5'-regulatory/NN region/NN reveals/VBZ that/IN the/DT c-met/NEWGENE promoter/NEWGENE lacks/VBZ TATA/NN or/CC CAAT/NN elements/NN but/CC has/VBZ an/DT extremely/RB high/JJ G-C/NN content/NN and/CC multiple/JJ Sp1/NEWGENE binding/NEWGENE sites/NEWGENE ./.
@@114600351337 In/NN the/DT last/NN case/NN ,/, both/DT hydroxychloroquine/NN ,/, carbamazepine/NN and/CC fluvoxamine/NN had/VBP a/DT common/JJ imputability/NN which/WDT was/VBD plausible/JJ ./.
@@22509196724 Perceptions/NNS of/IN illness/NN intrusiveness/NN were/VBD significantly/RB higher/JJ when/CC both/DT muscle/NN cramp/NN and/CC headache/NN symptoms/NNS occurred/VBN during/IN one/PRP or/CC more/JJ assessment/NN intervals/NNS as/IN compared/VBN to/IN when/CC muscle/NN cramps/NNS or/CC headaches/NNS ,/, only/RB ,/, occurred/VBN ./.
@@85526704603 Abp1/NEWGENE preferentially/RB binds/VBZ to/IN multiple/JJ sites/NNS in/IN ARS/NNS 3002/CD and/CC to/IN the/DT DNA/NN polymer/NN poly/NN [/NN d/NN (/NN A/NN ./NN T/NN )/NN ]/NN ./.
@@92347433659 Neither/CC of/IN these/DT proteins/NNS ,/, individually/RB or/CC as/IN a/DT pair/NN ,/, can/MD bind/VB the/DT alpha-globin/NEWGENE 3'UTR/NEWGENE unless/IN they/PRP are/VBP complexed/VBN with/IN the/DT remaining/JJ non-poly/NN (/NN C/NN )/NN binding/JJ proteins/NNS of/IN the/DT alpha-complex/NEWGENE ./.
@@90606221833 This/DT is/VBZ the/DT first/JJ report/NN that/IN an/DT in/NN vitro-synthesized/NN alphavirus/NN RNA/NN lacking/JJ a/DT poly/NN (/NN A/NN )/NN tail/NN can/MD initiate/VB infection/NN and/CC produce/VB 3'/CD polyadenylated/JJ viral/JJ genome/NN in/IN vivo/NN ./.
@@11701431543 Groups/NNS of/IN ten/CD dependent/JJ and/CC ten/CD saline/JJ mice/NNS were/VBD singly/RB tested/VBN in/IN both/DT light/NN and/CC dark/JJ conditions/NNS in/IN each/DT of/IN five/CD covered/VBN cylinders/NNS (/( 2-23/JJ in/IN high/JJ )/SYM ./.
@@97269917903 Mapping/NN of/IN the/DT DNA/NN binding/JJ domain/NN of/IN the/DT copper-responsive/JJ transcription/NN factor/NN Mac1/NEWGENE from/NEWGENE Saccharomyces/NEWGENE cerevisiae/NEWGENE ./.
@@27652147597 Hence/RB follows/VBZ Kurti's/NN demand/NN to/IN mete/VB out/RB appropriate/JJ importance/NN to/IN the/DT arguments/NNS ./.
@@67828694806 Nitrogen/NN balance/NN was/VBD compared/VBN ,/, and/CC metabolic/JJ complications/NNS were/VBD monitored/VBN by/IN evaluating/VBG BUN/NN ,/, serum/JJ creatinine/NN ,/, creatinine/NN clearance/NN ,/, serum/JJ CO2/NN ,/, SGOT/NN ,/, SGPT/NN ,/, serum/NEWGENE LDH/NEWGENE ,/, and/CC serum/NEWGENE alkaline/NEWGENE phosphatase/NEWGENE ./.
@@60953728558 The/DT drug/NN was/VBD given/VBP in/IN a/DT daily/JJ oral/JJ dose/NN of/IN 0/CD ./CD 5/CD g/NN //NN m2/NN ,/, 3/CD ./CD 5/CD h/NN prior/NN to/IN each/DT radiation/NN treatment/NN ./.
@@92656422801 Because/IN the/DT biosynthetic/JJ pathway/NN to/IN the/DT vacuole/NN intersects/VBZ with/IN the/DT endocytic/JJ pathway/NN ,/, internalization/NN of/IN a/DT bulk/NN membrane/NN endocytic/JJ marker/NN FM/NNP 4-64/NN was/VBD assayed/VBN in/IN the/DT sop/NEWGENE mutants/NEWGENE ./.
@@104723141748 RESULTS/NNS :/: 256/CD Periods/NNS of/IN TTP/NN or/CC PUNP/NN were/VBD reported/VBN by/IN men/NNS and/CC 174/CD by/IN women/NNS ./.
@@90461869003 The/DT protector/NN doubled/VBD the/DT estimated/VBN fall/NN distance/NN for/IN fracture/NN of/IN the/DT trochanter/NN ./.
@@92364419194 The/DT remaining/JJ 80/CD patients/NNS underwent/VBD recordings/NNS of/IN ECG/NN ,/, beat-to-beat/JJ arterial/JJ oxygen/NN saturation/NN (/( SaO2/NN )/SYM ,/, and/CC respiration/NN during/IN both/DT spontaneous/JJ and/CC controlled/VBN breathing/JJ ./.
@@974787345 The/DT SH2-containing/JJ adapter/NN protein/NN GRB10/NEWGENE interacts/VBZ with/IN BCR-ABL/NEWGENE ./.
@@29195303628 Controlled/JJ versus/IN uncontrolled/JJ reperfusion/NN of/IN ischemic/JJ myocardium/NN after/IN experimental/JJ coronary/JJ artery/NN occlusion/NN was/VBD studied/VBN to/IN determine/VB the/DT effect/NN on/IN regional/JJ ventricular/JJ wall/NN motion/NN and/CC associated/VBN biochemical/JJ alterations/NNS ./.
@@106799228913 No/DT somatic/JJ mutations/NNS were/VBD found/VBN in/IN any/DT of/IN the/DT samples/NNS ,/, suggesting/VBG that/IN ING1/NEWGENE is/VBZ not/RB a/DT tumor/NN suppressor/NN gene/NN target/NN in/IN head/NN and/CC neck/NN cancer/NN ./.
@@105804384259 In/NN electrophoretic/JJ mobility/NN shift/NN assay/NN (/( EMSA/NN )/SYM ,/, this/DT GLUT4/NEWGENE repressor/NEWGENE element/NEWGENE (/( G4RE/NEWGENE )/SYM generated/VBN specific/JJ bands/NNS with/IN nuclear/JJ extracts/NNS from/IN preadipocytes/NNS ,/, but/CC not/RB from/IN adipocytes/NNS ./.
@@96674822320 The/DT report/NN highlights/VBP the/DT possible/JJ contribution/NN of/IN stress/NN factors/NN in/IN the/DT context/NN of/IN therapy/NN resistant/JJ periodontal/JJ disease/NN ,/, and/CC the/DT results/NNS seem/VBP to/IN be/VB understandable/JJ within/IN the/DT context/NN of/IN a/DT stress/NN system/NN disorder/NN perspective/NN ./.
@@19680433598 Four/CD putative/JJ positive/JJ cDNA/NN clones/NNS were/VBD isolated/VBN ,/, and/CC the/DT largest/JJS insert/NN (/( pASB-1/NEWGENE )/SYM was/VBD sequenced/VBN in/IN both/DT orientations/NNS ./.
@@19902666592 DNA-protein/NN UV/NN cross-linking/VBG studies/NNS indicated/VBN that/IN UHF-1/NEWGENE has/VBZ an/DT electrophoretic/JJ mobility/NN on/IN sodium/NN dodecyl/NN sulfate-acrylamide/JJ gels/NNS of/IN approximately/RB 85/CD kDa/NN and/CC suggested/VBN that/IN additional/JJ proteins/NNS ,/, specific/JJ to/IN each/DT promoter/NN ,/, bind/NN to/IN each/DT site/NN ./.
@@106509392492 In/NN myometrial/JJ SMC/NN ,/, both/DT isoforms/NNS of/IN the/DT progesterone/NEWGENE receptor/NEWGENE ,/, PR-B/NEWGENE and/CC PR-A/NEWGENE ,/, caused/VBD a/DT ligand-dependent/JJ activation/NN of/IN PGDH-2368/NEWGENE //NEWGENE luc3/NEWGENE ./.
@@86188641646 Further/JJ analysis/NN of/IN this/DT domain/NN by/IN in/IN vitro/FW mutagenesis/NN pointed/VBN to/IN a/DT core/NN of/IN hydrophobic/NN and/CC acidic/NN residues/NNS as/IN critical/JJ for/IN the/DT activity/NN ./.
@@65419326331 Methods/NNS of/IN clinical/JJ and/CC experimental/JJ algesimetry/NN are/VBP described/VBN that/WDT have/VBP been/VBN used/VBN to/IN evaluate/VB effects/NNS of/IN peripherally/RB and/CC centrally/RB acting/JJ analgesics/NNS ./.
@@70443896817 Facts/NNP on/IN the/DT Economic/NNP Recovery/NNP Tax/NN Act/NN of/IN 1981/CD for/IN speech-language/NN pathologists/NNS and/CC audiologists/NNS ./.
@@93156784731 However/RB ,/, Cbf5p/NEWGENE was/VBD found/VBN to/IN be/VB nucleolar/JJ and/CC is/VBZ highly/RB homologous/JJ to/IN the/DT rat/NEWGENE nucleolar/NEWGENE protein/NEWGENE NAP57/NEWGENE ,/, which/WDT coimmunoprecipitates/NNS with/IN Nopp140/NEWGENE and/CC which/WDT is/VBZ postulated/VBN to/IN be/VB involved/VBN in/IN nucleolar-cytoplasmic/JJ shuttling/VBG (/( U/NNP ./NNP
@@95829537131 RESULTS/NNS :/: Horses/NNS with/IN colic/JJ had/VBP significantly/RB higher/JJ fibrinogen/NEWGENE concentration/NN ,/, greater/JJR alpha/NEWGENE 2AP/NEWGENE and/CC protein/NEWGENE C/NEWGENE activities/NNS ,/, and/CC longer/JJR PT/NN and/CC APTT/NN than/IN did/VBD healthy/JJ horses/NNS ./.
@@61112835933 Trial/NN treatment/NN of/IN schizophrenia/NN with/IN des-Tyr-gamma-endorphin/NEWGENE ./.
@@77522231003 The/DT Myc/NEWGENE LZ/NEWGENE was/VBD found/VBN to/IN prevent/VB homodimeric/JJ interactions/NNS ,/, thus/RB explaining/VBG Myc/NEWGENE inability/NN to/IN homodimerize/VB efficiently/RB ./.
@@96459425389 A/DT major/JJ pool/NN of/IN Dsg-plakoglobin/NEWGENE complexes/NEWGENE sedimented/VBN at/IN 8S/CD and/CC exhibited/VBD a/DT 1/CD :/: 1/CD stoichiometry/NN ./.
@@112360561067 Conclusion/NNS :/: The/DT Lp/NEWGENE (/NEWGENE a/NEWGENE )/NEWGENE levels/NNS in/IN these/DT children/NNS were/VBD the/DT lower/RBR ever/RB reported/VBN ./.
@@82689122403 In/NN vitro/FW translation/NN experiments/NNS show/VBP that/IN human/NN cDNA/NN derived/NN RNA/NN translates/VBZ into/IN a/DT protein/NN with/IN a/DT mobility/NN of/IN 44-46/JJ kD/NN on/IN SDS/NN polyacrylamide/NN gels/NNS ./.
@@25459035530 Antibodies/NNS raised/VBN to/IN the/DT expressed/VBN NS3/NEWGENE by/IN immunization/NN of/IN mice/NNS detected/VBD both/DT NS3/NEWGENE and/CC NS3A/NEWGENE in/IN BTV-10-infected/JJ BHK/NN cells/NNS but/CC not/RB in/IN purified/VBN BTV-10/NN virus/NN particles/NNS ./.
@@33320221913 There/EX is/VBZ a/DT cysteine/NN clustering/NN region/NN in/IN an/DT N-terminal/NN region/NN of/IN the/DT c-raf/NEWGENE (/NEWGENE -1/NEWGENE )/NEWGENE product/NEWGENE deduced/VBN from/IN the/DT nucleotide/NN sequence/NN ,/, and/CC this/DT cysteine/NN clustering/NN region/NN was/VBD found/VBN to/IN be/VB highly/RB homologous/JJ to/IN that/DT present/NN in/IN an/DT N-terminal/NN region/NN of/IN protein/NEWGENE kinase/NEWGENE C/NEWGENE ,/, although/IN ,/, in/IN the/DT latter/JJ cysteine/NN clusters/NN are/VBP present/VB in/IN duplicate/NN ./.
@@88165073818 In/NN transient/JJ cotransfections/NNS E1A/NEWGENE could/MD induce/VB the/DT activity/NN of/IN the/DT p53/NEWGENE promoter/NEWGENE to/IN a/DT high/JJ level/NN ;/: 12S/NEWGENE E1A/NEWGENE was/VBD threefold/RB as/RB efficient/JJ as/IN 13S/NEWGENE E1A/NEWGENE in/IN this/DT activity/NN ,/, and/CC YY1/NEWGENE bound/JJ to/IN the/DT composite/JJ element/NN was/VBD shown/VBP to/IN mediate/VB 55%/NN of/IN this/DT induction/NN ./.
@@15778196545 Two/CD variant/NN PRP-precursor/NEWGENE alleles/NEWGENE occur/VBP which/WDT slightly/RB differ/VB in/IN the/DT number/NN of/IN repeats/NNS in/IN domain/NEWGENE C/NEWGENE ./.
@@78717217036 The/DT first/JJ open/JJ reading/JJ frame/NN of/IN the/DT blueberry/NN scorch/NN carlavirus/NN (/( BBScV/NNP )/SYM genome/NN encodes/VBZ a/DT putative/JJ replication-associated/NN protein/NN of/IN 223/CD kDa/NN (/( p223/NEWGENE )/SYM ./.
@@17629145609 Hence/RB ,/, the/DT uPA/NEWGENE promoter/NEWGENE contains/VBZ multiple/JJ weak/JJ cis-acting/JJ elements/NNS distributed/VBN over/RB 7/CD ./CD 0/CD kb/NN 5'/CD to/IN the/DT translation/NN start/NN site/NN ./.
@@21054974381 An/DT evolutionary/JJ comparison/NN of/IN amino/JJ acid/NN sequences/NNS of/IN 34/NN HSP70/NEWGENE proteins/NEWGENE from/IN 17/CD species/NN suggests/VBZ that/IN BiP/NEWGENE genes/NEWGENE share/VBP a/DT common/JJ ancestor/NN ,/, which/WDT diverged/VBN from/IN other/DT HSP70/NEWGENE genes/NEWGENE near/IN the/DT time/NN when/CC eukaryotes/NNS first/RB appeared/VBN ./.
@@107343127292 To/TO understand/VB whether/IN Shc/NEWGENE localization/NN in/IN membrane/NN rafts/NNS is/VBZ sufficient/JJ to/IN regulate/VB Shc/NEWGENE function/NN ,/, we/PRP constructed/VBD a/DT Shc/NEWGENE chimera/NEWGENE containing/JJ the/DT Ras/NEWGENE membrane/NEWGENE localization/NEWGENE motif/NEWGENE at/IN the/DT C-terminus/NN ./.
@@75184602728 On/IN the/PDT other/DT hand/NN ,/, cells/NNS containing/NN a/NN PTP1C/NEWGENE in/IN which/WDT the/DT catalytic/JJ site/NN had/VBP been/VBN inactivated/VBN through/JJ mutagenesis/NN ,/, stably/RB phosphorylated/VBN the/DT phosphatase/NEWGENE ./.
@@9115909068 Haemodynamic/NN responses/NNS to/IN antagonism/NN of/IN bocurarine/NN block/NN with/IN atropine-neostigmine/JJ mixture/NN in/IN children/NNS ./.
@@40251784175 Retrospective/JJ analyses/NNS of/IN this/DT death/NN revealed/VBD a/DT significant/JJ decrease/NN of/IN the/DT left/JJ ventricular/JJ (/( LV/JJ )/SYM end-diastolic/JJ volume/NN index/NN (/( EDVI/NNS )/SYM of/IN 21/CD ml/NN //NN m2/NN (/( 36%/NN of/IN normal/JJ )/SYM ./.
@@109582717943 METHODS/IN AND/CC RESULTS/NNS :/: We/PRP prospectively/RB compared/VBD the/DT automated/JJ measurements/NNS of/IN left/NN ventricular/JJ ejection/NN fraction/NN (/( LVEF/NN )/SYM and/CC volumes/NNS from/IN rest-injected/JJ gated/NN Technetium/NN 99m/NN (/( Tc99m/NN )/SYM perfusion/NN SPECT/NN with/IN equilibrium/NN radionuclide/NN angiocardiography/NN (/( ERNA/NNP )/SYM in/IN 62/NNP patients/NNS and/CC the/DT assessment/NN of/IN regional/JJ function/NN with/IN echocardiography/NN in/IN 22/CD patients/NNS ./.
@@2556269234 The/DT DNA/NN helix/NN at/IN the/DT tandemly/RB repeated/JJ ,/, 13mer/NN sequence/NN is/VBZ thermodynamically/RB unstable/JJ ,/, as/IN evidenced/VBN by/IN hypersensitivity/NN to/IN single-strand-specific/NEWGENE nuclease/NEWGENE in/IN a/DT negatively/RB supercoiled/VBN plasmid/NN ,/, and/CC demonstrated/VBD by/IN stable/JJ DNA/NN unwinding/JJ seen/VBP after/IN two-dimensional/JJ gel/NN electrophoresis/NN of/IN topoisomers/NNS ./.
@@15695817924 Here/RB ,/, we/PRP present/VBP evidence/VBP for/IN a/DT model/NN in/IN which/WDT mRNA/NN sequences/NNS up/JJ to/IN around/IN 100/CD nucleotides/NNS downstream/RB from/IN the/DT start/NN codon/NN of/IN 21K/CD fold/NN back/NN and/CC base-pair/NN to/IN the/DT 21K/NN translation/NN initiation/NN region/NN ,/, thereby/RB decreasing/JJ the/DT translation/NN initiation/NN frequency/NN ./.
@@113316137431 Consistent/JJ effects/NNS on/IN pVHL/NEWGENE function/NN were/VBD observed/VBN for/IN all/DT mutations/NNS within/IN each/DT subclass/NN ./.
@@80845929663 In/NN HeLa/DT x/NN fibroblast/NN cell/NN hybrids/NNS its/PRP expression/NN correlates/VBP with/IN tumorigenicity/NN ./.
@@79619577632 Furthermore/RB ,/, our/PRP data/NN also/RB show/VB that/IN ,/, in/IN addition/NN to/IN TEF-1/NEWGENE ,/, another/DT HF-1a-related/NEWGENE factor/NEWGENE may/MD be/VB recognized/VBN by/IN the/DT alpha-MHC/NEWGENE gene/NEWGENE EM/NEWGENE1 element/NEWGENE1 ./.
@@71065346904 In/NN this/DT way/NN it/PRP is/VBZ possible/JJ to/IN simulate/VB the/DT growth/NN function/NN of/IN the/DT embryofetal/JJ curve/NN of/IN the/DT length'/NN increase/NN of/IN man/NN and/CC the/DT curve/NN of/IN the/DT mass'/NN increase/NN of/IN rat/NN ./.
@@84238318376 The/DT use/NN of/IN this/DT model/NN for/IN investigating/VBG pathophysiologically/RB significant/JJ issues/NNS in/IN denervating/JJ diseases/NNS is/VBZ illustrated/VBN with/IN five/CD different/JJ sets/NNS of/IN parameters/NNS ./.
@@90291049923 The/DT 14/NEWGENE ./NEWGENE 1/NEWGENE (/NEWGENE IGLL1/NEWGENE )/NEWGENE gene/NEWGENE is/VBZ expressed/VBN in/IN a/DT lineage-/JJ and/CC stage-restricted/JJ manner/NN ./.
@@31909143886 Determined/VBN as/IN migration/NN differentials/NNS ,/, chemotactic/JJ and/CC chemokinetic/JJ responsiveness/NN tended/VBN to/IN be/VB higher/JJ in/IN the/DT neutropenic/JJ group/NN ./.
@@97038162587 IA-CT/NNP with/IN cisplatin/NN 50/NN mg/NN and/CC doxorubicin/NN 30/NN mg/NN was/VBD administered/VBN by/IN one/PRP shot/JJ method/NN in/IN bilateral/JJ internal/JJ iliac/JJ arteries/NNS ./.
@@40661949515 Greater/NNP attenuation/NN of/IN the/DT N1-P2/NN and/CC baseline-P2/NN amplitude/NN of/IN the/DT probe/NN EPs/NNS was/VBD observed/VBN when/CC the/DT probe/NN stimulus/NN was/VBD presented/VBN to/IN the/DT right/JJ ear/NN and/CC the/DT verbal/JJ material/NN presented/VBN to/IN the/DT left/NN ear/NN than/IN when/CC the/DT opposite/NN stimulation/NN arrangement/NN was/VBD used/VBN ./.
@@2259334343 The/DT upstream/JJ promoter/NN is/VBZ located/VBN within/IN the/DT coding/JJ sequence/NN of/IN a/DT divergent/JJ gene/NN expressing/NN a/NN protein/NN of/IN Mr/NNP 39/CD kDa/NN of/IN unknown/JJ function/NN ./.
@@75697707469 METHODS/IN :/: All/PDT these/DT 30/CD non-responders/NNS received/VBD an/DT extra/JJ dose/NN of/IN the/DT same/JJ vaccine/NN 2/CD months/NNS after/IN primary/JJ immunization/NN and/CC a/DT booster/NN dose/NN with/IN a/DT yeast-derived/NN vaccine/NN 6/NN years/NNS later/JJR ./.
@@117877201644 In/NN sterilized/VBD milk/NN there/RB was/VBD a/DT slight/JJ decrease/NN of/IN linoleic/JJ acid/NN (/( C18/IN :/: 2n6/CD ;/: -0/CD ./CD 7%/CD vs/IN ./IN fresh/JJ ;/: P/NN =/SYM 0/CD ./CD 006/CD )/SYM and/CC arachidonic/JJ acid/NN (/( C20/NN :/: 4n6/CD ;/: -2/CD ./CD 5%/CD ;/: P/NN =/SYM 0/CD ./CD 045/CD )/SYM ./.
@@22177412855 The/DT interrelation/NN of/IN the/DT levels/NNS of/IN glucocorticoids/NNS and/CC insulin/NEWGENE in/IN the/DT blood/NN of/IN irradiated/JJ animals/NNS ./.
@@115529228667 CYP2C19/NEWGENE genotype/NEWGENE was/VBD determined/VBN by/IN the/DT polymerase/NN chain/NN reaction-restriction/JJ fragment/NN length/NN polymorphism/NN method/NN ./.
@@102070494998 The/DT results/NNS demonstrate/VBP that/IN the/DT Glc7/NEWGENE phosphatase/NEWGENE and/CC its/PRP Gac1/NEWGENE regulatory/NN subunit/NN play/NN positive/JJ roles/NNS in/IN HSF/NEWGENE activation/NN of/IN CUP1/NEWGENE transcription/NN ./.
@@25987453249 Most/JJS of/IN them/PRP were/VBD situated/VBN at/IN Sylvius/NN fissure/NN (/( 13/CD cases/NNS )/SYM ./.
@@76514006220 This/DT inhibition/NN can/MD be/VB overcome/VB by/IN mutating/JJ either/DT the/DT exon's/NNS 5'/CD or/CC 3'/CD splice/NN site/NN to/IN make/NN it/PRP correspond/VBP more/RB closely/RB to/IN the/DT relevant/JJ consensus/NN sequence/NN ./.
@@101011984832 A/DT database/NN search/NN has/VBZ revealed/VBN as/IN the/DT most/RB significative/JJ homology/NN a/DT match/NN with/IN the/DT human/NEWGENE mitochondrial/NEWGENE transcription/NEWGENE termination/NEWGENE factor/NEWGENE (/( mTERF/NEWGENE )/SYM ,/, a/DT protein/NN that/WDT also/RB binds/VBZ DNA/NN as/IN a/DT monomer/NN and/CC contains/VBZ three/CD leucine/NN zippers/NN forming/JJ intramolecular/JJ interactions/NNS ./.
@@91214764813 PRH75/NEWGENE ,/, a/DT new/JJ nucleus-localized/JJ member/NN of/IN the/DT DEAD-box/NEWGENE protein/NEWGENE family/NEWGENE from/IN higher/JJ plants/NNS ./.
@@82897935524 Furthermore/RB ,/, the/DT negative/JJ transcriptional/JJ effect/NN of/IN COUP-TFs/NEWGENE is/VBZ dominant/JJ over/RB the/DT activating/JJ effect/NN of/IN the/DT Oct4/NEWGENE embryonic/NEWGENE stem/NEWGENE cell-specific/NEWGENE enhancer/NEWGENE ./.
@@105854804614 Point/NNP mutations/NNS in/IN the/DT third/RB SH3/NEWGENE domain/NEWGENE abolished/VBD the/DT vinexin-Sos/NEWGENE interaction/NN ./.
@@74785147548 We/PRP have/VBP isolated/VBN a/DT new/JJ ,/, larger/JJR rat/NEWGENE B-myc/NEWGENE genomic/NEWGENE clone/NEWGENE ./.
@@90137606891 Cholesterol/NEWGENE side-chain/NEWGENE cleavage/NEWGENE cytochrome/NEWGENE P450/NEWGENE (/( CYP11A/NEWGENE ;/: P450scc/NEWGENE )/SYM gene/NN expression/NN is/VBZ regulated/VBN by/IN gonadotropins/NEWGENE via/NN cAMP/NN in/IN the/DT ovary/NN and/CC by/IN ACTH/NEWGENE via/NN cAMP/NN in/IN adrenal/JJ cortical/JJ cells/NNS ./.
@@32838813967 Stable/NN patients/NNS have/VBP mucous/JJ hypersecretion/NN and/CC little/JJ evidence/NN of/IN acute/JJ inflammation/NN ./.
@@70841988316 Selenium/NN status/NN of/IN thoroughbreds/NNS in/IN the/DT United/NNP Kingdom/NNP ./.
@@13777641988 The/DT carcinoma/NN was/VBD restricted/VBN within/IN the/DT epithelium/NN in/IN one/PRP ,/, the/DT mucosal/JJ layer/NN in/IN five/CD ,/, and/CC the/DT submucosal/JJ layer/NN in/IN two/NN ./.
@@68174104979 During/IN the/DT last/NN 6/CD months/NNS of/IN the/DT study/NN a/DT striking/JJ change/NN in/IN epidemiology/NN concerning/VBG hepatitis/NN A/NN was/VBD seen/VBP ,/, apparently/RB caused/VBN by/IN a/DT steep/JJ increase/NN in/IN the/DT incidence/NN of/IN this/DT type/NN of/IN hepatitis/NN among/IN drug/NN addicts/NNS ./.
@@10693246899 In/NN two-field/JJ nodal/JJ dissection/NN ,/, two/JJ components/NNS are/VBP included/VBN with/IN (/( modern/JJ two-field/JJ )/SYM or/CC without/IN (/( traditional/JJ two-field/JJ )/SYM nodal/JJ dissection/NN around/IN both/DT recurrent/JJ laryngeal/JJ nerve/NN chains/NN in/IN the/DT upper/JJ mediastinum/NN ./.
@@91320113199 Comparison/NNS of/IN the/DT p50/NEWGENE sequence/NEWGENE to/IN other/DT cloned/VBN proteins/NNS revealed/VBN 89%/CD homology/NN with/IN a/DT glycosaminoglycan-binding/NN protein/NN and/CC 54%/JJ homology/NN with/IN Drosophila/NEWGENE cell/NEWGENE cycle/NEWGENE control/NEWGENE protein/NEWGENE (/NEWGENE cdc/NEWGENE )/NEWGENE 37/CD ./CD
@@49424146804 The/DT metabolism/NN and/CC pharmacology/NN of/IN 5-fluorouracil/NN ./.
@@98892028835 Structure-function/NNS analysis/NN of/IN the/DT Z-DNA-binding/VBG domain/NN Zalpha/NN of/IN dsRNA/NEWGENE adenosine/NEWGENE deaminase/NEWGENE type/NEWGENE I/NEWGENE reveals/VBZ similarity/NN to/IN the/DT (/( alpha/NN +/SYM beta/NN )/SYM family/NN of/IN helix-turn-helix/NN proteins/NNS ./.
@@84193384401 L/NNP ./NNP ,/, Stange/NNP ,/, G/NNP ./NNP ,/, Markovich/NNP ,/, D/NN ./NN ,/, Biber/NNP ,/, J/NNP ./NNP ,/, Testar/JJ ,/, X/NNP ./NNP ,/, Zorzano/NNP ,/, A/NNP ./NNP ,/, Palacin/NNP ,/, M/NNP ./NNP ,/, and/CC Murer/NNP ,/, H/NNP ./NNP
@@77080581497 The/DT GRE/NEWGENE at/IN nucleotide/NN 7640/CD is/VBZ a/DT composite/NEWGENE GRE/NEWGENE (/( cGRE/NEWGENE )/SYM containing/JJ an/DT overlapping/JJ activator/NEWGENE protein-1/NEWGENE (/( AP-1/NEWGENE )/SYM motif/NN for/IN the/DT c-jun/NEWGENE homodimer/NEWGENE and/CC c-jun/NEWGENE //NEWGENE c-fos/NEWGENE heterodimer/NEWGENE ./.
@@88281422198 Feline/NNP leukemia/NN viruses/NNS (/( FeLVs/NNS )/SYM ,/, which/WDT are/VBP replication-competent/JJ oncoretroviruses/NNS of/IN the/DT domestic/JJ cat/NN species/NN ,/, are/VBP contagiously/RB transmitted/VBN in/IN natural/JJ environments/NNS ./.
@@75927903971 Altogether/RB our/PRP data/NN indicate/VB that/DT PEDF/NEWGENE belongs/VBZ to/IN the/DT subgroup/NN of/IN noninhibitory/JJ serpins/NEWGENE and/CC that/IN its/PRP N-terminal/NN region/NN confers/VBZ a/DT neurite-promoting/JJ activity/NN to/IN the/DT protein/NN ./.
@@107601328119 Our/PRP data/NN suggest/VB that/IN ,/, at/IN least/RB at/IN high/JJ temperature/NN ,/, a/DT critical/JJ minimal/JJ level/NN of/IN Ypt/NEWGENE protein/NEWGENE prenylation/NN is/VBZ required/VBN for/IN maintaining/VBG vesicle/NN polarization/NN ./.
@@13759138255 We/PRP have/VBP constructed/VBN ,/, using/VBG synthetic/JJ DNA/NN oligonucleotides/NNS ,/, a/DT U14/NEWGENE snRNA/NEWGENE gene/NEWGENE which/WDT has/VBZ been/VBN positioned/VBN behind/RB a/DT T7/NEWGENE RNA/NEWGENE polymerase/NEWGENE promoter/NEWGENE site/NEWGENE and/CC then/RB inserted/VBN into/IN a/DT plasmid/NN ./.
@@83193968924 On/IN T2/NN weighted/JJ images/NNS ,/, low/JJ intensity/NN areas/NNS in/IN the/DT thalamus/NN ,/, the/DT striatum/NN ,/, the/DT anterior/JJ limb/NN of/IN the/DT internal/JJ capsule/NN ,/, the/DT tegmentum/NN of/IN midbrain/NN ,/, high/JJ intensity/NN areas/NNS in/IN middle/JJ cerebellar/JJ peduncle/NN ,/, the/DT posterior/JJ limb/NN of/IN the/DT internal/JJ capsule/NN ,/, the/DT lateral/JJ part/NN of/IN the/DT cerebral/JJ peduncle/NN ,/, and/CC the/DT cerebral/JJ white/JJ matter/NN were/VBD noted/VBN ./.
@@86474513022 Northern/NNP blot/NN hybridization/NN demonstrated/VBN that/IN HEP-COP/NEWGENE was/VBD expressed/VBN in/IN a/DT wide/JJ range/NN of/IN human/JJ adult/JJ and/CC fetal/JJ tissues/NNS ./.
@@84126627681 We/PRP have/VBP isolated/VBN a/DT cosmid/NN containing/NN DNA/NN that/WDT corresponds/VBZ to/IN the/DT site/NN of/IN transposon/NN insertion/NN in/IN 257DH4/NNP and/CC have/VB localized/VBN Tn5/NEWGENE on/IN an/DT 8/NEWGENE ./NEWGENE 0/NEWGENE kb/NEWGENE EcoRI/NEWGENE fragment/NEWGENE ./.
@@82886334112 A/DT complementary/JJ DNA/NN was/VBD isolated/VBN from/IN Caenorhabditis/NNP elegans/NNS that/WDT encoded/VBN a/DT polypeptide/NN of/IN 1438/CD amino/JJ acid/JJ residues/NNS ,/, CeGAP/NEWGENE ,/, which/WDT contains/VBZ a/DT domain/NN with/IN sequence/NN similarity/NN to/IN the/DT COOH-terminal/NEWGENE segment/NEWGENE (/NEWGENE GTPase-activating/NEWGENE protein/NEWGENE region/NEWGENE )/NEWGENE of/IN Bcr/NEWGENE and/CC other/DT known/VBP GTPase-activating/NEWGENE proteins/NEWGENE of/IN the/DT Rho/NEWGENE subfamily/NEWGENE ./.
@@14084742024 PaO2/NN threshold/NN was/VBD determined/VBN through/RB an/DT indwelling/JJ O2/NN sensor/NN catheter/NN ./.
@@7572447472 The/DT results/NNS of/IN a/DT quantitative/JJ study/NN of/IN vasculosyncytial/JJ membranes/NNS in/IN 123/CD placentas/NNS are/VBP presented/VBN ./.
@@82835314154 The/DT Stryker/NN frame/NN modification/NN to/IN the/DT standard/JJ Dornier/NNP HM3/NN lithotriptor/NN allows/VBZ for/IN improved/VBN visualization/NN and/CC easier/JJR localization/NN of/IN distal/JJ ureteral/JJ calculi/NNS compared/VBN to/IN the/DT standard/JJ gantry/NN ./.
@@10553959370 The/DT Ishasha/NNP samples/NNS show/VBP a/DT range/NN encompassing/VBG three/CD trophic/JJ levels/NNS ./.
@@10657238733 Transfection/NNS experiments/NNS demonstrated/VBN that/IN the/DT 5'-flanking/JJ region/NN (/( -1894/CD to/IN +37/CD )/SYM of/IN the/DT mStaf/NEWGENE gene/NEWGENE drives/NNS transcription/NN in/IN mouse/NN NMuMG/NNP cells/NNS and/CC that/IN a/DT construct/NN containing/NN a/NN fragment/NN from/IN -387/CD to/IN +37/CD showed/VBD the/DT highest/JJS transcriptional/JJ activity/NN ./.
@@93610078906 A/DT DNase/NEWGENE I-hypersensitive/NEWGENE site/NEWGENE has/VBZ also/RB been/VBN mapped/VBN in/IN the/DT 258-base/JJ pair/NN enhancer/NN region/NN ./.
@@93687608990 Human/NEWGENE PDK1/NEWGENE is/VBZ homologous/JJ to/IN the/DT Drosophila/NEWGENE protein/NEWGENE kinase/NEWGENE DSTPK61/NEWGENE ,/, which/WDT has/VBZ been/VBN implicated/VBN in/IN the/DT regulation/NN of/IN sex/NN differentiation/NN ,/, oogenesis/NN and/CC spermatogenesis/NN ./.
@@97676872419 Phylogenetic/JJ position/NN of/IN the/DT Phacotaceae/NNP within/IN the/DT Chlamydophyceaeas/NNP revealed/VBD by/IN analysis/NN of/IN 18S/NEWGENE rDNA/NEWGENE and/CC rbcL/NEWGENE sequences/NEWGENE ./.
@@86047088581 Additional/JJ studies/NNS with/IN new/JJ and/CC reprocessed/VBN regenerated/VBN cellulose/NN dialyzers/NNS comparing/VBG 450/CD and/CC 220/CD mL/NN //NN min/NN blood/NN flow/NN rates/NNS at/IN 10/CD minutes/NNS showed/VBD no/DT change/NN in/IN BTG/NN ./.
@@94307301879 S/NNP ./NNP ,/, and/CC Walter/NN ,/, P/NNP ./NNP
@@95149626166 M-66/NEWGENE identified/VBD the/DT 14-kDa/NN protein/NN in/IN another/DT MMTV/NN bearing/JJ T-cell/NN lymphoma/NN ,/, EL-4/DT ./.
@@76775737608 A/DT significant/JJ correlation/NN between/IN a/DT number/NN of/IN functional/JJ parameters/NNS of/IN gastric/JJ secretion/NN ,/, incretion/NN and/CC histological/JJ changes/NNS of/IN gastric/JJ mucosa/NN was/VBD found/VBN in/IN patients/NNS with/IN chronic/JJ gastritis/NN ./.
@@111600966266 These/DT mutations/NNS ,/, when/CC placed/VBD in/IN a/DT wild-type/NEWGENE fliF/NEWGENE background/NN ,/, had/VBP no/DT mutant/JJ phenotype/NN ./.
@@80302399699 65/CD ,/, 3829-3838/CD ,/, 1991/NN )/NN ,/, a/DT truncated/JJ form/NN of/IN the/DT IE/NEWGENE polypeptide/NEWGENE lacking/JJ IE/NEWGENE amino/NEWGENE acid/NEWGENE residues/NEWGENE 1-322/NEWGENE (/( and/CC ,/, therefore/RB lacks/VBZ the/DT deduced/VBN transcriptional/JJ activation/NN domain/NN )/SYM ,/, fails/VBZ to/IN transactivate/VB the/DT EHV-1/NEWGENE tk/NEWGENE promoter/NEWGENE ,/, but/CC retains/VBZ the/DT ability/NN to/IN down-regulate/PDT the/DT EHV-1/NEWGENE IE/NEWGENE promoter/NEWGENE ./.
@@85090518473 Seven/CD out/RB of/IN 34/CD patients/NNS died/VBN ,/, giving/JJ a/DT mortality/NN rate/NN of/IN 21%/NN ./.
@@23471023000 The/DT pseudolymphoma/NN syndrome/NN is/VBZ a/DT reversible/JJ reactive/NN condition/NN consisting/VBG of/IN fever/NN ,/, lymphadenopathy/NN and/CC generalized/JJ rash/NN ./.
@@80700049907 Large/JJ interpatient/JJ variation/NN in/IN peak/NN PCZ/NNP plasma/NN levels/NNS (/( 91-3215/CD ng/NN //NN ml/NN )/SYM was/VBD seen/VBP ,/, with/IN the/DT plasma/NN half-life/NN (/( t1/NN //NN 2/NN alpha/NN )/SYM being/VBP approximately/RB 57/CD min/NN in/IN patients/NNS given/VBP 135-180/JJ mg/NN //NN m2/NN PCZ/NNP ./.
@@24849943138 Intravenous/JJ gamma/NEWGENE globulins/NEWGENE ./.
@@92578875766 G-CSF/NEWGENE was/VBD started/VBN on/IN day/NN 3/CD of/IN each/DT cycle/NN (/( 5/CD microg/NN //NN kg/NN //NN day/NN )/SYM and/CC was/VBD stopped/VBN the/DT day/NN before/IN the/DT last/NN apheresis/NN or/CC when/CC absolute/JJ neutrophil/JJ count/NN was/VBD above/RB 0/CD ./CD 5/CD x/NN 10/NN (/NN 9/NN )/NN //NN l/NN ./.
@@62592206057 Experiment/NN 3/CD showed/VBD that/IN the/DT long-term/JJ analgesic/JJ reaction/NN could/MD also/RB be/VB reduced/VBN by/IN administration/NN of/IN naltrexone/NN prior/NN to/IN reexposure/NN to/IN shock/NN ./.
@@77624312951 The/DT protein/NN expressed/VBN from/IN the/DT cloned/VBN cDNA/NN is/VBZ secreted/VBN into/IN the/DT culture/NN medium/NN and/CC yields/NNS of/IN up/JJ to/IN 40/CD mg/NN per/IN litre/NN have/NN been/VBN obtained/VBN ./.
@@90458055957 Acetoin-dependent/NN expression/NN of/IN the/DT acoABCD/NEWGENE operon/NEWGENE could/MD be/VB restored/VBN in/IN the/DT E/NEWGENE ./NEWGENE coli/NEWGENE acoK/NEWGENE mutants/NEWGENE by/IN supplying/VBG a/DT plasmid/NN carrying/JJ an/DT intact/JJ acoK/NEWGENE ,/, suggesting/VBG a/DT transactivating/JJ function/NN of/IN the/DT gene/NN product/NN ./.
@@11145887429 Activation/NNS of/IN transcription/NN through/RB the/DT AP-1/NEWGENE site/NEWGENE in/IN Jurkat/NN cells/NNS by/IN JunD/NEWGENE and/IN //IN or/IN Fra-2/NEWGENE was/VBD weak/JJ ./. c-Jun/NEWGENE ,/, JunB/NEWGENE ,/, and/CC c-Fos/NEWGENE activation/NN was/VBD greater/JJR ,/, although/IN the/DT level/NN was/VBD still/RB less/PRP than/IN that/DT with/IN Tax/NEWGENE ./.
@@117788041626 Frequency/NNP of/IN seeing/VBG curves/NNS were/VBD examined/VBN for/IN the/DT method/NN most/RB similar/JJ to/IN FDT/NN ./.
@@84572919839 Estradiol/CHEM is/NNS known/VBP to/IN induce/VB expression/NN of/IN certain/JJ proto-oncogenes/NNS ,/, and/CC this/DT led/VBN us/PRP to/IN examine/VB potential/JJ regulatory/JJ regions/NNS of/IN the/DT cellular/NEWGENE c-fos/NEWGENE oncogene/NEWGENE ./.
@@94726164636 Also/RB ,/, the/DT deduced/VBN amino/JJ acids/NNS of/IN the/DT antigenic/NEWGENE regions/NEWGENE A/NEWGENE ,/NEWGENE B/NEWGENE and/NEWGENE C/NEWGENE of/NEWGENE VP7/NEWGENE were/VBD nearly/RB conserved/VBN within/IN the/DT phylogenetic/JJ lineages/NNS ./.
@@107622542752 The/DT MMA/NEWGENE ,/NEWGENE DMA/NEWGENE ,/NEWGENE and/NEWGENE TMA/NEWGENE methyltransferases/NEWGENE are/VBP not/RB homologs/NNS ;/: however/RB ,/, like/VB the/DT MMA/NEWGENE methyltransferase/NEWGENE gene/NEWGENE ,/, the/DT genes/NNS encoding/VBG the/DT DMA/NEWGENE and/NEWGENE TMA/NEWGENE methyltransferases/NEWGENE each/DT contain/VB a/DT single/JJ in-frame/NN amber/JJ codon/NN ./.
@@108057374093 Mutational/JJ analysis/NN of/IN mammalian/NEWGENE translation/NEWGENE initiation/NEWGENE factor/NEWGENE 5/NEWGENE (/( eIF5/NEWGENE )/SYM :/: role/NN of/IN interaction/NN between/IN the/DT beta/NN subunit/NN of/IN eIF2/NEWGENE and/CC eIF5/NEWGENE in/IN eIF5/NEWGENE function/NN in/IN vitro/FW and/CC in/IN vivo/NN ./.
@@86053022044 DNA/NN methylation/NN ,/, especially/RB of/IN either/DT one/PRP or/CC both/DT of/IN the/DT deoxyadenosines/NNS at/IN the/DT two/NN GATC/NEWGENE motifs/NEWGENE (/( one/PRP in/IN the/DT first/JJ exon/NN and/CC the/PDT other/DT in/NN the/DT first/JJ intron/NN of/IN the/DT rice/NN CatA/NEWGENE gene/NEWGENE )/SYM ,/, appeared/VBN to/IN be/VB responsible/JJ for/IN the/DT CatA/NEWGENE promoter/NEWGENE activity/NN identified/VBN in/IN the/DT transient/JJ assay/NN ./.
@@95902944324 Genetic/NNP studies/NNS in/IN Drosophila/NN have/NN led/VBN to/IN the/DT identification/NN of/IN several/DT components/NNS of/IN the/PDT Notch/NEWGENE pathway/NEWGENE ./.
@@22087622834 The/DT grandfather/NN and/CC the/DT granddaughter/NN both/DT had/VBP microtia/NN and/CC meatal/JJ atresia/NN ,/, whereas/IN the/DT daughter/JJ had/VBP a/DT normal/JJ outer/JJ ear/NN except/VB for/IN a/DT narrow/JJ meatus/NN and/CC auricular/JJ appendages/NNS ./.
@@99208962994 No/DT significant/JJ differences/NNS between/IN the/DT substituted/JJ and/CC wild/JJ type/NN peptides/NNS were/VBD observed/VBN ,/, suggesting/VBG that/IN this/DT substitution/NN in/IN the/DT intact/JJ protein/NN may/MD cause/VB disruption/NN of/IN global/JJ rather/RB than/IN local/JJ structures/NNS ./.
@@106425319349 Competition/NN experiments/NNS demonstrate/VBP a/DT negative/JJ allosteric/JJ relationship/NN between/IN these/DT RGD/NEWGENE recognition/NEWGENE sites/NEWGENE ./.
@@71604918772 The/DT favourable/NN effect/NN of/IN thymic/JJ shielding/NN was/VBD also/RB reflected/VBN in/IN a/DT significant/JJ increase/NN of/IN LD50/NN //NN 30/NN ,/, and/CC the/DT dose/NN reduction/NN factor/NN was/VBD equal/VB to/IN 2/CD ./CD
@@7933076544 As/IN shown/VBP previously/RB ,/, EBNA2/NEWGENE transactivates/VBZ the/DT promoters/NNS of/IN the/DT viral/NEWGENE latent/NEWGENE membrane/NEWGENE proteins/NEWGENE ./.
@@24082481409 Likewise/RB ,/, whether/IN or/CC not/RB the/DT hypotensive/JJ action/NN of/IN converting/NN enzyme/NN inhibitors/NN is/VBZ age-related/VBG is/VBZ as/IN yet/RB unknown/JJ ./.
@@85296546852 The/DT B/NEWGENE ./NEWGENE germanica/NEWGENE cyclophilin/NEWGENE amino/NEWGENE acid/NEWGENE sequence/NEWGENE shares/VBP 83%/JJ identity/NN with/IN the/DT cytosolic/NEWGENE cyclophilin/NEWGENE isoform/NEWGENE from/NEWGENE Drosophila/NEWGENE melanogaster/NEWGENE (/( Cyp-1/NEWGENE )/SYM ./.
@@93824987726 First/RB ,/, two/JJ MCTs/NN using/VBG a/DT long/JJ electrode/NN ,/, 3/CD cm/NN in/IN size/NN ,/, were/VBD performed/VBN in/IN the/DT central/JJ area/NN of/IN the/DT tumor/NN ,/, and/CC eight/CD MCTs/NN by/IN a/DT short/JJ electrode/NN ,/, 2/CD cm/NN in/IN size/NN ,/, were/VBD done/VBP in/IN the/DT peripheral/JJ and/CC surrounding/JJ area/NN of/IN the/DT tumor/NN ./.
@@1002221016 Factors/NNS influencing/VBG direct-immersion/JJ (/( DI/JJ )/NN -SPME/NN process/NN were/VBD also/RB checked/VBN and/CC chosen/VBP experimentally/RB ./.
@@16154932073 Argatroban/NNP may/MD be/VB more/RB effective/JJ under/IN low/JJ HC/NEWGENE II/NEWGENE conditions/NNS because/IN of/IN its/PRP potent/JJ inhibition/NN of/IN thrombin/NEWGENE activity/NN at/IN sites/NNS of/IN vascular/JJ wall/NN damage/NN ./.
@@10423193280 CONCLUSION/IN :/: These/DT results/NNS suggest/VBP that/IN vibration-induced/JJ neural/JJ involvement/NN can/MD be/VB considered/VBN neither/DT pure/JJ digital/JJ neuropathy/NN ,/, nor/CC definite/JJ CTS/NN ,/, as/IN previously/RB described/VBN ./.
@@6487290703 Salivary/NNP estradiol/NN 17/CD beta/NN (/( E2-17/NN beta/NN )/SYM and/CC progesterone/NN (/( P/NN )/SYM were/VBD determined/VBN by/IN using/VBG radioimmunoassay/NN techniques/NNS in/IN 30/CD pregnant/JJ females/NNS in/IN the/DT first/NN ,/, second/JJ and/CC third/JJ trimesters/NNS as/RB well/VBP as/IN in/IN 10/CD non-pregnant/JJ controls/NNS during/IN the/DT luteal/JJ phase/NN of/IN the/DT menstrual/JJ cycle/NN ./.
@@83343044552 Triton-disrupted/JJ cells/NNS retained/VBD capacity/NN for/IN activation/NN of/IN the/DT pathway/NN by/IN both/DT peptide/NEWGENE growth/NEWGENE factors/NEWGENE and/CC by/IN addition/NN of/IN GTP-loaded/JJ p21/NEWGENE rasVal12/NEWGENE ./.
@@21993119724 In/NN vitro/FW transcription/NN extracts/NNS from/IN ret1-1/NEWGENE cells/NNS terminate/VBP less/PRP efficiently/RB at/IN weak/JJ transcription/NN termination/NN signals/NNS than/IN those/DT from/IN RET1/NEWGENE cells/NNS ,/, using/VBG a/DT variety/NN of/IN tRNA/NN templates/NNS ./.
@@83966575913 Liu/NNP ,/, B/NNP ./NNP
@@93714316521 Strain/NNS CFN037/CELL is/VBZ an/DT R/NNP ./NNP etli/NN mutant/RB induced/VBD by/IN a/DT single/JJ Tn5mob/NEWGENE insertion/NN in/IN the/DT promoter/NN region/NN of/IN the/DT thiCOGE/NEWGENE gene/NEWGENE cluster/NEWGENE ./.
@@1826003325 The/DT gene/NN is/VBZ 1/CD ,/CD 139/CD base/NN pairs/NNS (/( bp/NN )/SYM long/JJ ,/, and/CC ,/, like/VB other/DT members/NNS of/IN the/DT SIG/NEWGENE family/NEWGENE ,/, the/DT beta/NEWGENE TG/NEWGENE gene/NEWGENE is/VBZ divided/VBN into/IN 3/CD exons/NNS ./.
@@87945471637 The/DT rCBF/NN and/CC vasomotion/NN were/VBD recorded/VBN by/IN laser-doppler/JJ fluxmetry/NN ./.
@@90823359035 None/NN of/IN these/DT organic/JJ manifestations/NNS was/VBD discovered/VBN by/IN scintigraphic/JJ means/NN ./.
@@71949051462 TCZ/NN provides/VBZ quick/JJ ,/, inexpensive/JJ ,/, noninvasive/JJ indication/NN of/IN tissue/NN necrosis/NN ,/, moderate-to-severe/JJ intracranial/JJ hemorrhage/NN ,/, and/CC delayed/JJ brain/NN maturation/NN ./.
@@113132492201 A/DT novel/JJ myeloid-restricted/JJ zebrafish/NN CCAAT/NEWGENE //NEWGENE enhancer-binding/NEWGENE protein/NEWGENE with/IN a/DT potent/JJ transcriptional/JJ activation/NN domain/NN ./.
@@8614410463 The/DT alpha/NN T3-1/NN cell/NN line/NN ,/, a/DT GnRH-responsive/JJ gonadotroph/NN cell/NN line/NN developed/VBN by/IN targeted/JJ oncogenesis/NN in/IN transgenic/JJ mice/NNS ,/, was/VBD used/VBN to/IN study/NN regulation/NN of/IN the/DT glycoprotein/NEWGENE hormone/NEWGENE alpha-subunit/NEWGENE by/IN activin/NEWGENE ./.
@@100250503470 The/DT therapy/NN with/IN a/DT H2-receptor/NEWGENE antagonist/NN is/VBZ less/PRP effective/JJ than/IN the/DT triple/JJ therapies/NNS with/IN omeprazole/NN or/CC lansoprazole/NN ./.
@@91396659935 Finally/RB ,/, we/PRP show/VBP that/IN PhLP/NEWGENE complexes/NNS ,/, at/IN least/RB partially/RB ,/, with/IN Gbetagamma/NEWGENE in/IN vivo/NN ./.
@@106016063201 The/DT rhabdomyosarcoma/NN R1H/NN growing/JJ on/IN the/DT right/JJ flank/NN of/IN male/JJ WAG/NNP //NNP Rij/NNP rats/NNS was/VBD clamped/VBN for/IN 2/CD or/CC 4/CD h/NN at/IN 20/CD degrees/NNS C/NN or/CC 37/CD degrees/NNS C/NNP ./NNP
@@101956979239 However/RB ,/, F-SRC-1/NEWGENE mutant/NEWGENE lacking/JJ CBP-interacting/NEWGENE domain/NEWGENE still/RB preserved/VBD enhancing/JJ activity/NN ./.
@@69289746706 The/DT electrocardiogram/NN ./.
@@79728312107 PAI-1/NEWGENE levels/NNS increased/VBN significantly/RB in/IN patients/NNS who/WP received/VBD iohexol/NN but/CC not/RB in/IN those/DT who/WP received/VBD ioxaglate/NN ./.
@@69576335509 Development/NNP of/IN basophilic/JJ leukemia/NN with/IN trisomy/NN 8/CD and/CC atypical/JJ erythroblastosis/NN in/IN a/DT patient/NN with/IN a/DT history/NN of/IN aplastic/JJ anemia/NN 22/NN years/NNS earlier/JJR ./.
@@91320577796 A/DT polypeptide/NN encoded/VBN by/IN the/DT NTS/NN 16/NN open/JJ reading/JJ frame/NN has/VBZ sequence/NN similarity/NN to/IN the/DT catalytic/JJ domain/NN of/IN several/DT receptor/NEWGENE protein/NEWGENE kinases/NEWGENE from/NEWGENE plants/NEWGENE including/JJ the/DT S-receptor/NEWGENE kinases/NEWGENE implicated/VBN in/IN the/DT rejection/NN of/IN self-pollen/JJ in/IN Brassica/NNP species/NN and/CC the/DT Pto/NEWGENE gene/NEWGENE product/NEWGENE of/NEWGENE tomato/NEWGENE which/WDT confers/VBZ resistance/NN to/IN a/DT bacterial/JJ pathogen/NN ./.
@@24736196237 Spontaneous/JJ sensitization/NN to/IN cross-reacting/VBG chemicals/NNS in/IN a/DT proportion/NN of/IN control/NN animals/NNS is/VBZ strongly/RB suggested/VBN ,/, somewhat/RB akin/JJ to/IN spontaneous/JJ sensitization/NN in/IN patients/NNS with/IN anaphylactoid/JJ reactions/NNS to/IN neuromuscular/JJ blockers/NNS on/IN first/JJ exposure/NN ,/, and/CC in/IN whom/WP IgE/NEWGENE antibodies/NEWGENE are/VBP detected/VBN ./.
@@10856805663 Improving/VBG fissure/NN sealant/NN quality/NN :/: mechanical/JJ preparation/NN and/CC filling/JJ level/NN ./.
@@85983596716 Do/VBP overall/JJ treatment/NN time/NN ,/, field/NN size/NN ,/, and/CC treatment/NN energy/NN influence/NN local/JJ control/NN of/IN T1-T2/NN squamous/JJ cell/NN carcinomas/NNS of/IN the/DT glottic/JJ larynx/NN ?/. PURPOSE/NNS :/: To/TO evaluate/VB treatment/NN and/CC patient/NN related/VBD prognostic/JJ factors/NNS that/WDT may/MD influence/VB local/JJ control/NN in/IN the/DT treatment/NN of/IN T1-T2/NN squamous/JJ cell/NN carcinoma/NN of/IN the/DT glottic/JJ larynx/NN ./.
@@8246984688 These/DT results/NNS demonstrate/VBP the/DT existence/NN of/IN different/JJ PI/NEWGENE 3-kinase/NEWGENE isoforms/NEWGENE and/CC define/VB a/DT family/NN of/IN genes/NNS encoding/VBG distinct/JJ PI/NEWGENE 3-kinase/NEWGENE catalytic/NEWGENE subunits/NEWGENE that/WDT can/MD associate/VB with/IN p85/NEWGENE ./.
@@90429115721 Cognate/NN promoter/NN elements/NN implicated/VBN in/IN glucocorticoid-/JJ and/CC cAMP-mediated/JJ regulation/NN as/RB well/VB as/IN in/IN liver-/DT ,/, myeloid-/JJ ,/, and/CC lymphocyte-specific/JJ expression/NN are/VBP located/VBN within/IN the/DT 5'/CD flanking/JJ sequence/NN ./.
@@7290034444 Residues/NNS removed/VBN from/IN transcripts/NNS by/IN splicing/JJ were/VBD identified/VBN ./.
@@77973464376 An/DT outbreak/NN of/IN hepatitis/NN A/NN among/IN homosexual/JJ men/NNS in/IN Amsterdam/NN ,/, 1991-1993/CD ./.
@@70804966863 The/DT differential/JJ investigation/NN of/IN lipoproteins/NNS ,/, however/RB ,/, showed/VBD that/IN the/DT high-density/JJ lipoprotein/NN (/( HDL/NN )/SYM fractions/NNS are/VBP absolutely/RB or/CC relatively/RB decreased/VBN with/IN respect/NN to/IN low-density/NEWGENE lipoproteins/NEWGENE (/( LDL/NEWGENE )/SYM in/IN cerebral/JJ infarcts/NNS and/CC in/IN transient/JJ ischaemic/JJ attacks/NNS ./.
@@53573905490 Auto-/NNP and/CC isotopy/NN of/IN the/DT conjunctiva/NN ./.
@@946397800 Prazosin/NN alone/RB was/VBD effective/JJ in/IN volume/NN responsive/JJ patients/NNS at/IN a/DT dose/NN of/IN 5/CD +/NN //NN -/NN 1/CD ./CD 0/CD mg/NN daily/JJ ./.
@@53725115509 Diethylene/NNP benzene/NN ./.
@@10991648825 Coexisting/JJ vertical/JJ and/CC horizontal/JJ one/PRP and/CC a/DT half/NN syndromes/NNS ./.
@@17023611808 Recently/RB ,/, studies/VBZ of/IN agents/NNS that/WDT disrupt/VBP collagen/NEWGENE synthesis/NN and/CC deposition/NN have/NN yielded/VBD several/DT new/JJ angiogenesis/NN inhibitors/NNS ./.
@@30258628939 A/DT single/JJ exon/NN encodes/VBZ the/DT carboxyl-terminal/NN 26/NN amino/JJ acids/NNS of/IN the/DT ssd/NEWGENE chain/NEWGENE and/CC the/DT 3'/CD untranslated/JJ region/NN of/IN its/PRP mRNA/NN ,/, ending/NN with/IN a/DT poly/NN (/NN A/NN )/NN -addition/NN site/NN ./.
@@100986014444 Mutational/JJ analysis/NN of/IN the/DT -84/JJ //JJ -55/JJ DNA/NN showed/VBN that/IN JEG-3/NEWGENE nuclear/NEWGENE proteins/NEWGENE bound/JJ to/IN a/DT site/NN containing/JJ ,/, but/CC not/RB identical/JJ to/IN ,/, the/DT SF-1/NEWGENE sequence/NEWGENE ./.
@@93252843789 The/DT sequenced/VBN cDNA/NN predicts/VBZ a/DT 704-amino/JJ acid/NN protein/NN 80%/NN identical/JJ to/IN human/NEWGENE progelatinase/NEWGENE B/NEWGENE ./.
@@96272855964 RESULT/NN (/NN S/NN )/NN :/: In/NN patients/NNS with/IN elevated/VBN FSH/NEWGENE levels/NNS on/IN cycle/NN day/NN 3/CD ,/, a/DT low/JJ oocyte/NN yield/NN was/VBD achieved/VBN (/( 7/CD versus/IN 11/CD )/SYM and/CC a/DT high/JJ number/NN of/IN ampules/NNS of/IN hMG/NN was/VBD necessary/JJ (/( 56/CD versus/IN 33/CD )/SYM ./.
@@112741841815 Nrf2/NEWGENE regulates/VBZ expression/NN of/IN genes/NNS encoding/VBG enzymes/NNS with/IN antioxidant/JJ (/( e/NN ./NN g/NN ./. heme/NEWGENE oxygenase-1/NEWGENE (/( HO-1/NEWGENE )/NN )/NN or/CC xenobiotic/NN detoxification/NN (/( e/NN ./NN g/NN ./.
@@64598316261 Cardiovascular/NNP and/CC adrenal/JJ medullo-sympathetic/JJ reactions/NNS to/IN acute/JJ tobacco/NN poisoning/VBG ./.
@@28096513506 This/DT in/NN turn/NN will/MD further/RB enhance/VB the/DT role/NN of/IN meta-analysis/NN in/IN helping/JJ clinicians/NNS and/CC policy/NN makers/NNS answer/NN clinical/JJ questions/NNS ./.
@@92184599356 Serum/NEWGENE response/NEWGENE factor/NEWGENE (/( SRF/NEWGENE )/SYM ,/, a/DT member/NN of/IN an/DT ancient/JJ family/NN of/IN DNA-binding/NN proteins/NN ,/, is/VBZ generally/RB assumed/VBN to/IN be/VB a/DT ubiquitous/JJ transcription/NN factor/NN involved/VBN in/IN regulating/JJ growth/NEWGENE factor-responsive/NEWGENE genes/NEWGENE ./.
@@33153593999 Proctoscopy/NNP and/CC roentgenographic/JJ studies/NNS may/MD be/VB an/DT important/JJ part/NN of/IN evaluation/NN ,/, especially/RB in/IN patients/NNS who/WP present/VBP with/IN perianal/JJ suppuration/NN ,/, masses/NNS ,/, or/CC anal/JJ fissures/NNS ./.
@@99168096106 Human/NEWGENE MGP/NEWGENE is/VBZ a/DT 10-kD/NEWGENE skeletal/NEWGENE extracellular/NEWGENE matrix/NEWGENE (/NEWGENE ECM/NEWGENE )/NEWGENE protein/NEWGENE that/WDT consists/VBZ of/IN an/DT 84-aa/JJ mature/JJ protein/NN and/CC a/DT 19-aa/CD transmembrane/JJ signal/JJ peptide/NN ./.
@@98193915245 By/IN directly/RB interacting/VBG with/IN both/DT Arfs/NEWGENE and/CC tyrosine/NEWGENE kinases/NEWGENE involved/VBN in/IN regulating/JJ cell/NN growth/NN and/CC cytoskeletal/JJ organization/NN ,/, ASAP1/NEWGENE could/MD coordinate/VB membrane/NN remodeling/NN events/NNS with/IN these/DT processes/NNS ./.
@@75656726142 In/NN cells/NNS limited/VBN for/IN His/NN ,/, increased/VBN expression/NN of/IN arg-2/NEWGENE and/CC cpc-1/NEWGENE ,/, and/CC decreased/VBD expression/NN of/IN cox-5/NEWGENE ,/, also/RB had/VBP translational/JJ and/CC transcriptional/JJ components/NNS ./.
@@18537962451 Review/NNP :/: deterioration/NN of/IN glucose/NN tolerance/NN with/IN age/NN :/: the/DT role/NN of/IN insulin/NEWGENE resistance/NN ./.
@@462747744 Resistance/NNP pattern/NN of/IN Mycobacterium/NN tuberculosis/NN (/( H/NN 37/NN Rv/NN )/SYM to/IN a/DT new/JJ antibiotic/NN ,/, lividomycin/NN ./.
@@90251226270 Subsequent/JJ experiments/NNS showed/VBN that/IN motoric/JJ tasks/NNS rather/RB than/IN cognitive/JJ aspects/NNS of/IN the/DT COWA/NN task/NN were/VBD critical/JJ in/IN potentiating/JJ finger-tapping/NN performance/NN ./.
@@9172641562 Mutational/JJ studies/NNS provide/VBP evidence/NN to/IN this/DT end/NN and/CC indicate/VB that/IN the/DT side/JJ chains/NNS of/IN subdomain/NN 4/NN ./NN 2/NN make/VB specific/JJ contacts/NNS with/IN the/DT nucleotides/NNS at/IN -35/CD ./.
@@113030277262 These/DT data/NN reveal/VB a/DT complex/NN network/NN of/IN interactions/NNS between/IN GTPases/NEWGENE in/IN the/DT ARF/NEWGENE family/NEWGENE and/CC their/PRP effectors/NNS and/CC reveal/VB a/DT potential/NN for/IN cross-talk/NN not/RB demonstrated/VBD previously/RB ./.
@@46401555071 Sex/NN ratio/NN at/IN birth/NN ./.
@@1075075566 I/NNP ./NNP
@@25186916377 Using/VBG mutated/NEWGENE IL2R/NEWGENE alpha/NEWGENE promoter/NEWGENE constructs/NEWGENE in/IN transient/JJ transfection/NN and/CC DNA/NN binding/JJ assays/NNS ,/, we/PRP now/RB demonstrate/VBP that/IN sequences/NNS located/VBN immediately/RB upstream/RB and/CC downstream/RB of/IN the/DT kappa/NEWGENE B/NEWGENE enhancer/NEWGENE also/RB contribute/VB to/IN the/DT regulation/NN of/IN IL2R/NEWGENE alpha/NEWGENE gene/NEWGENE expression/NN ./.
@@20447851614 A/DT single/JJ case/NN of/IN an/DT adenocarcinoma/NN ,/, arising/VBG in/IN a/DT retroperitoneal/JJ enterogenous/JJ cyst/NN and/CC which/WDT presented/VBD as/IN a/DT left/JJ renal/NN cyst/NN ,/, is/VBZ reported/VBN ./.
@@83617543708 On/IN the/PDT other/DT hand/NN ,/, the/DT structures/NNS of/IN the/DT b-Zip/JJ domain/NN are/VBP well/VB conserved/VBN among/IN these/DT Maf-related/NEWGENE proteins/NEWGENE ./.
@@69940356772 On/IN line/NN calculation/NN of/IN steroid/JJ concentrations/NNS by/IN radioimmunoassay/NN ./.
@@27452801951 At/NN each/DT level/NN of/IN PaO2/NN we/PRP obtained/VBD simultaneous/JJ measures/NNS of/IN arterial/JJ and/CC venous/JJ blood/NN gases/NNS ,/, venous/JJ lactate/NN concentration/NN ,/, and/CC changes/NNS in/IN the/DT relative/JJ concentrations/NNS of/IN inorganic/JJ phosphate/NN ,/, phosphocreatine/NN ,/, and/CC ATP/NN measured/VBN with/IN 31P/CD magnetic/JJ resonance/NN spectroscopy/NN ./.
@@86226984878 Truncated/JJ mammalian/NEWGENE Notch1/NEWGENE activates/VBZ CBF1/NN //NN RBPJk-repressed/NN genes/NN by/IN a/DT mechanism/NN resembling/VBG that/IN of/IN Epstein-Barr/NEWGENE virus/NEWGENE EBNA2/NEWGENE ./.
@@95882281898 Immunohistochemically/RB ,/, anticytokeratin/NEWGENE 19/NEWGENE antibody/NEWGENE revealed/VBD strong/JJ staining/NN in/IN both/DT epithelial/JJ and/CC sarcomatous/JJ MPM/NNS tissues/NNS ./.
@@93236129286 Lack/NN of/IN controlled/VBN prospective/JJ studies/NNS of/IN sleep/NN electroencephalograms/NNS (/( EEG/NN )/SYM ,/, and/CC the/DT use/NN of/IN medication/NN ,/, in/IN children/NNS with/IN developmental/JJ dysphasia/NN ,/, may/MD deny/VB appropriate/JJ treatment/NN strategies/NNS to/IN children/NNS with/IN severe/JJ developmental/JJ speech/NN and/CC language/NN disorders/NNS ./.
@@112287001055 The/DT position/NN of/IN the/DT analyst/NN as/IN expert/JJ :/: yesterday/NN and/CC today/NN ./.
@@30238878262 Nuclease/NN footprinting/VBG revealed/VBN that/IN purified/NEWGENE glucocorticoid/NEWGENE receptor/NEWGENE bound/JJ at/IN multiple/JJ discrete/JJ sites/NNS within/IN and/CC at/IN the/DT borders/NN of/IN the/DT tandemly/RB repeated/JJ sequence/NN motif/NN that/WDT defines/VBZ Sa/NEWGENE ./.
@@42637484892 A/DT medical-geographical/JJ review/NN ./.
@@8184923512 Topical/JJ L-NNA/NN attenuated/VBN the/DT hypercapnic/JJ increase/NN of/IN CoBF/NN by/IN 52/NN +/NN //NN -/NN 6%/JJ and/CC CeBF/NN by/IN 29/CD +/NN //NN -/NN 5%/JJ after/IN 45-min/JJ exposure/NN ./.
@@74964003009 In/NN contrast/NN with/IN the/DT previously/RB reported/VBN HMGR1/NEWGENE mRNA/NEWGENE (/( HMGR1S/NEWGENE mRNA/NEWGENE )/SYM ,/, which/WDT is/VBZ detected/VBN at/IN high/JJ levels/NNS in/IN all/DT tissues/NNS of/IN the/DT plant/NN ,/, HMGR1L/NEWGENE mRNA/NEWGENE is/VBZ present/VB at/IN relatively/JJ low/JJ levels/NNS and/CC its/PRP expression/NN is/VBZ restricted/VBN mostly/RB to/IN seedlings/NNS ,/, roots/NNS and/CC inflorescences/NNS ./.
@@91221683752 This/DT study/NN provides/VBZ a/DT direct/JJ demonstration/NN of/IN a/DT role/NN for/IN G/NEWGENE betagamma/NEWGENE in/IN mediating/JJ the/DT agonist-stimulated/JJ translocation/NN of/IN GRK2/NEWGENE and/CC GRK3/NEWGENE in/IN an/DT intact/JJ cellular/JJ system/NN and/CC demonstrates/VBZ isoform/NN specificity/NN in/IN the/DT interaction/NN of/IN these/DT components/NNS ./.
@@2642406829 The/DT sequences/NNS following/IN the/DT X/NNP ./NNP borealis/NN oocyte/NN and/CC somatic/JJ 5S/NEWGENE genes/NEWGENE are/VBP identical/JJ in/IN 12/CD of/IN the/DT first/JJ 14/CD residues/NNS and/CC contain/VB two/JJ or/CC more/JJ T/NN clusters/NNS ,/, as/IN does/VBP the/DT corresponding/JJ region/NN of/IN X/NEWGENE ./NEWGENE laevis/NEWGENE oocyte/NEWGENE 5S/NEWGENE DNA/NEWGENE ./.
@@93946509348 The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN find/NN out/RB whether/IN it/PRP was/VBD possible/JJ to/IN detect/VB normal/JJ lymph/NN nodes/NNS by/IN high-resolution/JJ mediastinal/JJ US/NNP ./NNP
@@110002033080 While/IN mutations/NNS in/IN K-Rev/NEWGENE that/WDT inactivate/VBP any/DT one/PRP of/IN these/DT properties/NNS also/RB blocked/VBN K-Rev-dependent/NN nuclear/NN RNA/NN export/NN ,/, several/DT K-Rev/NEWGENE mutants/NEWGENE were/VBD comparable/JJ to/IN wild/JJ type/NN when/CC assayed/VBN for/IN any/DT of/IN these/DT individual/JJ activities/NNS yet/RB nevertheless/RB defective/JJ for/IN RNA/NN export/NN ./.
@@31332506041 A/DT randomized/JJ ,/, prospective/JJ study/NN was/VBD conducted/VBN to/IN compare/NN ovarian/JJ stimulation/NN with/IN human/NEWGENE menopausal/NEWGENE gonadotropin/NEWGENE (/( hMG/NEWGENE )/SYM and/CC human/NEWGENE follicle-stimulating/NEWGENE hormone/NEWGENE (/( hFSH/NEWGENE )/SYM in/IN an/DT in/NN vitro/FW fertilization/NN and/CC embryo/NN transfer/NN (/( IVF-ET/NNS )/SYM program/NN ./.
@@109284774576 This/DT study/NN demonstrated/VBN that/IN the/DT PFA-100/NN analyzer/NN can/MD accurately/RB assess/VB vWF-dependent/JJ platelet/NN function/NN and/CC detect/VB other/DT platelet/NN defects/NNS under/IN high/JJ shear/NN stress/NN in/IN complex/NN patient/NN populations/NNS ./.
@@117667471605 We/PRP conducted/VBD a/DT clinical/JJ and/CC pathologic/JJ review/NN of/IN nine/JJ patients/NNS with/IN immature/JJ ovarian/JJ teratoma/NN ./.
@@37437021487 Approximately/RB 60%/CD of/IN cell/NN bodies/NNS of/IN primary/JJ neurons/NNS innervating/VBG the/DT intra/CD and/CC perioral/JJ structures/NNS through/RB the/DT inferior/JJ alveolar/NN ,/, lingual/JJ ,/, mental/JJ ,/, and/CC buccal/JJ nerves/NNS were/VBD in/IN the/DT range/NN between/IN 300/CD and/CC 600/CD micron/NN 2/CD in/IN cross-sectional/JJ area/NN :/: mean/JJ +/NN //NN -/NN SD/NN 509/NN +/NN //NN -/NN 243/CD micron/NN 2/CD ,/, 420/CD +/NN //NN -/NN 181/CD micron/NN 2/CD ,/, 469/CD +/NN //NN -/NN 200/CD micron/NN 2/CD ,/, and/CC 444/CD +/NN //NN -/NN 186/CD micron/NN 2/CD ,/, respectively/RB ./.
@@24523139321 ASL-8123/NN demonstrated/VBN weak/JJ competitive/JJ beta-adrenoreceptor/NEWGENE blocking/JJ activity/NN in/IN isolated/VBN guinea/NN pig/NN right/JJ atria/NNS with/IN a/DT pA2/NN of/IN 3/CD ./CD 73/CD +/NN //NN -/NN 0/CD ./CD 07/CD ;/: no/DT agonist-like/JJ activity/NN was/VBD observed/VBN in/IN this/DT tissue/NN at/IN concentrations/NNS of/IN ASL-8123/NN from/IN 3/CD X/NN 10/NN (/NN -5/NN )/NN to/IN 1/CD X/NNP 10/NN (/NN -2/NN )/NN M/NNP ./NNP
@@75793287896 As/IN with/IN the/DT heterologous/JJ DNA/NN binding/JJ domain/NN ,/, MZF-1/NEWGENE represses/VBZ reporter/NN gene/NN expression/NN in/IN nonhematopoietic/JJ cell/NN lines/NNS and/CC activates/VBZ expression/NN in/IN hematopoietic/JJ cell/NN lines/NNS ./.
@@16151822999 The/DT present/NN study/NN highlights/VBP the/DT improvement/NN in/IN sputum/NN amoxycillin/NN (/( amoxy/NN )/SYM levels/NNS when/CC a/DT combination/NN tablet/NN ,/, amoxy/NN 500/CD mg/NN plus/IN bromhexeine/NN 8/NN mg/NN ,/, is/VBZ administered/VBN as/IN compared/VBN to/IN plain/JJ amoxy/NN 500/CD mg/NN ./NN
@@1429714917 Clin/VBP ./.
@@32287853917 Recovery/NNP was/VBD characterized/VBN by/IN rapid/JJ improvement/NN such/JJ that/IN all/DT measured/VBN parameters/NNS normalized/VBN by/IN 1/CD week/NN ,/, except/VB for/IN cross-sectional/JJ cardiac/JJ area/NN which/WDT remained/VBD dilated/JJ up/NN to/IN 4/CD weeks/NNS (/( 14/CD +/NN //NN -/NN 3/CD cm2/NN ,/, p/NN less/PRP than/IN 0/CD ./CD 05/CD versus/IN control/NN )/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@66584456411 Harmful/JJ effects/NNS in/IN animals/NNS and/CC man/NN may/MD result/VB from/IN both/DT deficient/JJ or/CC excessive/JJ amounts/NNS of/IN intake/NN ./.
@@78804497065 In/NN the/DT course/NN of/IN a/DT study/NN of/IN low/JJ dose/NN X-rays/NNS effects/NNS ,/, we/PRP found/VBP that/IN male/JJ ICR/NN white/NN Swiss/JJ mice/NNS showed/VBD remarkable/JJ suppression/NN of/IN mounting/JJ behavior/NN after/IN whole/JJ body/NN irradiation/NN by/IN 5/CD to/IN 15/CD cGy/NN X-rays/NNS ./.
@@29007601475 Three/CD sequence/NN elements/NNS are/VBP shown/VBP to/IN be/VB required/VBN for/IN accurate/JJ and/CC efficient/JJ transcription/NN termination/NN by/IN RNA/NEWGENE polymerase/NEWGENE I/NEWGENE (/( pol/NEWGENE I/NEWGENE )/SYM assayed/VBN both/DT in/NN a/DT cell-free/JJ transcription/NN system/NN and/CC in/IN vivo/NN after/IN transfection/NN of/IN rDNA/NN minigene/NN constructs/NN into/IN 3T6/CD cells/NNS ./.
@@110827158317 Simultaneous/JJ determination/NN of/IN theophylline/NN and/CC its/PRP metabolites/NNS by/IN HPLC/NN A/NN high/JJ performance/NN liquid/JJ chromatography/NN (/( HPLC/NN )/SYM method/NN has/VBZ been/VBN developed/VBN for/IN the/DT simultaneous/JJ determination/NN of/IN theophylline/NN and/CC its/PRP metabolites/NNS ,/, with/IN caffeine/NN and/CC its/PRP metabolites/NNS ./.
@@110543415072 RESULTS/NNS :/: Glaucoma/NNS suspects/NNS were/VBD divided/VBN into/IN two/JJ groups/NNS according/VBG to/IN their/PRP SWAP/NN results/NNS :/: high/JJ risk/NN (/( with/IN SWAP/NN abnormalities/NNS )/SYM and/CC low/JJ risk/NN (/( with/IN normal/JJ SWAP/NN result/NN )/SYM ./.
@@35683115684 Encompassing/VBG tamponade/NN and/CC pericardiocentesis/NN data/NN ,/, left/NN ventricular/JJ stroke/NN work/NN index/NN showed/VBD positive/JJ correlation/NN with/IN TMFP1/NN (/( r/JJ =/SYM ./CD 59/CD )/SYM and/CC TMFP2/NN (/( r/JJ =/SYM ./CD 52/CD )/SYM but/CC not/RB with/IN TMFP3/NN ./.
@@91650359357 Serum/NEWGENE alkaline/NEWGENE phosphatase/NEWGENE activity/NN ,/, bone/NN mass/JJ measurements/NNS ,/, dual/JJ energy/NN x-ray/NN absortiometric/JJ analysis/NN of/IN mineral/JJ density/NN ,/, and/CC mechanical/JJ testing/NN values/NNS in/IN vertebrae/NNS and/CC femora/NNS of/IN the/DT -D/CD Sal/NNP animals/NNS did/VBD not/RB significantly/RB differ/VB from/IN those/DT in/NNP +D/NNP Sal/NNP animals/NNS ./.
@@92026697748 We/PRP have/VBP developed/VBN a/DT rAAV-mediated/NN gene/NN transfer/NN system/NN for/IN the/DT rat/NEWGENE preproinsulin/NEWGENE II/NEWGENE gene/NEWGENE ./.
@@99491787014 We/PRP used/VBD expression/NN cloning/NN to/IN identify/VB interleukin-6/NEWGENE (/( IL-6/NEWGENE )/SYM as/IN one/PRP factor/NN that/WDT suppressed/VBD growth/NN of/IN a/DT pre-B-cell/NN variant/NN line/NN ,/, 1A9-M/CELL ./.
@@28403763537 (/( anti-IIa/JJ )/SYM and/CC Holmer/NNP et/FW al/NNS ./NNS
@@14182722029 Using/VBG 5/CD ng/NN //NN mL/NN as/IN the/DT cutoff/NN ,/, the/DT sensitivity/NN of/IN CEA/NN was/VBD 68%/JJ ./.
@@95219096605 APETALA3/NEWGENE transcripts/NEWGENE are/VBP first/RB detected/VBN in/IN a/DT meristematic/JJ region/NN that/WDT will/MD give/VB rise/VB to/IN the/DT petal/NN and/CC stamen/NN primordia/NNS ,/, and/CC expression/NN is/VBZ maintained/VBN in/IN this/DT region/NN during/IN subsequent/JJ development/NN of/IN these/DT organs/NNS ./.
@@77214227693 Primer/NNS extension/NN experiments/NNS showed/VBN that/IN there/RB are/VBP two/JJ transcription/NN initiation/NN sites/NNS 16/CD bp/NN apart/RB in/IN the/DT mouse/NEWGENE type/NEWGENE 2/NEWGENE receptor/NEWGENE gene/NEWGENE ./.
@@87803391418 In/NN a/DT randomized/JJ single-blind/JJ 3/CD x/NN 3/CD Latin-square/NNP study/NN with/IN corrections/NNS for/IN any/DT carryover/NN effects/NNS ,/, 27/CD males/NNS and/CC 30/CD females/NNS consumed/VBD supplements/NNS containing/JJ glucose/NN or/CC resistant/JJ starch/NN (/( RS/NN )/SYM from/IN raw/JJ high-amylose/JJ cornstarch/NN (/( RS2/NN )/SYM or/CC from/IN retrograded/VBN high-amylose/JJ cornstarch/NN (/( RS3/NN )/SYM ./.
@@4308894916 Biliary-enteric/NNP fistulas/NNS ./.
@@106065155928 Both/DT domains/NNS were/VBD required/VBN for/IN specific/JJ DNA/NN binding/JJ to/IN the/DT beta-retinoic/NEWGENE acid/NEWGENE receptor/NEWGENE element/NEWGENE ,/, producing/JJ a/DT DNase/NEWGENE I/NEWGENE footprint/NN covering/VBG predominantly/RB one/PRP strand/NN ./.
@@85472058531 The/DT results/NNS indicate/VBP that/IN the/DT bradycardic/JJ agents/NNS alinidine/NN and/CC zatebradine/NN do/NN not/RB exert/VB antiarrhythmic/JJ efficacy/NN against/IN SVT/NN induced/VBN during/IN subacute/JJ myocardial/JJ infarction/NN in/IN conscious/JJ dogs/NNS ./.
@@86472647231 Ligation/NNS of/IN CD40/NEWGENE rescues/VBP Ramos-Burkitt/NNP lymphoma/NN B/NNP cells/NNS from/IN calcium/NN ionophore-/NN and/CC antigen/NN receptor-triggered/JJ apoptosis/NN by/IN inhibiting/JJ activation/NN of/IN the/DT cysteine/NEWGENE protease/NEWGENE CPP32/NEWGENE //NEWGENE Yama/NEWGENE and/CC cleavage/NN of/IN its/PRP substrate/NN PARP/NEWGENE ./.
@@103189186643 Further/RB ,/, mutational/JJ analysis/NN of/IN NS5A/NEWGENE assigned/VBN the/DT SH3-binding/NEWGENE region/NEWGENE to/IN a/DT proline-rich/JJ motif/NN that/WDT is/VBZ highly/RB conserved/VBN among/IN HCV/NN genotypes/NNS ./.
@@81531468128 Dotarizine/NNP produced/VBD arterial/JJ dilation/NN in/IN both/DT systemic/JJ and/CC pulmonary/JJ circulation/NN :/: the/DT total/JJ peripheral/JJ resistance/NN dropped/VBN ,/, and/CC femoral/JJ artery/NN flow/NN rose/VBD ;/: aortic/JJ and/CC pulmonary/JJ artery/NN mean/JJ and/CC diastolic/JJ pressures/NNS declined/VBN ,/, and/CC systolic/JJ pressures/NNS remained/VBN almost/RB stable/JJ ./.
@@94746489435 We/PRP analyzed/VBD the/DT P-SAECG/NNP in/IN the/DT time/NN and/CC frequency/NN domain/NN in/IN 23/CD patients/NNS with/IN Paf/NN and/CC 19/CD controls/NNS ./.
@@14184942031 Rolandic/NNP spikes/NNS and/CC cognitive/JJ function/NN ./.
@@10901133728 Methyllevamisole/NNP was/VBD used/VBN as/IN the/DT internal/JJ standard/NN ./.
@@86395617114 Adduction/NNS of/IN the/DT human/NEWGENE N-ras/NEWGENE codon/NEWGENE 61/NEWGENE sequence/NEWGENE with/IN (/( -/: )/NN -/NN (/NN 7S/NN ,/NN 8R/NN ,/NN 9R/NN ,/NN 10S/NN )/NN -7/NN ,/NN 8-dihydroxy-9/NN ,/NN 10-epoxy-7/NN ,/NN 8/NN ,/NN 9/NN ,/NN 10-tetrahydrobenzo/NN [/NN a/NN ]/NN pyrene/NN :/: structural/JJ refinement/NN of/IN the/DT intercalated/JJ SRSR/NN (/NN 61/NN ,/NN 2/NN )/NN (/( -/: )/NN -/NN (/NN 7S/NN ,/NN 8R/NN ,/NN 9S/NN ,/NN 10R/NN )/NN -N6-/NN [/NN 10-/NN (/NN 7/NN ,/NN 8/NN ,/NN 9/NN ,/NN 10-/NN tetrahydrobenzo/NN [/NN a/NN ]/NN pyrenyl/NN )/NN ]/NN -2'-deoxyadenosyl/NN adduct/NN from/IN 1H/CD NMR/NN ./.
@@57185005665 Histological/JJ observations/NNS on/IN the/DT decidua/NN in/IN the/DT second/JJ half/NN of/IN pregnancy/NN ./.
@@63194216112 The/DT effect/NN of/IN desipramine/NN probably/RB represents/VBZ inhibition/NN of/IN neuronal/JJ uptake/NN and/CC that/IN of/IN amitriptyline/NN and/CC mianserin/NN blockade/NN of/IN neuronal/JJ uptake/NN and/CC prejunctional/JJ alpha/NEWGENE 2-adrenoreceptors/NEWGENE ./.
@@99613269952 Scaling/NN of/IN fluctuations/NNS in/IN one-dimensional/JJ interface/NN and/CC hopping/JJ models/NNS ./.
@@8816443495 Thus/RB ,/, the/DT multidomained/VBN ROK/NEWGENE alpha/NEWGENE appears/VBZ to/IN be/VB involved/VBN in/IN reorganization/NN of/IN the/DT cytoskeleton/NN ,/, with/IN the/DT N/NN and/CC C/NN termini/NNS acting/JJ as/IN positive/JJ and/CC negative/JJ regulators/NNS ,/, respectively/RB ,/, of/IN the/DT kinase/NN domain/NN whose/WP activity/NN is/VBZ crucial/JJ for/IN formation/NN of/IN stress/NN fibers/NNS and/CC focal/NEWGENE adhesion/NEWGENE complexes/NEWGENE ./.
@@10973400809 RESULTS/NNS :/: No/DT significant/JJ deformation/NN in/IN vertebral/JJ artery/NN flow/NN was/VBD noted/VBN in/IN the/DT flexion-distraction/NNP Stage/NNP I/PRP injuries/NNS within/IN the/DT physiologic/JJ range/NN of/IN cervical/JJ flexion/NN ./.
@@35377275275 The/DT poly/NN (/NN A/NN )/NN segment/NN of/IN the/DT RNA/NN was/VBD selectively/RB cross-linked/VBN to/IN the/DT 72/JJ ,/JJ 000-molecular-weight/JJ protein/NN (/( 72K/NN protein/NN )/SYM ./.
@@1774063983 Interspecific/NNP backcross/NN analysis/NN using/VBG progeny/NN derived/VBN from/IN matings/NNS of/IN (/( C57BL/NN //NN 6J/NN x/NN Mus/NNS spretus/NN )/SYM F1/NN x/NN C57BL/IN //IN 6J/IN mice/NNS indicates/VBZ that/IN the/DT thrombospondin/NEWGENE gene/NEWGENE is/VBZ tightly/RB linked/JJ to/IN the/DT Fshb/NEWGENE ,/, Actcl/NEWGENE ,/, Ltk/NEWGENE ,/, and/CC B2M/NEWGENE loci/NEWGENE on/IN murine/JJ chromosome/NN 2/CD ./CD
@@21823232337 However/RB ,/, primary/JJ transcripts/NNS of/IN a/DT variant/NEWGENE tRNA/NEWGENE (/NEWGENE Val/NEWGENE )/NEWGENE (/NEWGENE UAC/NEWGENE )/NEWGENE gene/NEWGENE are/VBP processing/VBG deficient/JJ under/IN standard/JJ growth/NN conditions/NNS (/( 30/CD degrees/NNS C/NN )/SYM ,/, due/NN to/IN a/DT slightly/RB altered/VBN 5'/CD flanking/JJ region/NN ./.
@@10972688806 On/IN long-term/JJ follow-up/NN ,/, there/RB was/VBD no/DT significant/JJ difference/NN in/IN the/DT incidence/NN of/IN hospitalizations/NNS (/( 1/CD per/IN 2/CD ./CD 1/CD vs/IN ./IN
@@104299469734 Furthermore/RB ,/, addition/NN of/IN B-Myb-glutathionine/NEWGENE S-transferase/NEWGENE fusion/NEWGENE protein/NEWGENE inhibited/VBD complex/NN formation/NN ./.
@@4099274707 Neomycin/NN is/VBZ fairly/RB effective/JJ against/IN staphylococci/NNS ,/, less/PRP effective/JJ against/IN streptococci/NNS ,/, and/CC fairly/RB effective/JJ against/IN gram-negative/JJ intestinal/JJ organisms/NNS ./.
@@82747748133 In/NN addition/NN ,/, REP21/NN plants/NNS were/VBD resistant/JJ to/IN an/DT unusually/RB broad/JJ range/NN of/IN tobamoviruses/NNS including/JJ tomato/NN mosaic/NN virus/NN ,/, tobacco/NN mild/JJ green/JJ mosaic/NN virus/NN ,/, TMV-U5/NN ,/, green/JJ tomato/NN atypical/JJ mosaic/NN virus/NN ,/, and/CC ribgrass/NN mosaic/NN virus/NN ./.
@@110058314268 Three/CD cDNAs/NNS encoding/VBG basic/NEWGENE leucine/NEWGENE zipper/NEWGENE (/NEWGENE bZIP/NEWGENE )/NEWGENE -type/NEWGENE ABRE-binding/NEWGENE proteins/NEWGENE were/VBD isolated/VBN by/IN using/VBG the/DT yeast/NN one-hybrid/JJ system/NN and/CC were/VBD designated/VBN AREB1/NEWGENE ,/, AREB2/NEWGENE ,/, and/CC AREB3/NEWGENE (/( ABA-responsive/NEWGENE element/NEWGENE binding/NEWGENE protein/NEWGENE )/SYM ./.
@@1285807362 The/DT mean/JJ (/( +/NN //NN -/NN SD/NN )/SYM PaO2/NN increased/VBN from/IN 80/CD ./CD 8/CD +/NN //NN -/NN 26/CD ./CD 9/CD mmHg/NN before/IN to/IN 89/NN ./NN 8/NN +/NN //NN -/NN 27/CD ./CD 3/CD mmHg/NN after/IN the/DT infusion/NN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM and/CC the/DT PaCO2/NN decreased/VBN from/IN 42/CD ./CD 4/CD +/NN //NN -/NN 8/CD ./CD 3/CD to/IN 39/CD ./CD 6/CD +/NN //NN -/NN 7/CD ./CD 9/CD mmHg/NN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@19250922588 Twenty-four/CD hours/NNS later/JJR ,/, the/DT animals/NNS were/VBD randomized/JJ to/IN subretinal/JJ treatment/NN with/IN 2/CD ./CD 5/CD micrograms/NNS of/IN tissue/NEWGENE plasminogen/NEWGENE activator/NEWGENE or/CC a/DT similar/JJ volume/NN of/IN physiologic/JJ saline/NN ./.
@@45067385001 Junctions/NNS between/IN cells/NNS of/IN the/DT human/NEWGENE enamel/NEWGENE organ/NN ./.
@@84406888703 These/DT studies/NNS demonstrate/VBP that/IN both/DT G/NEWGENE alpha/NEWGENE i/NEWGENE genes/NEWGENE are/VBP dynamically/RB regulated/VBN in/IN LLC-PK1/NNP cells/NNS by/IN both/DT growth/NN ,/, differentiation/NN ,/, and/CC hormone/NN signals/NNS ./.
@@2844767921 The/DT Nostoc/NN petBD/NEWGENE genes/NEWGENE are/VBP not/RB closely/RB linked/JJ to/IN the/DT psbB/NEWGENE gene/NEWGENE (/( encoding/VBG the/DT 51-kDa/JJ photosystem/NEWGENE II/NEWGENE polypeptide/NEWGENE )/SYM and/CC do/VB not/RB contain/VB introns/NNS as/IN do/NN the/DT closely/RB related/VBN chloroplast/NEWGENE genes/NEWGENE ./.
@@97394019717 OBJECTIVE/IN :/: The/DT purpose/NN of/IN this/DT article/NN is/VBZ to/IN review/NN balance/NN instruments/NNS developed/VBN within/IN the/DT past/JJ 10/CD years/NNS that/WDT can/MD be/VB used/VBN in/IN the/DT clinic/NN or/CC home/JJ environment/NN ./.
@@100514884574 Mutations/NNS of/IN the/DT AP-1/NEWGENE site/NEWGENE of/IN the/DT TIMP-1/NEWGENE promoter/NEWGENE that/WDT prevented/VBD formation/NN of/IN HMAP-1/NEWGENE caused/VBN a/DT 70%/CD loss/NN of/IN activity/NN in/IN transfected/VBN activated/VBN HSCs/NNS ./.
@@31929503890 Sera/NNS from/IN euthyroid/JJ post-menopausal/JJ or/CC pregnant/JJ women/NNS yielded/VBD TSH/NEWGENE levels/NNS within/IN the/DT normal/JJ range/NN ./.
@@15329142470 Expense/NN limits/VBZ the/DT use/NN of/IN hepatitis/NN B/NN vaccines/NNS ,/, but/CC low-dose/JJ intradermal/JJ immunization/NN has/VBZ been/VBN evaluated/VBN as/IN a/DT cost-saving/JJ strategy/NN in/IN numerous/JJ studies/NNS ./.
@@110079492866 It/PRP is/VBZ now/RB estimated/VBN that/IN inactivation/NN mutants/NNS of/IN PTEN/NEWGENE exist/VB in/IN 60%/CD of/IN all/DT forms/NNS of/IN solid/JJ tumors/NNS ./.
@@50122205308 Ten-year/JJ experience/NN with/IN one-stage/NN proctocolectomy/NN and/CC anal/JJ ileostomy/NN ./.
@@10997863832 In/NN the/DT TLE/NNS patients/NNS the/DT NAA/NN :/: Cr/NN ratios/NNS were/VBD reduced/VBN in/IN the/DT seizure/NN focus/NN ,/, while/CC in/IN the/DT FLE/NNP patients/NNS they/PRP were/VBD not/RB always/RB reduced/VBN in/IN the/DT seizure/NN focus/NN ./.
@@106509584255 Element/NEWGENE B/NEWGENE (/( -249/NN //NN -229/NN )/SYM shows/VBZ more/RB than/IN 80%/NN homology/NN to/IN a/DT consensus/NEWGENE c-myb/NEWGENE element/NEWGENE ,/, but/CC formed/VBD two/JJ specific/JJ complexes/NNS that/WDT differed/VBD from/IN that/DT of/IN c-myb/NEWGENE in/IN the/DT electrophoretic/JJ mobility/NN shift/NN assay/NN ./.
@@10864641349 These/DT results/NNS demonstrate/VBP that/IN N-glycans/NNPS flanking/JJ the/DT receptor-binding/NN site/NN of/IN the/DT HA/NEWGENE molecule/NEWGENE are/VBP potent/JJ regulators/NNS of/IN influenza/NN virus/NN growth/NN ,/, with/IN the/DT glycan/NN at/IN Asn149/CD being/VBP dominant/JJ and/CC that/IN at/IN Asn123/NN being/VBP less/PRP effective/JJ ./.
@@1076480276 These/DT data/NN show/NN that/IN the/DT alpha-helix/NN domain/NN of/IN p57/NEWGENE (/NEWGENE Kip2/NEWGENE )/NEWGENE ,/, which/WDT is/VBZ conserved/VBN in/IN the/DT Cip/NEWGENE //NEWGENE Kip/NEWGENE proteins/NEWGENE ,/, is/VBZ implicated/VBN in/IN protein-protein/JJ interaction/NN and/CC confers/VBZ a/DT specific/JJ regulatory/JJ mechanism/NN ,/, outside/RB of/IN their/PRP Cdk-inhibitory/JJ activity/NN ,/, by/IN which/WDT the/DT p57/NEWGENE (/NEWGENE Kip2/NEWGENE )/NEWGENE family/NN members/NNS positively/RB act/VBP on/IN myogenic/JJ differentiation/NN ./.
@@66074276358 Three/CD experiments/NNS contrasted/VBD the/DT effects/NNS of/IN 6-hydroxydopamine-induced/CD lesions/NNS of/IN the/DT ventral/JJ noradrenergic/JJ and/CC dorsal/JJ noradrenergic/JJ projections/NNS ,/, predominantly/RB to/IN hypothalamus/NN and/CC cortex/NN ,/, respectively/RB ,/, upon/IN body/NN weight/NN changes/NNS and/CC food-related/JJ behaviour/NN in/IN the/DT rat/NN ./.
@@94179283664 Replacement/NN of/IN residues/NNS in/IN positions/NNS +3/CD (/( His128Asn/NNP )/SYM and/CC +2/NN (/( Gln155Lys/NN )/SYM of/IN the/DT reading/JJ helices/NNS of/IN fingers/NNS 2/CD and/CC 3/CD ,/, respectively/RB ,/, prevented/VBN binding/JJ ./.
@@20942578401 Diagnostic/NNP value/NN of/IN adenosine/NEWGENE deaminase/NEWGENE activity/NN in/IN tuberculous/JJ effusions/NNS ./.
@@1093845384 Modern/NNP studies/NNS ,/, conducted/VBN with/IN Delta-9-THC/NN ,/, in/IN healthy/JJ voluntaries/NNS ,/, again/RB suggest/VB the/DT comparison/NN or/CC even/VB the/DT identity/NN of/IN the/DT modifications/NNS caused/VBN by/IN cannabis/NN with/IN sleep/NN and/CC dream/NN ./.
@@23005413930 To/TO determine/VB the/DT effects/NNS on/IN the/DT pulmonary/JJ barrier/NN of/IN several/DT surface/NN active/JJ agents/NNS ,/, a/DT series/NN of/IN metered/JJ dose/NN inhalers/NNS (/( MDIs/NN )/SYM was/VBD prepared/VBN and/CC used/VBN to/IN dose/NN aerosolized/JJ surfactant/NN to/IN the/DT airways/NNS of/IN isolated/VBN perfused/VBN rat/NN lungs/NNS ./.
@@91518063277 These/DT data/NN provide/VB evidence/NN that/IN the/DT 2/NEWGENE ./NEWGENE 0-kb/NEWGENE LAT/NEWGENE is/VBZ an/DT intron/NN of/IN the/DT mLAT/NEWGENE pre-mRNA/NEWGENE with/IN a/DT unique/JJ branch/NN point/NN ./.
@@113036386312 With/IN NEU/NEWGENE overexpression/NN ,/, nodal/JJ control/NN decreased/VBN from/IN 72%/JJ to/IN 34%/JJ (/( p/NN =/SYM ./CD 008/CD )/SYM ./.
@@27739303470 The/DT solitary/JJ kidney/NN :/: a/DT model/NN of/IN chronic/JJ hyperfiltration/NN in/IN humans/NNS ./.
@@92442821972 Mutagenesis/NNS of/IN the/DT pecT/NEWGENE regulatory/NN region/NN revealed/VBD the/DT presence/NN of/IN two/JJ sites/NNS in/IN which/WDT insertions/NNS reproduced/VBD the/DT pec-1/NEWGENE phenotype/NN ./.
@@97139965342 Overexpression/NNS of/IN MDR1/NEWGENE has/VBZ been/VBN demonstrated/VBN in/IN many/JJ cancers/NNS ,/, both/DT in/NN patient/NN tumors/NNS and/CC in/IN cell/NN lines/NNS selected/VBN with/IN a/DT variety/NN of/IN chemotherapeutic/JJ agents/NNS ./.
@@71956158083 The/DT number/NN of/IN muricidal/JJ rats/NNS increased/VBN with/IN increase/NN in/IN the/DT duration/NN of/IN Cd/NN administration/NN in/IN association/NN with/IN greater/JJR accumulation/NN of/IN Cd/NN in/IN the/DT olfactory/NN bulb/NN than/IN in/IN any/DT other/DT region/NN of/IN the/DT brain/NN ./.
@@98237755204 These/DT studies/NNS support/NN the/DT view/NN that/DT HMG/NEWGENE I/NEWGENE (/NEWGENE Y/NEWGENE )/NEWGENE is/VBZ an/DT important/JJ cofactor/NN for/IN HLA-DRA/NEWGENE gene/NEWGENE activation/NN by/IN Oct-2A/NEWGENE and/CC provide/VB insights/NNS into/IN its/PRP mechanism/NN of/IN action/NN ./.
@@98499614021 Down-regulation/NNS of/IN IRS-1/NEWGENE is/VBZ linked/JJ to/IN its/PRP serine/NN phosphorylation/NN dependent/JJ on/IN PI/NEWGENE 3-kinase/NEWGENE activity/NN and/CC appears/VBZ required/VBN for/IN differentiation/NN to/IN occur/VB ,/, as/IN IRS-1/NEWGENE is/VBZ not/RB modified/JJ and/CC continues/VBZ to/IN accumulate/VB in/IN a/DT nondifferentiating/JJ myoblast/NN cell/NN line/NN ./.
@@65977094318 As/IN pleural/JJ thickening/NN is/NNS seen/VBP commonly/RB in/IN asbestosis/NN and/CC may/MD influence/VB lung/NN volumes/NNS and/CC the/DT ratio/NN of/IN transfer/NN factor/NN to/IN effective/JJ alveolar/JJ volume/NN ,/, the/DT results/NNS of/IN these/DT measurements/NNS were/VBD compared/VBN only/RB in/IN the/DT cases/NNS showing/VBG absent/VB or/CC minimal/JJ pleural/JJ thickening/NN ./.
@@74737428106 The/DT protein/NEWGENE ELT-1/NEWGENE ,/, encoded/VBN by/IN a/DT single-copy/JJ gene/NN homologous/JJ to/IN the/DT GATA/NEWGENE family/NEWGENE of/NEWGENE vertebrate/NEWGENE transcription/NEWGENE factors/NEWGENE ,/, is/VBZ potentially/RB capable/JJ of/IN interacting/VBG with/IN this/DT element/NN ./.
@@49419515250 Dr/NN ./NN
@@111941838336 The/DT increase/NN in/IN number/NN of/IN terminal/JJ hairs/NNS ,/, which/WDT are/VBP defined/VBN as/IN hairs/NNS more/RB than/IN 60/CD microm/NN in/IN diameter/NN ,/, in/IN the/DT designated/VBN area/NN (/( 0/CD ./CD 5/CD cm/NN square/NN =/SYM 0/CD ./CD 25/CD cm2/NN area/NN )/SYM of/IN the/DT procyanidin/NNP B-2/NNP group/NN subjects/NNS after/IN the/DT 6-month/CD trial/NN was/VBD significantly/RB greater/JJR than/IN that/DT of/IN the/DT placebo/NN control/NN group/NN subjects/NNS (/( procyanidin/NN B-2/NN ,/, 1/CD ./CD 99/CD +/NN //NN -/NN 2/CD ./CD 58/CD (/( mean/JJ +/NN //NN -/NN SD/NN )/NN //NN 0/NN ./NN 25/NN cm2/NN ;/: placebo/NN ,/, -0/NN ./NN 82/NN +/NN //NN -/NN 3/CD ./CD 40/CD (/( mean/JJ +/NN //NN -/NN SD/NN )/NN //NN 0/NN ./NN 25/NN cm2/NN ;/: P/NN </SYM 0/CD ./CD 02/CD ,/, two-sample/JJ t/NN test/NN )/NN ./.
@@11727073239 CONCLUSION/IN :/: The/DT training/NN of/IN novices/NNS using/VBG MIST-VR/NN yields/VBZ quantifiable/JJ changes/NNS in/IN skill/NN that/WDT are/VBP transferable/JJ to/IN a/DT simple/JJ real/JJ task/NN and/CC are/VBP similar/JJ to/IN the/DT results/NNS achieved/VBN with/IN conventional/JJ training/NN ./.
@@92941396200 Within/IN a/DT 135-bp/JJ core/NN homology/NN region/NN ,/, the/DT human/NEWGENE HS12/NEWGENE enhancers/NEWGENE are/VBP approximately/RB 90%/NN identical/JJ to/IN the/DT murine/NN homolog/NN and/CC include/VB several/DT motifs/NNS previously/RB demonstrated/VBN to/IN be/VB important/JJ for/IN function/NN of/IN the/DT murine/NN enhancer/NN ;/: additional/JJ segments/NNS of/IN high/JJ sequence/NN conservation/NN suggest/VB the/DT possibility/NN of/IN previously/RB unrecognized/JJ functional/JJ motifs/NNS ./.
@@90181226684 The/DT detection/NN of/IN ORF-1/NN sequences/NN in/IN human/JJ tumors/NNS ,/, while/CC not/RB proof/VB per/IN se/FW ,/, is/VBZ a/DT prerequisite/NN for/IN establishing/VBG its/PRP role/NN in/IN tumor/NN development/NN ./.
@@79841056780 Moreover/RB ,/, by/IN complementation/NN of/IN the/DT WA/NEWGENE fyuA/NEWGENE mutant/NEWGENE by/IN the/DT cloned/VBN fyuA/NEWGENE gene/NEWGENE ,/, yersiniabactin/NN uptake/NN and/CC mouse/NN virulence/NN were/VBD restored/VBN ./.
@@4765725147 Roentgenographically/RB ,/, the/DT lesion/NN was/VBD usually/RB a/DT well-defined/JJ and/CC benign/JJ appearing/NN one/PRP ,/, either/DT purely/RB lytic/JJ (/( 3/CD cases/NNS )/SYM or/CC with/IN central/JJ radiodensity/NN (/( 2/CD cases/NNS )/SYM ./.
@@28322935894 The/DT use/NN of/IN CRF-41/NN in/IN the/DT differential/JJ diagnosis/NN of/IN Cushing's/NNP syndrome/NN and/CC obesity/NN ./.
@@87986432327 A/DT novel/JJ phosphotyrosine-binding/JJ domain/NN in/IN the/DT N-terminal/NN transforming/NN region/NN of/IN Cbl/NEWGENE interacts/VBZ directly/RB and/CC selectively/RB with/IN ZAP-70/NEWGENE in/NN T/NN cells/NNS ./.
@@26417625746 Ischemic/NNP heart/NN disease/NN evaluated/VBN by/IN exercise/NN stress/NN thallium-201/NN myocardial/JJ scintigraphy/NN :/: a/DT comparison/NN of/IN SPECT/NN and/CC bull's/NNS eye/NN display/NN ./.
@@27767423861 Heart/NNP rate/NN (/( HR/NN )/SYM ,/, rectal/JJ temperature/NN (/( Tre/NN )/SYM ,/, blood/NN pressure/NN ,/, temperature/NN and/CC relative/JJ humidity/NN changes/NNS inside/IN clothing/NN were/VBD measured/VBN on/IN 18/CD professional/JJ firemen/NNS (/( mean/JJ age/NN 29/CD ./CD 4/CD +/NN //NN -/NN 7/CD ./CD 4/CD yr/NN ,/, VO2/NN max/JJ 41/CD ./CD 4/CD +/SYM 8/CD ./CD 8/CD ml/NN kg-1/NN min-1/NN )/SYM wearing/JJ fire/NN fighter's/NNS uniforms/NNS (/( SU/JJ )/SYM or/CC aluminized/VBN ,/, fire/NN resistant/JJ ,/, impermeable/JJ clothing/NN with/IN self/NN contained/VBD breathing/JJ apparatus/NN (/( FE/NN )/SYM ./.
@@76160568532 Both/DT mu/NEWGENE and/CC gamma/NEWGENE 2b/NEWGENE heavy/NEWGENE1 chain/NEWGENE1 genes/NEWGENE1 cause/VBG this/DT feedback/NN inhibition/NN of/IN heavy/NEWGENE chain/NEWGENE gene/NEWGENE rearrangement/NN ./.
@@79798271061 KRN2391/NN and/CC cromakalim/NN produced/VBD a/DT dose-dependent/NN increase/NN in/IN aortic/JJ and/CC coronary/JJ blood/NN flow/NN ./.
@@20281252642 The/DT prevalence/NN of/IN opportunistic/JJ infection/NN among/IN surviving/JJ AIDS/NN patients/NNS and/CC the/DT probability/NN of/IN being/VBP in/IN tumour/NN response/NN following/IN cancer/NN therapy/NN conditional/JJ on/IN being/VBP alive/JJ are/VBP two/JJ examples/NNS of/IN such/JJ functions/NNS ./.
@@12019771849 The/DT interpretation/NN of/IN antibiotic/JJ disc/NN sensitivities/NNS ./.
@@114133107811 RANTES/NEWGENE (/( regulated/NEWGENE upon/NEWGENE activation/NEWGENE ,/NEWGENE normally/NEWGENE T-cell/NEWGENE expressed/NEWGENE and/NEWGENE presumably/NEWGENE secreted/NEWGENE )/SYM is/VBZ a/DT CC/NEWGENE chemokine/NEWGENE which/WDT recruits/NNS and/CC activates/VBZ monocytes/NNS ,/, lymphocytes/NNS ,/, and/CC eosinophils/NNS ,/, all/DT cell/NN types/NNS present/VBP in/IN the/DT lung/NN inflammatory/JJ infiltrate/NN induced/VBN by/IN RSV/NN infection/NN ./.
@@82180568184 The/DT ultrastructure/NN of/IN retinal/JJ vessels/NNS was/VBD examined/VBN in/IN three/CD eyes/NNS from/IN diabetic/JJ patients/NNS and/CC two/JJ eyes/NNS from/IN control/NN subjects/NNS ./.
@@107361618402 Enzyme/NEWGENE I/NEWGENE of/NEWGENE the/NEWGENE phosphoenolpyruvate/NEWGENE :/NEWGENE sugar/NEWGENE phosphotransferase/NEWGENE system/NEWGENE ./.
@@9708399691 Rainbow/NNP trout/NN were/VBD obtained/VBN from/IN a/DT commercial/JJ trout/NN farm/NN ,/, kept/VBP in/IN running/JJ water/NN and/CC feeding/JJ in/IN experimental/JJ pellets/NNS for/IN 4/CD to/IN 8/CD weeks/NNS ./.
@@8191768163 The/DT effect/NN of/IN hydrostatic/JJ pressure/NN on/IN the/DT swimming/JJ activity/NN of/IN three/CD hyponeustonic/JJ crustacea/NNS ,/, Anomalocera/NNP patersoni/NN ,/, Pontella/JJ mediterranea/NN ,/, Labidocera/NNP wollastoni/NN ./.
@@17802353328 The/DT EPO/NEWGENE levels/NNS were/VBD distinctly/RB increased/VBN before/IN transfusion/NN ;/: they/PRP did/VBD not/RB significantly/RB change/VB just/RB after/IN transfusion/NN ,/, but/CC subsequently/RB decreased/VBN ./.
@@109649953238 Taken/VBN together/RB ,/, they/PRP uphold/VBP the/DT emerging/JJ concern/NN that/IN women/NNS with/IN ER/NEWGENE (/NEWGENE +/NEWGENE )/NEWGENE cancers/NNS may/MD not/RB benefit/VB significantly/RB from/IN endocrine/JJ treatment/NN if/IN the/DT tumors/NNS also/RB overexpress/VBP HER-2/NEWGENE ./.
@@68383886629 Because/IN of/IN a/DT rapid/JJ development/NN of/IN the/DT connective/JJ tissue/NN scars/NNS ,/, however/RB ,/, at/IN the/DT place/NN of/IN the/DT destroyed/VBN glandular/JJ parenchyma/NN areas/NNS ,/, there/RB is/VBZ no/DT normalization/NN of/IN the/DT organ's/NNS structure/NN and/CC function/NN by/IN the/DT 42d/CD day/NN ./.
@@68036344219 In/NN silicosis/NN ,/, significant/JJ relationships/NNS between/IN patients/NNS and/CC sons/NNS were/VBD not/RB seen/VBP with/IN respect/NN to/IN arterial/JJ blood/NN gas/NN determinations/NNS and/CC ventilatory/JJ responses/NNS except/VBP for/IN Paco2/NN of/IN patients/NNS and/CC hypercapnic/JJ ventilatory/JJ responses/NNS of/IN sons/NNS ./.
@@1719684312 The/DT above/RB results/VBZ mean/JJ that/IN the/DT increase/NN in/IN alpha-adrenergic/NEWGENE receptors/NEWGENE makes/VBP the/DT prostate/NN ,/, which/WDT has/VBZ been/VBN already/RB hypertrophied/JJ ,/, less/PRP elastic/JJ ,/, inhibiting/JJ external/NN urinary/JJ sphincter/NN function/NN ./.
@@103932513625 The/DT PAC/NN clone/NN with/IN an/DT insert/NN size/NN of/IN 120kb/CD was/VBD isolated/VBN and/CC mapped/VBN by/IN restriction/NN analysis/NN ./.
@@90065555667 MAIN/NNP OUTCOME/NNP MEASURES/NNS :/: Systemic/JJ and/CC pulmonary/JJ hemodynamics/NN ,/, arterial/JJ blood/NN gas/NN determination/NN ,/, bronchoalveolar/JJ lavage/NN protein/NN and/CC neutrophil/JJ content/NN ,/, neutrophil/JJ oxidant/JJ burst/NN ,/, lung/NEWGENE myeloperoxidase/NEWGENE content/NN ,/, and/CC scanning/JJ electron/NN micrographic/JJ studies/NNS ./.
@@46460455077 Benign/NNP intramural/JJ tumors/NNS of/IN the/DT esophagus/NN ./.
@@92347277592 Gal4-Eed/NEWGENE fusion/NEWGENE protein/NEWGENE represses/VBZ transcription/NN of/IN a/DT reporter/NN gene/NN driven/VBP by/IN a/DT promoter/NN that/WDT contains/VBZ Gal4-binding/NEWGENE DNA/NEWGENE elements/NEWGENE ./.
@@17668763103 A/DT method/NN is/VBZ described/VBN for/IN detecting/JJ targeted/VBN events/NNS at/IN the/DT mu/NEWGENE heavy/NEWGENE chain/NEWGENE gene/NEWGENE which/WDT relies/VBZ on/IN co-conversion/NN (/( or/CC co-exchange/JJ )/SYM of/IN a/DT point/NN mutation/NN with/IN a/DT selectable/JJ marker/NN contained/VBN on/IN a/DT replacement/NN vector/NN ./.
@@92569736518 For/IN E2/NN ,/, each/DT cat/NN was/VBD given/VBP either/DT 5/CD (/( group/NN [/NN G/NN ]/NN 1/CD )/SYM or/CC 10/CD (/( G2/NN )/SYM mg/NN of/IN itraconazole/NN //NN kg/NN (/( capsules/NNS )/SYM twice/RB daily/JJ for/IN 6/CD weeks/NNS ./.
@@35616229846 As/IN a/DT last/NN resort/NN ,/, it/PRP may/MD be/VB possible/JJ to/IN maintain/VB a/DT patient/NN on/IN dialysis/NN in/IN reasonable/JJ health/NN with/IN a/DT DiaTAP/NN button/NN graft/NN complex/NN infected/VBN with/IN Staphylococcus/NN epidermidis/NN and/CC intermittent/JJ positive/JJ blood/NN cultures/NNS using/VBG long/JJ term/NN vancomycin/NN therapy/NN ./.
@@101979853178 Using/VBG an/DT RNase/NEWGENE H/NEWGENE protection/NN assay/NN and/CC specific/JJ blocking/JJ oligonucleotides/NNS ,/, we/PRP find/VBP that/DT recognition/NN of/IN the/DT 5'/CD splice-site/NN (/( 5'ss/CD )/SYM and/CC branchpoint/NEWGENE sequence/NEWGENE (/NEWGENE BPS/NEWGENE )/NEWGENE elements/NEWGENE by/IN U11/NEWGENE and/CC U12/NEWGENE snRNPs/NEWGENE ,/, respectively/RB ,/, displays/VBP strong/JJ cooperativity/NN ,/, requiring/JJ both/DT sites/NNS in/IN the/DT pre-mRNA/NN substrate/NN for/IN efficient/JJ complex/NN formation/NN ./.
@@103901586278 Point/NNP mutations/NNS of/IN the/DT site/NN that/WDT suppressed/VBD Pit-1/NEWGENE binding/JJ in/IN vitro/FW restored/VBN full/JJ tiGH/NEWGENE promoter/NEWGENE activity/NN ./.
@@116920046219 A/DT review/NN of/IN the/DT literature/NN identified/VBN 8/CD comprehensive/JJ clinical/JJ studies/NNS ,/, all/DT of/IN which/WDT failed/VBD to/IN document/NN any/DT relationship/NN between/IN NF1/NEWGENE and/CC intracranial/JJ aneurysms/NNS ./.
@@3013477525 In/NN order/NN to/IN study/NN the/DT influence/NN of/IN iron/NN overload/NN on/IN the/DT polymorphonuclear/JJ leucocyte/NN (/( PMN/NN )/SYM metabolism/NN of/IN patients/NNS on/IN chronic/JJ hemodialysis/NN ,/, generation/NN of/IN superoxide/NN anion/NN (/( O2-/NN )/SYM by/IN PMN/NN in/IN whole/JJ blood/NN was/VBD compared/VBN in/IN two/JJ groups/NNS of/IN hemodialyzed/JJ patients/NNS :/: group/NN A/DT consisted/VB of/IN twenty-one/CD individuals/NNS with/IN serum/JJ ferritin/NEWGENE levels/NNS above/RB 1000/CD ng/NN //NN ml/NN and/CC group/NN B/NNP of/IN nineteen/JJ individuals/NNS with/IN serum/JJ ferritin/NEWGENE levels/NNS below/RB 1000/CD ng/NN //NN ml/NN ./.
@@72998577169 LD50/NN values/NNS of/IN terms/NNS of/IN KP/NN were/VBD 84/CD mg/CD //CD kg/CD in/IN male/JJ rats/NNS and/CC 122/CD mg/CD //CD kg/CD in/IN female/JJ rats/NNS when/CC KP-CMC/NN was/VBD administered/VBN intrarectally/RB ,/, and/CC 117/CD mg/CD //CD kg/CD in/IN male/JJ and/CC 92/CD mg/CD //CD kg/CD in/IN female/JJ when/CC KP-T10/NN was/VBD administered/VBN intrarectally/CD ./CD ,/, while/CC peroral/JJ administration/NN of/IN KP-CMC/NNP showed/VBD LD50/NN values/NNS of/IN 68/CD mg/CD //CD kg/CD in/IN males/NNS and/CC 78/CD mg/CD //CD kg/CD in/IN females/NNS in/IN terms/NNS of/IN KP/NNP ./NNP
@@45484832896 Blood/NNP platelets/NNS ,/, coagulation/NN factors/NN and/CC morphologic/JJ organ/NN changes/NNS following/IN scadling/VBG shock/NN in/IN rhesus/NN monkeys/NNS ./.
@@13702818804 Sequencing/NN revealed/VBN one/PRP large/JJ open/JJ reading/JJ frame/NN encoding/VBG a/DT 39-kDa/NN protein/NN ./.
@@81191493277 Tumor/NEWGENE necrosis/NEWGENE factor-alpha/NEWGENE (/( TNF/NEWGENE alpha/NEWGENE )/SYM is/VBZ one/PRP of/IN several/DT autocrine/NN //NN paracrine/NN factors/NN known/VBP to/IN exert/VB potent/JJ inhibitory/JJ effects/NNS on/IN bone/NN ./.
@@118061321675 The/DT TB/NN incidence/NN in/IN the/DT "AIRIN"/NN area/NN ,/, where/CC about/RB 20%/CD TB/NN patients/NNS are/VBP homeless/JJ ,/, shows/VBZ highest/JJS rate/NN of/IN above/RB 1/CD ,/CD 000/CD //CD 100/CD ,/CD 000/CD ./.
@@104071842351 For/IN functional/JJ studies/NNS ,/, two/JJ promoter/NN regions/NNS were/VBD cloned/VBN upstream/RB of/IN the/DT reporter/NN gene/NN ,/, chloramphenicol/NEWGENE acetyl/NEWGENE transferase/NEWGENE (/( CAT/NEWGENE )/SYM :/: (/( i/NN )/SYM phbetaE-B/NN -/: the/DT plasmid/NN that/WDT contains/VBZ the/DT human/JJ (/( h/NN )/SYM promoter/NN region/NN (/( -2832/CD to/IN +101/NN )/SYM including/JJ URE/NEWGENE ,/, and/CC (/( ii/NN )/SYM prhbetaE-B/NN -/: the/DT plasmid/NN that/WDT contains/VBZ the/DT rhesus/NN (/( rh/NN )/SYM promoter/NN region/NN excluding/JJ URE/NEWGENE as/IN it/PRP lacks/VBZ a/DT 270/CD bp/NN region/NN of/IN the/DT hbetaAPP/NEWGENE promoter/NEWGENE (/( -2435/JJ to/IN -2165/JJ )/SYM ./.
@@90201697786 SIM1/NEWGENE and/CC SIM2/NEWGENE do/VB not/RB form/VB homodimers/NNS ,/, and/CC they/PRP do/VBP not/RB interact/VB with/IN AHR/NEWGENE ./.
@@64416245074 Our/PRP results/NNS indicate/VBP that/IN serum/NEWGENE BGP/NEWGENE is/VBZ a/DT valuable/NN measurement/NN of/IN bone/NN metabolism/NN ./.
@@40621287775 National/NNP Institutes/NNS of/IN Health/NNP Consensus/NNP Development/NNP Conference/NNP Statement/NN ./.
@@82206218189 Reviewing/VBG manuscripts/NNS :/: developing/JJ an/DT efficient/JJ system/NN ./.
@@77207105012 The/DT Oct/NEWGENE and/CC HMG2/NEWGENE proteins/NEWGENE also/RB interact/VBP in/IN vivo/NN ./.
@@10194225137 Voluntary/NNP wheel/NN running/NN did/VBD not/RB significantly/RB increase/VB estimated/VBN alanine/NN or/CC pyruvate/NN Gneo/NNP or/CC absolute/JJ glycerol/NN Ra/NN ./NN
@@27050723377 End/NN points/NNS measured/VBN were/VBD perioperative/JJ (/( 30-day/CD )/SYM myocardial/JJ infarction/NN (/( MI/NN )/SYM rate/NN and/CC death/NN ./.
@@79837443803 Surprisingly/RB ,/, nuclear/JJ forms/NNS of/IN IE110/NEWGENE were/VBD found/VBN to/IN move/NN a/DT cytoplasmic/JJ form/NN of/IN IE175/NEWGENE into/IN nuclear/JJ punctate/JJ structures/NNS ,/, and/CC a/DT cytoplasmic/JJ form/NN of/IN IE110/NEWGENE was/VBD able/JJ to/IN retain/VB nuclear/JJ forms/NNS of/IN IE175/NEWGENE in/IN cytoplasmic/JJ punctate/JJ structures/NNS ./.
@@103254132310 The/DT enhanced/VBN binding/NN of/IN c-Abl/NEWGENE to/IN DNA/NN containing/JJ 5-methylcytosine/NNP residues/NNS may/MD result/VB from/IN an/DT increased/VBN propensity/NN of/IN the/DT double/JJ helix/NN to/IN denature/VB locally/RB coupled/VBN with/IN a/DT protein-induced/JJ reduction/NN in/IN the/DT base/JJ stacking/JJ interaction/NN ./.
@@19237666709 Sequence/NN analysis/NN revealed/VBN that/IN in/IN addition/NN to/IN the/DT non-spliced/JJ variant/NN ,/, multiple/JJ mRNA/NN species/NN were/VBD generated/VBN by/IN alternative/JJ splicing/JJ resulting/VBG in/IN the/DT exclusion/NN of/IN 92/CD ,/, 166/CD ,/, 170/CD ,/, 174/CD and/CC 263/CD nucleotides/NNS (/( nt/NN )/SYM ,/, respectively/RB ,/, from/IN exon/NN 1/CD ./CD
@@103643195899 Cp/NN is/VBZ normally/RB the/DT main/JJ promoter/NN for/IN EBNA/NEWGENE mRNA/NEWGENE initiation/NN ,/, so/IN it/PRP appears/VBZ that/IN EBNA3C/NEWGENE contributes/VBZ to/IN a/DT negative/JJ autoregulatory/JJ control/NN loop/NN ./.
@@7935418350 Using/VBG a/DT v-erbA/NEWGENE probe/NN ,/, we/PRP obtained/VBD a/DT cDNA/NN which/WDT encodes/VBZ a/DT novel/JJ 445-amino-acid/JJ protein/NN ,/, RLD-1/NEWGENE ,/, that/WDT contains/VBZ the/DT characteristic/JJ domains/NNS of/IN nuclear/JJ receptors/NNS ./.
@@107543124030 The/DT solubility/NN of/IN all/PDT the/DT mutated/NN proteins/NN was/VBD remarkably/RB reduced/VBN ./.
@@79607961035 Peter/NNP Elfer/NN explores/VBZ the/DT implications/NNS of/IN the/DT ruling/NN ./.
@@104881295467 Synthesis/NNS of/IN antisense/NN RNA/NN and/CC S/NNP phase-dependent/JJ binding/NN of/IN E2F/NEWGENE complexes/NEWGENE in/IN intron/NN 1/CD ./CD
@@111149244736 ORFA/NN and/CC ccdA/NEWGENE were/VBD constitutively/RB cotranscribed/VBN as/IN determined/VBN by/IN primer/NN extension/NN analysis/NN ./.
@@24026783066 Commercially/RB available/JJ formulations/NNS of/IN 2/CD ./CD 5%/CD and/CC 5%/CD lambdacyhalothrin/NN can/MD be/VB diluted/VBN either/DT with/JJ water/NN for/IN ULV/NN cold/JJ aerosol/NN space-spraying/JJ or/CC with/IN diesel/NN //NN kerosene/NN for/IN thermal/JJ fogging/JJ at/IN recommended/VBN application/NN rates/NNS of/IN 0/CD ./CD 5-1/CD g/NN ai/NN //NN ha/NN for/IN mosquito/NN control/NN and/CC 2/CD g/NN ai/NN //NN ha/NN for/IN housefly/NN control/NN ./.
@@19588212580 Confocal/JJ fluorescence/NN microscopy/NN in/IN modern/JJ cell/NN biology/NN ./.
@@112975454990 Stable/NN transfection/NN of/IN human/NEWGENE CHOP/NEWGENE cDNA/NEWGENE into/IN mammary/JJ carcinoma/NN cells/NNS demonstrated/VBD that/DT CHOP/NEWGENE functioned/VBN not/RB as/IN a/DT mediator/NN of/IN hGH-stimulated/JJ mitogenesis/NN but/CC rather/RB enhanced/VBN the/DT protection/NN from/IN apoptosis/NN afforded/VBN by/IN hGH/NEWGENE in/IN a/DT p38/NEWGENE MAPK-dependent/NNP manner/NN ./.
@@79798107973 All/PDT other/DT ejaculate/VB parameters/NNS (/( density/NN ,/, motility/NN ,/, swelling/NN test/NN ,/, penetration/NN test/NN )/SYM remained/VBN unchanged/JJ ,/, and/CC there/RB was/VBD only/RB one/PRP post-therapeutic/JJ pregnancy/NN ./.
@@64921886285 Other/JJ than/IN d/NN 7/NN ,/, there/RB was/VBD no/DT significant/JJ effect/NN on/IN the/DT number/NN of/IN implants/NNS ./.
@@37322526253 However/RB ,/, further/JJ analyses/NNS of/IN the/DT data/NN indicate/VB that/IN increasing/JJ VO2/NN AT/IN (/( r/JJ =/SYM -0/CD ./CD 63/CD ,/, P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM rather/RB than/IN VO2max/NN (/( r/JJ =/SYM -0/NN ./NN 15/NN )/SYM could/MD result/VB in/IN improving/JJ the/DT 10/CD ,/CD 000/CD m/NN race/NN performance/NN to/IN a/DT larger/JJR extent/NN ,/, and/CC that/IN the/DT absolute/JJ amount/NN of/IN change/NN (/( delta/JJ )/SYM in/IN the/DT 10/CD ,/CD 000/CD m/NN run/NN time/NN is/VBZ best/RBS accounted/VBN for/IN by/IN a/DT combination/NN of/IN delta/NN VO2/NN AT/IN and/CC delta/NN 5/NN ,/NN 000/NN m/NN run/NN time/NN ./.
@@118227906461 For/IN instance/NN ,/, a/DT total/JJ SIP/NN score/NN of/IN an/DT individual/JJ patient/NN of/IN 28/CD ./CD 3%/CD (/( which/WDT is/NNS taken/VBP as/IN an/DT example/NN ,/, being/VBP the/DT mean/JJ score/NN in/IN the/DT study/NN population/NN )/SYM should/MD decrease/VB by/IN at/IN least/RB 9/CD ./CD 26%/CD or/CC approximately/RB 13/CD items/NNS ,/, before/IN any/DT improvement/NN beyond/RB reproducibility/NN noise/NN can/MD be/VB detected/VBN ./.
@@76764927603 We/PRP conclude/VBP that/IN ,/, in/IN comparison/NN to/IN reports/NNS from/IN other/DT regions/NNS ,/, Scandinavian/JJ renal/JJ transplant/NN recipients/NNS are/VBP at/IN high/JJ risk/NN of/IN dying/NN of/IN IHD/NN ./.
@@8100057713 Double-staining/VBG confirmed/VBN that/IN there/RB were/VBD separate/JJ populations/NNS of/IN CD68-positive/NNP macrophages/NNS and/CC XIIIa-positive/NN dendrocytes/VBZ ./.
@@112353351063 Managing/NNP HIV/NN ./.
@@96714642531 Deleting/JJ SNF1/NEWGENE repressed/VBN meiosis/NN at/IN the/DT same/JJ three/CD steps/NNS that/WDT were/VBD inhibited/VBN by/IN glucose/NN ,/, suggesting/VBG that/IN glucose/NN blocks/NNS meiosis/NN by/IN inhibiting/NN Snf1/NEWGENE ./.
@@81528007407 Gel/NNP shift/NN analysis/NN indicates/VBZ that/IN the/DT full-length/NEWGENE ERM/NEWGENE protein/NEWGENE is/VBZ able/JJ to/IN bind/NN specifically/RB to/IN an/DT oligonucleotide/NN containing/JJ the/DT consensus/NN nucleotide/NN core/NN sequence/NN GGAA/NNP recognized/VBD by/IN the/DT Ets/NNS proteins/NNS ./.
@@87116318692 Treatment/NNP is/VBZ instituted/VBN with/IN prednisone/NN and/CC cyclophosphamide/NN ./.
@@78011807778 This/DT paper/NN describes/VBZ the/DT advantages/NNS and/CC limitations/NNS of/IN the/DT main/JJ study/NN approaches/NNS used/VBN ./.
@@45430365023 Directives/NNS concerning/VBG medical/JJ care/NN ./.
@@16255272213 Whole/JJ blood/NN serotonin/NN levels/NNS were/VBD investigated/VBN in/IN a/DT control/NN group/NN (/( n/NN =/SYM 35/CD )/SYM and/CC in/IN a/DT group/NN of/IN chronic/JJ renal/JJ failure/NN patients/NNS (/( n/NN =/SYM 127/CD )/SYM on/IN various/JJ treatment/NN regimen/NN i/CD ./CD e/CD ./. conservative/JJ treatment/NN (/( n/NN =/SYM 39/CD )/SYM ,/, maintenance/NN haemodialysis/NN (/( n/NN =/SYM 35/CD )/SYM and/CC after/IN renal/JJ transplantation/NN (/( n/NN =/SYM 53/CD )/SYM ./.
@@6271296071 These/DT responses/NNS were/VBD compared/VBN with/IN others/NNS in/IN the/DT same/JJ subjects/NNS under/IN the/DT same/JJ conditions/NNS and/CC it/PRP was/VBD concluded/VBN that/IN the/DT antihypertensive/JJ effect/NN of/IN labetalol/NN is/VBZ explained/VBN by/IN concurrent/JJ blockade/NN of/IN alpha-and/NEWGENE beta-adrenoceptors/NEWGENE ./.
@@62908598126 Of/IN 115/NN hepatitis/NN B/NN patients/NNS seen/VBP at/IN 12/CD months/NNS ,/, 6%/JJ had/VBP chronic/JJ hepatitis/NN Bs/NN antigenaemia/NN ,/, 60%/NN had/VBP developed/VBN anti-HBs/NEWGENE antibodies/NEWGENE ,/, and/CC 7/CD ./CD 3%/CD still/RB had/VBP abnormal/JJ liver/NN function/NN ./.
@@23476556032 In/NN the/DT artificial/JJ lung/NN ,/, like/JJ in/IN the/DT natural/JJ lung/NN and/CC peripheral/JJ tissues/NNS ,/, gas/NN exchanges/NNS depend/VBP on/IN several/DT parameters/NNS :/: blood/NN inlet/NN conditions/NNS ,/, blood/NN flow/NN rate/NN ,/, temperature/NN ,/, composition/NN of/IN the/DT gas/NN mixture/NN used/VBN for/IN ventilation/NN ,/, blood/NN tissue/NN perfusion/NN ,/, O2/NN consumption/NN ,/, etc/NN ./.
@@88847577522 Confirmatory/JJ statistics/NN included/VBD item/NN 2/CD of/IN the/DT Clinical/NNP Global/NNP Impression/NNS (/( CGI/IN )/SYM ,/, the/DT total/JJ score/NN of/IN the/DT Sandoz/NNP Clinical/NNP Assessment/NNP Geriatric/NN (/( SCAG/NN )/SYM scale/NN ,/, the/DT subscale/NN 'need/NN for/IN help'/NN of/IN the/DT nurse's/NNS rating/NN of/IN geriatric/JJ patients/NNS (/( Beurteilungsskala/NNP fur/NN geriatrische/NNP Patienten/NNP ;/: BGP/NN )/SYM and/CC the/DT total/JJ score/NN of/IN the/DT Short/JJ Cognitive/NNP Performance/NNP Test/NNP (/( Syndrom-Kurztest/NNP ;/: SKT/NN )/SYM ./.
@@86150127461 Cotransfection/NNS with/IN the/DT ie1/NEWGENE gene/NEWGENE resulted/VBN in/IN a/DT dramatic/JJ increase/NN in/IN the/DT amount/NN of/IN the/DT two/JJ enzymes/NNS expressed/VBN in/IN the/DT transfected/VBN cells/NNS ./.
@@79812466798 Our/PRP previous/JJ study/NN suggested/VBD that/DT pertussis/NEWGENE toxin/NEWGENE (/( IAP/NEWGENE )/NN -sensitive/NN GTP-binding/NEWGENE protein/NEWGENE (/NEWGENE s/NEWGENE )/NEWGENE (/( G-protein/NEWGENE )/SYM is/VBZ involved/VBN in/IN the/DT process/NN of/IN differentiation/NN by/IN hormones/NN //NN IBMX/NN ,/, accompanied/VBN by/IN c-fos/NEWGENE induction/NN ./.
@@9847371495 Jembrana/NNP disease/NN virus/NN (/( JDV/NN )/SYM is/VBZ a/DT newly/RB identified/VBN bovine/JJ lentivirus/NN that/WDT is/VBZ closely/RB related/VBN to/IN the/DT bovine/JJ immunodeficiency/NN virus/NN (/( BIV/NN )/SYM ./.
@@10965905750 Insulin/NEWGENE receptor/NEWGENE substrate-1-mediated/JJ enhancement/NN of/IN growth/NN hormone-induced/NN mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE activation/NN ./.
@@75539422563 The/DT pea/NEWGENE rps10/NEWGENE intron/NEWGENE is/VBZ homologous/JJ to/IN introns/NNS in/IN rrn26/NEWGENE and/CC cox3/NEWGENE in/IN the/DT Marchantia/NNP mitochondrial/JJ genome/NN ,/, while/CC the/DT Marchantia/NEWGENE rps10/NEWGENE gene/NEWGENE lacks/VBZ an/DT intron/NN ./.
@@93532552900 Rip1p/NEWGENE is/VBZ inessential/JJ ,/, associated/VBN with/IN nuclear/NEWGENE pore/NEWGENE complexes/NEWGENE ,/, and/CC structurally/RB related/VBN to/IN the/DT FG-nucleoporin/NEWGENE family/NEWGENE of/IN pore/NEWGENE proteins/NEWGENE ./.
@@1373374382 Homodimers/NNS of/IN the/DT three/CD proteins/NNS specifically/RB recognize/VBP the/DT G-box/NN motif/NN ,/, with/IN GBF1/NEWGENE and/CC GBF3/NEWGENE binding/JJ symmetrically/RB to/IN this/DT palindromic/JJ sequence/NN ./.
@@25551774020 First/RB ,/, a/DT pet54/NEWGENE :/: :/: LEU2/NEWGENE cytoductant/NN bearing/JJ the/DT 'short'/JJ mitochondrial/JJ genome/NN that/WDT lacks/VBZ both/DT COX1/NEWGENE introns/NEWGENE aI5/NEWGENE1 alpha/NEWGENE1 and/CC aI5/NEWGENE beta/NEWGENE is/VBZ defective/JJ only/RB in/IN COX3/NEWGENE gene/NEWGENE expression/NN and/CC not/RB in/IN COX1/NEWGENE mRNA/NEWGENE splicing/JJ or/CC mRNA/NN translation/NN ./.
@@89790896251 Stable/NN transfection/NN of/IN the/DT BL/NNP cell/NN line/NN Raji/IN with/IN constructs/NNS containing/JJ core/NN promoter/NN mutations/NNS confirmed/VBN that/IN the/DT proximal/JJ Sp1/NEWGENE site/NEWGENE and/CC the/DT TATA/NN box/NN are/VBP essential/JJ for/IN the/DT activation/NN of/IN promoter/NEWGENE P1/NEWGENE by/IN the/DT Ig/NEWGENE kappa/NEWGENE enhancers/NEWGENE ./.
@@8038678035 Patients/NNS were/VBD subclassified/VBN into/IN age-matched/JJ groups/NNS of/IN primary/JJ untreated/JJ cancer/NN (/( 21/CD )/SYM ,/, recurrent/JJ cancer/NN (/( 18/CD )/SYM ,/, and/CC "cured"/JJ patients/NNS who/WP had/VBP been/VBN free/JJ of/IN disease/NN for/IN at/IN least/RB 9/CD months/NNS (/( 16/CD )/SYM ./.
@@27874303480 Histiocytic/JJ panniculitis/NN was/VBD observed/VBN in/IN biopsy/NN specimens/NNS with/IN cytophagocytosis/NN ./.
@@75823165394 With/IN each/DT of/IN the/DT three/CD pairs/NNS of/IN isolates/NNS (/( case/NN and/CC suspicious/JJ case/NN )/SYM ,/, identical/JJ IS6110/VBZ banding/JJ patterns/NNS were/VBD found/VBN suggesting/VBG identical/JJ MTB/NN strains/NNS ./.
@@85515779742 Retroviral/JJ replication/NN requires/VBZ that/IN a/DT portion/NN of/IN the/DT primary/JJ transcripts/NNS generated/VBN from/IN proviral/JJ DNA/NN be/VB spliced/VBN to/RB serve/NN as/IN mRNA/NN for/IN the/DT envelope/NEWGENE protein/NEWGENE and/CC in/IN Rous/NN sarcoma/NN virus/NN as/IN src/NEWGENE mRNA/NEWGENE ./.
@@110152001759 (/( 1995/CD )/SYM J/NNP ./NNP
@@33405489306 In/NN the/DT chicken/NN liver/NN ,/, levels/VBZ of/IN chicken/NEWGENE MT/NEWGENE mRNA/NEWGENE were/VBD rapidly/RB induced/VBN by/IN metals/NNS (/( Cd2+/NN ,/, Zn2+/NN ,/, Cu2+/NN )/SYM ,/, glucocorticoids/NNS and/CC lipopolysaccharide/NN ./.
@@92116059170 Tendon/VBP also/RB shows/VBZ a/DT degree/NN of/IN extensibility/NN ./.
@@88927578532 Molecular/NNP cloning/NN of/IN Elk-3/NEWGENE ,/, a/DT new/JJ member/NN of/IN the/DT Ets/NEWGENE family/NEWGENE expressed/VBN during/IN mouse/NN embryogenesis/NN and/CC analysis/NN of/IN its/PRP transcriptional/JJ repression/NN activity/NN ./.
@@27620063463 Cord/NN swelling/NN was/VBD observed/VBN in/IN 2/CD patients/NNS who/WP developed/VBD complete/JJ lesions/NNS ./.
@@95796029287 These/DT modifications/NNS may/MD improve/VB the/DT interlaboratory/JJ reproducibility/NN of/IN CD34/NEWGENE determinations/NNS due/NN to/IN the/DT reduction/NN in/IN sample/NN handling/VBG and/CC calculation/NN of/IN results/NNS ./.
@@56936025652 Evaluation/NN of/IN automatic/JJ blood/NN cell/NN counters/NNS ./.
@@90573255758 The/DT region/NN of/IN plasmid/NN pCM2/NN encoding/VBG the/DT pathogenicity/NEWGENE locus/NEWGENE pat-1/NEWGENE was/VBD mapped/VBN by/IN deletion/NN analysis/NN and/CC complementation/NN studies/NNS to/IN a/DT 1/NEWGENE ./NEWGENE 5-kb/NEWGENE Bg/NEWGENE //NEWGENE II/NEWGENE //NEWGENE SmaI/NEWGENE DNA/NEWGENE fragment/NEWGENE ./.
@@59921575862 The/DT pathogenicity/NN of/IN Achromobacter/NN puntatum/NN for/IN cold/JJ blooded/JJ and/CC warm/JJ blooded/JJ animals/NNS ./.
@@115226586410 This/DT plus/NN the/DT reduced/VBN phosphorylation/NN of/IN p27/NEWGENE by/IN MAPK/NEWGENE enhanced/VBD the/DT stability/NN of/IN p27/NEWGENE that/WDT associated/VBD with/IN nuclear/NEWGENE Cdk2/NEWGENE at/IN high/JJ stoichiometry/NN and/CC inhibited/VBN its/PRP kinase/NN activity/NN ./.
@@93251354827 The/DT Trx-CT/NEWGENE fusion/NEWGENE protein/NEWGENE was/VBD produced/VBN less/PRP efficiently/RB (/( 20%/CD of/IN total/JJ soluble/JJ cellular/JJ protein/NN )/SYM ./.
@@25919698550 The/DT elements/NNS responsible/JJ for/IN glucocorticoid/NN stimulation/NN of/IN ADH/NEWGENE gene/NEWGENE transcription/NN appear/VB to/IN reside/VB outside/RB of/IN this/DT region/NN ./.
@@107302922409 Early/JJ treatment/NN mechanics/NN of/IN the/DT Class/NN II/NN division/NN 2/CD malocclusion/NN ./.
@@108733883060 With/IN the/DT human/NEWGENE Rhotekin/NEWGENE cDNA/NEWGENE as/IN a/DT probe/NN ,/, Northern/NNP hybridization/NN revealed/VBN that/IN a/DT 4/NN ./NN 0-kb/NN transcript/NN was/VBD expressed/VBN at/IN a/DT high/JJ level/NN in/IN prostate/NN and/CC at/IN a/DT middle/JJ level/NN in/IN 13/CD of/IN 16/CD tissues/NNS examined/VBN ,/, but/CC it/PRP cannot/MD be/VB detected/VBN in/IN liver/NN and/CC lung/NN tissues/NNS ./.
@@81065122975 When/WRB the/DT promoter/NN region/NN was/VBD linked/JJ with/IN a/DT heterologous/JJ reporter/NN gene/NN ,/, we/PRP found/VBP that/IN the/DT promoter/NN region/NN is/VBZ inducible/JJ by/IN both/DT interferons/NEWGENE (/( interferon-alpha/NEWGENE and/CC -gamma/NEWGENE )/SYM and/CC interferon/NEWGENE regulatory/NEWGENE factor/NEWGENE 1/NEWGENE ./.
@@79935592757 A/DT recent/JJ index/NN (/( Fluorosis/NNS Risk/NNP Index/NNP )/SYM developed/VBN by/IN Pendrys/NN (/( 1990/CD )/SYM is/VBZ also/RB included/VBN in/IN this/DT review/NN ./.
@@85005245425 However/RB ,/, study/NN of/IN the/DT productive/NN gamma/NEWGENE gene/NEWGENE showed/VBN that/IN the/DT skipped/VBN variable/JJ exon/NN was/VBD bounded/VBN by/IN normal/JJ splicing/JJ signals/NNS and/CC that/IN the/DT adjacent/JJ intron/NN organization/NN was/VBD not/RB altered/VBN ./.
@@118820541550 Because/IN a/DT close/JJ correlation/NN between/IN regional/JJ decreases/NNS in/IN FMZ/NN binding/JJ and/CC spiking/JJ activity/NN was/VBD recently/RB demonstrated/VBN in/IN neocortical/JJ epilepsies/NNS ,/, abnormal/JJ peri-lesional/NNP FMZ/NN binding/NN may/MD bear/VB some/DT relation/NN to/IN the/DT mechanisms/NNS of/IN epileptogenesis/NN in/IN symptomatic/JJ epilepsies/NNS ./.
@@47530735133 Choice/NN of/IN vessel/NN ./.
@@70848146868 Preparation/NN of/IN a/DT stable/JJ phospholipid/NN reagent/NN for/IN coagulation/NN assays/NNS ./.
@@99006799909 Wave/NNP cybernetics/NNS :/: A/DT simple/JJ model/NN of/IN wave-controlled/JJ nonlinear/JJ and/CC nonlocal/JJ cooperative/JJ phenomena/NNS ./.
@@100361914150 The/DT microphthalmia-TFE/NEWGENE (/( MiT/NEWGENE )/SYM subfamily/NN of/IN basic/NEWGENE helix-loop-helix/NEWGENE leucine/NEWGENE zipper/NEWGENE (/NEWGENE bHLH-ZIP/NEWGENE )/NEWGENE transcription/NEWGENE factors/NEWGENE ,/, including/JJ TFE3/NEWGENE ,/, TFEB/NEWGENE ,/, TFEC/NEWGENE ,/, and/CC Mitf/NEWGENE ,/, has/VBZ been/VBN implicated/VBN in/IN the/DT regulation/NN of/IN tissue-specific/NN gene/NN expression/NN in/IN several/DT cell/NN lineages/NNS ./.
@@27724952599 Asthma/NNS was/VBD significantly/RB more/RB often/RB associated/VBN with/IN ASA/NN group/NN (/( 91%/CD )/SYM vs/NNP 46%/JJ at/IN AT/IN and/CC in/IN only/RB 16%/JJ at/IN INTR/NN group/NN ./.
@@117631766827 Moreover/RB ,/, a/DT severe/JJ decrease/NN of/IN antithrombin/NEWGENE activity/NN became/VBD evident/JJ during/IN both/DT experiments/NNS (/( eg/NN ,/, in/IN experiment/NN 2/CD from/IN 95/CD ./CD 6/CD +/NN //NN -/NN 4/CD ./CD 8/CD to/IN 59/CD ./CD 2/CD +/NN //NN -/NN 6/CD ./CD 6%/CD )/SYM ./.
@@105499121823 This/DT report/NN describes/VBZ a/DT patient/NN with/IN a/DT previous/JJ inferior/JJ acute/JJ myocardial/JJ infarction/NN who/WP developed/VBD right/JJ ventricular/JJ infarction/NN with/IN significant/JJ anterior/JJ lead/NN ST/NN segment/NN elevation/NN (/( V1-V4/NNP )/SYM caused/VBN by/IN the/DT loss/NN of/IN two/JJ large/JJ right/JJ ventricular/JJ branches/NNS during/IN a/DT coronary/JJ angioplasty/NN of/IN the/DT right/JJ coronary/JJ artery/NN ./.
@@23990532526 Sprague-Dawley/JJ newborn/JJ rats/NNS (/( n/NN =/SYM 85/CD )/SYM breathed/VBN 100%/CD oxygen/NN (/( O2/NN )/SYM or/CC room/NN air/NN (/( RA/NN )/SYM during/IN the/DT first/JJ 8/CD days/NNS of/IN life/NN ,/, and/CC then/RB RA/NN ./NN
@@64264938686 Following/VBG 20/CD min/NN of/IN steady/JJ state/NN anaesthesia/NN during/IN which/WDT measurements/NNS of/IN IOP/NN ,/, arterial/JJ pressure/NN ,/, heart/NN rate/NN ,/, FIO2/NN ,/, FE'CO2/NN and/CC CVP/NN were/VBD recorded/VBN ,/, one/PRP group/NN of/IN patients/NNS received/VBD atracurium/NN 0/CD ./CD 45/CD mg/NN kg-1/NN and/CC the/PDT other/DT pancuronium/NN 0/CD ./CD 1/CD mg/NN kg-1/NN ./.
@@94420244258 P/NNP ./NNP ,/, Peyron/NNP ,/, J/NNP ./NNP
@@114026741261 Newcastle/NEWGENE disease/NEWGENE antibody/NEWGENE titre/NN is/VBZ dependent/JJ on/IN serum/JJ calcium/NN concentration/NN ./.
@@118420371717 Based/VBN on/IN analytic/JJ precisions/NNS ,/, a/DT +/JJ //JJ -/JJ 2%/JJ urine-plasma/JJ difference/NN was/VBD set/NN as/IN the/DT cut-off/JJ value/NN ./.
@@15689609365 A/DT possible/JJ mechanism/NN is/VBZ that/WDT elevated/VBD alveolar/JJ pressure/NN and/CC decreased/VBN cardiac/JJ output/NN eliminate/VB blood/NN flow/NN from/IN corner/NN vessels/NNS in/IN nondependent/NN high/NN VA/NN //NN Q/NN regions/NN ./.
@@10831972471 RESULTS/NNS :/: Soluble/NN CD23/NEWGENE levels/NNS were/VBD significantly/RB higher/JJ in/IN women/NNS with/IN endometriosis/NN before/IN treatment/NN than/IN in/IN ten/CD normal/JJ controls/NNS ./.
@@93812614042 CONCLUSIONS/IN :/: We/PRP obtained/VBD normal/JJ EPO/NEWGENE levels/NNS for/IN mothers/NNS and/CC newborns/NNS for/IN our/PRP area/NN ,/, similarly/RB to/IN the/DT previously/RB described/VBN ones/NNS ./.
@@18508932442 Naturally/RB acquired/VBN antibodies/NNS were/VBD demonstrated/VBN in/IN some/DT rabbits/NNS kept/VBP on/IN commercial/JJ farms/NNS ./.
@@72523467085 A/DT surgical/JJ technique/NN for/IN correcting/VBG this/DT problem/NN is/VBZ described/VBN ./.
@@73779545564 The/DT following/NN aspects/NNS were/VBD assessed/VBN :/: (/( 1/CD )/SYM The/DT effect/NN on/IN the/DT cardiovascular/JJ system/NN in/IN terms/NNS of/IN brachial/JJ arterial/JJ pressure/NN ,/, pulse/NN rate/NN ,/, and/CC oxygen/NN consumption/NN (/( VO2/NN )/SYM during/IN exercise/NN in/IN 5/CD health/NN volunteers/NNS ;/: (/( 2/CD )/SYM emg/NN activity/NN of/IN the/DT tibialis/NN anterior/JJ and/CC gastrocnemius/NN muscles/NNS during/IN exercise/NN in/IN the/DT same/JJ 5/CD volunteers/NNS ;/: and/CC (/( 3/CD )/SYM postexercise/JJ ankle/NN pressure/NN changes/NNS in/IN 10/CD subjects/NNS with/IN angiographically/RB proven/VBP occlusive/JJ arterial/JJ diseases/NNS of/IN the/DT lower/JJR extremities/NNS ./.
@@59951405866 On/IN the/DT amount/NN and/CC significance/NN of/IN the/DT effective/JJ glucose/NN level/NN in/IN tumors/NNS ./.
@@108572621707 The/DT protein/NN encoded/VBN by/IN the/DT fruA/NEWGENE transcript/NEWGENE is/VBZ well/VB conserved/VBN with/IN the/DT D/NEWGENE ./NEWGENE melanogaster/NEWGENE type/NEWGENE A/NEWGENE protein/NEWGENE ,/, particularly/RB the/DT BTB/NEWGENE protein-protein-binding/NEWGENE domain/NEWGENE ,/, which/WDT is/VBZ encoded/VBN by/IN exons/NNS I/PRP and/CC II/NNP and/CC is/VBZ 100%/CD conserved/VBN ./.
@@97129151082 The/DT activity/NN of/IN the/DT minimal/JJ promoter/NN was/VBD found/VBN to/IN be/VB controlled/VBN by/IN a/DT combination/NN of/IN the/DT activities/NNS of/IN the/DT transcription/NN factors/NN Sp1/NEWGENE ,/, Sp3/NEWGENE ,/, and/CC NF-Y/NEWGENE ./.
@@111930457305 A/DT picture/NN is/VBZ emerging/JJ showing/NN a/DT gradient/NN of/IN function/NN among/IN p53/NEWGENE ,/, p73/NEWGENE ,/, p63/NEWGENE ranging/VBG from/IN tumor/NN suppression/NN to/IN development/NN ./.
@@119208961838 In/NN this/DT study/NN we/PRP wanted/VBD to/IN assess/VB the/DT DR/NN using/VBG the/DT 'combined/VBN test'/NN in/IN an/DT unselected/JJ population/NN of/IN self-referred/JJ pregnant/JJ women/NNS at/IN a/DT false-positive/JJ rate/NN (/( FPR/NNS )/SYM of/IN about/RB 5%/CD ./CD
@@30761243800 The/DT bile/NN acid/NN sequestrants/NNS (/( cholestyramine/NN and/CC colestipol/NN )/SYM ,/, nicotinic/JJ acid/NN ,/, fenofibrate/NN and/CC inhibitors/NNS of/IN hydroxymethylglutaryl/NEWGENE coenzyme/NEWGENE A/NEWGENE (/NEWGENE HMG/NEWGENE CoA/NEWGENE )/NEWGENE reductase/NEWGENE (/( e/NN ./NN g/NN ./. lovastatin/NN or/CC simvastatin/NN )/SYM are/VBP the/DT most/RB effective/JJ drugs/NNS for/IN use/NN in/IN patients/NNS with/IN primary/JJ hypercholesterolaemia/NN ;/: these/DT agents/NNS reduce/VBP plasma/NN concentrations/NNS of/IN total/NN and/CC LDL-cholesterol/NN by/IN 15/CD to/IN 45%/NN ./.
@@13265575514 Cloning/VBG and/CC primary/JJ structure/NN of/IN neurocan/NN ,/, a/DT developmentally/RB regulated/VBN ,/, aggregating/JJ chondroitin/NN sulfate/NN proteoglycan/NN of/IN brain/NN ./.
@@93891989344 During/IN the/DT aftermath/NN of/IN excitation/NN of/IN the/DT skin/NN sympathetic/JJ nerve/NN by/IN mental/JJ arithmetics/NNS ,/, 3/NN //NN 12/NN A/NN delta/NN units/NNS were/VBD turned/VBN to/IN the/DT active/JJ state/NN with/IN decreased/VBN mechanical/JJ threshold/NN ./.
@@103760659364 Both/DT filters/NNS equally/RB contributed/VBN to/IN elevation/NN of/IN iliac/JJ venous/JJ pressure/NN (/( median/JJ ,/, 9/CD ./CD 3/CD and/CC 7/CD ./CD 2/CD mm/NN Hg/NN [/NN n/NN =/SYM 9/NN ]/NN with/IN the/DT spring/NN filter/NN and/CC RF02/NN filter/NN ,/, respectively/RB )/SYM ./.
@@57898701560 Phosphate/NEWGENE glucose/NEWGENE dehydrogenase/NEWGENE deficiency/NN causing/JJ hyperbilirubinemia/NN in/IN the/DT newborn/NN ./.
@@90018288962 A/DT total/NN of/IN 1459/CD men/NNS aged/VBN 48/CD to/IN 84/CD years/NNS ,/, who/WP were/VBD diagnosed/VBN for/IN the/DT first/JJ time/NN by/RB physicians/NNS as/IN having/VBG BPH/NN in/IN 1994/CD and/CC who/WP had/VBP not/RB received/VBN treatment/NN ,/, participated/VBN in/IN the/DT study/NN ./.
@@39351174592 Selective/JJ effect/NN of/IN pulmonary/JJ oedema/NN on/IN prostaglandin/NN E2/NN pharmacokinetics/NN in/IN rat/NN lung/NN ./.
@@11921126293 As/IN measured/VBN by/IN the/DT PDQ-39/NN ,/, STN-DBS/NN significantly/RB improves/VBZ important/JJ aspects/NNS of/IN QoL/NN in/IN patients/NNS with/IN advanced/JJ PD/NNP ./NNP
@@11274368877 Deletion/NNS of/IN the/DT potential/JJ initiator/NN element/NN does/VBP not/RB affect/VB repression/NN of/IN the/DT p21/NEWGENE promoter/NEWGENE by/IN c-Myc/NEWGENE ./.
@@61475045968 Two/CD patients/NNS withdrew/VBD from/IN therapy/NN ,/, one/PRP for/IN personal/JJ reasons/NNS and/CC one/PRP because/IN a/DT paraspinal/JJ mass/RB developed/VBN ./.
@@107132394913 CONCLUSION/IN :/: A/DT valve-like/JJ mechanism/NN formed/VBN by/IN the/DT capsulorhexis/NN rim/NN partially/RB adhered/VBD to/IN the/DT IOL/NN optic/NN can/MD occur/VB postoperatively/RB ./.
@@78718919098 SUP46/NEWGENE is/VBZ implicated/VBN in/IN translation/NN fidelity/NN and/CC encodes/VBZ the/DT ribosomal/NEWGENE protein/NEWGENE S13/NEWGENE ./.
@@11042204324 The/DT present/NN study/NN shows/VBZ that/DT phosphatidylinositol/NN 3-kinase-dependent/NN p38/NEWGENE kinase/NEWGENE activation/NN regulates/VBZ Akt/NEWGENE phosphorylation/NN and/CC activity/NN in/IN human/JJ neutrophils/NNS ./.
@@110698254198 There/EX were/VBD 122/CD cases/NNS of/IN tuberculosis/NN over/RB an/DT average/JJ 10/CD ./CD 3/CD yr/NN of/IN follow-up/JJ (/( crude/JJ annual/JJ incidence/NN ,/, 76/NN ./NN 2/NN //NN 100/NN ,/NN 000/NN )/SYM ./.
@@1930470125 To/TO lower/JJR the/DT current/JJ high/JJ incidence/NN of/IN NANB-induced/JJ PTH/NN ,/, in/IN 1986/CD ,/, the/DT American/NNP Association/NNP of/IN Blood/NNP Banks/NNP (/( AABB/NN )/SYM recommended/VBN testing/NN for/IN these/DT PTH-associated/JJ "surrogate"/NN markers/NNS on/IN all/DT donated/VBN units/NNS of/IN blood/NN ./.
@@107130836698 As/IN assessed/VBN by/IN a/DT genetic/JJ assay/NN that/IN measures/NNS AAI-dependent/NN DNA/NN binding/JJ ,/, TraM/NEWGENE inhibited/VBD TraR/NEWGENE function/NN before/IN and/CC after/IN the/DT transcription/NN factor/NN had/VBP bound/JJ to/IN its/PRP DNA/NN recognition/NN site/NN ./.
@@92231228531 The/DT gray/JJ matter/NN NAA/NN //NN mI/NN ratio/NN clearly/RB separated/VBD the/DT two/JJ groups/NNS ./.
@@1010638110 The/DT feed/JJ consumed/VBN which/WDT was/VBD lowered/VBN by/IN 25%/JJ initially/RB ,/, did/VBD not/RB alter/VB later/JJR ./.
@@75408661975 As/IN expected/VBN ,/, the/DT insulin/NEWGENE effect/NN to/IN increase/NN ras/NEWGENE GTP/NEWGENE formation/NN and/CC MAP/NEWGENE kinase/NEWGENE activity/NN was/VBD negligible/JJ in/IN A/NNP //NNP K1018/NNP cells/NNS but/CC normal/JJ ,/, or/CC supernormal/JJ ,/, in/IN Y/NNP //NNP F2/NNP cells/NNS ./.
@@82547385672 Using/VBG a/DT series/NN of/IN mutant/JJ T/NN antigens/NNS expressed/VBN by/IN recombinant/JJ baculoviruses/NNS in/IN Sf9/CD cells/NNS ,/, we/PRP find/VBP that/IN the/DT origin/NN unwinding/JJ activities/NNS of/IN both/DT TS677--/NNP >/NNP A/NNP and/CC TS677/CD ,/CD 679--/CD >/CD A/CD are/VBP inhibited/VBN by/IN the/DT T-antigen/NEWGENE kinase/NEWGENE ,/, as/IN is/VBZ wild-type/NEWGENE T/NEWGENE antigen/NEWGENE ./.
@@18856133195 Information/NNP on/IN conserved/VBN noncoding/JJ sequences/NNS will/MD help/VB in/IN studies/NNS on/IN the/DT regulation/NN of/IN the/DT pro/NEWGENE alpha/NEWGENE 1/NEWGENE (/NEWGENE II/NEWGENE )/NEWGENE collagen/NEWGENE gene/NEWGENE ./.
@@65178166848 HA/NN resulted/VBN in/IN decreased/VBN (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM Tre/NN (/( 0/CD ./CD 4/CD degrees/NNS C/NN )/SYM and/CC HR/NN (/( 17/CD b/NN X/NN min-1/NN )/SYM ,/, and/CC increased/VBD (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM Msw/NNP (/( 16/CD g/NN X/NN m-2/NN X/NN h-1/NN )/SYM during/IN the/DT saline/JJ experiments/NNS ./.
@@98132599790 Our/PRP findings/NNS demonstrate/VBP a/DT dose-dependent/NN blockade/NN of/IN the/DT mechanical/JJ sensitivity/NN caused/VBN by/IN a/DT mild/JJ thermal/JJ injury/NN by/IN both/DT GBP/NN and/CC IBG/NN ./.
@@93216577805 In/NN this/DT study/NN we/PRP have/VBP introduced/VBN mutations/NNS into/IN the/DT corresponding/JJ elements/NNS of/IN two/JJ cox3/NEWGENE promoters/NEWGENE and/CC show/VB that/IN while/CC the/DT core/NEWGENE element/NEWGENE is/VBZ essential/JJ for/IN cox3/NEWGENE promoter/NEWGENE activity/NN ,/, upstream/JJ element/NN mutations/NNS have/VBP little/JJ or/CC no/DT effect/NN ./.
@@6652146383 The/DT method/NN described/VBN may/MD prove/VB useful/JJ in/IN studying/VBG the/DT physiology/NN of/IN the/DT nasal/JJ cycle/NN ./.
@@70188105528 Plasma/NEWGENE renin/NEWGENE concentration/NN is/VBZ significantly/RB higher/JJ in/IN the/DT subcapsular/JJ venous/JJ outflow/NN ,/, which/WDT drains/VBZ the/DT superficial/JJ cortex/NN ,/, than/IN in/IN the/DT deep/JJ venous/JJ outflow/NN ,/, which/WDT drains/VBZ the/DT inner/JJ half/NN of/IN the/DT cortex/NN and/CC medulla/NN of/IN the/DT cat/NN kidney/NN ./.
@@105214476568 The/DT factor/NN designated/VBN B/NNP formed/VBD a/DT complex/NN centered/VBN on/IN the/DT sequence/NN TGTGGT/NEWGENE ,/, a/DT core/NN motif/NN recognized/VBN by/IN members/NNS of/IN the/DT AML/NEWGENE //NEWGENE CBFalpha/NEWGENE transcription/NEWGENE factor/NEWGENE family/NEWGENE ./.
@@76424905455 A/DT new/JJ vector/NN ,/, pHBK280/NN ,/, was/VBD designed/VBN to/IN facilitate/VB this/DT analysis/NN ./.
@@8798443414 The/DT DNA/NN binding/NN and/CC multimerization/NN activities/NNS of/IN c-Myb/NEWGENE appear/VB to/IN be/VB unaffected/JJ by/IN the/DT S528A/NNP substitution/NN ,/, suggesting/VBG that/DT phosphorylation/NN of/IN serine/NN 528/CD may/MD mediate/VB its/PRP effect/NN on/IN the/DT transcription/NN transactivating/JJ activity/NN of/IN c-Myb/NEWGENE by/IN regulating/JJ interactions/NNS with/IN other/DT proteins/NNS ./.
@@110513645079 RESULTS/NNS :/: Twenty-two/CD (/( 26%/JJ )/SYM patients/NNS had/VBP PHG/NN before/IN (/( group/NN A/DT )/SYM and/CC 64/CD (/( 74%/JJ )/SYM developed/VBN PHG/NN after/IN variceal/JJ eradication/NN (/( group/NN B/NNP )/SYM ./SYM
@@10550139368 PATIENTS/IN AND/CC METHODS/IN :/: Immediately/RB before/IN radical/JJ prostatectomy/NN ,/, bone/NN marrow/NN aspirates/NNS from/IN both/DT sides/NNS of/IN the/DT iliac/JJ crest/NN were/VBD taken/VBP from/IN 287/CD patients/NNS ./.
@@91763409875 Transcription/NNS of/IN these/DT genes/NNS was/VBD also/RB elevated/VBN in/IN gut/NN and/CC lung/NN during/IN freezing/NN ,/, but/CC mRNA/NN levels/NNS in/IN these/DT tissues/NNS were/VBD lower/JJR than/IN in/IN liver/NN ./.
@@37460537170 Findings/NNS of/IN positive/JJ potentials/NNS showed/VBN that/IN N1/NN originated/VBN in/IN the/DT area/NN of/IN ventral/JJ gray/JJ matter/NN through/RB the/DT ventro-lateral/JJ column/NN and/CC N2/NN through/RB the/DT dorsal/JJ column/NN ./.
@@96713135225 Chem/NNP ./NNP ,/, 270/CD :/: 7117-7124/JJ ,/, 1995/CD ;/: and/CC MT/NN Hartsough/NNP et/FW al/NNS ./NNS ,/, J/NNP ./NNP
@@111607328757 Vector/NNP stocks/NNS containing/JJ envelope/NN proteins/NNS from/IN three/CD different/JJ SIVmac/ORG clones/NNS ,/, namely/RB ,/, SIVmac239/NN (/( T-lymphocyte/NN tropic/JJ [/NN T-tropic/NN ]/NN )/SYM ,/, SIVmac316/NN (/( macrophage/NN tropic/JJ [/NN M-tropic/NN ]/NN )/SYM ,/, and/CC SIVmac1A11/NN (/( dualtropic/JJ )/SYM ,/, were/VBD tested/VBN ./.
@@116065381874 A/DT twelfth/JJ insertion/NN disrupts/VBZ two/JJ genes/NNS ,/, Nrk/NEWGENE ,/, a/DT "neurospecific"/NEWGENE receptor/NEWGENE tyrosine/NEWGENE kinase/NEWGENE ,/, and/CC Tpp/NEWGENE ,/, which/WDT encodes/VBZ a/DT neuropeptidase/NEWGENE ./.
@@1544305512 The/DT Southern/NNP technique/NN allowed/VBD a/DT further/JJ localization/NN of/IN the/DT region/NN of/IN most/RB extensive/JJ transcription/NN to/IN a/DT 1/NEWGENE ./NEWGENE 8/NEWGENE kb/NEWGENE HindIII-EcoRI/NEWGENE fragment/NEWGENE ./.
@@72806549442 In/NN literature/NN ,/, the/DT HBE/NN has/VBZ been/VBN displayed/VBN by/IN application/NN of/IN the/DT averaging/VBG method/NN ./.
@@19038419674 One/CD of/IN its/PRP lysine/NN residues/NNS is/VBZ modified/JJ by/IN spermidine/NN to/IN form/NN hypusine/NN ,/, a/DT posttranslational/JJ modification/NN unique/JJ to/IN eIF-5A/NEWGENE ./.
@@1681762110 Patulin/NN is/VBZ extracted/VBN from/IN apple/NN butter/NN samples/NNS with/IN ethyl/NN acetate/NN and/CC the/DT extract/NN is/VBZ cleaned/VBN up/JJ on/IN a/DT silica/NN gel/NN column/NN ,/, using/VBG benzene-ethyl/JJ acetate/NN (/( 75+25/CD )/SYM as/IN the/DT eluant/NN ./.
@@1007389973 The/DT lowest/JJS culture/NN failure/NN rate/NN of/IN 0/CD ./CD 2/CD per/IN cent/NN was/VBD found/VBN after/IN EAF/NN compared/VBN with/IN 0/CD ./CD 9/CD per/IN cent/NN among/IN CVS/NN ./.
@@53225585470 Homograft/NNS response/NN and/CC hemagglutinin/NEWGENE production/NN by/IN sensitized/RB thymectomized/VBN irradiated/JJ adult/JJ mice/NNS ./.
@@34203246652 Pregnant/NNP rats/NNS were/VBD exposed/VBN to/IN one/PRP of/IN the/DT following/NN :/: (/( 1/CD )/SYM 10%/CD O2/NN in/IN N2/NN or/CC 100%/NN O2/NN for/IN 2/CD days/NNS beginning/NN at/IN day/NN 7/CD ,/, 11/CD ,/, 14/CD ,/, or/CC 18/CD of/IN pregnancy/NN ;/: (/( 2/CD )/SYM 10%/CD O2/NN in/IN N2/NN or/CC 100%/NN O2/NN for/IN 10/CD h/NN //NN day/NN beginning/NN at/IN day/NN 7/CD ;/: or/CC (/( 3/CD )/SYM 14-11%/JJ O2/NN in/IN N2/NNP continuously/RB beginning/JJ at/IN day/NN 14/CD till/NN day/NN 21/CD when/CC they/PRP were/VBD sacrificed/VBN ./.
@@90307819848 Most/JJS kinases/NEWGENE are/VBP not/RB significantly/RB inhibited/VBN by/IN roscovitine/NN ./. cdc2/NEWGENE //NEWGENE cyclin/NEWGENE B/NEWGENE ,/, cdk2/NEWGENE //NEWGENE cyclin/NEWGENE A/NEWGENE ,/, cdk2/NEWGENE //NEWGENE cyclin/NEWGENE E/NEWGENE and/CC cdk5/NEWGENE //NEWGENE p35/NEWGENE only/RB are/VBP substantially/RB inhibited/VBN (/( IC50/NN values/NNS of/IN 0/CD ./CD 65/CD ,/, 0/CD ./CD 7/CD ,/, 0/CD ./CD 7/CD and/CC 0/CD ./CD 2/CD microM/NN ,/, respectively/RB )/SYM ./. cdk4/NEWGENE //NEWGENE cyclin/NEWGENE D1/NEWGENE and/CC cdk6/NEWGENE //NEWGENE cyclin/NEWGENE D2/NEWGENE are/VBP very/RB poorly/RB inhibited/VBN by/IN roscovitine/NN (/( IC50/NN >/SYM 100/CD microM/NN )/SYM ./.
@@10617232439 Serum/NN HBV-DNA/NNS ,/, viral/JJ serology/NN ,/, and/CC liver/NN enzymes/NNS were/VBD measured/VBN sequentially/RB ;/: liver/NN histology/NN was/VBD taken/VBP before/IN and/CC during/IN treatment/NN in/IN 12/CD patients/NNS ./.
@@103853957038 The/DT high/NEWGENE density/NEWGENE lipoprotein/NEWGENE (/NEWGENE HDL/NEWGENE )/NEWGENE receptor/NEWGENE mediates/VBZ the/DT uptake/NN of/IN cholesterol/NN and/CC cholesteryl/NN esters/NNS ,/, substrates/NNS for/IN steroidogenesis/NN ,/, from/IN an/DT HDL/NN particle/NN in/IN the/DT adrenal/JJ gland/NN and/CC gonads/NNS ./.
@@26348723308 Retrograde/JJ filling/NN consists/VBZ in/IN sealing/JJ endodontics/NN system/NN directly/RB at/IN the/DT apical/JJ zone/NN after/IN surgical/JJ approach/NN ./.
@@98298439816 The/DT hematopoietic/NEWGENE colony-stimulating/NEWGENE factors/NEWGENE (/( CSF/NEWGENE )/SYM have/VB been/VBN introduced/VBN into/IN clinical/JJ practice/NN as/IN additional/JJ supportive/JJ measures/NNS that/WDT can/MD reduce/VB the/DT incidence/NN of/IN infectious/JJ complications/NNS in/IN patients/NNS with/IN cancer/NN and/CC neutropenia/NN ./.
@@115226263766 Furthermore/RB ,/, hormonal/JJ regulation/NN of/IN G/NN (/NN 1/NN )/NN gene/NN transcription/NN can/MD occur/VB even/VB without/IN additional/JJ activation/NN of/IN the/DT Mek-Erk1/NEWGENE //NEWGENE 2/NEWGENE pathway/NN by/IN estrogen/NEWGENE receptors/NEWGENE ./.
@@25656833217 A/DT critical/JJ heart/NN rate/NN and/IN //IN or/IN appropriate/JJ sympathetic/JJ state/NN was/VBD found/VBN to/IN provoke/VB all/DT instances/NNS of/IN reentrant/JJ or/CC automatic/JJ atrial/JJ tachycardia/NN and/CC atypical/JJ junctional/JJ tachycardia/NN ./.
@@38144938223 Chlorambucil/NN and/CC interferon/NEWGENE for/IN low/JJ grade/NN non-Hodgkin's/JJ lymphoma/NN ./.
@@95807003068 The/DT DNA/NN binding/JJ activities/NNS of/IN the/DT three/CD repressor/NN preparations/NNS were/VBD studied/VBN using/VBG fragments/NNS containing/JJ CIRs/NN (/( CIR3-CIR6/NN )/SYM from/IN the/DT essential/JJ early/JJ region/NN as/IN templates/NNS for/IN DNase/NEWGENE I/NEWGENE footprinting/VBG ./.
@@83601128322 XII/NNS ./.
@@105214438486 This/DT effect/NN required/VBN (/( i/NN )/SYM IR/NEWGENE activation/NN since/IN it/PRP was/VBD abrogated/VBN by/IN IR/NEWGENE mutation/NN at/IN tyrosines/NNS 1162/CD and/CC 1163/CD and/CC (/( ii/NN )/SYM NF-kappaB/NEWGENE activation/NN since/IN it/PRP was/VBD abolished/VBN by/IN overexpression/NN of/IN dominant-negative/NEWGENE IkappaB-alpha/NEWGENE (/NEWGENE A32/NEWGENE //NEWGENE 36/NEWGENE )/NEWGENE and/CC mimicked/VBN by/IN overexpression/NN of/IN the/DT NF-kappaB/NEWGENE c-Rel/NEWGENE1 subunit/NEWGENE1 ./.
@@107481944968 Synaptic/JJ targeting/NN of/IN the/DT postsynaptic/NEWGENE density/NEWGENE protein/NEWGENE PSD-95/NEWGENE mediated/JJ by/IN a/DT tyrosine-based/JJ trafficking/NN signal/JJ ./.
@@105517962978 Regulation/NN of/IN HIV-1/NNP transcription/NN ./.
@@96680989358 We/PRP isolated/VBD the/DT human/NEWGENE FGF-BP/NEWGENE promoter/NEWGENE and/CC determined/VBN by/IN deletion/NN analysis/NN that/DT TPA/NEWGENE regulatory/NEWGENE elements/NEWGENE were/VBD all/DT contained/VBN in/IN the/DT first/JJ 118/CD base/NN pairs/NNS upstream/RB of/IN the/DT transcription/NN start/NN site/NN ./.
@@50818145359 Derivatives/NNS of/IN boswellic/JJ acids/NNS ./.
@@11518868766 Testing/NN was/VBD associated/VBN with/IN a/DT history/NN of/IN nonsexual/JJ risk/NN behavior/NN ,/, increased/VBN knowledge/NN of/IN the/DT hepatitis/NN C/NN virus/NN ,/, and/CC healthcare/NN provider/NN communication/NN ./.
@@24687951101 Serum/NN prostatic/NEWGENE acid/NEWGENE phosphatase/NEWGENE levels/NNS showed/VBD a/DT significantly/RB weaker/JJR correlation/NN with/IN cancer/NN volume/NN (/( r/JJ equals/VBP 0/CD ./CD 51/CD )/SYM and/CC every/DT other/DT pathological/JJ parameter/NN ./.
@@103645237806 With/IN exon/NN trapping/JJ ,/, we/PRP could/MD isolate/VB five/CD potential/JJ exons/NNS from/IN the/DT YAC/NN 946E12/NN that/WDT spans/VBZ the/DT region/NN ,/, four/CD of/IN which/WDT could/MD be/VB placed/VBN in/IN the/DT contig/NN in/IN the/DT vicinity/NN of/IN the/DT breakpoints/NNS ./.
@@112823944189 No/DT preferential/JJ VH/NEWGENE //NEWGENE VL-chains/NEWGENE correlated/VBD with/IN any/DT of/IN the/DT 12/CD different/JJ antigen/NN reactivities/NNS ,/, even/VB for/IN mAbs/NNS with/IN nearly/RB identical/JJ cross-reactivities/NNS ./.
@@17652669031 In/NN Xenopus/JJ laevis/NNS ,/, the/DT gene/NN encoding/VBG the/DT elongation/NEWGENE factor/NEWGENE 1-alpha/NEWGENE variant/NEWGENE EF-1/NEWGENE1 alpha/NEWGENE1 O/NEWGENE1 ,/, where/CC O/NN stands/NNS for/IN oocyte/NN ,/, is/VBZ expressed/VBN in/IN oocytes/NNS and/CC early/JJ embryos/NNS ./.
@@98805132798 Both/DT proteins/NNS were/VBD shown/VBP to/IN be/VB constitutively/RB associated/VBN with/IN tubulin/NEWGENE ./.
@@108014824967 We/PRP also/RB show/VBP that/IN p65/NEWGENE binds/VBZ to/IN these/DT targets/NNS with/IN almost/JJ equal/NN affinity/NN and/CC that/IN different/JJ residues/NNS have/VBP variable/JJ roles/NNS in/IN binding/JJ different/JJ kappaB/NEWGENE targets/NEWGENE ./.
@@105236404388 Although/IN the/PDT Src/NEWGENE tyrosine/NEWGENE kinase/NEWGENE induces/VBZ constitutive/JJ Stat3/NEWGENE phosphorylation/NN on/IN tyrosine/NN ,/, activation/NN of/IN Stat3-mediated/NN gene/NN regulation/NN requires/VBZ both/DT tyrosine/NN and/CC serine/NN phosphorylation/NN of/IN Stat3/NEWGENE ./.
@@107739514645 IgM/NEWGENE and/CC IgG/NEWGENE anti/NEWGENE A/NEWGENE and/CC anti/NEWGENE B/NEWGENE antibody/NEWGENE status/NN of/IN 100/CD antenatal/JJ O/NN group/NN mothers/NNS (/( who/WP had/VBP non/FW O/NN group/NN husbands/NNS )/SYM were/VBD studied/VBN ./.
@@94884865139 A/DT triple-mutant/NEWGENE TBP/NEWGENE (/( R231E/NN +/SYM R235E/NN +/SYM R239S/CD )/SYM had/VBP greatly/RB reduced/VBN activity/NN for/IN yeast/NEWGENE U6/NEWGENE snRNA/NEWGENE gene/NEWGENE transcription/NN while/CC remaining/JJ active/NN for/IN Pol/NEWGENE II/NEWGENE basal/JJ transcription/NN ./.
@@93929799345 AIDS-related/JJ disseminated/JJ histoplasmosis/NN in/IN San/NNP Francisco/NN ,/, California/NN ./.
@@71056356899 Samples/NNS obtained/VBN from/IN normal/JJ volunteers/NNS and/CC from/IN the/DT great/JJ majority/NN of/IN the/DT patients/NNS ,/, excluding/JJ those/DT with/JJ asthma/NN ,/, had/VBP no/DT effect/NN on/IN ciliary/JJ beating/NN ./.
@@97907717326 Gng3lg/NEWGENE transcripts/NEWGENE are/VBP expressed/VBN in/IN a/DT variety/NN of/IN tissues/NNS including/JJ both/DT brain/NN and/CC testes/NNS ./.
@@91993286214 Interdigitated/JJ residues/NNS within/IN a/DT small/JJ region/NN of/IN VP16/NEWGENE interact/VB with/IN Oct-1/NEWGENE ,/, HCF/NEWGENE ,/, and/CC DNA/NN ./.
@@105518484934 In/NN an/DT earlier/JJR study/NN (/( Kimura/NNP ,/, Y/NNP ./NNP ,/, Kurzydlowski/NNP ,/, K/NNP ./NNP ,/, Tada/NNP ,/, M/NNP ./NNP ,/, and/CC MacLennan/NNP ,/, D/NN ./NN
@@101921348210 25-OH-D3/NN did/VBD not/RB adversely/RB affect/VB animal/NN health/NN at/IN the/DT proposed/VBN use/NN level/NN of/IN 99/CD micrograms/NN //NN kg/NN feed/JJ when/CC replacing/VBG vitamin/NN D3/NN in/IN turkey/NN rations/NNS ./.
@@79411747906 Laser/NNP therapy/NN of/IN penile/JJ carcinoma/NN ./.
@@33524394041 Vocal/NN cord/NN abduction/NN rehabilitation/NN by/IN nervous/JJ selective/JJ anastomosis/NN ./.
@@57494385704 Dissociative/NNP anesthetics/NNS 2-/NN (/NN o-chlorophenyl/NN )/NN -2-methyl-amino/NN cyclohexane/NN HCL/NN (/( CI-581/NN )/SYM ./.
@@19041542421 If/IN this/DT is/VBZ the/DT case/NN ,/, identification/NN and/CC characterization/NN of/IN transcripts/NNS from/IN the/DT Ig/NEWGENE loci/NEWGENE should/MD permit/VB a/DT better/JJR understanding/NN of/IN the/DT gene/NN rearrangement/NN process/NN ./.
@@30221297053 The/DT nucleosomal/JJ arrays/NNS detected/VBN by/IN MPE/NNS X/NN Fe/NN (/NN II/NN )/NN were/VBD characterized/VBN by/IN a/DT considerable/JJ loss/NN of/IN detail/NN and/CC significantly/RB enhanced/VBN accessibility/NN ,/, the/DT extent/NN of/IN which/WDT probably/RB reflected/VBN the/DT relative/JJ transcription/NN rate/NN of/IN each/DT gene/NN ./.
@@109180596291 Deletion/NNS of/IN the/DT RVH/NEWGENE domain/NEWGENE resulted/VBN in/IN loss/NN of/IN Ca/NN (/NN 2+/NN )/NN -dependent/NN activation/NN ./.
@@76939678001 The/DT presence/NN of/IN the/DT RV/NN 5'/NN (/NN +/NN )/NN SL/NN sequence/NN had/VBP the/DT primary/JJ enhancing/JJ effect/NN on/IN translation/NN ./.
@@96141065257 Three/CD high/JJ mobility/NN group-like/JJ sequences/NNS within/IN a/DT 48-base/JJ pair/NN enhancer/NN of/IN the/DT Col2a1/NEWGENE gene/NEWGENE are/VBP required/VBN for/IN cartilage-specific/JJ expression/NN in/IN vivo/NN ./.
@@91898969145 The/DT findings/NNS suggest/VBP that/IN ERP/NN effects/NNS of/IN distinct/JJ memory/NN processes/NNS are/VBP differentially/RB influenced/VBN by/IN the/DT encoding/VBG instructions/NNS ./.
@@105160722018 Duch/NNP ,/, and/CC F/NN ./NN
@@21762322788 Risk/NN factors/NNS influencing/VBG lymph/NN nodes/NNS metastasis/NN in/IN lung/NN cancer/NN with/IN stage/NN I/PRP ,/, II/NNP or/CC IIIA/NNS ./.
@@94439728337 Our/PRP results/NNS establish/VBP GKLF/NEWGENE as/IN a/DT sequence-specific/NN transcription/NN factor/NN likely/RB involved/VBD in/IN regulation/NN of/IN expression/NN of/IN endogenous/JJ genes/NNS ./.
@@112788197652 Sequence/NN comparison/NN and/CC binding/JJ studies/NNS of/IN the/DT 18-bp/NEWGENE MOK2-binding/NEWGENE sites/NEWGENE present/VBP in/IN intron/NN 2/CD of/IN human/JJ ,/, bovine/JJ ,/, and/CC mouse/NEWGENE IRBP/NEWGENE genes/NEWGENE show/VBP that/IN the/DT 3'-half/JJ sequence/NN is/VBZ the/DT essential/JJ core/NN element/NN for/IN MOK2/NEWGENE binding/JJ ./.
@@77117302578 Carnitine/NEWGENE palmitoyltransferase/NEWGENE (/NEWGENE CPT/NEWGENE )/NEWGENE II/NEWGENE deficiency/NN is/VBZ the/DT most/RB common/JJ inherited/JJ disorder/NN of/IN lipid/NN metabolism/NN affecting/VBG skeletal/JJ muscle/NN ./.
@@94990311417 The/DT intercistronic/JJ gene/NN junctions/NNS of/IN vesicular/JJ stomatitis/NN virus/NN (/( VSV/NN )/SYM contain/VB conserved/VBN sequence/NN elements/NNS that/WDT are/VBP important/JJ for/IN polyadenylation/NN and/CC transcription/NN termination/NN of/IN upstream/JJ transcript/NN as/RB well/VB as/IN reinitiation/NN of/IN transcription/NN of/IN downstream/JJ transcript/NN ./.
@@72025257027 Each/DT trial/NN consisted/VB of/IN light/NN and/CC buzzer/NN for/IN five/CD seconds/NNS as/IN conditioned/JJ stimuli/NNS and/CC electric/JJ shock/NN for/IN five/CD seconds/NNS as/IN an/DT unconditioned/JJ stimulus/NN ./.
@@8622645483 Conversely/RB ,/, when/CC VDR/NEWGENE is/VBZ overexpressed/VBN ,/, vitamin/NN D3/NN attenuates/VBZ 9-cis/NN RA/NN induction/NN from/IN an/DT RXR-responsive/NEWGENE element/NEWGENE ./.
@@118840142438 Rigorous/JJ treatment/NN protocols/NNS for/IN diet/NN delivery/NN and/CC EEN-related/NN GI/NN adverse/JJ effects/NNS were/VBD applied/VBN ./.
@@87098318690 Furthermore/RB ,/, the/DT potency/NN of/IN Dacarbacine/NNP in/IN the/DT treatment/NN of/IN carcinoid/NN tumors/NNS seems/VBZ to/IN be/VB underestimated/VBN up/JJ to/IN now/RB ./.
@@5944665834 The/DT induction/NN of/IN seizures/NNS in/IN "Papio/NN papio"/NN following/IN allylglycine/NN alone/RB or/CC in/IN combination/NN with/IN intermittent/JJ photic/JJ stimulation/NN ./.
@@106662386776 Thus/RB ,/, the/DT induction/NN of/IN E2F/NEWGENE binding/JJ to/IN the/DT E2F-1/NEWGENE promoter/NEWGENE by/IN the/DT E4-6/NEWGENE //NEWGENE 7/NEWGENE protein/NEWGENE observed/VBN in/IN vitro/FW correlates/VBP with/IN transactivation/NN of/IN E2F-1/NEWGENE promoter/NEWGENE activity/NN in/IN vivo/NN ./.
@@78904856471 With/IN steady/JJ illumination/NN ,/, outer/JJ retinal/JJ (/( photoreceptor/NN )/SYM QO2/NN decreased/VBN to/IN 1/CD ./CD 4/CD +/NN //NN -/NN 0/CD ./CD 9/CD ml/NN O2/NN //NN (/NN 100/NN g/NN ./NN min/NN )/NN ,/, but/CC inner/JJ retinal/JJ QO2/NN remained/VBN unchanged/JJ at/IN 3/CD ./CD 7/CD +/NN //NN -/NN 1/CD ./CD 5/CD ml/NN O2/NN //NN (/NN 100/NN g/NN ./NN min/NN )/NN (/( 5/CD cats/NNS )/SYM ./.
@@79999825621 Cumulated/JJ maximum/JJ lod/NN scores/NNS between/IN FRDA/NEWGENE and/CC D9S5/NEWGENE and/CC between/IN FRDA/NEWGENE and/CC D9S15/NEWGENE are/VBP above/RB 36/CD and/CC 61/CD ,/, respectively/RB ,/, at/IN a/DT recombination/NN fraction/NN of/IN 0/CD ,/, indicating/VBG that/IN recombination/NN events/NNS needed/VBN to/IN orient/VB the/DT search/NN of/IN the/DT gene/NN are/VBP very/RB difficult/JJ to/IN identify/VB and/CC ascertain/VB ./.
@@97591808690 BACKGROUND/IN :/: Fluoroquinolones/NN (/( FQ/NN )/SYM are/VBP contraindicated/VBN in/IN children/NNS because/IN of/IN the/DT risk/NN of/IN cartilage/NN damage/NN ./.
@@83378415474 In/NN infected/VBD mammalian/JJ cells/NNS ,/, the/DT ARV/NEWGENE G/NEWGENE and/CC GNS/NEWGENE genes/NEWGENE are/VBP transcribed/VBN primarily/RB as/IN a/DT polycistronic/JJ mRNA/NN which/WDT appears/VBZ to/IN extend/VB from/IN the/DT consensus/NN sequence/NN (/( AACAG/NEWGENE )/SYM at/IN the/DT start/NN of/IN the/DT G/NEWGENE gene/NEWGENE to/IN the/DT next/RB recognized/VBN polyadenylation/NN signal/JJ (/( CATG/NN [/NN A/NN ]/NN 7/NN )/SYM located/VBN 697/CD nucleotides/NNS downstream/RB of/IN the/DT GNS/NEWGENE protein/NEWGENE termination/NN codon/NN ./.
@@1423738874 On/IN the/PDT other/DT hand/NN ,/, total/JJ pinealectomy/NN in/IN these/DT already/RB sympathectomized/VBN blinded/JJ rabbits/NNS always/RB resulted/VBN in/IN a/DT substantial/JJ deceleration/NN of/IN the/DT rhythms/NNS (/( mean/JJ delta/NN tau/NN =/SYM +0/CD ./CD 23/CD h/NN )/SYM ./SYM
@@111337415236 NiCl/NN (/NN 2/NN )/NN -induced/NN MCP-1/NEWGENE synthesis/NN required/VBD activation/NN of/IN NF-kappaB/NEWGENE since/IN mutation/NN of/IN NF-kappaB-binding/NEWGENE sites/NEWGENE in/IN the/DT promoter/NN resulted/VBN in/IN complete/JJ loss/NN of/IN inducible/NN promoter/NN activity/NN ./.
@@80158508012 A/DT more/RB complete/JJ analysis/NN of/IN dose/NN response/NN ,/, time/NN and/CC mode/NN of/IN Ga/NN administration/NN (/( preinjury/NN or/CC postinjury/RB )/SYM ,/, and/CC availability/NN of/IN Ga/NN across/IN the/DT blood-brain/JJ barrier/NN is/VBZ needed/VBN to/IN further/RB evaluate/VB the/DT efficacy/NN of/IN this/DT compound/NN ./.
@@103395667002 Spc42p/NEWGENE also/RB was/VBD identified/VBN as/IN a/DT component/NN of/IN a/DT cytoplasmic/NEWGENE SPB/NEWGENE subcomplex/NEWGENE containing/JJ Spc94p/NEWGENE //NEWGENE Nud1p/NEWGENE ,/, Cnm67p/NEWGENE ,/, and/CC Spc42p/NEWGENE ./.
@@59473771348 The/DT 3-hour/JJ test/NN iodine/NN (/( I-132/NN )/SYM uptake/NN by/IN the/DT thyroid/NN in/IN children/NNS with/IN growth/NN deficiency/NN ./.
@@106921675990 However/RB ,/, such/JJ a/DT mechanism/NN was/VBD not/RB detected/VBN in/IN preliminary/JJ observations/NNS on/IN M/NNP ./NNP synoviae/NNS ./.
@@93384143846 Ea/NN value/NN was/VBD calculated/VBN as/IN the/DT ratio/NN of/IN the/DT steady-state/JJ end-systolic/JJ aortic/JJ pressure/NN (/( ESAP/NN )/SYM to/IN stroke/NN volume/NN (/( thermodilution/NN )/SYM ./.
@@93882719754 The/DT mobility/NN shift/NN of/IN both/DT of/IN these/DT proteins/NNS is/VBZ abolished/VBN by/IN treatment/NN with/IN inhibitors/NNS of/IN PKC/NEWGENE or/CC mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE //NEWGENE extracellular/NEWGENE signal-related/NEWGENE kinase/NEWGENE kinase/NEWGENE ./.
@@83099128287 Amiodarone/IN ,/, seldom/RB used/VBN as/IN first-line/NN treatment/NN ,/, appears/VBZ to/IN be/VB the/DT most/RB effective/JJ drug/NN ./.
@@111802553144 This/DT supports/VBP previous/JJ arguments/NNS for/IN the/DT improbability/NN of/IN biological/JJ effects/NNS at/IN UHF/NN frequencies/NNS unless/IN a/DT mechanism/NN can/MD be/VB found/VB for/IN accumulating/JJ energy/NN over/JJ time/NN and/CC space/NN and/CC focussing/NN it/CD ./CD
@@111893148754 These/DT results/NNS indicate/VBP that/IN BACM/NN has/VBZ antiplaque/NN and/CC stronger/JJR antidegradation/NN effects/NNS than/IN GLCM/NNP ./.
@@79250229572 Expression/NNS is/VBZ exclusively/RB limited/VBN to/IN the/DT CNS/NN at/IN this/DT and/CC later/JJR stages/NNS ./.
@@88184368796 However/RB ,/, in/IN a/DT multivariate/JJ analysis/NN considering/VBG age/NN ,/, gender/NN ,/, and/CC a/DT previous/JJ history/NN of/IN cardiovascular/JJ diseases/NNS ,/, female/JJ gender/NN was/VBD not/RB independently/RB associated/VBN with/IN death/NN ./.
@@25745514669 Antihistamines/NN in/IN asthma/NN ./.
@@9484463379 Cloning/VBG and/CC expression/NN of/IN two/JJ genes/NNS encoding/VBG auxin-binding/NEWGENE proteins/NEWGENE from/IN tobacco/NN ./.
@@30356583798 During/IN pentobarbital/NN anesthesia/NN ,/, the/DT basal/NN VO2/NN was/VBD 5/CD ./CD 26/CD ml/NN //NN kg/NN //NN min/NN and/CC was/VBD increased/VBN by/IN epinephrine/NN in/IN a/DT dose/NN dependent/JJ manner/NN at/IN plasma/NN concentrations/NNS between/IN 3/CD ./CD 9/CD ng/NN //NN ml/NN (/( VO2/NN =/SYM 5/CD ./CD 68/CD ml/NN //NN kg/NN //NN min/NN )/SYM and/CC 36/CD ./CD 5/CD ng/NN //NN ml/NN (/( VO2/NN =/SYM 6/CD ./CD 47/CD ml/NN //NN kg/NN //NN min/NN )/SYM ./.
@@1279696250 Previous/JJ studies/NNS have/VBP shown/VBP [/NN Hisanaga/NN ,/, S/NNP ./NNP ,/, Kusubata/NNP ,/, M/NNP ./NNP ,/, Okumura/NNP ,/, E/NNP ./NNP &/CC Kishimoto/NNP ,/, T/NNP ./NNP
@@39780456125 These/DT findings/NNS suggest/VBP that/IN both/DT in/NN the/DT early/JJ stages/NNS (/( 0T/NN ,/, 0N/CD )/SYM and/CC in/IN more/RB severe/JJ stages/NNS of/IN VWF/NN (/( stages/NNS 1-2/CD )/SYM cold/RB induced/VBN hyperreactivity/NN in/IN the/DT digital/JJ vessels/NNS and/CC Raynaud's/NNP syndrome/NN are/VBP vascular/JJ disorders/NNS of/IN functional/JJ origin/NN occurring/VBG without/IN any/DT prethrombotic/JJ alterations/NNS ./.
@@81675558140 Response/NNP to/IN treatment/NN was/VBD better/JJR in/IN patients/NNS with/IN less/PRP pretreatment/JJ (/( one-two/JJ prior/NN treatments/NNS )/SYM than/IN in/IN heavily/RB pretreated/VBN ones/NNS (/( more/RB than/IN three/CD )/SYM and/CC this/DT relation/NN was/VBD found/VBN to/IN be/VB statistically/RB significant/JJ (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@21950255066 Regulation/NN of/IN yeast/NEWGENE LEU2/NEWGENE ./.
@@112109881049 Can/MD survival/NN be/VB prolonged/JJ for/IN patients/NNS with/IN hormone-resistant/JJ prostate/NN cancer/NN ?/.
@@116052071499 Treatment/NNP of/IN ischemic/JJ heart/NN disease/NN in/IN the/DT elderly/JJ
@@1379150497 Thus/RB ,/, cibenzoline/NN is/VBZ an/DT effective/JJ antiarrhythmic/JJ agent/NN with/IN a/DT favourable/JJ pharmacokinetic/JJ profile/NN that/WDT may/MD be/VB considered/VBN with/IN other/DT class/NN I/NN drugs/NNS in/IN patients/NNS requiring/JJ therapy/NN for/IN high/JJ risk/NN arrhythmias/NNS ./.
@@85304328605 Using/VBG a/DT series/NN of/IN mutant/JJ proteins/NNS ,/, we/PRP have/VBP characterized/VBN domains/NNS responsible/JJ for/IN activation/NN or/CC repression/NN ./.
@@93546442034 Their/PRP biosynthesis/NN proceeds/NNS via/NN linear/JJ precursors/NNS that/WDT become/VBP branched/JJ by/IN beta1/NEWGENE ,/NEWGENE 6-GlcNAc/NEWGENE transferases/NEWGENE (/( IGnT6/NN ,/, GlcNAc/NN to/IN Gal/NNP )/SYM ./.
@@85550761432 Liposomal/JJ Amphotericin-B/NN failed/VBN in/IN 6/CD //CD 7/CD patients/NNS with/IN culture-proven/JJ mycosis/NN who/WP died/VBD from/IN infection/NN with/IN Aspergillus/NNS (/( n/NN =/SYM 2/CD )/SYM and/CC Candida/NN (/( n/NN =/SYM 4/CD )/SYM ,/, respectively/RB ./.
@@18225813840 In/NN all/DT instances/NNS the/DT apparent/JJ alcohol/NN responses/NNS were/VBD very/RB small/JJ and/CC never/RB exceeded/VBN a/DT reading/NN of/IN 1/CD microgram/NN //NN 100ml/NN for/IN breath/NN samples/NNS more/RB than/IN 10min/CD post-exposure/JJ ./.
@@109358806424 Viruses/NNS were/VBD isolated/VBN from/IN 9/CD lungs/NNS :/: 7/CD with/IN PI-3V/NN ,/, 1/CD with/IN NCP/NN BVDV/NN type/NN 1/NN ,/, and/CC 1/CD with/IN both/DT BVHV-1/NN and/CC BVDV/NN ./.
@@25493436264 In/NN consequence/NN ,/, the/DT gpI/NEWGENE derived/VBN from/IN cells/NNS infected/VBN with/IN mO74/CD showed/VBD antigenic/JJ characteristics/NNS similar/JJ to/IN those/DT of/IN gpI/NEWGENE from/IN VZV-infected/JJ cells/NNS as/IN determined/VBN from/IN the/DT immunoprecipitation/NN pattern/NN ,/, although/IN the/DT molecular/JJ weight/NN of/IN each/DT polypeptide/NN was/VBD different/JJ ,/, and/CC antibody/NN produced/VBN in/IN rabbits/NNS infected/VBN with/IN recombinant/JJ virus/NN had/VBP a/DT high/JJ neutralizing/JJ activity/NN ,/, when/CC the/DT reaction/NN was/VBD performed/VBN with/IN complement/NN ./.
@@2000093903 Landsberg/NNP (/( La-O/NNP )/SYM and/CC cv/CD ./CD
@@106238047540 As/IN an/DT alternative/JJ approach/NN to/IN this/DT question/NN ,/, we/PRP have/VBP studied/VBN the/DT effects/NNS of/IN ectopically/RB expressed/VBN SHIP/NEWGENE ,/, SHP-1/NEWGENE ,/, or/CC SHP-2/NEWGENE SH2-containing/JJ decoy/NN proteins/NNS on/IN Fc/NEWGENE gamma/NEWGENE RIIB1/NEWGENE signaling/JJ ./.
@@105126993885 This/DT machinery/NN involves/VBZ a/DT secondary/JJ structure/NN ,/, SECIS/NEWGENE element/NEWGENE ,/, in/IN the/DT selenoprotein-encoding/NEWGENE mRNA/NEWGENE ,/, directing/VBG selenocysteine/NN insertion/NN at/IN the/DT position/NN of/IN an/DT opal/NN (/( UGA/IN )/SYM codon/NN ,/, normally/RB conferring/JJ termination/NN of/IN translation/NN ./.
@@88977216598 Infection/NN with/IN Neisseria/NN meningitidis/NN group/NN B/NN has/VBZ been/VBN difficult/JJ to/IN detect/VB ,/, partly/RB because/IN this/DT bacterial/JJ group's/NNS polysaccharide/NN is/VBZ a/DT weak/JJ immunogen/NN ./.
@@90012133170 The/DT relatively/JJ high/JJ level/NN transcription/NN from/IN this/DT gene/NN shows/VBZ that/IN the/DT polymorphic/JJ chromosome/NN ends/NNS of/IN P/NNP ./NNP falciparum/NN ,/, which/WDT have/VBP been/VBN proposed/VBN to/IN be/VB transcriptionally/RB silent/JJ ,/, can/MD be/VB active/JJ expression/NN sites/NNS for/IN var/NEWGENE genes/NEWGENE ./.
@@103596644471 To/TO identify/VB these/DT sites/NNS ,/, Cdk2-phosphorylated/NEWGENE MARCKS/NEWGENE was/VBD digested/VBN with/IN lysyl/NEWGENE endoprotease/NEWGENE and/CC analysed/VBN by/IN electrospray/NN MS/NNP ./NNP
@@114804901366 Even/RB if/IN the/DT electrocardiographic/JJ signs/NNS are/VBP subdued/VBN ,/, the/DT underlying/JJ blockade/NN of/IN I/NN (/NN Kr/NN )/NN current/NN may/MD precipitate/VB the/DT occurrence/NN of/IN arrhythmia/NN ./.
@@21238758143 To/TO identify/VB structural/JJ features/NNS of/IN residues/NNS flanking/JJ the/DT c-region/NN that/DT influence/NN the/DT fidelity/NN and/CC efficiency/NN of/IN signal/NN peptidase/NEWGENE cleavage/NN as/RB well/VB as/IN co-translational/JJ translocation/NN ,/, we/PRP introduced/VBD six/CD amino/JJ acid/NN substitutions/NNS into/IN the/DT COOH/NNP terminus/NN of/IN the/DT hydrophobic/JJ core/NN and/CC seven/JJ substitutions/NNS at/IN the/DT NH2/NN terminus/NN of/IN the/DT mature/JJ region/NN (/( the/DT +1/NN position/NN )/SYM of/IN a/DT model/JJ eukaryotic/NEWGENE preprotein-human/NEWGENE pre/NEWGENE (/NEWGENE delta/NEWGENE pro/NEWGENE )/NEWGENE apoA-II/NEWGENE ./.
@@118445911724 We/PRP also/RB studied/VBD a/DT new/JJ parameter/NN :/: the/DT angle/NN to/IN maximal/JJ peak/NN torque/NN (/( APT/NN )/SYM ./.
@@50219125314 Photopic/NNP spectral/JJ sensitivity/NN determined/VBN electroretinographically/RB for/IN the/DT pigeon/NN eye/NN ./.
@@77588379829 The/DT emerging/JJ complexity/NN of/IN the/DT 5'/CD regulatory/JJ region/NN of/IN the/DT GH/NEWGENE receptor/NEWGENE gene/NEWGENE was/VBD emphasised/VBN by/IN the/DT observation/NN that/IN probes/NNS derived/VBN from/IN exon/NN 1B/NN and/CC the/DT distal/JJ 3'/CD intron/NN boundary/NN do/NN not/RB hybridise/VB with/IN previously/RB cloned/VBN genomic/JJ sequences/NNS that/WDT span/VBP the/DT liver-specific/NEWGENE P1/NEWGENE promoter/NEWGENE and/CC exon/NN 2/CD ./CD
@@13743923563 The/DT hydrophobicity/NN plot/NN of/IN NHE-3/NEWGENE is/VBZ very/RB similar/JJ to/IN that/DT of/IN NHE-1/NEWGENE and/CC NHE-2/NEWGENE ./.
@@76121747520 Subhuman/NNP primates/NNS appear/VBP to/IN be/VB more/RB sensitive/JJ to/IN reproductive/JJ and/CC other/DT adverse/JJ effects/NNS of/IN PCBs/NNS than/IN humans/NNS ./.
@@18080494159 CT/NN abnormalities/NNS noted/VBN in/IN term/NN babies/NNS included/VBD hemorrhage/NN (/( subarachnoid/JJ 5/CD ./CD 8%/CD ,/, intracerebral/JJ 11/CD ./CD 6%/CD )/SYM ,/, hypodensity/NN (/( mild/JJ 23/CD ./CD 2%/CD ,/, moderate/JJ 11/CD ./CD 6%/CD severe/JJ 5/CD ./CD 8%/CD )/SYM ;/: hypodensity/NN with/IN hemorrhage/NN 5/CD ./CD 8%/CD and/CC cerebral/JJ atrophy/NN 5/CD ./CD 8%/CD ./.
@@826766768 Repeated/VBN administration/NN of/IN GRg2/NN 20/CD mg/CD //CD kg/CD i/CD ./CD p/CD ./. significantly/RB improved/VBN the/DT CYP-induced/JJ recognitional/JJ deficits/NNS by/IN increasing/JJ the/DT CYP-decreased/JJ rate/NN from/IN 55/CD ./CD 8/CD +/NN //NN -/NN 9/CD ./CD 6/CD to/IN 80/CD ./CD 8/CD +/NN //NN -/NN 4/CD ./CD 2/CD in/IN d/NN 3/CD learning/JJ acquisition/NN (/( F/NN (/NN 1/NN ,/NN 14/NN )/SYM =/SYM 5/CD ./CD 6/CD ,/, p/NN </SYM 0/NN ./NN 05/NN )/NN ,/, from/IN 53/CD ./CD 4/CD +/NN //NN -/NN 8/CD ./CD 4/CD to/IN 60/CD ./CD 0/CD +/NN //NN -/NN 8/CD ./CD 2/CD in/IN 48/CD h/NN memory/NN acquisition/NN (/( F/NN (/NN 1/NN ,/NN 14/NN )/SYM =/SYM 7/CD ./CD 5/CD ,/, p/NN </SYM 0/NN ./NN 05/NN )/NN and/CC from/IN 55/CD ./CD 0/CD +/NN //NN -/NN 5/CD ./CD 5/CD to/IN 88/CD ./CD 3/CD +/NN //NN -/NN 2/CD ./CD 5/CD in/IN 24/CD h/NN memory/NN retention/NN (/( F/NN (/NN 1/NN ,/NN 12/NN )/SYM 27/CD ./CD 5/CD ,/, p/NN </SYM 0/NN ./NN 01/NN )/NN as/RB well/VB as/IN from/IN 60/NN ./NN 0/NN +/NN //NN -/NN 6/CD ./CD 8/CD to/IN 85/CD ./CD 6/CD +/NN //NN -/NN 6/CD ./CD 9/CD in/IN 48/CD h/NN memory/NN retrieval/NN (/( F/NN (/NN 1/NN ,/NN 12/NN )/SYM =/SYM 5/CD ./CD 2/CD ,/, p/NN </SYM 0/NN ./NN 05/NN )/NN ,/, respectively/RB ./.
@@97065655207 Anesthesia/NNS with/IN M/NN //NN K/NN was/VBD reversed/VBN after/IN 41/CD ./CD 6/CD min/NN of/IN immobilization/NN with/IN atipamezole/NN ./.
@@29491703651 This/DT study/NN reports/VBZ the/DT effects/NNS of/IN a/DT preparation/NN with/IN 50/CD micrograms/NNS ethinyl/NN estradiol/NN and/CC 2/CD mg/NN cyproterone/NN acetate/NN on/IN gonadotropins/NEWGENE ,/, prolactin/NEWGENE ,/, testosterone/NN ,/, sex/NEWGENE hormone/NEWGENE binding/NEWGENE globulin/NEWGENE (/( SHBG/NEWGENE )/SYM ,/, androstenedione/NN ,/, and/CC calculated/VBD free/JJ testosterone/NN index/NN before/IN and/CC after/IN six/CD months/NNS of/IN treatment/NN ./.
@@33838974075 Lithium-carbonate/JJ action/NN during/IN radiation/NN therapy/NN has/VBZ been/VBN studied/VBN ,/, valuing/JJ the/DT positive/JJ effect/NN on/IN leukopoiesis/NN and/CC the/DT consequent/RB better/RBR clinical/JJ conditions/NNS of/IN the/DT patients/NNS in/IN course/NN of/IN treatment/NN ./.
@@32866115936 Yang/NNP and/CC H/NNP ./NNP
@@91872773690 Type/NN I/NN position-vestibular-pause/JJ (/( PVP/NN I/NN )/SYM and/CC vestibular-only/JJ (/( V/NN I/NN )/SYM neurons/NNS ,/, as/RB well/VB as/IN a/DT smaller/JJR number/NN of/IN other/DT type/NN I/NN and/CC type/NN II/NN eye-plus-vestibular/JJ neurons/NNS were/VBD studied/VBN ./.
@@106289716063 The/DT collection/NN of/IN mutants/NNS displaying/VBG TGN/JJ sorting/JJ defects/NNS includes/VBZ members/NNS with/IN mutations/NNS in/IN previously/RB identified/VBN vacuolar/NEWGENE protein/NEWGENE sorting/NEWGENE genes/NEWGENE (/( VPS/NEWGENE )/SYM ,/, including/JJ the/DT dynamin/NEWGENE family/NN member/NN VPS1/NEWGENE ./.
@@84649245090 A/DT rat/NN cDNA/NN that/IN encodes/VBZ eIF-5/NEWGENE has/VBZ been/VBN isolated/VBN and/CC expressed/VBN in/IN Escherichia/NN coli/JJ to/IN yield/NN a/DT catalytically/RB active/JJ eIF-5/NEWGENE protein/NEWGENE ./.
@@93896668412 Thus/RB ,/, Hex/NEWGENE expression/NN marks/VBZ the/DT earliest/JJS unequivocal/JJ molecular/JJ anteroposterior/JJ asymmetry/NN in/IN the/DT mouse/NN embryo/NN and/CC indicates/VBZ that/IN the/DT anteroposterior/JJ axis/NN of/IN the/DT embryo/NN develops/VBZ from/IN conversion/NN of/IN a/DT proximodistal/JJ asymmetry/NN established/VBN in/IN the/DT primitive/JJ endoderm/NN lineage/NN ./.
@@30239708578 The/DT 96-bp/CD insert/NN contained/VBD a/DT termination/NN signal/JJ which/WDT caused/VBD the/DT premature/JJ termination/NN of/IN the/DT protein/NN ,/, leading/JJ to/IN the/DT generation/NN of/IN a/DT p53/NEWGENE product/NEWGENE 9/NN amino/JJ acids/NNS shorter/JJR than/IN usual/JJ ./.
@@108238371290 The/DT data/NN are/VBP compatible/JJ with/IN the/DT idea/NN that/IN YLL031c/NEWGENE transfers/VBZ the/DT ethanolaminephosphate/NN to/IN the/DT inner/JJ alpha1-2-linked/JJ mannose/NN ,/, i/NN ./NN e/NN ./. the/DT group/NN that/WDT links/VBZ the/DT GPI/NN lipid/NN anchor/NN to/IN proteins/NNS ,/, whereas/IN Mcd4p/NEWGENE and/CC Gpi7p/NEWGENE transfer/NN ethanolaminephosphate/NN onto/IN the/DT alpha1-4-/JJ and/CC alpha1-6-linked/JJ mannoses/NNS of/IN the/DT GPI/NN anchor/NN ,/, respectively/RB ./.
@@111827461024 An/DT additional/JJ 9/CD patients/NNS achieved/VBD normal/JJ levels/NNS with/IN adjunctive/JJ drug/NN therapy/NN ./.
@@87385108723 The/DT relative/JJ tumor/NN FDG-uptake/NNP (/( Q-MRGlu/NNP )/SYM (/( tumor/JJ //JJ contralateral/JJ cortex/NN )/SYM of/IN all/DT meningiomas/NNS was/VBD calculated/VBN with/IN 0/CD ./CD 73/CD +/NN //NN -/NN 0/CD ./CD 37/CD (/( 0/CD ./CD 24-1/CD ./CD 79/CD )/SYM ./.
@@85301052050 The/DT minimal/JJ region/NN of/IN overlap/NN of/IN Langer-Giedion/NEWGENE syndrome/NEWGENE deletions/NEWGENE ,/, previously/RB identified/VBN by/IN analysis/NN of/IN 15/CD patients/NNS ,/, was/VBD placed/VBN on/IN the/DT map/NN by/IN analysis/NN of/IN 2/CD patients/NNS whose/WP deletions/NNS define/VBP the/DT endpoints/NNS ./.
@@104448136300 For/IN symptomatic/JJ relief/NN and/CC inhibition/NN of/IN the/DT growth/NN of/IN the/DT metastases/NNS interferon-a/NEWGENE and/CC somatostatin/NEWGENE analogues/NNS can/MD be/VB employed/VBN ./.
@@25751743228 We/PRP have/VBP therefore/RB evaluated/VBN the/DT efficacy/NN and/CC safety/NN of/IN doxazosin/NN ,/, a/DT new/JJ orally/RB active/JJ selective/JJ alpha/NEWGENE 1/NEWGENE blocker/NN ,/, in/IN patients/NNS with/IN systemic/JJ hypertension/NN with/IN concomitant/JJ airflow/NN limitation/NN ./.
@@31171477289 A/DT complementary/JJ study/NN ,/, showing/VBG a/DT good/JJ agreement/NN between/IN surface/NN and/CC oesophageal/JJ EMGd/NN seems/VBZ to/IN confirm/VB that/DT surface/NN EMGd/NN is/VBZ a/DT useful/JJ and/CC promising/JJ tool/NN for/IN clinical/JJ investigation/NN ./.
@@79435567372 Of/IN 419/CD persons/NNS surveyed/VBN ,/, 207/CD (/( 49/CD ./CD 4%/CD )/SYM were/VBD antigen-positive/NN with/IN the/DT Og4C3/NEWGENE assay/NN ./.
@@6090458600 The/DT PEPCK/NEWGENE promoter/NN fragment/NN was/VBD introduced/VBN either/DT in/NN the/DT proper/JJ orientation/NN for/IN transcription/NN of/IN the/DT TK/NEWGENE gene/NEWGENE or/CC in/IN the/DT opposite/NN orientation/NN ./.
@@22911444728 Very/RB good/JJ accuracy/NN (/( r/JJ greater/JJR than/IN 0/CD ./CD 9/CD )/SYM was/VBD found/VBN when/CC except/VB comparing/VBG H*2/NN with/IN the/PDT other/DT machine/NN and/CC the/DT reference/NN methods/NNS ,/, except/VB for/IN MCHCH/NN and/CC basophil/NN count/NN ./.
@@77688369575 Primer/NNS extension/NN experiments/NNS revealed/VBD a/DT strong/JJ transcription/NN initiation/NN site/NN 102/CD bp/NN upstream/RB of/IN the/DT translational/JJ start/NN site/NN ./.
@@96140659756 Elimination/NN of/IN the/DT inducible/JJ response/NN requires/VBZ simultaneous/JJ mutation/NN of/IN both/DT sequences/NNS ,/, however/RB ,/, in/IN the/DT presence/NN of/IN an/DT intact/JJ EpRE/NEWGENE the/DT upstream/NN AP-1/NEWGENE site/NEWGENE is/VBZ irrelevant/JJ to/IN induction/NN ./.
@@110038057319 Studies/NNS suggest/VBP that/IN the/DT DGOR/NN without/IN acid/NN reflux/NN may/MD result/VB in/IN symptoms/NNS but/CC unless/IN acid/NN reflux/NN is/VBZ present/VB simultaneously/RB ,/, it/PRP does/VBP not/RB cause/VB oesophagitis/NN ./.
@@75285317406 In/NN viral/JJ infections/NNS ,/, G-CSF/NEWGENE was/VBD correlated/VBN with/IN mononuclear/JJ cells/NNS (/( rs/NNS =/SYM 0/CD ./CD 41/CD ,/, P/NN </SYM 0/CD ./CD 05/CD )/SYM ,/, white/JJ blood/NN cell/NN counts/NNS (/( rs/NNS =/SYM 0/CD ./CD 56/CD ,/, P/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, neutrophils/NNS (/( rs/NNS =/SYM 0/CD ./CD 41/CD ,/, P/NN </SYM 0/CD ./CD 05/CD )/SYM and/CC CRP/NEWGENE (/( rs/NNS =/SYM 0/CD ./CD 47/CD ,/, P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@68912706690 The/DT effect/NN of/IN emotional-painful/JJ stress/NN (/( EPS/NNS )/SYM on/IN myocardial/JJ extensibility/NN and/CC contractility/NN was/VBD studied/VBN on/IN an/DT isolated/VBN rat/NN atrium/NN ./.
@@95219132127 We/PRP also/RB recovered/VBD mutations/NNS in/IN the/DT 60A/NEWGENE gene/NEWGENE which/WDT encodes/VBZ another/DT TGF-beta-related/NEWGENE factor/NEWGENE in/IN Drosophila/NN ./.
@@90905926064 Although/IN methods/NNS to/IN align/VB the/DT control/NN and/CC activation/NN fMR/NN images/NNS may/MD correct/VB for/IN some/DT of/IN this/DT motional/JJ error/NN ,/, they/PRP will/MD be/VB incomplete/JJ in/IN correcting/VBG for/IN those/DT that/WDT depend/VBP on/IN spatial/JJ orientation/NN ./.
@@50206605312 Factors/NNS affecting/VBG the/DT inhibition/NN of/IN phagocytosis/NN by/IN chlorpromazine/NN ./.
@@93828508420 BACKGROUND/IN :/: Checkpoint/NN pathways/NNS prevent/VBP cell-cycle/VBG progression/NN in/IN the/DT event/NN of/IN DNA/NN lesions/NNS ./.
@@37724714447 There/EX were/VBD 18/CD patients/NNS with/IN Group/NNP II/NN (/NN a/NN )/NN tumors/NNS ;/: although/IN tumor/NN biopsy/NN was/VBD attempted/VBN on/IN eight/CD of/IN these/DT ,/, pathological/JJ diagnosis/NN at/IN the/DT time/NN of/IN surgery/NN was/VBD made/VBP in/IN only/RB one/PRP case/NN ./.
@@105056946306 Interleukin-12/NEWGENE (/( IL-12/NEWGENE )/SYM is/VBZ a/DT cytokine/NN produced/VBN by/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS (/( PBMC/NN )/SYM that/IN causes/NNS interferon-gamma/NEWGENE (/( IFN-gamma/NEWGENE )/SYM production/NN and/CC enhancement/NN of/IN cell-mediated/JJ cytotoxicity/NN ./.
@@8101171614 Instead/RB ,/, the/DT results/NNS support/NN the/DT idea/NN that/DT Pc/NEWGENE group/NEWGENE products/NEWGENE provide/VBP stable/JJ memory/NN or/CC imprinting/NN of/IN boundaries/NNS which/WDT are/VBP initially/RB specified/VBN by/IN gap/NN and/CC pair-rule/JJ regulators/NNS ./.
@@85301498219 Comparison/NNS of/IN promoters/NNS repressed/VBN by/IN c-myc/NEWGENE reveals/VBZ a/DT weak/JJ consensus/NN sequence/NN of/IN the/DT initiator/NEWGENE (/NEWGENE Inr/NEWGENE )/NEWGENE element/NEWGENE :/NEWGENE TCA/NEWGENE (/NEWGENE +1/NEWGENE )/NEWGENE YYYNY/NEWGENE ./.
@@73761657216 Ecthyma/NNP ,/, a/DT known/VBP disease/NN ,/, of/IN which/WDT little/NN is/NNS known/VBP ./.
@@92334877449 Future/NNP analysis/NN of/IN long-term/JJ outcome/NN measures/NNS of/IN performance/NN with/IN the/DT implant/NN will/MD confirm/VB or/CC dispute/VB the/DT benefit/NN of/IN ear/NN selection/NN using/VBG the/DT Prom-EABR/NN ./.
@@95372957460 Furthermore/RB ,/, a/DT minor/JJ start/NN site/NN was/VBD localized/VBN 179/CD bp/NN upstream/RB of/IN the/DT major/JJ site/NN using/VBG reverse/NEWGENE transcriptase-polymerase/NEWGENE chain/NN reaction/NN with/IN various/JJ P1/NEWGENE primers/NN (/( primer/NN walking/NN )/SYM ,/, primer/NN extension/NN ,/, and/CC cDNA/NN cloning/NN ./.
@@550402300 Ten/CD out-patients/NNS with/IN pustulosis/NN palmaris/JJ et/FW plantaris/JJ were/VBD examined/VBN with/IN direct/JJ immunofluorescence/NN (/( IF/IN )/SYM technique/NN for/IN deposition/NN of/IN fibrinogen/NEWGENE ,/, fibrin/NEWGENE or/CC its/PRP degradation/NN products/NNS (/( FR-antigen/NEWGENE )/SYM in/IN affected/VBN and/CC unaffected/JJ skin/NN ,/, together/RB with/IN heparin-precipitable/JJ fraction/NN (/( HPF/NN )/SYM ,/, cryoglobulin/NEWGENE and/CC total/JJ plasma/NN fibrinogen/NEWGENE in/IN the/DT blood/NN ./.
@@82058278178 CONCLUSIONS/IN :/: Translocation/NNS of/IN bacteria/NNS or/CC endotoxin/NEWGENE from/IN the/DT gastrointestinal/JJ tract/NN into/IN the/DT bloodstream/NN has/VBZ been/VBN noted/VBN in/IN animal/NN experiments/NNS ;/: however/RB ,/, translocation/NN was/VBD not/RB detected/VBN in/IN our/PRP patients/NNS with/IN hemorrhagic/JJ shock/NN ./.
@@13252215486 Nocodazole/NNP arrest/NN of/IN DU249/NNP cells/NNS was/VBD exploited/VBN for/IN the/DT detection/NN of/IN an/DT M-phase-activated/NN MBP/NEWGENE kinase/NEWGENE that/WDT was/VBD resolved/VBN from/IN p41/NEWGENE MAP/NEWGENE kinase/NEWGENE by/IN phenyl-Superose/JJ chromatography/NN ./.
@@109189486944 This/DT compound/NN is/VBZ the/DT main/JJ bioactive/JJ metabolite/NN of/IN trimebutine/NN II/NN (/( Debridat/NN ,/, CAS/IN 39133-31-8/CD )/SYM ,/, an/DT antispasmodic/JJ widely/RB used/VBN for/IN intestinal/JJ diseases/NNS since/IN 1969/CD ./.
@@1113908985 There/EX was/VBD a/DT slight/JJ increase/NN in/IN total/JJ transferrin/NEWGENE 2/NN hr/NN after/IN 1/CD tablet/NN and/CC values/NNS remained/VBD high/JJ throughout/IN the/DT experiment/NN ./.
@@92924993734 These/DT repressor/NN sites/NNS are/VBP pyrimidine/NN rich/JJ and/CC bind/VB avidly/RB to/IN the/DT polypyrimidine/NEWGENE tract/NEWGENE binding/NEWGENE protein/NEWGENE (/( PTB/NEWGENE )/SYM in/IN HeLa/DT nuclear/JJ extracts/NNS as/IN determined/VBN by/IN UV/NN crosslinking/NN //NN competition/NN assays/NNS ./.
@@103220223590 Rep63A/NEWGENE (/NEWGENE 513/NEWGENE amino/NEWGENE acids/NEWGENE [/NEWGENE aa/NEWGENE ]/NEWGENE )/NEWGENE ,/, encoded/VBN by/IN the/DT largest/JJS ORF/NN ,/, displayed/VBN strong/JJ similarity/NN (/( 40%/CD identity/NN )/SYM to/IN the/DT replication/NN proteins/NNS from/IN plasmids/NNS pAMbeta1/NN ,/, pIP501/NN ,/, and/CC pSM19035/NN ,/, indicating/VBG that/IN the/DT pAW63/NN replicon/NN belongs/VBZ to/IN the/DT pAMbeta1/NN family/NN of/IN gram-positive/JJ theta-replicating/JJ plasmids/NNS ./.
@@76100523845 Finally/RB ,/, we/PRP show/VBP that/IN complexes/NNS similar/JJ to/IN the/DT C25/NEWGENE ,/, C30/NEWGENE and/CC C35/NEWGENE complexes/NEWGENE are/VBP formed/VBN by/IN rat/NN cortex/NN nuclear/JJ extracts/NNS and/CC the/DT SAA/NEWGENE element/NEWGENE in/IN EMSA/NN experiments/NNS ,/, suggesting/VBG the/DT relevance/NN of/IN our/PRP in/IN vitro/FW observations/NNS to/IN the/DT in/NN vivo/NN functioning/NN of/IN the/DT rat/NEWGENE APP/NEWGENE promoter/NEWGENE ./.
@@21487998416 The/DT nmr/NEWGENE gene/NEWGENE is/VBZ the/DT major/JJ negative/JJ regulatory/JJ gene/NN in/IN the/DT nitrogen/NN control/NN circuit/NN of/IN Neurospora/NN crassa/NN ,/, which/WDT ,/, together/RB with/IN positive/JJ regulatory/JJ genes/NNS ,/, governs/VBZ the/DT expression/NN of/IN multiple/JJ unlinked/NN structural/NN genes/NN of/IN the/DT circuit/NN ./.
@@62817862102 At/NN least/RB one/PRP clone/NN ,/, lambda/NN HHG/NN 41/CD ,/, contains/VBZ ,/, in/IN addition/NN to/IN the/DT histone/NEWGENE genes/NEWGENE ,/, a/DT region/NN that/WDT hybridizes/VBZ with/IN a/DT cytoplasmic/JJ RNA/NN approximately/RB 330/CD nucleotides/NNS in/IN length/NN ./.
@@11028944856 Both/PDT the/DT Cmax/NN and/CC AUC/NN values/NNS were/VBD almost/RB doubled/VBN with/IN doubling/JJ the/DT dose/NN ./.
@@19619962586 Adult/NN H/NN ,/, but/CC not/RB R/NN ,/, manifested/VBD the/DT burrowing/JJ preference/NN whenever/CC offered/VBD the/DT opportunity/NN ./.
@@11164663658 Thromboplastin/NEWGENE time/NN ,/, partial/JJ thromboplastin/NEWGENE time/NN ,/, thrombin/NEWGENE time/NN ,/, heat-dependent/NN fibrin/NEWGENE ,/, clot/NN retraction/NN ,/, and/CC clotting/NEWGENE factors/NEWGENE II/NEWGENE ,/NEWGENE V/NEWGENE ,/NEWGENE VIII/NEWGENE ,/NEWGENE IX/NEWGENE ,/NEWGENE X/NEWGENE ,/, and/CC the/DT platelet/NN count/NN were/VBD determined/VBN ./.
@@88675194439 The/DT elevations/NNS achieved/VBN by/IN LDEE/NN given/VBP s/CD ./CD c/CD ./. were/VBD higher/JJ than/IN those/DT achieved/VBN after/IN i/CD ./CD p/CD ./. administration/NN and/CC lasted/VBN for/IN longer/JJR periods/NNS ./.
@@91214338525 We/PRP show/VBP that/IN Rlm1/NEWGENE and/CC Smp1/NEWGENE have/VB MEF2-related/JJ DNA-binding/NN specificities/NNS :/: Rlm1/NEWGENE binds/VBZ with/IN the/DT same/JJ specificity/NN as/IN MEF2/NEWGENE ,/, CTA/NEWGENE (/NEWGENE T/NEWGENE //NEWGENE A/NEWGENE )/NEWGENE 4TAG/NEWGENE ,/, while/CC SMP1/NEWGENE binds/VBZ a/DT more/RB extended/VBN consensus/NN sequence/NN ,/, ACTACTA/NEWGENE (/NEWGENE T/NEWGENE //NEWGENE A/NEWGENE )/NEWGENE 4TAG/NEWGENE ./.
@@4039307492 On/IN d/NN 112/NN ,/, progesterone/NN was/VBD higher/JJ (/( P/NN less/PRP than/IN ./CD 05/CD )/SYM in/IN hysterectomized/JJ heifers/NNS than/IN in/IN other/DT treatment/NN groups/NNS ./.
@@84993768276 Multizone/NN PRK/NN has/VBZ been/VBN suggested/VBN to/IN increase/NN the/DT predictability/NN of/IN higher/JJ myopic/JJ corrections/NNS ./.
@@67826126553 A/DT convenient/JJ measure/NN of/IN this/DT impairment/NN may/MD be/VB obtained/VBN using/VBG the/DT ratio/NN of/IN urine/NN volume/NN (/( V/NN )/SYM divided/VBN by/IN lithium/NN clearance/NN (/( CLi/NNS )/SYM ./.
@@10724436549 Depleted/JJ and/CC enriched/VBN U3O8/NN standard/JJ reference/NN materials/NNS were/VBD used/VBN to/IN calibrate/VB the/DT system/NN ./.
@@93644402293 Our/PRP study/NN reveals/VBZ that/IN the/DT modular/JJ structure/NN of/IN the/DT FSH/NEWGENE receptor/NEWGENE gene/NN generates/VBZ motifs/NNS that/WDT allows/VBZ coupling/NN to/IN different/JJ effectors/NNS ./.
@@84407206601 Constructs/NNS containing/JJ the/DT full-length/NEWGENE PfCPK/NEWGENE cDNA/NEWGENE have/NN been/VBN expressed/VBN in/IN Escherichia/NN coli/JJ at/IN a/DT high/JJ level/NN to/IN generate/VB a/DT 60-kDa/JJ recombinant/JJ protein/NN ./.
@@10425094281 The/DT in/NN vitro/FW relaxivity/NN of/IN the/DT complex/NN is/VBZ 16/CD ./CD 24/CD s/NN (/NN -1/NN )/NN mM/NN (/NN -1/NN )/NN ./.
@@95456382261 The/DT possible/JJ roles/NNS of/IN HRMT1L1/NEWGENE and/CC HRMT1L2/NEWGENE in/IN human/JJ disease/NN are/VBP currently/RB unknown/JJ ./.
@@78831686138 Mutations/NNS in/IN UPF1/NEWGENE lead/NN to/IN the/DT selective/JJ stabilization/NN of/IN mRNAs/NNS containing/JJ early/JJ nonsense/NN mutations/NNS without/IN affecting/VBG the/DT decay/NN rates/NNS of/IN most/RB other/DT mRNAs/NNS ./.
@@93716124442 Acad/NN ./.
@@10355536216 The/DT median/JJ age/NN was/VBD 33/CD years/NNS (/( range/NN 17-56/JJ years/NNS )/SYM ./.
@@61192625939 The/DT roll-over/NN test/NN to/IN predict/VB toxemia/NN in/IN pregnancy/NN ./.
@@10459809304 A/DT reduced/VBN matrix/NN distribution/NN and/CC enhanced/VBN cell/NN density/NN were/VBD observed/VBN as/IN the/DT biofilm/NN aged/VBN ./.
@@97699105048 The/DT activation/NN and/CC injury/NN of/IN endothelial/JJ cells/NNS induced/VBN by/IN TNF/NEWGENE and/CC other/DT proinflammatory/JJ cytokines/NNS may/MD underlie/VB the/DT local/JJ effects/NNS of/IN these/DT mediators/NNS in/IN vivo/NN ./.
@@47290635122 Compensative/NNP justice/NN and/CC moral/JJ investment/NN among/IN Japanese/JJ ,/, Chinese/JJ ,/, and/CC Koreans/NNS ./.
@@105126999647 High-level/JJ expression/NN in/IN Escherichia/NN coli/NN of/IN selenocysteine-containing/NN rat/NEWGENE thioredoxin/NEWGENE reductase/NEWGENE utilizing/VBG gene/NN fusions/NNS with/IN engineered/VBN bacterial-type/NEWGENE SECIS/NEWGENE elements/NEWGENE and/CC co-expression/NN with/IN the/DT selA/NEWGENE ,/, selB/NEWGENE and/CC selC/NEWGENE genes/NEWGENE ./.
@@90155435998 One/CD possible/JJ solution/NN is/VBZ a/DT thin/JJ radial/JJ forearm/NN free/JJ flap/NN ./.
@@22597952704 Assuming/VBG O2/NN consumption/NN of/IN the/DT isolated/VBN skin/NN to/IN be/VB same/JJ as/IN in/IN situ/NN ,/, calculations/NNS showed/VBN that/IN when/CC water/NN PO2/NN was/VBD high/JJ (/( 150/CD mm/NN Hg/NN )/SYM ,/, about/RB 40%/CD of/IN total/JJ cutaneous/JJ O2/NN uptake/NN was/VBD consumed/VBN by/IN the/DT skin/NN ./.
@@61650685992 Then/RB ,/, pure/JJ pancreatic/JJ juice/NN was/VBD infused/VBN into/IN the/DT duodenum/NN ./.
@@76754452334 These/DT clones/NNS were/VBD found/VBN to/IN share/NN a/DT common/JJ domain/NN encoded/VBN by/IN p/NN (/NN CA/NN )/NN n/NN repeats/NNS ;/: a/DT simple/JJ sequence/NN length/NN polymorphism/NN (/( SSLP/NN )/SYM ./.
@@90578419306 Derepression/NNS of/IN gene/NN expression/NN mediated/JJ by/IN the/DT 5'/CD upstream/JJ region/NN of/IN the/DT isocitrate/NEWGENE lyase/NEWGENE gene/NEWGENE of/NEWGENE Candida/NEWGENE tropicalis/NEWGENE is/VBZ controlled/VBN by/IN two/JJ distinct/JJ regulatory/JJ pathways/NNS in/IN Saccharomyces/NN cerevisiae/NN ./.
@@7775428456 The/DT other/DT two/JJ clones/NNS ,/, Ash-m/NEWGENE and/NEWGENE -s/NEWGENE ,/, had/VBP nucleotide/NN sequences/NNS identical/JJ with/IN Ash-l/NEWGENE cDNA/NN in/IN the/DT amino-terminal/NN region/NN ./.
@@20261447550 Temporal/JJ control/NN of/IN GUS/NEWGENE expression/NN was/VBD found/VBN to/IN involve/VB two/JJ negative/JJ regulatory/JJ sequences/NNS ,/, NRS1/NEWGENE (/NEWGENE -391/NEWGENE to/NEWGENE -295/NEWGENE )/NEWGENE and/CC NRS2/NEWGENE (/NEWGENE -518/NEWGENE to/NEWGENE -418/NEWGENE )/NEWGENE ,/, as/RB well/VB as/IN the/DT positive/JJ domain/NN UAS1/NEWGENE ./.
@@90675778047 In/NN untransformed/JJ cells/NNS ,/, three/CD major/JJ proteins/NNS coprecipitated/VBN with/IN CRKL/NEWGENE ,/, identified/VBN as/IN C3G/NEWGENE ,/, SOS/NEWGENE and/CC c-ABL/NEWGENE ./.
@@59429535833 I/NNP ./NNP
@@104870407253 Immunohistochemical/JJ staining/NN with/IN MIB-1/NEWGENE and/CC p53/NEWGENE antibodies/NEWGENE showed/VBD low/JJ (/( </SYM 1%/JJ )/SYM and/CC negative/JJ reaction/NN ./.
@@81494849272 These/DT results/NNS indicate/VBP that/IN both/DT PKC/NEWGENE alpha/NEWGENE (/( calcium/NN dependent/JJ )/SYM and/CC PKC/NEWGENE delta/NEWGENE (/( calcium/NN independent/JJ )/SYM may/MD mediate/VB the/DT transcription/NN of/IN TPA-inducible/NEWGENE genes/NEWGENE through/RB both/DT AP-1/NEWGENE and/CC non-AP-1/NEWGENE sequences/NEWGENE ./.
@@37461074414 One/CD hundred/JJ and/CC four/CD (/( 14/CD per/IN cent/NN )/SYM second/JJ primary/JJ tumours/NNS were/VBD reported/VBN ./.
@@107358483230 RegA/NEWGENE is/VBZ a/DT positive/JJ yet/RB nonessential/JJ regulator/NN of/IN tol-oprL/NEWGENE expression/NN ./.
@@23557656825 The/DT patient/NN was/VBD treated/VBN with/IN benzathine/NN penicillin/NN ,/, 2/NN ,/NN 400/NN ,/NN 000/NN U/NN weekly/JJ for/IN three/CD weeks/NNS ./.
@@109810941559 Recent/JJ target/NN BP/NN goals/NNS promulgated/VBN by/IN the/DT Sixth/NNP Report/NNP from/IN the/DT Joint/NNP National/NNP Committee/NNP (/( JNC/NN VI/NN )/SYM are/VBP based/VBN on/IN the/DT premise/NN that/IN the/DT intensity/NN of/IN treatment/NN directly/RB corresponds/VBZ to/IN the/DT magnitude/NN of/IN pretreatment/JJ risk/NN ./.
@@78905995515 We/PRP have/VBP screened/VBN the/DT mouse/NN cDNA/NN library/NN of/IN an/DT MIN6/NNP cell/NN line/NN ,/, derived/VBN from/IN pancreatic/JJ beta/JJ cells/NNS ,/, for/IN its/PRP novel/JJ isoform/NN and/CC have/VB identified/VBN a/DT cDNA/NN encoding/VBG a/DT 593-amino/CD acid/NN protein/NN having/VBG 63/CD ,/, 53/CD ,/, and/CC 30%/CD identity/NN with/IN munc-18/NEWGENE //NEWGENE n-Sec1/NEWGENE //NEWGENE rbSec1/NEWGENE ,/, Caenorhabditis/NEWGENE elegans/NEWGENE unc18/NEWGENE ,/, and/CC Saccharomyces/NEWGENE cerevisiae/NEWGENE Sec1p/NEWGENE ,/, respectively/RB ./.
@@10592791418 Comparison/NNS of/IN immunoassay/NN kits/NNS for/IN detection/NN of/IN staphylococcal/NEWGENE enterotoxins/NEWGENE produced/VBN by/IN Staphylococcus/NN aureus/NN ./.
@@8383217669 The/DT C-terminal/NN approximately/RB 50/CD amino/JJ acids/NNS of/IN Bel-1/NEWGENE are/VBP shown/VBP to/IN be/VB essential/JJ for/IN Bel-1/NEWGENE activity/NN but/CC can/MD be/VB effectively/RB substituted/JJ by/IN the/DT C-terminal/NN activation/NN domain/NN of/IN VP16/NEWGENE ./.
@@105139225184 Our/PRP study/NN also/RB demonstrated/VBD significant/JJ increases/NNS in/IN the/DT number/NN of/IN larger/RBR myelinated/JJ fibers/NNS crossing/VBG the/DT repair/NN site/NN in/IN comparison/NN with/IN the/DT neonatal/JJ and/CC adult/JJ groups/NNS (/( p/NN </SYM 0/CD ./CD 04/CD )/SYM ./.
@@77156028688 We/PRP suggest/VBP that/IN this/DT gene/NN cluster/NN codes/NNS for/IN (/( parts/NNS of/IN )/SYM a/DT multisubunit/NEWGENE cytochrome/NEWGENE c/NEWGENE haem/NEWGENE lyase/NEWGENE ./.
@@75216017401 Hematopoietic/NEWGENE growth/NEWGENE factors/NEWGENE are/VBP being/VBP used/VBN to/IN accelerate/VB the/DT recovery/NN of/IN myelopoiesis/NN following/IN high-dose/JJ chemotherapy/NN in/IN cancer/NN patients/NNS ./.
@@34529204159 Man/NN and/CC insect/NN ,/, past/JJ ,/, present/VB ,/, future/JJ ./.
@@13485901971 In/NN a/DT retrospective/JJ analysis/NN of/IN data/NN from/IN 35/CD cases/NNS with/IN malignant/JJ lymphoma/NN from/IN a/DT cohort/NN of/IN 2017/CD HIV-infected/JJ patients/NNS ,/, the/DT stage/NN of/IN HIV-disease/NNP ,/, the/DT CD4/NEWGENE counts/NNS at/IN the/DT time/NN of/IN diagnosis/NN ,/, and/CC the/DT use/NN of/IN antineoplastic/JJ agents/NNS or/CC radiotherapy/NN were/VBD correlated/VBN with/IN outcome/NN ./.
@@59307974022 Further/RB studies/VBZ on/IN a/DT "new"/JJ human/NN isoprecipitin/NN system/NN (/( Australia/NN antigen/NN )/SYM ./.
@@83739727438 SvO2/NN can/MD be/VB determined/VBN in/IN vitro/FW and/CC in/IN vivo/NN ./.
@@11458841332 A/DT clinical/JJ ,/, serological/JJ and/CC prognostic/JJ study/NN ./.
@@10670358486 Dermatology/NN is/VBZ no/DT exception/NN ./.
@@112827611119 Oral/NNP supplementation/NN of/IN L-arginine/NN significantly/RB increased/VBD plasma/NN L-citrulline/IN ,/, which/WDT indicated/VBD enhancement/NN of/IN NO/DT production/NN ./.
@@105363699416 The/DT relative/JJ importance/NN of/IN these/DT two/JJ mechanisms/NNS differed/VBN in/IN a/DT response/NN element-specific/NN manner/NN ./.
@@92294209183 Re-evaluation/NNS of/IN the/DT biopsy/NN specimen/NN from/IN the/DT right/JJ hip/NN taken/VBP at/IN the/DT time/NN of/IN the/DT initial/JJ operation/NN showed/VBD areas/NNS of/IN chondrosarcoma/NN arising/VBG in/IN the/DT background/NN of/IN synovial/JJ chondromatosis/NN ./.
@@107440264062 Invertases/NEWGENE are/VBP responsible/JJ for/IN the/DT breakdown/NN of/IN sucrose/NN to/IN fructose/NN and/CC glucose/NN ./.
@@106025021765 Like/IN the/DT Tob/NEWGENE protein/NEWGENE ,/, Tob2/NEWGENE inhibited/VBN cell/NN cycle/NN progression/NN from/IN the/DT G0/NN //NN G1/NN to/IN S/NNP phases/NNS ./.
@@31107943824 In/NN overdoses/NNS up/JJ to/IN 2/CD g/NN fluvoxamine/NN no/DT lasting/JJ toxic/JJ effects/NNS were/VBD observed/VBN ./.
@@72264407056 The/DT hemodynamics/NN of/IN isoproterenol-induced/JJ cardiac/JJ failure/NN in/IN the/DT rat/NN ./.
@@79691325369 One/CD class/NN of/IN plasmids/NNS contained/VBD tRNA/NEWGENE (/NEWGENE His/NEWGENE )/NEWGENE genes/NEWGENE and/CC conferred/VBN efficient/JJ suppression/NN only/RB when/CC cells/NNS were/VBD starved/JJ for/IN histidine/NN ;/: these/DT plasmids/NNS suppressed/VBD a/DT gcn2/NEWGENE deletion/NN much/JJ less/PRP efficiently/RB than/IN they/PRP suppressed/VBD gcn2-507/NEWGENE ./.
@@18272034678 Like/IN many/JJ eukaryotic/NN transcription/NN factors/NN ,/, these/DT proteins/NNS bind/VBP to/RB DNA/NN as/IN dimers/NNS ./.
@@91871363760 SSeCKS/NEWGENE (/( pronounced/VBN essex/NEWGENE )/SYM encodes/VBZ a/DT major/JJ protein/NEWGENE kinase/NEWGENE C/NEWGENE substrate/NN ,/, the/DT expression/NN of/IN which/WDT is/VBZ down-regulated/IN in/IN src-/JJ and/CC ras-transformed/JJ rodent/NN fibroblasts/NNS but/CC not/RB in/IN raf-transformed/JJ rodent/NN fibroblasts/NNS (/( X/NNP ./NNP
@@78264128103 A/DT new/JJ hypothesis/NN on/IN mechanisms/NNS for/IN inhibiting/JJ catalytic/JJ subunits/NNS by/IN gamma-subunits/NNS and/CC activation/NN of/IN a/DT holoenzyme/NN by/IN transducin/NEWGENE ./.
@@85087786560 Yeast/NN mutants/NNS lacking/JJ a/DT functional/JJ NOP1/NEWGENE gene/NEWGENE can/MD be/VB complemented/VBN by/IN human/NEWGENE fibrillarin/NEWGENE but/CC are/VBP temperature/NN sensitive/JJ for/IN growth/NN and/CC impaired/VBN in/IN pre-rRNA/NN processing/VBG ./.
@@89975326611 Specific/NN IgG/NEWGENE ,/, specific/NN IgE/NEWGENE and/CC total/JJ IgE/NEWGENE immunoglobulins/NEWGENE against/IN Toxocara/NEWGENE canis/NEWGENE excretory/NEWGENE //NEWGENE secretory/NEWGENE antigens/NEWGENE (/( TES/NEWGENE )/SYM were/VBD detected/VBN by/IN using/VBG ELISA/NN technique/NN ./.
@@17055416416 2/CD :/: 121-133/JJ ,/, 1988/NN )/NN ./.
@@85653301903 We/PRP propose/VBP that/IN epigenetic/JJ features/NNS of/IN tissue-specific/JJ control/NN and/CC of/IN the/DT control/NN of/IN allelic/JJ expression/NN are/VBP intricately/RB linked/JJ ./.
@@80671239912 According/VBG to/IN the/DT results/NNS of/IN assays/NNS obtained/VBN with/IN the/DT use/NN of/IN assay/NN systems/NNS ORTHO/NNP ELISA/NN and/CC ABBOTT/NN HCV/NN EIA/NN (/( USA/NN )/SYM ,/, the/DT detection/NN rate/NN of/IN anti-HCV-C100-3/NEWGENE among/IN primary/JJ blood/NN donors/NNS in/IN Moscow/NN was/VBD 1/CD ./CD 37%/CD and/CC was/VBD not/RB different/JJ from/IN that/DT among/IN HBsAg/NEWGENE carriers/NN (/( 1/CD ./CD 8%/CD )/SYM and/CC among/IN donors/NNS with/IN anti-HCV-C100-3/NEWGENE in/IN the/DT blood/NN (/( 1/CD ./CD 6%/CD )/SYM (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ./.
@@90056098969 Control/NNP examination/NN was/VBD performed/VBN at/IN the/DT end/NN of/IN each/DT period/NN ./.
@@13388678568 Comparison/NNS of/IN data/NN obtained/VBN with/IN the/DT results/NNS of/IN chronic/JJ treatment/NN with/IN the/DT opioid/NN antagonist/NN permits/VBP to/IN conclude/VB that/IN the/DT chronic/JJ blockade/NN increases/VBZ the/DT fatiguability/NN to/IN a/DT great/JJ extent/NN than/IN chronic/JJ activation/NN of/IN opioid/JJ system/NN ./.
@@30349563748 By/IN contrast/NN ,/, their/PRP basal/JJ adrenal/JJ androgen/NN levels/NNS were/VBD significantly/RB decreased/VBN compared/VBN to/IN those/DT in/NN normal/JJ subjects/NNS on/IN both/PDT the/DT day/NN on/IN and/CC the/DT day/NN off/JJ prednisone/NN (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@10378989252 The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN investigate/VB the/DT spontaneous/JJ reports/NNS of/IN suspected/VBN adverse/JJ drug/NN reactions/NNS ,/, observed/VBN in/IN elderly/JJ patients/NNS (/( over/RB 65/CD years/NNS of/IN age/NN )/SYM in/IN Sicily/NN (/( Italy/NN )/SYM during/IN the/DT period/NN from/IN 1/CD January/NN 1995/CD to/IN 31/CD December/NN 1997/CD ./.
@@52859785457 Second/JJ report/NN of/IN the/DT Norwegian/NNP Cancer/NNP Society/NNP ./.
@@26891363361 These/DT adverse/JJ effects/NNS usually/RB abate/VBP with/IN time/NN ./.
@@74618488044 The/DT mean/JJ values/NNS of/IN the/DT concentrations/NNS of/IN the/DT components/NNS due/NN to/IN tobacco/NN smoke/NN are/VBP :/: CO/NN =/SYM 1/CD ./CD 1/CD ppm/NN ,/, NO/DT =/SYM 32/CD ppb/NN ,/, NO2/NN =/SYM 24/CD ppb/NN ,/, nicotine/NN =/SYM 0/CD ./CD 9/CD micrograms/NN //NN m3/NN ,/, particulate/JJ matter/NN =/SYM 133/CD micrograms/NN //NN m3/NN ./.
@@25518866067 Restriction/NNS maps/NNS of/IN the/DT cloned/VBN plasmids/NNS revealed/VBN that/IN their/PRP chromosomal/JJ inserts/NNS consisted/VBP of/IN overlapping/JJ fragments/NNS ./.
@@17159757473 Opposite/IN effects/NNS of/IN CYP1/NEWGENE are/VBP observed/VBN in/IN aerobic/JJ ,/, heme-sufficient/JJ cells/NNS ./.
@@93624991671 The/DT Fis/NEWGENE protein/NEWGENE regulates/VBZ site-specific/NN DNA/NN inversion/NN catalyzed/VBN by/IN a/DT family/NN of/IN DNA/NEWGENE invertases/NEWGENE when/CC bound/JJ to/IN a/DT cis-acting/JJ recombinational/JJ enhancer/NN ./.
@@10785668609 How/WRB plants/NNS respond/VBP to/IN attack/NN by/IN the/DT range/NN of/IN herbivores/NNS and/CC pathogens/NNS that/WDT confront/VBP them/PRP in/IN the/DT field/NN is/VBZ the/DT subject/NN of/IN considerable/JJ research/NN by/IN both/DT molecular/JJ biologists/NNS and/CC ecologists/NNS ./.
@@84744565199 Transient/JJ transfection/NN analysis/NN with/IN these/DT mutations/NNS revealed/VBN that/IN only/RB a/DT 10-bp/JJ region/NN ,/, containing/JJ precisely/RB the/DT Ets/NEWGENE and/CC proximal/JJ LyF-1/NEWGENE binding/NEWGENE sites/NEWGENE ,/, was/VBD needed/VBN for/IN D'/NNS activity/NN ./.
@@18989282348 DNA/NN hybridization/NN analysis/NN revealed/VBN that/IN both/DT pigmented/JJ and/CC nonpigmented/JJ cells/NNS of/IN Y/NNP ./NNP pestis/NN possess/VB a/DT DNA/NN locus/NN homologous/JJ to/IN the/DT Escherichia/NEWGENE coli/NEWGENE fur/NEWGENE gene/NEWGENE ./.
@@96184753938 A/DT large/JJ deletion/NN in/IN the/DT CTD-binding/NEWGENE motif/NEWGENE blocks/NNS down-regulation/NN but/CC does/VBP not/RB affect/VB the/DT essential/JJ function/NN of/IN Nrd1/NEWGENE ./.
@@26479183319 Application/NNP of/IN different/JJ criteria/NNS of/IN cure/NN revealed/VBN that/IN 19/CD patients/NNS (/( 66%/JJ )/SYM had/VBP basal/NN GH/NEWGENE levels/NNS below/RB 5/CD ng/NN //NN ml/NN ,/, 17/CD patients/NNS (/( 59%/CD )/SYM had/VBP normal/JJ somatomedin-C/NEWGENE values/NNS ,/, 16/CD patients/NNS (/( 55%/JJ )/SYM had/VBP complete/JJ GH/NEWGENE suppression/NN (/( less/PRP than/IN 1/CD ng/NN //NN ml/NN )/SYM during/IN OGTT/NN ,/, and/CC 13/CD patients/NNS (/( 45%/JJ )/SYM met/VBP the/DT above-mentioned/JJ criteria/NNS with/IN disappearance/NN of/IN the/DT paradoxical/JJ GH/NEWGENE response/NN to/IN TRH/NEWGENE //NEWGENE GnRH/NEWGENE test/NN ./.
@@115299144999 NF-kappaB/NEWGENE is/VBZ involved/VBN in/IN the/DT regulation/NN of/IN CD154/NEWGENE (/( CD40/NEWGENE ligand/NEWGENE )/SYM expression/NN in/IN primary/JJ human/JJ T/NN cells/NNS ./.
@@75958578815 The/DT peak/NN velocities/NNS of/IN the/DT atrial/JJ systolic/JJ waves/NNS of/IN the/DT transmitral/JJ and/CC pulmonary/JJ venous/JJ flow/NN velocities/NNS (/( A/DT and/CC PVA/NN ,/, respectively/RB )/SYM and/CC first/JJ systolic/JJ wave/NN (/( PVS1/NN )/SYM of/IN pulmonary/JJ venous/JJ flow/NN ,/, durations/NNS of/IN both/DT atrial/JJ systolic/JJ waves/NNS ,/, and/CC amplitude/NN of/IN interatrial/JJ septal/JJ motion/NN during/IN atrial/JJ systole/NN increased/VBN significantly/RB ten/CD days/NNS after/IN cardioversion/NN compared/VBN with/IN those/DT measured/VBN within/IN a/DT day/NN of/IN cardioversion/NN in/IN all/DT patients/NNS except/VBP the/DT 5/CD patients/NNS with/IN dilated/JJ cardiomyopathy/NN ./.
@@19974656793 Radiation-induced/JJ changes/NNS in/IN the/DT area/NN of/IN alveoli/NNS and/CC septa/NNS as/RB well/VBP as/IN collagen/NEWGENE content/NN were/VBD seen/VBP 11/CD weeks/NNS after/IN irradiation/NN ./.
@@82705809869 A/DT favourable/NN response/NN was/VBD achieved/VBN with/IN a/DT combination/NN of/IN amphotericin/NN B/NN and/CC cotrimoxazole/NN ./.
@@97315133264 Taken/VBN together/RB ,/, these/DT results/NNS suggest/VBP that/IN the/DT cooperation/NN of/IN transcription/NEWGENE factors/NEWGENE NF-kappaB/NEWGENE and/CC AP-1/NEWGENE is/VBZ essential/JJ for/IN transactivation/NN of/IN IL-8/NEWGENE gene/NEWGENE by/IN HTLV-I/NEWGENE Tax/NEWGENE ./.
@@10656154471 Five/CD women/NNS (/( 15/CD ./CD 6%/CD )/SYM met/VBP criteria/NNS for/IN PMS/NN ./.
@@92273327915 In/NN summary/NN ,/, DDC/NN express/NN receptors/NNS for/IN a/DT broad/JJ panel/NN of/IN cytokines/NNS ,/, even/VB receptors/NNS for/IN cytokines/NNS whose/WP effects/NNS on/IN DC/JJ are/VBP still/RB unknown/JJ (/( i/CD ./CD e/CD ./.
@@88250874886 DNA/NN sequence/NN analysis/NN of/IN a/DT 3213/NEWGENE bp/NEWGENE BamHI-ClaI/NEWGENE fragment/NEWGENE revealed/VBN that/IN three/CD open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM were/VBD encoded/VBN in/IN the/DT same/JJ orientation/NN ./.
@@94206712472 CONCLUSIONS/IN :/: The/DT myocardial/JJ uptake/NN of/IN 99mTc/NN sestamibi/NN in/IN normal/JJ subjects/NNS and/CC patients/NNS with/IN coronary/JJ artery/NN disease/NN is/VBZ comparable/JJ after/IN exercise/NN ,/, dipyridamole/NN ,/, and/CC adenosine/NN stress/NN ./.
@@28330218325 The/DT results/NNS suggest/VBP that/IN the/DT organization/NN of/IN functional/JJ units/NNS of/IN the/DT 72-bp/JJ repeat/NN required/VBN for/IN transcriptional/JJ enhancement/NN of/IN the/DT early/JJ promoter/NN is/VBZ different/JJ from/IN that/DT required/VBD for/IN late/JJ promoter/NN function/NN ./.
@@94479737724 Consistent/JJ with/IN previous/JJ reports/NNS ,/, addition/NN of/IN a/DT myristoylation/NN signal/JJ to/IN mSos1/NEWGENE (/( MyrSos1/NEWGENE )/SYM rendered/VBN it/PRP transforming/JJ for/IN NIH/NN 3T3/CD cells/NNS and/CC deletion/NN of/IN the/DT mSos/NEWGENE C/NEWGENE terminus/NEWGENE (/( MyrSos1-deltaC/NEWGENE )/SYM did/VBD not/RB interfere/VB with/IN this/DT activity/NN ./.
@@92347207259 Although/IN neither/DT constitutively/RB activated/VBN MEK/NEWGENE (/( MEK-2E/NEWGENE )/SYM nor/CC v-Src/NEWGENE was/VBD sufficient/JJ individually/RB to/IN differentiate/VB the/DT H19-7/CD cells/NNS ,/, coexpression/NN of/IN constitutively/RB activated/VBN MEK/NEWGENE and/CC v-Src/NEWGENE induced/VBD neurite/NN outgrowth/NN ./.
@@78160259534 Comparison/NNS of/IN the/DT deduced/VBN amino/NEWGENE acid/NEWGENE sequence/NEWGENE of/NEWGENE gamma-kafirin/NEWGENE with/IN the/DT published/VBN sequences/NEWGENE of/NEWGENE gamma-prolamins/NEWGENE of/NEWGENE maize/NEWGENE ,/NEWGENE and/NEWGENE Coix/NEWGENE revealed/VBD highly/RB conserved/VBN domains/NNS ./.
@@69311249033 Setting/VBG takes/VBP place/NN through/JJ complex/NN formation/NN of/IN (/( NH4Mg/NNP PO4/NN ./NN 6H2O/NN )/NN n/NN ,/, excess/JJ reactants/NNS ,/, and/CC water/NN ./.
@@99493129945 Airflow/NN through/RB the/DT dust/NN trap/NN was/VBD controlled/VBN with/IN a/DT vacuum/NN pump/NN ./.
@@63854746185 Climatic/JJ treatment/NN of/IN children/NNS with/IN respiratory/JJ allergy/NN ./.
@@111606569172 Inactivity/NNS of/IN the/DT human/NEWGENE cytomegalovirus/NEWGENE (/NEWGENE HCMV/NEWGENE )/NEWGENE major/NEWGENE immediate-early/NEWGENE regulatory/NEWGENE region/NEWGENE (/( MIERR/NEWGENE )/SYM ,/, which/WDT is/VBZ composed/VBN of/IN promoter/NN ,/, enhancer/NN ,/, unique/JJ region/NN ,/, and/CC modulator/NN ,/, is/VBZ linked/JJ to/IN lack/NN of/IN HCMV/NN replication/NN in/IN latently/RB infected/VBN cells/NNS and/CC in/IN other/DT nonpermissive/JJ cell/NN types/NNS ,/, including/JJ human/JJ embryonal/JJ NTera2/NN carcinoma/NN (/( NT2/NNP )/SYM cells/NNS ./.
@@40637322949 In/JJ controls/NNS ,/, most/RB of/IN the/DT output/NN from/IN the/DT conduit/NN occurred/VBN during/IN type/NN I/NN activity/NN (/( 73/CD +/NN //NN -/NN 14%/JJ )/SYM ./.
@@110622579029 Thus/RB ,/, the/DT class/NEWGENE C-Vps/NEWGENE complex/NEWGENE directs/VBZ multiple/JJ reactions/NNS during/IN the/DT docking/JJ and/CC fusion/NN of/IN vesicles/NNS with/IN the/DT vacuole/NN ,/, each/DT of/IN which/WDT contributes/VBZ to/IN the/DT overall/JJ specificity/NN and/CC efficiency/NN of/IN this/DT transport/NN process/NN ./.
@@8533472725 The/DT predicted/VBN protein/NN products/NNS of/IN ORFs/NEWGENE N2417/NEWGENE and/CC N2403/NEWGENE present/VB similarities/NNS with/IN domains/NNS from/IN proteins/NNS of/IN other/DT organisms/NNS :/: the/DT Candida/NN maltosa/NN cycloheximide-resistance/NEWGENE protein/NEWGENE ,/, the/DT human/NN interleukin/NEWGENE enhancer-binding/NEWGENE factor/NEWGENE (/( ILF-2/NEWGENE )/SYM ./.
@@107084248479 Manganese/NNP ions/NNS were/VBD found/VBN to/IN be/VB essential/JJ for/IN autophosphorylation/NN of/IN BGLF4/NEWGENE ,/, and/CC magnesium/NN can/MD stimulate/VB the/DT activity/NN ./.
@@98171902425 However/RB ,/, the/DT use/NN of/IN cyclosporin/NN A/NN is/VBZ associated/VBN with/IN an/DT increased/VBN prevalence/NN of/IN hypertension/NN in/IN kidney/NN transplant/NN recipients/NNS ./.
@@87691324312 The/DT human/NEWGENE MSH-2/NEWGENE gene/NEWGENE product/NEWGENE is/VBZ a/DT member/NN of/IN a/DT highly/RB conserved/VBN family/NN of/IN proteins/NNS which/WDT are/VBP involved/VBN in/IN post-replication/JJ mismatch/NN repair/NN ./. hMSH-2/NEWGENE is/VBZ homologous/JJ to/IN Escherichia/NN coli/JJ (/( E/NNP ./NNP coli/JJ )/SYM MutS/NEWGENE and/CC Sacchromyces/NEWGENE cerevisiae/NEWGENE MSH-1/NEWGENE and/CC MSH-2/NEWGENE proteins/NEWGENE ,/, which/WDT recognise/VBP heteroduplex/JJ DNA/NN at/IN the/DT sites/NNS of/IN all/DT single/JJ base/NN mismatches/NNS and/CC deletions/NNS or/CC insertions/NNS up/JJ to/IN 4/CD base/NN pairs/NNS ./. hMSH-2/NEWGENE is/VBZ one/PRP of/IN the/DT hereditary/NEWGENE non-polyposis/NEWGENE colorectal/NEWGENE cancer/NEWGENE (/NEWGENE HNPCC/NEWGENE )/NEWGENE tumor/NEWGENE suppressor/NEWGENE genes/NEWGENE ,/, and/CC maps/NNS to/IN human/JJ chromosome/NN 2p16/NN ./.
@@21185252129 In/NN addition/NN ,/, the/DT -119/CD to/IN -81/CD fragment/NN of/IN the/DT CCK/NEWGENE promoter/NEWGENE contains/VBZ a/DT transcriptional/JJ enhancer/NN that/WDT potentiates/VBZ the/DT transcription/NN from/IN the/DT herpes/NN simplex/JJ virus/NN thymidine/NEWGENE kinase/NEWGENE promoter/NEWGENE in/IN a/DT position-/JJ and/CC orientation-independent/JJ manner/NN ./.
@@15518984744 This/DT vector/NN transfected/VBN into/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN directs/VBZ expression/NN of/IN a/DT secreted/VBN mature/JJ protein/NN at/IN levels/NNS up/JJ to/IN 200/CD mg/NN of/IN LAPP/NNP //NNP liter/NNP of/IN culture/NN medium/NN ./.
@@89798288924 Such/JJ multisensory/JJ interactions/NNS can/MD be/VB significant/JJ for/IN behavior/NN ./.
@@95010931453 Activation/NNS of/IN the/DT mitogen/NEWGENE activated/NEWGENE protein/NEWGENE (/NEWGENE MAP/NEWGENE )/NEWGENE kinase/NEWGENE is/VBZ a/DT primary/JJ consequence/NN of/IN Ras/NEWGENE activation/NN and/CC plays/VBP a/DT key/NN role/NN in/IN mediating/JJ Ras/NEWGENE signal/JJ transduction/NN ./.
@@88367408435 Neither/CC CES1/NEWGENE nor/CC CES4/NEWGENE is/VBZ essential/JJ for/IN cell/NN growth/NN ,/, and/CC a/DT double/JJ deletion/NN mutant/NN is/VBZ viable/JJ ./.
@@95287926008 Alternative/JJ splicing/JJ of/IN fibroblast/NEWGENE growth/NEWGENE factor/NEWGENE receptor/NEWGENE 2/NEWGENE (/( FGF-R2/NEWGENE )/SYM is/VBZ an/DT example/NN of/IN highly/RB regulated/VBN alternative/JJ splicing/JJ in/IN which/WDT exons/NNS IIIb/NNS and/CC IIIc/NNS are/VBP utilized/VBN in/IN a/DT mutually/RB exclusive/JJ manner/NN in/IN different/JJ cell/NN types/NNS ./.
@@9316937432 This/DT newly/RB described/VBN organism/NN was/VBD difficult/JJ to/IN identify/VB due/NN to/IN discrepancies/NNS between/IN the/DT Vitek/NNP and/CC API/NN 20E/NN identification/NN systems/NNS ./.
@@73694587211 This/DT relatively/JJ simple/JJ and/CC easily/RB performed/VBN technique/NN of/IN measuring/JJ deep/JJ muscle/NN temperature/NN appears/VBZ to/IN be/VB a/DT useful/JJ adjunct/NN in/IN choosing/VBG the/DT amputation/NN level/NN ./.
@@78647099852 METHODS/IN :/: Ten/CD influenza/NN A/DT (/( H3N2/NN )/SYM viruses/NNS isolated/VBN during/IN the/DT outbreaks/NNS were/VBD examined/VBN for/IN resistance/NN to/IN amantadine/NN and/CC rimantadine/NN by/IN means/NN of/IN an/DT enzyme/NN immunoassay/NN and/CC by/IN sequencing/VBG of/IN the/DT viral/JJ nucleic/JJ acid/NN that/IN encodes/VBZ the/DT transmembrane/JJ domain/NN of/IN the/DT M2/NEWGENE protein/NEWGENE ./.
@@1141447044 An/DT anatomical/JJ and/CC histochemical/JJ study/NN has/VBZ been/VBN undertaken/VBP and/CC as/IN a/DT result/NN emphasis/NN is/NNS given/VBP to/IN recent/JJ hypotheses/NNS that/WDT suggest/VBP there/RB are/VBP similarities/NNS with/IN Type/NN IV/NN glycogen/NN storage/NN disease/NN (/( Andersen's/NNP disease/NN )/SYM which/WDT ,/, although/IN clinically/RB distinct/JJ ,/, has/VBZ the/DT same/JJ enzyme/NN defect/NN ./.
@@79451341617 Ten/CD volunteers/NNS were/VBD tested/VBN at/IN 18/CD ,/CD 000/CD ft/NN (/( 5/CD ,/CD 486/CD m/NN )/SYM ,/, and/CC through/RB 12/CD ,/CD 000/CD ,/, 8/CD ,/CD 000/CD ,/, and/CC 5/CD ,/CD 000/CD ft/NN (/( 3/NN ,/NN 657/NN ,/, 2/CD ,/CD 438/CD ,/, and/CC 1/CD ,/CD 524/CD m/NN )/SYM with/IN directional/JJ sounds/NNS recorded/VBD via/NN a/DT dummy/JJ head/JJ microphone/NN and/CC presented/VBN binaurally/RB ./.
@@111455662716 Because/IN the/DT high-density/NEWGENE lipoprotein/NEWGENE receptor/NEWGENE (/( HDL-R/NEWGENE )/SYM is/VBZ a/DT key/NN element/NN in/IN cholesterol/NN homeostasis/NN and/CC a/DT potential/JJ therapeutic/JJ target/NN for/IN hypercholesterolemic/JJ drugs/NNS ,/, an/DT understanding/NN of/IN HDL-R/NEWGENE regulation/NN is/VBZ essential/JJ ./.
@@117436121761 Patients/NNS with/IN CF/NN and/CC meconium/NN ileus/NN presented/VBD a/DT poor/JJ nutritional/JJ status/NN at/IN diagnosis/NN and/CC a/DT lower/JJR survival/NN rate/NN compared/VBN to/IN the/DT general/NN CF/NN population/NN ./.
@@91217741387 A/DT role/NN for/IN the/DT small/NEWGENE GTPase/NEWGENE Rac/NEWGENE in/IN polyomavirus/NN middle-T/NN antigen-mediated/JJ activation/NN of/IN the/DT serum/NEWGENE response/NEWGENE element/NEWGENE and/CC in/IN cell/NN transformation/NN ./.
@@113906638122 Finally/RB ,/, profiling/VBG of/IN a/DT gcn4Delta/NEWGENE mutant/NEWGENE uncovered/VBN an/DT alternative/JJ induction/NN pathway/NN operating/JJ at/IN many/JJ Gcn4p/NEWGENE target/NEWGENE genes/NEWGENE in/IN histidine-starved/JJ cells/NNS ./.
@@93499679303 Our/PRP results/NNS suggest/VBP that/IN the/DT pattern/NN of/IN blood/NN supply/NN is/VBZ relevant/JJ to/IN the/DT structural/JJ organisation/NN of/IN mature/JJ lamellar/JJ bone/NN around/IN the/DT implant/NN ./.
@@35914644253 Thus/RB ,/, a/DT negative/JJ test/NN is/VBZ compatible/JJ with/IN low/JJ disease/NN activity/NN and/DT //DT or/DT efficacy/NN of/IN calcium/NN antagonist/NN treatment/NN ./.
@@109319606607 The/DT loss/NN of/IN avirulence/NN activity/NN because/IN of/IN mutations/NNS in/IN the/DT acidic/JJ transcriptional/JJ activation/NN domain/NN was/VBD restored/VBN by/IN addition/NN of/IN the/DT activation/NN domain/NN from/IN the/DT herpes/NEWGENE simplex/NEWGENE viral/NEWGENE protein/NEWGENE VP16/NEWGENE ./.
@@14382879785 Nonreplicating/VBG vaccinia/NN vector/NN efficiently/RB expresses/VBP recombinant/JJ genes/NNS ./.
@@105874612525 By/IN an/DT induced-fit/JJ mechanism/NN ,/, contacts/VBZ with/IN the/DT anticodon/NN can/MD activate/VB formation/NN of/IN a/DT robust/JJ transition/NN state/NN at/IN a/DT site/NN over/RB 70/CD A/DT away/RB ./.
@@27611503459 The/DT effect/NN of/IN zinc/NN deficiency/NN on/IN trace/NN metals/NNS in/IN the/DT liver/NN ,/, spleen/NN ,/, kidney/NN ,/, pancreas/NN and/CC duodenum/NN was/VBD investigated/VBN in/IN the/DT control/NN and/CC zinc-deficient/JJ rats/NNS at/IN 17/CD days/NNS and/CC 20/CD days/NNS of/IN pregnancy/NN ./.
@@94479942271 Several/JJ studies/NNS have/VBP characterized/VBN the/DT upstream/RB regulatory/JJ region/NN of/IN c-fos/NEWGENE ,/, and/CC identified/VBD cis-acting/JJ elements/NNS termed/VBD the/DT cyclic/NEWGENE AMP/NEWGENE (/NEWGENE cAMP/NEWGENE )/NEWGENE response/NEWGENE elements/NEWGENE (/( CREs/NEWGENE )/SYM that/WDT are/VBP critical/JJ for/IN c-fos/NEWGENE transcription/NN in/IN response/NN to/IN a/DT variety/NN of/IN extracellular/JJ stimuli/NNS ./.
@@85520967572 Using/VBG a/DT high-copy/JJ suppression/NN strategy/NN ,/, we/PRP have/VBP identified/VBN a/DT yeast/NN gene/NN (/( UBS1/NEWGENE )/SYM whose/WP elevated/VBN expression/NN suppresses/VBZ the/DT conditional/JJ cell/NN cycle/NN defects/NNS associated/VBN with/IN cdc34/NEWGENE mutations/NN ./.
@@98713539860 However/RB ,/, there/RB has/VBZ not/RB been/VBN any/DT evidence/NN of/IN A/NNP ./NNP salmonicida/JJ infections/NNS ,/, specifically/RB furunculosis/NN ,/, associated/VBN with/IN the/DT fish/NN in/IN this/DT loch/NN ./.
@@27526297590 Dynamic/NNP and/CC static/JJ scintigrams/NNS ,/, using/VBG 99mtechnetium/NN methylene/NN diphosphonate/NN ,/, were/VBD obtained/VBN at/IN zero/NN ,/, six/CD ,/, and/CC 12/CD weeks/NNS after/IN fracture/NN ./.
@@64947666286 The/DT persistent/JJ fetal/JJ dispersion/NN of/IN nodal/JJ and/CC Hiss/NNP bundle/NN fragments/NNS within/IN the/DT ventricular/JJ septum/NN is/VBZ proposed/VBN as/IN a/DT possible/JJ explanation/NN ./.
@@105853115457 Residual/JJ urinary/JJ abnormalities/NNS were/VBD significantly/RB more/RB frequent/VB in/IN patients/NNS with/IN type/NN III/NN than/IN type/NN I/NN MPGN/NN ./.
@@1084413650 A/DT range/NN of/IN normal/JJ ventricular/JJ measurements/NNS for/IN the/DT EMI/NNP scan/NN is/VBZ suggested/VBN ./.
@@21139013407 Inspired/VBN CO2/NN causing/JJ changes/NNS from/IN hypo-/JJ to/IN normocapnia/NN has/VBZ previously/RB been/VBN shown/VBP to/IN improve/VB arterial/JJ O2/NN tension/NN (/( PaO2/NN )/SYM and/CC to/IN reduce/VB alveolar-arterial/JJ O2/NN difference/NN ./.
@@107245195391 Most/JJS likely/RB they/PRP might/MD represent/VB regulatory/JJ RNAs/NNS or/CC transcribed/VBN transposable/JJ elements/NNS ./.
@@86493868656 A/DT new/JJ UASH/NEWGENE consensus/NEWGENE sequence/NEWGENE derived/VBN from/IN this/DT mutational/JJ analysis/NN closely/RB matches/VBZ a/DT consensus/NN Abf1/NEWGENE binding/NEWGENE site/NEWGENE ./.
@@94420244119 A/DT hybridoma/NN clone/NN (/( 7H1/NN )/SYM resulting/VBG from/IN the/DT fusion/NN between/IN CEMLAI/NNP //NNP NP/NNP and/CC human/JJ embryonic/JJ fibroblasts/NNS MRC5/NNP cells/NNS produced/VBN very/RB large/JJ amounts/NNS of/IN P47/NEWGENE that/WDT was/VBD purified/VBN using/VBG Jacalin/NN lectin/NN (/( specific/JJ for/IN O-glycans/NNPS )/SYM and/CC microsequenced/VBN ./.
@@96221213575 The/DT use/NN of/IN antibodies/NNS to/IN the/DT polypyrimidine/NEWGENE tract/NEWGENE binding/NEWGENE protein/NEWGENE (/( PTB/NEWGENE )/SYM to/IN analyze/VB the/DT protein/NN components/NNS that/WDT assemble/VBP on/IN alternatively/RB spliced/VBN pre-mRNAs/VBZ that/DT use/NN distant/JJ branch/NN points/NNS ./.
@@80156727488 In/NN control/JJ patients/NNS ,/, baseline/NN images/NNS presented/VBD Type/NN I/NN in/IN 25/CD ,/, Type/NN II/NN in/IN 7/CD ,/, and/CC the/DT Type/NN III/NN &/CC IV/NN in/IN 0/CD ,/, and/CC the/DT Type/NN after/IN loading/NN was/VBD the/DT same/JJ as/IN the/DT Type/NN at/IN baseline/NN ./.
@@83556805296 2-AP/CD induced/VBN marked/JJ ,/, steady/JJ rises/NNS in/IN mRNA/NN accumulation/NN from/IN both/DT transfected/VBN and/CC chromosomally/RB integrated/JJ HIV-1/NN constructs/NN but/CC no/DT increases/NNS from/IN an/DT endogenous/JJ gene/NN encoding/VBG gamma-actin/NEWGENE or/CC glucose/NEWGENE 6-phosphate/NEWGENE dehydrogenase/NEWGENE ./.
@@3042778922 The/DT gene/NN is/VBZ essential/JJ for/IN yeast/NN vegetative/JJ growth/NN ./.
@@95432279495 Group/NNP A/DT (/( 68/NN ./NN 7+/NN //NN -2/NN ./NN 7/NN years/NNS )/SYM consisted/VB of/IN patients/NNS with/IN 0/CD or/CC 1/CD risk/NN factors/NNS ;/: B/NNP (/( 68/CD ./CD 3+/CD //CD -4/CD ./CD 2/CD years/NNS )/SYM those/DT with/IN 2/CD risk/NN factors/NNS ;/: and/CC C/NN (/( 69/CD ./CD 2+/CD //CD -3/CD ./CD 6/CD years/NNS )/SYM those/DT with/IN 3/CD or/CC more/JJ risk/NN factors/NNS ./.
@@81985244953 50/CD kDa/NN and/CC 130-170/JJ kDa/NN were/VBD detected/VBN ./.
@@91546219108 These/DT results/NNS suggest/VBP that/IN dietary/JJ safflower/NN phospholipids/NNS may/MD be/VB a/DT valuable/NN ingredient/NN to/IN layers/NNS for/IN reducing/JJ liver/NN triglycerides/NNS and/CC serum/JJ cholesterol/NN without/IN any/DT adverse/JJ effects/NNS ./.
@@75595243244 Several/JJ different/JJ oncogenes/NNS and/CC growth/NEWGENE factors/NEWGENE promote/VBP G1/NN phase/NN progression/NN ./.
@@96322175948 The/DT opioid/NN antagonist/NN naltrexone/NN (/( 0/CD ./CD 01-1/CD ./CD 0/CD mg/CD //CD kg/CD )/SYM antagonized/VBN the/DT discriminative/JJ stimulus/NN effects/NNS of/IN heroin/NN ,/, but/CC naltrexone/NN at/IN doses/NNS up/JJ to/IN 10/CD mg/CD //CD kg/CD had/VBP no/DT effect/NN on/IN the/DT discriminative/JJ stimulus/NN effects/NNS of/IN cocaine/NN ./.
@@76306875846 The/DT objective/NN of/IN our/PRP study/NN was/VBD to/IN evaluate/VB the/DT age/NN ,/, sex/NN ,/, clinical/JJ conditions/NNS ,/, family/NN history/NN ,/, site/NN ,/, catheter/NN association/NN ,/, means/NN of/IN radiologic/JJ evaluation/NN ,/, development/NN of/IN pulmonary/JJ involvement/NN ,/, prevalence/NN of/IN antithrombin/NEWGENE III/NEWGENE ,/, protein/NEWGENE C/NEWGENE and/CC protein/NEWGENE S/NEWGENE deficiencies/NNS ,/, and/CC lupus/NN anticoagulants/NNS in/IN children/NNS who/WP suffered/VBD a/DT thrombotic/JJ event/NN ./.
@@77303289516 Vascular/JJ endothelial/JJ cells/NNS undergo/VBP profound/JJ changes/NNS upon/IN cellular/JJ activation/NN including/JJ expression/NN of/IN a/DT spectrum/NN of/IN cell/NN activation-associated/NN genes/NN ./.
@@75887505168 Cloning/VBG ,/, sequencing/VBG and/CC expression/NN of/IN the/DT 3-phosphoglycerate/NEWGENE kinase/NEWGENE gene/NEWGENE of/IN Pyrococcus/ORG woesei/NN in/IN Escherichia/NN coli/NN and/CC characterization/NN of/IN the/DT protein/NN ./.
@@9771967271 Furthermore/RB ,/, LB1/NEWGENE gene/NEWGENE mapped/VBN to/IN chromosome/NN 13q14/CD ,/, a/DT region/NN that/WDT has/VBZ been/VBN involved/VBN as/IN a/DT chromosomal/JJ breakpoint/NN in/IN DLBL/NN ./.
@@104908223702 These/DT results/NNS show/NN that/DT targeting/NN of/IN Ras-GAP/NEWGENE could/MD represent/VB a/DT novel/JJ anticancer/JJ approach/NN ./.
@@88780372890 The/DT gene/NEWGENE ccpA/NEWGENE encoding/VBG the/DT catabolite/NEWGENE control/NEWGENE protein/NEWGENE CcpA/NEWGENE of/IN Staphylococcus/NN xylosus/NN has/VBZ been/VBN cloned/VBN and/CC characterized/VBN ./.
@@107560948953 A/DT total/NN of/IN 194/NN STSs/NN map/NN to/IN this/DT interval/NN of/IN 3/CD Mb/NN ,/, giving/JJ an/DT average/JJ marker/NN resolution/NN of/IN approximately/RB one/PRP per/IN 15/CD kb/CD ./CD
@@8350398846 We/PRP suggest/VBP that/IN the/DT ER/NN lumenal/JJ variable/JJ domain/NN of/IN gp19K/NEWGENE has/VBZ a/DT specific/JJ tertiary/JJ structure/NN that/WDT is/VBZ important/JJ for/IN binding/JJ to/IN the/DT polymorphic/JJ alpha/NN 1/NN and/CC alpha/NN 2/NN domains/NN of/IN class/NEWGENE I/NEWGENE heavy/NEWGENE (/NEWGENE alpha/NEWGENE )/NEWGENE chains/NEWGENE ./.
@@83357108315 The/DT influence/NN of/IN a/DT high/JJ ionic/JJ strength/NN on/IN the/DT resolution/NN was/VBD clearly/RB shown/VBP ./.
@@11474361360 The/DT American/NNP Burkitt/NNP Lymphoma/NNP Registry/NNP :/: a/DT progress/NN report/NN ./.
@@24890324760 Immunoglobulin/NEWGENE light/NEWGENE chain/NEWGENE (/( IgL/NEWGENE )/SYM diversity/NN is/VBZ generated/VBN in/IN the/DT chicken/NN by/IN recombination/NN between/IN the/DT single/JJ functional/JJ variable/NEWGENE (/( VL/NEWGENE )/SYM and/CC joining/NEWGENE (/( JL/NEWGENE )/SYM gene/NN segments/NNS and/CC subsequent/JJ somatic/JJ diversification/NN of/IN the/DT rearranged/NEWGENE VL/NEWGENE region/NEWGENE ./.
@@114313483746 Interactions/NNS between/IN the/DT checkpoint/NN abrogator/NN UCN-01/NEWGENE and/CC several/DT pharmacological/JJ inhibitors/NNS of/IN the/DT mitogen-activated/NEWGENE protein/NEWGENE kinase/NEWGENE (/NEWGENE MAPK/NEWGENE )/NEWGENE kinase/NEWGENE (/( MEK/NEWGENE )/NN //NEWGENE MAPK/NEWGENE pathway/NN have/NN been/VBN examined/VBN in/IN a/DT variety/NN of/IN human/JJ leukemia/NN cell/NN lines/NNS ./.
@@22203049090 Our/PRP study/NN shows/VBZ that/IN the/DT area/NN of/IN Alcoy/NN is/VBZ a/DT medium/NN MS/NN risk/NN region/NN according/VBG to/IN the/DT thesis/NN of/IN Kurzke/NNP ,/, although/IN high/JJ MS/NN areas/NNS may/MD be/VB found/VB ,/, thus/RB confirming/VBG that/DT MS/NN distribution/NN in/IN southern/JJ Europe/NN is/VBZ not/RB uniform/JJ ./.
@@15378459574 Using/VBG bovine/NEWGENE and/NEWGENE murine/NEWGENE c-myb/NEWGENE clones/NNS ,/, no/DT change/NN in/IN the/DT rate/NN of/IN c-myb/NEWGENE gene/NEWGENE transcription/NN or/CC mRNA/NN stability/NN was/VBD detected/VBN during/IN the/DT cell/NN cycle/NN ./.
@@98755413443 The/DT orbitofrontal/NN ,/, cingulate/JJ ,/, and/CC anteromedial/JJ part/NN of/IN the/DT dorsal/JJ premotor/JJ areas/NNS were/VBD preferentially/RB activated/VBN by/IN the/DT self-initiated/JJ hand/NN movement/NN task/NN (/( SELF/NN )/SYM ./.
@@79782297969 An/DT unusual/JJ complication/NN in/IN an/DT unsuitable/JJ patient/NN ./.
@@7959011114 C/NEWGENE //NEWGENE EBP/NEWGENE alpha/NEWGENE also/RB activates/VBZ the/DT promoter/NN of/IN the/DT rat/NEWGENE class-I/NEWGENE ADH/NEWGENE gene/NEWGENE in/IN a/DT sequence-specific/JJ manner/NN [/NN Potter/NN et/FW al/NNS ./NNS ,/, Arch/NNP ./.
@@92116755372 Surveillance/NN for/IN preeclampsia/NN was/VBD conducted/VBN by/IN personnel/NN unaware/JJ of/IN treatment-group/JJ assignments/NNS ,/, using/VBG standardized/JJ measurements/NNS of/IN blood/NN pressure/NN and/CC urinary/NN protein/NN excretion/NN at/IN uniformly/RB scheduled/VBN prenatal/JJ visits/NNS ,/, protocols/NNS for/IN monitoring/VBG these/DT measurements/NNS during/IN the/DT hospitalization/NN for/IN delivery/NN ,/, and/CC reviews/VBP of/IN medical/JJ records/NNS of/IN unscheduled/JJ outpatient/NN visits/NNS and/CC all/DT hospitalizations/NNS ./.
@@91603612159 The/DT 30-day/CD mortality/NN in/IN the/DT CPB/NNP group/NN and/CC the/DT non-CPB/NN group/NN were/VBD 20%/CD and/CC 4/CD ./CD 6%/CD ,/, respectively/RB which/WDT was/VBD not/RB statistically/RB significant/JJ (/( p/NN =/SYM 0/CD ./CD 06/CD )/SYM ./.
@@79267751787 We/PRP show/VBP that/IN the/DT en/NEWGENE stripes/NNS expand/VBP anteriorly/RB in/IN slp/NEWGENE mutant/NN embryos/NNS and/CC that/DT slp/NEWGENE activity/NN is/VBZ an/DT absolute/JJ requirement/NN for/IN maintenance/NN of/IN wg/NEWGENE expression/NN at/IN the/DT same/JJ time/NN that/DT wg/NEWGENE transcription/NN is/VBZ dependent/JJ on/IN hh/NEWGENE ./.
@@10895851723 Bailey/NNP Instruments/NNPS and/CC Owen/NNP Mumford/NNP filaments/NNS were/VBD the/DT most/RB accurate/JJ with/IN 100%/CD buckling/NN within/IN +/CD //CD -1/CD ./CD 0/CD g/NN of/IN 10/CD g/CD ./CD
@@104545574880 In/NN the/DT budding/JJ yeast/NN ,/, Saccharomyces/NN cerevisiae/NN ,/, replicators/NNS can/MD function/VB outside/RB the/DT chromosome/NN as/IN autonomously/RB replicating/JJ sequence/NN (/( ARS/NNS )/SYM elements/NNS ;/: however/RB ,/, within/IN chromosome/NN III/NN ,/, certain/JJ ARSs/NNP near/IN the/DT transcriptionally/RB silent/JJ HML/NEWGENE locus/NEWGENE show/NN no/DT replication/NN origin/NN activity/NN ./.
@@82454569946 These/DT cells/NNS produce/NN a/DT low/JJ level/NN of/IN IL-5/NEWGENE when/CC stimulated/VBN with/IN PMA/NN alone/RB ;/: however/RB ,/, N6/NNS ,/, O2-dibutyryl/NNP cAMP/NN (/( Bt2cAMP/IN )/SYM ,/, in/IN combination/NN with/IN PMA/NN ,/, augmented/VBN by/IN more/RB than/IN tenfold/RB the/DT IL-5/NEWGENE production/NN at/IN the/DT mRNA/NN and/CC the/DT protein/NN levels/NNS ./.
@@29281126837 Molecular/NNP cloning/NN of/IN the/DT cDNA/NN for/IN the/DT human/NEWGENE U2/NEWGENE snRNA-specific/NEWGENE A'/NEWGENE protein/NEWGENE ./.
@@111819951734 Analysis/NNP of/IN the/DT genome/NN sequence/NN revealed/VBN 26/NN ,/NN 588/NN protein-encoding/NN transcripts/NN for/IN which/WDT there/RB was/VBD strong/JJ corroborating/VBG evidence/NN and/CC an/DT additional/JJ approximately/RB 12/CD ,/CD 000/CD computationally/RB derived/VBN genes/NNS with/IN mouse/NN matches/NNS or/CC other/DT weak/JJ supporting/VBG evidence/NN ./.
@@10523647836 Thus/RB ,/, CHOP/NEWGENE not/RB only/RB is/VBZ a/DT negative/JJ or/CC a/DT positive/JJ regulator/NN of/IN C/NEWGENE //NEWGENE EBP/NEWGENE target/NN genes/NN but/CC also/RB ,/, when/CC tethered/JJ to/IN AP-1/NEWGENE factors/NEWGENE ,/, can/MD activate/VB AP-1/NEWGENE target/NN genes/NN ./.
@@75107247396 The/DT lymph/NN nodes/NNS from/IN two/NN of/IN the/DT patients/NNS with/IN rheumatoid/JJ arthritis/NN contained/VBD numerous/JJ sarcoid/JJ like/JJ granulomata/NNS ,/, further/RB indicating/VBG a/DT possible/JJ association/NN between/IN sarcoidosis/NN and/CC rheumatoid/JJ arthritis/NN ./.
@@61134435937 Separation/NN of/IN malaria-infected/JJ erythrocytes/NNS from/IN whole/JJ blood/NN :/: use/NN of/IN a/DT selective/JJ high-gradient/JJ magnetic/JJ separation/NN technique/NN ./.
@@72533352499 Effects/NNPS of/IN prostaglandin/NN inhibitors/NN on/IN the/DT onset/NN of/IN proteinuria/NN and/CC stroke/NN in/IN stroke-prone/JJ spontaneously/RB hypertensive/JJ rats/NNS ./.
@@77434727700 Female/JJ patients/NNS with/IN breast/NN cancer/NN diagnosed/VBN between/IN 1982/CD and/CC 1991/CD at/IN Roswell/NNP Park/NNP Cancer/NNP Institute/NNP (/( RPCI/NN )/SYM in/IN Buffalo/NN ,/, New/NNP York/NN ,/, who/WP provided/VBD information/NN on/IN their/PRP cigarette/NN smoking/NN history/NN at/IN the/DT time/NN of/IN their/PRP diagnosis/NN were/VBD included/VBN ./.
@@75106358084 One/CD antibody/NN ,/, mAb1C2/NEWGENE ,/, and/CC a/DT synthetic/JJ peptide/NN comprising/VBG its/PRP epitope/NN selectively/RB inhibited/VBD in/IN vitro/FW transcription/NN from/IN TATA-containing/JJ ,/, but/CC not/RB from/IN TATA-less/NNP promoters/NNS ,/, irrespective/JJ of/IN whether/IN they/PRP were/VBD transcribed/VBN by/IN Pol/NEWGENE II/NEWGENE or/CC Pol/NEWGENE III/NEWGENE ./.
@@105749829096 Supershift/NNP EMSAs/NNS identified/VBN that/IN upstream/NEWGENE stimulatory/NEWGENE factor-1/NEWGENE and/NEWGENE -2/NEWGENE (/( USF-1/NEWGENE and/NEWGENE -2/NEWGENE )/SYM were/VBD part/NN of/IN these/DT complexes/NNS ./.
@@2582918575 After/IN hepatitis/NN B/NN vaccine/NN immunization/NN ,/, serum/JJ antibody/NN response/NN was/VBD of/IN primary/JJ type/NN in/IN 33/CD cases/NNS with/IN anti-HBs/NEWGENE less/PRP than/IN 2/CD ./CD 1/CD S/NN //NN N/NN (/( S/NN //NN N/NN Ratio/NNS Unit/NN )/SYM at/IN T0/NN ,/, the/DT anti-HBs/NEWGENE positive/JJ rate/NN was/VBD 39/CD ./CD 4%/CD ,/, 84/CD ./CD 8%/CD ,/, 96/CD ./CD 7%/CD and/CC 96/CD ./CD 7%/CD in/IN T1/NN ,/, T2/NN ,/, T0/NN and/CC T12/NN respectively/RB ./.
@@51623425406 Abdominal/JJ tumors/NNS in/IN childhood/NN ./.
@@75657972268 Deletion/NNS or/CC inactivation/NN of/IN CRY1/NEWGENE leads/VBP to/IN 5-/CD to/IN 10-fold-increased/CD levels/NNS of/IN CRY2/NEWGENE mRNA/NEWGENE ./.
@@100973992 Effect/NN of/IN indomethacin/NN on/IN coronary/JJ circulation/NN :/: effect/NN on/IN ECG/NN tracing/JJ ./.
@@1816655442 Review/NNP of/IN the/DT literature/NN and/CC report/NN of/IN a/DT case/NN of/IN a/DT dermoid/NN cyst/NN ./.
@@40482454723 Treatment/NNP with/IN oxyphenylbutazone/NN and/CC hydrocortisone/NN failed/VBN to/IN inhibit/VB the/DT raised/VBN serum/NEWGENE CPN/NEWGENE levels/NNS ./.
@@85526708587 Identification/NNP ,/, purification/NN ,/, and/CC molecular/JJ cloning/NN of/IN autonomously/NEWGENE replicating/NEWGENE sequence-binding/NEWGENE protein/NEWGENE 1/NEWGENE from/NEWGENE fission/NEWGENE yeast/NEWGENE Schizosaccharomyces/NEWGENE pombe/NEWGENE ./.
@@39393178439 A/DT comparison/NN among/IN the/DT 5'/CD flanking/JJ regions/NNS encompassing/VBG the/DT presumptive/JJ HS/NEWGENE promoter/NEWGENE of/IN the/DT soybean/NEWGENE HS-protein/NEWGENE genes/NEWGENE demonstrated/VBD this/DT region/NN to/IN be/VB extremely/RB homologous/JJ ./.
@@90799289581 M/NEWGENE ./NEWGENE leprae/NEWGENE OxyR/NEWGENE was/VBD overproduced/VBN and/CC purified/VBN ,/, and/CC its/PRP binding/JJ to/IN the/DT oxyR-ahpC/NEWGENE intergenic/NEWGENE region/NEWGENE of/NEWGENE M/NEWGENE ./NEWGENE leprae/NEWGENE was/VBD demonstrated/VBN ./.
@@105624565438 Regulatory/NNP regions/NNS in/IN the/DT promoter/NN and/CC third/JJ intron/NN of/IN the/DT growth/NEWGENE hormone/NEWGENE gene/NEWGENE in/NEWGENE rainbow/NEWGENE trout/NEWGENE ,/, Oncorhynchus/NN mykiss/NN walbaum/NN ./.
@@103951997957 This/DT scFv/NN was/VBD therefore/RB used/VBN as/IN control/NN in/IN experiments/NNS where/CC another/DT anti-Ras/NEWGENE scFv/NEWGENE (/( Y259/NEWGENE scFv/NEWGENE ,/, derived/VBN from/IN the/DT neutralizing/JJ anti-Ras/NEWGENE mAb/NEWGENE Y13-259/NEWGENE )/SYM blocked/VBN the/DT Ras/NEWGENE pathway/NEWGENE in/IN vitro/FW and/CC led/VBN to/IN tumor/NN regression/NN in/IN a/DT nude/JJ mouse/NN model/NN [/NN Cochet/NN ,/, O/NNP ./NNP ,/, Kenigsberg/NNP ,/, M/NNP ./NNP ,/, Delumeau/NNP ,/, I/NNP ./NNP ,/, Virone-Oddos/NNP ,/, A/NNP ./NNP ,/, Multon/NNP ,/, M/NN ./NN C/NN ./NN ,/, Fridman/NNP ,/, W/NNP ./NNP H/NNP ./NNP ,/, Schweighoffer/NNP ,/, F/NN ./NN ,/, Teillaud/NNP ,/, J/NNP ./NNP L/NNP ./NNP ,/, Tocque/NNP ,/, B/NNP ./NNP ,/, 1998/CD ./.
@@47914209445 Proceedings/NNP :/: Barrels/NNP and/CC somatotopy/NN in/IN S/NN I/NN neocortex/NN of/IN the/DT brush-tailed/JJ possum/NN ./.
@@85976365464 The/DT T-box/NN motif/NN is/VBZ present/VB in/IN a/DT family/NN of/IN genes/NNS whose/WP structural/JJ features/NNS and/CC expression/NN patterns/NNS support/VBP their/PRP involvement/NN in/IN developmental/JJ gene/NN regulation/NN ./.
@@80706549355 KAR1/NEWGENE encodes/VBZ an/DT essential/JJ component/NN of/IN the/DT yeast/NN spindle/NN pole/NN body/NN (/( SPB/NN )/SYM that/WDT is/VBZ required/VBN for/IN karyogamy/NN and/CC SPB/NN duplication/NN ./.
@@14545183954 To/TO study/VB the/DT significance/NN of/IN these/DT domains/NNS and/CC the/DT overall/JJ evolutionary/JJ conservation/NN of/IN the/DT gene/NN ,/, the/DT homolog/NN from/IN Drosophila/NN melanogaster/NN was/VBD isolated/VBN by/IN low/JJ stringency/NN hybridizations/NNS using/VBG two/JJ flanking/JJ probes/NNS of/IN the/DT human/NEWGENE ERCC3/NEWGENE cDNA/NEWGENE ./.
@@112797204863 SELECTION/NN CRITERIA/NNP :/: Randomised/RB controlled/VBN trials/NNS of/IN cabergoline/NN versus/IN placebo/NN in/IN patients/NNS with/IN a/DT clinical/JJ diagnosis/NN of/IN idiopathic/JJ Parkinson's/NNP disease/NN and/CC long-term/JJ complications/NNS of/IN levodopa/NN therapy/NN ./.
@@21627544922 PAO/NN blocks/NNS turnover/NN of/IN the/DT phosphoryl/NN group/NN of/IN pp15/NEWGENE ,/, causing/JJ its/PRP accumulation/NN ,/, and/CC thereby/RB appears/VBZ to/IN interrupt/VB signal/JJ transmission/NN from/IN the/DT receptor/NN to/IN the/DT glucose-transport/JJ system/NN ./.
@@90220402306 Because/IN L-plastin/NEWGENE expression/NN in/IN tissue-specifically/RB regulated/VBN in/IN both/DT humans/NNS and/CC rodents/NNS ,/, it/PRP is/VBZ likely/RB that/IN similar/JJ mechanisms/NNS regulate/VBP L-plastin/NEWGENE gene/NEWGENE expression/NN in/IN human/NN and/CC rodent/NN cells/NNS and/CC that/IN they/PRP could/MD be/VB identified/VBN by/IN comparing/VBG the/DT function/NN and/CC nucleotide/NN sequences/NNS of/IN the/DT human/JJ and/CC murine/NN L-plastin/NEWGENE gene/NN promoters/NN ./.
@@76709437869 We/PRP studied/VBD 120/CD male/JJ and/CC 42/CD female/JJ patients/NNS with/IN early/NN CAD/NN who/WP were/VBD unrelated/JJ to/IN each/DT other/DT but/CC were/VBD from/IN families/NNS in/IN which/WDT at/IN least/RB one/PRP other/DT sibling/NN had/VBP early/NN CAD/NN ./.
@@86167438590 On/IN the/DT trail/NN of/IN Dr/NN ./NN
@@4326159512 Such/JJ marked/JJ differences/NNS are/VBP found/VB occasionally/RB in/IN the/DT literature/NN :/: heterophile/NN antibodies/NNS against/IN bovine/NEWGENE gammaglobulin/NEWGENE are/VBP regarded/VBN as/IN responsible/JJ for/IN the/DT interference/NN in/IN the/DT Sephadex/NN system/NN of/IN RIST/NN ./.
@@106832445725 Second/JJ ,/, when/CC the/DT NBF1+R/NEWGENE protein/NEWGENE ,/, the/DT NBF2/NEWGENE protein/NEWGENE ,/, and/CC a/DT mixture/NN of/IN the/DT two/JJ proteins/NNS were/VBD folded/JJ separately/RB and/CC analyzed/VBN by/IN molecular/JJ sieve/NN chomatography/NN ,/, the/DT mixture/NN was/VBD found/VBN to/IN elute/VB prior/NN to/IN either/DT NBF1+R/NEWGENE or/CC NBF2/NEWGENE ./.
@@95350827677 The/DT addition/NN of/IN a/DT Paf-containing/VBG extract/NN does/VBP not/RB lead/VB to/IN significant/JJ protein/NN binding/JJ to/IN these/DT two/JJ hly/NEWGENE target/NEWGENE sequences/NEWGENE in/IN the/DT absence/NN of/IN PrfA/NEWGENE but/CC converts/VBP the/DT complex/NN (/( CIII/NEWGENE )/SYM consisting/VBG of/IN PrfA/NEWGENE and/CC the/DT 109/NEWGENE bp/NEWGENE hly/NEWGENE DNA/NEWGENE fragment/NEWGENE to/IN a/DT slower/RBR migrating/JJ PrfA-Paf-DNA/NEWGENE complex/NEWGENE (/( CI/NEWGENE )/SYM ./.
@@96700349704 We/PRP demonstrate/VBP that/IN Ddc1p/NEWGENE interacts/VBZ physically/RB in/IN vivo/NN with/IN Mec3p/NEWGENE ,/, and/CC this/DT interaction/NN requires/VBZ Rad17p/NEWGENE ./.
@@29586603663 Our/PRP data/NN ,/, however/RB ,/, did/VBD not/RB suggest/VB the/DT existence/NN of/IN a/DT conversion/NN factor/NN for/IN LDF/NN signal/JJ to/IN absolute/JJ flow/NN values/NNS from/IN experiment/NN to/IN experiment/NN ./.
@@57197463608 Children/NNS with/IN defective/NN vision/NN ./.
@@3325081435 Bullous/JJ keratopathy/NN was/VBD usually/RB aphakic/JJ in/IN origin/NN in/IN 1982/CD ,/, but/CC after/IN 1983/CD pseudophakic/JJ bullous/JJ keratopathy/NN (/( PBK/NN )/SYM was/VBD the/DT most/RB common/JJ cause/NN of/IN bullous/JJ keratopathy/NN ./.
@@14763762094 Assay/NNS of/IN urea/NN by/IN immobilized/JJ urease/NEWGENE coupled/VBN to/IN a/DT differential/JJ pH-meter/NN ./.
@@15427303204 Because/IN single-chamber/CD rate-adaptive/JJ atrial/JJ pacing/NN leaves/VBZ the/DT patient/NN exposed/VBN to/IN the/DT risk/NN of/IN future/JJ development/NN of/IN AV/JJ block/NN and/CC DDD/NN pacing/NN does/VBP not/RB provide/VB chronotropic/JJ support/NN ,/, it/PRP is/VBZ likely/RB that/IN the/DT new/JJ rate-adaptive/JJ dual-chamber/JJ (/( DDDR/NN )/SYM devices/NNS will/MD be/VB used/VBN in/IN a/DT significant/JJ number/NN of/IN these/DT patients/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@2510242622 Among/IN 100/CD cases/NNS of/IN post-transfusion/JJ hepatitis/NN ,/, 10/CD are/VBP due/NN to/IN the/DT hepatitis/NN B/NN virus/NN (/( despite/IN systematic/JJ search/NN for/IN HBs/NEWGENE Ag/NEWGENE )/SYM ,/, 89/CD are/VBP due/NN to/IN one/PRP of/IN the/DT non-A/JJ non-B/NN viruses/NNS (/( not/RB detectable/JJ by/IN specific/JJ serological/JJ tests/NNS )/SYM and/CC 1/CD to/IN several/DT viruses/NNS ,/, specially/RB CMV/NN ./.
@@77371183688 The/DT MPS1/NEWGENE open/NEWGENE reading/NEWGENE frame/NEWGENE has/VBZ been/VBN fused/VBN to/IN those/DT that/WDT encode/VBP the/PDT LexA/NEWGENE protein/NEWGENE or/CC the/DT GST/NEWGENE protein/NEWGENE and/CC both/DT of/IN these/DT constructs/NNS function/NN in/IN yeast/NN ./.
@@83494992660 Sex/NN of/IN calf/NN (/( variate/NN 2/NN )/SYM was/VBD associated/VBN most/RB closely/RB with/IN width/NN of/IN muzzle/NN and/CC head/JJ ./.
@@35523634219 Postglucose/NN serum/NEWGENE insulin/NEWGENE levels/NNS showed/VBD no/DT significant/JJ correlations/NNS with/IN systolic/JJ or/CC diastolic/JJ blood/NN pressure/NN levels/NNS in/IN men/NNS ,/, but/CC in/IN female/JJ diabetic/NN and/CC non-diabetic/NN subjects/VBZ significant/JJ correlations/NNS were/VBD found/VBN in/IN particular/JJ with/IN systolic/JJ blood/NN pressure/NN level/NN ./.
@@27456664843 Endometrial/JJ biopsies/NNS and/CC plasma/NN oestradiol/NN (/( E2/NN )/SYM and/CC progesterone/NN (/( P4/NN )/SYM levels/NNS in/IN 23/CD patients/NNS were/VBD evaluated/VBN during/IN 26/CD replacement/NN therapy/NN cycles/NNS for/IN premature/JJ ovarian/JJ failure/NN ./.
@@28991773605 We/PRP propose/VBP that/IN the/DT technique/NN of/IN low-frequency/JJ kindling/NN is/VBZ a/DT useful/JJ experimental/JJ model/NN in/IN assessing/JJ the/DT effects/NNS of/IN antipsychotic/JJ or/CC antiepileptic/JJ drugs/NNS on/IN the/DT excitability/NN of/IN the/DT limbic/JJ regions/NNS ./.
@@63215054996 A/DT promoter/NN sequence/NN (/( Goldberg-Hogness/NNP or/CC TATA/NN box/NN )/SYM is/VBZ situated/VBN 28/CD base/NN pairs/NNS upstream/RB from/IN the/DT point/NN of/IN initiation/NN of/IN transcription/NN which/WDT was/VBD found/VBN by/IN S1/NEWGENE nuclease/NEWGENE mapping/NN and/CC by/IN oligonucleotide-primed/JJ reverse/JJ transcription/NN of/IN rat/NEWGENE PTH/NEWGENE mRNA/NEWGENE ./.
@@93533434370 RNA/NEWGENE polymerase/NEWGENE II/NEWGENE inhibition/NN increased/VBD the/DT binding/NN of/IN ARE/VBP (/( AUBP/NN activity/NN )/SYM and/CC poly/NN (/NN U/NN )/NN -Sepharose/NN by/IN cytoplasmic/NEWGENE hnRNP/NEWGENE A1/NEWGENE ,/, while/CC nuclear/NEWGENE hnRNP/NEWGENE A1/NEWGENE binding/NN was/VBD unaffected/JJ ./.
@@40135764675 The/DT present/NN investigation/NN has/VBZ revealed/VBN that/IN the/DT distribution/NN of/IN the/DT main/JJ fatty/JJ acids/NNS in/IN Leptospira/NN phospholipids/NNS is/VBZ similar/JJ to/IN their/PRP distribution/NN in/IN Leptospira/JJ neutral/JJ lipids/NNS with/IN the/DT exception/NN of/IN unsaturated/JJ fatty/JJ acid/NN with/IN 14/CD carbon/NN atoms/NNS ,/, occurring/VBG mainly/RB in/IN phospholipids/NNS ./.
@@22705872915 The/DT endodontal/JJ treatment/NN need/NN has/VBZ been/VBN forming/JJ a/DT clinical/JJ order/NN of/IN magnitude/NN ./.
@@89703525023 These/DT data/NN do/NN not/RB support/VB the/DT use/NN of/IN LDD/DT to/IN reduce/VB risk/NN of/IN progression/NN to/IN MSOF/NN in/IN sepsis/NN ./.
@@109283374914 Partial/JJ correction/NN of/IN anemia/NN with/IN recombinant/NEWGENE human/NEWGENE erythropoietin/NEWGENE likely/RB reduces/VBZ left/NN ventricular/JJ mass/NN and/CC volume/NN ./.
@@54134285535 The/DT distribution/NN of/IN body/NN fluids/NNS following/IN hemorrhage/NN and/CC resuscitation/NN in/IN combat/NN casualties/NNS ./.
@@10224293742 Receptor/NEWGENE protein/NEWGENE tyrosine/NEWGENE phosphatases/NEWGENE (/( RPTPs/NEWGENE )/SYM comprise/VB a/DT family/NN of/IN proteins/VBZ that/DT feature/JJ intracellular/JJ phosphatase/NEWGENE domains/NN and/CC an/DT ectodomain/NN with/IN putative/JJ ligand-binding/NN motifs/NN ./.
@@100872134962 Analysis/NNP of/IN the/DT protein/NN sequences/NNS of/IN these/DT two/JJ replicases/NEWGENE ,/, together/RB with/IN previously/RB characterized/VBN H/NNP ./NNP pylori/NNS plasmid/NN replication/NN proteins/NNS ,/, supports/VBP the/DT formation/NN of/IN a/DT distinct/JJ class/NN of/IN H/NNP ./NNP pylori/NNS plasmid/NN proteins/NNS ./.
@@21224544337 Hence/RB ,/, the/DT replacement/NN of/IN Phe-62/NN with/IN Ser/NN specifically/RB affects/VBP a/DT determinant/NN on/IN the/DT lambda/NEWGENE I/NEWGENE light/NEWGENE chain/NEWGENE that/WDT is/VBZ necessary/JJ for/IN the/DT intracellular/JJ transport/NN of/IN this/DT molecule/NN ./.
@@83673889859 Cerebro-oculo-facioskeletal/JJ syndrome/NN (/( Pena-Shokeir/NNP syndrome/NN II/NN )/SYM ./.
@@65883066345 The/DT rational/JJ for/IN the/DT prophylactic/JJ treatment/NN ,/, the/DT therapy/NN of/IN the/DT meningopathy/NN and/CC AIL-/NNP AIEOP/NNP protocols/NNS are/VBP exposed/VBN ./.
@@98379455469 Immunolocalization/NNS of/IN Sop1p/NEWGENE revealed/VBN a/DT cytoplasmic/JJ distribution/NN and/CC cell/NN fractionation/NN studies/NNS showed/VBN that/IN a/DT significant/JJ fraction/NN of/IN Sop1p/NEWGENE was/VBD recovered/VBN in/IN a/DT sedimentable/JJ fraction/NN of/IN the/DT cytosolic/JJ material/NN ./.
@@94189056271 These/DT results/NNS indicate/VBP that/IN in/IN addition/NN to/IN Grb2-mediated/JJ activation/NN of/IN Ras/NEWGENE ,/, PLC-gamma1-mediated/JJ DAG/NN production/NN is/VBZ required/VBN for/IN EGF-/NNP and/CC PDGF-induced/NN S-phase/NN entry/NN and/CC gene/NN expression/NN ,/, possibly/RB through/JJ activation/NN of/IN PKC/NEWGENE ./.
@@22547495729 For/IN this/DT ,/, cDNAs/NNS containing/JJ the/DT 60K/NN ,/, 87K/NN ,/, 110K/NN and/CC 170K/NN protein/NN coding/JJ sequences/NNS were/VBD each/DT provided/VBN with/IN an/DT ATG/NN start/NN codon/NN and/CC the/DT cDNA/NN containing/JJ the/DT 60K/NN coding/JJ sequence/NN with/IN a/DT TAA/NN stop/NN codon/NN immediately/RB downstream/RB of/IN the/DT coding/JJ sequence/NN ./.
@@91608819028 As/IN opposed/VBN to/IN in/IN vitro/FW co-precipitation/JJ studies/NNS ,/, the/DT yeast/NN two-hybrid/JJ screen/NN reveals/VBZ in/IN vivo/NN protein-protein/NN interactions/NNS ./.
@@89933933330 Differential/JJ signaling/JJ and/CC immediate-early/NN gene/NN activation/NN by/IN four/CD splice/NN variants/NNS of/IN the/DT human/NEWGENE pituitary/NEWGENE adenylate/NEWGENE cyclase-activating/NEWGENE polypeptide/NEWGENE receptor/NEWGENE (/( hPACAP-R/NEWGENE )/SYM ./.
@@108932436255 Transcriptional/JJ regulation/NN of/IN the/DT mouse/NEWGENE cytosolic/NEWGENE chaperonin/NEWGENE subunit/NEWGENE gene/NEWGENE Ccta/NEWGENE1 //NEWGENE1 t-complex/NEWGENE1 polypeptide/NEWGENE1 1/NEWGENE1 by/IN selenocysteine/NEWGENE tRNA/NEWGENE gene/NEWGENE transcription/NEWGENE activating/NEWGENE factor/NEWGENE family/NEWGENE zinc/NEWGENE finger/NEWGENE proteins/NEWGENE ./.
@@113923061252 Online/NNP teaching/JJ :/: design/NN and/CC techniques/NNS ./.
@@111110517710 It/PRP was/VBD subsequently/RB shown/VBP that/IN Tip60/NEWGENE had/VBP histone/NEWGENE acetyltransferase/NEWGENE (/( HAT/NEWGENE )/SYM activity/NN ./.
@@107217148554 Electrophoretic/JJ mobility/NN shift/NN assays/NNS revealed/VBN that/IN Sp1/NEWGENE binds/VBZ to/IN two/JJ different/JJ regions/NNS in/IN the/DT proximal/JJ promoter/NN ,/, a/DT typical/JJ Sp1/NEWGENE site/NEWGENE located/VBN at/IN (/( -38/CD ;/: -33/CD )/SYM and/CC a/DT G/NN //NN C-rich/NN region/NN between/IN (/( -67/CD ;/: -62/CD )/SYM ./.
@@23748863030 The/DT Community/NNP Adjustment/NNP Scale/NNP provided/VBD outcome/NN data/NN related/VBN to/IN the/DT subjects'/JJ degree/NN of/IN productivity/NN ,/, ability/NN to/IN maintain/VB close/JJ relationships/NNS ,/, and/CC presence/NN //NN absence/NN of/IN symptomatology/NN an/DT average/NN of/IN 32/CD years/NNS after/IN initial/JJ admission/NN ./.
@@92424999202 Volunteers/NNPS were/VBD irradiated/JJ on/IN their/PRP backs/NNS with/IN suberythemal/JJ UV/NN daily/JJ for/IN 5/CD d/NN after/IN application/NN of/IN the/DT sunscreens/NNS and/CC their/PRP base/NN lotion/NN to/IN different/JJ sites/NNS ./.
@@69484936721 Range/NN ,/, variations/NNS and/CC neoplastic/JJ potential/NN ./.
@@89581378916 Lipid/NN hydroperoxide/NN levels/NNS in/IN plasma/NN and/CC LDL/NEWGENE remained/VBD unchanged/JJ throughout/IN the/DT study/NN ./.
@@117229933319 Paul/NNP Monagle/NN addresses/VBP the/DT epidemiology/NN of/IN neonatal/JJ thrombosis/NN outside/RB of/IN the/DT central/JJ nervous/JJ system/NN in/IN both/DT arterial/JJ and/CC venous/JJ locations/NNS ,/, and/CC those/DT that/WDT occur/VBP in/IN utero/NN ./.
@@118904381786 Patients/NNS subsequently/RB returned/VBN to/IN the/DT clinic/NN every/DT 3/CD days/NNS to/IN have/NN the/DT wounds/NNS checked/VBN and/CC dressings/NNS changed/VBN ./.
@@93881996316 In/NN an/DT effort/NN to/IN separate/JJ domains/NNS of/IN FadR/NEWGENE required/VBN for/IN DNA/NN binding/JJ ,/, dimerization/NN ,/, and/CC ligand/NN binding/JJ ,/, chimeric/JJ protein/NN fusions/NNS between/IN the/DT DNA/NN binding/JJ domain/NN of/IN LexA/NEWGENE and/CC different/JJ regions/NNS of/IN FadR/NEWGENE were/VBD constructed/VBN ./.
@@108218369182 These/DT natural/JJ antisense/NN S/NEWGENE transcripts/NEWGENE co-exist/NN with/IN several/DT less/PRP abundant/JJ sense/NN S/NEWGENE transcripts/NEWGENE ./.
@@99353779933 Genoa/NNP ,/, Italy/NN ,/, 24-28/CD August/NN 1997/CD ./.
@@86268091311 Significantly/RB ,/, pPKR/NEWGENE is/VBZ capable/JJ of/IN specifically/RB phosphorylating/JJ Ser51/NN in/IN a/DT synthetic/NEWGENE eIF-2alpha/NEWGENE peptide/NEWGENE ,/, a/DT key/NN characteristic/NN of/IN the/DT eIF-2alpha/NEWGENE kinase/NEWGENE family/NEWGENE ./.
@@117287711574 They/PRP have/VBP not/RB been/VBN previously/RB reported/VBN as/IN a/DT reaction/NN to/IN i/CD ./CD v/CD ./. contrast/NN material/NN ./.
@@76490989866 Our/PRP evidence/NN derives/VBZ from/IN three/CD principal/JJ observations/NNS :/: 1/NN )/NN a/DT transfection/NN construct/NN containing/JJ only/RB 122/CD nucleotides/NNS (/( nt/NN )/SYM of/IN promoter/NN 1/CD and/CC 328/CD nt/NN of/IN the/DT 5'-UTR/CD retained/VBN full/JJ PGE2-stimulated/JJ reporter/NN expression/NN ;/: 2/NN )/NN maximal/JJ PGE2-driven/NNP reporter/NN expression/NN required/VBD the/DT presence/NN of/IN nt/NN 196/CD to/IN 328/CD of/IN exon/NN 1/CD when/CC tested/VBN within/IN the/DT context/NN of/IN IGF-I/NEWGENE promoter/NEWGENE 1/NEWGENE ;/: 3/NN )/NN cotransfection/NN of/IN IGF-I/NEWGENE promoter-luciferase-reporter/NEWGENE constructs/NN with/IN a/DT plasmid/NN encoding/VBG the/DT alpha-isoform/NN of/IN the/DT catalytic/JJ subunit/NN of/IN murine/NEWGENE cAMP-dependent/NEWGENE protein/NEWGENE kinase/NEWGENE (/( PKA/NEWGENE )/SYM produced/VBN results/NNS comparable/JJ to/IN those/DT seen/VBP with/IN PGE2/NN treatment/NN ,/, whereas/IN cotransfection/NN with/IN a/DT plasmid/NN encoding/VBG a/DT mutant/JJ regulatory/JJ subunit/NN of/IN PKA/NEWGENE that/WDT cannot/MD bind/VB cAMP/NN blocked/VBD PGE2-induced/JJ reporter/NN expression/NN ./.
@@99380979934 Bound-exciton/NNP transfer/NN and/CC photoluminescence/NN undulation/NN spectra/NNS for/IN acceptors/NNS in/IN ZnTe/NNP ./.
@@93171315187 The/DT available/JJ data/NN suggest/VB that/IN the/DT NF/NEWGENE kappa/NEWGENE B2/NEWGENE nucleoprotein/NEWGENE complex/NEWGENE may/MD cooperate/VB with/IN DNA-bound/NN STAT6/NEWGENE to/IN achieve/VB IL-4-dependent/NNP activation/NN of/IN the/DT human/NEWGENE IgE/NEWGENE germline/NEWGENE gene/NEWGENE ./.
@@92388609592 These/DT cells/NNS fail/NN to/IN generate/VB the/DT signals/NNS to/IN phosphorylate/VB CREB/NEWGENE and/CC produce/VB significantly/RB less/PRP of/IN the/DT cytokine/NN Interleukin-2/NEWGENE (/( IL-2/NEWGENE )/SYM in/IN response/NN to/IN agents/NNS that/WDT either/DT increase/NN intracellular/JJ Ca2+/NN and/WDT //WDT or/WDT activate/VBP protein/NEWGENE kinase/NEWGENE C/NEWGENE ./.
@@79590151583 Our/PRP results/NNS show/VBP that/IN the/DT ORF/NN of/IN hAMPK/NEWGENE encodes/VBZ 552/CD amino/JJ acids/NNS (/( aa/NNS )/SYM (/( 62/CD ./CD 250/CD kDa/NN )/SYM and/CC is/VBZ highly/RB conserved/VBN with/IN rAMPK/NEWGENE with/IN identities/NNS of/IN 97/CD ./CD 3/CD and/CC 90%/CD at/IN the/DT aa/NNS and/CC nt/JJ levels/NNS ,/, respectively/RB ./.
@@14461322062 One/CD air/NN embolism/NN occurred/VBN ;/: this/DT was/VBD the/DT only/RB filter-/JJ or/CC retrieval-related/JJ complication/NN ./.
@@86768584484 Here/RB ,/, the/DT cloning/NN and/CC characterization/NN of/IN S-RNase/NEWGENE genes/NEWGENE from/IN two/JJ species/NN of/IN Rosaceae/NNP ,/, apple/NN (/( Malus/NNP x/NN domestica/NN )/SYM and/CC Japanese/JJ pear/NN (/( Pyrus/NNP serotina/NN )/SYM is/VBZ described/VBN and/CC these/DT sequences/NNS are/VBP compared/VBN with/IN those/DT of/IN other/DT T2-type/NEWGENE RNases/NEWGENE ./.
@@66585866412 Angionephroscintigraphy/NNP in/IN the/DT diagnosis/NN of/IN diseases/NNS of/IN the/DT kidney/NN ./.
@@12728168592 The/DT study/NN of/IN calcium/NN metabolism/NN in/IN ten/CD thalassaemic/JJ children/NNS comperatively/RB with/IN controls/NNS after/IN oral/JJ administration/NN of/IN 47Ca/NN has/VBZ shown/VBP diminished/VBN intestinal/JJ absorption/NN ./.
@@92590526308 Supershift/NNP assays/NNS ,/, using/VBG Jun/NEWGENE and/CC Fos/NEWGENE family/NEWGENE member-specific/NEWGENE antibodies/NEWGENE ,/, showed/VBD that/IN protein/NN complexes/NNS formed/VBN by/IN AtT-20/NNP cell/NN nuclear/JJ extracts/NNS bound/JJ to/IN the/DT c-jun/NEWGENE AP-1/NEWGENE1 site/NEWGENE1 were/VBD comprised/VBN of/IN Jun/NEWGENE family/NN members/NN ,/, JunD/NEWGENE ,/, JunB/NEWGENE ,/, and/CC cJun/NEWGENE ./.
@@85958368572 Curing/VBG shrinkage/NN and/CC volumetric/JJ changes/NNS of/IN resin-modified/JJ glass/NN ionomer/NN restorative/JJ materials/NNS ./.
@@106112429450 Consistent/JJ with/IN this/DT finding/NN ,/, wild-type/NEWGENE SAGA/NEWGENE inhibits/VBZ TBP/NEWGENE binding/JJ to/IN the/DT HIS3/NEWGENE promoter/NEWGENE in/IN vitro/FW ,/, while/CC SAGA/NEWGENE lacking/JJ Spt3/NEWGENE or/CC Spt8/NEWGENE is/VBZ not/RB inhibitory/JJ ./.
@@64936553076 Variable/NN FHR/NN decelerations/NNS or/CC bradycardias/NNS were/VBD encountered/VBN on/IN 95/CD nonstress/JJ tests/NNS (/( 18/CD ./CD 8%/CD )/SYM in/IN 80/CD (/( 33/NN ./NN 5%/NN )/SYM postdate/VB patients/NNS ./.
@@105024341708 Twelve/CD patients/NNS had/VBP stage/NN IBG3/NN ,/, 14/CD had/VBP ICG1/NN ,/, 9/CD had/VBP ICG2/NN ,/, and/CC 3/CD had/VBP ICG3/NN disease/NN ./.
@@24055893071 Information/NNP about/RB immunologic/JJ drug/NN interactions/NNS is/VBZ needed/VBN by/IN pharmacists/NNS to/IN make/NN rational/JJ drug-use/JJ decisions/NNS ./.
@@17511635968 The/DT authors/NNS evaluated/VBD the/DT potential/NN for/IN thrombotic/JJ complications/NNS arising/VBG from/IN implantation/NN of/IN a/DT ventricular/JJ assist/NN device/NN (/( Sarns/NN //NN 3M-VAD/NN )/SYM in/IN four/CD calves/NNS ./.
@@12474751887 A/DT late/JJ diagnosis/NN of/IN retinoblastoma/NN is/VBZ an/DT unquestionable/JJ fact/NN that/WDT allows/VBZ its/PRP growth/NN and/CC leads/VBP to/IN a/DT deterioration/NN in/IN the/DT outlook/NN ./.
@@114638344497 Through/IN deletion/NN mutagenesis/NN ,/, we/PRP identify/VBP amino/JJ acids/NNS 2003/CD to/IN 2212/CD of/IN CBP/NEWGENE ,/, which/WDT we/PRP call/VBP carboxy-terminal/JJ region/NN 2/CD (/( CR2/NN )/SYM ,/, as/IN the/DT minimal/JJ region/NN for/IN Tax/NEWGENE interaction/NN ./.
@@26664041150 The/DT galactose/NEWGENE transporter/NEWGENE shows/VBZ both/DT sequence/NN and/CC structural/JJ homology/NN with/IN a/DT superfamily/NN of/IN sugar/NEWGENE transporters/NEWGENE which/WDT includes/VBZ the/DT human/NEWGENE HepG2-erythrocyte/NEWGENE and/NEWGENE fetal/NEWGENE muscle/NEWGENE glucose/NEWGENE transporters/NEWGENE ,/, the/DT rat/NEWGENE brain/NEWGENE and/NEWGENE liver/NEWGENE glucose/NEWGENE transporters/NEWGENE ,/, the/DT Escherichia/NEWGENE coli/NEWGENE xylose/NEWGENE and/NEWGENE arabinose/NEWGENE permeases/NEWGENE ,/, and/CC the/DT S/NEWGENE ./NEWGENE cerevisiae/NEWGENE glucose/NEWGENE ,/NEWGENE maltose/NEWGENE ,/NEWGENE and/NEWGENE galactose/NEWGENE transporters/NEWGENE ./.
@@66347126372 Our/PRP results/NNS demonstrate/VBP the/DT importance/NN of/IN phosphate/NN and/CC calcium/NN in/IN influencing/VBG the/DT secretion/NN of/IN PTH/NEWGENE and/CC CT/NEWGENE in/IN uremia/NN ./.
@@109540932932 A/DT degenerate/JJ DNA/NN transposon/NN ,/, Pat/NEWGENE ,/, was/VBD identified/VBN in/IN the/DT genomes/NNS of/IN various/JJ wild-type/NN strains/NNS of/IN the/DT filamentous/JJ fungus/NN Podospora/JJ anserina/NN ./.
@@79757638483 The/DT importance/NN of/IN hepatitis/NN C/NN virus/NN (/( HCV/NN )/SYM infection/NN as/IN a/DT cause/NN of/IN chronic/JJ liver/NN disease/NN has/VBZ become/VBN clear/JJ with/IN the/DT introduction/NN of/IN serologic/JJ detection/NN methods/NNS ./.
@@60702045890 XXI/NNS ./.
@@108250004988 The/DT gene/NN amplification/NN model/NN of/IN Coquelle/NNP et/FW al/NNS ./NNS
@@110239342024 1111/NN )/NN ;/: L/CD //CD H/CD >/CD 0/CD ./CD 61/CD (/( chi/NN (/NN 2/NN )/NN =/NN 10/NN ./NN 8/NN ;/: P/NN :/: </SYM 0/NN ./NN 1111/NN )/NN and/CC a/DT restrictive/JJ filling/JJ pattern/NN (/( chi/NN (/NN 2/NN )/NN =/NN 3/NN ./NN 6/NN ;/: P/NN :/: </SYM 0/NN ./NN 09/NN )/NN were/VBD independent/NN predictors/NN of/IN events/NNS ./.
@@111380098650 In/NN addition/NN ,/, we/PRP identified/VBD two/JJ mutations/NNS ,/, Delta/NN M1281/NN and/CC IVS51+5G--/NN >/NN A/NN ,/, in/IN a/DT German/NN USH1/NEWGENE patient/NN ./.
@@98047795767 We/PRP propose/VBP that/IN two/JJ pathways/NNS regulate/VBP Stat5/NEWGENE serine/NN phosphorylation/NN ,/, one/PRP that/WDT is/VBZ prolactin-activated/JJ and/CC PD98059-resistant/CD and/CC one/PRP that/WDT is/VBZ constitutively/RB active/JJ and/CC PD98059-sensitive/CD and/CC preferentially/RB targets/VBZ Stat5a/NEWGENE ./.
@@73758643857 The/DT authors/NNS conclude/VBP that/DT nonspecificity/NN of/IN low/JJ platelet/NEWGENE MAO/NEWGENE as/IN a/DT possible/JJ correlate/NN of/IN bipolar/JJ affective/JJ disorder/NN ,/, as/RB well/VB as/IN schizophrenia/NN ,/, increases/VBZ the/DT burden/NN of/IN proof/NN necessary/JJ before/IN findings/NNS of/IN low/JJ platelet/NEWGENE MAO/NEWGENE can/MD be/VB accepted/VBN as/IN primary/NN ./.
@@31254206218 Biol/NNP ./.
@@64017492372 The/DT effect/NN of/IN lithium/NN on/IN the/DT osmoregulation/NN of/IN arginine/NEWGENE vasopressin/NEWGENE secretion/NN ./.
@@11319461168 Effect/NN of/IN ingestion/NN of/IN Norbiogest/NNP during/IN the/DT quiescent/JJ period/NN of/IN the/DT genital/JJ organs/NNS ./.
@@18331854362 The/DT Thr161Val/NN mutation/NN causes/VBZ a/DT lethal/JJ phenotype/NN in/IN the/DT fission/NN yeast/NN Schizosaccharomyces/NN pombe/NN ,/, while/CC replacement/NN of/IN Thr161/NN with/IN glutamic/JJ acid/NN ,/, potentially/RB mimicking/VBG phosphorylation/NN ,/, causes/NNS uncoordination/NN of/IN mitosis/NN and/CC multiple/JJ cytokinesis/NN ./.
@@31119463829 No/DT effect/NN was/VBD found/VBN on/IN grooming/NN behavior/NN ./.
@@34463324153 Nitrofurazone/NNP significantly/RB reduced/VBD the/DT rise/NN in/IN LH/NEWGENE induced/VBN by/IN LHRH/NEWGENE ./.
@@25067403154 Fourth/NNP ,/, sometime/RB between/IN 4/CD and/CC 24/CD hours/NNS of/IN recovery/NN is/VBZ necessary/JJ to/IN reverse/NN the/DT effect/NN of/IN chronic/JJ hypoxia/NN on/IN cerebral/JJ blood/NN flow/NN ./.
@@103802323929 OBJECTIVE/IN :/: To/TO perform/VB a/DT cost-effectiveness/NN analysis/NN (/( CEA/NN )/SYM between/IN a/DT standard/JJ antiemetic/JJ regimen-chlorpromazine/JJ +/SYM dexamethasone/NN (/( CPM-DEX/NNP )/JJ -/JJ and/CC a/DT 5-HT3/NEWGENE receptor/NEWGENE antagonist-tropisetron/JJ (/( TROP/NN )/NN --in/NN the/DT control/NN of/IN acute/JJ emesis/NN induced/VBN by/IN highly/RB emetogenic/JJ chemotherapy/NN in/IN children/NNS ,/, considering/VBG two/JJ analytic/JJ perspectives/NNS :/: hospital/NN and/CC patients/NNS ./.
@@12414377617 The/DT patients/NNS were/VBD divided/VBN into/IN 4/CD groups/NNS receiving/JJ NLA/NN II/NN with/IN or/CC without/IN nalorphine/NN ,/, morphine/NN or/CC Micoren/NNP ./.
@@89679631548 The/DT promoter/NN segment/NN was/VBD inactive/JJ when/CC introduced/VBN into/IN the/DT rat/NN glioma/NN cell/NN line/NN C6B4/CELL ,/, the/DT rat/NN submandibular/JJ cell/NN line/NN RSMT-A5/CELL ,/, and/CC the/DT rat/NN pancreatic/JJ beta/NN cell/NN line/NN RIN-5AH/NNP ,/, all/DT of/IN which/WDT do/VBP not/RB express/VB the/DT endogenous/JJ alpha2c-AR/NEWGENE gene/NEWGENE ./.
@@84572055073 Internal/NNP amino/JJ acid/NN sequence/NN has/VBZ now/RB been/VBN obtained/VBN from/IN this/DT protein/NN which/WDT shares/VBP 50-100%/JJ sequence/NN identity/NN with/IN sequences/NNS encoded/VBN by/IN mammalian/NEWGENE G/NEWGENE alpha/NEWGENE 11/NEWGENE and/CC G/NEWGENE alpha/NEWGENE q/NEWGENE cDNAs/NEWGENE ./.
@@19709842591 Following/VBG treatment/NN ,/, serum/JJ estradiol/NN levels/NNS were/VBD higher/JJ in/IN groups/NNS E/NN +/SYM T/NN and/CC E/NN than/IN in/IN group/NN C/NNP ./NNP
@@10674484491 These/DT data/NN suggest/VB that/IN combined/JJ lesions/NNS of/IN cholinergic/JJ and/CC serotonergic/JJ neurons/NNS in/IN the/DT rat/NN brain/NN do/NN not/RB alter/VB olfactory/JJ perception/NN or/CC olfactory/JJ short-term/JJ memory/NN ./.
@@21439612749 Both/DT antidepressants/NNS elevated/VBD the/DT pain/NN threshold/NN acutely/RB ,/, while/CC pretreatment/JJ with/IN pCPA/NN largely/RB blocked/VBD the/DT analgesia/NN ./.
@@91399108701 Sequence/NN analysis/NN of/IN cloned/VBN PCR/NN products/NNS confirmed/VBD the/DT presence/NN of/IN two/JJ different/JJ nifV-like/NEWGENE DNA/NEWGENE fragments/NEWGENE ,/, which/WDT were/VBD subsequently/RB used/VBN as/IN nifV-/JJ and/CC leuA-specific/NEWGENE probes/NEWGENE ,/, respectively/RB ,/, to/IN clone/NN XbaI/NEWGENE fragments/NEWGENE of/IN 2/CD ./CD 1/CD kbp/NN (/( pOST4/NN )/SYM and/CC 2/CD ./CD 6/CD kbp/NN (/( pOST2/NN )/SYM ./.
@@104389249088 The/DT B/NEWGENE cell/NEWGENE antigen/NEWGENE receptor/NEWGENE activates/VBZ the/DT Akt/NEWGENE (/( protein/NEWGENE kinase/NEWGENE B/NEWGENE )/NN //NEWGENE glycogen/NEWGENE synthase/NEWGENE kinase-3/NEWGENE signaling/JJ pathway/NN via/NN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE ./.
@@97702419759 A/DT technique/NN for/IN thermal/JJ imaging/NN of/IN the/DT animal/NN and/CC human/JJ brain/NN cortex/NN using/VBG an/DT infrared/JJ optical/JJ system/NN is/VBZ described/VBN ./.
@@100745208897 Identification/NNP and/CC characterization/NN of/IN IS2404/NEWGENE and/CC IS2606/NEWGENE :/: two/JJ distinct/JJ repeated/JJ sequences/NNS for/IN detection/NN of/IN Mycobacterium/NN ulcerans/VBZ by/IN PCR/NN ./.
@@8648726170 Cloning/NN of/IN individual/JJ ZI/NEWGENE domains/NEWGENE upstream/RB of/IN a/DT minimal/JJ promoter/NN demonstrated/VBN that/IN the/DT ZIA/NEWGENE ,/, ZIC/NEWGENE ,/, and/CC ZID/NEWGENE domains/NN ,/, but/CC not/RB the/DT ZIB/NEWGENE domain/NN ,/, are/VBP TPA/NEWGENE responsive/JJ ./.
@@20600522666 These/DT data/NN suggest/VB that/IN the/DT levels/NNS of/IN oxygen/NN free/JJ radicals/NNS were/VBD increased/VBN in/IN hepatocytes/NNS and/CC mitochondria/NNS ./.
@@80781672549 OBJECTIVE--To/NNP assess/VB the/DT risk/NN of/IN hepatitis/NN A/NN in/NN international/JJ travelers/NNS and/CC to/IN recommend/VB preventive/JJ measures/NNS ./.
@@114699261348 Breast/NN cancer/NN risk/NN assessment/NN :/: who/WP holds/VBP the/DT magic/JJ crystal/NN ball/NN ?/.
@@111671111010 Significantly/RB higher/JJ lung/NN function/NN parameters/NNS were/VBD obtained/VBN in/IN extubated/VBN recipients/NNS of/IN LPD/NN preserved/VBD grafts/NNS 2/CD weeks/NNS after/IN TX/NNP ./NNP
@@105644722172 These/DT mutants/NNS all/DT failed/VBN to/IN interact/VB with/IN the/DT TraR/NEWGENE fusion/NEWGENE in/IN the/DT two-hybrid/JJ system/NN ./.
@@105942392515 Tih1/NEWGENE maps/NNS to/IN distal/JJ mouse/NN Chr/NN 1/CD and/CC human/JJ Chr/NN 1q31/CD ,/, chromosomal/JJ regions/NNS that/WDT have/VBP not/RB shown/VBP evidence/NN for/IN imprinting/NN and/CC ,/, in/IN contrast/NN to/IN Ipl/NEWGENE ,/, Tih1/NEWGENE is/VBZ expressed/VBN equally/RB from/IN both/DT parental/JJ alleles/NNS ./.
@@25733039247 The/DT decrease/NN in/IN left/NN ventricular/JJ (/( LV/JJ )/SYM stroke/NN volume/NN during/IN positive/JJ end-expiratory/JJ pressure/NN (/( PEEP/NN )/SYM has/VBZ been/VBN attributed/VBN to/IN reduced/VBN LV/NN filling/JJ and/CC a/DT decreased/VBN contractile/JJ state/NN ./.
@@77404877687 To/TO establish/VB a/DT possible/JJ association/NN between/IN familial/JJ dysfibrinogenemia/NN and/CC thrombophilia/NN ,/, data/NN on/IN cases/NNS with/IN both/DT affections/NNS were/VBD collected/VBN in/IN a/DT study/NN within/IN the/DT framework/NN of/IN the/DT SSC/NN Subcommittee/NNP on/IN Fibrinogen/NEWGENE of/IN the/DT International/NNP Society/NNP on/IN Thrombosis/NNS and/CC Haemostasis/NNS ./.
@@12814722249 Rabbit/NEWGENE skeletal/NEWGENE muscle/NEWGENE glycogenin/NEWGENE ./.
@@94847819288 Furthermore/RB ,/, direct/JJ association/NN with/IN D3/NN phosphatidylinositides/NNS seems/VBZ to/IN be/VB essential/JJ for/IN activation/NN of/IN PKB/NEWGENE //NEWGENE Akt/NEWGENE ./.
@@87986109999 PIP2/NEWGENE ,/, when/CC incorporated/VBD into/IN phosphatidylcholine/NN carrier/NN vesicles/NNS ,/, binds/VBZ tightly/RB to/IN the/DT guanine/NN nucleotide-depleted/JJ form/NN of/IN Cdc42Hs/NEWGENE and/CC weakly/RB to/IN the/DT GDP-bound/NNP form/NN of/IN the/DT GTP-binding/NEWGENE protein/NEWGENE but/CC does/VBP not/RB bind/VB to/IN GTP-bound/NNP Cdc42Hs/NEWGENE ,/, similar/JJ to/IN what/WP was/VBD observed/VBN for/IN the/DT Dbl/NEWGENE oncoprotein/NEWGENE ./.
@@28902003596 Somatostatin-producing/JJ endocrine/JJ pancreatic/JJ tumor/NN in/IN Recklinghausen's/NNP neurofibromatosis/NN ./.
@@88245855885 We/PRP have/VBP cloned/VBN a/DT novel/JJ protein/NEWGENE kinase/NEWGENE ,/, termed/JJ hematopoietic/NEWGENE progenitor/NEWGENE kinase/NEWGENE 1/NEWGENE (/( HPK1/NEWGENE )/SYM ,/, that/WDT is/VBZ expressed/VBN predominantly/RB in/IN hematopoietic/JJ cells/NNS ,/, including/JJ early/JJ progenitor/NN cells/NNS ./.
@@110142153041 By/IN progressive/JJ 5'-deletion/CD studies/NNS ,/, we/PRP have/VBP identified/VBN a/DT 248-bp/JJ DNA/NN fragment/NN (/( -1018/JJ to/IN -771/CD ,/, relative/JJ to/IN the/DT translation/NN start/NN site/NN )/SYM at/IN the/DT 5'-flanking/JJ region/NN of/IN the/DT human/NEWGENE GnRHR/NEWGENE gene/NEWGENE that/WDT is/VBZ responsible/JJ for/IN the/DT GnRHa-mediated/JJ down-regulation/NN of/IN human/NEWGENE GnRHR/NEWGENE promoter/NEWGENE activity/NN ./.
@@50497116436 Working/NNP session/NN report/NN :/: in/IN vivo-in/NN vitro/NN screening/JJ ./.
@@113172561159 Nearly/RB all/DT isolates/NNS of/IN S/NNP ./NNP intermedius/JJ and/CC most/JJ isolates/NNS of/IN S/NNP ./NNP constellatus/NN ,/, but/CC only/RB 19%/CD of/IN those/DT of/IN S/NNP ./NNP anginosus/NN ,/, were/VBD associated/VBN with/IN abscess/NN ./.
@@108365425398 Up/IN to/IN 95%/NN of/IN the/DT total/JJ UV/NN exposure/NN received/VBN is/VBZ in/IN the/DT UV-A/NN waveband/NN (/( 320-400/JJ nm/NN )/SYM ./.
@@118903547587 Genetics/NNP Institute/NNP has/VBZ developed/VBN and/CC launched/VBN oprelvekin/NEWGENE (/( rhIL-11/NEWGENE ;/: Neumega/NN )/SYM ,/, a/DT recombinant/JJ form/NN of/IN human/NEWGENE IL-11/NEWGENE ./.
@@90289988992 In/NN order/NN to/IN provide/VB adequate/JJ local/JJ control/NN without/IN compromising/JJ cosmetic/JJ outcome/NN ,/, the/DT amount/NN of/IN breast/NN tissue/NN that/WDT must/MD be/VB excised/VBN in/IN BCT/DT needs/NN to/IN be/VB individualized/JJ ./.
@@14211453354 Fractionation/NNS of/IN crude/JJ nuclear/JJ extracts/NNS by/IN heparin-agarose/NN chromatography/NN indicates/VBZ that/IN PCAT-1/NEWGENE is/VBZ more/RB prevalent/JJ in/IN extracts/NNS prepared/VBN from/IN salt-stressed/JJ leaf/NN tissue/NN ./.
@@9175729124 Possibility/NNS of/IN a/DT TSH-Screening/VBG method/NN for/IN detection/NN of/IN hypothyroidism/NN in/IN the/DT newborn/NN ./.
@@36923315053 The/DT effect/NN of/IN a/DT beta-adrenoceptor/NEWGENE antagonist/NN ,/, pindolol/NN ,/, on/IN uterine/JJ smooth/JJ muscle/NN in/IN term/NN pregnant/JJ women/NNS was/VBD studied/VBN in/IN vitro/FW and/CC in/IN vivo/NN (/( in/IN hypertensive/JJ women/NNS )/SYM ./.
@@116862398188 The/DT 5'/CD flanking/JJ sequence/NN of/IN the/DT 3B/NEWGENE gene/NEWGENE is/VBZ extremely/RB A/DT +/SYM T/NN rich/JJ but/CC contains/VBZ five/CD G/NNP //NNP C/NNP rich/JJ stretches/NNS ,/, each/DT approximately/RB 7bp/NN long/JJ ,/, which/WDT have/VBP strong/JJ sequence/NN similarity/NN to/IN the/DT G/NN boxes/NNS found/VBP upstream/RB of/IN other/DT developmentally/RB regulated/VBN Dictyostelium/NN genes/NN ./.
@@98439442305 A-tracts/NNS functioned/VBN best/JJS when/CC positioned/VBN close/JJ to/IN the/DT -35/CD hexamer/NN rather/RB than/IN one/PRP helical/JJ turn/NN farther/RBR upstream/RB ,/, similar/JJ to/IN the/DT positioning/VBG optimal/JJ for/IN UP/NEWGENE element/NEWGENE function/NN ./.
@@108885707680 The/DT total/JJ alkaloids/NNS contained/VBN in/IN the/DT peel/NN of/IN Atzimba/NNP ,/, Lopez/NNP ,/, Marciana/NNP ,/, Montsama/NNP ,/, Murca/NNP ,/, and/CC Puebla/NN was/VBD lower/JJR than/IN the/DT limits/NNS recommended/VBN for/IN food/NN safety/NN ./.
@@77023789135 Scratching/VBG during/IN sleep/NN in/IN children/NNS with/IN atopic/JJ dermatitis/NN is/VBZ associated/VBN with/IN increased/VBN VO2/NN ./.
@@3311281680 High/NNP levels/NNS of/IN serum/JJ calcitonin/NEWGENE were/VBD found/VBN in/IN patients/NNS with/IN chronic/JJ renal/JJ failure/NN ./.
@@7506253996 This/DT enhancer/NN activates/VBZ both/PDT the/DT K19/NEWGENE and/CC TK/NEWGENE basal/NEWGENE promoters/NEWGENE in/IN HeLa/DT cells/NNS ./.
@@79853057975 The/DT treatment/NN of/IN hydronephrosis/NN in/IN children/NNS ./.
@@4639735069 Platelet/NN number/NN and/CC life/NN span/NN were/VBD determined/VBN in/IN the/DT last/NN trimester/NN of/IN pregnancy/NN in/IN 22/CD women/NNS who/WP were/VBD delivered/VBN of/IN small-for-gestational/JJ age/NN (/( SGA/JJ )/SYM infants/NNS and/CC in/IN 21/CD women/NNS with/IN infants/NNS having/VBG normal/JJ birth/NN weights/NNS ./.
@@3114188595 Significant/JJ treatment-related/JJ problems/NNS appeared/VBN during/IN the/DT second/JJ decade/NN in/IN 5/CD patients/NNS ,/, including/JJ one/PRP chest/NN wall/NN sarcoma/NN ;/: all/DT of/IN these/DT patients/NNS had/VBP received/VBN at/IN least/RB 60/CD Gy/JJ to/IN breast/NN and/CC regional/NN nodal/NN areas/NNS ./.
@@10334888197 In/NN reperfusion/NN B/NNP ,/, only/RB the/DT diabetic/JJ group/NN demonstrated/VBD a/DT significant/JJ increase/NN in/IN IL-8/NEWGENE concentrations/NNS at/IN 1/CD and/CC 15/CD min/NN compared/VBN to/IN nondiabetics/NNS ./.
@@76010782239 Subjects/NNS with/IN a/DT short/JJ postexposure/JJ time/NN and/CC a/DT dioxin/NN burden/NN >/SYM 0/CD ./CD 6/CD pg/NN //NN m3/NN had/VBP a/DT significantly/RB higher/JJ risk/NN of/IN hypoergy/NN than/IN unexposed/JJ subjects/NNS (/( hypoergy/NN I/PRP :/: OR/NN =/SYM 9/CD ./CD 51/CD ,/, 95%/CD CI/NN =/SYM 1/CD ./CD 96-42/CD ./CD 02/CD ;/: hypoergy/NN II/NNP :/: OR/NN =/SYM 2/CD ./CD 92/CD ,/, 95%/CD CI/NN =/SYM 1/CD ./CD 14-7/CD ./CD 5/CD )/SYM ./.
@@93967228151 The/DT gene/NN (/( ApxII/NEWGENE )/SYM encoding/VBG both/DT chloroplastic/NEWGENE ascorbate/NEWGENE peroxidase/NEWGENE isoenzymes/NEWGENE was/VBD isolated/VBN and/CC the/DT organization/NN of/IN the/DT gene/NN was/VBD determined/VBN ./.
@@75924679351 The/DT mechanism/NN of/IN peroxisome/NN proliferation/NN is/VBZ poorly/RB understood/VBP ./.
@@66091662440 The/DT method/NN involved/VBD deproteinizing/JJ samples/NNS with/IN two/JJ volumes/NNS of/IN acetonitrile/NN followed/VBN by/IN injection/NN of/IN 5/CD microliters/NNS of/IN deproteinized/NN supernatant/NN onto/IN a/DT C18/JJ reversed-phase/JJ column/NN ./.
@@92303076096 FOG/NEWGENE is/VBZ coexpressed/VBN with/IN GATA-1/NEWGENE during/IN embryonic/JJ development/NN and/CC in/IN erythroid/JJ and/CC megakaryocytic/JJ cells/NNS ./.
@@113675235671 However/RB ,/, C4B/NEWGENE proteins/NEWGENE encoded/VBN by/IN monomodular/JJ short/JJ genes/NNS may/MD have/VB relatively/JJ higher/JJ concentrations/NNS than/IN those/DT from/IN long/NEWGENE C4A/NEWGENE genes/NEWGENE ./.
@@100701585498 Independent/NNP splicing/JJ events/NNS involve/VBP three/CD previously/RB described/VBN cassette/NN exons/NNS ,/, which/WDT are/VBP predicted/VBN to/IN encode/VB most/RB of/IN the/DT second/JJ transmembrane/JJ domain/NN ./.
@@77457262106 As/IN it/PRP had/VBP been/VBN previously/RB reported/VBN that/IN the/DT 18-bp/JJ palindrome/NN contains/VBZ sufficient/JJ nucleotide/NN sequence/NN information/NN for/IN E1/NEWGENE binding/JJ ,/, we/PRP speculate/VBP that/IN a/DT minimal/JJ E1/NEWGENE recognition/NN motif/NN is/VBZ presented/VBN in/IN each/DT half/NN site/NN ./.
@@90435348999 Clinically/RB meaningful/JJ decreases/NNS due/NN to/IN alkalinization/NN alone/RB within/IN 30/CD minutes/NNS are/VBP unlikely/JJ ./.
@@39407334602 Using/VBG this/DT method/NN ,/, we/PRP measured/VBD absorption/NN of/IN low/JJ doses/NNS of/IN vitamin/NN A/DT ,/, which/WDT may/MD provide/VB a/DT more/RB physiological/JJ approach/NN to/IN assessment/NN of/IN fat/JJ malabsorption/NN ./.
@@95822671513 To/TO explore/VB the/DT function/NN of/IN human/JJ SINA-homologous/NEWGENE (/NEWGENE Siah/NEWGENE )/NEWGENE proteins/NEWGENE ,/, expression/NN plasmids/NNS encoding/VBG Siah-1A/NEWGENE were/VBD transiently/RB transfected/VBN into/IN 293/CD epithelial/JJ cells/NNS and/CC GM701/NNP fibroblast/NN cells/NNS ,/, resulting/VBG in/IN growth/NN arrest/NN without/IN induction/NN of/IN apoptosis/NN ./.
@@17587502350 Airway/NN pressure/NN and/CC air/NN flow/NN were/VBD measured/VBN at/IN the/DT endotracheal/JJ tube/NN in/IN 13/CD children/NNS on/IN a/DT variety/NN of/IN ventilators/NNS ./.
@@118791088320 MAIN/NNP OUTCOME/NNP MEASURE/NNP :/: A/DT positive/JJ test/NN result/NN for/IN gonococcal/JJ or/CC chlamydial/JJ infection/NN by/IN the/DT ligase/NEWGENE chain/NN reaction/NN assay/NN ;/: secondary/JJ outcome/NN measure/NN was/VBD a/DT positive/JJ test/NN result/NN for/IN human/JJ immunodeficiency/NN virus/NN (/( HIV/NN )/SYM ./.
@@105614603344 The/DT GPI/NEWGENE anchor/NEWGENE moiety/NEWGENE is/VBZ either/DT absent/JJ or/CC present/NN at/IN a/DT very/RB low/JJ level/NN in/IN the/DT polypeptide/NN expressed/VBN from/IN the/DT cDNA/NN that/WDT contained/VBD both/PDT the/DT signal/JJ peptide/NN and/CC GPI/NEWGENE signal/NEWGENE sequences/NEWGENE ./.
@@103447364830 CDK4/NEWGENE kinase/NEWGENE activities/NNS were/VBD unaffected/JJ ,/, as/IN were/VBD the/DT levels/NNS of/IN the/DT CDK/NEWGENE inhibitor/NEWGENE p21Cip1/NEWGENE present/VB in/IN cyclin/NEWGENE E/NEWGENE immunocomplexes/NEWGENE ./.
@@100686747558 We/PRP also/RB identified/VBD an/DT alternative/RB spliced/VBN form/NN of/IN Lyp/NEWGENE RNA/NEWGENE ,/, Lyp2/NEWGENE ./.
@@92325935292 With/IN regard/NN to/IN the/DT characteristic/JJ expression/NN pattern/NN of/IN DJ/NEWGENE protein/NEWGENE and/CC its/PRP conspicuous/JJ repeat/NN units/NNS possible/JJ functional/JJ roles/NNS are/VBP discussed/VBN ./.
@@10819046913 Fibrin/NEWGENE cloaking/NN along/IN the/DT catheter/NN was/VBD found/VBN in/IN 20/CD patients/NNS studied/VBN by/IN pull-out/NN arteriography/NN and/CC was/VBD unassociated/JJ with/IN clinical/JJ symptoms/NNS ./.
@@19019508610 Sequence/NN requirements/NNS for/IN premature/JJ transcription/NN arrest/NN within/IN the/DT first/JJ intron/NN of/IN the/DT mouse/NEWGENE c-fos/NEWGENE gene/NEWGENE ./.
@@85667519434 However/RB ,/, it/PRP remains/VBP an/DT open/JJ question/NN whether/IN vertebrate/NEWGENE Hox/NEWGENE genes/NEWGENE expressed/VBN under/IN the/DT control/NN of/IN Drosophila/NN regulatory/NN sequences/NN can/MD substitute/VB the/DT function/NN of/IN Drosophila/NEWGENE Hox/NEWGENE genes/NEWGENE ./.
@@34946494186 This/DT brief/JJ hypercapnic/JJ challenge/NN induced/VBD a/DT rapid/JJ increase/NN in/IN CBF/NN in/IN the/DT absence/NN of/IN any/DT change/NN in/IN MABP/NN ./.
@@30010846986 The/DT sequence/NN was/VBD determined/VBN for/IN a/DT 4024-base/JJ pair/NN (/( bp/NN )/SYM segment/NN that/WDT extends/VBZ from/IN 149/CD bp/NN 5'/CD to/IN the/DT cap/NN site/NN of/IN alpha/NEWGENE 1/NEWGENE to/IN 207/CD bp/NN 3'/CD to/IN psi/NEWGENE alpha/NEWGENE ./.
@@87039088709 Collectively/RB ,/, our/PRP findings/NNS demonstrate/VBP that/IN SF-1/NEWGENE plays/VBP a/DT key/NN role/NN in/IN controlling/JJ the/DT basal/JJ and/CC cAMP-stimulated/JJ expression/NN of/IN the/DT StAR/NEWGENE gene/NEWGENE ./.
@@113689016217 In/NN contrast/NN the/DT human/NN and/CC mouse/NEWGENE BCNT/NEWGENE proteins/NEWGENE contain/VBP one/PRP repeat/NN unit/NN and/CC lack/VB the/DT RTE-1-derived/JJ portion/NN ./.
@@98520054476 Competition/NN with/IN a/DT putative/JJ MADS/NEWGENE box/NEWGENE consensus/NN binding/JJ site/NN from/IN the/DT promoter/NN of/IN the/DT coordinately/RB regulated/VBN opaque-phase-specific/NEWGENE gene/NEWGENE PEP1/NEWGENE (/( SAP1/NEWGENE )/SYM and/CC the/DT human/NEWGENE MADS/NEWGENE box/NEWGENE consensus/NEWGENE binding/NEWGENE site/NEWGENE for/IN serum/NEWGENE response/NEWGENE factor/NEWGENE demonstrated/VBN that/IN one/PRP of/IN the/DT three/CD complexes/NNS formed/VBN was/VBD specific/JJ to/IN the/DT OP4/NEWGENE sequence/NEWGENE ./.
@@115426771419 This/DT article/NN comparatively/RB evaluates/VBZ five/CD Generic/NNP Systems/NNPS that/WDT describe/VBP the/DT basic/JJ alternatives/NNS to/IN composting/JJ facility/NN design/NN and/CC control/NN ./.
@@111196115111 ORFK10/NEWGENE ./NEWGENE 5/NEWGENE encodes/VBZ a/DT protein/NN ,/, latency-associated/NEWGENE nuclear/NEWGENE antigen/NEWGENE 2/NEWGENE (/( LANA2/NEWGENE )/SYM ,/, which/WDT is/VBZ expressed/VBN in/IN KSHV-infected/JJ hematopoietic/JJ tissues/NNS ,/, including/JJ PEL/NN and/CC CD/NN but/CC not/RB KS/VB lesions/NNS ./.
@@86012834313 In/NN view/NN of/IN the/DT presence/NN of/IN SECIS/NEWGENE elements/NEWGENE in/IN the/DT open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM of/IN bacterial/JJ selenoproteins/NNS ,/, we/PRP examine/VBP the/DT effects/NNS in/IN the/DT type/NEWGENE 1/NEWGENE deiodinase/NEWGENE of/IN extending/VBG the/DT ORF/NN into/IN the/DT SECIS/NEWGENE element/NEWGENE ,/, and/CC find/VB that/IN this/DT dramatically/RB inhibits/VBZ SECIS/NEWGENE function/NN ./.
@@1003737835 The/DT dorsal/JJ nerves/NNS of/IN the/DT penis/NN were/VBD anesthetized/JJ bilaterally/RB with/IN lidocaine/NN ./.
@@107884769608 Antibodies/NNS raised/VBN against/IN a/DT C-terminal/NN portion/NN of/IN Sec31A/NEWGENE co-precipitate/NN Sec13/NEWGENE and/CC inhibit/VB ER-Golgi/NNP transport/NN of/IN temperature-arrested/JJ vesicular/JJ stomatitis/NEWGENE G/NEWGENE protein/NEWGENE in/IN a/DT semi-intact/JJ cell/NN assay/NN ./.
@@33407746972 Dosimetric/NNP estimates/NNS for/IN these/DT organs/NNS were/VBD 2/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 1/CD and/CC 2/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 4/CD rad/NN (/( ./CD 02/CD +/NN //NN -/NN ./NN 01/NN Gy/NN )/SYM ,/, respectively/RB ,/, with/IN a/DT whole-body/NN estimate/NN of/IN 0/CD ./CD 28/CD rad/NN (/( ./NN 003/NN Gy/NN )/SYM ./.
@@99879619988 Its/PRP early/JJ lesions/NNS were/VBD characterized/VBN by/IN angiomatosis/NN ,/, vasculopathy/NN ,/, and/CC proliferation/NN of/IN synoviocytes/NNS and/CC fibroblasts/NNS ./.
@@93171311176 Ig/NEWGENE heavy/NEWGENE chain/NEWGENE class/NN switching/NN is/VBZ directed/VBN by/IN cytokines/NNS inducing/JJ transcription/NN from/IN unrearranged/JJ CH/NEWGENE genes/NEWGENE ./.
@@98953235734 Conserved/JJ and/CC distinct/JJ roles/NNS of/IN kreisler/NEWGENE in/IN regulation/NN of/IN the/DT paralogous/JJ Hoxa3/NEWGENE and/CC Hoxb3/NEWGENE genes/NEWGENE ./.
@@97186719702 The/DT Abbreviated/NN Injury/NNP Scale/NNP (/( AIS/NNS )/SYM ,/, Injury/NNP Severity/NNP Scale/NNP and/CC TRISS/NNP methodology/NN comprise/VB a/DT mathematically/RB sound/NN system/NN for/IN the/DT analysis/NN of/IN injuries/NNS and/CC injured/JJ patients/NNS ./.
@@14996162366 The/DT mean/JJ blood/NN flow/NN in/IN the/DT penile/JJ foreskin/NN was/VBD estimated/VBN to/IN be/VB 15/CD ml/CD //CD min/CD //CD 100/CD g/NN and/CC it/PRP increased/VBD to/IN 150-200%/JJ after/IN the/DT induction/NN of/IN anesthesia/NN ,/, and/CC then/RB decreased/VBN to/IN 72%/JJ at/IN the/DT tip/NN of/IN the/DT created/VBN parameatal/JJ foreskin/NN flap/NN ./.
@@15479429739 A/DT 32P-labeled/JJ LAP/NN DNA-binding/NN and/CC dimerization/NN domain/NN "zipper/NN probe"/NN was/VBD used/VBN to/IN isolate/NN a/NN clone/NN that/IN encodes/VBZ a/DT new/JJ C/NEWGENE //NEWGENE EBP-homologous/NEWGENE protein/NEWGENE :/: CHOP-10/NEWGENE ./.
@@64823186281 Thrombocyte/NN function/NN was/VBD impaired/VBN in/IN all/DT patients/NNS ,/, characterized/VBN by/IN a/DT diminished/JJ platelet/NN shape/NN change/NN ./.
@@109337327977 The/DT genome/NN of/IN the/DT human/JJ herpesvirus/NN 8/CD (/( HHV-8/NN )/SYM contains/VBZ a/DT cluster/NN of/IN open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM encoding/VBG proteins/NNS with/IN homology/NN to/IN the/DT cellular/JJ transcription/NN factors/NNS of/IN the/DT interferon/NEWGENE regulatory/NEWGENE factor/NEWGENE (/( IRF/NEWGENE )/SYM family/NN ./.
@@17441199865 The/DT constraints/NNS of/IN primase/NEWGENE recognition/NEWGENE sequences/NEWGENE ,/, nucleotide/NN substrate/NN requirements/NNS ,/, and/CC the/DT effects/NNS of/IN additional/JJ proteins/NNS on/IN oligoribonucleotide/NN synthesis/NN by/IN the/DT 63-kDa/NEWGENE gene/NEWGENE 4/NEWGENE protein/NEWGENE have/NN been/VBN examined/VBN using/VBG templates/NNS of/IN defined/VBN sequence/NN ./.
@@64634296269 Resting/VBG VE/NN in/IN the/DT luteal/JJ phase/NN was/VBD 7/CD ./CD 8%/CD greater/JJR than/IN that/DT in/NN the/DT follicular/JJ phase/NN ./.
@@91082079057 However/RB ,/, its/PRP participation/NN in/IN gagging/NN induced/VBN by/IN oropharyngeal/JJ irritation/NN is/VBZ unclear/JJ ./.
@@11555669468 Experience/NN with/IN xylene-free/JJ sections/NNS since/IN 1995/CD at/IN the/DT Vrinnevi/NN Hospital/NNP is/VBZ favorable/JJ ./.
@@110581327330 Among/IN the/DT total/JJ CDSs/NN ,/, 8/CD ./CD 8%/CD match/NN sequences/NNS of/IN proteins/NNS found/VBP only/RB in/IN Bacillus/NN subtilis/JJ and/CC 66/CD ./CD 7%/CD are/VBP widely/RB conserved/VBN in/IN comparison/NN with/IN the/DT proteins/NNS of/IN various/JJ organisms/NNS ,/, including/JJ B/NNP ./NNP subtilis/NNP ./.
@@107805186541 The/DT effects/NNS of/IN these/DT mutations/NNS on/IN protein/NN function/NN require/VB further/JJ examination/NN ./.
@@6328504965 USA/NN 80/CD ,/, 802-806/NN ]/NN was/VBD used/VBN to/IN isolate/NN a/DT genomic/JJ clone/NN lambda/NN PGK-1/NEWGENE containing/JJ a/DT portion/NN of/IN an/DT autosomal/JJ locus/NN for/IN phosphoglycerate/NEWGENE kinase/NEWGENE (/( PGK/NEWGENE )/SYM ./.
@@27814952275 Changes/NNS in/IN xanthine/NEWGENE oxidase/NEWGENE activity/NN in/IN patients/NNS with/IN circulatory/JJ failure/NN ./.
@@98785429565 Consistent/JJ with/IN these/DT findings/NNS ,/, relatively/JJ weak/JJ transcriptional/JJ silencing/VBG by/IN the/DT native/JJ VDR/NEWGENE was/VBD observed/VBN using/VBG the/DT osteopontin/NEWGENE VDRE/NEWGENE1 ./.
@@79141924556 HER2/NEWGENE overexpressing/JJ cells/NNS showed/VBD a/DT single/JJ prominent/JJ DNase/NEWGENE I/NEWGENE hypersensitive/JJ site/NN near/IN a/DT conserved/VBN and/CC hitherto/RB unrecognized/JJ ets/NEWGENE response/NEWGENE element/NEWGENE (/( GAGGAA/NEWGENE )/SYM ,/, located/VBN 38/CD bases/NNS down-stream/NN from/IN the/DT CAAT/NN box/NN and/CC directly/RB 5'/CD of/IN the/DT TATA/NN box/NN in/IN the/DT human/NEWGENE HER2/NEWGENE promoter/NEWGENE ./.
@@28893521237 Most/JJS patients/NNS with/IN high/JJ blood/NN pressure/NN (/( BP/NN )/SYM can/MD be/VB managed/VBN by/IN using/VBG one/PRP of/IN 4/CD classes/NNS of/IN compounds/NNS :/: a/DT diuretic/NN ,/, beta/NN blocker/NN ,/, converting/NN enzyme/NN inhibitor/NN or/CC calcium/NN antagonist/NN ./.
@@91834067035 A/DT neonatal/JJ alloimmune/JJ thrombocytopenia/NN with/IN an/DT HPA-3a/NN (/( Baka/NN )/SYM incompatibility/NN was/VBD confirmed/VBN ./.
@@106933149372 Of/IN the/DT 153/CD patients/NNS studied/VBN ,/, CK-MB/NEWGENE results/NNS were/VBD positive/JJ in/IN 91/NNP (/( 59%/CD )/SYM patients/NNS ;/: ECG/NN revealed/VBD AMI/NN in/IN 72/NNP (/( 47%/JJ )/SYM patients/NNS ./.
@@16343082230 Cardiovascular/NNP risk/NN factors/NNS were/VBD measured/VBN by/IN standardized/JJ techniques/NNS ./.
@@39040041473 Such/JJ studied/VBN acquired/VBN with/IN low/JJ energy/NN or/CC medium/NN energy/NN collimation/NN and/CC a/DT window/NN centered/VBN on/IN the/DT 159/CD keV/NN 123I/NN photopeak/NN contain/VB appreciable/JJ septal/JJ breakthrough/NN signals/NNS originating/VBG from/IN Compton/NN scatter/NN of/IN high/JJ energy/NN photons/NNS primarily/RB from/IN 124I/CD ./.
@@94985537096 Structural/NNP and/CC evolutionary/JJ studies/NNS on/IN sterol/NEWGENE 14-demethylase/NEWGENE P450/NEWGENE (/( CYP51/NEWGENE )/SYM ,/, the/DT most/RB conserved/VBN P450/NEWGENE monooxygenase/NEWGENE :/: I/NNP ./NNP
@@10748672558 Bites/NNS by/IN two/JJ species/NN of/IN adders/NNS (/( Vipera/NN aspis/NN and/CC Vipera/NN berus/NN )/SYM can/MD lead/VB to/IN extensive/JJ swelling/NN with/IN multiorgan/JJ failure/NN ./.
@@62161256024 In/NN addition/NN ,/, the/DT overall/JJ chance/NN that/IN a/DT patient/NN would/MD undergo/VB ET/NNP was/VBD greater/JJR in/IN a/DT cycle/NN in/IN which/WDT more/RB than/IN one/PRP follicle/NN 20/CD mm/NN or/CC larger/JJR was/VBD developing/JJ than/IN in/IN a/DT cycle/NN in/IN which/WDT a/DT single/JJ large/JJ follicle/NN was/VBD developing/JJ ./.
@@74712104774 The/DT 87K/NN protein/NN ,/, together/RB with/IN proteins/NNS of/IN 105/CD ,/CD 000/CD and/CC 75/CD ,/CD 000/CD daltons/NNS ,/, are/VBP translated/VBN from/IN leftward/RB transcribed/VBN (/( 1-strand/JJ )/SYM messenger/NN RNAs/NNS that/WDT are/VBP complementary/JJ to/IN the/DT viral/JJ genome/NN between/IN positions/NNS 11/CD ./CD 2/CD and/CC 31/CD ./CD 5/CD ./.
@@115875145987 However/RB ,/, the/DT abi1-1/NEWGENE gene/NEWGENE product/NEWGENE has/VBZ no/DT effect/NN on/IN the/DT ABA/NN suppression/NN of/IN a/DT GA-responsive/NNP alpha-amylase/NEWGENE gene/NEWGENE ./.
@@114106795109 The/DT selective/JJ alteration/NN of/IN the/DT genome/NN using/VBG Cre/NEWGENE recombinase/NEWGENE to/IN target/NN the/DT rearrangement/NN of/IN genes/NNS flanked/VBN by/IN LOX/NEWGENE recognition/NEWGENE sequences/NEWGENE has/VBZ required/VBN the/DT use/NN of/IN two/JJ separate/JJ genetic/JJ constructs/NNS in/IN trans/JJ ,/, one/PRP containing/JJ cre/NEWGENE and/CC the/PDT other/DT containing/JJ the/DT gene/NN of/IN interest/NN flanked/VBN by/IN LOX/NEWGENE sites/NEWGENE ./.
@@84972807259 Since/IN the/DT regulation/NN of/IN SWI4/NEWGENE is/VBZ required/VBN for/IN normal/JJ cell/NN cycle/NN progression/NN ,/, we/PRP have/VBP characterized/VBN cis-/JJ and/CC trans-acting/JJ regulators/NNS of/IN SWI4/NEWGENE transcription/NN ./.
@@34038269336 Which/WDT cineangiographically/RB assessed/VBN anatomic/JJ variable/JJ correlates/VBP best/JJS with/IN functional/JJ measurements/NNS of/IN stenosis/NN severity/NN ?/. A/DT comparison/NN of/IN quantitative/JJ analysis/NN of/IN the/DT coronary/JJ cineangiogram/NN with/IN measured/VBN coronary/JJ flow/NN reserve/NN and/CC exercise/NN //NN redistribution/NN thallium-201/NN scintigraphy/NN ./.
@@88137669958 The/DT third/JJ ORF/NN generates/VBZ a/DT transcript/NN of/IN 1/CD ./CD 6/CD kb/NN and/CC encodes/VBZ a/DT protein/NN of/IN 382/CD residues/NNS including/JJ a/DT perfect/JJ match/NN to/IN the/DT consensus/NN sequence/NN of/IN a/DT C2H2/NEWGENE zinc/NEWGENE finger/NEWGENE domain/NEWGENE ;/: it/PRP shares/VBP a/DT strong/JJ homology/NN with/IN yeast/NEWGENE Mig1p/NEWGENE and/CC Cre-A/NEWGENE from/NEWGENE Aspergillus/NEWGENE ,/NEWGENE Emericella/NEWGENE and/NEWGENE E/NEWGENE ./NEWGENE coli/NEWGENE ./.
@@71250646932 Parasitological/JJ and/CC pathological/JJ findings/NNS in/IN capuchin/NN monkeys/NNS infected/VBN with/IN Schistosoma/ORG japonicum/NN or/CC Schistosoma/ORG mansoni/NN ./.
@@87747328800 To/TO test/VB whether/IN Sp1/NEWGENE and/CC zif268/NEWGENE //NEWGENE egr-1/NEWGENE interact/VB with/IN this/DT motif/NN ,/, gel/NN retardation/NN assays/NNS were/VBD performed/VBN ./.
@@105675896502 The/DT multiple/JJ functions/NNS of/IN Pmt3p/NEWGENE described/VBN here/RB suggest/VB that/IN several/DT nuclear/JJ proteins/NNS are/VBP regulated/VBN by/IN Pmt3p/NEWGENE conjugation/NN ./.
@@38301479234 The/DT relationships/NNS among/IN four/CD descriptors/NNS of/IN lactate/NN increase/NN :/: lactate/NN threshold/NN (/( LT/NN )/SYM (/( the/DT VO2/NN at/IN which/WDT blood/VBP lactate/NN concentration/NN begins/VBZ to/IN increase/NN above/RB the/DT resting/JJ level/NN during/IN an/DT incremental/JJ exercise/NN test/NN )/SYM ,/, LT1/NN (/( the/DT VO2/NN at/IN which/WDT blood/VBP lactate/NN increases/NNS 1/CD mM/NN above/RB the/DT resting/JJ level/NN )/SYM ,/, LT2/NN (/( the/DT VO2/NN at/IN which/WDT blood/VBP lactate/NN concentration/NN reaches/VBP a/DT fixed/JJ value/NN of/IN 2/CD mM/NN )/SYM ,/, onset/NN of/IN blood/NN lactate/NN accumulation/NN (/( OBLA/NNP ;/: the/DT VO2/NN at/IN which/WDT blood/VBP lactate/NN reaches/VBP a/DT concentration/NN of/IN 4/CD mM/NN )/SYM ,/, were/VBD compared/VBN with/IN aerobic/JJ capacity/NN (/( VO2max/NN )/SYM and/CC 12/CD min/NN running/JJ performance/NN in/IN 19/CD untrained/JJ female/JJ students/NNS ./.
@@79353957931 The/DT protein/NN encoded/VBN is/VBZ 114/CD kDa/NN and/CC contains/VBZ eight/CD zinc/NN finger/NN motifs/NNS ,/, seven/NN of/IN which/WDT are/VBP present/VB in/IN two/JJ clusters/NNS at/IN opposite/NN ends/NNS of/IN the/DT molecule/NN ./.
@@118946051801 INTERPRETATION/NNP :/: It/PRP is/VBZ probable/JJ that/IN the/DT cognitive/JJ dissonance/NN created/VBN by/IN more/JJ health/NN information/NN on/IN smoking/NN after/IN 1964/CD ,/, i/CD ./CD e/CD ./. the/DT necessary/JJ motivation/NN to/IN quit/NN ,/, was/VBD reduced/VBN as/IN a/DT result/NN of/IN strategic/JJ changes/NNS in/IN the/DT amount/NN and/CC content/NN of/IN advertising/NN ./.
@@113139469835 A/DT novel/JJ potential/JJ effector/NN of/IN M-Ras/NEWGENE and/CC p21/NEWGENE Ras/NEWGENE negatively/RB regulates/VBZ p21/NEWGENE Ras-mediated/NN gene/NN induction/NN and/CC cell/NN growth/NN ./.
@@100262291196 In/NN addition/NN ,/, in/IN vitro/FW mutagenesis/NN of/IN both/DT Engrailed/NEWGENE and/CC Pbx1/NEWGENE sites/NEWGENE indicated/VBN that/IN other/DT unidentified/JJ sites/NNS are/VBP responsible/JJ for/IN the/DT transcriptional/JJ enhancement/NN observed/VBN with/IN the/DT intronic/JJ fragment/NN ./.
@@29144923620 On/IN admission/NN to/IN the/DT ICU/NN ,/, 117/CD patients/NNS (/( 61/CD percent/NN )/SYM had/VBP hypomagnesemia/NN (/( serum/JJ Mg/NN less/PRP than/IN 1/CD ./CD 5/CD mEq/NN //NN dl/NN )/SYM ,/, 66/CD patients/NNS (/( 34/CD percent/NN )/SYM had/VBP normomagnesemia/VBG (/( 1/CD ./CD 5/CD to/IN 2/CD ./CD 0/CD mEq/NN //NN dl/NN )/SYM ,/, and/CC ten/CD patients/NNS (/( 5/CD percent/NN )/SYM had/VBP hypermagnesemia/NN (/( greater/JJR than/IN 2/CD ./CD 0/CD mEq/NN //NN dl/NN )/SYM ./.
@@39135224568 With/IN aging/NN ,/, many/JJ aspects/NNS of/IN immune/JJ function/NN change/NN ./.
@@116808354417 In/NN the/DT base-case/JJ analysis/NN ,/, total/JJ direct/JJ costs/NNS per/IN patient/NN were/VBD $728/NN for/IN zoledronic/JJ acid/NN and/CC $776/CD for/IN pamidronate/NN ./.
@@63180911608 The/DT splice/NN acceptor/NN site/NN is/VBZ ca/NN ./NN
@@23050142955 In/NN the/DT first/JJ series/NN of/IN experiments/NNS ,/, Sprague-Dawley/JJ male/JJ rats/NNS were/VBD implanted/VBN unilaterally/RB with/IN guide/NN cannulas/NNS aimed/VBN at/IN the/DT lateral/JJ ventricle/NN ./.
@@2865502757 Double-blind/NNP randomised/JJ trial/NN of/IN intravenous/JJ tissue-type/NEWGENE plasminogen/NEWGENE activator/NEWGENE versus/IN placebo/NN in/IN acute/JJ myocardial/JJ infarction/NN ./.
@@8226118204 Up/IN to/IN now/RB the/DT number/NN of/IN patients/NNS examined/VBN is/VBZ about/RB 300/CD ,/, additionally/RB 6/CD persons/NNS who/WP underwent/VBD binephrectomy/NN ./.
@@90962348518 An/DT aromatic/JJ stacking/JJ interaction/NN between/IN subunits/NNS helps/VBP mediate/VB DNA/NN sequence/NN specificity/NN :/: operator/NN site/NN discrimination/NN by/IN phage/NEWGENE lambda/NEWGENE cI/NEWGENE repressor/NEWGENE ./.
@@78166193310 Furthermore/RB ,/, the/DT identification/NN of/IN a/DT Dr1-like/NEWGENE protein/NEWGENE in/IN A/NNP ./NNP thaliana/NNP strongly/RB argues/VBZ for/IN the/DT ubiquity/NN of/IN this/DT protein/NN among/IN eukaryotic/JJ genera/NNS and/CC for/IN a/DT conserved/VBN mechanism/NN to/IN regulate/VB transcription/NN initiation/NN that/WDT involves/VBZ Dr1/NEWGENE ./.
@@10326654190 According/VBG to/IN pilot/JJ experiments/NNS which/WDT considered/VBD various/JJ durations/NNS of/IN global/JJ no-flow/NN ischemia/NN ranging/VBG from/IN 10/CD to/IN 20/CD minutes/NNS ,/, two/JJ durations/NNS were/VBD chosen/VBP for/IN the/DT present/NN study/NN :/: 20/CD minutes/NNS (/( group/NN 20/CD )/SYM in/IN which/WDT ventricular/JJ fibrillation/NN (/( VF/NN )/SYM was/VBD the/DT predominant/JJ form/NN of/IN arrhythmias/NNS ,/, and/CC 18/CD minutes/NNS (/( group/NN 18/CD )/SYM in/IN which/WDT the/DT prevalence/NN of/IN VF/NN was/VBD markedly/RB lower/JJR despite/IN the/DT small/JJ difference/NN in/IN the/DT duration/NN of/IN ischemia/NN ./.
@@88480134085 The/DT nonconsensus/JJ TATA/NN box/NN in/IN promoter/NEWGENE B/NEWGENE plays/VBP a/DT more/RB important/JJ role/NN in/IN promoter/NN activity/NN than/IN the/DT TATA/NN box/NN in/IN promoter/NEWGENE A/NEWGENE ./.
@@15164272137 High-resolution/NNP computed/JJ tomography/NN in/IN the/DT diagnosis/NN of/IN miliary/JJ tuberculosis/NN ./.
@@45522638991 State-approved/NN schools/NNS of/IN nursing--R/CD ./CD Z/CD ./CD ,/, 1972/CD ./.
@@25774588461 The/DT discussion/NN focuses/VBP primarily/RB on/IN the/DT newer/JJR drugs/NNS like/JJ angiotensin/NEWGENE converting/NEWGENE enzyme/NEWGENE inhibitors/NN ,/, alpha-adrenergic/NEWGENE receptor/NEWGENE blockers/NNS ,/, and/CC calcium/NN antagonists/NNS ./.
@@35377219230 Based/VBN on/IN our/PRP observations/NNS ,/, we/PRP propose/VBP a/DT model/NN whereby/RB inactive/JJ precursor/NN molecules/NNS produced/VBN from/IN the/DT PEP4/NEWGENE gene/NEWGENE self-activate/JJ within/IN the/DT yeast/NN vacuole/NN and/CC subsequently/RB activate/VB other/DT vacuolar/JJ hydrolases/NNS ./.
@@65463924055 In/NN this/DT respect/NN C/NEWGENE reactive/NEWGENE protein/NEWGENE concentrations/NNS are/VBP superior/JJ to/IN white/JJ cell/NN count/NN ,/, erythrocyte/NN sedimentation/NN rate/NN ,/, and/CC temperature/NN and/CC the/DT concentrations/NNS of/IN antiproteases/NNS ./.
@@104962847955 During/IN both/DT encephalopathy/NN episodes/NNS ,/, CSF/NN protein/NN and/CC immunoglobulin/NEWGENE G/NEWGENE (/( IgG/NEWGENE )/SYM levels/NNS were/VBD elevated/VBN without/IN an/DT increased/VBN IgG/NEWGENE index/NN or/CC IgG/NEWGENE synthesis/NN rate/NN ./.
@@11383301232 Bulbar/JJ pouches/NNS were/VBD perfused/VBN with/IN solutions/NNS of/IN 0/CD ./CD 9%/CD Na/NN C1/NN ,/, 0/CD ./CD 1/CD N/JJ HC1/NN ,/, 40%/NN glucose/NN ,/, 40%/NN NaC1/NN ,/, and/CC 40%/CD peptone/NN or/CC with/IN 0/CD ./CD 1%/CD solutions/NNS of/IN acetylcholine/NN chloride/NN ./.
@@89429998770 Recurrent/JJ G-to-A/NN substitution/NN in/IN a/DT single/JJ codon/NN of/IN SREBP/NEWGENE cleavage-activating/NEWGENE protein/NEWGENE causes/NNS sterol/NN resistance/NN in/IN three/CD mutant/JJ Chinese/JJ hamster/NN ovary/NN cell/NN lines/NNS ./.
@@78352733349 Insulin-stimulated/JJ glucose/NN transport/NN in/IN adipocytes/NNS is/VBZ mediated/JJ by/IN the/DT insulin/NEWGENE receptor/NEWGENE ./.
@@76765877604 Veterinary/NNP certification/NN for/IN livestock/NN export/NN ./.
@@26506633327 A/DT 0/CD ./CD 5/CD rating/NN was/VBD intended/VBN to/IN characterize/VB subjects/NNS in/IN whom/WP mild/JJ cognitive/JJ impairment/NN due/NN to/IN senile/JJ dementia/NN of/IN the/DT Alzheimer/NN type/NN was/VBD suspected/VBN but/CC was/VBD insufficient/JJ in/IN degree/NN to/IN warrant/NN a/DT diagnosis/NN of/IN definite/JJ dementia/NN ./.
@@38184679797 Selenium/NN (/( ./CD 1/CD ppm/NN )/SYM and/CC E/NN (/( 50/CD IU/NNS //NNS kg/NNS )/SYM supplementation/NN of/IN the/DT diet/NN of/IN the/DT sow/NN increased/VBD plasma/NN tocopherol/NN and/CC Se/NNP concentrations/NNS ,/, but/CC did/VBD not/RB increase/VB plasma/NEWGENE glutathione/NEWGENE peroxidase/NEWGENE (/( GSH-Px/NEWGENE )/SYM activity/NN ./.
@@105919903642 A/DT group/NN of/IN 66/CD DSM-IV/IN paranoid/JJ schizophrenic/JJ in-patients/NNS were/VBD assessed/VBN three/CD times/NNS using/VBG the/DT SAPS/NN ,/, SANS/NN ,/, BPRS/VBZ and/CC PAS/NN ./.
@@34202664121 The/DT interaction/NN of/IN radiation/NN and/CC hyperthermia/NN was/VBD systematically/RB studied/VBN in/IN the/DT Dunning/NN R3327G/NN prostatic/JJ adenocarcinoma/NN ,/, the/DT preeminent/JJ animal/NN model/NN for/IN human/JJ prostatic/JJ cancer/NN ./.
@@40738484754 Failure/NN of/IN stapedius/NN reflexometry/NN in/IN the/DT diagnosis/NN of/IN myasthenia/NN gravis/MD ./.
@@17543817415 As/IN an/DT initial/JJ step/NN towards/IN the/DT characterization/NN of/IN replicative/JJ DNA/NEWGENE polymerases/NEWGENE of/NEWGENE trypanosomes/NEWGENE ,/, we/PRP have/VBP cloned/VBN ,/, sequenced/VBN and/CC examined/VBD the/DT expression/NN of/IN the/DT Trypanosoma/JJ (/( Trypanozoon/NNP )/SYM brucei/NN brucei/NN gene/NN that/IN encodes/VBZ the/DT DNA/NEWGENE polymerase/NEWGENE alpha/NEWGENE catalytic/NEWGENE core/NEWGENE (/( pol/NEWGENE alpha/NEWGENE )/SYM ./.
@@78534887102 Encapsidation/NNS of/IN poliovirus/NN replicons/NNS encoding/VBG the/DT complete/JJ human/NEWGENE immunodeficiency/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE gag/NEWGENE gene/NEWGENE by/IN using/VBG a/DT complementation/NN system/NN which/WDT provides/VBZ the/DT P1/NEWGENE capsid/NEWGENE protein/NEWGENE in/IN trans/JJ ./.
@@7590497486 The/DT micromethod/NN uses/VBZ microcuvettes/NNS and/CC substitutes/NNS ferrozine/NN for/IN the/DT bathophenanthroline/NN chromogen/NN of/IN the/DT ICSH/NN ./.
@@8510647665 Beg2/NEWGENE and/CC Beg1/NEWGENE are/VBP regulated/VBN differently/RB which/WDT may/MD indicate/VB variation/NN in/IN storage/NN or/CC utilization/NN properties/NNS among/IN the/DT barley/NEWGENE globulins/NEWGENE ./.
@@75717668722 An/DT abnormally/RB high/JJ percentage/NN of/IN hypertensive/JJ patients/NNS (/( approximately/RB 30%/CD )/SYM undergoing/VBG cardiac/JJ catheterization/NN because/IN of/IN anginal/JJ pain/NN and/IN //IN or/IN exercise-induced/NN ST-segment/NN depressions/NNS has/VBZ angiographically/RB normal/JJ coronary/JJ arteries/NNS ./.
@@27900097461 The/DT mature/JJ protein/NN also/RB contains/VBZ a/DT cysteine-rich/NN ,/, highly/RB hydrophilic/JJ region/NN homologous/JJ to/IN the/DT ovomucoid/NEWGENE serine/NEWGENE protease/NEWGENE inhibitors/NEWGENE (/( residues/NNS 76-132/CD )/SYM ./.
@@10367646237 Severe/JJ hemolysis/NN resulted/VBN in/IN statistically/RB significant/JJ changes/NNS in/IN the/DT mean/JJ values/NNS of/IN the/DT above/JJ analytes/NNS in/IN addition/NN to/IN the/DT following/NN increases/NNS :/: alanine/NEWGENE aminotransferase/NEWGENE ,/, calcium/NN ,/, and/CC serum/NEWGENE globulins/NEWGENE (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM and/CC albumin/NEWGENE and/CC total/JJ protein/NN (/( P/NN </SYM 0/CD ./CD 01/CD )/SYM ./.
@@94789762582 Oncostatin/NEWGENE M/NEWGENE stimulates/VBZ c-Fos/NEWGENE to/IN bind/NN a/DT transcriptionally/NN responsive/NN AP-1/NEWGENE element/NEWGENE within/IN the/DT tissue/NEWGENE inhibitor/NEWGENE of/NEWGENE metalloproteinase-1/NEWGENE promoter/NEWGENE ./.
@@67347136499 Diclofenac/NN sodium-chlormezanone/JJ poisoning/NN ./.
@@111690801008 If/IN you/PRP think/VBP education/NN is/VBZ expensive--try/NN ignorance--Bok's/NNP Law/NNP ./.
@@107044993253 Alternatively/RB ,/, PC12-E2/NNP cells/NNS were/VBD submitted/VBN to/IN treatment/NN with/IN antibodies/NNS to/IN the/DT fibroblast/NEWGENE growth/NEWGENE factor/NEWGENE (/NEWGENE FGF/NEWGENE )/NEWGENE receptor/NEWGENE ,/, inhibitors/NNS of/IN the/DT nonreceptor/NEWGENE tyrosine/NEWGENE kinase/NEWGENE p59/NEWGENE1 (/NEWGENE1 fyn/NEWGENE1 )/NN ,/, PLC/NEWGENE ,/, PKC/NEWGENE and/CC MEK/NEWGENE and/CC an/DT activator/NN of/IN PKC/NEWGENE ,/, phorbol-12-myristate-13-acetate/NNP (/( PMA/NN )/SYM ./.
@@24961093436 However/RB ,/, experiments/NNS with/IN S1/NEWGENE mapping/NN of/IN in/IN vivo/NN transcripts/NN ,/, gene/NN disruptions/NNS in/IN the/DT alpha/NN region/NN ,/, and/CC a/DT single-copy/JJ transcriptional/JJ fusion/NN vector/NN all/DT suggested/VBN that/IN these/DT possible/JJ promoters/NNS were/VBD largely/RB inactive/JJ during/IN logarithmic/JJ growth/NN ,/, that/IN the/DT major/JJ promoter/NN for/IN the/DT alpha/NEWGENE operon/NEWGENE lay/JJ upstream/RB from/IN the/DT region/NN cloned/VBN ,/, and/CC that/IN the/DT genes/NNS in/IN the/DT IF1/NEWGENE to/IN L17/NEWGENE interval/NN were/VBD cotranscribed/VBN ./.
@@71923697017 A/DT method/NN for/IN determining/JJ cumulative/JJ behavioral/JJ toxicity/NN after/IN chronic/JJ oral/JJ administration/NN of/IN l-alpha-acetylmethadol/JJ to/IN female/JJ rats/NNS ./.
@@8151787969 Mapping/NN of/IN intracellular/JJ localization/NN domains/NNS and/CC evidence/NN for/IN colocalization/NN interactions/NNS between/IN the/DT IE110/NEWGENE and/CC IE175/NEWGENE nuclear/NN transactivator/NN proteins/NN of/IN herpes/NN simplex/JJ virus/NN ./.
@@90874306918 However/RB ,/, the/DT same/JJ U1A/NEWGENE peptide/NEWGENE ,/, when/CC conjugated/JJ to/IN BSA/NEWGENE ,/, inhibits/VBZ vertebrate/NEWGENE PAP/NEWGENE ./.
@@1083784643 Lymphocyte/JJ subpopulations/NNS ,/, serum/NEWGENE IgE/NEWGENE and/CC total/JJ eosinophil/JJ counts/NNS in/IN patients/NNS with/IN bronchial/JJ asthma/NN ./.
@@91477889090 Respiratory/NNP chain/NN enzyme/NN activity/NN was/VBD normal/JJ ./.
@@115616231432 The/DT small/JJ copepod/NN Pseudonychocamptus/NN proximus/NN progressively/RB replaced/VBD the/DT large/JJ Tisbe/NNP furcata/NN in/IN sand/NN filters/NNS during/IN the/DT fall/NN of/IN 1995/CD and/CC was/VBD responsible/JJ for/IN the/DT large/JJ increase/NN in/IN meiofaunal/JJ biomass/NN observed/VBN after/IN spring/NN 1996/CD ./.
@@102218203693 An/DT undilated/JJ type/NN of/IN APBD/NN is/VBZ frequently/RB associated/VBN with/IN AMT/NNP and/CC we/PRP believe/VBP ,/, therefore/RB ,/, that/IN clinicians/NNS should/MD be/VB aware/JJ of/IN a/DT possible/JJ coexistence/NN of/IN APBD/NNP and/CC AMT/NNP ./.
@@97653946761 Cotransfection/NNS of/IN the/DT helicase-primase/NEWGENE proteins/NEWGENE ,/, one/PRP of/IN which/WDT was/VBD fused/VBN to/IN a/DT heterologous/JJ activation/NN domain/NN ,/, led/VBN to/IN Zta-dependent/NNP superactivation/NN of/IN CAT/NEWGENE expression/NN ./.
@@13714136127 In/NN addition/NN ,/, the/DT hGCSFR/NEWGENE gene/NEWGENE was/VBD chromosomally/RB localized/VBN by/IN Southern/NNP blot/NN analysis/NN of/IN its/PRP segregation/NN pattern/NN in/IN a/DT panel/NN of/IN rodent-human/JJ hybrid/JJ DNAs/NNS using/VBG the/DT radiolabeled/JJ cDNA/NN probe/NN ./.
@@110238538845 Concurrently/RB ,/, we/PRP monitored/VBD weather/VBP conditions/NNS and/CC used/VBN time-activity/JJ budget/NN data/NN of/IN free-living/NN birds/NNS and/CC laboratory/NN data/NN on/IN resting/JJ metabolic/JJ rate/NN to/IN construct/NN time-activity/JJ laboratory/NN (/( TAL/NNS )/SYM estimates/NNS of/IN daily/JJ energy/NN expenditure/NN (/( DEE/NNS )/SYM and/CC to/IN partition/NN the/DT verdins'/NN energy/NN budget/NN into/IN thermoregulatory/JJ ,/, activity/NN and/CC basal/JJ components/NNS ./.
@@25573509182 The/DT DNA/NN sequences/NNS predict/VBP proteins/NNS for/IN SRP54sc/NEWGENE and/CC SRP54sp/NEWGENE that/WDT are/VBP 47%/JJ and/CC 52%/JJ identical/JJ to/IN SRP54mam/NEWGENE ,/, respectively/RB ./.
@@90370324270 The/DT proliferation/NEWGENE potential/NEWGENE protein-related/NEWGENE (/( P2P-R/NEWGENE )/SYM gene/NN with/IN domains/NNS encoding/VBG heterogeneous/JJ nuclear/JJ ribonucleoprotein/NN association/NN and/CC Rb1/NEWGENE binding/JJ shows/NNS repressed/VBN expression/NN during/IN terminal/JJ differentiation/NN ./.
@@83843096169 The/DT intracellular/JJ basic/NEWGENE region/NEWGENE //NEWGENE helix-loop-helix/NEWGENE (/NEWGENE bHLH/NEWGENE )/NEWGENE dioxin/NEWGENE receptor/NEWGENE mediates/VBZ signal/JJ transduction/NN by/IN dioxin/NN (/( 2/JJ ,/JJ 3/JJ ,/JJ 7/JJ ,/JJ 8-tetrachlorodibenzo-p-dioxin/JJ )/SYM and/CC functions/NNS as/IN a/DT ligand-activated/NN DNA/NN binding/NN protein/NN directly/RB interacting/VBG with/IN target/NN genes/NNS by/IN binding/JJ to/IN dioxin/NEWGENE response/NEWGENE elements/NEWGENE ./.
@@19398784809 We/PRP conclude/VBP that/DT solidification/NN could/MD occur/VB in/IN all/DT feeds/NNS containing/NN casein/NEWGENE and/CC that/IN alternative/JJ feeds/NNS should/MD be/VB considered/VBN in/IN patients/NNS with/IN increased/VBN gastric/JJ acidity/NN ./.
@@22720952553 These/DT results/NNS may/MD suggest/VB involvement/NN of/IN peripheral/NN enkephalins/NEWGENE in/IN pain/NN modulation/NN in/IN patients/NNS with/IN episodic/JJ cluster/NN headache/NN ./.
@@20758762683 The/DT stimulus/NN threshold/NN for/IN EER/NN showed/VBD a/DT less/PRP individual/JJ variation/NN than/IN amplitude/NN ./.
@@107638234882 Overexpression/NNS of/IN mcl-1/NEWGENE is/VBZ sufficient/JJ to/IN protect/VB against/IN apoptosis/NN ,/, while/CC transfection/NN of/IN a/DT mcl-1/NEWGENE antisense/NN plasmid/NN causes/NNS cell/NN death/NN ./.
@@7906265844 Preliminary/JJ experiments/NNS demonstrated/VBN that/IN it/PRP was/VBD possible/JJ to/IN produce/NN fasD/NEWGENE mutants/NEWGENE ,/, whose/WP products/NNS remain/VBP functional/JJ for/IN fimbrial/JJ export/NN and/CC assembly/NN ./.
@@13893622004 Porcelain/NN to/IN dentin/NEWGENE bond/NN strength/NN with/IN a/DT dentin/NEWGENE adhesive/JJ ./.
@@114620049153 The/DT role/NN of/IN the/DT Vp1/NEWGENE DBD/NEWGENE during/IN infection/NN was/VBD investigated/VBN by/IN taking/VBG advantage/NN of/IN NLS/NEWGENE phenotypic/JJ complementation/NN (/( N/NNP ./NNP
@@91811304375 Recently/RB we/PRP have/VBP performed/VBN a/DT detailed/JJ analysis/NN of/IN specific/JJ neuronal/JJ populations/NNS affected/VBN by/IN the/DT mutation/NN which/WDT shed/VBP new/JJ light/NN on/IN the/DT role/NN of/IN Krox-20/NEWGENE in/IN the/DT segmentation/NN and/CC on/IN the/DT physiological/JJ consequences/NNS of/IN its/PRP inactivation/NN ./.
@@75595552333 Indeed/RB ,/, ERM/NEWGENE and/CC c-Jun/NEWGENE synergistically/RB activated/VBN the/DT EBS-CRE/NEWGENE without/IN making/VBG an/DT apparent/JJ ternary/JJ complex/NN ./.
@@82694397976 Pentazocine/NNP analgesia/NN :/: is/VBZ there/RB a/DT niche/NN for/IN Talwin/NN Nx/NN ?/. Pentazocine/CHEM can/MD be/VB a/DT useful/JJ analgesic/JJ agent/NN for/IN the/DT management/NN of/IN acute/JJ dental/JJ pain/NN ./.
@@90616971360 Myocardial/JJ SPET/NN imaging/JJ with/IN 99Tcm-tetrofosmin/NN in/IN clinical/JJ practice/NN :/: comparison/NN of/IN a/DT 1/CD day/NN and/CC a/DT 2/CD day/NN imaging/JJ protocol/NN ./.
@@107156022166 Animals/NNS received/VBD a/DT dose/NN of/IN dexamethasone/NN (/( 10/CD mg/CD //CD kg/CD i/CD ./CD p/CD ./CD )/SYM prior/NN to/IN the/DT protein-free/JJ surfactant/JJ preparation/NN Exosurf/IN (/( pure/JJ phospholipids/NNS containing/JJ surfactant/NN ,/, Wellcome/NN GmbH/NN ,/, Burgwedel/NNP ,/, Germany/NN )/SYM and/CC a/DT rSP-C/RB based/VBN surfactant/JJ ,/, respectively/RB ./.
@@111889711029 The/DT revitalization/NN of/IN surgery/NN for/IN Parkinson's/NNP disease/NN (/( PD/NN )/SYM has/VBZ fueled/VBN discussion/NN about/RB the/DT best/JJS methodology/NN to/IN define/VB the/DT target/NN ./.
@@1443047345 No/DT other/DT changes/NNS in/IN hematopoietic/JJ differentiation/NN status/NN were/VBD observed/VBN in/IN association/NN with/IN Id-SCL/NEWGENE expression/NN ./.
@@112741795885 Thus/RB ,/, our/PRP studies/NNS define/VBP Rac/NEWGENE //NEWGENE Cdc42/NEWGENE //NEWGENE Pak/NEWGENE as/IN a/DT module/NN upstream/RB of/IN Raf-1/NEWGENE during/IN its/PRP activation/NN by/IN microtubule/NN disruption/NN ./.
@@76801204947 RT-PCR/NN using/VBG 1/NN ./NN D-specific/NN primers/NN showed/VBD that/DT kidney/NN ,/, brain/NN and/CC prostate/NN do/NN not/RB express/VB 1/NN ./NN D/NN mRNA/NN even/VB though/CC kidney/NN and/CC brain/NN are/VBP the/DT most/RB abundant/JJ source/NN for/IN aFGF/NEWGENE protein/NEWGENE ./.
@@8702807101 Conversely/RB ,/, activation/NN of/IN this/DT signaling/JJ pathway/NN by/IN expression/NN of/IN a/DT constitutively/RB active/JJ MKK1/NEWGENE mutant/NEWGENE dramatically/RB increased/VBN cyclin/NEWGENE D1/NEWGENE promoter/NN activity/NN and/CC cyclin/NEWGENE D1/NEWGENE protein/NEWGENE expression/NN ,/, in/IN a/DT growth/JJ factor-independent/NN manner/NN ./.
@@82304458912 The/DT product/NN of/IN the/DT vpr/NEWGENE open/NEWGENE reading/NEWGENE frame/NEWGENE of/NEWGENE human/NEWGENE immunodeficiency/NEWGENE virus/NEWGENE type/NEWGENE 1/NEWGENE (/NEWGENE HIV-1/NEWGENE )/NEWGENE is/VBZ a/DT 15-kDa/NN ,/, arginine-rich/JJ protein/NN that/WDT is/VBZ present/VB in/IN virions/NNS in/IN molar/JJ quantities/NNS equivalent/JJ to/IN that/DT of/IN Gag/NEWGENE ./.
@@82125716599 Co-transfection/NNS of/IN a/DT tat/NEWGENE expressing/JJ plasmid/NN with/IN these/DT viruses/NNS containing/JJ the/DT tat/NEWGENE ORF/NEWGENE mutations/NN resulted/VBN in/IN higher/JJ levels/NNS of/IN virus/NN production/NN demonstrating/VBG that/IN the/DT effects/NNS of/IN both/DT mutants/NNS are/VBP tat/NEWGENE specific/JJ ./.
@@67132001036 Epileptiform/NNP activity/NN recorded/VBN from/IN superficial/JJ laminae/NNS bordering/VBG layer/NN 4/CD ,/, and/CC into/IN which/WDT layer/VBP 4's/VBZ primary/JJ projections/NNS terminate/VBP ,/, is/VBZ suppressed/VBN preferentially/RB by/IN phenytoin/NN ./.
@@112048973320 After/IN allowing/VBG time/NN for/IN absorption/NN ,/, participants/NNS completed/VBD a/DT bridge/NN simulator/NN task/NN ./.
@@72633742299 Static/NN lung/NN function/NN in/IN puppies/NNS after/IN pneumonectomy/NN ./.
@@76998451522 Clinical/NNP studies/NNS SY5555/NN was/VBD administered/VBN to/IN 45/CD patients/NNS with/IN various/JJ infectious/JJ diseases/NNS (/( 2/CD with/IN acute/JJ pharyngitis/NN ,/, 8/CD with/IN acute/JJ tonsillitis/NN ,/, 4/CD with/IN lacunar/JJ tonsillitis/NN ,/, 3/CD each/DT with/IN acute/JJ bronchitis/NN ,/, pneumonia/NN and/CC pertussis/NN ,/, 7/CD with/IN scarlet/JJ fever/NN ,/, 3/CD with/IN impetigo/NN contagiosa/NN ,/, 6/CD with/IN acute/JJ urinary/JJ tract/NN infections/NNS ,/, 2/CD with/IN balanoposthitis/NN and/CC 1/CD each/DT with/IN cervical/JJ lymphadenitis/NN ,/, S/NNP ./NNP S/NNP ./NNP S/NNP ./NNP S/NNP ./NNP ,/, vulvitis/NN and/CC acute/JJ colitis/NN )/SYM at/IN daily/JJ doses/NNS between/IN 3/CD ./CD 4-10/CD mg/CD //CD kg/CD ,/, t/NN ./NN i/NN ./NN d/NN ./NN ,/, for/IN 3-14/JJ days/NNS ./.
@@12973327939 This/DT analysis/NN ,/, together/RB with/IN a/DT consideration/NN of/IN the/DT SCBs/NNP found/VB upstream/RB of/IN known/VBP SWI4/NEWGENE ,/NEWGENE 6-dependent/NEWGENE genes/NEWGENE ,/, leads/VBP to/IN the/DT proposal/NN of/IN a/DT revised/VBN consensus/NN sequence/NN for/IN this/DT important/JJ regulatory/JJ element/NN ./.
@@37572948727 Of/IN the/DT cases/NNS with/IN PLD/NN ,/, 50%/NN had/VBP associated/VBN renal/JJ cysts/NNS and/CC 10%/CD of/IN the/DT cases/NNS with/IN APCD/NN had/VBP associated/VBN liver/NN cysts/NNS ./.
@@7255342983 It/PRP was/VBD postulated/VBN that/IN persistent/JJ challenge/NN by/IN M/NNP ./NNP leprae/NNS or/CC its/PRP antigens/NNS to/IN the/DT IgA/NEWGENE immunocytes/NNS of/IN the/DT intestinal/JJ epithelium/NN might/MD have/VB induced/VBN tolerance/NN leading/JJ to/IN IgA/NEWGENE deficiency/NN and/CC subsequent/JJ subtotal/JJ atrophy/NN of/IN the/DT intestinal/JJ villi/NNS in/IN the/DT patients/NNS with/IN lepromatous/JJ leprosy/NN ./.
@@24445075969 Lysozyme/NEWGENE activity/NN was/VBD evidently/RB increased/VBN as/IN well/NN in/RB undiluted/JJ as/IN in/IN diluted/VBN sera/NNS in/IN all/DT our/PRP tested/VBN patients/NNS ./.
@@92302163486 Human/NEWGENE thymine-DNA/NEWGENE glycosylase/NEWGENE maps/NNS at/IN chromosome/NN 12q22-q24/CD ./CD 1/CD :/: a/DT region/NN of/IN high/JJ loss/NN of/IN heterozygosity/NN in/IN gastric/JJ cancer/NN ./.
@@111602808548 As/IN well/NN ,/, IFN-gamma-induced/JJ expression/NN of/IN IRF-1/NEWGENE and/CC its/PRP binding/JJ to/IN the/DT IRF/NEWGENE element/NEWGENE is/VBZ inhibited/VBN ./.
@@17686489546 We/PRP exploit/VBP the/DT properties/NNS of/IN LexA/NEWGENE fusion/NEWGENE proteins/NEWGENE to/IN study/NN the/DT dimerization/NN and/CC DNA-contacting/NN domains/NN of/IN cRel/NEWGENE ./.
@@57189945666 Endocardial/JJ fibro-elastosis/NN ,/, mitral/JJ incompetence/NN ,/, and/CC coarctation/NN of/IN abdominal/JJ aorta/NN ./.
@@64686326273 Endothelium/NNS of/IN the/DT central/JJ ear/NN artery/NN of/IN an/DT anesthetized/JJ rabbit/NN is/VBZ damaged/VBN by/IN placing/VBG artery/NN forceps/NN on/IN the/DT ear/NN directly/RB over/RB the/DT vessel/NN ./.
@@12481241888 Total/JJ cholesterol/NN was/VBD measured/VBN in/IN amniotic/JJ fluids/NNS collected/VBN at/IN different/JJ stages/NNS of/IN gestation/NN ./.
@@98117182396 These/DT results/NNS demonstrate/VBP a/DT specific/JJ association/NN of/IN SIV/NN and/CC HIV-2/NEWGENE nef/NEWGENE ,/, but/CC not/RB HIV-1/NEWGENE nef/NEWGENE ,/, with/IN TCRzeta/NEWGENE ./.
@@21319028023 This/DT study/NN was/VBD performed/VBN to/IN clarify/VB the/DT location/NN of/IN a/DT transesophageal/JJ echocardiographic/JJ (/( TEE/NN )/SYM transducer/NN when/CC obtaining/JJ the/DT short-axis/NN view/NN of/IN the/DT left/NN ventricle/NN (/( S-LV/DT )/SYM ./.
@@98146377106 Low/NNP PbrO2/NN readings/NNS ,/, however/RB ,/, could/MD be/VB caused/VBN by/IN local/JJ microhemorrhages/NNS ,/, undetectable/JJ on/IN CT/NN or/CC MRI/NN ./.
@@11126806966 One/CD of/IN the/DT sequelae/NNS of/IN the/DT antiphospholipid-antibodies/NEWGENE is/VBZ an/DT impaired/VBN uteroplacental/JJ circulation/NN ./.
@@111239127414 The/DT structure/NN of/IN the/DT free/JJ SH2/NEWGENE domain/NEWGENE has/VBZ been/VBN compared/VBN to/IN that/DT of/IN the/DT SH2/NEWGENE complexed/VBN with/IN a/DT doubly/RB phosphorylated/VBN peptide/NN derived/VBN from/IN polyomavirus/NEWGENE middle/NEWGENE T/NEWGENE antigen/NEWGENE (/( MT/NEWGENE )/SYM ./.
@@26918113365 During/IN the/DT first/JJ 3/CD min/NN of/IN recovery/NN ,/, plasma/NN potassium/NN fell/NN rapidly/RB in/IN spite/NN of/IN nearly/RB unchanged/JJ blood/NN acidosis/NN and/CC significantly/RB decreasing/JJ bicarbonate/NN concentration/NN ./.
@@95667317880 All/DT three/CD genes/NNS have/VBP been/VBN mapped/VBN precisely/RB to/IN a/DT small/JJ region/NN on/IN human/JJ chromosome/NN 16p12/CD ./CD 1-p11/CD ./CD 2/CD (/( homologous/JJ to/IN mouse/NN chromosome/NN 7/CD )/SYM ,/, using/VBG somatic/JJ cell/NN hybrids/NNS and/CC cosmid/NN clones/NNS ./.
@@31239833846 The/DT role/NN of/IN neuroplasticity/NN in/IN the/DT response/NN to/IN drugs/NNS ./.
@@2315551660 Effect/NN of/IN corticosteroid-containing/JJ antirheumatic/JJ combination/NN drugs/NNS on/IN endogenous/JJ ACTH/NEWGENE and/CC cortisol/NN production/NN ./.
@@91433283962 This/DT finding/NN is/VBZ the/DT first/JJ example/NN of/IN utilization/NN of/IN noncomplementary/JJ dinucleotide/NN primer/NN by/IN an/DT RNA/NEWGENE polymerase/NEWGENE ./.
@@28947898666 Finally/RB ,/, the/DT recovery/NN indexes/NNS represented/VBN by/IN the/DT times/NNS required/VBN for/IN T1/NN //NN T0/NN and/CC T4/NN //NN T1/NN to/IN rise/NN from/IN 25%/JJ to/IN 75%/JJ respectively/RB were/VBD studied/VBN ./.
@@98889944311 This/DT Tbx6-subfamily/NEWGENE gene/NEWGENE is/VBZ likely/RB to/IN participate/VB in/IN paraxial/JJ mesoderm/NN formation/NN and/CC somitogenesis/NN in/IN human/JJ embryo/NN ./.
@@114593041334 Enantiomer/NN separation/NN of/IN venlafaxine/NN and/CC O-desmethylvenlafaxine/NNP in/IN human/JJ plasma/NN ./.
@@82315778215 Acid/JJ instilled/VBN on/IN the/DT larynx/NN of/IN maturing/JJ rabbits/NNS resulted/VBN in/IN significant/JJ obstructive/JJ ,/, central/JJ ,/, and/CC mixed/JJ apnea/NN ./.
@@12462101886 The/DT calcium/NN ratio/NN (/NN mean/NN ratio/NN of/IN the/DT predicted/VBN to/IN measured/VBN TBCa/NN )/NN in/IN men/NNS was/VBD 1/CD ./CD 000/CD +/NN //NN -/NN 7/CD ./CD 8%/CD and/CC in/IN women/NNS 0/CD ./CD 996/CD +/NN //NN -/NN 7/CD ./CD 1%/CD ./.
@@93664568784 METHODS/IN :/: Total/JJ muscle/NN paralysis/NN was/VBD induced/VBN under/IN general/JJ anesthesia/NN in/IN a/DT group/NN of/IN obese/JJ persons/NNS (/( n/NN =/SYM 9/CD ;/: body/NN mass/JJ index/NN ,/, 32/NN +/NN //NN -/NN 3/CD kg/NN [/NN -2/NN ]/NN )/SYM and/CC in/IN a/DT group/NN of/IN nonobese/JJ persons/NNS (/( n/NN =/SYM 9/CD ;/: body/NN mas/NN index/NN ,/, 21/NN +/NN //NN -/NN 2/CD kg/NN [/NN -2/NN ]/NN )/SYM ./.
@@114712311349 In/NN addition/NN ,/, these/DT patients/NNS show/NN both/DT quantitative/JJ and/CC qualitative/JJ differences/NNS in/IN their/PRP infectious/JJ microbiological/JJ spectrum/NN ,/, mainly/RB in/IN clean-contaminated/JJ ,/, contaminated/VBN and/CC dirty/JJ surgical/JJ procedures/NNS ./.
@@1001984115 Testing/NN gravity/NN to/IN second/JJ post-Newtonian/JJ order/NN :/: A/DT field-theory/JJ approach/NN ./.
@@87948693686 Several/JJ lines/NNS of/IN evidence/NN presented/VBN here/RB suggest/VB that/IN PKC-zeta/NEWGENE plays/VBP a/DT role/NN in/IN alpha/NEWGENE 2/NEWGENE integrin/NEWGENE gene/NEWGENE expression/NN ./.
@@104038396382 Comparison/NNS with/IN the/DT bHLH/NEWGENE //NEWGENE PAS/NEWGENE family/NEWGENE genes/NEWGENE revealed/VBN that/IN the/DT intron/NN //NN exon/NN splice/NN pattern/NN of/IN mBMAL1/NEWGENE most/RB closely/RB matches/VBZ that/IN of/IN the/DT mAhr/NEWGENE ,/, which/WDT suggests/VBZ that/IN BMAL1/NEWGENE and/CC Ahr/NEWGENE belong/VB to/IN the/DT same/JJ subclass/NN and/CC may/MD be/VB derived/VBN from/IN a/DT common/JJ primordial/JJ gene/NN ./.
@@1651232597 Each/DT mRNA/NN contained/VBN five/CD or/CC six/CD internal/JJ uridine/NN residues/NNS ,/, which/WDT were/VBD transcribed/VBN using/VBG a/DT mixture/NN of/IN UTP/NN and/CC thio-UTP/JJ ./.
@@90115918971 The/DT total/JJ number/NN of/IN specimens/NNS was/VBD 131/CD with/IN 78/CD nonsmokers/NNS and/CC 53/CD smokers/NNS ./.
@@93073128071 Evidence/NN for/IN such/JJ peak/NN shifts/NNS has/VBZ been/VBN found/VB in/IN the/DT responses/NNS of/IN auditory/JJ nerve/NN fibers/NNS ,/, cochlear/JJ microphonics/NNS ,/, and/CC the/DT responses/NNS of/IN outer/JJ hair/NN cells/NNS and/CC supporting/VBG cells/NNS in/IN the/DT cochlea/NN ,/, as/RB well/VB as/IN in/IN basilar/JJ membrane/NN vibration/NN measurements/NNS ,/, and/CC indirectly/RB ,/, in/IN psychophysical/JJ data/NN ./.
@@8708595572 The/DT data/NN normally/RB available/JJ are/VBP insufficient/JJ and/CC take/VB no/DT account/NN of/IN the/DT direction/NN of/IN recirculation/NN ,/, which/WDT may/MD be/VB a/DT determining/NN factor/NN ./.
@@10355085215 Subsets/NNS of/IN patients/NNS were/VBD performed/VBN according/VBG to/IN the/DT severity/NN of/IN trauma/NN (/( ISS/NN </SYM 9/CD ;/: 9-17/CD ;/: 18-31/CD ;/: >/SYM 32/CD )/SYM ,/, based/VBN on/IN the/DT different/JJ injury/NN pattern/NN ,/, and/CC survivors/NNS versus/IN nonsurvivors/NNS as/IN well/NN ./.
@@10561153380 We/PRP present/VBP a/DT case/NN of/IN carcinoma/NN of/IN the/DT breast/NN presenting/VBG concurrently/RB with/IN SSc/NNS that/WDT subsequently/RB progressed/VBN to/IN dialysis-dependent/JJ renal/JJ failure/NN in/IN just/RB 1/CD month/NN ./.
@@1559734533 Accepting/VBG arbitrarily/RB chosen/VBP limits/NNS of/IN maximized/VBN errors/NNS of/IN +/NN //NN -/NN 10%/CD ,/, it/PRP could/MD be/VB shown/VBP that/IN the/DT system/NN did/VBD not/RB work/VB acceptably/RB when/CC the/DT mean/JJ carbon/NN dioxide/NN concentration/NN was/VBD below/RB 1/CD ./CD 5/CD vol/CD ./CD %/CD within/IN the/DT fresh/JJ gas/NN flow/NN rates/NNS (/( 2/CD ./CD 2--7/CD ./CD 7/CD 1/CD min-1/NN )/SYM and/CC the/DT range/NN of/IN minute/JJ ventilation/NN (/( 4--10/NN 1/CD min-1/NN )/SYM employed/VBN ./.
@@95493985463 Overall/JJ agreement/NN between/IN rest/NN //NN postnitroglycerin/NN technetium-99m/NN tetrofosmin/NN SPET/NN studies/NNS and/CC rest/NN //NN redistribution/NN or/CC rest/NN //NN reinjection/NN thallium-201/NN SPET/JJ studies/NNS ,/, regarding/IN the/DT presence/NN of/IN myocardial/JJ viability/NN ,/, was/VBD 87%/JJ and/CC 90%/CD ,/, respectively/RB ./.
@@84433418109 Southern/NNP blot/NN analysis/NN using/VBG probes/NNS from/IN the/DT 3'/CD portions/NNS of/IN the/DT genomic/JJ and/CC B/NEWGENE ./NEWGENE napus/NEWGENE MA/NEWGENE and/CC MB/NEWGENE cDNA/NEWGENE clones/NNS showed/VBD that/DT MA/NEWGENE type/NEWGENE myrosinases/NEWGENE1 are/VBP encoded/VBN by/IN approximately/RB 4/CD genes/NNS ,/, while/CC MB/NEWGENE type/NEWGENE myrosinases/NEWGENE1 are/VBP encoded/VBN by/IN more/RB than/IN 10/CD genes/NNS in/IN B/NNP ./NNP napus/NN ./.
@@98585776514 The/DT loss/NN of/IN SKO1/NEWGENE completely/RB restored/VBN ENA1/NEWGENE expression/NN in/IN a/DT hog1/NEWGENE mutant/NEWGENE and/CC partially/RB suppressed/VBN the/DT osmotic/JJ stress/NN sensitivity/NN ,/, qualifying/JJ Sko1p/NEWGENE as/IN a/DT downstream/JJ effector/NN of/IN the/DT HOG/NN pathway/NN ./.
@@91499299097 Congruent/NNP with/IN empirical/JJ predictions/NNS ,/, the/DT most/RB homesick/JJ children/NNS perceived/JJ low/JJ control/NN over/JJ homesickness/NN and/CC separation/NN ,/, and/CC coped/VBN by/IN relinquishing/VBG control/NN ./.
@@96875116476 Downregulation/NNS of/IN FUS/NEWGENE expression/NN in/IN BCR/NNP //NNP ABL-expressing/NNP 32Dcl3/CD cells/NNS was/VBD associated/VBN with/IN suppression/NN of/IN growth/NN factor-independent/NN colony/NN formation/NN ,/, restoration/NN of/IN G-CSF-induced/JJ granulocytic/JJ differentiation/NN and/CC reduced/VBN tumorigenic/JJ potential/NN in/IN vivo/NN ./.
@@105016564381 Differential/JJ expression/NN was/VBD confirmed/VBN by/IN Northern/NNP blot/NN analysis/NN employing/VBG multiple/JJ normal/NN and/CC tumor/NN cell/NN lines/NNS ./.
@@82645832849 To/TO examine/VB the/DT biochemical/JJ basis/NN of/IN the/DT end/NN joining/VBG ,/, nuclear/JJ extracts/NNS were/VBD prepared/VBN from/IN a/DT wide/JJ variety/NN of/IN mammalian/JJ cell/NN lines/NNS and/CC tested/VBN for/IN their/PRP ability/NN to/IN join/NN test/NN plasmid/NN substrates/NNS ./.
@@8432696172 Deletion/NNS of/IN the/DT apeA/NEWGENE gene/NEWGENE ,/, either/DT with/IN or/CC without/IN deletion/NN of/IN other/DT proteinases/NEWGENE (/( protease/NEWGENE IV/NEWGENE and/CC aminopeptidase/NEWGENE N/NEWGENE )/SYM ,/, did/VBD not/RB have/VB any/DT effect/NN on/IN cell/NN growth/NN in/IN the/DT various/JJ media/NN tested/VBN ./.
@@108489939666 Genomic/NN DNA/NN sequencing/VBG in/IN the/DT vicinity/NN of/IN methylmalonyl-CoA/NEWGENE mutase/NEWGENE gene/NEWGENE (/( mutAB/NEWGENE )/SYM from/IN a/DT rifamycin/NN SV-producing/NNP Amycolatopsis/NNP mediterranei/NN U32/NN allowed/VBN us/PRP to/IN clone/NN ,/, sequence/NN ,/, and/CC identify/VB a/DT gene/NN encoding/VBG a/DT novel/JJ serine/NEWGENE //NEWGENE threonine/NEWGENE protein/NEWGENE kinase/NEWGENE (/( amk/NEWGENE )/SYM ./.
@@63554837757 The/DT genes/NNS at/IN each/DT locus/NN are/VBP divergently/RB transcribed/VBN and/CC the/DT coding/JJ sequences/NNS are/VBP separated/VBN by/IN 646/CD base-pairs/NNS at/IN one/PRP locus/NN and/CC 676/CD base-pairs/NNS at/IN the/PDT other/DT ./.
@@13785067409 Surprisingly/RB ,/, the/DT full-deletion/JJ mutant/NN showed/VBD a/DT strong/JJ block/NN in/IN virus/NN release/NN ,/, suggesting/VBG that/DT NC/NEWGENE is/VBZ involved/VBN in/IN virus/NN assembly/NN ./.
@@5033368589 It/PRP has/VBZ come/VBN out/RB that/IN CAEC/NN is/VBZ between/IN CC/NN and/CC CIEC/NNP and/CC that/IN attacks/NNS of/IN biliary/JJ fever/NN and/CC high/JJ levels/NNS of/IN alkaline/NEWGENE phosphatase/NEWGENE and/CC transaminases/NEWGENE in/IN the/DT serum/JJ are/VBP the/DT helpful/JJ findings/NNS for/IN preoperative/JJ diagnosis/NN ./.
@@111057167917 CONCLUSION/IN :/: Our/PRP results/NNS suggest/VBP that/IN AIF/NN peak/NN saturation/NN leads/VBP to/IN a/DT significant/JJ systematic/JJ error/NN in/IN the/DT determination/NN of/IN CBV/NN and/CC CBF/NN values/NNS and/CC has/VBZ necessarily/RB to/IN be/VB taken/VBP into/IN account/NN for/IN dynamic/JJ contrast-enhanced/JJ MR/NN perfusion/NN studies/NNS ./.
@@98624815902 The/DT Mig1/NEWGENE repressor/NEWGENE is/VBZ a/DT zinc/NEWGENE finger/NEWGENE protein/NEWGENE that/WDT mediates/VBZ glucose/NN repression/NN in/IN yeast/NN ./.
@@30393872180 Combined/VBN immunochemotherapy/NN with/IN cyclophosphamide/NN plus/IN BCG/NN gave/VBD a/DT better/JJR enhancement/NN of/IN the/DT antitumor/JJ effect/NN of/IN the/DT cytostatic/NN than/IN that/DT of/IN the/DT combination/NN of/IN methotrexate/NN plus/IN BCG/NN and/CC cyclophosphamide/NN plus/IN levamisole/NN ./.
@@106025163089 In/NN addition/NN ,/, SLK/NEWGENE displays/VBP high/JJ homology/NN to/IN microtubule/NEWGENE and/NEWGENE nuclear/NEWGENE associated/NEWGENE protein/NEWGENE (/( M-NAP/NEWGENE )/SYM and/CC AT1-46/NEWGENE ,/, both/DT of/IN unknown/JJ function/NN ./.
@@96559164580 In/NN the/DT DNA/NN recognition/NN helix/NN of/IN finger/NN II/NN ,/, the/DT conserved/VBN Arg/NN at/IN position/NN 62/CD (/( N-terminal/NN side/NN of/IN the/DT first/JJ zinc-coordinating/JJ histidine/NN )/SYM was/VBD changed/VBN to/IN a/DT Leu/NN or/CC Gln/NN ./.
@@97537744419 Plants/NNS transformed/VBN with/IN the/DT 35S-1-sst/NEWGENE construct/NEWGENE accumulated/VBD the/DT oligofructans/NNS 1-kestose/JJ (/( GF2/NN )/SYM ,/, 1/JJ ,/JJ 1-nystose/JJ (/( GF3/NN )/SYM and/CC 1/JJ ,/JJ 1/JJ ,/JJ 1-fructosylnystose/JJ (/( GF4/NN )/SYM ./.
@@85762622907 The/DT IL-8/NEWGENE receptor/NEWGENE is/VBZ a/DT seven-transmembrane/JJ spanning/VBG receptor/NN coupled/VBN to/IN specific/JJ heterotrimeric/NEWGENE G/NEWGENE proteins/NEWGENE including/JJ Gi/NEWGENE and/CC G16/NEWGENE ./.
@@94275516174 The/DT gene/NN contains/VBZ six/CD exons/NNS separated/VBN by/IN 1/CD ./CD 1-5/CD ./CD 8/CD kb/NN introns/NNS and/CC has/VBZ been/VBN localized/VBN to/IN the/DT murine/NN chromosome/NN 2/NN by/IN linkage/NN analysis/NN ./.
@@28447674864 RNA/NN blot/NN hybridizations/NNS identified/VBD an/DT 1/CD ./CD 8-kb/CD mRNA/NN common/JJ to/IN cytochrome/NEWGENE b6/NEWGENE and/CC subunit/NEWGENE IV/NEWGENE ,/, and/CC an/DT intensely/RB hybridizing/VBG 0/CD ./CD 8-kb/CD mRNA/NN specific/JJ to/IN the/DT subunit/NEWGENE IV/NEWGENE gene/NN probe/NN ./.
@@88913461691 To/TO address/VB the/DT biological/JJ effect/NN of/IN specific/JJ isoform/NN expression/NN ,/, NIH3T3/NNP cells/NNS were/VBD transfected/VBN with/IN a/DT eukaryotic/JJ expression/NN vector/NN containing/NN cDNA/NN for/IN FGF8a/NEWGENE ,/, FGF8b/NEWGENE ,/, or/CC FGF8e/NEWGENE ./.
@@27667453467 A/DT hospital-based/JJ study/NN of/IN the/DT relationship/NN between/IN retained/VBN placenta/NN and/CC mastitis/NN in/IN dairy/NN cows/NNS ./.
@@14002179148 Mutational/JJ analysis/NN of/IN essential/JJ IncP/NEWGENE alpha/NEWGENE plasmid/NEWGENE transfer/NEWGENE genes/NEWGENE traF/NEWGENE and/CC traG/NEWGENE and/CC involvement/NN of/IN traF/NEWGENE in/IN phage/NN sensitivity/NN ./.
@@14201771354 Substitution/NNS of/IN either/DT Val33/NN (/( by/IN Gly/NN )/SYM or/CC Gly28/NNP (/( by/IN Ser/NN )/SYM ,/, two/NN of/IN the/DT most/RB conserved/VBN residues/NNS in/IN all/DT protein/NEWGENE kinases/NEWGENE ,/, resulted/VBN in/IN enzyme/NN with/IN marginally/RB detectable/JJ activity/NN ./.
@@95452935825 Sites/NN 1/NN and/CC 4/CD in/IN lumican/NEWGENE and/CC keratocan/NEWGENE are/VBP in/IN a/DT homologous/JJ location/NN ./.
@@883880547 Genomic/NN organization/NN of/IN the/DT human/NEWGENE beta-catenin/NEWGENE gene/NEWGENE (/( CTNNB1/NEWGENE )/SYM ./.
@@19180706911 We/PRP examined/VBD the/DT binding/NN of/IN purified/VBN T3/NEWGENE receptor/NEWGENE alpha/NEWGENE (/( T3R/NEWGENE alpha/NEWGENE )/SYM ,/, overexpressed/VBN in/IN Escherichia/NN coli/JJ ,/, to/IN wild-type/NN and/CC up/NN and/CC down/NN mutations/NNS of/IN the/DT rGH/NEWGENE T3RE/NEWGENE1 to/IN evaluate/VB whether/IN transcriptional/JJ potency/NN correlates/VBP with/IN changes/NNS in/IN T3R/NEWGENE binding/JJ ./.
@@104589142941 Analysis/NNP of/IN the/DT mouse/NEWGENE STAP/NEWGENE gene/NEWGENE isolated/VBN from/IN the/DT genomic/JJ library/NN revealed/VBN that/IN the/DT STAP/NEWGENE gene/NEWGENE spans/VBZ a/DT region/NN of/IN over/RB 11/CD kb/NN and/CC comprises/VBZ eight/CD exons/NNS ./.
@@78943591098 Glomerular/JJ hemodynamics/NN during/IN abortion/NN induced/VBN by/IN RU/NN 486/NN and/CC sepsis/NN in/IN rats/NNS ./.
@@25277453530 Southern/NNP blot/NN analyses/NNS demonstrated/VBD a/DT low/NN ,/, if/IN not/RB single/JJ ,/, copy/NN number/NN for/IN this/DT gene/NN and/CC conservation/NN of/IN this/DT domain/NN in/IN other/DT vertebrates/NNS ./.
@@9785114986 Handling/VBG on/IN PND/NN 9/NN did/VBD not/RB result/VB in/IN elevated/VBN CORT/NN levels/NNS in/IN any/DT of/IN the/DT groups/NNS ./.
@@91222154128 We/PRP describe/VBP a/DT novel/JJ method/NN using/VBG Saccharomyces/NN cerevisiae/NN for/IN detecting/JJ protein-truncating/NN mutations/NN in/IN any/DT gene/NN of/IN interest/NN ./.
@@43218612451 Familial/JJ glutathione/NEWGENE reductase/NEWGENE deficiency/NN and/CC disorder/NN of/IN glutathione/NN synthesis/NN in/IN the/DT erythrocyte/NN ./.
@@80346828209 Stable/NN expression/NN of/IN truncated/NEWGENE inositol/NEWGENE 1/NEWGENE ,/NEWGENE 4/NEWGENE ,/NEWGENE 5-trisphosphate/NEWGENE receptor/NEWGENE subunits/NEWGENE in/IN 3T3/CD fibroblasts/NNS ./.
@@84377379299 Naval/NNP personnel/NN who/WP exceed/VBP standards/NNS for/IN %BF/NN can/MD be/VB separated/VBN from/IN active/JJ duty/NN ./.
@@110700077708 Transcription/NNS of/IN the/DT six/CD EBNA/NEWGENE genes/NEWGENE ,/, which/WDT are/VBP expressed/VBN in/IN EBV-immortalized/JJ primary/JJ B/NNP cells/NNS ,/, arises/VBZ from/IN one/PRP of/IN two/JJ promoters/NNS ,/, Cp/NEWGENE and/CC Wp/NEWGENE ,/, located/VBN near/IN the/DT left/NN end/NN of/IN the/DT viral/JJ genome/NN ./.
@@86435787539 Moreover/RB ,/, the/DT Rho/NEWGENE family/NEWGENE protein/NEWGENE Cdc42/NEWGENE1 ,/, a/DT conserved/VBN morphogenetic/NEWGENE G/NEWGENE protein/NEWGENE ,/, is/VBZ also/RB a/DT potent/JJ regulator/NN of/IN filamentous/JJ growth/NN and/CC FG/NEWGENE (/NEWGENE TyA/NEWGENE )/NEWGENE :/: :/: lacZ/NEWGENE expression/NN in/IN S/NNP ./NNP cerevisiae/NN ./.
@@108741518384 BACKGROUND/IN :/: Gamma/NNP knife/NN radiosurgery/NN (/( GKR/NN )/SYM is/VBZ a/DT safe/JJ and/CC effective/JJ alternative/NN to/IN surgery/NN for/IN intracranial/JJ lesions/NNS ./.
@@26894395243 Furthermore/RB ,/, the/DT 3'-untranslated/JJ regions/NNS of/IN pmGT10/NEWGENE display/NN a/DT marked/JJ degree/NN of/IN homology/NN to/IN the/DT 3'/CD region/NN of/IN the/DT rat/NEWGENE Yb1/NEWGENE gene/NEWGENE ,/, while/CC this/DT region/NN of/IN pmGT2/NEWGENE displays/VBP marked/JJ homology/NN to/IN the/DT corresponding/JJ region/NN of/IN the/DT rat/NEWGENE Yb2/NEWGENE gene/NEWGENE ./.
@@72860577142 Based/VBN on/IN AUC/NN infinity/NN analyses/NNS ,/, the/DT pharmacokinetics/NN of/IN buflomedil/NN were/VBD found/VBN to/IN be/VB linear/JJ within/IN the/DT dose/NN ranges/NNS studied/VBN (/( 50/CD to/IN 200/CD mg/NN for/IN i/JJ ./JJ v/NN ./NN injection/NN and/CC 150/CD to/IN 450/CD mg/NN for/IN oral/JJ administration/NN )/SYM ./.
@@19705605855 Translational/JJ fusions/NNS of/IN the/DT aroF/NEWGENE regulatory/NEWGENE regions/NEWGENE to/IN lacZ/NEWGENE were/VBD constructed/VBN and/CC then/RB introduced/VBN in/IN single/JJ copy/NN into/IN the/DT E/NNP ./NNP coli/JJ chromosome/NN ./. beta-Galactosidase/NEWGENE assays/NNS for/IN tyrR-mediated/JJ regulation/NN of/IN aroF-lacZ/NEWGENE expression/NN revealed/VBN that/IN the/DT E/NEWGENE ./NEWGENE coli/NEWGENE TyrR/NEWGENE repressor/NEWGENE apparently/RB recognizes/VBZ the/DT operators/NNS of/IN both/DT organisms/NNS with/IN about/JJ equal/NN efficiency/NN ./.
@@43166964929 Enzyme/VBZ histochemical/JJ findings/NNS in/IN the/DT ultimobranchial/JJ body/NN of/IN the/DT horse/NN ./.
@@90924935783 The/DT integration/NN at/IN the/DT VIP/NEWGENE CyRE/NEWGENE1 of/IN the/DT Jak-Stat/NEWGENE and/CC AP-1/NEWGENE signaling/NEWGENE pathways/NEWGENE with/IN other/DT pre-existing/JJ proteins/NNS provides/VBZ a/DT cellular/JJ mechanism/NN for/IN cell-/DT and/CC cytokine-specific/JJ signaling/NN ./.
@@113788982578 ORF1/NN (/( 1029/CD bp/NN ;/: EMBL/NN databank/NN ,/, Accession/NNS No/NN ./NN
@@90796503421 Members/NNS of/IN the/DT MAPK/NEWGENE family/NEWGENE include/VB the/DT extracellular/NEWGENE response/NEWGENE kinases/NEWGENE (/( ERKs/NEWGENE or/CC p42/NEWGENE //NEWGENE 44/NEWGENE (/NEWGENE MAPK/NEWGENE )/NEWGENE )/NN ,/, the/DT c-Jun/NEWGENE amino-terminal/NEWGENE kinases/NEWGENE (/( JNKs/NEWGENE )/SYM ,/, and/CC the/DT p38/NEWGENE //NEWGENE Hog/NEWGENE 1/NEWGENE protein/NEWGENE kinases/NEWGENE ./.
@@1088654713 Technique/NN for/IN obtaining/JJ refined/VBN ceramics/NN with/IN dense/JJ mass/NN ./.
@@103609472212 Employing/VBG fluorescence/NN spectroscopy/NN and/CC circular/JJ dichroism/NN ,/, we/PRP showed/VBD that/IN the/DT binding/NN of/IN Ca2+/NN to/IN ALG-2/NEWGENE induced/VBN significant/JJ conformational/JJ changes/NNS in/IN both/PDT the/DT N-terminal/NN and/CC C-terminal/NN domains/NN of/IN the/DT protein/NN ./.
@@86447349242 We/PRP report/VBP the/DT isolation/NN of/IN human/JJ cDNAs/NNS homologous/JJ to/IN the/DT Drosophila/NEWGENE dishevelled/NEWGENE (/( dsh/NEWGENE )/SYM segment-polarity/NN gene/NN ./.
@@111382316265 Closeup/NN :/: a/DT resource/NN for/IN nurses/NNS who/WP smoke/VBP ./.
@@116875173023 No/DT ISREs/NEWGENE could/MD be/VB identified/VBN in/IN the/DT mouse/NN promoter/NN ./.
@@82128979695 The/DT hydrophobicity/NN profile/NN of/IN the/DT methyltransferase/NEWGENE reveals/VBZ the/DT presence/NN of/IN at/IN least/RB five/CD potential/JJ transmembrane/JJ domains/NNS ./.
@@84252216153 We/PRP describe/VBP a/DT novel/JJ cytoplasmic/NEWGENE tyrosine/NEWGENE kinase/NEWGENE ,/, termed/JJ BPK/NEWGENE (/( B/NEWGENE cell/NEWGENE progenitor/NEWGENE kinase/NEWGENE )/SYM ,/, which/WDT is/VBZ expressed/VBN in/IN all/DT stages/NNS of/IN the/DT B/NNP lineage/NN and/CC in/IN myeloid/JJ cells/NNS ./.
@@11182931025 The/DT data/NN support/NN the/DT notion/NN that/DT suppression/NN of/IN images/NNS during/IN binocular/JJ rivalry/NN is/VBZ independent/JJ in/IN both/DT eyes/NNS ./.
@@111263538926 RESULTS/NNS :/: Prevalence/NNS of/IN obesity/NN (/( BMI/NN SDS/NN >/NN 2/NN ./NN 0/NN )/SYM was/VBD </SYM 2%/JJ at/IN diagnosis/NN ,/, but/CC increased/VBD to/IN 16%/JJ at/IN 3y/CD ./CD
@@94269074134 The/DT purpose/NN of/IN this/DT investigation/NN was/VBD to/IN describe/VB a/DT new/JJ formulation/NN of/IN silver/JJ sulfadiazine/NN in/IN a/DT water/JJ soluble/JJ gel/NN ,/, poloxamer/NN 188/NN ./.
@@91701591446 These/DT mutations/NNS create/VBP stop/NN codons/NNS in/IN exon/NN 7/CD and/CC 8/CD ,/, respectively/RB ,/, and/CC probably/RB result/VB in/IN truncated/JJ proteins/NNS lacking/JJ HLH-Zip/NEWGENE or/CC Zip/NEWGENE structure/NN ./.
@@11195861035 Glycogen/NEWGENE utilization/NN was/VBD increased/VBN ,/, but/CC tissue/NN levels/NNS of/IN creatine/NN phosphate/NN ,/, ATP/NN ,/, and/CC lactate/NN were/VBD similar/JJ to/IN those/DT in/NN hearts/NNS receiving/JJ normal/JJ flow/NN ./.
@@93806979443 Two/CD sterol/NEWGENE regulatory/NEWGENE element-like/NEWGENE sequences/NEWGENE mediate/VBP up-regulation/NN of/IN caveolin/NEWGENE gene/NEWGENE transcription/NN in/IN response/NN to/IN low/NEWGENE density/NEWGENE lipoprotein/NEWGENE free/JJ cholesterol/NN ./.
@@114620046088 2/CD were/VBD nonviable/JJ ,/, and/CC the/DT mutant/NEWGENE Vp1s/NEWGENE unexpectedly/RB failed/VBD to/IN localize/VB to/IN the/DT nucleus/NN though/CC Vp2/NEWGENE and/CC Vp3/NEWGENE did/VBD ,/, suggesting/VBG that/IN the/DT mutated/NEWGENE NLS1/NEWGENE acted/VBN as/IN a/DT dominant/JJ signal/NN for/IN the/DT cytoplasmic/JJ localization/NN of/IN Vp1/NEWGENE ./.
@@73957507242 Underestimations/NNS by/RB as/RB much/JJ as/IN 35%/NN may/MD occur/VB due/NN to/IN the/DT problems/NNS in/IN the/DT existing/JJ methodologies/NNS ./.
@@40391094822 This/DT laser/NN provided/VBD sufficient/JJ power/NN in/IN an/DT amniotic/JJ fluid/NN medium/NN to/IN occlude/VB placental/JJ vessels/NNS as/RB large/JJ as/IN 7/CD mm/NN in/IN diameter/NN within/IN 6/CD seconds/NNS at/IN a/DT power/NN density/NN of/IN 2000/CD W/NN //NN cm2/NN ./.
@@107736675639 The/DT HMG/NEWGENE domain/NEWGENE of/IN both/DT HMG20/NEWGENE proteins/NEWGENE is/VBZ most/RB similar/JJ to/IN that/DT of/IN yeast/NEWGENE NHP6A/NEWGENE (/( 38%/JJ to/IN 42%/JJ )/SYM ./.
@@91880944212 We/PRP have/VBP found/VBN that/IN mcs4-/NEWGENE cells/NNS are/VBP defective/JJ at/IN activation/NN of/IN Spc1/NEWGENE in/IN response/NN to/IN various/JJ forms/NNS of/IN stress/NN ./.
@@17179944973 Cloning/NN of/IN a/DT human/JJ cDNA/NN encoding/VBG a/DT CDC2-related/NEWGENE kinase/NEWGENE by/IN complementation/NN of/IN a/DT budding/NEWGENE yeast/NEWGENE cdc28/NEWGENE mutation/NN ./.
@@19564919393 A/DT 7-day/CD treatment/NN of/IN amphotericin/NN B/NN (/( 5/CD mg/NN //NN kg/NN //NN day/NN i/CD ./CD p/CD ./CD )/SYM significantly/RB reduced/VBN the/DT glomerular/JJ filtration/NN rate/NN (/( GFR/NN )/SYM measured/VBN as/IN inuline/NN clearance/NN and/CC creatinine/NN clearance/NN (/( 0/CD ./CD 74/CD +/NN //NN -/NN 0/CD ./CD 29/CD and/CC 0/NN ./NN 16/NN +/NN //NN -/NN 0/CD ./CD 04/CD ml/NN //NN min/NN ,/, respectively/RB )/SYM in/IN comparison/NN to/IN vehicle-treated/JJ rats/NNS (/( 2/CD ./CD 04/CD +/NN //NN -/NN 0/CD ./CD 23/CD and/CC 1/CD ./CD 29/CD +/NN //NN -/NN 0/CD ./CD 19/CD ml/NN //NN min/NN ,/, respectively/RB )/SYM ./.
@@112412151379 The/DT mutant/JJ receptors/NNS ,/, as/RB well/VB as/IN sBMPR-IA/NEWGENE ,/, were/VBD expressed/VBN as/IN fusion/NN proteins/NNS with/IN thioredoxin/NEWGENE in/IN Escherichia/NN coli/JJ ,/, and/CC purified/VBN using/VBG reverse/JJ phase/NN high/JJ performance/NN liquid/JJ chromatography/NN (/( RP-HPLC/NN )/SYM after/IN digestion/NN with/IN enterokinase/NEWGENE ./.
@@51337235392 Effect/NN of/IN phenformin/NN on/IN gluconeogenesis/NN in/IN perfused/VBN rat/NN liver/NN ./.
@@111796873485 The/DT Ig-related/NN ,/, typical/JJ metazoan/JJ ,/, module/NN is/VBZ classified/VBN to/IN the/DT disulphide/NN lacking/JJ Ig/NEWGENE members/NEWGENE and/CC represents/VBZ the/DT phylogenetic/JJ earliest/JJS member/NN of/IN this/DT group/NN ./.
@@89189344603 Comparison/NNS of/IN the/DT sequences/NNS of/IN the/DT xFxFG/NEWGENE repeat/NEWGENE regions/NEWGENE of/IN p62/NEWGENE and/CC Nsplp/NEWGENE indicated/VBN that/IN NTF2/NEWGENE was/VBD probably/RB interacting/VBG with/IN the/DT phenylalanine-containing/JJ core/NN of/IN these/DT repeats/NNS and/CC not/RB the/DT intervening/JJ hydrophilic/JJ linkers/NNS ./.
@@38021954631 These/DT fusion/NN proteins/NNS also/RB allowed/VBN the/DT localization/NN of/IN the/DT transcriptional/JJ activation/NN and/CC DNA/NN binding/JJ domains/NNS of/IN the/PDT ToxR/NEWGENE protein/NEWGENE to/IN its/PRP cytoplasmically/RB located/VBN N-terminal/NN portion/NN ./.
@@97105893891 Site-directed/JJ mutagenesis/NN of/IN residues/NNS in/IN this/DT domain/NN (/( R82A/NN ,/, K85A/NN ,/, K88A/NN ,/, and/CC V89A/NN )/SYM resulted/VBN in/IN proteins/NNS which/WDT failed/VBD to/IN transactivate/VB from/IN the/DT HTLV-1/NEWGENE LTR/NEWGENE in/IN vivo/NN ./.
@@68373128491 Fibromuscular/JJ intimal/JJ thickening/NN was/VBD seen/VBP in/IN the/DT ascending/JJ and/CC thoracic/JJ aorta/NN of/IN the/DT swine/NN fed/VBN 62/CD ,/CD 500/CD IU/NN of/IN vitamin/NN D3/NN //NN kg/NN of/IN diet/NN for/IN three/CD months/NNS duration/NN ;/: and/CC after/IN 3/CD months/NNS of/IN vitamin/NN D3/NN withdrawal/NN ,/, atherosclerotic/JJ lesions/NNS were/VBD found/VBN ./.
@@111533025946 Naltrexone/NN hydrochloride/NN is/VBZ a/DT synthetic/JJ opioid/NN receptor/NN antagonist/NN recently/RB used/VBD in/IN efforts/NNS to/IN provide/VB rapid/JJ opioid/JJ detoxification/NN ./.
@@22684612908 The/DT survival/NN in/IN the/DT case/NN of/IN these/DT patients/NNS was/VBD studied/VBN five/CD years/NNS later/JJR ./.
@@86629283457 Receptors/NNS for/IN interleukin/NEWGENE (/NEWGENE IL/NEWGENE )/NEWGENE -10/NEWGENE and/CC IL-6-type/NEWGENE cytokines/NEWGENE use/NN similar/JJ signaling/JJ mechanisms/NNS for/IN inducing/JJ transcription/NN through/JJ IL-6/NEWGENE response/NEWGENE elements/NEWGENE ./.
@@85016788464 This/DT new/JJ knowledge/NN has/VBZ contributed/VBN to/IN the/DT development/NN of/IN a/DT successful/JJ immunoprophylactic/JJ strategy/NN for/IN eliminating/JJ Hib/NN disease/NN ./.
@@78363643142 Self/NNP or/CC foreign/JJ cellular/JJ proteins/NNS provide/VBP peptides/NNS for/IN presentation/NN by/IN major/NEWGENE histocompatibility/NEWGENE complex/NEWGENE (/NEWGENE MHC/NEWGENE )/NEWGENE class/NEWGENE I/NEWGENE molecules/NEWGENE on/IN the/DT surface/NN of/IN antigen/NN presenting/VBG cells/NNS (/( APC/NN )/SYM ./.
@@98585720 The/DT yeast/NN retrotransposon/NEWGENE1 Ty5/NEWGENE1 preferentially/RB integrates/VBZ into/IN regions/NNS of/IN silent/JJ chromatin/NN ./.
@@64437146249 Finding/VBG of/IN Rhodnius/NN prolixus/NN Stal/JJ ,/, 1859/CD ,/, in/IN babassu/NN palm/NN trees/NNS ./.
@@78780409784 In/NN the/DT first/NN ,/, homologous/JJ sequences/NNS were/VBD deleted/VBN from/IN a/DT mouse/NN enhancer/NN ,/, resulting/JJ in/IN a/DT tissue-specific/JJ loss/NN of/IN activity/NN when/CC assayed/VBN in/IN transgenic/JJ mice/NNS ./.
@@37760809842 Parasitological/JJ post-mortem/JJ examination/NN of/IN all/DT seropositive/JJ animals/NNS showed/VBD five/CD and/CC seven/CD false-positive/JJ animals/NNS when/CC E/NEWGENE //NEWGENE S/NEWGENE and/NEWGENE CWE/NEWGENE antigens/NEWGENE were/VBD used/VBN ,/, respectively/RB ./.
@@16870502286 Diagnostic/NNP value/NN of/IN cerebrospinal/NEWGENE fluid/NEWGENE immunoglobulin/NEWGENE G/NEWGENE (/( IgG/NEWGENE )/SYM in/IN pediatric/JJ neurological/JJ diseases/NNS ./.
@@91478329092 Children's/NNP temperament/NN and/CC maternal/JJ socialization/NN at/IN Time/NNP 1/CD (/( n/NN =/SYM 103/CD ,/, aged/VBN 2-3/CD years/NNS )/SYM were/VBD considered/VBN predictors/NNS of/IN future/JJ conscience/NN ,/, assessed/VBN using/VBG new/JJ observational/JJ and/CC narrative/JJ measures/NNS ./.
@@114450086622 The/DT assay/NN herein/RB described/VBD allows/VBZ the/DT comparison/NN of/IN relative/JJ FGFR/NEWGENE expression/NN levels/NNS ,/, both/DT within/IN a/DT single/JJ RNA/NN pool/NN and/CC among/IN multiple/JJ RNA/NN pool/NN samples/NNS ./.
@@113161275918 The/DT %SVend/NN of/IN HCM-I/NNP was/VBD significantly/RB lower/JJR than/IN the/DT respective/JJ values/NNS of/IN the/DT HCM-II/NN and/CC Control/NNP groups/NNS ./.
@@35161899414 All/DT patients/NNS then/RB received/VBN suxamethonium/NN 1/NN ./NN 5/NN mg/NN kg-1/NN i/CD ./CD v/CD ./.
@@26375977339 Serological/JJ studies/NNS at/IN the/DT early/JJ relapse/NN stage/NN of/IN this/DT disease/NN showed/VBD increased/VBN serum/NEWGENE ANA/NEWGENE ,/, IgA/NEWGENE and/CC IgM/NEWGENE level/NN with/IN normal/JJ IgG/NEWGENE and/CC decrease/NN of/IN C3/NN and/CC C4/NNP ./NNP
@@14837552100 Magnetic/JJ resonance/NN spectroscopy/NN (/( MRS/NN )/SYM and/CC imaging/VBG (/( MRI/NN )/SYM are/VBP now/RB well/VB established/VBN techniques/NNS for/IN the/DT study/NN of/IN cellular/JJ metabolism/NN and/CC gross/JJ structure/NN of/IN muscle/NN ./.
@@101956907286 The/DT peroxisome/NEWGENE proliferator-activated/NEWGENE receptors/NEWGENE (/( PPARs/NEWGENE )/SYM are/VBP members/NNS of/IN the/DT nuclear/NEWGENE hormone/NEWGENE receptor/NEWGENE superfamily/NEWGENE ./.
@@79356265167 The/DT unexpected/JJ presence/NN of/IN the/DT tRNA/NEWGENE (/NEWGENE trp/NEWGENE )/NEWGENE (/NEWGENE CCA/NEWGENE )/NEWGENE -gene/NEWGENE transcript/NEWGENE in/NEWGENE mitochondria/NEWGENE is/VBZ also/RB reported/VBN ./.
@@10713176665 Cyclin/NEWGENE A/NEWGENE expression/NN is/VBZ repressed/VBN in/IN quiescent/JJ cells/NNS by/IN E2F/NEWGENE acting/JJ in/IN conjunction/NN with/IN its/PRP pocket/NN protein/NN partners/NNS Rb/NEWGENE ,/, p107/NEWGENE ,/, and/CC p130/NEWGENE ;/: however/RB ,/, v-Jun/NEWGENE overrides/VBZ this/DT control/NN ,/, causing/JJ phosphorylated/VBN Rb/NEWGENE and/CC proliferation-specific/NNP E2F-p107/NEWGENE complexes/NEWGENE to/IN persist/VB after/IN mitogen/NN withdrawal/NN ./.
@@33448122022 Thus/RB the/DT present/NN data/NN also/RB suggest/VB that/DT BP/NN and/CC HR/NN measurements/NNS are/VBP influenced/VBN not/RB only/RB by/IN state-dependent/NN factors/NN but/CC also/RB by/IN at/IN least/RB three/CD different/JJ factors/NNS that/WDT are/VBP each/DT independent/NN of/IN the/DT state/NN :/: one/PRP leads/VBP to/IN BP/NN and/CC HR/NN values/NNS that/WDT are/VBP influenced/VBN by/IN the/DT cycle/NN the/DT animal/NN is/VBZ in/IN and/CC the/PDT other/DT two/JJ influence/NN ,/, respectively/RB ,/, the/DT ranking/NN of/IN the/DT individual's/NNS BP/NN and/CC HR/NN levels/NNS within/IN the/DT population/NN ./.
@@111213971841 The/DT present/NN findings/NNS revealed/VBN that/IN the/DT rib-2/NEWGENE protein/NEWGENE was/VBD a/DT unique/JJ alpha1/NEWGENE ,/NEWGENE 4-N-acetylglucosaminyltransferase/NEWGENE involved/VBN in/IN the/DT biosynthetic/JJ initiation/NN and/CC elongation/NN of/IN heparan/NN sulfate/NN ./.
@@81253197654 The/DT ipiO/NEWGENE genes/NEWGENE code/NN for/IN two/JJ almost/RB identical/JJ 152-aa/JJ proteins/NNS which/WDT do/VBP not/RB have/VB any/DT homology/NN with/IN sequences/NNS present/VBP in/IN data/NN libraries/NNS ./.
@@115054078540 RESULTS/NNS :/: The/DT analyzed/VBN fragment/NN has/VBZ significant/JJ activity/NN in/IN EpCAM/NEWGENE positive/JJ cells/NNS ,/, and/CC it/PRP is/VBZ regulated/VBN negatively/RB by/IN tumor/NEWGENE necrosis/NEWGENE factor/NEWGENE alpha/NEWGENE (/( TNFalpha/NEWGENE )/SYM ./.
@@11117826957 Because/IN PET/NN is/VBZ also/RB useful/JJ for/IN the/DT pretreatment/JJ and/CC follow-up/JJ evaluation/NN ,/, the/DT use/NN of/IN stereotactic/JJ PET/NN in/IN these/DT patients/NNS can/MD enable/VB an/DT accurate/JJ comparison/NN of/IN PET-based/JJ metabolic/JJ data/NN with/IN MR-based/JJ anatomical/JJ data/NN ./.
@@78070023139 To/TO do/VB this/DT ,/, segments/NNS of/IN DNA/NN from/IN the/DT 5'/CD flank/NN of/IN the/DT initiation/NN sites/NNS for/IN germline/NN epsilon/NEWGENE RNA/NEWGENE were/VBD ligated/VBN to/IN a/DT luciferase/NEWGENE reporter/NEWGENE gene/NEWGENE and/CC transfected/VBN into/IN two/JJ mouse/NN B/NNP cell/NN lines/NNS ,/, one/PRP of/IN which/WDT can/MD be/VB induced/VBN to/IN switch/NN to/IN IgE/NEWGENE ./.
@@79278388731 In/NN eight/CD groups/NNS of/IN subjects/NNS operating/JJ various/JJ hand-held/JJ vibrating/JJ tools/NNS and/CC aged/VBN from/IN 30/CD to/IN 59/CD years/NNS ,/, the/DT prevalence/NN rates/NNS of/IN vibration-induced/NN white/NN finger/NN (/( VWF/NN )/SYM and/CC numbness/NN ,/, pain/NN ,/, or/CC stiffness/NN in/IN the/DT upper/JJ and/CC lower/JJR extremities/NNS were/VBD investigated/VBN ./.
@@10807900518 Among/IN non-cirrhotics/NNS ,/, lack/NN of/IN portal/JJ vein/NN visualisation/NN had/VBP a/DT 90%/CD sensitivity/NN ,/, 88%/JJ specificity/NN ,/, 94%/NN negative/JJ predictive/JJ value/NN ,/, and/CC 83%/JJ positive/JJ predictive/JJ value/NN in/IN the/DT diagnosis/NN of/IN pre-sinusoidal/JJ portal/JJ hypertension/NN ./.
@@103929006701 The/DT activation/NN of/IN the/DT HIV/NN promoter/NN required/VBD the/DT nuclear/JJ localization/NN of/IN c-Abl/NEWGENE and/CC could/MD be/VB correlated/VBN with/IN increased/VBN tyrosine/NN phosphorylation/NN of/IN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE ./.
@@87404161942 The/DT SEB1/NEWGENE homologue/NN thus/RB isolated/VBD ,/, SEB2/NEWGENE ,/, encodes/VBZ a/DT protein/NN 53%/JJ identical/JJ to/IN Seb1p/NEWGENE ./.
@@99905076485 CONCLUSIONS/IN :/: Fission/NEWGENE yeast/NEWGENE SCF/NEWGENE is/VBZ composed/VBN of/IN Pop1/NEWGENE and/CC Pop2/NEWGENE ,/, two/JJ structurally/RB related/VBN but/CC functionally/RB independent/NN F-box/NEWGENE //NEWGENE WD-repeat/NEWGENE proteins/NEWGENE ./.
@@98907789890 Carbohydrates/NNS and/CC glycoconjugates/NNS biophysical/JJ methods/NNS ./.
@@27336907234 Molecular/NNP cloning/NN and/CC characterisation/NN of/IN the/DT two/JJ homologous/JJ genes/NNS coding/JJ for/IN nitrate/NEWGENE reductase/NEWGENE in/NEWGENE tobacco/NEWGENE ./.
@@10850329654 IL-2/NEWGENE is/VBZ accepted/VBN as/IN a/DT standard/JJ treatment/NN used/VBN alone/RB ,/, or/CC in/IN combination/NN with/IN chemotherapy/NN or/CC biotherapy/NN in/IN the/DT management/NN of/IN metastatic/JJ melanoma/NN and/CC metastatic/JJ renal/JJ cell/NN carcinoma/NN ./.
@@106138743181 Cloning/VBG and/CC sequencing/VBG of/IN the/DT upstream/JJ region/NN of/IN pepX/NEWGENE revealed/VBD the/DT presence/NN of/IN two/JJ ORFs/NNS of/IN 360/CD and/CC 1/CD ,/CD 338/CD bp/NN that/WDT were/VBD shown/VBP to/IN be/VB able/JJ to/IN encode/VB proteins/NNS with/IN high/JJ homology/NN to/IN GlnR/NEWGENE and/CC GlnA/NEWGENE proteins/NEWGENE ,/, respectively/RB ./.
@@108285917143 The/DT transcript/NN was/VBD initially/RB identified/VBN as/IN a/DT partial/JJ cDNA/NN sequence/NN in/IN the/DT course/NN of/IN constructing/JJ a/DT transcript/NN map/NN of/IN the/DT region/NN between/IN markers/NNS D11S1765/NEWGENE and/CC uteroglobin/NEWGENE known/VBP to/IN encompass/VB the/DT gene/NN causing/JJ Best/NN disease/NN ./.
@@16178012200 DESIGN/IN :/: Serum/NN aldosterone/NN and/CC plasma/NEWGENE renin/NEWGENE activity/NN were/VBD measured/VBN supine/JJ prior/NN to/IN and/CC 60/CD ,/, 90/CD ,/, 120/CD minutes/NNS after/IN oral/JJ captopril/NN ,/, 25/CD mg/NN ./NN
@@68166091983 At/NN 43%/JJ blood/NN pressure/NN reduction/NN ,/, PCO2/NN fell/NN by/IN 0/CD ./CD 53/CD kPa/NN ,/, a/DT decrease/NN which/WDT could/MD not/RB explain/VB the/DT observed/VBN CBF/NN fall/NN of/IN 27%/NN ./.
@@14033912265 Chronic/NNP hepatitis/NN B/NN in/IN adopted/VBN Romanian/JJ children/NNS ./.
@@91902029018 This/DT coat/NEWGENE protein/NEWGENE consists/VBZ of/IN Sar1p/NEWGENE ,/, the/DT Sec23p/NEWGENE protein/NEWGENE complex/NEWGENE containing/JJ Sec23p/NEWGENE and/CC Sec24p/NEWGENE ,/, and/CC the/DT Sec13p/NEWGENE protein/NEWGENE complex/NEWGENE containing/JJ Sec13p/NEWGENE and/CC a/DT novel/JJ 150-kDa/NEWGENE protein/NEWGENE ,/NEWGENE p150/NEWGENE ./.
@@17829822325 Felodipine/NNP did/VBD not/RB alter/VB the/DT baseline/NN FEV1/NN ,/, but/CC showed/VBD a/DT small/JJ significant/JJ inhibitory/JJ effect/NN upon/IN histamine/NN and/CC AMP/NN induced/VBD bronchoconstriction/NN ./.
@@94510036210 Thus/RB ,/, Esigma54/NEWGENE promoters/NEWGENE are/VBP responsive/JJ to/IN CRP/NEWGENE ,/, a/DT protein/NN unrelated/JJ to/IN sigma54/NEWGENE activators/NEWGENE ,/, and/CC the/DT repression/NN exerted/VBN is/VBZ the/DT direct/JJ result/NN of/IN an/DT interaction/NN between/IN Esigma54/NEWGENE and/CC the/DT CRP-cAMP/NEWGENE complex/NEWGENE ./.
@@91737339821 Three/CD different/JJ techniques/NNS of/IN EA/NN analysis/NN were/VBD used/VBN in/IN the/DT study/NN :/: 1/NN )/NN fast/JJ Fourier/NN transformation/NN (/( FFT/NN )/SYM of/IN EA/NN in/IN a/DT broad/JJ band/NN ,/, 2/NN )/NN developed/VBN by/IN us/PRP alternative/JJ method/NN of/IN non-harmonic/JJ expansion/NN of/IN the/DT EEG/NN curves/NNS taking/VBG into/IN account/NN their/PRP shape/NN ,/, 3/NN )/NN factor/NN analysis/NN of/IN the/DT EA/NN spectral/JJ densities/NNS ./.
@@77134216183 We/PRP show/VBP that/IN these/DT three/CD gain-of-function/NN mutants/NNS differ/VBP considerably/RB in/IN their/PRP ability/NN to/IN bypass/NN the/DT sex/NN determination/NN signal/JJ ,/, with/IN SxlM4/NEWGENE being/VBP the/DT strongest/JJS and/CC SxlM1/NEWGENE the/DT weakest/JJS ./.
@@1075247557 These/DT studies/NNS identify/VBP several/DT of/IN the/DT signal-transduction/JJ events/NNS involved/VBN in/IN the/DT apoptosis/NN of/IN malignant/JJ B/NNP cells/NNS that/WDT transpire/VBP following/IN ligation/NN of/IN CD20/NEWGENE by/IN anti-CD20/NEWGENE antibodies/NEWGENE in/IN the/DT presence/NN of/IN Fc-receptor-expressing/JJ cells/NNS or/CC secondary/JJ goat/NN anti-/NEWGENE (/NEWGENE mouse/NEWGENE Ig/NEWGENE )/NEWGENE antibodies/NEWGENE and/CC which/WDT may/MD contribute/VB to/IN the/DT tumor/NN regressions/NNS observed/VBN in/IN mouse/NN models/NNS and/CC clinical/JJ trials/NNS ./.
@@96507897469 Orientation/NNS of/IN the/DT nuclear/JJ spin/NN system/NN by/IN optical/JJ pumping/JJ causes/VBZ an/DT Overhauser/NN shift/NN of/IN the/DT excitonic/JJ energy/NN levels/NNS proportional/JJ to/IN the/DT degree/NN of/IN nuclear/JJ orientation/NN ./.
@@64826656282 The/DT findings/NNS demonstrate/VBP that/IN AMPH/DT administration/NN induces/VBZ a/DT significant/JJ increase/NN in/IN the/DT height/NN of/IN a/DT major/JJ electroactive/JJ peak/NN in/IN the/DT caudate/JJ nucleus/NN of/IN pigtail/NN monkeys/NNS ,/, and/CC further/RB that/IN such/JJ amphetamine-induced/JJ increases/NNS can/MD be/VB manipulated/VBN by/IN altering/VBG the/DT affective/NN and/IN //IN or/IN emotional/JJ state/NN of/IN the/DT animal/NN ./.
@@8208540782 Cloning/VBG and/CC sequencing/VBG of/IN the/DT corresponding/JJ cDNAs/NNS indicates/VBZ that/IN ,/, via/NN alternative/JJ splicing/JJ ,/, the/DT rearranged/JJ gene/NN codes/NNS for/IN two/JJ proteins/NNS of/IN 84/CD and/CC 85/CD kD/NN (/( p84/NEWGENE //NEWGENE 85/NEWGENE )/SYM which/WDT retain/VBP the/DT DNA-binding/NN rel/NEWGENE domain/NEWGENE and/CC the/DT first/JJ five/CD ankyrin/NEWGENE repeats/NNS ,/, but/CC have/VB lost/VBP their/PRP carboxy-terminus/NN including/JJ the/DT seventh/JJ ankyrin/NEWGENE repeat/NN ./.
@@91930773023 Light/NEWGENE regulatory/NEWGENE unit/NEWGENE 1/NEWGENE (/( LRU1/NEWGENE )/SYM is/VBZ necessary/JJ for/IN and/CC sufficient/JJ to/IN mediate/VB light-dependent/JJ activation/NN of/IN the/DT chalcone/NEWGENE synthase/NEWGENE (/NEWGENE CHS/NEWGENE )/NEWGENE minimal/NEWGENE promoter/NEWGENE in/IN Petroselinum/NNP crispum/NN ./.
@@75104617394 One/CD patient/NN only/RB had/VBP any/DT test/NN abnormalities/NNS ./.
@@106478178780 Isolation/NNS of/IN cDNAs/NEWGENE encoding/NEWGENE gibbon/NEWGENE and/NEWGENE monkey/NEWGENE platelet/NEWGENE and/NEWGENE T/NEWGENE cell/NEWGENE activation/NEWGENE antigen/NEWGENE 1/NEWGENE (/( PTA1/NEWGENE )/SYM ./.
@@92347038107 JNK/NEWGENE is/VBZ additionally/RB regulated/VBN by/IN the/DT Ras-related/NN G/NEWGENE proteins/NEWGENE Rac/NEWGENE1 and/CC Cdc42/NEWGENE ./.
@@99322885285 Expression/NNS of/IN the/DT second/JJ gene/NN (/( XT3/NEWGENE )/SYM was/VBD found/VBN to/IN be/VB conserved/VBN in/IN human/JJ kidney/NN ,/, and/CC partial/JJ sequence/NN was/VBD obtained/VBN from/IN a/DT human/JJ cDNA/NN library/NN ./.
@@100213332649 Genetic/NNP experiments/NNS using/VBG mutants/NNS defective/JJ in/IN apontic/NEWGENE and/CC bruno/NEWGENE reveal/VB a/DT functional/JJ interaction/NN between/IN these/DT genes/NNS ./.
@@93156316508 Deletion/NNS of/IN the/DT POR2/NEWGENE gene/NEWGENE alone/RB had/VBP no/DT detectable/JJ phenotype/NN ,/, while/CC yeasts/NNS with/IN deletions/NNS of/IN both/PDT the/DT POR1/NEWGENE and/CC POR2/NEWGENE genes/NEWGENE were/VBD viable/JJ and/CC able/JJ to/IN grow/VB on/IN glycerol/NN at/IN 30/CD degrees/NNS C/NN ,/, albeit/IN more/RB slowly/RB than/IN delta/NEWGENE por1/NEWGENE single/NEWGENE mutants/NEWGENE ./.
@@9950394189 The/DT history/NN of/IN exposure/NN and/CC carboxyhemoglobin/NEWGENE levels/NNS should/MD alert/VB the/DT physician/NN to/IN this/DT diagnosis/NN ./.
@@65791476343 The/DT salient/JJ clinical/JJ features/NNS ,/, the/DT problems/NNS of/IN management/NN and/CC the/DT modern/JJ approaches/NNS to/IN the/DT reconstruction/NN of/IN facial/JJ deformities/NNS seen/VBP in/IN this/DT disease/NN are/VBP described/VBN ./.
@@88941448845 CsA/NN alone/RB resulted/VBD in/IN elevated/VBN bone/NN turnover/NN ./.
@@76291224401 Mutational/JJ analysis/NN of/IN potential/JJ activating/NN phosphorylation/NN sites/NN found/VBP in/IN NIMA/NEWGENE ,/, NIM-1/NEWGENE ,/, and/CC related/VBD protein/NEWGENE kinases/NEWGENE was/VBD performed/VBN on/IN NIMA/NEWGENE ./.
@@4652237671 In/NN the/DT 8/CD patients/NNS the/DT difference/NN betweent/NN he/PRP mean/JJ diastolic/JJ values/NNS of/IN delta/NN PU/NN and/CC delta/NN PM/NN was/VBD -/: 0/CD ./CD 54/CD +/NN //NN -/NN 1/CD ./CD 0/CD (/( SD/NN )/SYM mmHg/NN ./.
@@98910613282 As/IN expected/VBN for/IN a/DT positive/JJ SpHE/NEWGENE transcriptional/NEWGENE regulator/NEWGENE ,/, the/DT timing/NN of/IN SpEts4/NEWGENE gene/NEWGENE expression/NN precedes/VBZ the/DT transient/JJ expression/NN of/IN SpHE/NEWGENE in/IN the/DT very/RB early/NN sea/NN urchin/NN blastula/NN ./.
@@118585481745 The/DT structure/NN has/VBZ been/VBN established/VBN by/IN a/DT study/NN of/IN its/PRP mono-/JJ and/CC bidimensional/JJ NMR/NN spectra/NNS and/CC mass/JJ spectrometry/NN ./.
@@90322332437 Interaction/NNS of/IN Ets-1/NEWGENE and/CC the/DT POU-homeodomain/NEWGENE protein/NEWGENE GHF-1/NEWGENE1 //NEWGENE1 Pit-1/NEWGENE1 reconstitutes/VBZ pituitary-specific/NN gene/NN expression/NN ./.
@@88664851892 These/DT bacteria/NNS produce/NN and/CC export/NN proteins/NN capable/JJ of/IN specific/JJ interactions/NNS with/IN key/NN mammalian/JJ cell/NN regulatory/JJ molecules/NNS in/IN order/NN to/IN derail/VB the/DT normal/JJ functions/NNS of/IN the/DT cells/NNS ./.
@@709658711 Seventeen/CD of/IN the/DT 35/CD patients/NNS were/VBD randomly/RB chosen/VBP to/IN receive/VB a/DT training/NN program/NN (/( lasting/JJ approximately/RB 1/CD month/NN )/SYM designed/VBN to/IN establish/VB a/DT systematic/JJ strategy/NN of/IN organizing/JJ complex/NN visual/NN material/NN ./.
@@34760024174 Hair/NN and/CC blood/NN samples/NNS were/VBD taken/VBP before/IN vitamin/NN C/NN or/CC placebo/NN supplementation/NN was/VBD started/VBN and/CC at/IN monthly/JJ intervals/NNS thereafter/RB for/IN three/CD months/NNS ./.
@@7222987048 A/DT one-way/JJ analysis/NN of/IN variance/NN ,/, performed/VBD separately/RB for/IN men/NNS and/CC women/NNS for/IN differences/NNS among/IN the/DT three/CD phobic/JJ groups/NNS on/IN field/NN dependence/NN ,/, showed/VBD significance/NN (/( rho/NN less/PRP than/IN ./CD 05/CD )/SYM for/IN the/DT females/NNS ,/, with/IN the/DT famale/JJ agoraphobic/JJ being/NN more/JJ field/NN dependent/JJ than/IN the/DT female/JJ simple/JJ phobic/JJ groups/NNS ,/, but/CC not/RB for/IN the/DT males/NNS ./.
@@105019369347 Inactivation/NNS of/IN the/DT Neurospora/NEWGENE crassa/NEWGENE mitochondrial/NEWGENE outer/NEWGENE membrane/NEWGENE protein/NEWGENE TOM70/NEWGENE by/IN repeat-induced/JJ point/NN mutation/NN (/( RIP/NN )/SYM causes/NNS defects/NNS in/IN mitochondrial/JJ protein/NN import/NN and/CC morphology/NN ./.
@@11255252403 A/DT minimal/JJ ER3/NEWGENE sequence/NEWGENE of/IN DNA/NN was/VBD further/RB demonstrated/VBN to/RB function/NN as/IN a/DT FXR/NEWGENE HRE/NEWGENE and/CC was/VBD bound/JJ in/IN vitro/FW by/IN FXR-expressing/VBG yeast/NN extracts/NNS ./.
@@51459255398 Radiosensitive/NNP nature/NN of/IN paravascular/JJ infiltrate-producing/JJ potential/NN of/IN parental/JJ spleen/NN cells/NNS ./.
@@14382245075 205/CD ,/, 285-290/NN ]/NN and/CC was/VBD subsequently/RB cloned/VBN and/CC sequenced/VBN [/NN J/NN ./NN
@@111066672912 Thus/RB ,/, Pet111p/NEWGENE could/MD play/VB dual/JJ roles/NNS in/IN both/DT membrane/NN localization/NN and/CC regulation/NN of/IN Cox2p/NEWGENE synthesis/NN within/IN mitochondria/NNS ./.
@@89323852752 Small/NN Maf/NEWGENE proteins/NEWGENE interact/VBP with/IN the/DT human/NN transcription/NN factor/NN TCF11/NEWGENE //NEWGENE Nrf1/NEWGENE //NEWGENE LCR-F1/NEWGENE ./.
@@12067721853 A/DT study/NN of/IN chromosomes/NNS of/IN lymphocytes/NNS from/IN patients/NNS treated/VBN with/IN hycanthone/NN ./.
@@2775136841 These/DT results/NNS suggest/VBP that/IN HAPE-S-S/NN are/VBP prone/RB to/IN irregular/JJ nocturnal/JJ breathing/JJ patterns/NNS at/IN high/JJ altitude/NN ,/, which/WDT is/VBZ associated/VBN with/IN the/DT development/NN of/IN AMS/NNS ,/, but/CC it/PRP was/VBD not/RB possible/JJ to/IN determine/VB whether/IN these/DT abnormal/JJ breathing/JJ patterns/NNS are/VBP a/DT cause/NN or/CC an/DT effect/NN of/IN AMS/NNS ./.
@@86607338629 Reproducing/JJ populations/NNS of/IN this/DT aphid/NN were/VBD first/RB detected/VBN in/IN Puerto/NNP Rico/NNP in/IN April/NN 1992/CD ./.
@@1358880938 The/DT deduced/VBN amino/JJ acid/NN sequence/NN exhibited/VBN 98%/NN identity/NN to/IN the/DT human/JJ cellular/JJ transglutaminase/NEWGENE sequence/NN ./.
@@77062876114 However/RB ,/, the/DT inability/NN to/IN export/NN RNA/NN from/IN the/DT nucleus/NN to/IN the/DT cytoplasm/NN was/VBD not/RB limited/VBN to/IN a/DT particular/JJ phase/NN of/IN the/DT cell/NN division/NN cycle/NN ./.
@@75572764570 Alanine/NEWGENE aminotransferase/NEWGENE (/( ALT/NEWGENE )/SYM levels/NNS had/VBP been/VBN elevated/VBN for/IN six/CD months/NNS in/IN all/DT patients/NNS and/CC hepatitis/NNP B/NNP viral/JJ infection/NN was/VBD replicative/JJ ./.
@@95832081681 Marked/JJ elevation/NN of/IN creatine/NEWGENE kinase/NEWGENE was/VBD observed/VBN while/CC serum/JJ albumin/NEWGENE ,/, immunoglobulin/NEWGENE ,/, and/CC complement/NN were/VBD decreased/VBN ./.
@@72931007151 Gastrin/NEWGENE secretion/NN during/IN food/NN stimulation/NN in/IN digestive/JJ system/NN diseases/NNS ./.
@@19431842572 Endothelial/JJ cells/NNS stored/VBN with/IN University/NNP of/IN Wisconsin/NN solution/NN excluded/VBD trypan/JJ blue/RB better/JJR (/( 1/CD ./CD 0%/CD +/NN //NN -/NN 0/CD ./CD 5%/CD cells/NNS stained/VBN ,/, p/NN less/PRP than/IN 0/CD ./CD 001/CD ./.
@@83578342393 A/DT comparison/NN of/IN the/DT predicted/VBN amino/JJ acid/NN sequences/NNS of/IN the/DT two/JJ human/NEWGENE PKC-delta/NEWGENE clones/NNS with/IN the/DT rat/NN and/CC mouse/NN homologues/NNS indicated/VBD a/DT greater/JJR degree/NN of/IN sequence/NN divergence/NN (/( 89-90%/CD homology/NN )/SYM compared/VBN to/IN the/DT high/JJ degree/NN of/IN sequence/NN conservation/NN observed/VBN with/IN other/DT human/NEWGENE PKC/NEWGENE family/NEWGENE members/NEWGENE and/CC their/PRP mammalian/JJ counterparts/NNS ./.
@@55950365610 Students/NNS ,/, parents/NNS ,/, teachers/NNS and/CC hearing/JJ disorders/NNS ./.
@@8290278875 Therefore/RB ,/, Mxi1/NEWGENE and/CC Mad/NEWGENE might/MD antagonize/VB Myc/NEWGENE function/NN and/CC are/VBP candidate/NN tumor/NN suppressor/NN genes/NNS ./.
@@79109468379 Analysis/NNP of/IN a/DT set/NN of/IN deletion/NN constructs/NNS in/IN transient/JJ transfection/NN assays/NNS measuring/JJ heterologous/JJ reporter/NN gene/NN (/( luciferase/NEWGENE )/SYM activity/NN demonstrated/VBN that/IN the/DT 182-bp/JJ 5'-flanking/JJ region/NN provides/VBZ full/JJ promoter/NN activity/NN in/IN IL-2-stimulated/JJ L2/NN cells/NNS ./.
@@76125577522 When/WRB excluding/JJ children/NNS with/IN ocular/JJ and/CC cerebral/JJ pathology/NN ,/, 32/CD matched/JJ pairs/NNS of/IN premature/JJ and/CC control/NN children/NNS remained/VBN ./.
@@100074692785 Optically/RB detected/VBN librons/NNS and/CC phonons/NNS in/IN crystalline/NN C60/NN ./.
@@57272225673 The/DT effects/NNS of/IN loading/VBG the/DT respiratory/JJ pumps/NNS on/IN the/DT oxygen/NN consumption/NN of/IN Callionymus/NNP lyra/NN ./.
@@86494241212 Expression/NNS of/IN the/DT phenylalanine/NEWGENE hydroxylase/NEWGENE gene/NEWGENE in/IN livers/NNS and/CC kidneys/NNS of/IN rodents/NNS is/VBZ activated/VBN at/IN birth/NN and/CC is/VBZ induced/VBN by/IN glucocorticoids/NNS and/CC cyclic/JJ AMP/NN in/IN the/DT liver/NN ./.
@@109132765511 From/IN transient/JJ expression/NN studies/NNS ,/, we/PRP could/MD demonstrate/VB that/IN the/DT SH3/NEWGENE domain/NEWGENE of/IN PLC-gamma1/NEWGENE is/VBZ necessary/JJ for/IN the/DT association/NN with/IN SOS1/NEWGENE in/IN vivo/NN ./.
@@104908266768 EB-1/NEWGENE ,/, a/DT tyrosine/NEWGENE kinase/NEWGENE signal/NEWGENE transduction/NEWGENE gene/NEWGENE ,/, is/VBZ transcriptionally/RB activated/VBN in/IN the/DT t/NN (/NN 1/NN ;/: 19/NN )/NN subset/NN of/IN pre-B/NN ALL/NN ,/, which/WDT express/VBP oncoprotein/NEWGENE E2a-Pbx1/NEWGENE ./.
@@9920930251 C3/NEWGENE toxin/NEWGENE completely/RB inhibited/VBD RhoA/NEWGENE function/NN ,/, partially/RB inhibited/VBN SRE/NEWGENE :/: Luc/NEWGENE activity/NN ,/, but/CC had/VBP no/DT effect/NN on/IN LPA-stimulated/JJ c-Fos/NEWGENE expression/NN ./.
@@75650497226 It/PRP is/VBZ impossible/JJ to/IN define/VB only/RB one/PRP clinical/JJ outline/NN because/IN both/DT symptomatic/JJ and/CC asymptomatic/RB infected/VBN NB/NN may/MD be/VB found/VB with/IN gestational/JJ age/NN at/IN term/NN and/CC pre-term/NN and/CC when/CC born/JJ with/IN a/DT weight/NN above/RB or/CC below/RB 2000/CD g/CD ./CD
@@97432334718 Mutation/NN of/IN either/DT the/DT AP-1/NEWGENE or/CC the/DT ets/NEWGENE component/NN of/IN this/DT site/NN also/RB prevented/VBD promoter/NN activity/NN in/IN SMCs/NNS ./.
@@78286002872 Binding/NN of/IN SSP/NEWGENE to/IN the/DT stage/NEWGENE selector/NEWGENE element/NEWGENE (/( SSE/NEWGENE )/SYM in/IN the/DT proximal/JJ gamma-globin/NEWGENE promoter/NEWGENE is/VBZ integral/JJ to/IN the/DT competitive/JJ silencing/VBG of/IN a/DT linked/NN beta-promoter/NEWGENE in/IN embryonic/JJ //JJ fetal/JJ stage/NN erythroleukemia/NN (/( K562/NNP )/SYM cells/NNS ./.
@@80936167424 Novel/NN 8-base/JJ pair/NN sequence/NN (/( Drosophila/NEWGENE DNA/NEWGENE replication-related/NEWGENE element/NEWGENE )/SYM and/CC specific/JJ binding/JJ factor/NN involved/VBN in/IN the/DT expression/NN of/IN Drosophila/NN genes/NN for/IN DNA/NEWGENE polymerase/NEWGENE alpha/NEWGENE and/CC proliferating/NEWGENE cell/NEWGENE nuclear/NEWGENE antigen/NEWGENE ./.
@@17917543086 Mutational/JJ analysis/NN supports/VBP a/DT role/NN for/IN multiple/JJ structural/JJ features/NNS in/IN the/DT C-terminal/NN secretion/NN signal/NN of/IN Escherichia/NEWGENE coli/NEWGENE haemolysin/NEWGENE ./.
@@35158404197 Five/CD out/RB of/IN eight/CD consecutive/JJ cases/NNS with/IN initial/JJ symptoms/NNS of/IN a/DT 'midline/NN granuloma'/NN were/VBD identified/VBN as/IN malignant/JJ histiocytosis/NN (/( histiocytic/JJ sarcoma/NN )/SYM which/WDT within/IN 5/CD months/NNS to/IN 4/CD years/NNS led/VBN to/IN generalization/NN and/CC death/NN ./.
@@7851643777 Thus/RB ,/, these/DT studies/NNS indicate/VBP that/IN the/DT 104-kDa/NN isoform/NN is/VBZ required/VBN for/IN normal/JJ proliferation/NN of/IN female/JJ germline/NN cells/NNS and/CC perhaps/RB for/IN oocyte/NN differentiation/NN ./.
@@75650317455 Twenty/CD food/NN products/NNS were/VBD contaminated/VBN with/IN V/NNP ./NNP cholerae/NNS O1/NN ,/, Ogawa/NN ,/, toxigenic/JJ and/CC not/RB toxigenic/JJ strains/NNS :/: yoghurt/NN ,/, cream/VB cheese/NN ,/, apricot/NN marmelade/NN ,/, hip/NN rose/VBD marmelade/NN ,/, mayonnaise/NN ,/, italian/JJ pasta/NN for/IN "empanadas"/NN ,/, "dulce/NN de/FW leche"/NN ,/, meat/NN sausage/NN ,/, meat/NN and/CC spinach/NN ravioli/NN ,/, margarine/NN ,/, milk/NN dessert/NN (/( made/VBP with/IN cocoa/JJ ,/, milk/NN confiture/NN ,/, starch/NN and/CC additives/NNS )/SYM ,/, lettuce/NN ,/, tuna/NN fish/NN ,/, ricotta/NN and/CC sterilized/VBN milk/NN ./.
@@83827781718 A/DT region/NN of/IN the/DT deduced/VBN protein/NN shares/VBP extensive/JJ homology/NN with/IN a/DT catalytic/JJ region/NN of/IN Raf/NEWGENE kinases/NEWGENE ,/, a/DT feature/NN shared/VBN only/RB with/IN TFIIE/NEWGENE among/IN transcription/NN factors/NNS ./.
@@71077736913 Conjugated/JJ and/CC unconjugated/JJ phenylacetic/JJ acid/NN and/CC m-/NN and/CC p-hydroxyphenylacetic/JJ acid/NN have/NN been/VBN determined/VBN in/IN the/DT plasma/NN of/IN normal/JJ ,/, healthy/JJ subjects/NNS after/IN fasting/JJ ,/, consumption/NN of/IN a/DT meal/NN and/CC ingestion/NN of/IN deuterium/NN labelled/JJ amine/NN precursors/NNS ,/, by/IN high-resolution/JJ gas/NN chromatography--high/JJ resolution/NN mass/JJ spectrometry/NN with/IN selected/VBN ion/NN monitoring/NN of/IN their/PRP trifluoroethyl-pentafluoropropionyl/JJ derivatives/NNS ./.
@@103199556546 We/PRP calculated/VBD differences/NNS in/IN late/JJ occlusion/NN rates/NNS by/IN the/DT chi2/NN (/( chi-square/NN )/SYM test/NN ,/, and/CC found/VB these/DT differences/NNS were/VBD significant/JJ (/( P/CD =/CD ./CD 04/CD )/SYM ./.
@@33196467120 Plasma/NEWGENE renin/NEWGENE activity/NN does/VBP not/RB predict/VB the/DT antihypertensive/JJ efficacy/NN of/IN chlorthalidone/NN ./.
@@109209061506 CONCLUSION/IN :/: The/DT authors/NNS emphasize/VBP that/IN the/DT initial/JJ management/NN of/IN primary/NN STS/NN should/MD be/VB adequate/JJ and/CC suggest/VB that/IN safty/JJ margin/NN of/IN >/SYM or/CC =/SYM 2/CD cm/NN should/MD be/VB adhered/VBN to/CD ./CD
@@8472750940 Nitric/NNP oxide/NN inhalation/NN selectively/RB reduces/VBZ pulmonary/JJ hypertension/NN in/IN porcine/NN endotoxin/NEWGENE shock/NN and/CC improves/VBZ arterial/JJ oxygenation/NN and/CC pH/NN with/IN a/DT marked/JJ attenuation/NN of/IN sympathetic/JJ activation/NN ./.
@@95302519490 SNAC/NNP or/CC PBS/NNP was/VBD infused/VBN for/IN 6/CD ./CD 5/CD h/NN ,/, beginning/NN 30/CD min/NN before/IN ischemia/NN and/CC continuing/JJ throughout/IN the/DT duration/NN of/IN reperfusion/NN ./.
@@97511141990 Wild-type/NNP and/CC mutant/NN MyoD/NEWGENE were/VBD introduced/VBN into/IN cells/NNS using/VBG an/DT E1/NEWGENE ,/, E3-deleted/JJ adenoviral/JJ vector/NN ./.
@@72175231770 Results/NNS of/IN the/DT recognition/NN task/NN revealed/VBD significant/JJ effects/NNS of/IN consonant/JJ voicing/JJ ,/, position/NN and/CC vowel/NN context/NN on/IN syllable/NN recognition/NN ./.
@@13485045631 Thus/RB ,/, the/DT pol/NEWGENE alpha-primase/NEWGENE complex/NEWGENE appears/VBZ to/IN act/NN processively/RB for/IN only/RB a/DT short/JJ distance/NN ./.
@@4171664834 Pharmacokinetic/JJ profile/NN of/IN clonazepam/NN in/IN rhesus/NN monkeys/NNS ./.
@@110952483724 NH2-terminal/NN trimming/NN of/IN Xenopus/NN and/CC mammalian/NEWGENE FGF3s/NEWGENE may/MD therefore/RB be/VB a/DT prerequisite/NN of/IN optimal/JJ biological/JJ activity/NN ./.
@@101947627844 In/NN vitro/FW precipitation/NN with/IN a/DT glutathione-S-transferase-fusion/NEWGENE protein/NEWGENE containing/JJ the/DT C-terminal/NN transactivation/NN domain/NN of/IN STAT5a/NEWGENE showed/VBD GH-regulated/JJ association/NN of/IN ERK1/NEWGENE //NEWGENE 2/NEWGENE with/IN the/DT fusion/NN protein/NN ,/, while/CC this/DT was/VBD not/RB seen/VBP when/CC serine/NN 780/CD in/IN STAT5a/NEWGENE was/VBD changed/VBN to/IN alanine/NN ./.
@@96863449903 The/DT biochemical/JJ and/CC molecular/JJ spectrum/NN of/IN ornithine/NEWGENE transcarbamylase/NEWGENE deficiency/NN ./.
@@104642918435 IL-1beta/NEWGENE (/( 10/CD ng/NN //NN ml/NN )/SYM drastically/RB increased/VBN both/DT PDGFalphaR/NEWGENE and/CC CCAAT/NEWGENE //NEWGENE enhancer-binding/NEWGENE protein/NEWGENE delta/NEWGENE (/( C/NEWGENE //NEWGENE EBPdelta/NEWGENE )/SYM mRNA/NN levels/NNS in/IN a/DT time/NN dependent/JJ manner/NN ./.
@@115698001445 Temperature/NN measurement/NN in/IN microfluidic/JJ systems/NNS using/VBG a/DT temperature-dependent/JJ fluorescent/JJ dye/NN ./.
@@94215211291 Holliday/NEWGENE junction/NEWGENE resolvase/NEWGENE in/IN Schizosaccharomyces/NN pombe/NN has/VBZ identical/JJ endonuclease/NEWGENE activity/NN to/IN the/DT CCE1/NEWGENE homologue/NN YDC2/NEWGENE ./.
@@78239646637 The/DT negative/JJ regulatory/JJ activity/NN of/IN the/DT N-terminal/NN domain/NN was/VBD antagonized/VBN by/IN a/DT C-terminal/NN segment/NN of/IN Pho81p/NEWGENE supplied/VBN in/IN trans/JJ ./.
@@83926233994 IE2-IE2/NEWGENE interactions/NNS were/VBD mapped/VBN to/IN a/DT domain/NN containing/JJ a/DT putative/JJ helix-turn-helix/NEWGENE motif/NEWGENE located/VBN near/IN the/DT C/NN terminus/NN of/IN IE2/NEWGENE ,/, between/IN amino/JJ acids/NNS 456/CD and/CC 539/CD ./.
@@97270469018 Previously/RB ,/, we/PRP characterized/VBD a/DT DNA-binding/NN protein/NN ,/, HS2NF5/NEWGENE ,/, that/IN bound/JJ tightly/RB to/IN a/DT conserved/VBN region/NN within/IN hypersensitive/NEWGENE site/NEWGENE 2/NEWGENE (/( HS2/NEWGENE )/SYM of/IN the/DT human/NEWGENE beta-globin/NEWGENE locus/NEWGENE control/NEWGENE region/NEWGENE (/( LCR/NEWGENE )/SYM (/( Lam/NN ,/, L/NNP ./NNP
@@25980343248 Middle-latency/NNP auditory/RB evoked/VBD potentials/NNS (/( MAEPs/NNP )/SYM were/VBD recorded/VBN in/IN controls/NNS and/CC patients/NNS with/IN focal/JJ lesions/NNS in/IN dorsolateral/JJ prefrontal/JJ cortex/NN ./.
@@16338167496 From/IN the/DT 15-kb/JJ clone/NN a/DT 4-kb/NEWGENE EcoRI/NEWGENE fragment/NEWGENE containing/JJ the/DT first/JJ two/JJ exons/NNS and/CC 2/CD ./CD 6/CD kb/NN of/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT opn/NEWGENE gene/NEWGENE was/VBD sequenced/VBN ,/, and/CC the/DT transcriptional/JJ start/NN site/NN determined/VBN by/IN primer/NN extension/NN analysis/NN and/CC S1/NEWGENE nuclease/NEWGENE mapping/NN ./.
@@93964379353 With/IN a/DT BMI/NN cutoff/NN of/IN 27/CD ,/, mean/JJ cardiac/NN NE/NN spillover/NN was/VBD 46%/RB lower/JJR in/IN the/DT obese/JJ subjects/NNS when/CC compared/VBN with/IN the/DT lean/JJ subjects/NNS (/( P/NNP =/NNP ./NNP 017/NNP )/SYM ./.
@@103958276377 However/RB ,/, the/DT favored/VBN ,/, parallel/JJ beta/NN helix/NN model/NN is/VBZ a/DT compact/JJ coil/NN of/IN ten/CD helically/RB arranged/VBN beta/NN strands/NNS forming/JJ two/JJ parallel/JJ beta/NN sheet/NN faces/NNS ./.
@@10540015365 C-SP/NN duration/NN was/VBD significantly/RB reduced/VBN in/IN ALS/NN patients/NNS compared/VBN to/IN controls/NNS at/IN low/JJ stimulation/NN intensity/NN corresponding/JJ to/IN an/DT MEP/NN threshold/NN increased/VBN by/IN 15%/NN ./.
@@94276271957 Small-molecule/NNP control/NN of/IN insulin/NEWGENE and/CC PDGF/NEWGENE receptor/NEWGENE signaling/JJ and/CC the/DT role/NN of/IN membrane/NN attachment/NN ./.
@@104674033092 The/DT Trk/NEWGENE //NEWGENE Nerve/NEWGENE Growth/NEWGENE Factor/NEWGENE receptor/NEWGENE mediates/VBZ the/DT rapid/JJ activation/NN of/IN a/DT number/NN of/IN intracellular/JJ signaling/NN proteins/NN ,/, including/JJ phosphatidylinositol/NEWGENE 3-kinase/NEWGENE (/( PI/NEWGENE 3-kinase/NEWGENE )/SYM ./.
@@80694278051 Roux-en-Y/JJ gastroenterostomy/NN severely/RB disturbs/VBZ emptying/NN of/IN the/DT gallbladder/NN ./.
@@9219116779 Levels/NNS of/IN both/DT PGF/NN and/CC PGFM/NN were/VBD significantly/RB higher/JJ during/IN early/JJ spontaneous/JJ labour/NN ,/, at/IN a/DT cervical/JJ dilatation/NN of/IN less/PRP than/IN 4/CD cm/NN ,/, than/IN before/IN the/DT onset/NN of/IN labour/NN ./.
@@116023536474 These/DT included/VBN HNF-3/NEWGENE beta/NEWGENE ,/, HFH-1/NEWGENE ,/, HFH-2/NEWGENE ,/, HFH-3/NEWGENE ,/, C/NEWGENE //NEWGENE EBP/NEWGENE ,/, and/CC C/NEWGENE //NEWGENE EBP/NEWGENE beta/NEWGENE ,/, all/DT of/IN which/WDT are/VBP consistent/JJ with/IN the/DT tissue-specific/JJ expression/NN profiles/NNS of/IN the/DT gene/NN ./.
@@76631388346 After/IN nadolol/NN ,/, heart/NN rate/NN decreased/VBN (/( -22/CD +/NN //NN -/NN 8%/JJ )/SYM ,/, and/CC so/RB did/VBD PBV/NNS and/CC PBF/NN (/( 8/CD ./CD 8/CD +/NN //NN -/NN 3/CD ./CD 4/CD vs/IN ./IN
@@78461637697 The/DT mRNAs/NNS of/IN the/DT GRF/NEWGENE genes/NEWGENE are/VBP encoded/VBN by/IN six/CD exons/NNS interrupted/VBN by/IN five/CD introns/NNS ./.
@@39308946165 Changes/NNS in/IN muscarinic/NEWGENE acetylcholine/NEWGENE receptors/NEWGENE in/IN guinea-pig/NN lung/NN :/: effects/NNS of/IN aging/NN ,/, inhalation/NN of/IN an/DT allergen/NN ,/, administration/NN of/IN drugs/NNS ,/, and/CC vagotomy/NN ./.
@@24430283105 No/DT reflow/NN occurred/VBN in/IN approximately/RB 30/CD percent/NN of/IN the/DT muscle/NN microvasculature/NN upon/IN reperfusion/NN ./.
@@108654221204 All/DT were/VBD tested/VBN for/IN serum/JJ ferritin/NEWGENE (/( SF/NN )/SYM ,/, hemoglobin/NEWGENE (/( Hb/NEWGENE )/SYM level/NN and/CC asked/VBN for/IN detailed/JJ histories/NNS of/IN donations/NNS and/CC iron/NN supplementation/NN ./.
@@84457928406 Type/NN II/NN could/MD be/VB divided/VBN further/RB into/IN two/JJ forms/NNS (/( IIA/NN and/CC IIB/NN )/SYM that/WDT may/MD represent/VB two/JJ underscribed/JJ species/NN or/CC developmental/JJ stages/NNS of/IN the/DT same/JJ species/NN ./.
@@114036631267 Net/JJ lift/NN and/CC combined/JJ drag/NN from/IN all/DT 8/CD bearings/NNS of/IN the/DT 4-bladed/JJ impeller/NN are/VBP compared/VBN with/IN predictions/NNS based/VBN on/IN 2-D/JJ theory/NN ./.
@@70754386847 Transvenous/JJ serial/JJ xeroradiography/NN ./.
@@26746718620 Of/IN the/DT single-stranded/JJ DNA/NN transformants/NNS ,/, 65%/RB resulted/VBN from/IN replacement/NN of/IN the/DT resident/JJ met2/NEWGENE mutation/NEWGENE by/IN the/DT exogenous/JJ wild-type/NN allele/NN ./.
@@10694189611 The/DT effect/NN of/IN MIB/NN on/IN the/DT dose-response/NN curve/NN of/IN externally/RB applied/VBN noradrenaline/NN was/VBD also/RB studied/VBN ./.
@@87139338697 Laboratory/NNP evaluation/NN was/VBD normal/JJ ,/, and/CC neuroimaging/NN failed/VBN to/IN confirm/VB obstruction/NN of/IN venous/JJ or/CC lymphatic/JJ drainage/NN ./.
@@102090316739 The/DT Fyn/NEWGENE NH2/NEWGENE terminus/NEWGENE was/VBD necessary/JJ but/CC not/RB sufficient/JJ for/IN interaction/NN with/IN zeta/NEWGENE and/CC both/DT Fyn/NEWGENE kinase/NEWGENE and/CC SH2/NEWGENE domains/NEWGENE were/VBD required/VBN ,/, directing/VBG phosphorylation/NN of/IN zeta/NEWGENE ITAM/NEWGENE tyrosines/NNS and/CC binding/JJ to/IN zeta/NEWGENE ITAM/NEWGENE phosphotyrosines/NNS ./.
@@2831556591 These/DT offspring/NN of/IN the/DT alpha-MSH/NEWGENE treated/VBN mothers/NNS were/VBD less/PRP sensitive/JJ to/IN pain/NN and/CC as/IN adults/NNS showed/VBD a/DT reduced/VBN analgesic/JJ response/NN to/IN morphine/NN ./.
@@75593553346 Although/IN eight/CD contiguous/JJ genes/NNS necessary/JJ for/IN urease/NEWGENE activity/NN have/NN been/VBN cloned/VBN and/CC sequenced/VBN ,/, the/DT transcriptional/JJ organization/NN and/CC regulation/NN of/IN specific/JJ genes/NNS within/IN the/DT Proteus/NEWGENE gene/NEWGENE cluster/NEWGENE has/VBZ not/RB been/VBN investigated/VBN in/IN detail/NN ./.
@@110383175041 The/DT small/NEWGENE monomeric/NEWGENE GTP-binding/NEWGENE proteins/NEWGENE of/IN the/DT RAB/NEWGENE subfamily/NEWGENE are/VBP key/NN regulatory/JJ elements/NNS of/IN the/DT machinery/NN that/IN controls/NNS membrane/NN traffic/NN in/IN eukaryotic/JJ cells/NNS ./.
@@77425508944 The/DT cases/NNS included/VBN 35/CD de/FW novo/FW diffuse/JJ aggressive/JJ lymphomas/NNS (/( DAL/NN ;/: 19/CD large-cell/JJ ,/, 4/CD mixed-cell/JJ ,/, and/CC 12/CD large-cell/JJ immunoblastic/JJ )/SYM ,/, 52/CD transformed/VBN aggressive/JJ lymphomas/NNS derived/VBN from/IN follicular/JJ lymphomas/NNS (/( TFL/NN )/SYM ,/, 42/CD indolent/JJ follicular/JJ lymphomas/NNS (/( FL/NN )/SYM ,/, 14/CD mantle/NN cell/NN lymphomas/NNS (/( MCL/NN )/SYM ,/, and/CC 27/CD small/JJ noncleaved/JJ cell/NN lymphomas/NNS (/( SNCL/NN )/SYM ./.
@@80958728070 Furthermore/RB ,/, this/DT study/NN demonstrates/VBZ that/WDT reduced/VBD inotropy/NN with/IN timolol/NN helped/VBD uniform/JJ local/JJ contraction/NN as/IN estimated/VBN by/IN the/DT increased/JJ LONG/NNP //NNP CIRC/NNP ratio/NN ,/, a/DT transition/NN that/WDT could/MD improve/VB contraction/NN efficacy/NN ./.
@@37474934416 Splenectomized/JJ patients/NNS are/VBP predisposed/VBN toward/IN developing/JJ overwhelming/JJ bacterial/JJ infections/NNS ./.
@@100255062753 In/JJ humans/NNS ,/, three/CD tissue-specific/NEWGENE plastin/NEWGENE isoforms/NEWGENE have/VBP been/VBN identified/VBN ./.
@@33778643710 Static/NN magnetic/JJ fields/NNS affect/VBP the/DT diffusion/NN of/IN biological/JJ particles/NNS in/IN solutions/NNS through/RB the/DT Lorentz/NNP force/NN and/CC Maxwell/NNP stress/NN ./.
@@111815642589 In/NN the/DT mouse/NN ,/, both/DT genes/NNS reside/VBP in/IN the/DT syntenic/NEWGENE region/NEWGENE 8E1/NEWGENE on/IN chromosome/NN 8/CD ./CD
@@105185613938 Although/IN upstream/NN regulators/NN of/IN Tec/NEWGENE family/NEWGENE kinases/NEWGENE are/VBP relatively/JJ well/NN characterized/VBN ,/, little/NN is/NNS known/VBP of/IN the/DT downstream/JJ effectors/NNS of/IN these/DT enzymes/NNS ./.
@@118167791002 The/DT drug/NN packets/NNS contained/VBD acetyl/NN aspirin/NN ,/, acetaminophen/NN and/CC chloramphenicol/NN ./.
@@83439616586 Anterior/NNP body/NN pattern/NN in/IN Drosophila/NN is/VBZ specified/VBN by/IN the/DT graded/JJ distribution/NN of/IN the/DT bicoid/NEWGENE protein/NEWGENE (/( bcd/NEWGENE )/SYM ,/, which/WDT activates/VBZ subordinate/JJ genes/NNS in/IN distinct/JJ anterior/JJ domains/NNS ./.
@@80142283031 Sample/NN treatment/NN was/VBD optimized/VBN in/IN order/NN to/IN achieve/VB a/DT complete/JJ extraction/NN of/IN labetalol/NN diastereoisomers/NN and/CC to/IN avoid/VB racemization/NN during/IN extraction/NN ./.
@@90049878968 Serotonin/NNS concentration/NN in/IN the/DT blood/NN of/IN patients/NNS with/IN hemorrhagic/JJ fever/NN with/IN renal/JJ syndrome/NN ./.
@@27083534196 Primer/NNS extension/NN experiments/NNS indicated/VBN that/IN the/DT transcription/NN initiation/NN site/NN mapped/VBN to/IN a/DT position/NN on/IN gene/NEWGENE IV/NEWGENE that/WDT was/VBD analogous/JJ to/IN that/DT reported/VBD for/IN the/DT structurally/RB similar/JJ P-450e/NEWGENE gene/NEWGENE ./.
@@117869451637 Actuarial/JJ freedom/NN from/IN ventricular/JJ arrhythmias/NNS at/IN 4-year/JJ follow-up/NN was/VBD 74/CD ./CD 1/CD +/NN //NN -/NN 6/CD ./CD 0%/CD in/IN group/NN A/DT vs/NN ./NN
@@2619814632 Similarly/RB ,/, maternal/NEWGENE serum/NEWGENE somatomedin/NEWGENE A/NEWGENE was/VBD significantly/RB reduced/VBN in/IN rats/NNS nursing/JJ large/JJ litters/NNS ./.
@@9345037857 Recently/RB ,/, roles/NNS also/RB have/VBP been/VBN suggested/VBN for/IN the/DT nuclear/NN trans-factor/NN GATA-1/NEWGENE in/IN regulating/JJ progenitor/NN cell/NN proliferation/NN ./.
@@105632128222 They/PRP self-completed/VBD the/DT SF-36/NN questionnaire/NN and/CC their/PRP QoL/NN was/VBD described/VBN and/CC retrospectively/RB compared/VBN to/IN that/DT of/IN historical/JJ controls/NNS ./.
@@97947959975 Ligand/NN binding/JJ to/IN the/DT receptor/NN complex/NN leads/VBP to/IN tyrosine/NN phosphorylation/NN and/CC activation/NN of/IN Janus/NEWGENE kinases/NEWGENE (/( Jak/NEWGENE )/SYM ,/, phosphorylation/NN of/IN the/DT signal/NEWGENE transducing/NEWGENE subunit/NEWGENE gp130/NEWGENE ,/, followed/VBN by/IN recruitment/NN and/CC phosphorylation/NN of/IN the/DT signal/NEWGENE transducer/NEWGENE and/NEWGENE activator/NEWGENE of/NEWGENE transcription/NEWGENE factors/NEWGENE STAT3/NEWGENE1 and/CC STAT1/NEWGENE and/CC the/DT src/NEWGENE homology/NEWGENE domain/NEWGENE (/( SH2/NEWGENE )/NN -containing/NN protein/NEWGENE tyrosine/NEWGENE phosphatase/NEWGENE (/( SHP2/NEWGENE )/SYM ./.
@@19929531928 Alanine/NEWGENE aminotransferase/NEWGENE in/IN clinical/JJ practice/NN ./.
@@93702763288 An/DT open/JJ reading/JJ frame/NN of/IN 2862/CD bp/NN encoding/VBG a/DT 954/CD amino/JJ acid/NN protein/NN was/VBD identified/VBN ./.
@@90508494002 In/NN this/DT regard/NN ,/, it/PRP differs/VBZ from/IN a/DT recently/RB reported/VBN BFA-sensitive/NNP ARF-GEP/NEWGENE that/WDT contains/VBZ a/DT Sec7/NEWGENE domain/NEWGENE ./.
@@83931434440 The/DT Sp1/NEWGENE region/NEWGENE ,/, however/RB ,/, is/VBZ converted/VBN to/IN a/DT functionally/RB strong/JJ TRE/NN by/IN the/DT viral/NEWGENE tat/NEWGENE factor/NEWGENE ./.
@@19045469118 Disruption/NNS of/IN the/DT chromosomal/NEWGENE AAR1/NEWGENE gene/NEWGENE in/IN alpha/NN and/CC a/NN //NN alpha/NN cells/NNS conferred/VBD the/DT nonmating/JJ phenotype/NN ,/, and/CC the/DT a/NN //NN alpha/NN diploids/NNS could/MD not/RB sporulate/VB ./.
@@76656337590 All/DT clinical/JJ isolates/NNS were/VBD concomitantly/RB tested/VBN by/IN disk/NN diffusion/NN and/CC agar/NN dilution/NN procedures/NNS as/IN outlined/VBN by/IN the/DT National/NNP Committee/NNP for/IN Clinical/NNP Laboratory/NNP Standards/NNPS ./.
@@90846219036 Movement/NNP time/NN and/CC kinematic/JJ characteristics/NNS were/VBD analyzed/VBN together/RB with/IN the/DT magnitude/NN of/IN cerebral/JJ blood/NN flow/NN to/IN identify/VB areas/NNS of/IN brain/NN activity/NN proportionate/JJ to/IN task/NN and/CC movement/NN variables/NNS ./.
@@15479572606 Using/VBG a/DT degenerate/JJ oligodeoxyribonucleotide/NN (/( oligo/NN )/SYM based/VBN on/IN the/DT N-terminal/NN aa/NNS sequence/NN ,/, plus/IN an/DT internal/JJ oligo/NN homologous/JJ to/IN a/DT conserved/VBN region/NN within/IN the/DT portion/NN of/IN CYP1/NEWGENE and/CC CYP2/NEWGENE that/WDT had/VBP been/VBN deleted/VBN in/IN the/DT genome/NN ,/, a/DT CYP3-specific/NEWGENE DNA/NEWGENE fragment/NEWGENE was/VBD generated/VBN by/IN the/DT polymerase/NEWGENE chain/NN reaction/NN (/( PCR/NN )/SYM using/VBG GL81/NN genomic/JJ DNA/NN as/IN a/DT substrate/NN ./.
@@21589276457 We/PRP have/VBP determined/VBN the/DT nucleotide/NN (/( nt/NN )/SYM sequence/NN of/IN the/DT 7/NEWGENE ./NEWGENE 5-kb/NEWGENE COR/NEWGENE segment/NEWGENE that/WDT encompasses/VBZ a/DT cluster/NN of/IN six/CD genes/NNS (/( CYC1/NEWGENE ,/, UTR1/NEWGENE ,/, UTR3/NEWGENE ,/, OSM1/NEWGENE ,/, tRNA/NEWGENE (/NEWGENE Gly/NEWGENE )/NEWGENE and/CC RAD7/NEWGENE )/NN located/VBD on/IN chromosome/NN X/NN of/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN ./.
@@14185423013 The/DT effect/NN of/IN sodium/NN 18/NN beta-glycyrrhetate/JJ (/( SGA/JJ )/SYM on/IN experimental/JJ arrhythmia/NN was/VBD investigated/VBN ./.
@@16551262256 Extraction/NNS procedure/NN for/IN the/DT measurement/NN of/IN butyltin/NN compounds/NNS in/IN biological/JJ tissues/NNS using/VBG toluene/NN ,/, HBr/NNP ,/, and/CC tropolone/NN ./.
@@32642993961 In/NN untreated/JJ mice/NNS ,/, bactericidal/JJ activity/NN of/IN peritoneal/JJ macrophages/NNS decreased/VBN from/IN one/PRP day/NN to/IN 3/CD days/NNS after/IN ip/NN injection/NN of/IN killed/VBN L/NNP ./NNP monocytogenes/NNS ./.
@@113981345343 In/NN conclusion/NN ,/, obesity/NN ,/, alcohol/NN intake/NN ,/, and/CC multimetabolic/JJ disorders/NNS were/VBD determined/VBN to/IN be/VB independent/NN predictors/NN for/IN the/DT development/NN of/IN hyperuricemia/NN ./.
@@86316854789 The/DT structural/JJ gene/NN for/IN copper-/NEWGENE and/NEWGENE topa/NEWGENE quinone-containing/NEWGENE monoamine/NEWGENE oxidase/NEWGENE (/( maoA/NEWGENE )/SYM and/CC an/DT unknown/JJ amine/NEWGENE oxidase/NEWGENE gene/NEWGENE have/NN been/VBN located/VBN at/IN 30/CD ./CD 9/CD min/NN on/IN the/DT Escherichia/NN coli/JJ chromosome/NN ./.
@@115925328431 METHODS/IN :/: Humphrey/NNP Field/NNP Analyzer/NNP model/NN 630/CD (/( HFA/NN I/NN ,/, program/NN 30-2/CD with/IN a/DT rectangular/JJ 6/CD degrees/NNS x/NN 6/CD degrees/NNS grid/NN )/SYM was/VBD used/VBN as/IN the/DT conventional/JJ perimetric/JJ method/NN ./.
@@47182335117 Methyl/NN mercury/NN intoxication/NN in/IN rat/NN kidneys/NNS ./.
@@117925861658 Cyclic/NNP loading/NN of/IN bone/NN during/IN normal/JJ daily/JJ activity/NN leads/VBP to/IN the/DT formation/NN of/IN microcracks/NNS within/IN the/DT tissue/NN matrix/NN of/IN compact/JJ bone/NN ./.
@@16782877875 Because/IN the/DT human/NEWGENE Antp/NEWGENE TATAA/NEWGENE1 binding/NEWGENE1 protein/NEWGENE1 is/VBZ expressed/VBN in/IN both/DT lymphoid/JJ and/CC non-lymphoid/JJ cells/NNS ,/, we/PRP suggest/VBP that/IN this/DT homeobox/NEWGENE gene/NEWGENE has/VBZ evolved/VBN a/DT more/RB general/JJ transcriptional/JJ regulatory/JJ function/NN in/IN higher/JJ eukaryotic/JJ cells/NNS ./.
@@16420606765 The/DT clinical/JJ application/NN of/IN the/DT antibody-targeted/JJ Phthalocyanine/NN was/VBD performed/VBN in/IN 3/CD patients/NNS suffering/VBG from/IN an/DT advanced/JJ ovarian/JJ carcinoma/NN (/( FIGO/NN III/NN )/SYM ./.
@@86555558121 The/DT DNA/NN sequence/NN immediately/RB upstream/RB from/IN the/DT -/: 10/CD hexamer/NN contained/VBD the/DT TGn/NEWGENE motif/NEWGENE described/VBN as/IN an/DT extended/VBN -10/CD region/NN in/IN prokaryotic/JJ promoters/NNS ./.
@@82825016989 Because/IN of/IN the/DT small/JJ number/NN of/IN visceral/JJ angiography/NN procedures/NNS performed/VBN (/( 38/CD )/SYM ,/, no/DT definitive/JJ conclusions/NNS could/MD be/VB drawn/VBP as/IN to/IN the/DT differences/NNS between/IN ionic/JJ and/CC nonionic/JJ agents/NNS regarding/IN grade-2/NN and/CC grade-3/NN adverse/JJ events/NNS ./.
@@77581676655 Growth/NN curves/NNS indicated/VBD that/DT proliferation/NN of/IN clone/NN CA9/NN in/IN the/DT presence/NN of/IN 10%/CD serum/NN was/VBD reduced/VBN by/IN 60%/CD compared/VBN with/IN clone/NN ME10/NN ./.
@@30183566 Takayasu's/NNP disease/NN :/: association/NN with/IN HLA-B5/NEWGENE ./.
@@9548199500 These/DT data/NN suggest/VB that/IN spontaneous/JJ recovery/NN of/IN central/JJ respiratory/JJ function/NN after/IN intoxication/NN with/IN Soman/VB or/CC Sarin/NNP may/MD not/RB be/VB related/VBN to/IN the/DT return/NN of/IN AChE/NEWGENE activity/NN ./.
@@21238771406 Additionally/RB ,/, although/IN c-fos/NEWGENE and/CC egr-1/NEWGENE mRNAs/NEWGENE are/VBP expressed/VBN at/IN elevated/VBN levels/NNS in/IN stimulated/VBN liver/NN cells/NNS ,/, fos-B/NEWGENE ,/, fra-1/NEWGENE ,/, and/CC egr-2/NEWGENE are/VBP not/RB ,/, which/WDT suggests/VBZ that/IN factors/NNS in/IN addition/NN to/IN the/DT serum/NEWGENE response/NEWGENE factor/NEWGENE participate/VB in/IN the/DT regulation/NN of/IN immediate-early/NEWGENE gene/NEWGENE induction/NN ./.
@@14481079506 We/PRP describe/VBP here/RB 17/CD dominant/NEWGENE GCN2/NEWGENE mutations/NEWGENE that/WDT lead/VBP to/IN derepression/NN of/IN GCN4/NEWGENE expression/NN in/IN the/DT absence/NN of/IN amino/JJ acid/NN starvation/NN ./.
@@11239184893 Baseline/NN variables/NNS associated/VBN with/IN CD/NN included/VBD a/DT less/PRP frequent/VB use/NN of/IN prestroke/NN aspirin/NN and/CC a/DT higher/JJ incidence/NN of/IN early/NN CT/NN changes/NNS of/IN edema/NN or/CC mass/JJ effect/NN or/CC dense/JJ middle/JJ cerebral/JJ artery/NN sign/NN ./.
@@4564245033 The/DT effects/NNS of/IN intracisternal/JJ injection/NN (/( i/CD ./CD c/CD ./CD i/CD ./CD )/SYM of/IN clonidine/NN (/( 1/CD microgram/NN kg-1/NN )/SYM on/IN blood/NN pressure/NN and/CC heart/NN rate/NN were/VBD studied/VBN in/IN conscious/JJ rabbits/NNS with/IN an/DT implanted/VBN catheter/NN in/IN the/DT cisterna/NN magna/NN ./.
@@34176682830 These/DT findings/NNS indicate/VBP that/DT autophosphorylation/NN of/IN Thr286/NN (/( alpha/NN subunit/NN )/SYM and/CC Thr287/NN (/( beta/NN subunit/NN )/SYM is/VBZ responsible/JJ for/IN transition/NN of/IN CaM-kinase/NEWGENE II/NEWGENE to/IN the/DT Ca2+-independent/JJ form/NN ./.
@@77457269297 For/IN replication/NN reporter/NN constructs/NNS where/CC E1/NEWGENE and/CC E2/NEWGENE are/VBP supplied/VBN in/IN trans/JJ by/IN the/DT respective/JJ expression/NN vectors/NNS ,/, distance/NN between/IN the/DT half/NN sites/NNS seems/VBZ to/IN play/NN a/DT major/JJ role/NN ,/, yet/RB the/DT phasing/JJ relationships/NNS are/VBP measurable/JJ ./.
@@67841233257 Transcripts/NNS of/IN the/DT immunoglobulin/NEWGENE C/NEWGENE mu/NEWGENE gene/NEWGENE vary/VB in/IN structure/NN and/CC splicing/JJ during/IN lymphoid/JJ development/NN ./.
@@80944649031 Within/IN the/DT span/NN of/IN attenuator/NN region/NN encoding/VBG the/DT three/CD stem-loop/NN structures/NNS of/IN mRNA/NN secondary/JJ configuration/NN ,/, hot/JJ spots/NNS of/IN base-residue/JJ divergence/NN were/VBD localized/VBN to/IN looped-out/JJ regions/NNS ./.
@@71351127621 Repair/NNS of/IN a/DT cosmetic/JJ defect/NN of/IN the/DT lower/JJR leg/NN with/IN a/DT myocutaneous/JJ free/JJ flap/NN ./.
@@3198525810 In/NN a/DT 112-d/JJ feedlot/NN trial/NN ,/, 105/CD heifers/NNS were/VBD assigned/VBN to/IN light/NN ,/, medium/NN and/CC heavy/JJ weight/NN blocks/NNS on/IN five/CD treatments/NNS :/: dietary/JJ MGA/NN (/( ./NN 5/NN mg/NN ./NN hd-1/NN ./NN d-1/NN )/SYM ,/, control/NN (/( no/DT MGA/NN )/SYM or/CC DEPO-MGA/NNP on/IN d/NN 1/NN at/IN ./CD 5/CD ,/, 1/CD ./CD 0/CD or/CC 1/CD ./CD 5/CD ml/NN //NN hd/NN (/( 30/CD ,/, 60/CD or/CC 90/CD mg/NN MGA/NNP //NNP hd/NNP ,/, respectively/RB )/SYM ./.
@@6650536381 Escherichia/NN of/IN a/DT single/JJ sero-anzymatic/JJ type/NN (/( 06a6b/CD :/: K13/NNP :/: H1/NN )/SYM were/VBD isolated/VBN in/IN a/DT group/NN affection/NN ./.
@@77469377702 Lung/NNP function/NN tests/NNS (/( EFR/NN )/SYM were/VBD performed/VBN on/IN these/DT patients/NNS for/IN a/DT period/NN of/IN 19/CD ./CD 2/CD +/NN //NN -/NN 3/CD ./CD 4/CD months/NNS ./.
@@111800271737 Respiratory/NNP parameters/NNS suggested/VBN that/IN M6G/NN produced/VBN less/PRP respiratory/JJ depression/NN than/IN morphine/NN ./.
@@106733352089 Copyright/NNP 2000/CD Academic/NNP Press/NNP ./.
@@10722509547 Eight/CD patients/NNS received/VBN 1/CD ./CD 5/CD mg/NN of/IN adefovir/NN dipivoxil/NN per/IN kg/NN of/IN body/NN weight/NN ,/, and/CC six/CD patients/NNS received/VBN 3/CD ./CD 0/CD mg/NN of/IN adefovir/NN dipivoxil/NN per/IN kg/CD ./CD
@@25954515772 A/DT fine-structure/NN deletion/NN map/NN of/IN human/NN chromosome/NN 11p/NN :/: analysis/NN of/IN J1/NN series/NN hybrids/NNS ./.
@@89133872837 Rifabutin/NN has/VBZ substantial/JJ efficacy/NN when/CC combined/JJ with/IN other/DT agents/NNS ./.
@@86172163007 However/RB ,/, only/RB complete/NEWGENE DnaJ/NEWGENE can/MD cooperate/VB with/IN DnaK/NEWGENE and/CC a/DT third/JJ protein/NN ,/, GrpE/NEWGENE ,/, in/IN refolding/JJ denatured/NEWGENE firefly/NEWGENE luciferase/NEWGENE ./.
@@23300413410 Expression/NNS ,/, cellular/JJ localization/NN and/CC in/IN vitro/FW transcription/NN studies/NNS establish/VBP that/IN cloned/NEWGENE hUBF/NEWGENE encodes/VBZ a/DT nucleolar/JJ factor/NN that/WDT binds/VBZ specifically/RB to/IN the/DT upstream/JJ control/NN element/NN and/CC core/NN of/IN the/DT rRNA/NEWGENE gene/NEWGENE promoter/NEWGENE to/IN activate/VB transcription/NN in/IN a/DT binding/JJ site-dependent/JJ manner/NN ./.
@@109957519803 We/PRP have/VBP recently/RB discovered/VBN that/IN CCAAAT/NEWGENE //NEWGENE Enhancer/NEWGENE binding/NEWGENE protein-beta/NEWGENE (/( C/NEWGENE //NEWGENE EBP-b/NEWGENE )/SYM induces/VBZ gene/NN transcription/NN through/RB a/DT novel/JJ IFN-response/NEWGENE element/NEWGENE called/VBN ,/, gamma-IFN/NEWGENE activated/NEWGENE transcriptional/NEWGENE element/NEWGENE (/( GATE/NEWGENE )/SYM ./.
@@21062872710 Spore/NN inocula/NNS (/( approximately/RB 10/NN (/NN 6/NN )/NN //NN coupon/NN )/NN were/VBD dried/JJ onto/IN 0/CD ./CD 5-in/CD ./.
@@78266253198 Basal/JJ components/NNS of/IN the/DT transcription/NN apparatus/NN (/( RNA/NEWGENE polymerase/NEWGENE II/NEWGENE ,/, TATA-binding/NEWGENE protein/NEWGENE )/SYM contain/VB activation/NN domains/NN :/: is/VBZ the/DT repetitive/JJ C-terminal/NN domain/NN (/( CTD/NN )/SYM of/IN RNA/NEWGENE polymerase/NEWGENE II/NEWGENE a/DT "portable/JJ enhancer/NN domain"/NN ?/. Regions/NNS rich/JJ in/IN serine/NN ,/, threonine/NN ,/, and/CC proline/NN residues/NNS can/MD be/VB found/VB in/IN transcriptional/NN activation/NN domains/NN ,/, as/RB well/VB as/IN in/IN the/DT N-terminal/NN parts/NNS of/IN mammalian/NEWGENE TATA-binding/NEWGENE proteins/NEWGENE ,/, where/CC they/PRP are/VBP interrupted/VBN by/IN polyglutamine/NN stretches/NNS ./.
@@79491377926 The/DT pretransplant/JJ regimen/NN consisted/VB of/IN cyclophosphamide/NN (/( 120/CD mg/CD //CD kg/CD )/SYM and/CC total/JJ body/NN irradiation/NN ./.
